PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Stevens, GA; Finucane, MM; Paciorek, CJ; Flaxman, SR; White, RA; Donner, AJ; Ezzati, M				Stevens, Gretchen A.; Finucane, Mariel M.; Paciorek, Christopher J.; Flaxman, Seth R.; White, Richard A.; Donner, Abigail J.; Ezzati, Majid		Nutr Impact Model Study Grp Child	Trends in mild, moderate, and severe stunting and underweight, and progress towards MDG 1 in 141 developing countries: a systematic analysis of population representative data	LANCET			English	Article							CHILD UNDERNUTRITION; MALNUTRITION; GROWTH; HEALTH; MORTALITY; INTERVENTIONS; IMPACT; CASH	Background There is little information on country trends in the complete distributions of children's anthropometric status, which are needed to assess all levels of mild to severe undernutrition. We aimed to estimate trends in the distributions of children's anthropometric status and assess progress towards the Millennium Development Goal 1 (MDG 1) target of halving the prevalence of weight-for-age Z score (WAZ) below -2 between 1990 and 2015 or reaching a prevalence of 2.3% or lower. Methods We collated population-representative data on height-for-age Z score (HAZ) and WAZ calculated with the 2006 WHO child growth standards. Our data sources were health and nutrition surveys, summary statistics from the WHO Global Database on Child Growth and Malnutrition, and summary statistics from reports of other national and international agencies. We used a Bayesian hierarchical mixture model to estimate Z-score distributions. We quantified the uncertainty of our estimates, assessed their validity, compared their performance to alternative models, and assessed sensitivity to key modelling choices. Findings In developing countries, mean HAZ improved from -1.86 (95% uncertainty interval -2.01 to -1.72) in 1985 to -1.16 (-1.29 to -1.04) in 2011; mean WAZ improved from -1.31 (-1.41 to -1.20) to -0.84 (-0.93 to -0.74). Over this period, prevalences of moderate-and-severe stunting declined from 47.2% (44.0 to 50.3) to 29.9% (27.1 to 32.9) and underweight from 30.1% (26.7 to 33.3) to 19.4% (16.5 to 22.2). The largest absolute improvements were in Asia and the largest relative reductions in prevalence in southern and tropical Latin America. Anthropometric status worsened in sub-Saharan Africa until the late 1990s and improved thereafter. In 2011, 314 (296 to 331) million children younger than 5 years were mildly, moderately, or severely stunted and 258 (240 to 274) million were mildly, moderately, or severely underweight. Developing countries as a whole have less than a 5% chance of meeting the MDG 1 target; but 61 of these 141 countries have a 50-100% chance. Interpretation Macroeconomic shocks, structural adjustment, and trade policy reforms in the 1980s and 1990s might have been responsible for worsening child nutritional status in sub-Saharan Africa. Further progress in the improvement of children's growth and nutrition needs equitable economic growth and investment in pro-poor food and primary care programmes, especially relevant in the context of the global economic crisis.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Ctr Environm & Hlth,MRC HPA, London W2 1PG, England; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Finucane, Mariel M.; Donner, Abigail J.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [White, Richard A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Flaxman, Seth R.] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA; [Flaxman, Seth R.] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA	Imperial College London; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; Carnegie Mellon University; Carnegie Mellon University	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Ctr Environm & Hlth,MRC HPA, Med Fac Bldg,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Castetbon, Katia/F-2686-2017	White, Richard Aubrey/0000-0002-6747-1726; Monterrubio, Eric/0000-0003-1417-9243	Bill & Melinda Gates Foundation; UK Medical Research Council; Medical Research Council [G0801056B, MR/K005901/1] Funding Source: researchfish; MRC [MR/K005901/1] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Bill & Melinda Gates Foundation and the UK Medical Research Council.	ANAND S, 1993, J ECON PERSPECT, V7, P133, DOI 10.1257/jep.7.1.133; [Anonymous], 2008, INT TRADE CLIMATE CH; [Anonymous], 2011, MILL DEV GOALS REP; [Anonymous], [No title captured]; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de Onis M, 2000, B WORLD HEALTH ORGAN, V78, P1222; de Onis M, 2004, JAMA-J AM MED ASSOC, V291, P2600, DOI 10.1001/jama.291.21.2600; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; Dunson D.B., 2010, BAYESIAN NONPARAMETR, P223; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fruhwirth-Schnatter, 2006, FINITE MIXTURE MARKO, V425; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Haddad L, 2003, WORLD BANK ECON REV, V17, P107, DOI 10.1093/wber/lhg012; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/S0034-89102009000100005; Myerson R, 2011, GLOBAL HLTH METRICS; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Pongou R, 2006, INT J EPIDEMIOL, V35, P648, DOI 10.1093/ije/dyl016; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; RAVALLION M, 1990, ECON DEV CULT CHANGE, V38, P489, DOI 10.1086/451812; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; Rodriguez A, 2009, BIOSTATISTICS, V10, P155, DOI 10.1093/biostatistics/kxn024; Sanchez PA, 2005, LANCET, V365, P442, DOI 10.1016/S0140-6736(05)17834-9; Scrimshaw Nevin S., 1997, American Journal of Clinical Nutrition, V66, p464S; Smith LC, 2002, ECON DEV CULT CHANGE, V51, P55, DOI 10.1086/345313; Subramanyam MA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000424; Sundberg S, 2009, CAB REV PERSPECTIVES, V4, P92; Svedberg P, 2006, INT J EPIDEMIOL, V35, P1336, DOI 10.1093/ije/dyl157; Tentoni S, 2004, BJOG-INT J OBSTET GY, V111, P31, DOI 10.1046/j.1471-0528.2003.00006.x; UNICEF, 2020, STRAT IMPR NUTR CHIL; United Nations Statistics Division, 2004, IND MON MILL DEV GOA; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Von Braun J., 2008, ACCELERATING PROGR R; World Health Organization. Multicentre growth reference study group, 2006, WHO CHILD GROWTH STA	40	224	232	0	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2012	380	9844					824	834		10.1016/S0140-6736(12)60647-3	http://dx.doi.org/10.1016/S0140-6736(12)60647-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000OP	22770478	Green Published			2022-12-01	WOS:000308396300031
J	Tsai, PT; Hull, C; Chu, YX; Greene-Colozzi, E; Sadowski, AR; Leech, JM; Steinberg, J; Crawley, JN; Regehr, WG; Sahin, M				Tsai, Peter T.; Hull, Court; Chu, YunXiang; Greene-Colozzi, Emily; Sadowski, Abbey R.; Leech, Jarrett M.; Steinberg, Jason; Crawley, Jacqueline N.; Regehr, Wade G.; Sahin, Mustafa			Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice	NATURE			English	Article							TUBEROUS SCLEROSIS COMPLEX; MOUSE MODEL; ULTRASONIC VOCALIZATIONS; BRAIN; CHILDREN; MTORC1	Autism spectrum disorders (ASDs) are highly prevalent neurodevelopmental disorders(1), but the underlying pathogenesis remains poorly understood. Recent studies have implicated the cerebellum in these disorders, with post-mortem studies in ASD patients showing cerebellar Purkinje cell (PC) loss(2,3), and isolated cerebellar injury has been associated with a higher incidence of ASDs(4). However, the extent of cerebellar contribution to the pathogenesis of ASDs remains unclear. Tuberous sclerosis complex (TSC) is a genetic disorder with high rates of comorbid ASDs(5) that result from mutation of either TSC1 or TSC2, whose protein products dimerize and negatively regulate mammalian target of rapamycin (mTOR) signalling. TSC is an intriguing model to investigate the cerebellar contribution to the underlying pathogenesis of ASDs, as recent studies in TSC patients demonstrate cerebellar pathology(6) and correlate cerebellar pathology with increased ASD symptomatology(7,8). Functional imaging also shows that TSC patients with ASDs display hypermetabolism in deep cerebellar structures, compared to TSC patients without ASDs(9). However, the roles of Tsc1 and the sequelae of Tsc1 dysfunction in the cerebellum have not been investigated so far. Here we show that both heterozygous and homozygous loss of Tsc1 in mouse cerebellar PCs results in autistic-like behaviours, including abnormal social interaction, repetitive behaviour and vocalizations, in addition to decreased PC excitability. Treatment of mutant mice with the mTOR inhibitor, rapamycin, prevented the pathological and behavioural deficits. These findings demonstrate new roles for Tsc1 in PC function and define a molecular basis for a cerebellar contribution to cognitive disorders such as autism.	[Tsai, Peter T.; Greene-Colozzi, Emily; Sadowski, Abbey R.; Leech, Jarrett M.; Steinberg, Jason; Sahin, Mustafa] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA; [Hull, Court; Chu, YunXiang; Regehr, Wade G.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Crawley, Jacqueline N.] NIMH, Lab Behav Neurosci, Intramural Res Program, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Sahin, M (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA.	peter.tsai@childrens.harvard.edu; mustafa.sahin@childrens.harvard.edu	SAHIN, MUSTAFA/I-8653-2019	SAHIN, MUSTAFA/0000-0001-7044-2953; Hull, Court/0000-0002-0360-8367; tsai, peter/0000-0002-0729-9688	Developmental Neurology Training grant [T32 NS007473]; American Academy of Neurology; Nancy Lurie Marks Family Foundation; National Institutes of Health (NIH) [R01 NS58956]; John Merck Scholars Fund; Autism Speaks; Boston Children's Hospital Translational Research Program; Manton Center for Orphan Disease Research; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center [P30 HD18655]; Intramural Research Program, National Institute of Mental Health; NIH [R01NS032405]; Simons Foundation [SFARI 232304]; Howard Hughes Medical Institute Medical Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020017, ZIAMH002179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405, K12NS079414, R01NS058956, T32NS007473] Funding Source: NIH RePORTER	Developmental Neurology Training grant; American Academy of Neurology; Nancy Lurie Marks Family Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Merck Scholars Fund; Autism Speaks; Boston Children's Hospital Translational Research Program; Manton Center for Orphan Disease Research; Boston Children's Hospital Intellectual and Developmental Disabilities Research Center; Intramural Research Program, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Corfas, M. Fagiolini, P. Rosenberg, S. Goldman and the Neurodevelopmental Behavioral Core of Boston Children's Hospital for assistance with behavioural experiments. We are grateful to C. Walsh, L. Benowitz and members of the Sahin laboratory for critical reading of the manuscript, and to M. Gregas for advice regarding statistical analysis. P. T. T. received support from the Developmental Neurology Training grant (T32 NS007473), American Academy of Neurology, and the Nancy Lurie Marks Family Foundation. This work and M. S. are supported in part by the National Institutes of Health (NIH; grant R01 NS58956), the John Merck Scholars Fund, Autism Speaks, the Nancy Lurie Marks Family Foundation, Boston Children's Hospital Translational Research Program, Manton Center for Orphan Disease Research and Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (grant P30 HD18655). J.N.C. is supported by the Intramural Research Program, National Institute of Mental Health. W. G. R. is supported by the NIH (grant R01NS032405) and the Simons Foundation (grant SFARI 232304). Y.X.C. is supported by the Howard Hughes Medical Institute Medical Research Fellowship.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Asano E, 2001, NEUROLOGY, V57, P1269, DOI 10.1212/WNL.57.7.1269; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Bednar I, 2002, MOL CELL NEUROSCI, V20, P354, DOI 10.1006/mcne.2002.1112; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Eluvathingal TJ, 2006, J CHILD NEUROL, V21, P846, DOI 10.1177/08830738060210100301; Ertan G, 2010, J NEURORADIOLOGY, V37, P231, DOI 10.1016/j.neurad.2009.12.006; Holmes A, 2001, BEHAV NEUROSCI, V115, P1129, DOI 10.1037//0735-7044.115.5.1129; Hull C, 2012, NEURON, V73, P149, DOI 10.1016/j.neuron.2011.10.030; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Jeste SS, 2008, J CHILD NEUROL, V23, P520, DOI 10.1177/0883073807309788; Kurejova M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-18; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Muller RA, 2007, MENT RETARD DEV D R, V13, P85, DOI 10.1002/mrdd.20141; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Reith RM, 2011, NEUROBIOL DIS, V43, P113, DOI 10.1016/j.nbd.2011.02.014; Rice Catherine, 2009, Morbidity and Mortality Weekly Report, V58, P1; Ryu YH, 1999, EUR J NUCL MED, V26, P253, DOI 10.1007/s002590050385; Sajdel-Sulkowska EM, 2009, CEREBELLUM, V8, P366, DOI 10.1007/s12311-009-0105-9; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Steinlin M, 2008, CEREBELLUM, V7, P607, DOI 10.1007/s12311-008-0083-3; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tsai P, 2011, CURR OPIN NEUROL, V24, P106, DOI 10.1097/WCO.0b013e32834451c4; Weber AM, 2000, J AUTISM DEV DISORD, V30, P511, DOI 10.1023/A:1005679108529; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	38	535	547	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					647	+		10.1038/nature11310	http://dx.doi.org/10.1038/nature11310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22763451	Green Submitted, Green Accepted			2022-12-01	WOS:000308095100054
J	Ayaz, P; Ye, XC; Huddleston, P; Brautigam, CA; Rice, LM				Ayaz, Pelin; Ye, Xuecheng; Huddleston, Patrick; Brautigam, Chad A.; Rice, Luke M.			A TOG:alpha beta-tubulin Complex Structure Reveals Conformation-Based Mechanisms for a Microtubule Polymerase	SCIENCE			English	Article							CRYSTAL-STRUCTURE; GAMMA-TUBULIN; PLUS-END; BINDING; XMAP215; YEAST; STU2P; DYNAMICS; MUTANTS; PROTEIN	Stu2p/XMAP215/Dis1 family proteins are evolutionarily conserved regulatory factors that use alpha beta-tubulin-interacting tumor overexpressed gene (TOG) domains to catalyze fast microtubule growth. Catalysis requires that these polymerases discriminate between unpolymerized and polymerized forms of alpha beta-tubulin, but the mechanism by which they do so has remained unclear. Here, we report the structure of the TOG1 domain from Stu2p bound to yeast alpha beta-tubulin. TOG1 binds alpha beta-tubulin in a way that excludes equivalent binding of a second TOG domain. Furthermore, TOG1 preferentially binds a curved conformation of alpha beta-tubulin that cannot be incorporated into microtubules, contacting alpha- and beta-tubulin surfaces that do not participate in microtubule assembly. Conformation-selective interactions with alpha beta-tubulin explain how TOG-containing polymerases discriminate between unpolymerized and polymerized forms of alpha beta-tubulin and how they selectively recognize the growing end of the microtubule.	[Rice, Luke M.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rice, LM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	luke.rice@utsouthwestern.edu		Rice, Luke/0000-0001-6551-3307; Brautigam, Chad/0000-0001-6563-1338	U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Robert A. Welch Foundation [I-1692]; NIH [GM-098543]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098543] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Robert A. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Borek for assistance with diffraction data processing; D. Tomchick in the Univ. of Texas Southwestern Structural Biology Core Facility for advice and assistance; M. Rosen, Y. Jiang, and M. Moritz for sharing equipment/reagents; and S. Padrick for help with fluorescence anisotropy. H. Yu, X. Zhang, and M. Rosen gave critical comments on the manuscript. L.M.R. is the Thomas O. Hicks Scholar in Medical Research. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, beamline 19-ID. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work was supported by grants I-1692 (from the Robert A. Welch Foundation) and GM-098543 (from the NIH). Coordinates have been deposited in the Protein Data Bank with accession code 4FFB.	Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Johnson V, 2011, BIOCHEMISTRY-US, V50, P8636, DOI 10.1021/bi2005174; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108	16	152	153	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					857	860		10.1126/science.1221698	http://dx.doi.org/10.1126/science.1221698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904013	Green Accepted			2022-12-01	WOS:000307535600047
J	Francia, S; Michelini, F; Saxena, A; Tang, D; de Hoon, M; Anelli, V; Mione, M; Carninci, P; di Fagagna, FD				Francia, Sofia; Michelini, Flavia; Saxena, Alka; Tang, Dave; de Hoon, Michiel; Anelli, Viviana; Mione, Marina; Carninci, Piero; di Fagagna, Fabrizio d'Adda			Site-specific DICER and DROSHA RNA products control the DNA-damage response	NATURE			English	Article							DOUBLE-STRAND BREAKS; NONCODING RNAS; CELLULAR SENESCENCE; CHROMATIN; PROTEINS; HETEROCHROMATIN; BIOGENESIS; REVEALS; DISEASE; COMPLEX	Non-coding RNAs (ncRNAs) are involved in an increasingly recognized number of cellular events(1). Some ncRNAs are processed by DICER and DROSHA RNases to give rise to small double-stranded RNAs involved in RNA interference (RNAi)(2). The DNA-damage response (DDR) is a signalling pathway that originates from a DNA lesion and arrests cell proliferation(3). So far, DICER and DROSHA RNA products have not been reported to control DDR activation. Here we show, in human, mouse and zebrafish, that DICER and DROSHA, but not downstream elements of the RNAi pathway, are necessary to activate the DDR upon exogenous DNA damage and oncogene-induced genotoxic stress, as studied by DDR foci formation and by checkpoint assays. DDR foci are sensitive to RNase A treatment, and DICER-and DROSHA-dependent RNA products are required to restore DDR foci in RNase-A-treated cells. Through RNA deep sequencing and the study of DDR activation at a single inducible DNA double-strand break, we demonstrate that DDR foci formation requires site-specific DICER- and DROSHA-dependent small RNAs, named DDRNAs, which act in a MRE11-RAD50-NBS1-complex-dependent manner (MRE11 also known as MRE11A; NBS1 also known as NBN). DDRNAs, either chemically synthesized or in vitro generated by DICER cleavage, are sufficient to restore the DDR in RNase-A-treated cells, also in the absence of other cellular RNAs. Our results describe an unanticipated direct role of a novel class of ncRNAs in the control of DDR activation at sites of DNA damage.	[Francia, Sofia; Michelini, Flavia; Anelli, Viviana; Mione, Marina; di Fagagna, Fabrizio d'Adda] IFOM Fdn FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; [Francia, Sofia] Ist Italiano Tecnol, IIT SEMM, Center Genom Sci, I-20139 Milan, Italy; [Saxena, Alka; Tang, Dave; de Hoon, Michiel; Carninci, Piero] RIKEN Yokohama Inst, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [di Fagagna, Fabrizio d'Adda] CNR, Ist Genet Mol, I-27100 Pavia, Italy	IFOM - FIRC Institute of Molecular Oncology; Istituto Italiano di Tecnologia - IIT; RIKEN; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	di Fagagna, FD (corresponding author), IFOM Fdn FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	fabrizio.dadda@ifom-ieo-campus.it	Carninci, Piero/K-1568-2014; d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Tang, Dave/G-9670-2014; Mione, Maria Caterina/ABG-9926-2021; de Hoon, Michiel/A-6443-2013; Mione, Maria Caterina/I-3073-2013; Hoon, Dave SB/C-7146-2018	Carninci, Piero/0000-0001-7202-7243; d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Tang, Dave/0000-0002-4790-9014; Hoon, Dave SB/0000-0003-1915-3683; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; de Hoon, Michiel/0000-0003-0489-2352; Francia, Sofia/0000-0002-4578-9442; Mione, Maria Caterina/0000-0002-9040-3705; Michelini, Flavia/0000-0002-3727-4887; ANELLI, Viviana Vittoria/0000-0003-1964-3252	Fondazione Italiana Ricerca Sul Cancro (FIRC); Associazione Italiana Ricerca sul Cancro (AIRC) European Community's 7th Framework Programme [202230]; Telethon [GGP08183]; 7th Framework of the European Union commission, Funding Program for the Next Generation World-Leading Researchers (NEXT Program) [20241047]; MEXT; Center for Genomic Science of IIT@SEMM (Scuola Europea di Medicina Molecolare); AIRC; Cariplo [2007-5500]; JSPS [P09745]; European Union 7th Framework Programme [FP7-People-ITN-2008-238055]	Fondazione Italiana Ricerca Sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca sul Cancro (AIRC) European Community's 7th Framework Programme(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); 7th Framework of the European Union commission, Funding Program for the Next Generation World-Leading Researchers (NEXT Program); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Genomic Science of IIT@SEMM (Scuola Europea di Medicina Molecolare); AIRC(Fondazione AIRC per la ricerca sul cancro); Cariplo(Fondazione Cariplo); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Union 7th Framework Programme	We thank E. Soutoglou, W. C. Hahn, M. Kastan, V. Orlando, R. Shiekhattar, J. Amatruda, T. Halazonetis, E. Dejana, P. Ng and F. Nicassio for sharing reagents, M. Fumagalli and F. Rossiello for reading the manuscript, M. Dobreva, V. Matti and F. Pezzimenti for technical support, G. D'Ario for help with statistical analyses, B. Amati, M. Foiani, V. Costanzo and F.d.A.d.F. group members for help and discussions. The F.d.A.d.F. laboratory was supported by Fondazione Italiana Ricerca Sul Cancro (FIRC), Associazione Italiana Ricerca sul Cancro (AIRC) European Community's 7th Framework Programme (FP7/2007-2013) under grant agreement no. 202230, acronym "GENINCA", HFSP, AICR, the EMBO Young Investigator Program. The initial part of this project was supported by Telethon grant no. GGP08183. P. C. was supported by 7th Framework of the European Union commission to the Dopaminet consortium, a Grant-in-Aids for Scientific Research (A) no. 20241047, Funding Program for the Next Generation World-Leading Researchers (NEXT Program) to P. C. and a Research Grant to RIKEN Omics Science Center from MEXT. S. F. is supported by Center for Genomic Science of IIT@SEMM (Scuola Europea di Medicina Molecolare) and AIRC. M. M. was supported by Cariplo (grant no. 2007-5500) and AIRC. A. S. is supported by a JSPS fellowship P09745 and grant in aid by JSPS, and D. T. is supported by the European Union 7th Framework Programme under grant agreement FP7-People-ITN-2008-238055 ("BrainTrain" project) to P.C.	Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kawano M, 2010, BIOTECHNIQUES, V49, P751, DOI 10.2144/000113516; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Tritschler F, 2010, NAT REV MOL CELL BIO, V11, P379, DOI 10.1038/nrm2885; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	30	369	378	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					231	+		10.1038/nature11179	http://dx.doi.org/10.1038/nature11179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22722852	Green Accepted			2022-12-01	WOS:000307267000038
J	Buxton, OM; Ellenbogen, JM; Wang, W; Carballeira, A; O'Connor, S; Cooper, D; Gordhandas, AJ; McKinney, SM; Solet, JM				Buxton, Orfeu M.; Ellenbogen, Jeffrey M.; Wang, Wei; Carballeira, Andy; O'Connor, Shawn; Cooper, Dan; Gordhandas, Ankit J.; McKinney, Scott M.; Solet, Jo M.			Sleep Disruption due to Hospital Noises A Prospective Evaluation	ANNALS OF INTERNAL MEDICINE			English	Article							NEONATAL INTENSIVE-CARE; AIRCRAFT NOISE; AROUSAL; QUALITY; DEPRIVATION; AGE; IDENTIFICATION; ENVIRONMENT; ACTIVATION; DURATION	Background: Sleep plays a critical role in maintaining health and well-being; however, patients who are hospitalized are frequently exposed to noise that can disrupt sleep. Efforts to attenuate hospital noise have been limited by incomplete information on the interaction between sounds and sleep physiology. Objective: To determine profiles of acoustic disruption of sleep by examining the cortical (encephalographic) arousal responses during sleep to typical hospital noises by sound level and type and sleep stage. Design: 3-day polysomnographic study. Setting: Sound-attenuated sleep laboratory. Participants: Volunteer sample of 12 healthy participants. Intervention: Baseline (sham) night followed by 2 intervention nights with controlled presentation of 14 sounds that are common in hospitals (for example, voice, intravenous alarm, phone, ice machine, outside traffic, and helicopter). The sounds were administered at calibrated, increasing decibel levels (40 to 70 dBA [decibels, adjusted for the range of normal hearing]) during specific sleep stages. Measurements: Encephalographic arousals, by using established criteria, during rapid eye movement (REM) sleep and non-REM (NREM) sleep stages 2 and 3. Results: Sound presentations yielded arousal response curves that varied because of sound level and type and sleep stage. Electronic sounds were more arousing than other sounds, including human voices, and there were large differences in responses by sound type. As expected, sounds in NREM stage 3 were less likely to cause arousals than sounds in NREM stage 2; unexpectedly, the probability of arousal to sounds presented in REM sleep varied less by sound type than when presented in NREM sleep and caused a greater and more sustained elevation of instantaneous heart rate. Limitations: The study included only 12 participants. Results for these healthy persons may underestimate the effects of noise on sleep in patients who are hospitalized. Conclusion: Sounds during sleep influence both cortical brain activity and cardiovascular function. This study systematically quantifies the disruptive capacity of a range of hospital sounds on sleep, providing evidence that is essential to improving the acoustic environments of new and existing health care facilities to enable the highest quality of care.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Brigham & Womens Hosp, Boston, MA USA; Berklee Coll Mus, Boston, MA USA; Cambridge Hlth Alliance, Cambridge, England; Cavanaugh Tocci Assoc, Sudbury, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital	Buxton, OM (corresponding author), 221 Longwood Ave,BLI438-K, Boston, MA 02115 USA.	orfeu_buxton@hms.harvard.edu		Buxton, Orfeu/0000-0001-5057-633X	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design	This study was funded by investigator-initiated grants (Dr. Solet) from the Academy of Architecture for Health, the Facilities Guidelines Institute, and The Center for Health Design. Sleep laboratory work was completed through the generosity of Massachusetts General Hospital and with acoustic consultation by Cavanaugh Tocci Associates.	Altevogt BM., 2006, SLEEP DISORDERS SLEE; Ancoli-Israel S, 2005, J AM GERIATR SOC, V53, pS264, DOI 10.1111/j.1532-5415.2005.53392.x; [Anonymous], GUID DES CONSTR HLTH; Bartick Melissa C, 2010, J Hosp Med, V5, pE20, DOI 10.1002/jhm.549; Basner M, 2008, SLEEP MED, V9, P382, DOI 10.1016/j.sleep.2007.07.002; Basner M, 2007, SLEEP, V30, P1349, DOI 10.1093/sleep/30.10.1349; Basner M, 2006, J ACOUST SOC AM, V119, P2772, DOI 10.1121/1.2184247; Basner M, 2010, NOISE HEALTH, V12, P95, DOI 10.4103/1463-1741.63210; Berg S, 2001, SLEEP, V24, P289, DOI 10.1093/sleep/24.3.289; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P133; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P271; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Bruck D, 2009, J SLEEP RES, V18, P196, DOI 10.1111/j.1365-2869.2008.00710.x; Busch-Vishniac IJ, 2005, J ACOUST SOC AM, V118, P3629, DOI 10.1121/1.2118327; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Carpenter Dave, 2010, Health Facil Manage, V23, P11; Catcheside PG, 2002, SLEEP, V25, P797, DOI 10.1093/sleep/25.7.797; Cmiel CA, 2004, AM J NURS, V104, P40, DOI 10.1097/00000446-200402000-00019; Cohen S, 2009, ARCH INTERN MED, V169, P62, DOI 10.1001/archinternmed.2008.505; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; DEGENNARO L, 1995, ELECTROEN CLIN NEURO, V95, P252, DOI 10.1016/0013-4694(95)00090-L; Dijk DJ, 2001, SLEEP, V24, P565, DOI 10.1093/sleep/24.5.565; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Elmenhorst EM, 2010, INT ARCH OCC ENV HEA, V83, P743, DOI 10.1007/s00420-010-0515-5; Griefahn B, 2008, SLEEP, V31, P569, DOI 10.1093/sleep/31.4.569; Hagerman I, 2005, INT J CARDIOL, V98, P267, DOI 10.1016/j.ijcard.2003.11.006; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Iber C., 2007, RULES TERMINOL TECH, V176, P2012; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Johnson AN, 2003, J PERINAT NEONAT NUR, V17, P280, DOI 10.1097/00005237-200310000-00006; Kahn DM, 1998, CHEST, V114, P535, DOI 10.1378/chest.114.2.535; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Mayers AG, 2005, HUM PSYCHOPHARM CLIN, V20, P533, DOI 10.1002/hup.726; McNeer Richard R, 2007, J Clin Monit Comput, V21, P353, DOI 10.1007/s10877-007-9096-6; Montague KN, 2009, AM J NURS, V109, P65, DOI 10.1097/01.NAJ.0000360316.54373.0d; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Ryherd EE, 2008, J ACOUST SOC AM, V123, P747, DOI 10.1121/1.2822661; Schweitzer PK, 2010, PRINCIPLES PRACTICE, P542; Sforza E, 2000, CLIN NEUROPHYSIOL, V111, P1611, DOI 10.1016/S1388-2457(00)00363-1; Sforza E, 2004, CLIN NEUROPHYSIOL, V115, P2442, DOI 10.1016/j.clinph.2004.06.002; Siegel JM, 2010, PRINCIPLES PRACTICE, P92; Solet JM, 2012, PROG PEDIATR CARDIOL, V33, P85, DOI 10.1016/j.ppedcard.2011.12.014; SOUTHWELL MT, 1995, J ADV NURS, V21, P1101, DOI 10.1046/j.1365-2648.1995.21061101.x; Topf M, 1996, J ADV NURS, V24, P545, DOI 10.1046/j.1365-2648.1996.22315.x; Topf M, 2001, HEART LUNG, V30, P237, DOI 10.1067/mhl.2001.116592; Weinhouse GL, 2009, CRIT CARE, V13, DOI 10.1186/cc8131; Williams AL, 2007, J ACOUST SOC AM, V121, P2681, DOI 10.1121/1.2717500; Witmans M, 2005, J CLIN SLEEP MED, V1, pE488; World Health Organization Regional Office for Europe, 2010, NIGHT NOIS GUID EUR; YINNON AM, 1992, BRIT J CLIN PRACT, V46, P88	54	94	95	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					170	+		10.7326/0003-4819-156-12-201208070-00472	http://dx.doi.org/10.7326/0003-4819-156-12-201208070-00472			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992PB	22868834				2022-12-01	WOS:000307789900004
J	Tsugawa, Y; Mukamal, KJ; Davis, RB; Taylor, WC; Wee, CC				Tsugawa, Yusuke; Mukamal, Kenneth J.; Davis, Roger B.; Taylor, William C.; Wee, Christina C.			Should the Hemoglobin A(1c) Diagnostic Cutoff Differ Between Blacks and Whites? A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							HBA(1C) LEVELS; MICROVASCULAR COMPLICATIONS; DIABETIC-RETINOPATHY; ETHNIC-DIFFERENCES; GLUCOSE-TOLERANCE; PLASMA-GLUCOSE; A1C; ADULTS; ASSOCIATION; CHILDREN	Background: Hemoglobin A(1c) (HbA(1c)) levels are known to be consistently higher in black persons than in white persons at any given glycemic level. Whether the optimal diagnostic threshold of HbA1c should differ between blacks and whites is unclear. Objective: To compare the relationships between HbA(1c) level and the prevalence of retinopathy in black and white U. S. adults. Design: Cross-sectional study. Setting: A nationally representative sample of the National Health and Nutrition Examination Survey from 2005 through 2008. Patients: 2804 white persons and 1008 black persons aged 40 years or older in the United States. Measurements: Prevalence of retinopathy. Logistic regression models and restricted cubic spline models were constructed separately for white and black populations to test the HbA(1c) levels at which risk for retinopathy begins to increase. Results: After adjustment for age, sex, hypertension, body mass index, family history of diabetes, and use of antidiabetes medications or insulin, the lowest HbA(1c) category for which the prevalence of retinopathy was significantly higher than the reference category (<5.5%) was 6.0% to 6.4% for white persons (risk difference, 4.8% [95% CI, 0.5% to 9.1%]) and 5.5% to 5.9% for black persons (risk difference, 5.3% [CI, 1.0% to 9.5%]). The restricted cubic spline models indicated that the risk for retinopathy increased at lower HbA(1c) levels in black persons than in white persons. Limitation: The cross-sectional design of the study precluded examining the effect of the duration at each HbA(1c) level. Conclusion: The prevalence of retinopathy begins to increase at a lower HbA(1c) level in black Americans than in white Americans. The findings do not support increasing the diagnostic threshold of HbA(1c) in black persons.	[Tsugawa, Yusuke; Mukamal, Kenneth J.; Davis, Roger B.; Taylor, William C.; Wee, Christina C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Tsugawa, Y (corresponding author), Harvard Univ, Sch Med, Div Gen Med & Primary Care, Beth Israel Deaconess Med Ctr, 1309 Beacon St, Brookline, MA 02446 USA.	ytsugawa@bidmc.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Tsugawa, Yusuke/0000-0002-1937-4833	Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; Joint Japan/World Bank Graduate Scholarship Program; St. Luke's Life Science Institute, Tokyo, Japan; Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; National Institutes of Health [K24DK087932]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK087932] Funding Source: NIH RePORTER	Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; Joint Japan/World Bank Graduate Scholarship Program; St. Luke's Life Science Institute, Tokyo, Japan; Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Tsugawa is supported by the Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; the Joint Japan/World Bank Graduate Scholarship Program; and St. Luke's Life Science Institute, Tokyo, Japan. Dr. Davis is supported by Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health Award UL1 RR 025758), and financial contributions from Harvard University and its affiliated academic health care centers. Dr. Wee is supported by a midcareer mentorship award from the National Institutes of Health (K24DK087932).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2012, DAT 2011 NAT DIAB FA; [Anonymous], 1991, Ophthalmology, V98, P786; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Centers for Disease Control and Prevention, 2012, NAT HLTH NUTR EX SUR; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Davidson MB, 2010, DIABETES RES CLIN PR, V87, P415, DOI 10.1016/j.diabres.2009.12.013; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648; Gavin JR, 1997, DIABETES CARE, V20, P1183; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2010, ANN INTERN MED, V152, P815, DOI 10.7326/0003-4819-152-12-201006150-00011; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Kamps JL, 2010, DIABETES CARE, V33, P1025, DOI 10.2337/dc09-1440; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Korn E, 1999, ANAL HLTH SURVEYS; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; McCance DR, 1997, DIABETOLOGIA, V40, P247, DOI 10.1007/s001250050671; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Olabi B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4354; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Porta M, 2001, DIABETOLOGIA, V44, P2203, DOI 10.1007/s001250100030; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; SHAMOON H, 1995, ARCH OPHTHALMOL-CHIC, V113, P36; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wisdom K, 1997, DIABETES CARE, V20, P971, DOI 10.2337/diacare.20.6.971; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	40	60	61	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					153	+		10.7326/0003-4819-157-3-201208070-00004	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868832	Green Accepted			2022-12-01	WOS:000307789900002
J	Lundberg, DS; Lebeis, SL; Paredes, SH; Yourstone, S; Gehring, J; Malfatti, S; Tremblay, J; Engelbrektson, A; Kunin, V; del Rio, TG; Edgar, RC; Eickhorst, T; Ley, RE; Hugenholtz, P; Tringe, SG; Dangl, JL				Lundberg, Derek S.; Lebeis, Sarah L.; Paredes, Sur Herrera; Yourstone, Scott; Gehring, Jase; Malfatti, Stephanie; Tremblay, Julien; Engelbrektson, Anna; Kunin, Victor; del Rio, Tijana Glavina; Edgar, Robert C.; Eickhorst, Thilo; Ley, Ruth E.; Hugenholtz, Philip; Tringe, Susannah Green; Dangl, Jeffery L.			Defining the core Arabidopsis thaliana root microbiome	NATURE			English	Article							BACTERIAL ENDOPHYTES; RHIZOSPHERE; TRAITS; PLANTS	Land plants associate with a root microbiota distinct from the complex microbial community present in surrounding soil. The microbiota colonizing the rhizosphere (immediately surroundingthe root) and the endophytic compartment (within the root) contribute to plant growth, productivity, carbon sequestration and phytoremediation(1-3). Colonization of the root occurs despite a sophisticated plant immune system(4,5), suggesting finely tuned discrimination of mutualists and commensals from pathogens. Genetic principles governing the derivation of host-specific endophyte communities from soil communities are poorly understood. Here we report the pyrosequencing of the bacterial 16S ribosomal RNA gene of more than 600 Arabidopsis thaliana plants to test the hypotheses that the root rhizosphere and endophytic compartmentmicrobiota of plants grown under controlled conditions in natural soils are sufficiently dependent on the host to remain consistent across different soil types and developmental stages, and sufficiently dependent on host genotype to vary between inbred Arabidopsis accessions. We describe different bacterial communities in two geochemically distinct bulk soils and in rhizosphere and endophytic compartments prepared from roots grown in these soils. The communities in each compartment are strongly influenced by soil type. Endophytic compartments fromboth soils feature overlapping, low-complexity communities that are markedly enriched in Actinobacteria and specific families from other phyla, notably Proteobacteria. Some bacteria vary quantitatively between plants of different developmental stage and genotype. Our rigorous definition of an endophytic compartment microbiome should facilitate controlled dissection of plantmicrobe interactions derived from complex soil communities.	[Lundberg, Derek S.; Lebeis, Sarah L.; Paredes, Sur Herrera; Yourstone, Scott; Gehring, Jase; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lundberg, Derek S.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Yourstone, Scott] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Malfatti, Stephanie; Tremblay, Julien; Engelbrektson, Anna; Kunin, Victor; del Rio, Tijana Glavina; Hugenholtz, Philip; Tringe, Susannah Green] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Edgar, Robert C.] Taxon Biosci Inc, Tiburon, CA 94920 USA; [Eickhorst, Thilo] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany; [Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Hugenholtz, Philip] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); University of Bremen; Cornell University; University of Queensland; University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Eickhorst, Thilo/M-1200-2014; Tringe, Susannah Green/T-9431-2019; Ley, Ruth E/M-8542-2014; Hugenholtz, Philip/AAD-9138-2019; Ariel, Pablo/AGJ-4118-2022; Engelbrektson, Anna/K-5563-2012; Paredes, Sur Herrera/I-8617-2019; Hugenholtz, Philip/G-9608-2011; Engelbrektson, Anna/F-1687-2013	Tringe, Susannah Green/0000-0001-6479-8427; Ley, Ruth E/0000-0002-9087-1672; Hugenholtz, Philip/0000-0001-5386-7925; Paredes, Sur Herrera/0000-0001-9246-8337; Hugenholtz, Philip/0000-0001-5386-7925; Malfatti, Stephanie/0000-0003-4225-9857; Tremblay, Julien/0000-0002-6085-3481; Lundberg, Derek/0000-0001-7970-1595; Kunin, Victor/0000-0002-8741-7866	US NSF [IOS-0958245]; JGI Director's Discretionary Grand Challenge Program; HHMI-GBMF Plant Science Program; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences [K12GM000678]; Direct For Biological Sciences [0958245] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER	US NSF(National Science Foundation (NSF)); JGI Director's Discretionary Grand Challenge Program; HHMI-GBMF Plant Science Program; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Smithlund, M. Gonek, V. Madden, H. Schmidt, M. Rott and N. Zvenigorodsky for technical assistance. We thank A. Spor, J. Pfeiffer and J. Rawls for discussions and C. Herring for research field soil. This work was supported by US NSF grant IOS-0958245 (J. L. D.), the JGI Director's Discretionary Grand Challenge Program and the HHMI-GBMF Plant Science Program. J. L. D. is an HHMI-GBMF Plant Science Investigator. Work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. S. L. L. was supported by the National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences grant K12GM000678.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bates D., 2011, LINEAR MIXED EFFECTS, V1; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Firakova S, 2007, BIOLOGIA, V62, P251, DOI 10.2478/s11756-007-0044-1; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hugenholtz P, 2010, OPEN J, V1, P1; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; LANE D.J., 1991, 16S 23S RRNA SEQUENC, P115, DOI DOI 10.1007/S00227-012-2133-0; Levey S, 2005, PLANT CELL ENVIRON, V28, P223, DOI 10.1111/j.1365-3040.2004.01266.x; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MARSCHNER H, 1986, Z PFLANZ BODENKUNDE, V149, P441, DOI 10.1002/jpln.19861490408; Masclaux C, 2000, PLANTA, V211, P510, DOI 10.1007/s004250000310; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Motulsky, 2003, PRISM 4 STAT GUIDE S, P122; Oksanen J., 2011, VEGAN R FUNCTIONS VE; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Schulz Barbara J. E., 2006, V9, P1; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; VANELSAS JD, 1988, FEMS MICROBIOL ECOL, V53, P299, DOI 10.1016/0378-1097(88)90487-9; Warnes GR, 2011, GPLOTS VARIOUS R PRO	36	1498	1613	80	1490	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					86	+		10.1038/nature11237	http://dx.doi.org/10.1038/nature11237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859206	Green Accepted, Green Submitted			2022-12-01	WOS:000307010700038
J	Duncan, K; Sadanand, A; Davachi, L				Duncan, Katherine; Sadanand, Arhanti; Davachi, Lila			Memory's Penumbra: Episodic Memory Decisions Induce Lingering Mnemonic Biases	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; PROACTIVE-INTERFERENCE; PATTERN SEPARATION; NOVELTY DETECTION; HIPPOCAMPAL; MODULATION; RETRIEVAL; SYSTEMS; REGION	How do we decide if the people we meet and the things we see are familiar or new? If something is new, we need to encode it as a memory distinct from already stored episodes, using a process known as pattern separation. If familiar, it can be used to reactivate a previously stored memory, by a process known as pattern completion. To orchestrate these conflicting processes, current models propose that the episodic memory system uses environmental cues to establish processing biases that favor either pattern separation during encoding or pattern completion during retrieval. To assess this theory, we measured how people's memory formation and decisions are influenced by their recent engagement in episodic encoding and retrieval. We found that the recent encoding of novel objects improved subsequent identification of subtle changes, a task thought to rely on pattern separation. Conversely, recent retrieval of old objects increased the subsequent integration of stored information into new memories, a process thought to rely on pattern completion. These experiments provide behavioral evidence that episodic encoding and retrieval evoke lingering biases that influence subsequent mnemonic processing.	[Sadanand, Arhanti; Davachi, Lila] NYU, Dept Psychol, New York, NY 10003 USA; [Duncan, Katherine] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Davachi, Lila] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; Columbia University; New York University	Davachi, L (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lila.davachi@nyu.edu		Davachi, Lila/0000-0003-4317-0889; Duncan, Katherine/0000-0003-0456-851X	NIH [RO1 MH074692]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIH grant RO1 MH074692 to L.D. We thank V. Skvortsova, A. Berners-Lee, and M. Inhoff for data collection assistance; K. Ochsner and E. Phelps for their helpful comments on an earlier draft of the manuscript; G. Chin for his useful editorial comments; and C. Stark and W. Suzuki for the use of stimuli developed by their labs.	Allan K, 2005, J NEUROSCI, V25, P8122, DOI 10.1523/JNEUROSCI.1304-05.2005; Atri A, 2004, BEHAV NEUROSCI, V118, P223, DOI 10.1037/0735-7044.118.1.223; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; De Rosa E, 2000, BEHAV NEUROSCI, V114, P32, DOI 10.1037/0735-7044.114.1.32; Duncan K, 2012, HIPPOCAMPUS, V22, P389, DOI 10.1002/hipo.20933; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Hall G, 2003, J EXP PSYCHOL GEN, V132, P266, DOI 10.1037/0096-3445.132.2.266; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 2001, J NEUROPHYSIOL, V86, P1792, DOI 10.1152/jn.2001.86.4.1792; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Huijbers W, 2009, PLOS BIOL, V7, P63, DOI 10.1371/journal.pbio.1000011; Kirwan CB, 2007, LEARN MEMORY, V14, P625, DOI 10.1101/lm.663507; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Kunec S, 2005, J NEUROPHYSIOL, V94, P70, DOI 10.1152/jn.00731.2004; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073	30	82	82	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					485	487		10.1126/science.1221936	http://dx.doi.org/10.1126/science.1221936			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979FS	22837528	Green Accepted			2022-12-01	WOS:000306802300048
J	Pitsiladis, Y; Beis, L				Pitsiladis, Yannis; Beis, Lukas			To drink or not to drink to drink recommendations: the evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXERCISE; RUNNERS		[Pitsiladis, Yannis; Beis, Lukas] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Pitsiladis, Y (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland.	Yannis.Pitsiladis@glasgow.ac.uk		Pitsiladis, Yannis/0000-0001-6210-2449				Beis LY, 2012, CLIN J SPORT MED, V22, P254, DOI 10.1097/JSM.0b013e31824a55d7; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Convertino VA, 1996, MED SCI SPORT EXER, V28, pR1, DOI 10.1097/00005768-199610000-00045; Fudge BW, 2006, BRIT J NUTR, V95, P59, DOI 10.1079/BJN20051608; Fudge BW, 2006, E AFRICAN RUNNING CR, P63; Galloway SDR, 1997, MED SCI SPORT EXER, V29, P1240, DOI 10.1097/00005768-199709000-00018; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Montain SJ, 2006, BRIT J SPORT MED, V40, P98, DOI 10.1136/bjsm.2005.018481; Noakes TD, 2007, J SPORT SCI, V25, P781, DOI 10.1080/02640410600875036; Noakes T D, 1993, Exerc Sport Sci Rev, V21, P297; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Zouhal H, 2011, BRIT J SPORT MED, V45, P1101, DOI 10.1136/bjsm.2010.074641	12	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2012	345								e4868	10.1136/bmj.e4868	http://dx.doi.org/10.1136/bmj.e4868			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MA	22810390				2022-12-01	WOS:000306744300013
J	Nakamura, T; Zhao, Y; Yamagata, Y; Hua, YJ; Yang, W				Nakamura, Teruya; Zhao, Ye; Yamagata, Yuriko; Hua, Yue-Jin; Yang, Wei			Watching DNA polymerase eta make a phosphodiester bond	NATURE			English	Article							CRYSTAL-STRUCTURES; 2-METAL-ION MECHANISM; TERNARY COMPLEXES; TRANSITION-STATE; STRUCTURAL BASIS; ACTIVE-SITE; SUBSTRATE; FIDELITY; METAL; BINDING	DNA synthesis has been extensively studied, but the chemical reaction itself has not been visualized. Here we follow the course of phosphodiester bond formation using time-resolved X-ray crystallography. Native human DNA polymerase eta, DNA and dATP were co-crystallized at pH 6.0 without Mg2+. The polymerization reaction was initiated by exposing crystals to 1 mM Mg2+ at pH 7.0, and stopped by freezing at desired time points for structural analysis. The substrates and two Mg2+ ions are aligned within 40 s, but the bond formation is not evident until 80 s. From 80 to 300 s structures show a mixture of decreasing substrate and increasing product of the nucleotidyl-transfer reaction. Transient electron densities indicate that deprotonation and an accompanying C2'-endo to C3'-endo conversion of the nucleophile 3'-OH are rate limiting. A third Mg2+ ion, which arrives with the new bond and stabilizes the intermediate state, may be an unappreciated feature of the two-metal-ion mechanism.	[Nakamura, Teruya; Zhao, Ye; Yang, Wei] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Nakamura, Teruya; Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; [Zhao, Ye; Hua, Yue-Jin] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310029, Zhejiang, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Kumamoto University; Zhejiang University	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Zhao, Ye/I-2936-2014; Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011	Zhao, Ye/0000-0002-5455-2586; Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Nakamura, Teruya/0000-0003-2013-3057	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; Japan Society for the Promotion of Science; Kumamoto University; Kumayaku Alumni Research Fund; Chinese Ministry of Education; National Natural Science Foundation of China; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036146] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24113719] Funding Source: KAKEN	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kumamoto University; Kumayaku Alumni Research Fund; Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank D. Leahy, M. Gellert and R. Craigie for editing the manuscript. The research was supported by the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (W.Y., T.N. and Y.Z.); the Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas visits, Kumamoto University, and the Kumayaku Alumni Research Fund (T.N.); Chinese Ministry of Education scholarship (Y.Z.); National Natural Science Foundation of China (Y.-J.H.); and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Y.Y.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BRODY RS, 1981, BIOCHEMISTRY-US, V20, P1245, DOI 10.1021/bi00508a030; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; Cramer J, 2005, J BIOL CHEM, V280, P40552, DOI 10.1074/jbc.M504481200; DING XC, 1994, BIOCHEMISTRY-US, V33, P9285, DOI 10.1021/bi00197a032; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans RJ, 2008, P NATL ACAD SCI USA, V105, P20695, DOI 10.1073/pnas.0809989106; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garcia-Diaz M, 2007, DNA REPAIR, V6, P1333, DOI 10.1016/j.dnarep.2007.03.005; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Le Du MH, 2002, J MOL BIOL, V316, P941, DOI 10.1006/jmbi.2001.5384; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Murray JB, 2000, MOL CELL, V5, P279, DOI 10.1016/S1097-2765(00)80423-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; Romier C, 1998, PROTEINS, V32, P414, DOI 10.1002/(SICI)1097-0134(19980901)32:4<414::AID-PROT2>3.3.CO;2-5; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Scott WG, 1996, SCIENCE, V274, P2065, DOI 10.1126/science.274.5295.2065; Shah AM, 2001, J BIOL CHEM, V276, P10824, DOI 10.1074/jbc.M008680200; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Wang F, 2009, CELL, V139, P1279, DOI 10.1016/j.cell.2009.11.043; Wang LH, 2007, J AM CHEM SOC, V129, P4731, DOI 10.1021/ja068821c; Wang LH, 2009, J MOL BIOL, V389, P787, DOI 10.1016/j.jmb.2009.04.029; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zakharova E, 2004, BIOCHEMISTRY-US, V43, P6587, DOI 10.1021/bi049615p; Zhang H, 2007, NUCLEIC ACIDS RES, V35, P6052, DOI 10.1093/nar/gkm587; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	55	189	189	2	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					196	U77		10.1038/nature11181	http://dx.doi.org/10.1038/nature11181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22785315	Green Accepted			2022-12-01	WOS:000306278900031
J	Khunti, K; Davies, M				Khunti, Kamlesh; Davies, Melanie			Should we screen for type 2 diabetes: Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTENSIVE GLUCOSE CONTROL		[Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester Diabet Ctr, Leicester LE5 4PW, Leics, England; [Davies, Melanie] Univ Leicester, Dept Cardiovasc Sci, Leicester LE5 4PW, Leics, England	University of Leicester; University of Leicester	Khunti, K (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester Diabet Ctr, Leicester LE5 4PW, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099; Davies, Melanie/0000-0002-9987-9371				Duckworth WC, 2011, J DIABETES COMPLICAT, V25, P355, DOI 10.1016/j.jdiacomp.2011.10.003; Eborall H, BJGP IN PRESS; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Goyder E, 2008, FAM PRACT, V25, P370, DOI 10.1093/fampra/cmn054; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; National Institute for Health and Care Excellence, 2012, PREV TYP 2 DIAB RISK; Skinner TC, 2005, DIABETIC MED, V22, P1497, DOI 10.1111/j.1464-5491.2005.01680.x; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; WHO, 2011, USE GLYCATED HAEMOGL	15	10	10	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2012	345								e4514	10.1136/bmj.e4514	http://dx.doi.org/10.1136/bmj.e4514			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975NR	22777029				2022-12-01	WOS:000306518500004
J	Loh, ND; Hampton, CY; Martin, AV; Starodub, D; Sierra, RG; Barty, A; Aquila, A; Schulz, J; Lomb, L; Steinbrener, J; Shoeman, RL; Kassemeyer, S; Bostedt, C; Bozek, J; Epp, SW; Erk, B; Hartmann, R; Rolles, D; Rudenko, A; Rudek, B; Foucar, L; Kimmel, N; Weidenspointner, G; Hauser, G; Holl, P; Pedersoli, E; Liang, M; Hunter, MM; Gumprecht, L; Coppola, N; Wunderer, C; Graafsma, H; Maia, FRNC; Ekeberg, T; Hantke, M; Fleckenstein, H; Hirsemann, H; Nass, K; White, TA; Tobias, HJ; Farquar, GR; Benner, WH; Hau-Riege, SP; Reich, C; Hartmann, A; Soltau, H; Marchesini, S; Bajt, S; Barthelmess, M; Bucksbaum, P; Hodgson, KO; Struder, L; Ullrich, J; Frank, M; Schlichting, I; Chapman, HN; Bogan, MJ				Loh, N. D.; Hampton, C. Y.; Martin, A. V.; Starodub, D.; Sierra, R. G.; Barty, A.; Aquila, A.; Schulz, J.; Lomb, L.; Steinbrener, J.; Shoeman, R. L.; Kassemeyer, S.; Bostedt, C.; Bozek, J.; Epp, S. W.; Erk, B.; Hartmann, R.; Rolles, D.; Rudenko, A.; Rudek, B.; Foucar, L.; Kimmel, N.; Weidenspointner, G.; Hauser, G.; Holl, P.; Pedersoli, E.; Liang, M.; Hunter, M. M.; Gumprecht, L.; Coppola, N.; Wunderer, C.; Graafsma, H.; Maia, F. R. N. C.; Ekeberg, T.; Hantke, M.; Fleckenstein, H.; Hirsemann, H.; Nass, K.; White, T. A.; Tobias, H. J.; Farquar, G. R.; Benner, W. H.; Hau-Riege, S. P.; Reich, C.; Hartmann, A.; Soltau, H.; Marchesini, S.; Bajt, S.; Barthelmess, M.; Bucksbaum, P.; Hodgson, K. O.; Strueder, L.; Ullrich, J.; Frank, M.; Schlichting, I.; Chapman, H. N.; Bogan, M. J.			Fractal morphology, imaging and mass spectrometry of single aerosol particles in flight	NATURE			English	Article							FREE-ELECTRON LASER; OPTICAL-PROPERTIES; SOOT AEROSOLS; BLACK CARBON; MIXING STATE; SCATTERING; CLIMATE; FLAME	The morphology of micrometre-size particulate matter is of critical importance in fields ranging from toxicology(1) to climate science(2), yet these properties are surprisingly difficult to measure in the particles' native environment. Electron microscopy requires collection of particles on a substrate(3); visible light scattering provides insufficient resolution(4); and X-ray synchrotron studies have been limited to ensembles of particles(5). Here we demonstrate an in situ method for imaging individual sub-micrometre particles to nanometre resolution in their native environment, using intense, coherent X-ray pulses from the Linac Coherent Light Source(6) free-electron laser. We introduced individual aerosol particles into the pulsed X-ray beam, which is sufficiently intense that diffraction from individual particles can be measured for morphological analysis. At the same time, ion fragments ejected from the beam were analysed using mass spectrometry, to determine the composition of single aerosol particles. Our results show the extent of internal dilation symmetry of individual soot particles subject to non-equilibrium aggregation, and the surprisingly large variability in their fractal dimensions. More broadly, our methods can be extended to resolve both static and dynamic morphology of general ensembles of disordered particles. Such general morphology has implications in topics such as solvent accessibilities in proteins(7), vibrational energy transfer by the hydrodynamic interaction of amino acids(8), and large-scale production of nanoscale structures by flame synthesis(9).	[Loh, N. D.; Hampton, C. Y.; Starodub, D.; Sierra, R. G.; Bucksbaum, P.; Hodgson, K. O.; Bogan, M. J.] PULSE Inst, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Martin, A. V.; Barty, A.; Aquila, A.; Schulz, J.; Liang, M.; Gumprecht, L.; Fleckenstein, H.; Nass, K.; White, T. A.; Chapman, H. N.] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Aquila, A.; Schulz, J.; Coppola, N.] European XFEL GmbH, D-22761 Hamburg, Germany; [Lomb, L.; Steinbrener, J.; Shoeman, R. L.; Kassemeyer, S.; Rolles, D.; Foucar, L.; Schlichting, I.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Bostedt, C.; Bozek, J.] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Epp, S. W.; Erk, B.; Rolles, D.; Rudenko, A.; Rudek, B.; Foucar, L.; Schlichting, I.] Ctr Free Electron Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Epp, S. W.; Erk, B.; Rudenko, A.; Rudek, B.; Ullrich, J.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hartmann, R.; Holl, P.; Reich, C.; Hartmann, A.; Soltau, H.] PNSensor GmbH, D-81739 Munich, Germany; [Kimmel, N.; Weidenspointner, G.; Hauser, G.; Strueder, L.] Max Planck Inst Halbleiterlab, D-81739 Munich, Germany; [Kimmel, N.; Weidenspointner, G.; Hauser, G.; Strueder, L.] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Pedersoli, E.] Sincrotrone Trieste, Microscopy Sect, I-34149 Trieste, Italy; [Hunter, M. M.; Farquar, G. R.; Benner, W. H.; Hau-Riege, S. P.; Frank, M.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Wunderer, C.; Graafsma, H.; Hirsemann, H.; Bajt, S.; Barthelmess, M.] DESY, Photon Sci, D-22607 Hamburg, Germany; [Maia, F. R. N. C.] Natl Energy Res Sci Comp Ctr NERSC, Berkeley, CA 94720 USA; [Ekeberg, T.; Hantke, M.] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [Nass, K.; Chapman, H. N.] Univ Hamburg, D-22761 Hamburg, Germany; [Tobias, H. J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Marchesini, S.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European XFEL; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Max Planck Society; Max Planck Society; PNSensor GmbH; Max Planck Society; Max Planck Society; Elettra Sincrotrone Trieste; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Uppsala University; University of Hamburg; Cornell University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Loh, ND (corresponding author), PULSE Inst, SLAC Natl Accelerator Lab, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	duaneloh@slac.stanford.edu; mbogan@slac.stanford.edu	Bajt, Sasa/G-2228-2010; Bajt, Sasa/O-4695-2019; Nass, Karol/K-1970-2012; Bozek, John D/E-9260-2010; Maia, Filipe R.N.C./C-3146-2014; Loh, Duane/I-7371-2013; Marchesini, Stefano/A-6795-2009; Marchesini, Stefano/GYR-1409-2022; Schlichting, Ilme/I-1339-2013; FRS, Henry N Chapman/G-2153-2010; Frank, Matthias/O-9055-2014; Rudenko, Artem/C-7412-2009; Barty, Anton/K-5137-2014; Rudek, Benedikt/A-5100-2017; Rudek, Benedikt/AAX-1278-2021	Bajt, Sasa/0000-0002-7163-7602; Nass, Karol/0000-0001-8843-1566; Bozek, John D/0000-0001-7486-7238; Maia, Filipe R.N.C./0000-0002-2141-438X; Loh, Duane/0000-0002-8886-510X; Marchesini, Stefano/0000-0002-6798-2913; FRS, Henry N Chapman/0000-0002-4655-1743; Rudenko, Artem/0000-0002-9154-8463; Barty, Anton/0000-0003-4751-2727; Rudek, Benedikt/0000-0002-6404-4294; Pedersoli, Emanuele/0000-0003-0572-6735; Erk, Benjamin/0000-0001-8413-3588; Bucksbaum, Philip/0000-0003-1258-5571; Epp, Sascha/0000-0001-6366-9113; Aquila, Andrew/0000-0003-0358-2774; Bogan, Michael J./0000-0001-9318-3333; MARTIN, ANDREW/0000-0003-3704-1829; Wunderer, Cornelia/0000-0001-8211-3604; graafsma, heinz/0000-0003-2304-667X; Tobias, Herbert/0000-0002-2835-8739; White, Thomas/0000-0002-8407-0270; Frank, Matthias/0000-0002-5244-0791	AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy; SLAC Laboratory Directed Research and Development Program; Max Planck Society; Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics in Infection, CBST at UC [PHY 0120999]; US Department of Energy, National Nuclear Security Administration [DE-AC52-07NA27344]; University of California [09-LR-05-118036-BARA]; Swedish Research Council; European Research Council; Knut och Alice Wallenbergs Stiftelse; DFG Cluster of Excellence at the Munich Centre for Advanced Photonics	AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); SLAC Laboratory Directed Research and Development Program; Max Planck Society(Max Planck SocietyFoundation CELLEX); Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics in Infection, CBST at UC; US Department of Energy, National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); University of California(University of California System); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); DFG Cluster of Excellence at the Munich Centre for Advanced Photonics(German Research Foundation (DFG))	Experiments were carried out at the Linac Coherent Light Source, a national user facility operated by Stanford University on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences. N.D.L., C.Y.H., R. G. S., P. B. and M.J.B. were supported by the AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy. M.J.B. acknowledges support by the SLAC Laboratory Directed Research and Development Program. We acknowledge support from the Max Planck Society for funding the development and operation of the CAMP instrument within the ASG at CFEL, the Hamburg Ministry of Science and Research and Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research (LEXI) and the Hamburg School for Structure and Dynamics in Infection, CBST at UC under Cooperative Agreement number PHY 0120999. Lawrence Livermore National Laboratory (LLNL) is operated by Lawrence Livermore National Security, LLC, for the US Department of Energy, National Nuclear Security Administration under Contract DE-AC52-07NA27344. Work by LLNL has been supported, in part, by University of California Laboratory Fee grant 09-LR-05-118036-BARA. We also acknowledge support from the Swedish Research Council, the European Research Council, Knut och Alice Wallenbergs Stiftelse, and the DFG Cluster of Excellence at the Munich Centre for Advanced Photonics. We acknowledge the staff of the LCLS for their support in carrying out these experiments. The Max Planck Advanced Study Group at CFEL acknowledges technical support by R. Andritschke, K. Gartner, O. Halker, S. Herrmann, A. Homke, Ch. Kaiser, K.-U. Kuhnel, W. Leitenberger, D. Miessner, D. Pietschner, M. Porro, R. Richter, G. Schaller, C. Schmidt, F. Schopper, C.-D. Schroter, Ch. Thamm, A. Walenta, A. Ziegler and H. Gorke. N.D.L. thanks M. J. Berg, G. Simpson, G. Williams and J. Hajdu for their critique, and G. M. Stewart for rendering the experiment's schematic.	BALAFAS JS, 1995, PHYS REV E, V52, P880, DOI 10.1103/PhysRevE.52.880; Beaucage G, 2004, NAT MATER, V3, P370, DOI 10.1038/nmat1135; Berg MJ, 2010, OPT EXPRESS, V18, P23343, DOI 10.1364/OE.18.023343; Bogan MJ, 2010, PHYS REV SPEC TOP-AC, V13, DOI 10.1103/PhysRevSTAB.13.094701; Bogan MJ, 2008, NANO LETT, V8, P310, DOI 10.1021/nl072728k; Bogan MJ, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/19/194013; Bogan MJ, 2010, AEROSOL SCI TECH, V44, pI, DOI 10.1080/02786820903485800; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Braun A, 2005, CARBON, V43, P2588, DOI 10.1016/j.carbon.2005.05.017; Cho YS, 2007, LANGMUIR, V23, P12079, DOI 10.1021/la7018346; Dhaubhadel R, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011404; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; FIENUP JR, 1982, J OPT SOC AM, V72, P610, DOI 10.1364/JOSA.72.000610; Granek R, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.020902; Jacobson MZ, 2006, J PHYS CHEM A, V110, P6860, DOI 10.1021/jp056391r; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Luke DR, 2005, INVERSE PROBL, V21, P37, DOI 10.1088/0266-5611/21/1/004; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; MARTIN JE, 1987, J APPL CRYSTALLOGR, V20, P61, DOI 10.1107/S0021889887087107; MEAKIN P, 1988, ADV COLLOID INTERFAC, V28, P249, DOI 10.1016/0001-8686(87)80016-7; Moffet RC, 2009, P NATL ACAD SCI USA, V106, P11872, DOI 10.1073/pnas.0900040106; NELSON J, 1989, J MOD OPTIC, V36, P1031, DOI 10.1080/09500348914551081; NELSON J, 1989, NATURE, V339, P611, DOI 10.1038/339611a0; PURI R, 1993, COMBUST FLAME, V92, P320, DOI 10.1016/0010-2180(93)90043-3; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748; Sorensen CM, 2001, AEROSOL SCI TECH, V35, P648, DOI 10.1080/027868201316900007; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; Wentzel M, 2003, J AEROSOL SCI, V34, P1347, DOI 10.1016/S0021-8502(03)00360-4; Zereini F, 2010, ENVIRON SCI ENG, P1; Zhang RY, 2008, P NATL ACAD SCI USA, V105, P10291, DOI 10.1073/pnas.0804860105	31	144	144	2	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					513	517		10.1038/nature11222	http://dx.doi.org/10.1038/nature11222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739316				2022-12-01	WOS:000305760600039
J	Kalyana-Sundaram, S; Kumar-Sinha, C; Shankar, S; Robinson, DR; Wu, YM; Cao, XH; Asangani, IA; Kothari, V; Prensner, JR; Lonigro, RJ; Iyer, MK; Barrette, T; Shanmugam, A; Dhanasekaran, SM; Palanisamy, N; Chinnaiyan, AM				Kalyana-Sundaram, Shanker; Kumar-Sinha, Chandan; Shankar, Sunita; Robinson, Dan R.; Wu, Yi-Mi; Cao, Xuhong; Asangani, Irfan A.; Kothari, Vishal; Prensner, John R.; Lonigro, Robert J.; Iyer, Matthew K.; Barrette, Terrence; Shanmugam, Achiraman; Dhanasekaran, Saravana M.; Palanisamy, Nallasivam; Chinnaiyan, Arul M.			Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers	CELL			English	Article							PROSTATE-CANCER; TRANSCRIBED PSEUDOGENE; CONNEXIN43 PSEUDOGENE; GENE-EXPRESSION; GASTRIC-CANCER; IDENTIFICATION; RNA; CELLS; PROTEIN; GENOME	Pseudogene transcripts can provide a novel tier of gene regulation through generation of endogenous siRNAs or miRNA-binding sites. Characterization of pseudogene expression, however, has remained confined to anecdotal observations due to analytical challenges posed by the extremely close sequence similarity with their counterpart coding genes. Here, we describe a systematic analysis of pseudogene "transcription" from an RNA-Seq resource of 293 samples, representing 13 cancer and normal tissue types, and observe a surprisingly prevalent, genome-wide expression of pseudogenes that could be categorized as ubiquitously expressed or lineage and/or cancer specific. Further, we explore disease subtype specificity and functions of selected expressed pseudogenes. Taken together, we provide evidence that transcribed pseudogenes are a significant contributor to the transcriptional landscape of cells and are positioned to play significant roles in cellular differentiation and cancer progression, especially in light of the recently described ceRNA networks. Our work provides a transcriptome resource that enables high-throughput analyses of pseudogene expression.	[Kalyana-Sundaram, Shanker; Kumar-Sinha, Chandan; Shankar, Sunita; Robinson, Dan R.; Wu, Yi-Mi; Cao, Xuhong; Asangani, Irfan A.; Kothari, Vishal; Prensner, John R.; Lonigro, Robert J.; Iyer, Matthew K.; Barrette, Terrence; Dhanasekaran, Saravana M.; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Kalyana-Sundaram, Shanker; Kumar-Sinha, Chandan; Shankar, Sunita; Robinson, Dan R.; Wu, Yi-Mi; Asangani, Irfan A.; Prensner, John R.; Lonigro, Robert J.; Barrette, Terrence; Dhanasekaran, Saravana M.; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Kalyana-Sundaram, Shanker; Shanmugam, Achiraman] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli 620024, India	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Bharathidasan University	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012; Palanisamy, Nallasivam/ABC-8844-2020	Palanisamy, Nallasivam/0000-0002-0633-9772; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Kumar, Chandan/0000-0002-8696-3400; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Prensner, John/0000-0002-7024-636X; Kothari, Vishal/0000-0001-7453-1435; asangani, irfan/0000-0001-5381-1702	National Institutes of Health [R01CA132874]; Early Detection Research Network grant [UO1 CA111275]; Prostate SPORE grant [P50CA69568]; Department of Defense Era of Hope grant [BC075023]; Doris Duke Charitable Foundation Clinical Scientist Award; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [U01CA111275, R01CA132874, P50CA069568, T32CA009676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network grant; Prostate SPORE grant; Department of Defense Era of Hope grant(United States Department of Defense); Doris Duke Charitable Foundation Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Ram-Shankar Mani, Kalpana Ramnarayanan, Joseph Mierwaza, and Sooryanarayana Varambally for technical help and Javed Siddiqui for providing samples. This work was supported, in part, by the National Institutes of Health (R01CA132874), Early Detection Research Network grant UO1 CA111275, Prostate SPORE grant P50CA69568, and the Department of Defense Era of Hope grant BC075023 (A. M. C.). A. M. C. is supported by the Doris Duke Charitable Foundation Clinical Scientist Award and the Prostate Cancer Foundation. A. M. C. is an American Cancer Society Research Professor and A. Alfred Taubman Scholar.	Bier A, 2009, MOL CANCER THER, V8, P786, DOI 10.1158/1535-7163.MCT-08-0930; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Han H, 2011, CELL, V146, P1044, DOI 10.1016/j.cell.2011.09.002; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Kandouz M, 2004, ONCOGENE, V23, P4763, DOI 10.1038/sj.onc.1207506; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kastler S, 2010, PROSTATE, V70, P666, DOI 10.1002/pros.21100; Katoh M, 2003, INT J ONCOL, V23, P525; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Khoo C, 1997, PROTEIN EXPRES PURIF, V9, P379, DOI 10.1006/prep.1996.0709; Lai J, 2010, RNA, V16, P1156, DOI 10.1261/rna.2019810; Lam HYK, 2009, NUCLEIC ACIDS RES, V37, pD738, DOI 10.1093/nar/gkn758; Li G, 2011, MOL BIOL EVOL, V28, P911, DOI 10.1093/molbev/msq281; Lu W, 2006, PROSTATE, V66, P936, DOI 10.1002/pros.20382; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pong RC, 2003, CANCER RES, V63, P8680; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rieger MA, 2004, CANCER RES, V64, P2357, DOI 10.1158/0008-5472.CAN-03-0849; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yao A, 2006, NUCLEIC ACIDS RES, V34, P4477, DOI 10.1093/nar/gkl591; Zhang ZL, 2006, BIOINFORMATICS, V22, P1437, DOI 10.1093/bioinformatics/btl116; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26; Zhang ZL, 2004, CURR OPIN GENET DEV, V14, P328, DOI 10.1016/j.gde.2004.06.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s13; ZHOU BS, 1992, CANCER RES, V52, P4280; Zou MJ, 2009, NEOPLASIA, V11, P57, DOI 10.1593/neo.81044	44	197	211	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1622	1634		10.1016/j.cell.2012.04.041	http://dx.doi.org/10.1016/j.cell.2012.04.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726445	Green Accepted, Bronze			2022-12-01	WOS:000305753800025
J	Dey, A; Seshasayee, D; Noubade, R; French, DM; Liu, JF; Chaurushiya, MS; Kirkpatrick, DS; Pham, VC; Lill, JR; Bakalarski, CE; Wu, JS; Phu, L; Katavolos, P; LaFave, LM; Abdel-Wahab, O; Modrusan, Z; Seshagiri, S; Dong, K; Lin, ZH; Balazs, M; Suriben, R; Newton, K; Hymowitz, S; Garcia-Manero, G; Martin, F; Levine, RL; Dixit, VM				Dey, Anwesha; Seshasayee, Dhaya; Noubade, Rajkumar; French, Dorothy M.; Liu, Jinfeng; Chaurushiya, Mira S.; Kirkpatrick, Donald S.; Pham, Victoria C.; Lill, Jennie R.; Bakalarski, Corey E.; Wu, Jiansheng; Phu, Lilian; Katavolos, Paula; LaFave, Lindsay M.; Abdel-Wahab, Omar; Modrusan, Zora; Seshagiri, Somasekar; Dong, Ken; Lin, Zhonghua; Balazs, Mercedesz; Suriben, Rowena; Newton, Kim; Hymowitz, Sarah; Garcia-Manero, Guillermo; Martin, Flavius; Levine, Ross L.; Dixit, Vishva M.			Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation	SCIENCE			English	Article							MYELODYSPLASTIC SYNDROMES; UBIQUITIN HYDROLASE; GENE-EXPRESSION; MUTATIONS; MOUSE; PREDISPOSE; LEUKEMIA; ASXL1	De-ubiquitinating enzyme BAP1 is mutated in a hereditary cancer syndrome with increased risk of mesothelioma and uveal melanoma. Somatic BAP1 mutations occur in various malignancies. We show that mouse Bap1 gene deletion is lethal during embryogenesis, but systemic or hematopoietic-restricted deletion in adults recapitulates features of human myelodysplastic syndrome (MDS). Knockin mice expressing BAP1 with a 3xFlag tag revealed that BAP1 interacts with host cell factor-1 (HCF-1), O-linked N-acetylglucosamine transferase (OGT), and the polycomb group proteins ASXL1 and ASXL2 in vivo. OGT and HCF-1 levels were decreased by Bap1 deletion, indicating a critical role for BAP1 in stabilizing these epigenetic regulators. Human ASXL1 is mutated frequently in chronic myelomonocytic leukemia (CMML) so an ASXL/BAP1 complex may suppress CMML. A BAP1 catalytic mutation found in a MDS patient implies that BAP1 loss of function has similar consequences in mice and humans.	[Dey, Anwesha; Chaurushiya, Mira S.; Suriben, Rowena; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Seshasayee, Dhaya; Noubade, Rajkumar; Martin, Flavius] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Liu, Jinfeng; Bakalarski, Corey E.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Kirkpatrick, Donald S.; Pham, Victoria C.; Lill, Jennie R.; Wu, Jiansheng; Phu, Lilian] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Katavolos, Paula] Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA; [LaFave, Lindsay M.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [LaFave, Lindsay M.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10065 USA; [Modrusan, Zora; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Dong, Ken; Hymowitz, Sarah] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Lin, Zhonghua; Balazs, Mercedesz] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA; [Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Texas System; UTMD Anderson Cancer Center	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	levine, ross/AAE-7658-2019; Wu, Jian/AAU-5221-2020; Ferris, Laura/I-7689-2012; dixit, vishva m/A-4496-2012; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; dixit, vishva m/0000-0001-6983-0326; Abdel-Wahab, Omar/0000-0002-3907-6171; Kirkpatrick, Donald/0000-0003-3091-2804; Wu, Jian/0000-0002-3394-1507; Bakalarski, Corey/0000-0003-1085-7828; Katavolos, Paula/0000-0001-7923-5328; Liu, Jinfeng/0000-0002-0343-8222; Seshagiri, Somasekar/0000-0003-4272-6443	NATIONAL CANCER INSTITUTE [P30CA008748, R01CA173636] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA173636, P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Abdel-Wahab O, 2011, LEUKEMIA, V25, P1200, DOI 10.1038/leu.2011.58; Beachy SH, 2010, HEMATOL ONCOL CLIN N, V24, P361, DOI 10.1016/j.hoc.2010.02.002; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1999, CANCER LETT, V143, pS13, DOI 10.1016/S0304-3835(99)90004-6; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Pellagatti A, 2004, BRIT J HAEMATOL, V125, P576, DOI 10.1111/j.1365-2141.2004.04958.x; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910	25	290	293	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1541	1546		10.1126/science.1221711	http://dx.doi.org/10.1126/science.1221711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22878500	Green Accepted			2022-12-01	WOS:000308912900052
J	Havlir, D; Beyrer, C				Havlir, Diane; Beyrer, Chris			The Beginning of the End of AIDS?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV-1 INFECTION		[Havlir, Diane] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Havlir, Diane] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Ctr AIDS Res, Baltimore, MD USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Havlir, D (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.				NIAID NIH HHS [P30 AI094189] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2	5	41	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					685	687		10.1056/NEJMp1207138	http://dx.doi.org/10.1056/NEJMp1207138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CX	22809362	Bronze			2022-12-01	WOS:000307754200001
J	Shapiro, D				Shapiro, Daniel			Poolside	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Penn State Coll Med, Dept Humanities, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Shapiro, D (corresponding author), Penn State Coll Med, Dept Humanities, Hershey, PA USA.	shapiro@psu.edu		Shapiro, Daniel/0000-0002-7166-7705					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					775	776		10.1001/jama.2012.9425	http://dx.doi.org/10.1001/jama.2012.9425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910754				2022-12-01	WOS:000307705300020
J	Owen, J				Owen, James			Anybody else for warfarin?	BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 20	2012	345								e5543	10.1136/bmj.e5543	http://dx.doi.org/10.1136/bmj.e5543			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996GL	22906868				2022-12-01	WOS:000308072800002
J	Jinek, M; Chylinski, K; Fonfara, I; Hauer, M; Doudna, JA; Charpentier, E				Jinek, Martin; Chylinski, Krzysztof; Fonfara, Ines; Hauer, Michael; Doudna, Jennifer A.; Charpentier, Emmanuelle			A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity	SCIENCE			English	Article							CRISPR RNA; ANTIVIRAL DEFENSE; COMPLEX; SYSTEM; INTERFERENCE; RECOGNITION; MECHANISM; ENDORIBONUCLEASE; MATURATION; RESISTANCE	Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems provide bacteria and archaea with adaptive immunity against viruses and plasmids by using CRISPR RNAs (crRNAs) to guide the silencing of invading nucleic acids. We show here that in a subset of these systems, the mature crRNA that is base-paired to trans-activating crRNA (tracrRNA) forms a two-RNA structure that directs the CRISPR-associated protein Cas9 to introduce double-stranded (ds) breaks in target DNA. At sites complementary to the crRNA-guide sequence, the Cas9 HNH nuclease domain cleaves the complementary strand, whereas the Cas9 RuvC-like domain cleaves the noncomplementary strand. The dual-tracrRNA:crRNA, when engineered as a single RNA chimera, also directs sequence-specific Cas9 dsDNA cleavage. Our study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.	[Jinek, Martin; Doudna, Jennifer A.] Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA; [Jinek, Martin; Hauer, Michael; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chylinski, Krzysztof] Univ Vienna, MFPL, A-1030 Vienna, Austria; [Chylinski, Krzysztof; Fonfara, Ines; Charpentier, Emmanuelle] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Umea University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA.	doudna@berkeley.edu; emmanuelle.charpentier@mims.umu.se	Hauer, Michael/U-4800-2019; Jinek, Martin/E-6621-2011; Fonfara, Ines/S-8369-2018	Jinek, Martin/0000-0002-7601-210X; Fonfara, Ines/0000-0003-4075-9217; Chylinski, Krzysztof/0000-0001-7029-8090; Hauer, Michael/0000-0001-7463-3191	HHMI; Austrian Science Fund [W1207-B09]; Univ. of Vienna; Swedish Research Council [K2010-57X-21436-01-3, 621-2011-5752-LiMS]; Kempe Foundation; Umea University	HHMI(Howard Hughes Medical Institute); Austrian Science Fund(Austrian Science Fund (FWF)); Univ. of Vienna; Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation; Umea University	We thank K. Zhou, A. M. Smith, R. Haurwitz and S. Sternberg for excellent technical assistance; members of the Doudna and Charpentier laboratories and J. Cate for comments on the manuscript; and B. Meyer and T.-W. Lo (Univ. of California, Berkeley/HHMI) for providing the GFP plasmid. This work was funded by the HHMI (M.J. and J.A.D.), the Austrian Science Fund (grant W1207-B09; K.C. and E.C.), the Univ. of Vienna (K.C.), the Swedish Research Council (grants K2010-57X-21436-01-3 and 621-2011-5752-LiMS; E.C.), the Kempe Foundation (E.C.), and Umea University (K.C. and E.C.). J.A.D. is an Investigator and M.J. is a Research Specialist of the HHMI. K.C. is a fellow of the Austrian Doctoral Program in RNA Biology and is cosupervised by R. Schroeder. We thank A. Witte, U. Blasi, and R. Schroeder for helpful discussions, financial support to K.C., and for hosting K.C. in their laboratories at MFPL. M.J., K.C., J.A.D., and E.C. have filed a related patent.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Gottesman S, 2011, NATURE, V471, P588, DOI 10.1038/471588a; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Taylor GK, 2011, NUCLEIC ACIDS RES, V39, P9705, DOI 10.1093/nar/gkr669; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	38	8338	9886	1114	6712	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					816	821		10.1126/science.1225829	http://dx.doi.org/10.1126/science.1225829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22745249	Green Accepted, Green Submitted			2022-12-01	WOS:000307535600036
J	Rothballer, A; Kutay, U				Rothballer, Andrea; Kutay, Ulrike			SnapShot: The Nuclear Envelope I	CELL			English	Editorial Material							FUNCTIONAL ARCHITECTURE; PORE COMPLEX; PROTEINS; DISEASE		[Rothballer, Andrea; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	ETH Zurich	Rothballer, A (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.							Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-850511-102328, 10.1146/annurev-biophys-050511-102328]; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shimi T, 2012, CURR OPIN CELL BIOL, V24, P71, DOI 10.1016/j.ceb.2011.11.007; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09	10	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					868	U226	868.e1	10.1016/j.cell.2012.07.024	http://dx.doi.org/10.1016/j.cell.2012.07.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901815	Bronze			2022-12-01	WOS:000308002300020
J	D'Amico, AV; Smith, MR				D'Amico, Anthony V.; Smith, Matthew R.			Screening for Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; FOLLOW-UP; MORTALITY		[D'Amico, Anthony V.] Brigham & Womens Hosp, Boston, MA 02115 USA; [D'Amico, Anthony V.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Smith, Matthew R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	D'Amico, AV (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [K24CA121990] Funding Source: NIH RePORTER; NCI NIH HHS [K24 CA121990] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Catalona WJ, 2012, ANN INTERN MED, V157, P137, DOI 10.7326/0003-4819-157-2-201207170-00463; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; IVERSEN P, 1995, SCAND J UROL NEPHROL, P65; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Wolf AMD, 2012, NEW ENGL J MED, V366, P2230, DOI 10.1056/NEJMc1204298	10	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7								10.1056/NEJMclde1209426	http://dx.doi.org/10.1056/NEJMclde1209426			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	22894598	Green Accepted			2022-12-01	WOS:000307496600013
J	Berenyi, A; Belluscio, M; Mao, D; Buzsaki, G				Berenyi, Antal; Belluscio, Mariano; Mao, Dun; Buzsaki, Gyoergy			Closed-Loop Control of Epilepsy by Transcranial Electrical Stimulation	SCIENCE			English	Article							DEEP BRAIN-STIMULATION; SLEEP; SPINDLES; MEMORY; SPIKE; RATS	Many neurological and psychiatric diseases are associated with clinically detectable, altered brain dynamics. The aberrant brain activity, in principle, can be restored through electrical stimulation. In epilepsies, abnormal patterns emerge intermittently, and therefore, a closed-loop feedback brain control that leaves other aspects of brain functions unaffected is desirable. Here, we demonstrate that seizure-triggered, feedback transcranial electrical stimulation (TES) can dramatically reduce spike-and-wave episodes in a rodent model of generalized epilepsy. Closed-loop TES can be an effective clinical tool to reduce pathological brain patterns in drug-resistant patients.	[Berenyi, Antal; Belluscio, Mariano; Mao, Dun; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Berenyi, Antal; Buzsaki, Gyoergy] NYU, Sch Med, Inst Neurosci, New York, NY 10016 USA; [Berenyi, Antal] Univ Szeged, Dept Physiol, H-6720 Szeged, Hungary	Rutgers State University Newark; Rutgers State University New Brunswick; New York University; Szeged University	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	gyorgy.buzsaki@nyumc.org	Mao, Dun/AAK-2653-2021; Berényi, Antal/A-9174-2013	Mao, Dun/0000-0001-5523-657X; Berényi, Antal/0000-0003-0084-8530; Buzsaki, Gyorgy/0000-0002-3100-4800	NIH [NS34994, MH54671, NS074015]; Human Frontier Science Program; J. D. McDonnell Foundation; European Community [254780]; Rosztoczy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074015, R01NS034994] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); J. D. McDonnell Foundation; European Community(European Commission); Rosztoczy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS34994, MH54671, and NS074015; the Human Frontier Science Program; and the J. D. McDonnell Foundation. A. B. was supported by a Marie Curie FP7-PEOPLE-2009-IOF grant within the 7th European Community Framework Programme (no. 254780) and by the Rosztoczy Foundation.	Engel J, 2003, EPILEPSIA, V44, P741, DOI 10.1046/j.1528-1157.2003.48202.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2012, ANN NEUROL, V71, P157, DOI 10.1002/ana.22621; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; Hughes JR, 2009, EPILEPSY BEHAV, V15, P404, DOI 10.1016/j.yebeh.2009.06.007; Jackson A, 2011, IEEE T NEUR SYS REH, V19, P534, DOI 10.1109/TNSRE.2011.2158586; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kandel A, 1997, J NEUROSCI, V17, P6783; KOSTOPOULOS G, 1981, EXP NEUROL, V73, P55, DOI 10.1016/0014-4886(81)90045-5; Makeyev O., 2011, C P IEEE ENG MED BIO, V2011, P7560; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Motamedi GK, 2002, EPILEPSIA, V43, P836, DOI 10.1046/j.1528-1157.2002.24901.x; Najib U, 2011, NEUROSURG CLIN N AM, V22, P233, DOI 10.1016/j.nec.2011.01.002; Nitsche MA, 2009, NEUROTHERAPEUTICS, V6, P244, DOI 10.1016/j.nurt.2009.01.003; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rotenberg A, 2009, CLIN NEUROPHYSIOL, V120, P1417, DOI 10.1016/j.clinph.2009.05.004; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Varga ET, 2011, EPILEPSY RES, V97, P142, DOI 10.1016/j.eplepsyres.2011.07.016	27	295	308	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					735	737		10.1126/science.1223154	http://dx.doi.org/10.1126/science.1223154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879515	Green Accepted			2022-12-01	WOS:000307354500055
J	Roehr, B				Roehr, Bob			The slow and unknown route to a cure for AIDS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIV					BobRoehr@aol.com						Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deeks SG, 2012, NATURE, V487, P293, DOI 10.1038/487293a; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Roehr B., 2012, BRIT MED J, V345, pe4859; Roehr B., 2009, SCI AM; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4950; Roehr B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1373	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2012	345								e5265	10.1136/bmj.e5265	http://dx.doi.org/10.1136/bmj.e5265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NG	22885397				2022-12-01	WOS:000307497100006
J	Leakey, MG; Spoor, F; Dean, MC; Feibel, CS; Anton, SC; Kiarie, C; Leakey, LN				Leakey, Meave G.; Spoor, Fred; Dean, M. Christopher; Feibel, Craig S.; Anton, Susan C.; Kiarie, Christopher; Leakey, Louise N.			New fossils from Koobi Fora in northern Kenya confirm taxonomic diversity in early Homo	NATURE			English	Article							OLDUVAI-GORGE; TURKANA-BASIN; PLIOPLEISTOCENE HOMINID; EAST RUDOLF; HABILIS; ETHIOPIA; EVOLUTION; TANZANIA; REGION; MA	Since its discovery in 1972 (ref. 1), the cranium KNM-ER 1470 has been at the centre of the debate over the number of species of early Homo present in the early Pleistocene epoch(2) of eastern Africa. KNM-ER 1470 stands out among other specimens attributed to early Homo because of its larger size, and its flat and subnasally orthognathic face with anteriorly placed maxillary zygomatic roots(3). This singular morphology and the incomplete preservation of the fossil have led to different views as to whether KNM-ER 1470 can be accommodated within a single species of early Homo that is highly variable because of sexual, geographical and temporal factors(4-9), or whether it provides evidence of species diversity marked by differences in cranial size and facial or masticatory adaptation(3,10-20). Here we report on three newly discovered fossils, aged between 1.78 and 1.95 million years (Myr) old, that clarify the anatomy and taxonomic status of KNM-ER 1470. KNM-ER 62000, a well-preserved face of a late juvenile hominin, closely resembles KNM-ER 1470 but is notably smaller. It preserves previously unknown morphology, including moderately sized, mesiodistally long postcanine teeth. The nearly complete mandible KNM-ER 60000 and mandibular fragment KNM-ER 62003 have a dental arcade that is short anteroposteriorly and flat across the front, with small incisors; these features are consistent with the arcade morphology of KNM-ER 1470 and KNM-ER 62000. The new fossils confirm the presence of two contemporary species of early Homo, in addition to Homo erectus, in the early Pleistocene of eastern Africa.	[Leakey, Meave G.; Kiarie, Christopher; Leakey, Louise N.] Turkana Basin Inst, Nairobi 00502, Kenya; [Leakey, Meave G.; Leakey, Louise N.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Spoor, Fred] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Spoor, Fred; Dean, M. Christopher] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Feibel, Craig S.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Feibel, Craig S.] Rutgers State Univ, Dept Anthropol, Piscataway, NJ 08854 USA; [Anton, Susan C.] NYU, Dept Anthropol, New York, NY 10003 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Max Planck Society; University of London; University College London; Rutgers State University New Brunswick; Rutgers State University New Brunswick; New York University	Leakey, MG (corresponding author), Turkana Basin Inst, POB 24926, Nairobi 00502, Kenya.	meaveleakey@gmail.com; f.spoor@eva.mpg.de		Leakey, Louise/0000-0003-3420-6341	Turkana Basin Institute; National Geographic Society; Leakey Foundation; Max Planck Society	Turkana Basin Institute; National Geographic Society(National Geographic Society); Leakey Foundation; Max Planck Society(Max Planck Society)	We thank the Governments of Kenya and Tanzania for permission to carry out this research, the Kenya Wildlife Service for permission to work in the Sibiloi National Park, the National Museums of Kenya and the National Museum of Tanzania for access to specimens in their care, and the Turkana Basin Institute for support. The National Geographic Society, the Leakey Foundation and the Max Planck Society funded fieldwork or laboratory studies. Many people helped us with this research, including N. Adamali, R. Blumenschine, C. Boesch, F. Brown, P. Gunz, J. J. Hublin, W. Kimbel, K. Kupczik, R. Leakey, C. Lepre, D. Lieberman, P. Msemwa, R. Odoyo, R. Quinn, P. Rightmire, L. Schroeder, U. Schwarz, M. Skinner, H. Temming, A. Winzer and B. Wood. Curatorial assistance was given by A. Kweka, F. Manthi, E. Mbua, M. Muungu and J. Thiringi. KNM-ER60000 was discovered by C. Nyete, KNM-ER62000 by D. Elgite and KNM-ER 62003 by R. Moru. We particularly thank the Koobi Fora Research Project field crew: A. Aike, S. Aila, D. Elgite, M. Kirinya, D. Gidole, O. Kyalo, A. Longaye, A. Lawri, E. Linga, J. Lonyericho, S. Lomeiku, D. Muema, A. Moru, R. Moru, S. Muge, C. Nyete, L. Nzuve, H. Sale and A. Sharamo whose fieldwork led to the discovery of these specimens, and camp managers J. Mutuku and T. Ngundo. H. Churcher, J. Coreth, A. Hammond, J. LaCarrubba, F. Kirera, C. Lepre, M. Noback, R. Quinn, M. Skinner, I. Wallace and S. Wright participated in one or more of the 2007, 2008 or 2009 field expeditions when these specimens were discovered. We are grateful to F. and J. Pinto, W. Philips, M. Hettwer, P. Sylvester, H. Buchi, N. Seligman, E. von Simpson, J. Doerr and B. and J. Chelberg for their financial support of this fieldwork.	Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; BROCK A, 1974, NATURE, V247, P344, DOI 10.1038/247344a0; BROMAGE TG, 1995, J HUM EVOL, V28, P71, DOI 10.1006/jhev.1995.1007; BROWN FH, 1986, J GEOL SOC LONDON, V143, P297, DOI 10.1144/gsjgs.143.2.0297; Clarke R. J., 2012, J HUM EVOL; Dean M. Christopher, 2009, P101, DOI 10.1007/978-1-4020-9980-9_10; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Groves C., 1989, THEORY HUMAN PRIMATE; Howell F.C., 1978, P154; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; KRAMER A, 1995, J HUM EVOL, V29, P443, DOI 10.1006/jhev.1995.1068; LEAKEY REF, 1974, NATURE, V248, P653, DOI 10.1038/248653a0; LEAKEY REF, 1973, NATURE, V242, P447, DOI 10.1038/242447a0; LIEBERMAN DE, 1988, J HUM EVOL, V17, P503, DOI 10.1016/0047-2484(88)90039-5; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; McDougall I, 2006, J GEOL SOC LONDON, V163, P205, DOI 10.1144/0016-764904-166; McDougall I, 2012, J GEOL SOC LONDON, V169, P213, DOI 10.1144/0016-76492010-188; Miller JMA, 2000, AM J PHYS ANTHROPOL, V112, P103, DOI 10.1002/(SICI)1096-8644(200005)112:1<103::AID-AJPA10>3.0.CO;2-6; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; Stringer C.B., 1986, P266; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Tobias P. V., 1991, GODUVAI GORGE, V4; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1985, P206; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4	30	116	121	0	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					201	204		10.1038/nature11322	http://dx.doi.org/10.1038/nature11322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985LE	22874966				2022-12-01	WOS:000307267000031
J	Mauldin, RL; Berndt, T; Sipila, M; Paasonen, P; Petaja, T; Kim, S; Kurten, T; Stratmann, F; Kerminen, VM; Kulmala, M				Mauldin, R. L., III; Berndt, T.; Sipilae, M.; Paasonen, P.; Petaja, T.; Kim, S.; Kurten, T.; Stratmann, F.; Kerminen, V-M; Kulmala, M.			A new atmospherically relevant oxidant of sulphur dioxide	NATURE			English	Article							OH MEASUREMENTS; FOREST; OXIDATION; OZONE; ACID; SO2; MECHANISM; SYSTEM; CH2OO; AIR	Atmospheric oxidation is a key phenomenon that connects atmospheric chemistry with globally challenging environmental issues, such as climate change(1), stratospheric ozone loss(2), acidification of soils and water(3), and health effects of air quality(4). Ozone, the hydroxyl radical and the nitrate radical are generally considered to be the dominant oxidants that initiate the removal of trace gases, including pollutants, from the atmosphere. Here we present atmospheric observations from a boreal forest region in Finland, supported by laboratory experiments and theoretical considerations, that allow us to identify another compound, probably a stabilized Criegee intermediate (a carbonyl oxide with two free-radical sites) or its derivative, which has a significant capacity to oxidize sulphur dioxide and potentially other trace gases. This compound probably enhances the reactivity of the atmosphere, particularly with regard to the production of sulphuric acid, and consequently atmospheric aerosol formation. Our findings suggest that this new atmospherically relevant oxidation route is important relative to oxidation by the hydroxyl radical, at least at moderate concentrations of that radical. We also find that the oxidation chemistry of this compound seems to be tightly linked to the presence of alkenes of biogenic origin.	[Mauldin, R. L., III; Sipilae, M.; Paasonen, P.; Petaja, T.; Kurten, T.; Kerminen, V-M; Kulmala, M.] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Mauldin, R. L., III; Kim, S.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Mauldin, R. L., III] Univ Colorado Boulder, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Berndt, T.; Sipilae, M.; Stratmann, F.] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany; [Sipilae, M.] Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Kurten, T.] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland	University of Helsinki; National Center Atmospheric Research (NCAR) - USA; University of Colorado System; University of Colorado Boulder; Leibniz Institut fur Tropospharenforschung (TROPOS); Helsinki Institute of Physics; University of Helsinki	Mauldin, RL (corresponding author), Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland.	roy.mauldin@helsinki.fi	Petäjä, Tuukka/A-8009-2008; Sipilä, Mikko/G-3024-2010; Kurtén, Theo C/G-2120-2012; Kim, Saewung/E-4089-2012; Paasonen, Pauli/M-2972-2013; Kerminen, Veli-Matti/M-9026-2014; Kulmala, Markku T/I-7671-2016	Petäjä, Tuukka/0000-0002-1881-9044; Sipilä, Mikko/0000-0002-8594-7003; Kurtén, Theo C/0000-0002-6416-4931; Kim, Saewung/0000-0003-4847-3272; Paasonen, Pauli/0000-0002-4625-9590; Kulmala, Markku T/0000-0003-3464-7825	European Commission Sixth Framework programme project EUCAARI [036833-2]; Academy of Finland [251427, 139656, 141135]; European Research Council (ATMNUCLE); Kone Foundation; Vaisala Foundation; Maj and Tor Nessling Foundation [2010212]; Otto Malm Foundation; US National Science Foundation	European Commission Sixth Framework programme project EUCAARI; Academy of Finland(Academy of Finland); European Research Council (ATMNUCLE)(European Research Council (ERC)); Kone Foundation; Vaisala Foundation; Maj and Tor Nessling Foundation; Otto Malm Foundation; US National Science Foundation(National Science Foundation (NSF))	We thank K. Pielok and A. Rohmer for technical assistance. This work was partially funded by the European Commission Sixth Framework programme project EUCAARI, contract no. 036833-2 (EUCAARI), the Academy of Finland (251427, 139656, Finnish centre of excellence 141135), the European Research Council (ATMNUCLE), the Kone Foundation, the Vaisala Foundation, the Maj and Tor Nessling Foundation (2010212), the Otto Malm Foundation and the US National Science Foundation.	Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; Berndt T, 2010, ATMOS CHEM PHYS, V10, P7101, DOI 10.5194/acp-10-7101-2010; COCKS AT, 1986, ATMOS ENVIRON, V20, P2359, DOI 10.1016/0004-6981(86)90066-1; COX RA, 1971, NATURE, V230, P321, DOI 10.1038/230321a0; Demore W., 1997, JPL PUBLICATION, V97-4; Di Carlo P, 2004, SCIENCE, V304, P722, DOI 10.1126/science.1094392; Drozd GT, 2011, J PHYS CHEM A, V115, P161, DOI 10.1021/jp108773d; EISELE FL, 1991, J GEOPHYS RES-ATMOS, V96, P9295, DOI 10.1029/91JD00198; Fenger J, 2009, ATMOS ENVIRON, V43, P13, DOI 10.1016/j.atmosenv.2008.09.061; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; HATAKEYAMA S, 1986, J PHYS CHEM-US, V90, P4131, DOI 10.1021/j100408a059; Heald CL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009092; Hofzumahaus A, 2009, SCIENCE, V324, P1702, DOI 10.1126/science.1164566; Jiang L, 2010, J PHYS CHEM A, V114, P12452, DOI 10.1021/jp107783z; Johnson D, 2001, J PHYS CHEM A, V105, P2933, DOI 10.1021/jp003975e; Kurten T, 2011, J PHYS CHEM A, V115, P8669, DOI 10.1021/jp203907d; Kurten T, 2010, PHYS CHEM CHEM PHYS, V12, P12833, DOI 10.1039/c0cp00383b; Lappalainen HK, 2009, ATMOS CHEM PHYS, V9, P5447, DOI 10.5194/acp-9-5447-2009; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Liao H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010984; LIKENS GE, 1972, ENVIRONMENT, V14, P33, DOI 10.1080/00139157.1972.9933001; Lou S, 2010, ATMOS CHEM PHYS, V10, P11243, DOI 10.5194/acp-10-11243-2010; Mauldin RL, 1998, J GEOPHYS RES-ATMOS, V103, P16713, DOI 10.1029/98JD00882; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Petaja T, 2009, ATMOS CHEM PHYS, V9, P7435, DOI 10.5194/acp-9-7435-2009; Rowland FS, 2006, PHILOS T R SOC B, V361, P769, DOI 10.1098/rstb.2005.1783; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Spracklen DV, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033038; Su H, 2011, SCIENCE, V333, P1616, DOI 10.1126/science.1207687; Tanner DJ, 1997, J GEOPHYS RES-ATMOS, V102, P6415, DOI 10.1029/96JD03919; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229; XIE ZD, 1992, J PHYS CHEM-US, V96, P1543, DOI 10.1021/j100183a011	34	342	344	28	620	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					193	196		10.1038/nature11278	http://dx.doi.org/10.1038/nature11278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874964	Green Published			2022-12-01	WOS:000307267000029
J	Prosser, AT; Tang, T; Hall, HI				Prosser, Adria Tassy; Tang, Tian; Hall, H. Irene			HIV in Persons Born Outside the United States, 2007-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOREIGN-BORN; SURVEILLANCE DATA; MEXICAN MIGRANTS; MENTAL-HEALTH; NATIVE-BORN; HIV/AIDS; INFECTION; EPIDEMIC; CARE; IMMIGRANTS	Context Persons born outside the United States comprise about 13% of the US population, and the challenges these persons face in accessing health care may lead to poorer human immunodeficiency virus (HIV) disease outcomes. Objective To describe the epidemiology of HIV among persons born outside the United States and among US-born persons diagnosed in the United States. Design, Setting, and Participants Analysis of the estimated number of US-born persons and persons born outside the United States diagnosed with HIV from 2007 through 2010 in 46 states and 5 US territories, the demographic characteristics, and the HIV transmission risk factors reported to the National HIV Surveillance System. Foreign-born persons were defined as persons born outside the United States and its territories, inclusive of naturalized citizens. Main Outcome Measure Diagnosis of HIV infection. Results From 2007 through 2010, HIV was diagnosed in 191 697 persons in the US population; of these, 16.2% (95% CI, 16.0%-16.3%) (n=30 995) were born outside the United States. Of the 25 255 persons with a specified country or region of birth outside the United States, 14.5% (n=3656) were from Africa, 41.0% (n=10 343) were from Central America (including Mexico), and 21.5% (n=5418) were from the Caribbean. The 4 states (California, Florida, New York, and Texas) reporting the highest numbers of persons born outside the United States and diagnosed with HIV were also the top 4 reporters of HIV cases overall. Among persons born outside the United States with HIV, 73.5% (n=22 773) were male. Among whites, 1841 of 55 574 (3.3%) of HIV diagnoses were in persons born outside the United States; in blacks, 8614 of 86 547 diagnoses (10.0%); in Hispanics, 17 913 of 42 431 diagnoses (42.2%); and in Asians, 1987 of 3088 diagnoses (64.3%). The percentage infected through heterosexual contact was 39.4% among persons born outside the United States vs 27.2% for US-born persons. Conclusions Among persons in 46 US states and 5 US territories who received a diagnosis of HIV from 2007 through 2010, 16.2% were born outside the United States. Compared with US-born persons diagnosed with HIV, persons born outside the United States had different epidemiologic characteristics. JAMA. 2012;308(6):601-607 Published online July 22, 2012. doi:10.1001/jama.2012.9046	[Prosser, Adria Tassy; Hall, H. Irene] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Tang, Tian] ICF Int Inc, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Prosser, AT (corresponding author), CDC, Div HIV AIDS Prevent, 1600 Clifton Rd NE,MS E-47, Atlanta, GA 30333 USA.	ahp8@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention funds all states and the District of Columbia to conduct HIV surveillance and selected areas to conduct HIV incidence surveillance and provides technical assistance to all funded areas.	Akinsete OO, 2007, AIDS PATIENT CARE ST, V21, P356, DOI 10.1089/apc.2006.0074; Aynalem G, 2004, AIDS BEHAV, V8, P25, DOI 10.1023/B:AIBE.0000017523.39818.88; Beckwith CG, 2009, INT J INFECT DIS, V13, P186, DOI 10.1016/j.ijid.2008.06.004; Bouckenooghe Alain R, 2002, J Immigr Health, V4, P81, DOI 10.1023/A:1014546525310; Centers for Disease Control and Prevention, TERMS DEF CALC US CD; Centers for Disease Control and Prevention, DIST PUBL HLTH RES P; Centers for Disease Control and Prevention, HIV SURV REP; Centers for Disease Control and Prevention, 2009, TECHN APP 2 HIVECON; Centers for Disease Control and Prevention, SURV BRIEF SURV SYST; Centers for Disease Control & Prevention, 2011, DIAGN HIV INF AIDS U; Centres for Disease Control and Prevention, SURV BRIEF TERMS DEF; Cunningham SA, 2008, HEALTH PLACE, V14, P623, DOI 10.1016/j.healthplace.2007.12.002; DECOSAS J, 1995, LANCET, V346, P826, DOI 10.1016/S0140-6736(95)91631-8; Department of Health and Human Services; Assistant Secretary for Planning and Evaluation; Office of Human Services Policy, SUMM IMM EL RESTR CU; Department of Homeland Security, 2011, YB IMM STAT 2011; Derose KP, 2009, MED CARE RES REV, V66, P355, DOI 10.1177/1077558708330425; Foley EE, 2005, AIDS CARE, V17, P1030, DOI 10.1080/09540120500100890; Frisbie WP, 2001, AM J EPIDEMIOL, V153, P372, DOI 10.1093/aje/153.4.372; George C, 2007, AIDS CARE, V19, P9, DOI 10.1080/09540120600909398; Green TA, 1998, STAT MED, V17, P143, DOI 10.1002/(SICI)1097-0258(19980130)17:2&lt;143::AID-SIM757&gt;3.0.CO;2-Y; Grieco E, 2010, US CENSUS BUREAU AM; Gushulak B D, 2000, J Immigr Health, V2, P67, DOI 10.1023/A:1009581817682; Haag D, TRENDS HIV POSITIVE; Harawa NT, 2002, AM J PUBLIC HEALTH, V92, P1958, DOI 10.2105/AJPH.92.12.1958; Harrison KM, 2008, PUBLIC HEALTH REP, V123, P618, DOI 10.1177/003335490812300512; Johnson AS, 2010, PUBLIC HEALTH REP, V125, P61, DOI 10.1177/00333549101250S410; Kerani RP, 2008, JAIDS-J ACQ IMM DEF, V49, P102, DOI 10.1097/QAI.0b013e3181831806; MacPherson DW, 2006, EMERG INFECT DIS, V12, P612; Magis-Rodriguez C, 2009, JAIDS-J ACQ IMM DEF, V51, pS21, DOI 10.1097/QAI.0b013e3181a26433; Mali Sonja, 2009, Morbidity and Mortality Weekly Report, V58, P1; Marc LG, 2010, AIDS, V24, P2089, DOI 10.1097/QAD.0b013e32833bedff; Moreno A, 2003, JAIDS-J ACQ IMM DEF, V34, P251, DOI 10.1097/00126334-200310010-00022; Othieno J, 2007, J HEALTH CARE POOR U, V18, P170; Passel JS, PORTRAIT UNAUTHORIZE; Pence BW, 2009, J ANTIMICROB CHEMOTH, V63, P636, DOI 10.1093/jac/dkp006; Prosser A, 2010, 17 C RETR OPP INF FE; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Sanchez MA, 2004, JAIDS-J ACQ IMM DEF, V37, pS204, DOI 10.1097/01.qai.0000141253.54217.24; Schafer J. L., 1997, ANAL INCOMPLETE MULT, DOI [10.1201/9781439821862, DOI 10.1201/]; Serrano MT, 1997, AM J TROP MED HYG, V57, P678, DOI 10.4269/ajtmh.1997.57.678; Shedlin MG, 2006, J URBAN HEALTH, V83, P43, DOI 10.1007/s11524-005-9006-5; Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089; Steel Jennifer, 2003, Transcult Psychiatry, V40, P91, DOI 10.1177/1363461503401006; Thompson A, 2005, HOUS J HLTH L POL, V5, P145; Torian Lucia V., 2011, Morbidity and Mortality Weekly Report, V60, P985; UNAIDS, 2009, WORLD REG SUMM; US Census Bureau, SCHED C COUNTR COD D; US Citizenship and Immigration Services, IMM MED EX; Whetten K, 2008, PSYCHOSOM MED, V70, P531, DOI 10.1097/PSY.0b013e31817749dc; World Health Organization, WHO UNAIDS UNICEF GL; Zaidi IF, 2005, AIDS EDUC PREV, V17, P405, DOI 10.1521/aeap.2005.17.5.405	51	73	73	1	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					601	607		10.1001/jama.2012.9046	http://dx.doi.org/10.1001/jama.2012.9046			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	984YA	22820630	Bronze			2022-12-01	WOS:000307228400027
J	Zhong, FL; Batista, LFZ; Freund, A; Pech, MF; Venteicher, AS; Artandi, SE				Zhong, Franklin L.; Batista, Luis F. Z.; Freund, Adam; Pech, Matthew F.; Venteicher, Andrew S.; Artandi, Steven E.			TPP1 OB-Fold Domain Controls Telomere Maintenance by Recruiting Telomerase to Chromosome Ends	CELL			English	Article							CAJAL BODIES; REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; LENGTH REGULATOR; POT1; RNA; PROTECTION; LOCALIZATION; MUTATIONS; TRF1	Telomere synthesis in cancer cells and stem cells involves trafficking of telomerase to Cajal bodies, and telomerase is thought to be recruited to telomeres through interactions with telomere-binding proteins. Here, we show that the OB-fold domain of the telomere-binding protein TPP1 recruits telomerase to telomeres through an association with the telomerase reverse transcriptase TERT. When tethered away from telomeres and other telomere-binding proteins, the TPP1 OB-fold domain is sufficient to recruit telomerase to a heterologous chromatin locus. Expression of a minimal TPP1 OB-fold inhibits telomere maintenance by blocking access of telomerase to its cognate binding site at telomeres. We identify amino acids required for the TPP1-telomerase interaction, including specific loop residues within the TPP1 OB-fold domain and individual residues within TERT, some of which are mutated in a subset of pulmonary fibrosis patients. These data define a potential interface for telomerase-TPP1 interaction required for telomere maintenance and implicate defective telomerase recruitment in telomerase-related disease.	[Zhong, Franklin L.; Batista, Luis F. Z.; Freund, Adam; Pech, Matthew F.; Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Zhong, Franklin L.; Freund, Adam; Pech, Matthew F.; Artandi, Steven E.] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.] Stanford Univ, Biophys Program, Sch Med, Stanford, CA 94305 USA; [Artandi, Steven E.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493; Zhong, Franklin/0000-0002-0516-6021; Batista, Luis/0000-0002-7538-3240	Agency for Science, Technology, and Research (A*STAR), Singapore; California Institute of Regenerative Medicine; NIH [5T32 CA09302, AG033747, CA125453, CA111691]; NSF; Leukemia and Lymphoma Society; Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA111691, R01CA125453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG033747, R01AG033747] Funding Source: NIH RePORTER	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Amy Li for technical assistance and members of the Artandi lab for helpful discussion. F.L.Z. was supported by a fellowship from the Agency for Science, Technology, and Research (A*STAR), Singapore. L.F.Z.B. was supported by a fellowship from the California Institute of Regenerative Medicine. A. F. was supported by NIH 5T32 CA09302. M. F. P. is the recipient of an NSF graduate research fellowship. This work was supported by NIH grants AG033747, CA125453, and CA111691, by a SCOR grant from the Leukemia and Lymphoma Society, and by the Glenn Foundation for Medical Research.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Armbruster BN, 2003, MOL CELL BIOL, V23, P3237, DOI 10.1128/MCB.23.9.3237-3246.2003; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P990, DOI 10.1038/nsmb.1472; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Savage SA, 2008, MECH AGEING DEV, V129, P35, DOI 10.1016/j.mad.2007.11.002; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devce1.2010.03.011, 10.1016/j.devcel.2010.03.011]; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tsang AR, 2012, AGING CELL, V11, P482, DOI 10.1111/j.1474-9726.2012.00810.x; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Yu EY, 2008, NAT STRUCT MOL BIOL, V15, P985, DOI 10.1038/nsmb.1471; Zappulla DC, 2006, COLD SPRING HARB SYM, V71, P217, DOI 10.1101/sqb.2006.71.011; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	57	203	208	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					481	494		10.1016/j.cell.2012.07.012	http://dx.doi.org/10.1016/j.cell.2012.07.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863003	Green Accepted, Bronze			2022-12-01	WOS:000307301400009
J	Reaves, ML; Sinha, S; Rabinowitz, JD; Kruglyak, L; Redfield, RJ				Reaves, Marshall Louis; Sinha, Sunita; Rabinowitz, Joshua D.; Kruglyak, Leonid; Redfield, Rosemary J.			Absence of Detectable Arsenate in DNA from Arsenate-Grown GFAJ-1 Cells	SCIENCE			English	Article								A strain of Halomonas bacteria, GFAJ-1, has been claimed to be able to use arsenate as a nutrient when phosphate is limiting and to specifically incorporate arsenic into its DNA in place of phosphorus. However, we have found that arsenate does not contribute to growth of GFAJ-1 when phosphate is limiting and that DNA purified from cells grown with limiting phosphate and abundant arsenate does not exhibit the spontaneous hydrolysis expected of arsenate ester bonds. Furthermore, mass spectrometry showed that this DNA contains only trace amounts of free arsenate and no detectable covalently bound arsenate.	[Sinha, Sunita; Redfield, Rosemary J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Reaves, Marshall Louis] Univ British Columbia, Dept Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	University of British Columbia; Howard Hughes Medical Institute; Princeton University; University of British Columbia; Princeton University; Princeton University	Redfield, RJ (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	redfield@zoology.ubc.ca	Redfield, Rosemary/K-5633-2012; Rabinowitz, Joshua/GPP-4019-2022	Redfield, Rosemary/0000-0001-8940-587X; Rabinowitz, Joshua/0000-0002-1247-4727	National Science Foundation; Canadian Institutes of Health Research	National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	M.L.R. is supported by a Graduate Research Fellowship from the National Science Foundation. J.D.R. is supported by the CAREER Award from the National Science Foundation. L.K. is an Investigator of the Howard Hughes Medical Institute and a James S. McDonnell Foundation Centennial Fellow. R.J.R. thanks the Canadian Institutes of Health Research for funding and J. Blum and R. Oremland for providing strain GFAJ-1; M. Khoshnoodi for the trace-element mix; the Charles Thompson lab for use of their BioScreen Analyzer; and S. Silver and C. Rensing for helpful discussions. We also thank the ICP Laboratory in the Department of Geosciences at Princeton University for assistance with ICP-MS analysis.	Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BAER CD, 1981, INORG CHEM, V20, P905, DOI 10.1021/ic50217a052; Cotner JB, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00132; Hess DC, 2006, PLOS BIOL, V4, P2012, DOI 10.1371/journal.pbio.0040351; Lebrun E, 2003, MOL BIOL EVOL, V20, P686, DOI 10.1093/molbev/msg071; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Schoepp-Cothenet B, 2011, SCIENCE, V332, DOI 10.1126/science.1201438; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; Wolfe-Simon F., 2011, SCIENCE, V332, P1149; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258; Zimmermann MT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-264	11	82	83	0	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					470	473		10.1126/science.1219861	http://dx.doi.org/10.1126/science.1219861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22773140	Green Submitted, Green Accepted			2022-12-01	WOS:000306802300044
J	Eloubeidi, MA; El Majzoub, NW				Eloubeidi, Mohamad A.; El Majzoub, Nadim Walid			Duodenal Dieulafoy's Lesion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Eloubeidi, Mohamad A.; El Majzoub, Nadim Walid] Amer Univ Beirut, Beirut, Lebanon	American University of Beirut	Eloubeidi, MA (corresponding author), Amer Univ Beirut, Beirut, Lebanon.	me75@aub.edu.lb		El Majzoub, Nadim/0000-0002-6803-478X					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					E6	E6		10.1056/NEJMicm1014025	http://dx.doi.org/10.1056/NEJMicm1014025			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830483				2022-12-01	WOS:000306738300011
J	Mermin, J; Fenton, KA				Mermin, Jonathan; Fenton, Kevin A.			The Future of HIV Prevention in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COST-EFFECTIVENESS; INFECTION		[Mermin, Jonathan] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Mermin, Jonathan; Fenton, Kevin A.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mermin, J (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Mailstop E-21,1600 Clifton Rd, Atlanta, GA 30333 USA.	jhm7@cdc.gov	Mermin, Jonathan/J-9847-2012					[Anonymous], DIV HIV AIDS PREV AN; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Holtgrave DR, 2012, AIDS BEHAV, V16, P1365, DOI 10.1007/s10461-012-0207-0; Hutchinson AB, 2012, JAIDS-J ACQ IMM DEF, V59, P281, DOI 10.1097/QAI.0b013e31823e5bee; Koppenhaver RT, 2011, JAIDS-J ACQ IMM DEF, V58, pE51, DOI 10.1097/QAI.0b013e31822b74fe; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Steele CB, 2007, HLTH DISPARITIES HIV	10	30	30	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2012	308	4					347	348		10.1001/jama.2012.8693	http://dx.doi.org/10.1001/jama.2012.8693			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977SR	22820785				2022-12-01	WOS:000306685500020
J	Behrmann, E; Muller, M; Penczek, PA; Mannherz, HG; Manstein, DJ; Raunser, S				Behrmann, Elmar; Mueller, Mirco; Penczek, Pawel A.; Mannherz, Hans Georg; Manstein, Dietmar J.; Raunser, Stefan			Structure of the Rigor Actin-Tropomyosin-Myosin Complex	CELL			English	Article							MUSCLE THIN-FILAMENTS; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; CROSS-BRIDGE CYCLE; F-ACTIN; SKELETAL-MUSCLE; ELECTRON CRYOMICROSCOPY; ACTOMYOSIN COMPLEX; HELICAL FILAMENTS; MOTOR FUNCTIONS; N-TERMINUS	Regulation of myosin and filamentous actin interaction by tropomyosin is a central feature of contractile events in muscle and nonmuscle cells. However, little is known about molecular interactions within the complex and the trajectory of tropomyosin movement between its "open" and "closed" positions on the actin filament. Here, we report the 8 angstrom resolution structure of the rigor (nucleotide-free) actin-tropomyosin-myosin complex determined by cryo-electron microscopy. The pseudoatomic model of the complex, obtained from fitting crystal structures into the map, defines the large interface involving two adjacent actin monomers and one tropomyosin pseudorepeat per myosin contact. Severe forms of hereditary myopathies are linked to mutations that critically perturb this interface. Myosin binding results in a 23 angstrom shift of tropomyosin along actin. Complex domain motions occur in myosin, but not in actin. Based on our results, we propose a structural model for the tropomyosin-dependent modulation of myosin binding to actin.	[Mueller, Mirco; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Behrmann, Elmar; Mannherz, Hans Georg; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Penczek, Pawel A.] Univ Texas Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Mannherz, Hans Georg] Ruhr Univ Bochum, Dept Anat & Mol Embryol, D-44801 Bochum, Germany	Hannover Medical School; Max Planck Society; University of Texas System; University of Texas Health Science Center Houston; Ruhr University Bochum	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de; raunser@mpi-dortmund.mpg.de	Behrmann, Elmar/I-5808-2015; Manstein, Dietmar J. J/M-1034-2013; Raunser, Stefan/AHE-1573-2022; Manstein, Dietmar J./AAG-2640-2019	Behrmann, Elmar/0000-0001-6794-3669; Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147; Raunser, Stefan/0000-0001-9373-3016; Mannherz, Hans Georg/0000-0001-8158-5722	Deutsche Forschungsgemeinschaft [RA 1781/1-1, MA 807/17-2, MA 1081/11-2]; Fonds der chemischen Industrie [684052]; European Union [228971]; NIH [GM U54 094598, GM R01 60635]; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094598, R01GM060635] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to R.S. Goody for continuous support and thank him and C. Ungermann for useful comments on the manuscript. We thank O. Hofnagel for assistance at the electron microscope and I. Vetter for help with the installation of SPARX. We are grateful to G. Schroder for helpful comments on the use of DireX and W. Lehman for providing the tropomyosin model in the B state. We thank K. Chinthalapudi, R. Diensthuber, S.M. Heissler, and M. Taft for providing purified proteins. This work was supported by the "Deutsche Forschungsgemeinschaft" Grants RA 1781/1-1 (to S.R.), MA 807/17-2 (to H.G.M.), MA 1081/11-2 (to. D.J.M.), the "Fonds der chemischen Industrie" Grant 684052 (to E. B.), funding from the European Union Seventh Framework Programme (FP7/2007-2011) under grant agreement number 228971 (Molecular Motors-based Nano Devices-MONAD) (to D.J.M.), the NIH Grants GM U54 094598 and GM R01 60635 (to P.A.P.), and the Max Planck Society (to S.R. and E.B.).	Behrmann E, 2012, J STRUCT BIOL, V177, P302, DOI 10.1016/j.jsb.2011.12.020; Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580; Conibear PB, 2003, NAT STRUCT BIOL, V10, P831, DOI 10.1038/nsb986; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; EATON BL, 1976, SCIENCE, V192, P1337, DOI 10.1126/science.131972; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; GEEVES MA, 1986, PROC R SOC SER B-BIO, V229, P85, DOI 10.1098/rspb.1986.0076; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Giese KC, 1997, BIOCHEMISTRY-US, V36, P8465, DOI 10.1021/bi963141f; Goodson HV, 1999, J MOL BIOL, V287, P173, DOI 10.1006/jmbi.1999.2565; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hansen JE, 2000, BIOCHEMISTRY-US, V39, P1792, DOI 10.1021/bi991873c; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; Holthauzen LMF, 2004, J BIOL CHEM, V279, P15204, DOI 10.1074/jbc.M308904200; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; HUXLEY HE, 1980, NATURE, V284, P140, DOI 10.1038/284140a0; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; Joel PB, 2001, J BIOL CHEM, V276, P2998, DOI 10.1074/jbc.M006930200; Kim E, 2002, BIOCHEMISTRY-US, V41, P86, DOI 10.1021/bi0113824; Klein JC, 2008, P NATL ACAD SCI USA, V105, P12867, DOI 10.1073/pnas.0802286105; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Li XC, 2010, J STRUCT BIOL, V170, P313, DOI 10.1016/j.jsb.2010.01.016; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Miller CJ, 1996, BIOCHEMISTRY-US, V35, P16557, DOI 10.1021/bi962388+; MILLIGAN RA, 1987, J CELL BIOL, V105, P29, DOI 10.1083/jcb.105.1.29; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Sasaki N, 1999, J BIOL CHEM, V274, P37840, DOI 10.1074/jbc.274.53.37840; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Splettstoesser T, 2011, PROTEINS, V79, P2033, DOI 10.1002/prot.23017; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Van Dijk J, 1999, BIOCHEMISTRY-US, V38, P15078, DOI 10.1021/bi991595h; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Volkmann N, 2003, P NATL ACAD SCI USA, V100, P3227, DOI 10.1073/pnas.0536510100	53	245	247	1	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 20	2012	150	2					327	338		10.1016/j.cell.2012.05.037	http://dx.doi.org/10.1016/j.cell.2012.05.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817895	Bronze, Green Accepted			2022-12-01	WOS:000306595700012
J	Li, JX; McQuade, T; Siemer, AB; Napetschnig, J; Moriwaki, K; Hsiao, YS; Damko, E; Moquin, D; Walz, T; McDermott, A; Chan, FKM; Wu, H				Li, Jixi; McQuade, Thomas; Siemer, Ansgar B.; Napetschnig, Johanna; Moriwaki, Kenta; Hsiao, Yu-Shan; Damko, Ermelinda; Moquin, David; Walz, Thomas; McDermott, Ann; Chan, Francis Ka-Ming; Wu, Hao			The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis	CELL			English	Article							RECEPTOR-INTERACTING PROTEIN; NF-KAPPA-B; HOMOTYPIC INTERACTION MOTIF; INNATE IMMUNE-RESPONSE; SOLID-STATE NMR; CELL-DEATH; TNF-ALPHA; RIP3; APOPTOSIS; DOMAIN	RIP1 and RIP3 kinases are central players in TNF-induced programmed necrosis. Here, we report that the RIP homotypic interaction motifs (RHIMs) of RIP1 and RIP3 mediate the assembly of heterodimeric filamentous structures. The fibrils exhibit classical characteristics of beta-amyloids, as shown by Thioflavin T (ThT) and Congo red (CR) binding, circular dichroism, infrared spectroscopy, X-ray diffraction, and solid-state NMR. Structured amyloid cores are mapped in RIP1 and RIP3 that are flanked by regions of mobility. The endogenous RIP1/RIP3 complex isolated from necrotic cells binds ThT, is ultrastable, and has a fibrillar core structure, whereas necrosis is partially inhibited by ThT, CR, and another amyloid dye, HBX. Mutations in the RHIMs of RIP1 and RIP3 that are defective in the interaction compromise cluster formation, kinase activation, and programmed necrosis in vivo. The current study provides insight into the structural changes that occur when RIP kinases are triggered to execute different signaling outcomes and expands the realm of amyloids to complex formation and signaling.	[Li, Jixi; Napetschnig, Johanna; Damko, Ermelinda; Wu, Hao] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [McQuade, Thomas; Moriwaki, Kenta; Moquin, David; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Program Immunol & Virol, Dept Pathol, Worcester, MA 01655 USA; [Siemer, Ansgar B.; McDermott, Ann] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Hsiao, Yu-Shan; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Cornell University; University of Massachusetts System; University of Massachusetts Worcester; Columbia University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Wu, H (corresponding author), Childrens Hosp Boston, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA.	hao.wu@childrens.harvard.edu	Chan, Francis/ABB-1895-2021; Chan, Francis Ka-Ming/E-9647-2014	Chan, Francis Ka-Ming/0000-0002-4803-8353; Walz, Thomas/0000-0003-2606-2835; Moriwaki, Kenta/0000-0002-8724-4715; McDermott, Ann/0000-0002-9249-1649	NIH [T32 AI07349];  [AI083497];  [AI088502];  [AI045937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045937, R21AI088502, R01AI083497, T32AI007349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Cohen-Gould for help with EM imaging at the Weill Cornell Microscopy Facility, S.M. Damo for initial work on this project, Q. Li for insect cell expression, V. Kumar for ThT measurement of endogenous complexes, and D. Porter (Novartis) for the generous gift of LBW242. This work was supported by grants to F.K.C. (AI083497 and AI088502) and H.W. (AI045937). F.K.C. is a member of the UMass DERC (DK32520). J.N. is an Irvington Institute postdoctoral fellow of the Cancer Research Institute, and D.M. is supported by NIH training grant T32 AI07349. T.W. is an investigator in the Howard Hughes Medical Institute.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Avila J, 2010, BIOCHEM SOC T, V38, P977, DOI 10.1042/BST0380977; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Challa S, 2010, J VIROL, V84, P10467, DOI 10.1128/JVI.00983-10; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cho Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023209; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Detken A, 2002, CHEM PHYS LETT, V356, P298, DOI 10.1016/S0009-2614(02)00335-4; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li ZL, 2010, J ELECTRON MICROSC, V59, P53, DOI 10.1093/jmicro/dfp036; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Ramshini H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016075; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310; Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J., 2012, P NATL ACAD SCI US	59	734	758	9	141	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 20	2012	150	2					339	350		10.1016/j.cell.2012.06.019	http://dx.doi.org/10.1016/j.cell.2012.06.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817896	Green Accepted, Bronze			2022-12-01	WOS:000306595700013
J	Melles, M; Brigham-Grette, J; Minyuk, PS; Nowaczyk, NR; Wennrich, V; DeConto, RM; Anderson, PM; Andreev, AA; Coletti, A; Cook, TL; Haltia-Hovi, E; Kukkonen, M; Lozhkin, AV; Rosen, P; Tarasov, P; Vogel, H; Wagner, B				Melles, Martin; Brigham-Grette, Julie; Minyuk, Pavel S.; Nowaczyk, Norbert R.; Wennrich, Volker; DeConto, Robert M.; Anderson, Patricia M.; Andreev, Andrei A.; Coletti, Anthony; Cook, Timothy L.; Haltia-Hovi, Eeva; Kukkonen, Maaret; Lozhkin, Anatoli V.; Rosen, Peter; Tarasov, Pavel; Vogel, Hendrik; Wagner, Bernd			2.8 Million Years of Arctic Climate Change from Lake El'gygytgyn, NE Russia	SCIENCE			English	Article							ANTARCTIC ICE-SHEET; LATE PLIOCENE; PLEISTOCENE; PACIFIC; QUATERNARY; VARIABILITY; GREENLAND; RECORD; VEGETATION; RESOLUTION	The reliability of Arctic climate predictions is currently hampered by insufficient knowledge of natural climate variability in the past. A sediment core from Lake El'gygytgyn in northeastern (NE) Russia provides a continuous, high-resolution record from the Arctic, spanning the past 2.8 million years. This core reveals numerous "super interglacials" during the Quaternary; for marine benthic isotope stages (MIS) 11c and 31, maximum summer temperatures and annual precipitation values are similar to 4 degrees to 5 degrees C and similar to 300 millimeters higher than those of MIS 1 and 5e. Climate simulations show that these extreme warm conditions are difficult to explain with greenhouse gas and astronomical forcing alone, implying the importance of amplifying feedbacks and far field influences. The timing of Arctic warming relative to West Antarctic Ice Sheet retreats implies strong interhemispheric climate connectivity.	[Melles, Martin; Wennrich, Volker; Andreev, Andrei A.; Kukkonen, Maaret; Vogel, Hendrik; Wagner, Bernd] Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; [Brigham-Grette, Julie; DeConto, Robert M.; Coletti, Anthony; Cook, Timothy L.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Minyuk, Pavel S.; Lozhkin, Anatoli V.] Russian Acad Sci, NE Interdisciplinary Sci Res Inst, Far E Branch, Magadan 685000, Russia; [Nowaczyk, Norbert R.; Haltia-Hovi, Eeva] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany; [Anderson, Patricia M.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Rosen, Peter] Umea Univ, Climate Impacts Res Ctr, SE-98107 Abisko, Sweden; [Tarasov, Pavel] Free Univ Berlin, Inst Geol Sci, D-12249 Berlin, Germany	University of Cologne; University of Massachusetts System; University of Massachusetts Amherst; Russian Academy of Sciences; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Washington; University of Washington Seattle; Umea University; Free University of Berlin	Melles, M (corresponding author), Univ Cologne, Inst Geol & Mineral, Zuelpicher Str 49A, D-50674 Cologne, Germany.	mmelles@uni-koeln.de	Tarasov, Pavel/ABG-3993-2020; Andreev, Andrei A/J-2701-2015; Melles, Martin/J-4070-2012; Vogel, Hendrik/C-6148-2014; Wagner, Bernd/J-4682-2012; Wennrich, Volker/I-3435-2012; Vogel, Hendrik/ABG-1123-2020	Tarasov, Pavel/0000-0002-7219-5009; Andreev, Andrei A/0000-0002-8745-9636; Melles, Martin/0000-0003-0977-9463; Vogel, Hendrik/0000-0002-9902-8120; Wagner, Bernd/0000-0002-1369-7893; Wennrich, Volker/0000-0003-3617-1963; Cook, Timothy/0000-0002-4982-6415	ICDP; NSF; German Federal Ministry of Education and Research (BMBF); Alfred Wegener Institute; Helmholtz Centre Potsdam (GFZ); Russian Academy of Sciences Far East Branch; Russian Foundation for Basic Research; Austrian Federal Ministry of Science and Research; BMBF [03G0642]; German Research Foundation (Deutsche Forschungsgemeinschaft) [ME 1169/21, ME 1169/24]; NSF [0602471]; Vetenskapsradet; Swedish Research Council; Kempe Foundation; Civilian Research and Development Foundation [RUG1-2987-MA-10]	ICDP; NSF(National Science Foundation (NSF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Alfred Wegener Institute; Helmholtz Centre Potsdam (GFZ); Russian Academy of Sciences Far East Branch(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Austrian Federal Ministry of Science and Research; BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Vetenskapsradet(Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation; Civilian Research and Development Foundation	Drilling operations were funded by the ICDP, the NSF, the German Federal Ministry of Education and Research (BMBF), Alfred Wegener Institute and Helmholtz Centre Potsdam (GFZ), the Russian Academy of Sciences Far East Branch, the Russian Foundation for Basic Research, and the Austrian Federal Ministry of Science and Research. The Russian Global Lake Drilling 800 drilling system was developed and operated by DOSECC. We thank all participants of the expedition for their engagement during recovery of the ICDP 5011-1 cores. Funding of core analyses was provided by BMBF (grant 03G0642), German Research Foundation (Deutsche Forschungsgemeinschaft, grants ME 1169/21 and ME 1169/24), the NSF (grant 0602471), Vetenskapsradet, The Swedish Research Council, the Kempe Foundation, and the Civilian Research and Development Foundation (grant RUG1-2987-MA-10). We thank N. Mantke, A. Shahnazarian, and numerous students (Univ. of Cologne) for their competent help in core processing; T. Matrosova for contributing modern surface pollen data; and R. McKay for providing a modified lithological log of the ANDRILL 1B record. We also thank four anonymous reviewers for supportive and constructive comments that greatly improved the manuscript. The data reported in this paper are available in the databases of PANGAEA via www.pangaea.de (DOI:10.1594/PANGAEA.783305) and of the U. S. National Climatic Data Center via www. ncdc.noaa.gov/paleo/paleolim/paleolim_data.html.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson P, 2006, QUATERNARY SCI REV, V25, P1383, DOI 10.1016/j.quascirev.2006.01.033; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; BRIGHAMGRETTE J, 1992, ARCTIC, V45, P74; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Colville EJ, 2011, SCIENCE, V333, P620, DOI 10.1126/science.1204673; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; DeConto RM, 2012, GLOBAL PLANET CHANGE, V88-89, P45, DOI 10.1016/j.gloplacha.2012.03.003; Demske D, 2002, PALAEOGEOGR PALAEOCL, V184, P107, DOI 10.1016/S0031-0182(02)00251-1; Elias SA, 2002, CAN J EARTH SCI, V39, P911, DOI 10.1139/E01-096; Fawcett PJ, 2011, NATURE, V470, P518, DOI 10.1038/nature09839; Foldvik A, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002008; Fradkina A. F., 2005, 382 GEOL SOC AM; Funder S, 2001, B GEOL SOC DENMARK, V48, P117; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Gischler E, 2010, SEDIMENTOLOGY, V57, P1049, DOI 10.1111/j.1365-3091.2009.01133.x; Goodfriend GA, 1996, QUATERNARY RES, V45, P176, DOI 10.1006/qres.1996.0018; Hall IR, 2001, NATURE, V412, P809, DOI 10.1038/35090552; Haug G. H., 1995, P ODP SCI RESULTS, V145, P293, DOI DOI 10.2973/ODP.PROC.SR.145.115.1995; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Helmke JP, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000794; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Jaccard SL, 2010, QUATERNARY SCI REV, V29, P206, DOI 10.1016/j.quascirev.2009.10.007; KAUFMAN DS, 1993, QUATERNARY SCI REV, V12, P21, DOI 10.1016/0277-3791(93)90046-O; Koenig SJ, 2011, CLIM DYNAM, V37, P1247, DOI 10.1007/s00382-011-1050-0; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Layer PW, 2000, METEORIT PLANET SCI, V35, P591, DOI 10.1111/j.1945-5100.2000.tb01439.x; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Maiorano P, 2009, MAR MICROPALEONTOL, V71, P166, DOI 10.1016/j.marmicro.2009.03.002; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; McKay R, 2012, QUATERNARY SCI REV, V34, P93, DOI 10.1016/j.quascirev.2011.12.012; Melles M, 2007, J PALEOLIMNOL, V37, P89, DOI 10.1007/s10933-006-9025-6; Melles M, 2011, SCI DRILL, V11, P29, DOI 10.2204/iodp.sd.11.03.2011; Miller GH, 2010, QUATERNARY SCI REV, V29, P1679, DOI 10.1016/j.quascirev.2010.03.001; Miller GH, 2010, QUATERNARY SCI REV, V29, P1779, DOI 10.1016/j.quascirev.2010.02.008; Milne GA, 2008, QUATERNARY SCI REV, V27, P2292, DOI 10.1016/j.quascirev.2008.08.018; Mock CJ, 1998, INT J CLIMATOL, V18, P1085, DOI 10.1002/(SICI)1097-0088(199808)18:10<1085::AID-JOC305>3.0.CO;2-K; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nolan M., 2012, CLIM PAST DISCUSS, V8, P1443, DOI DOI 10.5194/CPD-8-1443-2012; Nolan M, 2007, J PALEOLIMNOL, V37, P17, DOI 10.1007/s10933-006-9020-y; O'Regan M, 2011, OCEANOGRAPHY, V24, P66, DOI 10.5670/oceanog.2011.57; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Polyak L, 2011, OCEANOGRAPHY, V24, P52, DOI 10.5670/oceanog.2011.55; Prokopenko AA, 2010, CLIM PAST, V6, P31, DOI 10.5194/cp-6-31-2010; Raymo ME, 2012, NATURE, V483, P453, DOI 10.1038/nature10891; Scherer RP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032254; Shuster DL, 2005, SCIENCE, V310, P1668, DOI 10.1126/science.1118519; Stein R, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001639; Tarasov PE, 2011, EARTH-SCI REV, V108, P64, DOI 10.1016/j.earscirev.2011.06.002; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Woodgate RA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041621; Yin Q. Z., 2011, CLIM DYNAM, V36, P1	55	316	326	6	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					315	320		10.1126/science.1222135	http://dx.doi.org/10.1126/science.1222135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22722254				2022-12-01	WOS:000306542600044
J	Landon, BE; Keating, NL; Barnett, ML; Onnela, JP; Paul, S; O'Malley, AJ; Keegan, T; Christakis, NA				Landon, Bruce E.; Keating, Nancy L.; Barnett, Michael L.; Onnela, Jukka-Pekka; Paul, Sudeshna; O'Malley, A. James; Keegan, Thomas; Christakis, Nicholas A.			Variation in Patient-Sharing Networks of Physicians Across the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE; SOCIAL NETWORKS; REGIONAL-VARIATIONS; QUALITY; COOPERATION; SPECIALIST; CHOICE	Context Physicians are embedded in informal networks that result from their sharing of patients, information, and behaviors. Objectives To identify professional networks among physicians, examine how such networks vary across geographic regions, and determine factors associated with physician connections. Design, Setting, and Participants Using methods adopted from social network analysis, Medicare administrative data from 2006 were used to study 4 586 044 Medicare beneficiaries seen by 68 288 physicians practicing in 51 hospital referral regions (HRRs). Distinct networks depicting connections between physicians (defined based on shared patients) were constructed for each of the 51 HRRs. Main Outcomes Measures Variation in network characteristics across HRRs and factors associated with physicians being connected. Results The number of physicians per HRR ranged from 135 in Minot, North Dakota, to 8197 in Boston, Massachusetts. There was substantial variation in network characteristics across HRRs. For example, the mean (SD) adjusted degree (number of other physicians each physician was connected to per 100 Medicare beneficiaries) across all HRRs was 27.3 (range, 11.7-54.4); also, primary care physician relative centrality (how central primary care physicians were in the network relative to other physicians) ranged from 0.19 to 1.06, suggesting that primary care physicians were more than 5 times more central in some markets than in others. Physicians with ties to each other were far more likely to be based at the same hospital (69.2% of unconnected physician pairs vs 96.0% of connected physician pairs; adjusted rate ratio, 0.12 [95% CI, 0.12-0.12]; P < .001), and were in closer geographic proximity (mean office distance of 21.1 km for those with connections vs 38.7 km for those without connections, P < .001). Connected physicians also had more similar patient panels in terms of the race or illness burden than unconnected physicians. For instance, connected physician pairs had an average difference of 8.8 points in the percentage of black patients in their 2 patient panels compared with a difference of 14.0 percentage points for unconnected physician pairs (P < .001). Conclusions Network characteristics vary across geographic areas. Physicians tend to share patients with other physicians with similar physician-level and patient-panel characteristics. JAMA. 2012;308(3):265-273 www.jama.com	[Landon, Bruce E.; Keating, Nancy L.; Barnett, Michael L.; Paul, Sudeshna; O'Malley, A. James; Keegan, Thomas; Christakis, Nicholas A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02215 USA; [Landon, Bruce E.; Keating, Nancy L.; Barnett, Michael L.; Paul, Sudeshna; O'Malley, A. James; Keegan, Thomas; Christakis, Nicholas A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA; [Onnela, Jukka-Pekka] Harvard Univ, Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA; [Onnela, Jukka-Pekka] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Christakis, Nicholas A.] Harvard Univ, Dept Sociol, Fac Arts & Sci, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Harvard Univ, Dept Sociol, Fac Arts & Sci, Boston, MA 02215 USA; [Landon, Bruce E.; Christakis, Nicholas A.] Beth Israel Deaconess Med Ctr, Dept Med, Div Primary Care & Gen Internal Med, Boston, MA 02215 USA; [Keating, Nancy L.; Barnett, Michael L.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02215 USA.	landon@hcp.med.harvard.edu	Barnett, Michael/ABA-4159-2021; Keating, Nancy L/I-9968-2019; Barnett, Michael/AAF-4017-2019	Barnett, Michael/0000-0002-4884-6609; Keating, Nancy L/0000-0002-8274-4681; Barnett, Michael/0000-0002-4884-6609	National Institute on Aging [P-01 AG-031093]; Doris Duke Charitable Foundation Clinical Research Fellowship; Harvard Medical School Research Fellowship; NATIONAL INSTITUTE ON AGING [P01AG031093] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Doris Duke Charitable Foundation Clinical Research Fellowship(Doris Duke Charitable Foundation (DDCF)); Harvard Medical School Research Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grant P-01 AG-031093 from the National Institute on Aging. Dr Barnett was supported by a Doris Duke Charitable Foundation Clinical Research Fellowship and a Harvard Medical School Research Fellowship.	[Anonymous], 1966, MEDICAL INNOVATION; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Baldwin LM, 2002, MED CARE, V40, P82; Barnett ML, 2012, J GEN INTERN MED, V27, P506, DOI 10.1007/s11606-011-1861-z; Barnett ML, 2012, MED CARE, V50, P152, DOI 10.1097/MLR.0b013e31822dcef7; Barnett ML, 2011, HEALTH SERV RES, V46, P1592, DOI 10.1111/j.1475-6773.2011.01262.x; BREIGER RL, 1974, SOC FORCES, V53, P181, DOI 10.2307/2576011; Bynum JPW, 2007, HEALTH SERV RES, V42, P45, DOI 10.1111/j.1475-6773.2006.00633.x; Dartmouth Medical School Center for the Evaluative Clinical Sciences, 1998, DARTM ATL HLTH CAR; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Everett M.G., 2005, MODELS METHODS SOCIA, P57, DOI [10.1017/cbo9780511811395.004, DOI 10.1017/CBO9780511811395.004]; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Ingenix Inc, WHAT AR ETGS; Iwashyna TJ, 2009, CHEST, V135, P827, DOI 10.1378/chest.08-1052; Keating NL, 2007, J GEN INTERN MED, V22, P794, DOI 10.1007/s11606-007-0190-8; Keating NL, 1998, JAMA-J AM MED ASSOC, V280, P900, DOI 10.1001/jama.280.10.900; Kinchen KS, 2004, ANN FAM MED, V2, P245, DOI 10.1370/afm.68; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Newman M, 2018, NETWORKS INTRO, DOI [DOI 10.1093/ACPROF:OSO/9780199206650.001.0001, 10.1162/artl_r_00062]; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Pollack CE, 2012, HEALTH SERV RES, V47, P380, DOI 10.1111/j.1475-6773.2011.01331.x; Pope GC, RISK ADJUSTMENT MEDI; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Wasserman S., 1994, NETWORK ANAL METHODS; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102	28	171	171	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2012	308	3					265	273		10.1001/jama.2012.7615	http://dx.doi.org/10.1001/jama.2012.7615			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975AC	22797644	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000306477900027
J	Wiggins, NM				Wiggins, Natasha M.			Stop using military metaphors for disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									Essex Cty Hosp, Dept Oncol, Colchester CO3 3NB, Essex, England		Wiggins, NM (corresponding author), Essex Cty Hosp, Dept Oncol, Colchester CO3 3NB, Essex, England.	natasha.wiggins@ic.ac.uk						Armstrong S., 2006, WAR TERROR; Benson J., 2010, I DO NOT BATTLE MY C; Pickering N, 1999, THEOR MED BIOETH, V20, P361, DOI 10.1023/A:1005403411725; Pirandello L., 1922, MAN FLOWER HIS MOUTH	4	17	17	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 12	2012	345								e4706	10.1136/bmj.e4706	http://dx.doi.org/10.1136/bmj.e4706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975NW	22791794				2022-12-01	WOS:000306519000008
J	Carter, RM; Bowling, DL; Reeck, C; Huettel, SA				Carter, R. McKell; Bowling, Daniel L.; Reeck, Crystal; Huettel, Scott A.			A Distinct Role of the Temporal-Parietal Junction in Predicting Socially Guided Decisions	SCIENCE			English	Article							HUMAN BRAIN; MIND; GAME; COGNITION; BEHAVIOR	To make adaptive decisions in a social context, humans must identify relevant agents in the environment, infer their underlying strategies and motivations, and predict their upcoming actions. We used functional magnetic resonance imaging, in conjunction with combinatorial multivariate pattern analysis, to predict human participants' subsequent decisions in an incentive-compatible poker game. We found that signals from the temporal-parietal junction provided unique information about the nature of the upcoming decision, and that information was specific to decisions against agents who were both social and relevant for future behavior.	[Carter, R. McKell; Bowling, Daniel L.; Reeck, Crystal; Huettel, Scott A.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; [Carter, R. McKell; Bowling, Daniel L.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Carter, R. McKell; Huettel, Scott A.] Duke Univ, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; [Reeck, Crystal; Huettel, Scott A.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Huettel, SA (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	scott.huettel@duke.edu		Bowling, Daniel/0000-0002-5303-5472; Carter, R. McKell/0000-0003-2235-6529	National Institute of Mental Health (NIMH) [R01-70685, R01-86712]; National Institute of Neurological Disorders and Stroke [P01-41328]; NSF; Duke Institute for Brain Sciences;  [5T32-NS051156-04]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070685, R01MH086712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS051156, P01NS041328] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); Duke Institute for Brain Sciences; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank P. Kragel and J. Pearson for assistance with analyses; D. Murty for assistance with data collection; and N. Clement, L. Harris, K. LaBar, M. Platt, V. Venkatraman, K. Watson, and A. Winecoff for comments on the manuscript. This project was supported by National Institute of Mental Health (NIMH) grant R01-70685, NIMH R01-86712, and National Institute of Neurological Disorders and Stroke P01-41328. R. M. C. was supported by 5T32-NS051156-04. C. R. was supported by an NSF Graduate Research Fellowship. S. A. H. was supported by an Incubator Award from the Duke Institute for Brain Sciences.	ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bhatt MA, 2010, P NATL ACAD SCI USA, V107, P19720, DOI 10.1073/pnas.1009625107; Blakemore SJ, 2003, CEREB CORTEX, V13, P837, DOI 10.1093/cercor/13.8.837; Bonaccio S, 2006, ORGAN BEHAV HUM DEC, V101, P127, DOI 10.1016/j.obhdp.2006.07.001; Clithero JA, 2009, NEUROIMAGE, V45, P1329, DOI 10.1016/j.neuroimage.2008.12.074; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; GOREN CC, 1975, PEDIATRICS, V56, P544; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Harris LT, 2009, EUR REV SOC PSYCHOL, V20, P192, DOI 10.1080/10463280902954988; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Kameda T, 1997, J PERS SOC PSYCHOL, V73, P296, DOI 10.1037/0022-3514.73.2.296; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Mitchell JP, 2011, J COGNITIVE NEUROSCI, V23, P857, DOI 10.1162/jocn.2010.21479; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Raafat RM, 2009, TRENDS COGN SCI, V13, P420, DOI 10.1016/j.tics.2009.08.002; Rapoport A, 1997, ORGAN BEHAV HUM DEC, V69, P31, DOI 10.1006/obhd.1996.2670; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Yoshida W, 2010, J NEUROSCI, V30, P10744, DOI 10.1523/JNEUROSCI.5895-09.2010	30	151	152	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					109	111		10.1126/science.1219681	http://dx.doi.org/10.1126/science.1219681			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	969KC	22767930	Green Accepted			2022-12-01	WOS:000306053100055
J	Lee, G; Bratkowski, MA; Ding, F; Ke, AL; Ha, T				Lee, Gwangrog; Bratkowski, Matthew A.; Ding, Fang; Ke, Ailong; Ha, Taekjip			Elastic Coupling Between RNA Degradation and Unwinding by an Exoribonuclease	SCIENCE			English	Article							VIRUS NS3 HELICASE; YEAST EXOSOME CORE; QUALITY-CONTROL; UVRD HELICASE; BASE-PAIR; DNA; MECHANISM; TRANSCRIPTION; RECRUITMENT; DYNAMICS	Rrp44 (Dis3) is a key catalytic subunit of the yeast exosome complex and can processively digest structured RNA one nucleotide at a time in the 3' to 5' direction. Its motor function is powered by the energy released from the hydrolytic nuclease reaction instead of adenosine triphosphate hydrolysis as in conventional helicases. Single-molecule fluorescence analysis revealed that instead of unwinding RNA in single base pair steps, Rrp44 accumulates the energy released by multiple single nucleotide step hydrolysis reactions until about four base pairs are unwound in a burst. Kinetic analyses showed that RNA unwinding, not cleavage or strand release, determines the overall RNA degradation rate and that the unwinding step size is determined by the nonlinear elasticity of the Rrp44/RNA complex, but not by duplex stability.	[Lee, Gwangrog; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lee, Gwangrog] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Bratkowski, Matthew A.; Ding, Fang; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Gwangju Institute of Science & Technology (GIST); Cornell University; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Lee, Gwangrog/0000-0002-1720-8524	National Science Foundation [0646550, 0822613]; National Institutes of Health [GM065367, GM-086766]; Jane Coffin Childs Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM086766] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Park, R. Vafabakhsh, A. Jain, S. Park, R. Zhou, X. Shi, M. Comstock, and S. Syed for helpful discussions; J. Yoo, C. Maffeo, and S. Arslan for experimental help; and K. Lee for the data acquisition program. Funds were provided by grants from National Science Foundation (0646550, 0822613 to T. H.) and National Institutes of Health (GM065367 to T. H. and GM-086766 to A. K.). G. L. was supported in part by the Jane Coffin Childs Medical Institute. T. H. is an investigator with Howard Hughes Medical Institute.	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee G, 2011, NAT CHEM BIOL, V7, P367, DOI [10.1038/NCHEMBIO.561, 10.1038/nchembio.561]; Lee G, 2010, NANO LETT, V10, P5123, DOI 10.1021/nl103754z; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MOFFITT JR, 2009, EMBO J, V457, P446, DOI DOI 10.1038/EMBOJ.2010.121; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schwartz A, 2009, NAT STRUCT MOL BIOL, V16, P1309, DOI 10.1038/nsmb.1711; Seol Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158103; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104	29	54	55	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1726	1729		10.1126/science.1216848	http://dx.doi.org/10.1126/science.1216848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745434	Green Accepted			2022-12-01	WOS:000305794500056
J	Dagdas, YF; Yoshino, K; Dagdas, G; Ryder, LS; Bielska, E; Steinberg, G; Talbot, NJ				Dagdas, Yasin F.; Yoshino, Kae; Dagdas, Gulay; Ryder, Lauren S.; Bielska, Ewa; Steinberg, Gero; Talbot, Nicholas J.			Septin-Mediated Plant Cell Invasion by the Rice Blast Fungus, Magnaporthe oryzae	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CYTOKINESIS; INFECTION; MEMBRANE; POLARITY; GRISEA; GENES; CYCLE; COMPARTMENTALIZATION	To cause rice blast disease, the fungus Magnaporthe oryzae develops a pressurized dome-shaped cell called an appressorium, which physically ruptures the leaf cuticle to gain entry to plant tissue. Here, we report that a toroidal F-actin network assembles in the appressorium by means of four septin guanosine triphosphatases, which polymerize into a dynamic, hetero-oligomeric ring. Septins scaffold F-actin, via the ezrin-radixin-moesin protein Tea1, and phosphatidylinositide interactions at the appressorium plasma membrane. The septin ring assembles in a Cdc42- and Chm1-dependent manner and forms a diffusion barrier to localize the inverse-bin-amphiphysin-RVS-domain protein Rvs167 and the Wiskott-Aldrich syndrome protein Las17 at the point of penetration. Septins thereby provide the cortical rigidity and membrane curvature necessary for protrusion of a rigid penetration peg to breach the leaf surface.	[Dagdas, Yasin F.; Yoshino, Kae; Dagdas, Gulay; Ryder, Lauren S.; Bielska, Ewa; Steinberg, Gero; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter EX4 4QG, Devon, England; [Yoshino, Kae] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Sakyo Ku, Kyoto 6068502, Japan	University of Exeter; Kyoto University	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Geoffrey Pope Bldg, Exeter EX4 4QG, Devon, England.	n.j.talbot@exeter.ac.uk	Talbot, Nicholas J/I-5618-2019; Bielska, Ewa/B-4936-2019; Talbot, Nicholas J/I-9584-2014	Talbot, Nicholas J/0000-0001-6434-7757; Bielska, Ewa/0000-0002-3138-4719; Talbot, Nicholas J/0000-0001-6434-7757; Dagdas, Yasin/0000-0002-9502-355X	Halpin Scholarship; Biotechnology and Biological Sciences Research Council; European Research Council; Kyoto University Foundation	Halpin Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Kyoto University Foundation	We thank J. Thorner (UC Berkeley) for providing yeast septin mutants, M. Momany for critical reading of the manuscript and valuable discussions, H. Florence from Exeter Mass Spectrometry facility, and M. Schuster from the Exeter Bio-imaging Centre. This work was funded by a Halpin Scholarship for rice blast research to Y.F.D. and grants to N.J.T. from the Biotechnology and Biological Sciences Research Council and the European Research Council. K.Y. is funded by the Kyoto University Foundation. Accession numbers are provided in supplementary materials.	ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; BOURETT TM, 1990, CAN J BOT, V68, P329, DOI 10.1139/b90-044; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; Li L, 2004, MOL PLANT MICROBE IN, V17, P547, DOI 10.1094/MPMI.2004.17.5.547; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Onishi M, 2010, MOL CELL BIOL, V30, P2057, DOI 10.1128/MCB.01529-09; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Saunders DGO, 2010, PLANT CELL, V22, P2417, DOI 10.1105/tpc.110.074492; Saunders DGO, 2010, PLANT CELL, V22, P497, DOI 10.1105/tpc.109.072447; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005	32	220	241	9	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1590	1595		10.1126/science.1222934	http://dx.doi.org/10.1126/science.1222934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723425	Green Accepted			2022-12-01	WOS:000305507500061
J	Harris, NL; Brown, S; Hagen, SC; Saatchi, SS; Petrova, S; Salas, W; Hansen, MC; Potapov, PV; Lotsch, A				Harris, Nancy L.; Brown, Sandra; Hagen, Stephen C.; Saatchi, Sassan S.; Petrova, Silvia; Salas, William; Hansen, Matthew C.; Potapov, Peter V.; Lotsch, Alexander			Baseline Map of Carbon Emissions from Deforestation in Tropical Regions	SCIENCE			English	Article							ANNUAL NET FLUX; LAND-USE; ATMOSPHERE; DIOXIDE; BIOMASS; ROOT; CO2	Policies to reduce emissions from deforestation would benefit from clearly derived, spatially explicit, statistically bounded estimates of carbon emissions. Existing efforts derive carbon impacts of land-use change using broad assumptions, unreliable data, or both. We improve on this approach using satellite observations of gross forest cover loss and a map of forest carbon stocks to estimate gross carbon emissions across tropical regions between 2000 and 2005 as 0.81 petagram of carbon per year, with a 90% prediction interval of 0.57 to 1.22 petagrams of carbon per year. This estimate is 25 to 50% of recently published estimates. By systematically matching areas of forest loss with their carbon stocks before clearing, these results serve as a more accurate benchmark for monitoring global progress on reducing emissions from deforestation.	[Harris, Nancy L.; Brown, Sandra; Petrova, Silvia] Winrock Int Livestock Res & Training Ctr, Ecosyst Serv Unit, Arlington, VA 22202 USA; [Hagen, Stephen C.; Salas, William] Appl GeoSolut, Durham, NH 03824 USA; [Saatchi, Sassan S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Saatchi, Sassan S.] Univ Calif Los Angeles, Inst Environm, Los Angeles, CA 90035 USA; [Hansen, Matthew C.; Potapov, Peter V.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Lotsch, Alexander] World Bank Grp, Washington, DC 20433 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; University System of Maryland; University of Maryland College Park; The World Bank	Harris, NL (corresponding author), Winrock Int Livestock Res & Training Ctr, Ecosyst Serv Unit, Arlington, VA 22202 USA.	nharris@winrock.org	Hansen, Matthew C/ABE-7226-2020; potapov, peter/AAE-7388-2019; Saatchi, Sassan/AAQ-2649-2021	Potapov, Peter/0000-0003-3977-0021	Winrock International under World Bank [7150484]; National Aeronautics and Space Administration [NNG06GD95G, NNX08AP33A]	Winrock International under World Bank; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	Funding for this work was provided to Winrock International under contract 7150484 by the World Bank's World Development Report 2010: Development and Climate Change. The findings, interpretations, and conclusions expressed in this paper are entirely those of the authors. They do not necessarily represent the views of the World Bank and its affiliated organizations or those of the Executive Directors of the World Bank or the governments they represent. Support for the forest cover loss mapping work was provided by National Aeronautics and Space Administration's Land Cover and Land Use Change and MEASURES programs under grants NNG06GD95G and NNX08AP33A. The authors would like to thank K. Mokany for providing the original data used to derive relationships between above- and belowground biomass. Forest loss data are available at http://globalmonitoring.sdstate.edu/projects/gfm. Carbon stock data are available at http://carbon.jpl.nasa.gov. Emissions data are available at www.appliedgeosolutions.com/science-paper.html.	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Arino O., 2007, GEOSC REM SENS S IEE; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/nclimate1354, 10.1038/NCLIMATE1354]; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; FAO, 2009, HARM WORLD SOIL DAT; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hiraishi T., 2014, 2006 IPCC GUIDELIN S, DOI DOI 10.1-10.84; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; HOUGHTON RA, 1985, NATURE, V316, P617, DOI 10.1038/316617a0; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; HOUGHTON RA, 1983, ECOL MONOGR, V53, P235, DOI 10.2307/1942531; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Mahli Y, 2010, CURR OPIN ENV SUST, V2, P237; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; van der Werf GR, 2008, P NATL ACAD SCI USA, V105, P20350, DOI 10.1073/pnas.0803375105	23	426	444	19	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1573	1576		10.1126/science.1217962	http://dx.doi.org/10.1126/science.1217962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723420				2022-12-01	WOS:000305507500055
J	Xiao, YM; Savchenko, T; Baidoo, EEK; Chehab, WE; Hayden, DM; Tolstikov, V; Corwin, JA; Kliebenstein, DJ; Keasling, JD; Dehesh, K				Xiao, Yanmei; Savchenko, Tatyana; Baidoo, Edward E. K.; Chehab, Wassim E.; Hayden, Daniel M.; Tolstikov, Vladimir; Corwin, Jason A.; Kliebenstein, Daniel J.; Keasling, Jay D.; Dehesh, Katayoon			Retrograde Signaling by the Plastidial Metabolite MEcPP Regulates Expression of Nuclear Stress-Response Genes	CELL			English	Article							METHYLERYTHRITOL PHOSPHATE-PATHWAY; MG-PROTOPORPHYRIN IX; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; CHLOROPLAST DEVELOPMENT; ANTIMALARIAL-DRUGS; OXIDATIVE STRESS; SINGLET OXYGEN; SALICYLIC-ACID; MUTANT REVEALS	Plastid-derived signals are known to coordinate expression of nuclear genes encoding plastid-localized proteins in a process termed retrograde signaling. To date, the identity of retrograde-signaling molecules has remained elusive. Here, we show that methylerythritol cyclodiphosphate (MEcPP), a precursor of isoprenoids produced by the plastidial methylerythritol phosphate (MEP) pathway, elicits the expression of selected stress-responsive nuclear-encoded plastidial proteins. Genetic and pharmacological manipulations of the individual MEP pathway metabolite levels demonstrate the high specificity of MEcPP as an inducer of these targeted stress-responsive genes. We further demonstrate that abiotic stresses elevate MEcPP levels, eliciting the expression of the aforementioned genes. We propose that the MEP pathway, in addition to producing isoprenoids, functions as a stress sensor and a coordinator of expression of targeted stress-responsive nuclear genes via modulation of the levels of MEcPP, a specific and critical retrograde-signaling metabolite.	[Xiao, Yanmei; Savchenko, Tatyana; Dehesh, Katayoon] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Tolstikov, Vladimir] Univ Calif Davis, Genome Sci Facil, Davis, CA 95616 USA; [Tolstikov, Vladimir] Univ Calif Davis, Biomed Sci Facil, Davis, CA 95616 USA; [Corwin, Jason A.; Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Baidoo, Edward E. K.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Baidoo, Edward E. K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Chehab, Wassim E.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Hayden, Daniel M.] Complete Genom, Mountain View, CA 94043 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rice University; University of California System; University of California Berkeley	Dehesh, K (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	kdehesh@ucdavis.edu	Tolstikov, Vladimir/P-2465-2019; Savchenko, Tatyana/E-7091-2014; Keasling, Jay D/J-9162-2012	Savchenko, Tatyana/0000-0003-0126-4932; Keasling, Jay D/0000-0003-4170-6088; Tolstikov, Vladimir/0000-0002-0445-884X; Xiao, Yanmei/0000-0002-3951-5787; Kliebenstein, Daniel/0000-0001-5759-3175; Corwin, Jason/0000-0001-6455-8474	National Science Foundation [IOS-1036491]; US Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics: GTL Foundational Science [DE-AC02-05CH11231]	National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics: GTL Foundational Science(United States Department of Energy (DOE))	We thank Dr. Andrew Grover for his insightful comments on the manuscript. This project is supported by the National Science Foundation grant IOS-1036491 (K. D.). This work was performed as part of ENIGMA, a Scientific Focus Area Program supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics: GTL Foundational Science through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy (E.E.K.B. and J.D.K).	Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Ankele E, 2007, PLANT CELL, V19, P1964, DOI 10.1105/tpc.106.048744; Beale SI, 2011, CURR BIOL, V21, pR391, DOI 10.1016/j.cub.2011.03.072; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; BRADBEER JW, 1979, NATURE, V279, P816, DOI 10.1038/279816a0; Chehab EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001904; Chehab EW, 2006, PLANT PHYSIOL, V141, P121, DOI 10.1104/pp.106.078592; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Eudes A, 2011, APPL MICROBIOL BIOT, V89, P989, DOI 10.1007/s00253-010-2939-y; Gil MJ, 2005, PLANT J, V44, P155, DOI 10.1111/j.1365-313X.2005.02517.x; Grieshaber NA, 2004, P NATL ACAD SCI USA, V101, P7451, DOI 10.1073/pnas.0400754101; Grieshaber NA, 2006, J BACTERIOL, V188, P5289, DOI 10.1128/JB.00526-06; Gutierrez-Nava MDL, 2004, PLANT PHYSIOL, V135, P471, DOI 10.1104/pp.103.036996; Heiber I, 2007, PLANT PHYSIOL, V143, P1774, DOI 10.1104/pp.106.093328; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jung HS, 2010, PLANT PHYSIOL, V152, P453, DOI 10.1104/pp.109.149070; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Laloi C, 2006, J EXP BOT, V57, P1719, DOI 10.1093/jxb/erj183; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Ostrovsky D, 1998, ARCH MICROBIOL, V171, P69, DOI 10.1007/s002030050680; OSTROVSKY D, 1992, BIOFACTORS, V3, P261; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Phillips MA, 2007, PLANT MOL BIOL, V65, P243, DOI 10.1007/s11103-007-9212-5; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Piippo M, 2006, PHYSIOL GENOMICS, V25, P142, DOI 10.1152/physiolgenomics.00256.2005; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2004, BIOORG CHEM, V32, P292, DOI 10.1016/j.bioorg.2004.05.012; Savchenko T, 2010, PLANT CELL, V22, P3193, DOI 10.1105/tpc.110.073858; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Sonderby IE, 2010, PLANT PHYSIOL, V153, P348, DOI 10.1104/pp.109.149286; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Walley JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000237; Walter MH, 2002, PLANT J, V31, P243, DOI 10.1046/j.1365-313X.2002.01352.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004	58	285	295	5	123	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1525	1535		10.1016/j.cell.2012.04.038	http://dx.doi.org/10.1016/j.cell.2012.04.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726439	Bronze			2022-12-01	WOS:000305753800018
J	Gao, Y; Zorman, S; Gundersen, G; Xi, ZQ; Ma, L; Sirinakis, G; Rothman, JE; Zhang, YL				Gao, Ying; Zorman, Sylvain; Gundersen, Gregory; Xi, Zhiqun; Ma, Lu; Sirinakis, George; Rothman, James E.; Zhang, Yongli			Single Reconstituted Neuronal SNARE Complexes Zipper in Three Distinct Stages	SCIENCE			English	Article							MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; SYNAPTOBREVIN; PROTEINS; EXOCYTOSIS; MOLECULE; COIL; ENERGETICS; MECHANISM; BINDING	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins drive membrane fusion by assembling into a four-helix bundle in a zippering process. Here, we used optical tweezers to observe in a cell-free reconstitution experiment in real time a long-sought SNARE assembly intermediate in which only the membrane-distal amino-terminal half of the bundle is assembled. Our findings support the zippering hypothesis, but suggest that zippering proceeds through three sequential binary switches, not continuously, in the amino-and carboxyl-terminal halves of the bundle and the linker domain. The half-zippered intermediate was stabilized by externally applied force that mimicked the repulsion between apposed membranes being forced to fuse. This intermediate then rapidly and forcefully zippered, delivering free energy of 36 k(B)T (where k(B) is Boltzmann's constant and T is temperature) to mediate fusion.	[Gao, Ying; Zorman, Sylvain; Gundersen, Gregory; Xi, Zhiqun; Ma, Lu; Sirinakis, George; Rothman, James E.; Zhang, Yongli] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Rothman, JE (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	james.rothman@yale.edu; yongli.zhang@yale.edu			NIH [GM093341, DK027044]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027044, R37DK027044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093341] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Ji and W. Xu for technical assistance and F. Pincet, T. Melia, and E. Karatekin for valuable discussion. This work is supported by NIH grants GM093341 to Y.Z. and DK027044 to J.E.R. Y.Z. designed the experiments; Y.G., S.Z., G. G., Z.X., L. M., and G. S. performed the experiments; Y.Z. and Y.G. analyzed the data; and Y.Z. and J.E.R. wrote the paper. The data and Matlab codes are in the paper and the supplementary materials.	Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2011, J AM CHEM SOC, V133, P12749, DOI 10.1021/ja204005r; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Li F, 2011, NAT STRUCT MOL BIOL, V18, P941, DOI 10.1038/nsmb.2102; Liu W, 2009, J Nanoneurosci, V1, P120; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Xi ZQ, 2012, P NATL ACAD SCI USA, V109, P5711, DOI 10.1073/pnas.1116784109; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878	31	262	266	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1340	1343		10.1126/science.1224492	http://dx.doi.org/10.1126/science.1224492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22903523	Green Accepted			2022-12-01	WOS:000308705000042
J	Zikherman, J; Parameswaran, R; Weiss, A				Zikherman, Julie; Parameswaran, Ramya; Weiss, Arthur			Endogenous antigen tunes the responsiveness of naive B cells but not T cells	NATURE			English	Article							SELF-TOLERANCE; EXPRESSION; CD45; ACTIVATION; RESOLUTION; SELECTION; ANERGY; MOUSE	In humans, up to 75% of newly generated B cells and about 30% of mature B cells show some degree of autoreactivity(1). Yet, how B cells establish and maintain tolerance in the face of autoantigen exposure during and after development is not certain. Studies of model B-cell antigen receptor (BCR) transgenic systems have highlighted the critical role of functional unresponsiveness or 'anergy'(2,3). Unlike T cells, evidence suggests that receptor editing and anergy, rather than deletion, account for much of B-cell tolerance(4,5). However, it remains unclear whether the mature diverse B-cell repertoire of mice contains anergic autoreactive B cells, and if so, whether antigen was encountered during or after their development. By taking advantage of a reporter mouse in which BCR signalling rapidly and robustly induces green fluorescent protein expression under the control of the Nur77 regulatory region, antigen-dependent and antigen-independent BCR signalling events in vivo during B-cell maturation were visualized. Here we show that B cells encounter antigen during development in the spleen, and that this antigen exposure, in turn, tunes the responsiveness of BCR signalling in B cells at least partly by downmodulating expression of surface IgM but not IgD BCRs, and by modifying basal calcium levels. By contrast, no analogous process occurs in naive mature T cells. Our data demonstrate not only that autoreactive B cells persist in the mature repertoire, but that functional unresponsiveness or anergy exists in the mature B-cell repertoire along a continuum, a fact that has long been suspected, but never yet shown. These results have important implications for understanding how tolerance in T and B cells is differently imposed, and how these processes might go awry in disease.	[Zikherman, Julie; Parameswaran, Ramya; Weiss, Arthur] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu	Parameswaran, Ramya/AAH-5791-2019	Zikherman, Julie/0000-0002-0873-192X	Rosalind Russell Medical Research Foundation Bechtel Award; American College of Rheumatology REF Rheumatology Investigator Award; Arthritis National Research Foundation; National Institutes of Health [K08 AR059723]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR059723] Funding Source: NIH RePORTER	Rosalind Russell Medical Research Foundation Bechtel Award; American College of Rheumatology REF Rheumatology Investigator Award; Arthritis National Research Foundation(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Roque for assisting with animal husbandry and Z. Wang and J. Paw for help with cell sorting. This work was supported by the Rosalind Russell Medical Research Foundation Bechtel Award (J. Z.), an American College of Rheumatology REF Rheumatology Investigator Award (J. Z.), an Arthritis National Research Foundation grant (J. Z.) and National Institutes of Health Grant K08 AR059723 (J. Z.), as well as the Howard Hughes Medical Institute (A.W.).	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Fields ML, 2003, CURR OPIN IMMUNOL, V15, P709, DOI 10.1016/j.coi.2003.09.016; Glynne R, 2000, IMMUNOL REV, V176, P216; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hermiston ML, 2005, IMMUNITY, V23, P635, DOI 10.1016/j.immuni.2005.11.001; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; MITTELSTADT PR, 1993, J IMMUNOL, V150, P4822; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Teague BN, 2007, J IMMUNOL, V178, P7511, DOI 10.4049/jimmunol.178.12.7511; The Gene Expression Nervous System Atlas (GENSAT) Project, N01NS02331 GENSAT PR; Virts EL, 2003, BLOOD, V101, P849, DOI 10.1182/blood-2002-07-1969; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x; Zikherman J, 2012, P NATL ACAD SCI USA, V109, pE3, DOI 10.1073/pnas.1117374108; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	29	204	205	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					160	U185		10.1038/nature11311	http://dx.doi.org/10.1038/nature11311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22902503	Green Accepted, Green Submitted			2022-12-01	WOS:000308347000055
J	Steinbrook, R				Steinbrook, Robert			Preexposure Prophylaxis for HIV Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,I-456 SHM,POB 208008, New Haven, CT 06520 USA.	rsteinbrook@attglobal.net						Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Centers for Disease Control and Prevention, 2012, HIV US GLANC; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; World Health Organization, GUID COUPL HIV TEST	8	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					865	866		10.1001/jama.2012.9885	http://dx.doi.org/10.1001/jama.2012.9885			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22820712				2022-12-01	WOS:000308292900012
J	Shigemura, J; Tanigawa, T; Saito, I; Nomura, S				Shigemura, Jun; Tanigawa, Takeshi; Saito, Isao; Nomura, Soichiro			Psychological Distress in Workers at the Fukushima Nuclear Power Plants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Shigemura, Jun; Nomura, Soichiro] Natl Def Med Coll, Dept Psychiat, Saitama, Japan; [Tanigawa, Takeshi; Saito, Isao] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsuyama, Ehime 790, Japan	National Defense Medical College - Japan; Ehime University	Shigemura, J (corresponding author), Natl Def Med Coll, Dept Psychiat, Saitama, Japan.	tt9178tt9178@gmail.com	Ley, Sarah/Y-9216-2019	Shigemura, Jun/0000-0002-7907-5034				Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; FONTANA A, 1994, J NERV MENT DIS, V182, P677, DOI 10.1097/00005053-199412000-00001; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Shigemura J, 2011, JAPAN J TRAUMA STRES, V9, P141	6	65	67	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					667	669		10.1001/jama.2012.9699	http://dx.doi.org/10.1001/jama.2012.9699			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893158	Bronze			2022-12-01	WOS:000307496700016
J	Shen, Y; Yue, F; McCleary, DF; Ye, Z; Edsall, L; Kuan, S; Wagner, U; Dixon, J; Lee, L; Lobanenkov, VV; Ren, B				Shen, Yin; Yue, Feng; McCleary, David F.; Ye, Zhen; Edsall, Lee; Kuan, Samantha; Wagner, Ulrich; Dixon, Jesse; Lee, Leonard; Lobanenkov, Victor V.; Ren, Bing			A map of the cis-regulatory sequences in the mouse genome	NATURE			English	Article							FUNCTIONAL ELEMENTS; ENHANCERS; REVEALS; IDENTIFICATION; VERTEBRATE; PROMOTERS; DYNAMICS; DATABASE; DISTINCT	The laboratory mouse is the most widely used mammalian model organism in biomedical research. The 2.6 x 10(9) bases of the mouse genome possess a high degree of conservation with the human genome(1), so a thorough annotation of the mouse genome will be of significant value to understanding the function of the human genome. So far, most of the functional sequences in the mouse genome have yet to be found, and the cis-regulatory sequences in particular are still poorly annotated. Comparative genomics has been a powerful tool for the discovery of these sequences(2), but on its own it cannot resolve their temporal and spatial functions. Recently, ChIP-Seq has been developed to identify cis-regulatory elements in the genomes of several organisms including humans, Drosophila melanogaster and Caenorhabditis elegans(3-5). Here we apply the same experimental approach to a diverse set of 19 tissues and cell types in the mouse to produce a map of nearly 300,000 murine cis-regulatory sequences. The annotated sequences add up to 11% of the mouse [GRAPHICS] genome, and include more than 70% of conserved non-coding sequences. We define tissue-specific enhancers and identify potential transcription factors regulating gene expression in each tissue or cell type. Finally, we show that much of the mouse genome is organized into domains of coordinately regulated enhancers and promoters. Our results provide a resource for the annotation of functional elements in the mammalian genome and for the study of mechanisms regulating tissue-specific gene expression.	[Shen, Yin; Yue, Feng; McCleary, David F.; Ye, Zhen; Edsall, Lee; Kuan, Samantha; Wagner, Ulrich; Dixon, Jesse; Lee, Leonard; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dixon, Jesse] Univ Calif San Diego, Sch Med, Med Scientist Training Program, La Jolla, CA 92093 USA; [Dixon, Jesse] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Lobanenkov, Victor V.] NIAID, Immunogenet Lab, Twinbrook NIAID Facil 1, Rockville, MD 20852 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Cellular & Mol Med,Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Lobanenkov, Victor V./AGQ-8903-2022; Dixon, Jesse/AAT-2914-2020; Lobanenkov, Victor/ABD-5710-2021	Dixon, Jesse/0000-0002-6273-2181; Lobanenkov, Victor/0000-0001-6665-3635; Edsall, Lee Elizabeth/0000-0002-0326-2829	National Human Genome Research Institute [R01HG003991]; Ludwig Institute for Cancer Research; International Rett Syndrome Foundation; California Institute for Regenerative Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000860, ZIAAI001021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Ludwig Institute for Cancer Research; International Rett Syndrome Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Jin, Y. Luu, S. Klugman, A. Y.-J. Kim, Q.-M. Ngo, B. A. Gomez and S. Selvaraj for consultation. The mESC line Bruce4 was a gift from UCSD Transgenic Core. Research funding was provided by the National Human Genome Research Institute (R01HG003991) and the Ludwig Institute for Cancer Research to B. R. Y. S. is supported by a postdoctoral fellowship from the International Rett Syndrome Foundation. J.D. is supported by a pre-doctoral fellowship from the California Institute for Regenerative Medicine.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	30	951	972	4	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					116	120		10.1038/nature11243	http://dx.doi.org/10.1038/nature11243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22763441	Green Accepted			2022-12-01	WOS:000307010700044
J	Shivaraju, M; Unruh, JR; Slaughter, BD; Mattingly, M; Berman, J; Gerton, JL				Shivaraju, Manjunatha; Unruh, Jay R.; Slaughter, Brian D.; Mattingly, Mark; Berman, Judith; Gerton, Jennifer L.			Cell-Cycle-Coupled Structural Oscillation of Centromeric Nucleosomes in Yeast	CELL			English	Article							NUCLEAR-PORE COMPLEX; CENP-A NUCLEOSOME; BUDDING YEAST; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; MOLECULAR ARCHITECTURE; CHROMATIN REQUIRES; POINT CENTROMERES; NONHISTONE SCM3; CHAPERONE SCM3	The centromere is a specialized chromosomal structure that regulates chromosome segregation. Centromeres are marked by a histone H3 variant. In budding yeast, the histone H3 variant Cse4 is present in a single centromeric nucleosome. Experimental evidence supports several different models for the structure of centromeric nucleosomes. To investigate Cse4 copy number in live yeast, we developed a method coupling fluorescence correlation spectroscopy and calibrated imaging. We find that centromeric nucleosomes have one copy of Cse4 during most of the cell cycle, whereas two copies are detected at anaphase. The proposal of an anaphase-coupled structural change is supported by Cse4-Cse4 interactions, incorporation of Cse4, and the absence of Scm3 in anaphase. Nucleosome reconstitution and ChIP suggests both Cse4 structures contain H2A/H2B. The increase in Cse4 intensity and deposition at anaphase are also observed in Candida albicans. Our experimental evidence supports a cell-cycle-coupled oscillation of centromeric nucleosome structure in yeast.	[Shivaraju, Manjunatha; Unruh, Jay R.; Slaughter, Brian D.; Mattingly, Mark; Gerton, Jennifer L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Shivaraju, Manjunatha] Open Univ, Milton Keynes MK7 6BJ, Bucks, England; [Berman, Judith] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Gerton, Jennifer L.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Open University - UK; University of Minnesota System; University of Minnesota Twin Cities; University of Kansas; University of Kansas Medical Center	Gerton, JL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jeg@stowers.org	Shivaraju, manjunatha/J-5173-2014; Berman, Judith/ABA-8528-2021; Berman, Judith/AAS-5115-2021	Berman, Judith/0000-0002-8577-0084; Unruh, Jay/0000-0003-3077-4990; Shivaraju, Manjunatha/0000-0001-6346-6279	NIH [R01GM080477]; SIMR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SIMR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jerry Workman, Christophe Lavelle, and Sue Jaspersen for valuable discussions. We thank Swaminathan Venkatesh for topoI. We thank Dan Bradford for technical assistance and all of the members of the Gerton lab for their help and support. We thank Yamini Dalal and Kerry Bloom for sharing unpublished data and valuable discussions and a special thanks to Minh Bui for composing the graphical abstract. This research was supported by NIH R01GM080477 and SIMR.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bui M, 2012, CELL, V150, P317, DOI 10.1016/j.cell.2012.05.035; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Cho US, 2011, P NATL ACAD SCI USA, V108, P9367, DOI 10.1073/pnas.1106389108; Coffman VC, 2011, J CELL BIOL, V195, P563, DOI 10.1083/jcb.201106078; Cole HA, 2011, P NATL ACAD SCI USA, V108, P12687, DOI 10.1073/pnas.1104978108; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Dechassa ML, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1320; Dimitriadis EK, 2010, P NATL ACAD SCI USA, V107, P20317, DOI 10.1073/pnas.1009563107; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Henikoff S, 2012, GENETICS, V190, P1575, DOI 10.1534/genetics.111.137711; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Jin QW, 2000, J CELL SCI, V113, P1903; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Kingston IJ, 2011, J BIOL CHEM, V286, P4021, DOI 10.1074/jbc.M110.189340; Krassovsky K, 2012, P NATL ACAD SCI USA, V109, P243, DOI 10.1073/pnas.1118898109; Lavelle C, 2009, CELL, V139, P1216, DOI 10.1016/j.cell.2009.12.014; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Lermontova I, 2006, PLANT CELL, V18, P2443, DOI 10.1105/tpc.106.043174; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Mellone BG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002068; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mishra PK, 2007, MOL GENET GENOMICS, V278, P455, DOI 10.1007/s00438-007-0263-8; Mishra PK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002303; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Prunell A, 1998, BIOPHYS J, V74, P2531, DOI 10.1016/S0006-3495(98)77961-5; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shivaraju M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.183640; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Takahashi K, 2005, PHILOS T R SOC B, V360, P595, DOI 10.1098/rstb.2004.1614; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Tanaka T, 2005, PHILOS T ROY SOC B, V360, P606; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119; Xiao H, 2011, MOL CELL, V43, P369, DOI 10.1016/j.molcel.2011.07.009; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zhou Z, 2011, NATURE, V472, P234, DOI 10.1038/nature09854	69	72	73	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					304	316		10.1016/j.cell.2012.05.034	http://dx.doi.org/10.1016/j.cell.2012.05.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817893	Bronze, Green Accepted			2022-12-01	WOS:000306595700010
J	Wortmann, UG; Paytan, A				Wortmann, Ulrich G.; Paytan, Adina			Rapid Variability of Seawater Chemistry Over the Past 130 Million Years	SCIENCE			English	Article							SULFUR; CARBON; FLUCTUATIONS; EVAPORITES; DEPOSITION; EVOLUTION; CYCLES; OCEAN	Fluid inclusion data suggest that the composition of major elements in seawater changes slowly over geological time scales. This view contrasts with high-resolution isotope data that imply more rapid fluctuations of seawater chemistry. We used a non-steady-state box model of the global sulfur cycle to show that the global delta S-34 record can be explained by variable marine sulfate concentrations triggered by basin-scale evaporite precipitation and dissolution. The record is characterized by long phases of stasis, punctuated by short intervals of rapid change. Sulfate concentrations affect several important biological processes, including carbonate mineralogy, microbially mediated organic matter remineralization, sedimentary phosphorous regeneration, nitrogen fixation, and sulfate aerosol formation. These changes are likely to affect ocean productivity, the global carbon cycle, and climate.	[Wortmann, Ulrich G.] Univ Toronto, Dept Geol, Geobiol Isotope Lab, Toronto, ON M5S 3B1, Canada; [Paytan, Adina] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of Toronto; University of California System; University of California Santa Cruz	Wortmann, UG (corresponding author), Univ Toronto, Dept Geol, Geobiol Isotope Lab, Toronto, ON M5S 3B1, Canada.	uli.wortmann@utoronto.ca; apaytan@ucsc.edu		Wortmann, Ulrich/0000-0001-7854-9173	Natural Sciences and Engineering Research Council of Canada; NSF CAREER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank B. Brunner, M. Kastner, and T. Lowenstein for discussions and their comments on an early draft of this manuscript. We also thank the three anonymous reviewers for their thoughtful comments, which helped clarify and improve the manuscript. This research was support by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to U. G. W. and a NSF CAREER award to A. P. Model Data and Code are available as supplementary materials on Science Online.	Adams DD, 2010, NAT GEOSCI, V3, P201, DOI 10.1038/NGEO743; ALLISON PA, 1988, PALAEONTOLOGY, V31, P1079; BERNER RA, 1983, GEOCHIM COSMOCHIM AC, V47, P855, DOI 10.1016/0016-7037(83)90151-5; Bots P, 2011, GEOLOGY, V39, P331, DOI 10.1130/G31619.1; BURKE K, 1988, MAR GEOL, V83, P309, DOI 10.1016/0025-3227(88)90064-3; Cardenas AL, 2010, NAT GEOSCI, V3, P430, DOI 10.1038/NGEO869; Clementz M, 2011, GEOLOGY, V39, P15, DOI 10.1130/G31585.1; DeBond N, 2012, ISOT ENVIRON HEALT S, V48, P180, DOI 10.1080/10256016.2012.659732; Einsele G., 1992, SEDIMENTARY BASINS E; GUSTAVSON TC, 1982, EARTH SURF PROC LAND, V7, P545, DOI 10.1002/esp.3290070604; Hay WW, 2006, PALAEOGEOGR PALAEOCL, V240, P3, DOI 10.1016/j.palaeo.2006.03.044; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; Kiel S, 2009, TERRA NOVA, V21, P279, DOI 10.1111/j.1365-3121.2009.00882.x; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Lowenstein TK, 2003, GEOLOGY, V31, P857, DOI 10.1130/G19728R.1; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Marino R., 2003, DEV HYDROBIOL, V171, P277; Najman Y, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007673; Nichols G., 2009, SEDIMENTARY PROCESSE, P242; Paytan A, 2004, SCIENCE, V304, P1663, DOI 10.1126/science.1095258; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Ribas VW, 2010, CHEM PHYS LETT, V492, P19, DOI 10.1016/j.cplett.2010.04.036; SOUTHAM JR, 1981, SEA, V7, P1617; WILKINSON BH, 1979, GEOLOGY, V7, P524, DOI 10.1130/0091-7613(1979)7<524:BPATEO>2.0.CO;2; Wortmann UG, 2007, NATURE, V446, P654, DOI 10.1038/nature05693; Zharkov M. A., 1981, HIST PALEOZOIC SALT; [No title captured]	27	79	80	4	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					334	336		10.1126/science.1220656	http://dx.doi.org/10.1126/science.1220656			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822148				2022-12-01	WOS:000306542600049
J	Hergott, LJ				Hergott, Lawrence J.			Making It From Home to First	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Colorado, Denver, CO 80202 USA	University of Colorado System; University of Colorado Denver	Hergott, LJ (corresponding author), Univ Colorado, Denver, CO 80202 USA.	lhergott@comcast.net						Finley J, 2012, PERS STAT TRANSF TRA; Hergott LJ, 2009, JAMA-J AM MED ASSOC, V302, P2188, DOI 10.1001/jama.2009.1586; Hergott LJ, 2009, ANN INTERN MED, V151, P753; O'Donohue J., 2008, BLESS SPACE US	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2012	308	3					245	246		10.1001/jama.2012.7816	http://dx.doi.org/10.1001/jama.2012.7816			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975AC	22797641				2022-12-01	WOS:000306477900024
J	Bourke, J				Bourke, Joanna			The art of medicine Languages of pain	LANCET			English	Editorial Material									Univ London Birkbeck Coll, Dept Hist, London WC1E 7HX, England	University of London; Birkbeck University London	Bourke, J (corresponding author), Univ London Birkbeck Coll, Dept Hist, London WC1E 7HX, England.	J.Bourke@bbk.ac.uk			Wellcome Trust [092708] Funding Source: Medline	Wellcome Trust(Wellcome Trust)		Bourke Joanna, 2011, WHAT IT MEANS BE HUM; Burney F, 1986, F BURNEY SELECTED LE, P127; Coulehan J, 2009, PERSPECT BIOL MED, V52, P585, DOI 10.1353/pbm.0.0130; Edson M, 2008, BODIES BARRIERS DRAM; Howell Joel D., 1995, TECHNOLOGY HOSP TRAN; Johnson M, 1980, METAPHORS WE LIVE; REISER SJ, 1993, EMPATHY PRACTICE MED	7	7	7	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2420	2421		10.1016/S0140-6736(12)61055-1	http://dx.doi.org/10.1016/S0140-6736(12)61055-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	967NV	22764375	Green Accepted			2022-12-01	WOS:000305915900014
J	Kreysing, M; Pusch, R; Haverkate, D; Landsberger, M; Engelmann, J; Ruiter, J; Mora-Ferrer, C; Ulbricht, E; Grosche, J; Franze, K; Streif, S; Schumacher, S; Makarov, F; Kacza, J; Guck, J; Wolburg, H; Bowmaker, JK; von der Emde, G; Schuster, S; Wagner, HJ; Reichenbach, A; Francke, M				Kreysing, Moritz; Pusch, Roland; Haverkate, Dorothee; Landsberger, Meik; Engelmann, Jacob; Ruiter, Janina; Mora-Ferrer, Carlos; Ulbricht, Elke; Grosche, Jens; Franze, Kristian; Streif, Stefan; Schumacher, Sarah; Makarov, Felix; Kacza, Johannes; Guck, Jochen; Wolburg, Hartwig; Bowmaker, James K.; von der Emde, Gerhard; Schuster, Stefan; Wagner, Hans-Joachim; Reichenbach, Andreas; Francke, Mike			Photonic Crystal Light Collectors in Fish Retina Improve Vision in Turbid Water	SCIENCE			English	Article							SENSITIVITY	Despite their diversity, vertebrate retinae are specialized to maximize either photon catch or visual acuity. Here, we describe a functional type that is optimized for neither purpose. In the retina of the elephantnose fish (Gnathonemus petersii), cone photoreceptors are grouped together within reflecting, photonic crystal-lined cups acting as macroreceptors, but rod photoreceptors are positioned behind these reflectors. This unusual arrangement matches rod and cone sensitivity for detecting color-mixed stimuli, whereas the photoreceptor grouping renders the fish insensitive to spatial noise; together, this enables more reliable flight reactions in the fish's dim and turbid habitat as compared with fish lacking this retinal specialization.	[Ruiter, Janina; Ulbricht, Elke; Grosche, Jens; Franze, Kristian; Reichenbach, Andreas; Francke, Mike] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Kreysing, Moritz; Franze, Kristian; Guck, Jochen; Francke, Mike] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Kreysing, Moritz] Univ Munich, Dept Phys, D-80799 Munich, Germany; [Pusch, Roland; Landsberger, Meik; Engelmann, Jacob; Schumacher, Sarah; von der Emde, Gerhard] Univ Bonn, Inst Zool, D-53115 Bonn, Germany; [Haverkate, Dorothee; Schuster, Stefan] Univ Bayreuth, Dept Anim Physiol, D-95440 Bayreuth, Germany; [Engelmann, Jacob] Univ Bielefeld, Dept Biol, D-33501 Bielefeld, Germany; [Mora-Ferrer, Carlos] Johannes Gutenberg Univ Mainz, Inst Zool Neurobiol, D-55099 Mainz, Germany; [Ulbricht, Elke; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Streif, Stefan] Univ Magdeburg, Inst Automat Engn Syst Theory & Automat Control L, D-39106 Magdeburg, Germany; [Makarov, Felix] IP Pavlov Physiol Inst, St Petersburg 199034, Russia; [Kacza, Johannes] Univ Leipzig, Fac Vet Med, Inst Anat Histol & Embryol, D-04109 Leipzig, Germany; [Guck, Jochen] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol & Neuropathol, D-72076 Tubingen, Germany; [Bowmaker, James K.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Wagner, Hans-Joachim] Univ Tubingen, Inst Anat, D-72074 Tubingen, Germany; [Francke, Mike] Univ Leipzig, Translat Ctr Regenerat Med, D-04103 Leipzig, Germany	Leipzig University; University of Cambridge; University of Munich; University of Bonn; University of Bayreuth; University of Bielefeld; Johannes Gutenberg University of Mainz; University of Cambridge; Otto von Guericke University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; Leipzig University; Technische Universitat Dresden; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of London; University College London; Eberhard Karls University of Tubingen; Leipzig University	Reichenbach, A (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany.	reia@medizin.uni-leipzig.de	Francke, Mike/A-7505-2017; Guck, Jochen/AAJ-9283-2021; Reichenbach, Andreas/B-2510-2017; Kreysing, Moritz/B-3751-2017; Pusch, Roland/AAX-1415-2021; Guck, Jochen/B-4412-2014	Guck, Jochen/0000-0002-1453-6119; Kreysing, Moritz/0000-0001-7432-3871; Guck, Jochen/0000-0002-1453-6119; Streif, Stefan/0000-0002-3398-1226; Schuster, Stefan/0000-0002-0873-8996; Pusch, Roland/0000-0002-6851-4839; Franze, Kristian/0000-0002-8425-7297	Deutsche Forschungsgemeinschaft; German Federal Ministry of Education and Research; Alexander-von-Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation)	This work was financially supported by the Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research, and the Alexander-von-Humboldt Foundation. Help with freeze-fracturing by Ria Knittel is gratefully acknowledged. Numerical simulations were run on the Darwin Supercomputer, University of Cambridge. A.R., H.-J.W., S. Schuster, G.v.d.E., J. Guck, M.K., and M.F. developed the idea of the project, supervised the research, and wrote the manuscript; H.-J.W., J.E., F.M., E.U., R.P., J.R., H.W., J.K., and M.F. obtained morphological data; M.K. performed the electrodynamical simulations; J.B. measured the absorption spectra; K.F. measured light reflection of the eye; J. Grosche measured light reflection of the isolated retina and provided the 3D reconstructions of the RPE; M.L., D.H., and S. Schumacher obtained behavioral data; J.E. and R.P. performed tectum measurements; C.M.-F. and D.H. performed the electroretinogram; and S. Schuster designed and S. Streif developed the programs applied in the dynamic noise and color-pooling experiments.	Brauer A., 1908, ERGEBNISSE DTSCH TIE, V15, P1; Ciali S, 1997, J FISH BIOL, V50, P1074, DOI 10.1006/jfbi.1996.0372; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Landsberger M, 2008, J PHYSIOL-PARIS, V102, P291, DOI 10.1016/j.jphysparis.2008.10.015; Large MCJ, 2007, PHYSICA B, V394, P229, DOI 10.1016/j.physb.2006.12.016; LOCKET NA, 1971, PROC R SOC SER B-BIO, V178, P161, DOI 10.1098/rspb.1971.0059; McEWAN MARY RUTH, 1938, ACTA ZOOL [STOCKHOLM], V19, P427; MOLLER P, 1979, BEHAV ECOL SOCIOBIOL, V4, P357, DOI 10.1007/BF00303242; Moller P., 1995, ELECT FISHES HIST BE; MORGAN MJ, 1992, P ROY SOC B-BIOL SCI, V248, P291, DOI 10.1098/rspb.1992.0074; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008; Rojas R, 2002, BRAIN BEHAV EVOLUT, V59, P211, DOI 10.1159/000064908; Schaerer S, 1996, VISION RES, V36, P4025, DOI 10.1016/S0042-6989(96)00149-6; Schuster S, 2002, J EXP BIOL, V205, P549; Seeliger Mathias W., 2002, Documenta Ophthalmologica, V104, P57, DOI 10.1023/A:1014454927931; Walls GL, 1963, VERTEBRATE EYE ITS A; WALMSLEY RD, 1980, HYDROBIOLOGIA, V70, P145, DOI 10.1007/BF00015500; WERBLIN FS, 1973, SCI AM, V228, P71; Yokoyama S, 2005, MOL BIOL EVOL, V22, P968, DOI 10.1093/molbev/msi080	21	56	56	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1700	1703		10.1126/science.1218072	http://dx.doi.org/10.1126/science.1218072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745429				2022-12-01	WOS:000305794500049
J	Mayer, A; Heidemann, M; Lidschreiber, M; Schreieck, A; Sun, M; Hintermair, C; Kremmer, E; Eick, D; Cramer, P				Mayer, Andreas; Heidemann, Martin; Lidschreiber, Michael; Schreieck, Amelie; Sun, Mai; Hintermair, Corinna; Kremmer, Elisabeth; Eick, Dirk; Cramer, Patrick			CTD Tyrosine Phosphorylation Impairs Termination Factor Recruitment to RNA Polymerase II	SCIENCE			English	Article							ELONGATION-FACTOR SPT6; TANDEM SH2 DOMAIN; TRANSCRIPTION TERMINATION; S. CEREVISIAE; CODE; COMPLEX; PROTEIN; IICTD; ASSOCIATION; SERINE-7	In different phases of the transcription cycle, RNA polymerase (Pol) II recruits various factors via its C-terminal domain (CTD), which consists of conserved heptapeptide repeats with the sequence Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7). We show that the CTD of transcribing yeast Pol II is phosphorylated at Tyr(1), in addition to Ser(2), Thr(4), Ser(5), and Ser(7). Tyr(1) phosphorylation stimulates binding of elongation factor Spt6 and impairs recruitment of termination factors Nrd1, Pcf11, and Rtt103. Tyr(1) phosphorylation levels rise downstream of the transcription start site and decrease before the polyadenylation site, largely excluding termination factors from gene bodies. These results show that CTD modifications trigger and block factor recruitment and lead to an extended CTD code that explains transcription cycle coordination on the basis of differential phosphorylation of Tyr(1), Ser(2), and Ser(5).	[Heidemann, Martin; Hintermair, Corinna; Eick, Dirk] Helmholtz Zentrum Munchen, Dept Mol Epigenet, D-81377 Munich, Germany; [Heidemann, Martin; Hintermair, Corinna; Eick, Dirk] CIPSM, D-81377 Munich, Germany; [Mayer, Andreas; Lidschreiber, Michael; Schreieck, Amelie; Sun, Mai; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Mayer, Andreas; Lidschreiber, Michael; Schreieck, Amelie; Sun, Mai; Cramer, Patrick] Univ Munich, CIPSM, Dept Biochem, D-81377 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eick, D (corresponding author), Helmholtz Zentrum Munchen, Dept Mol Epigenet, Marchioninistr 25, D-81377 Munich, Germany.	eick@helmholtz-muenchen.de; cramer@genzentrum.LMU.de	Sun, Mai/A-3837-2010; Mayer, Andreas/AAA-5173-2021	Sun, Mai/0000-0003-2824-7964; Mayer, Andreas/0000-0002-4532-9382	Deutsche Forschungsgemeinschaft (DFG) [SFB646, SFB960, TR5, SFB684]; NIM; BioImaging Network; European Research Council (ERC); Jung-Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIM; BioImaging Network; European Research Council (ERC)(European Research Council (ERC)); Jung-Stiftung	We thank S. Etzold and K. Leike for help and S. Hahn for providing yeast strains. P. C. was supported by the Deutsche Forschungsgemeinschaft (DFG), SFB646, SFB960, TR5, NIM, the BioImaging Network, a European Research Council (ERC) Advanced Grant, and the Jung-Stiftung. D. E. was supported by DFG, TR5, and SFB684. Microrray data have been deposited in ArrayExpress under accession code E-MTAB-1060. A. M. carried out ChIP-chip and fluorescence anisotropy experiments. M. H. and C. H. validated antibodies. M. L. analyzed ChIP-chip data. M. S. carried out modeling. A. S. carried out additional ChIP assays. E. K. generated the 3D12 antibody. D. E. and P. C. designed and supervised research. A. M. and P. C. prepared the manuscript, with help from all authors.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Baskaran R, 1999, CELL GROWTH DIFFER, V10, P387; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Close D, 2011, J MOL BIOL, V408, P697, DOI 10.1016/j.jmb.2011.03.002; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim KY, 2011, CELL, V144, P745, DOI 10.1016/j.cell.2011.01.034; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Liu JP, 2011, J BIOL CHEM, V286, P29218, DOI 10.1074/jbc.M111.252130; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Sun M, 2010, J BIOL CHEM, V285, P41597, DOI 10.1074/jbc.M110.144568; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; WEST ML, 1995, GENETICS, V140, P1223	30	174	175	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1723	1725		10.1126/science.1219651	http://dx.doi.org/10.1126/science.1219651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745433	Green Published			2022-12-01	WOS:000305794500055
J	Pecoits, E; Konhauser, KO; Aubet, NR; Heaman, LM; Veroslavsky, G; Stern, RA; Gingras, MK				Pecoits, Ernesto; Konhauser, Kurt O.; Aubet, Natalie R.; Heaman, Larry M.; Veroslavsky, Gerardo; Stern, Richard A.; Gingras, Murray K.			Bilaterian Burrows and Grazing Behavior at > 585 Million Years Ago	SCIENCE			English	Article							EDIACARAN ANIMAL EMBRYOS; MISTAKEN POINT FORMATION; FOSSILIZED NUCLEI; 1ST EVIDENCE; EVOLUTION; OXYGENATION; LOCOMOTION; EMERGENCE; ORIGIN; BIOTA	Based on molecular clocks and biomarker studies, it is possible that bilaterian life emerged early in the Ediacaran, but at present, no fossils or trace fossils from this time have been reported. Here we report the discovery of the oldest bilaterian burrows in shallow-water glaciomarine sediments from the Tacuari Formation, Uruguay. Uranium-lead dating of zircons in cross-cutting granite dykes constrains the age of these burrows to be at least 585 million years old. Their features indicate infaunal grazing activity by early eumetazoans. Active backfill within the burrow, an ability to wander upward and downward to exploit shallowly situated sedimentary laminae, and sinuous meandering suggest advanced behavioral adaptations. These findings unite the paleontological and molecular data pertaining to the evolution of bilaterians, and link bilaterian origins to the environmental changes that took place during the Neoproterozoic glaciations.	[Pecoits, Ernesto; Konhauser, Kurt O.; Aubet, Natalie R.; Heaman, Larry M.; Stern, Richard A.; Gingras, Murray K.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Veroslavsky, Gerardo] Univ Republica, Inst Ciencias Geol, Montevideo 11400, Uruguay	University of Alberta; Universidad de la Republica, Uruguay	Pecoits, E (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	epecoits@ualberta.ca		Konhauser, Kurt/0000-0001-7722-7068	Natural Sciences and Engineering Research Council (NSERC) of Canada; Comision Sectorial de Investigacion Cientifica-UdelaR; Agouron Institute; NSERC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Comision Sectorial de Investigacion Cientifica-UdelaR; Agouron Institute(Pfizer); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grants to K.O.K., M.K.G., and L.M.H.; by a Comision Sectorial de Investigacion Cientifica-UdelaR Grant ("El Ediacarano en Uruguay y su importancia en el contexto del origen de la vida animal") to K.O.K., G.V., M.K.G., E.P., and N.R.A.; and by an Agouron Institute Fellowship Program grant to E. Pecoits. Partial support for the U-Pb analyses was provided by an NSERC Major Resource Support Grant to L.M.H. Laboratory support for the thermal ionization mass spectrometry, LA-MC-ICPMS, and SHRIMP U-Pb analyses was provided by B. Herchuk, J. Schultz, G. Hatchard, A. DuFrane, and A. Simonetti. C. Magee and staff at Geoscience Australia facilitated SHRIMP analysis. We also thank G. Narbonne for many valuable insights. The data presented in this paper are available in the supplementary materials. The trace fossil collection can be found at the Department of Earth and Atmospheric Sciences, with accession nos. TF3 to TF16.	Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; Brasier MD, 1998, J GEOL SOC LONDON, V155, P5, DOI 10.1144/gsjgs.155.1.0005; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Collins AG, 2000, PALEOBIOLOGY, V26, P47, DOI 10.1666/0094-8373(2000)026<0047:MMCTAT>2.0.CO;2; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Droser ML, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P125; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Gingras M, 2011, NAT GEOSCI, V4, P372, DOI [10.1038/NGEO1142, 10.1038/ngeo1142]; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Huldtgren T, 2011, SCIENCE, V334, P1696, DOI 10.1126/science.1209537; Jensen S, 2005, PALAEOGEOGR PALAEOCL, V220, P19, DOI 10.1016/j.palaeo.2003.09.035; Jensen S, 2007, GEOL SOC SPEC PUBL, V286, P223, DOI 10.1144/SP286.16; Jensen Soren, 2006, V27, P115; Liu AG, 2010, GEOLOGY, V38, P123, DOI 10.1130/G30368.1; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Maloof AC, 2010, NAT GEOSCI, V3, P653, DOI 10.1038/NGEO934; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Matz MV, 2008, CURR BIOL, V18, P1849, DOI 10.1016/j.cub.2008.10.028; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; NARBONNE GM, 1990, PALAEONTOLOGY, V33, P945; Och LM, 2012, EARTH-SCI REV, V110, P26, DOI 10.1016/j.earscirev.2011.09.004; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Retallack GJ, 2010, GEOLOGY, V38, pE223, DOI 10.1130/G31137C.1; Shen YN, 2008, P NATL ACAD SCI USA, V105, P7376, DOI 10.1073/pnas.0802168105; Veroslavsky G., 2006, REV SOC URU GEOL, V13, P23; Xiao SH, 2012, SCIENCE, V335, DOI 10.1126/science.1218814	29	59	64	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1693	1696		10.1126/science.1216295	http://dx.doi.org/10.1126/science.1216295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745427				2022-12-01	WOS:000305794500047
J	Ryan, RJH; Bernstein, BE				Ryan, Russell J. H.; Bernstein, Bradley E.			Genetic Events That Shape the Cancer Epigenome	SCIENCE			English	Editorial Material							MUTATIONS; DIFFERENTIATION; EZH2		[Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02114 USA; [Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Ryan, Russell J. H.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ryan, Russell J. H.; Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ryan, RJH (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02114 USA.	bernstein.bradley@mgh.harvard.edu		Ryan, Russell/0000-0001-8174-3962	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Greenberg RA, 2011, FEBS LETT, V585, P2883, DOI 10.1016/j.febslet.2011.05.037; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pujadas E, 2012, CELL, V148, P1123, DOI 10.1016/j.cell.2012.02.045; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	20	47	48	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1513	1514		10.1126/science.1223730	http://dx.doi.org/10.1126/science.1223730			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723401				2022-12-01	WOS:000305507500035
J	Wu, QF; Yang, L; Li, S; Wang, Q; Yuan, XB; Gao, X; Bao, L; Zhang, X				Wu, Qing-Feng; Yang, Liu; Li, Shuai; Wang, Qiong; Yuan, Xiao-Bin; Gao, Xiang; Bao, Lan; Zhang, Xu			Fibroblast Growth Factor 13 Is a Microtubule-Stabilizing Protein Regulating Neuronal Polarization and Migration	CELL			English	Article							FACTOR HOMOLOGOUS FACTORS; MULTIPOLAR STAGE; NERVOUS-SYSTEM; DOUBLECORTIN; MICE; OUTGROWTH; MEMORY; MAP1B; NUCLEOKINESIS; TRANSLOCATION	Secretory fibroblast growth factors (FGFs) and their receptors are known for their regulatory function in the early stages of neural development. FGF13, a nonsecretory protein of the FGF family, is expressed in cerebral cortical neurons during development and is a candidate gene for syndromal and nonspecific forms of X-chromosome-linked mental retardation (XLMR). However, its function during development remains unclear. We show that FGF13 acts intracellularly as a microtubule-stabilizing protein required for axon and leading process development and neuronal migration in the cerebral cortex. FGF13 is enriched in axonal growth cones and interacts directly with microtubules. Furthermore, FGF13 polymerizes tubulins and stabilizes microtubules. The loss of FGF13 impairs neuronal polarization and increases the branching of axons and leading processes. Genetic deletion of FGF13 in mice results in neuronal migration defects in both the neocortex and the hippocampus. FGF13-deficient mice also exhibit weakened learning and memory, which is correlated to XLMR patients' intellectual disability.	[Wu, Qing-Feng; Yang, Liu; Li, Shuai; Yuan, Xiao-Bin; Zhang, Xu] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Wu, Qing-Feng; Yang, Liu; Li, Shuai; Yuan, Xiao-Bin; Zhang, Xu] Chinese Acad Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Wang, Qiong; Bao, Lan] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University	Zhang, X (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	xu.zhang@ion.ac.cn	Wu, Qing-Feng/AAA-5460-2022	Wu, Qing-Feng/0000-0003-3272-6247	NNSFC [31130066]; MOST [2011CBA00400, 2009CB522005]	NNSFC(National Natural Science Foundation of China (NSFC)); MOST	This work is published in memory of Prof. B. A. Afzelius at the University of Stockholm. We thank Drs. X. Yu, Z.-G. Luo, X.-L. Zhu, and J.-S. Guan for comments. This work was supported by NNSFC (31130066) and MOST (2011CBA00400 and 2009CB522005). Q.-F.W. did major experiments. L.Y. and S. L. worked with in utero electroporation in rats, Q. W. with in situ hybridization, and X. G. with mutant mice. X.-B.Y. contributed to experiment design. X.Z., L. B., and Q.-F.W. designed the project and wrote the manuscript.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Corbo JC, 2002, J NEUROSCI, V22, P7548; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gecz J, 1999, HUM GENET, V104, P56, DOI 10.1007/s004390050910; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kornack DR, 2005, CURR OPIN NEUROBIOL, V15, P58, DOI 10.1016/j.conb.2005.01.009; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Lysko DE, 2011, J NEUROSCI, V31, P1739, DOI 10.1523/JNEUROSCI.3118-10.2011; MALMGREN H, 1993, AM J HUM GENET, V52, P1046; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Nishimoto S, 2007, J BIOL CHEM, V282, P24255, DOI 10.1074/jbc.M704277200; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; Qiang L, 2010, MOL BIOL CELL, V21, P334, DOI 10.1091/mbc.E09-09-0834; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Solomon NM, 2002, GENOMICS, V79, P553, DOI 10.1006/geno.2002.6741; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh CA, 2010, NEURON, V68, P245, DOI 10.1016/j.neuron.2010.09.042; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wehner J. M., 2004, CURRENT PROTOCOLS NE; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004	51	114	125	6	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1549	1564		10.1016/j.cell.2012.04.046	http://dx.doi.org/10.1016/j.cell.2012.04.046			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726441	Bronze			2022-12-01	WOS:000305753800020
J	Timmann, C; Thye, T; Vens, M; Evans, J; May, J; Ehmen, C; Sievertsen, J; Muntau, B; Ruge, G; Loag, W; Ansong, D; Antwi, S; Asafo-Adjei, E; Nguah, SB; Kwakye, KO; Akoto, AOY; Sylverken, J; Brendel, M; Schuldt, K; Loley, C; Franke, A; Meyer, CG; Agbenyega, T; Ziegler, A; Horstmann, RD				Timmann, Christian; Thye, Thorsten; Vens, Maren; Evans, Jennifer; May, Juergen; Ehmen, Christa; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Loag, Wibke; Ansong, Daniel; Antwi, Sampson; Asafo-Adjei, Emanuel; Nguah, Samuel Blay; Kwakye, Kingsley Osei; Akoto, Alex Osei Yaw; Sylverken, Justice; Brendel, Michael; Schuldt, Kathrin; Loley, Christina; Franke, Andre; Meyer, Christian G.; Agbenyega, Tsiri; Ziegler, Andreas; Horstmann, Rolf D.			Genome-wide association study indicates two novel resistance loci for severe malaria	NATURE			English	Article							CEREBRAL MALARIA; ACTIVATION; DISEASES	Malaria causes approximately one million fatalities per year, mostly among African children(1). Although highlighted by the strong protective effect of the sickle-cell trait(2,3), the full impact of human genetics on resistance to the disease remains largely unexplored(4). Genome-wide association (GWA) studies are designed to unravel relevant genetic variants comprehensively; however, in malaria, as in other infectious diseases, these studies have been only partly successful(5). Here we identify two previously unknown loci associated with severe falciparum malaria in patients and controls from Ghana, West Africa. We applied the GWA approach to the diverse clinical syndromes of severe falciparum malaria, thereby targeting human genetic variants influencing any step in the complex pathogenesis of the disease. One of the loci was identified on chromosome 1q32 within the ATP2B4 gene, which encodes the main calcium pump of erythrocytes(6), the host cells of the pathogenic stage of malaria parasites. The second was indicated by an intergenic single nucleotide polymorphism on chromosome 16q22.2, possibly linked to a neighbouring gene encoding the tight-junction protein MARVELD3. The protein is expressed on endothelial cells(7) and might therefore have a role in microvascular damage caused by endothelial adherence of parasitized erythrocytes. We also confirmed previous reports on protective effects of the sickle-cell trait and blood group O-5,O-8,O-9. Our findings underline the potential of the GWA approach to provide candidates for the development of control measures against infectious diseases in humans.	[Timmann, Christian; Thye, Thorsten; Evans, Jennifer; Ehmen, Christa; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Brendel, Michael; Schuldt, Kathrin; Meyer, Christian G.; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [Timmann, Christian; Thye, Thorsten; Vens, Maren; Brendel, Michael; Loley, Christina; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometry & Stat, D-23562 Lubeck, Germany; [Evans, Jennifer] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [May, Juergen; Loag, Wibke] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol Grp, D-20359 Hamburg, Germany; [Ansong, Daniel; Antwi, Sampson; Asafo-Adjei, Emanuel; Nguah, Samuel Blay; Kwakye, Kingsley Osei; Akoto, Alex Osei Yaw; Sylverken, Justice; Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Lubeck; Kumasi Center for Collaborative Research; Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology; University of Kiel	Timmann, C (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	timmann@bnitm.de	Franke, Andre/B-2151-2010; Nguah, Samuel/AAQ-9725-2020; Ziegler, Andreas/G-4246-2012	Franke, Andre/0000-0003-1530-5811; Ziegler, Andreas/0000-0002-8386-5397; May, Jurgen/0000-0001-7831-8420; ANSONG, Daniel/0000-0003-1328-9117	National Genome Research Network of the German Ministry for Education and Research (BMBF) [NGFN1, NGFN2]; Wellcome Trust [WT077383/Z/05/Z]; Foundation for the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative [566]	National Genome Research Network of the German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Wellcome Trust(Wellcome TrustEuropean Commission); Foundation for the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative	We thank the participating children, their parents and guardians; L. N. Badu, S. Opoku, M. Attan-Ayibo and D. Sambian for technical assistance. Ethical approval was obtained from the Committee for Research, Publications and Ethics of the School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Informed consent was obtained from the parents or guardians of the children and documented by signature, or thumbprint in cases of illiteracy. The study complied with the Ethical Principles for Medical Research Involving Human Subjects as laid out in the Declaration of Helsinki. The study was supported by the National Genome Research Network (NGFN1, NGFN2) of the German Ministry for Education and Research (BMBF). In addition, this study makes use of data generated by MalariaGEN<SUP>5</SUP>. A full list of the investigators who contributed to the generation of the data is available from http://www.malariagen.net. The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and by the Foundation for the National Institutes of Health (566) as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative.	[Anonymous], 2010, LANCET INFECT DIS, V10, P577, DOI 10.1016/S1473-3099(10)70171-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a; de Bakker PIW, 2010, NAT GENET, V42, P731, DOI 10.1038/ng0910-731; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Idro R, 2010, PEDIATR RES, V68, P267, DOI [10.1203/PDR.0b013e3181eee738, 10.1203/00006450-201011001-00524]; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Loscertales MP, 2007, ADV PARASIT, V65, P1, DOI 10.1016/S0065-308X(07)65001-5; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MOLYNEUX ME, 1989, Q J MED, V71, P441; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Wassmer SC, 2005, PLOS MED, V2, P885, DOI 10.1371/journal.pmed.0020245	27	165	165	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					443	446		10.1038/nature11334	http://dx.doi.org/10.1038/nature11334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22895189				2022-12-01	WOS:000308860900048
J	Chen, LY; Redon, S; Lingner, J				Chen, Liuh-Yow; Redon, Sophie; Lingner, Joachim			The human CST complex is a terminator of telomerase activity	NATURE			English	Article							DNA-POLYMERASE-ALPHA; SINGLE-STRANDED-DNA; CHROMOSOME ENDS; REPLICATION; PROTECTION; EXTENSION; INTERACTS; PROTEIN; CELLS; PROCESSIVITY	The lengths of human telomeres, which protect chromosome ends from degradation and end fusions(1,2), are crucial determinants of cell lifespan(3). During embryogenesis and in cancer, the telomerase enzyme counteracts telomeric DNA shortening. As shown in cancer cells, human telomerase binds the shelterin component TPP1 at telomeres(4,5) during the S phase of the cell cycle, and adds similar to 60 nucleotides in a single round of extension(6), after which telomerase is turned off by unknown mechanisms. Here we show that the human CST (CTC1, STN1 and TEN1) complex, previously implicated in telomere protection and DNA metabolism(7-11), inhibits telomerase activity through primer sequestration and physical interaction with the protection of telomeres 1 (POT1)-TPP1 telomerase processivity factor(12,13). CST competes with POT1-TPP1 for telomeric DNA, and CST-telomeric-DNA binding increases during late S/G2 phase only on telomerase action, coinciding with telomerase shut-off. Depletion of CST allows excessive telomerase activity, promoting telomere elongation. We propose that through binding of the telomerase-extended telomere, CST limits telomerase action at individual telomeres to approximately one binding and extension event per cell cycle. Our findings define the sequence of events that occur to first enable and then terminate telomerase-mediated telomere elongation.	[Chen, Liuh-Yow; Redon, Sophie; Lingner, Joachim] Ecole Polytech Fed Lausanne, Frontiers Genet Natl Ctr Competence Res, Sch Life Sci, Swiss Inst Expt Canc Res ISREC,Stn 19, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Lingner, J (corresponding author), Ecole Polytech Fed Lausanne, Frontiers Genet Natl Ctr Competence Res, Sch Life Sci, Swiss Inst Expt Canc Res ISREC,Stn 19, CH-1015 Lausanne, Switzerland.	joachim.lingner@epfl.ch	Chen, Liuh-Yow/AAA-3963-2021	Chen, Liuh-Yow/0000-0002-9857-068X; Lingner, Joachim/0000-0002-2853-5803	Swiss National Science Foundation; European Research Council [232812]; Swiss Cancer League; EPFL	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Swiss Cancer League; EPFL	We thank P. Reichenbach, K. Ong and S. Feuerhahn for technical help, the PCF-EPFL core facility for protein expression and J. Cooper for discussion. Research in the laboratory of J.L. was supported by the Swiss National Science Foundation, a European Research Council advanced investigator grant (grant agreement no. 232812), the Swiss Cancer League and EPFL.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Cristofari G, 2007, NAT METHODS, V4, P851, DOI 10.1038/NMETH1099; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Martin V, 2007, P NATL ACAD SCI USA, V104, P14038, DOI 10.1073/pnas.0705497104; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Nakaoka H, 2012, J BIOL CHEM, V287, P619, DOI 10.1074/jbc.M111.263723; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Qi HY, 2000, GENE DEV, V14, P1777; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	22	216	222	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					540	+		10.1038/nature11269	http://dx.doi.org/10.1038/nature11269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22763445				2022-12-01	WOS:000307761600043
J	Barthelme, D; Sauer, RT				Barthelme, Dominik; Sauer, Robert T.			Identification of the Cdc48 center dot 20S Proteasome as an Ancient AAA+ Proteolytic Machine	SCIENCE			English	Article							REGULATORY PARTICLE; N-DOMAIN; ATPASE; DEGRADATION; P97/VCP; P97	Proteasomes are the major energy-dependent proteolytic machines in the eukaryotic and archaeal domains of life. To execute protein degradation, the 20S core peptidase combines with the AAA+ ring of the 19S regulatory particle in eukarya or with the AAA+ proteasome-activating nucleotidase ring in some archaea. Here, we find that Cdc48 and 20S from the archaeon Thermoplasma acidophilum interact to form a functional proteasome. Cdc48 is an abundant and essential double-ring AAA+ molecular machine ubiquitously present in archaea, where its function has been uncertain, and in eukarya where Cdc48 participates by largely unknown mechanisms in diverse cellular processes, including multiple proteolytic pathways. Thus, proteolysis in collaboration with the 20S peptidase may represent an ancestral function of the Cdc48 family.	[Barthelme, Dominik; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu	Barthelme, Dominik/E-8452-2010	Sauer, Robert/0000-0002-1719-5399	NIH [AI-16892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Hill, A. Horwich, H. Huber, S. Kim, K. Schmitz, B. Stinson, and M. Wohlever for materials and discussions. Supported by NIH grant AI-16892. The data reported in this manuscript are presented in the main paper and supplementary materials.	Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	17	89	92	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					843	846		10.1126/science.1224352	http://dx.doi.org/10.1126/science.1224352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837385	Green Accepted, Green Submitted			2022-12-01	WOS:000307535600043
J	Watson, RO; Manzanillo, PS; Cox, JS				Watson, Robert O.; Manzanillo, Paolo S.; Cox, Jeffery S.			Extracellular M. tuberculosis DNA Targets Bacteria for Autophagy by Activating the Host DNA-Sensing Pathway	CELL			English	Article							INNATE IMMUNE-RESPONSE; ESX-1 SECRETION SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; PHAGOSOME MATURATION; IL-1-BETA PRODUCTION; MYELOID CELLS; BCG; MACROPHAGES; RECOGNITION; INFECTION	Eukaryotic cells sterilize the cytosol by using autophagy to route invading bacterial pathogens to the lysosome. During macrophage infection with Mycobacterium tuberculosis, a vacuolar pathogen, exogenous induction of autophagy can limit replication, but the mechanism of autophagy targeting and its role in natural infection remain unclear. Here we show that phagosomal permeabilization mediated by the bacterial ESX-1 secretion system allows cytosolic components of the ubiquitin-mediated autophagy pathway access to phagosomal M. tuberculosis. Recognition of extracelluar bacterial DNA by the STING-dependent cytosolic pathway is required for marking bacteria with ubiquitin, and delivery of bacilli to autophagosomes requires the ubiquitin-autophagy receptors p62 and NDP52 and the DNA-responsive kinase TBK1. Remarkably, mice with monocytes incapable of delivering bacilli to the autophagy pathway are extremely susceptible to infection. Our results reveal an unexpected link between DNA sensing, innate immunity, and autophagy and indicate a major role for this autophagy pathway in resistance to M. tuberculosis infection.	[Watson, Robert O.; Manzanillo, Paolo S.; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA.	jeffery.cox@ucsf.edu			NIH [PO1 AI063302, RO1 AI081727]; Heiser Foundation Fellowship; Genentech Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI081727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heiser Foundation Fellowship; Genentech Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Vance, G. Barton, D. Monack, G. Barber, N. Mizushima, H. Virgin, and J. Debnath for mice and reagents. We are grateful to S. Johnson and J. Rubenstein for use of their microscopes. We thank S. Bell for critical reading of the manuscript. This work was supported by NIH grants PO1 AI063302 and RO1 AI081727, the Heiser Foundation Fellowship, and the Genentech Research Fellowship.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Barber GN, 2011, NAT IMMUNOL, V12, P929, DOI 10.1038/ni.2118; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hagstrom JE, 1997, J CELL SCI, V110, P2323; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	55	512	531	2	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					803	815		10.1016/j.cell.2012.06.040	http://dx.doi.org/10.1016/j.cell.2012.06.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901810	Green Accepted, Bronze			2022-12-01	WOS:000308002300014
J	Yang, WW; Xia, Y; Hawke, D; Li, XJ; Liang, J; Xing, DM; Aldape, K; Hunter, T; Yung, WKA; Lu, ZM				Yang, Weiwei; Xia, Yan; Hawke, David; Li, Xinjian; Liang, Ji; Xing, Dongming; Aldape, Kenneth; Hunter, Tony; Yung, W. K. Alfred; Lu, Zhimin			PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis	CELL			English	Article							PYRUVATE-KINASE M2; BETA-CATENIN TRANSACTIVATION; NUCLEAR TRANSLOCATION; DOWN-REGULATION; METABOLISM; ACTIVATION; EXPRESSION; MITOSIS; GROWTH; EGFR	Tumor-specific pyruvate kinase M2 (PKM2) is essential for the Warburg effect. In addition to its well-established role in aerobic glycolysis, PKM2 directly regulates gene transcription. However, the mechanism underlying this nonmetabolic function of PKM2 remains elusive. We show here that PKM2 directly binds to histone H3 and phosphorylates histone H3 at T11 upon EGF receptor activation. This phosphorylation is required for the dissociation of HDAC3 from the CCND1 and MYC promoter regions and subsequent acetylation of histone H3 at K9. PKM2-dependent histone H3 modifications are instrumental in EGF-induced expression of cyclin D1 and c-Myc, tumor cell proliferation, cell-cycle progression, and brain tumorigenesis. In addition, levels of histone H3 T11 phosphorylation correlate with nuclear PKM2 expression levels, glioma malignancy grades, and prognosis. These findings highlight the role of PKM2 as a protein kinase in its nonmetabolic functions of histone modification, which is essential for its epigenetic regulation of gene expression and tumorigenesis.	[Yang, Weiwei; Xia, Yan; Li, Xinjian; Liang, Ji; Yung, W. K. Alfred; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Yang, Weiwei; Xia, Yan; Li, Xinjian; Liang, Ji; Yung, W. K. Alfred; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Hawke, David] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xing, Dongming] Tsinghua Univ, Sch Life Sci, Lab Pharmaceut Sci, Beijing 100084, Peoples R China; [Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Lu, Zhimin] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tsinghua University; Salk Institute	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org		Hawke, David/0000-0002-6102-7843; Yang, Weiwei/0000-0002-1661-9137	National Cancer Institute [2R01CA109035, 5 P50 CA127001-03, CA16672, 2R01CA082683]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110252]; American Cancer Society Research Scholar Award [RSG-09-277-01-CSM]; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA109035, R01CA082683, P30CA016672, P50CA127001] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas (CPRIT); American Cancer Society Research Scholar Award(American Cancer Society); University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grants 2R01CA109035 (Z.L.), 5 P50 CA127001-03, and CA16672 (Cancer Center Support Grant); a research grant (RP110252; Z.L.) from the Cancer Prevention and Research Institute of Texas (CPRIT); an American Cancer Society Research Scholar Award RSG-09-277-01-CSM (Z.L.); and a Sister Institution Network Fund from The University of Texas MD Anderson Cancer Center (Z.L.). T. H. is a Frank and Else Schilling American Cancer Society Professor, and work in his group was supported by National Cancer Institute grant 2R01CA082683.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gomez-Manzano C, 2006, CLIN CANCER RES, V12, P556, DOI 10.1158/1078-0432.CCR-05-1892; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Lu ZM, 2004, CELL CYCLE, V3, P571; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MELLATI AA, 1992, CANCER BIOCHEM BIOPH, V13, P33; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Shimada M, 2008, CELL CYCLE, V7, P1555, DOI 10.4161/cc.7.11.6062; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	42	509	531	5	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					685	696		10.1016/j.cell.2012.07.018	http://dx.doi.org/10.1016/j.cell.2012.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901803	Bronze, Green Accepted			2022-12-01	WOS:000308002300005
J	Scimia, MC; Hurtado, C; Ray, S; Metzler, S; Wei, K; Wang, JM; Woods, CE; Purcell, NH; Catalucci, D; Akasaka, T; Bueno, OF; Vlasuk, GP; Kaliman, P; Bodmer, R; Smith, LH; Ashley, E; Mercola, M; Brown, JH; Ruiz-Lozano, P				Scimia, Maria Cecilia; Hurtado, Cecilia; Ray, Saugata; Metzler, Scott; Wei, Ke; Wang, Jianming; Woods, Chris E.; Purcell, Nicole H.; Catalucci, Daniele; Akasaka, Takeshi; Bueno, Orlando F.; Vlasuk, George P.; Kaliman, Perla; Bodmer, Rolf; Smith, Layton H.; Ashley, Euan; Mercola, Mark; Brown, Joan Heller; Ruiz-Lozano, Pilar			APJ acts as a dual receptor in cardiac hypertrophy	NATURE			English	Article							IN-VIVO; GENE-EXPRESSION; ANGIOTENSIN-II; APELIN; STRETCH; PROTEIN; CONTRACTILITY; MYOCYTES; CARDIOMYOCYTES; INVOLVEMENT	Cardiac hypertrophy is initiated as an adaptive response to sustained overload but progresses pathologically as heart failure ensues(1). Here we report that genetic loss of APJ, a G-protein-coupled receptor, confers resistance to chronic pressure overload by markedly reducing myocardial hypertrophy and heart failure. In contrast, mice lacking apelin (the endogenous APJ ligand) remain sensitive, suggesting an apelin-independent function of APJ. Freshly isolated APJ-null cardiomyocytes exhibit an attenuated response to stretch, indicating that APJ is a mechanosensor. Activation of APJ by stretch increases cardiomyocyte cell size and induces molecular markers of hypertrophy. Whereas apelin stimulates APJ to activate G alpha(i) and elicits a protective response, stretch signals in an APJ-dependent, G-protein-independent fashion to induce hypertrophy. Stretch-mediated hypertrophy is prevented by knockdown of beta-arrestins or by pharmacological doses of apelin acting through G alpha(i). Taken together, our data indicate that APJ is a bifunctional receptor for both mechanical stretch and the endogenous peptide apelin. By sensing the balance between these stimuli, APJ occupies a pivotal point linking sustained overload to cardiomyocyte hypertrophy.	[Scimia, Maria Cecilia; Hurtado, Cecilia; Ray, Saugata; Wei, Ke; Wang, Jianming; Akasaka, Takeshi; Bodmer, Rolf; Smith, Layton H.; Mercola, Mark; Ruiz-Lozano, Pilar] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Metzler, Scott; Ruiz-Lozano, Pilar] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Woods, Chris E.; Ashley, Euan] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Purcell, Nicole H.; Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Catalucci, Daniele] CNR, Biomed & Genet Res Inst, I-20138 Milan, Italy; [Catalucci, Daniele] Humanitas Clin & Res Ctr, I-20089 Milan, Italy; [Bueno, Orlando F.; Vlasuk, George P.] Wyeth Pharmaceut, Madison, NJ USA; [Kaliman, Perla] Inst Biomed Res August Pi & Sunyer IDIBAPS, E-08036 Barcelona, Spain	Sanford Burnham Prebys Medical Discovery Institute; Stanford University; Stanford University; University of California System; University of California San Diego; Consiglio Nazionale delle Ricerche (CNR); Pfizer; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Ruiz-Lozano, P (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	prlozano@stanford.edu	Catalucci, Daniele/AAA-6056-2022; Ray, Saugata/E-3160-2012; Catalucci, Daniele/B-6745-2015	Catalucci, Daniele/0000-0001-7041-6114; Catalucci, Daniele/0000-0001-7041-6114; Smith, Layton/0000-0003-2621-9740	Wyeth Sponsored Research Agreement; National Institutes of Health (NIH) [R01HL086879, R37HL059502, R01HL083463, R01HL054732, NS05422, RO1HL28143, P01 HL085577]; Sanford Children's Center; Ellison Medical Foundation; Muscular Dystrophy association; Florida Department of Health [06-NIR-09]; California Institute for Regenerative Medicine; Italian Ministry of Research and Education; Italian Society of Cardiology (SIC and Sanofi-Aventis Foundation); American Heart Association Postdoctoral Award; Ministerio de Ciencia e Innovacion (MICINN) Spain [SAF2010-15050]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054732, R01HL083463, P01HL085577, R37HL059502, R01HL086879, R01HL028143, R37HL028143] Funding Source: NIH RePORTER	Wyeth Sponsored Research Agreement; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford Children's Center; Ellison Medical Foundation(Lawrence Ellison Foundation); Muscular Dystrophy association(Muscular Dystrophy Association); Florida Department of Health; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Italian Ministry of Research and Education(Ministry of Education, Universities and Research (MIUR)); Italian Society of Cardiology (SIC and Sanofi-Aventis Foundation); American Heart Association Postdoctoral Award(American Heart Association); Ministerio de Ciencia e Innovacion (MICINN) Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are thankful to N. Ling, S. Zhao and F. Abdel-Wahhab for technical assistance; E. Sergienko for help optimizing arrestin assay; E. Adamson for reading the manuscript; and M. Querol for graphics design. This work was supported by Wyeth Sponsored Research Agreement and National Institutes of Health (NIH) grant R01HL086879 to P. R. L.; NIH grants R37HL059502 and R01HL083463 and the Sanford Children's Center to M. M.; NIH grant R01HL054732, grants from the Ellison Medical Foundation and the Muscular Dystrophy association to R. B., NIH grant (NS05422) and Florida Department of Health grant 06-NIR-09 to L. H. S., and NIH grants RO1HL28143, P01 HL085577 to J.H.B. M. C. S. has received support from the California Institute for Regenerative Medicine (clinical fellow), the Italian Ministry of Research and Education and the Italian Society of Cardiology (SIC and Sanofi-Aventis Foundation). C. H. holds an American Heart Association Postdoctoral Award, S. R. is a Sanford Children's Health Research Center fellow. P. K. is supported by SAF2010-15050 Ministerio de Ciencia e Innovacion (MICINN) Spain.	Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Bollensdorff C, 2011, PFLUG ARCH EUR J PHY, V462, P39, DOI 10.1007/s00424-011-0964-z; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Iribe G, 2009, CIRC RES, V104, P787, DOI 10.1161/CIRCRESAHA.108.193334; Jia YX, 2006, REGUL PEPTIDES, V133, P147, DOI 10.1016/j.regpep.2005.09.033; KNOWLTON KU, 1995, J CLIN INVEST, V96, P1311, DOI 10.1172/JCI118166; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Magga J, 1997, CIRCULATION, V96, P3053, DOI 10.1161/01.CIR.96.9.3053; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Rapacciuolo A, 2001, ACTA PHYSIOL SCAND, V173, P51, DOI 10.1046/j.1365-201X.2001.00884.x; ROCKMAN HA, 1994, P NATL ACAD SCI USA, V91, P2694, DOI 10.1073/pnas.91.7.2694; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Siddiquee K, 2011, J HYPERTENS, V29, P724, DOI 10.1097/HJH.0b013e32834347de; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	27	176	188	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					394	398		10.1038/nature11263	http://dx.doi.org/10.1038/nature11263			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22810587	Green Accepted, Green Submitted			2022-12-01	WOS:000307501000045
J	Saab, AS; Neumeyer, A; Jahn, HM; Cupido, A; Simek, AAM; Boele, HJ; Scheller, A; Le Meur, K; Gotz, M; Monyer, H; Sprengel, R; Rubio, ME; Deitmer, JW; De Zeeuw, CI; Kirchhoff, F				Saab, Aiman S.; Neumeyer, Alexander; Jahn, Hannah M.; Cupido, Alexander; Simek, Antonia A. M.; Boele, Henk-Jan; Scheller, Anja; Le Meur, Karim; Goetz, Magdalena; Monyer, Hannah; Sprengel, Rolf; Rubio, Maria E.; Deitmer, Joachim W.; De Zeeuw, Chris I.; Kirchhoff, Frank			Bergmann Glial AMPA Receptors Are Required for Fine Motor Coordination	SCIENCE			English	Article							KAINATE RECEPTORS; PLASTICITY; CEREBELLUM; CELLS; COMMUNICATION	The impact of glial neurotransmitter receptors in vivo is still elusive. In the cerebellum, Bergmann glial (BG) cells express alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) composed exclusively of GluA1 and/or GluA4 subunits. With the use of conditional gene inactivation, we found that the majority of cerebellar GluA1/A4-type AMPARs are expressed in BG cells. In young mice, deletion of BG AMPARs resulted in retraction of glial appendages from Purkinje cell (PC) synapses, increased amplitude and duration of evoked PC currents, and a delayed formation of glutamatergic synapses. In adult mice, AMPAR inactivation also caused retraction of glial processes. The physiological and structural changes were accompanied by behavioral impairments in fine motor coordination. Thus, BG AMPARs are essential to optimize synaptic integration and cerebellar output function throughout life.	[Simek, Antonia A. M.; Boele, Henk-Jan; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Saab, Aiman S.; Jahn, Hannah M.; Cupido, Alexander; Scheller, Anja; Le Meur, Karim; Kirchhoff, Frank] Univ Saarland, Dept Mol Physiol, D-6650 Homburg, Germany; [Saab, Aiman S.; Jahn, Hannah M.; Scheller, Anja; Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, D-3400 Gottingen, Germany; [Neumeyer, Alexander; Deitmer, Joachim W.] Tech Univ Kaiserslautern, Fachbereich Biol, Kaiserslautern, Germany; [Goetz, Magdalena] Univ Munich, Dept Physiol, D-8000 Munich, Germany; [Goetz, Magdalena] Helmholtz Ctr Munich, Inst Stem Cell Res, Neuherberg, Germany; [Monyer, Hannah] Heidelberg Univ, German Canc Res Ctr, Dept Clin Neurobiol, Heidelberg, Germany; [Monyer, Hannah] Heidelberg Univ, Fac Med, Heidelberg, Germany; [Sprengel, Rolf] Max Planck Inst Med Res, Dept Mol Neurobiol, Heidelberg, Germany; [Rubio, Maria E.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [De Zeeuw, Chris I.] Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Saarland University; Max Planck Society; University of Kaiserslautern; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl; frank.kirchhoff@uks.eu	Boele, Henk-Jan/AAK-3836-2021; Boele, Henk-Jan/AAI-7261-2021; Scheller, Anja/B-8577-2018; Kirchhoff, Frank/B-9335-2008	Boele, Henk-Jan/0000-0001-8449-4391; Scheller, Anja/0000-0001-8955-2634; Kirchhoff, Frank/0000-0002-2324-2761; Saab, Aiman S./0000-0003-3886-8369	Max-Planck Society (INSERM-AMIGO); Deutsche Forschungsgemeinschaft (DFG)-Research Center Molecular Physiology of the Brain; DFG-SPP [1172]; DFG-Transregio [TRR43]; European Union (EU) [FP7-202167 NeuroGLIA, FP7-ITN-237956 EdU-Glia]; Research Initiative in Membrane Biology University of Kaiserslautern; Dutch Organization for Medical Sciences; Life Sciences; Fund for Economic Structure Reinforcement (NeuroBasic); Prinses Beatrix Fonds; EU ERCadvanced, CEREBNET program; EU C7 program;  [DFG-SFB870];  [DFG-SFB894];  [R01-DC006881]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006881] Funding Source: NIH RePORTER	Max-Planck Society (INSERM-AMIGO); Deutsche Forschungsgemeinschaft (DFG)-Research Center Molecular Physiology of the Brain(German Research Foundation (DFG)); DFG-SPP(German Research Foundation (DFG)); DFG-Transregio(German Research Foundation (DFG)); European Union (EU)(CGIAREuropean Commission); Research Initiative in Membrane Biology University of Kaiserslautern; Dutch Organization for Medical Sciences; Life Sciences(European Commission); Fund for Economic Structure Reinforcement (NeuroBasic); Prinses Beatrix Fonds; EU ERCadvanced, CEREBNET program; EU C7 program; ; ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K.-A. Nave for continuous support, S. Rudolph and P. G. Hirrlinger for early contributions, T. Ruhwedel and F. Rhode for technical assistance, and D. Rhode and C. Casper for animal husbandry. This work was supported by the Max-Planck Society (INSERM-AMIGO, F. K.); Deutsche Forschungsgemeinschaft (DFG)-Research Center Molecular Physiology of the Brain (F. K.); DFG-SPP 1172 (F. K. and J.W.D.); DFG-SFB870 (M. G.); DFG-SFB894 (F. K.); DFG-Transregio TRR43 (F. K.); European Union (EU)-FP7-202167 NeuroGLIA (F. K.) and FP7-ITN-237956 EdU-Glia (F. K.); R01-DC006881 (M. E. R.); the Research Initiative in Membrane Biology University of Kaiserslautern (J.W.D.); the Dutch Organization for Medical Sciences (C.I.D.Z.); Life Sciences (C.I.D.Z.); Fund for Economic Structure Reinforcement (NeuroBasic; C.I.D.Z.); Prinses Beatrix Fonds (C.I.D.Z.); and the EU ERCadvanced, CEREBNET, and C7 programs (C.I.D.Z.).	BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Lavialle M, 2011, P NATL ACAD SCI USA, V108, P12915, DOI 10.1073/pnas.1100957108; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; Verkhratsky A, 2007, J ANAT, V210, P651, DOI 10.1111/j.1469-7580.2007.00734.x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	20	125	126	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					749	753		10.1126/science.1221140	http://dx.doi.org/10.1126/science.1221140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22767895				2022-12-01	WOS:000307354500059
J	LaFerla, FM				LaFerla, Frank M.			Preclinical Success against Alzheimer's Disease with an Old Drug	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BETA		Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA	University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.							Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Lowenthal J, 2012, NEW ENGL J MED, V367, P488, DOI 10.1056/NEJMp1203104; Querfurth HW, 2011, NEW ENGL J MED, V364, P588; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142	5	24	24	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					570	572		10.1056/NEJMcibr1204890	http://dx.doi.org/10.1056/NEJMcibr1204890			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873540				2022-12-01	WOS:000307310800014
J	Rai, A				Rai, Arti			Use Patents, Carve-Outs, and Incentives - A New Battle in the Drug-Patent Wars	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Sch Law, Durham, NC 27706 USA	Duke University	Rai, A (corresponding author), Duke Univ, Sch Law, Durham, NC 27706 USA.							Eisenberg Rebecca S, 2005, Yale J Health Policy Law Ethics, V5, P717; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Stevens AJ, 2011, NEW ENGL J MED, V364, P535, DOI 10.1056/NEJMsa1008268; 2003, FED REG, V68, P36683	4	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					491	493		10.1056/NEJMp1206573	http://dx.doi.org/10.1056/NEJMp1206573			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986AE	22873529	Green Published			2022-12-01	WOS:000307310800003
J	Abrams, EW; Zhang, H; Marlow, FL; Kapp, L; Lu, SM; Mullins, MC				Abrams, Elliott W.; Zhang, Hong; Marlow, Florence L.; Kapp, Lee; Lu, Sumei; Mullins, Mary C.			Dynamic Assembly of Brambleberry Mediates Nuclear Envelope Fusion during Early Development	CELL			English	Article							MITOTIC SPINDLE; MEMBRANE-FUSION; PROTEIN; ZEBRAFISH; TRANSITION; CLEAVAGE; ZYGOTE; REORGANIZATION; CONGRESSION; INTERPHASE	To accommodate the large cells following zygote formation, early blastomeres employ modified cell divisions. Karyomeres are one such modification, mitotic intermediates wherein individual chromatin masses are surrounded by nuclear envelope; the karyomeres then fuse to form a single mononucleus. We identified brambleberry, a maternal-effect zebrafish mutant that disrupts karyomere fusion, resulting in formation of multiple micronuclei. As karyomeres form, Brambleberry protein localizes to the nuclear envelope, with prominent puncta evident near karyomere-karyomere interfaces corresponding to membrane fusion sites. brambleberry corresponds to an unannotated gene with similarity to Kar5p, a protein that participates in nuclear fusion in yeast. We also demonstrate that Brambleberry is required for pronuclear fusion following fertilization in zebrafish. Our studies provide insight into the machinery required for karyomere fusion and suggest that specialized proteins are necessary for proper nuclear division in large dividing blastomeres.	[Abrams, Elliott W.; Zhang, Hong; Marlow, Florence L.; Kapp, Lee; Lu, Sumei; Mullins, Mary C.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Mullins, MC (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, 1211 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	mullins@mail.med.upenn.edu			NRSA postdoctoral fellowships [5F32GM77835, 1F32GM080926, DRG1826-04];  [R21HD062952];  [R01HD050901];  [R01HD065600];  [T32-HD007516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065600, T32HD007516] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050901, R21HD062952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077835, F32GM080926] Funding Source: NIH RePORTER	NRSA postdoctoral fellowships; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Lemon for technical assistance; P. Klein, E. Bi, S. DiNardo, and P. Tran for critical reading of the manuscript; the Mullins Lab for thoughtful discussions; and the fish facility staff for maintaining the fish stocks. This work was supported by grants R21HD062952, R01HD050901, and R01HD065600 to M.C.M., training grant T32-HD007516 to E.W.A., and NRSA postdoctoral fellowships 5F32GM77835 to E. W. A., 1F32GM080926 to L. K., and DRG1826-04 to F.L.M.	Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Balakier H, 1997, HUM REPROD, V12, P800, DOI 10.1093/humrep/12.4.800; Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181; Beh CT, 1997, J CELL BIOL, V139, P1063, DOI 10.1083/jcb.139.5.1063; Bownds C, 2010, J EXP BIOL, V213, P3796, DOI 10.1242/jeb.043356; Buch C, 2009, J CELL SCI, V122, P2100, DOI 10.1242/jcs.047373; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; Cummins J M, 2002, Reprod Biomed Online, V4, P176; Dekens MPS, 2003, DEVELOPMENT, V130, P3907, DOI 10.1242/dev.00606; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FERNANDEZ J, 1995, DEV BIOL, V171, P541, DOI 10.1006/dbio.1995.1303; Fichtman B, 2010, MOL BIOL CELL, V21, P4197, DOI 10.1091/mbc.E10-04-0309; Gard DL, 1995, CURR TOP DEV BIOL, V31, P383; GONDOS B, 1972, J CELL SCI, V10, P61; Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2; GULYAS BJ, 1972, J CELL BIOL, V55, P533, DOI 10.1083/jcb.55.3.533; HAREL A, 1989, J CELL SCI, V94, P463; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hofmann K., 1993, BIOL CHEM, V374, P166; Huang QM, 2010, BIOCHEM BIOPH RES CO, V391, P542, DOI 10.1016/j.bbrc.2009.11.094; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jasik Krzysztof, 2006, Wiadomosci Parazytologiczne, V52, P291; Knapik EW, 1996, DEVELOPMENT, V123, P451; KURIHARA LJ, 1994, J CELL BIOL, V126, P911, DOI 10.1083/jcb.126.4.911; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; LONGO FJ, 1972, J MORPHOL, V138, P207, DOI 10.1002/jmor.1051380206; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Melloy P, 2009, MOL BIOL CELL, V20, P3773, DOI 10.1091/mbc.E09-02-0163; MONTAG M, 1988, CHROMOSOMA, V96, P187, DOI 10.1007/BF00302357; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; NEWPORT J, 1992, J CELL BIOL, V116, P295, DOI 10.1083/jcb.116.2.295; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Pelegri F, 2004, METHOD CELL BIOL, V77, P21; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Schoft VK, 2003, J CELL SCI, V116, P2505, DOI 10.1242/jcs.00450; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024; ZAMBONI L, 1972, BIOL REPROD, V7, P170, DOI 10.1093/biolreprod/7.2.170	51	35	36	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					521	532		10.1016/j.cell.2012.05.048	http://dx.doi.org/10.1016/j.cell.2012.05.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863006	Green Accepted, Bronze			2022-12-01	WOS:000307301400012
J	Jonsson, T; Atwal, JK; Steinberg, S; Snaedal, J; Jonsson, PV; Bjornsson, S; Stefansson, H; Sulem, P; Gudbjartsson, D; Maloney, J; Hoyte, K; Gustafson, A; Liu, YC; Lu, YM; Bhangale, T; Graham, RR; Huttenlocher, J; Bjornsdottir, G; Andreassen, OA; Jonsson, EG; Palotie, A; Behrens, TW; Magnusson, OT; Kong, A; Thorsteinsdottir, U; Watts, RJ; Stefansson, K				Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Jonsson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari			A mutation in APP protects against Alzheimer's disease and age-related cognitive decline	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; IDENTIFICATION; PURIFICATION; PREVALENCE; IMPUTATION; DEMENTIA; CLEAVAGE; GENE; BACE	The prevalence of dementia in the Western world in people over the age of 60 has been estimated to be greater than 5%, about two-thirds of which are due to Alzheimer's disease(1-4). The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3). Here, to search for low-frequency variants in the amyloid-beta precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1,795 Icelanders. We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease. This substitution is adjacent to the aspartyl protease beta-site in APP, and results in an approximately 40% reduction in the formation of amyloidogenic peptides in vitro. The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the beta-cleavage of APP may protect against the disease. Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.	[Jonsson, Thorlakur; Steinberg, Stacy; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Huttenlocher, Johanna; Bjornsdottir, Gyda; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Atwal, Jasvinder K.; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Behrens, Timothy W.; Watts, Ryan J.] Genentech Inc, San Francisco, CA 94080 USA; [Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn] Landspitali Univ Hosp, Dept Geriatr, IS-101 Reykjavik, Iceland; [Huttenlocher, Johanna] Inst Human Genet, Dept Med Genet, D-72026 Tubingen, Germany; [Andreassen, Ole A.] Univ Oslo, Ulleval Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Andreassen, Ole A.] Univ Oslo, Inst Psychiat, N-0407 Oslo, Norway; [Jonsson, Erik G.] Karolinska Hosp & Inst, HUBIN Project, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Jonsson, Palmi V.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Roche Holding; Genentech; Landspitali National University Hospital; Eberhard Karls University of Tubingen; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; University of Iceland	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Andreassen, Ole A./AAY-7531-2020; Stefansson, Kari/AAE-7187-2019	Jonsson, Erik/0000-0001-8368-6332; Palotie, Aarno/0000-0002-2527-5874; Stefansson, Hreinn/0000-0002-9331-6666; Andreassen, Ole A./0000-0002-4461-3568; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Bjornsdottir, Gyda/0000-0002-8100-0306	Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]	Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project	We would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruts M, 2012, ALZHEIMERS DIS FRONT; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; Hardy J, 2010, APP MUTATIONS TABLE; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; NHLBI Exome Sequencing Project (ESP), 2012, EX VAR SERV; PEACOCK ML, 1993, NEUROLOGY, V43, P1254, DOI 10.1212/WNL.43.6.1254; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI 10.1101/cshperspect.a006239; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; St George-Hyslop PH, 2000, BIOL PSYCHIAT, V47, P183, DOI 10.1016/S0006-3223(99)00301-7; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	28	1138	1192	9	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					96	99		10.1038/nature11283	http://dx.doi.org/10.1038/nature11283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22801501				2022-12-01	WOS:000307010700040
J	Wilson, TR; Fridlyand, J; Yan, YB; Penuel, E; Burton, L; Chan, E; Peng, J; Lin, E; Wang, YL; Sosman, J; Ribas, A; Li, J; Moffat, J; Sutherlin, DP; Koeppen, H; Merchant, M; Neve, R; Settleman, J				Wilson, Timothy R.; Fridlyand, Jane; Yan, Yibing; Penuel, Elicia; Burton, Luciana; Chan, Emily; Peng, Jing; Lin, Eva; Wang, Yulei; Sosman, Jeff; Ribas, Antoni; Li, Jiang; Moffat, John; Sutherlin, Daniel P.; Koeppen, Hartmut; Merchant, Mark; Neve, Richard; Settleman, Jeff			Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors	NATURE			English	Article							RECEPTOR TYROSINE KINASES; CELL LUNG-CANCER; ACQUIRED-RESISTANCE; MET AMPLIFICATION; TUMOR-CELLS; SENSITIVITY; SURVIVAL; THERAPY; HETEROGENEITY; ACTIVATION	Mutationally activated kinases define a clinically validated class of targets for cancer drug therapy(1). However, the efficacy of kinase inhibitors in patients whose tumours harbour such alleles is invariably limited by innate or acquired drug resistance(2,3). The identification of resistance mechanisms has revealed a recurrent theme-the engagement of survival signals redundant to those transduced by the targeted kinase(4). Cancer cells typically express multiple receptor tyrosine kinases (RTKs) that mediate signals that converge on common critical downstream cell-survival effectors-most notably, phosphatidylinositol-3-OH kinase (PI(3)K) and mitogen-activated protein kinase (MAPK)(5). Consequently, an increase in RTK-ligand levels, through autocrine tumour-cell production, paracrine contribution from tumour stroma(6) or systemic production, could confer resistance to inhibitors of an oncogenic kinase with a similar signalling output. Here, using a panel of kinase-'addicted' human cancer cell lines, we found that most cells can be rescued from drug sensitivity by simply exposing them to one or more RTK ligands. Among the findings with clinical implications was the observation that hepatocyte growth factor(HGF) confers resistance to the BRAF inhibitor PLX4032 (vemurafenib) in BRAF-mutant melanoma cells. These observations highlight the extensive redundancy of RTK-transduced signalling in cancer cells and the potentially broad role of widely expressed RTK ligands in innate and acquired resistance to drugs targeting oncogenic kinases.	[Wilson, Timothy R.; Chan, Emily; Peng, Jing; Lin, Eva; Merchant, Mark; Neve, Richard; Settleman, Jeff] Genentech Inc, Res Oncol, San Francisco, CA 94080 USA; [Fridlyand, Jane] Genentech Inc, Biostatast, San Francisco, CA 94080 USA; [Yan, Yibing; Penuel, Elicia; Burton, Luciana; Wang, Yulei] Genentech Inc, Dev Sci, San Francisco, CA 94080 USA; [Sosman, Jeff] Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN 37232 USA; [Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Li, Jiang] Roche Nutley, Med Dev Biometr Biostat, Nutley, NJ 07110 USA; [Moffat, John] Genentech Inc, Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Sutherlin, Daniel P.] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA; [Koeppen, Hartmut] Genentech Inc, Res Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Vanderbilt University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Settleman, J (corresponding author), Genentech Inc, Res Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	settleman.jeffrey@gene.com	Wilson, Timothy R/F-8210-2012	Merchant, Mark/0000-0003-0690-8581; Wang, Yulei/0000-0002-9057-9786	NCI NIH HHS [K24 CA097588] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K24CA097588] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Catenacci DVT, 2011, CANCER DISCOV, V1, P573, DOI 10.1158/2159-8290.CD-11-0175; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garrett JT, 2011, CANCER BIOL THER, V11, P793, DOI 10.4161/cbt.11.9.15045; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; Liederer BM, 2011, XENOBIOTICA, V41, P327, DOI 10.3109/00498254.2010.542500; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Straussman R., 2012, NATURE; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Zhang W, 2011, CANCER BIOL THER, V11, P150, DOI 10.4161/cbt.11.2.14623	29	877	918	5	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					505	U1652		10.1038/nature11249	http://dx.doi.org/10.1038/nature11249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22763448	Green Accepted			2022-12-01	WOS:000306815300043
J	Hallal, PC; Bauman, AE; Heath, GW; Kohl, HW; Lee, IM; Pratt, M				Hallal, Pedro C.; Bauman, Adrian E.; Heath, Gregory W.; Kohl, Harold W., III; Lee, I-Min; Pratt, Michael			Physical activity: more of the same is not enough	LANCET			English	Editorial Material							HEALTH		[Hallal, Pedro C.] Univ Fed Pelotas, BR-96030002 Pelotas, Brazil; [Bauman, Adrian E.] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia; [Heath, Gregory W.] Univ Tennessee, Coll Med, Chattanooga, TN USA; [Kohl, Harold W., III] Univ Texas Hlth Sci Ctr, Houston Sch Publ Hlth, Austin, TX USA; [Kohl, Harold W., III] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Lee, I-Min] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA USA; [Pratt, Michael] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Universidade Federal de Pelotas; University of Sydney; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Austin; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Centers for Disease Control & Prevention - USA	Hallal, PC (corresponding author), Univ Fed Pelotas, BR-96030002 Pelotas, Brazil.	prchallal@terra.com.br	Heath, Gregory Wayne/AAE-2464-2020; Lee, I-Min/ABD-5409-2021; Hallal, Pedro C/A-3249-2011	Heath, Gregory Wayne/0000-0003-2864-5225; Hallal, Pedro C/0000-0003-1470-6461				[Anonymous], 2010, GLOB REC PHYS ACT HL; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; International Olympic Committee, 2006, 2006 HAV SPORT ALL D; MORRIS JN, 1953, LANCET, V265, P1053; Mountjoy M, 2011, BRIT J SPORT MED, V45, P839, DOI 10.1136/bjsports-2011-090228; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; United Nations, 2011, 2011 HIGH LEV M PREV; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; WHO, 2011, PHYS IN GLOB PUBL HL	9	108	113	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2012	380	9838					190	191		10.1016/S0140-6736(12)61027-7	http://dx.doi.org/10.1016/S0140-6736(12)61027-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	976TV	22818932				2022-12-01	WOS:000306609200005
J	Wang, JB; Fan, HC; Behr, B; Quake, SR				Wang, Jianbin; Fan, H. Christina; Behr, Barry; Quake, Stephen R.			Genome-wide Single-Cell Analysis of Recombination Activity and De Novo Mutation Rates in Human Sperm	CELL			English	Article							HOT-SPOTS; GENE; EVOLUTION; PATTERNS; CROSSOVERS; HOTSPOTS; REGIONS; PRDM9	Meiotic recombination and de novo mutation are the two main contributions toward gamete genome diversity, and many questions remain about how an individual human's genome is edited by these two processes. Here, we describe a high-throughput method for single-cell whole-genome analysis that was used to measure the genomic diversity in one individual's gamete genomes. A microfluidic system was used for highly parallel sample processing and to minimize nonspecific amplification. High-density genotyping results from 91 single cells were used to create a personal recombination map, which was consistent with population-wide data at low resolution but revealed significant differences from pedigree data at higher resolution. We used the data to test for meiotic drive and found evidence for gene conversion. High-throughput sequencing on 31 single cells was used to measure the frequency of large-scale genome instability, and deeper sequencing of eight single cells revealed de novo mutation rates with distinct characteristics.	[Wang, Jianbin; Fan, H. Christina; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Behr, Barry] Stanford Univ, Dept Obstet, Stanford, CA 94305 USA; [Behr, Barry] Stanford Univ, Dept Gynecol, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu	t, lf/AAJ-4924-2020; Wang, Jianbin/G-7533-2015	Wang, Jianbin/0000-0001-6725-7925	CCNE-T; NCI-NIH [U54CA151459]; Chinese Scholarship Council; Siebel Foundation; NATIONAL CANCER INSTITUTE [U54CA151459] Funding Source: NIH RePORTER	CCNE-T; NCI-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese Scholarship Council(China Scholarship Council); Siebel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Jessica Melin and the Stanford Microfluidic Foundry for fabrication of the microfluidic devices. We thank Janice Gebhardt and the Stanford IVF Laboratory for semen sample processing. We thank Norma Neff, Gary Mantalas, and Ben Passarelli for assistance in sequencing experiments and data processing. We also thank Jad Kanbar for help with PCR experiments. The project was supported by CCNE-T, a grant funded by NCI-NIH (grant number U54CA151459). J.W. was supported by a scholarship from the Chinese Scholarship Council. H.C.F was supported by a scholarship from the Siebel Foundation.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Gay J, 2007, GENETICS, V177, P881, DOI 10.1534/genetics.107.078907; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li J, 2012, PLOS GENET, V8, P201, DOI [10.1371/journal.pgen.1002630, 10.1371/journal.pgen.1002692]; Luetjens CM, 2002, HUM REPROD, V17, P1826, DOI 10.1093/humrep/17.7.1826; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Quelin C, 2009, EUR J MED GENET, V52, P41, DOI 10.1016/j.ejmg.2008.10.002; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Wang JYJ, 2006, CANCER CELL, V9, P417, DOI 10.1016/j.ccr.2006.05.013; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WILLIAMS C, 1993, HUM MOL GENET, V2, P445, DOI 10.1093/hmg/2.4.445; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zollner S, 2004, AM J HUM GENET, V74, P62, DOI 10.1086/381131	38	359	392	3	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					402	412		10.1016/j.cell.2012.06.030	http://dx.doi.org/10.1016/j.cell.2012.06.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817899	Bronze, Green Accepted			2022-12-01	WOS:000306595700018
J	Noakes, TD				Noakes, T. D.			Commentary: role of hydration in health and exercise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ULTRAMARATHON RUNNERS; POSTURAL HYPOTENSION; HYPONATREMIA; MANAGEMENT; TRIAL		[Noakes, T. D.] Univ Cape Town, Dept Human Biol, ZA-7700 Newlands, South Africa; [Noakes, T. D.] Sports Sci Inst S Africa, ZA-7700 Newlands, South Africa	University of Cape Town	Noakes, TD (corresponding author), Univ Cape Town, Dept Human Biol, ZA-7700 Newlands, South Africa.	Timothy.noakes@uct.ac.za	Noakes, Timothy D./E-7253-2011; Noakes, Tim/AAD-3162-2020	Noakes, Timothy D./0000-0001-7244-2375; Noakes, Tim/0000-0001-7244-2375				Anley C, 2011, BRIT J SPORT MED, V45, P1113, DOI 10.1136/bjsm.2010.071951; Cuthill JA, 2009, EMERG MED J, V26, P906, DOI 10.1136/emj.2008.065524; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Hew-Butler T, 2005, CLIN J SPORT MED, V15, P206, DOI 10.1097/01.jsm.0000174702.23983.41; Hew-Butler T, 2008, CLIN J SPORT MED, V18, P350, DOI 10.1097/JSM.0b013e3181802c6d; HOLTZHAUSEN LM, 1994, MED SCI SPORT EXER, V26, P1095; HOLTZHAUSEN LM, 1995, MED SCI SPORT EXER, V27, P1595; IRVING RA, 1991, J APPL PHYSIOL, V70, P342, DOI 10.1152/jappl.1991.70.1.342; McGarvey J, 2010, BRIT J SPORT MED, V44, P716, DOI 10.1136/bjsm.2008.053249; Noakes T., 2012, WATERLOGGED SERIOUS; Noakes TD, 2005, P NATL ACAD SCI USA, V102, P18550, DOI 10.1073/pnas.0509096102; Rae DE, 2008, MED SCI SPORT EXER, V40, P1193, DOI 10.1249/MSS.0b013e31816a7155	12	6	6	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2012	345								e4171	10.1136/bmj.e4171	http://dx.doi.org/10.1136/bmj.e4171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MA	22810384				2022-12-01	WOS:000306744300001
J	Cleland, J; Conde-Agudelo, A; Peterson, H; Ross, J; Tsui, A				Cleland, John; Conde-Agudelo, Agustin; Peterson, Herbert; Ross, John; Tsui, Amy			Contraception and health	LANCET			English	Article							SHORT INTERPREGNANCY INTERVAL; INTRAUTERINE-DEVICE USE; MATERNAL MORTALITY; PERINATAL OUTCOMES; NUTRITIONAL-STATUS; RISK; BIRTH; INFANT; CHILD; DISEASE	Increasing contraceptive use in developing countries has cut the number of maternal deaths by 40% over the past 20 years, merely by reducing the number of unintended pregnancies. By preventing high-risk pregnancies, especially in women of high parities, and those that would have ended in unsafe abortion, increased contraceptive use has reduced the maternal mortality ratio-the risk of maternal death per 100 000 livebirths-by about 26% in little more than a decade. A further 30% of maternal deaths could be avoided by fulfilment of unmet need for contraception. The benefits of modern contraceptives to women's health, including non-contraceptive benefits of specific methods, outweigh the risks. Contraception can also improve perinatal outcomes and child survival, mainly by lengthening interpregnancy intervals. In developing countries, the risk of prematurity and low birthweight doubles when conception occurs within 6 months of a previous birth, and children born within 2 years of an elder sibling are 60% more likely to die in infancy than are those born more than 2 years after their sibling.	[Cleland, John] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Conde-Agudelo, Agustin] Eunice Kennedy Shriver Natl Inst Hlth & Human Dev, Perinatol Res Branch, Hutzel Womens Hosp, NIH, Bethesda, MD USA; [Conde-Agudelo, Agustin] Eunice Kennedy Shriver Natl Inst Hlth & Human Dev, Perinatol Res Branch, Hutzel Womens Hosp, NIH, Detroit, MI USA; [Peterson, Herbert] Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Peterson, Herbert] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Ross, John] Futures Grp Inc, Washington, DC USA; [Tsui, Amy] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA	University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cleland, J (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	john.cleland@lshtm.ac.uk	Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016	Bill and Melinda Gates Institute	Bill and Melinda Gates Institute	We thank Anyeli Rosas-Bermudez for assistance with the section on perinatal health. AT's participation was supported by funding from the Bill and Melinda Gates Institute to the Johns Hopkins Bloomberg School of Public Health.	Adam I, 2009, J MATERN-FETAL NEO M, V22, P1068, DOI 10.3109/14767050903009222; Ahmed S., 2012, LANCET; Ali MM, 2010, STUD FAMILY PLANN, V41, P129, DOI 10.1111/j.1728-4465.2010.00234.x; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; ATRASH HK, 1990, OBSTET GYNECOL, V76, P1055; Auger N, 2008, BMC PREGNANCY CHILDB, V8, P7, DOI DOI 10.1186/1471-2393-8-7; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Beining RM, 2008, ANN EPIDEMIOL, V18, P492, DOI 10.1016/j.annepidem.2007.11.011; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; BHATIA JC, 1993, STUD FAMILY PLANN, V24, P310, DOI 10.2307/2939224; Bouvier-Colle MH, 2001, ACTA OBSTET GYN SCAN, V80, P113; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Canning D, 2011, ASS MATERNAL HLTH IN; Castellsague X, 2011, LANCET ONCOL, V12, P1023, DOI 10.1016/S1470-2045(11)70223-6; Cecatti JG, 2008, MATERN CHILD HLTH J, V12, P275, DOI 10.1007/s10995-007-0219-y; Cibula D, 2010, HUM REPROD UPDATE, V16, P631, DOI 10.1093/humupd/dmq022; Collumbien M., 2004, COMP QUANTIFICATION, P1255; Conde-Agudelo A, 2000, BRIT MED J, V321, P1255, DOI 10.1136/bmj.321.7271.1255; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Curtis KM, 2009, AIDS, V23, pS55, DOI 10.1097/01.aids.0000363778.58203.b6; Darroch Jacqueline E., 2011, ESTIMATING UNINTENDE; DeFranco EA, 2007, AM J OBSTET GYNECOL, V197, p264e1; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; FARLEY TMM, 1992, LANCET, V339, P785, DOI 10.1016/0140-6736(92)91904-M; Fikree FF, 1997, ACTA OBSTET GYN SCAN, V76, P637, DOI 10.3109/00016349709024603; FORTNEY JA, 1987, STUD FAMILY PLANN, V18, P109, DOI 10.2307/1966702; FRANKS AL, 1990, AM J OBSTET GYNECOL, V163, P1120, DOI 10.1016/0002-9378(90)90668-W; Garenne M, 1997, Afr J Reprod Health, V1, P14, DOI 10.2307/3583271; Glasier AF, 2003, CONTRACEPTION, V67, P1, DOI 10.1016/S0010-7824(02)00474-2; Goldie SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000264; Grisaru-Granovsky S, 2009, CONTRACEPTION, V80, P512, DOI 10.1016/j.contraception.2009.06.006; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; HOBCRAFT J, 1983, POPUL INDEX, V49, P585, DOI 10.2307/2737284; Hobcraft J, 1987, INT C BETT HLTH WOM; HOBCRAFT JN, 1985, POP STUD-J DEMOG, V39, P363, DOI 10.1080/0032472031000141576; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jain AK, 2011, STUD FAMILY PLANN, V42, P247, DOI 10.1111/j.1728-4465.2011.00288.x; KOENIG MA, 1988, STUD FAMILY PLANN, V19, P69, DOI 10.2307/1966492; KOST K, 1991, FAM PLANN PERSPECT, V23, P54, DOI 10.2307/2135450; Magadi M, 2001, J BIOSOC SCI, V33, P375, DOI 10.1017/S0021932001003753; Mahy M, 2003, DEMOGRAPHIC HLTH SUR, V4; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; MHANGO C, 1986, STUD FAMILY PLANN, V17, P243, DOI 10.2307/1966974; Nabukera SK, 2008, J OBSTET GYNAECOL RE, V34, P941, DOI 10.1111/j.1447-0756.2008.00808.x; *NAT I POP RES TRA, 2003, BANGL MAT HLTH SERV; Peterson HB, 2008, OBSTET GYNECOL, V111, P189, DOI 10.1097/01.AOG.0000298621.98372.62; Petitti DB, 2003, NEW ENGL J MED, V349, P1443, DOI 10.1056/NEJMcp030751; Rodrigues T, 2008, EUR J OBSTET GYN R B, V136, P184, DOI 10.1016/j.ejogrb.2007.03.014; Ross JA, 2012, MATERN CHILD HLTH J, V16, P456, DOI 10.1007/s10995-011-0777-x; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Rutstein SO, 2005, EFFECT BIRTH SPACING; Rutstein SO, 2008, 41 MACR INT DEM HLTH; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Shah I, 2011, INT J GYNECOL OBSTET, V115, P1338; Singh S., 2009, ADDING IT COSTS BENE; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Smits LJM, 2001, LANCET, V358, P2074, DOI 10.1016/S0140-6736(01)07105-7; Stringer EM, 2009, AIDS, V23, P1377, DOI 10.1097/QAD.0b013e32832cbca8; TRUSSELL J, 1984, STUD FAMILY PLANN, V15, P267, DOI 10.2307/1966071; TUNCER RA, 1995, ACTA OBSTET GYN SCAN, V74, P604, DOI 10.3109/00016349509013470; Ujah IAO, 2003, AFR J REPROD HEALTH, V9, P27; UN Department for Economic and Social Information Analysis Population Division, 1994, HLTH RAT FAM PLANN T; Vessey M, 2010, CONTRACEPTION, V82, P221, DOI 10.1016/j.contraception.2010.04.006; Wee DW, 2010, AM J EPIDEMIOL, V172, P855, DOI 10.1093/aje/kwq207; WHO, 2005, Wkly Epidemiol Rec, V80, P302; Williams EK, 2008, J TROP PEDIATRICS, V54, P321, DOI 10.1093/tropej/fmn027; WINIKOFF B, 1987, STUD FAMILY PLANN, V18, P128, DOI 10.2307/1966808; World Health Organization, 2007, WHORHR071; World Health Organization, 2011, UNS AB GLOB REG EST; World Health Organization UNICEF UNFPA The World Bank, 2010, TRENDS MAT MOR 1990; World Health Organization (WHO) Department of Reproductive Health and Research, 2012, HORM CONTR HIV TECHN; Yerushalmy J, 1940, PUBLIC HEALTH REP, V55, P1195, DOI 10.2307/4583352; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	74	350	353	1	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2012	380	9837					149	156		10.1016/S0140-6736(12)60609-6	http://dx.doi.org/10.1016/S0140-6736(12)60609-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	973KN	22784533				2022-12-01	WOS:000306359100042
J	O'Neill, BC; Liddle, B; Jiang, LW; Smith, KR; Pachauri, S; Dalton, M; Fuchs, R				O'Neill, Brian C.; Liddle, Brant; Jiang, Leiwen; Smith, Kirk R.; Pachauri, Shonali; Dalton, Michael; Fuchs, Regina			Demographic change and carbon dioxide emissions	LANCET			English	Article							POPULATION-GROWTH; CO2 EMISSIONS; CLIMATE-CHANGE; ENVIRONMENTAL-IMPACT; ENERGY USE; STIRPAT; URBANIZATION; COUNTRIES; AFFLUENCE; DYNAMICS	Relations between demographic change and emissions of the major greenhouse gas carbon dioxide (CO2) have been studied from different perspectives, but most projections of future emissions only partly take demographic influences into account. We review two types of evidence for how CO2 emissions from the use of fossil fuels are affected by demographic factors such as population growth or decline, ageing, urbanisation, and changes in household size. First, empirical analyses of historical trends tend to show that CO2 emissions from energy use respond almost proportionately to changes in population size and that ageing and urbanisation have less than proportional but statistically significant effects. Second, scenario analyses show that alternative population growth paths could have substantial effects on global emissions of CO2 several decades from now, and that ageing and urbanisation can have important effects in particular world regions. These results imply that policies that slow population growth would probably also have climate-related benefits.	[O'Neill, Brian C.; Jiang, Leiwen] Natl Ctr Atmospher Res, Boulder, CO 80305 USA; [Liddle, Brant] Victoria Univ, Melbourne, Vic 8001, Australia; [Smith, Kirk R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Pachauri, Shonali; Fuchs, Regina] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Dalton, Michael] NOAA, Alaska Fisheries Sci Ctr, Seattle, WA USA	National Center Atmospheric Research (NCAR) - USA; Victoria University; University of California System; University of California Berkeley; International Institute for Applied Systems Analysis (IIASA); National Oceanic Atmospheric Admin (NOAA) - USA	O'Neill, BC (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80305 USA.	boneill@ucar.edu	Liddle, Brantley/K-9542-2014; Pachauri, Shonali/AAR-7383-2020	Liddle, Brantley/0000-0003-3199-0214; jiang, leiwen/0000-0002-2073-6440; Pachauri, Shonali/0000-0001-8138-3178				[Anonymous], 2000, SPECIAL REPORT EMISS; Birdsall N, 1992, ANOTHER LOOK POPULAT, V1020; BONGAARTS J, 1992, POPUL DEV REV, V18, P299, DOI 10.2307/1973681; Bryant L, 2009, B WORLD HEALTH ORGAN, V87, P852, DOI 10.2471/BLT.08.062562; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Chertow M.R., 2000, J IND ECOL, V4, P13, DOI [10.1162/10881980052541927, DOI 10.1162/10881980052541927]; Cohen JE, 2010, P AM PHILOS SOC, V154, P158; Cole MA, 2004, POPUL ENVIRON, V26, P5, DOI 10.1023/B:POEN.0000039950.85422.eb; COMMONER B, 1971, ENVIRONMENT, V13, P2, DOI 10.1080/00139157.1971.9930577; Cramer JC, 1998, DEMOGRAPHY, V35, P45, DOI 10.2307/3004026; Cramer JC, 2000, POPUL ENVIRON, V21, P315, DOI 10.1007/BF02436134; Dalton M, 2008, ENERG ECON, V30, P642, DOI 10.1016/j.eneco.2006.07.002; de Sherbinin A, 2007, ANNU REV ENV RESOUR, V32, P345, DOI 10.1146/annurev.energy.32.041306.100243; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dietz T, 1997, P NATL ACAD SCI USA, V94, P175, DOI 10.1073/pnas.94.1.175; Dodman D, 2009, ENVIRON URBAN, V21, P185, DOI 10.1177/0956247809103016; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Engelman R., 2010, 183 WORLDW I; Fan Y, 2006, ENVIRON IMPACT ASSES, V26, P377, DOI 10.1016/j.eiar.2005.11.007; Fisher B., 2007, CLIMATE CHANGE 2007; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gaffin SR, 1997, POPUL ENVIRON, V18, P389, DOI 10.1007/BF02208514; JIANG Leiwen, 2009, IR09026 IIASA; Jorgenson AK, 2010, POPUL ENVIRON, V32, P27, DOI 10.1007/s11111-010-0117-x; Krey V, 2012, ENERG ECON, V34, pS272, DOI 10.1016/j.eneco.2012.04.013; Liddle B, 2004, POPUL ENVIRON, V26, P23, DOI 10.1023/B:POEN.0000039951.37276.f3; Liddle B, 2010, POPUL ENVIRON, V31, P317, DOI 10.1007/s11111-010-0101-5; Liddle B, 2011, DEMOGR RES, V24, P749, DOI 10.4054/DemRes.2011.24.30; Lutz W, 2011, SCIENCE, V333, P587, DOI 10.1126/science.1206964; MacKellar FL, 1995, POPUL DEV REV, V21, P849, DOI 10.2307/2137777; Martinez-Zarzoso I, 2007, ENVIRON RESOUR ECON, V38, P497, DOI 10.1007/s10640-007-9096-5; Martinez-Zarzoso I, 2011, ECOL ECON, V70, P1344, DOI 10.1016/j.ecolecon.2011.02.009; Menz T, 2012, ENERG ECON, V34, P842, DOI 10.1016/j.eneco.2011.07.016; Moreland Scott., 2010, WORLD POPULATION PRO; Murtaugh PA, 2009, GLOBAL ENVIRON CHANG, V19, P14, DOI 10.1016/j.gloenvcha.2008.10.007; NRC, 1999, NAT NUMB EXP NAT EC, P262, DOI [10.17226/6374, DOI 10.17226/6374]; O'Neill BC, 2000, CLIMATIC CHANGE, V47, P283, DOI 10.1023/A:1005627509071; O'Neill BC., 2001, POPULATION CLIMATE C; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P17521, DOI 10.1073/pnas.1004581107; O'Neill BC, 2002, POPUL DEV REV, V28, P53; Poumanyvong P, 2010, ECOL ECON, V70, P434, DOI 10.1016/j.ecolecon.2010.09.029; Prskawetz A., 2004, VIENNA YB POPULATION, V2, P175, DOI DOI 10.1553/P0PULATI0NYEARB00K2004S175; Rosa EA, 2004, AMBIO, V33, P509, DOI 10.1639/0044-7447(2004)033[0509:TTADOE]2.0.CO;2; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; Stephenson J, 2010, J PUBLIC HEALTH-UK, V32, P150, DOI 10.1093/pubmed/fdq038; United Nations, 2004, WORLD POP 2300; Wheeler D., 2010, 229 CGD; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; York R, 2002, SOC SCI QUART, V83, P18, DOI 10.1111/1540-6237.00068	49	113	117	6	122	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2012	380	9837					157	164		10.1016/S0140-6736(12)60958-1	http://dx.doi.org/10.1016/S0140-6736(12)60958-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	973KN	22784534				2022-12-01	WOS:000306359100043
J	Asencio, C; Davidson, IF; Santarella-Mellwig, R; Thi, BNLH; Mall, M; Wallenfang, MR; Mattaj, IW; Gorjanacz, M				Asencio, Claudio; Davidson, Iain F.; Santarella-Mellwig, Rachel; Thi Bach Nga Ly-Hartig; Mall, Moritz; Wallenfang, Matthew R.; Mattaj, Iain W.; Gorjanacz, Matyas			Coordination of Kinase and Phosphatase Activities by Lem4 Enables Nuclear Envelope Reassembly during Mitosis	CELL			English	Article							TO-AUTOINTEGRATION FACTOR; CAENORHABDITIS-ELEGANS; MITOTIC EXIT; MEMBRANE PROTEIN; HUMAN-CELLS; C. ELEGANS; BAF; EMERIN; INSIGHTS; EMBRYOS	Mitosis in metazoa requires nuclear envelope (NE) disassembly and reassembly. NE disassembly is driven by multiple phosphorylation events. Mitotic phosphorylation of the protein BAF reduces its affinity for chromatin and the LEM family of inner nuclear membrane proteins; loss of this BAF-mediated chromatin-NE link contributes to NE disassembly. BAF must reassociate with chromatin and LEM proteins at mitotic exit to reform the NE; however, how its dephosphorylation is regulated is unknown. Here, we show that the C. elegans protein LEM-4L and its human ortholog Lem4 (also called ANKLE2) are both required for BAF dephosphorylation. They act in part by inhibiting BAF's mitotic kinase, VRK-1, in vivo and in vitro. In addition, Lem4/LEM-4L interacts with PP2A and is required for it to dephosphorylate BAF during mitotic exit. By coordinating VRK-1- and PP2A-mediated signaling on BAF, Lem4/LEM-4L controls postmitotic NE formation in a function conserved from worms to humans.	[Asencio, Claudio; Davidson, Iain F.; Santarella-Mellwig, Rachel; Thi Bach Nga Ly-Hartig; Mall, Moritz; Mattaj, Iain W.; Gorjanacz, Matyas] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Wallenfang, Matthew R.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	European Molecular Biology Laboratory (EMBL); Johns Hopkins University	Mattaj, IW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	mattaj@embl.org	Mall, Moritz/AAA-3558-2019	Mall, Moritz/0000-0002-1278-2594; Mattaj, Iain/0000-0002-5537-8284	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Tokuko Haraguchi for GFP-BAF plasmid; Toby Gibson, Norman Davey, and Damien Devos for bioinformatics assistance; Ulrike Bauer and Victoria McParland for technical assistance; Stefan Leicht for help with 2D gels; and members of the Advanced Light Microscopy Facility (EMBL Heidelberg) for microscopy help. We thank Jan Ellenberg, Peter Lenart, Maja Kohn, Geraldine Seydoux, Boris Bryk, and the Mattaj lab for comments on the manuscript. The NIH-funded Caenorhabditis Genetic Center provided some C. elegans strains. I.F.D. was an EMBO Long-Term Fellow, C.A. a Spanish Ministry of Science and Innovation Fellow, and M.G. a Human Frontier Science Program Organization Fellow.	Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Browne GJ, 2007, BIOCHEM J, V402, P187, DOI 10.1042/BJ20060600; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Fernandez AG, 2006, CURR BIOL, V16, P1757, DOI 10.1016/j.cub.2006.07.071; Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Galy V, 2006, CURR BIOL, V16, P1748, DOI 10.1016/j.cub.2006.06.067; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Haraguchi T, 2001, J CELL SCI, V114, P4575; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kitagawa D, 2011, DEV CELL, V20, P550, DOI 10.1016/j.devcel.2011.02.005; Klerkx EPF, 2009, DEV BIOL, V335, P12, DOI 10.1016/j.ydbio.2009.08.007; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Song MH, 2011, DEV CELL, V20, P563, DOI 10.1016/j.devcel.2011.03.007; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Ulbert S, 2006, FEBS LETT, V580, P6435, DOI 10.1016/j.febslet.2006.10.060; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149	35	104	127	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 6	2012	150	1					122	135		10.1016/j.cell.2012.04.043	http://dx.doi.org/10.1016/j.cell.2012.04.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770216	Bronze			2022-12-01	WOS:000306115000012
J	Capra, EJ; Perchuk, BS; Skerker, JM; Laub, MT				Capra, Emily J.; Perchuk, Barrett S.; Skerker, Jeffrey M.; Laub, Michael T.			Adaptive Mutations that Prevent Crosstalk Enable the Expansion of Paralogous Signaling Protein Families	CELL			English	Article							ESCHERICHIA-COLI K-12; TRANSDUCTION PATHWAYS; 2-COMPONENT; SYSTEMS; SPECIFICITY; IDENTIFICATION; EVOLUTION	Orthologous proteins often harbor numerous substitutions, but whether these differences result from neutral or adaptive processes is usually unclear. To tackle this challenge, we examined the divergent evolution of a model bacterial signaling pathway comprising the kinase PhoR and its cognate substrate PhoB. We show that the specificity-determining residues of these proteins are typically under purifying selection but have, in alpha-proteobacteria, undergone a burst of diversification followed by extended stasis. By reversing mutations that accumulated in an alpha-proteobacterial PhoR, we demonstrate that these substitutions were adaptive, enabling PhoR to avoid crosstalk with a paralogous pathway that arose specifically in alpha-proteobacteria. Our findings demonstrate that duplication and the subsequent need to avoid crosstalk strongly influence signaling protein evolution. These results provide a concrete example of how system-wide insulation can be achieved postduplication through a surprisingly limited number of mutations. Our work may help explain the apparent ease with which paralogous protein families expanded in all organisms.	[Capra, Emily J.; Perchuk, Barrett S.; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Laub, Michael T.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Skerker, Jeffrey M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Laub, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	laub@mit.edu		Laub, Michael/0000-0002-8288-7607	NSF [0821391]	NSF(National Science Foundation (NSF))	We thank O. Ashenberg for help with bioinformatics, Y.E. Chen for help with strain construction, and A. Podgornaia, A. Keating, O. Ashenberg, and K. Foster for helpful comments on the manuscript. Sequence analyses were performed on a computer cluster supported by NSF grant 0821391. M.T.L. is an Early Career Scientist of the Howard Hughes Medical Institute. This work was supported by an NSF graduate fellowship to E.J.C. and an NSF CAREER award to M.T.L.	Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Bell CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000306; Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; ELY B, 1991, METHOD ENZYMOL, V204, P372; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gora KG, 2010, MOL CELL, V39, P455, DOI 10.1016/j.molcel.2010.06.024; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Hou TJ, 2009, MOL CELL PROTEOMICS, V8, P639, DOI 10.1074/mcp.M800450-MCP200; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Liu BA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002105; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Noriega CE, 2010, MOL MICROBIOL, V75, P394, DOI 10.1111/j.1365-2958.2009.06987.x; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Siryaporn A, 2008, MOL MICROBIOL, V70, P494, DOI 10.1111/j.1365-2958.2008.06426.x; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Huynh TN, 2011, MOL MICROBIOL, V82, P275, DOI 10.1111/j.1365-2958.2011.07829.x; WANNER BL, 1987, J BACTERIOL, V169, P5569, DOI 10.1128/jb.169.12.5569-5574.1987; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wistrand M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-99; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	31	79	81	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					222	232		10.1016/j.cell.2012.05.033	http://dx.doi.org/10.1016/j.cell.2012.05.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770222	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000306115000019
J	Lazar, MA; Birnbaum, MJ				Lazar, Mitchell A.; Birnbaum, Morris J.			De-Meaning of Metabolism	SCIENCE			English	Editorial Material									[Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu; birnbaum@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	Birnbaum, Morris/0000-0001-9972-8680	NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886, P01DK049210] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA093615] Funding Source: Medline; NIDDK NIH HHS [P01 DK49210, R01 DK056886] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2010, OXFORD DICT ENGLISH; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92	8	27	27	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1651	1652		10.1126/science.1221834	http://dx.doi.org/10.1126/science.1221834			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745413				2022-12-01	WOS:000305794500032
J	Chung, HC; Pamp, SJ; Hill, JA; Surana, NK; Edelman, SM; Troy, EB; Reading, NC; Villablanca, EJ; Wang, S; Mora, JR; Umesaki, Y; Mathis, D; Benoist, C; Relman, DA; Kasper, DL				Chung, Hachung; Pamp, Suenje J.; Hill, Jonathan A.; Surana, Neeraj K.; Edelman, Sanna M.; Troy, Erin B.; Reading, Nicola C.; Villablanca, Eduardo J.; Wang, Sen; Mora, Jorge R.; Umesaki, Yoshinori; Mathis, Diane; Benoist, Christophe; Relman, David A.; Kasper, Dennis L.			Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota	CELL			English	Article							SEGMENTED FILAMENTOUS BACTERIA; ROR-GAMMA-T; CELLS; DIFFERENTIATION; RECEPTORS; TOLERANCE; SEQUENCES; EVOLUTION; RESPONSES; INDUCER	Gut microbial induction of host immune maturation exemplifies host-microbe mutualism. We colonized germ-free (GF) mice with mouse microbiota (MMb) or human microbiota (HMb) to determine whether small intestinal immune maturation depends on a coevolved host-specific microbiota. Gut bacterial numbers and phylum abundance were similar in MMb and HMb mice, but bacterial species differed, especially the Firmicutes. HMb mouse intestines had low levels of CD4(+) and CD8(+) T cells, few proliferating T cells, few dendritic cells, and low antimicrobial peptide expression-all characteristics of GF mice. Rat microbiota also failed to fully expand intestinal T cell numbers in mice. Colonizing GF or HMb mice with mouse-segmented filamentous bacteria (SFB) partially restored T cell numbers, suggesting that SFB and other MMb organisms are required for full immune maturation in mice. Importantly, MMb conferred better protection against Salmonella infection than HMb. A host-specific microbiota appears to be critical for a healthy immune system.	[Chung, Hachung; Surana, Neeraj K.; Edelman, Sanna M.; Troy, Erin B.; Reading, Nicola C.; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [Chung, Hachung; Hill, Jonathan A.; Surana, Neeraj K.; Edelman, Sanna M.; Troy, Erin B.; Reading, Nicola C.; Mathis, Diane; Benoist, Christophe; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Pamp, Suenje J.; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Pamp, Suenje J.; Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Villablanca, Eduardo J.; Wang, Sen; Mora, Jorge R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Gastrointestinal Unit, Boston, MA 02114 USA; [Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 1868650, Japan; [Pamp, Suenje J.; Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Surana, Neeraj K.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yakult Honsha Company, Limited; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Boston Children's Hospital	Kasper, DL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu	Villablanca, Eduardo/E-1380-2016; Pamp, Sünje Johanna/AAP-5178-2020; Pamp, Sünje/H-8787-2012	Villablanca, Eduardo/0000-0001-9522-9729; Pamp, Sünje Johanna/0000-0002-6236-1763; Pamp, Sünje/0000-0002-6236-1763; Relman, David A./0000-0001-8331-1354	Crohn's & Colitis Foundation of America; Juvenile Diabetes Research Foundation; Danish Council for Independent Research Natural Sciences; National Institutes of Health [F32 AI091104]; Director's Pioneer Award [DP1OD000964]; Thomas C. and Joan M. Merigan Endowment at Stanford University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061, R21AI090102, F32AI091104] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's Pioneer Award; Thomas C. and Joan M. Merigan Endowment at Stanford University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Shakir Edwards for gnotobiotic animal care, Julie B. McCoy for editing, Tom DiCesare for image design, Dr. Rod Bronson for pathology scoring, Jennifer Dinalo for ten human fecal samples, and Les Dethlefsen and Robert Edgar for helpful advice. This work was supported by a Senior Research Award from the Crohn's & Colitis Foundation of America (to D. L. K.), by the Juvenile Diabetes Research Foundation (to H. C.), by the Danish Council for Independent Research Natural Sciences (to S.J.P.), by National Institutes of Health Grant F32 AI091104 (to N.K.S.), and by Director's Pioneer Award DP1OD000964 (to D. A. R.). D. A. R. is supported by the Thomas C. and Joan M. Merigan Endowment at Stanford University.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; BANDEIRA A, 1990, J EXP MED, V172, P239, DOI 10.1084/jem.172.1.239; Chassin C, 2010, CELL HOST MICROBE, V8, P358, DOI 10.1016/j.chom.2010.09.005; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2010, CURR OPIN IMMUNOL, V22, P448, DOI 10.1016/j.coi.2010.06.002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hand T, 2010, CURR OPIN IMMUNOL, V22, P63, DOI 10.1016/j.coi.2010.01.008; Heczko U, 2000, J INFECT DIS, V181, P1027, DOI 10.1086/315348; Imaoka A, 2004, J APPL MICROBIOL, V96, P656, DOI 10.1111/j.1365-2672.2004.02189.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; KLAASEN HLBM, 1993, LAB ANIM-UK, V27, P141, DOI 10.1258/002367793780810441; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pais R, 2008, APPL ENVIRON MICROB, V74, P5965, DOI 10.1128/AEM.00741-08; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	58	756	793	9	206	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1578	1593		10.1016/j.cell.2012.04.037	http://dx.doi.org/10.1016/j.cell.2012.04.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726443	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000305753800022
J	Lin, CC; Melo, FA; Ghosh, R; Suen, KM; Stagg, LJ; Kirkpatrick, J; Arold, ST; Ahmed, Z; Ladbury, JE				Lin, Chi-Chuan; Melo, Fernando A.; Ghosh, Ragini; Suen, Kin M.; Stagg, Loren J.; Kirkpatrick, John; Arold, Stefan T.; Ahmed, Zamal; Ladbury, John E.			Inhibition of Basal FGF Receptor Signaling by Dimeric Grb2	CELL			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; TRANSFORMING ACTIVITY; SH3 DOMAIN; CANCER; MUTATIONS; BINDING; ADAPTER; KINASE; AUTOPHOSPHORYLATION	Receptor tyrosine kinase activity is known to occur in the absence of extracellular stimuli. Importantly, this "background" level of receptor phosphorylation is insufficient to effect a downstream response, suggesting that strict controls are present and prohibit full activation. Here a mechanism is described in which control of FGFR2 activation is provided by the adaptor protein Grb2. Dimeric Grb2 binds to the C termini of two FGFR2 molecules. This heterotetramer is capable of a low-level receptor transphosphorylation, but C-terminal phosphorylation and recruitment of signaling proteins are sterically hindered. Upon stimulation, FGFR2 phosphorylates tyrosine residues on Grb2, promoting dissociation from the receptor and allowing full activation of downstream signaling. These observations establish a role for Grb2 as an active regulator of RTK signaling.	[Lin, Chi-Chuan; Melo, Fernando A.; Suen, Kin M.; Stagg, Loren J.; Arold, Stefan T.; Ahmed, Zamal; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lin, Chi-Chuan; Melo, Fernando A.; Suen, Kin M.; Stagg, Loren J.; Arold, Stefan T.; Ahmed, Zamal; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Lin, Chi-Chuan; Ghosh, Ragini; Kirkpatrick, John] UCL, Inst Struct Mol Biol, London WC1E 6BT, England	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of London; Birkbeck University London; University College London	Ladbury, JE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000,1515 Holcombe Blvd, Houston, TX 77030 USA.	jeladbury@mdanderson.org	Arold, Stefan/T-2612-2019; Melo, Fernando A/A-6242-2013	Melo, Fernando A/0000-0002-8676-3150; Arold, Stefan T/0000-0001-5278-0668; suen, kin man/0000-0001-9452-2528; Ladbury, John/0000-0002-6328-7200	G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the G. Harold and Leila Y. Mathers Charitable Foundation.	Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant MR, 2009, GLIA, V57, P935, DOI 10.1002/glia.20818; Cha JY, 2008, MOL CANCER RES, V6, P435, DOI 10.1158/1541-7786.MCR-07-0187; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gartside MG, 2009, MOL CANCER RES, V7, P41, DOI 10.1158/1541-7786.MCR-08-0021; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; ISHII H, 1995, MOL CELL BIOL, V15, P3664; ITOH H, 1994, CANCER RES, V54, P3237; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; KOHDA D, 1994, STRUCTURE, V2, P1029, DOI 10.1016/S0969-2126(94)00106-5; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; McDonald CB, 2008, ARCH BIOCHEM BIOPHYS, V475, P25, DOI 10.1016/j.abb.2008.04.008; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Takeda M, 2007, CLIN CANCER RES, V13, P3051, DOI 10.1158/1078-0432.CCR-06-2743; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Yuzawa S, 2001, J MOL BIOL, V306, P527, DOI 10.1006/jmbi.2000.4396; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao WM, 2010, CLIN CANCER RES, V16, P5750, DOI 10.1158/1078-0432.CCR-10-0531	36	111	113	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1514	1524		10.1016/j.cell.2012.04.033	http://dx.doi.org/10.1016/j.cell.2012.04.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726438	Bronze			2022-12-01	WOS:000305753800017
J	Lefebvre, JL; Kostadinov, D; Chen, WSV; Maniatis, T; Sanes, JR				Lefebvre, Julie L.; Kostadinov, Dimitar; Chen, Weisheng V.; Maniatis, Tom; Sanes, Joshua R.			Protocadherins mediate dendritic self-avoidance in the mammalian nervous system	NATURE			English	Article							RETINAL GANGLION-CELLS; BAX-DEFICIENT MICE; MOUSE RETINA; GAMMA-PROTOCADHERINS; TRANSGENIC MICE; PURKINJE-CELLS; AMACRINE CELLS; REQUIRE DSCAM; AXON GUIDANCE; EXPRESSION	Dendritic arborizations of many neurons are patterned by a process called self-avoidance, in which branches arising from a single neuron repel each other(1-7). By minimizing gaps and overlaps within the arborization, self-avoidance facilitates complete coverage of a neuron's territory by its neurites(1-3). Remarkably, some neurons that display self-avoidance interact freely with other neurons of the same subtype, implying that they discriminate self from non-self. Here we demonstrate roles for the clustered protocadherins (Pcdhs) in dendritic self-avoidance and self/non-self discrimination. The Pcdh locus encodes 58 related cadherin-like transmembrane proteins, at least some of which exhibit isoform-specific homophilic adhesion in heterologous cells and are expressed stochastically and combinatorially in single neurons(7-11). Deletion of all 22 Pcdh genes in the mouse gamma-subcluster (Pcdhg genes) disrupts self-avoidance of dendrites in retinal starburst amacrine cells (SACs) and cerebellar Purkinje cells. Further genetic analysis of SACs showed that Pcdhg proteins act cell-autonomously during development, and that replacement of the 22 Pcdhg proteins with a single isoform restores self-avoidance. Moreover, expression of the same single isoform in all SACs decreases interactions among dendrites of neighbouring SACs (heteroneuronal interactions). These results suggest that homophilic Pcdhg interactions between sibling neurites (isoneuronal interactions) generate a repulsive signal that leads to self-avoidance. In this model, heteroneuronal interactions are normally permitted because dendrites seldom encounter a matched set of Pcdhg proteins unless they emanate from the same soma. In many respects, our results mirror those reported for Dscam1 (Down syndrome cell adhesion molecule) in Drosophila: this complex gene encodes thousands of recognition molecules that exhibit stochastic expression and isoform-specific interactions, and mediate both self-avoidance and self/non-self discrimination(4-7,12-15). Thus, although insect Dscam and vertebrate Pcdh proteins share no sequence homology, they seem to underlie similar strategies for endowing neurons with distinct molecular identities and patterning their arborizations.	[Lefebvre, Julie L.; Kostadinov, Dimitar; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Lefebvre, Julie L.; Kostadinov, Dimitar; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Chen, Weisheng V.; Maniatis, Tom] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Harvard University; Harvard University; Columbia University	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, 52 Oxford St, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu		Kostadinov, Dimitar/0000-0001-7548-2209; Lefebvre, Julie/0000-0002-3110-860X	NIH [R01NS029169, R01EY022073, R01NS043915]; NARSAD; NATIONAL EYE INSTITUTE [R01EY022073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS078893, R01NS029169, R01NS043915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of our laboratory for providing advice and reagents, including D. Cai and K. Cohen (rAAV), I.-J. Kim (fstl4-line 1 mice) and M. Yamagata for modified Rosa-CAG targeting vector. We also thank B. Stevens (Children's Hospital) for advice on culture methods. This work was supported by grants from NIH to J.R.S. (R01NS029169 and R01EY022073) and T.M. (R01NS043915) and NARSAD Young Investigator Award to J.L.L.	Chen W. V., NEURON IN PRESS; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hong YK, 2011, J COMP NEUROL, V519, P1691, DOI 10.1002/cne.22595; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Jelinek HF, 1998, J NEUROSCI METH, V81, P9, DOI 10.1016/S0165-0270(98)00021-1; Kaneko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020108; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MONTAGUE PR, 1991, J NEUROSCI, V11, P1440; MONTAGUE PR, 1989, P NATL ACAD SCI USA, V86, P7223, DOI 10.1073/pnas.86.18.7223; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Srinivas S, 1999, DEV GENET, V24, P241; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; White FA, 1998, J NEUROSCI, V18, P1428; Whitney IE, 2008, J COMP NEUROL, V508, P1, DOI 10.1002/cne.21630; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhang XM, 2004, GENESIS, V40, P45, DOI 10.1002/gene.20062; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	50	276	282	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					517	+		10.1038/nature11305	http://dx.doi.org/10.1038/nature11305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22842903	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000307761600038
J	Wu, CH; Fallini, C; Ticozzi, N; Keagle, PJ; Sapp, PC; Piotrowska, K; Lowe, P; Koppers, M; McKenna-Yasek, D; Baron, DM; Kost, JE; Gonzalez-Perez, P; Fox, AD; Adams, J; Taroni, F; Tiloca, C; Leclerc, AL; Chafe, SC; Mangroo, D; Moore, MJ; Zitzewitz, JA; Xu, ZS; van den Berg, LH; Glass, JD; Siciliano, G; Cirulli, ET; Goldstein, DB; Salachas, F; Meininger, V; Rossoll, W; Ratti, A; Gellera, C; Bosco, DA; Bassell, GJ; Silani, V; Drory, VE; Brown, RH; Landers, JE				Wu, Chi-Hong; Fallini, Claudia; Ticozzi, Nicola; Keagle, Pamela J.; Sapp, Peter C.; Piotrowska, Katarzyna; Lowe, Patrick; Koppers, Max; McKenna-Yasek, Diane; Baron, Desiree M.; Kost, Jason E.; Gonzalez-Perez, Paloma; Fox, Andrew D.; Adams, Jenni; Taroni, Franco; Tiloca, Cinzia; Leclerc, Ashley Lyn; Chafe, Shawn C.; Mangroo, Dev; Moore, Melissa J.; Zitzewitz, Jill A.; Xu, Zuo-Shang; van den Berg, Leonard H.; Glass, Jonathan D.; Siciliano, Gabriele; Cirulli, Elizabeth T.; Goldstein, David B.; Salachas, Francois; Meininger, Vincent; Rossoll, Wilfried; Ratti, Antonia; Gellera, Cinzia; Bosco, Daryl A.; Bassell, Gary J.; Silani, Vincenzo; Drory, Vivian E.; Brown, Robert H., Jr.; Landers, John E.			Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis	NATURE			English	Article							HEXANUCLEOTIDE REPEAT; SPASTIC PARAPLEGIA; NEURITE OUTGROWTH; MUTANT SOD1; PROTEIN; ACTIN; ALS; C9ORF72; EXPANSION; INCREASE	Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disorder resulting from motor neuron death. Approximately 10% of cases are familial (FALS), typically with a dominant inheritance mode. Despite numerous advances in recent years(1-9), nearly 50% of FALS cases have unknown genetic aetiology. Here we show that mutations within the profilin 1 (PFN1) gene can cause FALS. PFN1 is crucial for the conversion of monomeric (G)-actin to filamentous (F)-actin. Exome sequencing of two large ALS families showed different mutations within the PFN1 gene. Further sequence analysis identified 4 mutations in 7 out of 274 FALS cases. Cells expressing PFN1 mutants contain ubiquitinated, insoluble aggregates that in many cases contain the ALS-associated protein TDP-43. PFN1 mutants also display decreased bound actin levels and can inhibit axon outgrowth. Furthermore, primary motor neurons expressing mutant PFN1 display smaller growth cones with a reduced F/G-actin ratio. These observations further document that cytoskeletal pathway alterations contribute to ALS pathogenesis.	[Wu, Chi-Hong; Keagle, Pamela J.; Sapp, Peter C.; Piotrowska, Katarzyna; Lowe, Patrick; McKenna-Yasek, Diane; Baron, Desiree M.; Kost, Jason E.; Gonzalez-Perez, Paloma; Fox, Andrew D.; Adams, Jenni; Leclerc, Ashley Lyn; Bosco, Daryl A.; Brown, Robert H., Jr.; Landers, John E.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Fallini, Claudia; Rossoll, Wilfried; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Ticozzi, Nicola; Tiloca, Cinzia; Ratti, Antonia; Silani, Vincenzo] IRCCS Ist Auxol Italiano, Dept Neurol, I-20149 Milan, Italy; [Ticozzi, Nicola; Tiloca, Cinzia; Ratti, Antonia; Silani, Vincenzo] IRCCS Ist Auxol Italiano, Neurosci Lab, I-20149 Milan, Italy; [Sapp, Peter C.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Koppers, Max; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3584 CX Utrecht, Netherlands; [Taroni, Franco; Gellera, Cinzia] Fdn IRCCS Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, I-20133 Milan, Italy; [Tiloca, Cinzia] Univ Milan, Dept Sci & Biomed Technol, Doctoral Sch Mol Med, I-20122 Milan, Italy; [Chafe, Shawn C.; Mangroo, Dev] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Zitzewitz, Jill A.; Xu, Zuo-Shang] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Glass, Jonathan D.; Bassell, Gary J.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Neurol, Atlanta, GA 30322 USA; [Siciliano, Gabriele] Univ Pisa, Dept Neurosci, I-56126 Pisa, Italy; [Cirulli, Elizabeth T.; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Salachas, Francois; Meininger, Vincent] UPMC, Hop La Pitie Salpetriere, APHP, Ctr Referent Malad Rares, F-75013 Paris, France; [Ratti, Antonia; Silani, Vincenzo] Univ Milan, Dino Ferrari Ctr, Dipartimento Fisiopatol Medicochirurg & Trapianti, I-20122 Milan, Italy; [Drory, Vivian E.] Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-64239 Tel Aviv, Israel	University of Massachusetts System; University of Massachusetts Worcester; Emory University; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Utrecht University; Utrecht University Medical Center; IRCCS Istituto Neurologico Besta; University of Milan; University of Guelph; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Emory University; University of Pisa; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Milan; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Landers, JE (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	john.landers@umassmed.edu	Goldstein, David/AAY-8125-2020; Fallini, Claudia/AAZ-1244-2020; Gellera, Cinzia/J-7887-2016; Ticozzi, Nicola/K-8094-2016; Silani, Vincenzo/P-4421-2017; Sander-Effron, Samuel/AAX-2231-2020; Taroni, Franco/N-3879-2013; Resource Center, NINDS Human Genetics/AGF-2474-2022	Fallini, Claudia/0000-0001-8329-3467; Gellera, Cinzia/0000-0002-3582-665X; Ticozzi, Nicola/0000-0001-5963-7426; Silani, Vincenzo/0000-0002-7698-3854; Taroni, Franco/0000-0002-2420-5233; Rossoll, Wilfried/0000-0002-9622-541X; Koppers, Max/0000-0002-7751-1082; Cirulli Rogers, Liz/0000-0001-7808-2809	ALS Therapy Alliance; Project ALS; P2ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [1R01NS065847, 1R01NS050557, RC2-NS070-342]; Muscular Dystrophy Association [MDA173851]; Ministry of Health; SMA Europe fellowship; Massachusetts Institute of Technology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070342, U01NS052225, R01NS065847, R01NS050557] Funding Source: NIH RePORTER	ALS Therapy Alliance; Project ALS; P2ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Ministry of Health; SMA Europe fellowship; Massachusetts Institute of Technology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the ALS Therapy Alliance, Project ALS, P2ALS, the Angel Fund, the Pierre L. de Bourgknecht ALS Research Foundation, the Al-Athel ALS Research Foundation, the ALS Family Charitable Foundation and a Francesco Caleffi donation (N.T. and V.S.). Grant support was provided by the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) (1R01NS065847 (J.E.L.), 1R01NS050557 (R.H.B.), and RC2-NS070-342 (R.H.B.)), Muscular Dystrophy Association (MDA173851 (W.R.)) and AriSLA co-financed with support of '5x1000'-Healthcare research of the Ministry of Health (EXOMEFALS (N.T., C.G., V.S. and J.E.L.)). Support was provided by an SMA Europe fellowship to C.F. P.C.S. was supported through the auspices of H. R. Horvitz (Massachusetts Institute of Technology), an investigator of the Howard Hughes Medical Institute. We thank the laboratory of S. Doxsey, the UMass Medical School Digital Light Microscopy Core, the UMass Medical School Deep Sequencing Core, the Emory University Neuropathology Core, and M. Gearing and D. Cooper for their assistance.	Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Braun A, 2002, GENE, V283, P219, DOI 10.1016/S0378-1119(01)00855-1; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Duan WS, 2011, BRAIN RES, V1397, P1, DOI 10.1016/j.brainres.2011.05.006; Fallini C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-17; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Gros-Louis F, 2004, J BIOL CHEM, V279, P45951, DOI 10.1074/jbc.M408139200; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; Perrot R, 2009, BRAIN RES BULL, V80, P282, DOI 10.1016/j.brainresbull.2009.06.004; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; TILNEY LG, 1983, J CELL BIOL, V97, P112, DOI 10.1083/jcb.97.1.112; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967	39	402	413	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					499	+		10.1038/nature11280	http://dx.doi.org/10.1038/nature11280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22801503	Green Accepted			2022-12-01	WOS:000307761600034
J	Gleeson, T; Wada, Y; Bierkens, MFP; van Beek, LPH				Gleeson, Tom; Wada, Yoshihide; Bierkens, Marc F. P.; van Beek, Ludovicus P. H.			Water balance of global aquifers revealed by groundwater footprint	NATURE			English	Article							HUMAN APPROPRIATION; RESOURCES	Groundwater is a life-sustaining resource that supplies water to billions of people, plays a central part in irrigated agriculture and influences the health of many ecosystems(1,2). Most assessments of global water resources have focused on surface water(3-6), but unsustainable depletion of groundwater has recently been documented on both regional(7,8) and global scales(9-11). It remains unclear how the rate of global groundwater depletion compares to the rate of natural renewal and the supply needed to support ecosystems. Here we define the groundwater footprint (the area required to sustain groundwater use and groundwater-dependent ecosystem services) and show that humans are overexploiting groundwater in many large aquifers that are critical to agriculture, especially in Asia and North America. We estimate that the size of the global groundwater footprint is currently about 3.5 times the actual area of aquifers and that about 1.7 billion people live in areas where groundwater resources and/or groundwater-dependent ecosystems are under threat. That said, 80 per cent of aquifers have a groundwater footprint that is less than their area, meaning that the net global value is driven by a few heavily overexploited aquifers. The groundwater footprint is the first tool suitable for consistently evaluating the use, renewal and ecosystem requirements of groundwater at an aquifer scale. It can be combined with the water footprint and virtual water calculations(12-14), and be used to assess the potential for increasing agricultural yields with renewable groundwaterref(15). The method could be modified to evaluate other resources with renewal rates that are slow and spatially heterogeneous, such as fisheries, forestry or soil.	[Gleeson, Tom] McGill Univ, Dept Civil Engn, Montreal, PQ H3A 0C3, Canada; [Wada, Yoshihide; Bierkens, Marc F. P.; van Beek, Ludovicus P. H.] Univ Utrecht, Fac Geosci, Dept Phys Geog, NL-3508 TC Utrecht, Netherlands; [Bierkens, Marc F. P.] Deltares, NL-3508 AL Utrecht, Netherlands	McGill University; Utrecht University; Deltares	Gleeson, T (corresponding author), McGill Univ, Dept Civil Engn, Montreal, PQ H3A 0C3, Canada.	tom.gleeson@mcgill.ca	Wada, Yoshihide/F-3595-2012; Gleeson, Tom/F-2552-2011; Van Beek, Rens/B-4904-2014; Bierkens, Marc F.P./AAE-8176-2019	Wada, Yoshihide/0000-0003-4770-2539; Gleeson, Tom/0000-0001-9493-7707; Van Beek, Rens/0000-0002-4758-108X; Bierkens, Marc F.P./0000-0002-7411-6562	Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research junior fellowship; Utrecht University Focus Areas Theme 'Earth and sustainability'	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Advanced Research junior fellowship(Canadian Institute for Advanced Research (CIFAR)); Utrecht University Focus Areas Theme 'Earth and sustainability'	S. Siebert, M. Jellinek, M. Lathuilliere, A. Henderson and W. Rees read or discussed earlier versions of the manuscript, which markedly improved it. T. G. was supported by the Natural Sciences and Engineering Research Council of Canada and a Canadian Institute for Advanced Research junior fellowship. Y.W. was supported by Utrecht University Focus Areas Theme 'Earth and sustainability'.	Alcamo J, 2003, HYDROLOG SCI J, V48, P339, DOI 10.1623/hysj.48.3.339.45278; Allan JA, 1998, GROUND WATER, V36, P545, DOI 10.1111/j.1745-6584.1998.tb02825.x; CIESIN, 2011, GRIDD POP WORLD VER; Doll P, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/035006; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Foster S, 2004, HYDROGEOL J, V12, P81, DOI 10.1007/s10040-003-0300-6; Giordano M, 2009, ANNU REV ENV RESOUR, V34, P153, DOI 10.1146/annurev.environ.030308.100251; Gleeson T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045565; Hoekstra A., 2011, WATER FOOTPRINT ASSE; Hoekstra AY, 2009, ECOL ECON, V68, P1963, DOI 10.1016/j.ecolecon.2008.06.021; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Hoekstra AY, 2009, P NATL ACAD SCI USA, V106, pE114, DOI 10.1073/pnas.0909948106; Konikow LF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048604; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Rees, 1996, ECOLOGICAL FOOTPRINT; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Smakhtin V, 2004, WATER INT, V29, P307, DOI 10.1080/02508060408691785; Smakhtin VU, 2001, J HYDROL, V240, P147, DOI 10.1016/S0022-1694(00)00340-1; Sophocleous M, 2010, HYDROGEOL J, V18, P559, DOI 10.1007/s10040-009-0540-1; van Beek LPH, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009791; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wada Y, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010562; Wada Y, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009792; Wada Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044571; [No title captured], DOI DOI 10.5194/hess-14-1863-2010	29	734	747	35	689	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					197	200		10.1038/nature11295	http://dx.doi.org/10.1038/nature11295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874965				2022-12-01	WOS:000307267000030
J	Coustham, V; Li, PJ; Strange, A; Lister, C; Song, J; Dean, C				Coustham, Vincent; Li, Peijin; Strange, Amy; Lister, Clare; Song, Jie; Dean, Caroline			Quantitative Modulation of Polycomb Silencing Underlies Natural Variation in Vernalization	SCIENCE			English	Article							FLOWERING-LOCUS-C; NONCODING RNA; ARABIDOPSIS; FLC; REPRESSION; PROTEIN	Arabidopsis thaliana accessions have adapted to growth in a wide range of climates. Variation in flowering and alignment of vernalization response with winter length are central to this adaptation. Vernalization involves the epigenetic silencing of the floral repressor FLC via a conserved Polycomb (PRC2) mechanism involving trimethylation of Lys(27) on histone H3 (H3K27me3). We found that variation for response to winter length maps to cis polymorphism within FLC. A rare combination of four polymorphisms localized around the nucleation region of a PHD-Polycomb complex determines a need for longer cold. Chromatin immunoprecipitation experiments indicate that these polymorphisms influence the accumulation of H3K27me3 in Arabidopsis accession Lov-1, both at the nucleation site and over the gene body. Quantitative modulation of chromatin silencing through cis variation may be a general mechanism contributing to evolutionary change.	[Coustham, Vincent; Li, Peijin; Strange, Amy; Lister, Clare; Song, Jie; Dean, Caroline] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Coustham, Vincent/GON-4976-2022; Li, Peijin/AAT-6978-2021; Li, Peijin/D-5764-2016; Coustham, Vincent/C-1836-2014	Coustham, Vincent/0000-0002-5399-2723; Li, Peijin/0000-0003-1579-7553; Coustham, Vincent/0000-0002-5399-2723; Dean, Caroline/0000-0002-6555-3525	European Community; UK Biotechnology and Biological Sciences Research Council (BBSRC); European Research Council; BBSRC [BBS/E/J/000CA355, BBS/E/J/000CA344, BB/E009662/1, BBS/E/J/000CA369] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA355, BBS/E/J/000CA369, BB/E009662/1, BBS/E/J/000CA344] Funding Source: researchfish	European Community(European Commission); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all members of the Dean and Howard groups for discussions, and D. Filiault (Gregor Mendel Institute, Vienna) for help with analysis of the SNPs in the worldwide A. thaliana accessions. Supported by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (V. C.), a UK Biotechnology and Biological Sciences Research Council (BBSRC) Core Strategic Grant to the John Innes Centre, and a European Research Council Advanced Investigator grant (C.D.).	Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Strange A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019949; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	21	109	115	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					584	587		10.1126/science.1221881	http://dx.doi.org/10.1126/science.1221881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22798408	Green Submitted			2022-12-01	WOS:000307058700046
J	Yu, HB; Remer, LA; Chin, M; Bian, HS; Tan, Q; Yuan, TL; Zhang, Y				Yu, Hongbin; Remer, Lorraine A.; Chin, Mian; Bian, Huisheng; Tan, Qian; Yuan, Tianle; Zhang, Yan			Aerosols from Overseas Rival Domestic Emissions over North America	SCIENCE			English	Article							DUST; TRANSPORT; POLLUTION; AERONET; CALIPSO	Many types of aerosols have lifetimes long enough for their transcontinental transport, making them potentially important contributors to air quality and climate change in remote locations. We estimate that the mass of aerosols arriving at North American shores from overseas is comparable with the total mass of particulates emitted domestically. Curbing domestic emissions of particulates and precursor gases, therefore, is not sufficient to mitigate aerosol impacts in North America. The imported contribution is dominated by dust leaving Asia, not by combustion-generated particles. Thus, even a reduction of industrial emissions of the emerging economies of Asia could be overwhelmed by an increase of dust emissions due to changes in meteorological conditions and potential desertification.	[Yu, Hongbin] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20740 USA; [Yu, Hongbin; Chin, Mian; Bian, Huisheng; Tan, Qian; Yuan, Tianle; Zhang, Yan] NASA, Earth Sci Directorate, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Remer, Lorraine A.; Bian, Huisheng; Yuan, Tianle] Univ Maryland Baltimore Cty, Joint Ctr Earth Syst Technol, Baltimore, MD 21228 USA; [Tan, Qian; Zhang, Yan] Univ Space Res Assoc, Goddard Earth Sci Technol & Res Ctr, Columbia, MD 21044 USA	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; Universities Space Research Association (USRA)	Yu, HB (corresponding author), Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20740 USA.	hongbin.yu@nasa.gov	Yu, Hongbin/C-6485-2008; Yuan, Tianle/D-3323-2011; Chin, Mian/J-8354-2012; Zhang, Yan/C-4792-2012	Yu, Hongbin/0000-0003-4706-1575; Yuan, Tianle/0000-0002-2187-3017; ZHANG, Yan/0000-0002-6954-5178	NASA [NNXAH66G, NNX11AJ91G]; GMI [NNX10AK61G]	NASA(National Aeronautics & Space Administration (NASA)); GMI	We acknowledge the NASA support of this work via NNXAH66G (The Science of Terra and Aqua Program) and NNX11AJ91G (Atmospheric Composition Modeling and Analysis Program) (H.Y.), both managed by R. Eckman. The NASA Modeling, Analysis, and Prediction program managed by D. Considine is acknowledged for supporting the model development of GOCART (M. C.) and GMI (H. B., under NNX10AK61G). We are grateful to J. Zhang for providing his reprocessed MODIS data, Z. Liu for providing insights in the lidar characterization of Asian dust, and X. Pan for acquiring CALIOP data. The MODIS data were obtained from the NASA Level 1 and Atmosphere Archive and Distribution System. The CALIOP data were obtained from the NASA Langley Research Center Atmospheric Science Data Center.	Bian H, 2009, ATMOS CHEM PHYS, V9, P2375, DOI 10.5194/acp-9-2375-2009; Biscaye PE, 2000, SCIENCE, V290, P2258, DOI 10.1126/science.290.5500.2258; Chin M, 2007, ATMOS CHEM PHYS, V7, P5501, DOI 10.5194/acp-7-5501-2007; Chin M, 2009, ANN GEOPHYS-GERMANY, V27, P3439, DOI 10.5194/angeo-27-3439-2009; Dentener F., 2010, AIR POLLUTION STUDIE, V17; Eck TF, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005274; Hadley OL, 2010, ATMOS CHEM PHYS, V10, P7505, DOI 10.5194/acp-10-7505-2010; Heald CL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006847; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; Kalashnikova OV, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010083; KAUFMAN YJ, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2003JD004436; Liu J, 2008, ATMOS CHEM PHYS, V8, P3721, DOI 10.5194/acp-8-3721-2008; Liu ZY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008878; Maring H, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002536; Prospero JM, 2005, AEROBIOLOGIA, V21, P1, DOI 10.1007/s10453-004-5872-7; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Remer LA, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009661; Sassen K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014051; Stith JL, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010924; Su L, 2011, ATMOS CHEM PHYS, V11, P3263, DOI 10.5194/acp-11-3263-2011; Warneke C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036194; Winker DM, 2010, B AM METEOROL SOC, V91, P1211, DOI 10.1175/2010BAMS3009.1; Yu H., 2009, ATMOSPHERIC AEROSOL; Yu HB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000754; Yu HB, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009349; Yu HB, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010648; Zhu P, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011991	27	172	177	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					566	569		10.1126/science.1217576	http://dx.doi.org/10.1126/science.1217576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859485				2022-12-01	WOS:000307058700041
J	Bulgarelli, D; Rott, M; Schlaeppi, K; van Themaat, EVL; Ahmadinejad, N; Assenza, F; Rauf, P; Huettel, B; Reinhardt, R; Schmelzer, E; Peplies, J; Gloeckner, FO; Amann, R; Eickhorst, T; Schulze-Lefert, P				Bulgarelli, Davide; Rott, Matthias; Schlaeppi, Klaus; van Themaat, Emiel Ver Loren; Ahmadinejad, Nahal; Assenza, Federica; Rauf, Philipp; Huettel, Bruno; Reinhardt, Richard; Schmelzer, Elmon; Peplies, Joerg; Gloeckner, Frank Oliver; Amann, Rudolf; Eickhorst, Thilo; Schulze-Lefert, Paul			Revealing structure and assembly cues for Arabidopsis root-inhabiting bacterial microbiota	NATURE			English	Article							CATALYZED REPORTER DEPOSITION; IN-SITU HYBRIDIZATION; DIVERSITY; ENDOPHYTES; PATTERNS	The plant root defines the interface between amulticellular eukaryote and soil, one of the richest microbial ecosystems on Earth(1). Notably, soil bacteria are able to multiply inside roots as benign endophytes and modulate plant growth and development(2), with implications ranging from enhanced crop productivity(3) to phytoremediation(4). Endophytic colonization represents an apparent paradox of plant innate immunity because plant cells can detect an array of microbeassociated molecular patterns (also known as MAMPs) to initiate immune responses to terminate microbial multiplication(5). Several studies attempted to describe the structure of bacterial root endophytes(6); however, different sampling protocols and low-resolution profiling methods make it difficult to infer general principles. Here we describemethodology to characterize and compare soil-and rootinhabiting bacterial communities, which reveals not only a function formetabolically active plant cells but also for inert cell-wall features in the selection of soil bacteria for host colonization. We showthat the roots ofArabidopsis thaliana, grown in different natural soils under controlled environmental conditions, are preferentially colonized by Proteobacteria, Bacteroidetes and Actinobacteria, and each bacterial phylum is represented by a dominating class or family. Soil type defines the composition of root-inhabiting bacterial communities and host genotype determines their ribotype profiles to a limited extent. The identification of soil-type-specific members within the root-inhabiting assemblies supports our conclusion that these represent soil-derived root endophytes. Surprisingly, plant cell-wall features of other tested plant species seem to provide a sufficient cue for the assembly of approximately 40% of the Arabidopsis bacterial root-inhabitingmicrobiota, with a bias for Betaproteobacteria. Thus, this root sub-community may not beArabidopsis-specific but saprophytic bacteria that would naturally be found on any plant root or plant debris in the tested soils. By contrast, colonization of Arabidopsis roots by members of the Actinobacteria depends on other cues from metabolically active host cells.	[Bulgarelli, Davide; Rott, Matthias; Schlaeppi, Klaus; van Themaat, Emiel Ver Loren; Ahmadinejad, Nahal; Assenza, Federica; Rauf, Philipp; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Huettel, Bruno; Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Max Planck Genome Ctr, D-50829 Cologne, Germany; [Peplies, Joerg; Gloeckner, Frank Oliver] Ribocon GmbH, D-28359 Bremen, Germany; [Gloeckner, Frank Oliver; Amann, Rudolf] Max Planck Inst Marine Microbiol, Dept Mol Ecol, D-28359 Bremen, Germany; [Eickhorst, Thilo] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Bremen	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany.	schlef@mpipz.mpg.de	Amann, Rudolf I/C-6534-2014; Schlaeppi, Klaus/ABE-6731-2020; Schulze-Lefert, Paul/B-6707-2011; Eickhorst, Thilo/M-1200-2014	Amann, Rudolf I/0000-0002-0846-7372; Schlaeppi, Klaus/0000-0003-3620-0875; Brocke-Ahmadinejad, Nahal/0000-0002-7335-6564; Bulgarelli, Davide/0000-0002-2020-6642; Reinhardt, Richard/0000-0001-9376-2132	Max Planck Society [M.IF. A. ZUCH8048]; Swiss National Science Foundation [PBFRP3-133544]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank R. Franzen and S. Schumacher for technical assistance, S. Wulfert for providing Arabidopsis liquid cultures, H. Schmidt for sharing the CARD-FISH protocol and performing the cell counts. We thank S. Klages and K. Stuber for support with bioinformatic pipelines. We are grateful to R. Panstruga and P. Bakker for comments on the manuscript. Golm soil was shipped by J. Schwachtje and J. van Dongen. This work was supported by funds from the Max Planck Society to P. S.-L. (M.IF. A. ZUCH8048). K. S. is supported by the Swiss National Science Foundation (PBFRP3-133544).	Basilio A, 2003, J APPL MICROBIOL, V95, P814, DOI 10.1046/j.1365-2672.2003.02049.x; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BuchholzCleven BEE, 1997, SYST APPL MICROBIOL, V20, P301, DOI 10.1016/S0723-2020(97)80077-X; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Hugenholtz P, 2010, OPEN J, V1, P1; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Mei Chuansheng, 2010, Recent Pat Biotechnol, V4, P81, DOI 10.2174/187220810790069523; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012	21	1283	1367	64	1176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					91	95		10.1038/nature11336	http://dx.doi.org/10.1038/nature11336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859207				2022-12-01	WOS:000307010700039
J	Robinson, G; Parker, M; Kranenburg, TA; Lu, C; Chen, X; Ding, L; Phoenix, TN; Hedlund, E; Wei, L; Zhu, XY; Chalhoub, N; Baker, SJ; Huether, R; Kriwacki, R; Curley, N; Thiruvenkatam, R; Wang, JM; Wu, G; Rusch, M; Hong, X; Becksfort, J; Gupta, P; Ma, J; Easton, J; Vadodaria, B; Onar-Thomas, A; Lin, T; Li, SY; Pounds, S; Paugh, S; Zhao, D; Kawauchi, D; Roussel, MF; Finkelstein, D; Ellison, DW; Lau, CC; Bouffet, E; Hassall, T; Gururangan, S; Cohn, R; Fulton, RS; Fulton, LL; Dooling, DJ; Ochoa, K; Gajjar, A; Mardis, ER; Wilson, RK; Downing, JR; Zhang, JH; Gilbertson, RJ				Robinson, Giles; Parker, Matthew; Kranenburg, Tanya A.; Lu, Charles; Chen, Xiang; Ding, Li; Phoenix, Timothy N.; Hedlund, Erin; Wei, Lei; Zhu, Xiaoyan; Chalhoub, Nader; Baker, Suzanne J.; Huether, Robert; Kriwacki, Richard; Curley, Natasha; Thiruvenkatam, Radhika; Wang, Jianmin; Wu, Gang; Rusch, Michael; Hong, Xin; Becksfort, Jared; Gupta, Pankaj; Ma, Jing; Easton, John; Vadodaria, Bhavin; Onar-Thomas, Arzu; Lin, Tong; Li, Shaoyi; Pounds, Stanley; Paugh, Steven; Zhao, David; Kawauchi, Daisuke; Roussel, Martine F.; Finkelstein, David; Ellison, David W.; Lau, Ching C.; Bouffet, Eric; Hassall, Tim; Gururangan, Sridharan; Cohn, Richard; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Ochoa, Kerri; Gajjar, Amar; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Zhang, Jinghui; Gilbertson, Richard J.			Novel mutations target distinct subgroups of medulloblastoma	NATURE			English	Article							BOX RNA HELICASE; E-CADHERIN GENE; BETA-CATENIN; SOMATIC MUTATIONS; BREAST-CANCER; STEM-CELLS; DROSOPHILA; EZH2; TRANSACTIVATION; METHYLATION	Medulloblastoma is a malignant childhood brain tumour comprising four discrete subgroups. Here, to identify mutations that drive medulloblastoma, we sequenced the entire genomes of 37 tumours and matched normal blood. One-hundred and thirty-six genes harbouring somatic mutations in this discovery set were sequenced in an additional 56 medulloblastomas. Recurrent mutations were detected in 41 genes not yet implicated in medulloblastoma; several target distinct components of the epigenetic machinery in different disease subgroups, such as regulators of H3K27 and H3K4 trimethylation in subgroups 3 and 4 (for example, KDM6A and ZMYM3), and CTNNB1-associated chromatin re-modellers in WNT-subgroup tumours (for example, SMARCA4 and CREBBP). Modelling of mutations in mouse lower rhombic lip progenitors that generate WNT-subgroup tumours identified genes that maintain this cell lineage (DDX3X), as well as mutated genes that initiate (CDH1) or cooperate (PIK3CA) in tumorigenesis. These data provide important new insights into the pathogenesis of medulloblastoma subgroups and highlight targets for therapeutic development.	[Robinson, Giles; Parker, Matthew; Kranenburg, Tanya A.; Lu, Charles; Chen, Xiang; Ding, Li; Phoenix, Timothy N.; Hedlund, Erin; Wei, Lei; Zhu, Xiaoyan; Chalhoub, Nader; Baker, Suzanne J.; Huether, Robert; Kriwacki, Richard; Curley, Natasha; Thiruvenkatam, Radhika; Wang, Jianmin; Wu, Gang; Rusch, Michael; Hong, Xin; Becksfort, Jared; Gupta, Pankaj; Ma, Jing; Easton, John; Vadodaria, Bhavin; Onar-Thomas, Arzu; Lin, Tong; Li, Shaoyi; Pounds, Stanley; Paugh, Steven; Zhao, David; Kawauchi, Daisuke; Roussel, Martine F.; Finkelstein, David; Ellison, David W.; Lau, Ching C.; Bouffet, Eric; Hassall, Tim; Gururangan, Sridharan; Cohn, Richard; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Ochoa, Kerri; Gajjar, Amar; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Zhang, Jinghui; Gilbertson, Richard J.] Washington Univ, St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Robinson, Giles; Kranenburg, Tanya A.; Phoenix, Timothy N.; Zhu, Xiaoyan; Chalhoub, Nader; Baker, Suzanne J.; Curley, Natasha; Thiruvenkatam, Radhika; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Robinson, Giles; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Parker, Matthew; Chen, Xiang; Hedlund, Erin; Wei, Lei; Huether, Robert; Wu, Gang; Rusch, Michael; Easton, John; Vadodaria, Bhavin; Finkelstein, David; Zhang, Jinghui] St Jude Childrens Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Lu, Charles; Ding, Li; Hong, Xin; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Wei, Lei; Ma, Jing; Ellison, David W.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Huether, Robert; Kriwacki, Richard] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wang, Jianmin; Becksfort, Jared; Gupta, Pankaj; Zhao, David] St Jude Childrens Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Onar-Thomas, Arzu; Lin, Tong; Li, Shaoyi; Pounds, Stanley] St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; [Paugh, Steven] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Kawauchi, Daisuke; Roussel, Martine F.] St Jude Childrens Hosp, Dept Tumour Biol & Genet, Memphis, TN 38105 USA; [Lau, Ching C.] Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA; [Bouffet, Eric] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Hassall, Tim] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Gururangan, Sridharan] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Cohn, Richard] Univ New S Wales, Sch Womens & Childrens Hlth, Kensington, NSW 2052, Australia; [Mardis, Elaine R.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Wilson, Richard K.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Texas Children's Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Children's Hospital Melbourne; Duke University; University of New South Wales Sydney; Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Gilbertson, RJ (corresponding author), Washington Univ, St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA.	Jinghui.Zhang@stjude.org; Richard.Gilbertson@stjude.org	Lin, Tong/G-4105-2012; Chen, Xiang/N-2524-2018; Zhang, Jing/GWZ-7332-2022; Robinson, Giles W/N-8095-2018; Downing, James R./N-8102-2018; wang, jian/GVS-0711-2022; Roussel, Martine F/F-1469-2016; Kawauchi, Daisuke/ABE-9133-2021; Gilbertson, Richard James/ABE-1346-2021; Paugh, Steven/A-7739-2008; Gajjar, Amar/N-8059-2018; Wu, Gang/M-8012-2014; Kriwacki, Richard/N-8154-2018; Huether, Robert/E-9638-2012; Wilson, Richard K./AAF-4139-2019; Pounds, Stanley B/N-2480-2018; Rusch, Michael/AAG-1998-2019; Bouffet, Eric/AAB-8999-2020; Onar-Thomas, Arzu/M-9356-2018; Ellison, David/N-4806-2018; Kranenburg, Tanya/F-7138-2012; Mardis, Elaine/W-2202-2019; Baker, Suzanne J/N-8167-2018	Chen, Xiang/0000-0002-2499-8261; Robinson, Giles W/0000-0001-7441-9486; Roussel, Martine F/0000-0002-1740-8139; Gilbertson, Richard James/0000-0001-7539-9472; Paugh, Steven/0000-0001-5697-9228; Wu, Gang/0000-0002-1678-5864; Kriwacki, Richard/0000-0002-9798-6018; Huether, Robert/0000-0001-7077-7470; Wilson, Richard K./0000-0002-1992-1358; Pounds, Stanley B/0000-0002-9167-2114; Rusch, Michael/0000-0002-5363-1848; Kranenburg, Tanya/0000-0002-5329-4968; Parker, Matthew/0000-0003-2999-3870; Cohn, Richard/0000-0002-2400-1353; Hassall, Timothy/0000-0002-7883-3710; Easton, John/0000-0003-4503-6608	St Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project; National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); Musicians against Childhood Cancer (MACC); Noyes Brain Tumour Foundation; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, R01CA129541, P01CA096832] Funding Source: NIH RePORTER	St Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); Musicians against Childhood Cancer (MACC); Noyes Brain Tumour Foundation; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported as part of the St Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project. This work was supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765; R.J.G.), the Collaborative Ependymoma Research Network (CERN), Musicians against Childhood Cancer (MACC), The Noyes Brain Tumour Foundation, and by the American Lebanese Syrian Associated Charities (ALSAC). We are grateful to S. Temple for the gift of reagents and the staff of the Hartwell Center for Bioinformatics and Biotechnology and ARC at St Jude Children's Research Hospital for technical assistance.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; BECKER KF, 1994, CANCER RES, V54, P3845; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Castellino RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010849; Central Brain Tumor Registry of the United States, 2006, STAT REP PRIM BRAIN; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Khan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005076; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Orsulic S, 1999, J CELL SCI, V112, P1237; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pek JW, 2011, P NATL ACAD SCI USA, V108, P12007, DOI 10.1073/pnas.1106245108; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Taylor MD, 2001, PEDIATR NEUROSURG, V35, P235, DOI 10.1159/000050428; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	50	582	594	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					43	48		10.1038/nature11213	http://dx.doi.org/10.1038/nature11213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22722829	hybrid, Green Accepted			2022-12-01	WOS:000307010700029
J	Van Brabandt, H; Neyt, M; Hulstaert, F				Van Brabandt, Hans; Neyt, Mattias; Hulstaert, Frank			Transcatheter aortic valve implantation (TAVI): risky and costly	BRITISH MEDICAL JOURNAL			English	Editorial Material							ELDERLY-PATIENTS; REPLACEMENT; STENOSIS; SURGERY		[Van Brabandt, Hans; Neyt, Mattias; Hulstaert, Frank] KCE, Belgian Hlth Care Knowledge Ctr, Adm Ctr Kruidtuin, B-1000 Brussels, Belgium; [Van Brabandt, Hans] CEBAM, Belgian Ctr Evidence Based Med, Louvain, Belgium; [Van Brabandt, Hans] Branch Dutch Cochrane Ctr, Louvain, Belgium		Neyt, M (corresponding author), KCE, Belgian Hlth Care Knowledge Ctr, Adm Ctr Kruidtuin, Kruidtuinlaan 55, B-1000 Brussels, Belgium.	mattias.neyt@kce.fgov.be		Hulstaert, Frank/0000-0003-2879-9910				[Anonymous], 2012, HEARTWIRE        MAY; [Anonymous], 2006, BUSINESSWEEK; Blackman D, 2011, OUTCOME TAVI VALVE A; [British Cardiovascular Intervention Society Society of Cardiothoracic Surgeons], TRANSC AORT VALV IMP; Cortez M, 2011, BLOOMBERG NEWS  0404; FDA, 2011, SAPIEN THV BRIEF DOC, P301; FDA, EDW SAPIEN TRANSC HE; FDA, 2011, FDA EX SUMM EDW SAPI; Guard M, 2011, EUROPCR C PAR 17 20; Hirschler B, 2012, EU MED HEAD URGES TO; Hulstaert F, 2011, 158CD20111027331 KCE; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Nainggolan L, 2011, GERMANY TOPS TAVI TA; National Institute for Health and Care Excellence (NICE), 2012, TRANSC AORT VALV IMP; Neyt M, 2011, KCE REPORTS C; Neyt M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001032; Nielsen HH, 2012, EUROINTERVENTION; O'Riordan M, 2011, HEARTWIRE       1110; Ray S, 2008, CONS M 16 DEC 2008; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Varadarajan P, 2006, EUR J CARDIO-THORAC, V30, P722, DOI 10.1016/j.ejcts.2006.07.028; Wood S, 2012, HEARTWIRE       0614	26	42	42	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 31	2012	345								e4710	10.1136/bmj.e4710	http://dx.doi.org/10.1136/bmj.e4710			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XB	22849955				2022-12-01	WOS:000307302700001
J	Archin, NM; Liberty, AL; Kashuba, AD; Choudhary, SK; Kuruc, JD; Crooks, AM; Parker, DC; Anderson, EM; Kearney, MF; Strain, MC; Richman, DD; Hudgens, MG; Bosch, RJ; Coffin, JM; Eron, JJ; Hazuda, DJ; Margolis, DM				Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Anderson, E. M.; Kearney, M. F.; Strain, M. C.; Richman, D. D.; Hudgens, M. G.; Bosch, R. J.; Coffin, J. M.; Eron, J. J.; Hazuda, D. J.; Margolis, D. M.			Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy	NATURE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; VALPROIC ACID; IN-VIVO; TYPE-1; EXPRESSION; INFECTION; CELLS; PCR; ACTIVATION	Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection(1). Inducing the expression of latent genomes within resting CD4(+) T cells is the primary strategy to clear this reservoir(2,3). Although histone deacetylase inhibitors such as suberoylanilide hydroxamic acid (also known as vorinostat, VOR) can disrupt HIV-1 latency in vitro(4-6), the utility of this approach has never been directly proven in a translational clinical study of HIV-infected patients. Here we isolated the circulating resting CD4(+) T cells of patients in whom viraemia was fully suppressed by antiretroviral therapy, and directly studied the effect of VOR on this latent reservoir. In each of eight patients, a single dose of VOR increased both biomarkers of cellular acetylation, and simultaneously induced an increase in HIV RNA expression in resting CD4(+) cells (mean increase, 4.8-fold). This demonstrates that a molecular mechanism known to enforce HIV latency can be therapeutically targeted in humans, provides proof-of-concept for histone deacetylase inhibitors as a therapeutic class, and defines a precise approach to test novel strategies to attack and eradicate latent HIV infection directly.	[Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Hudgens, M. G.; Eron, J. J.; Margolis, D. M.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Anderson, E. M.; Kearney, M. F.; Coffin, J. M.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; [Strain, M. C.; Richman, D. D.] VA San Diego Healthcare Syst, San Diego, CA 92093 USA; [Strain, M. C.; Richman, D. D.] Univ Calif San Diego, San Diego, CA 92093 USA; [Bosch, R. J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hazuda, D. J.] Merck Res Labs, White Horse Junction, PA USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Harvard University; Harvard T.H. Chan School of Public Health; Merck & Company	Margolis, DM (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	dmargo@med.unc.edu	Kearney, Mary/AAU-8132-2020; Margolis, David M./Y-2468-2019	Margolis, David M./0000-0001-5714-0002; Parker, Daniel/0000-0001-8512-1044; Kearney, Mary/0000-0003-3839-6576	National Institutes of Health [AI084553, AI095052, AI096113, RR024383, AI50410]; Merck Co; James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, U01AI095052, U19AI096113, R34AI084553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Co(Merck & Company); James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grants AI084553, AI095052 and AI096113, and by a grant from Merck & Co to D. M. M., National Institutes of Health grants RR024383 to the UNC TRaCS Institute, AI50410 to the UNC Center for AIDS Research, and an equipment grant from the James B. Pendleton Charitable Trust. Merck & Co provided VOR. The ClinicalTrials.gov identifier is NCT01319383. We thank N. P. Dahl, R. Sackmann, M. Cheema, A. Wiegand and N. White for technical support, Y. Park and the staff the UNC Blood Bank, R. J. Bedimo and C. M. van der Horst for study oversight, and J. Scepanski and A. Sugarbaker for patient follow-up and study coordination. We thank M. S. Cohen, J. V. Garcia-Martinez, W. C. Greene, J. Karn and R. F. Siliciano for discussions. Finally, we are grateful for the contributions of the patients who have participated in these studies.	Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Du LH, 2005, RAPID COMMUN MASS SP, V19, P1779, DOI 10.1002/rcm.1984; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Israel-Ballard K, 2005, J CLIN VIROL, V34, P253, DOI 10.1016/j.jcv.2005.02.013; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee JH, 2011, P NATL ACAD SCI USA, V108, P19629, DOI 10.1073/pnas.1117544108; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; May R. C., 2012, U N CAROLINA CHAPEL; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Robinson LH, 2002, J VIROL METHODS, V104, P147, DOI 10.1016/S0166-0934(02)00059-9; Rubin EH, 2006, CLIN CANCER RES, V12, P7039, DOI 10.1158/1078-0432.CCR-06-1802; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Tonelli R, 2006, LEUKEMIA, V20, P1307, DOI 10.1038/sj.leu.2404221; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x	25	836	875	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					482	U1650		10.1038/nature11286	http://dx.doi.org/10.1038/nature11286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837004	Green Accepted, Green Submitted			2022-12-01	WOS:000306815300038
J	Hubbell, JA; Chilkoti, A				Hubbell, Jeffrey A.; Chilkoti, Ashutosh			Nanomaterials for Drug Delivery	SCIENCE			English	Editorial Material							IN-VIVO; NANOPARTICLES; TUMOR; TRANSPORT; PEPTIDES		[Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, CH-1015 Lausanne, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Chilkoti, Ashutosh] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Chilkoti, Ashutosh] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Duke University; Duke University	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	Hubbell, Jeffrey A/A-9266-2008	Hubbell, Jeffrey A/0000-0003-0276-5456				Baish JW, 2011, P NATL ACAD SCI USA, V108, P1799, DOI 10.1073/pnas.1018154108; Christian DA, 2009, MOL PHARMACEUT, V6, P1343, DOI 10.1021/mp900022m; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Gao WP, 2010, P NATL ACAD SCI USA, V107, P16432, DOI 10.1073/pnas.1006044107; Hatakeyama S, 2011, P NATL ACAD SCI USA, V108, P19587, DOI 10.1073/pnas.1105057108; Hirosue S, 2010, VACCINE, V28, P7897, DOI 10.1016/j.vaccine.2010.09.077; MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Murakami M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001385; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Peters D, 2009, P NATL ACAD SCI USA, V106, P9815, DOI 10.1073/pnas.0903369106; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/NMAT3049, 10.1038/nmat3049]; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499	17	406	418	4	312	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					303	305		10.1126/science.1219657	http://dx.doi.org/10.1126/science.1219657			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822138				2022-12-01	WOS:000306542600038
J	Montagner, M; Enzo, E; Forcato, M; Zanconato, F; Parenti, A; Rampazzo, E; Basso, G; Leo, G; Rosato, A; Bicciato, S; Cordenonsi, M; Piccolo, S				Montagner, Marco; Enzo, Elena; Forcato, Mattia; Zanconato, Francesca; Parenti, Anna; Rampazzo, Elena; Basso, Giuseppe; Leo, Genesio; Rosato, Antonio; Bicciato, Silvio; Cordenonsi, Michelangelo; Piccolo, Stefano			SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors	NATURE			English	Article							P53; EXPRESSION; HIF-1-ALPHA; PROTEASOME; PATHWAY; COMPLEX; PROTEIN; GROWTH; P63	The molecular determinants of malignant cell behaviours in breast cancer remain only partially understood(1). Here we show that SHARP1 (also known as BHLHE41 or DEC2) is a crucial regulator of the invasive and metastatic phenotype in triple-negative breast cancer (TNBC), one of the most aggressive types of breast cancer. SHARP1 is regulated by the p63 metastasis suppressor and inhibits TNBC aggressiveness through inhibition of hypoxia-inducible factor 1 alpha (HIF-1 alpha) and HIF-2 alpha (HIFs). SHARP1 opposes HIF-dependent TNBC cell migration in vitro, and invasive or metastatic behaviours in vivo. SHARP1 is required, and sufficient, to limit expression of HIF-target genes. In primary TNBC, endogenous SHARP1 levels are inversely correlated with those of HIF targets. Mechanistically, SHARP1 binds to HIFs and promotes HIF proteasomal degradation by serving as the HIF-presenting factor to the proteasome. This process is independent of pVHL (von Hippel-Lindau tumour suppressor), hypoxia and the ubiquitination machinery. SHARP1 therefore determines the intrinsic instability of HIF proteins to act in parallel to, and cooperate with, oxygen levels. This work sheds light on the mechanisms and pathways by which TNBC acquires invasiveness and metastatic propensity.	[Montagner, Marco; Enzo, Elena; Zanconato, Francesca; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Sch Med, Dept Med Biotechnol, I-35131 Padua, Italy; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy; [Parenti, Anna] Univ Padua, Sect Pathol, Dept Med Diagnost Sci & Special Therapies, I-35126 Padua, Italy; [Rampazzo, Elena; Basso, Giuseppe] Univ Padua, Dept Pediat, I-35128 Padua, Italy; [Leo, Genesio] Hosp San Bassiano, Div Anat Pathol, I-36061 Bassano Del Grappa, Italy; [Rosato, Antonio] Dept Surg Oncol & Gastroenterol, I-35126 Padua, Italy; [Rosato, Antonio] Ist Oncol Veneto IRCCS, I-35126 Padua, Italy	University of Padua; Universita di Modena e Reggio Emilia; University of Padua; University of Padua; ULSS 7 Pedemontana; Ospedale San Bassiano; IRCCS Istituto Oncologico Veneto (IOV)	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Med Biotechnol, Viale Colombo 3, I-35131 Padua, Italy.	piccolo@bio.unipd.it	Bicciato, Silvio/C-9825-2009; Cordenonsi, Michelangelo/K-7692-2016; Rosato, Antonio/E-8626-2010; Montagner, Marco/AAY-3236-2020; Forcato, Mattia/B-7733-2015; BICCIATO, Silvio/J-4466-2019	Bicciato, Silvio/0000-0002-1944-7078; Cordenonsi, Michelangelo/0000-0002-8253-5724; Rosato, Antonio/0000-0002-5263-8386; Montagner, Marco/0000-0003-3080-2138; Forcato, Mattia/0000-0002-7383-6576; BICCIATO, Silvio/0000-0002-1944-7078; Enzo, Elena/0000-0001-9768-6368; BASSO, GIUSEPPE/0000-0002-2634-9302; PICCOLO, STEFANO/0000-0002-2037-0004	FIRC (Federazione Italiana Ricerca Cancro); Cariparo PhD fellowship; AIRC (Italian Association for Cancer Research); Italian Welfare Ministry; AIRC (Associazione Italiana per la Ricerca sul Cancro); Fondazione Citta della Speranza; MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca Italia); PRIN grants; AIRC; HSFP; University of Padua; IIT Excellence grant; CNR-Miur Epigenetics Flagship project; Comitato Promotore Telethon	FIRC (Federazione Italiana Ricerca Cancro)(Fondazione AIRC per la ricerca sul cancro); Cariparo PhD fellowship(Fondazione Cariparo); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); Italian Welfare Ministry; AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione Citta della Speranza; MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca Italia); PRIN grants; AIRC(Fondazione AIRC per la ricerca sul cancro); HSFP; University of Padua; IIT Excellence grant; CNR-Miur Epigenetics Flagship project; Comitato Promotore Telethon(Fondazione Telethon)	We thank O. Wessely, G. Del Sal, C. Oakman and A. Di Leo for comments; and W. Kaelin, C. Borner, S. Libutti, Y. Maeda and Y. Kato for gifts of reagents. M.M. is a recipient of a FIRC (Federazione Italiana Ricerca Cancro) fellowship. We are in debt to E. Tagliafico and the Modena Affimetrix platform team for help with microarrays. E.E. is a recipient of a Cariparo PhD fellowship. M.M. was a recipient of an AIRC (Italian Association for Cancer Research) fellowship. This work is supported by a Young Italian Researchers grant of the Italian Welfare Ministry and an AIRC (Associazione Italiana per la Ricerca sul Cancro) MFAGgrant to M.C.; a Fondazione Citta della Speranza Grant, and MIUR (Ministero dell'Istruzione dell'Universita e della Ricerca Italia) and PRIN grants to G.B; and an AIRC Principal Investigator grant, an AIRC Special Program Molecular Clinical Oncology '5 per mille' grant, an HSFP grant, a University of Padua Strategic grant, an IIT Excellence grant, a CNR-Miur Epigenetics Flagship project, and a Comitato Promotore Telethon grant to S.P.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Cho S, 2001, FEBS LETT, V498, P62, DOI 10.1016/S0014-5793(01)02499-1; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; Lu X, 2010, CANCER RES, V70, P3905, DOI 10.1158/0008-5472.CAN-09-3739; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Sato F, 2008, GENES CELLS, V13, P131, DOI 10.1111/j.1365-2443.2007.01153.x; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Zhang HZ, 2011, APPL COMPUT HARMON A, V31, P1, DOI 10.1016/j.acha.2010.09.007	24	174	183	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					380	384		10.1038/nature11207	http://dx.doi.org/10.1038/nature11207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22801492				2022-12-01	WOS:000306506500046
J	Dietz, WH; Scanlon, KS				Dietz, William H.; Scanlon, Kelley S.			Eliminating the Use of Partially Hydrogenated Oil in Food Production and Preparation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRANS-FATTY-ACIDS; POPULATION		[Dietz, William H.; Scanlon, Kelley S.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Nutr Phys Act & Obes, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Scanlon, KS (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Nutr Phys Act & Obes, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	kscanlon@cdc.gov						Doell D, 2012, FOOD ADDIT CONTAM A, V29, P861, DOI 10.1080/19440049.2012.664570; IOM, 2005, DIET REF INT EN CARB; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Mozaffarian D, 2010, NEW ENGL J MED, V362, P2037, DOI 10.1056/NEJMc1001841; Ratnayake WMN, 2009, J AOAC INT, V92, P1258; US Department of Agriculture & US Department of Health and Human Services, 2010, DIET GUID AM 2010; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; [No title captured]	10	19	19	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2012	308	2					143	144		10.1001/jama.2012.7379	http://dx.doi.org/10.1001/jama.2012.7379			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971QS	22782414				2022-12-01	WOS:000306219500026
J	Banerji, S; Cibulskis, K; Rangel-Escareno, C; Brown, KK; Carter, SL; Frederick, AM; Lawrence, MS; Sivachenko, AY; Sougnez, C; Zou, LH; Cortes, ML; Fernandez-Lopez, JC; Peng, SY; Ardlie, KG; Auclair, D; Bautista-Pina, V; Duke, F; Francis, J; Jung, J; Maffuz-Aziz, A; Onofrio, RC; Parkin, M; Pho, NH; Quintanar-Jurado, V; Ramos, AH; Rebollar-Vega, R; Rodriguez-Cuevas, S; Romero-Cordoba, SL; Schumacher, SE; Stransky, N; Thompson, KM; Uribe-Figueroa, L; Baselga, J; Beroukhim, R; Polyak, K; Sgroi, DC; Richardson, AL; Jimenez-Sanchez, G; Lander, ES; Gabriel, SB; Garraway, LA; Golub, TR; Melendez-Zajgla, J; Toker, A; Getz, G; Hidalgo-Miranda, A; Meyerson, M				Banerji, Shantanu; Cibulskis, Kristian; Rangel-Escareno, Claudia; Brown, Kristin K.; Carter, Scott L.; Frederick, Abbie M.; Lawrence, Michael S.; Sivachenko, Andrey Y.; Sougnez, Carrie; Zou, Lihua; Cortes, Maria L.; Fernandez-Lopez, Juan C.; Peng, Shouyong; Ardlie, Kristin G.; Auclair, Daniel; Bautista-Pina, Veronica; Duke, Fujiko; Francis, Joshua; Jung, Joonil; Maffuz-Aziz, Antonio; Onofrio, Robert C.; Parkin, Melissa; Pho, Nam H.; Quintanar-Jurado, Valeria; Ramos, Alex H.; Rebollar-Vega, Rosa; Rodriguez-Cuevas, Sergio; Romero-Cordoba, Sandra L.; Schumacher, Steven E.; Stransky, Nicolas; Thompson, Kristin M.; Uribe-Figueroa, Laura; Baselga, Jose; Beroukhim, Rameen; Polyak, Kornelia; Sgroi, Dennis C.; Richardson, Andrea L.; Jimenez-Sanchez, Gerardo; Lander, Eric S.; Gabriel, Stacey B.; Garraway, Levi A.; Golub, Todd R.; Melendez-Zajgla, Jorge; Toker, Alex; Getz, Gad; Hidalgo-Miranda, Alfredo; Meyerson, Matthew			Sequence analysis of mutations and translocations across breast cancer subtypes	NATURE			English	Article							HIGH-FREQUENCY; PIK3CA GENE; GENOME; LANDSCAPES; PATTERNS; FUSION; DOMAIN; KINASE	Breast carcinoma is the leading cause of cancer-related mortality in women worldwide, with an estimated 1.38 million new cases and 458,000 deaths in 2008 alone(1). This malignancy represents a heterogeneous group of tumours with characteristic molecular features, prognosis and responses to available therapy(2-4). Recurrent somatic alterations in breast cancer have been described, including mutations and copy number alterations, notably ERBB2 amplifications, the first successful therapy target defined by a genomic aberration(5). Previous DNA sequencing studies of breast cancer genomes have revealed additional candidate mutations and gene rearrangements(6-10). Here we report the whole-exome sequences of DNA from 103 human breast cancers of diverse subtypes from patients in Mexico and Vietnam compared to matched-normal DNA, together with whole-genome sequences of 22 breast cancer/normal pairs. Beyond confirming recurrent somatic mutations in PIK3CA(11), TP53(6), AKT1(12), GATA3(13) and MAP3K1(10), we discovered recurrent mutations in the CBFB transcription factor gene and deletions of its partner RUNX1. Furthermore, we have identified a recurrent MAGI3-AKT3 fusion enriched in triple-negative breast cancer lacking oestrogen and progesterone receptors and ERBB2 expression. The MAGI3-AKT3 fusion leads to constitutive activation of AKT kinase, which is abolished by treatment with an ATP-competitive AKT small-molecule inhibitor.	[Banerji, Shantanu; Cibulskis, Kristian; Carter, Scott L.; Frederick, Abbie M.; Lawrence, Michael S.; Sivachenko, Andrey Y.; Sougnez, Carrie; Zou, Lihua; Cortes, Maria L.; Ardlie, Kristin G.; Auclair, Daniel; Duke, Fujiko; Francis, Joshua; Jung, Joonil; Onofrio, Robert C.; Parkin, Melissa; Pho, Nam H.; Ramos, Alex H.; Schumacher, Steven E.; Stransky, Nicolas; Thompson, Kristin M.; Beroukhim, Rameen; Lander, Eric S.; Gabriel, Stacey B.; Garraway, Levi A.; Golub, Todd R.; Getz, Gad; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Banerji, Shantanu; Peng, Shouyong; Schumacher, Steven E.; Beroukhim, Rameen; Polyak, Kornelia; Richardson, Andrea L.; Garraway, Levi A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Banerji, Shantanu; Baselga, Jose; Beroukhim, Rameen; Polyak, Kornelia; Sgroi, Dennis C.; Richardson, Andrea L.; Lander, Eric S.; Garraway, Levi A.; Golub, Todd R.; Toker, Alex; Meyerson, Matthew] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rangel-Escareno, Claudia; Fernandez-Lopez, Juan C.; Quintanar-Jurado, Valeria; Rebollar-Vega, Rosa; Romero-Cordoba, Sandra L.; Uribe-Figueroa, Laura; Jimenez-Sanchez, Gerardo; Melendez-Zajgla, Jorge; Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Mexico City 01900, DF, Mexico; [Brown, Kristin K.; Toker, Alex] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Bautista-Pina, Veronica; Maffuz-Aziz, Antonio; Rodriguez-Cuevas, Sergio] FUCAM, Inst Enfermedades Mama, Mexico City 04980, DF, Mexico; [Baselga, Jose] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Polyak, Kornelia] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Cambridge, MA 02139 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Instituto Nacional de Medicina Genomica; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Meyerson, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	atoker@bidmc.harvard.edu; gadgetz@broadinstitute.org; ahidalgo@inmegen.gob.mx; matthew_meyerson@dfci.harvard.edu	Melendez-Zajgla, Jorge/A-5708-2008; Fernandez, Juan Carlos/C-4976-2013; Cibulskis, Kristian/AAC-7380-2019; Hidalgo-Miranda, Alfredo/B-2123-2010; Lawrence, Michael/AAC-8202-2020; Rangel-Escareno, Claudia/F-4587-2012; Meyerson, Matthew L/E-7123-2012; Schumacher, Steven/E-9821-2013; Romero, Sandra/A-2246-2014; Sgroi, Dennis/AAV-2487-2021; Romero-Cordoba, Sandra/AAY-2625-2020	Fernandez, Juan Carlos/0000-0003-3680-4193; Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Rangel-Escareno, Claudia/0000-0003-1303-0834; Schumacher, Steven/0000-0002-6819-5647; Romero, Sandra/0000-0002-5591-696X; REBOLLAR VEGA, ROSA GLORIA/0000-0002-9293-5959; BROWN, KRISTIN/0000-0002-4991-8870; Meyerson, Matthew/0000-0002-9133-8108; Cibulskis, Kristian/0000-0003-1343-1582	Carlos Slim Health Institute in Mexico; CancerCare Manitoba; University of Manitoba; John Gavin Post-doctoral Fellowship; Genesis Oncology Trust of New Zealand; Mexican Council of Science and Technology (CONACyT); NIH [CA122099]; Dana-Farber/Harvard SPORE in breast cancer under NCI grant [CA089393]; NATIONAL CANCER INSTITUTE [R01CA122099, P50CA089393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	Carlos Slim Health Institute in Mexico; CancerCare Manitoba; University of Manitoba; John Gavin Post-doctoral Fellowship; Genesis Oncology Trust of New Zealand; Mexican Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard SPORE in breast cancer under NCI grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank all patients who contributed samples to this study. This study was a collaboration of the Broad Institute in Cambridge, Massachusetts, USA, and the National Institute of Genomic Medicine (INMEGEN) in Mexico City, Mexico. The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Health Institute in Mexico. This work is part of a global effort in collaboration with the International Cancer Genome Consortium (ICGC). The authors would also like to acknowledge J. Barretina and H. Greulich for their critical review of the manuscript. In addition, we would like to acknowledge the technical expertise and data generation efforts of The Broad Institute Biological Samples, Genome Sequencing, and Genetic Analysis Platforms. S. B. has received fellowship support co-sponsored by CancerCare Manitoba and the University of Manitoba. K. K. B. is a recipient of the John Gavin Post-doctoral Fellowship, Genesis Oncology Trust of New Zealand. R. R.-V. and S. L. R.-C. received a scholarship from the Mexican Council of Science and Technology (CONACyT). R. B. is a V Foundation Scholar. A. T. is funded by NIH grant CA122099. This work was partially supported by the Dana-Farber/Harvard SPORE in breast cancer under NCI grant reference CA089393.	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shigesada K, 2004, ONCOGENE, V23, P4297, DOI 10.1038/sj.onc.1207748; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199	29	875	904	3	169	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					405	409		10.1038/nature11154	http://dx.doi.org/10.1038/nature11154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722202	Green Accepted, hybrid			2022-12-01	WOS:000305466800044
J	Narod, SA				Narod, Steven A.			Ten types of breast cancer?	LANCET			English	Editorial Material									[Narod, Steven A.] Univ Toronto, Womens Coll, Res Inst, Toronto, ON M5G 1N8, Canada	University of Toronto; Women's College Research Institute	Narod, SA (corresponding author), Univ Toronto, Womens Coll, Res Inst, Toronto, ON M5G 1N8, Canada.	steven.narod@wchospital.ca	Narod, Steven A/AAA-6112-2022					Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Mehta R, 2011, CLIN BREAST CANCER, V11, P20, DOI 10.3816/CBC.2011.n.004; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178	6	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2012	380	9849					1212	+		10.1016/S0140-6736(12)60781-8	http://dx.doi.org/10.1016/S0140-6736(12)60781-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	020NG	22781491				2022-12-01	WOS:000309817500008
J	von Moltke, J; Trinidad, NJ; Moayeri, M; Kintzer, AF; Wang, SB; van Rooijen, N; Brown, CR; Krantz, BA; Leppla, SH; Gronert, K; Vance, RE				von Moltke, Jakob; Trinidad, Norver J.; Moayeri, Mahtab; Kintzer, Alexander F.; Wang, Samantha B.; van Rooijen, Nico; Brown, Charles R.; Krantz, Bryan A.; Leppla, Stephen H.; Gronert, Karsten; Vance, Russell E.			Rapid induction of inflammatory lipid mediators by the inflammasome in vivo	NATURE			English	Article							CASPASE-1 ACTIVATION; IMMUNE RECOGNITION; MICE DEFICIENT; PYROPTOSIS; MECHANISM; INFECTION; INJURY; SUSCEPTIBILITY; SUBSTRATE; FLAGELLIN	Detection of microbial products by host inflammasomes is an important mechanism of innate immune surveillance. Inflammasomes activate the caspase-1 (CASP1) protease, which processes the cytokines interleukin (IL)-1 beta and IL-18, and initiates a lytic host cell death called pyroptosis(1). To identify novel CASP1 functions in vivo, we devised a strategy for cytosolic delivery of bacterial flagellin, a specific ligand for the NAIP5 (NLR family, apoptosis inhibitory protein 5)/NLRC4 (NLR family, CARD-domain-containing 4) inflammasome(2-4). Here we show that systemic inflammasome activation by flagellin leads to a loss of vascular fluid into the intestine and peritoneal cavity, resulting in rapid (less than 30 min) death in mice. This unexpected response depends on the inflammasome components NAIP5, NLRC4 and CASP1, but is independent of the production of IL-1 beta or IL-18. Instead, inflammasome activation results, within minutes, in an 'eicosanoid storm'-a pathological release of signalling lipids, including prostaglandins and leukotrienes, that rapidly initiate inflammation and vascular fluid loss. Mice deficient in cyclooxygenase-1, a critical enzyme in prostaglandin biosynthesis, are resistant to these rapid pathological effects of systemic inflammasome activation by either flagellin or anthrax lethal toxin. Inflammasome-dependent biosynthesis of eicosanoids is mediated by the activation of cytosolic phospholipase A(2) in resident peritoneal macrophages, which are specifically primed for the production of eicosanoids by high expression of eicosanoid biosynthetic enzymes. Our results therefore identify eicosanoids as a previously unrecognized cell-type-specific signalling output of the inflammasome with marked physiological consequences in vivo.	[von Moltke, Jakob; Trinidad, Norver J.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Kintzer, Alexander F.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wang, Samantha B.; Gronert, Karsten] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Moayeri, Mahtab; Leppla, Stephen H.] NIAID, Parasit Dis Lab, Microbial Pathogenesis Sect, NIH, Bethesda, MD 20892 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Brown, Charles R.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vrije Universiteit Amsterdam; University of Missouri System; University of Missouri Columbia	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	kgronert@berkeley.edu; rvance@berkeley.edu	Van Rooijen, Nico/Z-1578-2019	Kintzer, Alexander/0000-0001-9630-7258; Krantz, Bryan/0000-0002-4911-5824; Moayeri, Mahtab/0000-0002-4448-8883; Brown, Charles/0000-0002-1914-9601	Burroughs Wellcome Fund; Cancer Research Institute; National Institutes of Health (NIH) [AI075039, AI080749, AI063302, EY016136, EY022208]; Cancer Research Coordinating Committee of the University of California; NATIONAL EYE INSTITUTE [R01EY022208, R01EY016136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075039, ZIAAI001032, P01AI063302, R01AI080749] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Coordinating Committee of the University of California(University of California System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Mariathasan and V. Dixit for Nlrc4<SUP>-/-</SUP> mice; I. Bergin and S. Griffey for pathology reports; D. Crown for help with survival experiments; L. Lopez for support in our animal facility; D. Bautista and R. Nichols for help with calcium imaging; and M. Fontana and members of the Barton and Vance laboratories for discussions. Work in R.E.V.'s laboratory is supported by Investigator Awards from the Burroughs Wellcome Fund and the Cancer Research Institute and by National Institutes of Health (NIH) grants AI075039, AI080749 and AI063302. K.G.'s laboratory is supported by NIH grants EY016136 and EY022208. J.v.M. is supported by a grant from the Cancer Research Coordinating Committee of the University of California.	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Bergsbaken T, 2011, J IMMUNOL, V187, P2748, DOI 10.4049/jimmunol.1100477; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gijon MA, 2000, ADV ENZYME REGUL, V40, P255, DOI 10.1016/S0065-2571(99)00031-X; Glomski IJ, 2003, INFECT IMMUN, V71, P6754, DOI 10.1128/IAI.71.12.6754-6765.2003; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liclican EL, 2010, INVEST OPHTH VIS SCI, V51, P6311, DOI 10.1167/iovs.10-5455; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; RIVIERE PJM, 1991, J PHARMACOL EXP THER, V256, P547; ROBERT A, 1976, PROSTAG OTH LIPID M, V11, P809, DOI 10.1016/0090-6980(76)90189-1; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serhan C. N., 2011, FUNDAMENTALS INFLAMM, P153; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	311	314	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					107	U126		10.1038/nature11351	http://dx.doi.org/10.1038/nature11351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22902502	Green Accepted, Green Submitted			2022-12-01	WOS:000309446800042
J	Coulthard, G; Erb, W; Aggarwal, VK				Coulthard, Graeme; Erb, William; Aggarwal, Varinder K.			Stereocontrolled organocatalytic synthesis of prostaglandin PGF(2 alpha) in seven steps	NATURE			English	Article							PROSTACYCLIN; ANALOGS; ROUTE	Prostaglandins are hormone-like chemical messengers that regulate a broad range of physiological activities, including blood circulation, digestion and reproduction(1,2). Their biological activities and their complex molecular architectures have made prostaglandins popular targets for synthetic organic chemists for over 40 years(3,4). Prostaglandin analogues are widely used as pharmaceuticals and some, such as latanoprost, which is used to treat glaucoma(5,6), have become billion-dollar drugs. Previously reported syntheses of these compounds are quite lengthy, and every chemical step costs time and energy, generates waste and is accompanied by material losses. Using a new bond disconnection, here we report a concise synthesis of the most complex prostaglandin, PGF(2 alpha), with high levels of control of relative and absolute stereochemistry, and fewer steps. The key step is an aldol cascade reaction of succinaldehyde using proline organocatalysis to create a bicyclic enal in one step and an enantiomeric excess of 98%. This intermediate bicyclic enal is fully primed with the appropriate functionality for attachment of the remaining groups(7). Access to this bicyclic enal will not only render existing prostaglandin-based drugs more affordable, but will also facilitate the rapid exploration of related chemical structures around the ubiquitous five-membered ring motif, such as potentially therapeutic prostaglandin analogues.	[Coulthard, Graeme; Erb, William; Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Aggarwal, VK (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	v.aggarwal@bristol.ac.uk	Aggarwal, Varinder/AAG-8504-2019	Erb, William/0000-0002-2906-2091; Aggarwal, Varinder/0000-0003-0344-6430	EPSRC; European Research Council [246785]; Royal Society; Engineering and Physical Sciences Research Council [EP/D501725/1, EP/E052185/1] Funding Source: researchfish; EPSRC [EP/E052185/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank EPSRC and the European Research Council (FP7/2007-2013, ERC grant no. 246785) for financial support. V. K. A. thanks the Royal Society for a Wolfson Research Merit Award and EPSRC for a Senior Research Fellowship.	[Anonymous], 2011, PFIZER REPORTS 4 QUA; Bahmanyar S, 2003, J AM CHEM SOC, V125, P2475, DOI 10.1021/ja028812d; Bindra J. S., 1981, TOTAL SYNTHESIS NATU, V4, P353; Bindra J. S., 1977, PROSTAGLANDIN SYNTHE; COLLINS PW, 1993, CHEM REV, V93, P1533, DOI 10.1021/cr00020a007; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; COREY EJ, 1978, J AM CHEM SOC, V100, P8031, DOI 10.1021/ja00493a055; COREY EJ, 1969, J AM CHEM SOC, V91, P5675, DOI 10.1021/ja01048a062; COREY EJ, 1971, TETRAHEDRON LETT, P4753; COREY EJ, 1974, TETRAHEDRON LETT, P2439; DANISHEFSKY SJ, 1989, J AM CHEM SOC, V111, P3456, DOI 10.1021/ja00191a067; Das S, 2007, CHEM REV, V107, P3286, DOI 10.1021/cr068365a; EULER U. S. v., 1934, ARCH EXP PATH U PHARMAKOL, V175, P78; Flower RJ, 2006, BRIT J PHARMACOL, V147, pS182, DOI 10.1038/sj.bjp.0706506; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gourlay BS, 2006, TETRAHEDRON LETT, V47, P799, DOI 10.1016/j.tetlet.2005.11.104; HOWARD CC, 1980, J CHEM SOC PERK T 1, P852, DOI 10.1039/p19800000852; LIPSHUTZ BH, 1985, J ORGANOMET CHEM, V285, P437, DOI 10.1016/0022-328X(85)87388-5; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Nair S. K., 2010, MODERN DRUG SYNTHESI, P329; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378; RESUL B, 1993, J MED CHEM, V36, P243, DOI 10.1021/jm00054a008; Rey MDA, 1999, J ORG CHEM, V64, P3196; Sheddan NA, 2006, ORG LETT, V8, P3101, DOI 10.1021/ol061141u; Stix G, 2006, SCI AM, V294, P60, DOI 10.1038/scientificamerican0506-60; STORK G, 1986, J AM CHEM SOC, V108, P6384, DOI 10.1021/ja00280a043; SUZUKI M, 1988, J AM CHEM SOC, V110, P4718, DOI 10.1021/ja00222a033; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; WOODWARD RB, 1973, J AM CHEM SOC, V95, P6853, DOI 10.1021/ja00801a066	30	100	103	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					278	281		10.1038/nature11411	http://dx.doi.org/10.1038/nature11411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22895192				2022-12-01	WOS:000308635900038
J	Hirota, T; Lee, JW; St John, PC; Sawa, M; Iwaisako, K; Noguchi, T; Pongsawakul, PY; Sonntag, T; Welsh, DK; Brenner, DA; Doyle, FJ; Schultz, PG; Kay, SA				Hirota, Tsuyoshi; Lee, Jae Wook; St John, Peter C.; Sawa, Mariko; Iwaisako, Keiko; Noguchi, Takako; Pongsawakul, Pagkapol Y.; Sonntag, Tim; Welsh, David K.; Brenner, David A.; Doyle, Francis J., III; Schultz, Peter G.; Kay, Steve A.			Identification of Small Molecule Activators of Cryptochrome	SCIENCE			English	Article							MAMMALIAN CIRCADIAN CLOCK; CHEMICAL BIOLOGY; PERIOD; REVEALS; METABOLISM; PHOSPHORYLATION; OSCILLATIONS; DEGRADATION; HOMEOSTASIS; RHYTHMS	Impairment of the circadian clock has been associated with numerous disorders, including metabolic disease. Although small molecules that modulate clock function might offer therapeutic approaches to such diseases, only a few compounds have been identified that selectively target core clock proteins. From an unbiased cell-based circadian phenotypic screen, we identified KL001, a small molecule that specifically interacts with cryptochrome (CRY). KL001 prevented ubiquitin-dependent degradation of CRY, resulting in lengthening of the circadian period. In combination with mathematical modeling, our studies using KL001 revealed that CRY1 and CRY2 share a similar functional role in the period regulation. Furthermore, KL001-mediated CRY stabilization inhibited glucagon-induced gluconeogenesis in primary hepatocytes. KL001 thus provides a tool to study the regulation of CRY-dependent physiology and aid development of clock-based therapeutics of diabetes.	[Lee, Jae Wook; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Hirota, Tsuyoshi; Sawa, Mariko; Pongsawakul, Pagkapol Y.; Sonntag, Tim; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [St John, Peter C.; Doyle, Francis J., III] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Iwaisako, Keiko; Brenner, David A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Noguchi, Takako; Welsh, David K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Noguchi, Takako; Welsh, David K.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA; [Welsh, David K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Hirota, Tsuyoshi; Kay, Steve A.] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California Santa Barbara; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	schultz@scripps.edu; skay@ucsd.edu	Pongsawakul, Pagkapol Y./GSD-2959-2022; Kay, Steve A/F-6025-2011; Hirota, Tsuyoshi/D-8158-2015; St. John, Peter/AAQ-1508-2021	Kay, Steve A/0000-0002-0402-2878; Hirota, Tsuyoshi/0000-0003-4876-3608; St. John, Peter/0000-0002-7928-3722; Brenner, David/0000-0003-2573-525X	NIH [GM074868, MH051573, GM085764, GM096873, MH082945]; Skaggs Institute for Chemical Biology; U.S. Army Research Office [W911NF-09-0001]; Department of Veterans Affairs Career Development Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096873, R01GM074868, R01GM041804, P50GM085764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082945, R01MH051573] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; U.S. Army Research Office; Department of Veterans Affairs Career Development Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Peters, X. Liu, M. Garcia, C. Cho, and R. Glynne for assistance; C. Doherty for critical reading; and K. Lamia and J. Takahashi for reagents. This work was supported in part by grants from NIH (GM074868, MH051573, and GM085764 to S. A. K.; GM096873 to F. J. D.; and MH082945 to D. K. W.), Skaggs Institute for Chemical Biology (to P. G. S), the U.S. Army Research Office (W911NF-09-0001 to F. J. D.), and a Department of Veterans Affairs Career Development Award (to D. K. W.). S. A. K. and P. G. S. serve on the Board of Reset Therapeutics and are paid consultants.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chen Z, 2012, P NATL ACAD SCI USA, V109, P101, DOI 10.1073/pnas.1118034108; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hirota T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000559; Hirota T, 2009, CHEM BIOL, V16, P921, DOI 10.1016/j.chembiol.2009.09.002; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Kelly MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032670; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lee JW, 2011, ANGEW CHEM INT EDIT, V50, P10608, DOI 10.1002/anie.201103915; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	24	297	313	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1094	1097		10.1126/science.1223710	http://dx.doi.org/10.1126/science.1223710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22798407	Green Accepted			2022-12-01	WOS:000308125800047
J	Lu, B; Nakamura, T; Inouye, K; Li, JH; Tang, YT; Lundback, P; Valdes-Ferrer, SI; Olofsson, PS; Kalb, T; Roth, J; Zou, YR; Erlandsson-Harris, H; Yang, H; Ting, JPY; Wang, HC; Andersson, U; Antoine, DJ; Chavan, SS; Hotamisligil, GS; Tracey, KJ				Lu, Ben; Nakamura, Takahisa; Inouye, Karen; Li, Jianhua; Tang, Yiting; Lundback, Peter; Valdes-Ferrer, Sergio I.; Olofsson, Peder S.; Kalb, Thomas; Roth, Jesse; Zou, Yongrui; Erlandsson-Harris, Helena; Yang, Huan; Ting, Jenny P. -Y.; Wang, Haichao; Andersson, Ulf; Antoine, Daniel J.; Chavan, Sangeeta S.; Hotamisligil, Goekhan S.; Tracey, Kevin J.			Novel role of PKR in inflammasome activation and HMGB1 release	NATURE			English	Article							PROTEIN-KINASE PKR; SUBSTRATE RECOGNITION; NLRP3 INFLAMMASOME; APOPTOSIS; ACID; ELF2-ALPHA; INFECTION; PATHWAYS; BINDING; STRESS	The inflammasome regulates the release of caspase activation-dependent cytokines, including interleukin (IL)-1 beta, IL-18 and high-mobility group box 1 (HMGB1)(1-5). By studying HMGB1 release mechanisms, here we identify a role for double-stranded RNA-dependent protein kinase (PKR, also known as EIF2AK2) in inflammasome activation. Exposure of macrophages to inflammasome agonists induced PKR autophosphorylation. PKR inactivation by genetic deletion or pharmacological inhibition severely impaired inflammasome activation in response to double-stranded RNA, ATP, monosodium urate, adjuvant aluminium, rotenone, live Escherichia coli, anthrax lethal toxin, DNA transfection and Salmonella typhimurium infection. PKR deficiency significantly inhibited the secretion of IL-1 beta, IL-18 and HMGB1 in E. coli-induced peritonitis. PKR physically interacts with several inflammasome components, including NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3), NLRP1, NLR family CARD domain-containing protein 4 (NLRC4), absent in melanoma 2 (AIM2), and broadly regulates inflammasome activation. PKR autophosphorylation in a cell-free system with recombinant NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC, also known as PYCARD) and pro-caspase-1 reconstitutes inflammasome activity. These results show a crucial role for PKR in inflammasome activation, and indicate that it should be possible to pharmacologically target this molecule to treat inflammation.	[Lu, Ben; Li, Jianhua; Valdes-Ferrer, Sergio I.; Olofsson, Peder S.; Kalb, Thomas; Roth, Jesse; Yang, Huan; Chavan, Sangeeta S.; Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA; [Lu, Ben; Valdes-Ferrer, Sergio I.; Tracey, Kevin J.] N Shore LIJ Hlth Syst, Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA; [Nakamura, Takahisa; Inouye, Karen; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Tang, Yiting; Zou, Yongrui] Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, New York, NY 11030 USA; [Lundback, Peter; Erlandsson-Harris, Helena] Karolinska Univ Hosp, Karolinska Inst, Dept Med, S-17176 Stockholm, Sweden; [Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Wang, Haichao] N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY 11030 USA; [Antoine, Daniel J.] Univ Liverpool, Dept Mol & Clin Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England	Northwell Health; Northwell Health; Harvard University; Harvard T.H. Chan School of Public Health; Northwell Health; Karolinska Institutet; Karolinska University Hospital; University of North Carolina; University of North Carolina Chapel Hill; Northwell Health; North Shore University Hospital; University of Liverpool	Tracey, KJ (corresponding author), Feinstein Inst Med Res, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.	blu@nshs.edu; kjtracey@nshs.edu	Lu, Ben/AAN-1068-2021; Wang, Haichao/K-6310-2012; Valdés-Ferrer, Sergio Iván/ABD-1057-2020; Andersson, Ulf/ABD-5162-2021; Wang, Haichao/AAU-2237-2021; Lundbäck, Peter/B-5010-2013	Lu, Ben/0000-0002-8597-0406; Wang, Haichao/0000-0002-0211-9000; Valdés-Ferrer, Sergio Iván/0000-0002-4863-6484; Andersson, Ulf/0000-0003-0316-3860; Wang, Haichao/0000-0002-0211-9000; Nakamura, Takahisa/0000-0003-4922-4569; Lundback, Peter/0000-0003-0399-0399; Tracey, Kevin J/0000-0003-1884-6314; Chavan, Sangeeta S./0000-0002-4822-3356	National Institutes of Health [RO1 GM62508, DK052539]; foundation of Elmezzi Graduate School of Molecular Medicine; International Human Frontier Science Program; American Heart Association; Medical Research Council [G0700654, G0700654B] Funding Source: researchfish; MRC [G0700654] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226, R01GM062508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); foundation of Elmezzi Graduate School of Molecular Medicine; International Human Frontier Science Program(Human Frontier Science Program); American Heart Association(American Heart Association); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. LaQueta, M. Dancho, M. McCarty, E. Lau, D. Katz and J. Scheinerman for technical assistance. This work was supported in part by grants from the National Institutes of Health (RO1 GM62508 to K. J. T. and DK052539 to G. S. H.). B. L. and S.I.V.-F. are supported by the foundation of Elmezzi Graduate School of Molecular Medicine. T.N. is supported by fellowships from the International Human Frontier Science Program and a Career Development Award from the American Heart Association.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Jiang WW, 2007, J IMMUNOL, V178, P6495, DOI 10.4049/jimmunol.178.10.6495; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Manfredi AA, 2008, J IMMUNOL, V180, P2270, DOI 10.4049/jimmunol.180.4.2270; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107	26	538	579	7	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					670	+		10.1038/nature11290	http://dx.doi.org/10.1038/nature11290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22801494	Green Accepted, Green Submitted			2022-12-01	WOS:000308095100059
J	Wheeler, TM; Leger, AJ; Pandey, SK; MacLeod, AR; Nakamori, M; Cheng, SH; Wentworth, BM; Bennett, CF; Thornton, CA				Wheeler, Thurman M.; Leger, Andrew J.; Pandey, Sanjay K.; MacLeod, A. Robert; Nakamori, Masayuki; Cheng, Seng H.; Wentworth, Bruce M.; Bennett, C. Frank; Thornton, Charles A.			Targeting nuclear RNA for in vivo correction of myotonic dystrophy	NATURE			English	Article							MODIFIED ANTISENSE OLIGONUCLEOTIDE; TRINUCLEOTIDE REPEAT; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; GENE-EXPRESSION; MESSENGER-RNA; MOUSE MODELS; CTG REPEAT; TOXIC RNA; 3' END; PROTEIN	Antisense oligonucleotides (ASOs) hold promise for gene-specific knockdown in diseases that involve RNA or protein gain-of-function effects. In the hereditary degenerative disease myotonic dystrophy type 1 (DM1), transcripts from the mutant allele contain an expanded CUG repeat(1-3) and are retained in the nucleus(4,5). The mutant RNA exerts a toxic gain-of-function effect(6), making it an appropriate target for therapeutic ASOs. However, despite improvements in ASO chemistry and design, systemic use of ASOs is limited because uptake in many tissues, including skeletal and cardiac muscle, is not sufficient to silence target messenger RNAs7,8. Here we show that nuclear-retained transcripts containing expanded CUG (CUG(exp)) repeats are unusually sensitive to antisense silencing. In a transgenic mouse model of DM1, systemic administration of ASOs caused a rapid knockdown of CUG(exp) RNA in skeletal muscle, correcting the physiological, histopathologic and transcriptomic features of the disease. The effect was sustained for up to 1 year after treatment was discontinued. Systemically administered ASOs were also effective for muscle knockdown of Malat(1), a long non-coding RNA (lncRNA) that is retained in the nucleus(9). These results provide a general strategy to correct RNA gain-of-function effects and to modulate the expression of expanded repeats, lncRNAs and other transcripts with prolonged nuclear residence.	[Wheeler, Thurman M.; Nakamori, Masayuki; Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Wheeler, Thurman M.; Nakamori, Masayuki; Thornton, Charles A.] Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Leger, Andrew J.; Cheng, Seng H.; Wentworth, Bruce M.] Genzyme Corp, Framingham, MA 01701 USA; [Pandey, Sanjay K.; MacLeod, A. Robert; Bennett, C. Frank] Isis Pharmaceut, Carlsbad, CA 92010 USA	University of Rochester; University of Rochester; Sanofi-Aventis; Genzyme Corporation; Isis Pharmaceuticals Inc	Thornton, CA (corresponding author), Univ Rochester, Dept Neurol, 601 Elmwood Ave, Rochester, NY 14642 USA.	charles_thornton@urmc.rochester.edu	Nakamori, Masayuki/ABE-2169-2020; Cheng, Seng H/AAC-6564-2022	Nakamori, Masayuki/0000-0003-4714-3044; 	US National Institutes of Health (NIH) [AR049077, U54NS48843, AR/NS48143, K08NS064293, U01NS072323]; Saunders Family Neuromuscular Research Fund; Run America; Muscular Dystrophy Association; Uehara Memorial Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048143, R01AR049077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064293, U54NS048843, U01NS072323] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saunders Family Neuromuscular Research Fund; Run America; Muscular Dystrophy Association(Muscular Dystrophy Association); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was carried out at the Wellstone Muscular Dystrophy Cooperative Research Center and Center for RNA Biology at the University of Rochester, with support from the US National Institutes of Health (NIH) (grants AR049077, U54NS48843, AR/NS48143, K08NS064293 and U01NS072323), the Saunders Family Neuromuscular Research Fund, Run America and a fellowship (to M.N.) from the Muscular Dystrophy Association and Uehara Memorial Foundation. The authors thank G. Gourdon for providing DM328XL mice, M. Sabripour for assistance with principal components analysis and L. Richardson and S. Leistman for technical assistance.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Cheruvallath ZS, 2003, NUCLEOS NUCLEOT NUCL, V22, P461, DOI 10.1081/NCN-120022050; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Geary RS, 1999, ANAL BIOCHEM, V274, P241, DOI 10.1006/abio.1999.4290; Geary RS, 2003, DRUG METAB DISPOS, V31, P1419, DOI 10.1124/dmd.31.11.1419; Gomes-Pereira M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030052; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Hasselblatt P, 2005, NUCLEIC ACIDS RES, V33, P114, DOI 10.1093/nar/gki155; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Leeds JM, 1996, ANAL BIOCHEM, V235, P36, DOI 10.1006/abio.1996.0088; Li LB, 2010, TRENDS NEUROSCI, V33, P292, DOI 10.1016/j.tins.2010.03.004; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Lorenz P, 2000, NUCLEIC ACIDS RES, V28, P582, DOI 10.1093/nar/28.2.582; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Nakamori M, 2011, MOL THER, V19, P2222, DOI 10.1038/mt.2011.191; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; PONTIUS BW, 1992, J BIOL CHEM, V267, P13815; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200	43	345	357	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					111	+		10.1038/nature11362	http://dx.doi.org/10.1038/nature11362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859208	Green Accepted			2022-12-01	WOS:000307010700043
J	Iess, L; Jacobson, RA; Ducci, M; Stevenson, DJ; Lunine, JI; Armstrong, JW; Asmar, SW; Racioppa, P; Rappaport, NJ; Tortora, P				Iess, Luciano; Jacobson, Robert A.; Ducci, Marco; Stevenson, David J.; Lunine, Jonathan I.; Armstrong, John W.; Asmar, Sami W.; Racioppa, Paolo; Rappaport, Nicole J.; Tortora, Paolo			The Tides of Titan	SCIENCE			English	Article							OCEAN; ICE	We have detected in Cassini spacecraft data the signature of the periodic tidal stresses within Titan, driven by the eccentricity (e = 0.028) of its 16-day orbit around Saturn. Precise measurements of the acceleration of Cassini during six close flybys between 2006 and 2011 have revealed that Titan responds to the variable tidal field exerted by Saturn with periodic changes of its quadrupole gravity, at about 4% of the static value. Two independent determinations of the corresponding degree-2 Love number yield k(2) = 0.589 +/- 0.150 and k(2) = 0.637 +/- 0.224 (2 sigma). Such a large response to the tidal field requires that Titan's interior be deformable over time scales of the orbital period, in a way that is consistent with a global ocean at depth.	[Iess, Luciano; Ducci, Marco; Racioppa, Paolo] Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerosp, I-00184 Rome, Italy; [Jacobson, Robert A.; Armstrong, John W.; Asmar, Sami W.; Rappaport, Nicole J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Stevenson, David J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lunine, Jonathan I.] Cornell Univ, Dept Astron, Ithaca, NY 14850 USA; [Tortora, Paolo] Univ Bologna, DIEM II Fac Ingn, I-47121 Forli, Italy	Sapienza University Rome; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; Cornell University; University of Bologna	Iess, L (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerosp, Via Eudossiana 18, I-00184 Rome, Italy.	luciano.iess@uniroma1.it	Tortora, Paolo/J-6191-2012; IESS, Luciano/F-4902-2011	Tortora, Paolo/0000-0001-9259-7673; IESS, Luciano/0000-0002-6230-5825; Lunine, Jonathan/0000-0003-2279-4131; Ducci, Marco/0000-0003-2586-1037	Italian Space Agency; NASA	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA(National Aeronautics & Space Administration (NASA))	L.I., M.D., P.R., and P.T. acknowledge support from the Italian Space Agency. The work of R.A.J., J.W.A., S.W.A., and N.J.R. was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. The Doppler data used in this analysis are archived in NASA's Planetary Data System.	Asmar SW, 2005, RADIO SCI, V40, DOI 10.1029/2004RS003101; Beghin C, 2010, CR GEOSCI, V342, P425, DOI 10.1016/j.crte.2010.03.003; Castillo-Rogez JC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044398; Darwin G.H., 1879, PHIL T R SOC, V170, P1; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Goldsby DL, 2001, J GEOPHYS RES-SOL EA, V106, P11017, DOI 10.1029/2000JB900336; Iess L, 2010, SCIENCE, V327, P1367, DOI 10.1126/science.1182583; Paganelli F, 2008, PLANET SPACE SCI, V56, P100, DOI 10.1016/j.pss.2007.03.015; Rappaport N, 1997, ICARUS, V126, P313, DOI 10.1006/icar.1996.5661; Rappaport NJ, 2008, ICARUS, V194, P711, DOI 10.1016/j.icarus.2007.11.024; Sohl F, 2010, SCIENCE, V327, P1338, DOI 10.1126/science.1186255; Tobie G, 2005, ICARUS, V175, P496, DOI 10.1016/j.icarus.2004.12.007	12	171	173	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					457	459		10.1126/science.1219631	http://dx.doi.org/10.1126/science.1219631			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22745254	Green Published			2022-12-01	WOS:000306802300040
J	Bui, M; Dimitriadis, EK; Hoischen, C; An, E; Quenet, D; Giebe, S; Nita-Lazar, A; Diekmann, S; Dalal, Y				Bui, Minh; Dimitriadis, Emilios K.; Hoischen, Christian; An, Eunkyung; Quenet, Delphine; Giebe, Sindy; Nita-Lazar, Aleksandra; Diekmann, Stephan; Dalal, Yamini			Cell-Cycle-Dependent Structural Transitions in the Human CENP-A Nucleosome In Vivo	CELL			English	Article							CENTROMERIC CHROMATIN; BUDDING YEAST; NONHISTONE SCM3; TERMINAL DOMAIN; DNA; COMPLEX; HJURP; DYNAMICS; LOCALIZATION; PROPAGATION	In eukaryotes, DNA is packaged into chromatin by canonical histone proteins. The specialized histone H3 variant CENP-A provides an epigenetic and structural basis for chromosome segregation by replacing H3 at centromeres. Unlike exclusively octameric canonical H3 nucleosomes, CENP-A nucleosomes have been shown to exist as octamers, hexamers, and tetramers. An intriguing possibility reconciling these observations is that CENP-A nucleosomes cycle between octamers and tetramers in vivo. We tested this hypothesis by tracking CENP-A nucleosomal components, structure, chromatin folding, and covalent modifications across the human cell cycle. We report that CENP-A nucleosomes alter from tetramers to octamers before replication and revert to tetramers after replication. These structural transitions are accompanied by reversible chaperone binding, chromatin fiber folding changes, and previously undescribed modifications within the histone fold domains of CENP-A and H4. Our results reveal a cyclical nature to CENP-A nucleosome structure and have implications for the maintenance of epigenetic memory after centromere replication.	[Bui, Minh; Quenet, Delphine; Dalal, Yamini] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Dimitriadis, Emilios K.] Natl Inst Biomed Imaging & Bioengn, Lab Biomed Engn & Phys Sci, NIH, Bethesda, MD 20892 USA; [An, Eunkyung; Nita-Lazar, Aleksandra] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Hoischen, Christian; Giebe, Sindy; Diekmann, Stephan] Fritz Lipmann Inst, Jena, Germany	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Dalal, Y (corresponding author), NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA.	dalaly@mail.nih.gov	Nita-Lazar, Aleksandra/N-3740-2018	Nita-Lazar, Aleksandra/0000-0002-8523-605X; Bui, Minh/0000-0002-7984-3275; Dalal, Yamini/0000-0002-7655-6182	NIH/NCI; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [ZIABC011209, ZIABC011207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001084, ZIAAI001085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000070, ZICEB000085] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Drs. Shiv Grewal, Tom Misteli, Gordon Hager, Sam John, and anonymous reviewers for insightful comments and suggestions, and P. Donlin-Asp for preliminary FRET experiments. The NIH/NCI Intramural Research Programs (Y.D., A.N.-L., and E.K.D.), and the Deutsche Forschungsgemeinschaft (S.D.) supported this work. We thank Jennifer Gerton for sharing unpublished work complementary to our findings in this manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Bintu L, 2011, NAT STRUCT MOL BIOL, V18, P1394, DOI 10.1038/nsmb.2164; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bloom K, 2010, NATURE, V463, P446, DOI 10.1038/nature08912; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Dalai Y, 2010, CURR OPIN CELL BIOL, V22, P392, DOI 10.1016/j.ceb.2010.02.005; Dalal Y, 2005, NUCLEIC ACIDS RES, V33, P934, DOI 10.1093/nar/gki224; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Dechassa ML, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1320; Dimitriadis EK, 2010, P NATL ACAD SCI USA, V107, P20317, DOI 10.1073/pnas.1009563107; Dunleavy EM, 2011, NUCLEUS-PHILA, V2, P146, DOI 10.4161/nucl.2.2.15211; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Hellwig D, 2011, J CELL SCI, V124, P3871, DOI 10.1242/jcs.088625; Hellwig D, 2008, J BIOPHOTONICS, V1, P245, DOI 10.1002/jbio.200810014; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Henikoff S, 2010, COLD SH Q B, V75, P51, DOI 10.1101/sqb.2010.75.001; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kalitsis P, 2003, CHROMOSOME RES, V11, P345, DOI 10.1023/A:1024044008009; Marshall OJ, 2008, J CELL BIOL, V183, P1193, DOI 10.1083/jcb.200804078; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Screpanti E, 2011, CURR BIOL, V21, P391, DOI 10.1016/j.cub.2010.12.039; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Shukla MS, 2010, P NATL ACAD SCI USA, V107, P1936, DOI 10.1073/pnas.0904497107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; Trazzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005832; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang HD, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-10; Xiao H, 2011, MOL CELL, V43, P369, DOI 10.1016/j.molcel.2011.07.009; Zhang WG, 2012, MOL CELL, V45, P263, DOI 10.1016/j.molcel.2011.12.010; Zlatanova J, 2006, MOL CELL, V24, P317, DOI 10.1016/j.molcel.2006.10.017	49	103	106	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 20	2012	150	2					317	326		10.1016/j.cell.2012.05.035	http://dx.doi.org/10.1016/j.cell.2012.05.035			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817894	Green Accepted, Bronze			2022-12-01	WOS:000306595700011
J	Grasso, CS; Wu, YM; Robinson, DR; Cao, XH; Dhanasekaran, SM; Khan, AP; Quist, MJ; Jing, X; Lonigro, RJ; Brenner, JC; Asangani, IA; Ateeq, B; Chun, SY; Siddiqui, J; Sam, L; Anstett, M; Mehra, R; Prensner, JR; Palanisamy, N; Ryslik, GA; Vandin, F; Raphael, BJ; Kunju, LP; Rhodes, DR; Pienta, KJ; Chinnaiyan, AM; Tomlins, SA				Grasso, Catherine S.; Wu, Yi-Mi; Robinson, Dan R.; Cao, Xuhong; Dhanasekaran, Saravana M.; Khan, Amjad P.; Quist, Michael J.; Jing, Xiaojun; Lonigro, Robert J.; Brenner, J. Chad; Asangani, Irfan A.; Ateeq, Bushra; Chun, Sang Y.; Siddiqui, Javed; Sam, Lee; Anstett, Matt; Mehra, Rohit; Prensner, John R.; Palanisamy, Nallasivam; Ryslik, Gregory A.; Vandin, Fabio; Raphael, Benjamin J.; Kunju, Lakshmi P.; Rhodes, Daniel R.; Pienta, Kenneth J.; Chinnaiyan, Arul M.; Tomlins, Scott A.			The mutational landscape of lethal castration-resistant prostate cancer	NATURE			English	Article							ANDROGEN RECEPTOR; FOXA1; NETWORK; FUSIONS; BINDING	Characterization of the prostate cancer transcriptome and genome has identified chromosomal rearrangements and copy number gains and losses, including ETS gene family fusions, PTEN loss and androgen receptor (AR) amplification, which drive prostate cancer development and progression to lethal, metastatic castration-resistant prostate cancer (CRPC)(1). However, less is known about the role of mutations(2-4). Here we sequenced the exomes of 50 lethal, heavily pre-treated metastatic CRPCs obtained at rapid autopsy (including three different foci from the same patient) and 11 treatment-naive, high-grade localized prostate cancers. We identified low overall mutation rates even in heavily treated CRPCs (2.00 per megabase) and confirmed the monoclonal origin of lethal CRPC. Integrating exome copy number analysis identified disruptions of CHD1 that define a subtype of ETS gene family fusion-negative prostate cancer. Similarly, we demonstrate that ETS2, which is deleted in approximately one-third of CRPCs (commonly through TMPRSS2:ERG fusions), is also deregulated through mutation. Furthermore, we identified recurrent mutations in multiple chromatin- and histone-modifying genes, including MLL2 (mutated in 8.6% of prostate cancers), and demonstrate interaction of the MLL complex with the AR, which is required for AR-mediated signalling. We also identified novel recurrent mutations in the AR collaborating factor FOXA1, which is mutated in 5 of 147 (3.4%) prostate cancers (both untreated localized prostate cancer and CRPC), and showed that mutated FOXA1 represses androgen signalling and increases tumour growth. Proteins that physically interact with the AR, such as the ERG gene fusion product, FOXA1, MLL2, UTX (also known as KDM6A) and ASXL1 were found to be mutated in CRPC. In summary, we describe the mutational landscape of a heavily treated metastatic cancer, identify novel mechanisms of AR signalling deregulated in prostate cancer, and prioritize candidates for future study.	[Grasso, Catherine S.; Wu, Yi-Mi; Robinson, Dan R.; Cao, Xuhong; Dhanasekaran, Saravana M.; Khan, Amjad P.; Quist, Michael J.; Jing, Xiaojun; Lonigro, Robert J.; Brenner, J. Chad; Asangani, Irfan A.; Ateeq, Bushra; Chun, Sang Y.; Siddiqui, Javed; Sam, Lee; Mehra, Rohit; Prensner, John R.; Palanisamy, Nallasivam; Kunju, Lakshmi P.; Rhodes, Daniel R.; Pienta, Kenneth J.; Chinnaiyan, Arul M.; Tomlins, Scott A.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Grasso, Catherine S.; Wu, Yi-Mi; Robinson, Dan R.; Dhanasekaran, Saravana M.; Khan, Amjad P.; Quist, Michael J.; Jing, Xiaojun; Asangani, Irfan A.; Ateeq, Bushra; Siddiqui, Javed; Mehra, Rohit; Prensner, John R.; Palanisamy, Nallasivam; Kunju, Lakshmi P.; Rhodes, Daniel R.; Chinnaiyan, Arul M.; Tomlins, Scott A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Lonigro, Robert J.; Palanisamy, Nallasivam; Pienta, Kenneth J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Anstett, Matt; Rhodes, Daniel R.] Compendia Biosci, Ann Arbor, MI 48104 USA; [Ryslik, Gregory A.] Yale Sch Publ Hlth, Div Biostat, New Haven, CT 06520 USA; [Vandin, Fabio; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Vandin, Fabio; Raphael, Benjamin J.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Brown University; Brown University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pienta, KJ (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	kpienta@med.umich.edu; arul@umich.edu	Ateeq, Bushra/I-3967-2019; Palanisamy, Nallasivam/ABC-8844-2020; Pienta, Kenneth/E-7679-2015	Ateeq, Bushra/0000-0003-4682-9773; Palanisamy, Nallasivam/0000-0002-0633-9772; Prensner, John/0000-0002-7024-636X; Pienta, Kenneth/0000-0002-4138-2186; Dhanasekaran, saravana mohan/0000-0002-0489-2224; asangani, irfan/0000-0001-5381-1702; Tomlins, Scott/0000-0001-8661-9821	National Institutes of Health S.P.O.R.E. [P50 CA69568]; Early Detection Research Network [U01 CA111275, U01 CA113913]; National Functional Genomics Center [W81XWH-09-2-0014]; Prostate Cancer Foundation; American Cancer Society; Doris Duke Foundation; Department of Defense (DOD) [W81XWH-11-1-0339, PC094290]; UM SPORE career development award;  [R01CA132874]; NATIONAL CANCER INSTITUTE [P50CA069568, R01CA132874, R01CA013287, P30CA046592, U01CA113913, U01CA111275, T32CA009676] Funding Source: NIH RePORTER	National Institutes of Health S.P.O.R.E.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; National Functional Genomics Center; Prostate Cancer Foundation; American Cancer Society(American Cancer Society); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Department of Defense (DOD)(United States Department of Defense); UM SPORE career development award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the patients and families who participated in the rapid autopsy program. The authors thank C. Kumar, J. Shendure, M. Chaisson and A. Mortazavi for assistance with next-generation sequencing data analysis, K. Giles for assistance with manuscript preparation, and S. Varambally, A. Yocum, T. Barrette and M. Iyer for technical assistance. Supported in part by the National Institutes of Health S.P.O.R.E. (P50 CA69568) to K. J. P. and A. M. C., the Early Detection Research Network (U01 CA111275 and U01 CA113913) to A. M. C., R01CA132874 and the National Functional Genomics Center (W81XWH-09-2-0014) to A. M. C. A. M. C. and K. J. P. are supported by the Prostate Cancer Foundation and are American Cancer Society Clinical Research Professors and A. Alfred Taubman Scholars. A. M. C. is supported by the Doris Duke Foundation. D. R. Robinson is supported by a Department of Defense (DOD) Postdoctoral Award (W81XWH-11-1-0339). J. R. P. is supported by a DOD Predoctoral Award (PC094290). N.P. was supported by a UM SPORE career development award. S. A. T. and J. C. B. were supported by Young Investigator Awards from the Prostate Cancer Foundation.	Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Werner MH, 1997, J BIOMOL NMR, V10, P317, DOI 10.1023/A:1018399711996; Yoshimoto M, 2006, NEOPLASIA, V8, P465, DOI 10.1593/neo.06283; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu XP, 2005, ANN NY ACAD SCI, V1061, P77, DOI 10.1196/annals.1336.009; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882	23	1721	1770	7	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					239	243		10.1038/nature11125	http://dx.doi.org/10.1038/nature11125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722839	Green Accepted			2022-12-01	WOS:000306278900041
J	Di Giuseppe, D; Alfredsson, L; Bottai, M; Askling, J; Wolk, A				Di Giuseppe, Daniela; Alfredsson, Lars; Bottai, Matteo; Askling, Johan; Wolk, Alicja			Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							TIME-SCALE; CONSUMPTION; INFLAMMATION; CELL; QUESTIONNAIRE; INHIBITION; INDUCTION; RESPONSES; SMOKING; DISEASE	Objective To analyse the association between alcohol intake and incidence of rheumatoid arthritis in women. Design Prospective cohort study with repeated measurements. Setting The Swedish Mammography Cohort, a population based cohort from central Sweden. Participants 34 141 women born between 1914 and 1948, followed up from 1 January 2003 to 31 December 2009. Main outcome measures Newly diagnosed cases of rheumatoid arthritis identified by linkage with two Swedish national registers. Data on alcohol consumption were collected in 1987 and 1997. Results During the follow-up period (226 032 person years), 197 incident cases of rheumatoid arthritis were identified. There was a statistically significant 37% decrease in risk of rheumatoid arthritis among women who drank >4 glasses of alcohol (1 glass = 15 g of ethanol) per week compared with women who drank <1 glass per week or who never drank alcohol (relative risk 0.63 (95% confidence interval 0.42 to 0.96), P=0.04). Drinking of all types of alcohol (beer, wine, and liquor) was non-significantly inversely associated with the risk of rheumatoid arthritis. Analysis of long term alcohol consumption showed that women who reported drinking >3 glasses of alcohol per week in both 1987 and 1997 had a 52% decreased risk of rheumatoid arthritis compared with those who never drank (relative risk 0.48 (0.24 to 0.98)). Conclusion Moderate consumption of alcohol is associated with reduced risk of rheumatoid arthritis.	[Di Giuseppe, Daniela; Wolk, Alicja] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-17177 Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-17177 Stockholm, Sweden; [Bottai, Matteo] Karolinska Inst, Inst Environm Med, Div Biostat, S-17177 Stockholm, Sweden; [Askling, Johan] Karolinska Hosp, Dept Med, Clin Epidemiol Unit, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Wolk, A (corresponding author), Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, Box 210, S-17177 Stockholm, Sweden.	Alicja.Wolk@ki.se	Alfredsson, Lars/AAC-9007-2019	Alfredsson, Lars/0000-0003-1688-6697; Di Giuseppe, Daniela/0000-0003-3817-8288	Swedish Research Council's Committee for Research Infrastructure; Karolinska Institute's Award for PhD students (KID)	Swedish Research Council's Committee for Research Infrastructure; Karolinska Institute's Award for PhD students (KID)	The study was supported by research grants from the Swedish Research Council's Committee for Research Infrastructure for maintenance of the Swedish Mammography Cohort, and from the Karolinska Institute's Award for PhD students (KID-funding).	AHO K, 1993, ANN RHEUM DIS, V52, P897, DOI 10.1136/ard.52.12.897-b; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Cerhan JR, 2002, J RHEUMATOL, V29, P246; Fan J, 2011, ALCOHOL CLIN EXP RES, V35, P47, DOI 10.1111/j.1530-0277.2010.01321.x; Friberg E, 2009, CANCER EPIDEM BIOMAR, V18, P355, DOI 10.1158/1055-9965.EPI-08-0993; Hansson LM, 2000, NUTR CANCER, V36, P1, DOI 10.1207/S15327914NC3601_1; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; HAZES JMW, 1990, ANN RHEUM DIS, V49, P980, DOI 10.1136/ard.49.12.980; Heliovaara M, 2000, ANN RHEUM DIS, V59, P631, DOI 10.1136/ard.59.8.631; Imhof A, 2004, EUR HEART J, V25, P2092, DOI 10.1016/j.ehj.2004.09.032; Jonsson IM, 2007, P NATL ACAD SCI USA, V104, P258, DOI 10.1073/pnas.0608620104; Kallberg H, 2009, ANN RHEUM DIS, V68, P222, DOI 10.1136/ard.2007.086314; Knight A, 2010, J RHEUMATOL, V37, P2553, DOI 10.3899/jrheum.091280; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lu B, 2010, ARTHRITIS RHEUM-US, V62, P3554, DOI 10.1002/art.27739; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Mandrekar P, 2006, ALCOHOL CLIN EXP RES, V30, P135, DOI 10.1111/j.1530-0277.2006.00012.x; Mandrekar P, 2004, J IMMUNOL, V173, P3398, DOI 10.4049/jimmunol.173.5.3398; Maxwell JR, 2010, RHEUMATOLOGY, V49, P2140, DOI 10.1093/rheumatology/keq202; Messerer M, 2004, J NUTR, V134, P1800, DOI 10.1093/jn/134.7.1800; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Verma Shilpi, 2008, V447, P295, DOI 10.1007/978-1-59745-242-7_20; VOIGT LF, 1994, EPIDEMIOLOGY, V5, P525; Waldschmidt TJ, 2006, ALCOHOL, V38, P121, DOI 10.1016/j.alcohol.2006.05.001	27	68	71	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 10	2012	345								e4230	10.1136/bmj.e4230	http://dx.doi.org/10.1136/bmj.e4230			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975NT	22782847	hybrid, Green Published			2022-12-01	WOS:000306518700001
J	Albert, DM; Blanchard, JW; Knox, BL				Albert, Daniel M.; Blanchard, June Weisberger; Knox, Barbara L.			Ensuring Appropriate Expert Testimony for Cases Involving the "Shaken Baby"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ABUSIVE HEAD TRAUMA; INFANTS		[Albert, Daniel M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA; [Knox, Barbara L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53792 USA; [Blanchard, June Weisberger] Univ Wisconsin, Sch Law, Madison, WI 53792 USA; [Knox, Barbara L.] Amer Family Childrens Hosp, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Albert, DM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, 600 Highland Ave,F4-334 CSC, Madison, WI 53792 USA.	dalbert@ophth.wisc.edu			NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER; NEI NIH HHS [P30-EY016665, P30 EY016665] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chadwick D, 1997, CHILD MALTREATMENT, V2, P313, DOI DOI 10.1177/1077559597002004004; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Findley KA, 2012, HOUSTON J HLTH POLIC; Fountain TR, 2008, ALBERT JAKOBIECS PRI, V4, P5425; Gallegos A., 2011, AM MED NEWS; Hewes HA, 2011, ARCH PEDIAT ADOL MED, V165, P918, DOI 10.1001/archpediatrics.2011.151; Parks S, 2012, INJURY PREVENTION; Parks S. E., 2012, PEDIAT ABUSIVE HEAD; Ricci L, 2003, CHILD ABUSE NEGLECT, V27, P271, DOI 10.1016/S0145-2134(03)00006-1; Rorke-Adams L, 2011, J PRIM HEALTH CARE, V3, P161, DOI 10.1071/HC11161	10	13	14	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2012	308	1					39	40		10.1001/jama.2012.6763	http://dx.doi.org/10.1001/jama.2012.6763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971DD	22760288	Green Accepted			2022-12-01	WOS:000306183000020
J	Spence, D				Spence, Des			Bad medicine: chest examination	BRITISH MEDICAL JOURNAL			English	Editorial Material							PLEURAL EFFUSION; RELIABILITY; DIAGNOSIS; SIGNS					destwo@yahoo.co.uk						Benbassat J, 2010, J GEN INTERN MED, V25, P865, DOI 10.1007/s11606-010-1327-8; Kalantri S, 2007, RESP MED, V101, P431, DOI 10.1016/j.rmed.2006.07.014; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; Movahed MR, 2007, ECHOCARDIOGR-J CARD, V24, P447, DOI 10.1111/j.1540-8175.2007.00425.x; Rolston D, 2008, CLEV CLIN J MED, V75, P297; Wong CL, 2009, JAMA-J AM MED ASSOC, V301, P309, DOI 10.1001/jama.2008.937	6	7	7	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 4	2012	344								e4569	10.1136/bmj.e4569	http://dx.doi.org/10.1136/bmj.e4569			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972KE	22763573				2022-12-01	WOS:000306275200010
J	Brogaard, K; Xi, LQ; Wang, JP; Widom, J				Brogaard, Kristin; Xi, Liqun; Wang, Ji-Ping; Widom, Jonathan			A map of nucleosome positions in yeast at base-pair resolution	NATURE			English	Article							CENTROMERIC NUCLEOSOME; DNA INTERACTIONS; CHROMATIN; TRANSCRIPTION; ORGANIZATION; SEQUENCE; HISTONE; FACILITATE; MECHANISM; CLEAVAGE	The exact positions of nucleosomes along genomic DNA can influence many aspects of chromosome function. However, existing methods for mapping nucleosomes do not provide the necessary single-base-pair accuracy to determine these positions. Here we develop and apply a new approach for direct mapping of nucleosome centres on the basis of chemical modification of engineered histones. The resulting map locates nucleosome positions genome-wide in unprecedented detail and accuracy. It shows new aspects of the in vivo nucleosome organization that are linked to transcription factor binding, RNA polymerase pausing and the higher-order structure of the chromatin fibre.	[Xi, Liqun; Wang, Ji-Ping] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Brogaard, Kristin; Widom, Jonathan] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Widom, Jonathan] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Wang, JP (corresponding author), Northwestern Univ, Dept Stat, Evanston, IL 60208 USA.	jzwang@northwestern.edu	Xi, Liqun/I-7689-2014		National Institutes of Health [T32GM00806, R01GM058617, R01GM075313, U54CA143869]; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058617, R01GM075313, T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this paper to J.W., who guided this project. We thank R. Holmgren, A. Matouschek, B. Meyer, R. Phillips, E. Segal and O. Uhlenbeck for comments and discussions. We are grateful to Northwestern University's Genomic Core for all sequencing completed for this project. The work was supported by National Institutes of Health grants T32GM00806 (to K. B.), R01GM058617 (to J.W.), R01GM075313 (to J.-P.W.) and U54CA143869 (to J.W.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; BECKMANN JS, 1991, P NATL ACAD SCI USA, V88, P2380, DOI 10.1073/pnas.88.6.2380; Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; COCKELL M, 1983, J MOL BIOL, V170, P423, DOI 10.1016/S0022-2836(83)80156-9; Cole HA, 2011, P NATL ACAD SCI USA, V108, P12687, DOI 10.1073/pnas.1104978108; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Flaus A, 1999, METHOD ENZYMOL, V304, P251; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Koslover EF, 2010, BIOPHYS J, V99, P3941, DOI 10.1016/j.bpj.2010.10.024; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; LOHR D, 1979, P NATL ACAD SCI USA, V76, P6326, DOI 10.1073/pnas.76.12.6326; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017521; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Owen-Hughes Thomas, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P403; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Teif VB, 2009, NUCLEIC ACIDS RES, V37, P5641, DOI 10.1093/nar/gkp610; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175; Wang JPZ, 2005, NUCLEIC ACIDS RES, V33, P6743, DOI 10.1093/nar/gki977; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	49	301	305	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					496	501		10.1038/nature11142	http://dx.doi.org/10.1038/nature11142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722846	Green Accepted			2022-12-01	WOS:000305760600035
J	Diaz, LA; Williams, RT; Wu, J; Kinde, I; Hecht, JR; Berlin, J; Allen, B; Bozic, I; Reiter, JG; Nowak, MA; Kinzler, KW; Oliner, KS; Vogelstein, B				Diaz, Luis A., Jr.; Williams, Richard T.; Wu, Jian; Kinde, Isaac; Hecht, J. Randolph; Berlin, Jordan; Allen, Benjamin; Bozic, Ivana; Reiter, Johannes G.; Nowak, Martin A.; Kinzler, Kenneth W.; Oliner, Kelly S.; Vogelstein, Bert			The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers	NATURE			English	Article							MET AMPLIFICATION; LUNG-CANCER; MUTATIONS; DNA; CETUXIMAB; CELLS; KRAS	Colorectal tumours that are wild type for KRAS are often sensitive to EGFR blockade, but almost always develop resistance within several months of initiating therapy(1,2). The mechanisms underlying this acquired resistance to anti-EGFR antibodies are largely unknown. This situation is in marked contrast to that of small-molecule targeted agents, such as inhibitors of ABL, EGFR, BRAF and MEK, in which mutations in the genes encoding the protein targets render the tumours resistant to the effects of the drugs(3-6). The simplest hypothesis to account for the development of resistance to EGFR blockade is that rare cells with KRAS mutations preexist at low levels in tumours with ostensibly wild-type KRAS genes. Although this hypothesis would seem readily testable, there is no evidence in pre-clinical models to support it, nor is there data from patients. To test this hypothesis, we determined whether mutant KRAS DNA could be detected in the circulation of 28 patients receiving monotherapy with panitumumab, a therapeutic anti-EGFR antibody. We found that 9 out of 24 (38%) patients whose tumours were initially KRAS wild type developed detectable mutations in KRAS in their sera, three of which developed multiple different KRAS mutations. The appearance of these mutations was very consistent, generally occurring between 5 and 6 months following treatment. Mathematical modelling indicated that the mutations were present in expanded subclones before the initiation of panitumumab treatment. These results suggest that the emergence of KRAS mutations is a mediator of acquired resistance to EGFR blockade and that these mutations can be detected in a non-invasive manner. They explain why solid tumours develop resistance to targeted therapies in a highly reproducible fashion.	[Diaz, Luis A., Jr.; Wu, Jian; Kinde, Isaac; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21287 USA; [Diaz, Luis A., Jr.; Wu, Jian; Kinde, Isaac; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21287 USA; [Diaz, Luis A., Jr.] Swim Amer Lab Johns Hopkins, Baltimore, MD 21287 USA; [Williams, Richard T.; Oliner, Kelly S.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Wu, Jian] Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Wu, Jian] Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China; [Hecht, J. Randolph] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Berlin, Jordan] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Allen, Benjamin; Bozic, Ivana; Reiter, Johannes G.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Reiter, Johannes G.] IST Austria, A-3400 Klosterneuburg, Austria	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Amgen; Air Force Military Medical University; Air Force Military Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vanderbilt University; Harvard University; Institute of Science & Technology - Austria	Diaz, LA (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21287 USA.	ldiaz1@jhmi.edu; koliner@amgen.com	Zheng, Wei/O-3351-2013; Reiter, Johannes G./Y-4083-2019; Allen, Benjamin I/F-1829-2011; Nowak, Martin A/A-6977-2008; Bozic, Ivana/C-5003-2008; ravegnini, gloria/K-1330-2016	Zheng, Wei/0000-0003-1226-070X; Reiter, Johannes G./0000-0002-0170-7353; Allen, Benjamin I/0000-0002-9746-7613; Bozic, Ivana/0000-0003-2761-825X; ravegnini, gloria/0000-0002-7774-402X; Diaz, Luis/0000-0002-7079-8914	Virginia and D. K. Ludwig Fund for Cancer Research; National Colorectal Cancer Research Alliance; NIH [CA129825, CA43460, CA57345, CA62924, CA095103, R01 GM078986]; NCI [N01-CN-43309]; ERC [279307]; FWF NFN [S11407-N23]; John Templeton Foundation; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA057345, R01CA129825, R37CA057345, P50CA062924, R37CA043460, R01CA043460, R01CA043309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008, R01GM078986] Funding Source: NIH RePORTER	Virginia and D. K. Ludwig Fund for Cancer Research; National Colorectal Cancer Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ERC(European Research Council (ERC)European Commission); FWF NFN(Austrian Science Fund (FWF)); John Templeton Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Schaeffer, J. Ptak, N. Silliman and L. Dobbyn for technical assistance and M. Ekdahl for operational assistance. This work was supported by The Virginia and D. K. Ludwig Fund for Cancer Research, the National Colorectal Cancer Research Alliance, NIH grants CA129825, CA43460, CA57345, CA62924, CA095103, and R01 GM078986, NCI contract N01-CN-43309, ERC Start grant (279307: Graph Games), FWF NFN Grant No S11407-N23 (Rise), and the John Templeton Foundation. Simulations were performed on the Orchestra cluster supported by the Harvard Medical School Research Information Technology Group.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Dewanji A, 2005, MATH BIOSCI, V197, P140, DOI 10.1016/j.mbs.2005.07.003; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Hecht JR, 2010, CLIN CANCER RES, V16, P2205, DOI 10.1158/1078-0432.CCR-09-2017; Holdhoff M, 2009, JNCI-J NATL CANCER I, V101, P1284, DOI 10.1093/jnci/djp240; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Leder K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027682; Lenaerts T, 2010, HAEMATOL-HEMATOL J, V95, P900, DOI 10.3324/haematol.2009.015271; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Luria SE, 1943, GENETICS, V28, P491; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442	28	1234	1278	3	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					537	540		10.1038/nature11219	http://dx.doi.org/10.1038/nature11219			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722843	Green Accepted			2022-12-01	WOS:000305760600044
J	Han, S; Tai, C; Westenbroek, RE; Yu, FH; Cheah, CS; Potter, GB; Rubenstein, JL; Scheuer, T; de la Iglesia, HO; Catterall, WA				Han, Sung; Tai, Chao; Westenbroek, Ruth E.; Yu, Frank H.; Cheah, Christine S.; Potter, Gregory B.; Rubenstein, John L.; Scheuer, Todd; de la Iglesia, Horacio O.; Catterall, William A.			Autistic-like behaviour in Scn1a(+/-) mice and rescue by enhanced GABA-mediated neurotransmission	NATURE			English	Article							SEVERE MYOCLONIC EPILEPSY; DE-NOVO MUTATIONS; REDUCED SODIUM CURRENT; FRAGILE-X-SYNDROME; DRAVET-SYNDROME; MOUSE MODEL; SPECTRUM DISORDERS; NA(V)1.1 CHANNELS; RETT-SYNDROME; INFANCY	Haploinsufficiency of the SCN1A gene encoding voltage-gated sodium channel Na(V)1.1 causes Dravet's syndrome, a childhood neuropsychiatric disorder including recurrent intractable seizures, cognitive deficit and autism-spectrum behaviours. The neural mechanisms responsible for cognitive deficit and autism-spectrum behaviours in Dravet's syndrome are poorly understood. Here we report that mice with Scn1a haploinsufficiency exhibit hyperactivity, stereotyped behaviours, social interaction deficits and impaired context-dependent spatial memory. Olfactory sensitivity is retained, but novel food odours and social odours are aversive to Scn1a(+/-) mice. GABAergic neurotransmission is specifically impaired by this mutation, and selective deletion of Na(V)1.1 channels in forebrain interneurons is sufficient to cause these behavioural and cognitive impairments. Remarkably, treatment with low-dose clonazepam, a positive allosteric modulator of GABA(A) receptors, completely rescued the abnormal social behaviours and deficits in fear memory in the mouse model of Dravet's syndrome, demonstrating that they are caused by impaired GABAergic neurotransmission and not by neuronal damage from recurrent seizures. These results demonstrate a critical role for Na(V)1.1 channels in neuropsychiatric functions and provide a potential therapeutic strategy for cognitive deficit and autism-spectrum behaviours in Dravet's syndrome.	[Han, Sung; de la Iglesia, Horacio O.; Catterall, William A.] Univ Washington, Graduate Program Neurobiol & Behav, Seattle, WA 98195 USA; [Han, Sung; Tai, Chao; Westenbroek, Ruth E.; Yu, Frank H.; Cheah, Christine S.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Han, Sung; de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Potter, Gregory B.; Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Catterall, WA (corresponding author), Univ Washington, Graduate Program Neurobiol & Behav, Seattle, WA 98195 USA.	horaciod@uw.edu; wcatt@uw.edu		Potter, Gregory/0000-0002-0585-6575; Yu, Frank/0000-0001-9306-1731	National Institutes of Health [R01 NS25704, R01 MH075016, R37 MH049428]; McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075016, R37MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Research Grants R01 NS25704 (W. A. C.), R01 MH075016 (H.O.d.) and R37 MH049428 (J.L.R.) from the National Institutes of Health and by a grant from the McKnight Foundation (W. A. C.). The authors thank E. Strakbein in the Machine Division at the University of Washington for making all the mazes for the behavioural experiments in this study.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; BESAG FMC, 2004, EPILEPSY BEHAV, V5, P3; Brunklaus A, 2011, EPILEPSIA, V52, P1476, DOI 10.1111/j.1528-1167.2011.03129.x; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cheah C. S., P NATL ACAD IN PRESS; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Genton P, 2011, EPILEPSIA, V52, P44, DOI 10.1111/j.1528-1167.2011.03001.x; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Gomot M, 2006, NEUROIMAGE, V29, P475, DOI 10.1016/j.neuroimage.2005.07.027; Han S, 2012, P NATL ACAD SCI USA, V109, pE368, DOI 10.1073/pnas.1115729109; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Kalume F, 2007, J NEUROSCI, V27, P11065, DOI 10.1523/JNEUROSCI.2162-07.2007; Li BM, 2011, EPILEPSY BEHAV, V21, P291, DOI 10.1016/j.yebeh.2011.04.060; Long J.E., 2009, CEREB CORTEX, V19, pi96, DOI [DOI 10.1093/CERCOR/BHP045, DOI 10.1093/CERCOR/BHP045BHP045, 10.1093/cercor/bhp045]; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Mahoney K, 2009, SEIZURE-EUR J EPILEP, V18, P492, DOI 10.1016/j.seizure.2009.04.009; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Paluszkiewicz SM, 2011, DEV NEUROSCI-BASEL, V33, P349, DOI 10.1159/000329420; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Pescucci C, 2007, EUR J MED GENET, V50, P21, DOI 10.1016/j.ejmg.2006.09.001; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P3, DOI 10.1016/j.physbeh.2004.07.018; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wolff M, 2006, EPILEPSIA, V47, P45, DOI 10.1111/j.1528-1167.2006.00688.x; YAKOUB M, 1992, BRAIN DEV-JPN, V14, P299, DOI 10.1016/S0387-7604(12)80147-1; Yang M, 2012, PHYSL BEHAV; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	44	406	425	3	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					385	390		10.1038/nature11356	http://dx.doi.org/10.1038/nature11356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22914087	Green Submitted, Green Accepted			2022-12-01	WOS:000308860900036
J	Onwuteaka-Philipsen, BD; Brinkman-Stoppelenburg, A; Penning, C; de Jong-Krul, GJF; van Delden, JJM; van der Heide, A				Onwuteaka-Philipsen, Bregje D.; Brinkman-Stoppelenburg, Arianne; Penning, Corine; de Jong-Krul, Gwen J. F.; van Delden, Johannes J. M.; van der Heide, Agnes			Trends in end-of-life practices before and after the enactment of the euthanasia law in the Netherlands from 1990 to 2010: a repeated cross-sectional survey	LANCET			English	Article							6 EUROPEAN COUNTRIES; PALLIATIVE CARE; ASSISTED SUICIDE; HASTENED DEATH; DECISIONS; SEDATIVES; OPIOIDS; CANCER; SURVIVAL; BELGIUM	Background In 2002, the euthanasia act came into effect in the Netherlands, which was followed by a slight decrease in the euthanasia frequency. We assessed frequency and characteristics of euthanasia, physician-assisted suicide, and other end-of-life practices in 2010, and assessed trends since 1990. Methods In 1990, 1995, 2001, 2005, and 2010 we did nationwide studies of a stratified sample from the death registry of Statistics Netherlands, to which all deaths and causes were reported. We mailed questionnaires to physicians attending these deaths (2010: n=8496 deaths). All cases were weighted to adjust for the stratification procedure and for differences in response rates in relation to the age, sex, marital status, region of residence, and cause and place of death. Findings In 2010, of all deaths in the Netherlands, 2.8% (95% CI 2.5-3.2; 475 of 6861) were the result of euthanasia. This rate is higher than the 1.7% (1.5-1.8; 294 of 9965) in 2005, but comparable with those in 2001 and 1995. Distribution of sex, age, and diagnosis was stable between 1990 and 2010. In 2010, 77% (3136 of 4050) of all cases of euthanasia or physician-assisted suicide were reported to a review committee (80% [1933 of 2425] in 2005). Ending of life without an explicit patient request in 2010 occurred less often (0.2%; 95% CI 0.1-0.3; 13 of 6861) than in 2005, 2001, 1995, and 1990 (0.8%; 0.6-1.1; 45 of 5197). Continuous deep sedation until death occurred more frequently in 2010 (12.3% [11.6-13.1; 789 of 6861]) than in 2005 (8.2% [7.8-8.6; 521 of 9965]). Of all deaths in 2010, 0.4% (0.3-0.6; 18 of 6861) were the result of the patient's decision to stop eating and drinking to end life; in half of these cases the patient had made a euthanasia request that was not granted. Interpretation Our study provides insight in consequences of regulating euthanasia and physician-assisted suicide within the broader context of end-of-life practices. In the Netherlands the euthanasia law resulted in a relatively transparent practice. Although translating these results to other countries is not straightforward, they can inform the debate on legalisation of assisted dying in other countries.	[Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, NL-1081 BT Amsterdam, Netherlands; [Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, Med Ctr, VUmc Expertise Ctr Palliat Care, EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands; [Brinkman-Stoppelenburg, Arianne; van der Heide, Agnes] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Penning, Corine; de Jong-Krul, Gwen J. F.] Stat Netherlands, The Hague, Netherlands; [van Delden, Johannes J. M.] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Onwuteaka-Philipsen, BD (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	b.philipsen@vumc.nl		Stoppelenburg, Arianne/0000-0001-6377-1599	Netherlands Organization for Research and Development (ZonMw)	Netherlands Organization for Research and Development (ZonMw)	The Netherlands Organization for Research and Development (ZonMw).	Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Bosshard G, 2008, J MED ETHICS, V34, P28, DOI 10.1136/jme.2006.018911; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Chabot BE, 2009, SOC SCI MED, V68, P1745, DOI 10.1016/j.socscimed.2009.03.005; Delbeke E, 2011, EUR J HEALTH LAW, V18, P149, DOI 10.1163/157180911X565191; Deliens L, 2003, LANCET, V362, P1239, DOI 10.1016/S0140-6736(03)14520-5; den Hartogh G, 2003, MED CONTACT, V58, P1063; Dyer C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6779; Ferrand E, 2011, LANCET, V377, P467, DOI 10.1016/S0140-6736(11)60160-8; Finlay I, 2006, PALLIATIVE MED, V20, P115, DOI 10.1191/0269216306pm1119xx; Fleming JI, 1992, BIOETHICS RES NOTES, V4, P1; Good PD, 2005, INTERN MED J, V35, P512, DOI 10.1111/j.1445-5994.2005.00888.x; Gordijn B, 2004, HEALTH CARE ANAL, V12, P195, DOI 10.1023/B:HCAN.0000044926.05523.ef; Levene IR, 2010, CAN MED ASSOC J, V182, P1330, DOI 10.1503/cmaj.110-2092; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Pereira J, 2011, CURR ONCOL, V18, pE38; Regional Review Committees Euthanasia, 2011, ANN REP 2010; Rodin G, 2007, J PAIN SYMPTOM MANAG, V33, P661, DOI 10.1016/j.jpainsymman.2006.09.034; Seale C, 2009, PALLIATIVE MED, V23, P198, DOI 10.1177/0269216308102042; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; TENHAVE HAMJ, 1992, HASTINGS CENT REP, V22, P34, DOI 10.2307/3562563; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; van der Steen JT, 2009, J PALLIAT MED, V12, P789, DOI 10.1089/jpm.2009.0049; vanderWal G, 1996, NEW ENGL J MED, V335, P1706	28	190	193	1	76	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 8	2012	380	9845					908	915		10.1016/S0140-6736(12)61034-4	http://dx.doi.org/10.1016/S0140-6736(12)61034-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	002QL	22789501				2022-12-01	WOS:000308547300033
J	Zalatan, JG; Coyle, SM; Rajan, S; Sidhu, SS; Lim, WA				Zalatan, Jesse G.; Coyle, Scott M.; Rajan, Saravanan; Sidhu, Sachdev S.; Lim, Wendell A.			Conformational Control of the Ste5 Scaffold Protein Insulates Against MAP Kinase Misactivation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNALING SPECIFICITY; CASCADE ACTIVATION; YEAST; PATHWAYS; MODULES; DOMAIN; TRANSDUCTION; ORGANIZATION; COMPONENTS	Cells reuse signaling proteins in multiple pathways, raising the potential for improper cross talk. Scaffold proteins are thought to insulate against such miscommunication by sequestering proteins into distinct physical complexes. We show that the scaffold protein Ste5, which organizes the yeast mating mitogen-activated protein kinase (MAPK) pathway, does not use sequestration to prevent misactivation of the mating response. Instead, Ste5 appears to use a conformation mechanism: Under basal conditions, an intramolecular interaction of the pleckstrin homology (PH) domain with the von Willebrand type A (VWA) domain blocks the ability to coactivate the mating-specific MAPK Fus3. Pheromone-induced membrane binding of Ste5 triggers release of this autoinhibition. Thus, in addition to serving as a conduit guiding kinase communication, Ste5 directly receives input information to decide if and when signal can be transmitted to mating output.	[Zalatan, Jesse G.; Coyle, Scott M.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Coyle, Scott M.] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Rajan, Saravanan; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Rajan, Saravanan; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Toronto; University of Toronto	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu		Zalatan, Jesse/0000-0002-1458-0654	Damon Runyon Cancer Research Foundation [DRG 2012-09]; National Science Foundation; Canadian Institutes for Health Research [MOPS-93725]; NIH [RO1 GM55040, RO1 GM62583, PN2 EY016546, P50 GM081879]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, R01GM062583, P50GM081879] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.G.Z. is supported by the Damon Runyon Cancer Research Foundation (DRG 2012-09). S. M. C. is supported by a National Science Foundation Graduate Research Fellowship. S. S. S. and S. R. are supported by a grant from the Canadian Institutes for Health Research (MOPS-93725). This work was also supported by NIH grants RO1 GM55040, RO1 GM62583, PN2 EY016546, and P50 GM081879 (W. A. L.) and by the Howard Hughes Medical Institute (W. A. L.). We thank G. Narlikar, H. Madhani, and M. Good for helpful discussions and comments; N. Helman and S. Vidal for plasmids; H. Madhani for providing yeast strains; and C. Waddling for assistance with x-ray data collection. Coordinates have been submitted to the Protein Data Bank (4F2H).	Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CAIRNS BR, 1992, GENE DEV, V6, P1305, DOI 10.1101/gad.6.7.1305; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Jansen G, 2001, MOL GENET GENOMICS, V265, P102, DOI 10.1007/s004380000394; Lamson RE, 2006, CURR BIOL, V16, P618, DOI 10.1016/j.cub.2006.02.060; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7	28	59	61	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1218	1222		10.1126/science.1220683	http://dx.doi.org/10.1126/science.1220683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22878499	Green Accepted			2022-12-01	WOS:000308414000036
J	Chan, KL; Roig, MB; Hu, B; Beckouet, F; Metson, J; Nasmyth, K				Chan, Kok-Lung; Roig, Maurici B.; Hu, Bin; Beckouet, Frederic; Metson, Jean; Nasmyth, Kim			Cohesin's DNA Exit Gate Is Distinct from Its Entrance Gate and Is Regulated by Acetylation	CELL			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; CHROMOSOME ARMS; ATP HYDROLYSIS; REPLICATION; YEAST; PROTEINS; COMPLEX; BINDING; ESTABLISHMENT	Sister chromatid cohesion is mediated by entrapment of sister DNAs by a tripartite ring composed of cohesin's Smc1, Smc3, and alpha-kleisin subunits. Cohesion requires acetylation of Smc3 by Eco1, whose role is to counteract an inhibitory (antiestablishment) activity associated with cohesin's Wapl subunit. We show that mutations abrogating antiestablishment activity also reduce turnover of cohesin on pericentric chromatin. Our results reveal a "releasing" activity inherent to cohesin complexes transiently associated with Wapl that catalyzes their dissociation from chromosomes. Fusion of Smc3's nucleotide binding domain to alpha-kleisin's N-terminal domain also reduces cohesin turnover within pericentric chromatin and permits establishment of Wapl-resistant cohesion in the absence of Eco1. We suggest that releasing activity opens the Smc3/alpha-kleisin interface, creating a DNA exit gate distinct from its proposed entry gate at the Smc1/3 interface. According to this notion, the function of Smc3 acetylation is to block its dissociation from alpha-kleisin. The functional implications of regulated ring opening are discussed.	[Chan, Kok-Lung; Roig, Maurici B.; Hu, Bin; Beckouet, Frederic; Metson, Jean; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Hu, Bin/GWZ-8912-2022; Beckouet, Frederic/P-5389-2016	Hu, Bin/0000-0001-6316-2830; Beckouet, Frederic/0000-0002-9009-1852; chan, kok-lung/0000-0002-8796-8385; Nasmyth, Kim/0000-0001-7030-4403	Cancer Research UK; Wellcome Trust; Croucher Foundation Fellowship; Cancer Research UK [12386] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Croucher Foundation Fellowship; Cancer Research UK(Cancer Research UK)	This study is supported by Cancer Research UK and Wellcome Trust. We thank all members of the Nasmyth group for invaluable discussion; Raquel Oliveira for critical comments on the manuscript; MICRON unit for microscopy support. We specially thank Mike Tyers for a gift of sic1(9 m) plasmid, Haruo Takahashi for the plasmids of the improved galactose-inducible system, and Tongli Zhang for advice and discussion of photobleaching data. K.-L.C. was supported by the Croucher Foundation Fellowship.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hartman T, 2000, J CELL BIOL, V151, P613, DOI 10.1083/jcb.151.3.613; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kucej M, 2010, NUCLEUS-PHILA, V1, P4, DOI 10.4161/nucl.1.1.10010; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Lafont AL, 2010, P NATL ACAD SCI USA, V107, P20364, DOI 10.1073/pnas.1011069107; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Matsuyama T, 2011, J BIOSCI BIOENG, V111, P175, DOI 10.1016/j.jbiosc.2010.09.014; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mishra A, 2010, CURR BIOL, V20, P279, DOI 10.1016/j.cub.2009.12.059; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nasmyth K, 2004, PHILOS T R SOC B, V359, P99, DOI 10.1098/rstb.2003.1417; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pehlivan D, 2012, GENET MED, V14, P313, DOI 10.1038/gim.2011.13; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	49	160	161	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					961	974		10.1016/j.cell.2012.07.028	http://dx.doi.org/10.1016/j.cell.2012.07.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22901742	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000308500200011
J	Cho, I; Yamanishi, S; Cox, L; Methe, BA; Zavadil, J; Li, K; Gao, Z; Mahana, D; Raju, K; Teitler, I; Li, HL; Alekseyenko, AV; Blaser, MJ				Cho, Ilseung; Yamanishi, Shingo; Cox, Laura; Methe, Barbara A.; Zavadil, Jiri; Li, Kelvin; Gao, Zhan; Mahana, Douglas; Raju, Kartik; Teitler, Isabel; Li, Huilin; Alekseyenko, Alexander V.; Blaser, Martin J.			Antibiotics in early life alter the murine colonic microbiome and adiposity	NATURE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; CHAIN FATTY-ACIDS; RECEPTOR KNOCKOUT MICE; DIET-INDUCED OBESITY; GUT MICROBIOME; INTESTINAL MICROBIOTA; COMMUNITIES; DIVERSITY; SEQUENCES; DISEASE	Antibiotics administered in low doses have been widely used as growth promoters in the agricultural industry since the 1950s, yet the mechanisms for this effect are unclear. Because antimicrobial agents of different classes and varying activity are effective across several vertebrate species, we proposed that such subtherapeutic administration alters the population structure of the gut microbiome as well as its metabolic capabilities. We generated a model of adiposity by giving subtherapeutic antibiotic therapy to young mice and evaluated changes in the composition and capabilities of the gut microbiome. Administration of subtherapeutic antibiotic therapy increased adiposity in young mice and increased hormone levels related to metabolism. We observed substantial taxonomic changes in the microbiome, changes in copies of key genes involved in the metabolism of carbohydrates to short-chain fatty acids, increases in colonic short-chain fatty acid levels, and alterations in the regulation of hepatic metabolism of lipids and cholesterol. In this model, we demonstrate the alteration of early-life murine metabolic homeostasis through antibiotic manipulation.	[Cho, Ilseung; Yamanishi, Shingo; Alekseyenko, Alexander V.; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Cho, Ilseung; Blaser, Martin J.] VA New York Harbor Healthcare Syst, Med Serv, New York, NY 10010 USA; [Cox, Laura; Gao, Zhan; Mahana, Douglas; Raju, Kartik; Teitler, Isabel; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Methe, Barbara A.; Li, Kelvin] J Craig Venter Inst, Rockville, MD 20850 USA; [Zavadil, Jiri] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri; Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Li, Huilin] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA	New York University; New York University; J. Craig Venter Institute; New York University; New York University; New York University	Blaser, MJ (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	martin.blaser@med.nyu.edu	Cox, Laura/ABG-5883-2020; Zavadil, Jiri/ABG-1780-2020; Blaser, Martin/ABF-6878-2021	Cox, Laura/0000-0002-9564-9894; Zavadil, Jiri/0000-0003-0640-5562; Li, Huilin/0000-0002-8288-7068; Alekseyenko, Alexander/0000-0002-5748-2085; Cho, Ilseung/0000-0002-7308-8707	NIH [T-RO1-DK090989, 1UL1-RR029893, UL1-TR000038]; Diane Belfer Program in Human Microbial Ecology; Philip and Janice Levin Foundation; Michael Saperstein Fellowship; J. Craig Venter Institute; NYU Genome Technology Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diane Belfer Program in Human Microbial Ecology; Philip and Janice Levin Foundation; Michael Saperstein Fellowship; J. Craig Venter Institute; NYU Genome Technology Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part with grants from the NIH (T-RO1-DK090989, 1UL1-RR029893, UL1-TR000038), the Diane Belfer Program in Human Microbial Ecology, the Philip and Janice Levin Foundation, the Michael Saperstein Fellowship, and institutional funds provided by the J. Craig Venter Institute, and the NYU Genome Technology Center. We thank N. Javitt for advice and J. Chung for technical assistance.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; BUFFA R, 1975, HISTOCHEMISTRY, V43, P249, DOI 10.1007/BF00499706; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Henderson G, 2010, APPL ENVIRON MICROB, V76, P2058, DOI 10.1128/AEM.02580-09; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JUKES TH, 1970, NEW ENGL J MED, V282, P49; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li Kelvin, 2010, BMC Res Notes, V3, P199, DOI 10.1186/1756-0500-3-199; Lovell CR, 2005, METHOD ENZYMOL, V397, P454, DOI 10.1016/S0076-6879(05)97028-6; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; OZAWA E, 1955, J ANTIBIOT, V8, P205; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pavoine S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-156; Pickett S.T., 2013, ECOLOGY NATURAL DIST; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Robinson CJ, 2010, GUT MICROBES, V1, P279, DOI 10.4161/gmic.1.4.12614; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsukiyama K, 2004, EUR J ENDOCRINOL, V151, P407, DOI 10.1530/eje.0.1510407; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yamada Y, 2004, HORM METAB RES, V36, P771, DOI 10.1055/s-2004-826162; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhou HY, 2005, BIOCHEM BIOPH RES CO, V335, P937, DOI 10.1016/j.bbrc.2005.07.164	62	1040	1104	13	422	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					621	+		10.1038/nature11400	http://dx.doi.org/10.1038/nature11400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22914093	Green Accepted			2022-12-01	WOS:000308095100049
J	Odoardi, F; Sie, C; Streyl, K; Ulaganathan, VK; Schlager, C; Lodygin, D; Heckelsmiller, K; Nietfeld, W; Ellwart, J; Klinkert, WEF; Lottaz, C; Nosov, M; Brinkmann, V; Spang, R; Lehrach, H; Vingron, M; Wekerle, H; Flugel-Koch, C; Flugel, A				Odoardi, Francesca; Sie, Christopher; Streyl, Kristina; Ulaganathan, Vijay K.; Schlaeger, Christian; Lodygin, Dmitri; Heckelsmiller, Klaus; Nietfeld, Wilfried; Ellwart, Joachim; Klinkert, Wolfgang E. F.; Lottaz, Claudio; Nosov, Mikhail; Brinkmann, Volker; Spang, Rainer; Lehrach, Hans; Vingron, Martin; Wekerle, Hartmut; Fluegel-Koch, Cassandra; Fluegel, Alexander			T cells become licensed in the lung to enter the central nervous system	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ADHESION MOLECULE; MICROARRAY DATA; MYELOID CELLS; LYMPHOCYTES; MIGRATION; ANTIGEN; CNS; INFECTIONS	The blood-brain barrier (BBB) and the environment of the central nervous system (CNS) guard the nervous tissue from peripheral immune cells. In the autoimmune disease multiple sclerosis, myelin-reactive T-cell blasts are thought to transgress the BBB1,2 and create a pro-inflammatory environment in the CNS, thereby making possible a second autoimmune attack that starts from the leptomeningeal vessels and progresses into the parenchyma(3-6). Using a Lewis rat model of experimental autoimmune encephalomyelitis, we show here that contrary to the expectations of this concept, T-cell blasts do not efficiently enter the CNS and are not required to prepare the BBB for immune-cell recruitment. Instead, intravenously transferred T-cell blasts gain the capacity to enter the CNS after residing transiently within the lung tissues. Inside the lung tissues, they move along and within the airways to bronchus-associated lymphoid tissues and lung-draining mediastinal lymph nodes before they enter the blood circulation from where they reach the CNS. Effector T cells transferred directly into the airways showed a similar migratory pattern and retained their full pathogenicity. On their way the T cells fundamentally reprogrammed their gene-expression profile, characterized by downregulation of their activation program and upregulation of cellular locomotion molecules together with chemokine and adhesion receptors. The adhesion receptors include ninjurin 1, which participates in T-cell intravascular crawling on cerebral blood vessels. We detected that the lung constitutes a niche not only for activated T cells but also for resting myelin-reactive memory T cells. After local stimulation in the lung, these cells strongly proliferate and, after assuming migratory properties, enter the CNS and induce paralytic disease. The lung could therefore contribute to the activation of potentially autoaggressive T cells and their transition to a migratory mode as a prerequisite to entering their target tissues and inducing autoimmune disease.	[Odoardi, Francesca; Sie, Christopher; Schlaeger, Christian; Lodygin, Dmitri; Fluegel, Alexander] Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Dept Neuroimmunol, D-37073 Gottingen, Germany; [Odoardi, Francesca; Sie, Christopher; Schlaeger, Christian; Lodygin, Dmitri; Fluegel, Alexander] Univ Med Ctr Gottingen, D-37073 Gottingen, Germany; [Streyl, Kristina; Ulaganathan, Vijay K.; Heckelsmiller, Klaus; Klinkert, Wolfgang E. F.; Wekerle, Hartmut] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Nietfeld, Wilfried; Lehrach, Hans; Vingron, Martin] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Ellwart, Joachim] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Lottaz, Claudio; Spang, Rainer] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Nosov, Mikhail] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Regenerat Med Inst, Coll Med Nursing & Hlth Sci, Galway, Ireland; [Brinkmann, Volker] Autoimmun Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Brinkmann, Volker] Transplantat Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Brinkmann, Volker] Inflammat Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Fluegel-Koch, Cassandra] Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany	University of Gottingen; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; Ollscoil na Gaillimhe-University of Galway; Novartis; Novartis; Novartis; University of Erlangen Nuremberg	Flugel, A (corresponding author), Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Dept Neuroimmunol, D-37073 Gottingen, Germany.	fluegel@med.uni-goettingen.de	Ulaganathan, Vijay Kumar/H-6306-2018	Ulaganathan, Vijay Kumar/0000-0002-4717-6228; Lottaz, Claudio/0000-0003-0781-4827; Spang, Rainer/0000-0002-1326-4297	Deutsche Forschungsgemeinschaft [TRR-SFB43, FORR 1336]; Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS'); Hertie Foundation [1.01.1/11/004]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS')(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	The authors thank A. Stas, S. Hamann, N. Meyer and I. Haarmann for technical assistance. N. Plesnila supported this work with advice in surgical preparations; T. Issekutz provided anti-CXCR3 and anti-VLA4 monoclonal antibodies. We are grateful to D. Johnson and F. Luhder for critical reading of the manuscript. We thank W. Leibold for critical discussions. We thank C. Ludwig for text editing. Hartmut Wekerle is Senior Research Professor of the Hertie Foundation. This work was supported by the Deutsche Forschungsgemeinschaft (TRR-SFB43, FORR 1336), the Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS') and the Hertie Foundation (grant 1.01.1/11/004).	Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cordiglieri C, 2010, BRAIN, V133, P1930, DOI 10.1093/brain/awq135; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Eylar E H, 1974, Methods Enzymol, V32, P323; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Glabinski AR, 1995, BRAIN BEHAV IMMUN, V9, P315, DOI 10.1006/brbi.1995.1030; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KARIN N, 1993, J IMMUNOL, V150, P4116; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pintelon I, 2005, CELL TISSUE RES, V321, P21, DOI 10.1007/s00441-005-1111-y; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SIBLEY WA, 1985, LANCET, V1, P1313; Sporici R, 2010, EUR J IMMUNOL, V40, P2751, DOI 10.1002/eji.200939975; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tham EL, 2002, J IMMUNOL, V168, P1190, DOI 10.4049/jimmunol.168.3.1190; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zheng HM, 2011, INFLAMM RES, V60, P759, DOI 10.1007/s00011-011-0331-8	44	279	286	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					675	+		10.1038/nature11337	http://dx.doi.org/10.1038/nature11337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22914092	Green Published			2022-12-01	WOS:000308095100060
J	Wilson, NR; Runyan, CA; Wang, FL; Sur, M				Wilson, Nathan R.; Runyan, Caroline A.; Wang, Forea L.; Sur, Mriganka			Division and subtraction by distinct cortical inhibitory networks in vivo	NATURE			English	Article							CAT VISUAL-CORTEX; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; NORMALIZATION MODEL; NEURONS; INTERNEURONS; EXCITATION; DYNAMICS; INPUT; MOUSE	Brain circuits process information through specialized neuronal subclasses interacting within a network. Revealing their interplay requires activating specific cells while monitoring others in a functioning circuit. Here we use a new platform for two-way light-based circuit interrogation in visual cortex in vivo to show the computational implications of modulating different subclasses of inhibitory neurons during sensory processing. We find that soma-targeting, parvalbumin-expressing (PV) neurons principally divide responses but preserve stimulus selectivity, whereas dendrite-targeting, somatostatin-expressing (SOM) neurons principally subtract from excitatory responses and sharpen selectivity. Visualized in vivo cell-attached recordings show that division by PV neurons alters response gain, whereas subtraction by SOM neurons shifts response levels. Finally, stimulating identified neurons while scanning many target cells reveals that single PV and SOM neurons functionally impact only specific subsets of neurons in their projection fields. These findings provide direct evidence that inhibitory neuronal subclasses have distinct and complementary roles in cortical computations.	[Wilson, Nathan R.; Runyan, Caroline A.; Wang, Forea L.; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Sur, M (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nathan1@mit.edu; msur@mit.edu			US National Institutes of Health (NIH); Simons Foundation; NIH; NATIONAL EYE INSTITUTE [R01EY018648, R01EY007023] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Huang for providing the SOM-Cre mouse line; C. Le for performing animal care support and viral injections; S. Yan and Y. Deng for help in the development of optogenetics and imaging methods in vitro; S. El-Boustani for collecting data for in vivo deconvolution; J. Sharma, M. Goard and A. Banerjee for comments and discussions on the manuscript; L.-H. Tsai, K. Meletis and M. Carlen for early provision of viral constructs and PV-Cre viral injections; and James Schummers and Hiroki Sugihara for participating in early pilot experiments testing optogenetics stimulation in vivo. This work was supported by postdoctoral fellowships from the US National Institutes of Health (NIH) and the Simons Foundation (N.R.W.), an NIH predoctoral fellowship (C. A. R.) and grants from the NIH and the Simons Foundation (M.S.).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Lillis KP, 2008, J NEUROSCI METH, V172, P178, DOI 10.1016/j.jneumeth.2008.04.024; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Mao R, 2012, CEREB CORTEX, V22, P493, DOI 10.1093/cercor/bhr057; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Xing DJ, 2011, J NEUROSCI, V31, P15972, DOI 10.1523/JNEUROSCI.2245-11.2011; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	45	351	351	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					343	348		10.1038/nature11347	http://dx.doi.org/10.1038/nature11347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22878717	Green Published, Green Accepted			2022-12-01	WOS:000307501000034
J	Van Handel, B; Montel-Hagen, A; Sasidharan, R; Nakano, H; Ferrari, R; Boogerd, CJ; Schredelseker, J; Wang, YL; Hunter, S; Org, T; Zhou, J; Li, XM; Pellegrini, M; Chen, JN; Orkin, SH; Kurdistani, SK; Evans, SM; Nakano, A; Mikkola, HKA				Van Handel, Ben; Montel-Hagen, Amelie; Sasidharan, Rajkumar; Nakano, Haruko; Ferrari, Roberto; Boogerd, Cornelis J.; Schredelseker, Johann; Wang, Yanling; Hunter, Sean; Org, Tonis; Zhou, Jian; Li, Xinmin; Pellegrini, Matteo; Chen, Jau-Nian; Orkin, Stuart H.; Kurdistani, Siavash K.; Evans, Sylvia M.; Nakano, Atsushi; Mikkola, Hanna K. A.			Scl Represses Cardiomyogenesis in Prospective Hemogenic Endothelium and Endocardium	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIUM; PROGENITOR CELLS; CARDIOVASCULAR PROGENITORS; HAEMOGENIC ENDOTHELIUM; DEFINED FACTORS; SMOOTH-MUSCLE; MOUSE EMBRYO; DIFFERENTIATION; BLOOD	Endothelium in embryonic hematopoietic tissues generates hematopoietic stem/progenitor cells; however, it is unknown how its unique potential is specified. We show that transcription factor Scl/Tal1 is essential for both establishing the hematopoietic transcriptional program in hemogenic endothelium and preventing its misspecification to a cardiomyogenic fate. Scl(-/-) embryos activated a cardiac transcriptional program in yolk sac endothelium, leading to the emergence of CD31(+)Pdgfr alpha(+) cardiogenic precursors that generated spontaneously beating cardiomyocytes. Ectopic cardiogenesis was also observed in Scl(-/-) hearts, where the disorganized endocardium precociously differentiated into cardiomyocytes. Induction of mosaic deletion of Scl in Scl(fl/fl)Rosa26Cre-ERT2 embryos revealed a cell-intrinsic, temporal requirement for Scl to prevent cardiomyogenesis from endothelium. Scl(-/-) endothelium also upregulated the expression of Wnt antagonists, which promoted rapid cardiomyocyte differentiation of ectopic cardiogenic cells. These results reveal unexpected plasticity in embryonic endothelium such that loss of a single master regulator can induce ectopic cardiomyogenesis from endothelial cells.	[Van Handel, Ben; Montel-Hagen, Amelie; Sasidharan, Rajkumar; Nakano, Haruko; Schredelseker, Johann; Wang, Yanling; Hunter, Sean; Org, Tonis; Pellegrini, Matteo; Chen, Jau-Nian; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Ferrari, Roberto; Kurdistani, Siavash K.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zhou, Jian; Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Boogerd, Cornelis J.; Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Boogerd, Cornelis J.; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	hmikkola@mcdb.ucla.edu	Chen, Jau-Nian/AAM-7808-2020; Evans, Sylvia/G-1980-2015; Org, Tõnis/E-8596-2010; Boogerd, Cornelis/A-7470-2016; Ferrari, Roberto/O-8143-2015; Boogerd, Cornelis J/D-3244-2009	Org, Tõnis/0000-0003-3071-2183; Ferrari, Roberto/0000-0002-0453-0899; Boogerd, Cornelis J/0000-0002-7119-5381; Yamada-Hunter, Sean/0000-0002-4372-6587; Chen, Jau-Nian/0000-0001-8807-3607; Pellegrini, Matteo/0000-0001-9355-9564; Schredelseker, Johann/0000-0002-6657-0466	California Institute for Regenerative Medicine (CIRM) New Faculty Award; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH [HL097766-01]; Ruth L. Kirschstein National Research Service Award [GM07185]; NIH/National Heart, Lung, and Blood Institute [T32 HL69766]; European Molecular Biology Organisation; Human Frontier Science Program; CIRM; Netherlands Organization for Scientific Research [825.10.016]; European Union [MJD284]; Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097766, T32HL069766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) New Faculty Award; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Molecular Biology Organisation; Human Frontier Science Program(Human Frontier Science Program); CIRM(California Institute for Regenerative Medicine); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Joshua Bloomekatz and Dr. Deborah Yelon for critical reading of the manuscript and sharing unpublished data and Guillaume Hagen for preparing the movies. The authors thank the Broad Stem Cell Research Center Flow Cytometry Core for FACS sorting. This work was funded by the California Institute for Regenerative Medicine (CIRM) New Faculty Award, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award and NIH/RO1 (HL097766-01) grants to H. K. A. M. B. V. H. was supported by the Ruth L. Kirschstein National Research Service Award GM07185 and NIH/National Heart, Lung, and Blood Institute Grant T32 HL69766. A. M.-H was supported by successive fellowships from the European Molecular Biology Organisation and the Human Frontier Science Program. R. F. was funded in part by a CIRM grant to S. K. K. C.J.B. was funded by Rubicon Grant 825.10.016 from the Netherlands Organization for Scientific Research. T.O. was supported by the European Union through the European Social Fund (Mobilitas Grant No. MJD284). S.H.O., an Investigator of the Howard Hughes Medical Institute, is supported in part by a Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases.	Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; Jaspard B, 2000, MECH DEVELOP, V90, P263, DOI 10.1016/S0925-4773(99)00236-1; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kinder SJ, 2001, TRENDS CARDIOVAS MED, V11, P177, DOI 10.1016/S1050-1738(01)00091-3; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Simoes FC, 2011, DEVELOPMENT, V138, P3235, DOI 10.1242/dev.059634; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yamagishi T, 2009, ANAT SCI INT, V84, P77, DOI 10.1007/s12565-009-0027-0; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	47	117	119	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					590	605		10.1016/j.cell.2012.06.026	http://dx.doi.org/10.1016/j.cell.2012.06.026			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863011	Green Accepted, Bronze			2022-12-01	WOS:000307301400017
J	Jones, DTW; Jager, N; Kool, M; Zichner, T; Hutter, B; Sultan, M; Cho, YJ; Pugh, TJ; Hovestadt, V; Stutz, AM; Rausch, T; Warnatz, HJ; Ryzhova, M; Bender, S; Sturm, D; Pleier, S; Cin, H; Pfaff, E; Sieber, L; Wittmann, A; Remke, M; Witt, H; Hutter, S; Tzaridis, T; Weischenfeldt, J; Raeder, B; Avci, M; Amstislavskiy, V; Zapatka, M; Weber, UD; Wang, Q; Lasitschka, B; Bartholomae, CC; Schmidt, M; von Kalle, C; Ast, V; Lawerenz, C; Eils, J; Kabbe, R; Benes, V; van Sluis, P; Koster, J; Volckmann, R; Shih, D; Betts, MJ; Russell, RB; Coco, S; Tonini, GP; Schuller, U; Hans, V; Graf, N; Kim, YJ; Monoranu, C; Roggendorf, W; Unterberg, A; Herold-Mende, C; Milde, T; Kulozik, AE; von Deimling, A; Witt, O; Maass, E; Rossler, J; Ebinger, M; Schuhmann, MU; Fruhwald, MC; Hasselblatt, M; Jabado, N; Rutkowski, S; von Bueren, AO; Williamson, D; Clifford, SC; McCabe, MG; Collins, VP; Wolf, S; Wiemann, S; Lehrach, H; Brors, B; Scheurlen, W; Felsberg, J; Reifenberger, G; Northcott, PA; Taylor, MD; Meyerson, M; Pomeroy, SL; Yaspo, ML; Korbel, JO; Korshunov, A; Eils, R; Pfister, SM; Lichter, P				Jones, David T. W.; Jaeger, Natalie; Kool, Marcel; Zichner, Thomas; Hutter, Barbara; Sultan, Marc; Cho, Yoon-Jae; Pugh, Trevor J.; Hovestadt, Volker; Stuetz, Adrian M.; Rausch, Tobias; Warnatz, Hans-Joerg; Ryzhova, Marina; Bender, Sebastian; Sturm, Dominik; Pleier, Sabrina; Cin, Huriye; Pfaff, Elke; Sieber, Laura; Wittmann, Andrea; Remke, Marc; Witt, Hendrik; Hutter, Sonja; Tzaridis, Theophilos; Weischenfeldt, Joachim; Raeder, Benjamin; Avci, Meryem; Amstislavskiy, Vyacheslav; Zapatka, Marc; Weber, Ursula D.; Wang, Qi; Lasitschka, Baerbel; Bartholomae, Cynthia C.; Schmidt, Manfred; von Kalle, Christof; Ast, Volker; Lawerenz, Chris; Eils, Juergen; Kabbe, Rolf; Benes, Vladimir; van Sluis, Peter; Koster, Jan; Volckmann, Richard; Shih, David; Betts, Matthew J.; Russell, Robert B.; Coco, Simona; Tonini, Gian Paolo; Schueller, Ulrich; Hans, Volkmar; Graf, Norbert; Kim, Yoo-Jin; Monoranu, Camelia; Roggendorf, Wolfgang; Unterberg, Andreas; Herold-Mende, Christel; Milde, Till; Kulozik, Andreas E.; von Deimling, Andreas; Witt, Olaf; Maass, Eberhard; Roessler, Jochen; Ebinger, Martin; Schuhmann, Martin U.; Fruehwald, Michael C.; Hasselblatt, Martin; Jabado, Nada; Rutkowski, Stefan; von Bueren, Andre O.; Williamson, Dan; Clifford, Steven C.; McCabe, Martin G.; Collins, V. Peter; Wolf, Stephan; Wiemann, Stefan; Lehrach, Hans; Brors, Benedikt; Scheurlen, Wolfram; Felsberg, Joerg; Reifenberger, Guido; Northcott, Paul A.; Taylor, Michael D.; Meyerson, Matthew; Pomeroy, Scott L.; Yaspo, Marie-Laure; Korbel, Jan O.; Korshunov, Andrey; Eils, Roland; Pfister, Stefan M.; Lichter, Peter			Dissecting the genomic complexity underlying medulloblastoma	NATURE			English	Article							TETRAPLOID TUMOR-CELLS; MUTATIONS; ACTIVATION; SUBGROUPS; LANDSCAPE; GENES; TBR1	Medulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. It is the most common malignant brain tumour in children, and shows tremendous biological and clinical heterogeneity(1). Despite recent treatment advances, approximately 40% of children experience tumour recurrence, and 30% will die from their disease. Those who survive often have a significantly reduced quality of life. Four tumour subgroups with distinct clinical, biological and genetic profiles are currently identified(2,3). WNT tumours, showing activated wingless pathway signalling, carry a favourable prognosis under current treatment regimens(4). SHH tumours show hedgehog pathway activation, and have an intermediate prognosis(2). Group 3 and 4 tumours are molecularly less well characterized, and also present the greatest clinical challenges(2,3,5). The full repertoire of genetic events driving this distinction, however, remains unclear. Here we describe an integrative deep-sequencing analysis of 125 tumour-normal pairs, conducted as part of the International Cancer Genome Consortium (ICGC) PedBrain Tumor Project. Tetraploidy was identified as a frequent early event in Group 3 and 4 tumours, and a positive correlation between patient age and mutation rate was observed. Several recurrent mutations were identified, both in known medulloblastoma-related genes (CTNNB1, PTCH1, MLL2, SMARCA4) and in genes not previously linked to this tumour (DDX3X, CTDNEP1, KDM6A, TBR1), often in subgroup-specific patterns. RNA sequencing confirmed these alterations, and revealed the expression of what are, to our knowledge, the first medulloblastoma fusion genes identified. Chromatin modifiers were frequently altered across all subgroups. These findings enhance our understanding of the genomic complexity and heterogeneity underlying medulloblastoma, and provide several potential targets for new therapeutics, especially for Group 3 and 4 patients.	[Jaeger, Natalie; Hutter, Barbara; Wang, Qi; Kabbe, Rolf; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Jones, David T. W.; Kool, Marcel; Bender, Sebastian; Sturm, Dominik; Pleier, Sabrina; Cin, Huriye; Pfaff, Elke; Sieber, Laura; Wittmann, Andrea; Remke, Marc; Witt, Hendrik; Hutter, Sonja; Tzaridis, Theophilos; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Zichner, Thomas; Stuetz, Adrian M.; Weischenfeldt, Joachim; Raeder, Benjamin; Korbel, Jan O.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Sultan, Marc; Warnatz, Hans-Joerg; Avci, Meryem; Amstislavskiy, Vyacheslav; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Cho, Yoon-Jae] Stanford Univ, Div Child Neurol, Palo Alto, CA 94304 USA; [Pugh, Trevor J.; Meyerson, Matthew; Pomeroy, Scott L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Hovestadt, Volker; Zapatka, Marc; Weber, Ursula D.; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Ryzhova, Marina] NN Burdenko Inst Neurosurg, Dept Neuropathol, Moscow 125047, Russia; [Witt, Hendrik; Milde, Till; Kulozik, Andreas E.; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; Schmidt, Manfred; von Kalle, Christof] German Canc Res Ctr, Div Translat Oncol, D-69120 Heidelberg, Germany; [Bartholomae, Cynthia C.; Schmidt, Manfred; von Kalle, Christof] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [van Sluis, Peter; Koster, Jan; Volckmann, Richard] Univ Amsterdam, AMC, Dept Oncogenom, NL-1105 AZ Amsterdam, Netherlands; [Shih, David; Northcott, Paul A.] Hosp Sick Children, Arthur & Sonia Labbatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Betts, Matthew J.; Russell, Robert B.] Heidelberg Univ, Cell Networks Cluster Excellence, D-69120 Heidelberg, Germany; [Coco, Simona; Tonini, Gian Paolo] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Dept Adv Diagnost Technol, I-16132 Genoa, Italy; [Schueller, Ulrich] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Hans, Volkmar] Evangel Krankenhaus, Inst Neuropathol, D-33617 Bielefeld, Germany; [Graf, Norbert] Saarland Univ Hosp, Dept Paediat Oncol & Haematol, D-66421 Homburg, Germany; [Kim, Yoo-Jin] Saarland Univ Hosp, Inst Pathol, D-66424 Homburg, Germany; [Monoranu, Camelia; Roggendorf, Wolfgang] Inst Pathol, Dept Neuropathol, D-97080 Wurzburg, Germany; [Unterberg, Andreas; Herold-Mende, Christel] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany; [Milde, Till; Witt, Olaf] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, D-69120 Heidelberg, Germany; [von Deimling, Andreas; Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [von Deimling, Andreas; Korshunov, Andrey] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Maass, Eberhard] Klinikum Stuttgart Olgahosp, Dept Pediat Oncol Hematol & Immunol, D-70176 Stuttgart, Germany; [Roessler, Jochen] Univ Hosp Freiburg, Dept Paediat Haematol & Oncol, D-79106 Freiburg, Germany; [Ebinger, Martin] Childrens Univ Hosp, Dept Hematol & Oncol, D-72076 Tubingen, Germany; [Schuhmann, Martin U.] Univ Hosp, Dept Neurosurg, D-72076 Tubingen, Germany; [Fruehwald, Michael C.] Childrens Hosp Augsburg, D-86156 Augsburg, Germany; [Hasselblatt, Martin] Univ Hosp Munster, Inst Neuropathol, D-48149 Munster, Germany; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Jabado, Nada] McGill Univ Hlth Ctr Res Inst, Montreal, PQ H3Z 2Z3, Canada; [Rutkowski, Stefan; von Bueren, Andre O.] Univ Med Ctr Hamburg Eppendorf, Dept Paediat Haematol & Oncol, D-20246 Hamburg, Germany; [Williamson, Dan; Clifford, Steven C.] Newcastle Univ, Royal Victoria Infirm, No Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [McCabe, Martin G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Canc & Enabling Sci, Manchester M13 9PL, Lancs, England; [Collins, V. Peter] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 0QQ, England; [Wiemann, Stefan] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Scheurlen, Wolfram] Nurnberg Childrens Hosp, Cnopfsche Kinderklinik, D-90419 Nurnberg, Germany; [Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Meyerson, Matthew] Dana Farber Canc Inst, Boston, MA 02215 USA; [Pomeroy, Scott L.] Childrens Hosp, Boston, MA 02115 USA; [Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); Max Planck Society; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Amsterdam; Academic Medical Center Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ruprecht Karls University Heidelberg; University of Genoa; IRCCS AOU San Martino IST; University of Munich; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; University of Wurzburg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Klinikum Stuttgart; University of Freiburg; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munster; McGill University; McGill University; McGill University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Newcastle University - UK; University of Manchester; University of Cambridge; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	r.eils@dkfz-heidelberg.de; s.pfister@dkfz-heidelberg.de; m.macleod@dkfz-heidelberg.de	Shih, David J H/H-3186-2011; Jones, David T. W./Z-1963-2019; Zapatka, Marc/G-9896-2013; Northcott, Paul A/N-4022-2018; Jones, David TW/G-9588-2013; Milde, Till/L-7755-2015; Ebinger, Martin/O-4936-2016; Witt, Hendrik/L-7810-2015; Russell, Robert/GWU-6389-2022; Weischenfeldt, Joachim/O-3681-2015; Kool, Marcel/H-2541-2013; von Deimling, Andreas/F-7774-2013; Kulozik, Andreas/AAO-2432-2020; Ryzhova, Marina/G-4178-2014; Wiemann, Stefan/E-4424-2013; Eils, Roland/B-6121-2009; Jabado, Nada/AAN-4026-2020; Meyerson, Matthew L/E-7123-2012; Milde, Till/AAR-4528-2021; Rausch, Tobias/H-6511-2019; wang, edwin/G-5372-2010; Coco, Simona/J-6051-2016; von Bueren, Andre/AAF-2065-2020; Shih, David J. H./AAE-8726-2019; Korbel, Jan O/G-6470-2012; Koster, Jan/C-5934-2008; Reifenberger, Guido/AAE-3599-2019; Sturm, Dominik/AAL-3689-2020; Russell, Rob/AAH-9145-2019; Pugh, Trevor/Y-2535-2019; Brors, Benedikt/E-5620-2013; Pfister, Stefan M/F-6860-2013; Graf, Norbert/H-1328-2011; McCabe, Martin/P-5896-2015	Shih, David J H/0000-0002-9802-4937; Zapatka, Marc/0000-0001-8287-5967; Northcott, Paul A/0000-0002-1220-5252; Jones, David TW/0000-0002-2036-5141; Ebinger, Martin/0000-0002-4229-8058; Russell, Robert/0000-0002-7213-1398; Weischenfeldt, Joachim/0000-0002-3917-5524; von Deimling, Andreas/0000-0002-5863-540X; Ryzhova, Marina/0000-0001-7206-6365; Wiemann, Stefan/0000-0003-4683-3174; Eils, Roland/0000-0002-0034-4036; Milde, Till/0000-0002-7267-1052; Rausch, Tobias/0000-0001-5773-5620; Coco, Simona/0000-0002-5296-4325; Shih, David J. H./0000-0002-9802-4937; Korbel, Jan O/0000-0002-2798-3794; Koster, Jan/0000-0002-0890-7585; Sturm, Dominik/0000-0003-0250-1696; Russell, Rob/0000-0002-1905-4717; Pugh, Trevor/0000-0002-8073-5888; Brors, Benedikt/0000-0001-5940-3101; Pfister, Stefan M/0000-0002-5447-5322; Graf, Norbert/0000-0002-2248-323X; McCabe, Martin/0000-0002-5138-0707; Hovestadt, Volker/0000-0002-3480-6649; Warnatz, Hans-Jorg/0000-0002-0327-9209; Raeder, Benjamin/0000-0002-9494-8884; Stuetz, Adrian/0000-0001-7650-3470; Jaeger, Natalie/0000-0002-9589-7580; Rossler, Jochen/0000-0003-4022-4917; Benes, Vladimir/0000-0002-0352-2547; von Bueren, Andre/0000-0003-4197-6264; Schuller, Ulrich/0000-0002-8731-1121; Hutter, Barbara/0000-0002-9034-0329; Meyerson, Matthew/0000-0002-9133-8108; Remke, Marc/0000-0002-9404-9993; Taylor, Michael/0000-0001-7009-3466; Hasselblatt, Martin/0000-0003-2707-8484; Wang, Qi/0000-0002-6420-1720; Tzaridis, Theophilos/0000-0001-9651-1144; Clifford, Steve/0000-0003-4893-2184; Korshunov, Andrey/0000-0002-5257-3623; Zichner, Thomas/0000-0001-9848-7598	PedBrain Tumor Project contributing to the International Cancer Genome Consortium (ICGC PedBrain Tumor Project); German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01GS0883]; German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Max Planck Society; Pediatric Brain Tumor Foundation; Italian Neuroblastoma Foundation; Samantha Dickson Brain Tumour Trust; UK Children's Cancer and Leukaemia Group (CCLG) [BS-2007-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA109467] Funding Source: NIH RePORTER; Cancer Research UK [13457] Funding Source: researchfish; The Brain Tumour Charity [16/92, 10/106] Funding Source: researchfish	PedBrain Tumor Project contributing to the International Cancer Genome Consortium (ICGC PedBrain Tumor Project); German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Max Planck Society(Max Planck Society); Pediatric Brain Tumor Foundation; Italian Neuroblastoma Foundation; Samantha Dickson Brain Tumour Trust; UK Children's Cancer and Leukaemia Group (CCLG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); The Brain Tumour Charity	We thank GATC Biotech AG for sequencing services. For technical support and expertise we thank: B. Haase, D. Pavlinic, B. Baying, M. Wahlers, R. Luck, I. Kutschera, K. Schlangen, M. Metsger, K. Schulz, A. Nurnberger, A. Kovacsovics, M. Linser, J. C. Lindsey, S. Bailey, D. M. Pearson, the EMBL Genomics Core Facility, the EMBL High-performance Computing Core Facility and the DKFZ Genomics and Proteomics Core Facility. This work was principally supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium (ICGC PedBrain Tumor Project, http://www.pedbraintumor.org/), funded by German Cancer Aid (109252) and the German Federal Ministry of Education and Research (BMBF, NGFN<SUP>plus</SUP> #01GS0883). Additional support came from the German Cancer Research Center-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the Max Planck Society, the Pediatric Brain Tumor Foundation, the Italian Neuroblastoma Foundation and the Samantha Dickson Brain Tumour Trust. This study included samples provided by the UK Children's Cancer and Leukaemia Group (CCLG) as part of CCLG-approved biological study BS-2007-04.	Clifford SC, 2006, CELL CYCLE, V5, P2666, DOI 10.4161/cc.5.22.3446; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Gilbertson RJ, 1997, CANCER RES, V57, P3272; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pietsch T, 1997, CANCER RES, V57, P2085; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rello-Varona S, 2009, CELL CYCLE, V8, P1030, DOI 10.4161/cc.8.7.7950; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vitale I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001337; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016	25	596	609	3	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					100	105		10.1038/nature11284	http://dx.doi.org/10.1038/nature11284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22832583	Green Published, hybrid, Green Accepted			2022-12-01	WOS:000307010700041
J	Storch, D; Keil, P; Jetz, W				Storch, David; Keil, Petr; Jetz, Walter			Universal species-area and endemics-area relationships at continental scales	NATURE			English	Article							SPATIAL TURNOVER; GLOBAL PATTERNS; RANGE; DISTRIBUTIONS; RICHNESS; GEOMETRY; MODEL; EVOLUTIONARY; BIODIVERSITY; BIOGEOGRAPHY	Despite the broad conceptual and applied relevance of how the number of species or endemics changes with area (the species-area and endemics-area relationships (SAR and EAR)), our understanding of universality and pervasiveness of these patterns across taxa and regions has remained limited. The SAR has traditionally been approximated by a power law(1), but recent theories predict a triphasic SAR in logarithmic space, characterized by steeper increases in species richness at both small and large spatial scales(2-6). Here we uncover such universally upward accelerating SARs for amphibians, birds and mammals across the world's major landmasses. Although apparently taxon-specific and continent-specific, all curves collapse into one universal function after the area is rescaled by using the mean range sizes of taxa within continents. In addition, all EARs approximately follow a power law with a slope close to 1, indicating that for most spatial scales there is roughly proportional species extinction with area loss. These patterns can be predicted by a simulation model based on the random placement of contiguous ranges within a domain. The universality of SARs and EARs after rescaling implies that both total and endemic species richness within an area, and also their rate of change with area, can be estimated by using only the knowledge of mean geographic range size in the region and mean species richness at one spatial scale.	[Storch, David] Charles Univ Prague, Ctr Theoret Study, Prague 11000 1, Czech Republic; [Storch, David] Acad Sci Czech Republ, Prague 11000 1, Czech Republic; [Storch, David] Charles Univ Prague, Fac Sci, Dept Ecol, CR-12844 Prague 2, Czech Republic; [Keil, Petr; Jetz, Walter] Yale Univ, Dept Ecol & Evolut Biol, New Haven, CT 06520 USA	Charles University Prague; Czech Academy of Sciences; Charles University Prague; Yale University	Storch, D (corresponding author), Charles Univ Prague, Ctr Theoret Study, Jilska 1, Prague 11000 1, Czech Republic.	storch@cts.cuni.cz	Keil, Petr/A-9875-2014; Jetz, Walter/ABF-1517-2020; Storch, David/C-3339-2017	Storch, David/0000-0001-5967-1544; Jetz, Walter/0000-0002-1971-7277	Grant Agency of the Czech Republic [P505/11/2387]; Czech Ministry of Education [MSM0021620845]; EU FP7 SCALES project [26852]; National Science Foundation [DBI 0960550, DEB 1026764]; NASA Biodiversity Program [NNX11AP72G]; Direct For Biological Sciences [1026764] Funding Source: National Science Foundation	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); EU FP7 SCALES project; National Science Foundation(National Science Foundation (NSF)); NASA Biodiversity Program(National Aeronautics & Space Administration (NASA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Belmaker, K. Mertes-Schwartz, C. Sheard and D. Rosauer for useful comments. The study was supported by the Grant Agency of the Czech Republic (P505/11/2387), the Czech Ministry of Education (MSM0021620845) and the EU FP7 SCALES project ('Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales'; project No. 26852). W. J. acknowledges support from National Science Foundation grants DBI 0960550 and DEB 1026764, and NASA Biodiversity Program grant number NNX11AP72G.	Allen AP, 2003, EVOL ECOL RES, V5, P493; Arita HT, 2002, ECOGRAPHY, V25, P541, DOI 10.1034/j.1600-0587.2002.250504.x; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Harte J, 1997, OIKOS, V80, P417, DOI 10.2307/3546614; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hubbell Stephen P., 2001, V32, pi; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Kinzig AP, 2000, ECOLOGY, V81, P3305, DOI 10.2307/177495; Kunin WE, 1997, BIOL CONSERV, V82, P369, DOI 10.1016/S0006-3207(97)00042-6; Lawton JH, 1995, EXTINCTION RATES; Leitner WA, 1997, OIKOS, V79, P503, DOI 10.2307/3546894; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; McGill B, 2003, EVOL ECOL RES, V5, P469; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Pereira HM, 2012, NATURE, V482, pE3, DOI 10.1038/nature10857; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Sizling AL, 2004, ECOL LETT, V7, P60, DOI 10.1046/j.1461-0248.2003.00549.x; Sizling AL, 2011, AM NAT, V178, P602, DOI 10.1086/662176; Smith AB, 2010, BIOL CONSERV, V143, P555, DOI 10.1016/j.biocon.2009.11.003; Storch D, 2008, ECOL LETT, V11, P771, DOI 10.1111/j.1461-0248.2008.01206.x; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x	34	113	114	4	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					78	+		10.1038/nature11226	http://dx.doi.org/10.1038/nature11226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22722856				2022-12-01	WOS:000307010700036
J	Brewer, C				Brewer, Colin			"Beau de Jour"-a male doctor who bought and sold sex	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stapleford Ctr, London SW1W 9NP, England		Brewer, C (corresponding author), Stapleford Ctr, London SW1W 9NP, England.								0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 1	2012	345								e5115	10.1136/bmj.e5115	http://dx.doi.org/10.1136/bmj.e5115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XC	22859772				2022-12-01	WOS:000307302800009
J	Rompolas, P; Deschene, ER; Zito, G; Gonzalez, DG; Saotome, I; Haberman, AM; Greco, V				Rompolas, Panteleimon; Deschene, Elizabeth R.; Zito, Giovanni; Gonzalez, David G.; Saotome, Ichiko; Haberman, Ann M.; Greco, Valentina			Live imaging of stem cell and progeny behaviour in physiological hair-follicle regeneration	NATURE			English	Article							NICHE; SKIN; MORPHOGENESIS; ACTIVATION; INDUCTION; GROWTH; CYCLE	Tissue development and regeneration depend on cell-cell interactions and signals that target stem cells and their immediate progeny(1). However, the cellular behaviours that lead to a properly regenerated tissue are not well understood. Using a new, non-invasive, intravital two-photon imaging approach we study physiological hair-follicle regeneration over time in live mice. By these means we have monitored the behaviour of epithelial stem cells and their progeny(2-4) during physiological hair regeneration and addressed how the mesenchyme(5) influences their behaviour. Consistent with earlier studies(6), stem cells are quiescent during the initial stages of hair regeneration, whereas the progeny are more actively dividing. Moreover, stem cell progeny divisions are spatially organized within follicles. In addition to cell divisions, coordinated cell movements of the progeny allow the rapid expansion of the hair follicle. Finally, we show the requirement of the mesenchyme for hair regeneration through targeted cell ablation and long-term tracking of live hair follicles. Thus, we have established an in vivo approach that has led to the direct observation of cellular mechanisms of growth regulation within the hair follicle and that has enabled us to precisely investigate functional requirements of hair-follicle components during the process of physiological regeneration.	[Rompolas, Panteleimon; Deschene, Elizabeth R.; Zito, Giovanni; Saotome, Ichiko; Greco, Valentina] Yale Univ, Sch Med, Yale Canc Ctr, Dept Genet,Dept Dermatol,Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Gonzalez, David G.; Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Yale University; Yale University	Greco, V (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, Dept Genet,Dept Dermatol,Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06510 USA.	valentina.greco@yale.edu	Zito, Giovanni/AAC-3639-2022; , Zito/O-3836-2019	, Zito/0000-0002-0482-6729	James Hudson Brown-Alexander Brown Coxe postdoctoral fellowship; National Institute of General Medical Sciences, US National Institutes of Health, Public Health Service; American Skin Association; American Cancer Society; Yale Rheumatologic Disease Research Core Center [NIH P30AR053495]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495, R01AR063663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	James Hudson Brown-Alexander Brown Coxe postdoctoral fellowship; National Institute of General Medical Sciences, US National Institutes of Health, Public Health Service; American Skin Association; American Cancer Society(American Cancer Society); Yale Rheumatologic Disease Research Core Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Horwich, V. Reinke and A. Giraldez for critical discussion of the work. We thank S. King for feedback on the manuscript, and E. Fuchs for the K14H2BGFP, Lef1RFP and pTREH2BGFP mice and A. Glick for the K5tta mice. P. R. is supported by the James Hudson Brown-Alexander Brown Coxe postdoctoral fellowship. G.Z. is a New York Stem Cell Foundation-Druckenmiller Fellow. E. D. is supported by the Cell and Molecular Biology Training Grant of the National Institute of General Medical Sciences, US National Institutes of Health, Public Health Service. This work was supported in part by the American Skin Association, the American Cancer Society and the Yale Rheumatologic Disease Research Core Center grant NIH P30AR053495.	COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Petersson M, 2011, EMBO J, V30, P3004, DOI 10.1038/emboj.2011.199; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Ra H, 2011, J INVEST DERMATOL, V131, P1061, DOI 10.1038/jid.2010.401; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; RUBIN L, 1972, DEV BIOL, V28, P94, DOI 10.1016/0012-1606(72)90129-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Uchugonova A, 2011, CELL CYCLE, V10, P2017, DOI 10.4161/cc.10.12.15895; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	22	238	242	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					496	U1600		10.1038/nature11218	http://dx.doi.org/10.1038/nature11218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22763436	Green Accepted, Green Published			2022-12-01	WOS:000306815300041
J	Mougi, A; Kondoh, M				Mougi, A.; Kondoh, M.			Diversity of Interaction Types and Ecological Community Stability	SCIENCE			English	Article							FOOD WEBS; PREDATOR-PREY; NETWORKS; ECOSYSTEMS; BIODIVERSITY; ARCHITECTURE; COMPETITION; COMPLEXITY; LINKS; MODEL	Ecological theory predicts that a complex community formed by a number of species is inherently unstable, guiding ecologists to identify what maintains species diversity in nature. Earlier studies often assumed a community with only one interaction type, either an antagonistic, competitive, or mutualistic interaction, leaving open the question of what the diversity of interaction types contributes to the community maintenance. We show theoretically that the multiple interaction types might hold the key to understanding community dynamics. A moderate mixture of antagonistic and mutualistic interactions can stabilize population dynamics. Furthermore, increasing complexity leads to increased stability in a "hybrid" community. We hypothesize that the diversity of species and interaction types may be the essential element of biodiversity that maintains ecological communities.	[Mougi, A.; Kondoh, M.] Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, Otsu, Shiga 5202194, Japan; [Kondoh, M.] Japanese Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Ryukoku University; Japan Science & Technology Agency (JST)	Kondoh, M (corresponding author), Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, 1-5 Yokoya,Seta Oe Cho, Otsu, Shiga 5202194, Japan.	mkondoh@rins.ryukoku.ac.jp	Kondoh, Michio/AAE-4332-2019		Ministry of the Environment, Japan [D-1102]; Japan Society for the Promotion of Science [23657019, 30388160];  [20370012]; Grants-in-Aid for Scientific Research [23657019] Funding Source: KAKEN	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Environment Research and Technology Development Fund (grant D-1102) of the Ministry of the Environment, Japan; a Grant-in-Aid for Scientific Research (B) (no. 20370012); and a Grant-in-Aid for Challenging Exploratory Research (no. 23657019, 30388160) of the Japan Society for the Promotion of Science. The authors declare no competing financial interests.	ADDICOTT JF, 1984, THEOR POPUL BIOL, V26, P320, DOI 10.1016/0040-5809(84)90037-6; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chen X, 2001, P ROY SOC B-BIOL SCI, V268, P869, DOI 10.1098/rspb.2001.1596; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Martinez ND, 2006, SFI S SCI C, P163; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Melian CJ, 2009, OIKOS, V118, P122, DOI 10.1111/j.1600-0706.2008.16751.x; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Pimm S.L., 1991, BALANCE NATURE; Pimm SL, 2002, FOOD WEBS; Ringel MS, 1996, THEOR POPUL BIOL, V50, P281, DOI 10.1006/tpbi.1996.0032; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson JN, 2006, SCIENCE, V312, P372, DOI 10.1126/science.1126904; Townsend SE, 2010, J THEOR BIOL, V267, P243, DOI 10.1016/j.jtbi.2010.08.018; Zhang F, 2011, ECOL LETT, V14, P797, DOI 10.1111/j.1461-0248.2011.01647.x	26	418	437	47	429	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					349	351		10.1126/science.1220529	http://dx.doi.org/10.1126/science.1220529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822151				2022-12-01	WOS:000306542600053
J	Lu, YH; Wu, KM; Jiang, YY; Guo, YY; Desneux, N				Lu, Yanhui; Wu, Kongming; Jiang, Yuying; Guo, Yuyuan; Desneux, Nicolas			Widespread adoption of Bt cotton and insecticide decrease promotes biocontrol services	NATURE			English	Article							NATURAL PEST-CONTROL; BIOLOGICAL-CONTROL; AGRICULTURAL LANDSCAPES; BENEFICIAL ARTHROPODS; POPULATION-DYNAMICS; MULTIPLE CROPS; NORTHERN CHINA; BIODIVERSITY; SUPPRESSION; MANAGEMENT	Over the past 16 years, vast plantings of transgenic crops producing insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) have helped to control several major insect pests(1-5) and reduce the need for insecticide sprays(1,5,6). Because broad-spectrum insecticides kill arthropod natural enemies that provide biological control of pests, the decrease in use of insecticide sprays associated with Bt crops could enhance biocontrol services(7-12). However, this hypothesis has not been tested in terms of long-term landscape-level impacts(10). On the basis of data from 1990 to 2010 at 36 sites in six provinces of northern China, we show here a marked increase in abundance of three types of generalist arthropod predators (ladybirds, lacewings and spiders) and a decreased abundance of aphid pests associated with widespread adoption of Bt cotton and reduced insecticide sprays in this crop. We also found evidence that the predators might provide additional biocontrol services spilling over from Bt cotton fields onto neighbouring crops (maize, peanut and soybean). Our work extends results from general studies evaluating ecological effects of Bt crops(1-4,6,12,13) by demonstrating that such crops can promote biocontrol services in agricultural landscapes.	[Lu, Yanhui; Wu, Kongming; Guo, Yuyuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Jiang, Yuying] Natl Agrotech Extens & Serv Ctr, Beijing 100026, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, UMR1355, ISA, F-06903 Sophia Antipolis, France	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn	Desneux, Nicolas/J-6262-2013	Lu, Yanhui/0000-0002-6552-0248	Key Project for Breeding Genetically Modified Organisms [2011ZX08012-004]; International Science and Technology Cooperation Project [2010DFA32200]	Key Project for Breeding Genetically Modified Organisms; International Science and Technology Cooperation Project	We thank the agricultural technicians of the 36 surveyed locations for providing data sets from cotton fields; W. Li and L. Wang for providing the predator exclusion cage data sets; Y. Zhang and C. Li for assistance in making the survey map; H. Yuan for help in preparing the list of insecticides in cotton; and R. Senoussi for advice on data analyses. This work was funded by the Key Project for Breeding Genetically Modified Organisms (grant no. 2011ZX08012-004) and the International Science and Technology Cooperation Project (grant no. 2010DFA32200).	Bale JS, 2008, PHILOS T R SOC B, V363, P761, DOI 10.1098/rstb.2007.2182; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ding Y. Q., 2010, J PEANUT SCI, V39, P45; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Gatehouse AMR, 2011, PHILOS T R SOC B, V366, P1438, DOI 10.1098/rstb.2010.0330; HARDIN MR, 1995, CROP PROT, V14, P3, DOI 10.1016/0261-2194(95)91106-P; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Institute of Plant Protection Chinese Academy of Agricultural Sciences, 1995, CROP DIS PESTS CHIN; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lu Y. H., 2010, INTEGRATED MANAGEMEN; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Miao J, 2007, ENVIRON ENTOMOL, V36, P840, DOI 10.1603/0046-225X(2007)36[840:PDOAGH]2.0.CO;2; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Qu X.F., 1992, COTTON PEST FORECAST; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rao C. N., 2007, ENCY PEST MANAGEMENT, V2, P597; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J., 2008, INTEGRATION INSECT R; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu K., 1992, ACTA ECOL SIN, V12, P341; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu Hongfu, 2000, Acta Phytophylacica Sinica, V27, P199; Yang Qin-min, 2004, Journal of Shandong Agricultural University, V35, P217	37	567	623	16	532	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					362	365		10.1038/nature11153	http://dx.doi.org/10.1038/nature11153			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722864				2022-12-01	WOS:000306506500042
J	Lobue, PA; Castro, KG				Lobue, Philip A.; Castro, Kenneth G.			Is It Time to Replace the Tuberculin Skin Test With a Blood Test?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GAMMA RELEASE ASSAYS; COST-EFFECTIVENESS; GOLD		[Lobue, Philip A.; Castro, Kenneth G.] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Lobue, PA (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, 1600 Clifton Rd,Mail Stop E-10, Atlanta, GA 30333 USA.	plobue@cdc.gov	Castro, Kenneth G/P-1882-2018	Castro, Kenneth G/0000-0001-7964-6354	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention, 2000, MMWR Recomm Rep, V49, P1; Belknap R, 2010, AM J RESP CRIT CARE, V181; Costa JT, 2011, INT ARCH OCC ENV HEA, V84, P461, DOI 10.1007/s00420-010-0571-x; de Perio MA, 2009, ARCH INTERN MED, V169, P179, DOI 10.1001/archinternmed.2008.524; Gandra S, 2010, INFECT CONT HOSP EP, V31, P1279, DOI 10.1086/657336; Hill AN, 2012, EPIDEMIOL INFECT, V11, P1; Marra F, 2008, INT J TUBERC LUNG D, V12, P1414; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9	10	19	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2012	308	3					241	242		10.1001/jama.2012.7511	http://dx.doi.org/10.1001/jama.2012.7511			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975AC	22797639	Green Accepted			2022-12-01	WOS:000306477900022
J	Prokopetz, JJZ; Lehmann, LS				Prokopetz, Julian J. Z.; Lehmann, Lisa Soleymani			Redefining Physicians' Role in Assisted Dying	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Prokopetz, Julian J. Z.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Ctr Bioeth, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Harvard Univ, Div Med Eth, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Prokopetz, JJZ (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA.							Curlin FA, 2008, AM J HOSP PALLIAT ME, V25, P112, DOI 10.1177/1049909107310141; Ganzini L, 2009, J PAIN SYMPTOM MANAG, V38, P807, DOI 10.1016/j.jpainsymman.2009.04.026; Lindsay RA, 2009, AM J BIOETHICS, V9, P19, DOI 10.1080/15265160802654137; Smith KA, 2011, J PALLIAT MED, V14, P445, DOI 10.1089/jpm.2010.0425	4	19	21	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2012	367	2					97	99		10.1056/NEJMp1205283	http://dx.doi.org/10.1056/NEJMp1205283			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	972IO	22784111				2022-12-01	WOS:000306270800003
J	Scuoppo, C; Miething, C; Lindqvist, L; Reyes, J; Ruse, C; Appelmann, I; Yoon, S; Krasnitz, A; Teruya-Feldstein, J; Pappin, D; Pelletier, J; Lowe, SW				Scuoppo, Claudio; Miething, Cornelius; Lindqvist, Lisa; Reyes, Jose; Ruse, Cristian; Appelmann, Iris; Yoon, Seungtai; Krasnitz, Alexander; Teruya-Feldstein, Julie; Pappin, Darryl; Pelletier, Jerry; Lowe, Scott W.			A tumour suppressor network relying on the polyamine-hypusine axis	NATURE			English	Article							INITIATION-FACTOR 5A; COMMONLY DELETED SEGMENT; AMINO-ACID; CANCER; GENES; EXPRESSION; EIF5A; IDENTIFICATION; DECARBOXYLASE; ACTIVATION	Tumour suppressor genes encode a broad class of molecules whose mutational attenuation contributes to malignant progression. In the canonical situation, the tumour suppressor is completely inactivated through a two-hit process involving a point mutation in one allele and chromosomal deletion of the other(1). Here, to identify tumour suppressor genes in lymphoma, we screen a short hairpin RNA library targeting genes deleted in human lymphomas. We functionally identify those genes whose suppression promotes tumorigenesis in a mouse lymphoma model. Of the nine tumour suppressors we identified, eight correspond to genes occurring in three physically linked 'clusters', suggesting that the common occurrence of large chromosomal deletions in human tumours reflects selective pressure to attenuate multiple genes. Among the new tumour suppressors are adenosylmethionine decarboxylase 1 (AMD1) and eukaryotic translation initiation factor 5A (eIF5A), two genes associated with hypusine, a unique amino acid produced as a product of polyamine metabolism through a highly conserved pathway(2). Through a secondary screen surveying the impact of all polyamine enzymes on tumorigenesis, we establish the polyamine-hypusine axis as a new tumour suppressor network regulating apoptosis. Unexpectedly, heterozygous deletions encompassing AMD1 and eIF5A often occur together in human lymphomas and co-suppression of both genes promotes lymphomagenesis in mice. Thus, some tumour suppressor functions can be disabled through a two-step process targeting different genes acting in the same pathway.	[Scuoppo, Claudio; Lowe, Scott W.] Watson Sch Biol Sci, Cold Spring Harbor Lab, New York, NY 11724 USA; [Miething, Cornelius; Reyes, Jose; Ruse, Cristian; Appelmann, Iris; Krasnitz, Alexander; Pappin, Darryl; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Miething, Cornelius; Appelmann, Iris; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10065 USA; [Lindqvist, Lisa; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Yoon, Seungtai] Mt Sinai Sch Med, New York, NY 10029 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; McGill University; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; McGill University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, New York, NY 11724 USA.	lowes@mskcc.org	Ruse, Cristian/A-4609-2011; Miething, Cornelius/F-9498-2014	Ruse, Cristian/0000-0001-8237-6308; Miething, Cornelius/0000-0003-4699-3805; Pappin, Darryl/0000-0002-8981-8401	Don Monti Memorial Research Foundation; National Cancer Institute [CA087497]; National Institutes of Health/American Recovery and Reinvestment Act [CA148532]; Canadian Institutes of Health Research [MOP-106530]; Angel Foundation; Curt Engelhorn fellowship; American Association for Cancer Research-Astellas fellowship; NATIONAL CANCER INSTITUTE [RC2CA148532, P01CA087497, P01CA013106] Funding Source: NIH RePORTER	Don Monti Memorial Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/American Recovery and Reinvestment Act(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Angel Foundation; Curt Engelhorn fellowship; American Association for Cancer Research-Astellas fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Simon, M. Taylor, D. Grace and S. Peacock for technical assistance, S. Muller for help in tumour sequencing and members of the Lowe laboratory for discussions. We thank G. Hannon and S. Powers for advice. We thank J. Maragulia, C. Gonzalez, A. Zelenetz, L. Lopez, E. Iskidarova, M. Asher and I. Linkov for help on the tissue microarray staining and data management. This work was supported by the Don Monti Memorial Research Foundation and grants from the National Cancer Institute (CA087497) and National Institutes of Health/American Recovery and Reinvestment Act (CA148532) to S. W. L. and by a Canadian Institutes of Health Research grant (MOP-106530) to J. P. C. S. was supported by the Angel Foundation with a Curt Engelhorn fellowship and C. M. was supported by an American Association for Cancer Research-Astellas fellowship. S. W. L. is a Howard Hughes Medical Institute Investigator.	Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Cano VSP, 2008, FEBS J, V275, P44, DOI 10.1111/j.1742-4658.2007.06172.x; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chen WY, 2006, BLOOD, V107, P2477, DOI 10.1182/blood-2005-07-2950; COOPER HL, 1982, CELL, V29, P791, DOI 10.1016/0092-8674(82)90441-X; Curtiss NP, 2005, GENOMICS, V85, P600, DOI 10.1016/j.ygeno.2005.01.013; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Eischen CM, 2001, MOL CELL BIOL, V21, P7653, DOI 10.1128/MCB.21.22.7653-7662.2001; Hanahan D, 2007, GENE DEV, V21, P2258, DOI 10.1101/gad.1583307; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knudson AG, 2002, AM J MED GENET, V111, P96, DOI 10.1002/ajmg.10320; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kratz CP, 2001, GENOMICS, V77, P171, DOI 10.1006/geno.2001.6636; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; McCurrach ME, 2001, METHOD CELL BIOL, V66, P197; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Parreiras-e-Silva LT, 2010, J CELL PHYSIOL, V225, P500, DOI 10.1002/jcp.22229; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rubio-Moscardo F, 2005, BLOOD, V105, P4445, DOI 10.1182/blood-2004-10-3907; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Salaverria I, 2007, J CLIN ONCOL, V25, P1216, DOI 10.1200/JCO.2006.08.4251; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Taylor P, 2009, J PROTEOME RES, V8, P1610, DOI 10.1021/pr800986c; Washburn Michael P., 2004, Briefings in Functional Genomics & Proteomics, V3, P280, DOI 10.1093/bfgp/3.3.280; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Young KH, 2007, BLOOD, V110, P4396, DOI 10.1182/blood-2007-02-072082; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	42	102	103	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					244	U131		10.1038/nature11126	http://dx.doi.org/10.1038/nature11126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722845	Green Accepted			2022-12-01	WOS:000306278900042
J	Jiang, YW; Jo, AY; Graff, JM				Jiang, Yuwei; Jo, A-Young; Graff, Jonathan M.			SnapShot: Adipocyte Life Cycle	CELL			English	Editorial Material							ADIPOSE-TISSUE; CELLS; WHITE; VASCULATURE; DYNAMICS		[Jiang, Yuwei; Jo, A-Young; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Jiang, YW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064261, R01DK064261, R01DK088220] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK064261, R01 DK088220, R56 DK064261] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012	10	19	20	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 6	2012	150	1					234	+		10.1016/j.cell.2012.06.022	http://dx.doi.org/10.1016/j.cell.2012.06.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770223	Bronze			2022-12-01	WOS:000306115000021
J	Pezzulo, AA; Tang, XX; Hoegger, MJ; Abou Alaiwa, MH; Ramachandran, S; Moninger, TO; Karp, PH; Wohlford-Lenane, CL; Haagsman, HP; van Eijk, M; Banfi, B; Horswill, AR; Stoltz, DA; McCray, PB; Welsh, MJ; Zabner, J				Pezzulo, Alejandro A.; Tang, Xiao Xiao; Hoegger, Mark J.; Abou Alaiwa, Mahmoud H.; Ramachandran, Shyam; Moninger, Thomas O.; Karp, Phillip H.; Wohlford-Lenane, Christine L.; Haagsman, Henk P.; van Eijk, Martin; Banfi, Botond; Horswill, Alexander R.; Stoltz, David A.; McCray, Paul B., Jr.; Welsh, Michael J.; Zabner, Joseph			Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung	NATURE			English	Article							ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL ACTIVITY; BICARBONATE SECRETION; ION COMPOSITION; EPITHELIA; LIQUID; CONDUCTANCE; ABSORPTION; TRANSPORT; MODEL	Cystic fibrosis (CF) is a life-shortening disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene(1). Although bacterial lung infection and the resulting inflammation cause most of the morbidity and mortality, how the loss of CFTR function first disrupts airway host defence has remained uncertain(2-6). To investigate the abnormalities that impair elimination when a bacterium lands on the pristine surface of a newborn CF airway, we interrogated the viability of individual bacteria immobilized on solid grids and placed onto the airway surface. As a model, we studied CF pigs, which spontaneously develop hallmark features of CF lung disease(7,8). At birth, their lungs lack infection and inflammation, but have a reduced ability to eradicate bacteria(8). Here we show that in newborn wild-type pigs, the thin layer of airway surface liquid (ASL) rapidly kills bacteria in vivo, when removed from the lung and in primary epithelial cultures. Lack of CFTR reduces bacterial killing. We found that the ASL pH was more acidic in CF pigs, and reducing pH inhibited the antimicrobial activity of ASL. Reducing ASL pH diminished bacterial killing in wild-type pigs, and, conversely, increasing ASL pH rescued killing in CF pigs. These results directly link the initial host defence defect to the loss of CFTR, an anion channel that facilitates HCO3- transport(9-13). Without CFTR, airway epithelial HCO3- secretion is defective, the ASL pH falls and inhibits antimicrobial function, and thereby impairs the killing of bacteria that enter the newborn lung. These findings suggest that increasing ASL pH might prevent the initial infection in patients with CF, and that assaying bacterial killing could report on the benefit of therapeutic interventions.	[Pezzulo, Alejandro A.; Tang, Xiao Xiao; Hoegger, Mark J.; Abou Alaiwa, Mahmoud H.; Karp, Phillip H.; Banfi, Botond; Stoltz, David A.; Welsh, Michael J.; Zabner, Joseph] Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Tang, Xiao Xiao; Karp, Phillip H.; Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ramachandran, Shyam; Wohlford-Lenane, Christine L.; McCray, Paul B., Jr.] Univ Iowa, Dept Pediat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Moninger, Thomas O.] Univ Iowa, Cent Electron Microscopy Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Haagsman, Henk P.; van Eijk, Martin] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Utrecht University; University of Iowa; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu; joseph-zabner@uiowa.edu	Hoegger, Mark/K-7926-2019; Haagsman, Henk P/F-8919-2010	Pezzulo, Alejandro/0000-0001-7544-5109; Welsh, Michael/0000-0002-1646-6206; McCray, Paul/0000-0002-4067-577X; Banfi, Botond/0000-0001-9273-1318; Stoltz, David/0000-0003-0893-9015; Abou Alaiwa, Mahmoud/0000-0003-4525-0217; Zabner, Joseph/0000-0002-9606-1339	National Institutes of Health (NIH) [HL51670, HL091842, HL102288]; Cystic Fibrosis Foundation; Gilead Sciences Research Scholars Program in Cystic Fibrosis; Human Frontier Science Program [RGP001612009-C];  [AI076671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, P01HL051670, U01HL102288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921, K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Gilead Sciences Research Scholars Program in Cystic Fibrosis; Human Frontier Science Program(Human Frontier Science Program); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bartlett, X. Chamling, J.-H. Chen, L. Durairaj, N. Gansemer, E. Hornick, P. Hughes, P. Ludwig, T. Mayhew, K. Mohn, L. Ostedgaard, M. Rector, L. Reznikov, L. Schneider, A. Shelton, T. Starner, P. Tan, A. Tucker, A. Walimbe and T. Yahr for assistance and/or discussion. This work was supported by the National Institutes of Health (NIH; HL51670, HL091842, HL102288) and the Cystic Fibrosis Foundation. D. A. S. was supported by AI076671 and Gilead Sciences Research Scholars Program in Cystic Fibrosis. H. P. H. was supported by Program Grant (RGP001612009-C) of the Human Frontier Science Program. M. J. W. is a Howard Hughes Medical Institute investigator.	Blossfeld S, 2007, PLANT CELL ENVIRON, V30, P176, DOI 10.1111/j.1365-3040.2006.01616.x; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Cole AM, 2000, J MICROBIOL METH, V41, P135, DOI 10.1016/S0167-7012(00)00140-8; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/nnano.2010.29, 10.1038/NNANO.2010.29]; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Foundation C. F., 2010, CYST FIBR FDN PAT RE; Ganz T, 2004, J LEUKOCYTE BIOL, V75, P34, DOI 10.1189/jlb.0403150; Garnett JP, 2011, J BIOL CHEM, V286, P41069, DOI 10.1074/jbc.M111.266734; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Grubb BR, 1999, PHYSIOL REV, V79, P193; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Knowles MR, 1997, J CLIN INVEST, V100, P2588, DOI 10.1172/JCI119802; Laubel DM, 2006, CURR TOP MICROBIOL, V306, P153; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2010, AM J PHYSIOL-CELL PH, V299, pC1222, DOI 10.1152/ajpcell.00362.2010; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984; Shuba YM, 2008, CELL CALCIUM, V44, P220, DOI 10.1016/j.ceca.2007.12.003; Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983; Singh PK, 2000, AM J PHYSIOL-LUNG C, V279, pL799, DOI 10.1152/ajplung.2000.279.5.L799; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; SMITH JJ, 1992, J CLIN INVEST, V89, P1148, DOI 10.1172/JCI115696; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; Welsh MJ., 2001, METABOLIC MOL BASES, P5121; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1	41	568	580	3	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					109	+		10.1038/nature11130	http://dx.doi.org/10.1038/nature11130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22763554	Green Accepted			2022-12-01	WOS:000305982900060
J	Morita, A; Kirino, T; Hashi, K; Aoki, N; Fukuhara, S; Hashimoto, N; Nakayama, T; Sakai, M; Teramoto, A; Tominari, S; Yoshimoto, T				Morita, Akio; Kirino, Takaaki; Hashi, Kazuo; Aoki, Noriaki; Fukuhara, Shunichi; Hashimoto, Nobuo; Nakayama, Takeo; Sakai, Michi; Teramoto, Akira; Tominari, Shinjiro; Yoshimoto, Takashi		UCAS Japan Investigators	The Natural Course of Unruptured Cerebral Aneurysms in a Japanese Cohort	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRACRANIAL ANEURYSMS; RUPTURE; MANAGEMENT; SHAPE; RISK	BACKGROUND The natural history of unruptured cerebral aneurysms has not been clearly defined. METHODS From January 2001 through April 2004, we enrolled patients with newly identified, unruptured cerebral aneurysms in Japan. Information on the rupture of aneurysms, deaths, and the results of periodic follow-up examinations were recorded. We included 5720 patients 20 years of age or older (mean age, 62.5 years; 68% women) who had saccular aneurysms that were 3 mm or more in the largest dimension and who initially presented with no more than a slight disability. RESULTS Of the 6697 aneurysms studied, 91% were discovered incidentally. Most aneurysms were in the middle cerebral arteries (36%) and the internal carotid arteries (34%). The mean (+/- SD) size of the aneurysms was 5.7 +/- 3.6 mm. During a follow-up period that included 11,660 aneurysm-years, ruptures were documented in 111 patients, with an annual rate of rupture of 0.95% (95% confidence interval [CI], 0.79 to 1.15). The risk of rupture increased with increasing size of the aneurysm. With aneurysms that were 3 to 4 mm in size as the reference, the hazard ratios for size categories were as follows: 5 to 6 mm, 1.13 (95% CI, 0.58 to 2.22); 7 to 9 mm, 3.35 (95% CI, 1.87 to 6.00); 10 to 24 mm, 9.09 (95% CI, 5.25 to 15.74); and 25 mm or larger, 76.26 (95% CI, 32.76 to 177.54). As compared with aneurysms in the middle cerebral arteries, those in the posterior and anterior communicating arteries were more likely to rupture (hazard ratio, 1.90 [95% CI, 1.12 to 3.21] and 2.02 [95% CI, 1.13 to 3.58], respectively). Aneurysms with a daughter sac (an irregular protrusion of the wall of the aneurysm) were also more likely to rupture (hazard ratio, 1.63; 95% CI, 1.08 to 2.48). CONCLUSIONS This study showed that the natural course of unruptured cerebral aneurysms varies according to the size, location, and shape of the aneurysm. (Funded by the Ministry of Health, Labor, and Welfare in Japan and others; UCAS Japan UMIN-CTR number, C000000418.)	[Morita, Akio] Univ Tokyo, Fac Med, UCAS Japan Coordinating Off, Dept Neurosurg,Bunkyo Ku, Tokyo 1138655, Japan; [Morita, Akio] NTT Med Ctr Tokyo, Dept Neurosurg, Tokyo, Japan; [Kirino, Takaaki] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Hashi, Kazuo] Pacific Neurosurg Consulting, Sapporo, Hokkaido, Japan; [Aoki, Noriaki] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Aoki, Noriaki] Outcomes Res & Dev Japan CHORD J, Ctr Hlth Serv, Tokyo, Japan; [Fukuhara, Shunichi] Kyoto Univ, Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Hashimoto, Nobuo] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan; [Nakayama, Takeo; Tominari, Shinjiro] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Sakai, Michi] CHORD J, Tokyo, Japan; [Teramoto, Akira] Nippon Med Sch, Dept Neurosurg, Tokyo 113, Japan; [Teramoto, Akira] Japan Neurosurg Soc, Tokyo, Japan; [Yoshimoto, Takashi] Natl Ctr Univ Entrance Examinat, Tokyo, Japan	University of Tokyo; Kanto Medical Center NTT EC; National Center for Global Health & Medicine - Japan; University of Texas System; University of Texas Health Science Center Houston; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; Nippon Medical School	Morita, A (corresponding author), Univ Tokyo, Fac Med, UCAS Japan Coordinating Off, Dept Neurosurg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ucasj-head@umin.ac.jp	Fujioka, Hiroyuki/E-7041-2013; NAKAYAMA, Takeo/HCH-0537-2022; Nakahara, Ichiro/G-3259-2010	Fujioka, Hiroyuki/0000-0001-8653-3761; Nakahara, Ichiro/0000-0001-8909-2949; Morita, Akio/0000-0002-2497-5772; Nakayama, Takeo/0000-0002-7918-6252	Ministry of Health, Labor and Welfare in Japan; National Cerebral and Cardiovascular Center in Japan; Japan Brain Foundation; UCAS Japan UMIN-CTR [C000000418]	Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); National Cerebral and Cardiovascular Center in Japan; Japan Brain Foundation; UCAS Japan UMIN-CTR	Funded by the Ministry of Health, Labor, and Welfare in Japan and others; UCAS Japan UMIN-CTR number, C000000418.); Supported by grants from the Ministry of Health, Labor and Welfare in Japan, the National Cerebral and Cardiovascular Center in Japan, and the Japan Brain Foundation.	Bederson JB, 2000, STROKE, V31, P2742, DOI 10.1161/01.STR.31.11.2742; Huang MC, 2011, STROKE, V42, P1730, DOI 10.1161/STROKEAHA.110.603803; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Morita A, 2005, J NEUROSURG, V102, P601, DOI 10.3171/jns.2005.102.4.0601; NAKAGAWA T, 1994, J NEUROSURG, V80, P217, DOI 10.3171/jns.1994.80.2.0217; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Weir B, 2002, J NEUROSURG, V96, P3, DOI 10.3171/jns.2002.96.1.0003; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1999, NEW ENGL J MED, V340, P744; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401; Yasui N, 1997, NEUROSURGERY, V40, P1155, DOI 10.1097/00006123-199706000-00007	17	841	897	3	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2474	2482		10.1056/nejmoa1113260	http://dx.doi.org/10.1056/nejmoa1113260			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738097				2022-12-01	WOS:000305747000007
J	Zisoulis, DG; Kai, ZS; Chang, RK; Pasquinelli, AE				Zisoulis, Dimitrios G.; Kai, Zoya S.; Chang, Roger K.; Pasquinelli, Amy E.			Autoregulation of microRNA biogenesis by let-7 and Argonaute	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; SMALL RNAS; LIN-28; EXPRESSION; MATURATION; SITES; BINDS; LIN28; DECAY	MicroRNAs (miRNAs) comprise a large family of small RNA molecules that post-transcriptionally regulate gene expression in many biological pathways(1). Most miRNAs are derived from long primary transcripts that undergo processing by Drosha to produce similar to 65-nucleotide precursors that are then cleaved by Dicer, resulting in the mature 22-nucleotide forms(2,3). Serving as guides in Argonaute protein complexes, mature miRNAs use imperfect base pairing to recognize sequences in messenger RNA transcripts, leading to translational repression and destabilization of the target messenger RNAs4,5. Here we show that the miRNA complex also targets and regulates non-coding RNAs that serve as substrates for the miRNA-processing pathway. We found that the Argonaute protein in Caenorhabditis elegans, ALG-1, binds to a specific site at the 3' end of let-7 miRNA primary transcripts and promotes downstream processing events. This interaction is mediated by mature let-7 miRNA through a conserved complementary site in its own primary transcript, thus creating a positive-feedback loop. We further show that ALG-1 associates with let-7 primary transcripts in nuclear fractions. Argonaute also binds let-7 primary transcripts in human cells, demonstrating that the miRNA pathway targets non-coding RNAs in addition to protein-coding messenger RNAs across species. Moreover, our studies in C. elegans reveal a novel role for Argonaute in promoting biogenesis of a targeted transcript, expanding the functions of the miRNA pathway in gene regulation. This discovery of autoregulation of let-7 biogenesis establishes a new mechanism for controlling miRNA expression.	[Zisoulis, Dimitrios G.; Kai, Zoya S.; Chang, Roger K.; Pasquinelli, Amy E.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Chang, Roger K.] Stockholm Univ, Dept Biol Educ, S-10691 Stockholm, Sweden	University of California System; University of California San Diego; Stockholm University	Pasquinelli, AE (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.	apasquinelli@ucsd.edu		Chang, Roger/0000-0001-8085-9285	Leukemia & Lymphoma Society [3611-11]; US National Institutes of Health (NIH) CMG; NIH/NCI [T32 CA009523]; Swedish Board of Study Support; NIH [GM071654]; Keck Foundation; Peter Gruber Foundation; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071654] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); US National Institutes of Health (NIH) CMG; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Board of Study Support; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); Peter Gruber Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lykke-Andersen and members of the Pasquinelli lab for reading the manuscript, and we thank D. Hogan for discussions. We thank F. Slack for originally pointing out the let-7 complementary site in pri-let-7; the M. David lab for sharing their real-time PCR machine; P. Van Wynsberghe for the Delta alg-1 primary let-7 plasmid; C. Mello for the worm fractionation protocol; E. Moss for LIN-28 antibodies; and A. Gorin, H. Jenq and S. Verma for technical assistance. Funding was provided by a Leukemia & Lymphoma Society Special Fellow Award 3611-11 (D.G.Z.); US National Institutes of Health (NIH) CMG and NIH/NCI T32 CA009523 Training Grants (Z.S.K.); the Swedish Board of Study Support (R. K. C.); and NIH grant GM071654, the Keck Foundation and the Peter Gruber Foundation (A.E.P.).	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Bussing I, 2010, EMBO J, V29, P1830, DOI 10.1038/emboj.2010.82; Castanotto D, 2009, P NATL ACAD SCI USA, V106, P21655, DOI 10.1073/pnas.0912384106; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	29	163	172	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					541	U140		10.1038/nature11134	http://dx.doi.org/10.1038/nature11134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722835	Green Accepted			2022-12-01	WOS:000305760600045
J	Broz, P; Ruby, T; Belhocine, K; Bouley, DM; Kayagaki, N; Dixit, VM; Monack, DM				Broz, Petr; Ruby, Thomas; Belhocine, Kamila; Bouley, Donna M.; Kayagaki, Nobuhiko; Dixit, Vishva M.; Monack, Denise M.			Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1	NATURE			English	Article							INFLAMMASOME RECEPTORS; HOST-DEFENSE; INTERLEUKIN-1-BETA; ACTIVATION; TYPHIMURIUM; FLAGELLIN; NEUTROPHILS; SECRETION; ADAPTERS; FAMILY	Inflammasomes are cytosolic multiprotein complexes assembled by intracellular nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and they initiate innate immune responses to invading pathogens and danger signals by activating caspase-1 (ref. 1). Caspase-1 activation leads to the maturation and release of the pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18, as well as lytic inflammatory cell death known as pyroptosis(2). Recently, a new non-canonical inflammasome was described that activates caspase-11, a pro-inflammatory caspase required for lipopolysaccharide-induced lethality(3). This study also highlighted that previously generated caspase-1 knockout mice lack a functional allele of Casp11 (also known as Casp4), making them functionally Casp1 Casp11 double knockouts(3-6). Previous studies have shown that these mice are more susceptible to infections with microbial pathogens(1), including the bacterial pathogen Salmonella enterica serovar Typhimurium (S. typhimurium)(7,8), but the individual contributions of caspase-1 and caspase-11 to this phenotype are not known. Here we show that non-canonical caspase-11 activation contributes to macrophage death during S. typhimurium infection. Toll-like receptor 4 (TLR4)-dependent and TIR-domaincontaining adaptor-inducing interferon-beta (TRIF)-dependent interferon-beta production is crucial for caspase-11 activation in macrophages, but is only partially required for pro-caspase-11 expression, consistent with the existence of an interferon-inducible activator of caspase-11. Furthermore, Casp1(-/-) mice were significantly more susceptible to infection with S. typhimurium than mice lacking both pro-inflammatory caspases (Casp1(-/-) Casp11(-/-)). This phenotype was accompanied by higher bacterial counts, the formation of extracellular bacterial microcolonies in the infected tissue and a defect in neutrophil-mediated clearance. These results indicate that caspase-11-dependent cell death is detrimental to the host in the absence of caspase-1-mediated innate immunity, resulting in extracellular replication of a facultative intracellular bacterial pathogen.	[Broz, Petr; Ruby, Thomas; Belhocine, Kamila; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA; [Bouley, Donna M.] Stanford Univ, Dept Comparat Med, Stanford Sch Med, Stanford, CA 94305 USA; [Kayagaki, Nobuhiko; Dixit, Vishva M.] Genentech Inc, San Francisco, CA 94080 USA	Stanford University; Stanford University; Roche Holding; Genentech	Monack, DM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.	dmonack@stanford.edu	dixit, vishva m/A-4496-2012; Broz, Petr/AAC-7940-2019	dixit, vishva m/0000-0001-6983-0326; Broz, Petr/0000-0002-2334-7790; Monack, Denise/0000-0003-3804-2209	National Institute of Allergy and Infectious Diseases (NIAID) [AI095396, AI08972]; Stanford Digestive Disease Center (DDC) pilot grant; Human Frontiers in Science Program (HFSP) [LT000636/2009-L]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089722, R01AI095396, F32AI008972] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Digestive Disease Center (DDC) pilot grant; Human Frontiers in Science Program (HFSP)(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Dong, M. Wong, P. Chu and H. Matthew for technical support, G. Barton for Tlr4<SUP>-/-</SUP> and Tlr2<SUP>-/-</SUP> mice, and all members of the Monack laboratory for discussions and help with animal experiments. This work was supported by awards AI095396 and AI08972 from the National Institute of Allergy and Infectious Diseases (NIAID) to D. M. M., a Stanford Digestive Disease Center (DDC) pilot grant to P. B. and a long-term fellowship (LT000636/2009-L) from the Human Frontiers in Science Program (HFSP) to P.B.	Akhter A, 2012, IMMUNITY; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Conlan JW, 1996, INFECT IMMUN, V64, P1043, DOI 10.1128/IAI.64.3.1043-1047.1996; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Monack DM, 2001, CELL MICROBIOL, V3, P825, DOI 10.1046/j.1462-5822.2001.00162.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Valdez Y, 2009, CURR TOP MICROBIOL, V337, P93, DOI 10.1007/978-3-642-01846-6_4; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	23	380	386	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					288	+		10.1038/nature11419	http://dx.doi.org/10.1038/nature11419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22895188	Green Accepted			2022-12-01	WOS:000309733300055
J	Hu, ZT; Hom, S; Kudze, T; Tong, XJ; Choi, S; Aramuni, G; Zhang, WQ; Kaplan, JM				Hu, Zhitao; Hom, Sabrina; Kudze, Tambudzai; Tong, Xia-Jing; Choi, Seungwon; Aramuni, Gayane; Zhang, Weiqi; Kaplan, Joshua M.			Neurexin and Neuroligin Mediate Retrograde Synaptic Inhibition in C. elegans	SCIENCE			English	Article							SPECTRUM DISORDERS; AUTISM; MATURATION; MUTATIONS; CELL	The synaptic adhesion molecules neurexin and neuroligin alter the development and function of synapses and are linked to autism in humans. Here, we found that Caenorhabditis elegans neurexin (NRX-1) and neuroligin (NLG-1) mediated a retrograde synaptic signal that inhibited neurotransmitter release at neuromuscular junctions. Retrograde signaling was induced in mutants lacking a muscle microRNA (miR-1) and was blocked in mutants lacking NLG-1 or NRX-1. Release was rapid and abbreviated when the retrograde signal was on, whereas release was slow and prolonged when retrograde signaling was blocked. The retrograde signal adjusted release kinetics by inhibiting exocytosis of synaptic vesicles (SVs) that are distal to the site of calcium entry. Inhibition of release was mediated by increased presynaptic levels of tomosyn, an inhibitor of SV fusion.	[Hu, Zhitao; Hom, Sabrina; Kudze, Tambudzai; Tong, Xia-Jing; Choi, Seungwon; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Hu, Zhitao; Hom, Sabrina; Tong, Xia-Jing; Choi, Seungwon; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Hom, Sabrina; Choi, Seungwon; Kaplan, Joshua M.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Aramuni, Gayane] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Zhang, Weiqi] Univ Munster, Dept Psychiat, D-48149 Munster, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Max Planck Society; University of Munster	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu		Hu, Zhitao/0000-0002-2948-3339; Choi, Seungwon/0000-0002-8644-3659	NSF; NIH [NS32196]; Simons Foundation for Autism Research [SF177948]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032196, R37NS032196] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following for strains, advice, reagents, and comments on the manuscript: C. elegans stock center, S. Mitani, S. Sassi, B. Seed, and members of the Kaplan and Ruvkun labs. This work was supported by an NSF predoctoral fellowship (S. H.) and by research grants to J.M.K. from the NIH (NS32196) and from the Simons Foundation for Autism Research (SF177948). Additional data described in the manuscript are presented in the supplementary materials.	Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Chen KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011115; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Hunter JW, 2010, DIS MODEL MECH, V3, P366, DOI 10.1242/dmm.003442; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Liu Q, 2005, J NEUROSCI, V25, P6745, DOI 10.1523/JNEUROSCI.1730-05.2005; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Novara F, 2010, CLIN GENET, V78, P471, DOI 10.1111/j.1399-0004.2010.01413.x; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106	24	72	75	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					980	984		10.1126/science.1224896	http://dx.doi.org/10.1126/science.1224896			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22859820	Green Accepted			2022-12-01	WOS:000307807600049
J	Kadauke, S; Udugama, MI; Pawlicki, JM; Achtman, JC; Jain, DP; Cheng, Y; Hardison, RC; Blobel, GA				Kadauke, Stephan; Udugama, Maheshi I.; Pawlicki, Jan M.; Achtman, Jordan C.; Jain, Deepti P.; Cheng, Yong; Hardison, Ross C.; Blobel, Gerd A.			Tissue-Specific Mitotic Bookmarking by Hematopoietic Transcription Factor GATA1	CELL			English	Article							LOCUS-CONTROL REGION; ZINC-FINGER PROTEIN; ACTIVE GENES; HISTONE H3; DYNAMIC CHANGES; LIVING CELLS; STEM-CELLS; CHROMATIN; MITOSIS; CHROMOSOMES	Tissue-specific transcription patterns are preserved throughout cell divisions to maintain lineage fidelity. We investigated whether transcription factor GATA1 plays a role in transmitting hematopoietic gene expression programs through mitosis when transcription is transiently silenced. Live-cell imaging revealed that a fraction of GATA1 is retained focally within mitotic chromatin. ChIP-seq of highly purified mitotic cells uncovered that key hematopoietic regulatory genes are occupied by GATA1 in mitosis. The GATA1 coregulators FOG1 and TAL1 dissociate from mitotic chromatin, suggesting that GATA1 functions as platform for their postmitotic recruitment. Mitotic GATA1 target genes tend to reactivate more rapidly upon entry into G1 than genes from which GATA1 dissociates. Mitosis-specific destruction of GATA1 delays reactivation selectively of genes that retain GATA1 during mitosis. These studies suggest a requirement of mitotic "bookmarking" by GATA1 for the faithful propagation of cell-type-specific transcription programs through cell division.	[Kadauke, Stephan; Udugama, Maheshi I.; Pawlicki, Jan M.; Achtman, Jordan C.; Blobel, Gerd A.] Childrens Hosp, Div Hematol, Philadelphia, PA 19104 USA; [Kadauke, Stephan; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jain, Deepti P.; Cheng, Yong; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Blobel, GA (corresponding author), Childrens Hosp, Div Hematol, Philadelphia, PA 19104 USA.	blobel@email.chop.edu	cheng, yong/I-4270-2012; Kadauke, Stephan/V-6197-2019; Hardison, Ross C/G-1142-2010	Hardison, Ross C/0000-0003-4084-7516; Udugama, Maheshi/0000-0003-0412-4142; Kadauke, Stephan/0000-0003-2996-8034	AHA predoctoral fellowship [90PRE2300139]; NIH [DK058044, DK054937, DK065806, HG005573]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054937, R01DK058044, R37DK058044, R56DK065806, R01DK065806] Funding Source: NIH RePORTER	AHA predoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Alan Lau, Margaret Chou, Jordan Orange, Aline Disimone, Paul Gadue, Rena Zheng, Joanna Balcerek, Chris Thom, Ariel Yang, and Merav Socolovsky for technical assistance and advice; and Christopher Vakoc, Mitchell Weiss, Mitchell Lazar, and members of the laboratory for comments on the manuscript. This work was supported by an AHA predoctoral fellowship (90PRE2300139, S. K.), NIH grants DK058044 and DK054937 (G. A. B.), and DK065806 and HG005573 (R. C. H.). Author contributions: S. K., M. I. U., J.M.P., J.C.A. performed experiments; S. K., D.P.J., Y.C. performed computational analyses; S. K., R. C. H. and G. A. B. conceived the study and wrote the manuscript.	Aoto T, 2008, J BIOL CHEM, V283, P18905, DOI 10.1074/jbc.M709322200; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Delcuve GP, 2008, J CELL BIOCHEM, V105, P1, DOI 10.1002/jcb.21806; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Elnitski L, 1997, J BIOL CHEM, V272, P369; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Johnson KD, 2007, BLOOD, V109, P5230, DOI 10.1182/blood-2007-02-072983; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Komura JI, 2007, P NATL ACAD SCI USA, V104, P15741, DOI 10.1073/pnas.0702363104; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; KUO MT, 1982, NUCLEIC ACIDS RES, V10, P4565, DOI 10.1093/nar/10.15.4565; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Porcher C, 1999, DEVELOPMENT, V126, P4603; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Sarge KD, 2009, CELL CYCLE, V8, P818, DOI 10.4161/cc.8.6.7849; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; TAYLOR JH, 1960, ANN NY ACAD SCI, V90, P409, DOI 10.1111/j.1749-6632.1960.tb23259.x; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Valls E, 2005, J BIOL CHEM, V280, P42592, DOI 10.1074/jbc.M507407200; Varier RA, 2010, EMBO J, V29, P3967, DOI 10.1038/emboj.2010.261; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Xin L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-31; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100	67	158	160	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					725	737		10.1016/j.cell.2012.06.038	http://dx.doi.org/10.1016/j.cell.2012.06.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901805	Green Accepted, Bronze			2022-12-01	WOS:000308002300008
J	Georgianna, DR; Mayfield, SP				Georgianna, D. Ryan; Mayfield, Stephen P.			Exploiting diversity and synthetic biology for the production of algal biofuels	NATURE			English	Review							TECHNOECONOMIC ANALYSIS; BIODIESEL PRODUCTION; MASS CULTIVATION; MICROALGAE; TEMPERATURE; BIOMASS; OIL; PHOTOSYNTHESIS; BIOSYNTHESIS; ACCUMULATION	Modern life is intimately linked to the availability of fossil fuels, which continue to meet the world's growing energy needs even though their use drives climate change, exhausts finite reserves and contributes to global political strife. Biofuels made from renewable resources could be a more sustainable alternative, particularly if sourced from organisms, such as algae, that can be farmed without using valuable arable land. Strain development and process engineering are needed to make algal biofuels practical and economically viable.	[Georgianna, D. Ryan; Mayfield, Stephen P.] Univ Calif San Diego, Div Biol Sci, San Diego Ctr Algae Biotechnol SD CAB, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Mayfield, SP (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego Ctr Algae Biotechnol SD CAB, 9500 Gilman Dr, La Jolla, CA 92093 USA.	smayfield@ucsd.edu			US Department of Energy [DE-EE-0003373]; California Energy Commission Initiative for Large Molecule Sustainable Fuels [500-10-039]	US Department of Energy(United States Department of Energy (DOE)); California Energy Commission Initiative for Large Molecule Sustainable Fuels	This work was supported by the US Department of Energy, grant number DE-EE-0003373, and the California Energy Commission Initiative for Large Molecule Sustainable Fuels, Agreement Number: 500-10-039.	Amer L, 2011, BIORESOURCE TECHNOL, V102, P9350, DOI 10.1016/j.biortech.2011.08.010; Amin S, 2009, ENERG CONVERS MANAGE, V50, P1834, DOI 10.1016/j.enconman.2009.03.001; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Bechet Q, 2010, ENVIRON SCI TECHNOL, V44, P2197, DOI 10.1021/es903214u; Beckmann J, 2009, J BIOTECHNOL, V142, P70, DOI 10.1016/j.jbiotec.2009.02.015; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; 배진희, 2011, Fisheries and Aquatic Sciences, V14, P323; Butterwick C, 2005, FRESHWATER BIOL, V50, P291; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Chen YH, 2011, BIOTECHNOL LETT, V33, P1973, DOI 10.1007/s10529-011-0672-y; Chowdhury R, 2012, BIORESOURCE TECHNOL, V108, P102, DOI 10.1016/j.biortech.2011.12.099; Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Darzins A., 2010, IEA BIOENERGY TASK, V39; Davis R, 2011, APPL ENERG, V88, P3524, DOI 10.1016/j.apenergy.2011.04.018; Doucha J, 2012, J APPL PHYCOL, V24, P35, DOI 10.1007/s10811-010-9643-2; Duan PG, 2011, BIORESOURCE TECHNOL, V102, P1899, DOI 10.1016/j.biortech.2010.08.013; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Grabski K, 2008, J APPL PHYCOL, V20, P323, DOI 10.1007/s10811-007-9260-x; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Jaycor, 1985, REV EV IMM ALG SYST; Johnson X, 2011, PLANT MOL BIOL, V76, P397, DOI 10.1007/s11103-011-9783-z; Keasling JD, 2008, NAT BIOTECHNOL, V26, P298, DOI 10.1038/nbt0308-298; Khoo HH, 2011, BIORESOURCE TECHNOL, V102, P5800, DOI 10.1016/j.biortech.2011.02.055; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Knothe G, 2009, ENERG ENVIRON SCI, V2, P759, DOI 10.1039/b903941d; La Russa M, 2012, J BIOTECHNOL; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Larkum AWD, 2012, TRENDS BIOTECHNOL, V30, P198, DOI 10.1016/j.tibtech.2011.11.003; Lee JT, 2009, APPL ENVIRON MICROB, V75, P1703, DOI 10.1128/AEM.02081-08; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; Levine RB, 2010, ENERG FUEL, V24, P5235, DOI 10.1021/ef1008314; Li Q, 2012, METAB ENG, V14, P1, DOI 10.1016/j.ymben.2011.12.003; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Luo Y, 2010, FUEL PROCESS TECHNOL, V91, P613, DOI 10.1016/j.fuproc.2010.01.007; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; MIYAMOTO K, 1979, APPL ENVIRON MICROB, V37, P454, DOI 10.1128/AEM.37.3.454-458.1979; Montagnes DJS, 2008, AQUAT MICROB ECOL, V53, P211, DOI 10.3354/ame01245; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Murphy CF, 2011, ENVIRON SCI TECHNOL, V45, P5861, DOI 10.1021/es200109z; Mutanda T, 2011, BIORESOURCE TECHNOL, V102, P57, DOI 10.1016/j.biortech.2010.06.077; Natrah FMI, 2011, AQUACULTURE, V317, P53, DOI 10.1016/j.aquaculture.2011.04.038; NYSE Euronext, 2012, LOND INT FIN FUT OPT; O'Neill BM, 2012, NUCLEIC ACIDS RES, V40, P2782, DOI 10.1093/nar/gkr1008; Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886; Pohnert G, 2007, TRENDS ECOL EVOL, V22, P198, DOI 10.1016/j.tree.2007.01.005; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Rajamani S, 2008, MOL PLANT MICROBE IN, V21, P1184, DOI 10.1094/MPMI-21-9-1184; Ras M, 2011, BIORESOURCE TECHNOL, V102, P200, DOI 10.1016/j.biortech.2010.06.146; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Rosch C, 2012, BIORESOURCE TECHNOL, V107, P191, DOI 10.1016/j.biortech.2011.12.016; Savage N, 2011, NATURE, V474, pS15, DOI 10.1038/474S015a; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Shen Y, 2009, T ASABE, V52, P1275, DOI 10.13031/2013.27771; Shirvani T, 2011, ENERG ENVIRON SCI, V4, P3773, DOI 10.1039/c1ee01791h; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Sukenik A, 2009, AQUAT MICROB ECOL, V56, P297, DOI 10.3354/ame01309; Teplitski M, 2004, PLANT PHYSIOL, V134, P137, DOI 10.1104/pp.103.029918; Tirichine L, 2011, PLANT J, V66, P45, DOI 10.1111/j.1365-313X.2011.04540.x; U.S. Department of Energy, 2010, NAT ALG BIOF TECHN R; US Department of Energy, 2010, SOL INT BIOR DIS FUE; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vardi A, 2007, ENVIRON MICROBIOL, V9, P360, DOI 10.1111/j.1462-2920.2006.01146.x; Wahlen BD, 2011, BIORESOURCE TECHNOL, V102, P2724, DOI 10.1016/j.biortech.2010.11.026; Wei D, 2004, BIOTECHNOL APPL BIOC, V40, P187, DOI 10.1042/BA20030142; Wigmosta MS, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009966; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; WOLF FR, 1985, PHYTOCHEMISTRY, V24, P733; Wu ZC, 2012, BIORESOURCE TECHNOL, V110, P496, DOI 10.1016/j.biortech.2012.01.101; Yang Y, 2011, BIORESOURCE TECHNOL, V102, P5076, DOI 10.1016/j.biortech.2011.02.014; Zamalloa C, 2012, APPL ENERG, V92, P733, DOI 10.1016/j.apenergy.2011.08.017; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	87	478	502	18	640	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					329	335		10.1038/nature11479	http://dx.doi.org/10.1038/nature11479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895338				2022-12-01	WOS:000307501000032
J	Lasker, SS; Chowdhury, TA				Lasker, Shawarna S.; Chowdhury, Tahseen A.			Myalgia while taking statins	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chowdhury, Tahseen A.] Royal London Hosp, Dept Diabet & Metab, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Chowdhury, TA (corresponding author), Royal London Hosp, Dept Diabet & Metab, London E1 1BB, England.	Tahseen.Chowdhury@bartshealth.nhs.uk						Eckel RH, 2010, J CLIN ENDOCR METAB, V95, P2015, DOI 10.1210/jc.2009-2689; Stein EA, 2008, AM J CARDIOL, V101, P490, DOI 10.1016/j.amjcard.2007.09.099	2	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 14	2012	345								e5348	10.1136/bmj.e5348	http://dx.doi.org/10.1136/bmj.e5348			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CD	22893641				2022-12-01	WOS:000307752000005
J	Shui, JW; Larange, A; Kim, G; Vela, JL; Zahner, S; Cheroutre, H; Kronenberg, M				Shui, Jr-Wen; Larange, Alexandre; Kim, Gisen; Vela, Jose Luis; Zahner, Sonja; Cheroutre, Hilde; Kronenberg, Mitchell			HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria	NATURE			English	Article							NF-KAPPA-B; HERPESVIRUS ENTRY MEDIATOR; CITROBACTER-RODENTIUM; PROTECTS MICE; NK CELLS; RECEPTOR; IL-22; INNATE; EXPRESSION; INFECTION	The herpes virus entry mediator (HVEM), a member of the tumour-necrosis factor receptor family, has diverse functions, augmenting or inhibiting the immune response(1). HVEM was recently reported as a colitis risk locus in patients(2), and in a mouse model of colitis we demonstrated an anti-inflammatory role for HVEM3, but its mechanism of action in the mucosal immune system was unknown. Here we report an important role for epithelial HVEM in innate mucosal defence against pathogenic bacteria. HVEM enhances immune responses by NF-kappa B-inducing kinase-dependent Stat3 activation, which promotes the epithelial expression of genes important for immunity. During intestinal Citrobacter rodentium infection(4-6), a mouse model for enteropathogenic Escherichia coli infection, Hvem(-/-) mice showed decreased Stat3 activation, impaired responses in the colon, higher bacterial burdens and increased mortality. We identified the immunoglobulin superfamily molecule CD160 (refs 7 and 8), expressed predominantly by innate-like intraepithelial lymphocytes, as the ligand engaging epithelial HVEM for host protection. Likewise, in pulmonary Streptococcus pneumoniae infection(9), HVEM is also required for host defence. Our results pinpoint HVEM as an important orchestrator of mucosal immunity, integrating signals from innate lymphocytes to induce optimal epithelial Stat3 activation, which indicates that targeting HVEM with agonists could improve host defence.	[Shui, Jr-Wen; Larange, Alexandre; Kim, Gisen; Vela, Jose Luis; Zahner, Sonja; Cheroutre, Hilde; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	mitch@liai.org	Kronenberg, Mitchell/AAT-6078-2021; Shui, Jr-Wen/Q-2617-2018	Shui, Jr-Wen/0000-0002-5243-3727	National Institutes of Health [RO1-AI061516, PO1 DK46763, F32-DK082249, F32-AI083029]; La Jolla Institute for Allergy and Immunology; Center for Infectious Disease [LIAI-JAN-2011-CID]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265, R01AI061516, F32AI083029, R01AI064584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK046763, F32DK082249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Jolla Institute for Allergy and Immunology; Center for Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (RO1-AI061516 to M. K.; PO1 DK46763 to M. K.; F32-DK082249 to J.-W.S.; F32-AI083029 to J.L.V.), La Jolla Institute for Allergy and Immunology and the Center for Infectious Disease (LIAI-JAN-2011-CID to J.-W.S.). We thank W. Quyang for providing Reg3 gamma-Ig fusion protein, and O. Turovskaya for performing histology staining and pathological scoring. We also thank C. Benedict for providing NIK<SUP>aly/aly</SUP> mice, K. Pfeffer for providing Hvem<SUP>-/-</SUP> and Light<SUP>-/-</SUP> mice and K. Murphy for Btla<SUP>-/-</SUP> mice. This is manuscript number 1347 from the La Jolla Institute for Allergy and Immunology.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Anumanthan A, 1998, J IMMUNOL, V161, P2780; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Gelebart P, 2011, TRANSL ONCOL, V4, P9, DOI 10.1593/tlo.10172; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ma CX, 2006, CELL MICROBIOL, V8, P1669, DOI 10.1111/j.1462-5822.2006.00741.x; Maeda M, 2005, J IMMUNOL, V175, P4426, DOI 10.4049/jimmunol.175.7.4426; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Mizgerd JP, 2008, AM J PHYSIOL-LUNG C, V294, pL387, DOI 10.1152/ajplung.00330.2007; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Nakamatsu M, 2007, MICROBES INFECT, V9, P364, DOI 10.1016/j.micinf.2006.12.003; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Quinton LJ, 2008, AM J RESP CELL MOL, V38, P699, DOI 10.1165/rcmb.2007-0365OC; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Quinton LJ, 2011, CELL TISSUE RES, V343, P153, DOI 10.1007/s00441-010-1044-y; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Schaer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018495; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Tachiiri A, 2003, GENES IMMUN, V4, P153, DOI 10.1038/sj.gene.6363934; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	33	95	98	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					222	+		10.1038/nature11242	http://dx.doi.org/10.1038/nature11242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22801499	Green Accepted			2022-12-01	WOS:000307267000036
J	Becker, WC; Fiellin, DA				Becker, William C.; Fiellin, David A.			Federal Plan for Prescriber Education on Opioids Misses Opportunities	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OVERDOSE; PAIN		[Becker, William C.; Fiellin, David A.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Becker, WC (corresponding author), Yale Univ, Sch Med, 367 Cedar St,POB 208056, New Haven, CT 06520 USA.	william.becker@yale.edu		Becker, William/0000-0002-0788-1467; Fiellin, David/0000-0002-4006-010X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025991, R01DA020576] Funding Source: NIH RePORTER; NIAAA NIH HHS [U01 AA020795] Funding Source: Medline; NIDA NIH HHS [R01 DA020576, R01 DA025991] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		American Medical Association, 2011, 1 AM MED ASS COUNC E; Center for Substance Abuse Treatment, 2004, TREATM IMPR PROT TIP, V40; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P869; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Egan JE, 2010, J GEN INTERN MED, V25, P936, DOI 10.1007/s11606-010-1377-y; FDA, 2011, FED REG; Food and Drug Administration, BLUEPR PRESCR CONT E; Holmboe ES, 2008, J CONTIN EDUC HEALTH, V28, pS4, DOI 10.1002/chp.200; Institute of Medicine, 2009, CONFL INT MED RES ED; Institute of Medicine, 2007, FUT DRUG SAF PROM PR; McLellan AT, 2010, ANN INTERN MED, V152, P123, DOI 10.7326/0003-4819-152-2-201001190-00012; Meier Barry, 2007, NY TIMES; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407	14	9	9	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					205	+		10.7326/0003-4819-156-11-201206050-00448	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868838				2022-12-01	WOS:000307789900007
J	Pichlmair, A; Kandasamy, K; Alvisi, G; Mulhern, O; Sacco, R; Habjan, M; Binder, M; Stefanovic, A; Eberle, CA; Goncalves, A; Burckstummer, T; Muller, AC; Fauster, A; Holze, C; Lindsten, K; Goodbourn, S; Kochs, G; Weber, F; Bartenschlager, R; Bowie, AG; Bennett, KL; Colinge, J; Superti-Furga, G				Pichlmair, Andreas; Kandasamy, Kumaran; Alvisi, Gualtiero; Mulhern, Orla; Sacco, Roberto; Habjan, Matthias; Binder, Marco; Stefanovic, Adrijana; Eberle, Carol-Ann; Goncalves, Adriana; Buerckstuemmer, Tilmann; Mueller, Andre C.; Fauster, Astrid; Holze, Cathleen; Lindsten, Kristina; Goodbourn, Stephen; Kochs, Georg; Weber, Friedemann; Bartenschlager, Ralf; Bowie, Andrew G.; Bennett, Keiryn L.; Colinge, Jacques; Superti-Furga, Giulio			Viral immune modulators perturb the human molecular network by common and unique strategies	NATURE			English	Article							PROTEIN; EXPRESSION; EVASION; INNATE; ACTIVATION; RESPONSES; PATHWAYS; REVEALS; SYSTEMS; SCREEN	Viruses must enter host cells to replicate, assemble and propagate. Because of the restricted size of their genomes, viruses have had to evolve efficient ways of exploiting host cell processes to promote their own life cycles and also to escape host immune defence mechanisms(1,2). Many viral open reading frames (viORFs) with immune-modulating functions essential for productive viral growth have been identified across a range of viral classes(3,4). However, there has been no comprehensive study to identify the host factors with which these viORFs interact for a global perspective of viral perturbation strategies(5-11). Here we show that different viral perturbation patterns of the host molecular defence network can be deduced from a mass-spectrometry-based host-factor survey in a defined human cellular system by using 70 innate immune-modulating viORFs from 30 viral species. The 579 host proteins targeted by the viORFs mapped to an unexpectedly large number of signalling pathways and cellular processes, suggesting yet unknown mechanisms of antiviral immunity. We further experimentally verified the targets heterogeneous nuclear ribonucleoprotein U, phosphatidylinositol-3-OH kinase, the WNK (with-no-lysine) kinase family and USP19 (ubiquitin-specific peptidase 19) as vulnerable nodes in the host cellular defence system. Evaluation of the impact of viral immune modulators on the host molecular network revealed perturbation strategies used by individual viruses and by viral classes. Our data are also valuable for the design of broad and specific antiviral therapies.	[Pichlmair, Andreas; Kandasamy, Kumaran; Sacco, Roberto; Stefanovic, Adrijana; Eberle, Carol-Ann; Goncalves, Adriana; Buerckstuemmer, Tilmann; Mueller, Andre C.; Fauster, Astrid; Bennett, Keiryn L.; Colinge, Jacques; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Pichlmair, Andreas; Habjan, Matthias; Holze, Cathleen] Max Planck Inst Biochem, Innate Immun Lab, D-82152 Martinsried, Germany; [Alvisi, Gualtiero; Binder, Marco; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Mulhern, Orla; Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Habjan, Matthias; Kochs, Georg; Weber, Friedemann] Univ Freiburg, Dept Virol, D-79104 Freiburg, Germany; [Lindsten, Kristina] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Goodbourn, Stephen] Univ London, Div Basic Med Sci, London SW17 0RE, England; [Weber, Friedemann] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79108 Freiburg, Germany; [Weber, Friedemann] Univ Marburg, Inst Virol, D-35043 Marburg, Germany	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Max Planck Society; Ruprecht Karls University Heidelberg; Trinity College Dublin; University of Freiburg; Karolinska Institutet; University of London; University of Freiburg; Philipps University Marburg	Superti-Furga, G (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at	Kandasamy, Richard Kumaran/C-8981-2009; Colinge, Jacques/Z-2613-2019; Binder, Marco/E-9717-2011; Superti-Furga, Giulio/F-4755-2015; Weber, Friedemann/AAB-3425-2019; Colinge, Jacques/D-1578-2017; Superti-Furga, Giulio/AAE-5681-2019; Bartenschlager, Ralf/L-2582-2015	Kandasamy, Richard Kumaran/0000-0002-0894-1222; Colinge, Jacques/0000-0003-2466-4824; Binder, Marco/0000-0002-5805-6109; Superti-Furga, Giulio/0000-0002-0570-1768; Colinge, Jacques/0000-0003-2466-4824; Mueller, Andre/0000-0002-0608-8176; Goodbourn, Stephen/0000-0002-4530-1179; Habjan, Matthias/0000-0002-3623-4496; Weber, Friedemann/0000-0001-9737-337X; Bennett, Keiryn L./0000-0001-9356-7708; Buerckstuemmer, Tilmann/0000-0002-5961-0829; Fauster, Astrid/0000-0003-4608-5604; Bowie, Andrew/0000-0001-5316-4373; Burckstummer, Tilmann/0000-0001-5681-8045; Bartenschlager, Ralf/0000-0001-5601-9307; Alvisi, Gualtiero/0000-0002-8177-3616; Stefanovic, Adrijana/0000-0002-5497-8843	Austrian Academy of Sciences; i-FIVE European Research Council; European Molecular Biology Organization [ATLF 463-2008]; Science Foundation Ireland [07/IN1/B934]; Deutsche Forschungsgemeinschaft [We2616/5-2, SFB593/B13, Ko1579/5-1, FOR1202]; German Ministry for Education and Research (Suszeptibilitat bei Infektionen) [01KI 0786]; Austrian Ministry of Science and Research (GEN-AU/BIN)	Austrian Academy of Sciences; i-FIVE European Research Council; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry for Education and Research (Suszeptibilitat bei Infektionen); Austrian Ministry of Science and Research (GEN-AU/BIN)	We thank C. Basler, A. Bergthaler, K.-K. Conzelmann, A. Garcia-Sastre, M. Hardy, W. Kaiser, E. Muhlberger, R. Randall, B. Roizman, N. Ruggli, B. Sherry and T. Wolf for providing viral ORF cDNAs; P. Jordan for providing WNK expression constructs; S. Nakagawa for Flag-hnRNP-U; M. Sophie-Hiet for GFP-NS5A; M. Zayas for the pFK-Jc1-NS5A-HAexpression plasmid; E. Rudashevskaya, A. Stukalov, F. Breitwieser and M. Trippler for support; H. Pickersgill and T. Brummelkamp for critically reading the manuscript; C. Baumann for discussions; and M. Vidal for discussions and for sharing unpublished information. The work was funded by the Austrian Academy of Sciences, an i-FIVE European Research Council grant to G.S.-F., a European Molecular Biology Organization long-term fellowship to A. P. (ATLF 463-2008), Science Foundation Ireland grant 07/IN1/B934 to O.M. and A. G. B., Deutsche Forschungsgemeinschaft grants We2616/5-2 and SFB593/B13 to F. W., Ko1579/5-1 to G. K., and FOR1202, TP1 to R. B., and the German Ministry for Education and Research (Suszeptibilitat bei Infektionen: HCV; TP1, 01KI 0786) to R. B. J.C. is funded by the Austrian Ministry of Science and Research (GEN-AU/BIN).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Burkard TR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-17; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Haura EB, 2011, J PROTEOME RES, V10, P182, DOI 10.1021/pr100863f; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schmolke M, 2010, CELL MICROBIOL, V12, P873, DOI 10.1111/j.1462-5822.2010.01475.x; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	39	180	185	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					486	U101		10.1038/nature11289	http://dx.doi.org/10.1038/nature11289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22810585	Green Published			2022-12-01	WOS:000306815300039
J	Wu, J; Bostrom, P; Sparks, LM; Ye, L; Choi, JH; Giang, AH; Khandekar, M; Virtanen, KA; Nuutila, P; Schaart, G; Huang, KX; Tu, H; Lichtenbelt, WDV; Hoeks, J; Enerback, S; Schrauwen, P; Spiegelman, BM				Wu, Jun; Bostrom, Pontus; Sparks, Lauren M.; Ye, Li; Choi, Jang Hyun; Giang, An-Hoa; Khandekar, Melin; Virtanen, Kirsi A.; Nuutila, Pirjo; Schaart, Gert; Huang, Kexin; Tu, Hua; Lichtenbelt, Wouter D. van Marken; Hoeks, Joris; Enerbaeck, Sven; Schrauwen, Patrick; Spiegelman, Bruce M.			Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human	CELL			English	Article							BROWN ADIPOSE-TISSUE; WHITE FAT; TRANSCRIPTIONAL CONTROL; SKELETAL-MUSCLE; IN-VIVO; IDENTIFICATION; PROGENITORS; ACTIVATION; INDUCTION; OBESITY	Brown fat generates heat via the mitochondrial uncoupling protein UCP1, defending against hypothermia and obesity. Recent data suggest that there are two distinct types of brown fat: classical brown fat derived from a myf-5 cellular lineage and UCP1-positive cells that emerge in white fat from a non-myf-5 lineage. Here, we report the isolation of "beige" cells from murine white fat depots. Beige cells resemble white fat cells in having extremely low basal expression of UCP1, but, like classical brown fat, they respond to cyclic AMP stimulation with high UCP1 expression and respiration rates. Beige cells have a gene expression pattern distinct from either white or brown fat and are preferentially sensitive to the polypeptide hormone irisin. Finally, we provide evidence that previously identified brown fat deposits in adult humans are composed of beige adipocytes. These data provide a foundation for studying this mammalian cell type with therapeutic potential.	[Wu, Jun; Bostrom, Pontus; Ye, Li; Choi, Jang Hyun; Giang, An-Hoa; Khandekar, Melin; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Wu, Jun; Bostrom, Pontus; Ye, Li; Choi, Jang Hyun; Giang, An-Hoa; Khandekar, Melin; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Sparks, Lauren M.; Lichtenbelt, Wouter D. van Marken; Hoeks, Joris; Schrauwen, Patrick] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Biol, NL-6229 ER Maastricht, Netherlands; [Schaart, Gert] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Movement Sci, NL-6229 ER Maastricht, Netherlands; [Enerbaeck, Sven] Gothenburg Univ, Inst Biomed, S-40530 Gothenburg, Sweden; [Virtanen, Kirsi A.; Nuutila, Pirjo] Univ Turku, Turku PET Ctr, FI-20521 Turku, Finland; [Huang, Kexin; Tu, Hua] Lakepharma Inc, Belmont, CA 94002 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Gothenburg; University of Turku	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA.	bruce_spiegelman@dfci.harvard.edu	Nuutila, Pirjo/J-2087-2012; Choi, Jang Hyun/B-3055-2012	Schaart, Gert/0000-0003-4259-9528; Sparks, Lauren/0000-0002-9257-5666; Nuutila, Pirjo/0000-0001-9597-338X; Hoeks, Joris/0000-0002-0265-0870; schrauwen, patrick/0000-0002-0973-847X	NIH [DK31405, DK90861]; JPB Foundation; Netherlands Organization for Scientific Research; American Heart Association [09POST2010078]; American Heart Association (National Center) [12SDG8070003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK094824, RC4DK090861, R01DK031405, R37DK031405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); American Heart Association(American Heart Association); American Heart Association (National Center)(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Wang (Center for Cancer Computational Biology at Dana-Farber Cancer Institute) for assistance with affymetrix gene chip analysis, S. White (Beth Israel Deaconess Medical Center Histology Core) for cryosectioning, and A. Korde for technical help. We are grateful to Drs. P. Seale, R. Gupta, P. Cohen, S. Kleiner, and J. Lo for useful discussions. B.M.S. is supported by NIH grants DK31405 and DK90861 and by a grant from the JPB Foundation. P.S. is supported by a VICI research grant for innovative research from the Netherlands Organization for Scientific Research. J.W. was supported in part by a postdoctoral fellowship from the American Heart Association (Founders Affiliate, 09POST2010078) and by a Scientist Developmental Grant from the American Heart Association (National Center, 12SDG8070003). J.W. and B.M.S. conceived and designed the experiments. J.W., P.B., L.M.S., L.Y., J.H.C., A.G., M.K., G.S., and J.H. performed experiments. All authors analyzed the data. P.N., W.D.M.L., and S.E. provided reagents and samples, and J.W. and B.M.S. wrote the manuscript. B.M.S. and S.E. are shareholders and consultants to Ember Therapeutics, which has licensed the rights to irisin from the DFCI.	Billon N, 2012, STEM CELL REV REP, V8, P55, DOI 10.1007/s12015-011-9242-x; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cinti S, 2002, J ENDOCRINOL INVEST, V25, P823, DOI 10.1007/BF03344046; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Mirbolooki MR, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-30; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; von Heydebreck A, 2001, Bioinformatics, V17 Suppl 1, pS107; Whittle AJ, 2011, TRENDS MOL MED, V17, P405, DOI 10.1016/j.molmed.2011.04.001; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	39	2208	2330	26	374	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					366	376		10.1016/j.cell.2012.05.016	http://dx.doi.org/10.1016/j.cell.2012.05.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22796012	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000306595700015
J	Thompson, M; Heneghan, C; Cohen, D				Thompson, Matthew; Heneghan, Carl; Cohen, Deborah			How valid is the European Food Safety Authority's assessment of sports drinks?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Thompson, Matthew; Heneghan, Carl] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Cohen, Deborah] BMJ, London WC1H 9JR, England	University of Oxford	Thompson, M (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	matthew.thompson@phc.ox.ac.uk						Agostoni C, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2211; [Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; EFSA, MEMB PAN DIET PROD N; Egger M, 1985, SYSTEMATIC REV HLTH; Heneghan C, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4797; James Lind Library, 2007, UP TO DAT SYST REV R; Scientific Committee on Food, 2001, REP SCI COMM FOOD CO	7	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2012	345								e4753	10.1136/bmj.e4753	http://dx.doi.org/10.1136/bmj.e4753			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MA	22810387				2022-12-01	WOS:000306744300010
J	Wearn, OR; Reuman, DC; Ewers, RM				Wearn, Oliver R.; Reuman, Daniel C.; Ewers, Robert M.			Extinction Debt and Windows of Conservation Opportunity in the Brazilian Amazon	SCIENCE			English	Article							DEFORESTATION; LOSSES; FUTURE; AREA	Predicting when future species extinctions will occur is necessary for directing conservation investments but has proved difficult. We developed a new method for predicting extinctions over time, accounting for the timing and magnitude of habitat loss. We applied this to the Brazilian Amazon, predicting that local extinctions of forest-dependent vertebrate species have thus far been minimal ( 1% of species by 2008), with more than 80% of extinctions expected to be incurred from historical habitat loss still to come. Realistic deforestation scenarios suggest that local regions will lose an average of nine vertebrate species and have a further 16 committed to extinction by 2050. There is a window of opportunity to dilute the legacy of historical deforestation by concentrating conservation efforts in areas with greatest debt.	[Wearn, Oliver R.; Reuman, Daniel C.; Ewers, Robert M.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; [Wearn, Oliver R.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Reuman, Daniel C.] Rockefeller Univ, New York, NY 10065 USA	Imperial College London; Zoological Society of London; Rockefeller University	Ewers, RM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Silwood Pk, Ascot SL5 7PY, Berks, England.	r.ewers@imperial.ac.uk		Wearn, Oliver/0000-0001-8258-3534	UK Natural Environment Research Council; European Research Council; Natural Environment Research Council [NE/I011889/1] Funding Source: researchfish; NERC [NE/I011889/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	R. Bernard provided GIS assistance, and T. Gardner, J. Barlow, and A. Lees commented on the manuscript and provided data. The UK Natural Environment Research Council supported O.R.W. and D. C. R. and the European Research Council supported R. M. E. during this work. Data were obtained from online sources (10, 18, 26).	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Grelle CEV, 2005, ORYX, V39, P347, DOI 10.1017/S0030605305000700; Hayashi S., 2011, MATO GROSSO SAD ALER; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; *INPE, 2009, PROJ PRODES MON FLOR; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; MAC ARTHUR ROBERT H., 1967; Metzger JP, 2010, SCIENCE, V329, P276, DOI 10.1126/science.329.5989.276-b; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; World Conservation Union, 2008, 2008 IUCN RED LIST T	25	152	153	1	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2012	337	6091					228	232		10.1126/science.1219013	http://dx.doi.org/10.1126/science.1219013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22798612				2022-12-01	WOS:000306323500057
J	Lu, CP; Polak, L; Rocha, AS; Pasolli, HA; Chen, SC; Sharma, N; Blanpain, C; Fuchs, E				Lu, Catherine P.; Polak, Lisa; Rocha, Ana Sofia; Pasolli, H. Amalia; Chen, Shann-Ching; Sharma, Neha; Blanpain, Cedric; Fuchs, Elaine			Identification of Stem Cell Populations in Sweat Glands and Ducts Reveals Roles in Homeostasis and Wound Repair	CELL			English	Article							FUNCTIONAL MAMMARY-GLAND; SKIN; EXPRESSION; CHANNEL; NICHE; FATE; MICE	Sweat glands are abundant in the body and essential for thermoregulation. Like mammary glands, they originate from epidermal progenitors. However, they display few signs of cellular turnover, and whether they have stem cells and tissue-regenerative capacity remains largely unexplored. Using lineage tracing, we here identify in sweat ducts multipotent progenitors that transition to unipotency after developing the sweat gland. In characterizing four adult stem cell populations of glandular skin, we show that they display distinct regenerative capabilities and remain unipotent when healing epidermal, myoepithelial-specific, and lumenal-specific injuries. We devise purification schemes and isolate and transcriptionally profile progenitors. Exploiting molecular differences between sweat and mammary glands, we show that only some progenitors regain multipotency to produce de novo ductal and glandular structures, but that these can retain their identity even within certain foreign microenvironments. Our findings provide insight into glandular stem cells and a framework for the further study of sweat gland biology.	[Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Lu, Catherine P.; Polak, Lisa; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Rocha, Ana Sofia; Sharma, Neha; Blanpain, Cedric] Univ Libre Brussels, IRIBHM, B-1050 Brussels, Belgium; [Chen, Shann-Ching] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Universite Libre de Bruxelles; St Jude Children's Research Hospital	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Blanpain, Cedric/ABD-8392-2021	Sharma, Neha/0000-0002-8062-1661; Pasolli, Hilda Amalia/0000-0003-3899-3530; Lu, Catherine/0000-0003-4593-327X	Stem Cell Research Foundation; Starr Foundation; NIH [R01-AR050452]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, K01AR066073, F32AR060654] Funding Source: NIH RePORTER	Stem Cell Research Foundation; Starr Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Chu for sparking interest in sweat glands in the Fuchs lab. We thank Y.-C. Hsu, X. Wu, and B. Keyes for intellectual input and helpful suggestions. We thank Rockefeller's Comparative Bioscience Center (AAALAC accredited) for care and breeding of mice in accordance with National Institutes of Health (NIH) guidelines; Bioimaging Center (A. North, director) for advice on image acquisition; and Flow Cytometry facility (S. Mazel, director) for FACS sorting. E.F. is an Investigator of The Howard Hughes Medical Institute. C.P.L. is a Ruth Kirschstein Postdoctoral Fellow (NIH 5F32AR060654-02). This work was supported initially by pilot grants from Stem Cell Research and Starr Foundations (E.F.) and more recently by NIH R01-AR050452 (E.F.).	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Biedermann T, 2010, J INVEST DERMATOL, V130, P1996, DOI 10.1038/jid.2010.83; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Cui CY, 2012, P NATL ACAD SCI USA, V109, P1199, DOI 10.1073/pnas.1117213109; Ferraris C, 2000, DEVELOPMENT, V127, P5487; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Krahl D, 2010, J CUTAN PATHOL, V37, P350, DOI 10.1111/j.1600-0560.2009.01369.x; Kunisada M, 2009, HUM MOL GENET, V18, P1769, DOI 10.1093/hmg/ddp089; Langbein L, 2005, J INVEST DERMATOL, V125, P428, DOI 10.1111/j.0022-202X.2005.23860.x; Lobitz Jr. W.C., 1956, J INVEST DERMATOL, V26, P259; LOBITZ WC, 1956, J INVEST DERMATOL, V26, P247, DOI 10.1038/jid.1956.37; LOBITZ WC, 1954, J INVEST DERMATOL, V23, P329, DOI 10.1038/jid.1954.116; LOBITZ WC, 1961, ANNU REV MED, V12, P289, DOI 10.1146/annurev.me.12.020161.001445; Miller SJ, 1998, J INVEST DERMATOL, V110, P13, DOI 10.1046/j.1523-1747.1998.00087.x; MOLL I, 1992, J INVEST DERMATOL, V98, P777, DOI 10.1111/1523-1747.ep12499950; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mustonen T, 2004, DEVELOPMENT, V131, P4907, DOI 10.1242/dev.01377; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Sato F, 2000, J HISTOCHEM CYTOCHEM, V48, P345, DOI 10.1177/002215540004800304; SATO K, 1973, J CLIN INVEST, V52, P2166, DOI 10.1172/JCI107401; Sato K., 1993, DERMATOLOGY GEN MED, P221; Schon M, 1999, J CELL SCI, V112, P1925; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Song YL, 2002, J PHYSIOL-LONDON, V541, P561, DOI 10.1113/jphysiol.2001.020180; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551	33	204	216	0	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 6	2012	150	1					136	150		10.1016/j.cell.2012.04.045	http://dx.doi.org/10.1016/j.cell.2012.04.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770217	Bronze, Green Accepted			2022-12-01	WOS:000306115000013
J	Mahadevan, A; D'Asaro, E; Lee, C; Perry, MJ				Mahadevan, Amala; D'Asaro, Eric; Lee, Craig; Perry, Mary Jane			Eddy-Driven Stratification Initiates North Atlantic Spring Phytoplankton Blooms	SCIENCE			English	Article							MIXED-LAYER EDDIES; PARAMETERIZATION; CONVECTION; ONSET; VARIABILITY; EXPORT; SINK; FLUX; SEA	Springtime phytoplankton blooms photosynthetically fix carbon and export it from the surface ocean at globally important rates. These blooms are triggered by increased light exposure of the phytoplankton due to both seasonal light increase and the development of a near-surface vertical density gradient (stratification) that inhibits vertical mixing of the phytoplankton. Classically and in current climate models, that stratification is ascribed to a springtime warming of the sea surface. Here, using observations from the subpolar North Atlantic and a three-dimensional biophysical model, we show that the initial stratification and resulting bloom are instead caused by eddy-driven slumping of the basin-scale north-south density gradient, resulting in a patchy bloom beginning 20 to 30 days earlier than would occur by warming.	[D'Asaro, Eric; Lee, Craig] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Mahadevan, Amala] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Perry, Mary Jane] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA	University of Washington; University of Washington Seattle; Woods Hole Oceanographic Institution; University of Maine System; University of Maine Orono	D'Asaro, E (corresponding author), Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA.	dasaro@apl.washington.edu			NSF [OCE-0628107, OCE-0628379, OCE-0928617, OPP-0901407]; ONR [N000141210101]; NASA [NNX-08AL92G, NNX-12AD47G, NNX08AW97G]; Directorate For Geosciences [0928617] Funding Source: National Science Foundation; Division Of Ocean Sciences [0928138] Funding Source: National Science Foundation; Division Of Polar Programs [0901650] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ONR(Office of Naval Research); NASA(National Aeronautics & Space Administration (NASA)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the NSF (grants OCE-0628107, OCE-0628379, OCE-0928617, and OPP-0901407), ONR (grant N000141210101), and NASA (grants NNX-08AL92G, NNX-12AD47G, and NNX08AW97G) for financial support. We also thank K. Gudmundsson, H. Valdimarsson, K. Fennel, I. Cetinic, M. Alkire, B. Sackmann, E. Kallin, N. Briggs, E. Rehm, A. Gray, J. Gobat, G, Shilling, A. Huxtable, M. Ohmart, and the captains and crews of R/V Bjarni Saemundsson and R/V Knorr for their efforts in gathering and analyzing the data. Data from NAB08 are publicly available at the Biological and Chemical Oceanography Data Management Office: http://osprey.bcodmo.org/project.cfm?flag=view&id=102&sortby=project. Argo float data were collected and made freely available by the International Argo Program (IAP) and the national programs that contribute to the IAP.	Alkire MB, 2012, DEEP-SEA RES PT I, V64, P157, DOI 10.1016/j.dsr.2012.01.012; Backhaus JO, 2003, MAR ECOL PROG SER, V251, P1, DOI 10.3354/meps251001; Bagniewski W., 2010, BIOGEOSCIENCES, V7, P1; Behrenfeld MJ, 2010, ECOLOGY, V91, P977, DOI 10.1890/09-1207.1; Boccaletti G, 2007, J PHYS OCEANOGR, V37, P2228, DOI 10.1175/JPO3101.1; Bracco A, 2000, P ROY SOC B-BIOL SCI, V267, P1795, DOI 10.1098/rspb.2000.1212; D'Asaro EA, 2003, J ATMOS OCEAN TECH, V20, P896, DOI 10.1175/1520-0426(2003)020<0896:POALF>2.0.CO;2; D'Asaro E, 2011, SCIENCE, V332, P318, DOI 10.1126/science.1201515; FALKOWSKI PG, 1994, PHOTOSYNTH RES, V39, P235, DOI 10.1007/BF00014586; Fennel K., 2011, EOS, V92, P465, DOI DOI 10.1029/2011E0500002; Fox-Kemper B, 2011, OCEAN MODEL, V39, P61, DOI 10.1016/j.ocemod.2010.09.002; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1166, DOI 10.1175/2007JPO3788.1; Frajka-Williams E, 2009, DEEP-SEA RES PT I, V56, P2144, DOI 10.1016/j.dsr.2009.07.008; Grist JP, 2003, J CLIMATE, V16, P3274, DOI 10.1175/1520-0442(2003)016<3274:IAAOTS>2.0.CO;2; Harcourt RR, 2010, J ATMOS OCEAN TECH, V27, P1918, DOI 10.1175/2010JTECHO731.1; Henson SA, 2006, DEEP-SEA RES PT I, V53, P1601, DOI 10.1016/j.dsr.2006.07.009; Holte J, 2009, J ATMOS OCEAN TECH, V26, P1920, DOI 10.1175/2009JTECHO543.1; Levy M, 1998, J MARINE SYST, V16, P7, DOI 10.1016/S0924-7963(97)00097-3; Levy M, 1999, DEEP-SEA RES PT I, V46, P1137, DOI 10.1016/S0967-0637(98)00105-8; Mahadevan A, 1996, J PHYS OCEANOGR, V26, P1881, DOI 10.1175/1520-0485(1996)026<1881:ANMOMP>2.0.CO;2; Mahadevan A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005203; Martin P, 2011, DEEP-SEA RES PT I, V58, P338, DOI 10.1016/j.dsr.2011.01.006; Okamoto S, 2010, DEEP-SEA RES PT II, V57, P1608, DOI 10.1016/j.dsr2.2010.03.005; Rudnick DL, 1999, SCIENCE, V283, P526, DOI 10.1126/science.283.5401.526; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Siegel DA, 2002, SCIENCE, V296, P730, DOI 10.1126/science.1069174; STONE PH, 1970, J ATMOS SCI, V27, P721, DOI 10.1175/1520-0469(1970)027<0721:ONGBSP>2.0.CO;2; Sverdrup H.U., 1953, J CONS CONS PERM INT, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; TANDON A, 1994, J PHYS OCEANOGR, V24, P1419, DOI 10.1175/1520-0485(1994)024<1419:MLRDTA>2.0.CO;2; Taylor JR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049312; Taylor JR, 2011, LIMNOL OCEANOGR, V56, P2293, DOI 10.4319/lo.2011.56.6.2293; Thomas LN, 2005, J PHYS OCEANOGR, V35, P1086, DOI 10.1175/JPO2737.1; Waniek JJ, 2003, J MARINE SYST, V39, P57, DOI 10.1016/S0924-7963(02)00248-8; WATSON AJ, 1991, NATURE, V350, P50, DOI 10.1038/350050a0	35	309	314	8	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2012	337	6090					54	58		10.1126/science.1218740	http://dx.doi.org/10.1126/science.1218740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22767922				2022-12-01	WOS:000306053100041
J	Powell, ALT; Nguyen, CV; Hill, T; Cheng, KL; Figueroa-Balderas, R; Aktas, H; Ashrafi, H; Pons, C; Fernandez-Munoz, R; Vicente, A; Lopez-Baltazar, J; Barry, CS; Liu, YS; Chetelat, R; Granell, A; Van Deynze, A; Giovannoni, JJ; Bennett, AB				Powell, Ann L. T.; Nguyen, Cuong V.; Hill, Theresa; Cheng, Kalai Lam; Figueroa-Balderas, Rosa; Aktas, Hakan; Ashrafi, Hamid; Pons, Clara; Fernandez-Munoz, Rafael; Vicente, Ariel; Lopez-Baltazar, Javier; Barry, Cornelius S.; Liu, Yongsheng; Chetelat, Roger; Granell, Antonio; Van Deynze, Allen; Giovannoni, James J.; Bennett, Alan B.			Uniform ripening Encodes a Golden 2-like Transcription Factor Regulating Tomato Fruit Chloroplast Development	SCIENCE			English	Article							SOLUBLE SOLIDS CONTENT; EXPRESSION; SPECIALIZATION; NUCLEAR	Modern tomato (Solanum lycopersicum) varieties are bred for uniform ripening (u) light green fruit phenotypes to facilitate harvests of evenly ripened fruit. U encodes a Golden 2-like (GLK) transcription factor, SlGLK2, which determines chlorophyll accumulation and distribution in developing fruit. In tomato, two GLKs-SlGLK1 and SlGLK2-are expressed in leaves, but only SlGLK2 is expressed in fruit. Expressing GLKs increased the chlorophyll content of fruit, whereas SlGLK2 suppression recapitulated the u mutant phenotype. GLK overexpression enhanced fruit photosynthesis gene expression and chloroplast development, leading to elevated carbohydrates and carotenoids in ripe fruit. SlGLK2 influences photosynthesis in developing fruit, contributing to mature fruit characteristics and suggesting that selection of u inadvertently compromised ripe fruit quality in exchange for desirable production traits.	[Powell, Ann L. T.; Hill, Theresa; Cheng, Kalai Lam; Figueroa-Balderas, Rosa; Aktas, Hakan; Ashrafi, Hamid; Vicente, Ariel; Lopez-Baltazar, Javier; Chetelat, Roger; Van Deynze, Allen; Bennett, Alan B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Nguyen, Cuong V.; Giovannoni, James J.] Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA; [Nguyen, Cuong V.; Giovannoni, James J.] Cornell Univ, Dept Genet & Plant Biol, Ithaca, NY 14853 USA; [Pons, Clara; Granell, Antonio] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Consejo Super Invest Cient, E-46022 Valencia, Spain; [Fernandez-Munoz, Rafael] Univ Malaga, Inst Hort Subtrop & Mediterranea Mayora, Consejo Super Invest Cient, E-29750 Malaga, Spain; [Vicente, Ariel] UNLP, Ctr Invest & Desarrollo Criotecnol Alimentos, Consejo Nacl Invest Cient & Tecn, RA-1900 La Plata, Argentina; [Vicente, Ariel] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, RA-1900 La Plata, Argentina; [Barry, Cornelius S.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Liu, Yongsheng; Giovannoni, James J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Liu, Yongsheng; Giovannoni, James J.] Cornell Univ, USDA ARS, Robert W Holley Ctr, Ithaca, NY 14853 USA	University of California System; University of California Davis; Cornell University; Cornell University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institute of Molecular & Cellular Biology of Plants (IBMCP); Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; Michigan State University; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; United States Department of Agriculture (USDA)	Powell, ALT (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	alpowell@ucdavis.edu; jjg33@cornell.edu	Bennett, Alan B/D-8980-2011; Pons, Clara/AAA-6233-2020; Barry, Cornelius/D-7759-2012; Granell, Antonio/G-3664-2010; Fernandez-Munoz, Rafael/F-3714-2010; Figueroa, Rosa/B-3172-2013; Lopez, Javier/G-6946-2019; AKTAS, Hakan/E-9174-2013; Vicente, Ariel/AAH-1908-2020	Bennett, Alan B/0000-0002-3684-4307; Pons, Clara/0000-0002-8296-2937; Fernandez-Munoz, Rafael/0000-0002-4054-8949; Vicente, Ariel/0000-0003-1289-9554; Ashrafi, Hamid/0000-0002-2094-2367; Figueroa-Balderas, Rosa/0000-0003-3321-1376; Barry, Cornelius/0000-0003-4685-0273	University of California; Vietnam Education Foundation; USDA-Agricultural Research Service; USDA-National Research Initiative [2007-02773]; NSF [IOS-0923312]	University of California(University of California System); Vietnam Education Foundation; USDA-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-National Research Initiative(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF))	Minimum Information About a Microarray Experiment (MIAME)-compliant microarray data are available at http://ted.bti.cornell.edu. and at http://www.ebi.ac.uk/arrayexpress/(accession E-MEXP-3652). F. Carrari and A. Fernie provided S. pennellii SlGLK2, and J. Maloof provided S. habrochaites SlGLK2 sequences. The U. S. Department of Agriculture (USDA)/National Institute of Food and Agriculture Solanaceae Coordinated Agricultural Project provided potato data. We are grateful to the Tomato Genome Consortium and the SOL Genomics Network for prepublication access to the tomato genome sequence. The S. pennellii introgression lines were provided by the C. M. Rick Tomato Genetics Resource Center; the S. pimpinellifolium populations were provided by the Instituto de Hortofruticultura Subtropical y Mediterranea "La Mayora," Consejo Superior de Investigaciones Cientificas; and both populations are available by request from the sources. The AtGLK-expressing lines were provided by Mendel Biotechnology and Seminis/Monsanto Vegetable Seeds. SlGLK2, the corresponding lines, and the F2 10-1 IL x M82 population lines and seeds are available from J. J. G. without restriction. Seminis/Monsanto will make available, upon request, and under a material transfer agreement indicating they are to be used for noncommercial purposes, the following lines: LexA:AtGLK1:p35S:LexA-Gal4; LexA:AtGLK1:pLTP:LexA-Gal4; LexA:AtGLK1:pRbcS:LexA-Gal4; LexA:AtGLK1:pPDS:LexA-Gal4; LexA:AtGLK2:p35S:LexA-Gal4; LexA:AtGLK2:pLTP:LexA-Gal4; LexA:AtGLK2:pRbcS:LexA-Gal4; LexA:AtGLK2:pPDS:LexA-Gal4; plus the T63 control line. Other biological materials are available by request from A. L. T. P. or J.J.G. A. L. T. P., T. H., K.L.-C., R.F.-B., and A. B. B. have filed a provisional U. S. patent application UC #2011-841, "Introduction of wild species GLK genes for improved ripe tomato fruit quality," through the University of California. A. L. T. P. and A. B. B. have filed the U. S. patent application #2010/0154078, " Transcription factors that enhance traits in plant organs," through Mendel Biotechnology. Assistance from B. Blanco-Ulate, S. Phothiset, S. Reyes, A. Abraham, L. Gilani, and G. Arellano is gratefully acknowledged. J. Langdale provided helpful advice regarding GLK phylogeny and nomenclature. G. Adamson and P. Kysar, Electron Microscopy (EM) Laboratory, University of California Davis Medical Center did the EM work. University of California Discovery and partners funded the pepper analysis and the initial investigations of the Arabidopsis GLKs. The Vietnam Education Foundation supported C.N. Fundacion Genoma Espana ESPSOL Project provided partial funding to A.G. USDA-Agricultural Research Service, USDA-National Research Initiative (2007-02773), and NSF (Plant Genome Program IOS-0923312) provided support to J.J.G.	BLANKE MM, 1989, PLANT CELL ENVIRON, V12, P31, DOI 10.1111/j.1365-3040.1989.tb01914.x; Bravo-Garcia A, 2009, NEW PHYTOL, V183, P133, DOI 10.1111/j.1469-8137.2009.02829.x; BUTLER L, 1952, J HERED, V43, P25, DOI 10.1093/oxfordjournals.jhered.a106252; Carrara S, 2001, PHOTOSYNTHETICA, V39, P75, DOI 10.1023/A:1012495903093; ESHED Y, 1995, GENETICS, V141, P1147; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Hetherington SE, 1998, J EXP BOT, V49, P1173, DOI 10.1093/jexbot/49.324.1173; KEMP G. A., 1960, CANADIAN JOUR PLANT SCI, V40, P306; KINZER SM, 1990, THEOR APPL GENET, V79, P489, DOI 10.1007/BF00226158; Langdale JA, 2011, PLANT CELL, V23, P3879, DOI 10.1105/tpc.111.092098; MANZARA T, 1993, PLANT MOL BIOL, V21, P69, DOI 10.1007/BF00039619; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Nakamura H, 2009, PLANT CELL PHYSIOL, V50, P1933, DOI 10.1093/pcp/pcp138; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PIECHULLA B, 1987, PLANT PHYSIOL, V84, P911, DOI 10.1104/pp.84.3.911; PIECHULLA B, 1987, EMBO J, V6, P3593, DOI 10.1002/j.1460-2075.1987.tb02690.x; RICK CM, 1956, ADV GENET, V8, P267, DOI 10.1016/S0065-2660(08)60504-0; RICK CM, 1974, HILGARDIA, V42, P493, DOI 10.3733/hilg.v42n15p493; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; SUGITA M, 1987, P NATL ACAD SCI USA, V84, P7104, DOI 10.1073/pnas.84.20.7104; Tanksley S. D., 1987, GENETIC MAPS 1987 CO, P655; TANKSLEY SD, 1988, THEOR APPL GENET, V75, P811, DOI 10.1007/BF00265610; WANNER LA, 1991, PLANT CELL, V3, P1289, DOI 10.1105/tpc.3.12.1289; Waters MT, 2008, PLANT J, V56, P432, DOI 10.1111/j.1365-313X.2008.03616.x; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Yasumura Y, 2005, PLANT CELL, V17, P1894, DOI 10.1105/tpc.105.033191; YEAGER A. F., 1935, PROC AMER SOC HORT SCI, V33, P512	28	257	283	22	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1711	1715		10.1126/science.1222218	http://dx.doi.org/10.1126/science.1222218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745430				2022-12-01	WOS:000305794500052
J	Zhang, XJ; Abreu, JG; Yokota, C; MacDonald, BT; Singh, S; Coburn, KLA; Cheong, SM; Zhang, MZM; Ye, QZ; Hang, HC; Steen, H; He, X				Zhang, Xinjun; Abreu, Jose Garcia; Yokota, Chika; MacDonald, Bryan T.; Singh, Sasha; Almeida Coburn, Karla Loureiro; Cheong, Seong-Moon; Zhang, Mingzi M.; Ye, Qi-Zhuang; Hang, Howard C.; Steen, Hanno; He, Xi			Tiki1 Is Required for Head Formation via Wnt Cleavage-Oxidation and Inactivation	CELL			English	Article							PROTEINS; WINGLESS; PALMITOYLATION; GLYCOSYLATION; RECEPTORS; INDUCTION; SECRETION; ORGANIZER; MEMBRANE; PATHWAY	Secreted Wnt morphogens are signaling molecules essential for embryogenesis, pathogenesis, and regeneration and require distinct modifications for secretion, gradient formation, and activity. Whether Wnt proteins can be posttranslationally inactivated during development and homeostasis is unknown. Here we identify, through functional cDNA screening, a transmembrane protein Tiki1 that is expressed specifically in the dorsal Spemann-Mangold Organizer and is required for anterior development during Xenopus embryogenesis. Tiki1 antagonizes Wnt function in embryos and human cells via a TIKI homology domain that is conserved from bacteria to mammals and acts likely as a protease to cleave eight amino-terminal residues of a Wnt protein, resulting in oxidized Wnt oligomers that exhibit normal secretion but minimized receptor-binding capability. Our findings identify a Wnt-specific protease that controls head formation, reveal a mechanism for morphogen inactivation through proteolysis-induced oxidation-oligomerization, and suggest a role of the Wnt amino terminus in evasion of oxidizing inactivation. TIKI proteins may represent potential therapeutic targets.	[Zhang, Xinjun; Abreu, Jose Garcia; Yokota, Chika; MacDonald, Bryan T.; Almeida Coburn, Karla Loureiro; Cheong, Seong-Moon; He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Abreu, Jose Garcia; Almeida Coburn, Karla Loureiro] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil; [Singh, Sasha; Steen, Hanno] Harvard Univ, Sch Med, Dept Pathol, Prote Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Zhang, Mingzi M.; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA; [Ye, Qi-Zhuang] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Universidade Federal do Rio de Janeiro; Harvard University; Boston Children's Hospital; Harvard Medical School; Rockefeller University; Indiana University System; Indiana University Bloomington	He, X (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu	Abreu, Jose G/ABB-1199-2021; Neurociencia, Inct/I-1011-2013; Abreu, Jose G/G-6159-2010; Singh, Sasha/H-3612-2012; Zhang, Xinjun/H-8034-2012	Abreu, Jose G/0000-0002-1363-1755; Abreu, Jose G/0000-0002-9875-7786; Singh, Sasha/0000-0003-0929-3164; Steen, Hanno/0000-0003-0179-6648; Zhang, Mingzi/0000-0002-1213-3340	William Randolph Hearst Fund of Harvard Medical School; NRSA/NIH postdoctoral fellowship; CNPq (Brazil); CAPES (Brazil); A*STAR, Singapore; Ellison Medical Foundation; NIH [R01 GM087544-01, R01-GM094844-01, RO1 GM057603, GM057603S1]; Boston Children's Hospital's Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087544, R01GM094844, R01GM057603] Funding Source: NIH RePORTER	William Randolph Hearst Fund of Harvard Medical School; NRSA/NIH postdoctoral fellowship; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital's Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this study to the 30th anniversary of the discovery of Wnt1 by R. Nusse and H. E. Varmus. We thank S. An (StemRD) for recombinant WNT3A, J. Brown, D. Kimelman, R. Nusse, S. Takada, M. Taira, and R. Weinberg (via Addgene) for reagents, M. Resh for <SUP>125</SUP>I-palmitate, A. Najafov, D. Winter, and W. Yang for help, K. Willert, R. Segal, Y.-J. Shi for discussion, J. Dubrulle and A. Schier for help on experimentation of zebrafish Tiki1/2, and Tufts Medical Proteomics Facility for peptide sequencing. X.Z. is supported by a grant from the William Randolph Hearst Fund of Harvard Medical School. B. T. M. was supported by a NRSA/NIH postdoctoral fellowship. J. G. A. was funded partially by CNPq (Brazil) as a visiting scientist, and K. L. A. C. by CAPES (Brazil) as a visiting student, both to the X. H. laboratory. M. M.Z. is supported by A*STAR, Singapore. H. C. H. acknowledges support from Ellison Medical Foundation and NIH (R01 GM087544-01). H. S. acknowledges support from NIH (R01-GM094844-01). This work was supported by NIH (RO1 GM057603 and GM057603S1) to X. H. and by Boston Children's Hospital's Intellectual and Developmental Disabilities Research Center (P30 HD-18655). X. H. was a Leukemia and Lymphoma Society Scholar.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrett AJ., 2012, HDB PROTEOLYTIC ENZY; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Singh S, 2009, J PROTEOME RES, V8, P2201, DOI 10.1021/pr800654s; Singh SA, 2012, NAT METHODS, V9, P504, DOI [10.1038/NMETH.1970, 10.1038/nmeth.1970]; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Voigt J, 2005, MECH DEVELOP, V122, P289, DOI 10.1016/j.mod.2004.11.002; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	38	101	118	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1565	1577		10.1016/j.cell.2012.04.039	http://dx.doi.org/10.1016/j.cell.2012.04.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726442	Bronze, Green Accepted			2022-12-01	WOS:000305753800021
J	Imai, M; Watanabe, T; Hatta, M; Das, SC; Ozawa, M; Shinya, K; Zhong, GX; Hanson, A; Katsura, H; Watanabe, S; Li, CJ; Kawakami, E; Yamada, S; Kiso, M; Suzuki, Y; Maher, EA; Neumann, G; Kawaoka, Y				Imai, Masaki; Watanabe, Tokiko; Hatta, Masato; Das, Subash C.; Ozawa, Makoto; Shinya, Kyoko; Zhong, Gongxun; Hanson, Anthony; Katsura, Hiroaki; Watanabe, Shinji; Li, Chengjun; Kawakami, Eiryo; Yamada, Shinya; Kiso, Maki; Suzuki, Yasuo; Maher, Eileen A.; Neumann, Gabriele; Kawaoka, Yoshihiro			Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets	NATURE			English	Article							RECEPTOR-BINDING SPECIFICITY; SWINE-ORIGIN H1N1; SINGLE AMINO-ACID; SIALIC-ACID; AVIAN H5N1; A VIRUSES; MEMBRANE-FUSION; MOLECULAR-BASIS; IN-VITRO; HEMAGGLUTININ	Highly pathogenic avian H5N1 influenza A viruses occasionally infect humans, but currently do not transmit efficiently among humans. The viral haemagglutinin (HA) protein is a known host-range determinant as it mediates virus binding to host-specific cellular receptors(1-3). Here we assess the molecular changes in HA that would allow a virus possessing subtype H5 HA to be transmissible among mammals. We identified a reassortant H5 HA/H1N1 virus-comprising H5 HA (from an H5N1 virus) with four mutations and the remaining seven gene segments from a 2009 pandemic H1N1 virus-that was capable of droplet transmission in a ferret model. The transmissible H5 reassortant virus preferentially recognized human-type receptors, replicated efficiently in ferrets, caused lung lesions and weight loss, but was not highly pathogenic and did not cause mortality. These results indicate that H5 HA can convert to an HA that supports efficient viral transmission in mammals; however, we do not know whether the four mutations in the H5 HA identified here would render a wholly avian H5N1 virus transmissible. The genetic origin of the remaining seven viral gene segments may also critically contribute to transmissibility in mammals. Nevertheless, as H5N1 viruses continue to evolve and infect humans, receptor-binding variants of H5N1 viruses with pandemic potential, including avian-human reassortant viruses as tested here, may emerge. Our findings emphasize the need to prepare for potential pandemics caused by influenza viruses possessing H5 HA, and will help individuals conducting surveillance in regions with circulating H5N1 viruses to recognize key residues that predict the pandemic potential of isolates, which will inform the development, production and distribution of effective countermeasures.	[Imai, Masaki; Watanabe, Tokiko; Hatta, Masato; Das, Subash C.; Ozawa, Makoto; Zhong, Gongxun; Hanson, Anthony; Watanabe, Shinji; Li, Chengjun; Maher, Eileen A.; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA; [Watanabe, Tokiko; Watanabe, Shinji; Kawakami, Eiryo; Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Ozawa, Makoto; Kawaoka, Yoshihiro] Univ Tokyo, Dept Special Pathogens, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1088639, Japan; [Shinya, Kyoko] Kobe Univ, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan; [Katsura, Hiroaki; Yamada, Shinya; Kiso, Maki; Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Inst Med Sci, Tokyo 1088639, Japan; [Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	University of Wisconsin System; University of Wisconsin Madison; Japan Science & Technology Agency (JST); University of Tokyo; Kobe University; University of Tokyo; Chubu University	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA.	kawaokay@svm.vetmed.wisc.edu	Li, Chengjun/GWM-7661-2022; Ozawa, Makoto/AFM-4137-2022	Ozawa, Makoto/0000-0002-7731-5321; Yasuo, Suzuki/0000-0003-3518-5642; Zhong, Gongxun/0000-0002-0748-9641	Bill & Melinda Gates Foundation [48339, OPPGH5383]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; ERATO (Japan Science and Technology Agency); National Institute of Allergy and Infectious Diseases Public Health Service Research grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985, R01AI069274] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); National Institute of Allergy and Infectious Diseases Public Health Service Research grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge D. Holtzman for his contributions to the initial concept for this project and thoughtful scientific discussions. We thank M. McGregor, R. Moritz, L. Burley, K. Moore, A. Luka, J. Bettridge, N. Fujimoto and M. Ito for technical support, S. Watson for editing the manuscript, and the National Institute of Hygiene and Epidemiology, Hanoi, Vietnam for the A/Vietnam/1203/2004 (H5N1) virus, which was obtained from the CDC. This work was supported by the Bill & Melinda Gates Foundation (Grants 48339 and OPPGH5383), by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by ERATO (Japan Science and Technology Agency), and by the National Institute of Allergy and Infectious Diseases Public Health Service Research grants. The following reagents were obtained from the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: polyclonal anti-monovalent influenza subvirion vaccine rgA/Vietnam/1203/2004 (H5N1), (antiserum, Human), high tire pool, NR-4109 and low titre pool, NR-4110.	Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Cline TD, 2011, J VIROL, V85, P12262, DOI 10.1128/JVI.05582-11; England RJA, 1999, CLIN OTOLARYNGOL, V24, P67, DOI 10.1046/j.1365-2273.1999.00223.x; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HAYWOOD AM, 1986, J GEN VIROL, V67, P2813, DOI 10.1099/0022-1317-67-12-2813; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Krenn BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018577; [李海燕 Li Haiyan], 2004, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V26, P1; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Pereda A, 2010, EMERG INFECT DIS, V16, P304, DOI 10.3201/eid1602.091230; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Welsh MD, 2010, VET REC, V166, P642, DOI 10.1136/vr.4851; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	46	1048	1102	10	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					420	+		10.1038/nature10831	http://dx.doi.org/10.1038/nature10831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722205	Green Accepted, hybrid			2022-12-01	WOS:000305466800047
J	Lesku, JA; Rattenborg, NC; Valcu, M; Vyssotski, AL; Kuhn, S; Kuemmeth, F; Heidrich, W; Kempenaers, B				Lesku, John A.; Rattenborg, Niels C.; Valcu, Mihai; Vyssotski, Alexei L.; Kuhn, Sylvia; Kuemmeth, Franz; Heidrich, Wolfgang; Kempenaers, Bart			Adaptive Sleep Loss in Polygynous Pectoral Sandpipers	SCIENCE			English	Article							LOCAL SLEEP; POLYMORPHISM; HOMEOSTASIS	The functions of sleep remain elusive. Extensive evidence suggests that sleep performs restorative processes that sustain waking brain performance. An alternative view proposes that sleep simply enforces adaptive inactivity to conserve energy when activity is unproductive. Under this hypothesis, animals may evolve the ability to dispense with sleep when ecological demands favor wakefulness. Here, we show that male pectoral sandpipers (Calidris melanotos), a polygynous Arctic breeding shorebird, are able to maintain high neurobehavioral performance despite greatly reducing their time spent sleeping during a 3-week period of intense male-male competition for access to fertile females. Males that slept the least sired the most offspring. Our results challenge the view that decreased performance is an inescapable outcome of sleep loss.	[Valcu, Mihai; Kuhn, Sylvia; Kempenaers, Bart] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany; [Lesku, John A.; Rattenborg, Niels C.] Max Planck Inst Ornithol, Avian Sleep Grp, D-82319 Seewiesen, Germany; [Vyssotski, Alexei L.] Univ Zurich, Inst Neuroinformat, ETH, CH-8092 Zurich, Switzerland; [Kuemmeth, Franz; Heidrich, Wolfgang] E Obs GmbH, D-82031 Gruenwald, Germany	Max Planck Society; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Kempenaers, B (corresponding author), Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany.	b.kempenaers@orn.mpg.de	/ABD-1334-2021; Valcu, Mihai/AAX-8842-2021; Valcu, Mihai/B-6497-2014	Valcu, Mihai/0000-0002-6907-7802; Lesku, John/0000-0001-5073-6954; Vyssotski, Alexei/0000-0002-9021-1471; Kempenaers, Bart/0000-0002-7505-5458	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank R. Barth, E. Bolund, W. Forstmeier, A. Jacot, L. Langlois, P. Loes, C. Muck, A. Mutzel, M. Oltrogge, H. Schielzeth, X. Schleuning, S. Steiger, K. Teltscher, K. Temnow, and A. Wittenzellner for help in the field; R. Lanctot from the U.S. Fish and Wildlife Service (Anchorage) and G. Sheehan from Barrow Arctic Science Consortium for logistical support; and four anonymous reviewers for comments. W. Forstmeier kindly made his photos available. This work was funded by the Max Planck Society. B. K. and M. V. designed the study. B. K., J.A.L., and N.C.R. designed the EEG/EMG component. B. K. and M. V. collected and analyzed the activity/interaction data. J.A.L. and N.C.R. conducted the surgeries and analyzed the EEG/EMG data. A. L. V. developed and provided Neurologgers. S. K. incubated eggs and genetically determined paternity. W. H. and F. K. developed the iTags. B. K., J.A.L., N.C.R., and M. V. wrote the manuscript. Data from this study can be found in the supplementary materials.	Andersson Malte, 1994; Bachmann V, 2012, CEREB CORTEX, V22, P962, DOI 10.1093/cercor/bhr173; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Daan S, 2011, SLEEP BIOL RHYTHMS, V9, P1, DOI 10.1111/j.1479-8425.2010.00482.x; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fuchs T, 2009, BIOL LETTERS, V5, P77, DOI 10.1098/rsbl.2008.0405; Horne J, 2011, BIOL PSYCHOL, V87, P1, DOI 10.1016/j.biopsycho.2010.10.004; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Jones SG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-87; Jung CM, 2011, J PHYSIOL-LONDON, V589, P235, DOI 10.1113/jphysiol.2010.197517; Klein BA, 2010, P NATL ACAD SCI USA, V107, P22705, DOI 10.1073/pnas.1009439108; Kripke DF, 2011, SLEEP MED, V12, P28, DOI 10.1016/j.sleep.2010.04.016; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Lesku JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023203; Lesku JA, 2011, P ROY SOC B-BIOL SCI, V278, P2419, DOI 10.1098/rspb.2010.2316; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lyamin O, 2005, NATURE, V435, P1177, DOI 10.1038/4351177a; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; PITELKA FA, 1974, AM ZOOL, V14, P185; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070	27	142	145	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1654	1658		10.1126/science.1220939	http://dx.doi.org/10.1126/science.1220939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22878501				2022-12-01	WOS:000309215400045
J	Dreyfus, C; Laursen, NS; Kwaks, T; Zuijdgeest, D; Khayat, R; Ekiert, DC; Lee, JH; Metlagel, Z; Bujny, MV; Jongeneelen, M; van der Vlugt, R; Lamrani, M; Korse, HJWM; Geelen, E; Sahin, O; Sieuwerts, M; Brakenhoff, JPJ; Vogels, R; Li, OTW; Poon, LLM; Peiris, M; Koudstaal, W; Ward, AB; Wilson, IA; Goudsmit, J; Friesen, RHE				Dreyfus, Cyrille; Laursen, Nick S.; Kwaks, Ted; Zuijdgeest, David; Khayat, Reza; Ekiert, Damian C.; Lee, Jeong Hyun; Metlagel, Zoltan; Bujny, Miriam V.; Jongeneelen, Mandy; van der Vlugt, Remko; Lamrani, Mohammed; Korse, Hans J. W. M.; Geelen, Eric; Sahin, Ozcan; Sieuwerts, Martijn; Brakenhoff, Just P. J.; Vogels, Ronald; Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik; Koudstaal, Wouter; Ward, Andrew B.; Wilson, Ian A.; Goudsmit, Jaap; Friesen, Robert H. E.			Highly Conserved Protective Epitopes on Influenza B Viruses	SCIENCE			English	Article							A VIRUSES; ANTIBODY; HEMAGGLUTININ; BROAD; NEUTRALIZATION; RECOGNIZES; LINEAGES; HIV-1; CELLS	Identification of broadly neutralizing antibodies against influenza A viruses has raised hopes for the development of monoclonal antibody-based immunotherapy and "universal" vaccines for influenza. However, a substantial part of the annual flu burden is caused by two cocirculating, antigenically distinct lineages of influenza B viruses. Here, we report human monoclonal antibodies, CR8033, CR8071, and CR9114, that protect mice against lethal challenge from both lineages. Antibodies CR8033 and CR8071 recognize distinct conserved epitopes in the head region of the influenza B hemagglutinin (HA), whereas CR9114 binds a conserved epitope in the HA stem and protects against lethal challenge with influenza A and B viruses. These antibodies may inform on development of monoclonal antibody-based treatments and a universal flu vaccine for all influenza A and B viruses.	[Dreyfus, Cyrille; Laursen, Nick S.; Khayat, Reza; Ekiert, Damian C.; Lee, Jeong Hyun; Metlagel, Zoltan; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Laursen, Nick S.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Kwaks, Ted; Zuijdgeest, David; Bujny, Miriam V.; Jongeneelen, Mandy; van der Vlugt, Remko; Lamrani, Mohammed; Korse, Hans J. W. M.; Geelen, Eric; Sahin, Ozcan; Sieuwerts, Martijn; Brakenhoff, Just P. J.; Vogels, Ronald; Koudstaal, Wouter; Goudsmit, Jaap; Friesen, Robert H. E.] Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, NL-2301 CA Leiden, Netherlands; [Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, State Key Lab Emerging Infect Dis, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Aarhus University; University of Hong Kong; University of Hong Kong; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; jaap.goudsmit@crucell.com	Ward, Andrew B/F-9203-2014; Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Laursen, Nick Stub/Q-5051-2017; Ward, Andrew/ABD-7728-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Ward, Andrew B/0000-0001-7153-3769; Poon, Leo Lit Man/0000-0002-9101-7953; Laursen, Nick Stub/0000-0002-7512-2649; Ward, Andrew/0000-0001-7153-3769; Ekiert, Damian/0000-0002-2570-0404; Kwaks, Ted/0000-0003-1608-9372; Lee, Jeong Hyun/0000-0001-7371-845X; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative [U54 GM094586]; NIH through the National Center for Research Resources' P41 program [RR017573]; Area of Excellence Scheme of the University Grants Committee, Hong Kong [AoE/M-12/06]; Achievement Rewards for College Scientists Foundation; NIH Molecular Evolution Training Program [GM080209]; Danish Council for Independent Research, Natural Sciences; Skaggs Institute; DOE Office of Biological and Environmental Research; NIH, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS [Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; DOE, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209, U54GM094586] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH through the National Center for Research Resources' P41 program; Area of Excellence Scheme of the University Grants Committee, Hong Kong; Achievement Rewards for College Scientists Foundation(General Electric); NIH Molecular Evolution Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Skaggs Institute; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Juraszek; B. Brandenburg; M. Koldijk; K. Hegmans; J. Meijer; N. Hafkemeier; A. Apetri; J. Dulos; L. Dekking; H. Vietsch; G. Perdok; H. Tien; D. Marciano; the staff of the Advanced Photon Source (APS) GM/CA-CAT 23ID-B and 23ID-D, Stanford Synchrotron Radiation Lightsource (SSRL) BL11-1 and SSRL BL7-1, and Advanced Light Source (ALS); X. Dai; R. Stanfield; W. Yu; J. P. Julien; R. N. Kirchdoerfer; and E. Brown of Ottawa University, Canada, for the mouse-adapted A/Hong Kong/1/68 strain. Crystallization experiments were carried out on the Rigaku Crystalmation system at the Joint Center for Structural Genomics, which is supported by the National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative U54 GM094586. The EM and image analysis was conducted by R. K., J. H. L., and Z.M. at the National Resource for Automated Molecular Microscopy, which is supported by NIH through the National Center for Research Resources' P41 program (RR017573). This project has been funded in part by the Area of Excellence Scheme of the University Grants Committee, Hong Kong (grant AoE/M-12/06); a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D. C. E.); grant GM080209 from the NIH Molecular Evolution Training Program (D. C. E.); a Saper Aude Postdoc grant from the Danish Council for Independent Research, Natural Sciences (N. S. L.), and the Skaggs Institute (I. A. W.). Portions of this research were carried out at the SSRL, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH, National Center for Research Resources, Biomedical Technology Program (P41RR001209), and the NIGMS. The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the APS was supported by the DOE, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. The ALS is supported by the director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract no. DE-AC02-05CH11231. Coordinates and structure factors are deposited in the Protein Data Bank (PDB code 4FQH for CR9114 Fab, 4FQI for CR9114 Fab-A/H5 HA, 4FQJ for CR8071 Fab-B/Florida HA1, 4FQK for CR8059 Fab-B/Brisbane HA, 4FQL for CR8033 Fab, 4FQM for B/Brisbane HA, 4FQY for CR9114 Fab-A/H3 HA, and 4FQV for CR9114 Fab-A/H7 HA). Image reconstructions have been deposited at the EMDataBank under accession numbers EMD-2143 (CR8033/Florida), EMD-2144 (CR8071/Florida), EMD-2145 (CR8071/Malaysia), EMD-2146 (CR9114/Florida), EMD-2147 (CR9114/H1), EMD-2148 (CR9114/H3), EMD-2149 (CR9114/H9), and EMD-2150 (CR9114/H7). Nucleotide sequences for the CR8033, CR8059 (CR8071), and CR9114 variable regions have been deposited in GenBank [accession numbers JX213635 (CR8033, VH), JX213636 (CR8033, Vk), JX213637 (CR8059, VH), JX213638 (CR8059, Vl), JX213639 (CR9114, VH), and JX213640 (CR9114, Vl)]. Patent applications relating to antibodies CR8033, CR8059, CR8071, and CR9114 have been filed (CR8033, CR8059, and CR8071 are claimed in EP 12158525.1 and U.S. 61/608,414. CR9114 is claimed in EP 11173953.8 and U.S. 61/572,417). Sharing will be subject to standard material transfer agreements.; This is publication 21741 from the Scripps Research Institute.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; World Health Organization (WHO), 2009, FACT SHEET 211 INFL; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	25	539	585	8	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1343	1348		10.1126/science.1222908	http://dx.doi.org/10.1126/science.1222908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22878502	Green Accepted			2022-12-01	WOS:000308705000043
J	Halpern, BS; Longo, C; Hardy, D; McLeod, KL; Samhouri, JF; Katona, SK; Kleisner, K; Lester, SE; O'Leary, J; Ranelletti, M; Rosenberg, AA; Scarborough, C; Selig, ER; Best, BD; Brumbaugh, DR; Chapin, FS; Crowder, LB; Daly, KL; Doney, SC; Elfes, C; Fogarty, MJ; Gaines, SD; Jacobsen, KI; Karrer, LB; Leslie, HM; Neeley, E; Pauly, D; Polasky, S; Ris, B; St Martin, K; Stone, GS; Sumaila, UR; Zeller, D				Halpern, Benjamin S.; Longo, Catherine; Hardy, Darren; McLeod, Karen L.; Samhouri, Jameal F.; Katona, Steven K.; Kleisner, Kristin; Lester, Sarah E.; O'Leary, Jennifer; Ranelletti, Marla; Rosenberg, Andrew A.; Scarborough, Courtney; Selig, Elizabeth R.; Best, Benjamin D.; Brumbaugh, Daniel R.; Chapin, F. Stuart; Crowder, Larry B.; Daly, Kendra L.; Doney, Scott C.; Elfes, Cristiane; Fogarty, Michael J.; Gaines, Steven D.; Jacobsen, Kelsey I.; Karrer, Leah Bunce; Leslie, Heather M.; Neeley, Elizabeth; Pauly, Daniel; Polasky, Stephen; Ris, Bud; St Martin, Kevin; Stone, Gregory S.; Sumaila, U. Rashid; Zeller, Dirk			An index to assess the health and benefits of the global ocean	NATURE			English	Article							SAFE OPERATING SPACE; ECOSYSTEM HEALTH; INDICATORS; FRAMEWORK; IMPACTS	The ocean plays a critical role in supporting human well-being, from providing food, livelihoods and recreational opportunities to regulating the global climate. Sustainable management aimed at maintaining the flow of a broad range of benefits from the ocean requires a comprehensive and quantitative method to measure and monitor the health of coupled human-ocean systems. We created an index comprising ten diverse public goals for a healthy coupled human-ocean system and calculated the index for every coastal country. Globally, the overall index score was 60 out of 100 (range 36-86), with developed countries generally performing better than developing countries, but with notable exceptions. Only 5% of countries scored higher than 70, whereas 32% scored lower than 50. The index provides a powerful tool to raise public awareness, direct resource management, improve policy and prioritize scientific research.	[Halpern, Benjamin S.; Longo, Catherine; Hardy, Darren; O'Leary, Jennifer; Ranelletti, Marla; Scarborough, Courtney] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Ctr Marine Assessment & Planning, Santa Barbara, CA 93106 USA; [McLeod, Karen L.] Oregon State Univ, Dept Zool, COMPASS, Corvallis, OR 97331 USA; [Samhouri, Jameal F.] NOAA, Conservat Biol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98112 USA; [Katona, Steven K.; Rosenberg, Andrew A.; Selig, Elizabeth R.; Karrer, Leah Bunce; Stone, Gregory S.] Conservat Int, Arlington, VA 22202 USA; [Kleisner, Kristin; Pauly, Daniel; Sumaila, U. Rashid; Zeller, Dirk] Univ British Columbia, Fisheries Ctr, Sea Us Project, Vancouver, BC V6T 1Z4, Canada; [Lester, Sarah E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Lester, Sarah E.; Gaines, Steven D.; Jacobsen, Kelsey I.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Best, Benjamin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Brumbaugh, Daniel R.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Chapin, F. Stuart] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Crowder, Larry B.] Stanford Univ, Ctr Ocean Solut, Monterey, CA 93940 USA; [Crowder, Larry B.] Stanford Univ, Hopkins Marine Stn, Monterey, CA 93940 USA; [Daly, Kendra L.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33705 USA; [Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Elfes, Cristiane] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Elfes, Cristiane] Conservat Int, IUCN Global Species Programme, Biodivers Assessment Unit, Arlington, VA 22202 USA; [Fogarty, Michael J.] NE Fisheries Sci Ctr, Woods Hole, MA 02453 USA; [Leslie, Heather M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Leslie, Heather M.] Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA; [Neeley, Elizabeth] Univ Washington, Sch Aquat & Fisheries Sci, COMPASS, Seattle, WA 98195 USA; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Ris, Bud] New England Aquarium, Cent Wharf, Boston, MA 02110 USA; [St Martin, Kevin] Rutgers State Univ, Dept Geog, Piscataway, NJ 08854 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; Conservation International; University of British Columbia; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Duke University; American Museum of Natural History (AMNH); University of Alaska System; University of Alaska Fairbanks; Stanford University; Stanford University; State University System of Florida; University of South Florida; Woods Hole Oceanographic Institution; University of California System; University of California Santa Barbara; Conservation International; National Oceanic Atmospheric Admin (NOAA) - USA; Brown University; Brown University; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	halpern@nceas.ucsb.edu	Leslie, Heather/B-4980-2014; O'Leary, Jennifer/C-9653-2013; Doney, Scott C/F-9247-2010; Neeley, Liz/AAT-2019-2020; Gaines, Steven/Y-3234-2019; Sumaila, U. Rashid/ABE-6475-2020; Polasky, Stephen/AAC-5341-2019; Pauly, Daniel Marc/AAY-2316-2021; Chapin, F Stuart/AAZ-3931-2020; Leslie, Heather M./I-7812-2019	O'Leary, Jennifer/0000-0002-1975-7893; Doney, Scott C/0000-0002-3683-2437; Neeley, Liz/0000-0002-3031-1470; Chapin, F Stuart/0000-0002-2558-9910; Leslie, Heather M./0000-0003-4512-9417; St. Martin, Kevin/0000-0003-3775-1601; Scarborough, Courtney/0000-0001-7270-9228; Pauly, Daniel/0000-0003-3756-4793; Zeller, Dirk/0000-0001-7304-4125	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic; National Center for Ecological Analysis and Synthesis; David and Lucile Packard Foundation; Pew Charitable Trusts; Direct For Social, Behav & Economic Scie [0949710] Funding Source: National Science Foundation	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic(National Geographic Society); National Center for Ecological Analysis and Synthesis; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Pew Charitable Trusts; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	B. Wrigley and H. Wrigley provided the founding grant. Additional financial and in-kind support was provided by the Pacific Life Foundation, Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation. We would like to thank L. Bergen, J. Bort, B. Bronson, C. Costello, N. Crone, A. Dickson, J. Francis, A. Ghermandi, R. Haskell, L. Kaufman, K. Law, L. Madin, P. Nunes, D. Obura, L. Onofri, J. Packard, R. Portela, N. Rao, J. Regetz, S. Running, K. Selkoe, L. Speer, B. Spitzer, P. Stevick, H. Tallis, H. Tausig, S. Troeng and D. Zeyen for helpful discussions and logistical support during development of the index. Individual authors also acknowledge additional support from NSF, NASA, NOAA, Stanford's Center for Ocean Solutions and the Jaffe Family Foundation. K. K., D. P., U. R. S. and D.Z. thank the Sea Around Us Project, with support from the Pew Charitable Trusts. Data reported in this paper are tabulated in the Supplementary Information and archived at http://ohi.nceas.ucsb.edu/data. Results can be explored and visualized at http://oceanhealthindex.org.	Alder J, 2010, MAR POLICY, V34, P468, DOI 10.1016/j.marpol.2009.10.001; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CAIRNS J, 1993, HYDROBIOLOGIA, V263, P1, DOI 10.1007/BF00006084; Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Costanza R, 1992, ECOSYSTEM HLTH NEW G, P239; Donoghue J., 1997, ANN M AM SOC INT LAW; Emerson J., 2008, STATE NATIONS ECOSYS; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Glover D. M., 2011, MODELING METHODS MAR; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Heinz H.J, 2013, STATE NATIONS ECOSYS; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kareiva Peter., 2011, BREAKTHROUGH J, V2, P29; KELLY JR, 1990, ENVIRON MANAGE, V14, P527, DOI 10.1007/BF02394708; Kershner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025248; McLeod K., 2009, ECOSYSTEM BASED MANA; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY, DOI DOI 10.1196/ANNALS.1439.003; Munoz-Erickson TA, 2007, ECOL SOC, V12; National Ocean Council, 2012, DRAFT NAT OC POL IMP; Nellemann C., 2008, DEAD WATER MERGING C; Newton AC, 2011, CONSERV LETT, V4, P264, DOI 10.1111/j.1755-263X.2011.00167.x; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Obama Barack H., 2010, 13547 ADM BH OB; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Rapport DJ, 1999, ECOSYST HEALTH, V5, P82, DOI 10.1046/j.1526-0992.1999.09913.x; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Shackeroff J. M., 2009, ECOSYSTEM BASED MANA, P33; United Nations Development Programme, 2010, HUM DEV REP; World Bank Group, 2010, WORLDW GOV IND; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	37	576	619	30	638	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					615	+		10.1038/nature11397	http://dx.doi.org/10.1038/nature11397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895186				2022-12-01	WOS:000308095100048
J	Pearce, TM; Moran, DW				Pearce, Thomas M.; Moran, Daniel W.			Strategy-Dependent Encoding of Planned Arm Movements in the Dorsal Premotor Cortex	SCIENCE			English	Article							MOTOR CORTICAL REPRESENTATION; REACHING MOVEMENTS; SPATIAL ATTENTION; DELAY PERIOD; DIRECTION; POSITION; PARIETAL; PRIMATE; AREA; HAND	The kinematic strategy encoded in motor cortical areas for classic straight-line reaching is remarkably simple and consistent across subjects, despite the complicated musculoskeletal dynamics that are involved. As tasks become more challenging, however, different conscious strategies may be used to improve perceived behavioral performance. We identified additional spatial information that appeared both in single neurons and in the population code of monkey dorsal premotor cortex when obstacles impeded direct reach paths. The neural correlate of movement planning varied between subjects in a manner consistent with the use of different strategies to optimize task completion. These distinct planning strategies were manifested in the timing and strength of the information contained in the neural population code.	[Pearce, Thomas M.; Moran, Daniel W.] Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Moran, DW (corresponding author), Washington Univ, St Louis, MO 63130 USA.	dmoran@wustl.edu		Pearce, Thomas/0000-0002-5712-9492	NIH [R01NS057813, F30 NS071690-01]; NSF [IGERT 0548890]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS071690, R01NS057813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for the support of NIH grant R01NS057813, NIH F30 NS071690-01, and NSF IGERT 0548890.	Baldauf D, 2011, NEUROPSYCHOLOGIA, V49, P1383, DOI 10.1016/j.neuropsychologia.2011.01.041; Busan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004621; Catalan MJ, 1998, BRAIN, V121, P253, DOI 10.1093/brain/121.2.253; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2007, J NEUROPHYSIOL, V97, P348, DOI 10.1152/jn.00808.2006; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; DIPELLEGRINO G, 1993, SOMATOSENS MOT RES, V10, P245; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; GEORGOPOULOS AP, 1989, EXP BRAIN RES, V75, P183; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kurata K, 2000, J NEUROPHYSIOL, V84, P1667, DOI 10.1152/jn.2000.84.3.1667; Lebedev MA, 2001, EUR J NEUROSCI, V13, P1002, DOI 10.1046/j.0953-816x.2001.01457.x; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Ochiai T, 2002, J NEUROPHYSIOL, V88, P2167, DOI 10.1152/jn.2002.88.4.2167; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Schaal S, 2007, PROG BRAIN RES, V165, P425, DOI 10.1016/S0079-6123(06)65027-9; Schwartz AB, 2004, SCIENCE, V303, P380, DOI 10.1126/science.1087788; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Simon SR, 2002, J NEUROPHYSIOL, V88, P2047, DOI 10.1152/jn.2002.88.4.2047; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WISE SP, 1985, ANNU REV NEUROSCI, V8, P1, DOI 10.1146/annurev.ne.08.030185.000245	27	45	45	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					984	988		10.1126/science.1220642	http://dx.doi.org/10.1126/science.1220642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22821987	Green Accepted			2022-12-01	WOS:000307807600050
J	Wang, Y; Kim, E; Wang, XJ; Novitch, BG; Yoshikawa, K; Chang, LS; Zhu, Y				Wang, Yuan; Kim, Edward; Wang, Xiaojing; Novitch, Bennett G.; Yoshikawa, Kazuaki; Chang, Long-Sheng; Zhu, Yuan			ERK Inhibition Rescues Defects in Fate Specification of Nf1-Deficient Neural Progenitors and Brain Abnormalities	CELL			English	Article							NEUROFIBROMATOSIS TYPE-1; SUBVENTRICULAR ZONE; SIGNALING PATHWAYS; CORPUS-CALLOSUM; SONIC HEDGEHOG; NF1; RAS; OLIGODENDROCYTES; NEURONS; NEUROGENESIS	Germline mutations in the RAS/ERK signaling pathway underlie several related developmental disorders collectively termed neuro-cardio-facial-cutaneous (NCFC) syndromes. NCFC patients manifest varying degrees of cognitive impairment, but the developmental basis of their brain abnormalities remains largely unknown. Neurofibromatosis type 1 (NF1), an NCFC syndrome, is caused by loss-of-function heterozygous mutations in the NF1 gene, which encodes neurofibromin, a RAS GTPase-activating protein. Here, we show that biallelic Nf1 inactivation promotes Erk-dependent, ectopic Olig2 expression specifically in transit-amplifying progenitors, leading to increased gliogenesis at the expense of neurogenesis in neonatal and adult subventricular zone (SVZ). Nf1-deficient brains exhibit enlarged corpus callosum, a structural defect linked to severe learning deficits in NF1 patients. Strikingly, these NF1-associated developmental defects are rescued by transient treatment with an MEK/ERK inhibitor during neonatal stages. This study reveals a critical role for Nf1 in maintaining postnatal SVZ-derived neurogenesis and identifies a potential therapeutic window for treating NF1-associated brain abnormalities.	[Wang, Yuan; Kim, Edward; Wang, Xiaojing; Zhu, Yuan] Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Yuan; Kim, Edward; Wang, Xiaojing; Zhu, Yuan] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Novitch, Bennett G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Chang, Long-Sheng] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Chang, Long-Sheng] Ohio State Univ, Columbus, OH 43205 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Osaka University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Zhu, Y (corresponding author), Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA.	yuanzhu@umich.edu	Zhu, Yuan/ABF-8405-2020; Chang, Long-sheng/E-2871-2011; Wang, Yuan/I-7717-2014	Novitch, Bennett/0000-0002-2696-3708; Wang, Yuan/0000-0003-1681-9566; Chang, Long-Sheng/0000-0002-5178-2992; Wang, Yuan/0000-0002-6324-6134	NIH [1R01 NS053900]; DOD [W81XWH-11-1-0251]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073762, R01NS053900, R01NS072804, R01NS053976] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Best, L. Cregan, and G. Tomasek for technical assistance; members of the Y.Z. lab for support; J. Harrison, D. Sorenson, and S. Meshinchi at the MIL core facility for EM analysis; A. Messing for providing hGFAP-cre mice; and Dr. H. Song, D. Wellik, K. S. O'Shea, J. Sebolt-Leopold, and E. Fearon for critically reading the manuscript. This work is supported by grants from the NIH (1R01 NS053900) and DOD (W81XWH-11-1-0251) (to Y.Z.).	Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bilican B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002863; BOS JL, 1989, CANCER RES, V49, P4682; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; De Schepper S, 2008, J INVEST DERMATOL, V128, P1050, DOI 10.1038/sj.jid.5701095; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Listernick R, 1999, AM J MED GENET, V89, P38, DOI 10.1002/(SICI)1096-8628(19990326)89:1<38::AID-AJMG8>3.0.CO;2-M; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Moore BD, 2000, NEUROLOGY, V54, P914, DOI 10.1212/WNL.54.4.914; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Payne JM, 2010, J NEUROL NEUROSUR PS, V81, P304, DOI 10.1136/jnnp.2009.179630; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pride N, 2010, J CHILD NEUROL, V25, P834, DOI 10.1177/0883073809350723; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Satoh Y, 2011, J NEUROSCI, V31, P1149, DOI 10.1523/JNEUROSCI.2243-10.2011; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Stevenson DA, 2006, AM J HUM GENET, V79, P143, DOI 10.1086/504441; Tan MJ, 2011, DEV CELL, V21, P1062, DOI 10.1016/j.devcel.2011.09.014; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Waggoner DJ, 2000, AM J MED GENET, V92, P132, DOI 10.1002/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.3.CO;2-Y; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu Y, 2005, DEVELOPMENT, V132, P5577, DOI 10.1242/dev.02162; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	48	97	101	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					816	830		10.1016/j.cell.2012.06.034	http://dx.doi.org/10.1016/j.cell.2012.06.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901811	Bronze, Green Accepted			2022-12-01	WOS:000308002300015
J	Muller, FL; Colla, S; Aquilanti, E; Manzo, VE; Genovese, G; Lee, J; Eisenson, D; Narurkar, R; Deng, PN; Nezi, L; Lee, MA; Hu, BL; Hu, J; Sahin, E; Ong, D; Fletcher-Sananikone, E; Ho, D; Kwong, L; Brennan, C; Wang, YA; Chin, L; DePinho, RA				Muller, Florian L.; Colla, Simona; Aquilanti, Elisa; Manzo, Veronica E.; Genovese, Giannicola; Lee, Jaclyn; Eisenson, Daniel; Narurkar, Rujuta; Deng, Pingna; Nezi, Luigi; Lee, Michelle A.; Hu, Baoli; Hu, Jian; Sahin, Ergun; Ong, Derrick; Fletcher-Sananikone, Eliot; Ho, Dennis; Kwong, Lawrence; Brennan, Cameron; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.			Passenger deletions generate therapeutic vulnerabilities in cancer	NATURE			English	Article							ENOLASE DEFICIENCY; INHIBITION; REGIONS; CELLS	Inactivation of tumour-suppressor genes by homozygous deletion is a prototypic event in the cancer genome, yet such deletions often encompass neighbouring genes. We propose that homozygous deletions in such passenger genes can expose cancer-specific therapeutic vulnerabilities when the collaterally deleted gene is a member of a functionally redundant family of genes carrying out an essential function. The glycolytic gene enolase 1 (ENO1) in the 1p36 locus is deleted in glioblastoma (GBM), which is tolerated by the expression of ENO2. Here we show that short-hairpin-RNA-mediated silencing of ENO2 selectively inhibits growth, survival and the tumorigenic potential of ENO1-deleted GBM cells, and that the enolase inhibitor phosphonoacetohydroxamate is selectively toxic to ENO1-deleted GBM cells relative to ENO1-intact GBM cells or normal astrocytes. The principle of collateral vulnerability should be applicable to other passenger-deleted genes encoding functionally redundant essential activities and provide an effective treatment strategy for cancers containing such genomic events.	[Muller, Florian L.; Colla, Simona; Aquilanti, Elisa; Manzo, Veronica E.; Genovese, Giannicola; Lee, Jaclyn; Eisenson, Daniel; Narurkar, Rujuta; Deng, Pingna; Nezi, Luigi; Lee, Michelle A.; Hu, Baoli; Hu, Jian; Sahin, Ergun; Ong, Derrick; Fletcher-Sananikone, Eliot; Ho, Dennis; Kwong, Lawrence; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Muller, Florian L.; Colla, Simona; Genovese, Giannicola; Deng, Pingna; Nezi, Luigi; Hu, Baoli; Hu, Jian; Ong, Derrick; Fletcher-Sananikone, Eliot; Kwong, Lawrence; Wang, Y. Alan; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Muller, Florian L.; Colla, Simona; Hu, Jian; Sahin, Ergun; Ong, Derrick; Ho, Dennis; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; [Lee, Michelle A.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hu, Baoli; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	rdepinho@mdanderson.org	Brennan, Cameron/R-7082-2019; Nezi, Luigi/AAB-1957-2019	Brennan, Cameron/0000-0003-4064-8891; Nezi, Luigi/0000-0002-4670-7656; Lee, Jaclyn/0000-0001-9804-6995; Eisenson, Daniel/0000-0003-3868-0403; Muller, Florian/0000-0001-7568-2948; DePinho, Ronald/0000-0002-5625-577X; Colla, Simona/0000-0001-6583-8910; Genovese, Giannicola/0000-0003-1392-9954	National Institutes of Health (NIH) [T32-CA009361, P01CA95616]; American Cancer Society [115992-PF-08-261-01-TBE]; Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant; Howard Hughes Medical Institute Medical Research Fellowship [57006984]; Harvard PRISE fellowship; Diversity in Health-Related research award [3 P01 CA095616-08S1]; Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE [P01CA095616, T32CA009361] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant; Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); Harvard PRISE fellowship; Diversity in Health-Related research award; Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Ligon, C. Maire, D. N. Louis, J. Kimand G. Mohapatra for sharing bioinformatics data from their tumour neurosphere banks. We also thank D. Bigner for sharing the D423-MG and D502-MG cell lines and D. N. Louis and J. Kim for sharing the Gli56 cell line. We thank G. Chu and D. Jakubosky for assistance with necropsy and histopathological analysis. F. L. M. was supported by a training grant from the National Institutes of Health (NIH T32-CA009361) and a fellowship from the American Cancer Society (115992-PF-08-261-01-TBE). S. C. was supported by a Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant. E. A. was supported by a Howard Hughes Medical Institute Medical Research Fellowship (57006984). V. M. was supported by a Harvard PRISE fellowship. M. A. L. was supported by a Diversity in Health-Related research award (3 P01 CA095616-08S1). F. L. M. thanks J. Mohr for assistance with figure preparations. We also thank K. Muller for assistance with manuscript editing. We thank all members of the DePinho and Chin laboratories for suggestions and discussions. This work is supported by the NIH (P01CA95616 to C. B., L. C. and R. A. D.) and by the Ben and Catherine Ivy Foundation (to R. A. D. and L.C.).	ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2779, DOI 10.1021/bi00307a038; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brookfield JFY, 1997, ADV GENET, V36, P137, DOI 10.1016/S0065-2660(08)60308-9; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Comi GP, 2001, ANN NEUROL, V50, P202, DOI 10.1002/ana.1095; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; De Soto Joseph A, 2006, Int J Med Sci, V3, P117; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Guha M, 2011, NAT BIOTECHNOL, V29, P373, DOI 10.1038/nbt0511-373; GuhaChowdhury N, 1997, ORAL MICROBIOL IMMUN, V12, P91, DOI 10.1111/j.1399-302X.1997.tb00623.x; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Jing M, 2007, AM J PHYSIOL-CELL PH, V292, pC477, DOI 10.1152/ajpcell.00196.2006; Joseph J, 1996, J NEUROCHEM, V66, P2484; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Navarro MVDS, 2007, FEBS J, V274, P5077, DOI 10.1111/j.1742-4658.2007.06027.x; Peng W. X., 2007, CANCER SCI, V96, P661; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; POYNER RR, 1992, BIOCHEMISTRY-US, V31, P7166, DOI 10.1021/bi00146a020; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; STEFANINI M, 1972, AM J CLIN PATHOL, V58, P408; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Weidle UH, 2011, CANCER GENOM PROTEOM, V8, P159; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	37	223	234	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					337	+		10.1038/nature11331	http://dx.doi.org/10.1038/nature11331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895339	Green Accepted			2022-12-01	WOS:000307501000033
J	Chakraborty, A; Wang, DY; Ebright, YW; Korlann, Y; Kortkhonjia, E; Kim, T; Chowdhury, S; Wigneshweraraj, S; Irschik, H; Jansen, R; Nixon, BT; Knight, J; Weiss, S; Ebright, RH				Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Korlann, You; Kortkhonjia, Ekaterine; Kim, Taiho; Chowdhury, Saikat; Wigneshweraraj, Sivaramesh; Irschik, Herbert; Jansen, Rolf; Nixon, B. Tracy; Knight, Jennifer; Weiss, Shimon; Ebright, Richard H.			Opening and Closing of the Bacterial RNA Polymerase Clamp	SCIENCE			English	Article							ALTERNATING-LASER EXCITATION; 3.3 ANGSTROM RESOLUTION; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSCRIPTION ELONGATION; SINGLE MOLECULES; SWITCH REGION; INITIATION; PROTEIN	Using single-molecule fluorescence resonance energy transfer, we have defined bacterial RNA polymerase (RNAP) clamp conformation at each step in transcription initiation and elongation. We find that the clamp predominantly is open in free RNAP and early intermediates in transcription initiation but closes upon formation of a catalytically competent transcription initiation complex and remains closed during initial transcription and transcription elongation. We show that four RNAP inhibitors interfere with clamp opening. We propose that clamp opening allows DNA to be loaded into and unwound in the RNAP active-center cleft, that DNA loading and unwinding trigger clamp closure, and that clamp closure accounts for the high stability of initiation complexes and the high stability and processivity of elongation complexes.	[Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Kortkhonjia, Ekaterine; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Kortkhonjia, Ekaterine; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Korlann, You; Kortkhonjia, Ekaterine; Weiss, Shimon] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Kim, Taiho] Nesher Technol Inc, Los Angeles, CA 90057 USA; [Chowdhury, Saikat; Nixon, B. Tracy] Penn State Univ, Dept Biochem, University Pk, PA 16802 USA; [Wigneshweraraj, Sivaramesh] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Irschik, Herbert; Jansen, Rolf] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Knight, Jennifer] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Imperial College London; Helmholtz Association; Helmholtz-Center for Infection Research; University of Michigan System; University of Michigan	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu	CHOWDHURY, SAIKAT/J-6016-2019; Jansen, Rolf/C-1570-2011; weiss, shimon/B-4164-2009; Ebright, Richard/O-3321-2019	CHOWDHURY, SAIKAT/0000-0001-8043-5028; Jansen, Rolf/0000-0002-3592-4807; weiss, shimon/0000-0002-0720-5426; Ebright, Richard/0000-0001-8915-7140; Wigneshweraraj, Sivaramesh/0000-0002-1418-4029	NIH [GM037554, GM069937, GM069709, GM41376, AI072766]; Howard Hughes Medical Institute Investigatorship; BBSRC [BB/K000233/1, BB/E023703/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K000233/1, BB/E023703/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069937, R37GM041376, R01GM069709, R01GM041376, R01GM037554] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Schultz and R. Mehl for plasmids and A. Reitmar for assistance with instrument set-up. This work was funded by NIH grants GM037554 to C. L. Brooks III, GM069937 to B.T.N., GM069709 to S. W., and GM41376 and AI072766 to R. H. E., and a Howard Hughes Medical Institute Investigatorship to R.H.E.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; Camara B, 2010, P NATL ACAD SCI USA, V107, P2247, DOI 10.1073/pnas.0907908107; Chakraborty A, 2010, METHOD ENZYMOL, V472, P19, DOI 10.1016/S0076-6879(10)72018-8; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Ghosh T, 2010, FEMS MICROBIOL REV, V34, P611, DOI 10.1111/j.1574-6976.2010.00239.x; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hartzog GA, 2011, MOL CELL, V43, P161, DOI 10.1016/j.molcel.2011.07.002; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Landick R, 2001, CELL, V105, P567, DOI 10.1016/S0092-8674(01)00381-6; Lee NK, 2007, BIOPHYS J, V92, P303, DOI 10.1529/biophysj.106.093211; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Mariani R, 2009, CURR MED CHEM, V16, P430, DOI 10.2174/092986709787315559; Mekler V, 2011, J MOL BIOL, V413, P1016, DOI 10.1016/j.jmb.2011.09.029; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Srivastava A, 2011, CURR OPIN MICROBIOL, V14, P532, DOI 10.1016/j.mib.2011.07.030; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	29	151	155	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					591	595		10.1126/science.1218716	http://dx.doi.org/10.1126/science.1218716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859489	Green Submitted, Green Accepted			2022-12-01	WOS:000307058700048
J	Lachance, J; Vernot, B; Elbers, CC; Ferwerda, B; Froment, A; Bodo, JM; Lema, G; Fu, WQ; Nyambo, TB; Rebbeck, TR; Zhang, K; Akey, JM; Tishkoff, SA				Lachance, Joseph; Vernot, Benjamin; Elbers, Clara C.; Ferwerda, Bart; Froment, Alain; Bodo, Jean-Marie; Lema, Godfrey; Fu, Wenqing; Nyambo, Thomas B.; Rebbeck, Timothy R.; Zhang, Kun; Akey, Joshua M.; Tishkoff, Sarah A.			Evolutionary History and Adaptation from High-Coverage Whole-Genome Sequences of Diverse African Hunter-Gatherers	CELL			English	Article							POPULATION-STRUCTURE; GROWTH-HORMONE; MODERN HUMANS; GENETIC-VARIATION; WIDE ASSOCIATION; DISORDERS; MUTATIONS; ADMIXTURE; SELECTION; VARIANCE	To reconstruct modern human evolutionary history and identify loci that have shaped hunter-gatherer adaptation, we sequenced the whole genomes of five individuals in each of three different hunter-gatherer populations at >60x coverage: Pygmies from Cameroon and Khoesan-speaking Hadza and Sandawe from Tanzania. We identify 13.4 million variants, substantially increasing the set of known human variation. We found evidence of archaic intro-gression in all three populations, and the distribution of time to most recent common ancestors from these regions is similar to that observed for introgressed regions in Europeans. Additionally, we identify numerous loci that harbor signatures of local adaptation, including genes involved in immunity, metabolism, olfactory and taste perception, reproduction, and wound healing. Within the Pygmy population, we identify multiple highly differentiated loci that play a role in growth and anterior pituitary function and are associated with height.	[Lachance, Joseph; Elbers, Clara C.; Ferwerda, Bart; Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Lachance, Joseph; Elbers, Clara C.; Ferwerda, Bart; Tishkoff, Sarah A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vernot, Benjamin; Fu, Wenqing; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98185 USA; [Froment, Alain] Musee Homme Paris, IRD MNHN, F-75116 Paris, France; [Bodo, Jean-Marie] Minist Rech Sci & Innovat, Yaounde, Cameroon; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ, Dept Biochem, Coll Hlth Sci, Dar Es Salaam, Tanzania; [Zhang, Kun] Univ Calif San Diego, Inst Genom Med, Dept Bioengn, San Diego, CA 92093 USA; [Zhang, Kun] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92093 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of California System; University of California San Diego; University of California System; University of California San Diego	Tishkoff, SA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	tishkoff@mail.med.upenn.edu	Vernot, Benjamin/ABH-1495-2021; Zhang, Kun/ABE-6349-2020; Rebbeck, Timothy/GLU-8348-2022	Vernot, Benjamin/0000-0002-6820-2181; Zhang, Kun/0000-0002-7596-5224; Rebbeck, Timothy/0000-0002-4799-1900; Lachance, Joseph/0000-0002-4650-3741; Akey, Joshua/0000-0002-4411-1330; Ferwerda, Bart/0000-0002-7050-5931	NSF [BCS-0827436]; NIH [R01GM076637, 8 DP1 ES022577-04]; NIH NRSA postdoctoral fellowship [F32HG006648-01]; Netherlands Organization of Scientific Research; Center of Excellence in Environmental Toxicology at the University of Pennsylvania [P30-ES013508-07]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center of Excellence in Environmental Toxicology at the University of Pennsylvania; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF (BCS-0827436) and NIH (R01GM076637, 8 DP1 ES022577-04) grants to S.A.T., an NIH NRSA postdoctoral fellowship (F32HG006648-01) to J.L., Rubicon Grants of the Netherlands Organization of Scientific Research to C.C.E. and B.F., and support from the Center of Excellence in Environmental Toxicology at the University of Pennsylvania, P30-ES013508-07. We thank J. Hirbo, J. Jarvis, A. Rawlings, L. Scheinfeld, and S. Soi for their critical feedback and advice and K. Addya, D. Baldwin, and B. Beggs for assistance in genotyping the samples. We also thank the 15 individuals who graciously supplied their DNA.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Brickman JM, 2001, DEVELOPMENT, V128, P5189; Burger R, 2011, THEOR POPUL BIOL, V80, P272, DOI 10.1016/j.tpb.2011.07.002; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Dattani MT, 2005, CLIN ENDOCRINOL, V63, P121, DOI 10.1111/j.1365-2265.2005.02289.x; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Falush D, 2003, GENETICS, V164, P1567; Galli GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002711; Gat-Yablonski G, 2009, HORM RES, V72, P302, DOI 10.1159/000245932; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henn BM, 2010, HUM MOL GENET, V19, pR221, DOI 10.1093/hmg/ddq403; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; Hunsaker TL, 2012, J MOL BIOL, V415, P29, DOI 10.1016/j.jmb.2011.11.001; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; JONES NGB, 1992, AM J PHYS ANTHROPOL, V89, P159, DOI 10.1002/ajpa.1330890204; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kiess W, 2011, HORM RES PAEDIAT, V76, P11, DOI 10.1159/000330140; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Mantovani G, 2006, MOL CELL ENDOCRINOL, V247, P135, DOI 10.1016/j.mce.2005.12.036; Marlowe, 2010, HADZA HUNTER GATHERE; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Pemberton T.J., 2012, AM J HUM GENET; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sands B., 1998, LANGUAGE IDENTITY CO, P265; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shimada MK, 2007, MOL BIOL EVOL, V24, P687, DOI 10.1093/molbev/msl196; Shriver Mark D, 2004, Hum Genomics, V1, P274; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	53	206	209	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					457	469		10.1016/j.cell.2012.07.009	http://dx.doi.org/10.1016/j.cell.2012.07.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22840920	Green Accepted, Bronze			2022-12-01	WOS:000307301400007
J	Padmanabhan, K; Robles, MS; Westerling, T; Weitz, CJ				Padmanabhan, Kiran; Robles, Maria S.; Westerling, Thomas; Weitz, Charles J.			Feedback Regulation of Transcriptional Termination by the Mammalian Circadian Clock PERIOD Complex	SCIENCE			English	Article							NEGATIVE FEEDBACK; COMPONENTS; MECHANISM; PROTEINS; LIMB; REPRESSION; OSCILLATOR; NEUROSPORA; ALPHA	Eukaryotic circadian clocks are built on transcriptional feedback loops. In mammals, the PERIOD (PER) and CRYPTOCHROME (CRY) proteins accumulate, form a large nuclear complex (PER complex), and repress their own transcription. We found that mouse PER complexes included RNA helicases DDX5 and DHX9, active RNA polymerase II large subunit, Per and Cry pre-mRNAs, and SETX, a helicase that promotes transcriptional termination. During circadian negative feedback, RNA polymerase II accumulated near termination sites on Per and Cry genes but not on control genes. Recruitment of PER complexes to the elongating polymerase at Per and Cry termination sites inhibited SETX action, impeding RNA polymerase II release and thereby repressing transcriptional reinitiation. Circadian clock negative feedback thus includes direct control of transcriptional termination.	[Padmanabhan, Kiran; Robles, Maria S.; Weitz, Charles J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Westerling, Thomas] Harvard Univ, Sch Med, Ctr Funct Canc Epigenet, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Robles, Maria/ABH-1497-2020; Robles, Maria S/D-6307-2015; Padmanabhan, Kiran/N-2953-2013	Robles, Maria/0000-0001-9149-8761; Robles, Maria S/0000-0001-9149-8761; Padmanabhan, Kiran/0000-0001-7020-1682; Westerling, Thomas/0000-0001-8537-6493	G. Harold and Leila Y. Mathers Charitable Foundation; David Mahoney Fellowship; Edward R. and Anne G. Lefler Center fellowship	G. Harold and Leila Y. Mathers Charitable Foundation; David Mahoney Fellowship; Edward R. and Anne G. Lefler Center fellowship	We thank M. Liu for technical assistance and J. Gray and M. Greenberg (Harvard Medical School) for helpful comments. All data are tabulated in the paper and supplementary materials. This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation (C. J. W.), a David Mahoney Fellowship (K. P.), and an Edward R. and Anne G. Lefler Center fellowship (M.S.R.).	Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Dunlap JC, 2006, CURR OPIN MICROBIOL, V9, P579, DOI 10.1016/j.mib.2006.10.008; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; West S, 2009, MOL CELL, V33, P354, DOI 10.1016/j.molcel.2009.01.008	21	110	120	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					599	602		10.1126/science.1221592	http://dx.doi.org/10.1126/science.1221592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22767893				2022-12-01	WOS:000307058700050
J	Papouin, T; Ladepeche, L; Ruel, J; Sacchi, S; Labasque, M; Hanini, M; Groc, L; Pollegioni, L; Mothet, JP; Oliet, SHR				Papouin, Thomas; Ladepeche, Laurent; Ruel, Jerome; Sacchi, Silvia; Labasque, Marilyne; Hanini, Marwa; Groc, Laurent; Pollegioni, Loredano; Mothet, Jean-Pierre; Oliet, Stephane H. R.			Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists	CELL			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; D-SERINE; GLYCINE TRANSPORTER; SUBUNIT COMPOSITION; AMBIENT GLUTAMATE; TONIC ACTIVATION; RELEASE; DEPRESSION; SYNAPSES	N-methyl-D-aspartate receptors (NMDARs) are located in neuronal cell membranes at synaptic and extrasynaptic locations, where they are believed to mediate distinct physiological and pathological processes. Activation of NMDARs requires glutamate and a coagonist whose nature and impact on NMDAR physiology remain elusive. We report that synaptic and extrasynaptic NMDARs are gated by different endogenous coagonists, D-serine and glycine, respectively. The regionalized availability of the coagonists matches the preferential affinity of synaptic NMDARs for D-serine and extrasynaptic NMDARs for glycine. Furthermore, glycine and D-serine inhibit NMDAR surface trafficking in a subunit-dependent manner, which is likely to influence NMDARs subcellular location. Taking advantage of this coagonist segregation, we demonstrate that long-term potentiation and NMDA-induced neurotoxicity rely on synaptic NMDARs only. Conversely, long-term depression requires both synaptic and extrasynaptic receptors. Our observations provide key insights into the operating mode of NMDARs, emphasizing functional distinctions between synaptic and extrasynaptic NMDARs in brain physiology.	[Papouin, Thomas; Mothet, Jean-Pierre; Oliet, Stephane H. R.] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Papouin, Thomas; Ladepeche, Laurent; Groc, Laurent; Mothet, Jean-Pierre; Oliet, Stephane H. R.] Univ Bordeaux, F-33077 Bordeaux, France; [Ladepeche, Laurent; Groc, Laurent] CNRS, Interdisciplinary Inst NeuroSci, UMR 5297, F-33077 Bordeaux, France; [Ruel, Jerome; Labasque, Marilyne; Hanini, Marwa; Mothet, Jean-Pierre] CNRS, CRN2M UMR 6231, F-13344 Marseille, France; [Ruel, Jerome; Mothet, Jean-Pierre] Univ Aix Marseille, F-13344 Marseille, France; [Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Mol, Varese, Italy; [Pollegioni, Loredano] Politecn Milan, Prot Factory, Ctr Interuniv Biotecnol Prot, Varese, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Insubria; Polytechnic University of Milan	Oliet, SHR (corresponding author), INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France.	stephane.oliet@inserm.fr	Papouin, Thomas/W-2769-2019; Labasque, Marilyne/AAE-2498-2022; Ladépêche, Laurent/G-3418-2015; Mothet, Jean-Pierre/ABE-3066-2020	Papouin, Thomas/0000-0001-5288-1944; Ladépêche, Laurent/0000-0002-2566-1206; POLLEGIONI, LOREDANO/0000-0003-1733-7243; Oliet, Stephane/0000-0003-0595-9029; Ruel, Jerome/0000-0003-2871-7321; MOTHET, Jean-Pierre/0000-0003-4991-0614; SACCHI, SILVIA/0000-0002-2338-2561; Labasque, Marilyne/0000-0002-1467-2866	INSERM; CNRS; Agence National pour la Recherche; Conseil Regional d'Aquitaine; Universite Bordeaux Segalen; Universite Aix-Marseille; NARSAD; Fondation pour la Recherche Medicale (Equipe FRM); Federation pour la Recherche sur le Cerveau; Human Frontier Science Program; Ministere de l'Enseignement Superieur et de la Recherche; Fondo di Ateneo per la Ricerca (Universita dell'Insubria); Fondazione Cariplo	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence National pour la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Universite Bordeaux Segalen; Universite Aix-Marseille; NARSAD(NARSAD); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Human Frontier Science Program(Human Frontier Science Program); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondo di Ateneo per la Ricerca (Universita dell'Insubria); Fondazione Cariplo(Fondazione Cariplo)	We thank Dr. Henneberger, Pr. Rusakov, and Pr. Voisin for critical reading of the manuscript and M. P. Blanchard and Dr. Choquet for their technical assistance. We are very grateful to Drs. Abrous and Sage for performing pilot experiments. This work was supported by grants from INSERM, CNRS, Agence National pour la Recherche, Conseil Regional d'Aquitaine, Universite Bordeaux Segalen, Universite Aix-Marseille, NARSAD, Fondation pour la Recherche Medicale (Equipe FRM), Federation pour la Recherche sur le Cerveau, and the Human Frontier Science Program. TP and LL were recipients of studentships from the Ministere de l'Enseignement Superieur et de la Recherche. S. S. and L. P. were supported by grants from Fondo di Ateneo per la Ricerca (Universita dell'Insubria) and from Fondazione Cariplo.	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Atkinson BN, 2001, MOL PHARMACOL, V60, P1414, DOI 10.1124/mol.60.6.1414; Bard L, 2010, P NATL ACAD SCI USA, V107, P19561, DOI 10.1073/pnas.1002690107; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kalbaugh TL, 2009, J NEUROSCI, V29, P1469, DOI 10.1523/JNEUROSCI.4240-08.2009; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Le Meur K, 2007, J PHYSIOL-LONDON, V580, P373, DOI 10.1113/jphysiol.2006.123570; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Lin CH, 2012, PHARMACOL BIOCHEM BE, V100, P665, DOI 10.1016/j.pbb.2011.03.023; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MATSUI T, 1995, J NEUROCHEM, V65, P454; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Molla G, 2000, J BIOL CHEM, V275, P24715, DOI 10.1074/jbc.M908193199; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; POLLEGIONI L, 1992, BIOCHIM BIOPHYS ACTA, V1120, P11, DOI 10.1016/0167-4838(92)90418-D; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rusakov DA, 2004, SCIENCE, V305, p1912B, DOI 10.1126/science.1101128; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Stevens ER, 2010, EUR J NEUROSCI, V31, P808, DOI 10.1111/j.1460-9568.2010.07135.x; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsai GC, 2004, BIOL PSYCHIAT, V55, P452, DOI 10.1016/j.biopsych.2003.09.012; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; Wake K, 2001, NEUROSCI LETT, V297, P25, DOI 10.1016/S0304-3940(00)01658-X; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yamamoto S, 2010, J PSYCHIATR RES, V44, P1069, DOI 10.1016/j.jpsychires.2010.03.013; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008; Zhao JP, 2007, J NEUROSCI, V27, P13649, DOI 10.1523/JNEUROSCI.3153-07.2007	72	465	471	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					633	646		10.1016/j.cell.2012.06.029	http://dx.doi.org/10.1016/j.cell.2012.06.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863013	Green Submitted, Bronze			2022-12-01	WOS:000307301400020
J	Farrell, L				Farrell, Liam			The dance of death	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 24	2012	345								e4956	10.1136/bmj.e4956	http://dx.doi.org/10.1136/bmj.e4956			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UQ	22833582				2022-12-01	WOS:000306996900007
J	Auslander, S; Auslander, D; Muller, M; Wieland, M; Fussenegger, M				Auslaender, Simon; Auslaender, David; Mueller, Marius; Wieland, Markus; Fussenegger, Martin			Programmable single-cell mammalian biocomputers	NATURE			English	Article							CANCER-CELLS; MICE; NETWORKS; CIRCUIT; COMMUNICATION; HOMEOSTASIS; SWITCHES	Synthetic biology has advanced the design of standardized control devices that program cellular functions and metabolic activities in living organisms(1). Rational interconnection of these synthetic switches resulted in increasingly complex designer networks that execute input-triggered genetic instructions with precision, robustness and computational logic reminiscent of electronic circuits(2,3). Using trigger-controlled transcription factors, which independently control gene expression(4,5), and RNA-binding proteins that inhibit the translation of transcripts harbouring specific RNA target motifs(6,7), we have designed a set of synthetic transcription-translation control devices that could be rewired in a plug-and-play manner. Here we show that these combinatorial circuits integrated a two-molecule input and performed digital computations with NOT, AND, NAND and N-IMPLY expression logic in single mammalian cells. Functional interconnection of two N-IMPLY variants resulted in bitwise intracellular XOR operations, and a combinatorial arrangement of three logic gates enabled independent cells to perform programmable half-subtractor and half-adder calculations. Individual mammalian cells capable of executing basic molecular arithmetic functions isolated or coordinated to metabolic activities in a predictable, precise and robust manner may provide new treatment strategies and bio-electronic interfaces in future gene-based and cell-based therapies.	[Auslaender, Simon; Auslaender, David; Mueller, Marius; Wieland, Markus; Fussenegger, Martin] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Fussenegger, Martin] Univ Basel, Fac Sci, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Fussenegger, M (corresponding author), ETH, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	fussenegger@bsse.ethz.ch			Swiss National Science Foundation [31003A-126022]; EC Framework 7 (Persist)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC Framework 7 (Persist)(European Commission)	We thank R. Singer for providing pMS2dIFG, M. Tigges for generous advice, E. Gutzwiller for experimental support, and M. Dessing and V. Jaggin for assistance with flow cytometry. This work was supported by the Swiss National Science Foundation (grant no. 31003A-126022) and in part by EC Framework 7 (Persist).	Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gitzinger M, 2009, P NATL ACAD SCI USA, V106, P10638, DOI 10.1073/pnas.0901501106; Greber D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq671; Kemmer C, 2011, J CONTROL RELEASE, V150, P23, DOI 10.1016/j.jconrel.2010.11.016; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Leisner M, 2010, NAT NANOTECHNOL, V5, P666, DOI [10.1038/NNANO.2010.135, 10.1038/nnano.2010.135]; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Paraskeva E, 1998, P NATL ACAD SCI USA, V95, P951, DOI 10.1073/pnas.95.3.951; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Saito H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1157; Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/NCHEMBIO.273, 10.1038/nchembio.273]; Stojanovic MN, 2003, J AM CHEM SOC, V125, P6673, DOI 10.1021/ja0296632; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Weber W, 2002, NAT BIOTECHNOL, V20, P901, DOI 10.1038/nbt731; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Weber W, 2011, CURR OPIN CHEM BIOL, V15, P414, DOI 10.1016/j.cbpa.2011.03.003; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	260	275	6	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2012	487	7405					123	+		10.1038/nature11149	http://dx.doi.org/10.1038/nature11149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722847				2022-12-01	WOS:000305982900063
J	Santos, SDM; Wollman, R; Meyer, T; Ferrell, JE				Santos, Silvia D. M.; Wollman, Roy; Meyer, Tobias; Ferrell, James E., Jr.			Spatial Positive Feedback at the Onset of Mitosis	CELL			English	Article							CELL-CYCLE REGULATION; PROTEIN-KINASE; NUCLEAR EXPORT; NEGATIVE REGULATION; NETWORK MOTIFS; XENOPUS-OOCYTE; LOCALIZATION; B1; PHOSPHORYLATION; ACTIVATION	Mitosis is triggered by the activation of Cdk1-cyclin B1 and its translocation from the cytoplasm to the nucleus. Positive feedback loops regulate the activation of Cdk1-cyclin B1 and help make the process irreversible and all-or-none in character. Here we examine whether an analogous process, spatial positive feedback, regulates Cdk1-cyclin B1 redistribution. We used chemical biology approaches and live-cell microscopy to show that nuclear Cdk1-cyclin B1 promotes the translocation of Cdk1-cyclin B1 to the nucleus. Mechanistic studies suggest that cyclin B1 phosphorylation promotes nuclear translocation and, conversely, nuclear translocation promotes cyclin B1 phosphorylation, accounting for the feedback. Interfering with the abruptness of Cdk1-cyclin B1 translocation affects the timing and synchronicity of subsequent mitotic events, underscoring the functional importance of this feedback. We propose that spatial positive feedback ensures a rapid, complete, robust, and irreversible transition from interphase to mitosis and suggest that bistable spatiotemporal switches may be widespread in biological regulation.	[Santos, Silvia D. M.; Wollman, Roy; Meyer, Tobias; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Santos, SDM (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, CCSR Bldg,269 Campus Dr, Stanford, CA 94305 USA.	sdsantos@stanford.edu; james.ferrell@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	National Institutes of Health [GM061276]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM061276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Pearlman and P. Beltrao for help with analysis scripts; M. Teruel, S. Bandara, and T. Wandless for iRap; O. Rocks and S. Spenser for reagents; J. Wu from the Stanford High-Throughput Bioscience Center for technical assistance; M. Covert for generous use of his microscope; and J. Skotheim, P. Beltrao, S. Collins, A. Hayer, A. Salmeen S. Carrasco, J. Chang, and the Meyer and Ferrell labs for helpful discussions and comments on the manuscript. This work was supported by a grant from the National Institutes of Health (GM061276). S. D. M. S. is a Human Frontier Science Program Fellow (HFSP) and an EMBO fellow.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; Borgne A, 1999, J BIOL CHEM, V274, P11977, DOI 10.1074/jbc.274.17.11977; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Eser U, 2011, MOL CELL, V43, P515, DOI 10.1016/j.molcel.2011.06.024; Ferrell JE, 2008, CURR BIOL, V18, pR244, DOI 10.1016/j.cub.2008.02.035; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Ferrell JE, 1998, TRENDS BIOCHEM SCI, V23, P461, DOI 10.1016/S0968-0004(98)01316-4; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guignet EG, 2008, NAT METHODS, V5, P393, DOI 10.1038/NMETH.1201; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Jones JT, 2004, NAT BIOTECHNOL, V22, P306, DOI 10.1038/nbt941; Kallstrom H, 2005, EXP CELL RES, V303, P89, DOI 10.1016/j.yexcr.2004.09.012; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/NMETH.1428, 10.1038/nmeth.1428]; KORNBLUTH S, 1994, MOL BIOL CELL, V5, P273, DOI 10.1091/mbc.5.3.273; Kumagai A, 1999, GENE DEV, V13, P1067, DOI 10.1101/gad.13.9.1067; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; LI JK, 1995, MOL BIOL CELL, V6, P1111, DOI 10.1091/mbc.6.9.1111; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Morgan DO., 2007, CELL CYCLE PRINCIPLE; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Walsh S, 2003, MOL CANCER RES, V1, P280; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yang J, 2001, J BIOL CHEM, V276, P3604, DOI 10.1074/jbc.M008151200	58	92	92	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1500	1513		10.1016/j.cell.2012.05.028	http://dx.doi.org/10.1016/j.cell.2012.05.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726437	Green Accepted, Bronze			2022-12-01	WOS:000305753800016
J	Hemmelgarn, BR; James, MT; Manns, BJ; O'Hare, AM; Muntner, P; Ravani, P; Quinn, RR; Turin, TC; Tan, Z; Tonelli, M				Hemmelgarn, Brenda R.; James, Matthew T.; Manns, Braden J.; O'Hare, Ann M.; Muntner, Paul; Ravani, Pietro; Quinn, Robert R.; Turin, Tanvir Chowdhury; Tan, Zhi; Tonelli, Marcello		Alberta Kidney Dis Network	Rates of Treated and Untreated Kidney Failure in Older vs Younger Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY RISK; RENAL-DISEASE; DIALYSIS; OUTCOMES; PROTEINURIA; POPULATION; PREVALENCE; SYMPTOMS	Context Studies of kidney failure in older adults have focused on receipt of dialysis, which may underestimate the burden of disease if older people are less likely to receive treatment. Objective To determine the extent to which age is associated with the likelihood of treatment of kidney failure. Design, Setting, and Participants Community-based cohort study of 1 816 824 adults in Alberta, Canada, who had outpatient estimated glomerular filtration rate (eGFR) measured between May 1, 2002, and March 31, 2008, with a baseline eGFR of 15 mL/min/1.73 m(2) or higher and who did not require renal replacement therapy at baseline. Age was categorized as 18 to 44, 45 to 54, 55 to 64, 65 to 74, 75 to 84, and 85 or more years and eGFR as 90 or higher, 60 to 89, 45 to 59, 30 to 44, and 15 to 29 mL/min/1.73 m(2). Main Outcome Measures Adjusted rates of treated kidney failure (receipt of dialysis or kidney transplantation), untreated kidney failure (progression to eGFR <15 mL/min/1.73 m(2) without renal replacement therapy), and death. Results During a median follow-up of 4.4 years, 97 451 (5.36%) died, 3295 (0.18%) developed kidney failure that was treated and 3116 (0.17%) developed kidney failure that went untreated. Within each eGFR stratum the rate of treated kidney failure was higher in younger compared with older people. For example, in the lowest eGFR stratum (15-29 mL/min/1.73 m(2)), adjusted rates of treated kidney failure were more than 10-fold higher among the youngest (18-44 years) compared with the oldest (>= 85 years) groups (adjusted rate, 24.00 [95% CI, 14.78-38.97] vs 1.53 [95% CI, 0.59-3.99] per 1000 person-years, respectively; P < .001). Rates of untreated kidney failure were consistently higher at older ages. In the eGFR stratum of 15 to 29 mL/min/1.73 m(2), adjusted rates of untreated kidney failure were more than 5-fold higher among the oldest (>= 85 years), compared with the youngest (18-44 years) groups (adjusted rate, 19.95 [95% CI, 15.79-25.19] vs 3.53 [95% CI, 1.56-8.01] per 1000 person-years, respectively; P < .001). Rates of kidney failure overall (treated and untreated combined) demonstrated less variation across age groups; eg, the adjusted rate per 1000 person years for those with eGFR of 15-29 mL/min/1.73 m(2) was 36.45 (95% CI, 24.46-54.32) among participants aged 18 to 44 years and 20.19 (95% CI, 15.27-26.69) among those aged 85 years or older (P=.01). Conclusion In Alberta, Canada, rates of untreated kidney failure are significantly higher in older compared with younger individuals. JAMA. 2012; 307(23):2507-2515 www.jama.com	[Hemmelgarn, Brenda R.; James, Matthew T.; Manns, Braden J.; Ravani, Pietro; Quinn, Robert R.; Turin, Tanvir Chowdhury; Tan, Zhi] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hemmelgarn, Brenda R.; James, Matthew T.; Manns, Braden J.; Ravani, Pietro] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Hemmelgarn, Brenda R.; James, Matthew T.; Manns, Braden J.; Ravani, Pietro; Quinn, Robert R.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [O'Hare, Ann M.] Univ Washington, Dept Med, Seattle, WA USA; [Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, W Midlands, England; [Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Washington; University of Washington Seattle; University of Alberta	Hemmelgarn, BR (corresponding author), Foothills Med Ctr, Div Nephrol, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	brenda.hemmelgarn@albertahealthservices.ca	Quinn, Robert R/E-7017-2011; Tonelli, Marcello/B-3028-2009; Turin, Tanvir C/L-7617-2016; Hemmelgarn, Brenda R./I-6894-2012; Manns, Braden J/I-8942-2012; Ravani, Pietro/J-3050-2015	Tonelli, Marcello/0000-0002-0846-3187; Turin, Tanvir C/0000-0002-7499-5050; Ravani, Pietro/0000-0001-6973-8570	Amgen; UpToDate; Canadian Institute of Health Research (CIHR); Alberta Innovates-Health Solutions (AI-HS); Roy and Vi Baay Chair in Kidney Research; Government of Canada Research Chair; Canadian Diabetes Association	Amgen(Amgen); UpToDate; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions (AI-HS); Roy and Vi Baay Chair in Kidney Research; Government of Canada Research Chair; Canadian Diabetes Association	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr O'Hare reports receiving royalties from UpToDate. Dr Muntner reports consulting for and receiving salary support through a grant to his institution by Amgen. No other disclosures were reported.; This work was supported by the Canadian Institute of Health Research (CIHR) and by an interdisciplinary team grant from Alberta Innovates-Health Solutions (AI-HS). Drs Hemmelgarn, Manns, and Tonelli were supported by career salary awards from AI-HS. Dr Hemmelgarn was supported by the Roy and Vi Baay Chair in Kidney Research and Dr Tonelli was supported by a Government of Canada Research Chair. Dr Turin is supported by Fellowship Awards from CIHR and the Canadian Diabetes Association.	Bello A, 2012, AM J KIDNEY DIS, V59, P364, DOI 10.1053/j.ajkd.2011.09.006; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Clark WF, 2011, CAN MED ASSOC J, V183, P47, DOI 10.1503/cmaj.100349; Clement FM, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-25; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Dor Avi, 2007, Int J Health Care Finance Econ, V7, P73, DOI 10.1007/s10754-007-9024-9; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hall YN, 2010, CLIN J AM SOC NEPHRO, V5, P828, DOI 10.2215/CJN.09011209; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jassal SV, 2007, CAN MED ASSOC J, V177, P1033, DOI 10.1503/cmaj.061765; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Murphy EL, 2009, NEPHRON CLIN PRACT, V111, pC74, DOI 10.1159/000183177; Murtagh FEM, 2007, J PALLIAT MED, V10, P1266, DOI 10.1089/jpm.2007.0017; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; O'Hare AM, 2010, JAMA-J AM MED ASSOC, V304, P180, DOI 10.1001/jama.2010.924; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Raymond NT, 2007, NEPHROL DIAL TRANSPL, V22, P3214, DOI 10.1093/ndt/gfm396; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Rosansky S, 2011, CLIN J AM SOC NEPHRO, V6, P1222, DOI 10.2215/CJN.09301010; Sekkarie MA, 1998, AM J KIDNEY DIS, V31, P464, DOI 10.1053/ajkd.1998.v31.pm9506683; Statistics Canada, ETHN PORTR CAN HIGHL; *US REN DAT SYST, 2003, USRDS 2003 ANN DAT R	32	110	117	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2012	307	23					2507	2515		10.1001/jama.2012.6455	http://dx.doi.org/10.1001/jama.2012.6455			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960MB	22797451	Bronze			2022-12-01	WOS:000305391400027
J	Tinetti, ME; Fried, TR; Boyd, CM				Tinetti, Mary E.; Fried, Terri R.; Boyd, Cynthia M.			Designing Health Care for the Most Common Chronic Condition-Multimorbidity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tinetti, Mary E.; Fried, Terri R.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Tinetti, Mary E.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA; [Fried, Terri R.] VA Connecticut Healthcare Syst, Clin Epidemiol Unit, New Haven, CT USA; [Boyd, Cynthia M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Boyd, Cynthia M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	mary.tinetti@yale.edu			NATIONAL INSTITUTE ON AGING [R01AG038528, K24AG028443, R03AG035146, P30AG021342, K23AG032910] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson G, 2010, CHRONIC CARE MAKING; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, GUIDING PRINCIPLES C; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; National Quality Forum, MULT CHRON COND MCC; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; RTI International, ACC CAR ORG 2012 PRO; Weiss CO, 2007, JAMA-J AM MED ASSOC, V298, P1160, DOI 10.1001/jama.298.10.1160-a	8	528	532	3	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2012	307	23					2493	2494		10.1001/jama.2012.5265	http://dx.doi.org/10.1001/jama.2012.5265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960MB	22797447	Green Accepted			2022-12-01	WOS:000305391400023
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			How to obtain the P value from a confidence interval	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England.	doug.altman@csm.ox.ac.uk						Altman DG, 2011, BRIT MED J, V342, pd2090; Bland JM, 1996, BRIT MED J, V312, P700; LIN JT, 1989, APPL STAT-J ROY ST C, V38, P69; Mancia G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1197; Taggart DP, 2001, LANCET, V358, P870, DOI 10.1016/S0140-6736(01)06069-X	5	291	291	2	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2011	343								d2304	10.1136/bmj.d2304	http://dx.doi.org/10.1136/bmj.d2304			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KQ	22803193	Green Submitted, Bronze			2022-12-01	WOS:000209545500002
J	Bateman, RJ; Xiong, CJ; Benzinger, TLS; Fagan, AM; Goate, A; Fox, NC; Marcus, DS; Cairns, NJ; Xie, XY; Blazey, TM; Holtzman, DM; Santacruz, A; Buckles, V; Oliver, A; Moulder, K; Aisen, PS; Ghetti, B; Klunk, WE; McDade, E; Martins, RN; Masters, CL; Mayeux, R; Ringman, JM; Rossor, MN; Schofield, PR; Sperling, RA; Salloway, S; Morris, JC				Bateman, Randall J.; Xiong, Chengjie; Benzinger, Tammie L. S.; Fagan, Anne M.; Goate, Alison; Fox, Nick C.; Marcus, Daniel S.; Cairns, Nigel J.; Xie, Xianyun; Blazey, Tyler M.; Holtzman, David M.; Santacruz, Anna; Buckles, Virginia; Oliver, Angela; Moulder, Krista; Aisen, Paul S.; Ghetti, Bernardino; Klunk, William E.; McDade, Eric; Martins, Ralph N.; Masters, Colin L.; Mayeux, Richard; Ringman, John M.; Rossor, Martin N.; Schofield, Peter R.; Sperling, Reisa A.; Salloway, Stephen; Morris, John C.			Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRESENILIN-1 MUTATION; AMYLOID DEPOSITION; ATROPHY; CORTEX; BRAIN; ONSET; STATE; MRI	BACKGROUND The order and magnitude of pathologic processes in Alzheimer's disease are not well understood, partly because the disease develops over many years. Autosomal dominant Alzheimer's disease has a predictable age at onset and provides an opportunity to determine the sequence and magnitude of pathologic changes that culminate in symptomatic disease. METHODS In this prospective, longitudinal study, we analyzed data from 128 participants who underwent baseline clinical and cognitive assessments, brain imaging, and cerebrospinal fluid (CSF) and blood tests. We used the participant's age at baseline assessment and the parent's age at the onset of symptoms of Alzheimer's disease to calculate the estimated years from expected symptom onset (age of the participant minus parent's age at symptom onset). We conducted cross-sectional analyses of baseline data in relation to estimated years from expected symptom onset in order to determine the relative order and magnitude of pathophysiological changes. RESULTS Concentrations of amyloid-beta (A beta)(42) in the CSF appeared to decline 25 years before expected symptom onset. A beta deposition, as measured by positron-emission tomography with the use of Pittsburgh compound B, was detected 15 years before expected symptom onset. Increased concentrations of tau protein in the CSF and an increase in brain atrophy were detected 15 years before expected symptom onset. Cerebral hypometabolism and impaired episodic memory were observed 10 years before expected symptom onset. Global cognitive impairment, as measured by the Mini-Mental State Examination and the Clinical Dementia Rating scale, was detected 5 years before expected symptom onset, and patients met diagnostic criteria for dementia at an average of 3 years after expected symptom onset. CONCLUSIONS We found that autosomal dominant Alzheimer's disease was associated with a series of pathophysiological changes over decades in CSF biochemical markers of Alzheimer's disease, brain amyloid deposition, and brain metabolism as well as progressive cognitive impairment. Our results require confirmation with the use of longitudinal data and may not apply to patients with sporadic Alzheimer's disease. (Funded by the National Institute on Aging and others; DIAN ClinicalTrials.gov number, NCT00869817.)	[Bateman, Randall J.; Fagan, Anne M.; Holtzman, David M.; Santacruz, Anna; Buckles, Virginia; Oliver, Angela; Moulder, Krista; Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Xiong, Chengjie; Xie, Xianyun] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA; [Goate, Alison] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Benzinger, Tammie L. S.; Marcus, Daniel S.; Blazey, Tyler M.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Fox, Nick C.; Rossor, Martin N.] UCL, Inst Neurol, London WC1E 6BT, England; [Aisen, Paul S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Klunk, William E.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Klunk, William E.; McDade, Eric] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Martins, Ralph N.] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA, Australia; [Masters, Colin L.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic, Australia; [Schofield, Peter R.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Mayeux, Richard] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Mayeux, Richard] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Ringman, John M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Sperling, Reisa A.] Massachusetts Gen Hosp, Brigham & Womens Hosp, Ctr Alzheimer Res & Treatment, Boston, MA 02114 USA; [Sperling, Reisa A.] Massachusetts Gen Hosp, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02114 USA; [Sperling, Reisa A.] Harvard Univ, Sch Med, Boston, MA USA; [Salloway, Stephen] Brown Univ, Warren Alpert Med Sch, Butler Hosp, Dept Neurol, Providence, RI 02912 USA; [Salloway, Stephen] Brown Univ, Warren Alpert Med Sch, Butler Hosp, Memory & Aging Program, Providence, RI 02912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; University of California System; University of California San Diego; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Edith Cowan University; University of Melbourne; University of New South Wales Sydney; Columbia University; Columbia University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University; Butler Hospital Rhode Island; Brown University; Butler Hospital Rhode Island	Bateman, RJ (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	batemanr@wustl.edu	Benzinger, Tammie L. S./ABA-8534-2020; Mayeux, Richard/E-9788-2013; Rossor, Martin/C-1598-2008; Benzinger, Tammie/L-6104-2013; Cairns, Nigel/AAB-9713-2020; Fox, Nick C/B-1319-2009; Fox, Nick C/AAE-1849-2021; Schofield, Peter/C-9669-2011	Benzinger, Tammie L. S./0000-0002-8114-0552; Mayeux, Richard/0000-0001-6519-9696; Cairns, Nigel/0000-0001-9858-3344; Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Klunk, William/0000-0001-5512-0251; Bateman, Randall/0000-0002-7729-1702; Rossor, Martin/0000-0001-8215-3120; Martins, Ralph/0000-0002-4828-9363; Goate, Alison/0000-0002-0576-2472; Schofield, Peter/0000-0003-2967-9662	National Institute on Aging; MRC [G0601846] Funding Source: UKRI; Medical Research Council [G0601846] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UF1AG032438, U19AG032438, U19AG010483] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging and others; DIAN ClinicalTrials.gov number, NCT00869817.; Supported by the National Institute on Aging and a private nonprofit foundation (see disclosure at NEJM.org).	[Anonymous], 2011, SUMM OP IN AUTH VYND; [Anonymous], 2007, BAP PAT MILD MOD ALZ; [Anonymous], 2009, EFF LY2062430 PROGR; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomez-Isla T, 1999, BRAIN, V122, P1709, DOI 10.1093/brain/122.9.1709; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2002, SCIENCE, V297, P2209; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Klunk WE, 2007, J NEUROSCI, V27, P6174, DOI 10.1523/JNEUROSCI.0730-07.2007; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Morris JC, 1997, NEUROLOGY, V48, P1508, DOI 10.1212/WNL.48.6.1508; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Ringman JM, 2008, NEUROLOGY, V71, P85, DOI 10.1212/01.wnl.0000303973.71803.81; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wijsman EM, 2005, AM J MED GENET B, V132B, P14, DOI 10.1002/ajmg.b.30087; YAMAMOTO A, 1980, ATHEROSCLEROSIS, V35, P259, DOI 10.1016/0021-9150(80)90124-0	33	2225	2271	18	409	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					795	804		10.1056/NEJMoa1202753	http://dx.doi.org/10.1056/NEJMoa1202753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22784036	Green Published, Green Accepted			2022-12-01	WOS:000308067400001
J	Turnhout, E; Bloomfield, B; Hulme, M; Vogel, J; Wynne, B				Turnhout, Esther; Bloomfield, Bob; Hulme, Mike; Vogel, Johannes; Wynne, Brian			Listen to the voices of experience	NATURE			English	Editorial Material									[Turnhout, Esther] Wageningen Univ, Forest & Nat Conservat Policy Grp, Wageningen, Netherlands; [Bloomfield, Bob] Nat Hist Museum, Sci Soc, London SW7 5BD, England; [Hulme, Mike] Univ E Anglia, Sch Environm Sci, Sci Soc & Sustainabil Grp, Norwich NR4 7TJ, Norfolk, England; [Vogel, Johannes] Museum Nat Kunde, Berlin, Germany; [Wynne, Brian] Univ Lancaster, UK ESRC Ctr Econ & Social Aspects Genom, Lancaster LA1 4YW, England	Wageningen University & Research; Natural History Museum London; University of East Anglia; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Lancaster University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC)	Turnhout, E (corresponding author), Wageningen Univ, Forest & Nat Conservat Policy Grp, Wageningen, Netherlands.	esther.turnhout@wur.nl	Hulme, Mike/F-9012-2010; Turnhout, Esther/K-9338-2017	Hulme, Mike/0000-0002-1273-7662; Turnhout, Esther/0000-0002-2190-2076				AGRAWAL A, 1995, DEV CHANGE, V26, P413, DOI 10.1111/j.1467-7660.1995.tb00560.x; Hayden Cori, 2004, NATURE GOES PUBLIC M; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Pinheiro S., 2009, EARTHSCAN READER SUS, P352; *ROYAL SOC, 2003, MEAS BIOD CONS; Van der Pleog J., 1993, ANTHR CRITIQUE DEV G, P209, DOI DOI 10.1525/AE.1995.22.3.02A00190; Walker S, 2009, CONSERV LETT, V2, P149, DOI 10.1111/j.1755-263X.2009.00061.x; Waterton C., 2003, SALMO TRUTTA, V6, P56; William W. B., 2003, IOWA LAW REV, V89, P3; Wynne B., 1989, ENV THREATS PERCEPTI, P233	10	152	159	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					454	455		10.1038/488454a	http://dx.doi.org/10.1038/488454a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992FS	22914151	Bronze			2022-12-01	WOS:000307761600016
J	Elde, NC; Child, SJ; Eickbush, MT; Kitzman, JO; Rogers, KS; Shendure, J; Geballe, AP; Malik, HS				Elde, Nels C.; Child, Stephanie J.; Eickbush, Michael T.; Kitzman, Jacob O.; Rogers, Kelsey S.; Shendure, Jay; Geballe, Adam P.; Malik, Harmit S.			Poxviruses Deploy Genomic Accordions to Adapt Rapidly against Host Antiviral Defenses	CELL			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; VACCINIA VIRUS; GENE AMPLIFICATION; EXPERIMENTAL EVOLUTION; SEQUENCE; RESISTANCE; MUTATION; K3L; DUPLICATION	In contrast to RNA viruses, double-stranded DNA viruses have low mutation rates yet must still adapt rapidly in response to changing host defenses. To determine mechanisms of adaptation, we subjected the model poxvirus vaccinia to serial propagation in human cells, where its antihost factor K3L is malad-apted against the antiviral protein kinase R (PKR). Viruses rapidly acquired higher fitness via recurrent K3L gene amplifications, incurring up to 7%-10% increases in genome size. These transient gene expansions were necessary and sufficient to counteract human PKR and facilitated the gain of an adaptive amino acid substitution in K3L that also defeats PKR. Subsequent reductions in gene amplifications offset the costs associated with larger genome size while retaining adaptive substitutions. Our discovery of viral "gene-accordions" explains how poxviruses can rapidly adapt to defeat different host defenses despite low mutation rates and reveals how classical Red Queen conflicts can progress through unrecognized intermediates.	[Elde, Nels C.; Eickbush, Michael T.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Child, Stephanie J.; Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Elde, Nels C.; Rogers, Kelsey S.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA; [Kitzman, Jacob O.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Geballe, Adam P.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Geballe, Adam P.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Malik, Harmit S.] Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Elde, NC (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	nelde@genetics.utah.edu; hsmalik@fhcrc.org	Malik, Harmit S/E-8519-2012; Malik, Harmit S/I-5591-2019; Shendure, Jay/AAU-3684-2021	Malik, Harmit S/0000-0001-6005-0016; Eickbush, Michael/0000-0001-9057-9156; Kitzman, Jacob/0000-0002-6145-882X; Shendure, Jay/0000-0002-1516-1865; Child, Stephanie/0000-0002-1987-9540	National Institutes of Health (NIH) [GM090042, 1R21CA160080-01, AI26672]; National Science Foundation (NSF) Graduate Research Fellowship; NSF CAREER award; NATIONAL CANCER INSTITUTE [R21CA160080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026672, R29AI026672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM090042, K99GM090042] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Jacobs for virus strains, J. Tartaglia for K3L antibody, B. Moss for vaccinia-reactive rabbit serum, and G. Smith for RecBCD and advice on recombination. We thank M. Daugherty, M. Dunham, M. Emerman, A. Frost, J. Kerns, M. Patel, and S. Sawyer for critical reading of the manuscript and B. Stackhouse for technical assistance with sequencing library preparation. This work is supported by the National Institutes of Health (NIH) K99/R00 award (GM090042 to N.C.E.), NIH grant (1R21CA160080-01 to J. S.), NIH grant (AI26672 to A. P. G.), a National Science Foundation (NSF) Graduate Research Fellowship (J.O.K.), and an NSF CAREER award (H. S. M.). H. S. M. is an Early Career Scientist of Howard Hughes Medical Institute. J. S. is a member of the scientific advisory board or serves as a consultant for Ariosa Diagnostics, Stratos Genomics, Good Start Genetics, and Adaptive TCR.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bratke KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-67; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Demuth JP, 2009, BIOESSAYS, V31, P29, DOI 10.1002/bies.080085; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Drake JW, 1998, GENETICS, V148, P1667; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; EICHLER DC, 1977, J BIOL CHEM, V252, P499; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; ESPOSITO J, 1981, J VIROL METHODS, V2, P175, DOI 10.1016/0166-0934(81)90036-7; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; FOSTER PL, 1994, GENETICS, V138, P253; Goebel S.J., 1990, VIROLOGY, V179, P517; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Hakki M, 2005, J VIROL, V79, P7311, DOI 10.1128/JVI.79.12.7311-7318.2005; Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Hendrickson H, 2002, P NATL ACAD SCI USA, V99, P2164, DOI 10.1073/pnas.032680899; Hendrickson RC, 2010, VIRUSES-BASEL, V2, P1933, DOI 10.3390/v2091933; Howley P.M., 2007, FIELDS VIROLOGY, V5th; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kerr PJ, 2010, VET MICROBIOL, V143, P167, DOI 10.1016/j.vetmic.2009.11.025; Kugelberg E, 2010, GENETICS, V185, P65, DOI 10.1534/genetics.110.114074; Langland J.O., 2002, BIOINFORMATICS, V299, P133; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Meisinger-Henschel C, 2007, J GEN VIROL, V88, P3249, DOI 10.1099/vir.0.83156-0; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Meyerson NR, 2011, TRENDS MICROBIOL, V19, P286, DOI 10.1016/j.tim.2011.03.006; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; MOSS B, 1981, P NATL ACAD SCI-BIOL, V78, P1614, DOI 10.1073/pnas.78.3.1614; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Pranting M, 2011, MOL MICROBIOL, V79, P305, DOI 10.1111/j.1365-2958.2010.07458.x; Rothenburg S, 2009, NAT STRUCT MOL BIOL, V16, P63, DOI 10.1038/nsmb.1529; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; SCHIMKE RT, 1986, CANCER, V57, P1912, DOI 10.1002/1097-0142(19860515)57:10<1912::AID-CNCR2820571004>3.0.CO;2-O; Searles RP, 1999, J VIROL, V73, P3040, DOI 10.1128/JVI.73.4.3040-3053.1999; SLABAUGH MB, 1986, J VIROL, V60, P506, DOI 10.1128/JVI.60.2.506-514.1986; SLABAUGH MB, 1989, NUCLEIC ACIDS RES, V17, P7073, DOI 10.1093/nar/17.17.7073; SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4; SMITH GR, 1995, PHILOS T ROY SOC B, V347, P13, DOI 10.1098/rstb.1995.0003; Stambuk BU, 2009, GENOME RES, V19, P2271, DOI 10.1101/gr.094276.109; Sun S, 2009, GENETICS, V182, P1183, DOI 10.1534/genetics.109.103028; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Werden SJ, 2008, ADV VIRUS RES, V71, P135, DOI 10.1016/S0065-3527(08)00003-1; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422	66	189	192	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					831	841		10.1016/j.cell.2012.05.049	http://dx.doi.org/10.1016/j.cell.2012.05.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901812	Green Accepted, Bronze			2022-12-01	WOS:000308002300016
J	Wang, ET; Cody, NAL; Jog, S; Biancolella, M; Wang, TT; Treacy, DJ; Luo, SJ; Schroth, GP; Housman, DE; Reddy, S; Lecuyer, E; Burge, CB				Wang, Eric T.; Cody, Neal A. L.; Jog, Sonali; Biancolella, Michela; Wang, Thomas T.; Treacy, Daniel J.; Luo, Shujun; Schroth, Gary P.; Housman, David E.; Reddy, Sita; Lecuyer, Eric; Burge, Christopher B.			Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins	CELL			English	Article							MYOTONIC-DYSTROPHY; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; STEM-CELLS; SYNAPSE FORMATION; MBNL1; TRANSLATION; DROSOPHILA; REVEALS; BINDING	The muscleblind-like (Mbnl) family of RNA-binding proteins plays important roles in muscle and eye development and in myotonic dystrophy (DM), in which expanded CUG or CCUG repeats functionally deplete Mbnl proteins. We identified transcriptome-wide functional and biophysical targets of Mbnl proteins in brain, heart, muscle, and myoblasts by using RNA-seq and CLIP-seq approaches. This analysis identified several hundred splicing events whose regulation depended on Mbnl function in a pattern indicating functional interchangeability between Mbnl1 and Mbnl2. A nucleotide resolution RNA map associated repression or activation of exon splicing with Mbnl binding near either 30 splice site or near the downstream 50 splice site, respectively. Transcriptomic analysis of subcellular compartments uncovered a global role for Mbnls in regulating localization of mRNAs in both mouse and Drosophila cells, and Mbnl-dependent translation and protein secretion were observed for a subset of mRNAs with Mbnl-dependent localization. These findings hold several new implications for DM pathogenesis.	[Wang, Eric T.; Wang, Thomas T.; Treacy, Daniel J.; Housman, David E.; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Wang, Eric T.; Housman, David E.; Burge, Christopher B.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02142 USA; [Wang, Eric T.; Wang, Thomas T.; Housman, David E.; Burge, Christopher B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Burge, Christopher B.] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Cody, Neal A. L.; Lecuyer, Eric] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Jog, Sonali; Biancolella, Michela; Reddy, Sita] Univ So Calif, Los Angeles, CA 90033 USA; [Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Lecuyer, Eric] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Southern California; Illumina; Universite de Montreal	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020		Poitras Fellowship; National Science Foundation [0821391]; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005624, R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319] Funding Source: NIH RePORTER	Poitras Fellowship; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tom Cooper for the anti-Mbnl1 antibody used to perform CLIP. We thank Andy Berglund and David Brook for insightful conversations about muscleblinds and Phil Sharp and Bob Brown Jr. for their comments and suggestions to perform cellular fractionation experiments. We thank Michael Zuker for suggestions on depleting ribosomal RNAs during ribosome footprint library preparation. We thank the MIT Biomicro Center and the IRCM molecular biology core facility for assistance with deep sequencing and the Koch Institute Swanson Biotechnology Center for microscopy assistance. This work was supported by a Poitras Fellowship (E. T. W.), by equipment grant 0821391 from the National Science Foundation, and by grants from the National Institutes of Health to C. B. B. E. T. W. performed CLIP-seq, cellular fractionation of mouse cells, ribosome footprint profiling, and luciferase assays and also analyzed RNA-seq, CLIP-seq, and footprint data. N.A.L.C. performed cellular fractionation of fly cells. S.J., M. B., and S. R. isolated RNA from mouse tissues and performed splicing RT-PCR assays. T. T. W. performed lentiviral knockdown of Mbnls in mouse cells. D.J.T. and S. L. prepared RNA-seq libraries. N.C., E. L., S. R., D. E. H., and G. P. S. contributed to study design. E. T. W. and C. B. B. designed the study and wrote the paper with contributions from E. L. and N.C.	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Amenta AR, 2012, J NEUROSCI, V32, P2324, DOI 10.1523/JNEUROSCI.4610-11.2012; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; Begemann G, 1997, DEVELOPMENT, V124, P4321; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; FFRENCHCONSTANT C, 1989, DEVELOPMENT, V106, P375; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HESKETH J, 1994, MOL BIOL REP, V19, P233, DOI 10.1007/BF00986965; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lecuyer E, 2009, CURR OPIN CELL BIOL, V21, P409, DOI 10.1016/j.ceb.2009.01.027; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Myotonic Dystrophy Foundation, 2017, VOIC PAT REP MYOT DY; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; PACHTER J S, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P1; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Panaite PA, 2008, J NEUROPATH EXP NEUR, V67, P763, DOI 10.1097/NEN.0b013e318180ec64; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sen S, 2010, J BIOL CHEM, V285, P25426, DOI 10.1074/jbc.M109.095224; Spilker KA, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-7; Squillace RM, 2002, DEV BIOL, V250, P218, DOI 10.1006/dbio.2002.0798; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; VEDELER A, 1991, MOL CELL BIOCHEM, V100, P183; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	65	331	337	3	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					710	724		10.1016/j.cell.2012.06.041	http://dx.doi.org/10.1016/j.cell.2012.06.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901804	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000308002300007
J	Angelo, K; Rancz, EA; Pimentel, D; Hundahl, C; Hannibal, J; Fleischmann, A; Pichler, B; Margrie, TW				Angelo, Kamilla; Rancz, Ede A.; Pimentel, Diogo; Hundahl, Christian; Hannibal, Jens; Fleischmann, Alexander; Pichler, Bruno; Margrie, Troy W.			A biophysical signature of network affiliation and sensory processing in mitral cells	NATURE			English	Article							HYPERPOLARIZATION-ACTIVATED CURRENT; PYRAMIDAL NEURONS; OLFACTORY-BULB; I-H; INTEGRATIVE PROPERTIES; ENTORHINAL CORTEX; DIVERSITY; CHANNELS; MOUSE; OSCILLATIONS	One defining characteristic of the mammalian brain is its neuronal diversity(1). For a given region, substructure, layer or even cell type, variability in neuronal morphology and connectivity persists(2-5). Although it is well known that such cellular properties vary considerably according to neuronal type, the substantial biophysical diversity of neurons of the same morphological class is typically averaged out and ignored. Here we show that the amplitude of hyperpolarization-evoked sag of membrane potential recorded in olfactory bulb mitral cells is an emergent, homotypic property of local networks and sensory information processing. Simultaneous whole-cell recordings from pairs of cells show that the amount of hyperpolarization-evoked sag potential and current (I-h)(6) is stereotypic for mitral cells belonging to the same glomerular circuit. This is corroborated by a mosaic, glomerulus-based pattern of expression of the HCN2 (hyperpolarization-activated cyclic nucleotidegated channel 2) subunit of the Ih channel. Furthermore, inter-glomerular differences in both membrane potential sag and HCN2 protein are diminished when sensory input to glomeruli is genetically and globally altered so that only one type of odorant receptor is universally expressed(7). Population diversity in this intrinsic property therefore reflects differential expression between local mitral cell networks processing distinct odour-related information.	[Angelo, Kamilla; Rancz, Ede A.; Pimentel, Diogo; Margrie, Troy W.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Angelo, Kamilla; Hundahl, Christian] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Rancz, Ede A.; Pichler, Bruno; Margrie, Troy W.] MRC Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; [Hundahl, Christian; Hannibal, Jens] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Biochem, DK-2200 Copenhagen N, Denmark; [Fleischmann, Alexander] Coll France, Ctr Interdisciplinary Res Biol CIRB, F-75231 Paris 05, France	University of London; University College London; University of Copenhagen; MRC National Institute for Medical Research; University of Copenhagen; Bispebjerg Hospital; UDICE-French Research Universities; PSL Research University Paris; College de France	Margrie, TW (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	troy.margrie@nimr.mrc.ac.uk	Hannibal, Jens/H-5482-2019; Hundahl, Christian Ansgar/H-3938-2015; Rancz, Ede Attila/AAS-6867-2020	Hannibal, Jens/0000-0001-9416-0125; Rancz, Ede Attila/0000-0002-7951-1385	Sir Henry Wellcome Fellowship; Oticon Foundation; Danish Council for Independent Research; Lundbeckfondation; Gulbenkian PhD Programme; Fundacao para a Ciencia e Tecnologia; Wellcome Trust; Medical Research Council [MC_U1175975156]; Medical Research Council [MC_U117597156] Funding Source: researchfish; MRC [MC_U117597156] Funding Source: UKRI	Sir Henry Wellcome Fellowship; Oticon Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeckfondation; Gulbenkian PhD Programme; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Velez-Fort for comments on the manuscript. E. A. R. is a recipient of a Sir Henry Wellcome Fellowship. This project was supported by the Oticon Foundation, the Danish Council for Independent Research and the Lundbeckfondation (K. A.), the Gulbenkian PhD Programme and Fundacao para a Ciencia e Tecnologia (D. P.), The Wellcome Trust (T. W. M.) and Medical Research Council MC_U1175975156 (B. P. and T.W.M.).	Angelo K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00050; Brochtrup A, 2011, CURR OPIN NEUROBIOL, V21, P85, DOI 10.1016/j.conb.2010.11.001; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Cadetti L, 2001, NEUROREPORT, V12, P3117, DOI 10.1097/00001756-200110080-00027; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Magee JC, 1998, J NEUROSCI, V18, P7613; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Mombaerts P, 1996, CURR OPIN NEUROBIOL, V6, P481, DOI 10.1016/S0959-4388(96)80053-5; Nolan MF, 2007, J NEUROSCI, V27, P12440, DOI 10.1523/JNEUROSCI.2358-07.2007; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Pimentel DO, 2008, J PHYSIOL-LONDON, V586, P2107, DOI 10.1113/jphysiol.2007.149575; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	30	57	57	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					375	378		10.1038/nature11291	http://dx.doi.org/10.1038/nature11291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22820253	Green Accepted			2022-12-01	WOS:000307501000041
J	Denning, DP; Hatch, V; Horvitz, HR				Denning, Daniel P.; Hatch, Victoria; Horvitz, H. Robert			Programmed elimination of cells by caspase-independent cell extrusion in C. elegans	NATURE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; DNA-DEGRADATION; DEATH; NEMATODE; MECHANISMS; ENGULFMENT; APOPTOSIS; KINASE; EPITHELIUM; PATHWAY	The elimination of unnecessary or defective cells from metazoans occurs during normal development and tissue homeostasis, as well as in response to infection or cellular damage(1). Although many cells are removed through caspase-mediated apoptosis followed by phagocytosis by engulfing cells(2), other mechanisms of cell elimination occur(3), including the extrusion of cells from epithelia through a poorly understood, possibly caspase-independent, process(4). Here we identify a mechanism of cell extrusion that is caspase independent and that can eliminate a subset of the Caenorhabditis elegans cells programmed to die during embryonic development. In wild-type animals, these cells die soon after their generation through caspase-mediated apoptosis. However, in mutants lacking all four C. elegans caspase genes, these cells are eliminated by being extruded from the developing embryo into the extra-embryonic space of the egg. The shed cells show apoptosis-like cytological and morphological characteristics, indicating that apoptosis can occur in the absence of caspases in C. elegans. We describe a kinase pathway required for cell extrusion involving PAR-4, STRD-1 and MOP-25.1/-25.2, the C. elegans homologues of the mammalian tumour-suppressor kinase LKB1 and its binding partners STRAD alpha and MO25 alpha. The AMPK-related kinase PIG-1, a possible target of the PAR-4-STRD-1-MOP-25 kinase complex, is also required for cell shedding. PIG-1 promotes shed-cell detachment by preventing the cell-surface expression of cell-adhesion molecules. Our findings reveal a mechanism for apoptotic cell elimination that is fundamentally distinct from that of canonical programmed cell death.	[Denning, Daniel P.; Hatch, Victoria; Horvitz, H. Robert] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Denning, Daniel P.; Hatch, Victoria; Horvitz, H. Robert] MIT, Dept Biol, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	horvitz@mit.edu			National Institutes of Health National Center for Research Resources (NCRR); Damon Runyon Cancer Research Foundation; Charles A. King Trust	National Institutes of Health National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Damon Runyon Cancer Research Foundation; Charles A. King Trust	We thank Z. Zhou, T. Hirose and S. Nakano for reporter constructs; B. Castor, E. Murphy and R. Droste for determining DNA sequences; S. Dennis for screening of the deletion library; N. An for strain management; and, J. Yuan, S. Nakano, N. Paquin, C. Engert and A. Saffer for discussions. The Caenorhabditis Genetic Center, which is funded by the National Institutes of Health National Center for Research Resources (NCRR), provided many strains. S. Mitani provided grp-1(tm1956). D. P. D. was supported by post-doctoral fellowships from the Damon Runyon Cancer Research Foundation and from the Charles A. King Trust. H. R. H. is the David H. Koch Professor of Biology at the Massachusetts Institute of Technology and an Investigator at the Howard Hughes Medical Institute.	Abdus-Saboor I, 2011, DEVELOPMENT, V138, P3545, DOI 10.1242/dev.068148; Abraham MC, 2007, DEV CELL, V12, P73, DOI 10.1016/j.devcel.2006.11.012; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRENNER S, 1974, GENETICS, V77, P71; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hirose T, 2010, P NATL ACAD SCI USA, V107, P15479, DOI 10.1073/pnas.1010023107; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Labouesse Michel, 2006, WormBook, P1; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu Q, 2008, DEVELOPMENT, V135, P1069, DOI 10.1242/dev.016063; Narbonne P, 2010, DEVELOPMENT, V137, P661, DOI 10.1242/dev.042044; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Potts MB, 2011, NAT REV CANCER, V11, P50, DOI 10.1038/nrc2984; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schwartz HT, 2007, NAT PROTOC, V2, P705, DOI 10.1038/nprot.2007.93; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaham S, 1998, J BIOL CHEM, V273, P35109, DOI 10.1074/jbc.273.52.35109; Shaham S, 1999, GENETICS, V153, P1655; Singhvi A, 2011, CURR BIOL, V21, P948, DOI 10.1016/j.cub.2011.04.025; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Venegas V, 2007, MOL BIOL CELL, V18, P3180, DOI 10.1091/mbc.E07-02-0138; Watson AJM, 2009, ANN NY ACAD SCI, V1165, P135, DOI 10.1111/j.1749-6632.2009.04027.x; Wu YC, 2000, GENE DEV, V14, P536; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	38	50	62	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					226	+		10.1038/nature11240	http://dx.doi.org/10.1038/nature11240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22801495	Green Accepted, Green Submitted			2022-12-01	WOS:000307267000037
J	Guichard, P; Desfosses, A; Maheshwari, A; Hachet, V; Dietrich, C; Brune, A; Ishikawa, T; Sachse, C; Gonczy, P				Guichard, Paul; Desfosses, Ambroise; Maheshwari, Aditi; Hachet, Virginie; Dietrich, Carsten; Brune, Andreas; Ishikawa, Takashi; Sachse, Carsten; Goenczy, Pierre			Cartwheel Architecture of Trichonympha Basal Body	SCIENCE			English	Article							CENTRIOLES		[Guichard, Paul; Hachet, Virginie; Goenczy, Pierre] Swiss Fed Inst Technol EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland; [Desfosses, Ambroise; Sachse, Carsten] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Maheshwari, Aditi; Ishikawa, Takashi] Paul Scherrer Inst, Villigen, Switzerland; [Dietrich, Carsten; Brune, Andreas] Max Planck Inst Terr Microbiol, Dept Biogeochem, D-35043 Marburg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Max Planck Society	Gonczy, P (corresponding author), Swiss Fed Inst Technol EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland.	pierre.gonczy@epfl.ch	Sachse, Carsten/AAY-9384-2020; Sachse, Carsten/H-2727-2012; Guichard, Paul/AAL-8603-2020; Ishikawa, Takashi/E-5023-2017; Brune, Andreas/C-6944-2011	Sachse, Carsten/0000-0002-1168-5143; Sachse, Carsten/0000-0002-1168-5143; Guichard, Paul/0000-0002-0363-1049; Ishikawa, Takashi/0000-0002-1976-7477; Brune, Andreas/0000-0002-2667-4391; HAMEL, VIRGINIE/0000-0001-5092-2343; Desfosses, Ambroise/0000-0002-6525-5042; Gonczy, Pierre/0000-0002-6305-6883	Swiss National Foundation [Sinergia CRSII3_125463, NF31003A-125131/1]; European Research Council [AdG 233335]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission)	We thank M. Steinmetz, A.-M. Tassin, and Y. Hongoh for fruitful discussions and comments on the manuscript; J.-D. Rochaix and A. Shapiguzov for Chlamydomonas; and S. Rosset and G. Knott (BioEM core facility, EPFL) for help with EM. Supported by grants from the Swiss National Foundation (Sinergia CRSII3_125463 to P. G.; NF31003A-125131/1 to T. I.) and the European Research Council (AdG 233335 to P. G.). Additional data and information are in the supplementary materials.	Cottee MA, 2011, NAT CHEM BIOL, V7, P650, DOI 10.1038/nchembio.660; GIBBONS IR, 1960, J BIOPHYS BIOCHEM CY, V7, P697, DOI 10.1083/jcb.7.4.697; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325	6	68	71	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					553	553		10.1126/science.1222789	http://dx.doi.org/10.1126/science.1222789			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22798403				2022-12-01	WOS:000307058700036
J	Herbst, CT; Stoeger, AS; Frey, R; Lohscheller, J; Titze, IR; Gumpenberger, M; Fitch, WT				Herbst, Christian T.; Stoeger, Angela S.; Frey, Roland; Lohscheller, Joerg; Titze, Ingo R.; Gumpenberger, Michaela; Fitch, W. Tecumseh			How Low Can You Go? Physical Production Mechanism of Elephant Infrasonic Vocalizations	SCIENCE			English	Article							AFRICAN ELEPHANTS; LONG-DISTANCE; ACOUSTIC CUES; RED DEER; COMMUNICATION; EVOLUTION; LARYNGES; IDENTITY; WEIGHT; CALLS	Elephants can communicate using sounds below the range of human hearing ("infrasounds" below 20 hertz). It is commonly speculated that these vocalizations are produced in the larynx, either by neurally controlled muscle twitching (as in cat purring) or by flow-induced self-sustained vibrations of the vocal folds (as in human speech and song). We used direct high-speed video observations of an excised elephant larynx to demonstrate flow-induced self-sustained vocal fold vibration in the absence of any neural signals, thus excluding the need for any "purring" mechanism. The observed physical principles of voice production apply to a wide variety of mammals, extending across a remarkably large range of fundamental frequencies and body sizes, spanning more than five orders of magnitude.	[Herbst, Christian T.; Stoeger, Angela S.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, A-1090 Vienna, Austria; [Frey, Roland] Leibniz Inst Zoo & Wildlife Res, D-10252 Berlin, Germany; [Lohscheller, Joerg] Univ Appl Sci, Dept Comp Sci, D-54293 Trier, Germany; [Titze, Ingo R.] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Gumpenberger, Michaela] Univ Vet Med Vienna, Clin Diagnost Imaging, A-1210 Vienna, Austria; [Fitch, W. Tecumseh] Univ Vet Med Vienna, Haidlhof Res Stn, Univ Vienna, Bad Voslau, Austria	University of Vienna; Leibniz Institut fur Zoo und Wildtierforschung; Utah System of Higher Education; University of Utah; University of Veterinary Medicine Vienna; University of Vienna	Herbst, CT (corresponding author), Univ Vienna, Dept Cognit Biol, Althanstr 14, A-1090 Vienna, Austria.	christian.herbst@univie.ac.at; tecumseh.fitch@univie.ac.at	Herbst, Christian T/D-6470-2011	Stoeger, Angela S/0000-0002-6714-8291; Herbst, Christian/0000-0001-9095-3953; Gumpenberger, Michaela/0000-0003-2412-0501	European Research Council Advanced Grant SOMACCA; University of Vienna; Austrian Science Fund (FWF) [P 23099]; Deutsche Forschungsgemeinschaft [LO1413/2]; National Institute for Deafness and Other Communication Disorders [R01 DC 008612]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008612] Funding Source: NIH RePORTER	European Research Council Advanced Grant SOMACCA; University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute for Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by European Research Council Advanced Grant SOMACCA and a startup grant from the University of Vienna (W. T. F.); an Austrian Science Fund (FWF) grant, P 23099 (A. S.); grant no. LO1413/2 by the Deutsche Forschungsgemeinschaft (J.L.); and grant R01 DC 008612 (A Simulator for Sound Production in Airways) from the National Institute for Deafness and Other Communication Disorders (I. R. T.). Our sincere thanks go to B. Blaszkiewitz (Direktor, Tierpark Berlin Friedrichsfelde) for supplying us with the elephant larynx. We thank R. Hofer for contributing to the setup of the excised larynx experiment, P. Pesak for assisting in the computed tomography scan of the larynx specimen, and N. Kavcik for creating the artwork in Fig. 1 and the figure of the excised larynx setup in Fig. 2. The data reported in this manuscript are available in the supplementary materials.	Alipour F, 2009, J VOICE, V23, P40, DOI 10.1016/j.jvoice.2007.03.007; Elemans CPH, 2010, J NEUROSCI, V30, P13246, DOI 10.1523/JNEUROSCI.1130-10.2010; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Garstang M, 2004, J COMP PHYSIOL A, V190, P791, DOI 10.1007/s00359-004-0553-0; GRIFFITHS TA, 1983, MAMMALIA, V47, P377; Harrison DFN, 1995, ANATOMY PHYSL MAMMAL; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Husson R., 1950, THESIS; Jones G, 1999, J EXP BIOL, V202, P3359; Langbauer WR, 2000, ZOO BIOL, V19, P425, DOI 10.1002/1098-2361(2000)19:5&lt;425::AID-ZOO11&gt;3.0.CO;2-A; Leong K. M., 2003, Bioacoustics, V13, P213; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; Mellinger DK, 2003, J ACOUST SOC AM, V114, P1108, DOI 10.1121/1.1593066; Mohres F. P., 1967, SYSTEMES SONARS ANIM, P401; PAYNE KB, 1986, BEHAV ECOL SOCIOBIOL, V18, P297, DOI 10.1007/BF00300007; Peters G, 2002, MAMMAL REV, V32, P245, DOI 10.1046/j.1365-2907.2002.00113.x; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; REMMERS JE, 1972, RESP PHYSIOL, V16, P351, DOI 10.1016/0034-5687(72)90064-3; Shoshani J, 1998, TRENDS ECOL EVOL, V13, P480, DOI 10.1016/S0169-5347(98)01491-8; Shoshani J., ENCY BRITANNICA; SISSOM DEF, 1991, J ZOOL, V223, P67, DOI 10.1111/j.1469-7998.1991.tb04749.x; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; Titze I., 2006, MYOELASTIC AERODYNAM; Titze I.R., 2000, PRINCIPLES VOICE PRO; Titze IR, 2010, J EXP BIOL, V213, P3866, DOI 10.1242/jeb.044982; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; VANDENBERG J, 1958, J SPEECH HEAR RES, V1, P227, DOI 10.1044/jshr.0103.227	30	84	84	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					595	599		10.1126/science.1219712	http://dx.doi.org/10.1126/science.1219712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859490				2022-12-01	WOS:000307058700049
J	Koch, C				Koch, Christof			Modular Biological Complexity	SCIENCE			English	Editorial Material									[Koch, Christof] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA	Allen Institute for Brain Science; California Institute of Technology	Koch, C (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	christofk@alleninstitute.org		Koch, Christof/0000-0001-6482-8067	Paul G. Allen Family Foundation	Paul G. Allen Family Foundation	I thank N. Joshi for the plot. Supported by the Paul G. Allen Family Foundation.	Allen P. G., 2011, TECHNOL REV, V12; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Buxhoeveden DP, 2002, BRAIN, V125, P935, DOI 10.1093/brain/awf110; DE BRUIJIN N.G, 1958, ASYMPTOTIC METHODS A; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Kurzweil R., 2005, SINGULARITY IS NEAR; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Qian JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017013; Sanchez C, 1999, NUCLEIC ACIDS RES, V27, P89, DOI 10.1093/nar/27.1.89	10	37	38	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					531	532		10.1126/science.1218616	http://dx.doi.org/10.1126/science.1218616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859475				2022-12-01	WOS:000307058700027
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			The cultural challenge of HIV/AIDS	LANCET			English	Editorial Material									[Das, Pamela; Horton, Richard] The Lancet, London NW1 7BY, England		Das, P (corresponding author), The Lancet, London NW1 7BY, England.							Altman D, 2012, LANCET; Beyrer C, 2012, LANCET; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Mayer KH, 2012, LANCET; Millett GA, 2012, LANCET; Sullivan PS, 2012, LANCET; The International AIDS Society Scientific Working Group on HIV Cure, 2012, NAT REV IMM IN PRESS; Trapence G, 2012, LANCET; UNAIDS, 2010, GLOB REP UNAIDS REP; US Department of State, 2011, COMMUNICATION   0308	10	15	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2012	380	9839					309	310		10.1016/S0140-6736(12)61074-5	http://dx.doi.org/10.1016/S0140-6736(12)61074-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	979TN	22819658				2022-12-01	WOS:000306842800004
J	Beltrao, P; Albanese, V; Kenner, LR; Swaney, DL; Burlingame, A; Villen, J; Lim, WA; Fraser, JS; Frydman, J; Krogan, NJ				Beltrao, Pedro; Albanese, Veronique; Kenner, Lillian R.; Swaney, Danielle L.; Burlingame, Alma; Villen, Judit; Lim, Wendell A.; Fraser, James S.; Frydman, Judith; Krogan, Nevan J.			Systematic Functional Prioritization of Protein Posttranslational Modifications	CELL			English	Article							PHOSPHORYLATION; EVOLUTION; NETWORKS; LYSINE; IDENTIFICATION; COMPLEXES; SELECTION; REVEALS; SWITCH; SITES	Protein function is often regulated by posttranslational modifications (PTMs), and recent advances in mass spectrometry have resulted in an exponential increase in PTM identification. However, the functional significance of the vast majority of these modifications remains unknown. To address this problem, we compiled nearly 200,000 phosphorylation, acetylation, and ubiquitination sites from 11 eukaryotic species, including 2,500 newly identified ubiquitylation sites for Saccharomyces cerevisiae. We developed methods to prioritize the functional relevance of these PTMs by predicting those that likely participate in cross-regulatory events, regulate domain activity, or mediate protein-protein interactions. PTM conservation within domain families identifies regulatory "hot spots" that overlap with functionally important regions, a concept that we experimentally validated on the HSP70 domain family. Finally, our analysis of the evolution of PTM regulation highlights potential routes for neutral drift in regulatory interactions and suggests that only a fraction of modification sites are likely to have a significant biological role.	[Beltrao, Pedro; Kenner, Lillian R.; Lim, Wendell A.; Fraser, James S.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA; [Burlingame, Alma] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94107 USA; [Beltrao, Pedro; Kenner, Lillian R.; Burlingame, Alma; Lim, Wendell A.; Fraser, James S.; Krogan, Nevan J.] QB3, Calif Inst Quantitat Biosci, San Francisco, CA 94107 USA; [Albanese, Veronique; Frydman, Judith] Clark Ctr, Dept Biol, BioX Program, Stanford, CA 94305 USA; [Swaney, Danielle L.; Villen, Judit] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Beltrao, P (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA.	pedro.beltrao@ucsf.edu; krogan@cmp.ucsf.edu	Beltrao, Pedro/B-3342-2010	Beltrao, Pedro/0000-0002-2724-7703; Villen, Judit/0000-0002-1005-1739; Fraser, James/0000-0002-5080-2859; Kenner, Lukas/0000-0003-2184-1338; , judith/0000-0003-2302-6943; Albanese, Veronique/0000-0002-5947-7415	National Institutes of Health [AI090935, GM082250, GM084448, GM084279, GM081879, GM55040, GM062583, PN2 EY016546, GM56433, DP5 OD009180, RR01614]; Howard Hughes Medical Institute; Packard Foundation; Human Frontier Science Program; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI090935, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433, P50GM081879, R01GM056433, R01GM055040, R01GM084279, R01GM084448, R01GM062583, P50GM082250] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Packard Foundation(The David & Lucile Packard Foundation); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stephen Michnick and Peter Kaiser for strains and plasmids, Betty Craig for the ssa1-45 ts cells, and Stephanie Escusa and Jonathan Warner for reagents. This work was supported by grants from the National Institutes of Health (AI090935, GM082250, GM084448, GM084279, GM081879 [N.J.K.]); GM55040, GM062583, GM081879, PN2 EY016546 [W.A.L.]; GM56433 [J.F.]; DP5 OD009180 [J.S.F.]; and RR01614 [A.B.]), the Howard Hughes Medical Institute (W.A.L.), and the Packard Foundation (W.A.L.). P.B. is supported by the Human Frontier Science Program, J.S.F. is a QB3@UCSF Fellow, and N.J.K. is a Searle Scholar and a Keck Young Investigator.	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Ear PH, 2009, NAT METHODS, V6, P813, DOI [10.1038/NMETH.1389, 10.1038/nmeth.1389]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Horton LE, 2001, J BIOL CHEM, V276, P14426, DOI 10.1074/jbc.M100266200; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jonkers W, 2009, EUKARYOT CELL, V8, P677, DOI 10.1128/EC.00386-08; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Li SY, 2010, BIOCOMPUT-PAC SYM, P337; Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Michnick SW, 2010, METHOD ENZYMOL, V470, P335, DOI 10.1016/S0076-6879(10)70014-8; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Stark C, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap026; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009	51	284	287	2	94	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					413	425		10.1016/j.cell.2012.05.036	http://dx.doi.org/10.1016/j.cell.2012.05.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817900	Bronze, Green Accepted			2022-12-01	WOS:000306595700019
J	Karr, JR; Sanghvi, JC; Macklin, DN; Gutschow, MV; Jacobs, JM; Bolival, B; Assad-Garcia, N; Glass, JI; Covert, MW				Karr, Jonathan R.; Sanghvi, Jayodita C.; Macklin, Derek N.; Gutschow, Miriam V.; Jacobs, Jared M.; Bolival, Benjamin; Assad-Garcia, Nacyra, Jr.; Glass, John I.; Covert, Markus W.			A Whole-Cell Computational Model Predicts Phenotype from Genotype	CELL			English	Article							GENOME-REDUCED BACTERIUM; ESCHERICHIA-COLI; RNA-POLYMERASE; MINIMAL CELL; MYCOPLASMA-GENITALIUM; REPLICATION; MOLECULE; PROTEIN; TIME; DEHYDROGENASE	Understanding how complex phenotypes arise from individual molecules and their interactions is a primary challenge in biology that computational approaches are poised to tackle. We report a whole-cell computational model of the life cycle of the human pathogen Mycoplasma genitalium that includes all of its molecular components and their interactions. An integrative approach to modeling that combines diverse mathematics enabled the simultaneous inclusion of fundamentally different cellular processes and experimental measurements. Our whole-cell model accounts for all annotated gene functions and was validated against a broad range of data. The model provides insights into many previously unobserved cellular behaviors, including in vivo rates of protein-DNA association and an inverse relationship between the durations of DNA replication initiation and replication. In addition, experimental analysis directed by model predictions identified previously undetected kinetic parameters and biological functions. We conclude that comprehensive whole-cell models can be used to facilitate biological discovery.	[Sanghvi, Jayodita C.; Macklin, Derek N.; Gutschow, Miriam V.; Jacobs, Jared M.; Bolival, Benjamin; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Karr, Jonathan R.] Stanford Univ, Grad Program Biophys, Stanford, CA 94305 USA; [Assad-Garcia, Nacyra, Jr.; Glass, John I.] J Craig Venter Inst, Rockville, MD 20850 USA	Stanford University; Stanford University; J. Craig Venter Institute	Covert, MW (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	mcovert@stanford.edu	Karr, Jonathan/D-1407-2013; Glass, John/A-6572-2015	Karr, Jonathan/0000-0002-2605-5080; Glass, John/0000-0002-3784-5301; Covert, Markus/0000-0002-5993-8912	NIH [1DP1OD006413]; Hellman Faculty Scholarship; NSF; Bio-X Graduate Student Fellowships; NDSEG; Stanford Graduate Student Fellowships; Benchmark Stanford Graduate Fellowship; U.S. Department of Energy [DE-FC02-02ER63453]; NATIONAL LIBRARY OF MEDICINE [DP1LM011510] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006413] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hellman Faculty Scholarship; NSF(National Science Foundation (NSF)); Bio-X Graduate Student Fellowships; NDSEG; Stanford Graduate Student Fellowships; Benchmark Stanford Graduate Fellowship; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Altman, S. Brenner, Z. Bryant, J. Ferrell, K. Huang, B. Palsson, S. Quake, L. Serrano, J. Swartz, E. Yus, and the Covert Lab for numerous enlightening discussions on bacterial physiology and computational modeling; T. Vora for critical reading of the manuscript; and M. O'Reilly and J. Maynard for graphical design assistance. This work was supported by an NIH Director's Pioneer Award (1DP1OD006413) and a Hellman Faculty Scholarship to M.W.C.; NSF and Bio-X Graduate Student Fellowships to J.C.S.; NDSEG, NSF, and Stanford Graduate Student Fellowships to J.R.K.; a Benchmark Stanford Graduate Fellowship to D.N.M.; and a U.S. Department of Energy Cooperative Agreement (DE-FC02-02ER63453) to the J. Craig Venter Institute.	Atlas JC, 2008, IET SYST BIOL, V2, P369, DOI 10.1049/iet-syb:20070079; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bratton BP, 2011, J BACTERIOL, V193, P5138, DOI 10.1128/JB.00198-11; Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Browning ST, 2004, BIOTECHNOL BIOENG, V88, P575, DOI 10.1002/bit.20223; Castellanos M, 2004, P NATL ACAD SCI USA, V101, P6681, DOI 10.1073/pnas.0400962101; Castellanos M, 2007, BIOTECHNOL BIOENG, V97, P397, DOI 10.1002/bit.21251; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Cordwell SJ, 1997, GENE, V195, P113, DOI 10.1016/S0378-1119(97)00063-2; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de Kok A, 1998, BBA-PROTEIN STRUCT M, V1385, P353, DOI 10.1016/S0167-4838(98)00079-X; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; DOMACH MM, 1984, BIOTECHNOL BIOENG, V26, P1140, DOI 10.1002/bit.260260925; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Morowitz H.J., 1992, BEGINNINGS CELLULAR; MOROWITZ HJ, 1962, J MOL BIOL, V4, P93, DOI 10.1016/S0022-2836(62)80041-2; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; SCHMIDT HL, 1986, EUR J BIOCHEM, V156, P149, DOI 10.1111/j.1432-1033.1986.tb09560.x; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	42	778	796	4	222	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 20	2012	150	2					389	401		10.1016/j.cell.2012.05.044	http://dx.doi.org/10.1016/j.cell.2012.05.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817898	Green Accepted, Bronze			2022-12-01	WOS:000306595700017
J	Dutta, P; Courties, G; Wei, Y; Leuschner, F; Gorbatov, R; Robbins, CS; Iwamoto, Y; Thompson, B; Carlson, AL; Heidt, T; Majmudar, MD; Lasitschka, F; Etzrodt, M; Waterman, P; Waring, MT; Chicoine, AT; van der Laan, AM; Niessen, HWM; Piek, JJ; Rubin, BB; Butany, J; Stone, JR; Katus, HA; Murphy, SA; Morrow, DA; Sabatine, MS; Vinegoni, C; Moskowitz, MA; Pittet, MJ; Libby, P; Lin, CP; Swirski, FK; Weissleder, R; Nahrendorf, M				Dutta, Partha; Courties, Gabriel; Wei, Ying; Leuschner, Florian; Gorbatov, Rostic; Robbins, Clinton S.; Iwamoto, Yoshiko; Thompson, Brian; Carlson, Alicia L.; Heidt, Timo; Majmudar, Maulik D.; Lasitschka, Felix; Etzrodt, Martin; Waterman, Peter; Waring, Michael T.; Chicoine, Adam T.; van der Laan, Anja M.; Niessen, Hans W. M.; Piek, Jan J.; Rubin, Barry B.; Butany, Jagdish; Stone, James R.; Katus, Hugo A.; Murphy, Sabina A.; Morrow, David A.; Sabatine, Marc S.; Vinegoni, Claudio; Moskowitz, Michael A.; Pittet, Mikael J.; Libby, Peter; Lin, Charles P.; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias			Myocardial infarction accelerates atherosclerosis	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE CORONARY SYNDROMES; MONOCYTE SUBSETS; PROGENITOR CELLS; ARTERY-DISEASE; BONE-MARROW; INFLAMMATION; PLAQUES; NICHE; IDENTIFICATION	During progression of atherosclerosis, myeloid cells destabilize lipid-rich plaques in the arterial wall and cause their rupture, thus triggering myocardial infarction and stroke. Survivors of acute coronary syndromes have a high risk of recurrent events for unknown reasons. Here we show that the systemic response to ischaemic injury aggravates chronic atherosclerosis. After myocardial infarction or stroke, Apoe(-/-) mice developed larger atherosclerotic lesions with a more advanced morphology. This disease acceleration persisted over many weeks and was associated with markedly increased monocyte recruitment. Seeking the source of surplus monocytes in plaques, we found that myocardial infarction liberated haematopoietic stem and progenitor cells from bone marrow niches via sympathetic nervous system signalling. The progenitors then seeded the spleen, yielding a sustained boost in monocyte production. These observations provide new mechanistic insight into atherogenesis and provide a novel therapeutic opportunity to mitigate disease progression.	[Dutta, Partha; Courties, Gabriel; Leuschner, Florian; Gorbatov, Rostic; Robbins, Clinton S.; Iwamoto, Yoshiko; Thompson, Brian; Carlson, Alicia L.; Heidt, Timo; Majmudar, Maulik D.; Etzrodt, Martin; Waterman, Peter; Stone, James R.; Vinegoni, Claudio; Pittet, Mikael J.; Lin, Charles P.; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Dutta, Partha; Courties, Gabriel; Leuschner, Florian; Gorbatov, Rostic; Robbins, Clinton S.; Iwamoto, Yoshiko; Thompson, Brian; Carlson, Alicia L.; Heidt, Timo; Majmudar, Maulik D.; Etzrodt, Martin; Waterman, Peter; Stone, James R.; Vinegoni, Claudio; Pittet, Mikael J.; Lin, Charles P.; Swirski, Filip K.; Weissleder, Ralph; Nahrendorf, Matthias] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Wei, Ying; Moskowitz, Michael A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol,Stroke & Neurovasc Regulat Lab, Charlestown, MA 02129 USA; [Wei, Ying; Moskowitz, Michael A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Stroke & Neurovasc Regulat Lab, Charlestown, MA 02129 USA; [Leuschner, Florian; Katus, Hugo A.] Med Univ Hosp Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany; [Majmudar, Maulik D.; Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Lasitschka, Felix] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Waring, Michael T.; Chicoine, Adam T.] MIT & Harvard Massachusetts Gen Hosp, Ragon Inst MGH, Charlestown, MA 02129 USA; [Waring, Michael T.; Chicoine, Adam T.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [van der Laan, Anja M.; Piek, Jan J.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Niessen, Hans W. M.] Vrije Univ Amsterdam Med Ctr, ICaR VU, Dept Pathol & Cardiac Surg, NL-1081 HV Amsterdam, Netherlands; [Rubin, Barry B.] Univ Toronto, Toronto Gen Hosp, Peter Munk Cardiac Ctr, Div Vasc Surg, Toronto, ON M5G 2C4, Canada; [Butany, Jagdish] Univ Toronto, Peter Munk Cardiac Ctr, Dept Pathol, Toronto, ON M5G 2C4, Canada; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Murphy, Sabina A.; Morrow, David A.; Sabatine, Marc S.] Brigham & Womens Hosp, Div Cardiovasc, Dept Med, TIMI Study Grp, Boston, MA 02145 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Ruprecht Karls University Heidelberg; Harvard University; Brigham & Women's Hospital; Ruprecht Karls University Heidelberg; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Peter Munk Cardiac Centre; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Nahrendorf, M (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu; mnahrendorf@mgh.harvard.edu	Vinegoni, Claudio/A-9490-2012; Etzrodt, Martin/P-3325-2015; Sabatine, Marc/AAJ-6751-2020; Swirski, Filip/AAF-1340-2019; vinegoni, claudio/AGU-2461-2022; Libby, Peter/AAY-6404-2021; Wei, Yen/H-5329-2012; Pittet, Mikael/ABD-6300-2021	Vinegoni, Claudio/0000-0002-9818-3639; Etzrodt, Martin/0000-0003-1928-3904; Sabatine, Marc/0000-0002-0691-3359; Libby, Peter/0000-0002-1502-502X; Swirski, Filip/0000-0002-3163-9152; Courties, Gabriel/0000-0002-0003-7407; /0000-0003-0828-4143; Butany, Jagdish/0000-0003-0549-7602; Robbins, Clinton/0000-0001-9848-1495; Niessen, Hans/0000-0001-9404-9822	National Institute of Health [R01-HL096576, R01-HL095629, R01-EB006432, T32-CA79443, P50-CA086355]; Deutsche Forschungsgemeinschaft [SFB 938/Z2]; NATIONAL CANCER INSTITUTE [T32CA079443, P50CA086355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612, R01HL096576, R01HL095629, T32HL094301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006432] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the CSB Mouse Imaging Program (J. Truelove, D. Jeon, J. Donahoe, B. Marinelli) and K. Naxerova for helpful discussions. This work was funded by grants from the National Institute of Health R01-HL096576, R01-HL095629 (M.N.); R01-EB006432, T32-CA79443, P50-CA086355 (R.W.). F.L. was funded in part by Deutsche Forschungsgemeinschaft SFB 938/Z2. Fig. 5e was produced using Servier Medical Art (http://www.servier.com).	Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; ERNST E, 1987, JAMA-J AM MED ASSOC, V257, P2318, DOI 10.1001/jama.257.17.2318; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; KRUSZEWSKA B, 1995, J IMMUNOL, V155, P4613; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Milonas C, 2010, AM J CARDIOL, V105, P1229, DOI 10.1016/j.amjcard.2009.12.032; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086; Psaltis PJ, 2012, CIRCULATION, V125, P592, DOI 10.1161/CIRCULATIONAHA.111.059360; Randolph GJ, 2009, J THROMB HAEMOST, V7, P28, DOI 10.1111/j.1538-7836.2009.03423.x; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Sabatine MS, 2002, J AM COLL CARDIOL, V40, P1761, DOI 10.1016/S0735-1097(02)02484-1; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; ZIGMOND RE, 1977, P NATL ACAD SCI USA, V74, P3078, DOI 10.1073/pnas.74.7.3078	36	716	745	6	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2012	487	7407					325	329		10.1038/nature11260	http://dx.doi.org/10.1038/nature11260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22763456	Green Accepted, Green Submitted			2022-12-01	WOS:000306506500034
J	Steinmetz, PRH; Kraus, JEM; Larroux, C; Hammel, JU; Amon-Hassenzahl, A; Houliston, E; Worheide, G; Nickel, M; Degnan, BM; Technau, U				Steinmetz, Patrick R. H.; Kraus, Johanna E. M.; Larroux, Claire; Hammel, Joerg U.; Amon-Hassenzahl, Annette; Houliston, Evelyn; Woerheide, Gert; Nickel, Michael; Degnan, Bernard M.; Technau, Ulrich			Independent evolution of striated muscles in cnidarians and bilaterians	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TETHYA-WILHELMA; SEA-ANEMONE; INVERTEBRATE MUSCLES; MOLECULAR EVOLUTION; GENOME REVEALS; EXPRESSION; PROTEIN; CHAIN; DEMOSPONGE	Striated muscles are present in bilaterian animals (for example, vertebrates, insects and annelids) and some non-bilaterian eumetazoans (that is, cnidarians and ctenophores). The considerable ultrastructural similarity of striated muscles between these animal groups is thought to reflect a common evolutionary origin(1,2). Here we show that a muscle protein core set, including a type II myosin heavy chain (MyHC) motor protein characteristic of striated muscles in vertebrates, was already present in unicellular organisms before the origin of multicellular animals. Furthermore, 'striated muscle' and 'non-muscle' myhc orthologues are expressed differentially in two sponges, compatible with a functional diversification before the origin of true muscles and the subsequent use of striated muscle MyHC in fast-contracting smooth and striated muscle. Cnidarians and ctenophores possess striated muscle myhc orthologues but lack crucial components of bilaterian striated muscles, such as genes that code for titin and the troponin complex, suggesting the convergent evolution of striated muscles. Consistently, jellyfish orthologues of a shared set of bilaterian Z-disc proteins are not associated with striated muscles, but are instead expressed elsewhere or ubiquitously. The independent evolution of eumetazoan striated muscles through the addition of new proteins to a pre-existing, ancestral contractile apparatus may serve as a model for the evolution of complex animal cell types.	[Steinmetz, Patrick R. H.; Kraus, Johanna E. M.; Technau, Ulrich] Univ Vienna, Dept Mol Evolut & Dev, Ctr Organismal Syst Biol, A-1090 Vienna, Austria; [Larroux, Claire; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, Ctr Marine Sci, Brisbane, Qld 4072, Australia; [Larroux, Claire; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, D-80333 Munich, Germany; [Hammel, Joerg U.; Nickel, Michael] Univ Jena, Inst Spezielle Zool & Evolut biol, Phyletischem Museum, D-07743 Jena, Germany; [Amon-Hassenzahl, Annette] Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany; [Houliston, Evelyn] CNRS, Biol Dev UMR 7009, F-06230 Villefranche Sur Mer, France; [Houliston, Evelyn] Univ Paris 06, F-06230 Villefranche Sur Mer, France; [Woerheide, Gert; Nickel, Michael] Univ Munich, GeoBio Ctr, D-80333 Munich, Germany; [Woerheide, Gert] Bayer Staatssammlung Palaontol & Geol, D-80333 Munich, Germany	University of Vienna; University of Queensland; University of Munich; Friedrich Schiller University of Jena; Technical University of Darmstadt; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Munich	Technau, U (corresponding author), Univ Vienna, Dept Mol Evolut & Dev, Ctr Organismal Syst Biol, Althanstr 14, A-1090 Vienna, Austria.	ulrich.technau@univie.ac.at	Steinmetz, Patrick/AAD-4093-2022; Nickel, Michael/D-1005-2010; Wörheide, Gert/C-1080-2008; Hammel, Jörg/D-6555-2011; Larroux, Claire/U-7981-2017	Nickel, Michael/0000-0003-2982-7805; Wörheide, Gert/0000-0002-6380-7421; Hammel, Jörg/0000-0002-6744-6811; Larroux, Claire/0000-0002-3503-4150; Technau, Ulrich/0000-0003-4472-8258; Houliston, Evelyn/0000-0001-9264-2585; Steinmetz, Patrick/0000-0002-3705-2774; Degnan, Bernard/0000-0001-7573-8518	Austrian Science Fund [P21108-B17]; ITN EVONET [215781]; Australian Research Council; Alexander von Humboldt Foundation; ANR; German Science Foundation [1174, Wo896/6]; Austrian Science Fund (FWF) [P 21108] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); ITN EVONET; Australian Research Council(Australian Research Council); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); ANR(French National Research Agency (ANR)); German Science Foundation(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	For access and use of publicly available, unpublished genome sequences, we thank the Origins of Multicellularity Sequencing Project, Broad Institute of Harvard and MIT (http://www.broadinstitute.org/), the Joint Genome Institute as well as A. Baxevanis and J. Ryan. We thank M. Adamska for providing Amphimedon total RNA, M. Kube for T. wilhelma transcriptome 454 sequencing, D. Fredman and T. Momose for the C. hemisphaerica and T. Nosenko for T. wilhelma transcriptome assemblies, H. Schmidt for advice on phylogeny, B. Weiss for technical assistance with T. wilhelma sections, Genoscope for C. hemisphaerica sequencing projects and the members of the Technau laboratory for discussion. The research was funded by fellowships of the Austrian Science Fund P21108-B17 and the ITN EVONET (project 215781) to U. T., the Australian Research Council to B. M. D., the Alexander von Humboldt Foundation to C. L., ANR grant DiploDevo to E. H. and the German Science Foundation through the Priority Program 1174 Deep Metazoan Phylogeny (project Wo896/6) to G.W.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adamska M, 2010, EVOL DEV, V12, P494, DOI 10.1111/j.1525-142X.2010.00435.x; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Ayme-Southgate AJ, 2008, J MOL EVOL, V67, P653, DOI 10.1007/s00239-008-9177-2; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; BOELSTERLI U, 1977, J MORPHOL, V154, P259, DOI 10.1002/jmor.1051540206; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burton P. M., 2007, J EXP ZOOL PART B, V308B, P1; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman D.M., 1974, P1; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Genikhovich G., 2009, COLD SPRING HARB PRO, V2009; GOODSON HV, 1993, P NATL ACAD SCI USA, V90, P659, DOI 10.1073/pnas.90.2.659; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hammel J. U., 2010, THESIS F SCHILLER U; Hammel JU, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-19; Hooper SL, 2008, PROG NEUROBIOL, V86, P72, DOI 10.1016/j.pneurobio.2008.06.004; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kenny PA, 1999, GENE, V232, P11, DOI 10.1016/S0378-1119(99)00122-5; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Korn ED, 2000, P NATL ACAD SCI USA, V97, P12559, DOI 10.1073/pnas.230441597; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C., 2008, COLD SPRING HARB PRO, V2008; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MACKIE GO, 1988, ZOOMORPHOLOGY, V107, P319, DOI 10.1007/BF00312216; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Nickel M, 2004, J EXP BIOL, V207, P4515, DOI 10.1242/jeb.01289; Nickel M, 2006, ZOOMORPHOLOGY, V125, P209, DOI 10.1007/s00435-006-0021-1; Nickel M, 2011, J EXP BIOL, V214, P1692, DOI 10.1242/jeb.049148; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rui YN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001208; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Sanger JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.132pe37; Sara Michele, 2001, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V631, P1; Schmidt-Rhaesa A., 2007, EVOLUTION ORGAN SYST; SCHUCHERT P, 1993, DIFFERENTIATION, V54, P11, DOI 10.1111/j.1432-0436.1993.tb00654.x; Seipel K, 2005, DEV BIOL, V282, P14, DOI 10.1016/j.ydbio.2005.03.032; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Squire JM, 2005, ADV PROTEIN CHEM, V71, P17, DOI 10.1016/S0065-3233(04)71002-5; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sutter SB, 2004, DEV GENES EVOL, V214, P352, DOI 10.1007/s00427-004-0413-5; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torruella G, 2012, MOL BIOL EVOL, V29, P531, DOI 10.1093/molbev/msr185; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; WEISSENFELS N, 1982, MICROSC ACTA, V85, P345; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	67	156	158	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					231	U1508		10.1038/nature11180	http://dx.doi.org/10.1038/nature11180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22763458	Green Accepted			2022-12-01	WOS:000306278900039
J	Somvanshi, VS; Sloup, RE; Crawford, JM; Martin, AR; Heidt, AJ; Kim, KS; Clardy, J; Ciche, TA				Somvanshi, Vishal S.; Sloup, Rudolph E.; Crawford, Jason M.; Martin, Alexander R.; Heidt, Anthony J.; Kim, Kwi-suk; Clardy, Jon; Ciche, Todd A.			A Single Promoter Inversion Switches Photorhabdus Between Pathogenic and Mutualistic States	SCIENCE			English	Article							XENORHABDUS-LUMINESCENS; ESCHERICHIA-COLI; GENE-EXPRESSION; BACTERIA; EVOLUTION; HETERORHABDITIS; CLASSIFICATION; IDENTIFICATION; BIOSYNTHESIS; NEMATODES	Microbial populations stochastically generate variants with strikingly different properties, such as virulence or avirulence and antibiotic tolerance or sensitivity. Photorhabdus luminescens bacteria have a variable life history in which they alternate between pathogens to a wide variety of insects and mutualists to their specific host nematodes. Here, we show that the P. luminescens pathogenic variant (P form) switches to a smaller-cell variant (M form) to initiate mutualism in host nematode intestines. A stochastic promoter inversion causes the switch between the two distinct forms. M-form cells are much smaller (one-seventh the volume), slower growing, and less bioluminescent than P-form cells; they are also avirulent and produce fewer secondary metabolites. Observations of form switching by individual cells in nematodes revealed that the M form persisted in maternal nematode intestines, were the first cells to colonize infective juvenile (IJ) offspring, and then switched to P form in the IJ intestine, which armed these nematodes for the next cycle of insect infection.	[Somvanshi, Vishal S.; Sloup, Rudolph E.; Martin, Alexander R.; Heidt, Anthony J.; Kim, Kwi-suk; Ciche, Todd A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Somvanshi, Vishal S.; Sloup, Rudolph E.; Martin, Alexander R.; Heidt, Anthony J.; Kim, Kwi-suk; Ciche, Todd A.] Michigan State Univ, Ctr Microbial Pathogenesis, E Lansing, MI 48824 USA; [Crawford, Jason M.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Michigan State University; Michigan State University; Harvard University; Harvard Medical School	Ciche, TA (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	ciche@msu.edu	Somvanshi, Vishal Singh/AAD-6959-2021	Somvanshi, Vishal Singh/0000-0002-6835-963X; Ciche, Todd/0000-0002-1462-5269; Heidt, Anthony/0000-0003-1741-3621	Michigan State University Research for Excellence Fund Center for Microbial Pathogenesis; AgBioResearch; NIH [R01 GM086258, 1K99 GM097096-01]; Damon Runyon Cancer Research Foundation [DRG-2002-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM097096, R00GM097096, R01GM086258] Funding Source: NIH RePORTER	Michigan State University Research for Excellence Fund Center for Microbial Pathogenesis; AgBioResearch; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. R. Kroos and L. R. Snyder for helpful discussions and comments on the manuscript and K. Lewis and J. Landgraf for technical assistance. This study was supported by Michigan State University Research for Excellence Fund Center for Microbial Pathogenesis, AgBioResearch, and startup funds (to T. A. C.) and by NIH (grant R01 GM086258 to J. C.). During the course of the work, J. M. C. was supported by a Damon Runyon Cancer Research Foundation fellowship (DRG-2002-09) and an NIH Pathway to Independence award (grant 1K99 GM097096-01 to J. M. C.). The microarray data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (GEO) (30) and are accessible through GEO Series accession no. GSE32088 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE32088).	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bintrim SB, 1998, J BACTERIOL, V180, P1261, DOI 10.1128/JB.180.5.1261-1269.1998; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Bowen DJ, 2003, MICROBIOL-SGM, V149, P1581, DOI 10.1099/mic.0.26171-0; Bowen DJ, 1998, APPL ENVIRON MICROB, V64, P3029; Chalabaev S, 2008, APPL ENVIRON MICROB, V74, P1717, DOI 10.1128/AEM.02589-07; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Ciche TA, 2008, APPL ENVIRON MICROB, V74, P2275, DOI 10.1128/AEM.02646-07; Crawford JM, 2010, CURR BIOL, V20, P69, DOI 10.1016/j.cub.2009.10.059; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichler K, 1996, J BACTERIOL, V178, P1248, DOI 10.1128/jb.178.5.1248-1257.1996; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; HURLBERT RE, 1989, APPL ENVIRON MICROB, V55, P1136, DOI 10.1128/AEM.55.5.1136-1143.1989; Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; RICHARDSON WH, 1988, APPL ENVIRON MICROB, V54, P1602, DOI 10.1128/AEM.54.6.1602-1605.1988; Somvanshi VS, 2010, MOL MICROBIOL, V77, P1021, DOI 10.1111/j.1365-2958.2010.07270.x; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Williams JS, 2005, MICROBIOL-SGM, V151, P2543, DOI 10.1099/mic.0.28136-0; ZIEG J, 1978, CELL, V15, P237, DOI 10.1016/0092-8674(78)90098-3	30	73	73	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					88	93		10.1126/science.1216641	http://dx.doi.org/10.1126/science.1216641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22767929	Green Accepted			2022-12-01	WOS:000306053100050
J	Toth, LT; Aronson, RB; Vollmer, SV; Hobbs, JW; Urrego, DH; Cheng, H; Enochs, IC; Combosch, DJ; van Woesik, R; Macintyre, IG				Toth, Lauren T.; Aronson, Richard B.; Vollmer, Steven V.; Hobbs, Jennifer W.; Urrego, Dunia H.; Cheng, Hai; Enochs, Ian C.; Combosch, David J.; van Woesik, Robert; Macintyre, Ian G.			ENSO Drove 2500-Year Collapse of Eastern Pacific Coral Reefs	SCIENCE			English	Article							NINO-SOUTHERN-OSCILLATION; EL-NINO; CLIMATE-CHANGE; TROPICAL PACIFIC; OCEAN ACIDIFICATION; HOLOCENE; RECORD; GROWTH; SEA; DISTURBANCES	Cores of coral reef frameworks along an upwelling gradient in Panama show that reef ecosystems in the tropical eastern Pacific collapsed for 2500 years, representing as much as 40% of their history, beginning about 4000 years ago. The principal cause of this millennial-scale hiatus in reef growth was increased variability of the El Nino-Southern Oscillation (ENSO) and its coupling with the Intertropical Convergence Zone. The hiatus was a Pacific-wide phenomenon with an underlying climatology similar to probable scenarios for the next century. Global climate change is probably driving eastern Pacific reefs toward another regional collapse.	[Toth, Lauren T.; Aronson, Richard B.; Hobbs, Jennifer W.; Urrego, Dunia H.; van Woesik, Robert] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Aronson, Richard B.; Macintyre, Ian G.] Smithsonian Inst, Dept Paleobiol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Vollmer, Steven V.; Combosch, David J.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA; [Urrego, Dunia H.] Univ Bordeaux 1, UMR CNRS EPOC 5805, F-33405 Talence, France; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, Hai] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; [Enochs, Ian C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Sci, Miami, FL 33149 USA; [Enochs, Ian C.] NOAA, Atlantic Oceanog & Meteorol Labs, Miami, FL 33149 USA	Florida Institute of Technology; Smithsonian Institution; Smithsonian National Museum of Natural History; Northeastern University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities; University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Aronson, RB (corresponding author), Florida Inst Technol, Dept Biol Sci, 150 W Univ Blvd, Melbourne, FL 32901 USA.	raronson@fit.edu	CHENG, HAI/H-3413-2017; Enochs, Ian/B-8051-2014	CHENG, HAI/0000-0002-5305-9458; Enochs, Ian/0000-0002-8867-0361; Toth, Lauren/0000-0002-2568-802X; Aronson, Richard/0000-0003-0383-3844; Combosch, David/0000-0001-7004-7435; Urrego, Dunia H./0000-0001-7938-5529	Smithsonian Institution; NSF; Florida Institute of Technology	Smithsonian Institution(Smithsonian Institution); NSF(National Science Foundation (NSF)); Florida Institute of Technology	We thank M. Bush, A. Correa-Metrio, P. Glynn, H. Lessios, D. Manzello, W. Precht, and P. Reimer for advice and V. Brandtneris, L. Camilli, M. Dardeau, K. Hendrickson, A. Lam, A. Moesinger, R. Muthukrishnan, E. Ochoa, J. Reynolds, B. Valencia, and A. Velarde for assistance. Supported by the Smithsonian Institution, NSF, and the Florida Institute of Technology. This research was carried out under permits from the Republic of Panama. Data are available online in NOAA's Paleoclimatology database (www.ncdc.noaa.gov/paleo/).	[Anonymous], 1969, MEMORIAS S INT LAGUN; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bellwood, 1988, P 6 INT COR REEF S A, P253; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Correge T, 2000, PALEOCEANOGRAPHY, V15, P465, DOI 10.1029/1999PA000409; CORTES J, 1994, CORAL REEFS, V13, P65, DOI 10.1007/BF00300763; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Donders TH, 2008, QUATERNARY SCI REV, V27, P571, DOI 10.1016/j.quascirev.2007.11.010; Eakin CM, 1996, CORAL REEFS, V15, P109; Gagan MK, 2004, QUATERN INT, V118, P127, DOI 10.1016/S1040-6182(03)00134-4; GLYNN P, 1977, P 3 INT COR REEF S, P251; GLYNN PW, 1992, AM ZOOL, V32, P707; GLYNN PW, 1977, J MAR RES, V35, P567; Hamanaka N, 2012, GLOBAL PLANET CHANGE, V80-81, P21, DOI 10.1016/j.gloplacha.2011.10.004; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Kleypas JA, 1997, PALEOCEANOGRAPHY, V12, P533, DOI 10.1029/97PA01134; Lachniet MS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004694; Lybolt M, 2011, FRONT ECOL ENVIRON, V9, P154, DOI 10.1890/090176; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Martinez I, 2006, PALAEOGEOGR PALAEOCL, V234, P114, DOI 10.1016/j.palaeo.2005.10.022; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Perry CT, 2010, GEOLOGY, V38, P119, DOI 10.1130/G30444.1; Rein B, 2007, QUATERN INT, V161, P56, DOI 10.1016/j.quaint.2006.10.023; Riedinger MA, 2002, J PALEOLIMNOL, V27, P1, DOI 10.1023/A:1013514408468; Sonnenholzner JI, 2009, MAR ECOL PROG SER, V375, P209, DOI 10.3354/meps07890; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Toscano MA, 2003, CORAL REEFS, V22, P257, DOI 10.1007/s00338-003-0315-4; U.S. Geological Survey, 1998, 98779 US GEOL SURV, P98; Wood R., 1999, REEF EVOLUTION; Yan H, 2011, NAT GEOSCI, V4, P611, DOI 10.1038/ngeo1231	34	108	112	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					81	84		10.1126/science.1221168	http://dx.doi.org/10.1126/science.1221168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22767927				2022-12-01	WOS:000306053100048
J	Barber, MF; Michishita-Kioi, E; Xi, YX; Tasselli, L; Kioi, M; Moqtaderi, Z; Tennen, RI; Paredes, S; Young, NL; Chen, KF; Struhl, K; Garcia, BA; Gozani, O; Li, W; Chua, KF				Barber, Matthew F.; Michishita-Kioi, Eriko; Xi, Yuanxin; Tasselli, Luisa; Kioi, Mitomu; Moqtaderi, Zarmik; Tennen, Ruth I.; Paredes, Silvana; Young, Nicolas L.; Chen, Kaifu; Struhl, Kevin; Garcia, Benjamin A.; Gozani, Or; Li, Wei; Chua, Katrin F.			SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation	NATURE			English	Article							LIFE-SPAN; HISTONE MODIFICATION; PREDICT PROGNOSIS; BINDING PROFILES; TRANSCRIPTION; GENE; CHROMATIN; EXPRESSION; PATTERNS; CANCER	Sirtuin proteins regulate diverse cellular pathways that influence genomic stability, metabolism and ageing(1,2). SIRT7 is a mammalian sirtuin whose biochemical activity, molecular targets and physiological functions have been unclear. Here we show that SIRT7 is an NAD(+)-dependent H3K18Ac (acetylated lysine 18 of histone H3) deacetylase that stabilizes the transformed state of cancer cells. Genome-wide binding studies reveal that SIRT7 binds to promoters of a specific set of gene targets, where it deacetylates H3K18Ac and promotes transcriptional repression. The spectrum of SIRT7 target genes is defined in part by its interaction with the cancer-associated E26 transformed specific (ETS) transcription factor ELK4, and comprises numerous genes with links to tumour suppression. Notably, selective hypoacetylation of H3K18Ac has been linked to oncogenic transformation, and in patients is associated with aggressive tumour phenotypes and poor prognosis(3-6). We find that deacetylation of H3K18Ac by SIRT7 is necessary for maintaining essential features of human cancer cells, including anchorage-independent growth and escape from contact inhibition. Moreover, SIRT7 is necessary for a global hypoacetylation of H3K18Ac associated with cellular transformation by the viral oncoprotein E1A. Finally, SIRT7 depletion markedly reduces the tumorigenicity of human cancer cell xenografts in mice. Together, our work establishes SIRT7 as a highly selective H3K18Ac deacetylase and demonstrates a pivotal role for SIRT7 in chromatin regulation, cellular transformation programs and tumour formation in vivo.	[Barber, Matthew F.; Michishita-Kioi, Eriko; Tasselli, Luisa; Tennen, Ruth I.; Paredes, Silvana; Chua, Katrin F.] Stanford Univ, Dept Med, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA; [Barber, Matthew F.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Michishita-Kioi, Eriko; Tasselli, Luisa; Paredes, Silvana; Chua, Katrin F.] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA; [Xi, Yuanxin; Chen, Kaifu; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Kioi, Mitomu] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Moqtaderi, Zarmik; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tennen, Ruth I.; Chua, Katrin F.] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA; [Young, Nicolas L.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Baylor College of Medicine; Stanford University; Harvard University; Harvard Medical School; Stanford University; Princeton University	Chua, KF (corresponding author), Stanford Univ, Dept Med, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA.	WL1@bcm.edu; kfchua@stanford.edu	Tasselli, Luisa/AAM-6781-2020; Young, Nicolas/AAI-5242-2020; Gozani, Or P/I-6157-2013	Tasselli, Luisa/0000-0003-3349-1371; Young, Nicolas/0000-0002-3323-2815; Gozani, Or/0000-0002-1365-4463; Li, Wei/0000-0001-9931-5990; Kioi, Mitomu/0000-0002-7981-3340; Barber, Matthew/0000-0003-2008-2165	National Institutes of Health (NIH) [K08 AG028961, R01 AG028867, U01DA025956, R01 GM079641, GM 30186, HG 4558, DP2OD007447, 1018438-142 PABCA, 3T32DK007217-36S1]; National Science Foundation [CBET-0941143]; Department of Defense [PC094421]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110471-C3]; Department of Veterans Affairs; ARCS Scholarship; American Italian Cancer Foundation Post-doctoral Research Fellowship; Duncan Scholar Award; Mason Case Graduate Fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641, R37GM030186, R01GM030186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG028961, R01AG028867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA025956] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Cancer Prevention and Research Institute of Texas (CPRIT); Department of Veterans Affairs(US Department of Veterans Affairs); ARCS Scholarship; American Italian Cancer Foundation Post-doctoral Research Fellowship; Duncan Scholar Award; Mason Case Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Snyder and colleagues for high-throughput sequencing (conducted as part of the ENCODE consortium), and members of the Chua and Gozani laboratories for discussions and comments on the manuscript. This work was supported by grants from the National Institutes of Health (NIH) to K. F. C. (K08 AG028961, R01 AG028867), W. L. (U01DA025956), O.G. (R01 GM079641), K. S. (GM 30186, HG 4558) and B. A. G. (DP2OD007447); from the National Science Foundation to B. A. G. (CAREER Award, CBET-0941143); from the Department of Defense to W. L. (PC094421); from the Cancer Prevention and Research Institute of Texas (CPRIT) to W. L. (RP110471-C3); from the Department of Veterans Affairs to K. F. C. (Merit Award); and by fellowship awards to M. F. B. (ARCS Scholarship and Mason Case Graduate Fellowship), R. I. T. (NIH training grant 1018438-142 PABCA), L. T. (American Italian Cancer Foundation Post-doctoral Research Fellowship), S. P. (NIH training grant 3T32DK007217-36S1) and N.L.Y. (NIH F32 NRSA). W. L. is a recipient of a Duncan Scholar Award. K. F. C. is a Paul Beeson Scholar and an Ellison Medical Foundation New Scholar in Aging.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; BRAITHWAITE AW, 1983, J VIROL, V45, P192, DOI 10.1128/JVI.45.1.192-199.1983; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; de Nigris F, 2002, BRIT J CANCER, V86, P917, DOI 10.1038/sj.bjc.6600156; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frye R, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600635; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kaikkonen S, 2010, BBA-GENE REGUL MECH, V1799, P555, DOI 10.1016/j.bbagrm.2010.07.001; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Makkonen H, 2008, ONCOGENE, V27, P4865, DOI 10.1038/onc.2008.125; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; O'Geen H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-689; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	404	415	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					114	+		10.1038/nature11043	http://dx.doi.org/10.1038/nature11043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722849	Green Submitted, Green Accepted			2022-12-01	WOS:000305982900061
J	Aarestrup, F				Aarestrup, Frank			Get pigs off antibiotics	NATURE			English	Editorial Material							PRODUCTIVITY; RESISTANCE; FARMS		[Aarestrup, Frank] Tech Univ Denmark, EU Reference Lab Antimicrobial Resistance, DK-2800 Lyngby, Denmark; [Aarestrup, Frank] Tech Univ Denmark, WHO Collaborating Ctr Antimicrobial Resistance Fo, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Aarestrup, F (corresponding author), Tech Univ Denmark, EU Reference Lab Antimicrobial Resistance, DK-2800 Lyngby, Denmark.	fmaa@food.dtu.dk		Aarestrup, Frank/0000-0002-7116-2723				Aarestrup FM, 1995, MICROB DRUG RESIST, V1, P255, DOI 10.1089/mdr.1995.1.255; Aarestrup FM, 2000, APMIS, V108, P5; Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Emborg HD, 2001, PREV VET MED, V50, P53, DOI 10.1016/S0167-5877(01)00218-5; FAOSTAT, 2010, FOOD AGR COMM PROD; Food and Drug Administration, 2012, JUD US MED IMP ANT D; Food and Drug Administration, 2011, 2010 SUMM REP ANT SO; Swann M.M., 1969, REPORT JOINT COMMITT; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	10	132	138	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					465	466		10.1038/486465a	http://dx.doi.org/10.1038/486465a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965IJ	22739296				2022-12-01	WOS:000305760600017
J	Xian, Y; Liang, L; Smith, EE; Schwamm, LH; Reeves, MJ; Olson, DM; Hernandez, AF; Fonarow, GC; Peterson, ED				Xian, Ying; Liang, Li; Smith, Eric E.; Schwamm, Lee H.; Reeves, Mathew J.; Olson, DaiWai M.; Hernandez, Adrian F.; Fonarow, Gregg C.; Peterson, Eric D.			Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; GUIDELINES-STROKE; CLINICAL-PRACTICE; THROMBOLYSIS; ALTEPLASE; MORTALITY; THERAPY; ASSOCIATION; OUTCOMES; DISEASE	Context Intravenous tissue plasminogen activator (tPA) is known to improve outcomes in ischemic stroke; however, patients receiving long-term chronic warfarin therapy may face an increased risk for intracranial hemorrhage when treated with tPA. Although current guidelines endorse administering intravenous tPA to warfarin-treated patients if their international normalized ratio (INR) is 1.7 or lower, there are few data on safety of intravenous tPA in warfarin-treated patients in clinical practice. Objectives To determine the risk of symptomatic intracranial hemorrhage (sICH) among patients with ischemic stroke treated with intravenous tPA who were receiving warfarin vs those who were not and to determine this risk as a function of INR. Design, Setting, and Patients Observational study, using data from the American Heart Association Get With The Guidelines-Stroke Registry, of 23 437 patients with ischemic stroke and with INR of 1.7 or lower, treated with intravenous tPA in 1203 registry hospitals from April 2009 through June 2011. Main Outcome Measure Symptomatic intracranial hemorrhage. Secondary end points include life-threatening/serious systemic hemorrhage, any tPA complications, and in-hospital mortality. Results Overall, 1802 (7.7%) patients with stroke treated with tPA were receiving warfarin (median INR, 1.20; interquartile range [IQR], 1.07-1.40). Warfarin-treated patients were older, had more comorbid conditions, and had more severe strokes. The unadjusted sICH rate in warfarin-treated patients was higher than in non-warfarin-treated patients (5.7% vs 4.6%, P < .001), but these differences were not significantly different after adjustment for baseline clinical factors (adjusted odds ratio [OR], 1.01 [95% CI, 0.82-1.25]). Similarly, there were no significant differences between warfarin-treated and non-warfarin-treated patients for serious systemic hemorrhage (0.9% vs 0.9%; adjusted OR, 0.78 [95% CI, 0.49-1.24]), any tPA complications (10.6% vs 8.4%; adjusted OR, 1.09 [95% CI, 0.93-1.29]), or in-hospital mortality (11.4% vs 7.9%; adjusted OR, 0.94 [95% CI, 0.79-1.13]). Among warfarin-treated patients with INRs of 1.7 or lower, the degree of anticoagulation was not statistically significantly associated with sICH risk (adjusted OR, 1.10 per 0.1-unit increase in INR [95% CI, 1.00-1.20]; P = .06). Conclusion Among patients with ischemic stroke, the use of intravenous tPA among warfarin-treated patients (INR <= 1.7) was not associated with increased sICH risk compared with non-warfarin-treated patients.	[Xian, Ying; Liang, Li; Olson, DaiWai M.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27715 USA; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Schwamm, Lee H.] Massachusetts Gen Hosp, Div Neurol, Boston, MA 02114 USA; [Reeves, Mathew J.] Michigan State Univ, Dept Epidemiol, E Lansing, MI 48824 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA	Duke University; University of Calgary; Harvard University; Massachusetts General Hospital; Michigan State University; University of California System; University of California Los Angeles	Peterson, ED (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	peter016@mc.duke.edu	Fonarow, Gregg C/D-5988-2014; Olson, DaiWai/I-5932-2019; Peterson, Eric David/ABF-5033-2021; Hernandez, Adrian F/A-7818-2016; Xian, Ying/O-1956-2019; Smith, Eric E/C-5443-2012	Fonarow, Gregg C/0000-0002-3192-8093; Olson, DaiWai/0000-0002-9280-078X; Hernandez, Adrian F/0000-0003-3387-9616; Smith, Eric E/0000-0003-3956-1668; Xian, Ying/0000-0002-1237-1162; Schwamm, Lee/0000-0003-0592-9145	American Heart Association; Johnson Johnson; Amylin; Portola; Preventis; National Institutes of Health; Eli Lilly; Janssen Pharmaceuticals; American Heart Association-Pharmaceutical Roundtable; David and Stevie Spina; Janssen Pharmaceutical Companies of Johnson Johnson; Boehringer Ingelheim; Merck; Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership; AHA Pharmaceutical Roundtable	American Heart Association(American Heart Association); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Amylin; Portola; Preventis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly(Eli Lilly); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); American Heart Association-Pharmaceutical Roundtable(American Heart Association); David and Stevie Spina; Janssen Pharmaceutical Companies of Johnson Johnson; Boehringer Ingelheim(Boehringer Ingelheim); Merck(Merck & Company); Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership(Bristol-Myers Squibb); AHA Pharmaceutical Roundtable(American Heart Association)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Smith reported serving as a volunteer for the American Heart Association (AHA) Get With The Guidelines (GWTG) Steering Committee and serving on the advisory board for Genentech. Dr Schwamm reported serving as the chair of the AHA GWTG Steering Committee; serving as a consultant to the Massachusetts Department of Public Health; providing expert review of medical records for malpractice claims against neurologists regarding care of acute stroke; and serving as principal investigator of a phase 2 multicenter study of extended-window intravenous thrombolysis (alteplase provided at no cost to Massachusetts General Hospital). Dr Olson reported receiving a grant from the American Heart Association (Duke Clinical Research Institute serves as the statistical coordinating center for AHA GWTG). Dr Hernandez reported serving as a consultant for Johnson & Johnson, AstraZeneca, sanofi, and Corthera; receiving research grants or grants pending from Johnson & Johnson, Amylin, Portola, and Preventis; and serving as a consultant to Corthera. Dr Fonarow reported serving as a consultant to Pfizer, Merck, Schering-Plough, Bristol-Myers Squibb, and sanofi-aventis; receiving research grants or grants pending from the National Institutes of Health; receiving speakers honoraria from Pfizer, Merck, Schering-Plough, Bristol-Myers Squibb, and sanofi-aventis; and that he is an employee of the University of California, which holds a patent on retriever devices for stroke. Dr Peterson reported receiving research grants from Johnson & Johnson, Eli Lilly, and Janssen Pharmaceuticals and serving as a consultant to Boehringer Ingelheim, Johnson & Johnson, Medscape, Merck, Novartis, Ortho-McNeil-Janssen, Pfizer, Westat, the Cardiovascular Research Foundation, WebMD, and United Healthcare. No other authors reported disclosures.; This study received an award from the American Heart Association-Pharmaceutical Roundtable and from David and Stevie Spina. The Get With The Guidelines-Stroke (GWTG-Stroke) program is provided by the American Heart Association/American Stroke Association. The GWTG-Stroke Program is currently supported in part by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson. GWTG-Stroke has been funded in the past through support from Boehringer Ingelheim, Merck, Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership, and the AHA Pharmaceutical Roundtable.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Bambauer KZ, 2006, ARCH NEUROL-CHICAGO, V63, P661, DOI 10.1001/archneur.63.5.661; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Matute MC, 2011, THROMB HAEMOSTASIS, V106, P178, DOI 10.1160/TH11-01-0042; De Marchis GM, 2011, STROKE, V42, P3061, DOI 10.1161/STROKEAHA.111.615476; De Smedt A, 2010, CEREBROVASC DIS, V30, P533, DOI 10.1159/000319886; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Graham GD, 2003, STROKE, V34, P2847, DOI 10.1161/01.STR.0000101752.23813.C3; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kim YD, 2010, J NEUROL SCI, V298, P101, DOI 10.1016/j.jns.2010.07.025; LaBresh KA, 2008, ARCH INTERN MED, V168, P411, DOI 10.1001/archinternmed.2007.101; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Menon BK, 2012, STROKE, V43, pA68; Meretoja A, 2010, STROKE, V41, P1450, DOI 10.1161/STROKEAHA.109.576140; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Prabhakaran S, 2010, ARCH NEUROL-CHICAGO, V67, P559, DOI 10.1001/archneurol.2010.25; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Seet RCS, 2011, STROKE, V42, P2333, DOI 10.1161/STROKEAHA.111.614214; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Tanne D, 2002, CIRCULATION, V105, P1679, DOI 10.1161/01.CIR.0000012747.53592.6A; Vergouwen MDI, 2011, STROKE, V42, P1041, DOI 10.1161/STROKEAHA.110.599183; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wann LS, 2011, CIRCULATION, V123, P1144, DOI 10.1161/CIR.0b013e31820f14c0; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012	34	115	125	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2600	2608		10.1001/jama.2012.6756	http://dx.doi.org/10.1001/jama.2012.6756			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	964KF	22735429				2022-12-01	WOS:000305692600028
J	Qu, Y; Misaghi, S; Izrael-Tomasevic, A; Newton, K; Gilmour, LL; Lamkanfi, M; Louie, S; Kayagaki, N; Liu, JF; Komuves, L; Cupp, JE; Arnott, D; Monack, D; Dixit, VM				Qu, Yan; Misaghi, Shahram; Izrael-Tomasevic, Anita; Newton, Kim; Gilmour, Laurie L.; Lamkanfi, Mohamed; Louie, Salina; Kayagaki, Nobuhiko; Liu, Jinfeng; Koemueves, Laszlo; Cupp, James E.; Arnott, David; Monack, Denise; Dixit, Vishva M.			Phosphorylation of NLRC4 is critical for inflammasome activation	NATURE			English	Article							INNATE IMMUNE RECOGNITION; III SECRETION APPARATUS; PROTEIN-KINASE-C; FRANCISELLA-TULARENSIS; AIM2 INFLAMMASOME; HOST-DEFENSE; IPAF; CASPASE-1; FLAGELLIN; SALMONELLA	NLRC4 is a cytosolic member of the NOD-like receptor family that is expressed in innate immune cells. It senses indirectly bacterial flagellin and type III secretion systems, and responds by assembling an inflammasome complex that promotes caspase-1 activation and pyroptosis(1-6). Here we use knock-in mice expressing NLRC4 with a carboxy-terminal 3xFlag tag to identify phosphorylation of NLRC4 on a single, evolutionarily conserved residue, Ser 533, following infection of macrophages with Salmonella enterica serovar Typhimurium (also known as Salmonella typhimurium). Western blotting with a NLRC4 phospho-Ser 533 antibody confirmed that this post-translational modification occurs only in the presence of stimuli known to engage NLRC4 and not the related protein NLRP3 or AIM2. Nlrc4(-/-) macrophages reconstituted with NLRC4 mutant S533A, unlike those reconstituted with wild-type NLRC4, did not activate caspase-1 and pyroptosis in response to S. typhimurium, indicating that S533 phosphorylation is critical for NLRC4 inflammasome function. Conversely, phosphomimetic NLRC4 S533D caused rapid macrophage pyroptosis without infection. Biochemical purification of the NLRC4-phosphorylating activity and a screen of kinase inhibitors identified PRKCD (PKC delta) as a candidate NLRC4 kinase. Recombinant PKC delta phosphorylated NLRC4 S533 in vitro, immunodepletion of PKC delta from macrophage lysates blocked NLRC4 S533 phosphorylation in vitro, and Prkcd(-/-) macrophages exhibited greatly attenuated caspase-1 activation and IL-1 beta secretion specifically in response to S. typhimurium. Phosphorylation-defective NLRC4 S533A failed to recruit procaspase-1 and did not assemble inflammasome specks(7) during S. typhimurium infection, so phosphorylation of NLRC4 S533 probably drives conformational changes necessary for NLRC4 inflammasome activity and host innate immunity.	[Qu, Yan; Newton, Kim; Kayagaki, Nobuhiko; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Misaghi, Shahram; Louie, Salina] Genentech Inc, Dept Early Stage Cell Culture, San Francisco, CA 94080 USA; [Izrael-Tomasevic, Anita; Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Gilmour, Laurie L.; Cupp, James E.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Koemueves, Laszlo] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Monack, Denise] Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Flanders Institute for Biotechnology (VIB); Ghent University; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Monack, Denise/0000-0003-3804-2209; Liu, Jinfeng/0000-0002-0343-8222				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; MIZUNO K, 1993, FEBS LETT, V330, P114, DOI 10.1016/0014-5793(93)80254-R; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; WOLF M, 1988, BIOCHEM BIOPH RES CO, V154, P1273, DOI 10.1016/0006-291X(88)90277-X; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	22	209	222	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					539	+		10.1038/nature11429	http://dx.doi.org/10.1038/nature11429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22885697				2022-12-01	WOS:000310196200042
J	Driessens, G; Beck, B; Caauwe, A; Simons, BD; Blanpain, C				Driessens, Gregory; Beck, Benjamin; Caauwe, Amelie; Simons, Benjamin D.; Blanpain, Cedric			Defining the mode of tumour growth by clonal analysis	NATURE			English	Article							CANCER STEM-CELLS; MOUSE SKIN; ADULT TISSUES; EVOLUTION; EPIDERMIS; REPLACEMENT; UNITS; FATE; BETA	Recent studies using the isolation of a subpopulation of tumour cells followed by their transplantation into immunodeficient mice provide evidence that certain tumours(1,2), including squamous skin tumours(3-5), contain cells with high clonogenic potential that have been referred to as cancer stem cells (CSCs). Until now, CSC properties have only been investigated by transplantation assays, and their existence in unperturbed tumour growth is unproven. Here we make use of clonal analysis of squamous skin tumours using genetic lineage tracing to unravel the mode of tumour growth in vivo in its native environment. To this end, we used a genetic labelling strategy that allows individual tumour cells to be marked and traced over time at different stages of tumour progression. Surprisingly, we found that the majority of labelled tumour cells in benign papilloma have only limited proliferative potential, whereas a fraction has the capacity to persist long term, giving rise to progeny that occupy a significant part of the tumour. As well as confirming the presence of two distinct proliferative cell compartments within the papilloma, mirroring the composition, hierarchy and fate behaviour of normal tissue, quantitative analysis of clonal fate data indicates that the more persistent population has stem-cell-like characteristics and cycles twice per day, whereas the second represents a slower cycling transient population that gives rise to terminally differentiated tumour cells. Such behaviour is shown to be consistent with double-labelling experiments and detailed clonal fate characteristics. By contrast, measurements of clone size and proliferative potential in invasive squamous cell carcinoma show a different pattern of behaviour, consistent with geometric expansion of a single CSC population with limited potential for terminal differentiation. This study presents the first experimental evidence for the existence of CSCs during unperturbed solid tumour growth.	[Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Driessens, Gregory; Beck, Benjamin; Caauwe, Amelie; Blanpain, Cedric] Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Blanpain, Cedric] WELBIO, B-1070 Brussels, Belgium	University of Cambridge; Universite Libre de Bruxelles; University of Cambridge; WELBIO	Simons, BD (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.	bds10@cam.ac.uk; Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Beck, Benjamin/0000-0001-8162-7566	Brussels Region; FNRS; program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC); EMBO; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; EPSRC [EP/F032773/1] Funding Source: UKRI	Brussels Region; FNRS(Fonds de la Recherche Scientifique - FNRS); program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C.B. is investigator of WELBIO and chercheur qualifie of the FRS/FNRS. B.B. is charge de recherche of the FRS/FNRS and G.D. is supported by the Brussels Region. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB foundation and the fond Gaston Ithier, a starting grant of the European Research Council (ERC), and the EMBO Young Investigator Program. We thank F. Bollet-Quivogne and J.-M. Vanderwinden for their help with confocal imaging.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Potten C S, 1981, Int Rev Cytol, V69, P271; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551	26	519	544	2	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					527	+		10.1038/nature11344	http://dx.doi.org/10.1038/nature11344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22854777	Green Accepted			2022-12-01	WOS:000307761600040
J	Kukulski, W; Schorb, M; Kaksonen, M; Briggs, JAG				Kukulski, Wanda; Schorb, Martin; Kaksonen, Marko; Briggs, John A. G.			Plasma Membrane Reshaping during Endocytosis Is Revealed by Time-Resolved Electron Tomography	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; FISSION YEAST; BUDDING YEAST; BAR DOMAINS; IN-VIVO; VESICLE; MICROSCOPY; CURVATURE; MECHANISM	Endocytosis, like many dynamic cellular processes, requires precise temporal and spatial orchestration of complex protein machinery to mediate membrane budding. To understand how this machinery works, we directly correlated fluorescence microscopy of key protein pairs with electron tomography. We systematically located 211 endocytic intermediates, assigned each to a specific time window in endocytosis, and reconstructed their ultrastructure in 3D. The resulting virtual ultrastructural movie defines the protein-mediated membrane shape changes during endocytosis in budding yeast. It reveals that clathrin is recruited to flat membranes and does not initiate curvature. Instead, membrane invagination begins upon actin network assembly followed by amphiphysin binding to parallel membrane segments, which promotes elongation of the invagination into a tubule. Scission occurs on average 9 s after initial bending when invaginations are similar to 100 nm deep, releasing nonspherical vesicles with 6,400 nm(2) mean surface area. Direct correlation of protein dynamics with ultrastructure provides a quantitative 4D resource.	[Kukulski, Wanda; Schorb, Martin; Kaksonen, Marko; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Kukulski, Wanda; Kaksonen, Marko; Briggs, John A. G.] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Kaksonen, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	kaksonen@embl.de; briggs@embl.de	Kukulski, Wanda/H-1766-2013; Briggs, John/J-3096-2012	Schorb, Martin/0000-0003-4910-1868; Briggs, John/0000-0003-3990-6910; Kaksonen, Marko/0000-0003-3645-7689	EMBL interdisciplinary postdoctoral fellowship; Swiss National Science Foundation	EMBL interdisciplinary postdoctoral fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was technically supported by Frank Thommen and by the EMBL EM core facility. We thank Jan Ellenberg and Francois Nedelec for critical reading of the manuscript and Wolfgang Huber for statistical advice. W. K. acknowledges an EMBL interdisciplinary postdoctoral fellowship and a fellowship for advanced researchers from the Swiss National Science Foundation.	ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Boettner DR, 2009, CURR BIOL, V19, P1979, DOI 10.1016/j.cub.2009.10.062; Boukellal H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061906; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Campelo F, 2010, FEBS LETT, V584, P1830, DOI 10.1016/j.febslet.2009.10.023; Carroll SY, 2012, MOL BIOL CELL, V23, P657, DOI 10.1091/mbc.E11-02-0108; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cureton DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001127; den Otter WK, 2011, TRAFFIC, V12, P1407, DOI 10.1111/j.1600-0854.2011.01241.x; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Hoffmann A, 2010, TRAFFIC, V11, P1129, DOI 10.1111/j.1600-0854.2010.01084.x; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Kishimoto T, 2011, P NATL ACAD SCI USA, V108, pE979, DOI 10.1073/pnas.1113413108; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pruggnaller S, 2008, J STRUCT BIOL, V164, P161, DOI 10.1016/j.jsb.2008.05.003; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Wu XF, 2003, MOL BIOL CELL, V14, P516, DOI 10.1091/mbc.E02-06-0353; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181	51	226	228	1	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					508	520		10.1016/j.cell.2012.05.046	http://dx.doi.org/10.1016/j.cell.2012.05.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863005	Bronze			2022-12-01	WOS:000307301400011
J	Hodis, E; Watson, IR; Kryukov, GV; Arold, ST; Imielinski, M; Theurillat, JP; Nickerson, E; Auclair, D; Li, LR; Place, C; DiCara, D; Ramos, AH; Lawrence, MS; Cibulskis, K; Sivachenko, A; Voet, D; Saksena, G; Stransky, N; Onofrio, RC; Winckler, W; Ardlie, K; Wagle, N; Wargo, J; Chong, K; Morton, DL; Stemke-Hale, K; Chen, G; Noble, M; Meyerson, M; Ladbury, JE; Davies, MA; Gershenwald, JE; Wagner, SN; Hoon, DSB; Schadendorf, D; Lander, ES; Gabriel, SB; Getz, G; Garraway, LA; Chin, L				Hodis, Eran; Watson, Ian R.; Kryukov, Gregory V.; Arold, Stefan T.; Imielinski, Marcin; Theurillat, Jean-Philippe; Nickerson, Elizabeth; Auclair, Daniel; Li, Liren; Place, Chelsea; DiCara, Daniel; Ramos, Alex H.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey; Voet, Douglas; Saksena, Gordon; Stransky, Nicolas; Onofrio, Robert C.; Winckler, Wendy; Ardlie, Kristin; Wagle, Nikhil; Wargo, Jennifer; Chong, Kelly; Morton, Donald L.; Stemke-Hale, Katherine; Chen, Guo; Noble, Michael; Meyerson, Matthew; Ladbury, John E.; Davies, Michael A.; Gershenwald, Jeffrey E.; Wagner, Stephan N.; Hoon, Dave S. B.; Schadendorf, Dirk; Lander, Eric S.; Gabriel, Stacey B.; Getz, Gad; Garraway, Levi A.; Chin, Lynda			A Landscape of Driver Mutations in Melanoma	CELL			English	Article							SOMATIC MUTATIONS; HUMAN CANCER; PROTEIN COMPLEX; GENOME; RAS; AURORA; DISCOVERY; CATALOG	Despite recent insights into melanoma genetics, systematic surveys for driver mutations are challenged by an abundance of passenger mutations caused by carcinogenic UV light exposure. We developed a permutation-based framework to address this challenge, employing mutation data from intronic sequences to control for passenger mutational load on a per gene basis. Analysis of large-scale melanoma exome data by this approach discovered six novel melanoma genes (PPP6C, RAC1, SNX31, TACC1, STK19, and ARID2), three of which-RAC1, PPP6C, and STK19-harbored recurrent and potentially targetable mutations. Integration with chromosomal copy number data contextualized the landscape of driver mutations, providing oncogenic insights in BRAF- and NRAS-driven melanoma as well as those without known NRAS/BRAF mutations. The landscape also clarified a mutational basis for RB and p53 pathway deregulation in this malignancy. Finally, the spectrum of driver mutations provided unequivocal genomic evidence for a direct mutagenic role of UV light in melanoma pathogenesis.	[Hodis, Eran; Kryukov, Gregory V.; Imielinski, Marcin; Theurillat, Jean-Philippe; Nickerson, Elizabeth; Auclair, Daniel; DiCara, Daniel; Ramos, Alex H.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey; Voet, Douglas; Saksena, Gordon; Stransky, Nicolas; Onofrio, Robert C.; Winckler, Wendy; Ardlie, Kristin; Wagle, Nikhil; Noble, Michael; Meyerson, Matthew; Lander, Eric S.; Gabriel, Stacey B.; Getz, Gad; Garraway, Levi A.; Chin, Lynda] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Hodis, Eran; Kryukov, Gregory V.; Ramos, Alex H.; Wagle, Nikhil; Meyerson, Matthew; Garraway, Levi A.; Chin, Lynda] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Watson, Ian R.; Li, Liren; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Arold, Stefan T.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Arold, Stefan T.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Stemke-Hale, Katherine; Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Chen, Guo; Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Watson, Ian R.; Li, Liren; Place, Chelsea; Meyerson, Matthew; Garraway, Levi A.; Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Kryukov, Gregory V.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Wargo, Jennifer] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Chong, Kelly; Hoon, Dave S. B.] John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA; [Morton, Donald L.] John Wayne Canc Inst, Melanoma Dept, Santa Monica, CA 90404 USA; [Wagner, Stephan N.] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, A-1090 Vienna, Austria; [Wagner, Stephan N.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; John Wayne Cancer Institute; John Wayne Cancer Institute; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Duisburg Essen; Massachusetts Institute of Technology (MIT); Whitehead Institute	Garraway, LA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	levi_garraway@dfci.harvard.edu; lchin@mdanderson.org	Cibulskis, Kristian/AAC-7380-2019; Wagle, Nikhil/Q-7428-2019; Schadendorf, Dirk/AAE-8206-2019; Davies, Michael/GWV-2527-2022; Kryukov, Gregory V/A-9592-2008; Meyerson, Matthew L/E-7123-2012; Gershenwald, Jeff/AAX-4367-2020; Stemke-Hale, Katherine/K-9113-2013; Lawrence, Michael/AAC-8202-2020; Arold, Stefan/T-2612-2019; Hoon, Dave SB/C-7146-2018	Gershenwald, Jeff/0000-0003-4519-5369; Stemke-Hale, Katherine/0000-0002-1231-4192; Hoon, Dave SB/0000-0003-1915-3683; Ladbury, John/0000-0002-6328-7200; Watson, Ian/0000-0002-6025-3080; Wagner, Stephan/0000-0003-4941-7029; Arold, Stefan T/0000-0001-5278-0668; Cibulskis, Kristian/0000-0003-1343-1582; Kryukov, Gregory/0000-0002-6131-9483; Meyerson, Matthew/0000-0002-9133-8108	NHGRI [U54 HG003067]; Melanoma Research Alliance; University of Texas MD Anderson Cancer Center Melanoma Specialized Programs of Research Excellence and Melanoma Informatics, Tissue Resource, and Pathology [P50 CA93459]; NCI [CA-16672, R33CA126674, R01 CA093947]; Canadian Institutes of Health Research; Swiss National Science Foundation [PASMP3_134379/1]; G. Harold and Leila Y. Mathers Charitable Foundation; FWF-Austrian Science Fund [L590-B12]; NIH [DP2OD002750]; Starr Cancer Consortium; TCGA GDAC [U24 CA143845]; Milestein Innovation Award in Melanoma Research; Novartis; NATIONAL CANCER INSTITUTE [U24CA143845, T32CA009172, P30CA016672, P50CA093459, R01CA093947, R33CA126674] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [L 590] Funding Source: researchfish	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Melanoma Research Alliance; University of Texas MD Anderson Cancer Center Melanoma Specialized Programs of Research Excellence and Melanoma Informatics, Tissue Resource, and Pathology; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); G. Harold and Leila Y. Mathers Charitable Foundation; FWF-Austrian Science Fund(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; TCGA GDAC; Milestein Innovation Award in Melanoma Research; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank L. Ambrogio and E. Bevilacuqa for management of sequencing data production. We thank A. McKenna, L. Zou, S.L. Carter, P. Stojanov, P. Lin, L. Lichtenstein, and the rest of the Broad Cancer Genome Analysis group. We thank C.Z. Zhang and C. Johannessen for helpful discussion, as well as the members of the Garraway and Chin labs. This work was supported by the NHGRI Large Scale Sequencing Program; grant U54 HG003067 to the Broad Institute (PI, E.S.L.); the Melanoma Research Alliance; The University of Texas MD Anderson Cancer Center Melanoma Specialized Programs of Research Excellence and Melanoma Informatics, Tissue Resource, and Pathology (core grant P50 CA93459) (PI, J.E.G., M.A.D.); and the NCI Support Grant (CA-16672). I.R.W. is a recipient of the Canadian Institutes of Health Research Fellowship. J.-P.T. is supported by the Swiss National Science Foundation (PASMP3_134379/1). J.E.L. is supported by The G. Harold and Leila Y. Mathers Charitable Foundation. S.N.W. was supported by the FWF-Austrian Science Fund (L590-B12). L.A.G. is supported by the NIH New Innovator Award (DP2OD002750), NCI (R33CA126674), the Melanoma Research Alliance, and the Starr Cancer Consortium. L.C. is supported by NCI RO1 (R01 CA093947), TCGA GDAC (U24 CA143845), and the Melanoma Research Alliance. L.C. is a recipient of the Milestein Innovation Award in Melanoma Research and is a CPRIT Scholar. N.W. is a consultant and shareholder in Foundation Medicine. L.A.G. is an equity holder and consultant in Foundation Medicine, a consultant to Novartis and Millennium/Takeda, and a recipient of a grant from Novartis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Conte N, 2003, ONCOGENE, V22, P8102, DOI 10.1038/sj.onc.1206972; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cully M, 2005, CANCER RES, V65, P10363, DOI 10.1158/0008-5472.CAN-05-1633; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Delaval B, 2004, ONCOGENE, V23, P4516, DOI 10.1038/sj.onc.1207593; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Garibyan L, 2010, CURR ONCOL REP, V12, P319, DOI 10.1007/s11912-010-0119-y; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106	53	1748	1782	4	219	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					251	263		10.1016/j.cell.2012.06.024	http://dx.doi.org/10.1016/j.cell.2012.06.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817889	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000306595700006
J	Wagner, CE; Harmon, LJ; Seehausen, O				Wagner, Catherine E.; Harmon, Luke J.; Seehausen, Ole			Ecological opportunity and sexual selection together predict adaptive radiation	NATURE			English	Article							LOGISTIC-REGRESSION; MIXED MODELS; SPECIATION; EVOLUTION; DIVERSITY; DETERMINISM; GRADIENT; FISHES; SCALE	A fundamental challenge to our understanding of biodiversity is to explain why some groups of species undergo adaptive radiations, diversifying extensively into many and varied species, whereas others do not(1,2). Both extrinsic environmental factors (for example, resource availability, climate) and intrinsic lineage-specific traits (for example, behavioural or morphological traits, genetic architecture) influence diversification, but few studies have addressed how such factors interact. Radiations of cichlid fishes in the African Great Lakes provide some of the most dramatic cases of species diversification. However, most cichlid lineages in African lakes have not undergone adaptive radiations. Here we compile data on cichlid colonization and diversification in 46 African lakes, along with lake environmental features and information about the traits of colonizing cichlid lineages, to investigate why adaptive radiation does and does not occur. We find that extrinsic environmental factors related to ecological opportunity and intrinsic lineage-specific traits related to sexual selection both strongly influence whether cichlids radiate. Cichlids are more likely to radiate in deep lakes, in regions with more incident solar radiation and in lakes where there has been more time for diversification. Weak or negative associations between diversification and lake surface area indicate that cichlid speciation is not constrained by area, in contrast to diversification in many terrestrial taxa(3). Among the suite of intrinsic traits that we investigate, sexual dichromatism, a surrogate for the intensity of sexual selection, is consistently positively associated with diversification. Thus, for cichlids, it is the coincidence between ecological opportunity and sexual selection that best predicts whether adaptive radiation will occur. These findings suggest that adaptive radiation is predictable, but only when species traits and environmental factors are jointly considered.	[Wagner, Catherine E.; Seehausen, Ole] EAWAG Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland; [Wagner, Catherine E.; Seehausen, Ole] Univ Bern, Inst Ecol & Evolut, Dept Aquat Ecol, CH-3012 Bern, Switzerland; [Wagner, Catherine E.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Wagner, Catherine E.] Cornell Univ, Ornithol Lab, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern; Cornell University; Cornell University; Idaho; University of Idaho	Wagner, CE (corresponding author), EAWAG Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland.	catherine.wagner@eawag.ch; ole.seehausen@eawag.ch	Wagner, Catherine/F-4692-2012; Seehausen, Ole/C-8272-2011	Wagner, Catherine/0000-0001-8585-6120; Seehausen, Ole/0000-0001-6598-1434; Harmon, Luke/0000-0002-4985-5750	National Center for Research Resources [5P20RR016448-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103397-10]; Swiss National Science Foundation [31003A-118293]; US National Science Foundation [DEB 0919499]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103397] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Ives, T. J. Davies and A. Mooers for analytical advice, P. McIntyre and C. Reidy Liermann for access to global energy data, S. Mwaiko, R. B. Stelkens, C. Katongo and U. Schliewen for unpublished DNA sequences, U. Schliewen, J. Jenson and O. Rittner for photographs, and A. McCune, D. Rabosky, R. Harrison, I. Lovette, E. Michel, G. Mittelbach, C. Melian, J. Brodersen, M. Maan, T. Ingram, B. Matthews, B. Dalziel, M. Pennell, J. Eastman, the Harmon laboratory group, the McCune laboratory group and the Seehausen laboratory group for discussions and comments on the manuscript. Bioinformatics facilities were supported by grants from the National Center for Research Resources (5P20RR016448-10) and the National Institute of General Medical Sciences (8 P20 GM103397-10) from the National Institutes of Health. This work was supported by the Swiss National Science Foundation project 31003A-118293 (to O.S.) and US National Science Foundation grant DEB 0919499 (to L.J.H.).	Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Burnham KP., 2002, MODEL SELECTION MULT, V2; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FRYER G, 1959, EVOLUTION, V13, P440, DOI 10.2307/2406127; Greenwood P.H., 1979, Bulletin of the British Museum (Natural History) Zoology, V35, P265; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Ingram T, 2011, P ROY SOC B-BIOL SCI, V278, P613, DOI 10.1098/rspb.2010.1127; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Kraaijeveld K., 2010, BIOL REV CAMB PHILOS, V86, P366; Kuwamura T., 1997, FISH COMMUNITIES LAK, P59; Lande R, 1982, EVOLUTION, V36, P1; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2007, HEREDITY, V99, P361, DOI 10.1038/sj.hdy.6801047; Seehausen O, 1999, ECOL LETT, V2, P262; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Simpson G.G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; Trivers R.L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vamosi SM, 2003, EVOL ECOL RES, V5, P717; Worthington E. B., 1936, P ZOOL SOC LOND, V1936, P1061	33	337	341	4	365	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					366	U124		10.1038/nature11144	http://dx.doi.org/10.1038/nature11144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722840				2022-12-01	WOS:000306506500043
J	Illing, PT; Vivian, JP; Dudek, NL; Kostenko, L; Chen, ZJ; Bharadwaj, M; Miles, JJ; Kjer-Nielsen, L; Gras, S; Williamson, NA; Burrows, SR; Purcell, AW; Rossjohn, J; McCluskey, J				Illing, Patricia T.; Vivian, Julian P.; Dudek, Nadine L.; Kostenko, Lyudmila; Chen, Zhenjun; Bharadwaj, Mandvi; Miles, John J.; Kjer-Nielsen, Lars; Gras, Stephanie; Williamson, Nicholas A.; Burrows, Scott R.; Purcell, Anthony W.; Rossjohn, Jamie; McCluskey, James			Immune self-reactivity triggered by drug-modified HLA-peptide repertoire	NATURE			English	Article							STEVENS-JOHNSON-SYNDROME; T-CELL ALLORECOGNITION; GENETIC-VARIATIONS; B REGION; HYPERSENSITIVITY; ABACAVIR; HLA-B-ASTERISK-5701; ASSOCIATION; COMPLEXES; ANTIGENS	Human leukocyte antigens (HLAs) are highly polymorphic proteins that initiate immunity by presenting pathogen-derived peptides to T cells(1). HLA polymorphisms mostly map to the antigen-binding cleft, thereby diversifying the repertoire of self-derived and pathogen-derived peptide antigens selected by different HLA allotypes(2). A growing number of immunologically based drug reactions, including abacavir hypersensitivity syndrome (AHS) and carbamazepine-induced Stevens-Johnson syndrome (SJS), are associated with specific HLA alleles(3-7). However, little is known about the underlying mechanisms of these associations, including AHS, a prototypical HLA-associated drug reaction occurring exclusively in individuals with the common histocompatibility allele HLA-B*57:01, and with a relative risk of more than 1,000 (refs 6, 7). We show that unmodified abacavir binds non-covalently to HLA-B*57:01, lying across the bottom of the antigen-binding cleft and reaching into the F-pocket, where a carboxy-terminal tryptophan typically anchors peptides bound to HLA-B*57:01. Abacavir binds with exquisite specificity to HLA-B*57:01, changing the shape and chemistry of the antigen-binding cleft, thereby altering the repertoire of endogenous peptides that can bind HLA-B*57:01. In this way, abacavir guides the selection of new endogenous peptides, inducing a marked alteration in 'immunological self'. The resultant peptide-centric 'altered self' activates abacavir-specific T-cells, thereby driving polyclonal CD8 T-cell activation and a systemic reaction manifesting as AHS. We also show that carbamazepine, a widely used anti-epileptic drug associated with hypersensitivity reactions in HLA-B*15:02 individuals, binds to this allotype, producing alterations in the repertoire of presented self peptides. Our findings simultaneously highlight the importance of HLA polymorphism in the evolution of pharmacogenomics and provide a general mechanism for some of the growing number of HLA-linked hypersensitivities that involve small-molecule drugs.	[Illing, Patricia T.; Kostenko, Lyudmila; Chen, Zhenjun; Bharadwaj, Mandvi; Kjer-Nielsen, Lars; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Illing, Patricia T.; Dudek, Nadine L.; Williamson, Nicholas A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Illing, Patricia T.; Dudek, Nadine L.; Williamson, Nicholas A.; Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Vivian, Julian P.; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Miles, John J.; Burrows, Scott R.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Miles, John J.; Burrows, Scott R.] Australian Ctr Vaccine Dev, Brisbane, Qld 4029, Australia; [Miles, John J.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [McCluskey, James] Australian Red Cross Blood Serv, Victorian Transplantat & Immunogenet Serv, W Melbourne, Vic 3003, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Monash University; QIMR Berghofer Medical Research Institute; Cardiff University; Australian Red Cross Blood Service	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	apurcell@unimelb.edu.au; jamie.rossjohn@monash.edu; jamesm1@unimelb.edu.au	Miles, John J/ABC-1105-2020; Rossjohn, Jamie/F-9032-2013; Williamson, Nicholas A/O-9812-2016; gras, stephanie/C-8307-2013; Purcell, Anthony/AAH-1942-2019; McCluskey, James/A-1291-2007; Illing, Patricia/AAP-6045-2021; Bharadwaj, Mandvi/C-4446-2014; Burrows, Scott/G-2050-2011	Miles, John J/0000-0001-5506-6304; Rossjohn, Jamie/0000-0002-2020-7522; Williamson, Nicholas A/0000-0002-2173-3452; Purcell, Anthony/0000-0003-0532-8331; McCluskey, James/0000-0002-8597-815X; Illing, Patricia/0000-0002-3870-0796; Burrows, Scott/0000-0002-1430-0472; Vivian, Julian/0000-0002-9400-4437; Kostenko, Lyudmila/0000-0002-8466-7966; gras, stephanie/0000-0001-7416-038X	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council (ARC); Monash University; NHMRC	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Monash University(Monash University); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank R. Holdsworth and M. Diviney for support; N. Croft for discussions, and the staff at the MX2 beamline of the Australian synchrotron for assistance with data collection. This research was supported by a Program Grant from the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council (ARC). S. G. is supported by a Senior Fellowship from Monash University. A. W. P. is supported by an NHMRC Senior Research Fellowship; J.R. is supported by an NHMRC Australia Fellowship.	Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; Barber LD, 1997, J IMMUNOL, V158, P1660; Bharadwaj M, 2012, ANNU REV PHARMACOL, V52, P401, DOI 10.1146/annurev-pharmtox-010611-134701; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hughes AR, 2004, PHARMACOGENOMICS, V5, P203, DOI 10.1517/phgs.5.2.203.27481; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; Macdonald W, 2002, FEBS LETT, V527, P27, DOI 10.1016/S0014-5793(02)03149-6; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Martin AM, 2004, P NATL ACAD SCI USA, V101, P4180, DOI 10.1073/pnas.0307067101; McCluskey J, 1999, Rev Immunogenet, V1, P3; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Roder G, 2006, ACTA CRYSTALLOGR D, V62, P1300, DOI 10.1107/S0907444906027636; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	27	474	491	5	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					554	U158		10.1038/nature11147	http://dx.doi.org/10.1038/nature11147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722860				2022-12-01	WOS:000305760600048
J	Kraemer, JA; Erb, ML; Waddling, CA; Montabana, EA; Zehr, EA; Wang, HN; Nguyen, K; Pham, DSL; Agard, DA; Pogliano, J				Kraemer, James A.; Erb, Marcella L.; Waddling, Christopher A.; Montabana, Elizabeth A.; Zehr, Elena A.; Wang, Hannah; Nguyen, Katrina; Pham, Duy Stephen L.; Agard, David A.; Pogliano, Joe			A Phage Tubulin Assembles Dynamic Filaments by an Atypical Mechanism to Center Viral DNA within the Host Cell	CELL			English	Article							BACTERIAL CYTOSKELETON; STRUCTURAL INSIGHTS; HOMOLOG TUBZ; PROTEIN; PLASMID; FTSZ; PSEUDOMONAS; GENES; POLYMERIZATION; REPLICATION	Tubulins are essential for the reproduction of many eukaryotic viruses, but historically, bacteriophage were assumed not to require a cytoskeleton. Here, we identify a tubulin-like protein, PhuZ, from bacteriophage 201 phi 2-1 and show that it forms filaments in vivo and in vitro. The PhuZ structure has a conserved tubulin fold, with an unusual, extended C terminus that we demonstrate to be critical for polymerization in vitro and in vivo. Longitudinal packing in the crystal lattice mimics packing observed by EM of in-vitro-formed filaments, indicating how interactions between the C terminus and the following monomer drive polymerization. PhuZ forms a filamentous array that is required for positioning phage DNA within the bacterial cell. Correct positioning to the cell center and optimal phage reproduction only occur when the PhuZ filament is dynamic. Thus, we show that PhuZ assembles a spindle-like array that functions analogously to the microtubule-based spindles of eukaryotes.	[Kraemer, James A.; Waddling, Christopher A.; Montabana, Elizabeth A.; Zehr, Elena A.; Pham, Duy Stephen L.; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kraemer, James A.; Waddling, Christopher A.; Montabana, Elizabeth A.; Zehr, Elena A.; Pham, Duy Stephen L.; Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Erb, Marcella L.; Wang, Hannah; Nguyen, Katrina; Pogliano, Joe] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Diego	Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu; jpogliano@ucsd.edu		Pham, Duy Stephen/0000-0003-0943-2531	HHMI; NIH [GM031627, GM084334, GM073898]; Genentech predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031627, R01GM073898, R01GM084334] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Justin Farlow for help with early experiments, Dr. Justin Kollman for EM advice, and Jessica Polka for many helpful discussions. We also thank Drs. Julie Thomas and Steven Hardies of UT Health Sciences San Antonio for the 201 phi 2-1 phage and Dr. Hongwei D Yu of Marshall University for the pHERD30T vector. This work was funded by HHMI and NIH Grant GM031627 (to D. A. A.) and by NIH Grants GM084334 and GM073898 (to J.P.). J.A.K. is supported by a Genentech predoctoral fellowship.	Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Drew KRP, 2011, P NATL ACAD SCI USA, V108, P11075, DOI 10.1073/pnas.1018724108; Howard GT, 2007, J APPL MICROBIOL, V103, P2074, DOI 10.1111/j.1365-2672.2007.03447.x; Iwasaki K, 2010, CURR OPIN STRUC BIOL, V20, P632, DOI 10.1016/j.sbi.2010.08.007; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Munoz-Espin D, 2009, P NATL ACAD SCI USA, V106, P13347, DOI 10.1073/pnas.0906465106; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rivera CR, 2011, J BIOL CHEM, V286, P14282, DOI 10.1074/jbc.M110.203828; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Serwer P, 2004, VIROLOGY, V329, P412, DOI 10.1016/j.virol.2004.08.021; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thomas JA, 2008, VIROLOGY, V376, P330, DOI 10.1016/j.virol.2008.04.004; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500	39	68	69	2	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1488	1499		10.1016/j.cell.2012.04.034	http://dx.doi.org/10.1016/j.cell.2012.04.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726436	Bronze, Green Accepted			2022-12-01	WOS:000305753800015
J	Buckley, BA; Burkhart, KB; Gu, SG; Spracklin, G; Kershner, A; Fritz, H; Kimble, J; Fire, A; Kennedy, S				Buckley, Bethany A.; Burkhart, Kirk B.; Gu, Sam Guoping; Spracklin, George; Kershner, Aaron; Fritz, Heidi; Kimble, Judith; Fire, Andrew; Kennedy, Scott			A nuclear Argonaute promotes multigenerational epigenetic inheritance and germline immortality	NATURE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; CAENORHABDITIS-ELEGANS; GENE; INTERFERENCE; PROTEIN; MEMORY; PIRNAS; RDE-1	Epigenetic information is frequently erased near the start of each new generation(1). In some cases, however, epigenetic information can be transmitted from parent to progeny (multigenerational epigenetic inheritance)(2). A particularly notable example of this type of epigenetic inheritance is double-stranded RNA-mediated gene silencing in Caenorhabditis elegans. This RNA-mediated interference (RNAi) can be inherited for more than five generations(3-8). To understand this process, here we conduct a genetic screen for nematodes defective in transmitting RNAi silencing signals to future generations. This screen identified the heritable RNAi defective 1 (hrde-1) gene. hrde-1 encodes an Argonaute protein that associates with small interfering RNAs in the germ cells of progeny of animals exposed to double-stranded RNA. In the nuclei of these germ cells, HRDE-1 engages the nuclear RNAi defective pathway to direct the trimethylation of histone H3 at Lys 9 (H3K9me3) at RNAi-targeted genomic loci and promote RNAi inheritance. Under normal growth conditions, HRDE-1 associates with endogenously expressed short interfering RNAs, which direct nuclear gene silencing in germ cells. In hrde-1- or nuclear RNAi-deficient animals, germline silencing is lost over generational time. Concurrently, these animals exhibit steadily worsening defects in gamete formation and function that ultimately lead to sterility. These results establish that the Argonaute protein HRDE-1 directs gene-silencing events in germ-cell nuclei that drive multigenerational RNAi inheritance and promote immortality of the germ-cell lineage. We propose that C. elegans use the RNAi inheritance machinery to transmit epigenetic information, accrued by past generations, into future generations to regulate important biological processes.	[Buckley, Bethany A.; Burkhart, Kirk B.; Spracklin, George; Fritz, Heidi; Kimble, Judith; Kennedy, Scott] Univ Wisconsin, Lab Genet, Madison, WI 53706 USA; [Gu, Sam Guoping; Fire, Andrew] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Gu, Sam Guoping; Fire, Andrew] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kershner, Aaron; Fritz, Heidi] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Kershner, Aaron; Kimble, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Stanford University; Stanford University; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kennedy, S (corresponding author), Univ Wisconsin, Lab Genet, Madison, WI 53706 USA.	sgkennedy@wisc.edu		Kennedy, Scott/0000-0002-7974-8155; Spracklin, George/0000-0001-7352-7354; Fire, Andrew/0000-0001-6217-8312	Pew scholar's program; Shaw scholar's program; National Institutes of Health [GM88289, GM37706, GM069454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088289, R01GM104232, R01GM037706, R01GM069454] Funding Source: NIH RePORTER	Pew scholar's program; Shaw scholar's program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Anderson, H. Opalicious and D. Wassarman for discussions. We thank S. Ahmed and members of the Ahmed laboratory for sharing unpublished data concerning the role of nrde-1 in germline immortality. This work was supported by grants from the Pew and Shaw scholar's programs, and the National Institutes of Health, GM88289 (S. K.), GM37706 (A. F.) and GM069454 (J.K).	Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn M.P., 2012, SCIENCE; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Burkhart KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002249; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	21	301	308	0	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					447	451		10.1038/nature11352	http://dx.doi.org/10.1038/nature11352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22810588	Green Accepted			2022-12-01	WOS:000308860900049
J	Anderson, JG; Wilmouth, DM; Smith, JB; Sayres, DS				Anderson, James G.; Wilmouth, David M.; Smith, Jessica B.; Sayres, David S.			UV Dosage Levels in Summer: Increased Risk of Ozone Loss from Convectively Injected Water Vapor	SCIENCE			English	Article							IN-SITU MEASUREMENTS; ANTARCTIC OZONE; LOWER STRATOSPHERE; DEPLETION; RADICALS; CHLORINE; VORTEX; OH; REDUCTIONS; EVOLUTION	The observed presence of water vapor convectively injected deep into the stratosphere over the United States can fundamentally change the catalytic chlorine/bromine free-radical chemistry of the lower stratosphere by shifting total available inorganic chlorine into the catalytically active free-radical form, ClO. This chemical shift markedly affects total ozone loss rates and makes the catalytic system extraordinarily sensitive to convective injection into the mid-latitude lower stratosphere in summer. Were the intensity and frequency of convective injection to increase as a result of climate forcing by the continued addition of CO2 and CH4 to the atmosphere, increased risk of ozone loss and associated increases in ultraviolet dosage would follow.	[Anderson, James G.] Harvard Univ, Dept Chem & Chem Biol, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Anderson, JG (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA.	anderson@huarp.harvard.edu		Smith, Jessica/0000-0003-2070-1894	NASA	NASA(National Aeronautics & Space Administration (NASA))	We acknowledge those who have been central to the design of the flight instruments associated with these observations: J. Demusz, N. Allen, C. Tuozzolo, M. Greenberg, M. Rivero, T. Hanisco, J. Paul, L. Moyer, F. Keutsch, and M. Witinski. This research was supported by the NASA Upper Atmosphere Research Program under the technical oversight of K. Jucks.	ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; ANDERSON JG, 1991, SCIENCE, V251, P39, DOI 10.1126/science.251.4989.39; ANDERSON JG, 1993, GEOPHYS RES LETT, V20, P2499, DOI 10.1029/93GL03118; COHEN RC, 1994, GEOPHYS RES LETT, V21, P2539, DOI 10.1029/94GL01713; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; Dessler AE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008609; Dessler AE, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012075; Dessler AE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005209; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Drdla K., 2010, ATMOS CHEM PHYS DISC, V10, P28687, DOI DOI 10.5194/ACPD-10-28687-2010; Drdla K., 2005, EOS T AGU, V86, pA31D; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Hanisco TF, 2001, J PHYS CHEM A, V105, P1543, DOI 10.1021/jp002334g; Hanisco TF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027899; HOFMANN DJ, 1987, NATURE, V326, P59, DOI 10.1038/326059a0; Keim ER, 1996, GEOPHYS RES LETT, V23, P3223, DOI 10.1029/96GL02593; Keith DW, 2010, NATURE, V463, P426, DOI 10.1038/463426a; Keith DW, 2000, J GEOPHYS RES-ATMOS, V105, P15167, DOI 10.1029/2000JD900130; Kirk-Davidoff DB, 1999, NATURE, V402, P399, DOI 10.1038/46521; Lanzendorf EJ, 2001, J PHYS CHEM A, V105, P1535, DOI 10.1021/jp002384l; Liu CT, 2008, J APPL METEOROL CLIM, V47, P2712, DOI 10.1175/2008JAMC1890.1; Manney GL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002634; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; Moyer EJ, 1996, GEOPHYS RES LETT, V23, P2385, DOI 10.1029/96GL01489; NEWMAN P, 1991, GEOPHYS RES LETT, V18, P661, DOI 10.1029/91GL00546; Newman P. A., 2007, SCI ASSESSMENT OZONE; Newman PA, 1997, GEOPHYS RES LETT, V24, P2689, DOI 10.1029/97GL52831; Newman PA, 2001, GEOPHYS RES LETT, V28, P959, DOI 10.1029/2000GL011972; NEWMAN PA, 2003, SCI ASSESSMENT OZONE, pCH3; Peter T., 2012, STRATOSPHERIC OZONE, P4, DOI DOI 10.1039/9781849733182-00214; POLLOCK W, 1980, J GEOPHYS RES-OCEANS, V85, P5555, DOI 10.1029/JC085iC10p05555; Salawitch RJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021504; Sander S. P., 2011, JPL PUB, V10-6, P1; Sayres DS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013100; Shi Q, 2001, J GEOPHYS RES-ATMOS, V106, P24259, DOI 10.1029/2000JD000181; Sloan LC, 1998, GEOPHYS RES LETT, V25, P3517, DOI 10.1029/98GL02492; Smith J., 2012, THESIS HARVARD U; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; STIMPFLE RM, 1994, GEOPHYS RES LETT, V21, P2543, DOI 10.1029/94GL02373; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Thornton BF, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007640; Trapp RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036203; Van Klooster SL, 2009, J CLIMATE, V22, P3317, DOI 10.1175/2009JCLI2697.1; Weinstock MA, 1995, ENVIRON HEALTH PERSP, V103, P251, DOI 10.2307/3432320; WENNBERG PO, 1994, SCIENCE, V266, P398, DOI 10.1126/science.266.5184.398; Wilmouth DM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006951	49	142	146	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					835	839		10.1126/science.1222978	http://dx.doi.org/10.1126/science.1222978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837384				2022-12-01	WOS:000307535600041
J	Lee, D; Lin, BJ; Lee, AK				Lee, Doyun; Lin, Bei-Jung; Lee, Albert K.			Hippocampal Place Fields Emerge upon Single-Cell Manipulation of Excitability During Behavior	SCIENCE			English	Article							SPATIAL MAP; GRID CELLS; INPUT; CA1; DENDRITES; DYNAMICS; NEURONS; REPRESENTATION; INHIBITION; RECORDINGS	The origin of the spatial receptive fields of hippocampal place cells has not been established. A hippocampal CA1 pyramidal cell receives thousands of synaptic inputs, mostly from other spatially tuned neurons; however, how the postsynaptic neuron's cellular properties determine the response to these inputs during behavior is unknown. We discovered that, contrary to expectations from basic models of place cells and neuronal integration, a small, spatially uniform depolarization of the spatially untuned somatic membrane potential of a silent cell leads to the sudden and reversible emergence of a spatially tuned subthreshold response and place-field spiking. Such gating of inputs by postsynaptic neuronal excitability reveals a cellular mechanism for receptive field origin and may be critical for the formation of hippocampal memory representations.	[Lee, Doyun; Lin, Bei-Jung; Lee, Albert K.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Lee, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	leed@janelia.hhmi.org; leea@janelia.hhmi.org	Lee, Doyun/AAK-5369-2020	Lee, Doyun/0000-0002-9968-9113; Lin, Bei-Jung/0000-0002-1755-1664	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We would like to thank G. Shtengel, J. Osborne, L. Ramasamy, D. Cabaniss, S. Bassin, C. Werner, B. Shields, A. Hu, M. J. Kim, H.-P. Liaw, G. Crosby, and D. Culley for technical advice and assistance and J. Dudman, N. Spruston, G. Murphy, J. Magee, K. Svoboda, J. Cohen, and D. Rich for valuable discussions about the manuscript. This work was supported by the Howard Hughes Medical Institute.	Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Lee A. K., 2008, SOC NEUR ABSTR, V2008, P69022; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	32	158	159	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					849	853		10.1126/science.1221489	http://dx.doi.org/10.1126/science.1221489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904011				2022-12-01	WOS:000307535600045
J	Sander, PM				Sander, P. Martin			Reproduction in Early Amniotes	SCIENCE			English	Editorial Material							LIFE-HISTORY; REPTILIA		Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, D-53115 Bonn, Germany	University of Bonn	Sander, PM (corresponding author), Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, Nussallee 8, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de						BURGIN T, 1989, SCI AM, V260, P74; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; Cheng YN, 2009, J VERTEBR PALEONTOL, V29, P401, DOI 10.1671/039.029.0230; Hou LH, 2010, P ROY SOC B-BIOL SCI, V277, P1235, DOI 10.1098/rspb.2009.2035; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Koenigswald Wighart V., 2004, Palaeontologische Zeitschrift, V78, P417; Modesto SP, 2010, J VERTEBR PALEONTOL, V30, P1378, DOI 10.1080/02724634.2010.501443; O'Keefe FR, 2011, SCIENCE, V333, P870, DOI 10.1126/science.1205689; Pineiro G, 2012, HIST BIOL, V24, P620, DOI 10.1080/08912963.2012.662230; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; SANDER PM, 1988, SCIENCE, V239, P780, DOI 10.1126/science.3340859; Sumida S. S., 1997, AMNIOTE ORIGINS COMP; Wilkinson M, 2002, J NAT HIST, V36, P2185, DOI 10.1080/00222930110071714	14	35	35	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					806	808		10.1126/science.1224301	http://dx.doi.org/10.1126/science.1224301			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904001				2022-12-01	WOS:000307535600029
J	Alexander, CMO; Bowden, R; Fogel, ML; Howard, KT; Herd, CDK; Nittler, LR				Alexander, C. M. O'D.; Bowden, R.; Fogel, M. L.; Howard, K. T.; Herd, C. D. K.; Nittler, L. R.			The Provenances of Asteroids, and Their Contributions to the Volatile Inventories of the Terrestrial Planets	SCIENCE			English	Article							TAGISH LAKE METEORITE; OXYGEN-ISOTOPE; SOLAR NEBULA; CARBONACEOUS CHONDRITES; ORGANIC-MATTER; LOW-MASS; ORIGIN; WATER; CONSTRAINTS; MIGRATION	Determining the source(s) of hydrogen, carbon, and nitrogen accreted by Earth is important for understanding the origins of water and life and for constraining dynamical processes that operated during planet formation. Chondritic meteorites are asteroidal fragments that retain records of the first few million years of solar system history. The deuterium/hydrogen (D/H) values of water in carbonaceous chondrites are distinct from those in comets and Saturn's moon Enceladus, implying that they formed in a different region of the solar system, contrary to predictions of recent dynamical models. The D/H values of water in carbonaceous chondrites also argue against an influx of water ice from the outer solar system, which has been invoked to explain the nonsolar oxygen isotopic composition of the inner solar system. The bulk hydrogen and nitrogen isotopic compositions of CI chondrites suggest that they were the principal source of Earth's volatiles.	[Alexander, C. M. O'D.; Nittler, L. R.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Bowden, R.; Fogel, M. L.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Howard, K. T.] Nat Hist Museum, London SW7 5BD, England; [Howard, K. T.] CUNY, Kingsborough Community Coll, Brooklyn, NY 11235 USA; [Herd, C. D. K.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	Carnegie Institution for Science; Carnegie Institution for Science; Natural History Museum London; City University of New York (CUNY) System; University of Alberta	Alexander, CMO (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	alexander@dtm.ciw.edu	Alexander, Conel M. O'D./N-7533-2013	Alexander, Conel M. O'D./0000-0002-8558-1427; Herd, Christopher/0000-0001-5210-4002	NASA [NNX11AG67G]; NASA Astrobiology Institute; Carnegie Canada; Natural Sciences and Engineering Research Council of Canada; W.M. Keck Foundation; UK Cosmochemical Analysis Network	NASA(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute; Carnegie Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); W.M. Keck Foundation(W.M. Keck Foundation); UK Cosmochemical Analysis Network	All the data reported in this paper are presented in the supplementary materials. This work was partially funded by NASA Cosmochemistry grant NNX11AG67G (C.M.O'D.A.), the NASA Astrobiology Institute (C.M.O'D.A., R. B., M. L. F., L.R.N.), Carnegie Canada (C.M.O'D.A., C. D. K. H., L.R.N.), the Natural Sciences and Engineering Research Council of Canada (C. D. K. H.), the W.M. Keck Foundation (M. L. F., R. B.), and the UK Cosmochemical Analysis Network (K. T. H.). For supplying the many samples that were necessary for this work, we thank the members of the Meteorite Working Group, C. Satterwhite and K. Righter (NASA, Johnson Space Center), T. McCoy and L. Welzenbach (Smithsonian Museum for Natural History), L. Garvie (Arizona State University), S. Russell, C. Smith, and D. Cassey (Natural History Museum, London).	Alexander CMO, 2007, GEOCHIM COSMOCHIM AC, V71, P4380, DOI 10.1016/j.gca.2007.06.052; Alexander CMO, 2010, GEOCHIM COSMOCHIM AC, V74, P4417, DOI 10.1016/j.gca.2010.05.005; Brearley A. J., 2006, METEORITES EARLY SOL, P584; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Coutens A, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201117627; Drouart A, 1999, ICARUS, V140, P129, DOI 10.1006/icar.1999.6137; Gounelle M, 2006, METEORIT PLANET SCI, V41, P135, DOI 10.1111/j.1945-5100.2006.tb00198.x; Haack H., 2011, LUNAR PLANET SCI, V43, P9100; Hartogh P, 2011, NATURE, V478, P218, DOI 10.1038/nature10519; Herd CDK, 2011, SCIENCE, V332, P1304, DOI 10.1126/science.1203290; Hiroi T, 2001, SCIENCE, V293, P2234, DOI 10.1126/science.1063734; Jewitt D, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/3/66; Levison HF, 2009, NATURE, V460, P364, DOI 10.1038/nature08094; Levison HF, 2003, NATURE, V426, P419, DOI 10.1038/nature02120; Liu FC, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015519; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; McCanta MC, 2008, GEOCHIM COSMOCHIM AC, V72, P5757, DOI 10.1016/j.gca.2008.07.034; McKeegan KD, 2011, SCIENCE, V332, P1528, DOI 10.1126/science.1204636; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Raymond SN, 2009, ICARUS, V203, P644, DOI 10.1016/j.icarus.2009.05.016; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; Walsh KJ, 2011, NATURE, V475, P206, DOI 10.1038/nature10201; Warren PH, 2011, EARTH PLANET SC LETT, V311, P93, DOI 10.1016/j.epsl.2011.08.047; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	28	416	420	9	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					721	723		10.1126/science.1223474	http://dx.doi.org/10.1126/science.1223474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22798405				2022-12-01	WOS:000307354500051
J	Wen, Q; Goldenson, B; Silver, SJ; Schenone, M; Dancik, V; Huang, Z; Wang, LZ; Lewis, TA; An, WF; Li, XY; Bray, MA; Thiollier, C; Diebold, L; Gilles, L; Vokes, MS; Moore, CB; Bliss-Moreau, M; VerPlank, L; Tolliday, NJ; Mishra, R; Vemula, S; Shi, JJ; Wei, L; Kapur, R; Lopez, CK; Gerby, B; Ballerini, P; Pflumio, F; Gilliland, DG; Goldberg, L; Birger, Y; Izraeli, S; Gamis, AS; Smith, FO; Woods, WG; Taub, J; Scherer, CA; Bradner, JE; Goh, BC; Mercher, T; Carpenter, AE; Gould, RJ; Clemons, PA; Carr, SA; Root, DE; Schreiber, SL; Stern, AM; Crispino, JD				Wen, Qiang; Goldenson, Benjamin; Silver, Serena J.; Schenone, Monica; Dancik, Vlado; Huang, Zan; Wang, Ling-Zhi; Lewis, Timothy A.; An, W. Frank; Li, Xiaoyu; Bray, Mark-Anthony; Thiollier, Clarisse; Diebold, Lauren; Gilles, Laure; Vokes, Martha S.; Moore, Christopher B.; Bliss-Moreau, Meghan; VerPlank, Lynn; Tolliday, Nicola J.; Mishra, Rama; Vemula, Sasidhar; Shi, Jianjian; Wei, Lei; Kapur, Reuben; Lopez, Cecile K.; Gerby, Bastien; Ballerini, Paola; Pflumio, Francoise; Gilliland, D. Gary; Goldberg, Liat; Birger, Yehudit; Izraeli, Shai; Gamis, Alan S.; Smith, Franklin O.; Woods, William G.; Taub, Jeffrey; Scherer, Christina A.; Bradner, James E.; Goh, Boon-Cher; Mercher, Thomas; Carpenter, Anne E.; Gould, Robert J.; Clemons, Paul A.; Carr, Steven A.; Root, David E.; Schreiber, Stuart L.; Stern, Andrew M.; Crispino, John D.			Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL	CELL			English	Article							ACUTE MEGAKARYOBLASTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; AURORA-A KINASE; INHIBITOR MLN8237; DOWN-SYNDROME; CELL-CYCLE; B KINASE; PHOSPHORYLATION; MEGAKARYOPOIESIS; VALIDATION	The mechanism by which cells decide to skip mitosis to become polyploid is largely undefined. Here we used a high-content image-based screen to identify small-molecule probes that induce polyploidization of megakaryocytic leukemia cells and serve as perturbagens to help understand this process. Our study implicates five networks of kinases that regulate the switch to polyploidy. Moreover, we find that dimethylfasudil (diMF, H-1152P) selectively increased polyploidization, mature cell-surface marker expression, and apoptosis of malignant megakaryocytes. An integrated target identification approach employing proteomic and shRNA screening revealed that a major target of diMF is Aurora kinase A (AURKA). We further find that MLN8237 (Alisertib), a selective inhibitor of AURKA, induced polyploidization and expression of mature megakaryocyte markers in acute megakaryocytic leukemia (AMKL) blasts and displayed potent anti-AMKL activity in vivo. Our findings provide a rationale to support clinical trials of MLN8237 and other inducers of polyploidization and differentiation in AMKL.	[Silver, Serena J.; Schenone, Monica; Dancik, Vlado; Lewis, Timothy A.; An, W. Frank; Li, Xiaoyu; Bray, Mark-Anthony; Vokes, Martha S.; Moore, Christopher B.; Bliss-Moreau, Meghan; VerPlank, Lynn; Tolliday, Nicola J.; Scherer, Christina A.; Bradner, James E.; Carpenter, Anne E.; Gould, Robert J.; Clemons, Paul A.; Carr, Steven A.; Root, David E.; Schreiber, Stuart L.; Stern, Andrew M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wen, Qiang; Goldenson, Benjamin; Huang, Zan; Diebold, Lauren; Gilles, Laure; Crispino, John D.] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Wang, Ling-Zhi; Goh, Boon-Cher] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Thiollier, Clarisse; Lopez, Cecile K.; Mercher, Thomas] Inst Gustave Roussy, INSERM, U985, F-94805 Villejuif, France; [Mishra, Rama] CMIDD, Evanston, IL USA; [Mishra, Rama] Northwestern Univ, Chicago, IL 60208 USA; [Vemula, Sasidhar; Shi, Jianjian; Wei, Lei; Kapur, Reuben] Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA; [Gerby, Bastien; Pflumio, Francoise] INSERM, CEA, Inst Radiobiol Cellulaire & Mol, EA 92265,UMR967, Fontenay Aux Roses, France; [Ballerini, Paola] Hop Trousseau, AP HP, F-75571 Paris, France; [Gilliland, D. Gary] Merck Sharp & Dohme Ltd, West Point, PA 19446 USA; [Goldberg, Liat; Birger, Yehudit; Izraeli, Shai] Tel Aviv Univ, Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Gamis, Alan S.] Childrens Mercy Hosp & Clin, Kansas City, MO 64108 USA; [Smith, Franklin O.] Univ Cincinnati, Inst Canc, Cincinnati, OH 45229 USA; [Woods, William G.] Childrens Healthcare Atlanta, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Woods, William G.] Emory Univ, Atlanta, GA 30322 USA; [Taub, Jeffrey] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Northwestern University; National University of Singapore; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Northwestern University; Indiana University System; Indiana University-Purdue University Indianapolis; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Merck & Company; Chaim Sheba Medical Center; Tel Aviv University; Children's Mercy Hospital; University System of Ohio; University of Cincinnati; Children's Healthcare of Atlanta (CHOA); Emory University; Children's Hospital of Michigan; Harvard University; Dana-Farber Cancer Institute	Stern, AM (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	astern@broadinstitute.org; j-crispino@northwestern.edu	Pflumio, Francoise/E-2074-2017; Carpenter, Anne/C-4982-2008; Wang, Lingzhi/AAF-1851-2020; Bray, Mark/C-5973-2008; Mercher, Thomas/J-2446-2014; Gerby, Bastien/D-8623-2017; Carr, Steven A./AAH-8366-2019	Carpenter, Anne/0000-0003-1555-8261; Wang, Lingzhi/0000-0001-5585-5426; Bray, Mark/0000-0002-9748-3592; Mercher, Thomas/0000-0003-1552-087X; Gerby, Bastien/0000-0002-2657-4200; Lewis, Timothy/0000-0001-9748-9575; Crispino, John/0000-0002-8182-8306; Huang, Zan/0000-0001-5623-6950; Lopez, Cecile/0000-0003-4473-6311; Stern, Andrew/0000-0002-8437-2957; Goldenson, Benjamin/0000-0001-6724-7858; Gilles, Laure/0000-0001-6567-256X; Pflumio, Francoise/0000-0001-8995-596X	Samuel Waxman Cancer Research Foundation; US Israel Binational Science Foundation; Leukemia and Lymphoma Society Translational Research Program; Children with Leukaemia UK; Israel Science Foundation; European Hematology Association; Leukemia Research Foundation; NIH [CA101774, HL077177, HL075816, HL081111, GM089652, U54 HG005032, RL1-CA133834, RL1-GM084437, RL1-HG004671, UL1-DE019585]; Foundation Gustave Roussy; Jose Carreras Leukemia Foundation- European Hematology Association; CEA-EA; Ligue Nationale Contre le Cancer; Association Laurette Fugain; Societe Francaise d'Hematologie; Foundation pour la Recherche Medicale; National Cancer Institute (NCI) [U10 CA98543]; NCI's Initiative for Chemical Genetics [N01-CO-12400]; NATIONAL CANCER INSTITUTE [RL1CA133834, U10CA098543, R01CA101774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL075816, R01HL077177, P01HL085098, R01HL081111, R01HL075816] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671, U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437, R01GM089652] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation; US Israel Binational Science Foundation(US-Israel Binational Science Foundation); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Children with Leukaemia UK; Israel Science Foundation(Israel Science Foundation); European Hematology Association; Leukemia Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Gustave Roussy; Jose Carreras Leukemia Foundation- European Hematology Association; CEA-EA; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association Laurette Fugain; Societe Francaise d'Hematologie; Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI's Initiative for Chemical Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Sandeep Gurbuxani, Alex Minella, and Lou Dore for critical reading of the manuscript and Bang Wong for valuable advice on figures of the manuscript. This research was funded by grants from the Samuel Waxman Cancer Research Foundation (J.D.C. and S. I.), the US Israel Binational Science Foundation (to S. I. and J.D.C.), the Leukemia and Lymphoma Society Translational Research Program (J.D.C.), the Children with Leukaemia UK (S. I.), the Israel Science Foundation (S. I.), European Hematology Association (Y.B.), and the Leukemia Research Foundation (Y.B.) and by NIH grants CA101774 (J.D.C.), HL077177 (R. K.), HL075816 (R. K.), and HL081111 (R. K.). Other support included an NIH grant to A. E. C. supporting CellProfiler (GM089652), an NIH grant supporting screening informatics (U54 HG005032), NIH Genomics Based Drug Discovery U54 grants Discovery Pipeline RL1-CA133834, and Driving Medical Projects RL1-GM084437, administratively linked to NIH grants RL1-HG004671 and UL1-DE019585 (A. E. C., P. A. C., V. D., C. B. M., A. M. S., C. A. S., and M. S.). Y.B. is a European Hematology Association Fellow. In vivo treatment of human AMKL samples was supported by Foundation Gustave Roussy and Jose Carreras Leukemia Foundation- European Hematology Association (T. M.), CEA-EA, Ligue Nationale Contre le Cancer (F. P.), Association Laurette Fugain (F. P.), Societe Francaise d'Hematologie (B. G., F. P.), and Foundation pour la Recherche Medicale (C. T.). The authors would also like to thank Jason Berman, Soheil Meshinchi, Todd Alonzo, and Sommer Castro and the Children's Oncology Group (COG) for their assistance with DS-AMKL specimens. Research with DS-AMKL samples was supported by the Chair's Grant U10 CA98543 (to COG) from the National Cancer Institute (NCI). The project has also been funded in part with Federal funds from the NCI's Initiative for Chemical Genetics under Contract N01-CO-12400. The content of this publication is solely the responsibility of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. A part of this work was performed by the Northwestern University ChemCore at the Center for Molecular Innovation and Drug Discovery (CMIDD), which is funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. D. G. G. is an employee and shareholder of Merck and Co., Inc. R.J.G. is an employee, shareholder, and board member of Epizyme, Inc. and a member of the SAB of the Michael J. Fox Foundation.	Bluteau D, 2009, J THROMB HAEMOST, V7, P227, DOI 10.1111/j.1538-7836.2009.03398.x; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; D'Alise AM, 2008, MOL CANCER THER, V7, P1140, DOI 10.1158/1535-7163.MCT-07-2051; Ding J, 2011, MOL REPROD DEV, V78, P80, DOI 10.1002/mrd.21272; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; Lannutti BJ, 2005, BLOOD, V105, P3875, DOI 10.1182/blood-2004-10-3934; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Lok W, 2010, ANTI-CANCER DRUG, V21, P339, DOI 10.1097/CAD.0b013e3283350dd1; Lordier L, 2010, BLOOD, V116, P2345, DOI 10.1182/blood-2010-01-265785; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901; Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Pradines JR, 2005, J COMPUT BIOL, V12, P113, DOI 10.1089/cmb.2005.12.113; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Tallman MS, 2000, BLOOD, V96, P2405; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wen Q, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002043; Wen Q, 2009, BLOOD, V114, P153, DOI 10.1182/blood-2008-11-190801; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	109	115	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					575	589		10.1016/j.cell.2012.06.032	http://dx.doi.org/10.1016/j.cell.2012.06.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863010	Green Submitted, Bronze, Green Accepted			2022-12-01	WOS:000307301400016
J	Jarrell, TA; Wang, Y; Bloniarz, AE; Brittin, CA; Xu, M; Thomson, JN; Albertson, DG; Hall, DH; Emmons, SW				Jarrell, Travis A.; Wang, Yi; Bloniarz, Adam E.; Brittin, Christopher A.; Xu, Meng; Thomson, J. Nichol; Albertson, Donna G.; Hall, David H.; Emmons, Scott W.			The Connectome of a Decision-Making Neural Network	SCIENCE			English	Article							MALE MATING-BEHAVIOR; CAENORHABDITIS-ELEGANS MALE; C-ELEGANS; ULTRASTRUCTURAL ANALYSIS; SENSORY REGULATION; MODEL; NEURONS; GENERATION; DYNAMICS; MALES	In order to understand the nervous system, it is necessary to know the synaptic connections between the neurons, yet to date, only the wiring diagram of the adult hermaphrodite of the nematode Caenorhabditis elegans has been determined. Here, we present the wiring diagram of the posterior nervous system of the C. elegans adult male, reconstructed from serial electron micrograph sections. This region of the male nervous system contains the sexually dimorphic circuits for mating. The synaptic connections, both chemical and gap junctional, form a neural network with four striking features: multiple, parallel, short synaptic pathways directly connecting sensory neurons to end organs; recurrent and reciprocal connectivity among sensory neurons; modular substructure; and interneurons acting in feedforward loops. These features help to explain how the network robustly and rapidly selects and executes the steps of a behavioral program on the basis of the inputs from multiple sensory neurons.	[Jarrell, Travis A.; Wang, Yi; Bloniarz, Adam E.; Brittin, Christopher A.; Xu, Meng; Emmons, Scott W.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Thomson, J. Nichol; Albertson, Donna G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Hall, David H.; Emmons, Scott W.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; MRC Laboratory Molecular Biology; Yeshiva University; Albert Einstein College of Medicine	Emmons, SW (corresponding author), Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	scott.emmons@einstein.yu.edu			MRC; U.S. NIH [R21MH63223, OD 010943]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH063223] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H. Eckholdt played a key role in the early stages of this project. Contributions were also made by Z. Martirosyan, A. Singh, T. Stephney, and M. Zhang. C. Crocker made the figures. We thank J. White for encouragement and interest; A. Bergman, M. Chklovskii, D. Faber, A. Massimi, and S. Seung for helpful discussions; N. Baker, H. Buelow, D. Faber, R. Garcia, Z. Kaprielian, R. Lints, D. Portman, J. Sze, and J. Vijg for comments on the manuscript; and J. White and J. Hodgkin for their help in transferring archival transmission EM data from the U.K. Medical Research Council (MRC)-Laboratory of Molecular Biology to the Hall lab at Einstein for long-term curation and study. This work was supported by MRC, the U.S. NIH (R21MH63223 to S.W.E. and OD 010943 to D.H.H.), and by the G. Harold and Leila Y. Mathers Charitable Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BARR MM, 2006, WORMBOOK; Barrios A, 2008, CURR BIOL, V18, P1865, DOI 10.1016/j.cub.2008.10.050; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; BRENNER S, 1974, GENETICS, V77, P71; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; de Bono M, 2007, COLD SPRING HARB MON, V49, P437; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Haykin S., 2009, NEURAL NETWORKS LEAR; Hertz J, 1991, INTRO THEORY NEURAL; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kleemann GA, 2007, ANIM BEHAV, V74, P1339, DOI 10.1016/j.anbehav.2007.02.031; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; KLEINFELD D, 1988, BIOPHYS J, V54, P1039, DOI 10.1016/S0006-3495(88)83041-8; Koo PK, 2011, J NEUROSCI, V31, P7497, DOI 10.1523/JNEUROSCI.6153-10.2011; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Liu K., 1995, THESIS CALTECH; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Nagarajan N, 2008, CURR BIOL, V18, pR756, DOI 10.1016/j.cub.2008.06.043; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Schikorski T, 1997, J NEUROSCI, V17, P5858; Seung H. S., 2012, CONNECTOME BRAINS WI; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whittaker AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-33; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	45	269	271	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					437	444		10.1126/science.1221762	http://dx.doi.org/10.1126/science.1221762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837521				2022-12-01	WOS:000306802300035
J	Yehia, BR; Fleishman, JA; Metlay, JP; Moore, RD; Gebo, KA				Yehia, Baligh R.; Fleishman, John A.; Metlay, Joshua P.; Moore, Richard D.; Gebo, Kelly A.			Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PREVENTION; CARE		[Yehia, Baligh R.; Metlay, Joshua P.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fleishman, John A.] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA; [Moore, Richard D.; Gebo, Kelly A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	University of Pennsylvania; Pennsylvania Medicine; Agency for Healthcare Research & Quality; Johns Hopkins University	Yehia, BR (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	byehia@upenn.edu	Gebo, Kelly/AHA-7533-2022	Gebo, Kelly/0000-0003-4010-398X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069918, K24AI073957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602, K24DA000432] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA016893, R01 AA 16893] Funding Source: Medline; NIAID NIH HHS [U01 AI069918, K24 AI073957] Funding Source: Medline; NIDA NIH HHS [R01 DA011602, K24 DA 00432, R01DA11602, K24 DA000432] Funding Source: Medline; PHS HHS [290-01-0012] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; *DEP HLTH HUM SERV, GUID US ANT AG HIV 1; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Moore RD, 2011, CLIN INFECT DIS, V53, P600, DOI 10.1093/cid/cir467; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419	6	66	66	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2012	308	4					339	342		10.1001/jama.2012.5927	http://dx.doi.org/10.1001/jama.2012.5927			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977SR	22820781	Green Accepted, Bronze			2022-12-01	WOS:000306685500016
J	Kohler, M; Marin-Moratalla, N; Jordana, X; Aanes, R				Koehler, Meike; Marin-Moratalla, Nekane; Jordana, Xavier; Aanes, Ronny			Seasonal bone growth and physiology in endotherms shed light on dinosaur physiology	NATURE			English	Article							AMPRINOS RULE; REINDEER; DEER; HYPOMETABOLISM; HISTOLOGY; HORMONES; FOOD	Cyclical growth leaves marks in bone tissue that are in the forefront of discussions about physiologies of extinct vertebrates(1). Ectotherms show pronounced annual cycles of growth arrest that correlate with a decrease in body temperature and metabolic rate; endotherms are assumed to grow continuously until they attain maturity because of their constant high body temperature and sustained metabolic rate(1,2). This apparent dichotomy has driven the argument that zonal bone denotes ectotherm-like physiologies, thus fuelling the controversy on dinosaur thermophysiology and the evolution of endothermy in birds and mammal-like reptiles(1-4). Here we show, from a comprehensive global study of wild ruminants from tropical to polar environments, that cyclical growth is a universal trait of homoeothermic endotherms. Growth is arrested during the unfavourable season concurrently with decreases in body temperature, metabolic rate and bone-growth-mediating plasma insulin-like growth factor-1 levels, forming part of a plesiomorphic thermometabolic strategy for energy conservation. Conversely, bouts of intense tissue growth coincide with peak metabolic rates and correlated hormonal changes at the beginning of the favourable season, indicating an increased efficiency in acquiring and using seasonal resources. Our study supplies the strongest evidence so far that homeothermic endotherms arrest growth seasonally, which precludes the use of lines of arrested growth as an argument in support of ectothermy. However, high growth rates are a distinctive trait of mammals, suggesting the capacity for endogenous heat generation. The ruminant annual cycle provides an extant model on which to base inferences regarding the thermophysiology of dinosaurs and other extinct taxa.	[Koehler, Meike] Univ Autonoma Barcelona, ICREA, Inst Catala Paleontol Miquel Crusafont, Bellaterra 08193, Spain; [Aanes, Ronny] Norwegian Polar Res Inst, Fram Ctr, NO-9296 Tromso, Norway; [Aanes, Ronny] Norwegian Directorate Nat Management, NO-7047 Trondheim, Norway	Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP); Norwegian Polar Institute	Kohler, M (corresponding author), Univ Autonoma Barcelona, ICREA, Inst Catala Paleontol Miquel Crusafont, Bellaterra 08193, Spain.	meike.kohler@icp.cat	Jordana, Xavier/G-7537-2017; Jordana, Xavier/L-9301-2014	Jordana, Xavier/0000-0002-6016-6630; Jordana, Xavier/0000-0001-8990-4388; Kohler, Meike/0000-0002-6816-6651; Kohler, Meike/0000-0001-9228-3164	Spanish Ministry of Science and Innovation [CGL2008-06204/BTE, CGL2011-24685, BES-2009-02641, JCI-2010-08157]; Norwegian Research Council [NORKLIMA 178561/S30]; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Norwegian Research Council(Research Council of NorwayEuropean Commission); ICREA(ICREA)	We thank Th. Kaiser for permission to cut femora of skeletons from the Oboussier collections and from zoological material housed at the Zoological Institute and Museum of the University of Hamburg; W. Arnold for providing alpine red deer material, and A. Kubber for preparing and sending it; R. Garcia Gonzalez for providing red deer femora from Jaca (Spanish Pyrenees) and Capra ibex from Alfarc (Tarragona, Spain); all the people that helped collect the Svalbard material, and R. Garcia for preparation of the thin sections; and J. Horner, H. Woodward, S. Moya-Sola, T. Bromage and J. Cubo for comments on the manuscript. This work was supported by the Spanish Ministry of Science and Innovation (CGL2008-06204/BTE, 2012: CGL2011-24685, M.K.; BES-2009-02641, N.M.-M.; JCI-2010-08157, X.J.); the work was partly funded by the Norwegian Research Council (NORKLIMA 178561/S30, R.A.). The material is tabulated in the Supporting Online Material and archived at the Institut Catala de Paleontologia, Catalonia, Spain.	Aanes R, 2000, ECOGRAPHY, V23, P437, DOI 10.1034/j.1600-0587.2000.230406.x; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; Bennett A.F., 1986, P207; Bubenik GA, 1998, COMP BIOCHEM PHYS C, V120, P307, DOI 10.1016/S0742-8413(98)10010-5; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Chinsamy A, 2012, ANAT REC, V295, P610, DOI 10.1002/ar.22428; Courtland HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014762; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; Fastovsky D. E., 2009, DINOSAURS CONCISE NA; Gruber A., 2008, 128 WCRP WORLD MET O; Hetem RS, 2010, J COMP PHYSIOL B, V180, P1111, DOI 10.1007/s00360-010-0480-z; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klevezal GA., 1996, RECORDING STRUCTURES; Lawler James P., 1997, Rangifer, V17, P135; McNab B.K., 2002, PHYSL ECOLOGY VERTEB; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Montes L, 2010, ANIM BIOL, V60, P25, DOI 10.1163/157075610X12610595764093; Ostrowski S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P810, DOI 10.1086/504614; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Piccione G, 2009, BIOL RHYTHM RES, V40, P455, DOI 10.1080/09291010802568848; REID REH, 1984, GEOL MAG, V121, P589, DOI 10.1017/S0016756800030739; REIMERS E, 1984, Rangifer, V4, P16; RINGBERG T, 1979, ACTA PHYSIOL SCAND, V105, P268, DOI 10.1111/j.1748-1716.1979.tb06341.x; Sander PM, 2006, PALAEONTOGR ABT A, V277, P143; Signer C, 2011, FUNCT ECOL, V25, P537, DOI 10.1111/j.1365-2435.2010.01806.x; SUTTIE JM, 1995, AM ZOOL, V35, P215; Todini L, 2007, ANIMAL, V1, P997, DOI 10.1017/S1751731107000262; Turbill C, 2011, J EXP BIOL, V214, P963, DOI 10.1242/jeb.052282; Tyler N. J. C., 1990, Rangifer, P211	30	148	148	2	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2012	487	7407					358	361		10.1038/nature11264	http://dx.doi.org/10.1038/nature11264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22763443				2022-12-01	WOS:000306506500041
J	Jaques, R; Loosemore, M				Jaques, Rod; Loosemore, Mike			Sports and exercise medicine in undergraduate training	LANCET			English	Editorial Material							10-YEAR FOLLOW-UP; BREAST-CANCER; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; HIP FRACTURE; PREVENTION; WOMEN; RISK; OUTCOMES		[Jaques, Rod] Fac Sport & Exercise Med UK, Edinburgh EH8 9DR, Midlothian, Scotland; [Loosemore, Mike] Univ Coll London Hosp, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Jaques, R (corresponding author), Fac Sport & Exercise Med UK, Edinburgh EH8 9DR, Midlothian, Scotland.	rod.jaques@eis2win.co.uk						Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Hackshaw A, 2011, J CLIN ONCOL, V29, P1657, DOI 10.1200/JCO.2010.32.2933; Hambrecht R, 2004, CIRCULATION, V109, P1371, DOI 10.1161/01.CIR.0000121360.31954.1F; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Moradi T, 2002, INT J CANCER, V100, P76, DOI 10.1002/ijc.10447; National Health Service, FRESH APPR 2012; Oluwajana F, 2010, BRIT J SPORT MED, V44, pi6; Pigozzi F, 2009, BRIT J SPORT MED, V43, P1085, DOI 10.1136/bjsm.2008.055350; Royal College of General Practitioners-Birmingham Research Unit, ANN PREV REP 2006; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; YOUNG A, 1983, MED EDUC, V17, P369, DOI 10.1111/j.1365-2923.1983.tb01122.x	19	14	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2012	380	9836					4	5		10.1016/S0140-6736(12)60992-1	http://dx.doi.org/10.1016/S0140-6736(12)60992-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970GK	22770445				2022-12-01	WOS:000306115900005
J	Samstein, RM; Josefowicz, SZ; Arvey, A; Treuting, PM; Rudensky, AY				Samstein, Robert M.; Josefowicz, Steven Z.; Arvey, Aaron; Treuting, Piper M.; Rudensky, Alexander Y.			Extrathymic Generation of Regulatory T Cells in Placental Mammals Mitigates Maternal-Fetal Conflict	CELL			English	Article							IMPRINTED GENE; IMMUNE-SYSTEM; FOXP3 GENE; TGF-BETA; PROTEIN; AUTOIMMUNITY; PREGNANCY; RETROTRANSPOSON; EXPRESSION; INTERFACE	Regulatory T (Treg) cells, whose differentiation and function are controlled by X chromosome-encoded transcription factor Foxp3, are generated in the thymus (tTreg) and extrathymically (peripheral, pTreg), and their deficiency results in fatal autoimmunity. Here, we demonstrate that a Foxp3 enhancer, conserved noncoding sequence 1 (CNS1), essential for pTreg but dispensable for tTreg cell generation, is present only in placental mammals. CNS1 is largely composed of mammalian-wide interspersed repeats (MIR) that have undergone retrotransposition during early mammalian radiation. During pregnancy, pTreg cells specific to a model paternal alloantigen were generated in a CNS1-dependent manner and accumulated in the placenta. Furthermore, when mated with allogeneic, but not syngeneic, males, CNS1-deficient females showed increased fetal resorption accompanied by increased immune cell infiltration and defective remodeling of spiral arteries. Our results suggest that, during evolution, a CNS1-dependent mechanism of extrathymic differentiation of Treg cells emerged in placental animals to enforce maternal-fetal tolerance.	[Samstein, Robert M.; Josefowicz, Steven Z.; Arvey, Aaron; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Samstein, Robert M.; Josefowicz, Steven Z.; Arvey, Aaron; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; josefowicz, steven/0000-0001-7453-779X; Samstein, Robert/0000-0001-6860-2401; Arvey, Aaron/0000-0002-8789-0290	NIH [DK091968, R37 AI21609]; MSTP [GM07739]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091968] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank J. Gerard, Y. Liang, D. Canner, and M. Samstein; Z. Williams for helpful discussion; S. Gelber for review of histology; and P. Samollow and J. Vandeberg for providing opossum genomic DNA. R.M.S. was supported by NIH DK091968 and MSTP grant GM07739. A.Y.R. was supported by NIH grant R37 AI21609. A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arruvito L, 2009, J REPROD IMMUNOL, V82, P158, DOI 10.1016/j.jri.2009.04.010; Avagliano L, 2011, J CLIN PATHOL, V64, P1064, DOI 10.1136/jclinpath-2011-200092; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Darmochwal-Kolarz D, 2012, J REPROD IMMUNOL, V93, P75, DOI 10.1016/j.jri.2012.01.006; Dupressoir A, 2011, P NATL ACAD SCI USA, V108, pE1164, DOI 10.1073/pnas.1112304108; Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x; Hunt JS, 1997, J IMMUNOL, V158, P4122; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; JURKA J, 1995, NUCLEIC ACIDS RES, V23, P170, DOI 10.1093/nar/23.1.170; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Nikolaev S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030002; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Petroff MG, 2010, AM J REPROD IMMUNOL, V63, P506, DOI 10.1111/j.1600-0897.2010.00841.x; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quintana FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009478; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Simpson H, 2002, PLACENTA, V23, P44, DOI 10.1053/plac.2001.0746; SMIT AFA, 1995, NUCLEIC ACIDS RES, V23, P98, DOI 10.1093/nar/23.1.98; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Winger EE, 2011, AM J REPROD IMMUNOL, V66, P320, DOI 10.1111/j.1600-0897.2011.00992.x; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	51	423	435	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					29	38		10.1016/j.cell.2012.05.031	http://dx.doi.org/10.1016/j.cell.2012.05.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770213	Green Accepted, Bronze			2022-12-01	WOS:000306115000004
J	Leow, D; Li, G; Mei, TS; Yu, JQ				Leow, Dasheng; Li, Gang; Mei, Tian-Sheng; Yu, Jin-Quan			Activation of remote meta-C-H bonds assisted by an end-on template	NATURE			English	Article							CARBON-HYDROGEN BONDS; ROOM-TEMPERATURE; ARYLATION; OLEFINATION; CATALYST; ARENES; FUNCTIONALIZATION; SELECTIVITY; REACTIVITY; COMPLEXES	Functionalization of unactivated carbon-hydrogen (C-H) single bonds is an efficient strategy for rapid generation of complex molecules from simpler ones. However, it is difficult to achieve selectivity when multiple inequivalent C-H bonds are present in the target molecule. The usual approach is to use sigma-chelating directing groups, which lead to ortho-selectivity through the formation of a conformationally rigid six- or seven-membered cyclic pre-transition state(1-14). Despite the broad utility of this approach, proximity-driven reactivity prevents the activation of remote C-H bonds. Here we report a class of easily removable nitrile-containing templates that direct the activation of distal meta-C-H bonds (more than ten bonds away) of a tethered arene. We attribute this new mode of C-H activation to a weak 'end-on' interaction(15) between the linear nitrile group and the metal centre. The 'end-on' coordination geometry relieves the strain of the cyclophane-like pre-transition state of the meta-C-H activation event. In addition, this template overrides the intrinsic electronic and steric biases as well as ortho-directing effects with two broadly useful classes of arene substrates (toluene derivatives and hydrocinnamic acids).	[Leow, Dasheng; Li, Gang; Mei, Tian-Sheng; Yu, Jin-Quan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Mei, Tian-Sheng/Y-3266-2019; Li, Gang/I-2960-2012; mei, tiansheng/H-5293-2011; Li, Gang/ABF-3486-2021; Leow, Dasheng/A-9549-2012	Mei, Tian-Sheng/0000-0002-4985-1071; Li, Gang/0000-0001-5229-554X; Li, Gang/0000-0001-5229-554X; Leow, Dasheng/0000-0001-9823-0258	Scripps Research Institute; NIH (NIGMS) [1 R01 GM084019-03]; Agency for Science, Technology and Research (A*STAR) in Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Agency for Science, Technology and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank The Scripps Research Institute and the NIH (NIGMS, 1 R01 GM084019-03) for their financial support. We also thank the Agency for Science, Technology and Research (A*STAR) in Singapore for a postdoctoral fellowship (to D.L.).	Ackermann L, 2011, ORG LETT, V13, P4153, DOI 10.1021/ol201563r; Boele MDK, 2002, J AM CHEM SOC, V124, P1586, DOI 10.1021/ja0176907; BRESLOW R, 1980, ACCOUNTS CHEM RES, V13, P170, DOI 10.1021/ar50150a002; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Duong HA, 2011, ANGEW CHEM INT EDIT, V50, P463, DOI 10.1002/anie.201004704; Engle K. M., 2011, ACC CHEM RES; Flemming JP, 2008, ORG BIOMOL CHEM, V6, P1215, DOI 10.1039/b716954j; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Gurtler C, 1999, CHEM-EUR J, V5, P3107, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3107::AID-CHEM3107>3.0.CO;2-#; Hartung C. G., 2004, MODERN ARENE CHEM, P330, DOI DOI 10.1002/3527601767.CH10; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Jun CH, 1999, SYNLETT, P1; KAKIUCHI F, 1995, B CHEM SOC JPN, V68, P62, DOI 10.1246/bcsj.68.62; Li JJ, 2008, TETRAHEDRON, V64, P6979, DOI 10.1016/j.tet.2008.03.026; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Park SH, 2011, ORG LETT, V13, P2372, DOI 10.1021/ol200600p; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; RYABOV AD, 1985, SYNTHESIS-STUTTGART, P233, DOI 10.1055/s-1985-31169; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; SCHWARZ H, 1989, ACCOUNTS CHEM RES, V22, P282, DOI 10.1021/ar00164a004; Ueda K, 2010, ANGEW CHEM INT EDIT, V49, P8946, DOI 10.1002/anie.201005082; Wang DH, 2010, SCIENCE, V327, P315, DOI 10.1126/science.1182512; Wang XS, 2011, J AM CHEM SOC, V133, P13864, DOI 10.1021/ja206572w; Ye MC, 2011, J AM CHEM SOC, V133, P6964, DOI 10.1021/ja2021075; Zhang YH, 2009, J AM CHEM SOC, V131, P5072, DOI 10.1021/ja900327e	30	666	668	16	416	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					518	522		10.1038/nature11158	http://dx.doi.org/10.1038/nature11158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739317	Green Accepted			2022-12-01	WOS:000305760600040
J	Cresswell, JA; Campbell, OMR; De Silva, MJ; Filippi, V				Cresswell, Jenny A.; Campbell, Oona M. R.; De Silva, Mary J.; Filippi, Veronique			Effect of maternal obesity on neonatal death in sub-Saharan Africa: multivariable analysis of 27 national datasets	LANCET			English	Article							BODY-MASS INDEX; UTERINE CONTRACTILITY; NUTRITION TRANSITION; DEVELOPING-COUNTRIES; PREPREGNANCY WEIGHT; PREGNANCY OUTCOMES; RISK; WOMEN; STILLBIRTHS; UNDERWEIGHT	Background Rates of obesity are increasing worldwide, including in sub-Saharan Africa. Neonates born to obese mothers in low-income settings are at increased risk of complications including admission to neonatal intensive care, macrosomia, low Apgar scores, and perinatal death. We investigated whether maternal obesity is a risk factor for neonatal death in sub-Saharan Africa and the effect on the detailed timing of death within the neonatal period. Methods Cross-sectional Demographic and Health Surveys from 27 sub-Saharan countries (2003-09) were pooled. We used multivariable logistic regression to assess the risk of neonatal death (in women's most recent singleton livebirth in the 5 years preceding the survey) by maternal body-mass index (BMI) category (measured during the survey). Timing of death was investigated with a discrete-time survival model. Findings 15 518 of 81 126 eligible women were overweight (4266 were obese), 52 006 had an optimum BMI, and 13 602 were underweight. Maternal obesity was associated with an increased odds of neonatal death after adjustment for confounding factors (adjusted odds ratio 1.46, 95% CI 1.11-1.91). Maternal obesity was a significant risk factor for neonatal deaths occurring during the first 2 days of life (1.62, 1.11-2.37). We noted no statistically significant relation later in the neonatal period (days 2-6 1.36, 0.84-2.21; days 7-27 1.19, 0.65-2.18), possibly because of low statistical power. Interpretation Maternal obesity in sub-Saharan Africa is associated with increased risk of early neonatal death. Potential mechanisms include prematurity, intrapartum events, or infections. Strategies to prevent and reduce obesity need to be considered; obese women should be advised to deliver in a health-care facility that can provide emergency obstetric and neonatal care.	[Cresswell, Jenny A.; Campbell, Oona M. R.; De Silva, Mary J.; Filippi, Veronique] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Cresswell, JA (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	jenny.cresswell@lshtm.ac.uk		Campbell, Oona/0000-0002-9311-0115; Cresswell, Jenny/0000-0002-9553-1132	Economic and Social Research Council [PTA-031-2006-00109]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Economic and Social Research Council.; JC was funded by a PhD studentship from the Economic and Social Research Council (PTA-031-2006-00109). We thank Emma Slaymaker for her support and advice during data analysis, and the reviewers who provided us with many helpful suggestions.	[Anonymous], 2006, DHS METHODOLOGICAL R; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Cedergren MI, 2009, EUR J OBSTET GYN R B, V145, P163, DOI 10.1016/j.ejogrb.2009.05.022; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chen MH, 2010, J MATERN-FETAL NEO M, V23, P89, DOI 10.3109/14767050903168440; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Idemyor V, 2010, J NATL MED ASSOC, V102, P650, DOI 10.1016/S0027-9684(15)30643-X; Kalk P, 2009, EUR J MED RES, V14, P216; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Pullum TW, 2008, DHS METHODOLOGICAL R; Sebire NJ, 2001, BRIT J OBSTET GYNAEC, V108, P61, DOI 10.1111/j.1471-0528.2001.00021.x; The NHS Information Centre, 2010, LIF STAT STAT OB PHY; Verdiales M, 2009, J PERINAT MED, V37, P651, DOI 10.1515/JPM.2009.110; Zhang J, 2007, BJOG-INT J OBSTET GY, V114, P343, DOI 10.1111/j.1471-0528.2006.01233.x	29	61	62	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1325	1330		10.1016/S0140-6736(12)60869-1	http://dx.doi.org/10.1016/S0140-6736(12)60869-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	22884609				2022-12-01	WOS:000309931400031
J	Sasaki, M; Knobbe, CB; Munger, JC; Lind, EF; Brenner, D; Brustle, A; Harris, IS; Holmes, R; Wakeham, A; Haight, J; You-Ten, A; Li, WY; Schalm, S; Su, SM; Virtanen, C; Reifenberger, G; Ohashi, PS; Barber, DL; Figueroa, ME; Melnick, A; Zuniga-Pflucker, JC; Mak, TW				Sasaki, Masato; Knobbe, Christiane B.; Munger, Joshua C.; Lind, Evan F.; Brenner, Dirk; Bruestle, Anne; Harris, Isaac S.; Holmes, Roxanne; Wakeham, Andrew; Haight, Jillian; You-Ten, Annick; Li, Wanda Y.; Schalm, Stefanie; Su, Shinsan M.; Virtanen, Carl; Reifenberger, Guido; Ohashi, Pamela S.; Barber, Dwayne L.; Figueroa, Maria E.; Melnick, Ari; Zuniga-Pfluecker, Juan-Carlos; Mak, Tak W.			IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; FALSE DISCOVERY RATE; STEM-CELLS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; IDH2 MUTATIONS; DIFFERENTIATION; GENOME; NOTCH; MICE	Mutations in the IDH1 and IDH2 genes encoding isocitrate dehydrogenases are frequently found in human glioblastomas(1) and cytogenetically normal acute myeloid leukaemias (AML)(2). These alterations are gain-of-function mutations in that they drive the synthesis of the 'oncometabolite' R-2-hydroxyglutarate (2HG)(3). It remains unclear how IDH1 and IDH2 mutations modify myeloid cell development and promote leukaemogenesis. Here we report the characterization of conditional knock-in (KI) mice in which the most common IDH1 mutation, IDH1(R132H), is inserted into the endogenous murine Idh1 locus and is expressed in all haematopoietic cells (Vav-KI mice) or specifically in cells of the myeloid lineage (LysM-KI mice). These mutants show increased numbers of early haematopoietic progenitors and develop splenomegaly and anaemia with extramedullary haematopoiesis, suggesting a dysfunctional bone marrow niche. Furthermore, LysM-KI cells have hypermethylated histones and changes to DNA methylation similar to those observed in human IDH1- or IDH2-mutant AML. To our knowledge, our study is the first to describe the generation and characterization of conditional IDH1(R132H)-KI mice, and also the first report to demonstrate the induction of a leukaemic DNA methylation signature in a mouse model. Our report thus sheds light on the mechanistic links between IDH1 mutation and human AML.	[Sasaki, Masato; Knobbe, Christiane B.; Lind, Evan F.; Brenner, Dirk; Bruestle, Anne; Harris, Isaac S.; Wakeham, Andrew; Haight, Jillian; You-Ten, Annick; Li, Wanda Y.; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; [Knobbe, Christiane B.; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Munger, Joshua C.] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA; [Harris, Isaac S.; Barber, Dwayne L.; Mak, Tak W.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; [Holmes, Roxanne; Zuniga-Pfluecker, Juan-Carlos] Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada; [Virtanen, Carl] Univ Hlth Network, Microarray Ctr, Toronto, ON M5S 1A8, Canada; [Figueroa, Maria E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Melnick, Ari] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Schalm, Stefanie; Su, Shinsan M.] Agios Pharmaceut Inc, Cambridge, MA 02139 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Heinrich Heine University Dusseldorf; University of Rochester; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Michigan System; University of Michigan; Cornell University; Agios Pharmaceuticals	Mak, TW (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada.	tmak@uhnres.utoronto.ca	Knobbe-Thomsen, Christiane B/D-3116-2019; Figueroa, Maria/AAE-8662-2019; Knobbe-Thomsen, Christiane/J-4963-2014; Munger, Joshua/ABA-6395-2020; Zuniga-Pflucker, Juan C/H-1295-2012; Melnick, Ari/AAA-5763-2020; Reifenberger, Guido/AAE-3599-2019	Bruestle, Anne/0000-0002-3842-5683; Figueroa, Maria Eugenia/0000-0003-4887-4981; Munger, Joshua/0000-0001-5379-9440; Lind, Evan/0000-0001-7026-2012; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Harris, Isaac/0000-0002-6855-2763; Barber, Dwayne/0000-0001-5528-8150; Ohashi, Pamela S./0000-0003-2915-9317; Brenner, Dirk/0000-0001-8979-1045; Knobbe-Thomsen, Christiane/0000-0003-1231-0076	Feodor-Lynen Postdoctoral Research Fellowship from the Alexander-von-Humboldt-Foundation, Germany; German Research Foundation (DFG); National Institute of Health [NIH R01AI081773]; Damon Runyon Cancer Research Foundation [DRR-09-10]; Leukemia & Lymphoma Society; Doris Duke Clinical Scientist Development Award; LLS SCOR grant [7132-08]; Burroughs Wellcome Clinical Translational Scientist Award; Starr Cancer Consortium [I4-A442]; Canada Research Chair in Developmental Immunology; Canadian Institutes of Health Research (CIHR); Ontario Ministry of Health and Long Term Care; Terry Fox Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI081773, R01AI081773] Funding Source: NIH RePORTER	Feodor-Lynen Postdoctoral Research Fellowship from the Alexander-von-Humboldt-Foundation, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); LLS SCOR grant; Burroughs Wellcome Clinical Translational Scientist Award; Starr Cancer Consortium; Canada Research Chair in Developmental Immunology(Canada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Terry Fox Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Animal Research Colony (ARC) at the Ontario Cancer Institute for mouse care; I. Ng, A. Shahinian, J. Sylvester and S. McCracken for administrative and organizational expertise; M. Bailey and J. Tsao for technical assistance; F. Tong and R. Nayyar for assistance with flow cytometric analysis and sorting; the Weill Cornell Medical College (WCMC) Epigenomics Core Facility for technical help and expertise; G. Melino, D. Green, M. Minden, H. Chang and P. Lang for helpful discussions; J. Thomsen for figure layout and M. Saunders for scientific editing. C. B. K. and D. B. were supported in part by a Feodor-Lynen Postdoctoral Research Fellowship from the Alexander-von-Humboldt-Foundation, Germany. D. B. and A. B. were supported in part by a Fellowship from the German Research Foundation (DFG). J. C. M. is supported by a National Institute of Health grant (NIH R01AI081773) and is a Damon Runyon-Rachleff Innovation Awardee supported by the Damon Runyon Cancer Research Foundation (DRR-09-10). P.S.O. holds a Canada Research Chair in Autoimmunity and Tumor Immunity. M. E. F. is supported by the Leukemia & Lymphoma Society Special Fellow Award and a Doris Duke Clinical Scientist Development Award. A. M. is supported by an LLS SCOR grant (7132-08), a Burroughs Wellcome Clinical Translational Scientist Award and a Starr Cancer Consortium grant (I4-A442). J.-C.Z.-P. is supported by a Canada Research Chair in Developmental Immunology. This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Ontario Ministry of Health and Long Term Care to T. W. M., and a program grant from the Terry Fox Foundation to P.S.O., J.-C.Z.-P. and T. W. M. Please note that the views expressed do not necessarily reflect those of the OMOHLTC.	Akalin A., PLOS GENET IN PRESS; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Callens C, 2010, J EXP MED, V207, P731, DOI 10.1084/jem.20091488; Campbell C, 2008, CURR OPIN HEMATOL, V15, P319, DOI 10.1097/MOH.0b013e328303b9df; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Heidel FH, 2011, INT J HEMATOL, V94, P109, DOI 10.1007/s12185-011-0901-0; Holmes R, 2009, COLD SPRING HARB PRO, V2009; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patel KP, 2011, AM J CLIN PATHOL, V135, P35, DOI 10.1309/AJCPD7NR2RMNQDVF; Patnaik MM, 2012, LEUKEMIA, V26, P101, DOI 10.1038/leu.2011.298; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soderberg SS, 2009, ANN NY ACAD SCI, V1176, P55, DOI 10.1111/j.1749-6632.2009.04569.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	34	379	393	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					656	+		10.1038/nature11323	http://dx.doi.org/10.1038/nature11323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22763442	Green Accepted			2022-12-01	WOS:000308095100056
J	Schuster-Bockler, B; Lehner, B				Schuster-Boeckler, Benjamin; Lehner, Ben			Chromatin organization is a major influence on regional mutation rates in human cancer cells	NATURE			English	Article							HUMAN GENOME; SOMATIC MUTATIONS; MAMMALIAN GENOME; MAP; RECOMBINATION; METHYLATIONS; LEUKEMIA; REPAIR	Cancer genome sequencing provides the first direct information on how mutation rates vary across the human genome in somatic cells(1-7). Testing diverse genetic and epigenetic features, here we show that mutation rates in cancer genomes are strikingly related to chromatin organization. Indeed, at the megabase scale, a single feature-levels of the heterochromatin-associated histone modification H3K9me3-can account for more than 40% of mutation-rate variation, and a combination of features can account for more than 55%. The strong association between mutation rates and chromatin organization is upheld in samples from different tissues and for different mutation types. This suggests that the arrangement of the genome into heterochromatin- and euchromatin-like domains is a dominant influence on regional mutation-rate variation in human somatic cells.	[Schuster-Boeckler, Benjamin; Lehner, Ben] CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Schuster-Boeckler, Benjamin; Lehner, Ben] UPF, Barcelona 08003, Spain; [Schuster-Boeckler, Benjamin] Pear Comp LLP, London W5 1SH, England; [Lehner, Ben] Passeig Lluis Co 23, ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Lehner, B (corresponding author), CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain.	ben.lehner@crg.es	Lehner, Ben/L-3413-2014; Schuster-Böckler, Benjamin/H-8339-2019; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; Schuster-Böckler, Benjamin/0000-0002-8892-5133; Lehner, Ben/0000-0002-8817-1124	European Research Council (ERC); European Union [277899 4DCellFate]; ERASysBioPLUS; Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-00365, BFU2011-26206]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR); European Molecular Biology Organization (EMBO); EMBL-CRG Systems Biology Program; Juan de la Cierva postdoctoral fellowship; ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)European Commission); European Union(European Commission); ERASysBioPLUS; Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); EMBL-CRG Systems Biology Program; Juan de la Cierva postdoctoral fellowship(Instituto de Salud Carlos III); ICREA(ICREA)	This work was funded by an European Research Council (ERC) Starting Grant, European Union Framework 7 project 277899 4DCellFate, ERASysBioPLUS, Ministerio de Ciencia e Innovacion (MICINN) grants BFU2008-00365 and BFU2011-26206, Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), the European Molecular Biology Organization (EMBO) Young Investigator Program, the EMBL-CRG Systems Biology Program and a Juan de la Cierva postdoctoral fellowship to B.S-B. We thank T. Vavouri and T. Warnecke for comments on the manuscript, and R.S. Hansen for assistance with analysing replication timing data.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Durbin RM., 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Ellegren H, 2003, CURR OPIN GENET DEV, V13, P562, DOI 10.1016/j.gde.2003.10.008; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gossmann TI, 2011, GENETICS, V189, P1389, DOI 10.1534/genetics.111.132654; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Hodgkinson A, 2012, HUM MUTAT, V33, P136, DOI 10.1002/humu.21616; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Vavouri T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002036; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537	30	405	412	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					504	+		10.1038/nature11273	http://dx.doi.org/10.1038/nature11273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22820252				2022-12-01	WOS:000307761600035
J	Fernandez, IE; Eickelberg, O				Fernandez, Isis E.; Eickelberg, Oliver			New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis	LANCET			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLLAGEN-PRODUCING CELLS; PROSTAGLANDIN E-2; GASTROESOPHAGEAL-REFLUX; INTERSTITIAL PNEUMONIA; FIBROBLASTIC FOCI; SONIC HEDGEHOG; STEM-CELLS; ACTIVATION; RECEPTOR	Idiopathic pulmonary fibrosis is a serious and progressive chronic lung disease that is characterised by altered cellular composition and homoeostasis in the peripheral lung, leading to excessive accumulation of extracellular matrix and, ultimately, loss of lung function. It is the interstitial pneumonia with the worst prognosis-mortality 3-5 years after diagnosis is 50%. During the past decade, researchers have described several novel cellular and molecular mechanisms and signalling pathways implicated in the pathogenesis of idiopathic pulmonary fibrosis, resulting in the identification of new therapeutic targets. These advances will hopefully result in increased survival rates and improved quality of life for patients with this disorder in future.	[Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Fernandez, Isis E.; Eickelberg, Oliver] Helmholtz Ctr Munich, German Ctr Lung Res, D-81377 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eickelberg, O (corresponding author), Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, D-81377 Munich, Germany.	oliver.eickelberg@helmholtz-muenchen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360	Roche; Bayer; InterMune; Helmholtz Association	Roche(Roche Holding); Bayer(Bayer AG); InterMune; Helmholtz Association(Helmholtz Association)	Both authors have sponsored grants for fibrosis research from Roche. OE has received speaker's fees from Roche, Bayer, and InterMune.; We thank the Helmholtz Association for funding.	Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Eickelberg O, 2010, AM J RESP CRIT CARE, V181, P883, DOI 10.1164/rccm.201001-0124UP; Enomoto N, 2006, CHEST, V130, P22, DOI 10.1378/chest.130.1.22; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fitch PM, 2011, INT J EXP PATHOL, V92, P8, DOI 10.1111/j.1365-2613.2010.00743.x; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Funke M, 2012, AM J RESP CELL MOL, V46, P355, DOI 10.1165/rcmb.2010-0155OC; Gardner A, 2012, AM J PATHOL, V180, P2293, DOI 10.1016/j.ajpath.2012.02.022; Ghosh M, 2011, AM J RESP CELL MOL, V45, P459, DOI 10.1165/rcmb.2010-0314OC; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Haspel JA, 2011, AM J RESP CRIT CARE, V184, P1237, DOI 10.1164/rccm.201106-0966CI; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jayachandran A, 2009, THORAX, V64, P1053, DOI 10.1136/thx.2009.121798; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Jin Y, 2012, AUTOPHAGY, V8, P426, DOI 10.4161/auto.19258; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Konigshoff M, 2011, EMBO MOL MED, V3, P575, DOI 10.1002/emmm.201100166; Konigshoff M, 2010, THORAX, V65, P949, DOI 10.1136/thx.2009.134353; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lasithiotaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027800; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Misumi Shigeki, 2006, Proc Am Thorac Soc, V3, P307, DOI 10.1513/pats.200602-018TK; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mubarak KK, 2012, EUR RESPIR J, V39, P133, DOI 10.1183/09031936.00141010; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Oh CK, 2012, PULM MED, V2012, DOI 10.1155/2012/808260; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Patel P, 2010, MATRIX BIOL, V29, P97, DOI 10.1016/j.matbio.2009.10.004; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Raghu G, 2006, EUR RESPIR J, V27, P136, DOI 10.1183/09031936.06.00037005; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Ryter SW, 2012, ANNU REV PHYSIOL, V74, P377, DOI 10.1146/annurev-physiol-020911-153348; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Sundberg C, 1996, LAB INVEST, V74, P452; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Venkatesan N, 2011, AM J PHYSIOL-LUNG C, V300, pL191, DOI 10.1152/ajplung.00214.2010; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P322, DOI 10.1513/pats.200602-019TK; Walker NM, 2012, AM J RESP CRIT CARE, V185, P77, DOI 10.1164/rccm.201105-0834OC; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019; Yang SZ, 2012, AM J PATHOL, V180, P484, DOI 10.1016/j.ajpath.2011.10.005; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	95	293	310	17	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					680	688		10.1016/S0140-6736(12)61144-1	http://dx.doi.org/10.1016/S0140-6736(12)61144-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901889				2022-12-01	WOS:000307721000033
J	Kruidenier, L; Chung, CW; Cheng, ZJ; Liddle, J; Che, KH; Joberty, G; Bantscheff, M; Bountra, C; Bridges, A; Diallo, H; Eberhard, D; Hutchinson, S; Jones, E; Katso, R; Leveridge, M; Mander, PK; Mosley, J; Ramirez-Molina, C; Rowland, P; Schofield, CJ; Sheppard, RJ; Smith, JE; Swales, C; Tanner, R; Thomas, P; Tumber, A; Drewes, G; Oppermann, U; Patel, DJ; Lee, K; Wilson, DM				Kruidenier, Laurens; Chung, Chun-wa; Cheng, Zhongjun; Liddle, John; Che, KaHing; Joberty, Gerard; Bantscheff, Marcus; Bountra, Chas; Bridges, Angela; Diallo, Hawa; Eberhard, Dirk; Hutchinson, Sue; Jones, Emma; Katso, Roy; Leveridge, Melanie; Mander, Palwinder K.; Mosley, Julie; Ramirez-Molina, Cesar; Rowland, Paul; Schofield, Christopher J.; Sheppard, Robert J.; Smith, Julia E.; Swales, Catherine; Tanner, Robert; Thomas, Pamela; Tumber, Anthony; Drewes, Gerard; Oppermann, Udo; Patel, Dinshaw J.; Lee, Kevin; Wilson, David M.			A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response	NATURE			English	Article							HISTONE LYSINE DEMETHYLASES; SUBSTRATE-SPECIFICITY; STRUCTURAL INSIGHTS; GENE-EXPRESSION; JMJD3; METHYLATION; DISEASE; FAMILY; UTX	The jumonji (JMJ) family of histone demethylases are Fe2+ - and a-ketoglutarate-dependent oxygenases that are essential components of regulatory transcriptional chromatin complexes(1-4). These enzymes demethylate lysine residues in histones in a methylation-state and sequence-specific context(5). Considerable effort has been devoted to gaining a mechanistic understanding of the roles of histone lysine demethylases in eukaryotic transcription, genome integrity and epigenetic inheritance(2,4,6), as well as in development, physiology and disease(3,7). However, because of the absence of any selective inhibitors, the relevance of the demethylase activity of JMJ enzymes in regulating cellular responses remains poorly understood. Here we present a structure-guided small-molecule and chemoproteomics approach to elucidating the functional role of the H3K27me3-specific demethylase subfamily (KDM6 subfamily members JMJD3 and UTX)(8). The liganded structures of human and mouse JMJD3 provide novel insight into the specificity determinants for cofactor, substrate and inhibitor recognition by the KDM6 subfamily of demethylases. We exploited these structural features to generate the first small-molecule catalytic site inhibitor that is selective for the H3K27me3-specific JMJ subfamily. We demonstrate that this inhibitor binds in a novel manner and reduces lipopolysaccharide-induced proinflammatory cytokine production by human primary macrophages, a process that depends on both JMJD3 and UTX. Our results resolve the ambiguity associated with the catalytic function of H3K27-specific JMJs in regulating disease-relevant inflammatory responses and provide encouragement for designing small-molecule inhibitors to allow selective pharmacological intervention across the JMJ family.	[Kruidenier, Laurens; Liddle, John; Diallo, Hawa; Mander, Palwinder K.; Ramirez-Molina, Cesar; Sheppard, Robert J.; Smith, Julia E.; Lee, Kevin; Wilson, David M.] GlaxoSmithKline R&D, Med Res Ctr, Immunoinflammat Therapy Area, Epinova DPU, Stevenage SG1 2NY, Herts, England; [Chung, Chun-wa; Bridges, Angela; Hutchinson, Sue; Jones, Emma; Katso, Roy; Leveridge, Melanie; Mosley, Julie; Rowland, Paul; Tanner, Robert; Thomas, Pamela] GlaxoSmithKline R&D, Med Res Ctr, Platform Technol & Sci, Stevenage SG1 2NY, Herts, England; [Cheng, Zhongjun; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Che, KaHing; Bountra, Chas; Schofield, Christopher J.; Tumber, Anthony; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England; [Che, KaHing; Swales, Catherine; Oppermann, Udo] Univ Oxford, NIHR Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England; [Joberty, Gerard; Bantscheff, Marcus; Eberhard, Dirk; Drewes, Gerard] Cellzome AG, D-69117 Heidelberg, Germany	GlaxoSmithKline; GlaxoSmithKline; Memorial Sloan Kettering Cancer Center; University of Oxford; University of Oxford; GlaxoSmithKline; Cellzome GmbH	Wilson, DM (corresponding author), GlaxoSmithKline R&D, Med Res Ctr, Immunoinflammat Therapy Area, Epinova DPU, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.	david.m.wilson@gsk.com	Bantscheff, Marcus/AAQ-2903-2021	Bantscheff, Marcus/0000-0002-8343-8977; Sheppard, Robert/0000-0002-5876-5589; Schofield, Christopher/0000-0002-0290-6565; Drewes, Gerard/0000-0003-0575-6766	Starr Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; Versus Arthritis [18358] Funding Source: researchfish	Starr Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Versus Arthritis(Versus Arthritis)	We thank the following colleagues for their help and advice in preparing the manuscript: A. Argyrou, S. Atkinson, M. Barker, M. Campbell, L. Gordon, R. Gregory, R. Grimley, P. Humphreys, P. Jeffrey, A. Kucik, B. Leavens, C. Lewis, V. Ludbrook, R. Prinjha, S. Ratcliffe, C. Sharp, D. Thomas, D. Tough and M. Woodrow. Help was also provided by N. Burgess-Brown, S. Ng, J. Dunford, A. Kawamura, N. Rose and M. Daniel. D. J. P. was supported by funds from the Starr Foundation, the Abby Rockefeller Mauze Trust and the Maloris Foundation. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust. This study was supported by the National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford. Thanks also to M. Boesche and the Cellzome biochemistry and mass spectrometry teams for assistance with the chemoproteomics experiments. Finally, we acknowledge additional contributions from members of Platform Technology Sciences and the Epinova DPU and the JMJD3 programme team for supporting this research.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Mackeen MM, 2010, J PROTEOME RES, V9, P4082, DOI 10.1021/pr100269b; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Sakurai M, 2010, MOL BIOSYST, V6, P357, DOI 10.1039/b912993f; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Yang Y, 2010, CELL RES, V20, P886, DOI 10.1038/cr.2010.86; Yu M, 2006, BIOCHEMISTRY-US, V45, P14788, DOI 10.1021/bi061621t	25	628	650	5	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					404	408		10.1038/nature11262	http://dx.doi.org/10.1038/nature11262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22842901	Green Accepted			2022-12-01	WOS:000307501000047
J	Lee, SH; Kwan, AC; Zhang, SY; Phoumthipphavong, V; Flannery, JG; Masmanidis, SC; Taniguchi, H; Huang, ZJ; Zhang, F; Boyden, ES; Deisseroth, K; Dan, Y				Lee, Seung-Hee; Kwan, Alex C.; Zhang, Siyu; Phoumthipphavong, Victoria; Flannery, John G.; Masmanidis, Sotiris C.; Taniguchi, Hiroki; Huang, Z. Josh; Zhang, Feng; Boyden, Edward S.; Deisseroth, Karl; Dan, Yang			Activation of specific interneurons improves V1 feature selectivity and visual perception	NATURE			English	Article							ORIENTATION SELECTIVITY; CORTICAL-NEURONS; ELECTRODE ARRAYS; CORTEX; INHIBITION; RESPONSES; INNERVATION; POPULATIONS; PERFORMANCE; MODULATION	Inhibitory interneurons are essential components of the neural circuits underlying various brain functions. In the neocortex, a large diversity of GABA (gamma-aminobutyric acid) interneurons has been identified on the basis of their morphology, molecular markers, biophysical properties and innervation pattern(1-3). However, how the activity of each subtype of interneurons contributes to sensory processing remains unclear. Here we show that optogenetic activation of parvalbumin-positive (PV+) interneurons in the mouse primary visual cortex (V1) sharpens neuronal feature selectivity and improves perceptual discrimination. Using multichannel recording with silicon probes(4,5) and channelrhodopsin-2 (ChR2)-mediated optical activation(6), we found that increased spiking of PV+ interneurons markedly sharpened orientation tuning and enhanced direction selectivity of nearby neurons. These effects were caused by the activation of inhibitory neurons rather than a decreased spiking of excitatory neurons, as archaerhodopsin-3 (Arch)-mediated optical silencing(7) of calcium/calmodulindependent protein kinase II alpha (CAMKII alpha)-positive excitatory neurons caused no significant change in V1 stimulus selectivity. Moreover, the improved selectivity specifically required PV+ neuron activation, as activating somatostatin or vasointestinal peptide interneurons had no significant effect. Notably, PV+ neuron activation in awake mice caused a significant improvement in their orientation discrimination, mirroring the sharpened V1 orientation tuning. Together, these results provide the first demonstration that visual coding and perception can be improved by increased spiking of a specific subtype of cortical inhibitory interneurons.	[Lee, Seung-Hee; Kwan, Alex C.; Zhang, Siyu; Phoumthipphavong, Victoria; Flannery, John G.; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Lee, Seung-Hee; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Masmanidis, Sotiris C.] CALTECH, Kavli Nanosci Inst, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA; [Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, McGovern Inst, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; California Institute of Technology; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Stanford University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Macrae, Rhiannon/AAX-1536-2020; Lee, Seung-Hee/J-5971-2013	Dan, Yang/0000-0002-3818-877X; Zhang, Siyu/0000-0001-7298-1475; Zhang, Siyu/0000-0003-1745-2532; Flannery, John/0000-0002-0720-8897; Huang, Z. Josh/0000-0003-0592-028X; Kwan, Alex/0000-0003-2169-1667	National Institutes of Health [R01 EY018861, PN2 EY018241]; National Science Foundation [22250400-42533]; NATIONAL EYE INSTITUTE [R01EY018861, PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Goard, L. Pinto, M. Xu and M. Viesel for help with experimental setup, A. Kaluszka for help with data analysis and H. Alitto and M. Poo for discussion and comments on the manuscript. This work was supported by National Institutes of Health grants R01 EY018861 and PN2 EY018241 and National Science Foundation grant 22250400-42533.	Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Ayaz A, 2009, J NEUROPHYSIOL, V101, P958, DOI 10.1152/jn.90547.2008; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI [10.1038/nmeth.f.324, 10.1038/NMETH.F.324]; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Du JG, 2009, J NEUROPHYSIOL, V101, P1671, DOI 10.1152/jn.90992.2008; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Green DG., 1966, SIGNAL DETECTION THE, DOI 10.1901/jeab.1969.12-475; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Kang KJ, 2004, J NEUROSCI, V24, P3726, DOI 10.1523/JNEUROSCI.4272-03.2004; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mehaffey WH, 2005, J NEUROSCI, V25, P9968, DOI 10.1523/JNEUROSCI.2682-05.2005; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	36	385	385	8	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					379	+		10.1038/nature11312	http://dx.doi.org/10.1038/nature11312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22878719	Green Accepted, Green Submitted			2022-12-01	WOS:000307501000042
J	Tsubokura, M; Gilmour, S; Takahashi, K; Oikawa, T; Kanazawa, Y				Tsubokura, Masaharu; Gilmour, Stuart; Takahashi, Kyohei; Oikawa, Tomoyoshi; Kanazawa, Yukio			Internal Radiation Exposure After the Fukushima Nuclear Power Plant Disaster	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHERNOBYL		[Tsubokura, Masaharu] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Tokyo, Japan; [Gilmour, Stuart] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Takahashi, Kyohei] Hara Machi Cent Obstet & Gynecol Clin, Minamisoma, Fukushima, Japan; [Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Dept Internal Med, Minamisoma, Fukushima, Japan	University of Tokyo; University of Tokyo	Tsubokura, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Tokyo, Japan.	tsubokura-tky@umin.ac.jp	Ley, Sarah/Y-9216-2019; Tsubokura, Masaharu/D-7300-2017; Tsubokura, Masaharu/AAV-4364-2021	Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X				Brumfiel G, 2011, NATURE, V471, P273, DOI 10.1038/471273a; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; National Council on Radiation Protection and Measurement, 2008, HDB NAT COUNC RAD PR; Ruhm W, 1999, HEALTH PHYS, V77, P373, DOI 10.1097/00004032-199910000-00004; Takatsuji T, 2000, HEALTH PHYS, V78, P86, DOI 10.1097/00004032-200001000-00014	5	98	99	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					669	670		10.1001/jama.2012.9839	http://dx.doi.org/10.1001/jama.2012.9839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893159	Bronze			2022-12-01	WOS:000307496700017
J	Pugh, TJ; Weeraratne, SD; Archer, TC; Krummel, DAP; Auclair, D; Bochicchio, J; Carneiro, MO; Carter, SL; Cibulskis, K; Erlich, RL; Greulich, H; Lawrence, MS; Lennon, NJ; McKenna, A; Meldrim, J; Ramos, AH; Ross, MG; Russ, C; Shefler, E; Sivachenko, A; Sogoloff, B; Stojanov, P; Tamayo, P; Mesirov, JP; Amani, V; Teider, N; Sengupta, S; Francois, JP; Northcott, PA; Taylor, MD; Yu, FR; Crabtree, GR; Kautzman, AG; Gabriel, SB; Getz, G; Jager, N; Jones, DTW; Lichter, P; Pfister, SM; Roberts, TM; Meyerson, M; Pomeroy, SL; Cho, YJ				Pugh, Trevor J.; Weeraratne, Shyamal Dilhan; Archer, Tenley C.; Krummel, Daniel A. Pomeranz; Auclair, Daniel; Bochicchio, James; Carneiro, Mauricio O.; Carter, Scott L.; Cibulskis, Kristian; Erlich, Rachel L.; Greulich, Heidi; Lawrence, Michael S.; Lennon, Niall J.; McKenna, Aaron; Meldrim, James; Ramos, Alex H.; Ross, Michael G.; Russ, Carsten; Shefler, Erica; Sivachenko, Andrey; Sogoloff, Brian; Stojanov, Petar; Tamayo, Pablo; Mesirov, Jill P.; Amani, Vladimir; Teider, Natalia; Sengupta, Soma; Francois, Jessica Pierre; Northcott, Paul A.; Taylor, Michael D.; Yu, Furong; Crabtree, Gerald R.; Kautzman, Amanda G.; Gabriel, Stacey B.; Getz, Gad; Jaeger, Natalie; Jones, David T. W.; Lichter, Peter; Pfister, Stefan M.; Roberts, Thomas M.; Meyerson, Matthew; Pomeroy, Scott L.; Cho, Yoon-Jae			Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations	NATURE			English	Article							STRUCTURAL BASIS; CHILDHOOD; LANDSCAPE; COMPLEX; GENES	Medulloblastomas are themost commonmalignant brain tumours in children(1). Identifying and understanding the genetic events that drive these tumours is critical for the development of more effective diagnostic, prognostic and therapeutic strategies. Recently, our group and others described distinct molecular subtypes ofmedulloblastoma on the basis of transcriptional and copy number profiles(2-5). Here we use whole-exome hybrid capture and deep sequencing to identify somatic mutations across the coding regions of 92 primary medulloblastoma/normal pairs. Overall, medulloblastomas have low mutation rates consistent with other paediatric tumours, with a median of 0.35 non-silent mutations per megabase. We identified twelve genes mutated at statistically significant frequencies, including previously known mutated genes in medulloblastoma such as CTNNB1, PTCH1, MLL2, SMARCA4 andTP53. Recurrent somatic mutations were newly identified in an RNA helicase gene, DDX3X, often concurrent with CTNNB1 mutations, and in the nuclear co-repressor (N-CoR) complex genes GPS2, BCOR and LDB1. We show that mutant DDX3X potentiates transactivation of a TCF promoter and enhances cell viability in combination with mutant, but not wild-type, beta-catenin. Together, our study reveals the alteration ofWNT, hedgehog, histone methyltransferase and now N-CoR pathways across medulloblastomas and within specific subtypes of this disease, and nominates theRNA helicase DDX3X as a component of pathogenic b-catenin signalling in medulloblastoma.	[Pugh, Trevor J.; Auclair, Daniel; Bochicchio, James; Carneiro, Mauricio O.; Carter, Scott L.; Cibulskis, Kristian; Erlich, Rachel L.; Greulich, Heidi; Lawrence, Michael S.; Lennon, Niall J.; McKenna, Aaron; Meldrim, James; Ramos, Alex H.; Ross, Michael G.; Russ, Carsten; Shefler, Erica; Sivachenko, Andrey; Sogoloff, Brian; Stojanov, Petar; Tamayo, Pablo; Mesirov, Jill P.; Gabriel, Stacey B.; Getz, Gad; Meyerson, Matthew; Pomeroy, Scott L.; Cho, Yoon-Jae] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Pugh, Trevor J.; Greulich, Heidi; Ramos, Alex H.; Roberts, Thomas M.; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Pugh, Trevor J.; Greulich, Heidi; Ramos, Alex H.; Roberts, Thomas M.; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Dept Med Oncol, Boston, MA 02115 USA; [Pugh, Trevor J.; Weeraratne, Shyamal Dilhan; Archer, Tenley C.; Greulich, Heidi; Ramos, Alex H.; Amani, Vladimir; Teider, Natalia; Sengupta, Soma; Francois, Jessica Pierre; Roberts, Thomas M.; Meyerson, Matthew; Pomeroy, Scott L.; Cho, Yoon-Jae] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Weeraratne, Shyamal Dilhan; Archer, Tenley C.; Amani, Vladimir; Teider, Natalia; Sengupta, Soma; Francois, Jessica Pierre; Pomeroy, Scott L.; Cho, Yoon-Jae] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Krummel, Daniel A. Pomeranz] Brandeis Univ, Waltham, MA 02453 USA; [Northcott, Paul A.; Taylor, Michael D.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Yu, Furong; Crabtree, Gerald R.; Kautzman, Amanda G.; Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Yu, Furong; Crabtree, Gerald R.; Kautzman, Amanda G.; Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Jaeger, Natalie; Jones, David T. W.; Lichter, Peter; Pfister, Stefan M.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Meyerson, Matthew] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Brandeis University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Brigham & Women's Hospital	Cho, YJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	matthew_meyerson@dfci.harvard.edu; scott.pomeroy@childrens.harvard.edu; yjcho1@stanford.edu	Northcott, Paul A/N-4022-2018; Lawrence, Michael/AAC-8202-2020; Pugh, Trevor/Y-2535-2019; Jones, David TW/G-9588-2013; Meyerson, Matthew L/E-7123-2012; Stojanov, Petar/GQI-4462-2022; Pfister, Stefan M/F-6860-2013; Cibulskis, Kristian/AAC-7380-2019; Mesirov, Jill/AGF-7626-2022; Jones, David T. W./Z-1963-2019	Northcott, Paul A/0000-0002-1220-5252; Pugh, Trevor/0000-0002-8073-5888; Jones, David TW/0000-0002-2036-5141; Stojanov, Petar/0000-0001-7815-776X; Pfister, Stefan M/0000-0002-5447-5322; Cibulskis, Kristian/0000-0003-1343-1582; Archer, Tenley/0000-0003-2723-4192; Crabtree, Robert/0000-0002-6639-8707; Taylor, Michael/0000-0001-7009-3466; Sengupta, Soma/0000-0003-4577-1397; Meyerson, Matthew/0000-0002-9133-8108; Jaeger, Natalie/0000-0002-9589-7580	NIH [NHGRI U54HG003067, R01CA109467, R01CA105607, P30 HD18655, R01 CA030002, CA050661, R01 NS046789, R01 CA154480, R25NS070682, R01CA148699]; St. Baldrick's Foundation Scholar Award; Beirne Faculty Scholar endowment and Center for Children's Brain Tumors at Stanford University; German Cancer Aid [109252]; BMBF ICGC-PedBrain project; HHMI; Pediatric Brain Tumor Foundation; Canadian Institutes of Health Research Fellowship; Hospital for Sick Children; Mullarkey Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA030002, R01CA105607, R01CA109467, P01CA050661, R01CA148699, R01CA154480] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS070682, R01NS046789] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation Scholar Award; Beirne Faculty Scholar endowment and Center for Children's Brain Tumors at Stanford University; German Cancer Aid(Deutsche Krebshilfe); BMBF ICGC-PedBrain project; HHMI(Howard Hughes Medical Institute); Pediatric Brain Tumor Foundation; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children(University of Toronto); Mullarkey Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NHGRI U54HG003067 to E. S. Lander (E. S., D. A., S. B. G., G. G., M. M.); R01CA109467(S. L. P., J.P.M.); R01CA105607 (H. G., T. M. R., M. M., S. L. P.); P30 HD18655 (S. L. P.); R01 CA030002 and CA050661 (T. M. R.); R01 NS046789 (G. R. C.); R01 CA154480 (P. T.); R25NS070682 (S. S.) and R01CA148699 (M. D. T.); St. Baldrick's Foundation Scholar Award and the Beirne Faculty Scholar endowment and Center for Children's Brain Tumors at Stanford University (Y.-J.C.); German Cancer Aid (109252) and the BMBF ICGC-PedBrain project (N.J., D.T.W.J., P. L., S. M. P.); HHMI (G. R. C.); the Pediatric Brain Tumor Foundation (M. D. T.); Canadian Institutes of Health Research Fellowship (T.J.P.); Restracomp funding from the Hospital for Sick Children (P.A.N.); and the Mullarkey Research Fund (S. L. P.). We thank Children's Oncology Group and the Cooperative Human Tissue Network for providing tumour samples, the staff of the Broad Institute Biological Samples, Genome Sequencing and Genetic Analysis Platforms for their assistance in genomic processing of samples and generating the sequencing data used in this analysis, K. Keho and M. Brown at Pacific Biosciences for technical support with sample barcoding methods, and L. Gaffney of Broad Institute Communications for assistance with figure layout and design.	Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Central Brain Tumor Registry of the United States, 2011, STAT REP PRIM BRAIN; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garbelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019810; Genome Reference Consortium, 2012, HUM GEN OV; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ming JE, 2002, HUM GENET, V110, P297, DOI 10.1007/s00439-002-0695-5; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos A, 2012, ONCOTATOR; Remke M, 2011, J CLIN ONCOL, V29, P2717, DOI 10.1200/JCO.2011.34.9373; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Satow R, 2006, DEV CELL, V11, P763, DOI 10.1016/j.devcel.2006.10.001; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Smoll NR, 2012, CANCER-AM CANCER SOC, V118, P1313, DOI 10.1002/cncr.26387; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	29	541	554	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					106	110		10.1038/nature11329	http://dx.doi.org/10.1038/nature11329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22820256	Green Accepted, Green Submitted			2022-12-01	WOS:000307010700042
J	Kaelin, WG				Kaelin, William G., Jr.			Use and Abuse of RNAi to Study Mammalian Gene Function	SCIENCE			English	Editorial Material							HUMAN-CELLS; SCREENS; INTERFERENCE; EXPRESSION		Dana Farber Canc Inst, Dept Adult Oncol, Off M457, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Off M457, 450 Brookline Ave, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA068490, R01 CA076120] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076120, R01CA068490] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrows NJ, 2010, J BIOMOL SCREEN, V15, P735, DOI 10.1177/1087057110374994; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599	15	117	122	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					421	422		10.1126/science.1225787	http://dx.doi.org/10.1126/science.1225787			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837515	Green Accepted			2022-12-01	WOS:000306802300029
J	Malta, DC; da Silva, JB				Malta, Deborah Carvalho; da Silva, Jarbas Barbosa			Policies to promote physical activity in Brazil	LANCET			English	Editorial Material									[Malta, Deborah Carvalho; da Silva, Jarbas Barbosa] Minist Saude Brasil, Secretaria Vigilancia Saude, BR-70070600 Brasilia, DF, Brazil; [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Malta, DC (corresponding author), Minist Saude Brasil, Secretaria Vigilancia Saude, BR-70070600 Brasilia, DF, Brazil.	dcmalta@uol.com.br	Malta, Deborah C/H-7880-2012; Malta, Deborah Carvalho/L-2491-2019; Malta, Deborah/GNM-8218-2022	Malta, Deborah C/0000-0002-8214-5734; Malta, Deborah Carvalho/0000-0002-8214-5734; Malta, Deborah/0000-0002-8214-5734				[Anonymous], UN GEN ASS 66 SESS P; Brasil Ministerio da Saude, 2011, STRAT ACT PLAN TACKL; Brasil Ministerio da Saude, 2011, VIG BRAS 2011 VIG FA; Hallal Pedro C, 2011, Rev. bras. epidemiol., V14, P53, DOI 10.1590/S1415-790X2011000500006; Malta DC, 2011, EPIDEMIOL SERV SAUDE, V20, P425, DOI 10.5123/S1679-49742011000400002; Malta DC, 2009, EPIDEMIOL SERV SAUDE, V18, P7; Ministerio do Planejamento Orcamento e Gestao (BR); Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20; Reis RS, 2010, J PHYS ACT HEALTH, V7, pS137, DOI 10.1123/jpah.7.s2.s137; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Simoes EJ, 2009, AM J PUBLIC HEALTH, V99, P68, DOI 10.2105/AJPH.2008.141978; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7; WHO, 2011, GLOB STAT REP NONC D	12	70	82	2	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2012	380	9838					195	196		10.1016/S0140-6736(12)61041-1	http://dx.doi.org/10.1016/S0140-6736(12)61041-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	976TV	22818935				2022-12-01	WOS:000306609200008
J	Bhatt, DM; Pandya-Jones, A; Tong, AJ; Barozzi, I; Lissner, MM; Natoli, G; Black, DL; Smale, ST				Bhatt, Dev M.; Pandya-Jones, Amy; Tong, Ann-Jay; Barozzi, Iros; Lissner, Michelle M.; Natoli, Gioacchino; Black, Douglas L.; Smale, Stephen T.			Transcript Dynamics of Proinflammatory Genes Revealed by Sequence Analysis of Subcellular RNA Fractions	CELL			English	Article							MESSENGER-RNA; POLYMERASE-II; INFLAMMATORY RESPONSE; MAMMALIAN-CELLS; SEQ; EXPRESSION; ELONGATION; INDUCTION; MEDIATORS; MOLECULES	Macrophages respond to inflammatory stimuli by modulating the expression of hundreds of genes in a defined temporal cascade, with diverse transcriptional and posttranscriptional mechanisms contributing to the regulatory network. We examined proinflammatory gene regulation in activated macrophages by performing RNA-seq with fractionated chromatin-associated, nucleoplasmic, and cytoplasmic transcripts. This methodological approach allowed us to separate the synthesis of nascent transcripts from transcript processing and the accumulation of mature mRNAs. In addition to documenting the subcellular locations of coding and noncoding transcripts, the results provide a high-resolution view of the relationship between defined promoter and chromatin properties and the temporal regulation of diverse classes of coexpressed genes. The data also reveal a striking accumulation of full-length yet incompletely spliced transcripts in the chromatin fraction, suggesting that splicing often occurs after transcription has been completed, with transcripts retained on the chromatin until fully spliced.	[Bhatt, Dev M.; Pandya-Jones, Amy; Tong, Ann-Jay; Lissner, Michelle M.; Black, Douglas L.; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Pandya-Jones, Amy; Black, Douglas L.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Tong, Ann-Jay; Black, Douglas L.; Smale, Stephen T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Barozzi, Iros; Natoli, Gioacchino] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; IRCCS European Institute of Oncology (IEO)	Black, DL (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	dougb@microbio.ucla.edu; smale@mednet.ucla.edu	Barozzi, Iros/GLQ-8907-2022; Natoli, gioacchino/ABB-8679-2020; Natoli, gioacchino/J-2100-2018	Barozzi, Iros/0000-0003-0690-3473; Pandya-Jones, Amy/0000-0001-5519-4613; Bhatt, Dev/0000-0003-3616-3701; Natoli, Gioacchino/0000-0003-0711-2411	UCLA; NIH [R01GM086372, R01CA127279]; Broad Stem Cell Research Center at UCLA; NATIONAL CANCER INSTITUTE [R01CA127279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086372, R01GM049662] Funding Source: NIH RePORTER	UCLA(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Stem Cell Research Center at UCLA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Christopher Glass for sharing results prior to their publication; Alexander Hoffmann, Steve Horvath, Justin Langerman, Steve Ley, Chia-Ho Lin, and Matteo Pellegrini for helpful discussions; and Owen Witte for invaluable support. This work was supported by a UCLA Dissertation-Year Fellowship (to A.P.-J.), by NIH grants R01GM086372 and R01CA127279 (to S.T.S.), and by the Broad Stem Cell Research Center at UCLA. D.L.B. is an Investigator of the Howard Hughes Medical Institute.	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Brody Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000573; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Chen Q, 2011, MOL BIOL CELL, V22, P2646, DOI 10.1091/mbc.E11-03-0239; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Friedel CC, 2009, MOL BIOSYST, V5, P1271, DOI 10.1039/b911233b; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; NEVINS JR, 1978, CELL, V15, P1477, DOI 10.1016/0092-8674(78)90071-5; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Pawlicki JM, 2008, J CELL BIOL, V182, P61, DOI 10.1083/jcb.200803111; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Schmid M, 2010, WIRES RNA, V1, P474, DOI 10.1002/wrna.24; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vaidya SA, 2003, CURR OPIN IMMUNOL, V15, P402, DOI 10.1016/S0952-7915(03)00070-0; Vargas DY, 2011, CELL, V147, P1054, DOI 10.1016/j.cell.2011.10.024; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	43	316	320	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 20	2012	150	2					279	290		10.1016/j.cell.2012.05.043	http://dx.doi.org/10.1016/j.cell.2012.05.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817891	Bronze, Green Accepted			2022-12-01	WOS:000306595700008
J	Halevy, I; Peters, SE; Fischer, WW				Halevy, Itay; Peters, Shanan E.; Fischer, Woodward W.			Sulfate Burial Constraints on the Phanerozoic Sulfur Cycle	SCIENCE			English	Article							MESSINIAN SALINITY CRISIS; ATMOSPHERIC OXYGEN; SEDIMENTARY SULFUR; MARINE EVAPORITES; NORTH-AMERICA; EVOLUTION; SEAWATER; MIOCENE; HISTORY; CARBON	The sulfur cycle influences the respiration of sedimentary organic matter, the oxidation state of the atmosphere and oceans, and the composition of seawater. However, the factors governing the major sulfur fluxes between seawater and sedimentary reservoirs remain incompletely understood. Using macrostratigraphic data, we quantified sulfate evaporite burial fluxes through Phanerozoic time. Approximately half of the modern riverine sulfate flux comes from weathering of recently deposited evaporites. Rates of sulfate burial are unsteady and linked to changes in the area of marine environments suitable for evaporite formation and preservation. By contrast, rates of pyrite burial and weathering are higher, less variable, and largely balanced, highlighting a greater role of the sulfur cycle in regulating atmospheric oxygen.	[Halevy, Itay] Weizmann Inst Sci, Environm Sci & Energy Res, IL-76100 Rehovot, Israel; [Halevy, Itay; Fischer, Woodward W.] CALTECH, Pasadena, CA 91125 USA; [Peters, Shanan E.] Univ Wisconsin, Madison, WI 53706 USA	Weizmann Institute of Science; California Institute of Technology; University of Wisconsin System; University of Wisconsin Madison	Halevy, I (corresponding author), Weizmann Inst Sci, Environm Sci & Energy Res, IL-76100 Rehovot, Israel.	itay.halevy@weizmann.ac.il	Halevy, Itay/W-9850-2019; HALEVY, ITAY/K-1364-2012; Peters, Shanan E/A-5620-2013	Halevy, Itay/0000-0002-7325-8139; HALEVY, ITAY/0000-0002-7325-8139; Peters, Shanan E/0000-0002-3346-4317	Texaco Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology; Sir Charles Clore Prize for Outstanding Appointment in the Experimental Sciences at the Weizmann Institute of Science; NSF [EAR-0819931]; Agouron Institute; David and Lucile Packard Foundation Fellowship for Science and Engineering	Texaco Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology; Sir Charles Clore Prize for Outstanding Appointment in the Experimental Sciences at the Weizmann Institute of Science; NSF(National Science Foundation (NSF)); Agouron Institute(Pfizer); David and Lucile Packard Foundation Fellowship for Science and Engineering(The David & Lucile Packard Foundation)	We thank D. Canfield and J. Adkins for helpful discussion, and C. Scotese for help with the paleogeographic reconstructions. I. H. acknowledges support from a Texaco Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology and a Sir Charles Clore Prize for Outstanding Appointment in the Experimental Sciences at the Weizmann Institute of Science. S. E. P. was funded by NSF grant EAR-0819931. W. W. F. acknowledges support from the Agouron Institute and a David and Lucile Packard Foundation Fellowship for Science and Engineering. The binned macrostratigraphic data are available as a supplementary table on Science Online.	[Anonymous], 2001, ATLAS EARTH HIST; Berner RA, 2004, AM J SCI, V304, P438, DOI 10.2475/ajs.304.5.438; BERNER RA, 1984, GEOCHIM COSMOCHIM AC, V48, P605, DOI 10.1016/0016-7037(84)90089-9; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Edmond J.M., 1997, TECTONIC UPLIFT CLIM, P330, DOI [DOI 10.1007/978-1-4615-5935-1_14, 10.1007/978-1-4615-5935-1_14]; GARRELS RM, 1984, AM J SCI, V284, P989, DOI 10.2475/ajs.284.9.989; Gill BC, 2011, NATURE, V469, P80, DOI 10.1038/nature09700; Haq BU, 2005, GEOARABIA, V10, P127; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kampschulte A, 2004, CHEM GEOL, V204, P255, DOI 10.1016/j.chemgeo.2003.11.013; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Morel F. M. M., 1993, PRINCIPLES APPL AQUA; Peryt TM, 2006, SEDIMENT GEOL, V188, P379, DOI 10.1016/j.sedgeo.2006.03.014; Peters SE, 2010, PALEOBIOLOGY, V36, P61, DOI 10.1666/0094-8373-36.1.61; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; Rahimpour-Bonab H, 2007, GEOL J, V42, P37, DOI 10.1002/gj.1069; Raiswell R, 2011, ELEMENTS, V7, P101, DOI 10.2113/gselements.7.2.101; Ronov A.B., 1982, INT GEOL REV, V24, P1313, DOI [10.1080/00206818209451075, DOI 10.1080/00206818209451075]; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; ROUCHY JM, 1995, SEDIMENT GEOL, V94, P277, DOI 10.1016/0037-0738(94)00095-C; Rowley DB, 2002, GEOL SOC AM BULL, V114, P927, DOI 10.1130/0016-7606(2002)114<0927:ROPCAD>2.0.CO;2; Sadler P. M., 1999, GEORESEARCH FORUM, V5, P15; Strauss H, 1997, PALAEOGEOGR PALAEOCL, V132, P97, DOI 10.1016/S0031-0182(97)00067-9; Warren JK, 2010, EARTH-SCI REV, V98, P217, DOI 10.1016/j.earscirev.2009.11.004; Wu NP, 2010, GEOCHIM COSMOCHIM AC, V74, P2053, DOI 10.1016/j.gca.2009.12.012; Zharkov M. A., 1981, HIST PALEOZOIC SALT	32	93	93	4	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					331	334		10.1126/science.1220224	http://dx.doi.org/10.1126/science.1220224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822147				2022-12-01	WOS:000306542600048
J	Sugimura, R; He, XC; Venkatraman, A; Arai, F; Box, A; Semerad, C; Haug, JS; Peng, L; Zhong, XB; Suda, T; Li, LH				Sugimura, Ryohichi; He, Xi C.; Venkatraman, Aparna; Arai, Fumio; Box, Andrew; Semerad, Craig; Haug, Jeffrey S.; Peng, Lai; Zhong, Xiao-bo; Suda, Toshio; Li, Linheng			Noncanonical Wnt Signaling Maintains Hematopoietic Stem Cells in the Niche	CELL			English	Article							7-PASS TRANSMEMBRANE CADHERIN; BONE-MARROW; SELF-RENEWAL; ENDOTHELIAL-CELLS; PROGENITOR CELLS; PROTEIN; QUIESCENCE; EXPRESSION; IDENTIFICATION; MAINTENANCE	Wnt signaling is involved in self-renewal and maintenance of hematopoietic stem cells (HSCs); however, the particular role of noncanonical Wnt signaling in regulating HSCs in vivo is largely unknown. Here, we show Flamingo (Fmi) and Frizzled (Fz) 8, members of noncanonical Wnt signaling, both express in and functionally maintain quiescent long-term HSCs. Fmi regulates Fz8 distribution at the interface between HSCs and N-cadherin(+) osteoblasts (N-cad(+)OBs that enrich osteoprogenitors) in the niche. We further found that N-cad(+)OBs predominantly express noncanonical Wnt ligands and inhibitors of canonical Wnt signaling under homeostasis. Under stress, noncanonical Wnt signaling is attenuated and canonical Wnt signaling is enhanced in activation of HSCs. Mechanistically, noncanonical Wnt signaling mediated by Fz8 suppresses the Ca2+-NFAT- IFN gamma pathway, directly or indirectly through the CDC42-CK1 alpha complex and also antagonizes canonical Wnt signaling in HSCs. Taken together, our findings demonstrate that noncanonical Wnt signaling maintains quiescent long-term HSCs through Fmi and Fz8 interaction in the niche.	[Sugimura, Ryohichi; He, Xi C.; Venkatraman, Aparna; Box, Andrew; Semerad, Craig; Haug, Jeffrey S.; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Venkatraman, Aparna] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore 632002, Tamil Nadu, India; [Arai, Fumio; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Shinjuku Ku, Tokyo 1608582, Japan; [Peng, Lai; Zhong, Xiao-bo] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Christian Medical College & Hospital (CMCH) Vellore; Keio University; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	lil@stowers.org	Sugimura, Rio/AAR-7280-2020; Suda, Toshio/H-6761-2013; Arai, Fumio/J-5241-2013	Sugimura, Rio/0000-0001-5701-3628; Suda, Toshio/0000-0001-7540-1771; Li, Linheng/0000-0001-9963-430X; Arai, Fumio/0000-0003-1936-4907	SIMR; NIH, National Institute of General Medical Science [GM087376]; Department of Biotechnology, Government of India; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087376] Funding Source: NIH RePORTER	SIMR; NIH, National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Paulson and H. Li for RNA-sequencing analysis, and Dr. H. Nakauchi for training in sorted HSC immunostaining. We appreciate Drs. G. Enikolopov, D. Rowe, V. Bautch, E. Fuchs, F. Costantini, and T. Xie for providing these mouse lines respectively: Nestin-GFP, Col2.3-GFP, CD31-ESCs, TOP-GAL, Axin2-d2EGFP, and pSicoR-EF1 alpha. We are grateful to J. Perry and other Li lab members for scientific discussion and critical reading of the manuscript; to M. Hembree, K. Westpfahl, D. Dukes, and B. Lewis for technical support; and to K. Tannen for manuscript editing and proofreading. We thank Y. Takahashi, J. Zhang, X. He, and K. Li for the art and graphic work. This work was funded by SIMR. X.-b.Z. is supported by NIH, National Institute of General Medical Science (Grant GM087376). A.V. is the recipient of an overseas research associateship from the Department of Biotechnology, Government of India. R.S. is a PhD student registered with the Open University.	Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Challen GA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002357; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Grassinger J, 2010, BLOOD, V116, P3185, DOI 10.1182/blood-2009-12-260703; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Heinonen KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019279; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Huang T, 2011, J BIOL CHEM, V286, P37399, DOI 10.1074/jbc.M111.251165; Jeong M, 2009, J IMMUNOL, V183, P2495, DOI 10.4049/jimmunol.0804221; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura H, 2006, J CELL SCI, V119, P1118, DOI 10.1242/jcs.02832; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Louis I, 2008, IMMUNITY, V29, P57, DOI 10.1016/j.immuni.2008.04.023; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800; Lymperi S, 2011, BLOOD, V117, P1540, DOI 10.1182/blood-2010-05-282855; Mahmood A, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/735420; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; MINTA A, 1989, J BIOL CHEM, V264, P8171; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; MOON RT, 1993, DEVELOPMENT, V119, P97; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nemeth MJ, 2009, STEM CELLS, V27, P1109, DOI 10.1002/stem.32; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Schaniel C, 2011, BLOOD, V118, P2420, DOI 10.1182/blood-2010-09-305664; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zemlickova E, 2004, BIOCHEM BIOPH RES CO, V316, P39, DOI 10.1016/j.bbrc.2004.02.014; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	73	193	199	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					351	365		10.1016/j.cell.2012.05.041	http://dx.doi.org/10.1016/j.cell.2012.05.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817897	Green Accepted, Bronze			2022-12-01	WOS:000306595700014
J	De Wals, P; Deceuninck, G; Toth, E; Boulianne, N; Brunet, D; Boucher, RM; Landry, M; De Serres, G				De Wals, Philippe; Deceuninck, Genevieve; Toth, Eveline; Boulianne, Nicole; Brunet, Denis; Boucher, Renee-Myriam; Landry, Monique; De Serres, Gaston			Risk of Guillain-Barre Syndrome Following H1N1 Influenza Vaccination in Quebec	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTROLLED CASE SERIES; A H1N1; ADJUVANTED VACCINE; SAFETY	Context In fall 2009 in Quebec, Canada, an immunization campaign was launched against the 2009 influenza A(H1N1) pandemic strain, mostly using an AS03 adjuvant vaccine. By the end of the year, 57% of the 7.8 million residents had been vaccinated. Objective To assess the risk of Guillain-Barre syndrome (GBS) following pandemic influenza vaccine administration. Design Population-based cohort study with follow-up over the 6-month period October 2009 through March 2010. The investigation was ordered by the chief medical officer of health in accordance with the Quebec Public Health Act. Setting All acute care hospitals and neurology clinics in Quebec. Population Suspected and confirmed GBS cases reported by physicians, mostly neurologists, during active surveillance or identified in the provincial hospital summary discharge database. Medical records were reviewed and cases classified according to Brighton Collaboration definitions (categorized as level 1, 2, or 3, corresponding to criteria of decreasing certainty in diagnosis). Immunization status was verified and denominators were estimated from the provincial immunization registry (4.4 million vaccinated) and census data (total target population aged >= 6 months, 7.8 million), with a total of 3 623 046 person-years of observation. Main Outcome Measures Relative and attributable risks were calculated using a Poisson model and the self-controlled case-series method. Results Over a 6-month period, 83 confirmed GBS cases were identified, including 71 Brighton level 1 through 3 cases. Twenty-five confirmed cases had been vaccinated against 2009 influenza A(H1N1) 8 or fewer weeks before disease onset, with most (19/25) vaccinated 4 or fewer weeks before onset. In the Poisson model, the age-and sex-adjusted relative risk was 1.80 (95% CI, 1.12-2.87) for all confirmed cases during the 8-week postvaccination period and was 2.75 (95% CI, 1.63-4.62) during the 4-week postvaccination period. Using the self-controlled case-series method, relative risk estimates during the 4-week postvaccination period were 3.02 (95% CI, 1.64-5.56) for all confirmed cases (n=42) and 2.33 (95% CI, 1.19-4.57) for Brighton level 1 through 3 cases (n=36). The number of GBS cases attributable to vaccination was approximately 2 per 1 million doses. There was no indication of an excess risk in persons younger than 50 years. Conclusions In Quebec, the 2009 influenza A(H1N1) vaccine was associated with a small but significant risk of GBS. It is likely that the benefits of immunization outweigh the risks. JAMA. 2012;308(2):175-181	[De Wals, Philippe] Univ Laval, Dept Med Sociale & Prevent, CRIUCPQ, Quebec City, PQ G1V 4G5, Canada; [Deceuninck, Genevieve] Quebec Univ Hosp, Publ Hlth Res Unit, Quebec City, PQ, Canada; [Boucher, Renee-Myriam] Quebec Univ Hosp, Dept Pediat Neurol, Quebec City, PQ, Canada; [Boulianne, Nicole; De Serres, Gaston] Quebec Natl Publ Hlth Inst, Quebec City, PQ, Canada; [Brunet, Denis] Hop Enfants Jesus, Dept Neurol, Quebec City, PQ, Canada; [Toth, Eveline; Landry, Monique] Quebec Minist Hlth & Social Serv, Montreal, PQ, Canada	Laval University; Institut national de sante publique du Quebec (INSPQ); Laval University	De Wals, P (corresponding author), Univ Laval, Dept Med Sociale & Prevent, CRIUCPQ, 2725 Chemin Ste Foy, Quebec City, PQ G1V 4G5, Canada.	Philippe.De.Wals@ssss.gouv.qc.ca			GlaxoSmithKline; Novartis; Sanofi Pasteur; Merck; Pfizer; Ministere de la Sante et des Services sociaux du Quebec; Public Health Agency of Canada-Canadian Institutes for Health Research Influenza Research Network	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Sanofi Pasteur; Merck(Merck & Company); Pfizer(Pfizer); Ministere de la Sante et des Services sociaux du Quebec; Public Health Agency of Canada-Canadian Institutes for Health Research Influenza Research Network(Canadian Institutes of Health Research (CIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr De Wals reports receiving research grants, honoraria, and reimbursements of travel expenses from vaccine manufacturers including GlaxoSmithKline, Novartis, Sanofi Pasteur, Merck, and Pfizer. Ms Boulianne reports receiving research grants from Sanofi Pasteur and GlaxoSmithKline. Dr De Serres reports receiving research grants from Sanofi Pasteur and GlaxoSmithKline. No other disclosures were reported.; This study was funded by the Ministere de la Sante et des Services sociaux du Quebec and by the Public Health Agency of Canada-Canadian Institutes for Health Research Influenza Research Network.	Agence de la Sante et des Services sociaux du Saguenay-Lac-Saint-Jean, 2010, BIL CAMP VACC INFL P; Andrews N, 2011, VACCINE, V29, P7878, DOI 10.1016/j.vaccine.2011.08.069; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Direction de la Protection de la Sante publique, 2011, BIL DIR GEN SANT PUB; Douville-Fradet M, 2010, BIL EP PAND INFL AH1; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005; Hahn AF, 1998, LANCET, V352, P635, DOI 10.1016/S0140-6736(97)12308-X; Institute of Medicine, 2003, IMM SAF REV INFL VAC; LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Ministere de la Sante et des Services sociaux, 2010, FLASH INFLUENZA, V14, P1; Nachamkin I, 2008, J INFECT DIS, V198, P226, DOI 10.1086/589624; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Stratton K., 2012, ADVERSE EFFECTS VACC, DOI 10.17226/13164; Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220; Van Buynder PG, 2010, INFLUENZA OTHER RESP, V4, P171, DOI 10.1111/j.1750-2659.2010.00146.x; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736	23	63	63	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2012	308	2					175	181		10.1001/jama.2012.7342	http://dx.doi.org/10.1001/jama.2012.7342			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971QS	22782419				2022-12-01	WOS:000306219500031
J	Wu, P; Takai, H; de Lange, T				Wu, Peng; Takai, Hiroyuki; de Lange, Titia			Telomeric 3 ' Overhangs Derive from Resection by Exo1 and Apollo and Fill-In by POT1b-Associated CST	CELL			English	Article							DNA-POLYMERASE-ALPHA; SINGLE-STRANDED-DNA; HUMAN-CHROMOSOMES; DAMAGE RESPONSE; CHECKPOINT ACTIVATION; PROTECTS TELOMERES; REPLICATION FORK; POT1 PROTEINS; S-PHASE; TRF2	A 3' overhang is critical for the protection and maintenance of mammalian telomeres, but its synthesis must be regulated to avoid excessive resection of the 5' end, which could cause telomere shortening. How this balance is achieved in mammals has not been resolved. Here, we determine the mechanism for 3' overhang synthesis in mouse cells by evaluating changes in telomeric overhangs throughout the cell cycle and at leading-and lagging-end telomeres. Apollo, a nuclease bound to the shelterin subunit TRF2, initiates formation of the 3' overhang at leading-, but not lagging-end telomeres. Hyperresection by Apollo is blocked at both ends by the shelterin protein POT1b. Exo1 extensively resects both telomere ends, generating transient long 3' overhangs in S/G2. CST/AAF, a DNA pol alpha.primase accessory factor, binds POT1b and shortens the extended overhangs produced by Exo1, likely through fill-in synthesis. 3' overhang formation is thus a multistep, shelterin-controlled process, ensuring functional telomeric overhangs at chromosome ends.	[Wu, Peng; Takai, Hiroyuki; de Lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011; Takai, Helio/C-3301-2012; Takai, Hiroyuki/B-8352-2011	de Lange, Titia/0000-0002-9267-367X; Takai, Helio/0000-0001-9253-8307; Wu, Peng/0000-0001-6565-0002	NIA/NIH Ruth L. Kirschstein NRSA Individual Fellowship [F30AG034744]; NIH MSTP [GM07739]; Breast Cancer Research Foundation; NIH [CA076027]; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034744] Funding Source: NIH RePORTER	NIA/NIH Ruth L. Kirschstein NRSA Individual Fellowship; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are thankful to W. Wright, J. Shay, Y. Zhao, and T. Chow at UTSW in Dallas for teaching one of us (P.W.) how to separate leading-and lagging-end telomeres. We thank D. White for expert mouse husbandry and the RU Flow Cytometry Resource Center for help with FACS sorting. De Lange lab members are thanked for advice. P.W. was supported by the NIA/NIH Ruth L. Kirschstein NRSA Individual Fellowship F30AG034744 and NIH MSTP grant GM07739 to the Weill Cornell/RU/MSKCC Tri-Institutional MD-PhD Program. H.T. was supported by a grant from the Breast Cancer Research Foundation. TdL is an American Cancer Society Research Professor. This work was supported by a grant from the NIH (CA076027).	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Attwooll CL, 2009, MOL CELL BIOL, V29, P5540, DOI 10.1128/MCB.00479-09; Bae JB, 2008, ONCOGENE, V27, P5045, DOI 10.1038/onc.2008.139; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Dai XY, 2010, EMBO J, V29, P2788, DOI 10.1038/emboj.2010.156; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Longhese MP, 2010, EMBO J, V29, P2864, DOI 10.1038/emboj.2010.165; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; Ohki R, 2004, NUCLEIC ACIDS RES, V32, P1627, DOI 10.1093/nar/gkh309; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Qi HY, 2000, GENE DEV, V14, P1777; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Wu P, 2010, MOL CELL, V39, P606, DOI 10.1016/j.molcel.2010.06.031; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	44	206	210	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 6	2012	150	1					39	52		10.1016/j.cell.2012.05.026	http://dx.doi.org/10.1016/j.cell.2012.05.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22748632	Green Accepted, Bronze			2022-12-01	WOS:000306115000005
J	Zarnetske, PL; Skelly, DK; Urban, MC				Zarnetske, Phoebe L.; Skelly, David K.; Urban, Mark C.			Biotic Multipliers of Climate Change	SCIENCE			English	Editorial Material							COMMUNITIES		[Zarnetske, Phoebe L.; Skelly, David K.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Urban, Mark C.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Unit 3043, Storrs, CT 06269 USA	Yale University; University of Connecticut	Zarnetske, PL (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 195 Prospect St, New Haven, CT 06511 USA.	phoebe.zarnetske@yale.edu	Urban, Mark Christopher/Y-2430-2019; Skelly, David/D-3878-2013; Zarnetske, Phoebe/C-5484-2012; Zarnetske, Phoebe/V-3974-2019	Zarnetske, Phoebe/0000-0001-6257-6951; Zarnetske, Phoebe/0000-0001-6257-6951				Araujo MB, 2011, ECOGRAPHY, V34, P897, DOI 10.1111/j.1600-0587.2011.06919.x; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Helland IP, 2011, J ANIM ECOL, V80, P539, DOI 10.1111/j.1365-2656.2010.01793.x; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Kissling W.D., 2012, Journal of Biogeography, V39, P2163; Post E., 2012, ECOLOGY CLIMATE CHAN; Schmitz OJ, 2003, BIOSCIENCE, V53, P1199, DOI 10.1641/0006-3568(2003)053[1199:ERTGCC]2.0.CO;2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Wilmers CC, 2006, ECOL LETT, V9, P383, DOI 10.1111/j.1461-0248.2006.00890.x	16	185	186	7	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1516	1518		10.1126/science.1222732	http://dx.doi.org/10.1126/science.1222732			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723403				2022-12-01	WOS:000305507500037
J	Allen, NJ; Bennett, ML; Foo, LC; Wang, GX; Chakraborty, C; Smith, SJ; Barres, B				Allen, Nicola J.; Bennett, Mariko L.; Foo, Lynette C.; Wang, Gordon X.; Chakraborty, Chandrani; Smith, Stephen J.; Barres, Ben A.			Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors	NATURE			English	Article							SYNAPTIC PLASTICITY; CNS SYNAPTOGENESIS; SECRETED PROTEINS; NEURONS; BRAIN; STRENGTH; ROLES; LAR	In the developing central nervous system (CNS), the control of synapse number and function is critical to the formation of neural circuits. We previously demonstrated that astrocyte-secreted factors powerfully induce the formation of functional excitatory synapses between CNS neurons(1). Astrocyte-secreted thrombospondins induce the formation of structural synapses, but these synapses are postsynaptically silent(2). Here we use biochemical fractionation of astrocyte-conditioned medium to identify glypican 4 (Gpc4) and glypican 6 (Gpc6) as astrocyte-secreted signals sufficient to induce functional synapses between purified retinal ganglion cell neurons, and show that depletion of these molecules from astrocyte-conditioned medium significantly reduces its ability to induce postsynaptic activity. Application of Gpc4 to purified neurons is sufficient to increase the frequency and amplitude of glutamatergic synaptic events. This is achieved by increasing the surface level and clustering, but not overall cellular protein level, of the GluA1 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) glutamate receptor (AMPAR). Gpc4 and Gpc6 are expressed by astrocytes in vivo in the developing CNS, with Gpc4 expression enriched in the hippocampus and Gpc6 enriched in the cerebellum. Finally, we demonstrate that Gpc4-deficient mice have defective synapse formation, with decreased amplitude of excitatory synaptic currents in the developing hippocampus and reduced recruitment of AMPARs to synapses. These data identify glypicans as a family of novel astrocyte-derived molecules that are necessary and sufficient to promote glutamate receptor clustering and receptivity and to induce the formation of postsynaptically functioning CNS synapses.	[Allen, Nicola J.; Bennett, Mariko L.; Foo, Lynette C.; Chakraborty, Chandrani; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Wang, Gordon X.; Smith, Stephen J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Allen, NJ (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nallen@salk.edu	Ritter, Stefanie L/D-9312-2012	Smith, Stephen/0000-0002-2290-8701; Bennett, Mariko/0000-0002-1642-2887; Wang, Gordon/0000-0002-2707-7118	NIDA [R01DA015043]; Human Frontiers Long Term Fellowship; NIH/NINDS [R01NS0725252, R01NS077601]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077601, R01NS075252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Human Frontiers Long Term Fellowship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Winant for mass spectrometry analysis, A. Olson for array tomography assistance, S. Pasca for assistance with quantitative real-time PCR and M. Fabian for technical assistance with cell cultures. This project was funded by a NIDA grant to B. A. B. (R01DA015043). N.J.A. was supported by a Human Frontiers Long Term Fellowship. S.J.S. is supported by grants R01NS0725252 and R01NS077601 from the NIH/NINDS.	Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calboli FCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011504; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Steinmetz CC, 2006, J PHYSIOL-LONDON, V577, P249, DOI 10.1113/jphysiol.2006.117358; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Ybot-Gonzalez P, 2005, DEV DYNAM, V233, P1013, DOI 10.1002/dvdy.20383	32	414	424	6	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					410	+		10.1038/nature11059	http://dx.doi.org/10.1038/nature11059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722203	Green Accepted			2022-12-01	WOS:000305466800045
J	Yumoto, N; Kim, N; Burden, SJ				Yumoto, Norihiro; Kim, Natalie; Burden, Steven J.			Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses	NATURE			English	Article							IN-VIVO; ORGANIZING MOLECULES; NEURAL DEVELOPMENT; SKELETAL-MUSCLE; RECEPTOR; JUNCTION; AGRIN; MUSK; FORM; NEUROTRANSMITTER	Motor axons receive retrograde signals from skeletal muscle that are essential for the differentiation and stabilization of motor nerve terminals(1). Identification of these retrograde signals has proved elusive, but their production by muscle depends on the receptor tyrosine kinase, MuSK (muscle, skeletal receptor tyrosine-protein kinase), and Lrp4 (low-density lipoprotein receptor (LDLR)-related protein 4), an LDLR family member that forms a complex with MuSK, binds neural agrin and stimulates MuSK kinase activity(2-5). Here we show that Lrp4 also functions as a direct muscle-derived retrograde signal for early steps in presynaptic differentiation. We demonstrate that Lrp4 is necessary, independent of MuSK activation, for presynaptic differentiation in vivo, and we show that Lrp4 binds to motor axons and induces clustering of synaptic-vesicle and active-zone proteins. Thus, Lrp4 acts bidirectionally and coordinates synapse formation by binding agrin, activating MuSK and stimulating postsynaptic differentiation, and functioning in turn as a muscle-derived retrograde signal that is necessary and sufficient for presynaptic differentiation.	[Yumoto, Norihiro; Kim, Natalie; Burden, Steven J.] NYU, Sch Med, Mol Neurobiol Program,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10012 USA	New York University	Burden, SJ (corresponding author), NYU, Sch Med, Mol Neurobiol Program,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, 540 1st Ave, New York, NY 10012 USA.	burden@saturn.med.nyu.edu		Burden, Steven/0000-0002-3550-6891	New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI)) [5 P30CA16087-31]; National Institutes of Health [NS36193]; Skirball Institute; New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036193, R37NS036193] Funding Source: NIH RePORTER	New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skirball Institute; New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Landmesser and K. Hata for helping us to establish a motor-neuron and muscle co-culture system, W. Zhang for constructs encoding Fc- and AP-tagged forms of Lrp4, T. Jessell and J. Dasen for HB9::GFP mice, J. Sanes for agrin-mutant mice, K. Anderson and L. Niswander for Lrp4-mutant mice, and D. Littman and R. Lehmann for comments on the manuscript. We are grateful to P. Lopez and M. J. Sunshine and personnel in the transgenic mouse core for their assistance. The flow cytometry and transgenic mouse cores are supported by a New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI) 5 P30CA16087-31). This work was supported with funds from the National Institutes of Health (NS36193 to S. J. B.), the Skirball Institute and postdoctoral training support to N.Y. from New York State Stem Cell Science (NYSTEM).	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Burden SJ, 2011, CELL, V144, P826, DOI 10.1016/j.cell.2011.02.037; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Drescher U, 1997, CURR BIOL, V7, pR799, DOI 10.1016/S0960-9822(06)00409-X; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gomez AM, 2011, DEV DYNAM, V240, P2626, DOI 10.1002/dvdy.22772; Hata K, 2007, J NEUROSCI, V27, P14481, DOI 10.1523/JNEUROSCI.3847-07.2007; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang W, 2011, J BIOL CHEM	29	136	146	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					438	U130		10.1038/nature11348	http://dx.doi.org/10.1038/nature11348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22854782	Green Accepted			2022-12-01	WOS:000308860900047
J	Keleman, K; Vrontou, E; Kruttner, S; Yu, JY; Kurtovic-Kozaric, A; Dickson, BJ				Keleman, Krystyna; Vrontou, Eleftheria; Kruettner, Sebastian; Yu, Jai Y.; Kurtovic-Kozaric, Amina; Dickson, Barry J.			Dopamine neurons modulate pheromone responses in Drosophila courtship learning	NATURE			English	Article							SEX-PEPTIDE; EXPRESSION; BEHAVIOR; MEMORY; FEMALES	Learning through trial-and-error interactions allows animals to adapt innate behavioural 'rules of thumb' to the local environment, improving their prospects for survival and reproduction. Naive Drosophila melanogaster males, for example, court both virgin and mated females, but learn through experience to selectively suppress futile courtship towards females that have already mated(1). Here we show that courtship learning reflects an enhanced response to the male pheromone cis-vaccenyl acetate (cVA), which is deposited on females during mating and thus distinguishes mated females from virgins. Dissociation experiments suggest a simple learning rule in which unsuccessful courtship enhances sensitivity to cVA. The learning experience can be mimicked by artificial activation of dopaminergic neurons, and we identify a specific class of dopaminergic neuron that is critical for courtship learning. These neurons provide input to the mushroom body (MB) gamma lobe, and the DopR1 dopamine receptor is required in MB gamma neurons for both natural and artificial courtship learning. Our work thus reveals critical behavioural, cellular and molecular components of the learning rule by which Drosophila adjusts its innate mating strategy according to experience.	[Keleman, Krystyna; Vrontou, Eleftheria; Kruettner, Sebastian; Yu, Jai Y.; Kurtovic-Kozaric, Amina; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Keleman, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	keleman@imp.ac.at; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Kozaric, Amina/0000-0002-6063-7260; Yu, Jai/0000-0003-0628-2531	European Research Council; Austrian Science Fund; European Molecular Biology Organization; Boehringer Ingelheim GmbH	European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank E. Leitner for performing the gas chromatography-mass spectrometry analysis; P. Garrity, U. Heberlein, M. Heisenberg, E. Kubli, S. Waddell, the Drosophila Genetic Resource Centre, the Bloomington Stock Center and the VDRC for fly stocks; K. Jandrasits and Z. Portik-Dobos for technical assistance; M. Zimmer for critical comments on the manuscript. Basic research at the Institute of Molecular Pathology is funded in part by Boehringer Ingelheim GmbH. This work was additionally supported by grants from the European Research Council (B.J.D.) and the Austrian Science Fund (K. K.). E. V. was supported by a European Molecular Biology Organization long-term postdoctoral fellowship.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI [10.1038/nmeth.1567, 10.1038/NMETH.1567]; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Nakayama S, 1997, MOL GEN GENET, V254, P449, DOI 10.1007/s004380050438; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Saudan P, 2002, EUR J BIOCHEM, V269, P989, DOI 10.1046/j.0014-2956.2001.02733.x; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	35	136	139	0	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					145	U210		10.1038/nature11345	http://dx.doi.org/10.1038/nature11345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22902500				2022-12-01	WOS:000308347000052
J	Koo, BK; Spit, M; Jordens, I; Low, TY; Stange, DE; van de Wetering, M; van Es, JH; Mohammed, S; Heck, AJR; Maurice, MM; Clevers, H				Koo, Bon-Kyoung; Spit, Maureen; Jordens, Ingrid; Low, Teck Y.; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Mohammed, Shabaz; Heck, Albert J. R.; Maurice, Madelon M.; Clevers, Hans			Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors	NATURE			English	Article							SMALL-INTESTINE; NEGATIVE REGULATOR; BETA-CATENIN; IN-VITRO; LGR5; CANCER; COLON; UBIQUITYLATION; TRANSCRIPTION; INHIBITION	LGR5(+) stem cells reside at crypt bottoms, intermingled with Paneth cells that provide Wnt, Notch and epidermal growth factor signals(1). Here we find that the related RNF43 and ZNRF3 transmembrane E3 ubiquitin ligases are uniquely expressed in LGR5(+) stem cells. Simultaneous deletion of the two genes encoding these proteins in the intestinal epithelium of mice induces rapidly growing adenomas containing high numbers of Paneth and LGR5(+) stem cells. In vitro, growth of organoids derived from these adenomas is arrested when Wnt secretion is inhibited, indicating a dependence of the adenoma stem cells on Wnt produced by adenoma Paneth cells. In the HEK293T human cancer cell line, expression of RNF43 blocks Wnt responses and targets surface-expressed frizzled receptors to lysosomes. In the RNF43-mutant colorectal cancer cell line HCT116, reconstitution of RNF43 expression removes its response to exogenous Wnt. We conclude that RNF43 and ZNRF3 reduce Wnt signals by selectively ubiquitinating frizzled receptors, thereby targeting these Wnt receptors for degradation.	[Spit, Maureen; Jordens, Ingrid; Maurice, Madelon M.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Koo, Bon-Kyoung; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Koo, Bon-Kyoung; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Maurice, MM (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands.	M.M.Maurice@umcutrecht.nl; h.clevers@hubrecht.eu	Mohammed, Shabaz/D-1042-2010; Galmes-Spit, Maureen/T-6013-2019; Heck, Albert/D-7098-2011; Stange, Daniel E/O-1837-2015; Koo, Bon-Kyoung/V-5219-2017; Low, Teck Yew/J-4403-2014; Mohammed, Shabaz/AAY-6313-2020; Low, Teck Yew/Q-5946-2019; van+Es, Johan/ABD-5411-2021	Mohammed, Shabaz/0000-0003-2640-9560; Heck, Albert/0000-0002-2405-4404; Stange, Daniel E/0000-0003-4246-2230; Koo, Bon-Kyoung/0000-0002-4134-8033; Low, Teck Yew/0000-0001-7878-7534; Mohammed, Shabaz/0000-0003-2640-9560; Low, Teck Yew/0000-0001-7878-7534; Maurice, Madelon/0000-0001-6885-5361; Jordens, Ingrid/0000-0001-7865-2816; Spit, Maureen/0000-0002-8593-0447	European Research Council [EU/232814-StemCeLLMark]; National Research Foundation of Korea [NRF-2011-357-C00093]; Centre van Biomedical Genetics; European Research Council, ERC-StG [242958]; KNAW/3V-fund;  [EU/Health-F4-2007-200720];  [Ti Pharma/T3-106]	European Research Council(European Research Council (ERC)European Commission); National Research Foundation of Korea(National Research Foundation of Korea); Centre van Biomedical Genetics; European Research Council, ERC-StG(European Research Council (ERC)); KNAW/3V-fund; ; 	We thank A. A. Rolf, I. Kuper, M. van den Born, C. Kroon-Veenboer, H. Begthel, J. Korving and S. van den Brink for technical assistance, L. Lum for providing IWP1 and S. Bartfeld for the schematic drawing. This work was funded in part by grants from the European Research Council, EU/232814-StemCeLLMark and the National Research Foundation of Korea, NRF-2011-357-C00093 (B.-K.K.); EU/Health-F4-2007-200720 (M.v.d.W.); The Centre van Biomedical Genetics (D. E. S.); Ti Pharma/T3-106 (J.H.v.E.); the European Research Council, ERC-StG no. 242958 (M. M. M.) and the KNAW/3V-fund.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yagyu R, 2004, INT J ONCOL, V25, P1343; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	31	576	601	11	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					665	+		10.1038/nature11308	http://dx.doi.org/10.1038/nature11308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895187				2022-12-01	WOS:000308095100058
J	Browne, SK; Burbelo, PD; Chetchotisakd, P; Suputtamongkol, Y; Kiertiburanakul, S; Shaw, PA; Kirk, JL; Jutivorakool, K; Zaman, R; Ding, L; Hsu, AP; Patel, SY; Olivier, KN; Lulitanond, V; Mootsikapun, P; Anunnatsiri, S; Angkasekwinai, N; Sathapatayavongs, B; Hsueh, PR; Shieh, CC; Brown, MR; Thongnoppakhun, W; Claypool, R; Sampaio, EP; Thepthai, C; Waywa, D; Dacombe, C; Reizes, Y; Zelazny, AM; Saleeb, P; Rosen, LB; Mo, A; Iadarola, M; Holland, SM				Browne, Sarah K.; Burbelo, Peter D.; Chetchotisakd, Ploenchan; Suputtamongkol, Yupin; Kiertiburanakul, Sasisopin; Shaw, Pamela A.; Kirk, Jennifer L.; Jutivorakool, Kamonwan; Zaman, Rifat; Ding, Li; Hsu, Amy P.; Patel, Smita Y.; Olivier, Kenneth N.; Lulitanond, Viraphong; Mootsikapun, Piroon; Anunnatsiri, Siriluck; Angkasekwinai, Nasikarn; Sathapatayavongs, Boonmee; Hsueh, Po-Ren; Shieh, Chi-Chang; Brown, Margaret R.; Thongnoppakhun, Wanna; Claypool, Reginald; Sampaio, Elizabeth P.; Thepthai, Charin; Waywa, Duangdao; Dacombe, Camilla; Reizes, Yona; Zelazny, Adrian M.; Saleeb, Paul; Rosen, Lindsey B.; Mo, Allen; Iadarola, Michael; Holland, Steven M.			Adult-Onset Immunodeficiency in Thailand and Taiwan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONTUBERCULOUS MYCOBACTERIAL INFECTION; INTERFERON-GAMMA AUTOANTIBODY; IFN-GAMMA; AVIUM COMPLEX; PATIENT; DISEASES; SUSCEPTIBILITY; RECURRENT; HIV	BACKGROUND Autoantibodies against interferon-gamma are associated with severe disseminated opportunistic infection, but their importance and prevalence are unknown. METHODS We enrolled 203 persons from sites in Thailand and Taiwan in five groups: 52 patients with disseminated, rapidly or slowly growing, nontuberculous mycobacterial infection (group 1); 45 patients with another opportunistic infection, with or without nontuberculous mycobacterial infection (group 2); 9 patients with disseminated tuberculosis (group 3); 49 patients with pulmonary tuberculosis (group 4); and 48 healthy controls (group 5). Clinical histories were recorded, and blood specimens were obtained. RESULTS Patients in groups 1 and 2 had CD4+ T-lymphocyte counts that were similar to those in patients in groups 4 and 5, and they were not infected with the human immunodeficiency virus (HIV). Washed cells obtained from patients in groups 1 and 2 had intact cytokine production and a response to cytokine stimulation. In contrast, plasma obtained from these patients inhibited the activity of interferon-gamma in normal cells. High-titer anti-interferon-gamma autoantibodies were detected in 81% of patients in group 1, 96% of patients in group 2, 11% of patients in group 3, 2% of patients in group 4, and 2% of controls (group 5). Forty other anticytokine autoantibodies were assayed. One patient with cryptococcal meningitis had autoantibodies only against granulocyte-macrophage colony-stimulating factor. No other anticytokine autoantibodies or genetic defects correlated with infections. There was no familial clustering. CONCLUSIONS Neutralizing anti-interferon-gamma autoantibodies were detected in 88% of Asian adults with multiple opportunistic infections and were associated with an adult-onset immunodeficiency akin to that of advanced HIV infection. (Funded by the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research; ClinicalTrials.gov number, NCT00814827.)	[Browne, Sarah K.; Jutivorakool, Kamonwan; Zaman, Rifat; Ding, Li; Hsu, Amy P.; Olivier, Kenneth N.; Brown, Margaret R.; Claypool, Reginald; Sampaio, Elizabeth P.; Saleeb, Paul; Rosen, Lindsey B.; Mo, Allen; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Shaw, Pamela A.; Kirk, Jennifer L.] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Burbelo, Peter D.; Iadarola, Michael] Natl Inst Dent & Craniofacial Res, Lab Sensory Biol, NIH, Bethesda, MD USA; [Zelazny, Adrian M.] NIH, Microbiol Serv, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Dacombe, Camilla; Reizes, Yona] Systex, Rockville, MD USA; [Chetchotisakd, Ploenchan; Lulitanond, Viraphong; Mootsikapun, Piroon; Anunnatsiri, Siriluck] Khon Kaen Univ, Srinagarind Hosp, Khon Kaen, Thailand; [Suputtamongkol, Yupin; Angkasekwinai, Nasikarn; Thongnoppakhun, Wanna; Thepthai, Charin; Waywa, Duangdao] Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand; [Browne, Sarah K.; Sathapatayavongs, Boonmee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Jutivorakool, Kamonwan] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand; [Jutivorakool, Kamonwan] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Patel, Smita Y.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Hsueh, Po-Ren] Natl Taiwan Univ, Taipei 10764, Taiwan; [Shieh, Chi-Chang] Natl Cheng Kung Univ, Tainan 70101, Taiwan; [Sampaio, Elizabeth P.] Inst Oswaldo Cruz, Leprosy Lab, BR-20001 Rio De Janeiro, Brazil; [Mo, Allen] Colgate Univ, Hamilton, NY 13346 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Khon Kaen University; Mahidol University; Mahidol University; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; University of Oxford; National Taiwan University; National Cheng Kung University; Fundacao Oswaldo Cruz; Colgate University	Browne, SK (corresponding author), CRC B3-4141,MSC 1684,9000 Rockville Pike, Bethesda, MD 20892 USA.	brownesa@niaid.nih.gov	Hsueh, Po-Ren/ABE-1594-2021; Angkasekwinai, Nasikarn/AAS-3199-2020	HSUEH, PO-REN/0000-0002-7502-9225; Patel, Smita/0000-0002-6207-2208	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health; National Institute of Allergy and Infectious Diseases; National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000724] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090034, ZIACL080013] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and the Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health.; Funded by the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research	Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Anekthananon Thanomsak, 2004, Journal of the Medical Association of Thailand, V87, P173; Baerlecken N, 2009, CLIN INFECT DIS, V49, pE76, DOI 10.1086/605581; Browne SK, 2012, BLOOD, V119, P3933, DOI 10.1182/blood-2011-12-395707; Browne SK, 2010, LANCET INFECT DIS, V10, P875, DOI 10.1016/S1473-3099(10)70196-1; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Carey B, 2010, CLIN IMMUNOL, V135, P223, DOI 10.1016/j.clim.2010.02.017; *CDCP, 2003, GUID APPR EV HIV TES; Chen YP, 2008, APMIS, V116, P850, DOI 10.1111/j.1600-0463.2008.00935.x; Chetchotisakd P, 2000, CLIN INFECT DIS, V30, P29, DOI 10.1086/313589; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Clark S, 2011, J ALLERGY CLIN IMMUN, V128, P838, DOI 10.1016/j.jaci.2011.05.025; Crum NF, 2005, MEDICINE, V84, P291, DOI 10.1097/01.md.0000180044.19285.9a; Ding LW, 2006, EPIDEMIOL INFECT, V134, P1060, DOI 10.1017/S0950268805005698; Ding L, 2012, J CLIN IMMUNOL, V32, P238, DOI 10.1007/s10875-011-9621-8; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Kampitak T, 2011, INFECTION, V39, P65, DOI 10.1007/s15010-010-0067-3; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Kony SJ, 2000, J INFECTION, V41, P167, DOI 10.1053/jinf.2000.0721; Koya T, 2009, J INFECT CHEMOTHER, V15, P118, DOI 10.1007/s10156-008-0662-8; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; Sungkanuparph Somnuek, 2003, International Journal of Infectious Diseases, V7, P198, DOI 10.1016/S1201-9712(03)90052-X; SUTHERLAND R, 2006, 17 INT AIDS C MEX CI, V20, P821; Tanaka Y, 2007, INTERNAL MED, V46, P1005, DOI 10.2169/internalmedicine.46.6452; Tang BSF, 2010, CLIN VACCINE IMMUNOL, V17, P1132, DOI 10.1128/CVI.00053-10; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; World Health Organization, 2010, WHO GLOB TUB CONTR	30	318	325	4	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					725	734		10.1056/NEJMoa1111160	http://dx.doi.org/10.1056/NEJMoa1111160			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913682	Green Accepted, Bronze			2022-12-01	WOS:000307754200007
J	Lalmohamed, A; de Vries, F; Bazelier, MT; Cooper, A; van Staa, TP; Cooper, C; Harvey, NC				Lalmohamed, Arief; de Vries, Frank; Bazelier, Marloes T.; Cooper, Alun; van Staa, Tjeerd-Pieter; Cooper, Cyrus; Harvey, Nicholas C.			Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE-MINERAL DENSITY; VERTICAL-BANDED GASTROPLASTY; GASTRIC BYPASS-SURGERY; MORBIDLY OBESE WOMEN; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; SURGICAL-TREATMENT; HIP/FEMUR FRACTURE; CALCIUM-METABOLISM; WEIGHT-LOSS	Objectives To estimate fracture risk in patients receiving bariatric surgery versus matched controls. Design Population based, retrospective cohort study. Setting Use of records from the United Kingdom General Practice Research Database, now known as the Clinical Practice Research Datalink (from January 1987 to December 2010). Participants Patients with a body mass index of at least 30, with a record of bariatric surgery (n=2079), and matched controls without a record (n=10 442). Each bariatric surgery patient was matched to up to six controls by age, sex, practice, year, and body mass index. Patients were followed from the date of bariatric surgery for the occurrence of any fracture. We used time dependent Cox regression to calculate relative rates of fracture, adjusted for disease and previous drug treatment, and time-interaction terms to evaluate fracture timing patterns. Main outcome measure Relative rates of any, osteoporotic, and non-osteoporotic fractures. Results Mean follow-up time was 2.2 years. Overall, there was no significantly increased risk of fracture in patients who underwent bariatric surgery, compared with controls (8.8 v 8.2 per 1000 person years; adjusted relative risk 0.89, 95% confidence interval 0.60 to 1.33). Bariatric surgery also did not affect risk of osteoporotic and non-osteoporotic fractures. However, we saw a trend towards an increased fracture risk after three to five years following surgery, as well as in patients who had a greater decrease in body mass index after surgery, but this was not significant. Conclusion Bariatric surgery does not have a significant effect on the risk of fracture. For the first few years after surgery, these results are reassuring for patients undergoing such operations, but do not exclude a more protracted adverse influence on skeletal health in the longer term.	[de Vries, Frank; van Staa, Tjeerd-Pieter; Cooper, Cyrus; Harvey, Nicholas C.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; [Lalmohamed, Arief; de Vries, Frank; Bazelier, Marloes T.; van Staa, Tjeerd-Pieter] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [de Vries, Frank] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands; [Cooper, Alun] Bridge Med Ctr, Crawley, England; [van Staa, Tjeerd-Pieter] Medicines & Healthcare Prod Regulatory Agcy, London, England; [Cooper, Cyrus] Univ Oxford, Inst Musculoskeletal Sci, Oxford, England	University of Southampton; Utrecht University; Maastricht University; The Medicines & Healthcare Products Regulatory Agency; University of Oxford	Cooper, C (corresponding author), Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	cc@mrc.soton.ac.uk	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; Cooper, Cyrus/0000-0003-3510-0709; Harvey, Nicholas/0000-0002-8194-2512; van Staa, Tjeerd/0000-0001-9363-742X	International Osteoporosis Foundation; SERVIER; Netherlands Organisation for Health Research; Development, Dutch Health Care Insurance Board; Royal Dutch Pharmacists Association; Top Institute Pharma; EU Innovative Medicines Initiative; EU; Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer)	International Osteoporosis Foundation; SERVIER(Servier); Netherlands Organisation for Health Research(Netherlands Organization for Health Research and Development); Development, Dutch Health Care Insurance Board; Royal Dutch Pharmacists Association; Top Institute Pharma; EU Innovative Medicines Initiative; EU(European Commission); Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer)	This study was funded by a research grant from the International Osteoporosis Foundation and SERVIER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the International Osteoporosis Foundation and SERVIER for the submitted work; AL, FV, MB, and TS are employed by the Division of Pharmacoepidemiology and Clinical Pharmacology at Utrecht Institute for Pharmaceutical Sciences, which has received unrestricted research funding from the Netherlands Organisation for Health Research and Development, Dutch Health Care Insurance Board, Royal Dutch Pharmacists Association, private-publicly funded Top Institute Pharma (www.tipharma.nl, which includes cofunding from universities, government, and industry), EU Innovative Medicines Initiative, EU 7th Framework Program, Dutch Medicines Evaluation Board, Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer); no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	Adachi Y, 2000, CALCIFIED TISSUE INT, V66, P119, DOI 10.1007/s002230010025; Bano G, 1999, INT J OBESITY, V23, P361, DOI 10.1038/sj.ijo.0800827; Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0; Chapin BL, 1996, ARCH SURG-CHICAGO, V131, P1048; Coates PS, 2004, J CLIN ENDOCR METAB, V89, P1061, DOI 10.1210/jc.2003-031756; Cundy T, 1996, BRIT J SURG, V83, P1468, DOI 10.1002/bjs.1800831046; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; de Vries F, 2007, J INTERN MED, V261, P170, DOI 10.1111/j.1365-2796.2006.01754.x; DiGiorgi M, 2008, OBES SURG, V18, P1144, DOI 10.1007/s11695-007-9408-4; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FRAX, 2001, FRAX WHO FRACTURE RI; Giusti V, 2005, INT J OBESITY, V29, P1429, DOI 10.1038/sj.ijo.0803040; Gomez JM, 2009, OBES SURG, V19, P345, DOI 10.1007/s11695-008-9529-4; Goode LR, 2004, OBES RES, V12, P40, DOI 10.1038/oby.2004.7; Guney E, 2003, OBES SURG, V13, P383, DOI 10.1381/096089203765887705; Hamoui N, 2003, ARCH SURG-CHICAGO, V138, P891, DOI 10.1001/archsurg.138.8.891; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Johnson JM, 2005, J GASTROINTEST SURG, V9, P1106, DOI 10.1016/j.gassur.2005.07.012; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kolanowski J, 1997, BRIT MED BULL, V53, P433, DOI 10.1093/oxfordjournals.bmb.a011621; Lalmohamed A, 2012, OSTEOPOROSIS INT, V23, P861, DOI 10.1007/s00198-011-1852-2; Lalmohamed A, 2012, ARCH INTERN MED, V172, P1229, DOI 10.1001/archinternmed.2012.2713; Leff DR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3402; Lewis JD, 2004, PHARMACOEPIDEM DR S, V13, P437, DOI 10.1002/pds.902; Madsen OR, 1997, EUR J APPL PHYSIOL O, V75, P554, DOI 10.1007/s004210050204; Marceau P, 2002, J GASTROINTEST SURG, V6, P690, DOI 10.1016/S1091-255X(01)00086-5; MARTIN LF, 1995, SOUTH MED J, V88, P895, DOI 10.1097/00007611-199509000-00001; Meier CA, 2002, J CLIN ENDOCR METAB, V87, P1184, DOI 10.1210/jc.87.3.1184; Nakamura K, 2009, ENDO C; Newbury L, 2003, OBES SURG, V13, P893, DOI 10.1381/096089203322618722; Olmos JM, 2008, OBES SURG, V18, P197, DOI 10.1007/s11695-007-9307-8; Pouwels S, 2011, OSTEOPOROSIS INT, V22, P903, DOI 10.1007/s00198-010-1337-8; Pouwels S, 2009, OSTEOPOROSIS INT, V20, P1499, DOI 10.1007/s00198-008-0826-5; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Pugnale N, 2003, INT J OBESITY, V27, P110, DOI 10.1038/sj.ijo.0802177; Recker R, 2000, J BONE MINER RES, V15, P1965, DOI 10.1359/jbmr.2000.15.10.1965; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Slater GH, 2004, J GASTROINTEST SURG, V8, P48, DOI 10.1016/j.gassur.2003.09.020; Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8; Valderas JP, 2009, OBES SURG, V19, P1132, DOI 10.1007/s11695-009-9890-y; Van Loan MD, 1998, AM J CLIN NUTR, V67, P734, DOI 10.1093/ajcn/67.4.734; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; Viegas M, 2010, ARQ BRAS ENDOCRINOL, V54, P158, DOI 10.1590/S0004-27302010000200011; Vilarrasa N, 2009, OBES SURG, V19, P860, DOI 10.1007/s11695-009-9843-5; von Mach MA, 2004, METABOLISM, V53, P918, DOI 10.1016/j.metabol.2004.01.015	46	118	120	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2012	345								e5085	10.1136/bmj.e5085	http://dx.doi.org/10.1136/bmj.e5085			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NA	22867649	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-01	WOS:000307496500003
J	Khalil, AS; Lu, TK; Bashor, CJ; Ramirez, CL; Pyenson, NC; Joung, JK; Collins, JJ				Khalil, Ahmad S.; Lu, Timothy K.; Bashor, Caleb J.; Ramirez, Cherie L.; Pyenson, Nora C.; Joung, J. Keith; Collins, James J.			A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions	CELL			English	Article							ZINC-FINGER NUCLEASES; STRUCTURE-BASED DESIGN; GENE NETWORKS; SYNERGISTIC ACTIVATION; PROTEIN; CELLS; COMPLEX; GAL4; CONSTRUCTION; DIMERIZATION	Eukaryotic transcription factors (TFs) perform complex and combinatorial functions within transcriptional networks. Here, we present a synthetic framework for systematically constructing eukaryotic transcription functions using artificial zinc fingers, modular DNA-binding domains found within many eukaryotic TFs. Utilizing this platform, we construct a library of orthogonal synthetic transcription factors (sTFs) and use these to wire synthetic transcriptional circuits in yeast. We engineer complex functions, such as tunable output strength and transcriptional cooperativity, by rationally adjusting a decomposed set of key component properties, e. g., DNA specificity, affinity, promoter design, protein-protein interactions. We show that subtle perturbations to these properties can transform an individual sTF between distinct roles (activator, cooperative factor, inhibitory factor) within a transcriptional complex, thus drastically altering the signal processing behavior of multi-input systems. This platform provides new genetic components for synthetic biology and enables bottom-up approaches to understanding the design principles of eukaryotic transcriptional complexes and networks.	[Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Synthet Biol Grp, Cambridge, MA 02139 USA; [Khalil, Ahmad S.; Bashor, Caleb J.; Pyenson, Nora C.; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Khalil, Ahmad S.; Bashor, Caleb J.; Pyenson, Nora C.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Ramirez, Cherie L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA; [Ramirez, Cherie L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Ramirez, Cherie L.] Harvard Univ, Sch Med, Div Med Sci, Biol & Biomed Sci Program, Boston, MA 02115 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Synthet Biol Grp, Cambridge, MA 02139 USA.	timlu@mit.edu	Lu, Timothy/G-4267-2012	Lu, Timothy/0000-0002-3918-8923; Ramirez, Cherie/0000-0002-0397-6872	Howard Hughes Medical Institute; NIH [DP1 OD003644, DP1 OD006862]; Office of Naval Research Multidisciplinary University Research Initiative (MURI); National Science Foundation [CCF-1124247]; Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008435, DP1OD006862, DP1OD003644] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research Multidisciplinary University Research Initiative (MURI)(MURI); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Collins Lab for helpful discussions, Carl O. Pabo for helpful suggestions on reducing nonspecific affinity of zinc fingers, and Katie M. Flynn for help with artwork. This work was supported by the Howard Hughes Medical Institute (J.J.C.), NIH Director's Pioneer Awards DP1 OD003644 (J.J.C.) and DP1 OD006862 (J.K.J.), an Office of Naval Research Multidisciplinary University Research Initiative (MURI) grant (T. K. L.), the National Science Foundation CCF-1124247 (T. K. L.), a Defense Advanced Research Projects Agency grant (DARPA-BAA-11-23), and a National Science Foundation Graduate Research Fellowship (C.L.R.).	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; JOUNG JK, 1993, P NATL ACAD SCI USA, V90, P3083, DOI 10.1073/pnas.90.7.3083; JOUNG JK, 1994, SCIENCE, V265, P1863, DOI 10.1126/science.8091212; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; MA J, 1988, NATURE, V334, P631, DOI 10.1038/334631a0; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Maxon ME, 2001, P NATL ACAD SCI USA, V98, P1495, DOI 10.1073/pnas.98.4.1495; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pomerantz JL, 1998, BIOCHEMISTRY-US, V37, P965, DOI 10.1021/bi972464o; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ptashne M., 2002, GENES SIGNALS; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sander JD, 2011, NAT METHODS, V8, P67, DOI [10.1038/nmeth.1542, 10.1038/NMETH.1542]; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Wang BS, 1999, P NATL ACAD SCI USA, V96, P9568, DOI 10.1073/pnas.96.17.9568; Wang BS, 2001, NAT STRUCT BIOL, V8, P589, DOI 10.1038/89617; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3; Wolfe SA, 2000, STRUCT FOLD DES, V8, P739, DOI 10.1016/S0969-2126(00)00161-1; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	60	222	248	5	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					647	658		10.1016/j.cell.2012.05.045	http://dx.doi.org/10.1016/j.cell.2012.05.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863014	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000307301400021
J	Kyomya, M; Todyrs, KW; Amon, JJ				Kyomya, Michael; Todyrs, Katherine W.; Amon, Joseph J.			Laws against sodomy and the HIV epidemic in African prisons	LANCET			English	Editorial Material									[Todyrs, Katherine W.; Amon, Joseph J.] Human Rights Watch, New York, NY 10118 USA; [Kyomya, Michael] Uganda Prisons Serv, Kampala, Uganda		Amon, JJ (corresponding author), Human Rights Watch, New York, NY 10118 USA.	amonj@hrw.org		Amon, Joseph/0000-0002-2455-6703				Human Rights Watch, 2010, UNJ UNH HIV TB AB ZA; Human Rights Watch, 2008, THIS AL LEG OR SOD L; Human Rights Watch, 2011, EV DEAD BOD MUST WOR; Lesotho Correctional Service, 2009, HIV AIDS POL; Simooya OO, 2001, AIDS, V15, P1741, DOI 10.1097/00002030-200109070-00023; Todrys KW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001215; Todrys KW, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-8; Todrys KW., 2011, INT J PRISON HEALTH, V7, P10; Uganda Prisons Service, 2009, RAP SIT ASS HIV STI; Uganda Prisons Service, 2010, PROGR 04 PRIS MED SE; UN Office on Drugs and Crime UNAIDS World Bank, 2007, HIV PRIS SUBS AFR OP; World Health Organization, 2007, INT ADDR HIV PRIS PR; World Health Organization, 2011, PREVENTION TREATMENT	13	15	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2012	380	9839					310	312		10.1016/S0140-6736(12)60682-5	http://dx.doi.org/10.1016/S0140-6736(12)60682-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	979TN	22819651				2022-12-01	WOS:000306842800005
J	Rozenblatt-Rosen, O; Deo, RC; Padi, M; Adelmant, G; Calderwood, MA; Rolland, T; Grace, M; Dricot, A; Askenazi, M; Tavares, M; Pevzner, SJ; Abderazzaq, F; Byrdsong, D; Carvunis, AR; Chen, AA; Cheng, JW; Correll, M; Duarte, M; Fan, CY; Feltkamp, MC; Ficarro, SB; Franchi, R; Garg, BK; Gulbahce, N; Hao, T; Holthaus, AM; James, R; Korkhin, A; Litovchick, L; Mar, JC; Pak, TR; Rabello, S; Rubio, R; Shen, Y; Singh, S; Spangle, JM; Tasan, M; Wanamaker, S; Webber, JT; Roecklein-Canfield, J; Johannsen, E; Barabasi, AL; Beroukhim, R; Kieff, E; Cusick, ME; Hill, DE; Munger, K; Marto, JA; Quackenbush, J; Roth, FP; DeCaprio, JA; Vidal, M				Rozenblatt-Rosen, Orit; Deo, Rahul C.; Padi, Megha; Adelmant, Guillaume; Calderwood, Michael A.; Rolland, Thomas; Grace, Miranda; Dricot, Amelie; Askenazi, Manor; Tavares, Maria; Pevzner, Samuel J.; Abderazzaq, Fieda; Byrdsong, Danielle; Carvunis, Anne-Ruxandra; Chen, Alyce A.; Cheng, Jingwei; Correll, Mick; Duarte, Melissa; Fan, Changyu; Feltkamp, Mariet C.; Ficarro, Scott B.; Franchi, Rachel; Garg, Brijesh K.; Gulbahce, Natali; Hao, Tong; Holthaus, Amy M.; James, Robert; Korkhin, Anna; Litovchick, Larisa; Mar, Jessica C.; Pak, Theodore R.; Rabello, Sabrina; Rubio, Renee; Shen, Yun; Singh, Saurav; Spangle, Jennifer M.; Tasan, Murat; Wanamaker, Shelly; Webber, James T.; Roecklein-Canfield, Jennifer; Johannsen, Eric; Barabasi, Albert-Laszlo; Beroukhim, Rameen; Kieff, Elliott; Cusick, Michael E.; Hill, David E.; Muenger, Karl; Marto, Jarrod A.; Quackenbush, John; Roth, Frederick P.; DeCaprio, James A.; Vidal, Marc			Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins	NATURE			English	Article							EPSTEIN-BARR-VIRUS; ASSOCIATION; COMPLEX	Genotypic differences greatly influence susceptibility and resistance to disease. Understanding genotype-phenotype relationships requires that phenotypes be viewed as manifestations of network properties, rather than simply as the result of individual genomic variations(1). Genome sequencing efforts have identified numerous germline mutations, and large numbers of somatic genomic alterations, associated with a predisposition to cancer(2). However, it remains difficult to distinguish background, or 'passenger', cancer mutations from causal, or 'driver', mutations in these data sets. Human viruses intrinsically depend on their host cell during the course of infection and can elicit pathological phenotypes similar to those arising from mutations(3). Here we test the hypothesis that genomic variations and tumour viruses may cause cancer through related mechanisms, by systematically examining host interactome and transcriptome network perturbations caused by DNA tumour virus proteins. The resulting integrated viral perturbation data reflects rewiring of the host cell networks, and highlights pathways, such as Notch signalling and apoptosis, that go awry in cancer. We show that systematic analyses of host targets of viral proteins can identify cancer genes with a success rate on a par with their identification through functional genomics and large-scale cataloguing of tumour mutations. Together, these complementary approaches increase the specificity of cancer gene identification. Combining systems-level studies of pathogen-encoded gene products with genomic approaches will facilitate the prioritization of cancer-causing driver genes to advance the understanding of the genetic basis of human cancer.	[Rozenblatt-Rosen, Orit; Deo, Rahul C.; Padi, Megha; Adelmant, Guillaume; Calderwood, Michael A.; Rolland, Thomas; Dricot, Amelie; Askenazi, Manor; Tavares, Maria; Abderazzaq, Fieda; Byrdsong, Danielle; Chen, Alyce A.; Duarte, Melissa; Fan, Changyu; Ficarro, Scott B.; Franchi, Rachel; Garg, Brijesh K.; Gulbahce, Natali; Hao, Tong; Holthaus, Amy M.; James, Robert; Korkhin, Anna; Litovchick, Larisa; Mar, Jessica C.; Rabello, Sabrina; Rubio, Renee; Shen, Yun; Spangle, Jennifer M.; Tasan, Murat; Johannsen, Eric; Barabasi, Albert-Laszlo; Kieff, Elliott; Cusick, Michael E.; Hill, David E.; Muenger, Karl; Marto, Jarrod A.; Quackenbush, John; Roth, Frederick P.; DeCaprio, James A.; Vidal, Marc] Dana Farber Canc Inst, CCSB, Genom Anal Network Perturbat Ctr Excellence Genom, Boston, MA 02215 USA; [Rozenblatt-Rosen, Orit; Tavares, Maria; Cheng, Jingwei; Korkhin, Anna; Litovchick, Larisa; Beroukhim, Rameen; DeCaprio, James A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Rozenblatt-Rosen, Orit; Tavares, Maria; Cheng, Jingwei; Korkhin, Anna; Litovchick, Larisa; Rabello, Sabrina; Barabasi, Albert-Laszlo; Beroukhim, Rameen; DeCaprio, James A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Deo, Rahul C.; Adelmant, Guillaume; Askenazi, Manor; Ficarro, Scott B.; Garg, Brijesh K.; Singh, Saurav; Tasan, Murat; Webber, James T.; Marto, Jarrod A.; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Deo, Rahul C.] Univ Calif San Francisco, Dept Med, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Deo, Rahul C.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Padi, Megha; Abderazzaq, Fieda; Correll, Mick; Mar, Jessica C.; Rubio, Renee; Quackenbush, John] Dana Farber Canc Inst, CCCB, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Padi, Megha; Adelmant, Guillaume; Calderwood, Michael A.; Rolland, Thomas; Dricot, Amelie; Askenazi, Manor; Tavares, Maria; Pevzner, Samuel J.; Abderazzaq, Fieda; Byrdsong, Danielle; Carvunis, Anne-Ruxandra; Correll, Mick; Duarte, Melissa; Fan, Changyu; Ficarro, Scott B.; Franchi, Rachel; Garg, Brijesh K.; Gulbahce, Natali; Hao, Tong; James, Robert; Mar, Jessica C.; Rabello, Sabrina; Rubio, Renee; Shen, Yun; Singh, Saurav; Wanamaker, Shelly; Webber, James T.; Roecklein-Canfield, Jennifer; Barabasi, Albert-Laszlo; Beroukhim, Rameen; Cusick, Michael E.; Hill, David E.; Marto, Jarrod A.; Quackenbush, John; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Padi, Megha; Mar, Jessica C.; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Adelmant, Guillaume; Askenazi, Manor; Tavares, Maria; Ficarro, Scott B.; Garg, Brijesh K.; Singh, Saurav; Webber, James T.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02215 USA; [Calderwood, Michael A.; Rolland, Thomas; Dricot, Amelie; Pevzner, Samuel J.; Byrdsong, Danielle; Carvunis, Anne-Ruxandra; Fan, Changyu; Hao, Tong; James, Robert; Shen, Yun; Wanamaker, Shelly; Cusick, Michael E.; Hill, David E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Calderwood, Michael A.; Duarte, Melissa; Holthaus, Amy M.; Johannsen, Eric; Kieff, Elliott] Brigham & Womens Hosp, Channing Lab, Div Infect Dis, Boston, MA 02115 USA; [Calderwood, Michael A.; Grace, Miranda; Chen, Alyce A.; Duarte, Melissa; Holthaus, Amy M.; Spangle, Jennifer M.; Johannsen, Eric; Kieff, Elliott; Muenger, Karl] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Calderwood, Michael A.; Duarte, Melissa; Holthaus, Amy M.; Johannsen, Eric; Kieff, Elliott] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Pevzner, Samuel J.] Boston Univ, Dept Biomed Engn, Boston, MA 02118 USA; [Pevzner, Samuel J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Feltkamp, Mariet C.] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands; [Franchi, Rachel; Wanamaker, Shelly; Roecklein-Canfield, Jennifer] Simmons Coll, Dept Chem, Boston, MA 02115 USA; [Gulbahce, Natali; Rabello, Sabrina; Barabasi, Albert-Laszlo] Northeastern Univ, CCNR, Boston, MA 02115 USA; [Gulbahce, Natali; Rabello, Sabrina; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Gulbahce, Natali] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Pak, Theodore R.; Tasan, Murat; Roth, Frederick P.] Univ Toronto, Donnelly Ctr, Toronto, ON M5G 1X5, Canada; [Pak, Theodore R.; Tasan, Murat; Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Pak, Theodore R.; Tasan, Murat; Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5G 1X5, Canada; [Pak, Theodore R.; Tasan, Murat; Roth, Frederick P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Beroukhim, Rameen] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Boston University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Simmons University; Northeastern University; Northeastern University; University of California System; University of California San Francisco; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Marto, JA (corresponding author), Dana Farber Canc Inst, CCSB, Genom Anal Network Perturbat Ctr Excellence Genom, Boston, MA 02215 USA.	jarrod_marto@dfci.harvard.edu; johnq@jimmy.harvard.edu; fritz.roth@utoronto.ca; james_decaprio@dfci.harvard.edu; marc_vidal@dfci.harvard.edu	Feltkamp, Mariet/A-3788-2010; Rozenblatt-Rosen, Orit/HDN-4182-2022; Roth, Frederick P/H-6308-2011; Barabasi, Albert-Laszlo/S-6474-2017; Calderwood, Mike/B-2475-2014; Hill, David E/B-6617-2011	Feltkamp, Mariet/0000-0001-5993-9846; Calderwood, Mike/0000-0001-6475-1418; Mar, Jessica/0000-0002-5147-9299; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Trigg, Shelly/0000-0001-6904-4149; Webber, James/0000-0001-8594-9888; Quackenbush, John/0000-0002-2702-5879; Rolland, Thomas/0000-0001-6468-8391; Roth, Frederick/0000-0002-6628-649X; Barabasi, Albert/0000-0002-4028-3522; Pak, Theodore/0000-0002-1676-2523; Askenazi, Manor/0000-0003-1646-833X; Chen, Alyce/0000-0002-5018-8908; Munger, Karl/0000-0003-3288-9935; Litovchick, Larisa/0000-0002-9540-597X	Center of Excellence in Genomic Science (CEGS) from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) [P50HG004233]; Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative; NIH [R01HG001715, R01CA093804, R01CA063113, P01CA050661, R01CA081135, R01CA066980, U01CA141583, R01CA131354, R01CA047006, R01CA085180, T32HL007208, K08HL098361, K08CA122833, F32GM095284, K25HG006031]; Canada Excellence Research Chairs (CERC) Program, Canadian Institute for Advanced Research Fellowship and Ontario Research Fund; James S. McDonnell Foundation [220020084]; NATIONAL CANCER INSTITUTE [K08CA122833, R01CA063113, R01CA066980, R01CA081135, R01CA131354, R01CA085180, R01CA093804, U01CA141583, R01CA047006, P01CA050661] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098361, T32HL007208] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K25HG006031, P50HG004233, R01HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095284] Funding Source: NIH RePORTER	Center of Excellence in Genomic Science (CEGS) from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH); Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Excellence Research Chairs (CERC) Program, Canadian Institute for Advanced Research Fellowship and Ontario Research Fund; James S. McDonnell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Center for Cancer Systems Biology (CCSB) and J. Aster, M. Meyerson, W. Kaelin, G. Superti-Furga and S. Sunyaev for discussions, and J. W. Harper, W. Hahn, P. Howley, Y. Jacob, M. Imperiale, I. Koralnik, H. Pfister and D. Wang for reagents. This work was primarily supported by Center of Excellence in Genomic Science (CEGS) grant P50HG004233 from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH) awarded to M. V. (principal investigator), A.-L. B., J. A. D., E. K., J. A. M., K. M., J. Q. and F. P. R. Additional funding included Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative to M. V.; NIH grants R01HG001715 to M. V., D. E. H. and F. P. R.; R01CA093804, R01CA063113 and P01CA050661 to J. A. D.; R01CA081135, R01CA066980 and U01CA141583 to K. M.; R01CA131354, R01CA047006 and R01CA085180 to E. K.; T32HL007208 and K08HL098361 to R. C. D.; K08CA122833 to R. B.; F32GM095284 and K25HG006031 to M. P.; Canada Excellence Research Chairs (CERC) Program, Canadian Institute for Advanced Research Fellowship and Ontario Research Fund to F. P. R.; and James S. McDonnell Foundation grant 220020084 to A.-L. B. M. V. is a 'Chercheur Qualifie Honoraire' from the Fonds de la Recherche Scientifique (Wallonia-Brussels Federation, Belgium).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; [Anonymous], 2007, NAT GENET, V39, P423; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Brimer N, 2012, ONCOGENE, V31, P4639, DOI 10.1038/onc.2011.589; Brimer N, 2007, VIROLOGY, V358, P303, DOI 10.1016/j.virol.2006.08.038; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Calderwood MA, 2011, VIROLOGY, V414, P19, DOI 10.1016/j.virol.2011.02.018; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Howley PM, 2009, VIROLOGY, V384, P256, DOI 10.1016/j.virol.2008.12.006; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marcuzzi GP, 2009, J GEN VIROL, V90, P2855, DOI 10.1099/vir.0.012872-0; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zhou F, 2010, J PROTEOME RES, V9, P6242, DOI 10.1021/pr1004696	29	278	283	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					491	495		10.1038/nature11288	http://dx.doi.org/10.1038/nature11288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22810586	Green Submitted, Green Accepted			2022-12-01	WOS:000306815300040
J	Rimmer, JH; Marques, AC				Rimmer, James H.; Marques, Alexandre C.			Physical activity for people with disabilities	LANCET			English	Editorial Material							RECREATION FACILITIES; PARTICIPATION; BARRIERS; CHILDREN; FITNESS		[Rimmer, James H.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Rimmer, James H.] Lakeshore Fdn, Birmingham, AL 35294 USA; [Marques, Alexandre C.] Univ Fed Pelotas, Pelotas, Brazil	University of Alabama System; University of Alabama Birmingham; Universidade Federal de Pelotas	Rimmer, JH (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35294 USA.	jrimmer@uab.edu						Barnes C, 2010, DISABIL SOC, V25, P771, DOI 10.1080/09687599.2010.520889; Ginis KAM, 2007, APPL PHYSIOL NUTR ME, V32, pS135, DOI 10.1139/H07-108; Murphy NA, 2008, PEDIATRICS, V121, P1057, DOI 10.1542/peds.2008-0566; Nortvedt MW, 2005, NEUROL SCI, V26, P334, DOI 10.1007/s10072-005-0498-2; Phillips M, 2009, CLIN REHABIL, V23, P746, DOI 10.1177/0269215509334838; Riley BB, 2008, J PHYS ACT HEALTH, V5, P158, DOI 10.1123/jpah.5.1.158; Rimmer J. H., 2007, Morbidity and Mortality Weekly Report, V56, P1021; Rimmer JA, 2008, DEV NEUROREHABIL, V11, P141, DOI 10.1080/17518420701688649; Rimmer JH, 2005, AM J HEALTH PROMOT, V19, P327, DOI 10.4278/0890-1171-19.5.327; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 2005, AM J HLTH PROMOT, V19, pii; Sit CHP, 2007, PREV MED, V45, P424, DOI 10.1016/j.ypmed.2007.02.003; United Nations, 2007, UN CONVENTION RIGHTS; WHO, 2011, WORLD REPORT ON DISABILITY, P1	14	103	103	1	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2012	380	9838					193	195		10.1016/S0140-6736(12)61028-9	http://dx.doi.org/10.1016/S0140-6736(12)61028-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	976TV	22818934				2022-12-01	WOS:000306609200007
J	Burmann, BM; Knauer, SH; Sevostyanova, A; Schweimer, K; Mooney, RA; Landick, R; Artsimovitch, I; Rosch, P				Burmann, Bjoern M.; Knauer, Stefan H.; Sevostyanova, Anastasia; Schweimer, Kristian; Mooney, Rachel A.; Landick, Robert; Artsimovitch, Irina; Roesch, Paul			An alpha Helix to beta Barrel Domain Switch Transforms the Transcription Factor RfaH into a Translation Factor	CELL			English	Article							POLYMERASE-II ELONGATION; RNA-POLYMERASE; ESCHERICHIA-COLI; FACTOR NUSG; IN-VITRO; CRYSTAL-STRUCTURE; OPS ELEMENT; PROTEIN; COMPLEX; ANTITERMINATION	NusG homologs regulate transcription and coupled processes in all living organisms. The Escherichia coli (E. coli) two-domain paralogs NusG and RfaH have conformationally identical N-terminal domains (NTDs) but dramatically different carboxy-terminal domains (CTDs), a beta barrel in NusG and an alpha hairpin in RfaH. Both NTDs interact with elongating RNA polymerase (RNAP) to reduce pausing. In NusG, NTD and CTD are completely independent, and NusG-CTD interacts with termination factor Rho or ribosomal protein S10. In contrast, RfaH-CTD makes extensive contacts with RfaH-NTD to mask an RNAP-binding site therein. Upon RfaH interaction with its DNA target, the operon polarity suppressor (ops) DNA, RfaH-CTD is released, allowing RfaH-NTD to bind to RNAP. Here, we show that the released RfaH-CTD completely refolds from an all-alpha to an all-beta conformation identical to that of NusG-CTD. As a consequence, RfaH-CTD binding to S10 is enabled and translation of RfaH-controlled operons is strongly potentiated.	[Sevostyanova, Anastasia; Artsimovitch, Irina] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Sevostyanova, Anastasia; Artsimovitch, Irina] Ohio State Univ, RNA Grp, Columbus, OH 43210 USA; [Burmann, Bjoern M.; Knauer, Stefan H.; Schweimer, Kristian; Roesch, Paul] Univ Bayreuth, Lehrstuhl Biopolymere, D-95447 Bayreuth, Germany; [Burmann, Bjoern M.; Knauer, Stefan H.; Schweimer, Kristian; Roesch, Paul] Univ Bayreuth, Forschungszentrum Biomakromol, D-95447 Bayreuth, Germany; [Mooney, Rachel A.; Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Bayreuth; University of Bayreuth; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Artsimovitch, I (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	artsimovitch1@osu.edu; roesch@unibt.de	Burmann, Björn M./AAI-7760-2021; Rösch, Paul/I-5445-2014; Knauer, Stefan/GXG-9861-2022; Burmann, Björn/M-8913-2015; Artsimovitch, Irina/L-3467-2019; Burmann, Björn M./AAR-7399-2020	Burmann, Björn M./0000-0002-3135-7964; Rösch, Paul/0000-0003-3330-2446; Burmann, Björn/0000-0002-3135-7964; Schweimer, Kristian/0000-0002-3837-8442; Knauer, Stefan/0000-0002-4143-0694	DFG [Ro617/18-1]; NIH [GM67153, GM38660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038660, R01GM038660, R37GM038660, R01GM067153] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Heissmann for excellent technical assistance and H.K. Seoh and C. Squires for the generous gift of antibodies used for ChIP-chip experiments. This project was supported by DFG (Ro617/18-1 to P.R.) and NIH (GM67153 to I.A.; GM38660 to R.L.).	Alexander PA, 2009, P NATL ACAD SCI USA, V106, P21149, DOI 10.1073/pnas.0906408106; Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Bailey MJA, 1997, MOL MICROBIOL, V26, P845, DOI 10.1046/j.1365-2958.1997.6432014.x; Bailey MJA, 2000, MOL GEN GENET, V262, P1052, DOI 10.1007/PL00008648; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Belogurov GA, 2010, MOL MICROBIOL, V76, P286, DOI 10.1111/j.1365-2958.2010.07056.x; Belogurov GA, 2009, EMBO J, V28, P112, DOI 10.1038/emboj.2008.268; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Burmann BM, 2011, BIOCHEM J, V435, P783, DOI 10.1042/BJ20101679; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; BURNS CM, 1995, P NATL ACAD SCI USA, V92, P4738, DOI 10.1073/pnas.92.11.4738; BUROVA E, 1995, J BACTERIOL, V177, P1388, DOI 10.1128/jb.177.5.1388-1392.1995; Carter HD, 2004, J BACTERIOL, V186, P2829, DOI 10.1128/JB.186.9.2829-2840.2004; Chalissery J, 2011, J MOL BIOL, V405, P49, DOI 10.1016/j.jmb.2010.10.044; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Knowlton JR, 2003, BIOCHEMISTRY-US, V42, P2275, DOI 10.1021/bi0272508; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; LI J, 1993, GENE DEV, V7, P161, DOI 10.1101/gad.7.1.161; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Luo X, 2008, MOL CELL, V32, P791, DOI 10.1016/j.molcel.2008.10.028; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Reay P, 2004, PROTEINS, V56, P40, DOI 10.1002/prot.20054; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Sevostyanova A, 2011, MOL CELL, V43, P253, DOI 10.1016/j.molcel.2011.05.026; Squires CL, 2000, ANNU REV MICROBIOL, V54, P775, DOI 10.1146/annurev.micro.54.1.775; Steiner T, 2002, EMBO J, V21, P4641, DOI 10.1093/emboj/cdf455; SULLIVAN SL, 1992, J BACTERIOL, V174, P1339, DOI 10.1128/jb.174.4.1339-1344.1992; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Zhou HH, 2009, PROTEINS, V76, P787, DOI 10.1002/prot.22465; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	48	142	141	1	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 20	2012	150	2					291	303		10.1016/j.cell.2012.05.042	http://dx.doi.org/10.1016/j.cell.2012.05.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817892	Bronze, Green Accepted			2022-12-01	WOS:000306595700009
J	Welch, JS; Ley, TJ; Link, DC; Miller, CA; Larson, DE; Koboldt, DC; Wartman, LD; Lamprecht, TL; Liu, FL; Xia, J; Kandoth, C; Fulton, RS; McLellan, MD; Dooling, DJ; Wallis, JW; Chen, K; Harris, CC; Schmidt, HK; Kalicki-Veizer, JM; Lu, C; Zhang, QY; Lin, L; O'Laughlin, MD; McMichael, JF; Delehaunty, KD; Fulton, LA; Magrini, VJ; McGrath, SD; Demeter, RT; Vickery, TL; Hundal, J; Cook, LL; Swift, GW; Reed, JP; Alldredge, PA; Wylie, TN; Walker, JR; Watson, MA; Heath, SE; Shannon, WD; Varghese, N; Nagarajan, R; Payton, JE; Baty, JD; Kulkarni, S; Klco, JM; Tomasson, MH; Westervelt, P; Walter, MJ; Graubert, TA; DiPersio, JF; Ding, L; Mardis, ER; Wilson, RK				Welch, John S.; Ley, Timothy J.; Link, Daniel C.; Miller, Christopher A.; Larson, David E.; Koboldt, Daniel C.; Wartman, Lukas D.; Lamprecht, Tamara L.; Liu, Fulu; Xia, Jun; Kandoth, Cyriac; Fulton, Robert S.; McLellan, Michael D.; Dooling, David J.; Wallis, John W.; Chen, Ken; Harris, Christopher C.; Schmidt, Heather K.; Kalicki-Veizer, Joelle M.; Lu, Charles; Zhang, Qunyuan; Lin, Ling; O'Laughlin, Michelle D.; McMichael, Joshua F.; Delehaunty, Kim D.; Fulton, Lucinda A.; Magrini, Vincent J.; McGrath, Sean D.; Demeter, Ryan T.; Vickery, Tammi L.; Hundal, Jasreet; Cook, Lisa L.; Swift, Gary W.; Reed, Jerry P.; Alldredge, Patricia A.; Wylie, Todd N.; Walker, Jason R.; Watson, Mark A.; Heath, Sharon E.; Shannon, William D.; Varghese, Nobish; Nagarajan, Rakesh; Payton, Jacqueline E.; Baty, Jack D.; Kulkarni, Shashikant; Klco, Jeffery M.; Tomasson, Michael H.; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.			The Origin and Evolution of Mutations in Acute Myeloid Leukemia	CELL			English	Article							INTERNAL TANDEM DUPLICATION; ALPHA CHIMERIC GENE; PML/RAR-ALPHA; PROMYELOCYTIC LEUKEMIA; CLONAL EVOLUTION; RETINOIC ACID; MOLECULAR-GENETICS; SOMATIC MUTATIONS; PROGNOSTIC IMPACT; DNMT3A MUTATIONS	Most mutations in cancer genomes are thought to be acquired after the initiating event, which may cause genomic instability and drive clonal evolution. However, for acute myeloid leukemia (AML), normal karyotypes are common, and genomic instability is unusual. To better understand clonal evolution in AML, we sequenced the genomes of M3-AML samples with a known initiating event (PML-RARA) versus the genomes of normal karyotype M1-AML samples and the exomes of hematopoietic stem/progenitor cells (HSPCs) from healthy people. Collectively, the data suggest that most of the mutations found in AML genomes are actually random events that occurred in HSPCs before they acquired the initiating mutation; the mutational history of that cell is "captured" as the clone expands. In many cases, only one or two additional, cooperating mutations are needed to generate the malignant founding clone. Cells from the founding clone can acquire additional cooperating mutations, yielding subclones that can contribute to disease progression and/or relapse.	[Welch, John S.; Ley, Timothy J.; Link, Daniel C.; Wartman, Lukas D.; Lamprecht, Tamara L.; Liu, Fulu; Xia, Jun; Heath, Sharon E.; Shannon, William D.; Tomasson, Michael H.; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.; Ding, Li] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Welch, John S.; Ley, Timothy J.; Link, Daniel C.; Watson, Mark A.; Shannon, William D.; Nagarajan, Rakesh; Payton, Jacqueline E.; Kulkarni, Shashikant; Tomasson, Michael H.; Westervelt, Peter; Walter, Matthew J.; Graubert, Timothy A.; DiPersio, John F.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Ley, Timothy J.; Miller, Christopher A.; Larson, David E.; Koboldt, Daniel C.; Kandoth, Cyriac; Fulton, Robert S.; McLellan, Michael D.; Dooling, David J.; Wallis, John W.; Harris, Christopher C.; Schmidt, Heather K.; Kalicki-Veizer, Joelle M.; Lu, Charles; Lin, Ling; O'Laughlin, Michelle D.; McMichael, Joshua F.; Delehaunty, Kim D.; Fulton, Lucinda A.; Magrini, Vincent J.; McGrath, Sean D.; Demeter, Ryan T.; Vickery, Tammi L.; Hundal, Jasreet; Cook, Lisa L.; Swift, Gary W.; Reed, Jerry P.; Alldredge, Patricia A.; Wylie, Todd N.; Walker, Jason R.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63110 USA; [Watson, Mark A.; Varghese, Nobish; Nagarajan, Rakesh; Payton, Jacqueline E.; Kulkarni, Shashikant; Klco, Jeffery M.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Baty, Jack D.] Washington Univ, Dept Biostat, St Louis, MO 63110 USA; [Zhang, Qunyuan; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Chen, Ken] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	Ley, TJ (corresponding author), Washington Univ, Dept Med, St Louis, MO 63110 USA.	timley@wustl.edu	Weinstock, George M/C-6314-2013; Walter, Matthew J/S-7758-2018; Mardis, Elaine/W-2202-2019; Klco, Jeffery/M-9717-2018; Miller, Christopher A./A-1060-2009; Chen, Ken/AAU-1432-2021; McGrath, Sean David/AAT-3540-2020; Wilson, Richard K./AAF-4139-2019; Walker, Jason/A-9702-2013; Magrini, Vincent/AAT-5830-2020	Weinstock, George M/0000-0002-2997-4592; Klco, Jeffery/0000-0003-2961-6960; Miller, Christopher A./0000-0003-4266-6700; Chen, Ken/0000-0003-4013-5279; McGrath, Sean David/0000-0001-9064-8449; Wilson, Richard K./0000-0002-1992-1358; Walker, Jason/0000-0001-7547-5789; Magrini, Vincent/0000-0002-2019-4872; Larson, David/0000-0001-7934-5906; Tomasson, Michael/0000-0003-4518-7123; Graubert, Timothy/0000-0002-7710-1171; Kandoth, Cyriac/0000-0002-1345-3573; MCLELLAN, MICHAEL/0000-0002-2703-8784; Westover, Tamara/0000-0002-1000-6698	Washington University Cancer Genome Initiative; NCI Cancer Center [P30 CA91842]; Washington University in St. Louis; National Human Genome Research Institute [NHGRI U54 HG003079]; National Cancer Institute [K99 HL103975]; Barnes-Jewish Hospital Foundation [00335-0505-02]; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA083962, P01CA101937, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103975, R00HL103975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Washington University Cancer Genome Initiative; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Washington University in St. Louis; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Analysis Pipeline group for developing the automated sequence analysis pipelines; the LIMS group for developing tools and software to manage samples and sequencing; and the Systems group for providing the IT infrastructure and HPC solutions required for sequencing and analysis. We thank William S. Schierding and Nathan D. Dees for their help on tumor clonality analysis, Dr. David Spencer for help with pathway analysis, and Joshua McMichael for help with figure preparation. We also thank The Cancer Genome Atlas for allowing us to use unpublished data for this study, the Washington University Cancer Genome Initiative for their support, and the Siteman Cancer Center Flow Cytometry Core, which provided cell sorting service and is supported in part by an NCI Cancer Center Support grant P30 CA91842. This work was funded by grants to Richard K. Wilson from Washington University in St. Louis and the National Human Genome Research Institute (NHGRI U54 HG003079), and grants to John S. Welch (K99 HL103975) and Timothy J. Ley from the National Cancer Institute (PO1 CA101937) and the Barnes-Jewish Hospital Foundation (00335-0505-02).	Abkowitz JL, 2000, BLOOD, V96, P3399, DOI 10.1182/blood.V96.10.3399.h8003399_3399_3405; Abkowitz JL, 1996, NAT MED, V2, P190, DOI 10.1038/nm0296-190; Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Allford S, 1999, BRIT J HAEMATOL, V105, P198; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; Bacher U, 2010, CURR OPIN ONCOL, V22, P646, DOI 10.1097/CCO.0b013e32833ed806; Betz BL, 2010, ARCH PATHOL LAB MED, V134, P1427, DOI 10.1043/2010-0245-RA.1; Bullinger L, 2010, LEUKEMIA, V24, P438, DOI 10.1038/leu.2009.263; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; Carretero M, 2010, CURR OPIN CELL BIOL, V22, P781, DOI 10.1016/j.ceb.2010.07.004; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Funk RK, 2008, BLOOD, V112, P1434, DOI 10.1182/blood-2008-01-132084; Gilliland DG, 2002, SEMIN HEMATOL, V39, P6, DOI 10.1053/shem.2002.36921; Gundry M, 2012, MUTAT RES-FUND MOL M, V729, P1, DOI [10.1016/mrfmmm.2011.10.001, 10.1016/j.mrfmmm.2011.10.001]; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Imaizumi M, 1998, BLOOD, V92, P374, DOI 10.1182/blood.V92.2.374.414a40_374_382; Ishikawa Y, 2009, EUR J HAEMATOL, V83, P90, DOI 10.1111/j.1600-0609.2009.01261.x; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Kelly LM, 2002, P NATL ACAD SCI USA, V99, P8283, DOI 10.1073/pnas.122233699; Kogan SC, 2007, CURR TOP MICROBIOL, V313, P3; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Larson RA, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.032; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li L, 2008, BLOOD, V111, P3849, DOI 10.1182/blood-2007-08-109942; Lin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026906; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; LOEB LA, 1974, CANCER RES, V34, P2311; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Markova J, 2012, EUR J HAEMATOL, V88, P128, DOI 10.1111/j.1600-0609.2011.01716.x; McCormick SR, 2010, ARCH PATHOL LAB MED, V134, P1143, DOI 10.1043/2009-0292-OA.1; Millau JF, 2011, BIOCHEM CELL BIOL, V89, P505, DOI [10.1139/O11-052, 10.1139/o11-052]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Pedersen-Bjergaard J, 2008, LEUKEMIA, V22, P240, DOI 10.1038/sj.leu.2405078; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Rocquain J, 2010, AM J HEMATOL, V85, P717, DOI 10.1002/ajh.21798; ROWLEY JD, 1977, INT J CANCER, V20, P869, DOI 10.1002/ijc.2910200608; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Shih LY, 2004, CLIN CANCER RES, V10, P1326, DOI 10.1158/1078-0432.CCR-0835-03; Sohal J, 2003, BLOOD, V101, P3188, DOI 10.1182/blood-2002-06-1800; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Suela J, 2007, CYTOGENET GENOME RES, V118, P304, DOI 10.1159/000108314; Takayama N, 2001, EXP HEMATOL, V29, P864, DOI 10.1016/S0301-472X(01)00651-8; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Walter MJ, 2004, MOL CELL BIOL, V24, P10882, DOI 10.1128/MCB.24.24.10882-10893.2004; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Zheng XM, 2009, INT J ONCOL, V34, P1521, DOI 10.3892/ijo_00000281	67	1102	1128	3	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					264	278		10.1016/j.cell.2012.06.023	http://dx.doi.org/10.1016/j.cell.2012.06.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817890	Green Accepted, Bronze			2022-12-01	WOS:000306595700007
J	Bharat, TAM; Davey, NE; Ulbrich, P; Riches, JD; de Marco, A; Rumlova, M; Sachse, C; Ruml, T; Briggs, JAG				Bharat, Tanmay A. M.; Davey, Norman E.; Ulbrich, Pavel; Riches, James D.; de Marco, Alex; Rumlova, Michaela; Sachse, Carsten; Ruml, Tomas; Briggs, John A. G.			Structure of the immature retroviral capsid at 8 angstrom resolution by cryo-electron microscopy	NATURE			English	Article							PFIZER MONKEY VIRUS; TERMINAL DOMAIN; PARTICLE-PRODUCTION; ASSEMBLY INHIBITOR; HIV-1 VIRIONS; NUCLEIC-ACID; PROTEIN; MATURATION; ORGANIZATION	The assembly of retroviruses such as HIV-1 is driven by oligomerization of their major structural protein, Gag. Gag is a multidomain polyprotein including three conserved folded domains: MA (matrix), CA (capsid) and NC (nucleocapsid)(1). Assembly of an infectious virion proceeds in two stages(2). In the first stage, Gag oligomerization into a hexameric protein lattice leads to the formation of an incomplete, roughly spherical protein shell that buds through the plasma membrane of the infected cell to release an enveloped immature virus particle. In the second stage, cleavage of Gag by the viral protease leads to rearrangement of the particle interior, converting the non-infectious immature virus particle into a mature infectious virion. The immature Gag shell acts as the pivotal intermediate in assembly and is a potential target for anti-retroviral drugs both in inhibiting virus assembly and in disrupting virus maturation(3). However, detailed structural information on the immature Gag shell has not previously been available. For this reason it is unclear what protein conformations and interfaces mediate the interactions between domains and therefore the assembly of retrovirus particles, and what structural transitions are associated with retrovirus maturation. Here we solve the structure of the immature retroviral Gag shell from Mason-Pfizer monkey virus by combining cryo-electron microscopy and tomography. The 8-angstrom resolution structure permits the derivation of a pseudo-atomic model of CA in the immature retrovirus, which defines the protein interfaces mediating retrovirus assembly. We show that transition of an immature retrovirus into its mature infectious form involves marked rotations and translations of CA domains, that the roles of the amino-terminal and carboxy-terminal domains of CA in assembling the immature and mature hexameric lattices are exchanged, and that the CA interactions that stabilize the immature and mature viruses are almost completely distinct.	[Bharat, Tanmay A. M.; Davey, Norman E.; Riches, James D.; de Marco, Alex; Sachse, Carsten; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Ulbrich, Pavel; Ruml, Tomas] Inst Chem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic; [Rumlova, Michaela] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, Prague 16610, Czech Republic	European Molecular Biology Laboratory (EMBL); University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Briggs, JAG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	briggs@embl.de	Rumlova, Michaela/G-6140-2014; Ulbrich, Pavel/F-5747-2010; Davey, Norman E/D-5362-2013; Ruml, Tomas/R-2543-2017; Sachse, Carsten/H-2727-2012; Briggs, John/J-3096-2012; Sachse, Carsten/AAY-9384-2020; , Alex/AAK-8000-2020; Riches, James/M-3873-2013; Rumlova, Michaela/G-9142-2018	Ulbrich, Pavel/0000-0002-9076-8210; Ruml, Tomas/0000-0002-5698-4366; Sachse, Carsten/0000-0002-1168-5143; Sachse, Carsten/0000-0002-1168-5143; , Alex/0000-0001-6238-5653; Riches, James/0000-0001-8494-4743; Rumlova, Michaela/0000-0002-5645-8227; Davey, Norman/0000-0001-6988-4850; Bharat, Tanmay/0000-0002-0168-0277; Briggs, John/0000-0003-3990-6910	Deutsche Forschungsgemeinschaft [SPP1175]; Czech Science foundation [P302/12/1895, 204/09/1388]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Czech Science foundation(Grant Agency of the Czech Republic)	This study was technically supported by the use of the European Molecular Biology Laboratory Information Technology Service unit. This work was partly funded by a grant from the Deutsche Forschungsgemeinschaft within SPP1175 to J.A.G.B. and by grants P302/12/1895 and 204/09/1388 from the Czech Science foundation to T.R. and M.R.	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Chu HH, 2006, J BIOMED SCI, V13, P645, DOI 10.1007/s11373-006-9094-6; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; de Marco A, 2010, J VIROL, V84, P11729, DOI 10.1128/JVI.01423-10; Egelman EH, 2010, METHOD ENZYMOL, V482, P167, DOI 10.1016/S0076-6879(10)82006-3; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gottlinger HG, 2001, AIDS, V15, pS13; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Johnson MC, 2002, J VIROL, V76, P11177, DOI 10.1128/JVI.76.22.11177-11185.2002; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Macek P, 2009, J MOL BIOL, V392, P100, DOI 10.1016/j.jmb.2009.06.029; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Ulbrich P, 2006, J VIROL, V80, P7089, DOI 10.1128/JVI.02694-05; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Waheed AA, 2012, AIDS RES HUM RETROV, V28, P54, DOI [10.1089/aid.2011.0230, 10.1089/AID.2011.0230]; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264	30	129	130	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					385	389		10.1038/nature11169	http://dx.doi.org/10.1038/nature11169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722831				2022-12-01	WOS:000306506500047
J	Heneghan, C; Perera, R; Nunan, D; Mahtani, K; Gill, P				Heneghan, Carl; Perera, Rafael; Nunan, David; Mahtani, Kamal; Gill, Peter			Forty years of sports performance research and little insight gained	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARBOHYDRATE-ELECTROLYTE SOLUTION; MARATHON RUNNING PERFORMANCE; PROLONGED EXERCISE; PSYCHOLOGICAL AFFECT; ENDURANCE CAPACITY; FLUID BALANCE; INTERMITTENT; INGESTION; ENVIRONMENT; GLUCOSE		[Heneghan, Carl; Perera, Rafael; Nunan, David; Mahtani, Kamal; Gill, Peter] Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX1 2ET, England	University of Oxford	Heneghan, C (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX1 2ET, England.	carl.heneghan@phc.ox.ac.uk	Gill, Peter J./A-6021-2012	Gill, Peter J./0000-0002-6253-1312; Perera, Rafael/0000-0003-2418-2091	National Institute for Health Research [CL-2011-13-006] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Ali A, 2007, MED SCI SPORT EXER, V39, P1969, DOI 10.1249/mss.0b013e31814fb3e3; Arkinstall MJ, 2001, J APPL PHYSIOL, V91, P2125, DOI 10.1152/jappl.2001.91.5.2125; Atkinson G, 2011, INT J SPORTS MED, V32, P611, DOI 10.1055/s-0031-1273739; Atkinson G, 2001, J SPORT SCI, V19, P811, DOI 10.1080/026404101317015447; Betts JA, 2009, APPL PHYSIOL NUTR ME, V34, P773, DOI 10.1139/H09-070; Bilzon JLJ, 2000, EUR J APPL PHYSIOL, V82, P305, DOI 10.1007/s004210000206; Carter J, 2003, PFLUG ARCH EUR J PHY, V446, P211, DOI 10.1007/s00424-003-1020-4; Clarke ND, 2005, INT J SPORT NUTR EXE, V15, P625, DOI 10.1123/ijsnem.15.6.625; Currell K, 2006, EUR J APPL PHYSIOL, V98, P583, DOI 10.1007/s00421-006-0305-7; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Foskett A, 2008, MED SCI SPORT EXER, V40, P96, DOI [10.1249/mss.0013e3181586b2c, 10.1249/mss.0b013e3181586b2c]; Galloway SDR, 2000, J SPORT SCI, V18, P339, DOI 10.1080/026404100402403; Galloway SDR, 2001, J APPL PHYSIOL, V91, P654, DOI 10.1152/jappl.2001.91.2.654; GREEN L F, 1972, Proceedings of the Nutrition Society, V31, P5; Green L.F., 1972, BRIT J SPORT MED, V6, P125; Heneghan C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001702; Hooper S, 2004, J DENT, V32, P541, DOI 10.1016/j.jdent.2004.05.002; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, BRIT MED J, V322, P879, DOI 10.1136/bmj.322.7291.879; Jentjens RLPG, 2005, BRIT J NUTR, V93, P485, DOI 10.1079/BJN20041368; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Jeukendrup AE, 2010, SCAND J MED SCI SPOR, V20, P112, DOI 10.1111/j.1600-0838.2008.00862.x; Lancaster GI, 2005, J APPL PHYSIOL, V98, P565, DOI 10.1152/japplphysiol.00754.2004; Morris JG, 2003, J SPORT SCI, V21, P371, DOI 10.1080/0264041031000071191; MUCKLE DS, 1973, BRIT J SPORT MED, V7, P340; Nassis GP, 1998, BRIT J SPORT MED, V32, P248, DOI 10.1136/bjsm.32.3.248; Nicholas Ceri W., 1995, Journal of Sports Sciences, V13, P283, DOI 10.1080/02640419508732241; Nicholas CW, 1999, MED SCI SPORT EXER, V31, P1280, DOI 10.1097/00005768-199909000-00008; Noakes TD, 1998, MED SCI SPORT EXER, V30, P1381, DOI 10.1097/00005768-199809000-00007; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Peacock OJ, 2012, APPETITE, V58, P56, DOI 10.1016/j.appet.2011.08.023; Peacock OJ, 2011, J SPORT SCI, V29, P897, DOI 10.1080/02640414.2011.568511; Rollo I, 2011, MED SCI SPORT EXER, V43, P468, DOI 10.1249/MSS.0b013e3181f1cda3; TSINTZAS OK, 1995, EUR J APPL PHYSIOL O, V70, P154, DOI 10.1007/BF00361543; VIST GE, 1994, MED SCI SPORT EXER, V26, P1269; WIDRICK JJ, 1993, J APPL PHYSIOL, V74, P2998, DOI 10.1152/jappl.1993.74.6.2998; WILLIAMS C, 1990, EUR J APPL PHYSIOL O, V60, P112, DOI 10.1007/BF00846030	37	21	21	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 19	2012	345								e4797	10.1136/bmj.e4797	http://dx.doi.org/10.1136/bmj.e4797			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MA	22810388				2022-12-01	WOS:000306744300011
J	Winterstein, AG; Gerhard, T; Kubilis, P; Saidi, A; Linden, S; Crystal, S; Zito, J; Shuster, JJ; Olfson, M				Winterstein, Almut G.; Gerhard, Tobias; Kubilis, Paul; Saidi, Arwa; Linden, Stephan; Crystal, Stephen; Zito, Julie; Shuster, Jonathan J.; Olfson, Mark			Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TACHYCARDIA-INDUCED CARDIOMYOPATHY; AMBULATORY BLOOD-PRESSURE; PHARMACOLOGICAL-TREATMENT; ADHD DRUGS; MEDICATION; EVENTS; YOUTHS; ADULTS; RISK; METHYLPHENIDATE	Objectives To evaluate the cardiac safety of central nervous system stimulants in children and adolescents. Design Population based retrospective cohort study. Setting Automated healthcare claims data from 1 219 847 children and young people eligible for 28 state Medicaid programmes from 1999 to 2006 linked to the Social Security Death Master File and the National Death Index. Participants Children and young people age 3-18 entered the cohort at the first diagnosis of a mental health condition commonly treated with stimulants (such as attention-deficit/hyperactivity disorder) after a minimum period of six months' eligibility and were followed until loss of eligibility, their 19th birthday, admission to hospital for longer than 30 days, or death. Exclusion criteria included transplant recipients, receipt of dialysis, or claims indicating substance misuse. We retained high risk groups with similar use of stimulants as low risk children (such as children with congenital heart disease). Sociodemographic characteristics, cardiac risk factors, and psychiatric diagnoses obtained from before the index period were summarised with a propensity score. We used discrete survival analysis to estimate the relative risk for periods of stimulant use and non-use, adjusted for propensity score and antipsychotic use for the full cohort and the high risk and low risk groups. Main outcome measures Composite endpoint of stroke, acute myocardial infarction, or sudden cardiac death; a secondary composite endpoint added ventricular arrhythmia Results A total of 66 (95 including ventricular arrhythmia) events occurred during 2 321 311 years of follow-up. The odds ratio adjusted for propensity score and antipsychotic use for current versus no stimulant use was 0.62 (95% confidence interval 0.27 to 1.44), with a corresponding adjusted incidence rate of 2.2 and 3.5 per 100 000 patient years for current stimulant and non-use, respectively. Twenty six events occurred in high risk patients (incidence rate 63 per 100 000 patient years) with an odds ratio of 1.02 (0.28 to 3.69). Odds ratios for the secondary endpoint were similar to those for the primary endpoint (0.74, 0.38 to 1.46). Conclusions Treatment of children with central nervous stimulants is not significantly associated with an increase in the short term risk of severe cardiac events. Analyses cannot be generalised to children with long term use of stimulants. Furthermore, long term effects of slight increases in heart rate or blood pressure are unknown.	[Winterstein, Almut G.; Kubilis, Paul; Linden, Stephan] Univ Florida, Coll Pharm, Coll Med, Gainesville, FL 32611 USA; [Gerhard, Tobias] Rutgers State Univ, Ernest Mario Sch Pharm, New Brunswick, NJ 08901 USA; [Gerhard, Tobias] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08901 USA; [Shuster, Jonathan J.] Univ Florida, Coll Med, UF Clin Res Ctr, Dept Hlth Outcomes & Policy, Gainesville, FL 32611 USA; [Crystal, Stephen] Rutgers State Univ, Ctr Hlth Serv Res Pharmacotherapy Chron Dis Manag, New Brunswick, NJ 08901 USA; [Zito, Julie] Univ Maryland, Baltimore, MD 21201 USA; [Olfson, Mark] Columbia Univ, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA; [Winterstein, Almut G.; Kubilis, Paul; Linden, Stephan] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University System of Florida; University of Florida; Rutgers State University New Brunswick; University System of Maryland; University of Maryland Baltimore; Columbia University; New York State Psychiatry Institute; State University System of Florida; University of Florida	Winterstein, AG (corresponding author), Univ Florida, Coll Pharm, Coll Med, Gainesville, FL 32611 USA.	almut@cop.ufl.edu	Shuster, Jonathan/ABB-5773-2021; winterstein, Almut/A-3017-2014; winterstein, almut/ABH-1838-2020; Olfson, Mark/AAA-8547-2021	Shuster, Jonathan/0000-0001-9499-5616; winterstein, Almut/0000-0002-6518-5961; Gerhard, Tobias/0000-0002-8598-5771	Agency of Healthcare Research and Quality (AHRQ) [R01-HS0185606]; NIH from National Center for Advancing Translational Sciences [1UL1 TR000064]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018506] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Agency of Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIH from National Center for Advancing Translational Sciences; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by grant R01-HS0185606 from the Agency of Healthcare Research and Quality (AHRQ) and in part by NIH grant 1UL1 TR000064 from the National Center for Advancing Translational Sciences. AHRQ and NIH had no role in the design, conduct, or reporting of the study or in the decision to submit the manuscript for publication.	Belanger SA, 2009, PAED CHILD HEALT-CAN, V14, P579, DOI 10.1093/pch/14.9.579; Biederman J, 2006, BIOL PSYCHIAT, V59, P829, DOI 10.1016/j.biopsych.2005.09.011; Chen CY, 2009, J CHILD ADOL PSYCHOP, V19, P187, DOI 10.1089/cap.2008.096; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; CORNFIELD J, 1951, J NATL CANCER I, V11, P1269; COX DR, 1972, J R STAT SOC B, V34, P187; El Hajjar M, 2004, ARCH PEDIATRIE, V11, P24, DOI 10.1016/j.arcped.2003.11.005; Findling RL, 2001, J AM ACAD CHILD PSY, V40, P525, DOI 10.1097/00004583-200105000-00011; Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; HERNDON JE, 1995, STAT MED, V14, P2119, DOI 10.1002/sim.4780141906; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McCarthy S, 2009, DRUG SAFETY, V32, P1089, DOI 10.2165/11317630-000000000-00000; Nissen SE, 2006, NEW ENGL J MED, V354, P1445, DOI 10.1056/NEJMp068049; Olfson M, 2012, J AM ACAD CHILD PSY, V51, P147, DOI 10.1016/j.jaac.2011.11.008; Perrin JM, 2008, PEDIATRICS, V122, P451, DOI 10.1542/peds.2008-1573; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Samuels JA, 2006, PEDIATR NEPHROL, V21, P92, DOI 10.1007/s00467-005-2051-1; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709, DOI 10.1016/S0735-1097(96)00592-X; Stowe CD, 2002, ANN PHARMACOTHER, V36, P1142, DOI 10.1345/aph.1A367; Umana E, 2003, AM J MED, V114, P51, DOI 10.1016/S0002-9343(02)01472-9; Vetter VL, 2008, CIRCULATION, V117, P2407, DOI 10.1161/CIRCULATIONAHA.107.189473; Weisler RH, 2005, CNS SPECTRUMS, V10, P35, DOI 10.1017/S109285290000242X; Winterstein AG, 2008, ANN PHARMACOTHER, V42, P24, DOI 10.1345/aph.1K143; Winterstein AG, 2007, PEDIATRICS, V120, pE1494, DOI 10.1542/peds.2007-0675; Zito JM, 1999, ARCH PEDIAT ADOL MED, V153, P1257, DOI 10.1001/archpedi.153.12.1257	32	29	29	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 18	2012	345								e4627	10.1136/bmj.e4627	http://dx.doi.org/10.1136/bmj.e4627			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978LU	22809800	hybrid, Green Published			2022-12-01	WOS:000306743400008
J	Catalona, WJ; D'Amico, AV; Fitzgibbons, WF; Kosoko-Lasaki, O; Leslie, SW; Lynch, HT; Moul, JW; Rendell, MS; Walsh, PC				Catalona, William J.; D'Amico, Anthony V.; Fitzgibbons, William F.; Kosoko-Lasaki, Omofolasade; Leslie, Stephen W.; Lynch, Henry T.; Moul, Judd W.; Rendell, Marc S.; Walsh, Patrick C.			What the US Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FOLLOW-UP; MORTALITY; TRIAL; LUNG		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Creighton Univ, Sch Med, Omaha, NE USA; Duke Univ, Sch Med, Durham, NC USA; Duke Canc Inst, Durham, NC USA; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Creighton University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Medicine	Rendell, MS (corresponding author), Creighton Diabet Ctr, 601 N 30th St, Omaha, NE 68131 USA.	Rendell@asndi.com						Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Chornokur G, 2011, PROSTATE, V71, P985, DOI 10.1002/pros.21314; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Etzioni R, 2008, CANCER CAUSE CONTROL, V19, P175, DOI 10.1007/s10552-007-9083-8; Ganz PA, 2012, ANN INTERN MED, V156, P591, DOI [10.7326/0003-4819-156-8-201204170-00010, 10.7326/0003-4819-156-8-201204170-00401]; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Pinsky PF, 2010, CLIN TRIALS, V7, P303, DOI 10.1177/1740774510374091; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	12	56	56	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2012	157	2					137	+		10.7326/0003-4819-157-2-201207170-00463	http://dx.doi.org/10.7326/0003-4819-157-2-201207170-00463			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992ON	22801676				2022-12-01	WOS:000307787900019
J	Baxter, I; Dilkes, BP				Baxter, Ivan; Dilkes, Brian P.			Elemental Profiles Reflect Plant Adaptations to the Environment	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; MINERAL CONCENTRATIONS; SERPENTINE SOILS; LEAF IONOME; IDENTIFICATION; TOLERANCE; EFFLUX; BORON; PANEL; QTL	Most mineral elements found in plant tissues come exclusively from the soil, necessitating that plants adapt to highly variable soil compositions to survive and thrive. Profiling element concentrations in genetically diverse plant populations is providing insights into the plant-environment interactions that control elemental accumulation, as well as identifying the underlying genes. The resulting molecular understanding of plant adaptation to the environment both demonstrates how soils can shape genetic diversity and provides solutions to important agricultural challenges.	[Baxter, Ivan] USDA ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Dilkes, Brian P.] Purdue Univ, W Lafayette, IN 47907 USA	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Baxter, I (corresponding author), USDA ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	ivan.baxter@ars.usda.gov; bdilkes@purdue.edu	Dilkes, Brian/C-9293-2012; Baxter, Ivan R/A-1052-2009	Dilkes, Brian/0000-0003-2799-954X; Baxter, Ivan R/0000-0001-6680-1722	Direct For Biological Sciences [1126950] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Caspary R., 1865, BEMERKUNGEN SCHUTZSC; Chao DY, 2011, PLANT CELL, V23, P1061, DOI 10.1105/tpc.110.079095; Duan GL, 2012, PLANT CELL PHYSIOL, V53, P154, DOI 10.1093/pcp/pcr161; Ghandilyan A, 2009, J EXP BOT, V60, P1409, DOI 10.1093/jxb/erp084; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Klein MA, 2009, GENOME, V52, P677, DOI [10.1139/g09-039, 10.1139/G09-039]; Mitani-Ueno N, 2011, J EXP BOT, V62, P4391, DOI 10.1093/jxb/err158; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Norton GJ, 2012, NEW PHYTOL, V193, P650, DOI 10.1111/j.1469-8137.2011.03983.x; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.010331; Wood S., 2000, Pilot analysis of global ecosystems: agroecosystems, P45; Yost JM, 2012, AM J BOT, V99, P890, DOI 10.3732/ajb.1100521; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x	28	78	82	4	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1661	1663		10.1126/science.1219992	http://dx.doi.org/10.1126/science.1219992			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745418				2022-12-01	WOS:000305794500037
J	Misale, S; Yaeger, R; Hobor, S; Scala, E; Janakiraman, M; Liska, D; Valtorta, E; Schiavo, R; Buscarino, M; Siravegna, G; Bencardino, K; Cercek, A; Chen, CT; Veronese, S; Zanon, C; Sartore-Bianchi, A; Gambacorta, M; Gallicchio, M; Vakiani, E; Boscaro, V; Medico, E; Weiser, M; Siena, S; Di Nicolantonio, F; Solit, D; Bardelli, A				Misale, Sandra; Yaeger, Rona; Hobor, Sebastijan; Scala, Elisa; Janakiraman, Manickam; Liska, David; Valtorta, Emanuele; Schiavo, Roberta; Buscarino, Michela; Siravegna, Giulia; Bencardino, Katia; Cercek, Andrea; Chen, Chin-Tung; Veronese, Silvio; Zanon, Carlo; Sartore-Bianchi, Andrea; Gambacorta, Marcello; Gallicchio, Margherita; Vakiani, Efsevia; Boscaro, Valentina; Medico, Enzo; Weiser, Martin; Siena, Salvatore; Di Nicolantonio, Federica; Solit, David; Bardelli, Alberto			Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer	NATURE			English	Article							K-RAS MUTATIONS; CETUXIMAB; PANITUMUMAB; MECHANISMS; TUMORS; CELLS	A main limitation of therapies that selectively target kinase signalling pathways is the emergence of secondary drug resistance. Cetuximab, a monoclonal antibody that binds the extracellular domain of epidermal growth factor receptor (EGFR), is effective in a subset of KRAS wild-type metastatic colorectal cancers(1). After an initial response, secondary resistance invariably ensues, thereby limiting the clinical benefit of this drug(2). The molecular bases of secondary resistance to cetuximab in colorectal cancer are poorly understood(3-8). Here we show that molecular alterations (in most instances point mutations) of KRAS are causally associated with the onset of acquired resistance to anti-EGFR treatment in colorectal cancers. Expression of mutant KRAS under the control of its endogenous gene promoter was sufficient to confer cetuximab resistance, but resistant cells remained sensitive to combinatorial inhibition of EGFR and mitogen-activated protein-kinase kinase (MEK). Analysis of metastases from patients who developed resistance to cetuximab or panitumumab showed the emergence of KRAS amplification in one sample and acquisition of secondary KRAS mutations in 60% (6 out of 10) of the cases. KRAS mutant alleles were detectable in the blood of cetuximab-treated patients as early as 10 months before radiographic documentation of disease progression. In summary, the results identify KRAS mutations as frequent drivers of acquired resistance to cetuximab in colorectal cancers, indicate that the emergence of KRAS mutant clones can be detected non-invasively months before radiographic progression and suggest early initiation of a MEK inhibitor as a rational strategy for delaying or reversing drug resistance.	[Yaeger, Rona; Cercek, Andrea; Solit, David] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Misale, Sandra; Hobor, Sebastijan; Scala, Elisa; Buscarino, Michela; Siravegna, Giulia; Zanon, Carlo; Di Nicolantonio, Federica; Bardelli, Alberto] Inst Canc Res & Treatment IRCC, Mol Genet Lab, I-10060 Turin, Italy; [Misale, Sandra; Scala, Elisa; Buscarino, Michela; Medico, Enzo; Bardelli, Alberto] Univ Torino, Sch Med, Dept Oncol Sci, I-10060 Turin, Italy; [Janakiraman, Manickam; Solit, David] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Liska, David; Chen, Chin-Tung; Weiser, Martin] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Valtorta, Emanuele; Veronese, Silvio; Gambacorta, Marcello] Osped Niguarda Ca Granda, Dept Pathol, I-20162 Milan, Italy; [Schiavo, Roberta; Bencardino, Katia; Sartore-Bianchi, Andrea; Siena, Salvatore] Osped Niguarda Ca Granda, Falck Div Med Oncol, I-20162 Milan, Italy; [Gallicchio, Margherita; Boscaro, Valentina] Univ Turin, Dipartimento Sci & Tecnol Farmaco, I-10125 Turin, Italy; [Vakiani, Efsevia] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Medico, Enzo] Inst Canc Res & Treatment IRCC, Lab Funct Genom, I-10060 Turin, Italy; [Di Nicolantonio, Federica; Bardelli, Alberto] FIRC Inst Mol Oncol IFOM, I-20139 Milan, Italy	Memorial Sloan Kettering Cancer Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Turin; Memorial Sloan Kettering Cancer Center; IRCCS Fondazione del Piemonte per l'Oncologia; IFOM - FIRC Institute of Molecular Oncology	Solit, D (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	solitd@mskcc.org; alberto.bardelli@ircc.it	Sartore-Bianchi, Andrea/AAB-9848-2019; Solit, David B./AAC-5309-2019; SIENA, SALVATORE/AAC-5806-2019; ravegnini, gloria/K-1330-2016; Di Nicolantonio, Federica/A-2503-2011; Liska, David/L-9180-2019; Medico, Enzo/AAC-3185-2021; Siravegna, Giulia/Z-2826-2019; BARDELLI, Alberto/J-9721-2018	Sartore-Bianchi, Andrea/0000-0003-0780-0409; SIENA, SALVATORE/0000-0002-2681-2846; ravegnini, gloria/0000-0002-7774-402X; Di Nicolantonio, Federica/0000-0001-9618-2010; Liska, David/0000-0002-8632-6065; Medico, Enzo/0000-0002-3917-2438; Siravegna, Giulia/0000-0002-7132-6484; Janakiraman, Manickam/0000-0003-4423-6237; BARDELLI, Alberto/0000-0003-1647-5070; VALTORTA, EMANUELE/0000-0002-5087-6233; Zanon, Carlo/0000-0003-2539-7238; Misale, Sandra/0000-0002-6031-0137; Veronese, Silvio Marco/0000-0002-5280-3740	European Union [259015 COLTHERES]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [9970]; Regione Piemonte; Fondazione Piemontese per la Ricerca sul Cancro (FPRC) Intramural Grant, 5xmille 2008, ONLUS; AIRC MFAG [11349]; Oncologia Ca' Granda ONLUS (OCGO); Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Society of MSKCC; National Institutes of Health; Beene Foundation; Regione Lombardia; Ministerio Salute grant 'Gene Mutation Monitoring in mCRC'; NATIONAL CANCER INSTITUTE [T32CA009207, P30CA008748, R01CA127240] Funding Source: NIH RePORTER	European Union(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte(Regione Piemonte); Fondazione Piemontese per la Ricerca sul Cancro (FPRC) Intramural Grant, 5xmille 2008, ONLUS; AIRC MFAG(Fondazione AIRC per la ricerca sul cancro); Oncologia Ca' Granda ONLUS (OCGO); Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Society of MSKCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beene Foundation; Regione Lombardia(Regione Lombardia); Ministerio Salute grant 'Gene Mutation Monitoring in mCRC'; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are particularly indebted to S. Lamba for generating the KRAS(G12R) knock-in in Lim1215 cells. We thank C. Cancelliere and S. Destefanis for technical assistance. We thank S. Arena, M. Russo and D. Zecchin for critically reading the manuscript. We also thank A. Heguy, A. Viale, N. Socci and M. Pirun for assistance with analysis of next generation sequencing data. This work was supported by European Union Seventh Framework Programme, grant 259015 COLTHERES (A.B. and S. S.); Associazione Italiana per la Ricerca sul Cancro (AIRC) 2010 Special Program Molecular Clinical Oncology 5 x 1000, project 9970 (A. B. and S. S.); Regione Piemonte (A. B. and F.D.N.); Fondazione Piemontese per la Ricerca sul Cancro (FPRC) Intramural Grant, 5xmille 2008, ONLUS (A. B. and F.D.N.); AIRC MFAG 11349 (F.D.N.); Oncologia Ca' Granda ONLUS (OCGO) (S. S.); Mr William H. Goodwin and Mrs Alice Goodwin and the Commonwealth Foundation for Cancer Research; the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center (D. S.); the Society of MSKCC (M. W.); the National Institutes of Health (D. S.); the Beene Foundation (D. S.) and Regione Lombardia and Ministerio Salute grant 'Gene Mutation Monitoring in mCRC' (S.S.).	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Benavente S, 2009, CLIN CANCER RES, V15, P1585, DOI 10.1158/1078-0432.CCR-08-2068; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Hatakeyama H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012702; Janne PA, 2008, LUNG CANCER, V60, pS3, DOI 10.1016/S0169-5002(08)70099-0; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442	21	1300	1369	10	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					532	U131		10.1038/nature11156	http://dx.doi.org/10.1038/nature11156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722830	Green Accepted, Green Submitted			2022-12-01	WOS:000305760600043
J	McCartney, M				McCartney, Margaret			Are schoolchildren unhealthily underhydrated?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2012, ZEENEWS         0504; [Anonymous], 2012, SCOTSMAN        0503; [Anonymous], 2012, DAILY MAIL      0503; [Anonymous], 2012, MSN NZ          0503; [Anonymous], 1996, BMJ, V312, P1337; British Bottled Water Producers, WAT VIT STAT IND DAT; Clayton B., 1980, PAEDIAT CHEM PATHOLO; European Food Safety Authority, SCI OP DIET REF VAL; Higgens D, 2012, INDEPENDENT     0503; Higgens D, 2012, KIDS NOT DRINKING EN; Manz F, 2003, EUR J CLIN NUTR, V57, pS10, DOI 10.1038/sj.ejcn.1601896; Manz F, 2002, J PEDIATR-US, V141, P587, DOI 10.1067/mpd.2002.128031; McCartney M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4280; Nestle Waters, OUR PROD OUR SOL	14	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 19	2012	344								e4196	10.1136/bmj.e4196	http://dx.doi.org/10.1136/bmj.e4196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965CU	22718965				2022-12-01	WOS:000305744600012
J	Singh, D; Chan, JM; Zoppoli, P; Niola, F; Sullivan, R; Castano, A; Liu, EM; Reichel, J; Porrati, P; Pellegatta, S; Qiu, KL; Gao, ZB; Ceccarelli, M; Riccardi, R; Brat, DJ; Guha, A; Aldape, K; Golfinos, JG; Zagzag, D; Mikkelsen, T; Finocchiaro, G; Lasorella, A; Rabadan, R; Iavarone, A				Singh, Devendra; Chan, Joseph Minhow; Zoppoli, Pietro; Niola, Francesco; Sullivan, Ryan; Castano, Angelica; Liu, Eric Minwei; Reichel, Jonathan; Porrati, Paola; Pellegatta, Serena; Qiu, Kunlong; Gao, Zhibo; Ceccarelli, Michele; Riccardi, Riccardo; Brat, Daniel J.; Guha, Abhijit; Aldape, Ken; Golfinos, John G.; Zagzag, David; Mikkelsen, Tom; Finocchiaro, Gaetano; Lasorella, Anna; Rabadan, Raul; Iavarone, Antonio			Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma	SCIENCE			English	Article							RECEPTOR TYROSINE KINASE; CHROMOSOMAL INSTABILITY; SELECTIVE INHIBITOR; CANCER; ANEUPLOIDY; FAMILY; DISCOVERY; POTENT	The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1%; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation defects and triggers aneuploidy. Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma. FGFR-TACC fusions could potentially identify a subset of GBM patients who would benefit from targeted FGFR kinase inhibition.	[Singh, Devendra; Zoppoli, Pietro; Niola, Francesco; Sullivan, Ryan; Castano, Angelica; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA; [Chan, Joseph Minhow; Liu, Eric Minwei; Reichel, Jonathan; Rabadan, Raul] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Chan, Joseph Minhow; Liu, Eric Minwei; Reichel, Jonathan; Rabadan, Raul] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY USA; [Reichel, Jonathan] Cornell Univ, Triinst Program Computat Biol & Med, New York, NY 10021 USA; [Reichel, Jonathan] Weill Cornell Med Coll, New York, NY USA; [Porrati, Paola; Pellegatta, Serena; Finocchiaro, Gaetano] Carattere Sci Ist Neurol C, Fdn Ist Ricovero & Cura, Milan, Italy; [Qiu, Kunlong; Gao, Zhibo] Beijing Genome Inst, Bioinformat Ctr, Shenzhen, Peoples R China; [Ceccarelli, Michele] Biogem, Ist Ric Genet Gaetano Salvatore, Ariano Irpino, AV, Italy; [Ceccarelli, Michele] Univ Sannio, Dipartimento Sci Biol & Ambientali, Benevento, Italy; [Riccardi, Riccardo] Univ Cattolica Sacro Cuore, Dept Pediat Oncol, Rome, Italy; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Lab Med, Atlanta, GA 30322 USA; [Guha, Abhijit] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5S 1A1, Canada; [Aldape, Ken] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Golfinos, John G.; Zagzag, David] NYU, Dept Neurosurg, Langone Med Ctr, New York, NY 10016 USA; [Zagzag, David] NYU, Dept Neuropathol, Langone Med Ctr, New York, NY USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; [Lasorella, Anna] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA	Columbia University; Columbia University; Columbia University; Cornell University; Cornell University; Beijing Genomics Institute (BGI); University of Sannio; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Emory University; Emory University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Texas System; UTMD Anderson Cancer Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Columbia University; Columbia University; Columbia University	Lasorella, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA.	al2179@columbia.edu; rabadan@dbmi.columbia.edu; ai2102@columbia.edu	Rabadan, Raul/AAZ-7367-2020; Finocchiaro, Gaetano/AAG-6791-2020; Ceccarelli, Michele/AGP-1739-2022; Zoppoli, Pietro/J-9954-2018; Liu, Eric Minwei/V-1738-2019; Pellegatta, Serena/AAL-3693-2021	Zoppoli, Pietro/0000-0002-7860-9655; Liu, Eric Minwei/0000-0002-3594-6678; Pellegatta, Serena/0000-0001-7804-9486; RICCARDI, RICCARDO/0000-0001-7515-6622; Finocchiaro, Gaetano/0000-0003-3583-4040; Chan, Joseph/0000-0001-5249-7395; Rabadan, Raul/0000-0001-7946-9255; Iavarone, Antonio/0000-0002-0683-4634; Ceccarelli, Michele/0000-0002-4702-6617	National Cancer Institute [R01CA101644, R01CA131126, R01CA085628, R01CA127643, U54 CA121852-05]; National Library of Medicine [1R01LM010140-01]; National Institute of Neurological Disorders and Stroke [R01NS061776]; Partnership for Cure [7-78947]; Chemotherapy Foundation; Italian Ministry of Welfare/Provincia di Benevento; Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA085628, U54CA121852, R01CA131126, R01CA101644, R01CA127643, R01CA190891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Partnership for Cure; Chemotherapy Foundation; Italian Ministry of Welfare/Provincia di Benevento; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Cancer Institute grants R01CA101644 and R01CA131126 (A. L.), R01CA085628 and R01CA127643 (A. I.), U54 CA121852-05 (R. R.), National Library of Medicine grant 1R01LM010140-01 (R. R.), National Institute of Neurological Disorders and Stroke grant R01NS061776 (A. I.), a grant from Partnership for Cure (R. R., 7-78947), and a grant from The Chemotherapy Foundation (A. I.). P.Z. and F.N. are supported by fellowships from the Italian Ministry of Welfare/Provincia di Benevento. G. F. was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and from the Italian Ministry of Health. Three of the authors (A. I., A. L., and R. R.) and Columbia University Medical Center have filed a patent application related to the diagnostic and therapeutic use of FGFR-TACC gene fusions. Next-generation RNA-sequencing data have been deposited into the Database of Genotypes and Phenotypes (accession no. phs000505.v1.p1).	Ablain J, 2011, CANCER DISCOV, V1, P117, DOI 10.1158/2159-8290.CD-11-0087; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coschi CH, 2012, CELL MOL LIFE SCI, V69, P2009, DOI 10.1007/s00018-011-0910-4; Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hood Fiona E, 2011, Bioarchitecture, V1, P105; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Still IH, 1999, GENOMICS, V58, P165, DOI 10.1006/geno.1999.5829; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Yao R, 2012, ONCOGENE, V31, P135, DOI 10.1038/onc.2011.235	28	516	566	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1231	1235		10.1126/science.1220834	http://dx.doi.org/10.1126/science.1220834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22837387	Green Accepted			2022-12-01	WOS:000308414000040
J	Johnson, JN; Ackerman, MJ				Johnson, Jonathan N.; Ackerman, Michael J.			Competitive Sports Participation in Athletes With Congenital Long QT Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RISK-FACTORS; CHILDREN		[Johnson, Jonathan N.] Mayo Clin, Div Pediat Cardiol, Rochester, MN 55905 USA; [Ackerman, Michael J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Johnson, JN (corresponding author), Mayo Clin, Div Pediat Cardiol, Rochester, MN 55905 USA.	ackerman.michael@mayo.edu						Ackerman MJ, 2004, NAT MED, V10, P463, DOI 10.1038/nm0504-463; Goldenberg I, 2008, CIRCULATION, V117, P2184, DOI 10.1161/CIRCULATIONAHA.107.701243; Liu JF, 2011, J AM COLL CARDIOL, V57, P941, DOI 10.1016/j.jacc.2010.10.025; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; Pelliccia A, 2005, EUR HEART J, V26, P1422, DOI 10.1093/eurheartj/ehi325; Zipes DP, 2005, J AM COLL CARDIOL, V45, P1354, DOI 10.1016/j.jacc.2005.02.014	6	58	59	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					764	765		10.1001/jama.2012.9334	http://dx.doi.org/10.1001/jama.2012.9334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22820673	Bronze			2022-12-01	WOS:000307705300014
J	Basler, M; Mekalanos, JJ				Basler, M.; Mekalanos, J. J.			Type 6 Secretion Dynamics Within and Between Bacterial Cells	SCIENCE			English	Article									[Basler, M.; Mekalanos, J. J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 200 Longwood Ave, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu	Basler, Marek/A-3559-2012	Basler, Marek/0000-0001-5414-2088	National Institute of Allergy and Infectious Disease [AI-018045, AI-26289]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018045, R22AI018045, R01AI018045, R01AI026289] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. G. Bernhardt and N. T. Peters for suggestions on the use of fluorescence microscopy resources and B. Ho and K. Roberts for helpful discussions. This work was supported by National Institute of Allergy and Infectious Disease grants AI-018045 and AI-26289 to J.J.M.	Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Silverman JM, 2011, MOL MICROBIOL, V82, P1277, DOI 10.1111/j.1365-2958.2011.07889.x	8	165	168	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					815	815		10.1126/science.1222901	http://dx.doi.org/10.1126/science.1222901			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22767897	Green Accepted			2022-12-01	WOS:000307535600035
J	Schepers, AG; Snippert, HJ; Stange, DE; van den Born, M; van Es, JH; van de Wetering, M; Clevers, H				Schepers, Arnout G.; Snippert, Hugo J.; Stange, Daniel E.; van den Born, Maaike; van Es, Johan H.; van de Wetering, Marc; Clevers, Hans			Lineage Tracing Reveals Lgr5(+) Stem Cell Activity in Mouse Intestinal Adenomas	SCIENCE			English	Article							COLORECTAL-CANCER; HUMAN COLON; DIFFERENTIATION; IDENTIFICATION; ORIGIN; TUMORS; GENE; MICE	The concept that tumors are maintained by dedicated stem cells, the so-called cancer stem cell hypothesis, has attracted great interest but remains controversial. Studying mouse models, we provide direct, functional evidence for the presence of stem cell activity within primary intestinal adenomas, a precursor to intestinal cancer. By "lineage retracing" using the multicolor Cre-reporter R26R-Confetti, we demonstrate that the crypt stem cell marker Lgr5 (leucine-rich repeat-containing heterotrimeric guanine nucleotide-binding protein-coupled receptor 5) also marks a subpopulation of adenoma cells that fuel the growth of established intestinal adenomas. These Lgr5(+) cells, which represent about 5 to 10% of the cells in the adenomas, generate additional Lgr5(+) cells as well as all other adenoma cell types. The Lgr5(+) cells are intermingled with Paneth cells near the adenoma base, a pattern reminiscent of the architecture of the normal crypt niche.	[Clevers, Hans] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Stange, Daniel E/O-1837-2015	Stange, Daniel E/0000-0003-4246-2230	KWF (the Dutch Cancer Society); CBG (the Centre for Biomedical Genetics); TI Pharma	KWF (the Dutch Cancer Society); CBG (the Centre for Biomedical Genetics); TI Pharma	We thank C. Kroon-Veenboer for help with mouse experiments. A. G. S and H.J.S. were funded by KWF (the Dutch Cancer Society); D. E. S. by CBG (the Centre for Biomedical Genetics); and M.vdB., J.vE., and M.vdW. by TI Pharma. Array data sets are deposited at Gene Expression Omnibus (accession no. GSE37926).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Merritt AJ, 1997, P NATL ACAD SCI USA, V94, P13927, DOI 10.1073/pnas.94.25.13927; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; PIERCE GB, 1988, CANCER RES, V48, P1996; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	24	776	814	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					730	735		10.1126/science.1224676	http://dx.doi.org/10.1126/science.1224676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22855427				2022-12-01	WOS:000307354500054
J	Tzeng, SR; Kalodimos, CG				Tzeng, Shiou-Ru; Kalodimos, Charalampos G.			Protein activity regulation by conformational entropy	NATURE			English	Article							CATABOLITE ACTIVATOR PROTEIN; MOLECULAR RECOGNITION; DYNAMIC ACTIVATION; ESCHERICHIA-COLI; RECEPTOR PROTEIN; NMR-SPECTROSCOPY; ORDER PARAMETERS; LIGAND-BINDING; FREE-ENERGY; RELAXATION	How the interplay between protein structure and internal dynamics regulates protein function is poorly understood. Often, ligand binding, post-translational modifications and mutations modify protein activity in a manner that is not possible to rationalize solely on the basis of structural data(1). It is likely that changes in the internal motions of proteins have a major role in regulating protein activity(2-7), but the nature of their contributions remains elusive, especially in quantitative terms. Here we show that changes in conformational entropy can determine whether protein-ligand interactions will occur, even among protein complexes with identical binding interfaces. We have used NMR spectroscopy to determine the changes in structure and internal dynamics that are elicited by the binding of DNA to several variants of the catabolite activator protein (CAP) that differentially populate the inactive and active DNA-binding domain states. We found that the CAP variants have markedly different affinities for DNA, despite the CAP-DNA-binding interfaces being essentially identical in the various complexes. Combined with thermodynamic data, the results show that conformational entropy changes can inhibit the binding of CAP variants that are structurally poised for optimal DNA binding or can stimulate the binding activity of CAP variants that only transiently populate the DNA-binding-domain active state. Collectively, the data show how changes in fast internal dynamics (conformational entropy) and slow internal dynamics (energetically excited conformational states) can regulate binding activity in a way that cannot be predicted on the basis of the protein's ground-state structure.	[Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Kalodimos, CG (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Kalodimos, Charalampos/Q-9846-2018	Kalodimos, Charalampos/0000-0001-6354-2796; TZENG, SHIOU-RU/0000-0002-7180-0190	National Science Foundation (NSF) [MCB1121896]; Div Of Molecular and Cellular Bioscience [1121896] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to L. Kay for providing the methyl relaxation pulse sequences, D. Korzhnev for his help with the relaxation dispersion data analysis, and S. Kim and M.-T. Pai for their help with protein preparation and NMR experiments. This work was supported by National Science Foundation (NSF) grant MCB1121896 to C.G.K.	AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Akke M, 2012, BIOCHEM SOC T, V40, P419, DOI 10.1042/BST20110750; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; CHERVENAK MC, 1994, J AM CHEM SOC, V116, P10533, DOI 10.1021/ja00102a021; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; Olsson TSG, 2011, PROTEIN SCI, V20, P1607, DOI 10.1002/pro.692; Palmer AG, 2005, METHOD ENZYMOL, V394, P430, DOI 10.1016/S0076-6879(05)94018-4; Petit CM, 2009, P NATL ACAD SCI USA, V106, P18249, DOI 10.1073/pnas.0904492106; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Sapienza PJ, 2010, CURR OPIN PHARMACOL, V10, P723, DOI 10.1016/j.coph.2010.09.006; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99; Youn H, 2008, J BACTERIOL, V190, P4532, DOI 10.1128/JB.00074-08	30	358	359	7	280	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					236	240		10.1038/nature11271	http://dx.doi.org/10.1038/nature11271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22801505				2022-12-01	WOS:000307267000039
J	Chaki, M; Airik, R; Ghosh, AK; Giles, RH; Chen, R; Slaats, GG; Wang, H; Hurd, TW; Zhou, WB; Cluckey, A; Gee, HY; Ramaswami, G; Hong, CJ; Hamilton, BA; Cervenka, I; Ganji, RS; Bryja, V; Arts, HH; van Reeuwijk, J; Oud, MM; Letteboer, SJF; Roepman, R; Husson, H; Ibraghimov-Beskrovnaya, O; Yasunaga, T; Walz, G; Eley, L; Sayer, JA; Schermer, B; Liebau, MC; Benzing, T; Le Corre, S; Drummond, I; Janssen, S; Allen, SJ; Natarajan, S; O'Toole, JF; Attanasio, M; Saunier, S; Antignac, C; Koenekoop, RK; Ren, HN; Lopez, I; Nayir, A; Stoetzel, C; Dollfus, H; Massoudi, R; Gleeson, JG; Andreoli, SP; Doherty, DG; Lindstrad, A; Golzio, C; Katsanis, N; Pape, L; Abboud, EB; Al-Rajhi, AA; Lewis, RA; Omran, H; Lee, EYHP; Wang, SH; Sekiguchi, JM; Saunders, R; Johnson, CA; Garner, E; Vanselow, K; Andersen, JS; Shlomai, J; Nurnberg, G; Nurnberg, P; Levy, S; Smogorzewska, A; Otto, EA; Hildebrandt, F				Chaki, Moumita; Airik, Rannar; Ghosh, Amiya K.; Giles, Rachel H.; Chen, Rui; Slaats, Gisela G.; Wang, Hui; Hurd, Toby W.; Zhou, Weibin; Cluckey, Andrew; Gee, Heon Yung; Ramaswami, Gokul; Hong, Chen-Jei; Hamilton, Bruce A.; Cervenka, Igor; Ganji, Ranjani Sri; Bryja, Vitezslav; Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald; Husson, Herve; Ibraghimov-Beskrovnaya, Oxana; Yasunaga, Takayuki; Walz, Gerd; Eley, Lorraine; Sayer, John A.; Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas; Le Corre, Stephanie; Drummond, Iain; Janssen, Sabine; Allen, Susan J.; Natarajan, Sivakumar; O'Toole, John F.; Attanasio, Massimo; Saunier, Sophie; Antignac, Corinne; Koenekoop, Robert K.; Ren, Huanan; Lopez, Irma; Nayir, Ahmet; Stoetzel, Corinne; Dollfus, Helene; Massoudi, Rustin; Gleeson, Joseph G.; Andreoli, Sharon P.; Doherty, Dan G.; Lindstrad, Anna; Golzio, Christelle; Katsanis, Nicholas; Pape, Lars; Abboud, Emad B.; Al-Rajhi, Ali A.; Lewis, Richard A.; Omran, Heymut; Lee, Eva Y. -H. P.; Wang, Shaohui; Sekiguchi, Joann M.; Saunders, Rudel; Johnson, Colin A.; Garner, Elizabeth; Vanselow, Katja; Andersen, Jens S.; Shlomai, Joseph; Nurnberg, Gudrun; Nurnberg, Peter; Levy, Shawn; Smogorzewska, Agata; Otto, Edgar A.; Hildebrandt, Friedhelm			Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response Signaling	CELL			English	Article							MULTIPOINT LINKAGE ANALYSIS; POLYCYSTIC KIDNEY-DISEASE; ATAXIA-TELANGIECTASIA; SECKEL-SYNDROME; CENTROSOMAL PROTEIN; GENOMIC STABILITY; JOUBERT-SYNDROME; HUMAN-CELLS; GENE; MOUSE	Nephronophthisis-related ciliopathies (NPHP-RC) are degenerative recessive diseases that affect kidney, retina, and brain. Genetic defects in NPHP gene products that localize to cilia and centrosomes defined them as "ciliopathies.'' However, disease mechanisms remain poorly understood. Here, we identify by whole-exome resequencing, mutations of MRE11, ZNF423, and CEP164 as causing NPHP-RC. All three genes function within the DNA damage response (DDR) pathway. We demonstrate that, upon induced DNA damage, the NPHP-RC proteins ZNF423, CEP164, and NPHP10 colocalize to nuclear foci positive for TIP60, known to activate ATM at sites of DNA damage. We show that knockdown of CEP164 or ZNF423 causes sensitivity to DNA damaging agents and that cep164 knockdown in zebrafish results in dysregulated DDR and an NPHP-RC phenotype. Our findings link degenerative diseases of the kidney and retina, disorders of increasing prevalence, to mechanisms of DDR.	[Chaki, Moumita; Airik, Rannar; Ghosh, Amiya K.; Hurd, Toby W.; Zhou, Weibin; Cluckey, Andrew; Gee, Heon Yung; Ramaswami, Gokul; Janssen, Sabine; Allen, Susan J.; Natarajan, Sivakumar; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Sekiguchi, Joann M.; Saunders, Rudel; Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Giles, Rachel H.; Slaats, Gisela G.] Univ Med Ctr, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Chen, Rui; Wang, Hui] Baylor Coll Med, HGSC Dept Mol & Human Genet, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Hong, Chen-Jei; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Dept Med, Div Med Genet,Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hong, Chen-Jei; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Inst Genom Med, George Palade Labs, La Jolla, CA 92093 USA; [Cervenka, Igor; Ganji, Ranjani Sri; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6525 GA Nijmegen, Netherlands; [Husson, Herve; Ibraghimov-Beskrovnaya, Oxana] Genzyme Corp, Cell Biol, Framingham, MA 01701 USA; [Yasunaga, Takayuki; Walz, Gerd] Univ Freiburg, Div Renal, Med Ctr, D-79001 Freiburg, Germany; [Eley, Lorraine; Sayer, John A.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas] Univ Cologne, Dept Internal Med 2, D-50937 Cologne, Germany; [Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas] Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Nurnberg, Gudrun; Nurnberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Liebau, Max C.] Univ Cologne, Dept Pediat & Adolescent Med, D-50937 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Syst Biol Aging, D-50937 Cologne, Germany; [Nurnberg, Gudrun; Nurnberg, Peter] Univ Cologne, Cologne Ctr Genom & Mol Med, D-50937 Cologne, Germany; [Shlomai, Joseph] Hebrew Univ Hadassah Med Sch, Fac Med, Dept Microbiol & Mol Genet, IMRIC, IL-91120 Jerusalem, Israel; [Le Corre, Stephanie; Drummond, Iain] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Nephrol Div, Charlestown, MA 02129 USA; [Le Corre, Stephanie; Drummond, Iain] Harvard Univ, Sch Med, Dept Genet, Charlestown, MA 02129 USA; [O'Toole, John F.] Metrohlth Med Ctr, Dept Internal Med, Div Nephrol, Cleveland, OH 44109 USA; [O'Toole, John F.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44109 USA; [Attanasio, Massimo] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Attanasio, Massimo] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Growth & Dev, Dallas, TX 75390 USA; [Saunier, Sophie; Antignac, Corinne] Paris Descartes Univ, Hop Necker Enfants Malades, Inserm U983, AP HP, Paris, France; [Koenekoop, Robert K.; Ren, Huanan; Lopez, Irma] McGill Univ, Montreal Childrens Hosp, McGill Ocular Genet Lab, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Nayir, Ahmet] Istanbul Univ, Fac Med, Dept Pediat Nephrol, Istanbul, Turkey; [Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg, Fac Med, Lab Genet Med EA3949, Equipe AVENIR Inserm, F-67000 Strasbourg, France; [Massoudi, Rustin; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Pediat, La Jolla, CA 92093 USA; [Andreoli, Sharon P.] Indiana Univ, James Whitcomb Riley Hosp Children, Dept Pediat, Med Ctr, Indianapolis, IN 46202 USA; [Doherty, Dan G.] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Div Genet Med,Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Lindstrad, Anna; Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Med Ctr, Durham, NC 27710 USA; [Pape, Lars] Hannover Med Sch, Dept Pediat Nephrol, D-30625 Hannover, Germany; [Abboud, Emad B.; Al-Rajhi, Ali A.] King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; [Omran, Heymut] Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed Allgemeine Pad, D-48149 Munster, Germany; [Lee, Eva Y. -H. P.; Wang, Shaohui] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Garner, Elizabeth; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA; [Vanselow, Katja; Andersen, Jens S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utrecht University; Utrecht University Medical Center; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Radboud University Nijmegen; Radboud University Nijmegen; Sanofi-Aventis; Genzyme Corporation; University of Freiburg; Newcastle University - UK; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; MetroHealth System; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Istanbul University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Franche-Comte; Howard Hughes Medical Institute; University of California System; University of California San Diego; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Duke University; Hannover Medical School; King Khaled Eye Specialist Hospital; University of Munster; University of California System; University of California Irvine; Saint James's University Hospital; University of Leeds; Rockefeller University; University of Southern Denmark; HudsonAlpha Institute for Biotechnology; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Schermer, Bernhard/E-9972-2014; Ganji, Ranjani/AGD-5702-2022; Letteboer, Stef JF/P-8272-2015; Oud, Machteld/P-6939-2015; Lindstrand, Anna/AAT-9969-2021; Janssen, S./F-2917-2016; Oud, Machteld/S-9062-2019; Bryja, Vítězslav/P-4217-2019; Andersen, Jens S/L-2100-2015; Bryja, Vít?zslav/H-1925-2014; Saunier, Sophie/G-6044-2015; Liebau, Max Christoph/K-3470-2019; Airik, Rannar/AAS-7810-2021; Roepman, Ronald/B-1339-2014; Sayer, John A./AAN-2729-2020; Katsanis, Nicholas/E-1837-2012; Lindstrand, Anna M/J-3566-2012; Slaats, Gisela/HDO-1608-2022; Pape, Lars/AAF-1477-2021; van Reeuwijk, Jeroen/P-8665-2015; Koenekoop, Robert/AAT-6676-2021; Benzing, Thomas/X-5476-2019; Gee, Heon Yung/K-7781-2019; arts, heleen/ACL-6040-2022; NAYIR, AHMET NEVZAT/A-9276-2019; ANTIGNAC, Corinne/H-8945-2017	Schermer, Bernhard/0000-0002-5194-9000; Oud, Machteld/0000-0003-4864-9346; Lindstrand, Anna/0000-0003-0806-5602; Janssen, S./0000-0001-8470-3050; Bryja, Vítězslav/0000-0002-9136-5085; Andersen, Jens S/0000-0002-6091-140X; Bryja, Vít?zslav/0000-0002-9136-5085; Saunier, Sophie/0000-0002-1069-0047; Liebau, Max Christoph/0000-0003-0494-9080; Airik, Rannar/0000-0002-7055-6325; Roepman, Ronald/0000-0002-5178-8163; Sayer, John A./0000-0003-1881-3782; Lindstrand, Anna M/0000-0003-0806-5602; Slaats, Gisela/0000-0002-4567-0134; Pape, Lars/0000-0002-3635-6418; van Reeuwijk, Jeroen/0000-0002-0658-4399; Gee, Heon Yung/0000-0002-8741-6177; ANTIGNAC, Corinne/0000-0002-9934-4940; Johnson, Colin/0000-0002-2979-8234; Omran, Heymut/0000-0003-0282-6765; Sekiguchi, JoAnn/0000-0002-7178-4258; Hamilton, Bruce/0000-0001-5599-9139; Arts, Heleen/0000-0002-9860-3744; Otto, Edgar/0000-0002-2387-9973; Smogorzewska, Agata/0000-0001-6285-1562; Dollfus, Helene/0000-0002-2249-895X; Levy, Shawn/0000-0002-1369-5740; Golzio, Christelle/0000-0002-4420-3921; Katsanis, Nicholas/0000-0002-2480-0171; Saunders, Rudel/0000-0001-6042-556X; Giles, Rachel/0000-0001-9133-2008; Attanasio, Massimo/0000-0002-1278-3650	NIH [DK068306, DK090917, NS054871, NS060109, HD042601, DK075972, DK072301, DK091405, F32EY19430]; March of Dimes Foundation; Center for Organogenesis of the University of Michigan; Netherlands Organization for Scientific Research [NWO Vidi-91786396, NWO Vidi-917.66.354]; Avenir-INSERM program; Agence Nationale pour la Recherche; Union Nationale pour les Aveugles et Deficients Visuels; RETINA France; Programme Hospitalier de Recherche National; Association Bardet-Biedl, France; European Community [241955, SYSCILIA]; Dutch Kidney Foundation [KJPB09.009, IP11.58]; Retina Research Foundation; National Eye Institute [R01EY018571]; DFG [SCHE1562, SFB832, SFB829, SFB592]; FFB-Canada; CIHR; FRSQ; Reseau Vision; Lundbeck Foundation; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622430]; Czech Science Foundation [204/09/H058, 204/09/0498]; EMBO Installation Grant; Brno PhD Talent of South Moravian Center for International Mobility; Burroughs Wellcome Fund Career Award for Medical Scientists; Doris Duke Charitable Foundation; MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018571, F32EY019430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095545] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, P60DK020572, K99DK091405, R01DK072301, R00DK091405, RC4DK090917, P30DK020572, R01DK068306, R01DK088767, R01DK076683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054871, R01NS060109] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Center for Organogenesis of the University of Michigan; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Avenir-INSERM program; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Union Nationale pour les Aveugles et Deficients Visuels; RETINA France; Programme Hospitalier de Recherche National; Association Bardet-Biedl, France; European Community(European Commission); Dutch Kidney Foundation; Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DFG(German Research Foundation (DFG)); FFB-Canada; CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Reseau Vision; Lundbeck Foundation(Lundbeckfonden); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Installation Grant; Brno PhD Talent of South Moravian Center for International Mobility; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the study individuals for their contributions. This research was supported by grants from the NIH to F. H. (DK068306, DK090917), B. A. H (NS054871, NS060109), N.K. (HD042601, DK075972, DK072301), and W.Z. (DK091405); the March of Dimes Foundation and the Center for Organogenesis of the University of Michigan to F. H.; the Netherlands Organization for Scientific Research to R. R. (NWO Vidi-91786396) and R. H. G. (NWO Vidi-917.66.354), the Avenir-INSERM program, the Agence Nationale pour la Recherche, the Union Nationale pour les Aveugles et Deficients Visuels, RETINA France, Programme Hospitalier de Recherche National 2007, and the Association Bardet-Biedl, France to H. D. and C. S.; the European Community's Seventh Framework Programme FP7/2009 under grant agreement no: 241955, SYSCILIA (to R. H. G., G. G. S., N.K., R. R., H.O., C.A.J. and G. W.); the Dutch Kidney Foundation (KJPB09.009 and IP11.58 to H. H. A); the Retina Research Foundation and the National Eye Institute (R01EY018571) to R.C.; the NIH to H. W. (F32EY19430); and the DFG (SCHE1562 and SFB832 to B. S.; SFB829 to T. B.; SFB592 to H.O.). R. K. K. is supported by FFB-Canada, CIHR, FRSQ, and Reseau Vision. J.S.A. is supported by the Lundbeck Foundation. V. B. is supported by MSM0021622430 (Ministry of Education, Youth and Sports of the Czech Republic), 204/09/H058, and 204/09/0498 (Czech Science Foundation) and EMBO Installation Grant; I. C. is supported by the programme, Brno PhD Talent of South Moravian Center for International Mobility. S. S. is a laureate of the "Equipe FRM" (DEQ20071210558) and the Agence National de la Recherche (R09087KS, R11012KK). W.Z. is a Carl. W. Gottschalk research scholar of the American Society of Nephrology. J.A.S. is a GlaxoSmithKline clinician scientist. A. S. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists and the Doris Duke Charitable Foundation Clinical Scientist Development Awards and is a Rita Allen Foundation and an Irma T. Hirschl scholar. F. H. is an Investigator of the Howard Hughes Medical Institute, a Frederick G. L. Huetwell Professor, and a Doris Duke Distinguished Clinical Scientist.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Alcaraz WA, 2011, HUM MOL GENET, V20, P3822, DOI 10.1093/hmg/ddr300; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Elias E, 2003, EXP CELL RES, V291, P176, DOI 10.1016/S0014-4827(03)00377-X; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Janderovd-Rossmeislova L, 2007, J STRUCT BIOL, V159, P56, DOI 10.1016/j.jsb.2007.02.008; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Maude SL, 2005, CANCER RES, V65, P780; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pan YR, 2009, CELL CYCLE, V8, P655, DOI 10.4161/cc.8.4.7844; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Reinhardt HC, 2011, CELL CYCLE, V10, P23, DOI 10.4161/cc.10.1.14351; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sivasubramaniam S, 2008, GENE DEV, V22, P587, DOI 10.1101/gad.1627708; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Szczerbal I, 2010, CHROMOSOME RES, V18, P887, DOI 10.1007/s10577-010-9176-1; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	51	244	258	1	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					533	548		10.1016/j.cell.2012.06.028	http://dx.doi.org/10.1016/j.cell.2012.06.028			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863007	Green Accepted, Bronze			2022-12-01	WOS:000307301400013
J	Thorogood, R; Davies, NB				Thorogood, Rose; Davies, Nicholas B.			Cuckoos Combat Socially Transmitted Defenses of Reed Warbler Hosts with a Plumage Polymorphism	SCIENCE			English	Article							NEST DEFENSE; COLOR POLYMORPHISM; MIMICRY; EVOLUTION; BIRDS; COMMUNICATION; PARASITISM; SELECTION; ECOLOGY; SIGNALS	In predator-prey and host-parasite interactions, an individual's ability to combat an opponent often improves with experience-for example, by learning to identify enemy signals. Although learning occurs through individual experience, individuals can also assess threats from social information. Such recognition could promote the evolution of polymorphisms if socially transmitted defenses depend on enemy morph frequency. This would allow rare variants to evade detection. Female brood parasitic common cuckoos, Cuculus canorus, are either gray or rufous. The gray morph is a Batesian mimic whose hawk-like appearance deters host attack. Hosts reject this disguise through social learning, increasing their own defenses when they witness neighbors mobbing a cuckoo. Our experiments reveal that social learning is specific to the cuckoo morph that neighbors mob. Therefore, while neighbors alert hosts to local cuckoo activity, frequency-dependent social information selects for a cuckoo plumage polymorphism to thwart host detection. Our results suggest that selection for mimicry and polymorphisms comes not only from personal experience but also from social learning.	[Thorogood, Rose; Davies, Nicholas B.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Thorogood, R (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	rt303@cam.ac.uk		Thorogood, Rose/0000-0001-5010-2177	Natural Environment Research Council; Natural Environment Research Council [NE/H003444/1] Funding Source: researchfish; NERC [NE/H003444/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Davies for making the wooden models, illustrations, and help in the field; C. Lindstedt, J. Mappes, and attendees of the Coevolution Symposium at the University of Jyvaskyla (October 2011) for helpful discussion; R. Kilner, M. Stevens, H. Rowland, and three anonymous referees for constructive comments on the manuscript; the National Trust, C. Thorne, and the Wicken Fen Group for facilitating our work at Wicken Fen; Natural England for a license for experimental work at reed warbler nests; and the Natural Environment Research Council for funding. Both authors contributed equally to the work, and data for all analyses are included within the supplementary materials.	Bleay C, 2007, P ROY SOC B-BIOL SCI, V274, P2019, DOI 10.1098/rspb.2007.0361; Campobello D, 2011, BEHAV ECOL, V22, P422, DOI 10.1093/beheco/arq225; Campobello D, 2010, ETHOLOGY, V116, P498, DOI 10.1111/j.1439-0310.2010.01764.x; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Comeault AA, 2011, J EVOLUTION BIOL, V24, P1374, DOI 10.1111/j.1420-9101.2011.02258.x; Darst CR, 2006, NATURE, V440, P208, DOI 10.1038/nature04297; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; Davies NB, 2009, SCIENCE, V324, P1318, DOI 10.1126/science.1172227; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Endler JA, 2009, AM NAT, V173, pE62, DOI 10.1086/596528; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Honza M, 2006, J ORNITHOL, V147, P629, DOI 10.1007/s10336-006-0088-y; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; PAYNE RB, 1967, AM NAT, V101, P363, DOI 10.1086/282504; Pfennig D, 2012, CURR ZOOL, V58, P604, DOI 10.1093/czoolo/58.4.604; Plotnick RE, 2010, PALEOBIOLOGY, V36, P303, DOI 10.1666/08062.1; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Ruxton GD., 2004, AVOIDING ATTACK EVOL; Speed MP, 1999, BIOL J LINN SOC, V67, P281, DOI 10.1006/bijl.1998.0310; Stoddard MC, 2012, CURR ZOOL, V58, P630, DOI 10.1093/czoolo/58.4.630; Voipio P., 1953, ORNIS FENNICA, V30, P99; Welbergen JA, 2011, BEHAV ECOL, V22, P574, DOI 10.1093/beheco/arr008; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6	26	68	70	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					578	580		10.1126/science.1220759	http://dx.doi.org/10.1126/science.1220759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859487				2022-12-01	WOS:000307058700044
J	Tseng, VL; Yu, F; Lum, F; Coleman, AL				Tseng, Victoria L.; Yu, Fei; Lum, Flora; Coleman, Anne L.			Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIP FRACTURE; HEALTH-STATUS; OLDER-ADULTS; 2ND EYE; WOMEN; FALLS; VISION	Context Visual impairment is a known risk factor for fractures. Little is known about the association of cataract surgery with fracture risk. Objective To determine the association of cataract surgery with subsequent fracture risk in US Medicare beneficiaries with a diagnosis of cataract. Design, Setting, and Participants Retrospective study of 1-year fracture incidence in a 5% random sample of Medicare Part B beneficiaries with cataract who received and did not receive cataract surgery from 2002 through 2009. Main Outcome Measures One-year incidence of hip fractures. Analyses were adjusted for age; sex; race/ethnicity; US region of residence; systemic comorbidities, including Charlson Comorbidity Index (CCI) score; ocular comorbidities; cataract severity; and presence of physically limiting conditions. Adjusted odds ratios (ORs) of hip fractures were calculated using logistic regression modeling. Results There were 1 113 640 US Medicare beneficiaries 65 years and older with a diagnosis of cataract between 2002 and 2009 in the 5% random sample; of these patients, 410 809 (36.9%) received cataract surgery during the study period. There were 13 976 patients (1.3%) who sustained a hip fracture during the study period. The most common fracture-related comorbidity was osteoporosis (n = 134 335; 12.1%). The most common ocular comorbidity was glaucoma (n = 212 382; 19.1%). Compared with 1-year hip fracture incidence in patients with cataract who did not have cataract surgery, adjusted OR of hip fracture within 1 year after cataract surgery was 0.84 (95% CI, 0.81-0.87) with an absolute risk difference of 0.20%. Compared with matched subgroups of patients who did not receive cataract surgery, patient subgroups that experienced lower odds of hip fracture after cataract surgery included patients with severe cataract, patients most likely to receive cataract surgery based on propensity score, patients 75 years and older, and patients with a CCI score of 3 or greater. Conclusion In a cohort of US Medicare beneficiaries aged 65 years and older with a diagnosis of cataract, patients who had cataract surgery had lower odds of hip fracture within 1 year after surgery compared with patients who had not undergone cataract surgery. JAMA. 2012;308(5):493-501 www.jama.com	[Yu, Fei; Coleman, Anne L.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Ctr Eye Epidemiol, Los Angeles, CA 90095 USA; [Tseng, Victoria L.] Brown Univ, Warren Alpert Med Sch, Div Ophthalmol, Providence, RI 02912 USA; [Yu, Fei] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA; [Coleman, Anne L.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Lum, Flora; Coleman, Anne L.] Amer Acad Ophthalmol, H Dunbar Hoskins Jr MD Ctr Qual Eye Care, San Francisco, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brown University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Coleman, AL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Ctr Eye Epidemiol, 100 Stein Plaza 2-118, Los Angeles, CA 90095 USA.	colemana@ucla.edu			Center for Eye Epidemiology, Jules Stein Eye Institute	Center for Eye Epidemiology, Jules Stein Eye Institute	This study was supported by the Center for Eye Epidemiology, Jules Stein Eye Institute.	Anand V, 2003, INVEST OPHTH VIS SCI, V44, P4670, DOI 10.1167/iovs.03-0455; [Anonymous], 2009, DAT COMP 2010 TABL 4; [Anonymous], 2009, NCEST200901 US CENS; Beebe M, 2007, CURRENT PROCEDURAL T, P282; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Brannan S, 2003, BRIT J OPHTHALMOL, V87, P560, DOI 10.1136/bjo.87.5.560; Busbee BG, 2003, OPHTHALMOLOGY, V110, P2310, DOI 10.1016/S0161-6420(03)00796-6; Busbee BG, 2002, OPHTHALMOLOGY, V109, P606, DOI 10.1016/S0161-6420(01)00971-X; Centers for Medicare & Medicaid Services, AR YOU HOSP INP OUTP; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman AL, 2009, J AM GERIATR SOC, V57, P1825, DOI 10.1111/j.1532-5415.2009.02432.x; Cox A, 2005, EYE, V19, P652, DOI 10.1038/sj.eye.6701610; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Desapriya E, 2010, J CATARACT REFR SURG, V36, P13, DOI 10.1016/j.jcrs.2009.07.032; Ensrud KE, 1997, AM J MED, V103, P274, DOI 10.1016/S0002-9343(97)00025-9; FELSON DT, 1989, J AM GERIATR SOC, V37, P495, DOI 10.1111/j.1532-5415.1989.tb05678.x; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Hodge W, 2007, CAN MED ASSOC J, V176, P1285, DOI 10.1503/cmaj.060962; JAVITT JC, 1992, OPHTHALMOLOGY, V99, P1487, DOI 10.1016/s0161-6420(92)31775-0; McGwin G, 2006, J AM GERIATR SOC, V54, P1089, DOI 10.1111/j.1532-5415.2006.00770.x; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Waldo DR, HLTH CARE FINANCING	27	136	138	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					493	501		10.1001/jama.2012.9014	http://dx.doi.org/10.1001/jama.2012.9014			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851116	Bronze			2022-12-01	WOS:000306947400027
J	Lyons, JA; Aragao, D; Slattery, O; Pisliakov, AV; Soulimane, T; Caffrey, M				Lyons, Joseph A.; Aragao, David; Slattery, Orla; Pisliakov, Andrei V.; Soulimane, Tewfik; Caffrey, Martin			Structural insights into electron transfer in caa(3)-type cytochrome oxidase	NATURE			English	Article							CRYSTALLIZING MEMBRANE-PROTEINS; C-OXIDASE; THERMUS-THERMOPHILUS; PARACOCCUS-DENITRIFICANS; NUCLEOTIDE-SEQUENCE; MOLECULAR-DYNAMICS; FORCE-FIELD; SUBUNIT; COMPLEX; SITE	Cytochrome c oxidase is a member of the haem copper oxidase superfamily (HCO)(1). HCOs function as the terminal enzymes in the respiratory chain of mitochondria and aerobic prokaryotes, coupling molecular oxygen reduction to transmembrane proton pumping. Integral to the enzyme's function is the transfer of electrons from cytochrome c to the oxidase via a transient association of the two proteins. Electron entry and exit are proposed to occur from the same site on cytochrome c(2-4). Here we report the crystal structure of the caa(3)-type cytochrome oxidase from Thermus thermophilus, which has a covalently tethered cytochrome c domain. Crystals were grown in a bicontinuous mesophase using a synthetic short-chain monoacylglycerol as the hosting lipid. From the electron density map, at 2.36 angstrom resolution, a novel integral membrane subunit and a native glycoglycerophospholipid embedded in the complex were identified. Contrary to previous electron transfer mechanisms observed for soluble cytochrome c, the structure reveals the architecture of the electron transfer complex for the fused cupredoxin/cytochrome c domain, which implicates different sites on cytochrome c for electron entry and exit. Support for an alternative to the classical proton gate characteristic of this HCO class is presented.	[Lyons, Joseph A.; Slattery, Orla; Soulimane, Tewfik] Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland; [Lyons, Joseph A.; Aragao, David; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Aragao, David] Australian Synchrotron, Clayton, Vic 3168, Australia; [Pisliakov, Andrei V.] RIKEN Adv Sci Inst, Theoret Biochem Lab, Wako, Saitama 3510198, Japan; [Soulimane, Tewfik] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Caffrey, Martin] Trinity Coll Dublin, Sch Med, Dublin, Ireland	University of Limerick; Trinity College Dublin; RIKEN; University of Limerick; Trinity College Dublin	Soulimane, T (corresponding author), Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland.	tewfik.soulimane@ul.ie; martin.caffrey@tcd.ie	Aragao, David/A-1695-2012; Lyons, Joseph/AAA-2528-2020; Pisliakov, Andrei/C-7007-2012; Aragao, David/AAV-5514-2021	Aragao, David/0000-0002-6551-4657; Pisliakov, Andrei/0000-0003-1536-0589; Aragao, David/0000-0002-6551-4657; Lyons, Joseph/0000-0003-0218-4862; Caffrey, Martin/0000-0002-2931-4551	Science Foundation Ireland [07/IN.1/B1836, BICF685]; National Institutes of Health [GM75915, P50GM073210, U54GM094599]; FP7 COST [CM0902]; Marie Curie Actions [PIEF-GA-2009-235612]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075915, R01GM061070, U54GM094599, P50GM073210] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP7 COST; Marie Curie Actions(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from Science Foundation Ireland Grants 07/IN.1/B1836 (M. C.) and BICF685 (T. S.), the National Institutes of Health Grants GM75915, P50GM073210, U54GM094599 (M. C.), and FP7 COST CM0902 (M. C.) and Marie Curie Actions PIEF-GA-2009-235612 (D. A.). We thank D. Hart, J. Lee and T. Smyth for help with 7.7 MAG synthesis, M. Dewor for amino acid sequencing, C. Soares for discussions regarding surface potential calculations, and G. Winter for help with data reduction from multiple crystals. The assistance and support of beamline scientists at the Advanced Photon Source (23-ID), Diamond Light Source (I24) and Swiss Light Source (PX1) are gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Backgren C, 2000, BIOCHEMISTRY-US, V39, P7863, DOI 10.1021/bi000806b; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASHFORD D, 1992, J MOL BIOL, V224, P473, DOI 10.1016/0022-2836(92)91009-E; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; Caffrey M, 2009, CURR TOP MEMBR, V63, P83, DOI 10.1016/S1063-5823(09)63004-0; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Drosou V, 2002, EUR J BIOCHEM, V269, P2980, DOI 10.1046/j.1432-1033.2002.02979.x; Drosou V, 2002, BIOCHEMISTRY-US, V41, P10629, DOI 10.1021/bi020094k; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FEE JA, 1980, P NATL ACAD SCI-BIOL, V77, P147, DOI 10.1073/pnas.77.1.147; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hofer N, 2011, CRYST GROWTH DES, V11, P1182, DOI 10.1021/cg101384p; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Li DF, 2011, CRYST GROWTH DES, V11, P530, DOI 10.1021/cg101378s; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maneg O, 2004, BBA-BIOENERGETICS, V1655, P274, DOI 10.1016/j.bbabio.2003.10.010; Maneg O, 2003, J BIOL CHEM, V278, P46734, DOI 10.1074/jbc.M307594200; MATHER MW, 1991, J BIOL CHEM, V266, P5025; MATHER MW, 1993, J BIOL CHEM, V268, P5395; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misquitta LV, 2004, STRUCTURE, V12, P2113, DOI 10.1016/j.str.2004.09.020; Muresanu L, 2006, J BIOL CHEM, V281, P14503, DOI 10.1074/jbc.M601108200; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Pereira MM, 2008, BBA-BIOENERGETICS, V1777, P929, DOI 10.1016/j.bbabio.2008.05.441; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pereira MM, 2006, FEBS LETT, V580, P1350, DOI 10.1016/j.febslet.2006.01.055; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santana M, 2001, J BACTERIOL, V183, P687, DOI 10.1128/JB.183.2.687-699.2001; Soares CM, 2004, J BIOL INORG CHEM, V9, P124, DOI 10.1007/s00775-003-0509-9; Soulimane T, 2000, PROTEIN SCI, V9, P2068, DOI 10.1110/ps.9.11.2068; Soulimane T., 2003, MEMBRANE PROTEIN PUR, P229; Srinivasan V, 2005, J MOL BIOL, V345, P1047, DOI 10.1016/j.jmb.2004.10.069; STEFFENS GCM, 1987, EUR J BIOCHEM, V164, P295, DOI 10.1111/j.1432-1033.1987.tb11057.x; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wienk H, 2003, BIOCHEMISTRY-US, V42, P6005, DOI 10.1021/bi027198f; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	58	96	97	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					514	518		10.1038/nature11182	http://dx.doi.org/10.1038/nature11182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22763450	Green Accepted			2022-12-01	WOS:000306815300045
J	Yvon-Durocher, G; Caffrey, JM; Cescatti, A; Dossena, M; del Giorgio, P; Gasol, JM; Montoya, JM; Pumpanen, J; Staehr, PA; Trimmer, M; Woodward, G; Allen, AP				Yvon-Durocher, Gabriel; Caffrey, Jane M.; Cescatti, Alessandro; Dossena, Matteo; del Giorgio, Paul; Gasol, Josep M.; Montoya, Jose M.; Pumpanen, Jukka; Staehr, Peter A.; Trimmer, Mark; Woodward, Guy; Allen, Andrew P.			Reconciling the temperature dependence of respiration across timescales and ecosystem types	NATURE			English	Article							BIOMASS DISTRIBUTION; METABOLIC BALANCE; CARBON EXCHANGE; COMMUNITIES; PATTERNS; EMISSIONS; CLIMATE; LINKING; SOILS; CYCLE	Ecosystem respiration is the biotic conversion of organic carbon to carbon dioxide by all of the organisms in an ecosystem, including both consumers and primary producers. Respiration exhibits an exponential temperature dependence at the subcellular and individual levels(1), but at the ecosystem level respiration can be modified by many variables(2-4) including community abundance and biomass(5), which vary substantially among ecosystems(6). Despite its importance for predicting the responses of the biosphere to climate change, it is as yet unknown whether the temperature dependence of ecosystem respiration varies systematically between aquatic and terrestrial environments. Here we use the largest database of respiratory measurements yet compiled to show that the sensitivity of ecosystem respiration to seasonal changes in temperature is remarkably similar for diverse environments encompassing lakes, rivers, estuaries, the open ocean and forested and non-forested terrestrial ecosystems, with an average activation energy similar to that of the respiratory complex(3) (approximately 0.65 electronvolts (eV)). By contrast, annual ecosystem respiration shows a substantially greater temperature dependence across aquatic (approximately 0.65 eV) versus terrestrial ecosystems (approximately 0.32 eV) that span broad geographic gradients in temperature. Using a model(5) derived from metabolic theory(7), these findings can be reconciled by similarities in the biochemical kinetics of metabolism at the subcellular level, and fundamental differences in the importance of other variables besides temperature-such as primary productivity and allochthonous carbon inputs-on the structure of aquatic and terrestrial biota at the community level.	[Yvon-Durocher, Gabriel; Dossena, Matteo; Trimmer, Mark; Woodward, Guy] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Yvon-Durocher, Gabriel] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England; [Caffrey, Jane M.] Univ W Florida, Ctr Environm Diagnost & Bioremediat, Pensacola, FL 32514 USA; [Cescatti, Alessandro] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, Italy; [del Giorgio, Paul] Univ Quebec Montreal, Dept Sci Biol, Montreal, PQ H2X 3X8, Canada; [Gasol, Josep M.; Montoya, Jose M.] Inst Marine Sci ICM CSIC, E-08003 Barcelona, Spain; [Pumpanen, Jukka] Univ Helsinki, Dept Forest Sci, FI-00014 Helsinki, Finland; [Staehr, Peter A.] Aarhus Univ, Inst Biosci, DK-4000 Roskilde, Denmark; [Allen, Andrew P.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	University of London; Queen Mary University London; University of Exeter; State University System of Florida; University of West Florida; European Commission Joint Research Centre; EC JRC ISPRA Site; University of Quebec; University of Quebec Montreal; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Helsinki; Aarhus University; Macquarie University	Yvon-Durocher, G (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	g.yvon-durocher@exeter.ac.uk	Trimmer, Mark/ABB-2336-2021; Yvon-Durocher, Gabriel/M-4600-2014; Pumpanen, Jukka/B-1254-2012; del Giorgio, Paul/AAD-1315-2019; Gasol, Josep M M/B-1709-2008; Montoya, Jose/AAH-2369-2019; Staehr, Peter/S-6110-2018; Staehr, Peter/J-3693-2013; Cescatti, Alessandro/ABE-6319-2020; Allen, Andrew/B-8045-2011	Trimmer, Mark/0000-0002-9859-5537; Yvon-Durocher, Gabriel/0000-0002-1749-3417; Pumpanen, Jukka/0000-0003-4879-3663; del Giorgio, Paul/0000-0003-1866-8159; Gasol, Josep M M/0000-0001-5238-2387; Staehr, Peter/0000-0002-1580-4875; Staehr, Peter/0000-0002-1580-4875; Allen, Andrew/0000-0003-0304-7544; Montoya, Jose M./0000-0002-6676-7592	Natural Environment Research Council, UK [NE/F004753/1]; Danish Council for Independent Research, Natural Sciences [10-085238]; Danish Centre for Lake Restoration(CLEAR); Academy of Finland Centre of Excellence program [218094]; Ramon y Cajal Fellowship [RYC-892 2008-03664]; Ministry of Economy [CGL2010-20091]; Generalitat de Catalunya [2009SGR142]; Natural Environment Research Council [NE/H022511/1] Funding Source: researchfish; NERC [NE/H022511/1] Funding Source: UKRI	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Danish Centre for Lake Restoration(CLEAR); Academy of Finland Centre of Excellence program(Academy of Finland); Ramon y Cajal Fellowship(Spanish Government); Ministry of Economy; Generalitat de Catalunya(Generalitat de Catalunya); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We wish to thank J. Cole, M. Pace, M. Reichstein and D. Baldocchi for helpful comments that greatly improved the manuscript. M. Mahecha, C. S. Hopkinson, E. Smith, C. Gudasz, C. Solomon, E. Gaiser, E. de Eyto, C.-Y. Chiu, D. Hamilton, S. Hendricks, R. Adrian, K. Rose, D. Bruesewitz, D. Richardson, M. Van de Bogert, FLUXNET and GLEON are gratefully acknowledged for supplying raw data. G.Y.-D., M. T. and G. W. acknowledge the support of the Natural Environment Research Council, UK (grant NE/F004753/1) for financial support. P. A. S. was funded by the Danish Council for Independent Research, Natural Sciences grant 10-085238 and the Danish Centre for Lake Restoration(CLEAR). J. P. acknowledges the Academy of Finland Centre of Excellence program (project number 218094) for funding. J. M. M. was supported by a Ramon y Cajal Fellowship (RYC-892 2008-03664), a Ministry of Economy grant (CGL2010-20091) and Generalitat de Catalunya grant (2009SGR142).	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; [Anonymous], 2011, R LANG ENV STAT COMP; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Chapin III S.F., 2002, PRINCIPLES TERRESTRI; Del Giorgio P., 2005, RESP AQUATIC ECOSYST, P57, DOI DOI 10.1093/ACPROF:OSO/9780198527084.001.0001; Del Giorgio PA, 1999, ECOLOGY, V80, P1422, DOI 10.1890/0012-9658(1999)080[1422:LPBAMT]2.0.CO;2; DELGIORGIO PA, 1995, AM NAT, V146, P135, DOI 10.1086/285790; Dewar RC, 1999, GLOBAL CHANGE BIOL, V5, P615, DOI 10.1046/j.1365-2486.1999.00253.x; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gu LH, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003164; Kesselmeier J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001813; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Pereira JS, 2007, BIOGEOSCIENCES, V4, P791, DOI 10.5194/bg-4-791-2007; Pinheiro JC., 2000, MIXED EFFECTS MODELS, V43, P111; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Regaudie-De-Gioux A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003907; Savage VM, 2004, J THEOR BIOL, V227, P525, DOI 10.1016/j.jtbi.2003.11.030; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	28	286	295	15	454	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					472	476		10.1038/nature11205	http://dx.doi.org/10.1038/nature11205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22722862				2022-12-01	WOS:000306815300036
J	Fauci, AS; Folkers, GK				Fauci, Anthony S.; Folkers, Gregory K.			Toward an AIDS-Free Generation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV PREVENTION		[Fauci, Anthony S.; Folkers, Gregory K.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 31 Ctr Dr,Bldg 31,Room 7A-03,MSC 2520, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Johnston MI, 2011, NEW ENGL J MED, V365, P873, DOI 10.1056/NEJMp1107621; UNAIDS, 2011, GLOB HIV AIDS RESP E	7	62	62	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2012	308	4					343	344		10.1001/jama.2012.8142	http://dx.doi.org/10.1001/jama.2012.8142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977SR	22820783	Bronze			2022-12-01	WOS:000306685500018
J	Lyons, PA; Rayner, TF; Trivedi, S; Holle, JU; Watts, RA; Jayne, DRW; Baslund, B; Brenchley, P; Bruchfeld, A; Chaudhry, AN; Tervaert, JWC; Deloukas, P; Feighery, C; Gross, WL; Guillevin, L; Gunnarsson, I; Harper, L; Hruskova, Z; Little, MA; Martorana, D; Neumann, T; Ohlsson, S; Padmanabhan, S; Pusey, CD; Salama, AD; Sanders, JSF; Savage, CO; Segelmark, M; Stegeman, CA; Tesar, V; Vaglio, A; Wieczorek, S; Wilde, B; Zwerina, J; Rees, AJ; Clayton, DG; Smith, KGC				Lyons, Paul A.; Rayner, Tim F.; Trivedi, Sapna; Holle, Julia U.; Watts, Richard A.; Jayne, David R. W.; Baslund, Bo; Brenchley, Paul; Bruchfeld, Annette; Chaudhry, Afzal N.; Tervaert, Jan Willem Cohen; Deloukas, Panos; Feighery, Conleth; Gross, Wolfgang L.; Guillevin, Loic; Gunnarsson, Iva; Harper, Lorraine; Hruskova, Zdenka; Little, Mark A.; Martorana, Davide; Neumann, Thomas; Ohlsson, Sophie; Padmanabhan, Sandosh; Pusey, Charles D.; Salama, Alan D.; Sanders, Jan-Stephan F.; Savage, Caroline O.; Segelmark, Mrten; Stegeman, Coen A.; Tesar, Vladimir; Vaglio, Augusto; Wieczorek, Stefan; Wilde, Benjamin; Zwerina, Jochen; Rees, Andrew J.; Clayton, David G.; Smith, Kenneth G. C.			Genetically Distinct Subsets within ANCA-Associated Vasculitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; ANTIBODY-ASSOCIATED VASCULITIS; GENOME-WIDE ASSOCIATION; SMALL-VESSEL VASCULITIS; WEGENERS-GRANULOMATOSIS; SYSTEMIC VASCULITIS; PATHOGENESIS; PROTEINASE-3; NEUTROPHILS; DISEASE	BACKGROUND Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a severe condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis) and microscopic polyangiitis. Its cause is unknown, and there is debate about whether it is a single disease entity and what role ANCA plays in its pathogenesis. We investigated its genetic basis. METHODS A genomewide association study was performed in a discovery cohort of 1233 U. K. patients with ANCA-associated vasculitis and 5884 controls and was replicated in 1454 Northern European case patients and 1666 controls. Quality control, population stratification, and statistical analyses were performed according to standard criteria. RESULTS We found both major-histocompatibility-complex (MHC) and non-MHC associations with ANCA-associated vasculitis and also that granulomatosis with polyangiitis and microscopic polyangiitis were genetically distinct. The strongest genetic associations were with the antigenic specificity of ANCA, not with the clinical syndrome. Anti-proteinase 3 ANCA was associated with HLA-DP and the genes encoding alpha(1)-antitrypsin (SERPINA1) and proteinase 3 (PRTN3) (P = 6.2x10(-89), P = 5.6x10(-12), and P = 2.6x10(-7), respectively). Anti-myeloperoxidase ANCA was associated with HLA-DQ (P = 2.1x10(-8)). CONCLUSIONS This study confirms that the pathogenesis of ANCA-associated vasculitis has a genetic component, shows genetic distinctions between granulomatosis with polyangiitis and microscopic polyangiitis that are associated with ANCA specificity, and suggests that the response against the autoantigen proteinase 3 is a central pathogenic feature of proteinase 3 ANCA-associated vasculitis. These data provide preliminary support for the concept that proteinase 3 ANCA-associated vasculitis and myeloperoxidase ANCA-associated vasculitis are distinct autoimmune syndromes. (Funded by the British Heart Foundation and others.)	[Lyons, Paul A.; Rayner, Tim F.; Trivedi, Sapna; Clayton, David G.; Smith, Kenneth G. C.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Lyons, Paul A.; Rayner, Tim F.; Trivedi, Sapna; Jayne, David R. W.; Chaudhry, Afzal N.; Smith, Kenneth G. C.] Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Clayton, David G.] Addenbrookes Hosp, Dept Med Genet, Cambridge, England; [Trivedi, Sapna; Jayne, David R. W.; Chaudhry, Afzal N.; Smith, Kenneth G. C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge, England; [Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge, England; [Watts, Richard A.] Ipswich Hosp Natl Hlth Serv Trust, Dept Rheumatol, Ipswich, Suffolk, England; [Watts, Richard A.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Brenchley, Paul] Univ Manchester, Sch Biomed, Manchester, Lancs, England; [Savage, Caroline O.] GlaxoSmithKline, Stevenage, Herts, England; [Harper, Lorraine; Stegeman, Coen A.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England; [Little, Mark A.; Salama, Alan D.] UCL, Ctr Nephrol, Royal Free Hosp, London, England; [Padmanabhan, Sandosh] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Pusey, Charles D.; Salama, Alan D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Renal Sect, London, England; [Holle, Julia U.; Gross, Wolfgang L.] Univ Hosp Schleswig Holstein, Dept Rheumatol, Lubeck, Germany; [Holle, Julia U.; Gross, Wolfgang L.] Klinikum Bad Bramstedt, Dept Rheumatol & Immunol, Bad Bramstedt, Germany; [Wieczorek, Stefan] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Neumann, Thomas] Univ Hosp, Dept Internal Med 3, Jena, Germany; [Zwerina, Jochen] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Baslund, Bo] Copenhagen Univ Hosp, Dept Rheumatol, Rigshospitalet, Copenhagen, Denmark; [Bruchfeld, Annette] Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden; [Gunnarsson, Iva] Karolinska Univ Hosp, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Ohlsson, Sophie; Segelmark, Mrten] Karolinska Inst, Stockholm, Sweden; [Ohlsson, Sophie; Segelmark, Mrten] Lund Univ, Dept Clin Sci, Lund, Sweden; [Segelmark, Mrten] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Tervaert, Jan Willem Cohen; Wilde, Benjamin] Maastricht Univ, Med Ctr, Cardiovasc Res Inst, Div Clin & Expt Immunol,Dept Internal Med, Maastricht, Netherlands; [Sanders, Jan-Stephan F.; Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9700 AB Groningen, Netherlands; [Feighery, Conleth] Trinity Coll Dublin, Dept Immunol, Dublin, Ireland; [Feighery, Conleth] St James Hosp, Dublin, Ireland; [Guillevin, Loic] Univ Paris, Hop Cochin, F-75252 Paris, France; [Hruskova, Zdenka; Tesar, Vladimir] Charles Univ Prague, Dept Nephrol, Prague, Czech Republic; [Hruskova, Zdenka; Tesar, Vladimir] Gen Univ Hosp, Prague, Czech Republic; [Martorana, Davide] Univ Hosp, Mol Genet Unit, Parma, Italy; [Vaglio, Augusto] Univ Hosp, Nephrol Unit, Parma, Italy; [Zwerina, Jochen] Med Univ Vienna, Hanusch Hosp Wiener Gebietskrankenkasse, Ludwig Boltzmann Inst Osteol, Vienna, Austria; [Zwerina, Jochen] Med Univ Vienna, Hanusch Hosp, Allgemeine Unfallversicherungsanstalt, Trauma Ctr Meidling, Vienna, Austria; [Rees, Andrew J.] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Ipswich Hospital NHS Trust; Ipswich Hospital; University of East Anglia; University of Manchester; GlaxoSmithKline; University of Birmingham; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Glasgow; Imperial College London; University of Kiel; Schleswig Holstein University Hospital; Ruhr University Bochum; Friedrich Schiller University of Jena; University of Erlangen Nuremberg; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Lund University; Linkoping University; Maastricht University; University of Groningen; Trinity College Dublin; Trinity College Dublin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Charles University Prague; General University Hospital Prague; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; Ludwig Boltzmann Institute; Medical University of Vienna; WGKK - Hanusch Hospital; Medical University of Vienna; WGKK - Hanusch Hospital; Medical University of Vienna	Smith, KGC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Box 139,Hills Rd, Cambridge CB2 0XY, England.	kgcs2@cam.ac.uk	Tesar, Vladimir/O-2312-2017; Gross, Wolfgang Ludwig WG/C-8733-2011; Wieczorek, Stefan/F-7721-2014; Neumann, Thomas/F-2116-2016; Sanders, Jan-Stephan/ABC-6782-2021; tervaert, jan willem cohen/AAB-1111-2019; Little, Mark/O-2161-2019; Deloukas, Panos/B-2922-2013; Hrušková, Zdenka/O-2079-2017; Padmanabhan, Sandosh/S-3963-2016; Martorana, Davide/K-6374-2016; Wilde, Benjamin/H-9986-2012; Ohlsson, Sophie/W-9495-2019; Vaglio, Augusto/AHE-8117-2022; Little, Mark A/E-7072-2014; Holle, Julia/G-6138-2012	Tesar, Vladimir/0000-0001-6982-0689; Neumann, Thomas/0000-0001-6810-6889; Little, Mark/0000-0001-6003-397X; Deloukas, Panos/0000-0001-9251-070X; Hrušková, Zdenka/0000-0002-2658-365X; Martorana, Davide/0000-0002-7572-7031; Wilde, Benjamin/0000-0002-5115-6799; Ohlsson, Sophie/0000-0002-5253-1650; Vaglio, Augusto/0000-0002-3814-9172; Little, Mark A/0000-0001-6003-397X; Stegeman, Coen/0000-0002-0224-0927; Bruchfeld, Annette/0000-0002-9752-9941; Padmanabhan, Sandosh/0000-0003-3869-5808; Sanders, Jan-Stephan/0000-0002-0904-3969; Rayner, Tim/0000-0002-6992-5592; Smith, Kenneth/0000-0003-3829-4326; harper, lorraine/0000-0003-1343-9234; Jayne, David/0000-0002-1712-0637; Segelmark, Marten/0000-0002-1221-0772; Brenchley, Paul/0000-0003-1290-9919	British Heart Foundation [SP/09/001/27117]; Wellcome Trust [083650/Z/07/Z]; National Institute of Health Research Biomedical Research Centres of Cambridge, Imperial College, and Manchester; Medical Research Council; Kidney Research UK; West Anglia Comprehensive Local Research Network; Norfolk and Suffolk Comprehensive Local Research Network; German Research Foundation [KFO170]; European Union [CP-FP 261382]; Medical Research Council [G0400929] Funding Source: researchfish; MRC [G0400929] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); National Institute of Health Research Biomedical Research Centres of Cambridge, Imperial College, and Manchester; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); West Anglia Comprehensive Local Research Network; Norfolk and Suffolk Comprehensive Local Research Network; German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the British Heart Foundation (SP/09/001/27117, to Dr. Smith); the Wellcome Trust (083650/Z/07/Z, to Dr. Smith); the National Institute of Health Research Biomedical Research Centres of Cambridge, Imperial College, and Manchester; the Medical Research Council and Kidney Research UK (to Drs. Rees and Pusey); the West Anglia Comprehensive Local Research Network (to Drs. Smith and Jayne); the Norfolk and Suffolk Comprehensive Local Research Network (to Dr. Watts); and the German Research Foundation (KFO170, to Drs. Holle and Wieczorek); and by a contract from the European Union FP7 Infectious Triggers of Chronic Autoimmunity Consortium (CP-FP 261382, to Drs. Smith, Lyons, and Rees).	Borgmann S, 2001, CLIN IMMUNOL, V98, P244, DOI 10.1006/clim.2000.4962; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen M, 2010, NAT REV RHEUMATOL, V6, P653, DOI 10.1038/nrrheum.2010.158; Ciavatta DJ, 2010, J CLIN INVEST, V120, P3209, DOI 10.1172/JCI40034; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; ESNAULT VLM, 1993, KIDNEY INT, V43, P1329, DOI 10.1038/ki.1993.186; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Falk RJ, 2011, ARTHRITIS RHEUM-US, V63, P863, DOI 10.1002/art.30286; Finkielman JD, 2007, ANN INTERN MED, V147, P611, DOI 10.7326/0003-4819-147-9-200711060-00005; Flossmann O, 2011, ANN RHEUM DIS, V70, P488, DOI 10.1136/ard.2010.137778; Gencik M, 2000, KIDNEY INT, V58, P2473, DOI 10.1046/j.1523-1755.2000.00430.x; Hagen EC, 1998, KIDNEY INT, V53, P743, DOI 10.1046/j.1523-1755.1998.00807.x; Hoffman GS, 2005, ANN INTERN MED, V143, P683, DOI 10.7326/0003-4819-143-9-200511010-00012; Hogan SL, 2006, ANN INTERN MED, V144, P377, DOI 10.7326/0003-4819-144-5-200603070-00019; Jagiello P, 2004, HUM GENET, V114, P468, DOI 10.1007/s00439-004-1092-z; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Knight A, 2008, ARTHRITIS RHEUM-US, V58, P302, DOI 10.1002/art.23157; Lane SE, 2005, QJM-INT J MED, V98, P97, DOI 10.1093/qjmed/hci015; Linder R, 2011, J RHEUMATOL, V38, P1039, DOI 10.3899/jrheum.100814; Little MA, 2011, CLIN EXP IMMUNOL, V164, P124; Monach PA, 2010, CURR OPIN RHEUMATOL, V22, P157, DOI 10.1097/BOR.0b013e32833654a8; Mukhtyar C, 2008, ANN RHEUM DIS, V67, P1004, DOI 10.1136/ard.2007.071936; Radford DJ, 2000, ARTHRITIS RHEUM, V43, P1337, DOI 10.1002/1529-0131(200006)43:6<1337::AID-ANR16>3.0.CO;2-M; Rarok AA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028642.26222.00; Sable-Fourtassou G, 2005, ANN INTERN MED, V143, P632, DOI 10.7326/0003-4819-143-9-200511010-00006; Savage COS, 2011, CLIN EXP IMMUNOL, V164, P23, DOI 10.1111/j.1365-2249.2011.04362.x; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Stegeman CA, 2002, NEPHROL DIAL TRANSPL, V17, P2077, DOI 10.1093/ndt/17.12.2077; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Suppiah R, 2011, ARTHRIT CARE RES, V63, P588, DOI 10.1002/acr.20433; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Wieczorek S, 2010, CURR OPIN RHEUMATOL, V22, P8, DOI 10.1097/BOR.0b013e3283331151; Willcocks LC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2928; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918	40	605	635	3	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2012	367	3					214	223		10.1056/NEJMoa1108735	http://dx.doi.org/10.1056/NEJMoa1108735			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975PI	22808956	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000306522900005
J	Liu, W; Chun, E; Thompson, AA; Chubukov, P; Xu, F; Katritch, V; Han, GW; Roth, CB; Heitman, LH; IJzerman, AP; Cherezov, V; Stevens, RC				Liu, Wei; Chun, Eugene; Thompson, Aaron A.; Chubukov, Pavel; Xu, Fei; Katritch, Vsevolod; Han, Gye Won; Roth, Christopher B.; Heitman, Laura H.; IJzerman, Adriaan P.; Cherezov, Vadim; Stevens, Raymond C.			Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions	SCIENCE			English	Article							ADENOSINE A(2A) RECEPTOR; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; MODULATION; RHODOPSIN; COMPLEX; AMILORIDE; RESIDUES; SITE	Pharmacological responses of G protein-coupled receptors (GPCRs) can be fine-tuned by allosteric modulators. Structural studies of such effects have been limited due to the medium resolution of GPCR structures. We reengineered the human A(2A) adenosine receptor by replacing its third intracellular loop with apocytochrome b(562)RIL and solved the structure at 1.8 angstrom resolution. The high-resolution structure allowed us to identify 57 ordered water molecules inside the receptor comprising three major clusters. The central cluster harbors a putative sodium ion bound to the highly conserved aspartate residue Asp(2.50). Additionally, two cholesterols stabilize the conformation of helix VI, and one of 23 ordered lipids intercalates inside the ligand-binding pocket. These high-resolution details shed light on the potential role of structured water molecules, sodium ions, and lipids/cholesterol in GPCR stabilization and function.	[Liu, Wei; Chun, Eugene; Thompson, Aaron A.; Chubukov, Pavel; Xu, Fei; Katritch, Vsevolod; Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Roth, Christopher B.] Receptos, San Diego, CA 92121 USA; [Heitman, Laura H.; IJzerman, Adriaan P.] Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands	Scripps Research Institute; Leiden University; Leiden University - Excl LUMC	Cherezov, V (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vcherezo@scripps.edu; stevens@scripps.edu	IJzerman, Ad/ABG-1353-2020; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8724-2022; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLT-1531-2022; Heitman, Laura/H-9019-2017	IJzerman, Ad/0000-0002-1182-2259; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Stevens, Raymond/0000-0002-4522-8725; Heitman, Laura/0000-0002-1381-8464; Thompson, Aaron/0000-0003-4314-4242	NIH Common Fund in Structural Biology grant [P50 GM073197]; NIH/National Institute of General Medical Sciences (NIGMS) PSI: Biology grant [U54 GM094618]; NIGMS [R01 GM089857, Y1-GM-1104]; Dutch Research Council Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP grant [714.011.001]; NWO Veni grant [11188]; National Cancer Institute [Y1-CO-1020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089857, U54GM094618, P50GM073197] Funding Source: NIH RePORTER	NIH Common Fund in Structural Biology grant; NIH/National Institute of General Medical Sciences (NIGMS) PSI: Biology grant; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Dutch Research Council Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP grant; NWO Veni grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Common Fund in Structural Biology grant P50 GM073197 for technology development, NIH/National Institute of General Medical Sciences (NIGMS) PSI: Biology grant U54 GM094618 for biological studies and structure production, NIGMS grant R01 GM089857 to V. C., a Dutch Research Council Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) TOP grant (714.011.001: "The crystal structure of the adenosine A<INF>2A</INF> receptor: The follow-up") to A. P. I., and an NWO Veni grant (11188) to L. H. H. We thank J. Velasquez for help on molecular biology; T. Trinh, K. Allin, and M. Chu for help on baculovirus expression; T. Mulder-Krieger and H. de Vries for their technical expertise in the biochemical characterization, G. van Westen for his educated comments on the crystal structure; M. Mileni for reviewing the final structure; J. P. Changeux for discussions on GPCR allostery and the potential for allosteric stabilizers; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and NIGMS grant Y1-GM-1104. Coordinates and the structure factors have been deposited in the Protein Data Bank under the accession code (4EIY). R. C. S. is a founder and on the Board of Directors of Receptos, a GPCR structure-based drug discovery company. R. C. S., C. B. R., A. A. T., W. L., F. X., E. C., and V. K. are inventors on a patent applied for jointly by The Scripps Research Institute and Receptos on the use of fusion proteins to crystallize GPCRs.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Barbhaiya H, 1996, MOL PHARMACOL, V50, P1635; Burger K, 2000, CELL MOL LIFE SCI, V57, P1577, DOI 10.1007/PL00000643; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Gao ZG, 2003, MOL PHARMACOL, V63, P1021, DOI 10.1124/mol.63.5.1021; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Goblyos A, 2011, BBA-BIOMEMBRANES, V1808, P1309, DOI 10.1016/j.bbamem.2010.06.013; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hansen MC, 2013, SCIENCE, V342, P850, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; HOWARD MJ, 1987, MOL PHARMACOL, V32, P53; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Katritch V, 2011, NEUROPHARMACOLOGY, V60, P108, DOI 10.1016/j.neuropharm.2010.07.009; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; NUNNARI JM, 1987, J BIOL CHEM, V262, P12387; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Parker MS, 2008, AMINO ACIDS, V35, P1, DOI 10.1007/s00726-008-0637-6; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Selent J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000884; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zhorov BS, 1998, J BIOMOL STRUCT DYN, V15, P631, DOI 10.1080/07391102.1998.10508980	35	874	889	6	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2012	337	6091					232	236		10.1126/science.1219218	http://dx.doi.org/10.1126/science.1219218			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22798613	Green Accepted			2022-12-01	WOS:000306323500058
J	Krautler, NJ; Kana, V; Kranich, J; Tian, YH; Perera, D; Lemm, D; Schwarz, P; Armulik, A; Browning, JL; Tallquist, M; Buch, T; Oliveira-Martins, JB; Zhu, CH; Hermann, M; Wagner, U; Brink, R; Heikenwalder, M; Aguzzi, A				Krautler, Nike Julia; Kana, Veronika; Kranich, Jan; Tian, Yinghua; Perera, Dushan; Lemm, Doreen; Schwarz, Petra; Armulik, Annika; Browning, Jeffrey L.; Tallquist, Michelle; Buch, Thorsten; Oliveira-Martins, Jose B.; Zhu, Caihong; Hermann, Mario; Wagner, Ulrich; Brink, Robert; Heikenwalder, Mathias; Aguzzi, Adriano			Follicular Dendritic Cells Emerge from Ubiquitous Perivascular Precursors	CELL			English	Article							TUMOR-NECROSIS-FACTOR; LYMPHOTOXIN-BETA-RECEPTOR; LYMPH-NODE; B-CELL; T-CELL; ABNORMAL-DEVELOPMENT; APOPTOTIC CELLS; IMMUNE-RESPONSE; RETICULAR CELLS; MICE DEFICIENT	The differentiation of follicular dendritic cells (FDC) is essential to the remarkable microanatomic plasticity of lymphoid follicles. Here we show that FDC arise from ubiquitous perivascular precursors (preFDC) expressing platelet-derived growth factor receptor beta (PDGFR beta). PDGFR beta-Cre-driven reporter gene recombination resulted inFDClabeling, whereas conditional ablation of PDGFR beta(+)-derived cells abolished FDC, indicating that FDC originate from PDGFR beta(+) cells. Lymphotoxin-alpha-overexpressing prion protein (PrP)(+) kidneys developed PrP+ FDC after transplantation into PrP- mice, confirming that preFDC exist outside lymphoid organs. Adipose tissue-derived PDGFR beta(+) stromal-vascular cells responded to FDC maturation factors and, when transplanted into lymphotoxin b receptor (LT beta R)(-) kidney capsules, differentiated into Mfge8(+)CD21/35(+) Fc gamma RII beta+PrP+FDC capable of trapping immune complexes and recruiting B cells. Spleens of lymphocyte-deficient mice contained perivascular PDGFRb + FDC precursors whose expansion required both lymphoid tissue inducer (LTi) cells and lymphotoxin. The ubiquity of preFDC and their strategic location at blood vessels may explain the de novo generation of organized lymphoid tissue at sites of lymphocytic inflammation.	[Krautler, Nike Julia; Kana, Veronika; Kranich, Jan; Perera, Dushan; Lemm, Doreen; Schwarz, Petra; Armulik, Annika; Oliveira-Martins, Jose B.; Zhu, Caihong; Hermann, Mario; Heikenwalder, Mathias; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Tian, Yinghua] Univ Zurich Hosp, Div Visceral & Transplant Surg, CH-8091 Zurich, Switzerland; [Krautler, Nike Julia; Brink, Robert] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Browning, Jeffrey L.] Biogen Idec Inc, Immunobiol, Cambridge Ctr 124, Cambridge, MA 02142 USA; [Tallquist, Michelle] UT SW Med Ctr Dallas, Dallas, TX 75390 USA; [Buch, Thorsten] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Hermann, Mario] Univ Zurich, Inst Lab Anim Sci, CH-8057 Zurich, Switzerland; [Wagner, Ulrich] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Garvan Institute of Medical Research; Biogen; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Zurich; University of Zurich; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Heikenwalder, Mathias/AAA-2269-2020; Tallquist, Michelle/AAU-5277-2021; Brink, Robert/B-7910-2010; Buch, Thorsten/P-1659-2019; Aguzzi, Adriano/A-3351-2008	Tallquist, Michelle/0000-0002-1383-144X; Brink, Robert/0000-0002-9586-3655; Buch, Thorsten/0000-0002-2236-9074; Kranich, Jan/0000-0002-9928-4132; Browning, Jeffrey/0000-0001-9168-5233; Kana, Veronika/0000-0002-9362-3156; Aguzzi, Adriano/0000-0002-0344-6708; Keller, Annika/0000-0003-1466-3633	European Union (PRIORITY and LUPAS); Swiss National Foundation (SNF); Stammbach Foundation; Novartis Research Foundation; European Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074257, U01HL100401] Funding Source: NIH RePORTER	European Union (PRIORITY and LUPAS); Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Stammbach Foundation; Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Nagata, M. Kopf, and R. Adams for generously providing Mfge8<SUP>-/-</SUP>, Cd21/35<SUP>-/-</SUP> and Pdgfrb-Cre mice. S. Luther, H. Zeilhofer, S. Uhlig, T. Suter for materials and reagents. D. Junghans, I. Fischer, M. Nuvolone, T. Chtanova, H. Takizawa, T. Phan, and R. Salomon for discussions. R. Moos, M. Delic, A. Wethmar, N. Wey, S. Behnke, A. Fitsche, S. Walters, K. Webster, N. Zammit and J.M. Mateos (Center for Microscopy and Image Analysis, University of Zurich) for technical assistance, and R. Krautler for editing. A. Aguzzi is supported by grants of the European Union (PRIORITY and LUPAS), the Swiss National Foundation (SNF) (one individual award and one Sinergia award with T. Buch and P. Pelczar), the Stammbach Foundation, and the Novartis Research Foundation. A. Aguzzi also holds an Advanced Investigator Grant of the European Research Council. N. Krautler and A. Armulik are supported by the SNF.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Balogh P, 2001, CELL IMMUNOL, V214, P45, DOI 10.1006/cimm.2001.1874; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Bofill M, 2000, J PATHOL, V191, P217; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Cupedo T, 2004, J IMMUNOL, V173, P4889, DOI 10.4049/jimmunol.173.8.4889; Cyster JG, 2000, IMMUNOL REV, V176, P181; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; FORCE WR, 1995, J IMMUNOL, V155, P5280; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; HUMPHREY JH, 1984, EUR J IMMUNOL, V14, P859, DOI 10.1002/eji.1830140916; IMAZEKI N, 1992, IMMUNOLOGY, V76, P508; KAMPERDIJK EWA, 1978, CELL TISSUE RES, V192, P1; Kapasi ZF, 1998, J IMMUNOL, V160, P1078; KAPASI ZF, 1993, ADV EXP MED BIOL, V329, P383; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Kim MY, 2008, IMMUNOLOGY, V124, P166, DOI 10.1111/j.1365-2567.2007.02750.x; Kim MY, 2006, J IMMUNOL, V177, P3074, DOI 10.4049/jimmunol.177.5.3074; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Lee IY, 2003, BIOCHEM BIOPH RES CO, V304, P701, DOI 10.1016/S0006-291X(03)00649-1; LeHir M, 1996, J INFLAMM, V47, P76; LeHir M, 1996, J EXP MED, V183, P2367, DOI 10.1084/jem.183.5.2367; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MANDEL TE, 1980, IMMUNOL REV, V53, P29, DOI 10.1111/j.1600-065X.1980.tb01039.x; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Motegi S, 2011, ARTERIOSCL THROM VAS, V31, P2653, DOI 10.1161/ATVBAHA.111.233619; Motegi S, 2011, ARTERIOSCL THROM VAS, V31, P2024, DOI 10.1161/ATVBAHA.111.232587; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; Pasparakis M, 2000, CELL IMMUNOL, V201, P33, DOI 10.1006/cimm.2000.1636; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; PICARELLA DE, 1992, P NATL ACAD SCI USA, V89, P10036, DOI 10.1073/pnas.89.21.10036; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Strick-Marchand H, 2008, J IMMUNOL, V181, P2764, DOI 10.4049/jimmunol.181.4.2764; Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TEW JG, 1982, J RETICULOENDOTH SOC, V31, P371; Tian YH, 2010, J SURG RES, V163, pE91, DOI 10.1016/j.jss.2010.04.019; Tumanov AV, 2004, J IMMUNOL, V173, P86, DOI 10.4049/jimmunol.173.1.86; WARE CF, 1992, J IMMUNOL, V149, P3881; Wilke G, 2010, EUR J IMMUNOL, V40, P2165, DOI 10.1002/eji.200940202; YOSHIDA T, 1989, ARCH HISTOL CYTOL, V52, P327, DOI 10.1679/aohc.52.327; Zhang N, 2003, J IMMUNOL, V171, P1667, DOI 10.4049/jimmunol.171.4.1667	69	255	257	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					194	206		10.1016/j.cell.2012.05.032	http://dx.doi.org/10.1016/j.cell.2012.05.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770220	Green Accepted, Bronze			2022-12-01	WOS:000306115000017
J	Hoffmeyer, K; Raggioli, A; Rudloff, S; Anton, R; Hierholzer, A; Del Valle, I; Hein, K; Vogt, R; Kemler, R				Hoffmeyer, Katrin; Raggioli, Angelo; Rudloff, Stefan; Anton, Roman; Hierholzer, Andreas; Del Valle, Ignacio; Hein, Kerstin; Vogt, Riana; Kemler, Rolf			Wnt/beta-Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells	SCIENCE			English	Article							BETA-CATENIN; TARGET; GENE; ACTIVATION; CHROMATIN	Telomerase activity controls telomere length and plays a pivotal role in stem cells, aging, and cancer. Here, we report a molecular link between Wnt/beta-catenin signaling and the expression of the telomerase subunit Tert. beta-Catenin-deficient mouse embryonic stem (ES) cells have short telomeres; conversely, ES cell expressing an activated form of beta-catenin (beta-cat(Delta Ex3/+)) have long telomeres. We show that beta-catenin regulates Tert expression through the interaction with Klf4, a core component of the pluripotency transcriptional network. beta-Catenin binds to the Tert promoter in a mouse intestinal tumor model and in human carcinoma cells. We uncover a previously unknown link between the stem cell and oncogenic potential whereby beta-catenin regulates Tert expression, and thereby telomere length, which could be critical in human regenerative therapy and cancer.	[Hoffmeyer, Katrin; Raggioli, Angelo; Rudloff, Stefan; Anton, Roman; Hierholzer, Andreas; Del Valle, Ignacio; Hein, Kerstin; Vogt, Riana; Kemler, Rolf] Max Planck Inst Immunobiol & Epigenet, Dept Mol Embryol, D-79108 Freiburg, Germany	Max Planck Society	Kemler, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Mol Embryol, Stuebeweg 51, D-79108 Freiburg, Germany.	kemler@immunbio.mpg.de		Raggioli, Angelo/0000-0002-6748-0307; del Valle, Ignacio/0000-0003-2595-3652; Anton, Roman/0000-0002-9036-0012	Max Planck Society	Max Planck Society(Max Planck Society)	We thank H. H. Ng (Singapore) for the antibody against Klf4, I. Horikawa (NIH) for the 300-bp promoter construct, and J.-H. Lee (Indiana University) for Ash2l and Setd1a expression vectors. We thank E. M. Varela and M. Blasco (Madrid) for advice and reagents for the Q-fish analysis and for antibodies against Tert. We are grateful to M. M. Taketo (Kyoto) and to S. Robine (Paris) for providing mutant mice. We thank S. Lugert for advice on neurosphere cultures, J. Volkind for technical assistance, V. Taylor and D. Junghans for discussion and critical reading, and R. Schneider for typing of the manuscript. K. H. and A. R. are members of the International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB). This work was supported by the Max Planck Society. The authors declare no financial interests.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Wong CW, 2010, STEM CELLS, V28, P1510, DOI 10.1002/stem.477; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370	16	374	397	5	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1549	1554		10.1126/science.1218370	http://dx.doi.org/10.1126/science.1218370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723415				2022-12-01	WOS:000305507500049
J	Schneier, B				Schneier, Bruce			Securing Medical Research: A Cybersecurity Point of View	SCIENCE			English	Editorial Material								The problem of securing biological research data is a difficult and complicated one. Our ability to secure data on computers is not robust enough to ensure the security of existing data sets. Lessons from cryptography illustrate that neither secrecy measures, such as deleting technical details, nor national solutions, such as export controls, will work.				schneier@schneier.com						[Anonymous], 2012, M H5N1 RES BIOS BIOS; Daly MK, 2009, 23 LARG INST SYST AD; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kerckhoffs A, 1883, J SCI MILITAIRES, V9, P5; Kerckhoffs A., 1883, J SCI MILITARIES, V9, P161; Levy S., 2001, CRYPTO CODE REBELS B; National Institute of Standards and Technology, 2007, FED REG         1107, V72, P62212; Schneier B., 2000, CRYPTOGRAM      0215; Schneier B., 1994, APPL CRYPTOGRAPHY PR; Schneier B., 2001, CRYPTOGRAM      1115; Schneier B, 2000, CRYPTOGRAM 0915	12	8	8	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1527	1529		10.1126/science.1224321	http://dx.doi.org/10.1126/science.1224321			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723410				2022-12-01	WOS:000305507500044
J	Vaseva, AV; Marchenko, ND; Ji, K; Tsirka, SE; Holzmann, S; Moll, UM				Vaseva, Angelina V.; Marchenko, Natalie D.; Ji, Kyungmin; Tsirka, Stella E.; Holzmann, Sonja; Moll, Ute M.			p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis	CELL			English	Article							FOCAL CEREBRAL-ISCHEMIA; CYCLOPHILIN-D; CELL-DEATH; MEMBRANE PERMEABILIZATION; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; NECROTIC DEATH; DNA-DAMAGE; APOPTOSIS; TRANSLOCATION	Ischemia-associated oxidative damage leading to necrosis is a major cause of catastrophic tissue loss, and elucidating its signaling mechanism is therefore of paramount importance. p53 is a central stress sensor responding to multiple insults, including oxidative stress to orchestrate apoptotic and autophagic cell death. Whether p53 can also activate oxidative stress-induced necrosis is, however, unknown. Here, we uncover a role for p53 in activating necrosis. In response to oxidative stress, p53 accumulates in the mitochondrial matrix and triggers mitochondrial permeability transition pore (PTP) opening and necrosis by physical interaction with the PTP regulator cyclophilin D (CypD). Intriguingly, a robust p53-CypD complex forms during brain ischemia/reperfusion injury. In contrast, reduction of p53 levels or cyclosporine A pretreatment of mice prevents this complex and is associated with effective stroke protection. Our study identifies the mitochondrial p53-CypD axis as an important contributor to oxidative stress-induced necrosis and implicates this axis in stroke pathology.	[Vaseva, Angelina V.; Marchenko, Natalie D.; Moll, Ute M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Ji, Kyungmin; Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Holzmann, Sonja; Moll, Ute M.] Univ Gottingen, Dept Mol Oncol, D-37077 Gottingen, Germany	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Gottingen	Moll, UM (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	ute.moll@sbumed.org	Tsirka, Stella/AAD-4018-2019		National Cancer Institute [CA060664]; NATIONAL CANCER INSTITUTE [R01CA060664, R29CA060664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Susan Vanhorn and Ioana Russ for technical assistance and Franz X. Schmid and Philipp Schmidpeter for discussion. This work was funded by a grant from the National Cancer Institute (CA060664) to U.M.M.	Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; Bianchi ME, 2004, BBA-GENE STRUCT EXPR, V1677, P181, DOI 10.1016/j.bbaexp.2003.10.017; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Heyne K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-54; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Palacios G, 2008, CELL CYCLE, V7, P2584, DOI 10.4161/cc.7.16.6070; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Pietsch EC, 2007, CANCER BIOL THER, V6, P1576, DOI 10.4161/cbt.6.10.4719; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	42	524	543	3	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1536	1548		10.1016/j.cell.2012.05.014	http://dx.doi.org/10.1016/j.cell.2012.05.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726440	Green Accepted, Bronze			2022-12-01	WOS:000305753800019
J	Gurbel, PA; Nolin, TD; Tantry, US				Gurbel, Paul A.; Nolin, Thomas D.; Tantry, Udaya S.			Clopidogrel Efficacy and Cigarette Smoking Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gurbel, Paul A.] Sinai Hosp Baltimore, Sinai Ctr Thrombosis Res, Cardiac Catheterizat Lab, Baltimore, MD 21215 USA; [Nolin, Thomas D.] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA; [Nolin, Thomas D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gurbel, PA (corresponding author), Sinai Hosp Baltimore, Sinai Ctr Thrombosis Res, Cardiac Catheterizat Lab, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.	pgurbel@lifebridgehealth.org	Nolin, Thomas/AAB-7311-2020	Nolin, Thomas/0000-0003-4339-1382				Berger JS, 2009, CIRCULATION, V120, P2337, DOI 10.1161/CIRCULATIONAHA.109.866533; Bliden KP, 2008, J AM COLL CARDIOL, V52, P531, DOI 10.1016/j.jacc.2008.04.045; Desai NR, 2009, J AM COLL CARDIOL, V53, P1273, DOI 10.1016/j.jacc.2008.12.044; Ferreiro JL, 2012, J AM COLL CARDIOL, V59, pA62; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Salek FS, 2010, PHARMACOTHERAPY, V30, p154e; SARAFF KY, 2006, J AM COLL CARDIOL, V47, pB36	7	47	48	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2012	307	23					2495	2496		10.1001/jama.2012.5930	http://dx.doi.org/10.1001/jama.2012.5930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960MB	22797448				2022-12-01	WOS:000305391400024
J	Lane, JE; Kruuk, LEB; Charmantier, A; Murie, JO; Dobson, FS				Lane, Jeffrey E.; Kruuk, Loeske E. B.; Charmantier, Anne; Murie, Jan O.; Dobson, F. Stephen			Delayed phenology and reduced fitness associated with climate change in a wild hibernator	NATURE			English	Article							COLUMBIAN GROUND-SQUIRRELS; SPERMOPHILUS-COLUMBIANUS; PHENOTYPIC PLASTICITY; SPRING EMERGENCE; MIGRATORY BIRD; BODY-MASS; POPULATION; PATTERNS	The most commonly reported ecological effects of climate change are shifts in phenologies, in particular of warmer spring temperatures leading to earlier timing of key events(1,2). Among animals, however, these reports have been heavily biased towards avian phenologies, whereas we still know comparatively little about other seasonal adaptations, such as mammalian hibernation. Here we show a significant delay (0.47 days per year, over a 20-year period) in the hibernation emergence date of adult females in a wild population of Columbian ground squirrels in Alberta, Canada. This finding was related to the climatic conditions at our study location: owing to within-individual phenotypic plasticity, females emerged later during years of lower spring temperature and delayed snowmelt. Although there has not been a significant annual trend in spring temperature, the date of snowmelt has become progressively later owing to an increasing prevalence of late-season snowstorms. Importantly, years of later emergence were also associated with decreased individual fitness. There has consequently been a decline in mean fitness (that is, population growth rate) across the past two decades. Our results show that plastic responses to climate change may be driven by climatic trends other than increasing temperature, and may be associated with declines in individual fitness and, hence, population viability.	[Lane, Jeffrey E.; Kruuk, Loeske E. B.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Lane, Jeffrey E.; Charmantier, Anne; Dobson, F. Stephen] CNRS, Ctr Ecol Fonct & Evolut, Unite Mixte Rech 5175, F-34293 Montpellier 5, France; [Lane, Jeffrey E.; Murie, Jan O.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Dobson, F. Stephen] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	University of Edinburgh; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Alberta; Auburn University System; Auburn University	Lane, JE (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	u.columbianus@hotmail.com	Dobson, F. Stephen/R-7310-2019; Kruuk, Loeske E. B./J-3295-2012; Kruuk, Loeske/AAB-8714-2019; Murie, Jan/F-3663-2014	Kruuk, Loeske E. B./0000-0001-8588-1123; Kruuk, Loeske/0000-0001-8588-1123; Murie, Jan/0000-0002-2658-4986; Dobson, F. Stephen/0000-0001-5562-6316	Natural Sciences and Engineering Research Council of Canada (NSERC); National Science Foundation [DEB-0089473]; Royal Society of London; Agence Nationale de la Recherche of France [ANR-08-JCJC-0041-01]; Alberta Conservation Association	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); Royal Society of London(Royal Society of London); Agence Nationale de la Recherche of France(French National Research Agency (ANR)); Alberta Conservation Association	We thank the volunteers and assistants who helped with fieldwork, and the University of Calgary for providing accommodation at the Biogeosciences Institute (E. Johnson and J. Buchanan-Mappin). D. Stralberg, S. Boutin and E. Bayne provided comments and assistance that improved an earlier version of this paper, and M. Low wrote the R script to calculate the spring temperature climate window. Funding was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) (J.O.M. and S. Boutin (University of Alberta)), National Science Foundation (DEB-0089473) (F. S. D.), the Royal Society of London (J. E. L. and L. E. B. K) and Agence Nationale de la Recherche of France (ANR-08-JCJC-0041-01) (A. C., F. S. D. and J. E. L.) and the Alberta Conservation Association (J. E. L.). All protocols were approved by the Life and Environmental Sciences Animal Care Committee at the University of Calgary as well as the Animal Care and Use Committee at the University of Alberta (1992 to 1998) or the Institutional Animal Care and Use Committee at Auburn University (1999 to 2011).	BOAG DA, 1981, CAN J ZOOL, V59, P999, DOI 10.1139/z81-139; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; CHRISTENSEN JH, 2007, PHYS SCI BASIS CONTR, P847; Dai B., 2008, IME4 LINEAR MIXED EF; DOBSON FS, 1992, CAN J ZOOL, V70, P1364, DOI 10.1139/z92-192; DOBSON FS, 1987, AM NAT, V129, P382, DOI 10.1086/284643; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Intergovernmental Panel on Climate Change, 2007, PHYS SCI BAS CONTR W; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.2307/2408842, 10.1111/j.1558-5646.1983.tb00236.x]; Lane JE, 2011, J EVOLUTION BIOL, V24, P1949, DOI 10.1111/j.1420-9101.2011.02334.x; MICHENER GR, 1983, BEHAV ECOL SOCIOBIOL, V14, P29, DOI 10.1007/BF00366653; MICHENER GR, 1977, CAN J ZOOL, V55, P693, DOI 10.1139/z77-091; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; MURIE JO, 1982, J MAMMAL, V63, P431, DOI 10.2307/1380440; MURIE JO, 1980, J MAMMAL, V61, P237, DOI 10.2307/1380044; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saether BE, 1999, J ANIM ECOL, V68, P628, DOI 10.1046/j.1365-2656.1999.00314.x; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Whiteman C. D., 2000, MOUNTAIN METEOROLOGY; WIGGETT DR, 1989, CAN J ZOOL, V67, P42, DOI 10.1139/z89-007	31	168	172	4	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					554	+		10.1038/nature11335	http://dx.doi.org/10.1038/nature11335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22878721				2022-12-01	WOS:000311781500001
J	Seshagiri, S; Stawiski, EW; Durinck, S; Modrusan, Z; Storm, EE; Conboy, CB; Chaudhuri, S; Guan, YH; Janakiraman, V; Jaiswal, BS; Guillory, J; Ha, C; Dijkgraaf, GJP; Stinson, J; Gnad, F; Huntley, MA; Degenhardt, JD; Haverty, PM; Bourgon, R; Wang, WR; Koeppen, H; Gentleman, R; Starr, TK; Zhang, ZM; Largaespada, DA; Wu, TD; de Sauvage, FJ				Seshagiri, Somasekar; Stawiski, Eric W.; Durinck, Steffen; Modrusan, Zora; Storm, Elaine E.; Conboy, Caitlin B.; Chaudhuri, Subhra; Guan, Yinghui; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Guillory, Joseph; Ha, Connie; Dijkgraaf, Gerrit J. P.; Stinson, Jeremy; Gnad, Florian; Huntley, Melanie A.; Degenhardt, Jeremiah D.; Haverty, Peter M.; Bourgon, Richard; Wang, Weiru; Koeppen, Hartmut; Gentleman, Robert; Starr, Timothy K.; Zhang, Zemin; Largaespada, David A.; Wu, Thomas D.; de Sauvage, Frederic J.			Recurrent R-spondin fusions in colon cancer	NATURE			English	Article							CIRCULAR BINARY SEGMENTATION; COLORECTAL-CANCER; WNT/BETA-CATENIN; HUMAN BREAST; RECEPTORS; LGR5; MUTATIONS; ALGORITHM; DISCOVERY; SEQUENCES	Identifying and understanding changes in cancer genomes is essential for the development of targeted therapeutics(1). Here we analyse systematically more than 70 pairs of primary human colon tumours by applying next-generation sequencing to characterize their exomes, transcriptomes and copy-number alterations. We have identified 36,303 protein-altering somatic changes that include several new recurrent mutations in the Wnt pathway gene TCF7L2, chromatin-remodelling genes such as TET2 and TET3 and receptor tyrosine kinases including ERBB3. Our analysis for significantly mutated cancer genes identified 23 candidates, including the cell cycle checkpoint kinase ATM. Copy-number and RNA-seq data analysis identified amplifications and corresponding overexpression of IGF2 in a subset of colon tumours. Furthermore, using RNA-seq data we identified multiple fusion transcripts including recurrent gene fusions involving R-spondin family members RSPO2 and RSPO3 that together occur in 10% of colon tumours. The RSPO fusions were mutually exclusive with APC mutations, indicating that they probably have a role in the activation of Wnt signalling and tumorigenesis. Consistent with this we show that the RSPO fusion proteins were capable of potentiating Wnt signalling. The R-spondin gene fusions and several other gene mutations identified in this study provide new potential opportunities for therapeutic intervention in colon cancer.	[Seshagiri, Somasekar; Stawiski, Eric W.; Durinck, Steffen; Modrusan, Zora; Storm, Elaine E.; Chaudhuri, Subhra; Guan, Yinghui; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Guillory, Joseph; Ha, Connie; Dijkgraaf, Gerrit J. P.; Stinson, Jeremy; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Conboy, Caitlin B.; Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Gnad, Florian; Huntley, Melanie A.; Degenhardt, Jeremiah D.; Haverty, Peter M.; Bourgon, Richard; Gentleman, Robert; Zhang, Zemin; Wu, Thomas D.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Wang, Weiru] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Koeppen, Hartmut] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Starr, Timothy K.] Univ Minnesota, Masonic Canc Ctr, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA	Roche Holding; Genentech; University of Minnesota System; University of Minnesota Twin Cities; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Minnesota System; University of Minnesota Twin Cities	Seshagiri, S (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	sekar@gene.com; sauvage@gene.com	de Sauvage, Frederic/ABE-8400-2020; Starr, Tim/AAX-9342-2021; Largaespada, David/C-9832-2014	de Sauvage, Frederic/0000-0002-5275-2584; Bourgon, Richard/0000-0002-5890-4374; Wang, Weiru/0000-0001-8845-301X; Gnad, Florian/0000-0002-2287-2251; Starr, Timothy/0000-0002-6308-3451; Seshagiri, Somasekar/0000-0003-4272-6443; Conboy, Caitlin/0000-0001-8280-056X	National Institutes of Health [R01-CA134759]; NATIONAL CANCER INSTITUTE [T32CA009138, R01CA113636, R00CA151672, R01CA134759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge Genentech DNA Sequencing, Oligo, Microarray and gCell laboratories for their help with the project. We thank the Genentech Bioinformatics group for informatics infrastructure support and the Pathology Core Labs for providing histology, immunohistochemistry and tissue-management support. We also thank M. Costa, M. Callow, P. Polakis and the de Sauvage and Seshagiri laboratories for comments and suggestions. Work in the Largaespada laboratory was supported by National Institutes of Health grant R01-CA134759 (to D.A.L.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pichiorri F, 2008, FUTURE ONCOL, V4, P815, DOI 10.2217/14796694.4.6.815; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023; Yue P, 2010, HUM MUTAT, V31, P264, DOI 10.1002/humu.21194; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	38	677	734	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					660	+		10.1038/nature11282	http://dx.doi.org/10.1038/nature11282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895193	Green Accepted, hybrid			2022-12-01	WOS:000308095100057
J	Gregory, AP; Dendrou, CA; Attfield, KE; Haghikia, A; Xifara, DK; Butter, F; Poschmann, G; Kaur, G; Lambert, L; Leach, OA; Promel, S; Punwani, D; Felce, JH; Davis, SJ; Gold, R; Nielsen, FC; Siegel, RM; Mann, M; Bell, JI; McVean, G; Fugger, L				Gregory, Adam P.; Dendrou, Calliope A.; Attfield, Kathrine E.; Haghikia, Aiden; Xifara, Dionysia K.; Butter, Falk; Poschmann, Gereon; Kaur, Gurman; Lambert, Lydia; Leach, Oliver A.; Proemel, Simone; Punwani, Divya; Felce, James H.; Davis, Simon J.; Gold, Ralf; Nielsen, Finn C.; Siegel, Richard M.; Mann, Matthias; Bell, John I.; McVean, Gil; Fugger, Lars			TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; GENOME-WIDE ASSOCIATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RESONANCE ENERGY-TRANSFER; SUSCEPTIBILITY LOCI; DISEASE SUSCEPTIBILITY; METAANALYSIS; DEMYELINATION; INHIBITION; MECHANISMS	Although there has been much success in identifying genetic variants associated with common diseases using genome-wide association studies (GWAS)(1), it has been difficult to demonstrate which variants are causal and what role they have in disease. Moreover, the modest contribution that these variants make to disease risk has raised questions regarding their medical relevance(2). Here we have investigated a single nucleotide polymorphism (SNP) in the TNFRSF1A gene, that encodes tumour necrosis factor receptor 1 (TNFR1), which was discovered through GWAS to be associated with multiple sclerosis (MS)(3,4), but not with other autoimmune conditions such as rheumatoid arthritis(5), psoriasis(6) and Crohn's disease(7). By analysing MS GWAS(3,4) data in conjunction with the 1000 Genomes Project data(8) we provide genetic evidence that strongly implicates this SNP, rs1800693, as the causal variant in the TNFRSF1A region. We further substantiate this through functional studies showing that the MS risk allele directs expression of a novel, soluble form of TNFR1 that can block TNF. Importantly, TNF-blocking drugs can promote onset or exacerbation of MS9-11, but they have proven highly efficacious in the treatment of autoimmune diseases for which there is no association with rs1800693. This indicates that the clinical experience with these drugs parallels the disease association of rs1800693, and that the MS-associated TNFR1 variant mimics the effect of TNF-blocking drugs. Hence, our study demonstrates that clinical practice can be informed by comparing GWAS across common autoimmune diseases and by investigating the functional consequences of the disease-associated genetic variation.	[Gregory, Adam P.; Kaur, Gurman; Punwani, Divya; Felce, James H.; Davis, Simon J.; Fugger, Lars] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford OX3 9DS, England; [Dendrou, Calliope A.; Attfield, Kathrine E.; Haghikia, Aiden; Lambert, Lydia; Leach, Oliver A.; Proemel, Simone; Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Div Clin Neurol, Nuffield Dept Clin Neurosci, Oxford OX3 9DS, England; [Haghikia, Aiden; Gold, Ralf] Ruhr Univ Bochum, St Josef Hosp Bochum, Dept Neurol, D-44791 Bochum, Germany; [Xifara, Dionysia K.; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Butter, Falk; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Poschmann, Gereon] Univ Dusseldorf, Biol Med Forschungszentrum, Mol Prote Lab, D-40225 Dusseldorf, Germany; [Nielsen, Finn C.] Univ Copenhagen, Rigshosp, Ctr Genom Med, DK-2100 Copenhagen O, Denmark; [Siegel, Richard M.] NIAMSD, Immunoregulat Sect, Autoimmun Branch, NIH, Bethesda, MD 20892 USA; [Bell, John I.] Univ Oxford, Oxford OX3 7DG, England; [Fugger, Lars] Skejby Sygehus, Aarhus Univ Hosp, Inst Clin, DK-8200 Aarhus N, Denmark	University of Oxford; University of Oxford; Ruhr University Bochum; University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society; Heinrich Heine University Dusseldorf; Rigshospitalet; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Oxford; Aarhus University	Fugger, L (corresponding author), Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford OX3 9DS, England.	lars.fugger@imm.ox.ac.uk	Nielsen, Finn Cilius/AAA-4926-2020; Mann, Matthias/A-3454-2013	Mann, Matthias/0000-0003-1292-4799; Attfield, Kathrine/0000-0003-3387-521X; Butter, Falk/0000-0002-7197-7279; Dendrou, Calliope/0000-0003-1179-4021; Kaur, Gurman/0000-0001-7722-3956; McVean, Gil/0000-0002-5012-4162; Promel, Simone/0000-0001-7800-7323; Felce, James/0000-0001-5531-9244	UK Medical Research Council (MRC); European Union [FP7/2007-2013]; Naomi Bramson Trust; Wellcome Trust [090532/Z/09/Z, 086084/Z/08/Z]; MRC; Deutsche Forschungsgemeinschaft; Christopher Welch Scholarship; MS Society; Dorothy Hodgkin Postgraduate Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041175] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12010/4, MC_UU_12010/3, G1000800i] Funding Source: researchfish; Rosetrees Trust [M210] Funding Source: researchfish; MRC [MC_UU_12010/3, MC_UU_12010/4] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Naomi Bramson Trust; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Christopher Welch Scholarship; MS Society; Dorothy Hodgkin Postgraduate Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the volunteers who donated blood samples, the IMSGC and WTCCC2 for data access, A. Auton for help with association analysis data preparation, G. R. Screaton for providing TNFR1 constructs, and A. Vincent and N. Willcox for critical reading of the manuscript. Work in the authors' laboratories is supported by the UK Medical Research Council (MRC), the European Union through grant FP7/2007-2013 (SYBILLA), the Naomi Bramson Trust (L.F.), and the Wellcome Trust (090532/Z/09/Z and 086084/Z/08/Z; G.M.). A.P.G., A.H., L.L., O.A.L. and D.P. are supported by an MRC studentship, the Deutsche Forschungsgemeinschaft, a Christopher Welch Scholarship, funding from the MRC and the MS Society, and a Dorothy Hodgkin Postgraduate Award, respectively.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; BAKER D, 1994, EUR J IMMUNOL, V24, P2040, DOI 10.1002/eji.1830240916; Bosch X, 2011, NAT REV NEUROL, V7, P165, DOI 10.1038/nrneurol.2011.1; Brambilla R, 2011, BRAIN, V134, P2736, DOI 10.1093/brain/awr199; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kimberley FC, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2197; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Taoufik E, 2011, BRAIN, V134, P2722, DOI 10.1093/brain/awr203; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531	30	255	262	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					508	+		10.1038/nature11307	http://dx.doi.org/10.1038/nature11307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22801493	Green Accepted			2022-12-01	WOS:000307761600036
J	Mansour, AA; Gafni, O; Weinberger, L; Zviran, A; Ayyash, M; Rais, Y; Krupalnik, V; Zerbib, M; Amann-Zalcenstein, D; Maza, I; Geula, S; Viukov, S; Holtzman, L; Pribluda, A; Canaani, E; Horn-Saban, S; Amit, I; Novershtern, N; Hanna, JH				Mansour, Abed AlFatah; Gafni, Ohad; Weinberger, Leehee; Zviran, Asaf; Ayyash, Muneef; Rais, Yoach; Krupalnik, Vladislav; Zerbib, Mirie; Amann-Zalcenstein, Daniela; Maza, Itay; Geula, Shay; Viukov, Sergey; Holtzman, Liad; Pribluda, Ariel; Canaani, Eli; Horn-Saban, Shirley; Amit, Ido; Novershtern, Noa; Hanna, Jacob H.			The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming	NATURE			English	Article							EMBRYONIC STEM-CELLS; PLURIPOTENT GROUND-STATE; MOUSE; GENOME; JMJD3; DYNAMICS; NETWORK; NANOG; MODEL	Induced pluripotent stem cells (iPSCs) can be derived from somatic cells by ectopic expression of different transcription factors, classically Oct4 (also known as Pou5f1), Sox2, Klf4 and Myc (abbreviated as OSKM)(1). This process is accompanied by genome-wide epigenetic changes(2-5), but how these chromatin modifications are biochemically determined requires further investigation. Here we show in mice and humans that the histone H3 methylated Lys 27(H3K27) demethylase Utx(6-9) (also known as Kdm6a) regulates the efficient induction, rather than maintenance, of pluripotency. Murine embryonic stem cells lacking Utx can execute lineage commitment and contribute to adult chimaeric animals; however, somatic cells lacking Utx fail to robustly reprogram back to the ground state of pluripotency. Utx directly partners with OSK reprogramming factors and uses its histone demethylase catalytic activity to facilitate iPSC formation. Genomic analysis indicates that Utx depletion results in aberrant dynamics of H3K27me3 repressive chromatin demethylation in somatic cells undergoing reprogramming. The latter directly hampers the derepression of potent pluripotency promoting gene modules (including Sall1, Sall4 and Utf1), which can cooperatively substitute for exogenous OSK supplementation in iPSC formation. Remarkably, Utx safeguards the timely execution of H3K27me3 demethylation observed in embryonic day 10.5-11 primordial germcells (PGCs)(10), and Utx-deficientPGCs show cell-autonomous aberrant epigenetic reprogramming dynamics during their embryonic maturation in vivo. Subsequently, this disrupts PGC development by embryonic day 12.5, and leads to diminished germline transmission in mouse chimaeras generated from Utx-knockout pluripotent cells. Thus, we identify Utx as a novel mediator with distinct functions during the re-establishment of pluripotency and germ cell development. Furthermore, our findings highlight the principle that molecular regulators mediating loss of repressive chromatin during in vivo germ cell reprogramming can be co-opted during in vitro reprogramming towards ground state pluripotency.	[Mansour, Abed AlFatah; Gafni, Ohad; Weinberger, Leehee; Zviran, Asaf; Rais, Yoach; Krupalnik, Vladislav; Zerbib, Mirie; Maza, Itay; Geula, Shay; Viukov, Sergey; Holtzman, Liad; Pribluda, Ariel; Novershtern, Noa; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Ayyash, Muneef] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Amann-Zalcenstein, Daniela; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Amann-Zalcenstein, Daniela; Horn-Saban, Shirley] Weizmann Inst Sci, Dept Biol Serv, Genom Unit, IL-76100 Rehovot, Israel; [Canaani, Eli] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Hanna, JH (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	noa.novershtern@weizmann.ac.il; jacob.hanna@weizmann.ac.il	Hanna, Jacob/K-1339-2012; Geula, Shay Yosef/Z-3789-2019	Hanna, Jacob/0000-0003-2042-9974; Geula, Shay Yosef/0000-0001-8111-4410; Mansour, Abed AlFatah/0000-0001-9025-6998; Novershtern, Noa/0000-0002-2244-6877	ERC starting investigator grant [StG-2011-281906]; Israel Science Foundation Regular and Bikura research grants; ICRF Foundation; Fritz Thyssen Stiftung; Alon Foundation; E. A. and R. Drake, and the Leona M. and Harry B. Helmsley Charitable Trust; Weizmann Dean fellowship awards	ERC starting investigator grant; Israel Science Foundation Regular and Bikura research grants; ICRF Foundation; Fritz Thyssen Stiftung; Alon Foundation; E. A. and R. Drake, and the Leona M. and Harry B. Helmsley Charitable Trust; Weizmann Dean fellowship awards	J.H.H. is supported by a generous gift from Ilana and Pascal Mantoux, The Sir Charles Clore Research Prize, an ERC starting investigator grant (StG-2011-281906), the Israel Science Foundation Regular and Bikura research grants, the ICRF Foundation, Fritz Thyssen Stiftung, the Alon Foundation scholar award, a grant from E. A. and R. Drake, and the Leona M. and Harry B. Helmsley Charitable Trust. N.N. and A. P. are supported by Weizmann Dean fellowship awards. We thank A. Smith, H. Niwa and M. Saitou for reagents. We thank the Weizmann Institute management for providing critical financial and infrastructural support.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018189; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	35	267	282	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					409	+		10.1038/nature11272	http://dx.doi.org/10.1038/nature11272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22801502				2022-12-01	WOS:000307501000048
J	Kamerow, D				Kamerow, Douglas			The myth of an AIDS free world	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Brown D., 2012, WASHINGTON POST, pWashington; Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5265; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4879	3	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 14	2012	345								e5479	10.1136/bmj.e5479	http://dx.doi.org/10.1136/bmj.e5479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CD	22893652				2022-12-01	WOS:000307752000002
J	Barry, CL; Gollust, SE; Niederdeppe, J				Barry, Colleen L.; Gollust, Sarah E.; Niederdeppe, Jeff			Are Americans Ready to Solve the Weight of the Nation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Barry, Colleen L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Gollust, Sarah E.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Niederdeppe, Jeff] Cornell Univ, Dept Commun, Ithaca, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; Cornell University	Barry, CL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.							Bleich S, 2011, AM PUBLIC OPINION HL; Center for Consumer Freedom, 2012, I MED NEW OB PREV ST; DOWNS A, 1972, PUBLIC INTEREST, P38; Madison KM, 2011, J LAW MED ETHICS, V39, P450, DOI 10.1111/j.1748-720X.2011.00614.x; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557	5	32	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					389	391		10.1056/NEJMp1206519	http://dx.doi.org/10.1056/NEJMp1206519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981VZ	22853011				2022-12-01	WOS:000307001900001
J	Grover, S; Kastrinos, F; Steyerberg, EW; Cook, EF; Dewanwala, A; Burbidge, LA; Wenstrup, RJ; Syngal, S				Grover, Shilpa; Kastrinos, Fay; Steyerberg, Ewout W.; Cook, E. Francis; Dewanwala, Akriti; Burbidge, Lynn Anne; Wenstrup, Richard J.; Syngal, Sapna			Prevalence and Phenotypes of APC and MUTYH Mutations in Patients With Multiple Colorectal Adenomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GERM-LINE MUTATIONS; MYH GENE-MUTATIONS; POLYPOSIS PATIENTS; CANCER PATIENTS; FAMILIES; FAP; CHROMOSOME-5Q21; IDENTIFICATION; EXPRESSION; GUIDELINES	Context Patients with multiple colorectal adenomas may carry germline mutations in the APC or MUTYH genes. Objectives To determine the prevalence of pathogenic APC and MUTYH mutations in patients with multiple colorectal adenomas who had undergone genetic testing and to compare the prevalence and clinical characteristics of APC and MUTYH mutation carriers. Design, Setting, and Participants Cross-sectional study conducted among 8676 individuals who had undergone full gene sequencing and large rearrangement analysis of the APC gene and targeted sequence analysis for the 2 most common MUTYH mutations (Y179C and G396D) between 2004 and 2011. Individuals with either mutation underwent full MUTYH gene sequencing. APC and MUTYH mutation prevalence was evaluated by polyp burden; the clinical characteristics associated with a pathogenic mutation were evaluated using logistic regression analyses. Main Outcome Measure Prevalence of pathogenic mutations in APC and MUTYH genes. Results Colorectal adenomas were reported in 7225 individuals; 1457 with classic polyposis (>= 100 adenomas) and 3253 with attenuated polyposis (20-99 adenomas). The prevalence of pathogenic APC and biallelic MUTYH mutations was 95 of 119 (80% [95% CI, 71%-87%]) and 2 of 119 (2% [95% CI, 0.2%-6%]), respectively, among individuals with 1000 or more adenomas, 756 of 1338 (56% [95% CI, 54%-59%]) and 94 of 1338 (7% [95% CI, 6%-8%]) among those with 100 to 999 adenomas, 326 of 3253 (10% [95% CI, 9%-11%]) and 233 of 3253 (7% [95% CI, 6%-8%]) among those with 20 to 99 adenomas, and 50 of 970 (5% [95% CI, 4%-7%]) and 37 of 970 (4% [95% CI, 3%-5%]) among those with 10 to 19 adenomas. Adenoma count was strongly associated with a pathogenic mutation in multivariable analyses. Conclusions Among patients with multiple colorectal adenomas, pathogenic APC and MUTYH mutation prevalence varied considerably by adenoma count, including within those with a classic polyposis phenotype. APC mutations predominated in patients with classic polyposis, whereas prevalence of APC and MUTYH mutations was similar in attenuated polyposis. These findings require external validation. JAMA. 2012;308(5):485-492 www.jama.com	[Grover, Shilpa; Dewanwala, Akriti; Syngal, Sapna] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02215 USA; [Grover, Shilpa; Syngal, Sapna] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Grover, Shilpa; Syngal, Sapna] Harvard Univ, Sch Med, Boston, MA USA; [Cook, E. Francis] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Grover, Shilpa] Massachusetts Gen Hosp, Program Canc Outcomes Res Training, Boston, MA 02114 USA; [Kastrinos, Fay] Columbia Univ, Med Ctr, New York, NY USA; [Kastrinos, Fay] Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Rotterdam, Netherlands; [Burbidge, Lynn Anne; Wenstrup, Richard J.] Myriad Genet Labs Inc, Salt Lake City, UT USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Columbia University; Erasmus University Rotterdam; Erasmus MC; Myriad Genetics, Inc	Syngal, S (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 450 Brookline Ave, Boston, MA 02215 USA.	ssyngal@partners.org	Steyerberg, Ewout/C-1509-2018	Steyerberg, Ewout/0000-0002-7787-0122	National Cancer Institute [R25 CA 092203, K07 CA151769]; National Institutes of Health [K24113433]; Myriad Genetics Laboratories Inc.; NATIONAL CANCER INSTITUTE [R25CA092203, K24CA113433, K07CA151769] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myriad Genetics Laboratories Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grants R25 CA 092203 (Dr Grover) and K07 CA151769 (Dr Kastrinos) and by National Institutes of Health grant K24113433 (Dr Syngal).; Independent Statistical Analysis: Data sets were forwarded by investigators at Myriad Genetics Laboratories Inc to independent investigators at the Dana-Farber Cancer Institute, Boston, Massachusetts (Drs Grover and Syngal) and the Herbert Irving Comprehensive Cancer Center, New York, New York (Dr Kastrinos). Drs Grover, Kastrinos, and Steyerberg (Center for Medical Decision Making, Erasmus Medical Center, Rotterdam, the Netherlands) performed independent statistical analyses. All results reported in the article are from the independent statistical analyses. None of the coauthors not employed by Myriad Genetics Laboratories Inc received any funding for the study from Myriad Genetics Laboratories Inc.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Armstrong JG, 1997, HUM MUTAT, V10, P376, DOI 10.1002/(SICI)1098-1004(1997)10:5<376::AID-HUMU7>3.0.CO;2-D; Balaguer F, 2008, GASTROENTEROLOGY, V134, P39, DOI 10.1053/j.gastro.2007.10.042; Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Boparai KS, 2008, GASTROENTEROLOGY, V135, P2014, DOI 10.1053/j.gastro.2008.09.020; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8, DOI 10.6004/jnccn.2010.0003; Bussey HJ, 1975, FAMILIAL POLYPOSIS C; Castellsague E, 2010, GASTROENTEROLOGY, V139, P439, DOI 10.1053/j.gastro.2010.04.047; Cleary SP, 2009, GASTROENTEROLOGY, V136, P1251, DOI 10.1053/j.gastro.2008.12.050; Croitoru ME, 2007, J SURG ONCOL, V95, P499, DOI 10.1002/jso.20724; Croitoru ME, 2004, JNCI-J NATL CANCER I, V96, P1631, DOI 10.1093/jnci/djh288; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Filipe B, 2009, CLIN GENET, V76, P242, DOI 10.1111/j.1399-0004.2009.01241.x; Fleischmann C, 2004, INT J CANCER, V109, P554, DOI 10.1002/ijc.20020; Giardiello FM, 1997, NEW ENGL J MED, V336, P823, DOI 10.1056/NEJM199703203361202; Giardiello FM, 2001, GASTROENTEROLOGY, V121, P198, DOI 10.1053/gast.2001.25581; Giarola M, 1999, HUM MUTAT, V13, P116, DOI 10.1002/(SICI)1098-1004(1999)13:2<116::AID-HUMU3>3.0.CO;2-2; Gismondi V, 2004, INT J CANCER, V109, P680, DOI 10.1002/ijc.20054; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Jo WS, 2005, CLIN GASTROENTEROL H, V3, P1022, DOI 10.1016/S1542-3565(05)00411-8; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Nagase Hiroki, 1992, Human Mutation, V1, P467, DOI 10.1002/humu.1380010603; Nielsen M, 2007, CLIN GENET, V71, P427, DOI 10.1111/j.1399-0004.2007.00766.x; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Russell AM, 2006, INT J CANCER, V118, P1937, DOI 10.1002/ijc.21470; Sampson JR, 2003, LANCET, V362, P39, DOI 10.1016/S0140-6736(03)13805-6; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; vanderLuijt RB, 1997, HUM MUTAT, V9, P7, DOI 10.1002/(SICI)1098-1004(1997)9:1<7::AID-HUMU2>3.0.CO;2-8; Vasen HFA, 2008, GUT, V57, DOI 10.1136/gut.2007.136127; Venesio T, 2004, GASTROENTEROLOGY, V126, P1681, DOI 10.1053/j.gastro.2004.02.022; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070	36	127	129	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					485	492		10.1001/jama.2012.8780	http://dx.doi.org/10.1001/jama.2012.8780			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851115	Green Accepted, Bronze			2022-12-01	WOS:000306947400026
J	Limketkai, BN; Mehta, SH; Sutcliffe, CG; Higgins, YM; Torbenson, MS; Brinkley, SC; Moore, RD; Thomas, DL; Sulkowski, MS				Limketkai, Berkeley N.; Mehta, Shruti H.; Sutcliffe, Catherine G.; Higgins, Yvonne M.; Torbenson, Michael S.; Brinkley, Sherilyn C.; Moore, Richard D.; Thomas, David L.; Sulkowski, Mark S.			Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; SIMPLE NONINVASIVE INDEX; TRANSIENT ELASTOGRAPHY; SIGNIFICANT FIBROSIS; INFECTED PATIENTS; GENOTYPE 1; HIV; PROGRESSION	Context Human immunodeficiency virus (HIV) accelerates hepatitis C virus (HCV) disease progression; however, the effect of liver disease stage and antiviral therapy on the risk of clinical outcomes is incompletely understood. Objective To determine the incidence of end-stage liver disease (ESLD), hepatocellular carcinoma (HCC), or death according to baseline hepatic fibrosis and antiviral treatment for HIV/HCV coinfected individuals. Design, Setting, and Participants Prospective cohort of 638 coinfected adults (80% black, 66% men) receiving care at the Johns Hopkins HIV clinic and receiving a liver biopsy and who were prospectively monitored for clinical events between July 1993 and August 2011 (median follow-up, 5.82 years; interquartile range, 3.42-8.85 years). Histological specimens were scored for hepatic fibrosis stage according to the METAVIR scoring system. Main Outcome Measure Incidence of composite outcome of ESLD, HCC, or death. Results Patients experienced a graded increased risk in incidence of clinical outcomes based on baseline hepatic fibrosis stage (classification range, F0-F4): F0, 23.63 (95% CI, 16.80-33.24); F1, 36.33 (95% CI, 28.03-47.10); F2, 53.40 (95% CI, 33.65-84.76); F3, 56.14 (95% CI, 31.09-101.38); and F4, 79.43 (95% CI, 55.86-112.95) per 1000 person-years (P < .001). In multivariable negative binomial regression, fibrosis stages F2 through F4 and antiretroviral therapy were independently associated with composite ESLD, HCC, or all-cause mortality after adjustment for demographic characteristics, injection drug use, and CD4 cell count. Compared with F0, the incidence rate ratio (RR) for F2 was 2.31 (95% CI, 1.23-4.34; P = .009); F3, 3.18 (95% CI, 1.47-6.88; P = .003); and F4, 3.57 (95% CI, 2.06-6.19; P < .001). Human immunodeficiency virus treatment was associated with fewer clinical events (incidence RR, 0.27; 95% CI, 0.19-0.38; P < .001). For the 226 patients who underwent HCV treatment, the incidence of clinical events did not significantly differ between treatment nonresponders and untreated patients (incidence RR, 1.27; 95% CI, 0.86-1.86; P = .23). In contrast, no events were observed in the 51 patients with sustained virologic response (n = 36) and relapse (n = 15), including 19 with significant fibrosis. Conclusion In this cohort of patients with HIV/HCV coinfection, hepatic fibrosis stage was independently associated with a composite outcome of ESLD, HCC, or death.	[Limketkai, Berkeley N.; Higgins, Yvonne M.; Torbenson, Michael S.; Brinkley, Sherilyn C.; Moore, Richard D.; Thomas, David L.; Sulkowski, Mark S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Mehta, Shruti H.; Sutcliffe, Catherine G.; Moore, Richard D.; Thomas, David L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sulkowski, MS (corresponding author), 1830 Bldg,Room 445,1800 Orleans St, Baltimore, MD 21287 USA.	msulkowski@jhmi.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Bristol-Myers Squibb; Columbia University; International Cancer Control Association; Merck; Vertex Pharmaceuticals; Roche/Genentech; Gilead Sciences; Abbott Laboratories; Boehringer Ingelheim Pharmaceuticals; Gilead; Janssen; Vertex; National Institute on Drug Abuse (NIDA) [K24DA00432, K24DA034621, R01DA11602, R01DA16065, R37DA13806, P30DA13868]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01AA016893]; National Institute of Allergy and Infectious Diseases (NIAID) [P30AI094189]; National Center for Research Resources (NCRR), components of the National Institutes of Health (NIH) [UL1RR025005]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, U01AI069918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015032, R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA013806, R01DA016065, K24DA000432, P30DA013868, K24DA034621, R01DA011602] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Columbia University; International Cancer Control Association; Merck(Merck & Company); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Roche/Genentech(Roche HoldingGenentech); Gilead Sciences(Gilead Sciences); Abbott Laboratories(Abbott Laboratories); Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Vertex(Vertex Pharmaceuticals); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR), components of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Limketkai reported receiving a grant from Bristol-Myers Squibb. Dr Mehta reported receiving consulting fees from Columbia University. Dr Sutcliffe reported receiving payment for conference planning from the International Cancer Control Association. Ms Brinkley reported receiving consulting fees from Merck and Vertex Pharmaceuticals and payment for lectures from Merck, Vertex Pharmaceuticals, and Roche/Genentech. Dr Thomas reported receiving consulting fees from Merck and grants to Johns Hopkins University from Merck and Gilead Sciences. Dr Sulkowski reported receiving consulting fees and research grants to Johns Hopkins University from Abbott Laboratories, Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Gilead, Janssen, Merck, Roche/Genentech, and Vertex. Ms Higgins, Dr Torbenson, and Dr Moore reported no conflicts of interest.; Financial support for this study came from grants K24DA00432, K24DA034621, R01DA11602, R01DA16065, R37DA13806, and P30DA13868 from the National Institute on Drug Abuse (NIDA), R01AA016893 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), P30AI094189 from the National Institute of Allergy and Infectious Diseases (NIAID), and UL1RR025005 from the National Center for Research Resources (NCRR), components of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research.	Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; de Ledinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175; *DEP HLTH HUM SERV, GUID US ANT AG HIV 1; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Linas BP, 2011, J VIRAL HEPATITIS, V18, P506, DOI 10.1111/j.1365-2893.2010.01325.x; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Mehta SH, 2005, HEPATOLOGY, V41, P123, DOI 10.1002/hep.20541; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Mehta SH, 2006, AIDS, V20, P2361, DOI 10.1097/QAD.0b013e32801086da; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Myers RP, 2003, AIDS, V17, P721, DOI 10.1097/00002030-200303280-00010; Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Rockstroh JK, 2008, HIV MED, V9, P82, DOI 10.1111/j.1468-1293.2007.00535.x; Rodriguez-Torres M, 2009, 60 ANN M AM ASS STUD; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Subramanian A, 2010, GASTROENTEROLOGY, V138, P159, DOI 10.1053/j.gastro.2009.09.053; Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wise M, 2010, PUBLIC HEALTH REP, V125, P414, DOI 10.1177/003335491012500310	35	166	172	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2012	308	4					370	378		10.1001/jama.2012.7844	http://dx.doi.org/10.1001/jama.2012.7844			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977SR	22820790	Green Accepted, Bronze			2022-12-01	WOS:000306685500025
J	Borumandi, F; Gaggl, A				Borumandi, Farzad; Gaggl, Alexander			Traumatic Abducens Nerve Palsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Borumandi, Farzad; Gaggl, Alexander] Paracelsus Med Univ, Salzburg, Austria	Paracelsus Private Medical University	Borumandi, F (corresponding author), Paracelsus Med Univ, Salzburg, Austria.	f.borumandi@web.de							0	0	0	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2012	367	3					E5	E5		10.1056/NEJMicm1114545	http://dx.doi.org/10.1056/NEJMicm1114545			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975PI	22808984				2022-12-01	WOS:000306522900011
J	Kinoshita, M; Matsui, R; Kato, S; Hasegawa, T; Kasahara, H; Isa, K; Watakabe, A; Yamamori, T; Nishimura, Y; Alstermark, B; Watanabe, D; Kobayashi, K; Isa, T				Kinoshita, Masaharu; Matsui, Ryosuke; Kato, Shigeki; Hasegawa, Taku; Kasahara, Hironori; Isa, Kaoru; Watakabe, Akiya; Yamamori, Tetsuo; Nishimura, Yukio; Alstermark, Bror; Watanabe, Dai; Kobayashi, Kazuto; Isa, Tadashi			Genetic dissection of the circuit for hand dexterity in primates	NATURE			English	Article							DISYNAPTIC PYRAMIDAL EXCITATION; SPINAL-CORD-INJURY; PROPRIOSPINAL NEURONS; FORELIMB MOTONEURONS; MACAQUE MONKEY; MOTOR SYSTEM; EXPRESSION; PATHWAYS; INTEGRATION; CAT	It is generally accepted that the direct connection from the motor cortex to spinal motor neurons is responsible for dexterous hand movements in primates(1-3). However, the role of the 'phylogenetically older' indirect pathways from the motor cortex to motor neurons, mediated by spinal interneurons, remains elusive. Here we used a novel double-infection technique to interrupt the transmission through the propriospinal neurons (PNs)(4-6), which act as a relay of the indirect pathway in macaque monkeys (Macaca fuscata and Macaca mulatta). The PNs were double infected by injection of a highly efficient retrograde gene-transfer vector into their target area and subsequent injection of adeno-associated viral vector at the location of cell somata. This method enabled reversible expression of green fluorescent protein (GFP)-tagged tetanus neurotoxin, thereby permitting the selective and temporal blockade of the motor cortex-PN-motor neuron pathway. This treatment impaired reach and grasp movements, revealing a critical role for the PN-mediated pathway in the control of hand dexterity. Anti-GFP immunohistochemistry visualized the cell bodies and axonal trajectories of the blocked PNs, which confirmed their anatomical connection to motor neurons. This pathway-selective and reversible technique for blocking neural transmission does not depend on cell-specific promoters or transgenic techniques, and is a new and powerful tool for functional dissection in system-level neuroscience studies.	[Kinoshita, Masaharu; Isa, Kaoru; Nishimura, Yukio; Isa, Tadashi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Matsui, Ryosuke; Hasegawa, Taku; Kasahara, Hironori; Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima 9601295, Japan; [Watakabe, Akiya; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 4448585, Japan; [Watakabe, Akiya; Yamamori, Tetsuo; Nishimura, Yukio; Isa, Tadashi] Grad Univ Adv Studies Sokendai, Kanagawa 2400193, Japan; [Nishimura, Yukio] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo 1020076, Japan; [Alstermark, Bror] Umea Univ, Physiol Sect, Dept Integrat Med Biol, S-90187 Umea, Sweden	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kyoto University; Fukushima Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Umea University	Isa, T (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan.	tisa@nips.ac.jp	Yamamori, Tetsuo/N-6536-2015; Kinoshita, Masaharu/N-8450-2019; Kato, Shigeki/S-8016-2018; Kinoshita, Masaharu/A-5464-2019	Yamamori, Tetsuo/0000-0001-5016-0078; Kinoshita, Masaharu/0000-0001-8588-843X; Kato, Shigeki/0000-0002-8792-7591; Kinoshita, Masaharu/0000-0001-8588-843X; Kobayashi, Kazuto/0000-0002-7617-2939; Hasegawa, Taku/0000-0003-4837-0855	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Swedish Research Council	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank S. Nakanishi, H. Jingami and C. Akazawa for continuous encouragement. We thank P. Redgrave for comments on the earlier version of the manuscript. This study was supported by the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. B. A. was supported by the Swedish Research Council. We thank T. Oishi for providing macaque brain sample tissue. We thank P. Phongphanphanee, M. Togawa, Y. Yamanishi, T. Katoh, K. Shimizu, N. Takahashi and K. Takada for technical support.	ALSTERMARK B, 1981, EXP BRAIN RES, V42, P282, DOI 10.1007/BF00237495; Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; ALSTERMARK B, 1990, EXP BRAIN RES, V80, P1; Alstermark B, 2011, J NEUROPHYSIOL, V106, P122, DOI 10.1152/jn.00089.2011; ALSTERMARK B, 1992, IBRO SER, P327; BOCKER R, 1983, J CHROMATOGR, V274, P255, DOI 10.1016/S0378-4347(00)84428-X; Croyle MA, 2001, GENE THER, V8, P1281, DOI 10.1038/sj.gt.3301527; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hioki H, 2009, NEUROSCI RES, V63, P149, DOI 10.1016/j.neures.2008.10.010; ILLERT M, 1977, EXP BRAIN RES, V29, P323; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Kaneda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018452; Kato S, 2007, HUM GENE THER, V18, P1141, DOI 10.1089/hum.2007.082; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Komatsu Y, 2005, CEREB CORTEX, V15, P96, DOI 10.1093/cercor/bhh112; KUYPERS HGJM, 1982, PROG BRAIN RES, V57, P381, DOI 10.1016/S0079-6123(08)64138-2; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Watakabe A, 2010, METHODS, V52, P367, DOI 10.1016/j.ymeth.2010.07.003; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	32	172	173	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2012	487	7406					235	U1510		10.1038/nature11206	http://dx.doi.org/10.1038/nature11206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722837				2022-12-01	WOS:000306278900040
J	Alphonse, VD; Kemper, AR; Strom, BT; Beeman, SM; Duma, SM				Alphonse, Vanessa D.; Kemper, Andrew R.; Strom, Brock T., III; Beeman, Stephanie M.; Duma, Stefan M.			Mechanisms of Eye Injuries From Fireworks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Alphonse, Vanessa D.; Kemper, Andrew R.; Strom, Brock T., III; Beeman, Stephanie M.; Duma, Stefan M.] Wake Forest Univ, Virginia Tech, Ctr Injury Biomech, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Wake Forest University	Alphonse, VD (corresponding author), Wake Forest Univ, Virginia Tech, Ctr Injury Biomech, Blacksburg, VA 24061 USA.	vda@vt.edu	Duma, Stefan/A-8368-2012; Kemper, Andrew/B-4353-2012	Kemper, Andrew/0000-0002-5177-1820				*CDCP, 2004, MMWR-MORBID MORTAL W, V53, P562; Duma S, FINAL REPORT EYE INJ; Duma SM, 2012, CURR EYE RES, V37, P43, DOI 10.3109/02713683.2011.601841; Kennedy Eric A, 2004, Annu Proc Assoc Adv Automot Med, V48, P165; Smith GA, 1996, PEDIATRICS, V98, P1; US Consumer Product Safety Commission, 1991, NAT EL INJ SURV SYST	6	12	12	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2012	308	1					33	34		10.1001/jama.2012.6964	http://dx.doi.org/10.1001/jama.2012.6964			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971DD	22760285	Bronze			2022-12-01	WOS:000306183000017
J	Radecki, RP				Radecki, Ryan P.			Dabigatran: Uncharted Waters and Potential Harms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION; WARFARIN; THERAPY; RIVAROXABAN; ETEXILATE; APIXABAN; REVERSAL; RISK		Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Radecki, RP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, 6431 Fannin St,JJL 450, Houston, TX 77030 USA.	Ryan.P.Radecki@uth.tmc.edu		Radecki, Ryan/0000-0001-8590-6618				Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; [Anonymous], 2011, BOEHR BEST TOD DURCH; Naranjo IC, 2011, CEREBROVASC DIS, V32, P614, DOI 10.1159/000334578; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cotton BA, 2011, NEW ENGL J MED, V365, P2039, DOI 10.1056/NEJMc1111095; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Legrand M, 2011, ARCH INTERN MED, V171, P1285, DOI 10.1001/archinternmed.2011.314; Liesenfeld KH, 2011, J THROMB HAEMOST, V9, P2168, DOI 10.1111/j.1538-7836.2011.04498.x; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Moore TJ, 2012, SIGNALS DABIGATRAN M; Moore TJ, 2011, SIGNALS 2 NEWLY APPR; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666; US Food and Drug Administration (FDA), 2011, FDA DRUG SAF COMM SA; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758; Zhou W, 2011, STROKE, V42, P3594, DOI 10.1161/STROKEAHA.111.624650	19	22	22	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2012	157	1					66	U107		10.7326/0003-4819-157-1-201207030-00467	http://dx.doi.org/10.7326/0003-4819-157-1-201207030-00467			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NS	22751762				2022-12-01	WOS:000307784900007
J	Yen, KY; Vinayachandran, V; Batta, K; Koerber, RT; Pugh, BF				Yen, Kuangyu; Vinayachandran, Vinesh; Batta, Kiran; Koerber, R. Thomas; Pugh, B. Franklin			Genome-wide Nucleosome Specificity and Directionality of Chromatin Remodelers	CELL			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; EXTRANUCLEOSOMAL DNA; IN-VIVO; PROMOTER NUCLEOSOMES; ISW2-NUCLEOSOME COMPLEX; SWI/SNF COMPLEX; YEAST; TRANSCRIPTION; ISWI	How chromatin remodelers cooperate to organize nucleosomes around the start and end of genes is not known. We determined the genome-wide binding of remodeler complexes SWI/SNF, RSC, ISW1a, ISW1b, ISW2, and INO80 to individual nucleosomes in Saccharomyces, and determined their functional contributions to nucleosome positioning through deletion analysis. We applied ultra-high-resolution ChIP-exo mapping to Isw2 to determine its subnucleosomal orientation and organization on a genomic scale. Remodelers interacted with selected nucleosome positions relative to the start and end of genes and produced net directionality in moving nucleosomes either away or toward nucleosome-free regions at the 5' and 3' ends of genes. Isw2 possessed a subnucleosomal organization in accord with biochemical and crystallographic-based models that place its linker binding region within promoters and abutted against Reb1-bound locations. Together, these findings reveal a coordinated position-specific approach taken by remodelers to organize genic nucleosomes into arrays.	[Yen, Kuangyu; Vinayachandran, Vinesh; Batta, Kiran; Koerber, R. Thomas; Pugh, B. Franklin] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Yen, Kuangyu; Vinayachandran, Vinesh; Batta, Kiran; Koerber, R. Thomas; Pugh, B. Franklin] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	Vinayachandran, Vinesh/ABD-6386-2020	Vinayachandran, Vinesh/0000-0002-2045-6086	National Institutes of Health [5R01HG4160]; Pennsylvania Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Charles V. Meade, David Goffman, Anna Chan, Kasthuri Kannan, and Yunfei Li for assistance in nucleosome preparation, DNA sequencing, and data analysis. This work was funded by National Institutes of Health Grant 5R01HG4160 and The Pennsylvania Department of Health using Tobacco Settlement Funds.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; Angermayr M, 2003, J BIOL CHEM, V278, P17918, DOI 10.1074/jbc.M301806200; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Langst G, 2001, MOL CELL, V8, P1085, DOI 10.1016/S1097-2765(01)00397-5; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Matangkasombut O, 2000, GENE DEV, V14, P951; McKnight JN, 2011, MOL CELL BIOL, V31, P4746, DOI 10.1128/MCB.05735-11; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; Montel F, 2011, NUCLEIC ACIDS RES, V39, P2571, DOI 10.1093/nar/gkq1254; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHMID A, 1992, CELL, V71, P853, DOI 10.1016/0092-8674(92)90560-Y; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Singh SK, 2010, CELL, V142, P868, DOI 10.1016/j.cell.2010.08.013; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tirosh I, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r49; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	67	209	209	1	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1461	1473		10.1016/j.cell.2012.04.036	http://dx.doi.org/10.1016/j.cell.2012.04.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726434	Green Accepted, Bronze			2022-12-01	WOS:000305753800013
J	Nakanishi, K; Weinberg, DE; Bartel, DP; Patel, DJ				Nakanishi, Kotaro; Weinberg, David E.; Bartel, David P.; Patel, Dinshaw J.			Structure of yeast Argonaute with guide RNA	NATURE			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; SIRNA; DROSOPHILA; RISC; DNA; MECHANISMS; MICRORNAS; CLEAVAGE; SYSTEM	The RNA-induced silencing complex, comprising Argonaute and guide RNA, mediates RNA interference. Here we report the 3.2 angstrom crystal structure of Kluyveromyces polysporus Argonaute (KpAGO) fortuitously complexed with guide RNA originating from small-RNA duplexes autonomously loaded and processed by recombinant KpAGO. Despite their diverse sequences, guide-RNA nucleotides 1-8 are positioned similarly, with sequence-independent contacts to bases, phosphates and 2'-hydroxyl groups pre-organizing the backbone of nucleotides 2-8 in a near-A-form conformation. Compared with prokaryotic Argonautes, KpAGO has numerous surface-exposed insertion segments, with a cluster of conserved insertions repositioning the N domain to enable full propagation of guide-target pairing. Compared with Argonautes in inactive conformations, KpAGO has a hydrogen-bond network that stabilizes an expanded and repositioned loop, which inserts an invariant glutamate into the catalytic pocket. Mutation analyses and analogies to ribonuclease H indicate that insertion of this glutamate finger completes a universally conserved catalytic tetrad, thereby activating Argonaute for RNA cleavage.	[Nakanishi, Kotaro; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Weinberg, David E.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weinberg, David E.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Weinberg, David E.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	dbartel@wi.mit.edu; pateld@mskcc.org		Nakanishi, Kotaro/0000-0002-9857-6010	National Institutes of Health [AI068776, GM61835]; Human Frontier Science Program Long-term Fellowship; Japan Society for the Promotion of Science; National Science Foundation graduate research fellowship; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061835, R37GM061835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Long-term Fellowship(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rajashankar for data processing and phasing, V. Auyeung and D. Shechner for discussions, the Whitehead Genome Technology Core for high-throughput sequencing, and the NE-CAT beamline at the Advanced Photon Source. This work was supported by National Institutes of Health grants AI068776 (D.J.P.) and GM61835 (D. P. B.), a Human Frontier Science Program Long-term Fellowship (K.N.), a fellowship from the Japan Society for the Promotion of Science for Research Abroad (K.N.), and a National Science Foundation graduate research fellowship (D. E. W.). D. P. B. is an Investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Boland A, 2010, EMBO REP, V11, P522, DOI 10.1038/embor.2010.81; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan YP, 2003, NUCLEIC ACIDS RES, V31, P7131, DOI 10.1093/nar/gkg941; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parker James S, 2010, Silence, V1, P3, DOI 10.1186/1758-907X-1-3; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schirle N. T., 2012, SCIENCE         0426; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; SIKORSKI RS, 1989, GENETICS, V122, P19; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	64	221	227	2	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					368	+		10.1038/nature11211	http://dx.doi.org/10.1038/nature11211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722195	Green Accepted, Green Submitted			2022-12-01	WOS:000305466800036
J	Bach, PB; Gould, MK				Bach, Peter B.; Gould, Michael K.			When the Average Applies to No One: Personalized Decision Making About Potential Benefits of Lung Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK PREDICTION; MORTALITY; MODEL		Mem Sloan Kettering Canc Ctr, New York, NY USA; Kaiser Permanente So Calif, Pasadena, CA USA	Memorial Sloan Kettering Cancer Center; Kaiser Permanente	Bach, PB (corresponding author), 1275 York Ave, New York, NY 10065 USA.							Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American Lung Association, 2012, PROV GUID LUNG CANC; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2004, CHEST, V126, P1742, DOI 10.1378/chest.126.6.1742; Bach PB, 2012, JAMA-J AM MED ASSOC, P1; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; Elmore JG, 2005, NEW ENGL J MED, V353, P297, DOI 10.1056/NEJMe058111; Etzel CJ, 2011, SEMIN RESP CRIT CARE, V32, P3, DOI 10.1055/s-0031-1272864; Gigerenzer G, 2009, B WORLD HEALTH ORGAN, V87, P567, DOI 10.2471/BLT.09.069872; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Schwartz Lisa M., 1999, Journal of the National Cancer Institute Monographs, P124; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173	14	71	70	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					571	+		10.7326/0003-4819-157-8-201210160-00524	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00524			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	22893040				2022-12-01	WOS:000309906000018
J	Shiba, Y; Fernandes, S; Zhu, WZ; Filice, D; Muskheli, V; Kim, J; Palpant, NJ; Gantz, J; Moyes, KW; Reinecke, H; Van Biber, B; Dardas, T; Mignone, JL; Izawa, A; Hanna, R; Viswanathan, M; Gold, JD; Kotlikoff, MI; Sarvazyan, N; Kay, MW; Murry, CE; Laflamme, MA				Shiba, Yuji; Fernandes, Sarah; Zhu, Wei-Zhong; Filice, Dominic; Muskheli, Veronica; Kim, Jonathan; Palpant, Nathan J.; Gantz, Jay; Moyes, Kara White; Reinecke, Hans; Van Biber, Benjamin; Dardas, Todd; Mignone, John L.; Izawa, Atsushi; Hanna, Ramy; Viswanathan, Mohan; Gold, Joseph D.; Kotlikoff, Michael I.; Sarvazyan, Narine; Kay, Matthew W.; Murry, Charles E.; Laflamme, Michael A.			Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts	NATURE			English	Article							EMBRYONIC STEM-CELLS; RAT HEARTS; INFARCTION; TRANSPLANTATION; BLEBBISTATIN; REPERFUSION; INTEGRATION; MYOCARDIUM; INDICATORS; MYOCYTES	Transplantation studies in mice and rats have shown that human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) can improve the function of infarcted hearts(1-3), but two critical issues related to their electrophysiological behaviour in vivo remain unresolved. First, the risk of arrhythmias following hESC-CM transplantation in injured hearts has not been determined. Second, the electromechanical integration of hESC-CMs in injured hearts has not been demonstrated, so it is unclear whether these cells improve contractile function directly through addition of new force-generating units. Here we use a guinea-pig model to show that hESC-CM grafts in injured hearts protect against arrhythmias and can contract synchronously with host muscle. Injured hearts with hESC-CM grafts show improved mechanical function and a significantly reduced incidence of both spontaneous and induced ventricular tachycardia. To assess the activity of hESC-CM grafts in vivo, we transplanted hESC-CMs expressing the genetically encoded calcium sensor, GCaMP3 (refs 4, 5). By correlating the GCaMP3 fluorescent signal with the host ECG, we found that grafts in uninjured hearts have consistent 1:1 host-graft coupling. Grafts in injured hearts are more heterogeneous and typically include both coupled and uncoupled regions. Thus, human myocardial grafts meet physiological criteria for true heart regeneration, providing support for the continued development of hESC-based cardiac therapies for both mechanical and electrical repair.	[Shiba, Yuji; Fernandes, Sarah; Zhu, Wei-Zhong; Filice, Dominic; Muskheli, Veronica; Kim, Jonathan; Palpant, Nathan J.; Gantz, Jay; Moyes, Kara White; Reinecke, Hans; Van Biber, Benjamin; Murry, Charles E.; Laflamme, Michael A.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Shiba, Yuji; Izawa, Atsushi] Shinshu Univ, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan; [Filice, Dominic; Gantz, Jay; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Bioengn, Seattle, WA 98109 USA; [Dardas, Todd; Mignone, John L.; Hanna, Ramy; Viswanathan, Mohan; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Med & Cardiol, Seattle, WA 98195 USA; [Gold, Joseph D.] Geron Corp, Menlo Pk, CA 94025 USA; [Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Sarvazyan, Narine; Kay, Matthew W.] George Washington Univ, Dept Pharmacol & Physiol, Washington, DC 20037 USA; [Kay, Matthew W.] George Washington Univ, Dept Elect & Comp Engn, Washington, DC 20037 USA	University of Washington; University of Washington Seattle; Shinshu University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geron Corporation; Cornell University; George Washington University; George Washington University	Laflamme, MA (corresponding author), Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, 850 Republican St, Seattle, WA 98109 USA.	murry@uw.edu; laflamme@u.washington.edu	Laflamme, Michael/AAV-6791-2021; Palpant, Nathan/B-1641-2017; Kay, Matthew Wyatt/AAH-7336-2019; Zhu, Wei-Zhong/G-4919-2011; Gantz, Jay A/B-3581-2009	Laflamme, Michael/0000-0001-5908-880X; Palpant, Nathan/0000-0002-9334-8107; Kay, Matthew Wyatt/0000-0003-2756-5055; Sarvazyan, Narine/0000-0002-2002-5630; Kay, Mark/0000-0002-2799-2615	Geron Corporation; US National Institutes of Health [K08-HL80431, R01-HL064387, P01-HL094374, R01-HL084642, P01-GM81619, U01-HL100405, R01-HL095828]; University of Washington's Mouse Metabolic Phenotyping Center [U24-DK076126]; Grants-in-Aid for Scientific Research [23591035] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095828, K08HL080431, U01HL100405, P01HL094374, R01HL084642, R01HL064387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	Geron Corporation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington's Mouse Metabolic Phenotyping Center; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tallini, L. Linares, B. Johnson and S. Dupras for advice and technical assistance. This work was partly supported by a grant from Geron Corporation(M. A. L.), as well as by US National Institutes of Health grants K08-HL80431 (M. A. L.), R01-HL064387 (M. A. L. and C. E. M.), P01-HL094374 (M. A. L. and C. E. M.), R01-HL084642 (C. E. M.), P01-GM81619 (C. E. M.), U01-HL100405 (M. A. L. and C. E. M.) and R01-HL095828 (N.S. and M. W. K.). Animal experiments were supported in part by the University of Washington's Mouse Metabolic Phenotyping Center, U24-DK076126.	Asfour H, 2011, IEEE T BIO-MED ENG, V58, P2083, DOI 10.1109/TBME.2011.2143713; Biermann M, 1998, J CARDIOVASC ELECTR, V9, P1348, DOI 10.1111/j.1540-8167.1998.tb00110.x; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Gepstein L, 2011, STEM CELLS, V29, P1475, DOI 10.1002/stem.702; Gutstein DE, 2003, AM J PHYSIOL-HEART C, V285, pH1091, DOI 10.1152/ajpheart.00100.2003; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Jonsson MKB, 2010, STEM CELL RES, V4, P189, DOI 10.1016/j.scr.2010.02.001; Kay M, 2008, AM J PHYSIOL-HEART C, V294, pH2400, DOI 10.1152/ajpheart.01158.2007; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laurita KR, 2001, AM J PHYSIOL-HEART C, V280, pH2053, DOI 10.1152/ajpheart.2001.280.5.H2053; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Liao SY, 2010, HEART RHYTHM, V7, P1852, DOI 10.1016/j.hrthm.2010.09.006; Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052; Mandel Y, 2012, CIRCULATION, V125, P883, DOI 10.1161/CIRCULATIONAHA.111.045146; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Shiotani Motohiro, 2005, Journal of Toxicological Sciences, V30, P239, DOI 10.2131/jts.30.239; Shiotani Motohiro, 2007, Journal of Pharmacological and Toxicological Methods, V55, P27, DOI 10.1016/j.vascn.2006.04.008; Swift L, 2008, PHYSIOL MEAS, V29, P269, DOI 10.1088/0967-3334/29/2/009; Swoap SJ, 2004, AM J PHYSIOL-REG I, V287, pR391, DOI 10.1152/ajpregu.00731.2003; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Zhu WZ, 2011, METHODS MOL BIOL, V767, P419, DOI 10.1007/978-1-61779-201-4_31; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917	40	505	526	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					322	+		10.1038/nature11317	http://dx.doi.org/10.1038/nature11317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22864415	Green Accepted			2022-12-01	WOS:000308635900048
J	Oldenburg, M; Kruger, A; Ferstl, R; Kaufmann, A; Nees, G; Sigmund, A; Bathke, B; Lauterbach, H; Suter, M; Dreher, S; Koedel, U; Akira, S; Kawai, T; Buer, J; Wagner, H; Bauer, S; Hochrein, H; Kirschning, CJ				Oldenburg, Marina; Krueger, Anne; Ferstl, Ruth; Kaufmann, Andreas; Nees, Gernot; Sigmund, Anna; Bathke, Barbara; Lauterbach, Henning; Suter, Mark; Dreher, Stefan; Koedel, Uwe; Akira, Shizuo; Kawai, Taro; Buer, Jan; Wagner, Hermann; Bauer, Stefan; Hochrein, Hubertus; Kirschning, Carsten J.			TLR13 Recognizes Bacterial 23S rRNA Devoid of Erythromycin Resistance-Forming Modification	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; MACROLIDE RESISTANCE; DENDRITIC CELLS; LIPOPROTEINS; INFECTION; MUTATION; IMMUNITY; COMPLEX; SENSOR	Host protection from infection relies on the recognition of pathogens by innate pattern-recognition receptors such as Toll-like receptors (TLRs). Here, we show that the orphan receptor TLR13 in mice recognizes a conserved 23S ribosomal RNA (rRNA) sequence that is the binding site of macrolide, lincosamide, and streptogramin group (MLS) antibiotics (including erythromycin) in bacteria. Notably, 23S rRNA from clinical isolates of erythromycin-resistant Staphylococcus aureus and synthetic oligoribonucleotides carrying methylated adenosine or a guanosine mimicking a MLS resistance-causing modification failed to stimulate TLR13. Thus, our results reveal both a natural TLR13 ligand and specific mechanisms of antibiotic resistance as potent bacterial immune evasion strategy, avoiding recognition via TLR13.	[Oldenburg, Marina; Krueger, Anne; Sigmund, Anna; Buer, Jan; Kirschning, Carsten J.] Univ Duisburg Essen, Inst Med Microbiol, D-45147 Essen, Germany; [Ferstl, Ruth; Dreher, Stefan; Wagner, Hermann] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Kaufmann, Andreas; Nees, Gernot; Bauer, Stefan] Univ Marburg, Inst Immunol, D-35043 Marburg, Germany; [Bathke, Barbara; Lauterbach, Henning; Suter, Mark] Bavarian Nord GmbH, Dept Res Immunol, D-82152 Martinsried, Germany; [Suter, Mark] Univ Zurich, Inst Virol, CH-8006 Zurich, Switzerland; [Koedel, Uwe] Clin Univ Munich, Dept Neurol, D-81377 Munich, Germany; [Akira, Shizuo; Kawai, Taro] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Osaka 5650871, Japan	University of Duisburg Essen; Technical University of Munich; Philipps University Marburg; Bavarian Nordic; University of Zurich; University of Munich; Osaka University	Kirschning, CJ (corresponding author), Univ Duisburg Essen, Inst Med Microbiol, D-45147 Essen, Germany.	carsten.kirschning@uk-essen.de	Ferstl, Ruth/ABB-9679-2021; Akira, Shizuo/C-3134-2009; Hochrein, Hubertus/L-3697-2013	Oldenburg, Marina/0000-0001-5163-1724; Buer, Jan/0000-0002-7602-1698; Kruger, Anne/0000-0002-2103-4686; Bauer, Stefan/0000-0002-8462-1845; Lauterbach, Henning/0000-0002-6062-5163; Hochrein, Hubertus/0000-0001-9904-1934; Kawai, Taro/0000-0001-7510-4662	German research foundation (Deutsche Forschungsgemeinschaft) [KI 591/4-1, GK1045, BA 1618/5-1]; Japanese Government; Behring Rontgen Stiftung [56-0034]; Coley Pharmaceuticals/Pfizer	German research foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Japanese Government; Behring Rontgen Stiftung; Coley Pharmaceuticals/Pfizer(Pfizer)	We thank S. Schimanski, J. Patzold, R. Kassub, T. Scholtysik, and P. Juszczak, as well as C. Chebrolu for technical work; M. Freudenberg, J. Steinmann, and J. Kehrmann for provision of mice and bacteria; R. Lang for advice; the German research foundation (Deutsche Forschungsgemeinschaft) for funding of KI 591/4-1 and GK1045 (to C. J. K.) and BA 1618/5-1 (to S. B.), as well as to U.K.; and the Japanese Government for funding to S. A. and T. K. The Behring Rontgen Stiftung funded grant 56-0034 (to S. B.). The Univ. of Duisburg-Essen (C. J. K.), Bavarian Nordic GmbH (H. H.), and the Philipps Univ. of Marburg (S. B.) filed a patent on TLR13 activators (U. S. Patent 61/597,063; agonists and antagonists of TLR13). H. W. and S. B. had an advisory contract with Coley Pharmaceuticals/Pfizer that ended in 2010. The data presented in this paper are tabulated in the main paper and in the supplementary materials.	Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Pfister P, 2005, P NATL ACAD SCI USA, V102, P5180, DOI 10.1073/pnas.0501598102; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Sergiev PV, 2008, J MOL BIOL, V375, P291, DOI 10.1016/j.jmb.2007.10.051; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; SKINNER RH, 1982, J GEN MICROBIOL, V128, P2411; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577	25	287	314	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1111	1115		10.1126/science.1220363	http://dx.doi.org/10.1126/science.1220363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22821982				2022-12-01	WOS:000308125800052
J	Brenner, H; Chang-Claude, J; Jansen, L; Seiler, CM; Hoffmeister, M				Brenner, Hermann; Chang-Claude, Jenny; Jansen, Lina; Seiler, Christoph M.; Hoffmeister, Michael			Role of Colonoscopy and Polyp Characteristics in Colorectal Cancer After Colonoscopic Polyp Detection A Population-Based Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							SURVEILLANCE COLONOSCOPY; ADENOMA CHARACTERISTICS; SCREENING COLONOSCOPY; RISK-FACTORS; FOLLOW-UP; RECURRENCE; PREDICTORS; PROTECTION; NEOPLASMS; HISTORY	Background: Studies have identified characteristics of adenomas detected on colonoscopy to be predictive of adenoma recurrence. Objective: To assess the role of both colonoscopy-related factors and polyp characteristics on the risk for colorectal cancer after colonoscopic polyp detection. Design: Population-based case-control study (3148 case participants and 3274 control participants). Setting: Rhine-Neckar region of Germany. Patients: Case and control participants with physician-validated detection of polyps (other than hyperplastic polyps) at a previous colonoscopy in the past 10 years. Measurements: Detailed history and results of previous colonoscopies were obtained through interviews and medical records. Case and control participants were compared according to colonoscopy-related factors (incompleteness, poor bowel preparation, incomplete removal of all polyps, and no surveillance colonoscopy within 5 years) and polyp characteristics (>= 1 cm, villous components or high-grade dysplasia, >= 3 polyps, and >= 1 proximal polyp). Odds ratios (ORs) and attributable fractions were derived by using multiple logistic regression and the Levin formula. Results: 155 case participants and 260 control participants with physician-validated polyp detection in the past 10 years were identified. The following characteristics were significantly more common among case participants than among control participants: not all polyps completely removed (29.0% vs. 9.6%; OR, 3.73 [95% CI, 2.11 to 6.60]), no surveillance colonoscopy within 5 years (26.5% vs. 11.5%; OR, 2.96 [CI, 1.70 to 5.16]), and detection of 3 or more polyps (14.2% vs. 7.3%; OR, 2.21 [CI, 1.07 to 4.54]). Odds ratios ranged from 1.12 to 1.42 and CIs included 1.00 for all other variables. Overall, 41.1% and 21.7% of cancer cases were statistically attributable to colonoscopy-related factors and polyp characteristics, respectively. Limitation: This was an observational study with potential for residual confounding and selection bias. Conclusion: Colonoscopy-related factors are more important than polyp characteristics for stratification of colorectal cancer risk after colonoscopic polyp detection in the community setting.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; Heidelberg Univ, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	h.brenner@dkfz.de	Brenner, Hermann/ABE-6383-2020; Jansen, Lina/D-7255-2016; Seiler, Christoph/AAG-7056-2021; Hoffmeister, Michael/T-7187-2019; Brenner, Hermann/B-4627-2017; Hoffmeister, Michael/AAB-2321-2022	Brenner, Hermann/0000-0002-6129-1572; Jansen, Lina/0000-0001-8004-4940; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197	German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; German Research Council	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Council(German Research Foundation (DFG))	By grants BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, and CH 117/1-1 from the German Research Council (Deutsche Forschungsgemeinschaft) and grants 01KH0404 and 01ER0814 from the German Federal Ministry of Education and Research.; Primary Funding Source: German Research Council and German Federal Ministry of Education and Research.	Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Bertario L, 2003, INT J CANCER, V105, P82, DOI 10.1002/ijc.11036; Bonithon-Kopp C, 2004, DIS COLON RECTUM, V47, P323, DOI 10.1007/s10350-003-0054-1; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Cafferty FH, 2007, CANCER J, V13, P263, DOI 10.1097/PPO.0b013e318046ebf1; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Mannath J, 2011, DIGEST DIS SCI, V56, P2389, DOI 10.1007/s10620-011-1609-y; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Noshirwani KC, 2000, GASTROINTEST ENDOSC, V51, P433, DOI 10.1016/S0016-5107(00)70444-5; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; van Stolk RU, 1998, GASTROENTEROLOGY, V115, P13, DOI 10.1016/S0016-5085(98)70359-2; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	23	56	59	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					225	233		10.7326/0003-4819-157-4-201208210-00002	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910933				2022-12-01	WOS:000307813200013
J	Rabe, KF; Ward, B				Rabe, Klaus F.; Ward, Brian			Uncovering and tackling Europe's hidden respiratory illness	LANCET			English	Editorial Material									[Rabe, Klaus F.] Univ Kiel, D-24118 Kiel, Germany; [Ward, Brian] European Resp Soc, Brussels, Belgium	University of Kiel	Rabe, KF (corresponding author), Univ Kiel, D-24118 Kiel, Germany.	k.f.rabe@kh-grosshansdorf.de	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401				Department of Health, 2011, OUTC STRAT CHRON OBS; European Commission, 2012, REV EU AIR POL; European Respiratory Roadmap, PREV; London Health Observatory, 2010, JUB LIN HLTH IN 2004; Mackenbach JP, 2007, EC IMPLICATIONS SOCI; Samolinski B, 2012, LANCET, V379, pE45, DOI 10.1016/S0140-6736(12)60514-5; World Health Organization, 2008, TALL CHART HLTH SYST	7	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					623	624		10.1016/S0140-6736(12)61306-3	http://dx.doi.org/10.1016/S0140-6736(12)61306-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901869				2022-12-01	WOS:000307721000004
J	Peralta-Yahya, PP; Zhang, FZ; del Cardayre, SB; Keasling, JD				Peralta-Yahya, Pamela P.; Zhang, Fuzhong; del Cardayre, Stephen B.; Keasling, Jay D.			Microbial engineering for the production of advanced biofuels	NATURE			English	Review							MODULAR POLYKETIDE SYNTHASE; ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; SACCHAROMYCES-CEREVISIAE; BUTANOL PRODUCTION; BACILLUS-SUBTILIS; BIOSYNTHESIS; PRECURSOR; ACID; CONVERSION	Advanced biofuels produced by microorganisms have similar properties to petroleum-based fuels, and can 'drop in' to the existing transportation infrastructure. However, producing these biofuels in yields high enough to be useful requires the engineering of the microorganism's metabolism. Such engineering is not based on just one specific feedstock or host organism. Data-driven and synthetic-biology approaches can be used to optimize both the host and pathways to maximize fuel production. Despite some success, challenges still need to be met to move advanced biofuels towards commercialization, and to compete with more conventional fuels.	[Peralta-Yahya, Pamela P.; Zhang, Fuzhong; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Peralta-Yahya, Pamela P.; Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [del Cardayre, Stephen B.] LS9, San Francisco, CA 94080 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Zhang, Fuzhong/0000-0001-6979-7909	Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Synthetic Biology Engineering Research Center; National Science Foundation [0540879]	Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Synthetic Biology Engineering Research Center; National Science Foundation(National Science Foundation (NSF))	P.P.P.-Y. and F.Z. contributed equally to this work. This work was supported in part by the Joint BioEnergy Institute, which is funded by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231, and by the Synthetic Biology Engineering Research Center, which is funded by National Science Foundation Award No. 0540879.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Berezina OV, 2010, APPL MICROBIOL BIOT, V87, P635, DOI 10.1007/s00253-010-2480-z; Betancor L, 2008, CHEMBIOCHEM, V9, P2962, DOI 10.1002/cbic.200800475; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI [10.1038/nchembio.537, 10.1038/NCHEMBIO.537]; Buelter T., 2012, US patent, Patent No. [0,058,532 A1, 0058532]; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; de Jong B., 2011, CURR OPIN BIOTECHNOL; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Donaldson G. K., 2007, US Patent, Patent No. [0313206, 0,313,206 A1]; Donaldson G. K., 2011, US patent, Patent No. [0,313,206 A1, 0313206]; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Ezeji TC, 2007, J IND MICROBIOL BIOT, V34, P771, DOI 10.1007/s10295-007-0253-1; Festel G., 2011, US patent, Patent No. [0,053,235 A1, 0053235]; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Handke P, 2011, METAB ENG, V13, P28, DOI 10.1016/j.ymben.2010.10.007; Harvey BG, 2010, ENERG FUEL, V24, P267, DOI 10.1021/ef900799c; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Hong K. K., 2012, CELL MOL LIFE SCI; Huo YX, 2011, NAT BIOTECHNOL, V29, P346, DOI 10.1038/nbt.1789; Jacobsen JR, 1997, SCIENCE, V277, P367, DOI 10.1126/science.277.5324.367; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Katz L., 2011, US patent, Patent No. [CN102014623, 102014623]; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Knothe G, 2010, PROG ENERG COMBUST, V36, P364, DOI 10.1016/j.pecs.2009.11.004; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Liu TG, 2010, METAB ENG, V12, P378, DOI 10.1016/j.ymben.2010.02.003; Lutke-Eversloh T, 2011, CURR OPIN BIOTECH, V22, P634, DOI 10.1016/j.copbio.2011.01.011; Malaviya A, 2012, APPL MICROBIOL BIOT, V93, P1485, DOI 10.1007/s00253-011-3629-0; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McAndrew RP, 2011, STRUCTURE, V19, P1876, DOI 10.1016/j.str.2011.09.013; Meades G, 2010, NUCLEIC ACIDS RES, V38, P1217, DOI 10.1093/nar/gkp1079; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Michener JK, 2012, METAB ENG, V14, P212, DOI 10.1016/j.ymben.2011.09.004; Nawabi P, 2011, APPL ENVIRON MICROB, V77, P8052, DOI 10.1128/AEM.05046-11; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Nielsen J, 2011, NAT BIOTECHNOL, V29, P693, DOI 10.1038/nbt.1937; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; Qureshi N, 1999, BIOTECHNOL PROGR, V15, P594, DOI 10.1021/bp990080e; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Renninger N, 2008, U.S. Patent, Patent No. 7399323; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Seregina TA, 2010, APPL BIOCHEM MICRO+, V46, P745, DOI 10.1134/S000368381008003X; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Smolke CD, 2000, APPL ENVIRON MICROB, V66, P5399, DOI 10.1128/AEM.66.12.5399-5405.2000; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10; Sun J., 2012, US patent, Patent No. [0,040,426 A1, 0040426]; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Trimbur D., 2011, US patent, Patent No. [0,047,863 A1, 0047863]; Tsukahara K, 1999, J BIOSCI BIOENG, V87, P554, DOI 10.1016/S1389-1723(99)80112-1; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Ubersax J., 2010, Genetically modified microbes producing isoprenoids patent world, Patent No. [1,414,52 A1, 141452]; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Yan Y, 2009, J IND MICROBIOL BIOT, V36, P471, DOI 10.1007/s10295-009-0532-0; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Yuzawa S., CURR OPIN BIOTECHNOL; Yuzawa S., 2012, CURR OPIN BIOTECHNOL; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	100	745	779	19	868	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					320	328		10.1038/nature11478	http://dx.doi.org/10.1038/nature11478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895337				2022-12-01	WOS:000307501000031
J	Rist, PM; Kang, JH; Buring, JE; Glymour, MM; Grodstein, F; Kurth, T				Rist, Pamela M.; Kang, Jae H.; Buring, Julie E.; Glymour, M. Maria; Grodstein, Fran; Kurth, Tobias			Migraine and cognitive decline among women: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; RANDOMIZED-TRIAL; BRAIN INFARCTS; OLDER-ADULTS; VITAMIN-E; HEALTH; RISK; HEADACHE	Objective To evaluate the association between migraine and cognitive decline among women. Design Prospective cohort study. Setting Women's Health Study, United States. Participants 6349 women aged 65 or older enrolled in the Women's Health Study who provided information about migraine status at baseline and participated in cognitive testing during follow-up. Participants were classified into four groups: no history of migraine, migraine with aura, migraine without aura, and past history of migraine (reports of migraine history but no migraine in the year prior to baseline). Main outcome measures Cognitive testing was carried out at two year intervals up to three times using the telephone interview for cognitive status, immediate and delayed recall trials of the east Boston memory test, delayed recall trial of the telephone interview for cognitive status 10 word list, and a category fluency test. All tests were combined into a global cognitive score, and tests assessing verbal memory were combined to create a verbal memory score. Results Of the 6349 women, 853 (13.4%) reported any migraine; of these, 195 (22.9%) reported migraine with aura, 248 (29.1%) migraine without aura, and 410 (48.1%) a past history of migraine. Compared with women with no history of migraine, those who experienced migraine with or without aura or had a past history of migraine did not have significantly different rates of cognitive decline in any of the cognitive scores: values for the rate of change of the global cognitive score between baseline and the last observation ranged from -0.01 (SE 0.04) for past history of migraine to 0.08 (SE 0.04) for migraine with aura when compared with women without any history of migraine. Women who experienced migraine were also not at increased risk of substantial cognitive decline (worst 10% of the distribution of decline). When compared with women without a history of migraine, the relative risks for the global score ranged from 0.77 (95% confidence interval 0.46 to 1.28) for women with migraine without aura to 1.17 (0.84 to 1.63) for women with a past history of migraine. Conclusion In this prospective cohort of women, migraine status was not associated with faster rates of cognitive decline.	[Kurth, Tobias] Univ Bordeaux Segalen, INSERM, Unit Neuroepidemiol 708, F-33076 Bordeaux, France; [Rist, Pamela M.; Buring, Julie E.; Kurth, Tobias] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Rist, Pamela M.; Buring, Julie E.; Grodstein, Fran; Kurth, Tobias] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kang, Jae H.; Grodstein, Fran] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Glymour, M. Maria] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Cambridge, MA 02138 USA; [Kurth, Tobias] Univ Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Universite de Bordeaux	Kurth, T (corresponding author), Univ Bordeaux Segalen, INSERM, Unit Neuroepidemiol 708, 146 Rue Leo Saignat,Case 11, F-33076 Bordeaux, France.	tobias.kurth@univ-bordeaux.fr	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620	National Heart, Lung, and Blood Institute [HL-043851, HL-080467, HL-099355]; National Cancer Institute [CA-47988]; National Institute of Aging [AG-15933, AG-00158]; Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche) [R09177DD]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851, RC1HL099355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015933] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Women's Health Study is supported by grants from the National Heart, Lung, and Blood Institute (HL-043851, HL-080467, HL-099355) and the National Cancer Institute (CA-47988). The cognitive substudy of the Women's Health Study was supported by a grant from the National Institute of Aging (AG-15933). PMR was supported by a training grant from the National Institute of Aging (AG-00158). TK is supported in part by a Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche, R09177DD).	ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Baars MAE, 2010, HEADACHE, V50, P176, DOI 10.1111/j.1526-4610.2009.01572.x; Bigal ME, 2009, NEUROL CLIN, V27, P321, DOI 10.1016/j.ncl.2008.11.011; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaist D, 2005, NEUROLOGY, V64, P600, DOI 10.1212/01.WNL.0000151858.15482.66; Haverkamp F, 2002, HEADACHE, V42, P776, DOI 10.1046/j.1526-4610.2002.02179.x; HOOKER WD, 1986, ARCH NEUROL-CHICAGO, V43, P709, DOI 10.1001/archneur.1986.00520070065020; Jelicic M, 2000, HEADACHE, V40, P715, DOI 10.1046/j.1526-4610.2000.00124.x; Kalaydjian A, 2007, NEUROLOGY, V68, P1417, DOI 10.1212/01.wnl.0000268250.10171.b3; Kang JH, 2007, BMJ-BRIT MED J, V334, P987, DOI 10.1136/bmj.39166.597836.BE; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7357; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Le Pira F, 2000, CEPHALALGIA, V20, P475, DOI 10.1046/j.1468-2982.2000.00074.x; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lee SM, 2006, NEUROEPIDEMIOLOGY, V26, P93, DOI 10.1159/000090254; LEIJDEKKERS MLA, 1990, HEADACHE, V30, P352, DOI 10.1111/j.1526-4610.1990.hed3006352.x; Lipton RB, 2004, JAMA-J AM MED ASSOC, V291, P493, DOI 10.1001/jama.291.4.493; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Mulder EJCM, 1999, CEPHALALGIA, V19, P557, DOI 10.1046/j.1468-2982.1999.019006557.x; Okereke OI, 2008, J AM GERIATR SOC, V56, P1028, DOI 10.1111/j.1532-5415.2008.01686.x; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Palmer JE, 1998, CEPHALALGIA, V18, P125, DOI 10.1046/j.1468-2982.1998.1803125.x; Pearson AJ, 2006, CEPHALALGIA, V26, P74, DOI 10.1111/j.1468-2982.2005.01001.x; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rist PM, 2011, CEPHALALGIA, V31, P1291, DOI 10.1177/0333102411417466; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2009, CEPHALALGIA, V29, P1086, DOI 10.1111/j.1468-2982.2008.01835.x; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Weuve J, 2006, EPIDEMIOLOGY, V17, P183, DOI 10.1097/01.ede.0000198183.60572.c9; ZEITLIN C, 1984, BRIT J CLIN PSYCHOL, V23, P27, DOI 10.1111/j.2044-8260.1984.tb00623.x	36	31	32	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e5027	10.1136/bmj.e5027	http://dx.doi.org/10.1136/bmj.e5027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ND	22875950	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000307496800002
J	Kjaer, KH; Khan, SA; Korsgaard, NJ; Wahr, J; Bamber, JL; Hurkmans, R; van den Broeke, M; Timm, LH; Kjeldsen, KK; Bjork, AA; Larsen, NK; Jorgensen, LT; Faerch-Jensen, A; Willerslev, E				Kjaer, Kurt H.; Khan, Shfaqat A.; Korsgaard, Niels J.; Wahr, John; Bamber, Jonathan L.; Hurkmans, Ruud; van den Broeke, Michiel; Timm, Lars H.; Kjeldsen, Kristian K.; Bjork, Anders A.; Larsen, Nicolaj K.; Jorgensen, Lars Tyge; Faerch-Jensen, Anders; Willerslev, Eske			Aerial Photographs Reveal Late-20th-Century Dynamic Ice Loss in Northwestern Greenland	SCIENCE			English	Article							RESOLUTION CLIMATE MODEL; JAKOBSHAVN ISBRAE; MASS-LOSS	Global warming is predicted to have a profound impact on the Greenland Ice Sheet and its contribution to global sea-level rise. Recent mass loss in the northwest of Greenland has been substantial. Using aerial photographs, we produced digital elevation models and extended the time record of recent observed marginal dynamic thinning back to the mid-1980s. We reveal two independent dynamic ice loss events on the northwestern Greenland Ice Sheet margin: from 1985 to 1993 and 2005 to 2010, which were separated by limited mass changes. Our results suggest that the ice mass changes in this sector were primarily caused by short-lived dynamic ice loss events rather than changes in the surface mass balance. This finding challenges predictions about the future response of the Greenland Ice Sheet to increasing global temperatures.	[Kjaer, Kurt H.; Korsgaard, Niels J.; Timm, Lars H.; Kjeldsen, Kristian K.; Bjork, Anders A.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, Copenhagen, Denmark; [Khan, Shfaqat A.] Tech Univ Denmark, DTU Space Natl Space Inst, Dept Geodesy, DK-2800 Lyngby, Denmark; [Wahr, John] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wahr, John] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Bamber, Jonathan L.; Hurkmans, Ruud] Univ Bristol, Bristol Glaciol Ctr, Bristol, Avon, England; [van den Broeke, Michiel] Univ Utrecht, Inst Marine & Atmospher Res, Utrecht, Netherlands; [Larsen, Nicolaj K.] Aarhus Univ, Dept Geosci, Aarhus, Denmark; [Jorgensen, Lars Tyge; Faerch-Jensen, Anders] Danish Natl Cadastre & Survey, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Bristol; Utrecht University; Aarhus University	Kjaer, KH (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, Copenhagen, Denmark.	kurtk@snm.ku.dk	Kjaer, Kurt/A-4199-2013; Hurkmans, Ruud/B-8286-2012; Van den Broeke, Michiel R./F-7867-2011; Korsgaard, Niels Jákup/D-8256-2013; Khan, Shfaqat A/B-2664-2012; Bamber, Jonathan/C-7608-2011; Kjeldsen, Kristian Kjellerup/A-9592-2013; Willerslev, Eske/AAA-5686-2019; Larsen, Nicolaj K./A-3509-2012; Willerslev, Eske/A-9619-2011; Bjørk, Anders/B-1625-2013; Khan, Shfaqat Abbas/AAP-6627-2021	Kjaer, Kurt/0000-0002-8871-5179; Hurkmans, Ruud/0000-0002-9164-7445; Van den Broeke, Michiel R./0000-0003-4662-7565; Korsgaard, Niels Jákup/0000-0002-8700-7023; Khan, Shfaqat A/0000-0002-2689-8563; Bamber, Jonathan/0000-0002-2280-2819; Kjeldsen, Kristian Kjellerup/0000-0002-8557-5131; Larsen, Nicolaj K./0000-0002-0117-1106; Willerslev, Eske/0000-0002-7081-6748; Bjørk, Anders/0000-0002-4919-792X; Khan, Shfaqat Abbas/0000-0002-2689-8563	Danish Research Council [272-08-0415]; Commission for Scientific Research in Greenland; European Union [226375]; NASA [NNX08AF02G, NNXI0AR66G]; NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program; Utrecht University; Netherlands Polar Program	Danish Research Council(Det Frie Forskningsrad (DFF)); Commission for Scientific Research in Greenland; European Union(European Commission); NASA(National Aeronautics & Space Administration (NASA)); NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program; Utrecht University; Netherlands Polar Program	This work is a part of the RinkProject, within the Centre for GeoGenetics, funded by the Danish Research Council, grant no. 272-08-0415, and the Commission for Scientific Research in Greenland. J.L.B. and R. H. were supported by funding from the ice2sea program from the European Union 7th Framework Programme, grant number 226375. J.W. was partially supported by NASA grants NNX08AF02G and NNXI0AR66G, and by NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program. M.v.d.B. acknowledges support from Utrecht University and the Netherlands Polar Program. Finally, we extend our gratitude toward the Danish National Cadastre and Survey for facilitating the erection of AirBase: a database containing registrations of aerial photographs from Greenland and their metadata. K. H. K., S. A. K., N.K.L., and E. W. wrote the majority of the main text with significant input from all authors. All authors contributed with interpretation and discussion of results. N.J.K. completed the aerial photogrammetric and validation analyses together with L. H. T., K. H. K., L.T.J., and A.F.-J. J.W. provided the GRACE data and analyses. K. K. K. handled the Geographical Information System and database management. J.B., M.v.d.B., and R. H. provided SMB and firn density data. A. A. B., L. H. T., and N.K.L. collected ice marginal data and analyzed their long-term significance.	AMAP, 2009, GREENL IC SHEET CHAN; Carstensen L. S., 2011, 1110 DMI TR; Chen JL, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007789; Ettema J, 2010, CRYOSPHERE, V4, P511, DOI 10.5194/tc-4-511-2010; Ettema J, 2010, CRYOSPHERE, V4, P529, DOI 10.5194/tc-4-529-2010; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; Ewert H., 2011, J GEODYN; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2011, J GLACIOL, V57, P389, DOI 10.3189/002214311796905631; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Khan SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042460; Krabill W.B, 2010, ICEBRIDGE ATM L2 ICE; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Reeh N, 2005, ANN GLACIOL-SER, V42, P101, DOI 10.3189/172756405781812871; Reeh N, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000746; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Sasgen I, 2012, EARTH PLANET SC LETT, V333, P293, DOI 10.1016/j.epsl.2012.03.033; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; Thomas RH, 2003, J GLACIOL, V49, P231, DOI 10.3189/172756503781830764; van As D, 2011, J GLACIOL, V57, P208, DOI 10.3189/002214311796405898; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Wahr J, 1998, J GEOPHYS RES-SOL EA, V103, P30205, DOI 10.1029/98JB02844; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zwally H. J., 2011, GLAS ICESAT L2 ANTAR; Zwally HJ, 2011, J GLACIOL, V57, P88, DOI 10.3189/002214311795306682	30	68	68	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					569	573		10.1126/science.1220614	http://dx.doi.org/10.1126/science.1220614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859486				2022-12-01	WOS:000307058700042
J	Rupar, PA; Chabanne, L; Winnik, MA; Manners, I				Rupar, Paul A.; Chabanne, Laurent; Winnik, Mitchell A.; Manners, Ian			Non-Centrosymmetric Cylindrical Micelles by Unidirectional Growth	SCIENCE			English	Article							BLOCK-COPOLYMER MICELLES; DIBLOCK COPOLYMERS; CONTROLLED LENGTH; ARCHITECTURES; MORPHOLOGIES; COMPLEX; WATER; CORE	Although solution self-assembly of block copolymers (BCPs) represents one of the most promising approaches to the creation of nanoparticles from soft matter, the formation of non-centrosymmetric nanostructures with shape anisotropy remains a major challenge. Through a combination of crystallization-driven self-assembly of crystalline-coil BCPs in solution and selective micelle corona cross-linking, we have created short (about 130 nanometers), monodisperse cylindrical seed micelles that grow unidirectionally. These nanostructures grow to form long, non-centrosymmetric cylindrical A-B and A-B-C block co-micelles upon the addition of further BCPs. We also illustrate the formation of amphiphilic cylindrical A-B-C block co-micelles, which spontaneously self-assemble into hierarchical star-shaped supermicelle architectures with a diameter of about 3 micrometers. The method described enables the rational creation of non-centrosymmetric, high aspect ratio, colloidally stable core-shell nanoparticles in a manner that until now has been restricted to the biological domain.	[Winnik, Mitchell A.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Rupar, Paul A.; Chabanne, Laurent; Manners, Ian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Toronto; University of Bristol	Winnik, MA (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	mwinnik@chem.utoronto.ca; ian.manners@bristol.ac.uk	Rupar, Paul/E-6496-2010; Winnik, Mitchell A/R-8621-2018	Rupar, Paul/0000-0002-9532-116X; Manners, Ian/0000-0002-3794-967X	Natural Science and Engineering Research Council (NSERC) of Canada; European Union (EU); Engineering and Physical Sciences Research Council; European Research Council Advanced Investigator Grant; Royal Society for a Wolfson Research Merit Award; NSERC of Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union (EU)(CGIAREuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council Advanced Investigator Grant(European Research Council (ERC)); Royal Society for a Wolfson Research Merit Award(Royal Society of London); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	P.A.R. is grateful to the Natural Science and Engineering Research Council (NSERC) of Canada for a postdoctoral fellowship and the European Union (EU) for a Marie Curie fellowship. L. C. thanks the EU and Engineering and Physical Sciences Research Council for support. I. M. thanks the EU for a Marie Curie Chair, a Reintegration Grant, and a European Research Council Advanced Investigator Grant and the Royal Society for a Wolfson Research Merit Award. M. A. W. thanks the NSERC of Canada for financial support. The authors also thank T. Gadt for synthesizing PFS<INF>28</INF>-b-PDMS<INF>560</INF> and PFS<INF>64</INF>-b-P2VP<INF>837</INF>.	Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Cheng L, 2008, ANGEW CHEM INT EDIT, V47, P10171, DOI 10.1002/anie.200803315; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Du ZX, 2007, MACROMOLECULES, V40, P7633, DOI 10.1021/ma070977p; Dupont J, 2010, SOFT MATTER, V6, P3654, DOI 10.1039/c0sm00044b; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/NMAT2356, 10.1038/nmat2356]; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Lazzari M, 2008, MACROMOL RAPID COMM, V29, P352, DOI 10.1002/marc.200700818; Lee E, 2011, J AM CHEM SOC, V133, P10390, DOI 10.1021/ja2038547; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; O'Reilly RK, 2006, CHEM SOC REV, V35, P1068, DOI 10.1039/b514858h; Park S, 2004, SCIENCE, V303, P348, DOI 10.1126/science.1093276; Patra SK, 2011, J AM CHEM SOC, V133, P8842, DOI 10.1021/ja202408w; Petzetakis N, 2011, CHEM SCI, V2, P955, DOI 10.1039/c0sc00596g; Pochan DJ, 2011, SOFT MATTER, V7, P2500, DOI 10.1039/c0sm00960a; Qian JS, 2011, ANGEW CHEM INT EDIT, V50, P1622, DOI 10.1002/anie.201006223; Rupar PA, 2011, J AM CHEM SOC, V133, P16947, DOI 10.1021/ja206370k; Schmelz J, 2011, ACS NANO, V5, P9523, DOI 10.1021/nn202638t; Voets IK, 2006, ANGEW CHEM INT EDIT, V45, P6673, DOI 10.1002/anie.200601000; Walther A, 2008, SOFT MATTER, V4, P663, DOI 10.1039/b718131k; Walther A, 2007, J AM CHEM SOC, V129, P6187, DOI 10.1021/ja068153v; Walther A, 2009, J AM CHEM SOC, V131, P4720, DOI 10.1021/ja808614q; Walther A, 2009, SOFT MATTER, V5, P385, DOI 10.1039/b812321g; Wang H, 2007, MACROMOLECULES, V40, P3784, DOI 10.1021/ma062728r; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Wang XS, 2007, J AM CHEM SOC, V129, P5630, DOI 10.1021/ja068730f; Xia Y, 2009, J AM CHEM SOC, V131, P18525, DOI 10.1021/ja908379q; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369	33	300	300	9	499	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					559	562		10.1126/science.1221206	http://dx.doi.org/10.1126/science.1221206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859484				2022-12-01	WOS:000307058700039
J	Moore, M				Moore, Mike			Looking for a good night's sleep	LANCET			English	Editorial Material							CHRONIC INSOMNIA; THERAPY; TRIAL		Pacific NW Univ Hlth Sci, Dept Clin Sci, Washington, WA 98901 USA		Moore, M (corresponding author), Pacific NW Univ Hlth Sci, Dept Clin Sci, Washington, WA 98901 USA.	mmoore@pnwu.edu						Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Perlis ML, 2008, J CLIN SLEEP MED, V4, P11; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Rosekind MR, 2010, AM J MANAG CARE, V16, P617; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307	7	6	8	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2012	380	9839					322	323		10.1016/S0140-6736(12)61220-3	http://dx.doi.org/10.1016/S0140-6736(12)61220-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22841325				2022-12-01	WOS:000306842800011
J	Erb, TJ; Kiefer, P; Hattendorf, B; Gunther, D; Vorholt, JA				Erb, Tobias J.; Kiefer, Patrick; Hattendorf, Bodo; Guenther, Detlef; Vorholt, Julia A.			GFAJ-1 Is an Arsenate-Resistant, Phosphate-Dependent Organism	SCIENCE			English	Article							TRANSPORT	The bacterial isolate GFAJ-1 has been proposed to substitute arsenic for phosphorus to sustain growth. We have shown that GFAJ-1 is able to grow at low phosphate concentrations (1.7 mu M), even in the presence of high concentrations of arsenate (40 mM), but lacks the ability to grow in phosphorus-depleted (<0.3 mu M), arsenate-containing medium. High-resolution mass spectrometry analyses revealed that phosphorylated central metabolites and phosphorylated nucleic acids predominated. A few arsenylated compounds, including C6 sugar arsenates, were detected in extracts of GFAJ-1, when GFAJ-1 was incubated with arsenate, but further experiments showed they formed abiotically. Inductively coupled plasma mass spectrometry confirmed the presence of phosphorus in nucleic acid extracts, while arsenic could not be detected and was below 1 per mil relative to phosphorus. Taken together, we conclude that GFAJ-1 is an arsenate-resistant, but still a phosphate-dependent, bacterium.	[Erb, Tobias J.; Kiefer, Patrick; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Hattendorf, Bodo; Guenther, Detlef] ETH, Inorgan Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Erb, TJ (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	toerb@ethz.ch; vorholt@micro.biol.ethz.ch	Vorholt, Julia/K-3514-2016; Kiefer, Patrick/G-5138-2010; Erb, Tobias/J-5214-2013	Vorholt, Julia/0000-0002-6011-4910; Erb, Tobias/0000-0003-3685-0894; Hattendorf, Bodo/0000-0001-9991-2410	ETH Fellowship	ETH Fellowship	We thank R. Oremland and J. S. Blum for providing strain GFAJ-1, P. Christen and F. Ryffel for technical and experimental assistance, as well as an anonymous reviewer for valuable suggestions and comments on our manuscript. T.J.E. was supported through an ETH Fellowship.	ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; Benner SA, 2011, SCIENCE, V332, DOI 10.1126/science.1201304; Borhani DW, 2011, SCIENCE, V332, DOI 10.1126/science.1201255; Canovas D, 2003, ENVIRON MICROBIOL, V5, P133, DOI 10.1046/j.1462-2920.2003.00386.x; Cotner JB, 2011, SCIENCE, V332, DOI 10.1126/science.1201943; Csabai I, 2011, SCIENCE, V332, DOI 10.1126/science.1201399; Foster PL, 2011, SCIENCE, V332, DOI 10.1126/science.1201551; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kiefer P, 2011, ANAL CHEM, V83, P850, DOI 10.1021/ac102445r; LAGUNAS R, 1980, ARCH BIOCHEM BIOPHYS, V205, P67, DOI 10.1016/0003-9861(80)90084-3; Liebig J., 1855, GRUNDSATZE AGRIKULTU; MOORE SA, 1983, J BIOL CHEM, V258, P6266; Oehler S, 2011, SCIENCE, V332, DOI 10.1126/science.1201381; Redfield RJ, 2011, SCIENCE, V332, DOI [10.1126/science.1201304, 10.1126/science.1201482]; Schoepp-Cothenet B, 2011, SCIENCE, V332, DOI 10.1126/science.1201438; WILLSKY GR, 1980, J BACTERIOL, V144, P366, DOI 10.1128/JB.144.1.366-374.1980; WILLSKY GR, 1980, J BACTERIOL, V144, P356, DOI 10.1128/JB.144.1.356-365.1980; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258	18	64	65	1	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					467	470		10.1126/science.1218455	http://dx.doi.org/10.1126/science.1218455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22773139				2022-12-01	WOS:000306802300043
J	Wen, CP; Wu, XF				Wen, Chi Pang; Wu, Xifeng			Stressing harms of physical inactivity to promote exercise	LANCET			English	Editorial Material							LIFE EXPECTANCY; MORTALITY; COHORT; TAIWAN		[Wen, Chi Pang] Natl Hlth Res Inst, Zhunan, Taiwan; [Wen, Chi Pang] China Med Univ Hosp, Zhunan, Taiwan; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Texas System; UTMD Anderson Cancer Center	Wen, CP (corresponding author), Natl Hlth Res Inst, Zhunan, Taiwan.	cwengood@nhri.org.tw						*CDCP, 1996, SURG GEN REP PHYS AC; Lee IM, 2012, LANCET; National Research Council. Committee on Physical Activity Land Use Institute of Medicine, 2005, DOES BUILT ENV INFL; Organization WH Control RfIT, 2008, WHO REP GLOB TOB EP; Pimlott N, 2010, CAN FAM PHYSICIAN, V56, P407; Shavelle Robert M, 2008, J Insur Med, V40, P170; Wai JPM, 2008, ASIA PAC J CLIN NUTR, V17, P297; Walsh JME, 1999, AM J PREV MED, V16, P307, DOI 10.1016/S0749-3797(99)00021-5; Wen CP, 2012, LANCET, V379, P800, DOI 10.1016/S0140-6736(12)60342-0; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wen CP, 2005, TOB CONTROL, V14, pI76, DOI 10.1136/tc.2004.007955; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; World Health Organization, WHO FRAM CONV TOB CO; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, UN HIGH LEV M NONC D	15	109	111	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2012	380	9838					192	193		10.1016/S0140-6736(12)60954-4	http://dx.doi.org/10.1016/S0140-6736(12)60954-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	976TV	22818933				2022-12-01	WOS:000306609200006
J	Heneghan, C; Gill, P; O'Neill, B; Lasserson, D; Thake, M; Thompson, M; Howick, J				Heneghan, Carl; Gill, Peter; O'Neill, Braden; Lasserson, Dan; Thake, Miriam; Thompson, Matthew; Howick, Jeremy			Mythbusting sports and exercise products	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHAIN AMINO-ACID; BULL ENERGY DRINK; GRADUATED COMPRESSION STOCKINGS; INDUCED MUSCLE DAMAGE; CYCLING TIME-TRIAL; CARBOHYDRATE-PROTEIN SUPPLEMENTATION; REPEATED SPRINT PERFORMANCE; CHOCOLATE MILK CONSUMPTION; WELL-TRAINED MEN; ENDURANCE PERFORMANCE		[Heneghan, Carl; Gill, Peter; O'Neill, Braden; Lasserson, Dan; Thake, Miriam; Thompson, Matthew; Howick, Jeremy] Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX1 2ET, England	University of Oxford	Heneghan, C (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford OX1 2ET, England.	carl.heneghan@phc.ox.ac.uk	Gill, Peter J./A-6021-2012; Howick, Jeremy/ADP-7644-2022	Gill, Peter J./0000-0002-6253-1312; Lasserson, Daniel/0000-0001-8274-5580				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021; Ali A, 2007, J SPORT SCI, V25, P413, DOI 10.1080/02640410600718376; Ali A, 2011, J STRENGTH COND RES, V25, P1385, DOI 10.1519/JSC.0b013e3181d6848e; Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; ARIEFF AI, 1976, MEDICINE, V55, P121, DOI 10.1097/00005792-197603000-00002; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Astorino TA, 2012, AMINO ACIDS, V42, P1803, DOI 10.1007/s00726-011-0900-8; Astorino TA, 2010, J STRENGTH COND RES, V24, P257, DOI 10.1519/JSC.0b013e3181c1f88a; Baum M, 2001, AMINO ACIDS, V20, P75, DOI 10.1007/s007260170067; Berardi JM, 2006, MED SCI SPORT EXER, V38, P1106, DOI 10.1249/01.mss.0000222826.49358.f3; Berardi JM, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-24; Bernhardt T, 2005, J STRENGTH COND RES, V19, P292; BERRY MJ, 1987, AM J PHYS MED REHAB, V66, P121; Betts JA, 2005, INT J SPORT NUTR EXE, V15, P590, DOI 10.1123/ijsnem.15.6.590; Betts J, 2007, J SPORT SCI, V25, P1449, DOI 10.1080/02640410701213459; Betts JA, 2011, MED SCI SPORT EXER, V43, P1244, DOI 10.1249/MSS.0b013e31821b0dcc; Betts JA, 2010, SPORTS MED, V40, P941, DOI 10.2165/11536900-000000000-00000; Blomstrand E, 1997, ACTA PHYSIOL SCAND, V159, P41, DOI 10.1046/j.1365-201X.1997.547327000.x; Candow DG, 2009, J STRENGTH COND RES, V23, P1271, DOI 10.1519/JSC.0b013e3181a026c2; Chatard JC, 2004, EUR J APPL PHYSIOL, V93, P347, DOI 10.1007/s00421-004-1163-9; Cheuvront SN, 2010, AM J CLIN NUTR, V92, P565, DOI 10.3945/ajcn.2010.29490; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI 10.1097/01.PHM.0000029772.45258.43; Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055; Coburn JW, 2006, J STRENGTH COND RES, V20, P284; Cockburn E, 2010, APPL PHYSIOL NUTR ME, V35, P270, DOI 10.1139/H10-017; Cockburn E, 2008, APPL PHYSIOL NUTR ME, V33, P775, DOI 10.1139/H08-057; Conger SA, 2011, INT J SPORT NUTR EXE, V21, P71, DOI 10.1123/ijsnem.21.1.71; Crowe MJ, 2006, EUR J APPL PHYSIOL, V97, P664, DOI 10.1007/s00421-005-0036-1; Davies V, 2009, J STRENGTH COND RES, V23, P1786, DOI 10.1519/JSC.0b013e3181b42589; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; de Glanville KM, 2012, J STRENGTH COND RES, V26, P480, DOI 10.1519/JSC.0b013e318225ff61; De Lorenzo A, 2003, DIABETES NUTR METAB, V16, P291; Del Coso J, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-21; Deldicque L, 2008, CURR OPIN CLIN NUTR, V11, P774, DOI 10.1097/MCO.0b013e3283139489; Doan BK, 2003, J SPORT SCI, V21, P601, DOI 10.1080/0264041031000101971; Doherty M, 2005, SCAND J MED SCI SPOR, V15, P69, DOI 10.1111/j.1600-0838.2005.00445.x; Doherty M, 2004, INT J SPORT NUTR EXE, V14, P626, DOI 10.1123/ijsnem.14.6.626; Duffield R, 2007, BRIT J SPORT MED, V41, P409, DOI 10.1136/bjsm.2006.033753; Duffield R, 2008, INT J SPORT PHYSIOL, V3, P454, DOI 10.1123/ijspp.3.4.454; Duffield R, 2010, J SCI MED SPORT, V13, P136, DOI 10.1016/j.jsams.2008.10.006; Duncan MJ, 2011, J STRENGTH COND 1124; Eberman LE, 2009, ATHL TRAIN SPORTS HL, V1, P267, DOI DOI 10.3928/19425864-20091020; FALLOWFIELD JL, 1995, INT J SPORT NUTR, V5, P285, DOI 10.1123/ijsn.5.4.285; Ferguson-Stegall L, 2011, J STRENGTH COND RES, V25, P1210, DOI 10.1519/JSC.0b013e318212db21; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; FLOYD JC, 1970, DIABETES, V19, P109, DOI 10.2337/diab.19.2.109; Forbes SC, 2007, INT J SPORT NUTR EXE, V17, P433, DOI 10.1123/ijsnem.17.5.433; French DN, 2008, MED SCI SPORT EXER, V40, P1297, DOI 10.1249/MSS.0b013e31816b10d5; Ganio MS, 2009, J STRENGTH COND RES, V23, P315, DOI 10.1519/JSC.0b013e31818b979a; GEISS KR, 1994, AMINO ACIDS, V7, P45, DOI 10.1007/BF00808445; Gill ND, 2006, BRIT J SPORT MED, V40, P260, DOI 10.1136/bjsm.2005.022483; Gilson SF, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-19; Goulet EDB, 2007, INT J SPORT NUTR EXE, V17, P391, DOI 10.1123/ijsnem.17.4.391; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Graff L, 1983, HDB ROUTINE URINALYS, P2; Green MS, 2008, INT J SPORT NUTR EXE, V18, P1, DOI 10.1123/ijsnem.18.1.1; Greer BK, 2007, INT J SPORT NUTR EXE, V17, P595, DOI 10.1123/ijsnem.17.6.595; Greer BK, 2011, J STRENGTH COND RES, V25, P539, DOI 10.1519/JSC.0b013e3181bf443a; Gualano AB, 2011, J SPORT MED PHYS FIT, V51, P82; Guard A, 2005, INJURY PREV, V11, P33, DOI 10.1136/ip.2003.004044; Gwacham N, 2012, INT J SPORT NUTR EXE, V22, P109, DOI 10.1123/ijsnem.22.2.109; Harvey G, 2008, J SCI MED SPORT, V11, P600, DOI 10.1016/j.jsams.2007.05.012; Heneghan C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001702; Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381; Higgins T, 2009, J SCI MED SPORT, V12, P223, DOI 10.1016/j.jsams.2007.08.018; Houghton LA, 2009, J SCI MED SPORT, V12, P303, DOI 10.1016/j.jsams.2007.09.004; Hsu MC, 2011, CHINESE J PHYSIOL, V54, P71, DOI 10.4077/CJP.2011.AMK075; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Ivy JL, 2009, INT J SPORT NUTR EXE, V19, P61, DOI 10.1123/ijsnem.19.1.61; Jakeman JR, 2010, J STRENGTH COND RES, V24, P3157, DOI 10.1519/JSC.0b013e3181e4f80c; Johnson AK, 1997, FRONT NEUROENDOCRIN, V18, P292, DOI 10.1006/frne.1997.0153; Karp JR, 2006, INT J SPORT NUTR EXE, V16, P78, DOI 10.1123/ijsnem.16.1.78; Kemmler W, 2009, J STRENGTH COND RES, V23, P101, DOI 10.1519/JSC.0b013e31818eaef3; Kerksick CM, 2006, J STRENGTH COND RES, V20, P643, DOI 10.1519/R-17695.1; Kipps C, 2011, BRIT J SPORT MED, V45, P14, DOI 10.1136/bjsm.2009.059535; Kovacs EMR, 1999, J SPORT MED PHYS FIT, V39, P47; Kraemer WJ, 2010, J STRENGTH COND RES, V24, P804, DOI 10.1519/JSC.0b013e3181d33025; KRAEMER WJ, 1996, J STRENGTH COND RES, V10, P180; Lew CH, 2010, INT J SPORT NUTR EXE, V20, P330, DOI 10.1123/ijsnem.20.4.330; Luden ND, 2007, INT J SPORT NUTR EXE, V17, P109, DOI 10.1123/ijsnem.17.1.109; Lunn WR, 2012, MED SCI SPORT EXER, V44, P682, DOI 10.1249/MSS.0b013e3182364162; Manz F, 2003, EUR J CLIN NUTR, V57, pS10, DOI 10.1038/sj.ejcn.1601896; Matsumoto K, 2009, J SPORT MED PHYS FIT, V49, P424; Matsumoto K, 2009, J NUTR SCI VITAMINOL, V55, P52, DOI 10.3177/jnsv.55.52; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; MAY ME, 1989, DIABETES METAB REV, V5, P227, DOI 10.1002/dmr.5610050303; Menetrier A, 2011, INT J SPORTS MED, V32, P864, DOI 10.1055/s-0031-1283181; Millard-Stafford M, 2005, INT J SPORT NUTR EXE, V15, P610, DOI 10.1123/ijsnem.15.6.610; Millward DJ, 2004, J SPORT SCI, V22, P143, DOI 10.1080/0264041031000140617; Nelson AR, 2012, MED SCI SPORT EXER, V44, P57, DOI 10.1249/MSS.0b013e3182290371; Nicholas CW, 1997, INT J SPORT NUTR, V7, P251, DOI 10.1123/ijsn.7.4.251; Nissen S, 1996, J APPL PHYSIOL, V81, P2095, DOI 10.1152/jappl.1996.81.5.2095; Noakes T., 2012, WATERLOGGED SERIOUS; Nutrition Working Group of the International Olympic Committee, NUTR ATHL; Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014; Pitkanen HT, 2003, AMINO ACIDS, V25, P85, DOI 10.1007/s00726-002-0343-3; Pollock NW, 1997, MED SCI SPORTS EXERC, V29l, P261; Portier H, 2008, EUR J APPL PHYSIOL, V104, P787, DOI 10.1007/s00421-008-0832-5; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Rimaud D, 2010, EUR J APPL PHYSIOL, V110, P425, DOI 10.1007/s00421-010-1503-x; ROBINSON TA, 1995, EUR J APPL PHYSIOL O, V71, P153, DOI 10.1007/BF00854973; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Rowlands DS, 2008, APPL PHYSIOL NUTR ME, V33, P39, DOI 10.1139/H07-136; Rowlands DS, 2007, INT J SPORT NUTR EXE, V17, P521, DOI 10.1123/ijsnem.17.6.521; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Scanlan AT, 2008, INT J SPORT PHYSIOL, V3, P424, DOI 10.1123/ijspp.3.4.424; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Shimomura Y, 2010, INT J SPORT NUTR EXE, V20, P236, DOI 10.1123/ijsnem.20.3.236; Shirreffs SM, 1996, MED SCI SPORT EXER, V28, P1260, DOI 10.1097/00005768-199610000-00009; Smith N, 2010, EVID-BASED COMPL ALT, V7, P279, DOI 10.1093/ecam/nem162; Spaccarotella KJ, 2011, J STRENGTH COND RES, V25, P3456, DOI 10.1519/JSC.0b013e3182163071; Sperlich B, 2010, J SPORT SCI, V28, P609, DOI 10.1080/02640410903582768; Stearns RL, 2010, J STRENGTH COND RES, V24, P2192, DOI 10.1519/JSC.0b013e3181ddfacf; Stock MS, 2010, J STRENGTH COND RES, V24, P2211, DOI 10.1519/JSC.0b013e3181dc3a10; Thomas K, 2009, APPL PHYSIOL NUTR ME, V34, P78, DOI 10.1139/H08-137; Thomson JS, 2011, APPL PHYSIOL NUTR ME, V36, P242, DOI [10.1139/h10-104, 10.1139/H10-104]; Tipton KD, 1999, AM J PHYSIOL-ENDOC M, V276, pE628, DOI 10.1152/ajpendo.1999.276.4.E628; VANHALL G, 1995, J PHYSIOL-LONDON, V486, P789, DOI 10.1113/jphysiol.1995.sp020854; Varela-Sanz A, 2011, J STRENGTH COND RES, V25, P2902, DOI 10.1519/JSC.0b013e31820f5049; VARNIER M, 1994, EUR J APPL PHYSIOL O, V69, P26, DOI 10.1007/BF00867923; Walker DK, 2011, MED SCI SPORT EXER, V43, P2249, DOI 10.1249/MSS.0b013e318223b037; Walker TB, 2010, INT J SPORT NUTR EXE, V20, P409, DOI 10.1123/ijsnem.20.5.409; WHO, 2012, WHO POS PAP OR REH S; Williams MB, 2003, J STRENGTH COND RES, V17, P12, DOI 10.1519/1533-4287(2003)017<0012:EORBOG>2.0.CO;2; Wojcik JR, 2001, INT J SPORT NUTR EXE, V11, P406, DOI 10.1123/ijsnem.11.4.406; Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827; ZAWADZKI KM, 1992, J APPL PHYSIOL, V72, P1854, DOI 10.1152/jappl.1992.72.5.1854	129	9	9	1	65	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2012	345								e4848	10.1136/bmj.e4848	http://dx.doi.org/10.1136/bmj.e4848			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MA	22810389				2022-12-01	WOS:000306744300012
J	Muzny, DM; Bainbridge, MN; Chang, K; Dinh, HH; Drummond, JA; Fowler, G; Kovar, CL; Lewis, LR; Morgan, MB; Newsham, IF; Reid, JG; Santibanez, J; Shinbrot, E; Trevino, LR; Wu, YQ; Wang, M; Gunaratne, P; Donehower, LA; Creighton, CJ; Wheeler, DA; Gibbs, RA; Lawrence, MS; Voet, D; Jing, R; Cibulskis, K; Sivachenko, A; Stojanov, P; McKenna, A; Lander, ES; Gabriel, S; Getz, G; Ding, L; Fulton, RS; Koboldt, DC; Wylie, T; Walker, J; Dooling, DJ; Fulton, L; Delehaunty, KD; Fronick, CC; Demeter, R; Mardis, ER; Wilson, RK; Chu, A; Chun, HJE; Mungall, AJ; Pleasance, E; Robertson, AG; Stoll, D; Balasundaram, M; Birol, I; Butterfield, YSN; Chuah, E; Coope, RJN; Dhalla, N; Guin, R; Hirst, C; Hirst, M; Holt, RA; Lee, D; Li, HI; Mayo, M; Moore, RA; Schein, JE; Slobodan, JR; Tam, A; Thiessen, N; Varhol, R; Zeng, T; Zhao, Y; Jones, SJM; Marra, MA; Bass, AJ; Ramos, AH; Saksena, G; Cherniack, AD; Schumacher, SE; Tabak, B; Carter, SL; Pho, NH; Nguyen, H; Onofrio, RC; Crenshaw, A; Ardlie, K; Beroukhim, R; Winckler, W; Getz, G; Meyerson, M; Protopopov, A; Zhang, J; Hadjipanayis, A; Lee, E; Xi, R; Yang, L; Ren, X; Zhang, H; Sathiamoorthy, N; Shukla, S; Chen, PC; Haseley, P; Xiao, Y; Lee, S; Seidman, J; Chin, L; Park, PJ; Kucherlapati, R; Auman, JT; Hoadley, KA; Du, Y; Wilkerson, MD; Shi, Y; Liquori, C; Meng, S; Li, L; Turman, YJ; Topal, MD; Tan, D; Waring, S; Buda, E; Walsh, J; Jones, CD; Mieczkowski, PA; Singh, D; Wu, J; Gulabani, A; Dolina, P; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, M; Mose, LE; Jefferys, SR; Balu, S; O'Connor, BD; Prins, JF; Chiang, DY; Hayes, DN; Perou, CM; Hinoue, T; Weisenberger, DJ; Maglinte, DT; Pan, F; Berman, BP; Van den Berg, DJ; Shen, H; Jr, TT; Baylin, SB; Laird, PW; Getz, G; Noble, M; Voet, D; Saksena, G; Gehlenborg, N; DiCara, D; Zhang, J; Zhang, H; Wu, CJ; Liu, SY; Shukla, S; Lawrence, MS; Zhou, L; Sivachenko, A; Lin, P; Stojanov, P; Jing, R; Park, RW; Nazaire, MD; Robinson, J; Thorvaldsdottir, H; Mesirov, J; Park, PJ; Chin, L; Thorsson, V; Reynolds, SM; Bernard, B; Kreisberg, R; Lin, J; Iype, L; Bressler, R; Erkkila, T; Gundapuneni, M; Liu, Y; Norberg, A; Robinson, T; Da Yang; Zhang, W; Shmulevich, I; De Ronde, JJ; Schultz, N; Cerami, E; Ciriello, G; Goldberg, AP; Gross, B; Jacobsen, A; Gao, J; Kaczkowski, B; Sinha, R; Aksoy, BA; Antipin, Y; Reva, B; Shen, R; Taylor, BS; Chan, TA; Ladanyi, M; Sander, C; Akbani, R; Zhang, N; Broom, BM; Casasent, T; Unruh, A; Wakefield, C; Hamilton, SR; Cason, RC; Baggerly, KA; Weinstein, JN; Haussler, D; Benz, CC; Stuart, JM; Benz, SC; Sanborn, JZ; Vaske, CJ; Zhu, J; Szeto, C; Scott, GK; Yau, C; Ng, S; Goldstein, T; Ellrott, K; Collisson, E; Cozen, AE; Zerbino, D; Wilks, C; Craft, B; Spellman, P; Penny, R; Shelton, T; Hatfield, M; Morris, S; Yena, P; Shelton, C; Sherman, M; Paulauskis, J; Gastier-Foster, JM; Bowen, J; Ramirez, NC; Black, A; Pyatt, R; Wise, L; White, P; Bertagnolli, M; Brown, J; Chan, TA; Chu, GC; Czerwinski, C; Denstman, F; Dhir, R; Doerner, A; Fuchs, CS; Guillem, JG; Iacocca, M; Juhl, H; Kaufman, A; Kohl, B; Van Le, X; Mariano, MC; Medina, EN; Meyers, M; Nash, GM; Paty, PB; Petrelli, N; Rabeno, B; Richards, WG; Solit, D; Swanson, P; Temple, L; Tepper, JE; Thorp, R; Vakiani, E; Weiser, MR; Willis, JE; Witkin, G; Zeng, Z; Zinner, MJ; Zornig, C; Jensen, MA; Sfeir, R; Kahn, AB; Chu, AL; Kothiyal, P; Wang, Z; Snyder, EE; Pontius, J; Pihl, TD; Ayala, B; Backus, M; Walton, J; Whitmore, J; Baboud, J; Berton, DL; Nicholls, MC; Srinivasan, D; Raman, R; Girshik, S; Kigonya, PA; Alonso, S; Sanbhadti, RN; Barletta, SP; Greene, JM; Pot, DA; Shaw, KRM; Dillon, LAL; Buetow, K; Davidsen, T; Demchok, JA; Eley, G; Ferguson, M; Fielding, P; Schaefer, C; Sheth, M; Yang, L; Guyer, MS; Ozenberger, BA; Palchik, JD; Peterson, J; Sofia, HJ; Thomson, E				Muzny, Donna M.; Bainbridge, Matthew N.; Chang, Kyle; Dinh, Huyen H.; Drummond, Jennifer A.; Fowler, Gerald; Kovar, Christie L.; Lewis, Lora R.; Morgan, Margaret B.; Newsham, Irene F.; Reid, Jeffrey G.; Santibanez, Jireh; Shinbrot, Eve; Trevino, Lisa R.; Wu, Yuan-Qing; Wang, Min; Gunaratne, Preethi; Donehower, Lawrence A.; Creighton, Chad J.; Wheeler, David A.; Gibbs, Richard A.; Lawrence, Michael S.; Voet, Douglas; Jing, Rui; Cibulskis, Kristian; Sivachenko, Andrey; Stojanov, Petar; McKenna, Aaron; Lander, Eric S.; Gabriel, Stacey; Getz, Gad; Ding, Li; Fulton, Robert S.; Koboldt, Daniel C.; Wylie, Todd; Walker, Jason; Dooling, David J.; Fulton, Lucinda; Delehaunty, Kim D.; Fronick, Catrina C.; Demeter, Ryan; Mardis, Elaine R.; Wilson, Richard K.; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Chuah, Eric; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Schein, Jacqueline E.; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard; Zeng, Thomas; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.; Bass, Adam J.; Ramos, Alex H.; Saksena, Gordon; Cherniack, Andrew D.; Schumacher, Stephen E.; Tabak, Barbara; Carter, Scott L.; Pho, Nam H.; Nguyen, Huy; Onofrio, Robert C.; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Meyerson, Matthew; Protopopov, Alexei; Zhang, Juinhua; Hadjipanayis, Angela; Lee, Eunjung; Xi, Ruibin; Yang, Lixing; Ren, Xiaojia; Zhang, Hailei; Sathiamoorthy, Narayanan; Shukla, Sachet; Chen, Peng-Chieh; Haseley, Psalm; Xiao, Yonghong; Lee, Semin; Seidman, Jonathan; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Auman, J. Todd; Hoadley, Katherine A.; Du, Ying; Wilkerson, Matthew D.; Shi, Yan; Liquori, Christina; Meng, Shaowu; Li, Ling; Turman, Yidi J.; Topal, Michael D.; Tan, Donghui; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Jones, Corbin D.; Mieczkowski, Piotr A.; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; O'Connor, Brian D.; Prins, Jan F.; Chiang, Derek Y.; Hayes, D. Neil; Perou, Charles M.; Hinoue, Toshinori; Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Berman, Benjamin P.; Van den Berg, David J.; Shen, Hui; Jr, Timothy Triche; Baylin, Stephen B.; Laird, Peter W.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Shukla, Sachet; Lawrence, Michael S.; Zhou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Thorsson, Vesteinn; Reynolds, Sheila M.; Bernard, Brady; Kreisberg, Richard; Lin, Jake; Iype, Lisa; Bressler, Ryan; Erkkilae, Timo; Gundapuneni, Madhumati; Liu, Yuexin; Norberg, Adam; Robinson, Tom; Da Yang; Zhang, Wei; Shmulevich, Ilya; De Ronde, Jorma J.; Schultz, Nikolaus; Cerami, Ethan; Ciriello, Giovanni; Goldberg, Arthur P.; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Kaczkowski, Bogumil; Sinha, Rileen; Aksoy, B. Arman; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Taylor, Barry S.; Chan, Timothy A.; Ladanyi, Marc; Sander, Chris; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod; Unruh, Anna; Wakefield, Chris; Hamilton, Stanley R.; Cason, R. Craig; Baggerly, Keith A.; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Benz, Stephen C.; Sanborn, J. Zachary; Vaske, Charles J.; Zhu, Jingchun; Szeto, Christopher; Scott, Gary K.; Yau, Christina; Ng, Sam; Goldstein, Ted; Ellrott, Kyle; Collisson, Eric; Cozen, Aaron E.; Zerbino, Daniel; Wilks, Christopher; Craft, Brian; Spellman, Paul; Penny, Robert; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron; Pyatt, Robert; Wise, Lisa; White, Peter; Bertagnolli, Monica; Brown, Jen; Chan, Timothy A.; Chu, Gerald C.; Czerwinski, Christine; Denstman, Fred; Dhir, Rajiv; Doerner, Arnulf; Fuchs, Charles S.; Guillem, Jose G.; Iacocca, Mary; Juhl, Hartmut; Kaufman, Andrew; Kohl, Bernard, III; Van Le, Xuan; Mariano, Maria C.; Medina, Elizabeth N.; Meyers, Michael; Nash, Garrett M.; Paty, Phillip B.; Petrelli, Nicholas; Rabeno, Brenda; Richards, William G.; Solit, David; Swanson, Pat; Temple, Larissa; Tepper, Joel E.; Thorp, Richard; Vakiani, Efsevia; Weiser, Martin R.; Willis, Joseph E.; Witkin, Gary; Zeng, Zhaoshi; Zinner, Michael J.; Zornig, Carsten; Jensen, Mark A.; Sfeir, Robert; Kahn, Ari B.; Chu, Anna L.; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric E.; Pontius, Joan; Pihl, Todd D.; Ayala, Brenda; Backus, Mark; Walton, Jessica; Whitmore, Jon; Baboud, Julien; Berton, Dominique L.; Nicholls, Matthew C.; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter A.; Alonso, Shelley; Sanbhadti, Rashmi N.; Barletta, Sean P.; Greene, John M.; Pot, David A.; Shaw, Kenna R. Mills; Dillon, Laura A. L.; Buetow, Ken; Davidsen, Tanja; Demchok, John A.; Eley, Greg; Ferguson, Martin; Fielding, Peter; Schaefer, Carl; Sheth, Margi; Yang, Liming; Guyer, Mark S.; Ozenberger, Bradley A.; Palchik, Jacqueline D.; Peterson, Jane; Sofia, Heidi J.; Thomson, Elizabeth			Comprehensive molecular characterization of human colon and rectal cancer	NATURE			English	Article							COLORECTAL-CANCER; INTESTINAL EPITHELIUM; SOMATIC MUTATIONS; HUMAN BREAST; WILMS-TUMOR; GENE; DIFFERENTIATION; ONCOGENE; CELLS; WTX	To characterize somatic alterations in colorectal carcinoma, we conducted a genome-scale analysis of 276 samples, analysing exome sequence, DNA copy number, promoter methylation and messenger RNA and microRNA expression. A subset of these samples (97) underwent low-depth-of-coverage whole-genome sequencing. In total, 16% of colorectal carcinomas were found to be hypermutated: three-quarters of these had the expected high microsatellite instability, usually with hypermethylation and MLH1 silencing, and one-quarter had somatic mismatch-repair gene and polymerase e (POLE) mutations. Excluding the hypermutated cancers, colon and rectum cancers were found to have considerably similar patterns of genomic alteration. Twenty-four genes were significantly mutated, and in addition to the expected APC, TP53, SMAD4, PIK3CA and KRAS mutations, we found frequent mutations in ARID1A, SOX9 and FAM123B. Recurrent copy-number alterations include potentially drug-targetable amplifications of ERBB2 and newly discovered amplification of IGF2. Recurrent chromosomal translocations include the fusion of NAV2 and WNT pathway member TCF7L1. Integrative analyses suggest new markers for aggressive colorectal carcinoma and an important role for MYC-directed transcriptional activation and repression.	[Hadjipanayis, Angela; Chen, Peng-Chieh; Seidman, Jonathan; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Donehower, Lawrence A.; Creighton, Chad J.; Sivachenko, Andrey] Baylor Coll Med, Human Genome Sequencing Ctr, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Gunaratne, Preethi] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Lawrence, Michael S.; Voet, Douglas; Jing, Rui; Cibulskis, Kristian; Stojanov, Petar; McKenna, Aaron; Lander, Eric S.; Gabriel, Stacey; Getz, Gad; Bass, Adam J.; Ramos, Alex H.; Saksena, Gordon; Cherniack, Andrew D.; Schumacher, Stephen E.; Tabak, Barbara; Carter, Scott L.; Pho, Nam H.; Nguyen, Huy; Onofrio, Robert C.; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Meyerson, Matthew; Chin, Lynda; Noble, Michael; Voet, Doug; Gehlenborg, Nils; DiCara, Daniel; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Shukla, Sachet; Zhou, Lihua; Sivachenko, Andrey; Lin, Pei; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Voet, Douglas; Jing, Rui; Cibulskis, Kristian; Stojanov, Petar; McKenna, Aaron; Lander, Eric S.; Gabriel, Stacey; Getz, Gad; Bass, Adam J.; Ramos, Alex H.; Saksena, Gordon; Cherniack, Andrew D.; Schumacher, Stephen E.; Tabak, Barbara; Carter, Scott L.; Pho, Nam H.; Nguyen, Huy; Onofrio, Robert C.; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Meyerson, Matthew; Chin, Lynda; Noble, Michael; Voet, Doug; Gehlenborg, Nils; DiCara, Daniel; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Shukla, Sachet; Zhou, Lihua; Sivachenko, Andrey; Lin, Pei; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill] Harvard Univ, Cambridge, MA 02142 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lander, Eric S.] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Ding, Li; Fulton, Robert S.; Koboldt, Daniel C.; Wylie, Todd; Walker, Jason; Dooling, David J.; Fulton, Lucinda; Delehaunty, Kim D.; Fronick, Catrina C.; Demeter, Ryan; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Chuah, Eric; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Schein, Jacqueline E.; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard; Zeng, Thomas; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Protopopov, Alexei; Zhang, Juinhua; Ren, Xiaojia; Zhang, Hailei; Shukla, Sachet; Xiao, Yonghong; Chin, Lynda; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Shukla, Sachet] Dana Farber Canc Inst, Dept Med Oncol, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Hadjipanayis, Angela; Lee, Eunjung; Chen, Peng-Chieh; Haseley, Psalm; Park, Peter J.; Kucherlapati, Raju] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lee, Eunjung; Xi, Ruibin; Yang, Lixing; Haseley, Psalm; Lee, Semin; Park, Peter J.; Gehlenborg, Nils; Park, Richard W.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Sathiamoorthy, Narayanan; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mieczkowski, Piotr A.; Chiang, Derek Y.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Topal, Michael D.; Mose, Lisle E.; Jefferys, Stuart R.; Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Du, Ying; Wilkerson, Matthew D.; Shi, Yan; Liquori, Christina; Meng, Shaowu; Li, Ling; Turman, Yidi J.; Topal, Michael D.; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew; Balu, Saianand; O'Connor, Brian D.; Chiang, Derek Y.; Hayes, D. Neil; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tan, Donghui] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Singh, Darshan; Prins, Jan F.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Chapel Hill, NC USA; [Hinoue, Toshinori; Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Berman, Benjamin P.; Van den Berg, David J.; Shen, Hui; Jr, Timothy Triche; Laird, Peter W.] Univ So Calif, Epigenome Ctr, Los Angeles, CA 90089 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Canc Biol, Baltimore, MD 21231 USA; [Thorsson, Vesteinn; Reynolds, Sheila M.; Bernard, Brady; Kreisberg, Richard; Lin, Jake; Iype, Lisa; Bressler, Ryan; Erkkilae, Timo; Gundapuneni, Madhumati; Norberg, Adam; Robinson, Tom; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Liu, Yuexin; Da Yang; Zhang, Wei; Hamilton, Stanley R.; Cason, R. Craig] Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; [De Ronde, Jorma J.; Schultz, Nikolaus; Cerami, Ethan; Ciriello, Giovanni; Goldberg, Arthur P.; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Kaczkowski, Bogumil; Sinha, Rileen; Antipin, Yevgeniy; Reva, Boris; Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [De Ronde, Jorma J.] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Dept Pathol, New York, NY 10065 USA; [Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod; Unruh, Anna; Wakefield, Chris; Baggerly, Keith A.; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Haussler, David; Stuart, Joshua M.; Benz, Stephen C.; Sanborn, J. Zachary; Vaske, Charles J.; Zhu, Jingchun; Szeto, Christopher; Ng, Sam; Goldstein, Ted; Ellrott, Kyle; Cozen, Aaron E.; Zerbino, Daniel; Wilks, Christopher; Craft, Brian] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Joshua M.; Benz, Stephen C.; Sanborn, J. Zachary; Vaske, Charles J.; Zhu, Jingchun; Szeto, Christopher; Ng, Sam; Goldstein, Ted; Ellrott, Kyle; Cozen, Aaron E.; Zerbino, Daniel; Wilks, Christopher; Craft, Brian] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Scott, Gary K.; Yau, Christina] Buck Inst Age Res, Novato, CA 94945 USA; [Collisson, Eric] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Spellman, Paul] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Penny, Robert; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph] Int Genom Consortium, Phoenix, AZ 85004 USA; [Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron; Pyatt, Robert; Wise, Lisa; White, Peter] Nationwide Childrens Hosp, Res Inst, Nationwide Childrens Hosp Biospecimen Core Resour, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.; Ramirez, Nilsa C.; Pyatt, Robert; White, Peter] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.; White, Peter] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43205 USA; [Bertagnolli, Monica] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Brown, Jen; Czerwinski, Christine; Iacocca, Mary; Rabeno, Brenda; Swanson, Pat; Witkin, Gary] Christiana Care Hlth Syst, Dept Pathol, Newark, DE 19718 USA; [Chu, Gerald C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Brookline, MA 02115 USA; [Denstman, Fred; Petrelli, Nicholas] Helen F Graham Canc Ctr Christiana Care, Dept Surg, Newark, DC 19718 USA; [Dhir, Rajiv] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Doerner, Arnulf] Krankenhaus Alten Eichen, Chirurg Klin, D-22527 Hamburg, Germany; [Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Brookline, MA 02115 USA; [Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Brookline, MA 02115 USA; [Guillem, Jose G.; Nash, Garrett M.; Paty, Phillip B.; Weiser, Martin R.; Zeng, Zhaoshi] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Juhl, Hartmut] Indivumed Inc, Kensington, MD 20895 USA; [Kohl, Bernard, III; Van Le, Xuan; Thorp, Richard] ILSbio LLC, Chestertown, MD 21620 USA; [Tepper, Joel E.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Solit, David] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Willis, Joseph E.] Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Zornig, Carsten] Israelit Krankenhaus, Chirurg Klin, D-22297 Hamburg, Germany; [Jensen, Mark A.; Sfeir, Robert; Kahn, Ari B.; Chu, Anna L.; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric E.; Pontius, Joan; Pihl, Todd D.; Ayala, Brenda; Backus, Mark; Walton, Jessica; Whitmore, Jon; Baboud, Julien; Berton, Dominique L.; Nicholls, Matthew C.; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter A.; Alonso, Shelley; Sanbhadti, Rashmi N.; Barletta, Sean P.; Greene, John M.; Pot, David A.] SRA Int, Fairfax, VA 22033 USA; [Shaw, Kenna R. Mills; Dillon, Laura A. L.; Demchok, John A.; Fielding, Peter; Sheth, Margi; Yang, Liming] NCI, Canc Genome Atlas Program Off, NIH, Bethesda, MD 20892 USA; [Buetow, Ken; Davidsen, Tanja; Schaefer, Carl] NCI, Ctr Biomed Informat & Informat Technol CBIIT, NIH, Rockville, MD 20852 USA; [Eley, Greg] Scimentis LLC, Statham, GA 30666 USA; [Ferguson, Martin] MLF Consulting, Arlington, MA 02474 USA; [Guyer, Mark S.; Ozenberger, Bradley A.; Palchik, Jacqueline D.; Peterson, Jane; Sofia, Heidi J.; Thomson, Elizabeth] NHGRI, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Baylor College of Medicine; University of Houston System; University of Houston; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); British Columbia Cancer Agency; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; Institute for Systems Biology (ISB); University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Netherlands Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; University of California System; University of California San Francisco; Oregon Health & Science University; International Genomics Consortium; International Genomics Consortium; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Christiana Care Health System; Harvard University; Brigham & Women's Hospital; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center; Case Western Reserve University; SRA International; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kucherlapati, R (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	rkucherlapati@partners.org	Mardis, Elaine/W-2202-2019; Weisenberger, Daniel/AAA-8314-2020; Lawrence, Michael/AAC-8202-2020; Laird, Peter W/G-8683-2012; Reva, Boris/AAB-8932-2022; Van Den Berg, David J/G-8598-2017; Berman, Benjamin P/D-5942-2014; Vaske, Charles/D-6018-2013; Auman, James/AAY-7748-2020; Reva, Boris A./B-6436-2014; Holt, Robert A/C-3303-2009; Gao, JianJiong/B-5673-2016; Jones, Steven J/C-3621-2009; Shen, Hui/AAO-4387-2020; Mesirov, Jill/AGF-7626-2022; Hirst, Martin/B-7684-2016; Shinbrot, Eve/V-2784-2019; Kaczkowski, Bogumil/D-5336-2017; Stojanov, Petar/GQI-4462-2022; Cibulskis, Kristian/AAC-7380-2019; Yang, Lixing/A-7073-2013; Lee, Semin/S-2629-2016; Cherniack, Andrew/AAC-5310-2019; Schein, Jacquie E/G-3674-2015; Kucherlapati, Raju/ABC-8807-2021; Wilson, Richard K./AAF-4139-2019; Walker, Jason/A-9702-2013; Perou, Charles M/H-9934-2014; Akbani, Rehan/AAG-1490-2019; White, Peter/E-4301-2011; Skanderup, Anders Jacobsen/K-1081-2013; Drummond, Jennifer/AAG-1654-2020; Yang, Da/I-9054-2012; Ganesh, Dunna Sai/AGX-5170-2022; Schultz, Nikolaus/ABE-6347-2020; Marra, Marco A/B-5987-2008; Meyerson, Matthew L/E-7123-2012; BERMAN, BENJAMIN/AAT-3720-2021; Chan, Timothy A/ABD-5850-2021; Mungall, Andrew J./U-7067-2018; Wheeler, David A/M-9740-2018; Solit, David B./AAC-5309-2019; Birol, Inanc/G-5440-2011; Cherniack, Andrew D./AAY-8132-2020; Chiang, Derek/L-6452-2019; Schumacher, Steven/E-9821-2013; Ladanyi, Marc/AAG-8585-2019	Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; Van Den Berg, David J/0000-0002-5404-5218; Berman, Benjamin P/0000-0002-2099-9005; Vaske, Charles/0000-0001-8151-6612; Reva, Boris A./0000-0002-8805-389X; Holt, Robert A/0000-0002-7259-1247; Gao, JianJiong/0000-0002-5739-1781; Jones, Steven J/0000-0003-3394-2208; Shinbrot, Eve/0000-0002-8879-3150; Kaczkowski, Bogumil/0000-0001-6554-5608; Stojanov, Petar/0000-0001-7815-776X; Lee, Semin/0000-0002-9015-6046; Wilson, Richard K./0000-0002-1992-1358; Walker, Jason/0000-0001-7547-5789; Perou, Charles M/0000-0001-9827-2247; White, Peter/0000-0002-5218-5903; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Drummond, Jennifer/0000-0002-2612-5958; Marra, Marco A/0000-0001-7146-7175; BERMAN, BENJAMIN/0000-0002-2099-9005; Mungall, Andrew J./0000-0002-0905-2742; Wheeler, David A/0000-0002-9056-6299; Birol, Inanc/0000-0003-0950-7839; Cherniack, Andrew D./0000-0003-0470-0111; Schumacher, Steven/0000-0002-6819-5647; Stuart, Joshua/0000-0002-2171-565X; Sinha, Rileen/0000-0001-5497-5055; O'Connor, Brian/0000-0002-7681-6415; Park, Peter/0000-0001-9378-960X; Meyerson, Matthew/0000-0002-9133-8108; Hoadley, Katherine/0000-0002-1216-477X; Zerbino, Daniel/0000-0001-5350-3056; Schultz, Nikolaus/0000-0002-0131-4904; Cozen, Aaron/0000-0003-2409-0023; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765; Chang, Kyle/0000-0001-5295-9676; Casasent, Anna/0000-0002-7857-179X; Weinstein, John/0000-0001-9401-6908; Mieczkowski, Piotr/0000-0003-2418-0096; Stoll, Dominik/0000-0003-0701-4301; Benz, Stephen/0000-0002-4067-0602; Bowen, Jay/0000-0001-6861-9043; Pot, David/0000-0002-1480-9826; Cibulskis, Kristian/0000-0003-1343-1582	National Institutes of Health [U24CA143799, U24CA143835, U24CA143840, U24CA143843, U24CA143845, U24CA143848, U24CA143858, U24CA143866, U24CA143867, U24CA143882, U24CA143883, U24CA144025, U54HG003067, U54HG003079, U54HG003273]; NATIONAL CANCER INSTITUTE [U24CA143866, U24CA144025, U24CA143835, U24CA143843, U24CA143867, P30CA016086, U24CA126554, U24CA143840, U24CA143848, U24CA143882, U24CA143883, U24CA143799, P30CA016672, U24CA143845, U24CA143858] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003079, U54HG003273, R01HG006272] Funding Source: NIH RePORTER; Emerging Frontiers [0850237] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the following grants from the National Institutes of Health: U24CA143799, U24CA143835, U24CA143840, U24CA143843, U24CA143845, U24CA143848, U24CA143858, U24CA143866, U24CA143867, U24CA143882, U24CA143883, U24CA144025, U54HG003067, U54HG003079 and U54HG003273.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; House CD, 2010, CANCER RES, V70, P6957, DOI 10.1158/0008-5472.CAN-10-1169; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jubb AM, 2011, GUT, V60, P1606, DOI 10.1136/gut.2010.231746; Liu ZH, 2005, MOL CANCER RES, V3, P21; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Minsky BD, 2011, SEMIN ONCOL, V38, P542, DOI 10.1053/j.seminoncol.2011.05.008; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Sack U, 2011, MOL BIOL CELL, V22, P3344, DOI 10.1091/mbc.E10-09-0739; Scheel SK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-413; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stange DE, 2010, GUT, V59, P1236, DOI 10.1136/gut.2009.195701; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; VARLEY JM, 1987, ONCOGENE, V1, P423; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108; YOKOTA J, 1986, LANCET, V1, P765	44	4786	4879	29	929	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2012	487	7407					330	337		10.1038/nature11252	http://dx.doi.org/10.1038/nature11252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22810696	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-01	WOS:000306506500035
J	Angell, SY; Cobb, LK; Curtis, CJ; Konty, KJ; Silver, LD				Angell, Sonia Y.; Cobb, Laura K.; Curtis, Christine J.; Konty, Kevin J.; Silver, Lynn D.			Change in Trans Fatty Acid Content of Fast-Food Purchases Associated With New York City's Restaurant Regulation A Pre-Post Study	ANNALS OF INTERNAL MEDICINE			English	Article							REFORMULATIONS; DISEASE	Background: Dietary trans fat increases risk for coronary heart disease. In 2006, New York City (NYC) passed the first regulation in the United States restricting trans fat use in restaurants. Objective: To assess the effect of the NYC regulation on the trans and saturated fat content of fast-food purchases. Design: Cross-sectional study that included purchase receipts matched to available nutritional information and brief surveys of adult lunchtime restaurant customers conducted in 2007 and 2009, before and after implementation of the regulation. Setting: 168 randomly selected NYC restaurant locations of 11 fast-food chains. Participants: Adult restaurant customers interviewed in 2007 and 2009. Measurements: Change in mean grams of trans fat, saturated fat, trans plus saturated fat, and trans fat per 1000 kcal per purchase, overall and by chain type. Results: The final sample included 6969 purchases in 2007 and 7885 purchases in 2009. Overall, mean trans fat per purchase decreased by 2.4 g (95% CI, -2.8 to -2.0 g; P < 0.001), whereas saturated fat showed a slight increase of 0.55 g (CI, 0.1 to 1.0 g; P = 0.011). Mean trans plus saturated fat content decreased by 1.9 g overall (CI, -2.5 to -1.2 g; P < 0.001). Mean trans fat per 1000 kcal decreased by 2.7 g per 1000 kcal (CI, -3.1 to -2.3 g per 1000 kcal; P < 0.001). Purchases with zero grams of trans fat increased from 32% to 59%. In a multivariate analysis, the poverty rate of the neighborhood in which the restaurant was located was not associated with changes. Limitation: Fast-food restaurants that were included may not be representative of all NYC restaurants. Conclusion: The introduction of a local restaurant regulation was associated with a substantial and statistically significant decrease in the trans fat content of purchases at fast-food chains, without a commensurate increase in saturated fat. Restaurant patrons from high-and low-poverty neighborhoods benefited equally. However, federal regulation will be necessary to fully eliminate population exposure to industrial trans fat sources.	[Curtis, Christine J.] New York City Dept Hlth & Mental Hyg, Gotham Ctr, CN24,42-09 28th St,9th Floor, Long Isl City, NY 11101 USA	New York City Department of Health & Mental Hygiene	Curtis, CJ (corresponding author), New York City Dept Hlth & Mental Hyg, Gotham Ctr, CN24,42-09 28th St,9th Floor, Long Isl City, NY 11101 USA.	cjohnso8@health.nyc.gov		Silver, Lynn/0000-0002-2680-7393	City of New York; Robert Wood Johnson Foundation Healthy Eating Research program [65839]	City of New York; Robert Wood Johnson Foundation Healthy Eating Research program(Robert Wood Johnson Foundation (RWJF))	The initial study to evaluate calorie labeling was funded by the City of New York and the Robert Wood Johnson Foundation Healthy Eating Research program (grant 65839). The secondary analysis on trans fat reported here was funded solely by the City of New York.	Agricultural Research Service, 2010, AW HOM PERC SEL NUTR; American Heart Association, 2009, POL POS STAT REG LEG; Angell SY, 2009, ANN INTERN MED, V151, P129, DOI 10.7326/0003-4819-151-2-200907210-00010; [Anonymous], 2011, LOCAL           0317; [Anonymous], 2009, CBC NEWS; Ascherio A, 1999, NEW ENGL J MED, V340, P1994, DOI 10.1056/NEJM199906243402511; Bassett MT, 2008, AM J PUBLIC HEALTH, V98, P1457, DOI 10.2105/AJPH.2008.135020; Carlesso J, 2011, HARFORD COURANT 0315; Center for Science in the Public Interest, 2012, TRANSF BANS REST; Dorfman B, 2008, CANADA REUTERS  0523; Dumanovsky T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4464; Karpati A, 2004, HLTH DISPARITIES NEW; Leth T, 2006, ATHEROSCLEROSIS SUPP, V7, P53, DOI 10.1016/j.atherosclerosissup.2006.04.019; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2010, NEW ENGL J MED, V362, P2037, DOI 10.1056/NEJMc1001841; Ratnayake WMN, 2009, EUR J CLIN NUTR, V63, P808, DOI 10.1038/ejcn.2008.39; Severson K, 2005, NY TIMES; U.S. Food and Drug Administration, 2003, FDA CONSUMER MA 0224	18	67	67	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2012	157	2					81	+		10.7326/0003-4819-157-2-201207170-00004	http://dx.doi.org/10.7326/0003-4819-157-2-201207170-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992ON	22801670				2022-12-01	WOS:000307787900013
J	Sun, XR; Giovannucci, A; Sgro, AE; Wang, SSH				Sun, X. Richard; Giovannucci, Andrea; Sgro, Allyson E.; Wang, Samuel S-H			SnapShot: Optical Control and Imaging of Brain Activity	CELL			English	Editorial Material							LIGHT		[Sun, X. Richard] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Sun, XR (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.		Giovannucci, Andrea/AAH-8084-2021	Giovannucci, Andrea/0000-0002-7850-444X; Sgro, Allyson/0000-0003-2155-3918				Card J.P., 2001, CURR PROTOC NEUROSCI, P151; Dombeck D, 2011, IMAGING NEUROSCIENCE, P827; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Thompson SM, 2005, J NEUROSCI, V25, P10358, DOI 10.1523/JNEUROSCI.3515-05.2005; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	10	2	2	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1650	+		10.1016/j.cell.2012.06.009	http://dx.doi.org/10.1016/j.cell.2012.06.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726446	Bronze			2022-12-01	WOS:000305753800028
J	Stephens, PJ; Tarpey, PS; Davies, H; Van Loo, P; Greenman, C; Wedge, DC; Nik-Zainal, S; Martin, S; Varela, I; Bignell, GR; Yates, LR; Papaemmanuil, E; Beare, D; Butler, A; Cheverton, A; Gamble, J; Hinton, J; Jia, MM; Jayakumar, A; Jones, D; Latimer, C; Lau, KW; McLaren, S; McBride, DJ; Menzies, A; Mudie, L; Raine, K; Rad, R; Chapman, MS; Teague, J; Easton, D; Langerod, A; Lee, MTM; Shen, CY; Tee, BTK; Huimin, BW; Broeks, A; Vargas, AC; Turashvili, G; Martens, J; Fatima, A; Miron, P; Chin, SF; Thomas, G; Boyault, S; Mariani, O; Lakhani, SR; van de Vijver, M; Van 'Tveer, L; Foekens, J; Desmedt, C; Sotiriou, C; Tutt, A; Caldas, C; Reis, JS; Aparicio, SAJR; Salomon, AV; Borresen-Dale, AL; Richardson, AL; Campbell, PJ; Futreal, PA; Stratton, MR				Stephens, Philip J.; Tarpey, Patrick S.; Davies, Helen; Van Loo, Peter; Greenman, Chris; Wedge, David C.; Nik-Zainal, Serena; Martin, Sancha; Varela, Ignacio; Bignell, Graham R.; Yates, Lucy R.; Papaemmanuil, Elli; Beare, David; Butler, Adam; Cheverton, Angela; Gamble, John; Hinton, Jonathan; Jia, Mingming; Jayakumar, Alagu; Jones, David; Latimer, Calli; Lau, King Wai; McLaren, Stuart; McBride, David J.; Menzies, Andrew; Mudie, Laura; Raine, Keiran; Rad, Roland; Chapman, Michael Spencer; Teague, Jon; Easton, Douglas; Langerod, Anita; Lee, Ming Ta Michael; Shen, Chen-Yang; Tee, Benita Tan Kiat; Huimin, Bernice Wong; Broeks, Annegien; Vargas, Ana Cristina; Turashvili, Gulisa; Martens, John; Fatima, Aquila; Miron, Penelope; Chin, Suet-Feung; Thomas, Gilles; Boyault, Sandrine; Mariani, Odette; Lakhani, Sunil R.; van de Vijver, Marc; Van 'tVeer, Laura; Foekens, John; Desmedt, Christine; Sotiriou, Christos; Tutt, Andrew; Caldas, Carlos; Reis-Filho, Jorge S.; Aparicio, Samuel A. J. R.; Salomon, Anne Vincent; Borresen-Dale, Anne-Lise; Richardson, Andrea L.; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.		OSBREAC	The landscape of cancer genes and mutational processes in breast cancer	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; GENOME-WIDE ASSOCIATION; SWI/SNF COMPLEX; SUSCEPTIBILITY; MECHANISMS; ARID1A; CELLS	All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer clonal selective advantage on cancer cells and are causally implicated in oncogenesis(1), and the remainder are passenger mutations. The driver mutations and mutational processes operative in breast cancer have not yet been comprehensively explored. Here we examine the genomes of 100 tumours for somatic copy number changes and mutations in the coding exons of protein-coding genes. The number of somatic mutations varied markedly between individual tumours. We found strong correlations between mutation number, age at which cancer was diagnosed and cancer histological grade, and observed multiple mutational signatures, including one present in about ten per cent of tumours characterized by numerous mutations of cytosine at TpC dinucleotides. Driver mutations were identified in several new cancer genes including AKT2, ARID1B, CASP8, CDKN1B, MAP3K1, MAP3K13, NCOR1, SMARCD1 and TBX3. Among the 100 tumours, we found driver mutations in at least 40 cancer genes and 73 different combinations of mutated cancer genes. The results highlight the substantial genetic diversity underlying this common disease.	[Stephens, Philip J.; Tarpey, Patrick S.; Davies, Helen; Van Loo, Peter; Greenman, Chris; Wedge, David C.; Nik-Zainal, Serena; Martin, Sancha; Varela, Ignacio; Bignell, Graham R.; Yates, Lucy R.; Papaemmanuil, Elli; Beare, David; Butler, Adam; Cheverton, Angela; Gamble, John; Hinton, Jonathan; Jia, Mingming; Jayakumar, Alagu; Jones, David; Latimer, Calli; Lau, King Wai; McLaren, Stuart; McBride, David J.; Menzies, Andrew; Mudie, Laura; Raine, Keiran; Rad, Roland; Chapman, Michael Spencer; Teague, Jon; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Van Loo, Peter] VIB, Human Genome Lab, Dept Human Genet, B-3000 Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Greenman, Chris] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Greenman, Chris] Genome Anal Ctr, Norwich NR4 7TJ, Norfolk, England; [Yates, Lucy R.; Tutt, Andrew] Kings Coll London, Breakthrough Breast Canc Res Unit, Sch Med, London SE1 9RT, England; [Yates, Lucy R.] Guys & St Thomas NHS Trust, Dept Clin Oncol, London SE1 7EH, England; [Easton, Douglas] Ctr Canc Genet Epidemiol, Dept Oncol, Strangeways Res Lab, Cambridge CB1 8RN, England; [Easton, Douglas] Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [Langerod, Anita; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Norwegian Radium Hosp, N-0310 Oslo, Norway; [Lee, Ming Ta Michael; Shen, Chen-Yang] Acad Sinica, Natl Genotyping Ctr, Inst Biomed Sci, Taipei 115, Taiwan; [Tee, Benita Tan Kiat] Singapore Gen Hosp, Dept Gen Surg, Singapore 169608, Singapore; [Huimin, Bernice Wong] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore 169610, Singapore; [Broeks, Annegien; Van 'tVeer, Laura] Netherlands Canc Inst, Dept Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Vargas, Ana Cristina; Lakhani, Sunil R.] Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia; [Turashvili, Gulisa; Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Turashvili, Gulisa; Aparicio, Samuel A. J. R.] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Martens, John; Foekens, John] Erasmus Univ, Dept Med Oncol, Med Ctr, Daniel den Hoed Canc Ctr, NL-3000 CA Rotterdam, Netherlands; [Martens, John; Foekens, John] Canc Genom Ctr, NL-3000 CA Rotterdam, Netherlands; [Fatima, Aquila; Miron, Penelope; Richardson, Andrea L.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Chin, Suet-Feung; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Chin, Suet-Feung; Caldas, Carlos] Canc Res UK, Cambridge Res Inst, Li Ka Shin Ctr, Cambridge CB2 0RE, England; [Thomas, Gilles; Boyault, Sandrine] Univ Lyon 1, INCa Synergie, Ctr Leon Berard, F-69365 Lyon 08, France; [Mariani, Odette; Salomon, Anne Vincent] Inst Curie, Dept Tumor Biol, F-75248 Paris 05, France; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia; [van de Vijver, Marc] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Desmedt, Christine; Sotiriou, Christos] Univ Libre Bruxelles, Breast Canc Translat Lab, Inst Jules Bordet, B-1000 Brussels, Belgium; [Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Expt Canc Med Ctr, Cambridge CB2 2QQ, England; [Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Salomon, Anne Vincent] INSERM, U830, Inst Curie, F-75248 Paris 05, France; [Borresen-Dale, Anne-Lise] Univ Oslo, KG Jebsen Ctr Breast Canc Res, Inst Clin Med, Fac Med, N-0318 Oslo, Norway; [Richardson, Andrea L.] Harvard Univ, Dept Pathol, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of East Anglia; The Genome Analysis Centre (TGAC); University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Oslo; Academia Sinica - Taiwan; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Netherlands Cancer Institute; Royal Brisbane & Women's Hospital; University of Queensland; University of British Columbia; British Columbia Cancer Agency; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Queensland; Royal Brisbane & Women's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Institut Jules Bordet; Universite Libre de Bruxelles; University of Cambridge; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of Oslo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk	Shen, CY/F-6271-2010; Desmedt, Christine/P-7438-2017; Caldas, Carlos/A-7543-2008; Nik-Zainal, Serena/ABD-4437-2020; Varela, Ignacio/AAA-7680-2021; Caldas, Carlos/U-7250-2019; Wedge, David/AAC-4977-2021; Vargas, Ana/GSE-1963-2022; Varela, Ignacio/G-1699-2016; Van Loo, Peter/A-3287-2012; Lakhani, Sunil R/I-1970-2018; Lee, Ming Ta Michael/N-5396-2015	Desmedt, Christine/0000-0002-5223-5579; Varela, Ignacio/0000-0002-0969-506X; Caldas, Carlos/0000-0003-3547-1489; Varela, Ignacio/0000-0002-0969-506X; Lakhani, Sunil R/0000-0003-4067-2760; Lee, Ming Ta Michael/0000-0003-2510-8977; Wong, Bernice/0000-0001-8981-1376; chin, suet-feung/0000-0001-5697-1082; Raine, Keiran/0000-0002-5634-1539; Turashvili, Gulisa/0000-0001-6125-5865; Van Loo, Peter/0000-0003-0292-1949; Nik-Zainal, Serena/0000-0001-5054-1727; Martin, Sancha/0000-0001-6213-5259; Spencer Chapman, Michael/0000-0002-5320-8193; Aparicio, Samuel/0000-0002-0487-9599; van de Vijver, Marc/0000-0002-0385-4787; Tutt, Andrew/0000-0001-8715-2901; Yates, Lucy/0000-0003-4519-7794; Wedge, David/0000-0002-7572-3196	Wellcome Trust [077012/Z/05/Z]; Breakthrough Breast Cancer; Wellcome Trust Senior Clinical Research Fellowship [WT088340MA]; Research Foundation - Flanders (FWO); travel grant from the FWO; International Human Frontier Science Program Organization; Norwegian Research Council; Norwegian Cancer Society; Radium Hospital Foundation; Health Region SO; 'Interface INSERM' grant; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; Cancer Research UK; National Institute for Health Research; Welsh Assembly Government; HSC R&D Office for Northern Ireland and the Chief Scientist Office, Scotland; MEDIC foundation; Fonds National de Recherche Scientifique; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Institut National du Cancer; Fondation Synergie-Lyon-Cancer; Canceropole Lyon Auverge Rhone Alpes; Centre Leon Berard; Ludwig Institute for Cancer Research; Dutch Genomics Initiative-Cancer Genomics Center; NATIONAL CANCER INSTITUTE [P50CA089393, P30CA016672] Funding Source: NIH RePORTER; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Cancer Research UK [10118, 11022] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Breakthrough Breast Cancer; Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust); Research Foundation - Flanders (FWO)(FWO); travel grant from the FWO(FWO); International Human Frontier Science Program Organization(Human Frontier Science Program); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Radium Hospital Foundation; Health Region SO; 'Interface INSERM' grant; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Welsh Assembly Government; HSC R&D Office for Northern Ireland and the Chief Scientist Office, Scotland; MEDIC foundation; Fonds National de Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation Synergie-Lyon-Cancer; Canceropole Lyon Auverge Rhone Alpes; Centre Leon Berard; Ludwig Institute for Cancer Research; Dutch Genomics Initiative-Cancer Genomics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z) and Breakthrough Breast Cancer. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). P. V. L. is a postdoctoral researcher at the Research Foundation - Flanders (FWO) and is a visiting scientist at the Wellcome Trust Sanger Institute, supported by a travel grant from the FWO. I. V. is supported by a fellowship from The International Human Frontier Science Program Organization. A.-L.B.-D. and A. L. are funded by the Norwegian Research Council, The Norwegian Cancer Society, The Radium Hospital Foundation and Health Region SO. A. V. S. was supported by an 'Interface INSERM' grant. J.S.R.-F. is funded in part by Breakthrough Breast Cancer and is a recipient of the 2010 CRUK Future Leaders Prize. D. E. is a Principal Research Fellow of Cancer Research UK. A. T. receives financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London, and from King's College Hospital NHS Foundation Trust in conjunction with The Experimental Cancer Medicine Centre Initiative jointly funded by Cancer Research UK, the National Institute for Health Research, the Welsh Assembly Government, the HSC R&D Office for Northern Ireland and the Chief Scientist Office, Scotland. C. D. and C. S. received partial funding from the MEDIC foundation and the Fonds National de Recherche Scientifique. J.M. and J.F. are funded in part by a research grant from the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The INCa-Synergie facility received support from the Institut National du Cancer, the Fondation Synergie-Lyon-Cancer, the Canceropole Lyon Auverge Rhone Alpes and the Centre Leon Berard. A. C. V. is funded by The Ludwig Institute for Cancer Research. L.v.'t.V. and A. Broeks receive funding from the Dutch Genomics Initiative-Cancer Genomics Center. We also acknowledge support for sample collection, banking and processing from the Biological Resource Center of Institut Curie; the Breakthrough Breast Cancer Unit; P. Watson and the BCCA Tumour Tissue Repository; the Centre for Translational Genomics; A. Lane and P. T. Simpson; the Australian Biospecimens Network; the Breast Unit at Royal Brisbane and Women's Hospital; the Dana-Farber/Harvard SPORE in breast cancer (reference CA089393); A. M. Sieuwerts; and the Singhealth Tissue Repository, Singapore. We are grateful also for the support of T. B. Tean, and acknowledge the input and guidance of P. Spellman and A. Ashworth.	Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Keshet Y, 2010, METHODS MOL BIOL, V661, P3, DOI 10.1007/978-1-60761-795-2_1; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Merrell KW, 2011, ONCOGENE, V30, P1608, DOI 10.1038/onc.2010.528; MILLER DG, 1980, CANCER, V46, P1307, DOI 10.1002/1097-0142(19800915)46:6<1307::AID-CNCR2820460602>3.0.CO;2-6; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Schinzel AC, 2008, FRONT BIOSCI-LANDMRK, V13, P71, DOI 10.2741/2661; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Spirin KS, 1996, CANCER RES, V56, P2400; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Su GH, 1998, CANCER RES, V58, P2339; Tigli Hatice, 2005, Mol Diagn, V9, P17, DOI 10.2165/00066982-200509010-00003; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Varghese JS, 2010, CURR OPIN GENET DEV, V20, P201, DOI 10.1016/j.gde.2010.03.012; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	34	1212	1249	8	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					400	+		10.1038/nature11017	http://dx.doi.org/10.1038/nature11017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722201	Green Published, Green Accepted			2022-12-01	WOS:000305466800043
J	Streiff, MB; Carolan, HT; Hobson, DB; Kraus, PS; Holzmueller, CG; Demski, R; Lau, BD; Biscup-Horn, P; Pronovost, PJ; Haut, ER				Streiff, Michael B.; Carolan, Howard T.; Hobson, Deborah B.; Kraus, Peggy S.; Holzmueller, Christine G.; Demski, Renee; Lau, Brandyn D.; Biscup-Horn, Paula; Pronovost, Peter J.; Haut, Elliott R.			Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOSPITALIZED-PATIENTS; PULMONARY-EMBOLISM; PROPHYLAXIS; RATES; RISK	Problem Venous thromboembolism (VTE) is a common cause of potentially preventable mortality, morbidity, and increased medical costs. Risk-appropriate prophylaxis can prevent most VTE events, but only a small fraction of patients at risk receive this treatment. Design Prospective quality improvement programme. Setting Johns Hopkins Hospital, Baltimore, Maryland, USA. Strategies for change A multidisciplinary team established a VTE Prevention Collaborative in 2005. The collaborative applied the four step TRIP (translating research into practice) model to develop and implement a mandatory clinical decision support tool for VTE risk stratification and risk-appropriate VTE prophylaxis for all hospitalised adult patients. Initially, paper based VTE order sets were implemented, which were then converted into 16 specialty-specific, mandatory, computerised, clinical decision support modules. Key measures for improvement VTE risk stratification within 24 hours of hospital admission and provision of risk-appropriate, evidence based VTE prophylaxis. Effects of change The VTE team was able to increase VTE risk assessment and ordering of risk-appropriate prophylaxis with paper based order sets to a limited extent, but achieved higher compliance with a computerised clinical decision support tool and the data feedback which it enabled. Risk-appropriate VTE prophylaxis increased from 26% to 80% for surgical patients and from 25% to 92% for medical patients in 2011. Lessons learnt A computerised clinical decision support tool can increase VTE risk stratification and risk-appropriate VTE prophylaxis among hospitalised adult patients admitted to a large urban academic medical centre. It is important to ensure the tool is part of the clinician's normal workflow, is mandatory (computerised forcing function), and offers the requisite modules needed for every clinical specialty.	[Hobson, Deborah B.; Haut, Elliott R.] Johns Hopkins Univ Hosp, Sch Med, Dept Surg, Baltimore, MD 21287 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Carolan, Howard T.; Hobson, Deborah B.; Holzmueller, Christine G.; Demski, Renee; Pronovost, Peter J.; Haut, Elliott R.] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Kraus, Peggy S.] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Holzmueller, Christine G.; Pronovost, Peter J.; Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA USA; [Lau, Brandyn D.] Johns Hopkins Univ Hosp, Dept Med, Pittsburgh, PA USA; [Biscup-Horn, Paula] Allegheny Gen Hosp, Dept Pharm, Pittsburgh, PA 15212 USA; [Pronovost, Peter J.; Haut, Elliott R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Grad Training Program Clin Invest, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Allegheny General Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Haut, ER (corresponding author), Johns Hopkins Univ Hosp, Sch Med, Dept Surg, Sheikh Zayed 6107C,1800 Orleans St, Baltimore, MD 21287 USA.	ehaut1@jhmi.edu	Haut, Elliott R./J-3948-2019; Lau, Brandyn/H-4825-2018	Lau, Brandyn/0000-0003-3575-2440; Haut, Elliott/0000-0001-7075-771X	Sanofi-Aventis; BristolMyersSquibb; Agency for Healthcare Research and Quality; Lippincott Williams Wilkins; Association for Professionals in Infection Control and Epidemiology; National Institutes of Health; Robert Wood Johnson Foundation; Commonwealth Fund	Sanofi-Aventis(Sanofi-Aventis); BristolMyersSquibb(Bristol-Myers Squibb); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Lippincott Williams Wilkins; Association for Professionals in Infection Control and Epidemiology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Commonwealth Fund	MBS has received research funding from Sanofi-Aventis and BristolMyersSquibb; honoraria for CME lectures from Sanofi-Aventis and Ortho-McNeil; consulted for Sanofi-Aventis, Eisai, Daiichi-Sankyo, and Janssen HealthCare; and has given expert witness testimony in various medical malpractice cases. DBH has given expert witness testimony in various medical malpractice cases. ERH is the primary investigator of a Mentored Clinical Scientist Development Award from the Agency for Healthcare Research and Quality entitled "Does screening variability make DVT an unreliable quality measure of trauma care?"; receives royalties from Lippincott Williams & Wilkins for the book Avoiding Common ICU Errors; and has given expert witness testimony in various medical malpractice cases. PJP receives consultancy fees from the Association for Professionals in Infection Control and Epidemiology; grant or contract support from the Agency for Healthcare Research and Quality, National Institutes of Health, Robert Wood Johnson Foundation, and the Commonwealth Fund; honoraria from various hospitals and the Leigh Bureau (Somerville NJ); and royalties from his book Safe Patients Smart Hospitals. CGH has received a honorarium from MCIC Vermont to speak about organising and writing a manuscript reporting patient safety or quality improvement research.	Alikhan R, 2004, J CLIN PATHOL, V57, P1254, DOI 10.1136/jcp.2003.013581; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Ashrani AA, 2009, J THROMB THROMBOLYS, V28, P465, DOI 10.1007/s11239-009-0309-3; Beeler PE, 2011, THROMB HAEMOSTASIS, V106, P734, DOI 10.1160/TH11-04-0220; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Haut ER, ARCH SURG IN PRESS; Haynes AB, 2011, BMJ QUAL SAF, V20, P102, DOI 10.1136/bmjqs.2009.040022; Lesselroth BJ, 2011, BMJ QUAL SAF, V20, P381, DOI 10.1136/bmjqs.2010.042689; National Institute for Health and Clinical Excellence, 2010, NICE CLIN GUID 92 VE; Prandoni P, 2009, BRIT J HAEMATOL, V145, P286, DOI 10.1111/j.1365-2141.2009.07601.x; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Schaden E, 2012, INTENS CARE MED, V38, P984, DOI 10.1007/s00134-012-2533-0; Spyropoulos AC, 2007, J MANAGE CARE PHARM, V13, P475, DOI 10.18553/jmcp.2007.13.6.475; Stein PD, 2010, CLIN CHEST MED, V31, P611, DOI 10.1016/j.ccm.2010.07.001; Streiff MB, 2009, JAMA-J AM MED ASSOC, V301, P1063, DOI 10.1001/jama.301.10.1063; Tooher R, 2005, ANN SURG, V241, P397, DOI 10.1097/01.sla.0000154120.96169.99; Welfare M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6452	25	92	94	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2012	344								e3935	10.1136/bmj.e3935	http://dx.doi.org/10.1136/bmj.e3935			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965CU	22718994	Green Published			2022-12-01	WOS:000305744600014
J	Nour-Eldin, HH; Andersen, TG; Burow, M; Madsen, SR; Jorgensen, ME; Olsen, CE; Dreyer, I; Hedrich, R; Geiger, D; Halkier, BA				Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Dreyer, Ingo; Hedrich, Rainer; Geiger, Dietmar; Halkier, Barbara Ann			NRT/PTR transporters are essential for translocation of glucosinolate defence compounds to seeds	NATURE			English	Article							ARABIDOPSIS-THALIANA; PHLOEM; ACCUMULATION; PRODUCTS; PATHWAY; NITRATE; CLONING; GROWTH; FIBER; FOOD	In plants, transport processes are important for the reallocation of defence compounds to protect tissues of high value(1), as demonstrated in the plant model Arabidopsis, in which the major defence compounds, glucosinolates(2), are translocated to seeds on maturation(3). The molecular basis for long-distance transport of glucosinolates and other defence compounds, however, remains unknown. Here we identify and characterize two members of the nitrate/peptide transporter family, GTR1 and GTR2, as high-affinity, proton-dependent glucosinolate-specific transporters. The gtr1 gtr2 double mutant did not accumulate glucosinolates in seeds and had more than tenfold over-accumulation in source tissues such as leaves and silique walls, indicating that both plasma membrane-localized transporters are essential for long-distance transport of glucosinolates. We propose that GTR1 and GTR2 control the loading of glucosinolates from the apoplasm into the phloem. Identification of the glucosinolate transporters has agricultural potential as a means to control allocation of defence compounds in a tissue-specific manner.	[Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Halkier, Barbara Ann] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, VKR Res Ctr Proact Plants, DK-1871 Frederiksberg C, Denmark; [Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Halkier, Barbara Ann] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DynaMo Ctr Excellence, DK-1871 Frederiksberg C, Denmark; [Dreyer, Ingo] Univ Politecn Madrid, Ctr Plant Biotechnol & Genom, E-28223 Pozuelo De Alarcon, Madrid, Spain; [Hedrich, Rainer; Geiger, Dietmar] Univ Wurzburg, Julius von Sachs Inst, D-97082 Wurzburg, Germany	University of Copenhagen; University of Copenhagen; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); University of Wurzburg	Halkier, BA (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, VKR Res Ctr Proact Plants, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	bah@life.ku.dk	Geiger, Dietmar/D-6914-2014; Halkier, Barbara A/H-3196-2014; Hedrich, Rainer/G-8771-2011; Dreyer, Ingo/N-4747-2014; Olsen, Carl E/H-3031-2014; Nour-Eldin, Hussam/I-1214-2014; Geiger, Dietmar/AAH-8140-2019; Jørgensen, Morten Egevang/A-2795-2016; Burow, Meike/A-6949-2010	Geiger, Dietmar/0000-0003-0715-5710; Halkier, Barbara A/0000-0002-3742-702X; Hedrich, Rainer/0000-0003-3224-1362; Dreyer, Ingo/0000-0002-2781-0359; Olsen, Carl E/0000-0002-2275-0596; Nour-Eldin, Hussam/0000-0001-6660-0509; Geiger, Dietmar/0000-0003-0715-5710; Jørgensen, Morten Egevang/0000-0001-6503-0495; Burow, Meike/0000-0002-2350-985X; Andersen, Tonni/0000-0002-8905-0850	Danish Research Council for Technology and Production (FTP) [09-065827/274-08-0354]; Marie Curie fellowship [PIEF-GA-2008-221236]; European Union [303674]; Deutsche Forschungsgemeinschaft [GE2195/1-1, FOR 1061]; Villum Kann Rasmussen Foundation; Danish National Research Foundation	Danish Research Council for Technology and Production (FTP); Marie Curie fellowship(European Commission); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Villum Kann Rasmussen Foundation(Villum Fonden); Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank M. Palmgren, A. Schulz and D. Kliebenstein for comments on the manuscript and H. K. S. Jepsen, L. B. Moller and A. Kraus for technical assistance. We thank D. Klaerke and technicians T. K. Soland, B. L. Christensen, M. Olsen and C. Derrer for providing X. laevis oocytes. We thank the Salk, Stanford, Plant Gene Expression Center (SSP) Consortium and the RIKEN Genome Science Center for providing full-length cDNAs. Imaging data were achieved at the Center for Advanced Bioimaging, University of Copenhagen. H.H.N-.E. was supported by the Danish Research Council for Technology and Production (FTP) grant 09-065827/274-08-0354. M.B. was supported by a Marie Curie fellowship (grant PIEF-GA-2008-221236). I.D. was supported by a Marie-Curie Career Integration Grant of the European Union (FP7-PEOPLE-2011-CIG No. 303674 (Regopoc)). D.G. was supported by the Deutsche Forschungsgemeinschaft grant GE2195/1-1 and R.H. by Deutsche Forschungsgemeinschaft grants within FOR 1061. B.A.H. is partner of The VKR Research Centre for Pro-Active Plants funded by the Villum Kann Rasmussen Foundation. Funding for DynaMo Center of Excellence is provided by the Danish National Research Foundation.	Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Ellerbrock BLJ, 2007, PLANT SIGNAL BEHAV, V2, P282, DOI 10.4161/psb.2.4.4014; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Feeny P.P., 1976, BIOCH INTERACTIONS P, V10, P1, DOI DOI 10.1007/978-1-4684-2646-5_1; Foster R, 2009, NUTR BULL, V34, P4, DOI 10.1111/j.1467-3010.2008.01738.x; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Mailer RJ, 2008, J AM OIL CHEM SOC, V85, P937, DOI 10.1007/s11746-008-1268-0; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Nour-Eldin HH, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-17; Nour-Eldin HH, 2009, PHYTOCHEM REV, V8, P53, DOI 10.1007/s11101-008-9110-8; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; Snowdon R., 2007, Oilseeds, P55; Townsend BJ, 2007, TRENDS BIOTECHNOL, V25, P239, DOI 10.1016/j.tibtech.2007.03.012; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; WINK M, 1983, Z NATURFORSCH C, V38, P905; Wittkop B, 2009, EUPHYTICA, V170, P131, DOI 10.1007/s10681-009-9940-5; Wu SQ, 2008, CURR OPIN BIOTECH, V19, P145, DOI 10.1016/j.copbio.2008.02.007; Zhang JX, 2011, PHYTOCHEMISTRY, V72, P1767, DOI 10.1016/j.phytochem.2011.06.002; Zust T, 2011, P ROY SOC B-BIOL SCI, V278, P2598, DOI 10.1098/rspb.2010.2475	30	311	324	6	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					531	534		10.1038/nature11285	http://dx.doi.org/10.1038/nature11285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22864417				2022-12-01	WOS:000307761600041
J	Krishnan, E; Lingala, B; Bhalla, V				Krishnan, Eswar; Lingala, Bharathi; Bhalla, Vivek			Low-Level Lead Exposure and the Prevalence of Gout An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD LEAD; SERUM CREATININE; NATIONAL-HEALTH; KIDNEY-FUNCTION; SATURNINE GOUT; BONE LEAD; RISK; MEN; NEPHROPATHY; MORTALITY	Background: Blood lead levels (BLLs) less than 1.21 mu mol/L (<25 mu g/dL) among adults are considered acceptable by current national standards. Lead toxicity can lead to gouty arthritis (gout), but whether the low lead exposure in the contemporary general population confers risk for gout is not known. Objective: To determine whether BLLs within the range currently considered acceptable are associated with gout. Design: Population-based cross-sectional study. Setting: The National Health and Nutrition Examination Survey for 2005 through 2008. Patients: 6153 civilians aged 40 years or older with an estimated glomerular filtration rate greater than 10 mL/min per 1.73 m(2). Measurements: Outcome variables were self-reported physician diagnosis of gout and serum urate level. Blood lead level was the principal exposure variable. Additional data collected were anthropometric measures, blood pressure, dietary purine intake, medication use, medical history, and serum creatinine concentration. Results: The prevalence of gout was 6.05% (95% CI, 4.49% to 7.62%) among patients in the highest BLL quartile (mean, 0.19 mu mol/L [3.95 mu g/dL]) compared with 1.76% (CI, 1.10% to 2.42%) among those in the lowest quartile (mean, 0.04 mu mol/L [0.89 mu g/dL]). Each doubling of BLL was associated with an unadjusted odds ratio of 1.74 (CI, 1.47 to 2.05) for gout and 1.25 (CI, 1.12 to 1.40) for hyperuricemia. After adjustment for renal function, diabetes, diuretic use, hypertension, race, body mass index, income, and education level, the highest BLL quartile was associated with a 3.6-fold higher risk for gout and a 1.9-fold higher risk for hyperuricemia compared with the lowest quartile. Limitation: Blood lead level does not necessarily reflect the total body lead burden. Conclusion: Blood lead levels in the range currently considered acceptable are associated with increased prevalence of gout and hyperuricemia.	[Krishnan, Eswar; Lingala, Bharathi; Bhalla, Vivek] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Stanford University	Krishnan, E (corresponding author), Stanford Univ, Sch Med, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA.		krishnan, Eswar/AAY-1269-2020	Bhalla, Vivek/0000-0002-5420-9657				Alarcon W. A., 2009, Morbidity and Mortality Weekly Report, V58, P365; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc11-S011, 10.2337/dc12-S064, 10.2337/dc09-S062]; BAKER MD, 1981, RHEUMATOL REHABIL, V20, P208, DOI 10.1093/rheumatology/20.4.208; Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; BARRY PSI, 1970, BRIT J IND MED, V27, P339; BATUMAN V, 1981, NEW ENGL J MED, V304, P520, DOI 10.1056/NEJM198102263040905; BATUMAN V, 1993, AM J MED SCI, V305, P241, DOI 10.1097/00000441-199304000-00008; CAMPBELL BC, 1978, BRIT MED J, V2, P1403, DOI 10.1136/bmj.2.6149.1403; Centers for Disease Control and Prevention, 2012, LAB PROC MAN LEAD CA; Centers for Disease Control and Prevention, LAB PROC MAN UR AC; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; DEKLERK NH, 1989, INT J EPIDEMIOL, V18, P705, DOI 10.1093/ije/18.3.705; EMMERSON BT, 1963, AUSTRALAS ANN MED, V12, P310, DOI 10.1111/imj.1963.12.4.310; EMMERSON BT, 1968, ARTHRITIS RHEUM-US, V11, P623, DOI 10.1002/art.1780110504; Gelber AC, 1997, ARCH INTERN MED, V157, P1436, DOI 10.1001/archinte.157.13.1436; Gulson BL, 1996, B ENVIRON CONTAM TOX, V56, P543; GULSON BL, 1995, J LAB CLIN MED, V125, P703; Hernberg S, 2000, AM J IND MED, V38, P244, DOI 10.1002/1097-0274(200009)38:3<244::AID-AJIM3>3.0.CO;2-F; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Kim R, 1996, JAMA-J AM MED ASSOC, V275, P1177, DOI 10.1001/jama.275.15.1177; KLINENBERG JR, 1969, NEW ENGL J MED, V280, P1238, DOI 10.1056/NEJM196905292802213; Kosnett MJ, 2010, CLIN PHARMACOL THER, V88, P412, DOI 10.1038/clpt.2010.132; KOSTER J, 1989, EUR J CLIN INVEST, V19, P228, DOI 10.1111/j.1365-2362.1989.tb00222.x; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lin JL, 2002, AM J MED, V113, P563, DOI 10.1016/S0002-9343(02)01296-2; LoghmanAdham M, 1997, ENVIRON HEALTH PERSP, V105, P928, DOI 10.4103/0019-5278.44689; LUDWIG GD, 1957, ARCH INTERN MED, V100, P802, DOI 10.1001/archinte.1957.00260110118017; Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; MIRANDA ME, 1991, ADV EXP MED BIOL, V309, P209; Morgan BW, 2001, ANN EMERG MED, V37, P51, DOI 10.1067/mem.2001.111708; MORGAN JM, 1972, ARCH INTERN MED, V130, P335, DOI 10.1001/archinte.130.3.335; Muntner P, 2005, ARCH INTERN MED, V165, P2155, DOI 10.1001/archinte.165.18.2155; Perazella M A, 1996, Conn Med, V60, P521; POOR G, 1989, BAILLIERE CLIN RHEUM, V3, P51, DOI 10.1016/S0950-3579(89)80035-4; Roberts JR, 2001, J TOXICOL-CLIN TOXIC, V39, P153, DOI 10.1081/CLT-100103831; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, V4; Schock MR, 2008, ENVIRON SCI TECHNOL, V42, P4285, DOI 10.1021/es702488v; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Shadick NA, 2000, J RHEUMATOL, V27, P1708; Smith DR, 1996, ENVIRON HEALTH PERSP, V104, P60, DOI 10.2307/3432761; Souci SW., 2000, FOOD COMPOSITION NUT; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Thottam Jyoti, 2007, Time, V170, P50; U.S. Environmental Protection Agency, 1995, REV STUD ADDR LEAD A; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WEDEEN RP, 1988, ENVIRON HEALTH PERSP, V78, P57, DOI 10.2307/3430500; Wengrovitz Anne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Wigle DT, 2005, PLOS MED, V2, P1232, DOI 10.1371/journal.pmed.0020350	57	37	37	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					233	+		10.7326/0003-4819-157-4-201208210-00003	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00003			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910934				2022-12-01	WOS:000307813200014
J	Gao, H; Chakraborty, G; Lee-Lim, AP; Mo, QX; Decker, M; Vonica, A; Shen, RL; Brogi, E; Brivanlou, AH; Giancotti, FG				Gao, Hua; Chakraborty, Goutam; Lee-Lim, Ai Ping; Mo, Qianxing; Decker, Markus; Vonica, Alin; Shen, Ronglai; Brogi, Edi; Brivanlou, Ali H.; Giancotti, Filippo G.			The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites	CELL			English	Article							GENE-EXPRESSION SIGNATURE; STEM-CELLS; TGF-BETA; PROLIFERATION; DISSEMINATION; SURVIVAL; GROWTH; NICHE	The mechanistic underpinnings of metastatic dormancy and reactivation are poorly understood. A gain-of-function cDNA screen reveals that Coco, a secreted antagonist of TGF-beta ligands, induces dormant breast cancer cells to undergo reactivation in the lung. Mechanistic studies indicate that Coco exerts this effect by blocking lung-derived BMP ligands. Whereas Coco enhances the manifestation of traits associated with cancer stem cells, BMP signaling suppresses it. Coco induces a discrete gene expression signature, which is strongly associated with metastatic relapse to the lung, but not to the bone or brain in patients. Experiments in mouse models suggest that these latter organs contain niches devoid of bioactive BMP. These findings reveal that metastasis-initiating cells need to overcome organ-specific antimetastatic signals in order to undergo reactivation.	[Gao, Hua; Chakraborty, Goutam; Lee-Lim, Ai Ping; Decker, Markus; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10065 USA; [Mo, Qianxing; Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Vonica, Alin; Brivanlou, Ali H.] Rockefeller Univ, Lab Mol Embryol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University	Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10065 USA.	f-giancotti@ski.mskcc.org	Chakraborty, Goutam/U-5559-2019; Chakraborty, Goutam/B-5099-2014	Gao, Hua/0000-0002-9698-5830	Geoffrey Beene Cancer Center at MSKCC; NIH [P01 CA094060]; NATIONAL CANCER INSTITUTE [P01CA094060, R01CA175712] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Center at MSKCC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Daley, J. Massague, and F. Miller for reagents, X. Zhang and X. Jing for help with X-ray imaging, M. Akram for Coco staining of human TMAs, members of the Giancotti laboratory for discussions, and the staff of the Genomics and the Molecular Cytology Facilities for their help. This work was supported by the Geoffrey Beene Cancer Center at MSKCC and NIH grant P01 CA094060.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buijs JT, 2012, ONCOGENE, V31, P2164, DOI 10.1038/onc.2011.400; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Koh EY, 2004, ONCOGENE, V23, P1214, DOI 10.1038/sj.onc.1207209; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	46	287	291	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					764	779		10.1016/j.cell.2012.06.035	http://dx.doi.org/10.1016/j.cell.2012.06.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901808	Bronze, Green Accepted			2022-12-01	WOS:000308002300011
J	Logan, BE; Elimelech, M				Logan, Bruce E.; Elimelech, Menachem			Membrane-based processes for sustainable power generation using water	NATURE			English	Review							MICROBIAL FUEL-CELLS; PRESSURE-RETARDED OSMOSIS; AMMONIA-CARBON DIOXIDE; ELECTRODIALYSIS ELECTROLYSIS CELLS; REVERSE-ELECTRODIALYSIS; SALINITY GRADIENTS; HYDROGEN-PRODUCTION; OSMOTIC POWER; BIOELECTROCHEMICAL SYSTEMS; ENERGY EFFICIENCY	Water has always been crucial to combustion and hydroelectric processes, but it could become the source of power in membrane-based systems that capture energy from natural and waste waters. Two processes are emerging as sustainable methods for capturing energy from sea water: pressure-retarded osmosis and reverse electrodialysis. These processes can also capture energy from waste heat by generating artificial salinity gradients using synthetic solutions, such as thermolytic salts. A further source of energy comes from organic matter in waste waters, which can be harnessed using microbial fuel-cell technology, allowing both wastewater treatment and power production.	[Logan, Bruce E.] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA; [Elimelech, Menachem] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Yale University	Logan, BE (corresponding author), Penn State Univ, Dept Civil & Environm Engn, 212 Sackett Bldg, University Pk, PA 16802 USA.	blogan@psu.edu	Elimelech, Menachem/E-7137-2012	Elimelech, Menachem/0000-0003-4186-1563	King Abdullah University of Science and Technology (KAUST) [KUS-I1-003-13]; National Research Foundation of Korea; Ministry of Education, Science and Technology [R33-10046]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The authors acknowledge support from the King Abdullah University of Science and Technology (KAUST) by Award KUS-I1-003-13 (BEL), and the World Class University (WCU) Program (Case III) through the National Research Foundation of Korea and the Ministry of Education, Science and Technology (R33-10046) (ME).	Achilli A, 2010, J MEMBRANE SCI, V364, P233, DOI 10.1016/j.memsci.2010.08.010; Achilli A, 2010, DESALINATION, V261, P205, DOI 10.1016/j.desal.2010.06.017; Achilli A, 2009, J MEMBRANE SCI, V343, P42, DOI 10.1016/j.memsci.2009.07.006; Alkhudhiri A, 2012, DESALINATION, V287, P2, DOI 10.1016/j.desal.2011.08.027; Borole AP, 2011, BIOFUEL BIOPROD BIOR, V5, P28, DOI 10.1002/bbb.265; Brogioli D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058501; Cath T. Y., 2011, US Patent, Patent No. [8,029,671, 8029671]; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Cheng SA, 2011, BIORESOURCE TECHNOL, V102, P4468, DOI 10.1016/j.biortech.2010.12.104; Chou SR, 2012, J MEMBRANE SCI, V389, P25, DOI 10.1016/j.memsci.2011.10.002; Clauwaert P, 2007, ENVIRON SCI TECHNOL, V41, P3354, DOI 10.1021/es062580r; Cusick RD, 2012, SCIENCE, V335, P1474, DOI [10.1126/science.1219330, 10.1126/science.1218781]; Dekker A, 2009, ENVIRON SCI TECHNOL, V43, P9038, DOI 10.1021/es901939r; Dlugolecki P, 2010, J MEMBRANE SCI, V347, P101, DOI 10.1016/j.memsci.2009.10.011; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Fan YZ, 2008, ENVIRON SCI TECHNOL, V42, P8101, DOI 10.1021/es801229j; Fan YZ, 2007, ENVIRON SCI TECHNOL, V41, P8154, DOI 10.1021/es071739c; Gerstandt K, 2008, DESALINATION, V224, P64, DOI 10.1016/j.desal.2007.02.080; Heidrich ES, 2011, ENVIRON SCI TECHNOL, V45, P827, DOI 10.1021/es103058w; Hoover LA, 2011, ENVIRON SCI TECHNOL, V45, P9824, DOI 10.1021/es202576h; Jiang DQ, 2011, INT J HYDROGEN ENERG, V36, P876, DOI 10.1016/j.ijhydene.2010.08.074; Kim Y, 2011, P NATL ACAD SCI USA, V108, P16176, DOI 10.1073/pnas.1106335108; Kim Y, 2011, ENVIRON SCI TECHNOL, V45, P5834, DOI 10.1021/es200979b; La Mantia F, 2011, NANO LETT, V11, P1810, DOI 10.1021/nl200500s; Lalaurette E, 2009, INT J HYDROGEN ENERG, V34, P6201, DOI 10.1016/j.ijhydene.2009.05.112; Lay WCL, 2011, DESALINATION, V283, P123, DOI 10.1016/j.desal.2011.01.036; Lee KP, 2011, J MEMBRANE SCI, V370, P1, DOI 10.1016/j.memsci.2010.12.036; LEE KL, 1981, J MEMBRANE SCI, V8, P141, DOI 10.1016/S0376-7388(00)82088-8; Liu H, 2005, ENVIRON SCI TECHNOL, V39, P4317, DOI 10.1021/es050244p; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Liu H, 2008, J POWER SOURCES, V179, P274, DOI 10.1016/j.jpowsour.2007.12.120; LOEB S, 1975, SCIENCE, V189, P654, DOI 10.1126/science.189.4203.654; Loeb S., 1980, US Patent, Patent No. [4,193,267, 4193267]; Logan B.E., 2008, MICROBIAL FUEL CELLS; Logan B, 2007, ENVIRON SCI TECHNOL, V41, P3341, DOI 10.1021/es062644y; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5172, DOI 10.1021/es0627592; Logan BE, 2010, APPL MICROBIOL BIOT, V85, P1665, DOI 10.1007/s00253-009-2378-9; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lu L, 2009, BIOSENS BIOELECTRON, V24, P3055, DOI 10.1016/j.bios.2009.03.024; McCarty PL, 2011, ENVIRON SCI TECHNOL, V45, P7100, DOI 10.1021/es2014264; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; McGinnis RL, 2007, J MEMBRANE SCI, V305, P13, DOI 10.1016/j.memsci.2007.08.027; McGinnis RL, 2007, DESALINATION, V207, P370, DOI 10.1016/j.desal.2006.08.012; McGinnis RL, 2008, ENVIRON SCI TECHNOL, V42, P8625, DOI 10.1021/es800812m; Nam JY, 2012, ENVIRON SCI TECHNOL, V46, P5240, DOI 10.1021/es300228m; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Nijmeijer K, 2010, SUSTAIN SCI ENG, V2, P95, DOI 10.1016/S1871-2711(09)00205-0; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; PATTLE RE, 1954, NATURE, V174, P660, DOI 10.1038/174660a0; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; Post JW, 2008, ENVIRON SCI TECHNOL, V42, P5785, DOI 10.1021/es8004317; Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422; Ramon GZ, 2011, ENERG ENVIRON SCI, V4, P4423, DOI 10.1039/c1ee01913a; Ren ZY, 2007, ENVIRON SCI TECHNOL, V41, P4781, DOI 10.1021/es070577h; Rozendal RA, 2006, INT J HYDROGEN ENERG, V31, P1632, DOI 10.1016/j.ijhydene.2005.12.006; Sales BB, 2010, ENVIRON SCI TECHNOL, V44, P5661, DOI 10.1021/es100852a; Skilhagen SE, 2010, DESALIN WATER TREAT, V15, P271, DOI 10.5004/dwt.2010.1759; Souhaimi M.K., 2011, MEMBRANE DISTILLATIO; STOUGHTON RW, 1965, J CHEM ENG DATA, V10, P254, DOI 10.1021/je60026a016; Ter Heijne A, 2006, ENVIRON SCI TECHNOL, V40, P5200, DOI 10.1021/es0608545; Ter Heijne A, 2010, ENVIRON SCI TECHNOL, V44, P4376, DOI 10.1021/es100526g; Thorsen T, 2009, J MEMBRANE SCI, V335, P103, DOI 10.1016/j.memsci.2009.03.003; Veerman J, 2010, J APPL ELECTROCHEM, V40, P1461, DOI 10.1007/s10800-010-0124-8; Veerman J, 2009, J MEMBRANE SCI, V343, P7, DOI 10.1016/j.memsci.2009.05.047; Veerman J, 2009, J MEMBRANE SCI, V327, P136, DOI 10.1016/j.memsci.2008.11.015; Veerman J, 2010, ENVIRON SCI TECHNOL, V44, P9207, DOI 10.1021/es1009345; Velasquez-Orta SB, 2009, BIOTECHNOL BIOENG, V103, P1068, DOI 10.1002/bit.22346; Vermaas DA, 2011, J MEMBRANE SCI, V385, P234, DOI 10.1016/j.memsci.2011.09.043; Vermaas DA, 2011, ENVIRON SCI TECHNOL, V45, P7089, DOI 10.1021/es2012758; WICK GL, 1978, SCIENCE, V199, P1436, DOI 10.1126/science.199.4336.1436; Xie X, 2012, ENERG ENVIRON SCI, V5, P5265, DOI 10.1039/c1ee02122b; Xu Y, 2010, J MEMBRANE SCI, V348, P298, DOI 10.1016/j.memsci.2009.11.013; Yip NY, 2012, ENVIRON SCI TECHNOL, V46, P5230, DOI 10.1021/es300060m; Yip NY, 2011, ENVIRON SCI TECHNOL, V45, P10273, DOI 10.1021/es203197e; Yip NY, 2011, ENVIRON SCI TECHNOL, V45, P4360, DOI 10.1021/es104325z; Yip NY, 2010, ENVIRON SCI TECHNOL, V44, P3812, DOI 10.1021/es1002555; Zhang BG, 2012, J POWER SOURCES, V204, P34, DOI 10.1016/j.jpowsour.2012.01.013; Zhang F, 2011, BIOSENS BIOELECTRON, V30, P49, DOI 10.1016/j.bios.2011.08.025; Zhang F, 2009, ELECTROCHEM COMMUN, V11, P2177, DOI 10.1016/j.elecom.2009.09.024; Zhang F, 2011, ENVIRON SCI TECHNOL, V45, P6690, DOI 10.1021/es201505t; Zhao SF, 2012, J MEMBRANE SCI, V396, P1, DOI 10.1016/j.memsci.2011.12.023	83	999	1027	95	1744	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					313	319		10.1038/nature11477	http://dx.doi.org/10.1038/nature11477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895336				2022-12-01	WOS:000307501000030
J	Olesen, JB; Lip, GYH; Kamper, AL; Hommel, K; Kober, L; Lane, DA; Lindhardsen, J; Gislason, GH; Torp-Pedersen, C				Olesen, Jonas Bjerring; Lip, Gregory Y. H.; Kamper, Anne-Lise; Hommel, Kristine; Kober, Lars; Lane, Deirdre A.; Lindhardsen, Jesper; Gislason, Gunnar Hilmar; Torp-Pedersen, Christian			Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RISK STRATIFICATION; PREDICTING STROKE; MORTALITY; VALIDITY; WARFARIN; ASPIRIN; THROMBOEMBOLISM; CLOPIDOGREL; PREVENTION	BACKGROUND Both atrial fibrillation and chronic kidney disease increase the risk of stroke and systemic thromboembolism. However, these risks, and the effects of antithrombotic treatment, have not been thoroughly investigated in patients with both conditions. METHODS Using Danish national registries, we identified all patients discharged from the hospital with a diagnosis of nonvalvular atrial fibrillation between 1997 and 2008. The risk of stroke or systemic thromboembolism and bleeding associated with non-end-stage chronic kidney disease and with end-stage chronic kidney disease (i.e., disease requiring renal-replacement therapy) was estimated with the use of time-dependent Cox regression analyses. In addition, the effects of treatment with warfarin, aspirin, or both in patients with chronic kidney disease were compared with the effects in patients with no renal disease. RESULTS Of 132,372 patients included in the analysis, 3587 (2.7%) had non-end-stage chronic kidney disease and 901 (0.7%) required renal-replacement therapy at the time of inclusion. As compared with patients who did not have renal disease, patients with non-end-stage chronic kidney disease had an increased risk of stroke or systemic thromboembolism (hazard ratio, 1.49; 95% confidence interval [CI], 1.38 to 1.59; P<0.001), as did those requiring renal-replacement therapy (hazard ratio, 1.83; 95% CI, 1.57 to 2.14; P<0.001); this risk was significantly decreased for both groups of patients with warfarin but not with aspirin. The risk of bleeding was also increased among patients who had non-end-stage chronic kidney disease or required renal-replacement therapy and was further increased with warfarin, aspirin, or both. CONCLUSIONS Chronic kidney disease was associated with an increased risk of stroke or systemic thromboembolism and bleeding among patients with atrial fibrillation. Warfarin treatment was associated with a decreased risk of stroke or systemic thromboembolism among patients with chronic kidney disease, whereas warfarin and aspirin were associated with an increased risk of bleeding. (Funded by the Lundbeck Foundation.)	[Olesen, Jonas Bjerring; Lindhardsen, Jesper; Gislason, Gunnar Hilmar; Torp-Pedersen, Christian] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Kamper, Anne-Lise; Hommel, Kristine] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark; [Kober, Lars] Univ Copenhagen, Rigshosp, Ctr Heart, DK-2100 Copenhagen, Denmark; [Olesen, Jonas Bjerring; Lip, Gregory Y. H.; Lane, Deirdre A.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Birmingham	Olesen, JB (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Post 635,Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	jo@heart.dk	Gislason, Gunnar/B-7561-2009; Lane, Deirdre/AAX-1866-2020; Torp-Pedersen, Christian/E-5931-2013	Gislason, Gunnar/0000-0002-0548-402X; Lane, Deirdre/0000-0002-5604-9378; Kober, Lars/0000-0002-6635-1466; Kamper, Anne-Lise/0000-0001-7523-6569	Lundbeck Foundation; Bristol-Myers Squibb; Bayer HealthCare	Lundbeck Foundation(Lundbeckfonden); Bristol-Myers Squibb(Bristol-Myers Squibb); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	(Funded by the Lundbeck Foundation.); Supported by the Lundbeck Foundation.; Dr. Olesen reports receiving travel support from AstraZeneca and Boehringer Ingelheim on behalf of his institution; Dr. Lip, receiving consulting fees from Astellas, AstraZeneca, Bayer, Biotronik, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, Merck, Portola, and Sanofi Aventis, and being on speakers bureaus for Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, and Sanofi Aventis; Dr. Kober, being on a speakers bureau for Servier; Dr. Lane, receiving grant support from Bayer HealthCare on behalf of her institution, lecture fees from Bayer HealthCare, Bristol-Myers Squibb/Pfizer, and Boehringer Ingelheim, and payment for the development of educational presentations from Bayer HealthCare, Bristol-Myers Squibb/Pfizer, and Boehringer Ingelheim; and Dr. Torp-Pedersen, receiving consulting fees from Cardiome and Merck on behalf of himself and from Sanofi Aventis on behalf of himself and his institution, grant support from Bristol-Myers Squibb on behalf of his institution, lecture fees from Cardiome, Merck, and Sanofi Aventis, and travel support from Bristol-Myers Squibb/Pfizer. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1994, ARCH INTERN MED, V154, P2254; [Anonymous], 2006, USRDS 2006 ANN DAT R; Atar I, 2006, INT J CARDIOL, V106, P47, DOI 10.1016/j.ijcard.2004.12.048; Camm AJ, 2011, EUR HEART J, V32, P1172, DOI 10.1093/eurheartj/ehq512; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gaist D, 1997, DAN MED BULL, V44, P445; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lee M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4249; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Marinigh R, 2011, J AM COLL CARDIOL, V57, P1339, DOI 10.1016/j.jacc.2010.12.013; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Reinecke H, 2009, J AM SOC NEPHROL, V20, P705, DOI 10.1681/ASN.2007111207; Rietbrock S, 2009, THROMB HAEMOSTASIS, V101, P527, DOI 10.1160/TH08-08-0499; Rocket Af Study Investigators, 2010, AM HEART J, V159; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Yang F, 2010, EUROPACE, V12, P1666, DOI 10.1093/europace/euq387	32	654	680	3	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					625	635		10.1056/NEJMoa1105594	http://dx.doi.org/10.1056/NEJMoa1105594			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894575				2022-12-01	WOS:000307496600006
J	Korin, N; Kanapathipillai, M; Matthews, BD; Crescente, M; Brill, A; Mammoto, T; Ghosh, K; Jurek, S; Bencherif, SA; Bhatta, D; Coskun, AU; Feldman, CL; Wagner, DD; Ingber, DE				Korin, Netanel; Kanapathipillai, Mathumai; Matthews, Benjamin D.; Crescente, Marilena; Brill, Alexander; Mammoto, Tadanori; Ghosh, Kaustabh; Jurek, Samuel; Bencherif, Sidi A.; Bhatta, Deen; Coskun, Ahmet U.; Feldman, Charles L.; Wagner, Denisa D.; Ingber, Donald E.			Shear-Activated Nanotherapeutics for Drug Targeting to Obstructed Blood Vessels	SCIENCE			English	Article							VON-WILLEBRAND-FACTOR; PLATELET-AGGREGATION; WALL SHEAR; NANOPARTICLES; FIBRINOLYSIS; STABILITY; ADHESION; PLGA; MICE	Obstruction of critical blood vessels due to thrombosis or embolism is a leading cause of death worldwide. Here, we describe a biomimetic strategy that uses high shear stress caused by vascular narrowing as a targeting mechanism-in the same way platelets do-to deliver drugs to obstructed blood vessels. Microscale aggregates of nanoparticles were fabricated to break up into nanoscale components when exposed to abnormally high fluid shear stress. When coated with tissue plasminogen activator and administered intravenously in mice, these shear-activated nanotherapeutics induce rapid clot dissolution in a mesenteric injury model, restore normal flow dynamics, and increase survival in an otherwise fatal mouse pulmonary embolism model. This biophysical strategy for drug targeting, which lowers required doses and minimizes side effects while maximizing drug efficacy, offers a potential new approach for treatment of life-threatening diseases that result from acute vascular occlusion.	[Korin, Netanel; Kanapathipillai, Mathumai; Bencherif, Sidi A.; Ingber, Donald E.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Matthews, Benjamin D.; Mammoto, Tadanori; Ghosh, Kaustabh; Jurek, Samuel; Ingber, Donald E.] Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program,Dept Pathol, Boston, MA 02115 USA; [Matthews, Benjamin D.; Mammoto, Tadanori; Ghosh, Kaustabh; Jurek, Samuel; Ingber, Donald E.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Surg, Boston, MA 02115 USA; [Matthews, Benjamin D.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Med, Boston, MA 02115 USA; [Crescente, Marilena; Brill, Alexander; Wagner, Denisa D.] Childrens Hosp Boston, Program Cellular & Mol Med, Immune Dis Inst, Boston, MA 02115 USA; [Crescente, Marilena; Brill, Alexander; Wagner, Denisa D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Bencherif, Sidi A.; Bhatta, Deen; Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Coskun, Ahmet U.] Northeastern Univ, Boston, MA 02115 USA; [Feldman, Charles L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019; Brill, Alexander/L-7587-2018	Brill, Alexander/0000-0002-4558-0390; Korin, Netanel/0000-0001-7244-889X; BENCHERIF, SIDI/0000-0002-7704-5608; Crescente, Marilena/0000-0003-3164-512X	U.S. Department of Defense [BC074986]; Novartis Pharmaceuticals; Boston Scientific; Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship	U.S. Department of Defense(United States Department of Defense); Novartis Pharmaceuticals(Novartis); Boston Scientific(Boston Scientific); Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship	We thank D. Huh, K. Roberts, and R. F. Valentini for helpful comments and K. Johnson and D. Stanton for help with the graphics. This work was supported by a U.S. Department of Defense Breast Cancer Innovator award BC074986 (to D. E. I.), grants from Novartis Pharmaceuticals and Boston Scientific (to C. L. F. and A. U. C.), and the Wyss Institute for Biologically Inspired Engineering at Harvard University. N.K. is a recipient of a Wyss Technology Development Fellowship. Harvard University and the authors (D. E. I., N.K., M.K.) have filed two patents related to this work: (i) Shear-Activated Nanotherapeutics for Drug Targeting (patent application pending) and (ii) Shear Controlled Release for Stenotic Lesions and Thrombolytic Therapies (patent application pending WO 2012/074588).	Bark DL, 2010, J BIOMECH, V43, P2970, DOI 10.1016/j.jbiomech.2010.07.011; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; Chauhan AK, 2006, J EXP MED, V203, P767, DOI 10.1084/jem.20051732; Danielyan K, 2008, CIRCULATION, V118, P1442, DOI 10.1161/CIRCULATIONAHA.107.750257; Di Marco M, 2010, INT J NANOMED, V5, P37; Frenette PS, 1998, BLOOD, V91, P1318, DOI 10.1182/blood.V91.4.1318; Ganguly K, 2006, J PHARMACOL EXP THER, V316, P1130, DOI 10.1124/jpet.105.093450; Goto S, 1999, CIRCULATION, V99, P608, DOI 10.1161/01.CIR.99.5.608; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Ingall TJ, 2004, STROKE, V35, P2418, DOI 10.1161/01.STR.0000140891.70547.56; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Murciano JC, 2003, NAT BIOTECHNOL, V21, P891, DOI 10.1038/nbt846; Murciano JC, 2002, AM J PHYSIOL-LUNG C, V282, pL529, DOI 10.1152/ajplung.00112.2001; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Rana S, 2010, CURR OPIN CHEM BIOL, V14, P828, DOI 10.1016/j.cbpa.2010.10.001; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Santander-Ortega MJ, 2007, COLLOID SURFACE A, V296, P132, DOI 10.1016/j.colsurfa.2006.09.036; Santander-Ortega MJ, 2006, J COLLOID INTERF SCI, V302, P522, DOI 10.1016/j.jcis.2006.07.031; SIEGEL JM, 1994, J BIOMECH ENG-T ASME, V116, P446, DOI 10.1115/1.2895795; Straub JA, 2007, INT J PHARM, V328, P35, DOI 10.1016/j.ijpharm.2006.07.052; STRONY J, 1993, AM J PHYSIOL, V265, pH1787; Wechsler LR, 2011, NEW ENGL J MED, V364, P2138, DOI 10.1056/NEJMct1007370; Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299	25	341	359	12	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					738	742		10.1126/science.1217815	http://dx.doi.org/10.1126/science.1217815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22767894				2022-12-01	WOS:000307354500056
J	D'Hont, A; Denoeud, F; Aury, JM; Baurens, FC; Carreel, F; Garsmeur, O; Noel, B; Bocs, S; Droc, G; Rouard, M; Da Silva, C; Jabbari, K; Cardi, C; Poulain, J; Souquet, M; Labadie, K; Jourda, C; Lengelle, J; Rodier-Goud, M; Alberti, A; Bernard, M; Correa, M; Ayyampalayam, S; Mckain, MR; Leebens-Mack, J; Burgess, D; Freeling, M; Mbeguie-A-Mbeguie, D; Chabannes, M; Wicker, T; Panaud, O; Barbosa, J; Hribova, E; Heslop-Harrison, P; Habas, R; Rivallan, R; Francois, P; Poiron, C; Kilian, A; Burthia, D; Jenny, C; Bakry, F; Brown, S; Guignon, V; Kema, G; Dita, M; Waalwijk, C; Joseph, S; Dievart, A; Jaillon, O; Leclercq, J; Argout, X; Lyons, E; Almeida, A; Jeridi, M; Dolezel, J; Roux, N; Risterucci, AM; Weissenbach, J; Ruiz, M; Glaszmann, JC; Quetier, F; Yahiaoui, N; Wincker, P				D'Hont, Angelique; Denoeud, France; Aury, Jean-Marc; Baurens, Franc-Christophe; Carreel, Francoise; Garsmeur, Olivier; Noel, Benjamin; Bocs, Stephanie; Droc, Gaetan; Rouard, Mathieu; Da Silva, Corinne; Jabbari, Kamel; Cardi, Celine; Poulain, Julie; Souquet, Marlene; Labadie, Karine; Jourda, Cyril; Lengelle, Juliette; Rodier-Goud, Marguerite; Alberti, Adriana; Bernard, Maria; Correa, Margot; Ayyampalayam, Saravanaraj; Mckain, Michael R.; Leebens-Mack, Jim; Burgess, Diane; Freeling, Mike; Mbeguie-A-Mbeguie, Didier; Chabannes, Matthieu; Wicker, Thomas; Panaud, Olivier; Barbosa, Jose; Hribova, Eva; Heslop-Harrison, Pat; Habas, Remy; Rivallan, Ronan; Francois, Philippe; Poiron, Claire; Kilian, Andrzej; Burthia, Dheema; Jenny, Christophe; Bakry, Frederic; Brown, Spencer; Guignon, Valentin; Kema, Gert; Dita, Miguel; Waalwijk, Cees; Joseph, Steeve; Dievart, Anne; Jaillon, Olivier; Leclercq, Julie; Argout, Xavier; Lyons, Eric; Almeida, Ana; Jeridi, Mouna; Dolezel, Jaroslav; Roux, Nicolas; Risterucci, Ange-Marie; Weissenbach, Jean; Ruiz, Manuel; Glaszmann, Jean-Christophe; Quetier, Francis; Yahiaoui, Nabila; Wincker, Patrick			The banana (Musa acuminata) genome and the evolution of monocotyledonous plants	NATURE			English	Article							DIFFERENTIAL EXPRESSION; DNA-SEQUENCES; GENE; DIVERSIFICATION; IDENTIFICATION; RESOURCE; RICE; POLYPLOIDY; ALIGNMENT; BALANCE	Bananas (Musa spp.), including dessert and cooking types, are giant perennial monocotyledonous herbs of the order Zingiberales, a sister group to the well-studied Poales, which include cereals. Bananas are vital for food security in many tropical and subtropical countries and the most popular fruit in industrialized countries(1). The Musa domestication process started some 7,000 years ago in Southeast Asia. It involved hybridizations between diverse species and subspecies, fostered by human migrations(2), and selection of diploid and triploid seedless, parthenocarpic hybrids thereafter widely dispersed by vegetative propagation. Half of the current production relies on somaclones derived from a single triploid genotype (Cavendish)(1). Pests and diseases have gradually become adapted, representing an imminent danger for global banana production(3,4). Here we describe the draft sequence of the 523-megabase genome of a Musa acuminata doubled-haploid genotype, providing a crucial stepping-stone for genetic improvement of banana. We detected three rounds of whole-genome duplications in the Musa lineage, independently of those previously described in the Poales lineage and the one we detected in the Arecales lineage. This first monocotyledon high-continuity whole-genome sequence reported outside Poales represents an essential bridge for comparative genome analysis in plants. As such, it clarifies commelinid-monocotyledon phylogenetic relationships, reveals Poaceae-specific features and has led to the discovery of conserved noncoding sequences predating monocotyledon-eudicotyledon divergence.	[D'Hont, Angelique; Baurens, Franc-Christophe; Carreel, Francoise; Garsmeur, Olivier; Bocs, Stephanie; Droc, Gaetan; Cardi, Celine; Souquet, Marlene; Jourda, Cyril; Lengelle, Juliette; Rodier-Goud, Marguerite; Rivallan, Ronan; Francois, Philippe; Poiron, Claire; Burthia, Dheema; Jenny, Christophe; Bakry, Frederic; Guignon, Valentin; Joseph, Steeve; Dievart, Anne; Leclercq, Julie; Argout, Xavier; Jeridi, Mouna; Risterucci, Ange-Marie; Ruiz, Manuel; Glaszmann, Jean-Christophe; Yahiaoui, Nabila] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR AGAP, F-34398 Montpellier, France; [Denoeud, France; Aury, Jean-Marc; Noel, Benjamin; Da Silva, Corinne; Jabbari, Kamel; Poulain, Julie; Labadie, Karine; Alberti, Adriana; Bernard, Maria; Correa, Margot; Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] CEA, IG, F-91057 Evry, France; [Denoeud, France; Jabbari, Kamel; Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] CNRS, UMR 8030, Evry, France; [Denoeud, France; Jabbari, Kamel; Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] Univ Evry, UMR 8030, Evry, France; [Carreel, Francoise; Chabannes, Matthieu; Habas, Remy] CIRAD, UMR BGPI, F-34398 Montpellier, France; [Rouard, Mathieu; Guignon, Valentin; Roux, Nicolas] Biovers Int, F-34397 Montpellier 5, France; [Ayyampalayam, Saravanaraj; Mckain, Michael R.; Leebens-Mack, Jim] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Burgess, Diane; Freeling, Mike; Almeida, Ana] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Mbeguie-A-Mbeguie, Didier] CIRAD, UMR QUALISUD Stn Neufchateau, F-97130 Capesterre Belle Eau, France; [Wicker, Thomas] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Panaud, Olivier; Barbosa, Jose] UMR 5096 CNRS UPVD, Lab Genome & Dev Plantes, F-66000 Perpignan, France; [Hribova, Eva] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, CZ-77200 Olomouc, Czech Republic; [Heslop-Harrison, Pat] Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England; [Kilian, Andrzej] Divers Arrays Technol, Yarralumla, ACT 2600, Australia; [Brown, Spencer] CNRS, UPR 2355, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Brown, Spencer] FRC3115, F-91198 Gif Sur Yvette, France; [Guignon, Valentin; Kema, Gert; Waalwijk, Cees] Univ Wageningen, Plant Res Int, NL-6700 AA Wageningen, Netherlands; [Lyons, Eric] Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; [Quetier, Francis] Univ Evry Val dEssonne, Dept Biol, Evry, France; [Dita, Miguel] Brazilian Agr Res Corp EMBRAPA, Embrapa Cassava & Fruits, BR-44380000 Salvador, BA, Brazil	CIRAD; Universite de Montpellier; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CIRAD; Alliance; Bioversity International; University System of Georgia; University of Georgia; University of California System; University of California Berkeley; CIRAD; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Leicester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research; University of Arizona; UDICE-French Research Universities; Universite Paris Saclay; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	D'Hont, A (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UMR AGAP, F-34398 Montpellier, France.	angelique.d'hont@cirad.fr; pwincker@genoscope.cns.fr	DHONT, Angélique/AAL-8074-2021; BAURENS, Franc-Christophe/ABC-7226-2021; Rodriguez, Miguel Angel Dita/O-6120-2014; Gaetan, DROC/AAH-2616-2021; Chabannes, Matthieu/AAR-7769-2021; Jaillon, Olivier/GRY-6287-2022; Poiron, Claire/M-7895-2015; Roux, Nicolas/ABG-4156-2020; Leebens-Mack, James/AAF-6770-2019; Alberti, Adriana/E-7142-2017; BAKRY, Frédéric/I-4857-2012; Labadie, Karine/AAG-7355-2022; Rouard, Mathieu/H-5035-2017; BROWN, Spencer/B-6878-2014; hribova, eva/F-7291-2014; Heslop-Harrison, JS/C-9207-2009; Leclercq, Julie/B-2147-2012; Labadie, Karine/AFL-7408-2022; Waalwijk, Cees/X-9439-2019; Wicker, Thomas/Z-1978-2019; MBEGUIE-A-MBEGUIE, Didier/C-8641-2009; Heslop-Harrison, J.S./M-9826-2019; Dolezel, Jaroslav/B-7716-2008; Alberti, Adriana/AAZ-2013-2021; Aury, Jean-Marc/N-1621-2019; Quetier, Francis/J-7923-2017	BAURENS, Franc-Christophe/0000-0002-5219-8771; Rodriguez, Miguel Angel Dita/0000-0002-0496-4267; Gaetan, DROC/0000-0003-1849-1269; Poiron, Claire/0000-0002-3995-1343; Leebens-Mack, James/0000-0003-4811-2231; Alberti, Adriana/0000-0003-3372-9423; Labadie, Karine/0000-0001-7467-8509; Rouard, Mathieu/0000-0003-0284-1885; Heslop-Harrison, JS/0000-0002-3105-2167; Labadie, Karine/0000-0001-7467-8509; Waalwijk, Cees/0000-0001-5367-2108; Heslop-Harrison, J.S./0000-0002-3105-2167; Dolezel, Jaroslav/0000-0002-6263-0492; Alberti, Adriana/0000-0003-3372-9423; Aury, Jean-Marc/0000-0003-1718-3010; Jourda, Cyril/0000-0002-7799-3501; Guignon, Valentin/0000-0003-0903-6811; DA SILVA, Corinne/0000-0002-7618-7831; Chabannes, Matthieu/0000-0001-5754-5982; Argout, Xavier/0000-0002-0100-5511; , Thomas/0000-0002-6777-7135; Jenny, Christophe/0000-0001-6165-6888; Leclercq, Julie/0000-0001-8110-3762; Kilian, Andrzej/0000-0002-2730-7462; Dievart, Anne/0000-0001-9460-4638; Ruiz, Manuel/0000-0001-8153-276X; Hribova, Eva/0000-0002-6868-4344; Quetier, Francis/0000-0003-4388-9287; Noel, Benjamin/0000-0002-5830-3253; Kema, Gerrit HJ/0000-0002-2732-6911; Denoeud, France/0000-0001-8819-7634; Poulain, Julie/0000-0002-8744-3116; Jaillon, Olivier/0000-0002-7237-9596	French National Research Agency; Commissariat a l'Energie Atomique; Centre de cooperation Internationale en Recherche Agronomique pour le Developpement; Direct For Biological Sciences [0830009] Funding Source: National Science Foundation; Division Of Environmental Biology [0841988] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0922742] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0820821] Funding Source: National Science Foundation	French National Research Agency(French National Research Agency (ANR)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre de cooperation Internationale en Recherche Agronomique pour le Developpement; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was mainly supported by French National Research Agency, Commissariat a l'Energie Atomique and Centre de cooperation Internationale en Recherche Agronomique pour le Developpement. The Generation Challenge program supported DArT genotyping, and Stichting Het Groene Woudt part of BAC-end sequencing. We thank M. Teixeira Souza for authorizing early access to BAC-End sequences, L. Baudouin and T. Hardcastle for their help with the Bayseq analysis, O. Inizan, T. Flutre and F. Choulet for their help in transposable-element mapping. We thank the SouthGreen Bioinformatics Platform (http://southgreen.cirad.fr) for providing us with computational resources. We thank D. Manley for his help with the English in this paper.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Aury JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-603; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bakry F, 2008, FRUITS, V63, P45, DOI 10.1051/fruits:2007044; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Carels N, 2000, GENETICS, V154, P1819; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; D'Hont A, 2000, THEOR APPL GENET, V100, P177, DOI 10.1007/s001220050024; de Bellaire LD, 2010, FRUITS, V65, P327, DOI 10.1051/fruits/2010034; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Fils-Lycaon B, 2011, SCI HORTIC-AMSTERDAM, V129, P197, DOI 10.1016/j.scienta.2011.03.029; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Freeling M, 2009, CURR OPIN PLANT BIOL, V12, P126, DOI 10.1016/j.pbi.2009.01.005; Gayral P, 2009, J MOL EVOL, V69, P65, DOI 10.1007/s00239-009-9253-2; Givnish TJ, 2010, ANN MO BOT GARD, V97, P584, DOI 10.3417/2010023; Glemet E, 1997, COMPUT APPL BIOSCI, V13, P137; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; Iskra-Caruana ML, 2010, MOL PLANT MICROBE IN, V23, P1394, DOI 10.1094/MPMI-05-10-0107; Jeridi M, 2011, ANN BOT-LONDON, V108, P975, DOI 10.1093/aob/mcr207; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lescot M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-58; Lescot T., 2011, FRUITROP, V189, P58; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; MARIE D, 1993, BIOL CELL, V78, P41, DOI 10.1016/0248-4900(93)90113-S; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Paterson AH, 2004, CURR OPIN BIOTECH, V15, P120, DOI 10.1016/j.copbio.2004.03.001; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Piffanelli P, 2008, FRUITS, V63, P375, DOI 10.1051/fruits:2008037; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Raboin LM, 2005, MOL BREEDING, V16, P333, DOI 10.1007/s11032-005-2452-7; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Simmonds N. W., 1962, EVOLUTION BANANAS, P101; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	61	703	732	16	360	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					213	+		10.1038/nature11241	http://dx.doi.org/10.1038/nature11241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22801500	hybrid			2022-12-01	WOS:000307267000034
J	Flamand, M; Duchaine, TF				Flamand, Mathieu; Duchaine, Thomas F.			SnapShot: Endogenous RNAi Machinery and Mechanisms	CELL			English	Editorial Material							INTERFERENCE; PATHWAYS; PROTEINS; ELEGANS; PIRNAS		[Flamand, Mathieu; Duchaine, Thomas F.] McGill Univ, Dept Biochem, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada	McGill University	Flamand, M (corresponding author), McGill Univ, Dept Biochem, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.		Flamand, Mathieu/R-6102-2019; Duchaine, Thomas/U-2399-2019	Duchaine, Thomas/0000-0002-3454-1839	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Li LD, 2011, METHODS MOL BIOL, V764, P169, DOI 10.1007/978-1-61779-188-8_11; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Tushir JS, 2009, CELL, V139, P830, DOI 10.1016/j.cell.2009.10.042	10	2	2	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					662	+		10.1016/j.cell.2012.07.016	http://dx.doi.org/10.1016/j.cell.2012.07.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863015	Bronze			2022-12-01	WOS:000307301400023
J	Qiang, L; Wang, LH; Kon, N; Zhao, WH; Lee, S; Zhang, YY; Rosenbaum, M; Zhao, YM; Gu, W; Farmer, SR; Accili, D				Qiang, Li; Wang, Liheng; Kon, Ning; Zhao, Wenhui; Lee, Sangkyu; Zhang, Yiying; Rosenbaum, Michael; Zhao, Yingming; Gu, Wei; Farmer, Stephen R.; Accili, Domenico			Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Ppar gamma	CELL			English	Article							ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; SIRT1; FAT; PGC-1-ALPHA; METABOLISM; ADIPOCYTES; OBESITY; MICE; THERMOGENESIS	Brown adipose tissue (BAT) can disperse stored energy as heat. Promoting BAT-like features in white adipose (WAT) is an attractive, if elusive, therapeutic approach to staunch the current obesity epidemic. Here we report that gain of function of the NAD-dependent deacetylase SirT1 or loss of function of its endogenous inhibitor Deleted in breast cancer-1 (Dbc1) promote "browning" of WAT by deacetylating peroxisome proliferator-activated receptor (Ppar)-gamma on Lys268 and Lys293. SirT1-dependent deacetylation of Lys268 and Lys293 is required to recruit the BAT program coactivator Prdm16 to Ppar gamma, leading to selective induction of BAT genes and repression of visceral WAT genes associated with insulin resistance. An acetylation-defective Pparg mutant induces a brown phenotype in white adipocytes, whereas an acetylated mimetic fails to induce "brown" genes but retains the ability to activate "white" genes. We propose that SirT1-dependent Pparg deacetylation is a form of selective Ppar gamma modulation of potential therapeutic import.	[Qiang, Li; Wang, Liheng; Accili, Domenico] Columbia Univ, Dept Med, Naomi Berrie Diabet Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Kon, Ning; Zhao, Wenhui; Gu, Wei] Columbia Univ, Dept Pathol, Inst Canc Genet, Coll Phys & Surg, New York, NY 10032 USA; [Zhang, Yiying; Rosenbaum, Michael] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Mol Genet, New York, NY 10032 USA; [Lee, Sangkyu; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Columbia University; Columbia University; Columbia University; University of Chicago; Boston University	Accili, D (corresponding author), Columbia Univ, Dept Med, Naomi Berrie Diabet Ctr, Coll Phys & Surg, New York, NY 10032 USA.	da230@columbia.edu	Qiang, Li/C-9560-2012	Farmer, Stephen/0000-0003-2483-2795; ZHAO, WENHUI/0000-0002-7703-7106; Qiang, Li/0000-0001-8322-1797	NIH [HL087123, DK58282, DK64773, DK063608, RR024156]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, R01DK058282, R37DK058282, P30DK063608, R01DK064773, P30DK026687, R01DK064819] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Tsuchiya and L. Ozcan for help with different aspects of this work, T. Kolar and A. Flete for technical support, Q. Zhang for help with structural analysis, U. Pajvani and G. Heinrich for comments on the manuscript, and members of the Accili laboratory for discussion of the data. We thank B. Spiegelman for providing HIB-1B cells. This work was supported by NIH grants HL087123, DK58282, DK64773, DK063608 (Columbia Diabetes Research Center), and RR024156 (Columbia University CTSA).	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chen W, 2009, MOL CELL, V35, P755, DOI 10.1016/j.molcel.2009.09.015; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Farmer SR, 2009, NATURE, V458, P839, DOI 10.1038/458839a; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim-Muller JY, 2011, SCIENCE, V331, P1529, DOI 10.1126/science.1204504; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Qiang L, 2012, CELL, V148, P397, DOI 10.1016/j.cell.2012.01.020; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Rosen CJ, 2010, NEW ENGL J MED, V363, P803, DOI 10.1056/NEJMp1008233; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Virtanen KA, 2011, CURR OPIN LIPIDOL, V22, P49, DOI 10.1097/MOL.0b013e3283425243; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	48	526	564	10	121	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					620	632		10.1016/j.cell.2012.06.027	http://dx.doi.org/10.1016/j.cell.2012.06.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863012	Green Accepted, Bronze			2022-12-01	WOS:000307301400019
J	Semugoma, P; Nemande, S; Baral, SD				Semugoma, Paul; Nemande, Steave; Baral, Stefan D.			The irony of homophobia in Africa	LANCET			English	Editorial Material									[Baral, Stefan D.] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Key Populat Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Semugoma, Paul] African Men Sexual Hlth & Rights, Johannesburg, South Africa; [Nemande, Steave] Integrat Clin, Douala, Cameroon	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Baral, SD (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Key Populat Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	sbaral@jhsph.edu	Baral, Stefan/D-2930-2013; Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419				amfAR Foundation for AIDS Research Johns Hopkins Bloomberg School of Public Health, 2011, ACH AIDS FREE GEN GA; amfAR International AIDS Vaccine Initiative Johns Hopkins University-Center for Public Health and Human Rights United Nations Development Program, 2011, RESP PROT FULF BEST; Andrew M, 2011, DEMOCRATIC REPUBLIC; [Anonymous], 2009, VOICE AM        1102; [Anonymous], 2012, MASK UGANDAS PRESIDE; Behen P, 2011, COMMUNICATION   0308; Beyrer C, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8726-9; Beyrer C, 2012, LANCET; Carter M., 2007, PEPFAR MONEY BEING U; Fadera H, 2012, GAMBIA NO ROOM GAYS; Haberlandt Michael, 1998, BOY WIVES FEMALE HUS, P63; International Gay and Lesbian Human Rights Commission, 2011, AFR CIV SOC COND MAL; International Lesbian Gay Bisexual Trans and Intersex Association, 2012, STAT SPONS HOM WORLD; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; Kaoma K, 2011, EXPOSING TRAFFICKING; Kenya National AIDS and STI Control Programme, 2012, MOST AT RISK POP UNV; Poteat T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028760; Trapence G, 2012, LANCET	18	30	30	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2012	380	9839					312	314		10.1016/S0140-6736(12)60901-5	http://dx.doi.org/10.1016/S0140-6736(12)60901-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	979TN	22819661				2022-12-01	WOS:000306842800006
J	Hashimoto, T; Perlot, T; Rehman, A; Trichereau, J; Ishiguro, H; Paolino, M; Sigl, V; Hanada, T; Hanada, R; Lipinski, S; Wild, B; Camargo, SMR; Singer, D; Richter, A; Kuba, K; Fukamizu, A; Schreiber, S; Clevers, H; Verrey, F; Rosenstiel, P; Penninger, JM				Hashimoto, Tatsuo; Perlot, Thomas; Rehman, Ateequr; Trichereau, Jean; Ishiguro, Hiroaki; Paolino, Magdalena; Sigl, Verena; Hanada, Toshikatsu; Hanada, Reiko; Lipinski, Simone; Wild, Birgit; Camargo, Simone M. R.; Singer, Dustin; Richter, Andreas; Kuba, Keiji; Fukamizu, Akiyoshi; Schreiber, Stefan; Clevers, Hans; Verrey, Francois; Rosenstiel, Philip; Penninger, Josef M.			ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation	NATURE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; MAMMALIAN TARGET; HARTNUP DISORDER; CROHNS-DISEASE; BLOOD-PRESSURE; IN-VIVO; MICE; COLITIS; CARBOXYPEPTIDASE; RAPAMYCIN	Malnutrition affects up to one billion people in the world and is a major cause of mortality(1,2). In many cases, malnutrition is associated with diarrhoea and intestinal inflammation, further contributing to morbidity and death(2). The mechanisms by which unbalanced dietary nutrients affect intestinal homeostasis are largely unknown. Here we report that deficiency in murine angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (Ace2), which encodes a key regulatory enzyme of the renin-angiotensin system (RAS), results in highly increased susceptibility to intestinal inflammation induced by epithelial damage. The RAS is known to be involved in acute lung failure(3), cardiovascular functions(4) and SARS infections(5). Mechanistically, ACE2 has a RAS-independent function, regulating intestinal amino acid homeostasis, expression of antimicrobial peptides, and the ecology of the gut microbiome. Transplantation of the altered microbiota from Ace2 mutant mice into germ-free wild-type hosts was able to transmit the increased propensity to develop severe colitis. ACE2-dependent changes in epithelial immunity and the gut microbiota can be directly regulated by the dietary amino acid tryptophan. Our results identify ACE2 as a key regulator of dietary amino acid homeostasis, innate immunity, gut microbial ecology, and transmissible susceptibility to colitis. These results provide a molecular explanation for how amino acid malnutrition can cause intestinal inflammation and diarrhoea.	[Hashimoto, Tatsuo; Perlot, Thomas; Trichereau, Jean; Paolino, Magdalena; Sigl, Verena; Hanada, Toshikatsu; Hanada, Reiko; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Hashimoto, Tatsuo; Ishiguro, Hiroaki] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Hashimoto, Tatsuo; Ishiguro, Hiroaki] Sch Med, Yokohama, Kanagawa 2360004, Japan; [Rehman, Ateequr; Lipinski, Simone; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Wild, Birgit; Richter, Andreas] Univ Vienna, Ctr Ecol, Dept Chem Ecol & Ecosyst Res, A-1090 Vienna, Austria; [Camargo, Simone M. R.; Singer, Dustin; Verrey, Francois] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Camargo, Simone M. R.; Singer, Dustin; Verrey, Francois] Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Kuba, Keiji] Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, Akita 0108543, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Yokohama City University; University of Kiel; University of Vienna; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Akita University; University of Tsukuba; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	p.rosenstiel@mucosa.de; josef.penninger@imba.oeaw.ac.at	Lipinski, Simone/L-9818-2017; Wild, Birgit/E-6476-2012; Penninger, Josef M/I-6860-2013; Paolino, Magdalena/AAN-9417-2020; Rosenstiel, Philip/A-5137-2009; fukamizu, akiyoshi/J-5350-2012; Rehman, Ateequr/O-3727-2016; Richter, Andreas/D-8483-2012	Lipinski, Simone/0000-0002-9322-7372; Wild, Birgit/0000-0002-9611-0815; Penninger, Josef M/0000-0002-8194-3777; Rosenstiel, Philip/0000-0002-9692-8828; fukamizu, akiyoshi/0000-0002-8786-6020; Rehman, Ateequr/0000-0002-5664-4628; Richter, Andreas/0000-0003-3282-4808; Paolino, Magdalena/0000-0001-9724-9029; Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824	European Respiratory Society; EuGeneHeart; SENSHIN; Marie Curie IIF; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC; EU network grants EuGeneHeart, ApoSys and INFLA-Care; BMBF Network 'Systematic genomics of chronic inflammation'; DFG Cluster of Excellence Inflammation at Interfaces [SPP1399, SFB877]; DFG [RO1394]	European Respiratory Society; EuGeneHeart; SENSHIN(SENSHIN Medical Research FoundationKayamori FoundationKayamori Foundation of Informational Science AdvancementMukai Science and Technology FoundationFukuda Foundation for Medical TechnologyInoue Foundation for Science); Marie Curie IIF(European Commission); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC(European Research Council (ERC)European Commission); EU network grants EuGeneHeart, ApoSys and INFLA-Care; BMBF Network 'Systematic genomics of chronic inflammation'(Federal Ministry of Education & Research (BMBF)); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank all members of our laboratories for discussions. T. Hashimoto was supported by grants from the European Respiratory Society, EuGeneHeart, and SENSHIN. T. P. was supported by a Marie Curie IIF. J.M.P. was supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse), an EU ERC Advanced Grant, and the EU network grants EuGeneHeart, ApoSys and INFLA-Care. P. R. was supported by the BMBF Network 'Systematic genomics of chronic inflammation', the DFG Cluster of Excellence Inflammation at Interfaces, SPP1399, SFB877, and the DFG project RO1394.	AbuQurshin R, 1997, AM J MED SCI, V313, P111, DOI 10.1097/00000441-199702000-00008; Attia E, 2005, BIOL PSYCHIAT, V57, P674, DOI 10.1016/j.biopsych.2004.11.045; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COOPER HS, 1993, LAB INVEST, V69, P238; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; DARBY WJ, 1975, NUTR REV, V33, P289; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Farkas S, 2006, INT J COLORECTAL DIS, V21, P747, DOI 10.1007/s00384-005-0793-7; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Hammer O., 2004, PALAEONTOL ELECTRON, V4; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Khan Y, 2010, PEDIATR CLIN N AM, V57, P1409, DOI 10.1016/j.pcl.2010.09.016; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; McCaffery DM, 1999, GUT, V45, P864, DOI 10.1136/gut.45.6.864; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Osterreicher CH, 2009, HEPATOLOGY, V50, P929, DOI 10.1002/hep.23104; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Reinisch W, 2008, AM J GASTROENTEROL, V103, P2284, DOI 10.1111/j.1572-0241.2008.02024.x; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; SEGAL I, 1986, INT J COLORECTAL DIS, V1, P238, DOI 10.1007/BF01648345; STRATIGOS JD, 1977, BRIT J DERMATOL, V96, P99, DOI 10.1111/j.1365-2133.1977.tb05197.x; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Weisstaub G, 2008, J PEDIATR GASTR NUTR, V47, pS10, DOI 10.1097/MPG.0b013e3181818e78	43	728	787	12	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					477	U89		10.1038/nature11228	http://dx.doi.org/10.1038/nature11228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837003	Green Published, Green Accepted			2022-12-01	WOS:000306815300037
J	Wang, TJ				Wang, Thomas J.			The Natriuretic Peptides and Fat Metabolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Wang, TJ (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.			Wang, Thomas/0000-0003-4063-6508				Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Chen-Tournoux A, 2010, AM J CARDIOL, V106, P1450, DOI 10.1016/j.amjcard.2010.06.076; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Neumayr G, 2005, AM J CARDIOL, V96, P732, DOI 10.1016/j.amjcard.2005.04.054; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA	5	47	50	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					377	378		10.1056/NEJMcibr1204796	http://dx.doi.org/10.1056/NEJMcibr1204796			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22830469				2022-12-01	WOS:000306738300014
J	Makela, KT; Visuri, T; Pulkkinen, P; Eskelinen, A; Remes, V; Virolainen, P; Junnila, M; Pukkala, E				Makela, Keijo T.; Visuri, Tuomo; Pulkkinen, Pekka; Eskelinen, Antti; Remes, Ville; Virolainen, Petri; Junnila, Mika; Pukkala, Eero			Risk of cancer with metal-on-metal hip replacements: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KNEE ARTHROPLASTY; WEAR DEBRIS; FOLLOW-UP; OSTEOARTHRITIS; DISSEMINATION; POLYETHYLENE; NATIONWIDE; FAILURE; COHORT	Objective To assess the risk of cancer associated with modern primary metal-on-metal hip replacements. Design Population based study. Setting Nationwide retrospective comparative register. Participants 10 728 patients who underwent metal-on-metal total hip arthroplasty and 18 235 patients who underwent conventional metal-on-polyethylene, ceramic-on-polyethylene, and ceramic-on-ceramic total hip arthroplasty (the non-metal-on-metal cohort) in the Finnish Arthroplasty Register 2001-10. Data on cancer cases up to 2010 for these cohorts were extracted from the Finnish Cancer Registry. Main outcome measures The relative risk of cancer was expressed as the ratio of observed to expected number of cases from the Finnish population-that is, the standardised incidence ratio. The relative risk of cancer in the metal-on-metal cohort compared with the non-metal-on-metal cohort was estimated with analyses of these ratios and Poisson regression. Results The overall risk of cancer in patients with metal-on-metal hip implants was similar to that in the Finnish population (378 observed v 400 expected, standardised incidence ratio 0.95, 95% confidence interval 0.85 to 1.04). The overall risk of cancer in patients with metal-on-metal hip implants was also no higher than in patients who had received non-metal-on-metal hip implants (relative risk 0.92, 0.81 to 1.05). Conclusions Metal-on-metal hip replacements are not associated with an increased overall risk of cancer during a mean follow-up of four years.	[Makela, Keijo T.; Virolainen, Petri; Junnila, Mika] Turku Univ Hosp, Surg Hosp, Dept Orthopaed & Traumatol, FI-20701 Turku, Finland; [Visuri, Tuomo; Pulkkinen, Pekka] Univ Helsinki, Hjelt Inst, FI-00014 Helsinki, Finland; [Eskelinen, Antti] Coxa Hosp Joint Replacement, FI-33101 Tampere, Finland; [Remes, Ville] Univ Helsinki, Cent Hosp, Peijas Hosp, Dept Orthopaed & Traumatol, FI-00029 Helsinki, Finland; [Pukkala, Eero] Univ Tampere, Sch Hlth Sci, FI-33100 Tampere, Finland; [Pukkala, Eero] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FI-00130 Helsinki, Finland	University of Turku; University of Helsinki; Coxa Hospital for Joint Replacement; University of Helsinki; Helsinki University Central Hospital; Tampere University; Finnish Cancer Registry	Makela, KT (corresponding author), Turku Univ Hosp, Surg Hosp, Dept Orthopaed & Traumatol, FI-20701 Turku, Finland.	keijo.makela@fimnet.fi	Eskelinen, Antti/E-6433-2015; Eskelinen, Antti/AAW-9209-2021; Eskelinen, Antti/AAW-9223-2021	Eskelinen, Antti/0000-0003-0302-0253; Eskelinen, Antti/0000-0003-0302-0253; Makela, Keijo/0000-0002-4115-1767	Turku University Hospital; Sigrid Juselius Foundation; Helsinki University Central Hospital	Turku University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital	This study was funded by Turku University Hospital (KTM) and Sigrid Juselius Foundation and Helsinki University Central Hospital (VR).	Australian Orthopaedic Association, 2010, ANN REP 2010; Bonassi S, 2000, CANCER RES, V60, P1619; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Case CP, 1996, CLIN ORTHOP RELAT R, pS269; Cohen D, 2011, BMJ-BRIT MED J, V13, P342; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Daley B, 2004, J BONE JOINT SURG BR, V86B, P598, DOI 10.1302/0301-620X.86B4.14368; Garbuz DS, 2010, CLIN ORTHOP RELAT R, V468, P318, DOI 10.1007/s11999-009-1029-x; GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539, DOI 10.1302/0301-620X.70B4.3403594; Gillispie WJ, 1996, CLIN ORTHOP S, V329s, P290; Goldacre MJ, 2005, BRIT J CANCER, V92, P1298, DOI 10.1038/sj.bjc.6602511; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Gross TP, 2012, J ARTHROPLASTY, V27, P533, DOI 10.1016/j.arth.2011.06.019; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P835, DOI 10.1302/0301-620X.91B6.21844; Jarvholm B, 2005, EUR J EPIDEMIOL, V20, P537, DOI 10.1007/s10654-005-4263-x; Kauppi MJ, 1996, ACTA PAEDIATR, V85, P248, DOI 10.1111/j.1651-2227.1996.tb14004.x; Kwasniak LA, 2011, INT J DERMATOL, V50, P645, DOI 10.1111/j.1365-4632.2010.04826.x; LANGKAMER VG, 1992, J BONE JOINT SURG BR, V74, P831, DOI 10.1302/0301-620X.74B6.1447243; MacDonald SJ, 2003, CLIN ORTHOP RELAT R, P282, DOI 10.1097/01.blo.0000043066.62337.9d; Meding JB, 2012, CLIN ORTHOP RELAT R, V470, P388, DOI 10.1007/s11999-011-2069-6; Min WK, 2008, JOINT BONE SPINE, V75, P319, DOI 10.1016/j.jbspin.2007.05.007; National Joint Registry for England and Wales (NJR England-Wales), 2011, 8 NJR ENGL WAL; NYREN O, 1995, JNCI-J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28; Ollivere B, 2009, J BONE JOINT SURG BR, V91B, P1025, DOI 10.1302/0301-620X.91B8.21701; Olsen JH, 1999, INT J CANCER, V81, P719, DOI 10.1002/(SICI)1097-0215(19990531)81:5<719::AID-IJC8>3.0.CO;2-D; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; PAAVOLAINEN P, 1991, ACTA ORTHOP SCAND, V62, P27, DOI 10.3109/17453679109155101; Paavolainen P, 1999, J ARTHROPLASTY, V14, P272, DOI 10.1016/S0883-5403(99)90051-7; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; SANTANA V, 1992, CLIN IMMUNOL IMMUNOP, V63, P205, DOI 10.1016/0090-1229(92)90224-C; Seppanen M, 2012, ACTA ORTHOP, V83, P207, DOI 10.3109/17453674.2012.693016; Shea KG, 1997, CLIN ORTHOP RELAT R, P219; Shimmin AJ, 2005, ORTHOP CLIN N AM, V36, P187, DOI 10.1016/j.ocl.2005.01.002; Treacy RBC, 2011, J BONE JOINT SURG BR, V93B, P27, DOI 10.1302/0301-620X.93B1.24134; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; VISURI T, 1991, ORTHOPEDICS, V14, P137; Visuri T, 2006, J ARTHROPLASTY, V21, P311, DOI 10.1016/j.arth.2005.03.046; Visuri T, 2003, ACTA ORTHOP SCAND, V74, P351, DOI 10.1080/00016470310014300; Visuri T, 1996, CLIN ORTHOP RELAT R, pS280; Visuri T, 2010, ACTA ORTHOP, V81, P77, DOI 10.3109/17453671003667150; Zahiri CA, 1999, J ARTHROPLASTY, V14, P326, DOI 10.1016/S0883-5403(99)90059-1	41	41	41	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2012	345								e4646	10.1136/bmj.e4646	http://dx.doi.org/10.1136/bmj.e4646			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UW	22833626	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000306997500002
J	Dix, MM; Simon, GM; Wang, C; Okerberg, E; Patricelli, MP; Cravatt, BF				Dix, Melissa M.; Simon, Gabriel M.; Wang, Chu; Okerberg, Eric; Patricelli, Matthew P.; Cravatt, Benjamin F.			Functional Interplay between Caspase Cleavage and Phosphorylation Sculpts the Apoptotic Proteome	CELL			English	Article							CATALYTIC SUBUNIT; KINASE; IDENTIFICATION; ACTIVATION; SUBSTRATE; SUSCEPTIBILITY; STAUROSPORINE; SPECIFICITY; TARGET; DEATH	Caspase proteases are principal mediators of apoptosis, where they cleave hundreds of proteins. Phosphorylation also plays an important role in apoptosis, although the extent to which proteolytic and phosphorylation pathways crosstalk during programmed cell death remains poorly understood. Using a quantitative proteomic platform that integrates phosphorylation sites into the topographical maps of proteins, we identify a cohort of over 500 apoptosis-specific phosphorylation events and show that they are enriched on cleaved proteins and clustered around sites of caspase proteolysis. We find that caspase cleavage can expose new sites for phosphorylation, and, conversely, that phosphorylation at the +3 position of cleavage sites can directly promote substrate proteolysis by caspase-8. This study provides a global portrait of the apoptotic phosphoproteome, revealing heretofore unrecognized forms of functional crosstalk between phosphorylation and caspase proteolytic pathways that lead to enhanced rates of protein cleavage and the unveiling of new sites for phosphorylation.	[Dix, Melissa M.; Simon, Gabriel M.; Wang, Chu; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Dix, Melissa M.; Simon, Gabriel M.; Wang, Chu; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Okerberg, Eric; Patricelli, Matthew P.] ActivX Biosci, La Jolla, CA 92307 USA	Scripps Research Institute; Scripps Research Institute; Kyorin Pharmaceutical Co Ltd	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu	Wang, Chu/AAE-8759-2021; Wang, Chu/C-4442-2015; wang, chu/GYJ-2191-2022	Wang, Chu/0000-0002-6925-1268; Wang, Chu/0000-0002-6925-1268; 	NIH [CA087660]; California Breast Cancer Foundation; ARCS Foundation; Koshland Graduate Fellowship in Enzyme Biochemistry; Skaggs Institute for Chemical Biology; Activx Biosciences; NATIONAL CANCER INSTITUTE [R37CA087660, R01CA087660] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Foundation; ARCS Foundation; Koshland Graduate Fellowship in Enzyme Biochemistry; Skaggs Institute for Chemical Biology; Activx Biosciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH (CA087660), a Predoctoral Fellowship from the California Breast Cancer Foundation (M.M.D.), the ARCS Foundation (M.M.D.), a Koshland Graduate Fellowship in Enzyme Biochemistry (G.M.S.), and the Skaggs Institute for Chemical Biology. We are grateful to Brian Grabiner and David Sabatini for their generous gift of lentiviral vectors. This work was supported in part by a grant from Activx Biosciences.	Agard NJ, 2012, P NATL ACAD SCI USA, V109, P1913, DOI 10.1073/pnas.1117158109; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; ALLALUNISTURNER MJ, 1995, CANCER RES, V55, P5200; Arntzen MO, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010447; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Blanchard H, 2000, J MOL BIOL, V302, P9, DOI 10.1006/jmbi.2000.4041; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Chakravarthy BR, 1999, J NEUROCHEM, V72, P933, DOI 10.1046/j.1471-4159.1999.0720933.x; Chen GG, 2005, J CELL PHYSIOL, V203, P127, DOI 10.1002/jcp.20230; Chen GG, 2005, APOPTOSIS, V10, P185, DOI 10.1007/s10495-005-6073-8; Chereau D, 2003, BIOCHEMISTRY-US, V42, P4151, DOI 10.1021/bi020593l; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Duncan JS, 2010, BBA-PROTEINS PROTEOM, V1804, P505, DOI 10.1016/j.bbapap.2009.11.001; Ekici OD, 2006, J MED CHEM, V49, P5728, DOI 10.1021/jm0601405; Esposti MD, 2003, J BIOL CHEM, V278, P15749, DOI 10.1074/jbc.M209208200; Fattman CL, 2001, ONCOGENE, V20, P2918, DOI 10.1038/sj.onc.1204414; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Han ZY, 1996, J BIOL CHEM, V271, P25035, DOI 10.1074/jbc.271.40.25035; Hehner SP, 1999, CELL DEATH DIFFER, V6, P833, DOI 10.1038/sj.cdd.4400559; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Na SQ, 1996, J BIOL CHEM, V271, P11209, DOI 10.1074/jbc.271.19.11209; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Rank KB, 2001, PROTEIN EXPRES PURIF, V22, P258, DOI 10.1006/prep.2001.1433; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Short DM, 2007, PROTEOMICS, V7, P3085, DOI 10.1002/pmic.200600964; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Stolzenberg I, 2000, CELL TISSUE RES, V301, P273, DOI 10.1007/s004410000239; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tozser J, 2003, BIOCHEM J, V372, P137, DOI 10.1042/BJ20021901; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174	43	104	107	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					426	440		10.1016/j.cell.2012.05.040	http://dx.doi.org/10.1016/j.cell.2012.05.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817901	Bronze, Green Accepted			2022-12-01	WOS:000306595700020
J	Duraffourd, C; De Vadder, F; Goncalves, D; Delaere, F; Penhoat, A; Brusset, B; Rajas, F; Chassard, D; Duchampt, A; Stefanutti, A; Gautier-Stein, A; Mithieux, G				Duraffourd, Celine; De Vadder, Filipe; Goncalves, Daisy; Delaere, Fabien; Penhoat, Armelle; Brusset, Bleuenn; Rajas, Fabienne; Chassard, Dominique; Duchampt, Adeline; Stefanutti, Anne; Gautier-Stein, Amandine; Mithieux, Gilles			Mu-Opioid Receptors and Dietary Protein Stimulate a Gut-Brain Neural Circuitry Limiting Food Intake	CELL			English	Article							GLUCAGON-LIKE PEPTIDE-1; RAT SMALL-INTESTINE; MESSENGER-RNA; EXPRESSION; GLUCONEOGENESIS; GENE; CHOLECYSTOKININ; MECHANISMS; NUCLEUS; SATIETY	Intestinal gluconeogenesis is involved in the control of food intake. We show that mu-opioid receptors (MORs) present in nerves in the portal vein walls respond to peptides to regulate a gut-brain neural circuit that controls intestinal gluconeogenesis and satiety. In vitro, peptides and protein digests behave as MOR antagonists in competition experiments. In vivo, they stimulate MOR-dependent induction of intestinal gluconeogenesis via activation of brain areas receiving inputs from gastrointestinal ascending nerves. MOR-knockout mice do not carry out intestinal gluconeogenesis in response to peptides and are insensitive to the satiety effect induced by protein-enriched diets. Portal infusions of MOR modulators have no effect on food intake in mice deficient for intestinal gluconeogenesis. Thus, the regulation of portal MORs by peptides triggering signals to and from the brain to induce intestinal gluconeogenesis are links in the satiety phenomenon associated with alimentary protein assimilation.	[Duraffourd, Celine; De Vadder, Filipe; Goncalves, Daisy; Delaere, Fabien; Penhoat, Armelle; Brusset, Bleuenn; Rajas, Fabienne; Chassard, Dominique; Duchampt, Adeline; Stefanutti, Anne; Gautier-Stein, Amandine; Mithieux, Gilles] INSERM, U855, F-69372 Lyon, France; [Duraffourd, Celine; De Vadder, Filipe; Goncalves, Daisy; Delaere, Fabien; Penhoat, Armelle; Brusset, Bleuenn; Rajas, Fabienne; Chassard, Dominique; Duchampt, Adeline; Stefanutti, Anne; Gautier-Stein, Amandine; Mithieux, Gilles] Univ Lyon, F-69008 Lyon, France; [Duraffourd, Celine; De Vadder, Filipe; Goncalves, Daisy; Delaere, Fabien; Penhoat, Armelle; Brusset, Bleuenn; Rajas, Fabienne; Chassard, Dominique; Duchampt, Adeline; Stefanutti, Anne; Gautier-Stein, Amandine; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Chassard, Dominique] HFME, Hosp Civils Lyon, F-69250 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Mithieux, G (corresponding author), INSERM, U855, F-69372 Lyon, France.	gilles.mithieux@inserm.fr	Penhoat, Armelle/M-1305-2018; RAJAS, Fabienne/P-4091-2016; PENHOAT, ARMELLE/GMX-2754-2022	RAJAS, Fabienne/0000-0002-9233-7633; PENHOAT, ARMELLE/0000-0003-3181-9564; Gilles, Mithieux/0000-0003-3579-8529; De Vadder, Filipe/0000-0001-9195-5344	INSERM; Centre National de la Recherche Scientifique; Institut National de la Recherche Agronomique; Universite Lyon 1; Ministere de la Recherche et de l'Enseignement Superieur; Ecole Normale Superieure de Lyon; Ecole Nationale du Genie Rural des Eaux et Forets; Agence Nationale de la Recherche [ANR1.14, ANR-07-PNRA-015]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique; Universite Lyon 1; Ministere de la Recherche et de l'Enseignement Superieur; Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Ecole Nationale du Genie Rural des Eaux et Forets; Agence Nationale de la Recherche(French National Research Agency (ANR))	All protocols used in this work were performed according to the recommendations of our local animal ethics committee for animal experimentation, which gave its authorization. The staff members of the animal facility of the University Claude Bernard-Lyon 1 (ALECS) are acknowledged for precious help in housing rats and mice, including Aude Barataud for helpful discussions on the pharmacology of MOR. The authors thank INSERM for funding their work and the Centre National de la Recherche Scientifique (A.S., G.M., F.R.), the Institut National de la Recherche Agronomique (A.G.-S.), the Universite Lyon 1 (D.C.) and INSERM (A. P) for funding their positions. The authors also wish to thank the Ministere de la Recherche et de l'Enseignement Superieur (C.D., D.G.) the Ecole Normale Superieure de Lyon (B.B., F.D.V.), the Ecole Nationale du Genie Rural des Eaux et Forets (F.D.) for funding their positions as postgraduate or Ph.D students. A.D. was hired thanks to grants from the Agence Nationale de la Recherche (ANR1.14 [NutriSens project] and ANR-07-PNRA-015 [SensoFat project]). The authors declare that there are no conflicts of interest in relation to this work.	Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Bohm SK, 1997, BIOCHEM J, V322, P1; BOLL M, 1994, PFLUG ARCH EUR J PHY, V429, P146, DOI 10.1007/BF02584043; BOOTH DA, 1970, PHYSIOL BEHAV, V5, P1299, DOI 10.1016/0031-9384(70)90044-2; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Capasso A, 1997, FEBS LETT, V417, P141, DOI 10.1016/S0014-5793(97)01271-4; CHIBA H, 1989, J DAIRY RES, V56, P363, DOI 10.1017/S0022029900028818; Croset M, 2001, DIABETES, V50, P740, DOI 10.2337/diabetes.50.4.740; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Ding YQ, 1996, J COMP NEUROL, V367, P375; GEORGE SR, 1994, BIOCHEM BIOPH RES CO, V205, P1438, DOI 10.1006/bbrc.1994.2826; GIBBS J, 1976, AM J PHYSIOL, V230, P15, DOI 10.1152/ajplegacy.1976.230.1.15; Glass MJ, 1999, NEUROPEPTIDES, V33, P360, DOI 10.1054/npep.1999.0050; Greenwood-Van Meerveld B, 2004, NEUROGASTROENT MOTIL, V16, P46, DOI 10.1111/j.1743-3150.2004.00555.x; Hayes MT, 2011, OBES SURG, V21, P759, DOI 10.1007/s11695-011-0380-7; HEDNER T, 1987, SCAND J GASTROENTERO, V22, P27, DOI 10.3109/00365528709090997; Holzer P, 2009, REGUL PEPTIDES, V155, P11, DOI 10.1016/j.regpep.2009.03.012; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Kotz CM, 2000, AM J PHYSIOL-REG I, V278, pR499, DOI 10.1152/ajpregu.2000.278.2.R499; KREIL G, 1983, LIFE SCI, V33, P137, DOI 10.1016/0024-3205(83)90463-0; Lee VHL, 2000, EUR J PHARM SCI, V11, pS41, DOI 10.1016/S0928-0987(00)00163-9; LORENTZ M, 1988, BRAIN RES, V445, P157, DOI 10.1016/0006-8993(88)91086-4; Meisel H, 2000, BRIT J NUTR, V84, pS27; Mithieux G, 2004, AM J PHYSIOL-ENDOC M, V286, pE370, DOI 10.1152/ajpendo.00299.2003; Mithieux G, 2004, J BIOL CHEM, V279, P44231, DOI 10.1074/jbc.R400011200; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Mithieux G, 2009, NUTRITION, V25, P881, DOI 10.1016/j.nut.2009.06.010; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; MORITOKI H, 1984, EUR J PHARMACOL, V100, P29, DOI 10.1016/0014-2999(84)90312-1; MORLEY JE, 1983, NEUROSCI BIOBEHAV R, V7, P281, DOI 10.1016/0149-7634(83)90020-9; Nielsen CU, 2003, CURR DRUG TARGETS, V4, P373, DOI 10.2174/1389450033491028; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pasternak DA, 2004, J NEUROCHEM, V91, P881, DOI 10.1111/j.1471-4159.2004.02767.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Penhoat A, 2011, PHYSIOL BEHAV, V105, P89, DOI 10.1016/j.physbeh.2011.03.012; Pillot B, 2009, ENDOCRINOLOGY, V150, P616, DOI 10.1210/en.2008-0601; Rajas F, 1999, GASTROENTEROLOGY, V117, P132, DOI 10.1016/S0016-5085(99)70559-7; Rajas F, 2000, DIABETES, V49, P1165, DOI 10.2337/diabetes.49.7.1165; Reimer K, 2009, PHARMACOLOGY, V83, P10, DOI 10.1159/000165778; ROLLS BJ, 1988, PHYSIOL BEHAV, V43, P145, DOI 10.1016/0031-9384(88)90230-2; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Schiller P., 2002, AM PEPTIDE S, V6, P229; Shin AC, 2010, NEUROSCIENCE, V170, P580, DOI 10.1016/j.neuroscience.2010.07.017; SHIOMI H, 1981, NEUROPHARMACOLOGY, V20, P633, DOI 10.1016/0028-3908(81)90109-X; Sternini C, 2000, NEUROSCIENCE, V98, P233, DOI 10.1016/S0306-4522(00)00118-4; Sternini C, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00553.x; Sternini C, 2001, AM J PHYSIOL-GASTR L, V281, pG8, DOI 10.1152/ajpgi.2001.281.1.G8; Taylor DA, 2001, J PHARMACOL EXP THER, V297, P11; TESCHEMACHER H, 1986, J DAIRY RES, V53, P135, DOI 10.1017/S0022029900024730; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Vahl TP, 2007, ENDOCRINOLOGY, V148, P4965, DOI 10.1210/en.2006-0153; WEST DB, 1984, AM J PHYSIOL, V246, pR776, DOI 10.1152/ajpregu.1984.246.5.R776; Will MJ, 2003, J NEUROSCI, V23, P2882; Yang JC, 2000, BRAIN RES, V870, P199, DOI 10.1016/S0006-8993(00)02369-6; Yeomans MR, 2002, NEUROSCI BIOBEHAV R, V26, P713, DOI 10.1016/S0149-7634(02)00041-6; Zhang JP, 2006, EUR J PHARMACOL, V545, P147, DOI 10.1016/j.ejphar.2006.06.069; Zheng HY, 2002, AM J PHYSIOL-REG I, V282, pR1773, DOI 10.1152/ajpregu.00019.2002; ZIOUDROU C, 1979, J BIOL CHEM, V254, P2446	60	72	77	4	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 20	2012	150	2					377	388		10.1016/j.cell.2012.05.039	http://dx.doi.org/10.1016/j.cell.2012.05.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22771138	Bronze, Green Submitted			2022-12-01	WOS:000306595700016
J	Carvunis, AR; Rolland, T; Wapinski, I; Calderwood, MA; Yildirim, MA; Simonis, N; Charloteaux, B; Hidalgo, CA; Barbette, J; Santhanam, B; Brar, GA; Weissman, JS; Regev, A; Thierry-Mieg, N; Cusick, ME; Vidal, M				Carvunis, Anne-Ruxandra; Rolland, Thomas; Wapinski, Ilan; Calderwood, Michael A.; Yildirim, Muhammed A.; Simonis, Nicolas; Charloteaux, Benoit; Hidalgo, Cesar A.; Barbette, Justin; Santhanam, Balaji; Brar, Gloria A.; Weissman, Jonathan S.; Regev, Aviv; Thierry-Mieg, Nicolas; Cusick, Michael E.; Vidal, Marc			Proto-genes and de novo gene birth	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST GENOME; EVOLUTION; ADAPTATION; SELECTION; PROTEINS; SEQUENCE; ORIGIN; DNA	Novel protein-coding genes can arise either through re-organization of pre-existing genes or de novo(1,2). Processes involving re-organization of pre-existing genes, notably after gene duplication, have been extensively described(1,2). In contrast, de novo gene birth remains poorly understood, mainly because translation of sequences devoid of genes, or 'non-genic' sequences, is expected to produce insignificant polypeptides rather than proteins with specific biological functions(1,3-6). Here we formalize an evolutionary model according to which functional genes evolve de novo through transitory proto-genes(4) generated by widespread translational activity in non-genic sequences. Testing this model at the genome scale in Saccharomyces cerevisiae, we detect translation of hundreds of short species-specific open reading frames (ORFs) located in non-genic sequences. These translation events seem to provide adaptive potential(7), as suggested by their differential regulation upon stress and by signatures of retention by natural selection. In line with our model, we establish that S. cerevisiae ORFs can be placed within an evolutionary continuum ranging from non-genic sequences to genes. We identify similar to 1,900 candidate proto-genes among S. cerevisiae ORFs and find that de novo gene birth from such a reservoir may be more prevalent than sporadic gene duplication. Our work illustrates that evolution exploits seemingly dispensable sequences to generate adaptive functional innovation.	[Carvunis, Anne-Ruxandra; Rolland, Thomas; Calderwood, Michael A.; Simonis, Nicolas; Charloteaux, Benoit; Barbette, Justin; Santhanam, Balaji; Cusick, Michael E.; Vidal, Marc] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Rolland, Thomas; Calderwood, Michael A.; Simonis, Nicolas; Charloteaux, Benoit; Barbette, Justin; Santhanam, Balaji; Cusick, Michael E.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Rolland, Thomas; Calderwood, Michael A.; Simonis, Nicolas; Charloteaux, Benoit; Barbette, Justin; Santhanam, Balaji; Cusick, Michael E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carvunis, Anne-Ruxandra; Thierry-Mieg, Nicolas] UJF Grenoble 1, CNRS, TIMC IMAG, UMR 5525,Computat & Math Biol Grp, F-38031 Grenoble, France; [Wapinski, Ilan] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Yildirim, Muhammed A.] Harvard Univ, Cambridge, MA 02138 USA; [Yildirim, Muhammed A.] Ctr Int Dev, Cambridge, MA 02138 USA; [Charloteaux, Benoit] Univ Liege, GIGA R, Unit Anim Genom, B-4000 Liege, Wallonia Brusse, Belgium; [Hidalgo, Cesar A.] MIT, MIT Media Lab, Cambridge, MA 02142 USA; [Brar, Gloria A.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cell & Mol Pharmacol, San Francisco, CA 94158 USA; [Brar, Gloria A.; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Charloteaux, Benoit] Univ Liege, Fac Vet Med, B-4000 Liege, Belgium	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Harvard University; Harvard Medical School; Harvard University; University of Liege; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Liege	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA.	marc_vidal@dfci.harvard.edu	Thierry-Mieg, Nicolas/M-6007-2014; Yildirim, Muhammed/J-3695-2014; Hidalgo, Cesar A./B-5155-2009; Calderwood, Mike/B-2475-2014	Thierry-Mieg, Nicolas/0000-0002-7667-2853; Yildirim, Muhammed/0000-0003-2826-1766; Hidalgo, Cesar A./0000-0002-6977-9492; Calderwood, Mike/0000-0001-6475-1418; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Weissman, Jonathan/0000-0003-2445-670X; Rolland, Thomas/0000-0001-6468-8391; /0000-0002-6031-5982	National Institute of Health; Scientific Interface from the Burroughs Wellcome Fund; Howard Hughes Medical Institute (HHMI); American Cancer Society [117945-PF-09-136-01-RMC]; National Human Genome Research Institute [R01-HG006061]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006061] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Duret, E. Levy, J. Vandenhaute, Q. Li, H. Yu, P. Braun, M. Dreze, C. Foo, M. Mann, N. Kulak, J. Cox, C. Maire and S. Jhavery-Schneider as well as members of the Center for Cancer Systems Biology (CCSB), in particular A. Dricot-Ziter, A. MacWilliams, F. Roth, Y. Jacob and D. Hill for discussions and proofreading. A.R. was supported by a National Institute of Health Pioneer Award, a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and the Howard Hughes Medical Institute (HHMI). I.W. is a HHMI fellow of the Damon Runyon Cancer Research Institute. G.A.B. was supported by American Cancer Society Postdoctoral fellowship 117945-PF-09-136-01-RMC. M.V. is a Chercheur Qualifie Honoraire from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia-Brussels Federation, Belgium). This work was supported by the grant R01-HG006061 from the National Human Genome Research Institute awarded to M.V.	Boyer J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r72; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Gao LZ, 2004, SCIENCE, V306, P1367, DOI 10.1126/science.1102033; Giacomelli MG, 2007, MOL BIOL EVOL, V24, P457, DOI 10.1093/molbev/msl172; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jansen R, 2000, NUCLEIC ACIDS RES, V28, P1481, DOI 10.1093/nar/28.6.1481; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Li QR, 2008, GENOME RES, V18, P1294, DOI 10.1101/gr.076661.108; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Pal C, 2001, GENETICS, V158, P927; Prat Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-285; Siepel A, 2009, GENOME RES, V19, P1693, DOI 10.1101/gr.098376.109; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Vishnoi A, 2010, GENOME RES, V20, P1574, DOI 10.1101/gr.109595.110; Wilson BA, 2011, GENOME BIOL EVOL, V3, P1245, DOI 10.1093/gbe/evr099; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Yomtovian I, 2010, BIOINFORMATICS, V26, P996, DOI 10.1093/bioinformatics/btq093; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003	30	339	347	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					370	374		10.1038/nature11184	http://dx.doi.org/10.1038/nature11184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722833	Green Accepted, Green Submitted			2022-12-01	WOS:000306506500044
J	Moritz, MA				Moritz, Max A.			Wildfires ignite debate on global warming	NATURE			English	Editorial Material									Univ Calif Berkeley, Environm Sci Policy & Management Dept, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Moritz, MA (corresponding author), Univ Calif Berkeley, Environm Sci Policy & Management Dept, Berkeley, CA 94720 USA.	mmoritz@berkeley.edu							0	8	8	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					273	273		10.1038/487273a	http://dx.doi.org/10.1038/487273a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JB	22810656	Bronze			2022-12-01	WOS:000306506500004
J	Acharyya, S; Oskarsson, T; Vanharanta, S; Malladi, S; Kim, J; Morris, PG; Manova-Todorova, K; Leversha, M; Hogg, N; Seshan, VE; Norton, L; Brogi, E; Massague, J				Acharyya, Swarnali; Oskarsson, Thordur; Vanharanta, Sakari; Malladi, Srinivas; Kim, Juliet; Morris, Patrick G.; Manova-Todorova, Katia; Leversha, Margaret; Hogg, Nancy; Seshan, Venkatraman E.; Norton, Larry; Brogi, Edi; Massague, Joan			A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis	CELL			English	Article							BREAST-CANCER; SUPPRESSOR-CELLS; MYELOID CELLS; TUMOR; RESISTANCE; CHEMOKINE; THERAPY; GENES; CHEMOTHERAPY; INFLAMMATION	Metastasis and chemoresistance in cancer are linked phenomena, but the molecular basis for this link is unknown. We uncovered a network of paracrine signals between carcinoma, myeloid, and endothelial cells that drives both processes in breast cancer. Cancer cells that overexpress CXCL1 and 2 by transcriptional hyperactivation or 4q21 amplification are primed for survival in metastatic sites. CXCL1/2 attract CD11b(+)Gr1(+) myeloid cells into the tumor, which produce chemokines including S100A8/9 that enhance cancer cell survival. Although chemotherapeutic agents kill cancer cells, these treatments trigger a parallel stromal reaction leading to TNF-alpha production by endothelial and other stromal cells. TNF-alpha via NF-kB heightens the CXCL1/2 expression in cancer cells, thus amplifying the CXCL1/2-S100A8/9 loop and causing chemoresistance. CXCR2 blockers break this cycle, augmenting the efficacy of chemotherapy against breast tumors and particularly against metastasis. This network of endothelial-carcinoma-myeloid signaling interactions provides a mechanism linking chemoresistance and metastasis, with opportunities for intervention.	[Acharyya, Swarnali; Oskarsson, Thordur; Vanharanta, Sakari; Malladi, Srinivas; Kim, Juliet; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Morris, Patrick G.; Norton, Larry] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Manova-Todorova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10065 USA; [Leversha, Margaret] Mem Sloan Kettering Canc Ctr, Mol Cytogenet Core Facil, New York, NY 10065 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Hogg, Nancy] Canc Res UK London Res Inst, Leukocyte Adhes Lab, London WC2A 3PX, England; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 21205 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cancer Research UK; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	massaguj@mskcc.org	Oskarsson, Thordur/HBP-9601-2022	Norton, Larry/0000-0003-3701-9250; Massague, Joan/0000-0001-9324-8408; Oskarsson, Thordur/0000-0002-0983-6969	NIH [CA94060, U54 CA163167]; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA163167, R37CA034610, P01CA094060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank J. Joyce, J. Bromberg, E. Pamer, H. G. Wendel, I. Ferrero, Z. Granot, R. Downey and members of Massague laboratory for insightful discussions, J. Howard for her help with clinical cases, D. Macalinao, W. Shu, M. Akram, K. Chadalavada, T. Tong, M. Turkekul, A. Barlas, and E. de Stanchina for technical advice and support. This work was funded by NIH grants CA94060 and U54 CA163167 and the Alan and Sandra Gerry Metastasis Research Initiative. S.A. is supported by a Department of Defense Era of Hope postdoctoral fellowship. J. M. is an Investigator of the Howard Hughes Medical Institute.	Amiri KI, 2003, PROG NUCLEIC ACID RE, V74, P1, DOI 10.1016/S0079-6603(03)01009-2; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Hsieh HL, 2003, BIOCHEM BIOPH RES CO, V307, P375, DOI 10.1016/S0006-291X(03)01190-2; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Montero AJ, 2012, BREAST CANCER RES TR, V132, P215, DOI 10.1007/s10549-011-1889-0; Morris PG, 2009, EXPERT OPIN PHARMACO, V10, P967, DOI [10.1517/14656560902834961, 10.1517/14656560902834961 ]; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P739, DOI 10.1093/jnci/djh131; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; TSAI S, 1993, P NATL ACAD SCI USA, V90, P7153, DOI 10.1073/pnas.90.15.7153; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Weiss L, 2000, CANCER METAST REV, V19, P193, DOI 10.1023/A:1010646304844; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	44	705	749	1	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					165	178		10.1016/j.cell.2012.04.042	http://dx.doi.org/10.1016/j.cell.2012.04.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770218	Green Accepted, Bronze			2022-12-01	WOS:000306115000015
J	Ch'ng, TH; Uzgil, B; Lin, P; Avliyakulov, NK; O'Dell, TJ; Martin, KC				Ch'ng, Toh Hean; Uzgil, Besim; Lin, Peter; Avliyakulov, Nuraly K.; O'Dell, Thomas J.; Martin, Kelsey C.			Activity-Dependent Transport of the Transcriptional Coactivator CRTC1 from Synapse to Nucleus	CELL			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; SENSITIVE COINCIDENCE DETECTOR; MEDIATED GENE-EXPRESSION; MEMORY STORAGE; CREB; PLASTICITY; HIPPOCAMPUS; ACTIVATION; RECEPTOR	Long-lasting changes in synaptic efficacy, such as those underlying long-term memory, require transcription. Activity-dependent transport of synaptically localized transcriptional regulators provides a direct means of coupling synaptic stimulation with changes in transcription. The CREB-regulated transcriptional coactivator (CRTC1), which is required for long-term hippocampal plasticity, binds CREB to potently promote transcription. We show that CRTC1 localizes to synapses in silenced hippocampal neurons but translocates to the nucleus in response to localized synaptic stimulation. Regulated nuclear translocation occurs only in excitatory neurons and requires calcium influx and calcineurin activation. CRTC1 is controlled in a dual fashion with activity regulating CRTC1 nuclear translocation and cAMP modulating its persistence in the nucleus. Neuronal activity triggers a complex change in CRTC1 phosphorylation, suggesting that CRTC1 may link specific types of stimuli to specific changes in gene expression. Together, our results indicate that synapse-to-nuclear transport of CRTC1 dynamically informs the nucleus about synaptic activity.	[Ch'ng, Toh Hean; Avliyakulov, Nuraly K.; Martin, Kelsey C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Uzgil, Besim] Univ Calif Los Angeles, David Geffen Sch Med, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Lin, Peter] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [O'Dell, Thomas J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, David Geffen Sch Med, Integrated Ctr Learning & Memory, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Martin, KC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu	Chng, Toh Hean/F-8753-2015	Ch'ng, Toh Hean/0000-0002-7170-1512	NARSAD; NIH [R01 MH077022, R01 MH609197]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077022] Funding Source: NIH RePORTER	NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Carew and K.C.M. lab for helpful discussions and C. Alberini, K. Olofsdotter-Otis, V. Ho, C. Houser, and L. Zipursky for critical reading of the manuscript. We thank M. Chin for advice on qPCR experiments, M. DeSalvo for processing tissue samples, M. Haykinson for advice on DIGE, and Z. Peng and C. Houser for immunohistochemistry of acute slices. The work was supported by a NARSAD Young Investigator Award (to T.H.C.), NIH R01 MH077022 (to K.C.M.), and R01 MH609197 (to T.J.O.).	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Balschun D, 2003, J NEUROSCI, V23, P6304; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Delgado JY, 2005, NEUROPHARMACOLOGY, V48, P936, DOI 10.1016/j.neuropharm.2005.01.008; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Johnson HA, 2007, J NEUROSCI, V27, P5915, DOI 10.1523/JNEUROSCI.0447-07.2007; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kauffman AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000372; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; McGaugh JL, 2006, TRENDS COGN SCI, V10, P345, DOI 10.1016/j.tics.2006.06.001; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; Neugebauer F, 2009, BRAIN RES, V1273, P29, DOI 10.1016/j.brainres.2009.03.055; O'Dell TJ, 2010, CELL SIGNAL, V22, P728, DOI 10.1016/j.cellsig.2009.12.004; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Watts AG, 2011, J NEUROENDOCRINOL, V23, P754, DOI 10.1111/j.1365-2826.2011.02178.x; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	44	135	141	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 6	2012	150	1					207	221		10.1016/j.cell.2012.05.027	http://dx.doi.org/10.1016/j.cell.2012.05.027			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770221	Bronze, Green Accepted			2022-12-01	WOS:000306115000018
J	Fei, Z; Rodin, AS; Andreev, GO; Bao, W; McLeod, AS; Wagner, M; Zhang, LM; Zhao, Z; Thiemens, M; Dominguez, G; Fogler, MM; Castro Neto, AH; Lau, CN; Keilmann, F; Basov, DN				Fei, Z.; Rodin, A. S.; Andreev, G. O.; Bao, W.; McLeod, A. S.; Wagner, M.; Zhang, L. M.; Zhao, Z.; Thiemens, M.; Dominguez, G.; Fogler, M. M.; Castro Neto, A. H.; Lau, C. N.; Keilmann, F.; Basov, D. N.			Gate-tuning of graphene plasmons revealed by infrared nano-imaging	NATURE			English	Article							METAMATERIALS; SPECTROSCOPY; OPTICS	Surface plasmons are collective oscillations of electrons in metals or semiconductors that enable confinement and control of electromagnetic energy at subwavelength scales(1-5). Rapid progress in plasmonics has largely relied on advances in device nano-fabrication(5-7), whereas less attention has been paid to the tunable properties of plasmonic media. One such medium-graphene-is amenable to convenient tuning of its electronic and optical properties by varying the applied voltage(8-11). Here, using infrared nano-imaging, we show that common graphene/SiO2/Si back-gated structures support propagating surface plasmons. The wavelength of graphene plasmons is of the order of 200 nanometres at technologically relevant infrared frequencies, and they can propagate several times this distance. We have succeeded in altering both the amplitude and the wavelength of these plasmons by varying the gate voltage. Using plasmon interferometry, we investigated losses in graphene by exploring real-space profiles of plasmon standing waves formed between the tip of our nano-probe and the edges of the samples. Plasmon dissipation quantified through this analysis is linked to the exotic electrodynamics of graphene(10). Standard plasmonic figures of merit of our tunable graphene devices surpass those of common metal-based structures.	[Fei, Z.; Rodin, A. S.; Andreev, G. O.; McLeod, A. S.; Wagner, M.; Fogler, M. M.; Basov, D. N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Bao, W.; Zhao, Z.; Lau, C. N.] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Bao, W.] Univ Maryland, Mat Res Sci & Engn Ctr, College Pk, MD 20742 USA; [Zhang, L. M.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Thiemens, M.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dominguez, G.] Calif State Univ, Dept Phys, San Marcos, CA 92096 USA; [Castro Neto, A. H.] Natl Univ Singapore, Graphene Res Ctr, Singapore 117542, Singapore; [Castro Neto, A. H.] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Keilmann, F.] Max Planck Inst Quantum Opt, D-85714 Garching, Germany; [Keilmann, F.] Ctr Nanosci, D-85714 Garching, Germany	University of California System; University of California San Diego; University of California System; University of California Riverside; University System of Maryland; University of Maryland College Park; Boston University; University of California System; University of California San Diego; California State University System; California State University San Marcos; National University of Singapore; National University of Singapore; Max Planck Society	Basov, DN (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dbasov@physics.ucsd.edu	Fei, Zhe/E-6475-2015; Bao, Wenzhong/B-2453-2012; Fogler, Michael M/O-4610-2017; Castro Neto, Antonio/C-8363-2014	Fei, Zhe/0000-0002-7940-5566; Bao, Wenzhong/0000-0002-3871-467X; Fogler, Michael M/0000-0001-8239-7221; Castro Neto, Antonio/0000-0003-0613-4010; Rodin, Aleksandr/0000-0001-5321-7690; Lau, Chun Ning/0000-0003-2159-6723; Andreev, Gregory/0000-0001-9908-2162	AFOSR; ONR [N00014-09-1-0724]; DARPA; DOE-BES [DE-FG02-00ER45799]; NSF [DMR/1106358, PHY11-25915]; ONR/DMEA [H94003-10-2-1003]; FENA Focus Center; NASA; UCOP; NRF-CRP [R-144-000-295-281]; DOE [DE-FG02-08ER46512]; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft through the Cluster of Excellence Munich Centre for Advanced Photonics; Direct For Mathematical & Physical Scien [1106358] Funding Source: National Science Foundation	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ONR(Office of Naval Research); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DOE-BES(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); ONR/DMEA(Office of Naval Research); FENA Focus Center; NASA(National Aeronautics & Space Administration (NASA)); UCOP; NRF-CRP(National Research Foundation, Singapore); DOE(United States Department of Energy (DOE)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft through the Cluster of Excellence Munich Centre for Advanced Photonics; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from AFOSR, ONR and DARPA. The analysis of plasmonic losses and many-body effects was supported by DOE-BES grant DE-FG02-00ER45799. W. B., Z.Z. and C.N.L. were supported by NSF DMR/1106358, ONR N00014-09-1-0724, ONR/DMEA H94003-10-2-1003 and FENA Focus Center. G. D. and M. T. were supported by NASA. M. M. F. was supported by UCOP and NSF PHY11-25915. A.H.C.N. acknowledges NRF-CRP grant R-144-000-295-281. L.M.Z was supported by DOE grant no. DE-FG02-08ER46512. M. W. thanks the Alexander von Humboldt Foundation for financial support. F. K. was supported by Deutsche Forschungsgemeinschaft through the Cluster of Excellence Munich Centre for Advanced Photonics.	Ando T, 2002, J PHYS SOC JPN, V71, P1318, DOI 10.1143/JPSJ.71.1318; Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Caridad JM, 2010, J APPL PHYS, V108, DOI 10.1063/1.3500295; Casiraghi C, 2009, NANO LETT, V9, P1433, DOI 10.1021/nl8032697; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Dallapiccola R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152291; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Fei Z, 2011, NANO LETT, V11, P4701, DOI 10.1021/nl202362d; Grushin AG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155417; Gusynin VP, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245411; Huber A, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2032595; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Hwang J, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/24/245601; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/NNANO.2011.146, 10.1038/nnano.2011.146]; Lal S, 2007, NAT PHOTONICS, V1, P641, DOI 10.1038/nphoton.2007.223; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; Maier S. A., 2007, PLASMONICS FUNDAMENT; Nagpal P, 2009, SCIENCE, V325, P594, DOI 10.1126/science.1174655; Novotny L., 2006, PRINCIPLES NANOOPTIC, DOI DOI 10.1017/CBO9780511813535; Peres NMR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.055501; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; Rana F, 2008, IEEE T NANOTECHNOL, V7, P91, DOI 10.1109/TNANO.2007.910334; Rodin A. S., 2012, THESIS UCSD; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Stockman MI, 2011, PHYS TODAY, V64, P39, DOI 10.1063/1.3554315; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055	29	1540	1572	35	970	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					82	85		10.1038/nature11253	http://dx.doi.org/10.1038/nature11253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722866	Green Submitted			2022-12-01	WOS:000305982900054
J	Cipolletta, D; Feuerer, M; Li, A; Kamei, N; Lee, J; Shoelson, SE; Benoist, C; Mathis, D				Cipolletta, Daniela; Feuerer, Markus; Li, Amy; Kamei, Nozomu; Lee, Jongsoon; Shoelson, Steven E.; Benoist, Christophe; Mathis, Diane			PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue T-reg cells	NATURE			English	Article							INSULIN-RESISTANCE; SYSTEM; MICE; THIAZOLIDINEDIONES; DIFFERENTIATION; RETROVIRUSES; INFLAMMATION; SENSITIVITY; ACTIVATION; EXPRESSION	Obesity and type-2 diabetes have increased markedly over the past few decades, in parallel. One of the major links between these two disorders is chronic, low-grade inflammation(1). Prolonged nutrient excess promotes the accumulation and activation of leukocytes in visceral adipose tissue (VAT) and ultimately other tissues, leading to metabolic abnormalities such as insulin resistance, type-2 diabetes and fatty-liver disease. Although invasion of VAT by pro-inflammatory macrophages is considered to be a key event driving adipose-tissue inflammation and insulin resistance, little is known about the roles of other immune system cell types in these processes. A unique population of VAT-resident regulatory T (T-reg) cells was recently implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity(2). Here we identify peroxisome proliferator-activated receptor (PPAR)-gamma, the 'master regulator' of adipocyte differentiation, as a crucial molecular orchestrator of VAT T-reg cell accumulation, phenotype and function. Unexpectedly, PPAR-gamma expression by VAT T-reg cells was necessary for complete restoration of insulin sensitivity in obese mice by the thiazolidinedione drug pioglitazone. These findings suggest a previously unknown cellular mechanism for this important class of thiazolidinedione drugs, and provide proof-of-principle that discrete populations of T-reg cells with unique functions can be precisely targeted to therapeutic ends.	[Cipolletta, Daniela; Feuerer, Markus; Li, Amy; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA; [Kamei, Nozomu; Lee, Jongsoon; Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Kamei, Nozomu; Lee, Jongsoon; Shoelson, Steven E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu	Lee, Jongsoon/AAG-1674-2020	Lee, Jongsoon/0000-0002-0891-5059; Kamei, Nozomu/0000-0002-7686-437X	National Institutes of Health (NIH) [DK092541, DK51729]; Ellison Foundation (Boston); Dana Foundation; American Diabetes Association [RA 110BS97]; Joslin Diabetes Center [P30DK36836]; King Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051729, P30DK036836, R01DK092541, R37DK051729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation (Boston)(Lawrence Ellison Foundation); Dana Foundation; American Diabetes Association(American Diabetes Association); Joslin Diabetes Center; King Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Rudensky, F. Gonzalez, R. Kahn, B. Spiegelman and D. Vignali for providing materials; K. Hattori, M. Davenport, J. LaVecchio, G. Buruzala, J. Ericson, K. Leatherbee and S. Davis for technical assistance; A. Ergun, A. Morton and J. Shu for experimental help; and M. Wilson and J. Hill for discussions. Supported by grants from the National Institutes of Health (NIH; DK092541) and Ellison Foundation (Boston) to D. M. and C. B., Dana Foundation to D. M. and S. E. S.; the American Diabetes Association (RA 110BS97) to J. L., and the NIH (DK51729) to S. E. S.; as well as by core facilities of the Joslin Diabetes Center (P30DK36836). M. F. received a postdoctoral fellowship from the King Trust.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olefsky J.M., 2010, NAT MED, V16, P972; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	23	768	796	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					549	U151		10.1038/nature11132	http://dx.doi.org/10.1038/nature11132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722857	Green Accepted, Green Submitted			2022-12-01	WOS:000305760600047
J	Lipsitch, M; Plotkin, JB; Simonsen, L; Bloom, B				Lipsitch, Marc; Plotkin, Joshua B.; Simonsen, Lone; Bloom, Barry			Evolution, Safety, and Highly Pathogenic Influenza Viruses	SCIENCE			English	Editorial Material							A H3N2 VIRUSES; ADAMANTANE RESISTANCE; TRANSMISSION; OSELTAMIVIR; VIRULENCE; FERRETS	Experience with influenza has shown that predictions of virus phenotype or fitness from nucleotide sequence are imperfect and that predicting the timing and course of evolution is extremely difficult. Such uncertainty means that the risk of experiments with mammalian-transmissible, possibly highly virulent influenza viruses remains high even if some aspects of their laboratory biology are reassuring; it also implies limitations on the ability of laboratory observations to guide interpretation of surveillance of strains in the field. Thus, we propose that future experiments with virulent pathogens whose accidental or deliberate release could lead to extensive spread in human populations should be limited by explicit risk-benefit considerations.	[Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc; Bloom, Barry] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Global Hlth, Washington, DC 20037 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; George Washington University	Lipsitch, M (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, 665 Huntington Ave, Boston, MA 02115 USA.	mlipsitc@hsph.harvard.edu	Simonsen, Lone/K-4531-2014; Plotkin, Joshua B/E-6947-2013	Simonsen, Lone/0000-0003-1535-8526; Lipsitch, Marc/0000-0003-1504-9213	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54GM088558, U54 GM088558] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2003, EURO SURVEILL, V7, P2347; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bouvier N. M., 2012, J VIROL; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cohen J, 2012, SCIENCE, V335, P1155, DOI 10.1126/science.335.6073.1155; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hottes A. K., 2012, BIOSECURITY CHALLENG; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kramarz P, 2009, EUROSURVEILLANCE, V14; Kryazhimskiy S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001301; National Science Advisory Board for Biosecurity, 2012, NAT SCI ADV BOARD BI; Pennington H, 2003, B WORLD HEALTH ORGAN, V81, P762; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; SWEET C, 1991, J INFECT DIS, V164, P969, DOI 10.1093/infdis/164.5.969; U. S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Institutes of Health, 2009, HHS PUBL; U.S. Department of Homeland Security, 2007, NAT BIO AGR FAC FIN; U.S. Government Accountability Office, 2009, GAO09574 US GOV ACC; UK Health and Safety Executive, 2007, FIN REP POT BREACH B; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, REP TECHN CONS H5N1	27	26	26	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1529	1531		10.1126/science.1223204	http://dx.doi.org/10.1126/science.1223204			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723411	Green Accepted, Green Submitted			2022-12-01	WOS:000305507500045
J	Riccomagno, MM; Hurtado, A; Wang, HB; Macopson, JGJ; Griner, EM; Betz, A; Brose, N; Kazanietz, MG; Kolodkin, AL				Riccomagno, Martin M.; Hurtado, Andres; Wang, HongBin; Macopson, Joshua G. J.; Griner, Erin M.; Betz, Andrea; Brose, Nils; Kazanietz, Marcelo G.; Kolodkin, Alex L.			The RacGAP beta 2-Chimaerin Selectively Mediates Axonal Pruning in the Hippocampus	CELL			English	Article							MOSSY FIBERS; IN-VIVO; RETRACTION; ALPHA-2-CHIMAERIN; SCHIZOPHRENIA; DEGENERATION; GUIDANCE; NEURONS; PROTEIN; RATS	Axon pruning and synapse elimination promote neural connectivity and synaptic plasticity. Stereotyped pruning of axons that originate in the hippocampal dentate gyrus (DG) and extend along the infrapyramidal tract (IPT) occurs during postnatal murine development by neurite retraction and resembles axon repulsion. The chemorepellent Sema3F is required for IPT axon pruning, dendritic spine remodeling, and repulsion of DG axons. The signaling events that regulate IPT axon pruning are not known. We find that inhibition of the small G protein Rac1 by the Rac GTPase-activating protein (GAP) beta 2-Chimaerin (beta 2Chn) mediates Sema3F-dependent pruning. The Sema3F receptor neuropilin-2 selectively binds beta 2Chn, and ligand engagement activates this GAP to ultimately restrain Rac1-dependent effects on cytoskeletal reorganization. beta 2Chn is necessary for axon pruning both in vitro and in vivo, but it is dispensable for axon repulsion and spine remodeling. Therefore, a Npn2/beta 2Chn/Rac1 signaling axis distinguishes DG axon pruning from the effects of Sema3F on repulsion and dendritic spine remodeling.	[Riccomagno, Martin M.; Macopson, Joshua G. J.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Hurtado, Andres] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Riccomagno, Martin M.; Macopson, Joshua G. J.; Kolodkin, Alex L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wang, HongBin; Griner, Erin M.; Kazanietz, Marcelo G.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Betz, Andrea; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Betz, Andrea; Brose, Nils] Max Planck Inst Expt Med, DFG Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; [Hurtado, Andres] Hugo W Moser Res Inst Kennedy Krieger, Int Ctr Spinal Cord Injury, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; Max Planck Society; German Research Foundation (DFG); Max Planck Society	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu		Riccomagno, Martin/0000-0002-1867-4439	National Ataxia Foundation; NIH [R01 CA74197, RO1 MH59199]; NATIONAL CANCER INSTITUTE [R01CA074197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274] Funding Source: NIH RePORTER	National Ataxia Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Silvio Gutkind for the RacQL construct, Barbara Smith and the JHU School of Medicine Microscope Facility for assistance with the TEM, and Dr. Michael Greenberg for the pLLX and pLEMPRA vectors. We also thank Drs. Cynthia Duggan, Roman Giger, David Ginty, Randal Hand, Kang Shen, and Marc Tessier-Lavigne for helpful comments on the manuscript and discussions, and we thank members of Kolodkin laboratory for assistance. This work was supported by a postdoctoral fellowship from the National Ataxia Foundation to M. M. R, NIH R01 CA74197 to M. G. K, and NIH RO1 MH59199 to A. L. K. A. L. K. is an investigator of the Howard Hughes Medical Institute.	Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; CRUSIO WE, 1987, BRAIN RES, V425, P182, DOI 10.1016/0006-8993(87)90498-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Grosse G, 1998, J NEUROSCI RES, V51, P602, DOI 10.1002/(SICI)1097-4547(19980301)51:5<602::AID-JNR7>3.0.CO;2-J; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Hashimoto R, 2005, SCHIZOPHR RES, V73, P383, DOI 10.1016/j.schres.2004.01.017; Holmes GL, 1999, J COMP NEUROL, V404, P537, DOI 10.1002/(SICI)1096-9861(19990222)404:4<537::AID-CNE9>3.0.CO;2-#; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Ip JPK, 2012, NAT NEUROSCI, V15, P39, DOI 10.1038/nn.2972; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LAUDER JM, 1977, NATURE, V268, P335, DOI 10.1038/268335a0; Lee T, 1999, DEVELOPMENT, V126, P4065; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; LIPP HP, 1988, J NEUROSCI, V8, P1905; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; Sahay A, 2003, J NEUROSCI, V23, P6671; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Siliceo M, 2006, J CELL SCI, V119, P141, DOI 10.1242/jcs.02722; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Vanderhaeghen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001859; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; WEST JR, 1981, SCIENCE, V211, P957; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	48	54	55	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1594	1606		10.1016/j.cell.2012.05.018	http://dx.doi.org/10.1016/j.cell.2012.05.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726444	Green Accepted, Bronze			2022-12-01	WOS:000305753800023
J	Duhren-von Minden, M; Ubelhart, R; Schneider, D; Wossning, T; Bach, MP; Buchner, M; Hofmann, D; Surova, E; Follo, M; Kohler, F; Wardemann, H; Zirlik, K; Veelken, H; Jumaa, H				Duehren-von Minden, Marcus; Uebelhart, Rudolf; Schneider, Dunja; Wossning, Thomas; Bach, Martina P.; Buchner, Maike; Hofmann, Daniel; Surova, Elena; Follo, Marie; Koehler, Fabian; Wardemann, Hedda; Zirlik, Katja; Veelken, Hendrik; Jumaa, Hassan			Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling	NATURE			English	Article							B-CELLS; FOSTAMATINIB DISODIUM; RECEPTOR; LYMPHOMA; SYK; PROLIFERATION; INHIBITION; PRECURSORS; EXPRESSION; CLONING	B-cell antigen receptor (BCR) expression is an important feature of chronic lymphocytic leukaemia (CLL), one of the most prevalent B-cell neoplasias in Western countries(1). The presence of stereotyped and quasi-identical BCRs in different CLL patients suggests that recognition of specific antigens might drive CLL pathogenesis. Here we show that, in contrast to other B-cell neoplasias, CLL-derived BCRs induce antigen-independent cell-autonomous signalling, which is dependent on the heavy-chain complementarity-determining region (HCDR3) and an internal epitope of the BCR. Indeed, transferring the HCDR3 of a CLL-derived BCR provides autonomous signalling capacity to a non-autonomously active BCR, whereas mutations in the internal epitope abolish this capacity. Because BCR expression was required for the binding of secreted CLL-derived BCRs to target cells, and mutations in the internal epitope reduced this binding, our results indicate a new model for CLL pathogenesis, with cell-autonomous antigen-independent signalling as a crucial pathogenic mechanism.	[Duehren-von Minden, Marcus; Uebelhart, Rudolf; Schneider, Dunja; Wossning, Thomas; Bach, Martina P.; Hofmann, Daniel; Surova, Elena; Koehler, Fabian; Jumaa, Hassan] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Uebelhart, Rudolf; Surova, Elena] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Buchner, Maike; Follo, Marie; Zirlik, Katja] Univ Med Ctr Freiburg, Dept Hematol Oncol, D-79106 Freiburg, Germany; [Wardemann, Hedda] Max Planck Inst Infect Biol, Max Planck Res Grp Mol Immunol, D-10117 Berlin, Germany; [Veelken, Hendrik] Leiden Univ, Med Ctr, Dept Hematol, NL-2333 ZA Leiden, Netherlands; [Jumaa, Hassan] Univ Freiburg, Fac Biol, Dept Mol Immunol, D-79108 Freiburg, Germany; [Jumaa, Hassan] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Freiburg; Max Planck Society	Jumaa, H (corresponding author), Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany.	jumaa@immunbio.mpg.de		Follo, Marie/0000-0002-3090-7442; Veelken, Hendrik/0000-0002-9108-3125; Wardemann, Hedda/0000-0003-3921-5933	Deutsche Krebshilfe [108935]; Deutsche Forschungsgemeinschaft [SFB746, JU463/2-1]; Excellence Initiative of the German Federal and State Governments [GSC-4]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	We thank C. Croce for providing the TCL1 mice, M. Reth and P. Nielsen for scientific discussion and reading the manuscript, C. Wehr for help cloning TCL1-derived BCRs, A. Ott, A. Wurch, S. Hopitz and B. Wehrle for help with FACS experiments and cloning, and D. Pfeifer and M. Pantic for providing clinical data. This work was supported by the Deutsche Krebshilfe (Project 108935), the Deutsche Forschungsgemeinschaft (SFB746 and JU463/2-1) and the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School).	Bertinetti C, 2006, EUR J HAEMATOL, V77, P395, DOI 10.1111/j.1600-0609.2006.00740.x; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bikos V, 2012, LEUKEMIA, V26, P1638, DOI 10.1038/leu.2012.3; Binder M, 2011, CANCER-AM CANCER SOC, V117, P1891, DOI 10.1002/cncr.25755; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herling M, 2009, BLOOD, V114, P4675, DOI 10.1182/blood-2009-03-208256; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; Seiler T, 2009, BLOOD, V114, P3615, DOI 10.1182/blood-2009-01-197822; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; STHOEGER ZM, 1989, J EXP MED, V169, P255, DOI 10.1084/jem.169.1.255; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Suljagic M, 2010, BLOOD, V116, P4894, DOI 10.1182/blood-2010-03-275180; Tiller T, 2010, J EXP MED, V207, P2767, DOI 10.1084/jem.20100171; Ubelhart R, 2010, NAT IMMUNOL, V11, P759, DOI 10.1038/ni.1903; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103	28	356	362	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					309	+		10.1038/nature11309	http://dx.doi.org/10.1038/nature11309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22885698				2022-12-01	WOS:000308635900045
J	Krupic, J; Burgess, N; O'Keefe, J				Krupic, Julija; Burgess, Neil; O'Keefe, John			Neural Representations of Location Composed of Spatially Periodic Bands	SCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; GRID CELLS; OSCILLATORY INTERFERENCE; PATH-INTEGRATION; PLACE CELLS; THETA; RAT; PHASE; MODEL; PARASUBICULUM	The mammalian hippocampal formation provides neuronal representations of environmental location, but the underlying mechanisms are poorly understood. Here, we report a class of cells whose spatially periodic firing patterns are composed of plane waves (or bands) drawn from a discrete set of orientations and wavelengths. The majority of cells recorded in parasubicular and medial entorhinal cortices of freely moving rats belonged to this class and included grid cells, an important subset that corresponds to three bands at 60 orientations and has the most stable firing pattern. Occasional changes between hexagonal and nonhexagonal patterns imply a common underlying mechanism. Our results indicate a Fourier-like spatial analysis underlying neuronal representations of location, and suggest that path integration is performed by integrating displacement along a restricted set of directions.	[Krupic, Julija; O'Keefe, John] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Burgess, Neil] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Burgess, Neil] UCL, Inst Neurol, London WC1N 3BG, England; [O'Keefe, John] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	O'Keefe, J (corresponding author), UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.	j.okeefe@ucl.ac.uk	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Krupic, Julija/0000-0001-6299-1629; O'Keefe, John/0000-0001-5697-4881	European Union; UK Medical Research Council; Gatsby Charitable Foundation; Wellcome Trust; CoMPLEX studentship; MRC [G1000854] Funding Source: UKRI; Medical Research Council [G1000854] Funding Source: researchfish	European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gatsby Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); CoMPLEX studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Union Framework 7 (SPACEBRAIN) grant, the UK Medical Research Council, the Gatsby Charitable Foundation, and the Wellcome Trust. J.K. received support from a CoMPLEX studentship. We thank M. Bauza, T. Wills, C. Barry, F. Cacucci, and M. Witter for useful discussions and S. Burton for help with histology. This work was conducted in accordance with the UK Animals (Scientific Procedures) Act (1986).	Barry C., 2009, SOC NEUR ANN M CHIC; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Blair HT, 2008, HIPPOCAMPUS, V18, P1239, DOI 10.1002/hipo.20509; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Borckmans P, 2002, INT J BIFURCAT CHAOS, V12, P2307, DOI 10.1142/S0218127402005881; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011	26	103	107	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					853	857		10.1126/science.1222403	http://dx.doi.org/10.1126/science.1222403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904012	Green Accepted, Green Submitted			2022-12-01	WOS:000307535600046
J	Yu, FX; Zhao, B; Panupinthu, N; Jewell, JL; Lian, I; Wang, LH; Zhao, JG; Yuan, HX; Tumaneng, K; Li, HR; Fu, XD; Mills, GB; Guan, KL				Yu, Fa-Xing; Zhao, Bin; Panupinthu, Nattapon; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Li, Hairi; Fu, Xiang-Dong; Mills, Gordon B.; Guan, Kun-Liang			Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling	CELL			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; GROWTH-CONTROL; TISSUE-GROWTH; F-ACTIN; TUMORIGENESIS	The Hippo pathway is crucial in organ size control, and its dysregulation contributes to tumorigenesis. However, upstream signals that regulate the mammalian Hippo pathway have remained elusive. Here, we report that the Hippo pathway is regulated by G-protein-coupled receptor (GPCR) signaling. Serum-borne lysophosphatidic acid (LPA) and sphingosine 1-phosphophate (S1P) act through G12/13-coupled receptors to inhibit the Hippo pathway kinases Lats1/2, thereby activating YAP and TAZ transcription coactivators, which are oncoproteins repressed by Lats1/2. YAP and TAZ are involved in LPA-induced gene expression, cell migration, and proliferation. In contrast, stimulation of Gs-coupled receptors by glucagon or epinephrine activates Lats1/2 kinase activity, thereby inhibiting YAP function. Thus, GPCR signaling can either activate or inhibit the Hippo-YAP pathway depending on the coupled G protein. Our study identifies extracellular diffusible signals that modulate the Hippo pathway and also establishes the Hippo-YAP pathway as a critical signaling branch downstream of GPCR.	[Yu, Fa-Xing; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Yu, Fa-Xing; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhao, Bin] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Panupinthu, Nattapon; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Yu, Fa-Xing/0000-0003-4834-9335	NIH [P30 CA23100]; CIRM; Breast Cancer Research Foundation; National Cancer Institute [T32CA121938];  [GM052872]; NATIONAL CANCER INSTITUTE [R01CA132809, T32CA121938, P50CA098258, P30CA016672, P30CA023100] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052872, T32GM007752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Jack Dixon, Edward Dennis, Joan Heller Brown, and Jerold Chun for constructive comments; Dr. Rick Neubig for several G protein constructs; Drs. Ji Zhang, Richard Rivera, Zhongrui Zhou, Sunny Xiang, Andrew Markley, Dong Zhang, and Richard Harkewicz for technical help; and Jean Guan and Drs. Yanhui Xu and Ryan Russell for critical reading of the manuscript. This work was supported by grants from NIH and CIRM to K.-L.G. and GM052872 to X.-D.F. and a grant from Breast Cancer Research Foundation to G. B. M. J.L.J. was supported by the National Cancer Institute Training Grant T32CA121938. The cost of confocal imaging was partially supported by NIH Grant P30 CA23100.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Shida D, 2003, CANCER RES, V63, P1706; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	1049	1095	8	273	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					780	791		10.1016/j.cell.2012.06.037	http://dx.doi.org/10.1016/j.cell.2012.06.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22863277	Green Accepted, Bronze			2022-12-01	WOS:000308002300012
J	Alon, A; Grossman, I; Gat, Y; Kodali, VK; DiMaio, F; Mehlman, T; Haran, G; Baker, D; Thorpe, C; Fass, D				Alon, Assaf; Grossman, Iris; Gat, Yair; Kodali, Vamsi K.; DiMaio, Frank; Mehlman, Tevie; Haran, Gilad; Baker, David; Thorpe, Colin; Fass, Deborah			The dynamic disulphide relay of quiescin sulphydryl oxidase	NATURE			English	Article							K EPOXIDE REDUCTASE; PROTEIN-STRUCTURE; FAMILY; QSOX; ER	Protein stability, assembly, localization and regulation often depend on the formation of disulphide crosslinks between cysteine side chains. Enzymes known as sulphydryl oxidases catalysede novo disulphide formation and initiate intra-and intermolecular dithiol/disulphide relays to deliver the disulphides to substrate proteins(1,2). Quiescin sulphydryl oxidase (QSOX) is a unique, multi-domain disulphide catalyst that is localized primarily to the Golgi apparatus and secreted fluids(3) and has attracted attention owing to its overproduction in tumours(4,5). In addition to its physiological importance, QSOX is a mechanistically intriguing enzyme, encompassing functions typically carried out by a series of proteins in other disulphide-formation pathways. How disulphides are relayed through the multiple redox-active sites of QSOX and whether there is a functional benefit to concatenating these sites on a single polypeptide are open questions. Here we present the first crystal structure of an intact QSOX enzyme, derived from a trypanosome parasite. Notably, sequential sites in the disulphide relay were found more than 40 angstrom apart in this structure, too far for direct disulphide transfer. To resolve this puzzle, we trapped and crystallized an intermediate in the disulphide hand-off, which showed a 165 degrees domain rotation relative to the original structure, bringing the two active sites within disulphide-bonding distance. The comparable structure of a mammalian QSOX enzyme, also presented here, shows further biochemical features that facilitate disulphide transfer in metazoan orthologues. Finally, we quantified the contribution of concatenation to QSOX activity, providing general lessons for the understanding of multi-domain enzymes and the design of new catalytic relays.	[Alon, Assaf; Grossman, Iris; Gat, Yair; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Kodali, Vamsi K.; Thorpe, Colin] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [DiMaio, Frank; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Mehlman, Tevie] Weizmann Inst Sci, Dept Biol Res Support, IL-76100 Rehovot, Israel; [Haran, Gilad] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science; University of Delaware; University of Washington; University of Washington Seattle; Weizmann Institute of Science; Weizmann Institute of Science	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	deborah.fass@weizmann.ac.il	Baker, David/K-8941-2012; HARAN, GILAD/K-1489-2012; Kodali, Vamsi/A-8530-2010	Baker, David/0000-0001-7896-6217; Kodali, Vamsi/0000-0001-8941-9761; Alon, Assaf/0000-0001-8102-5290	Israel Science Foundation; Kimmelman Center for Macromolecular Assemblies; National Institutes of Health (NIH) [GM26643]; NIH [P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026643] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Kimmelman Center for Macromolecular Assemblies; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S. Rogotner and O. Dym helped in growing the TbQSOX<INF>C</INF> crystals. We thank T. Ilani and A. Horovitz for reading of the manuscript and N. Nelson and his research group for help with X-ray data collection. A. Moseri assisted with high-performance liquid chromatography. This study was funded by the Israel Science Foundation. D. F. and A. A. acknowledge the Kimmelman Center for Macromolecular Assemblies for additional support. C. T. and V. K. K. acknowledge National Institutes of Health (NIH) grant GM26643. The molecular movie was produced using the University of California San Francisco Chimera package from the Resource for Biocomputing, Visualization and Informatics (supported by NIH grant P41 RR001081).	Afonine P. V., 2005, CCP4 NEWSLETT; Alon A, 2010, FEBS LETT, V584, P1521, DOI 10.1016/j.febslet.2010.03.001; Antwi K, 2009, J PROTEOME RES, V8, P4722, DOI 10.1021/pr900414f; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; Jaje J, 2007, BIOCHEMISTRY-US, V46, P13031, DOI 10.1021/bi7016975; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; Kodali VK, 2010, BIOCHEMISTRY-US, V49, P2075, DOI 10.1021/bi902222s; Leslie A. G., 1992, JOINT CCP4 ESF EAMCB; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitra P, 2010, FEBS LETT, V584, P1163, DOI 10.1016/j.febslet.2010.02.021; OSTROWSKI MC, 1980, BIOCHEMISTRY-US, V19, P2639, DOI 10.1021/bi00553a016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Tordai H, 2005, FEBS J, V272, P5064, DOI 10.1111/j.1742-4658.2005.04917.x; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z; Zanata SM, 2005, REDOX REP, V10, P319, DOI 10.1179/135100005X83699	34	60	65	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					414	+		10.1038/nature11267	http://dx.doi.org/10.1038/nature11267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22801504	Green Accepted			2022-12-01	WOS:000307501000049
J	Sundd, P; Gutierrez, E; Koltsova, EK; Kuwano, Y; Fukuda, S; Pospieszalska, MK; Groisman, A; Ley, K				Sundd, Prithu; Gutierrez, Edgar; Koltsova, Ekaterina K.; Kuwano, Yoshihiro; Fukuda, Satoru; Pospieszalska, Maria K.; Groisman, Alex; Ley, Klaus			'Slings' enable neutrophil rolling at high shear	NATURE			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; INTERCELLULAR-ADHESION MOLECULE-1; SLOW VISCOUS MOTION; P-SELECTIN; IN-VIVO; PHYSIOLOGICAL FLOW; SPHERE PARALLEL; PLANE WALL; MICE; TETHERS	Most leukocytes can roll along the walls of venules at lowshear stress (1 dyn cm(-2)), but neutrophils have the ability to roll at tenfold higher shear stress in microvessels in vivo(1,2). The mechanisms involved in this shear-resistant rolling are known to involve cell flattening(3) and pulling of long membrane tethers at the rear(4-6). Here we show that these long tethers do not retract as postulated(6,7), but instead persist and appear as 'slings' at the front of rolling cells. We demonstrate slings in a model of acute inflammationin vivo and on P-selectin in vitro, where P-selectin-glycoprotein-ligand-1 (PSGL-1) is found in discrete sticky patches whereas LFA-1 is expressed over the entire length on slings. As neutrophils roll forward, slings wrap around the rolling cells and undergo a step-wise peeling from the P-selectin substrate enabled by the failure of PSGL-1 patches under hydrodynamic forces. The 'step-wise peeling of slings' is distinct from the 'pulling of tethers' reported previously(4-6,8). Each sling effectively lays out a cell-autonomous adhesive substrate in front of neutrophils rolling at high shear stress during inflammation.	[Sundd, Prithu; Koltsova, Ekaterina K.; Kuwano, Yoshihiro; Pospieszalska, Maria K.; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Gutierrez, Edgar; Groisman, Alex] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kuwano, Yoshihiro] Univ Tokyo, Dept Dermatol, Tokyo 1138655, Japan; [Fukuda, Satoru] Univ Tokyo, Lab Electron Microscopy, Tokyo 1138655, Japan	La Jolla Institute for Immunology; University of California System; University of California San Diego; University of Tokyo; University of Tokyo	Ley, K (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.	klaus@liai.org	Groisman, Alexander/AAU-7843-2021; Sawant, Kirti V/H-3778-2013		American Heart Association [11SDG7340005, 10POST4160142-01]; NIH [EB 02185]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002185] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank A. Zychlinsky for comments and reading the manuscript. This study was supported by the NCRP-Scientist Development Grant 11SDG7340005 from the American Heart Association (P. S.), WSA postdoctoral fellowship 10POST4160142-01 from American Heart Association (E. K. K.) and NIH EB 02185 (K.L.).	Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; Damiano ER, 1996, CIRC RES, V79, P1122, DOI 10.1161/01.RES.79.6.1122; Ding ZM, 1999, J IMMUNOL, V163, P5029; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Faust N, 2000, BLOOD, V96, P719; FIRRELL JC, 1989, AM J PHYSIOL, V256, pH1667, DOI 10.1152/ajpheart.1989.256.6.H1667; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P637, DOI 10.1016/0009-2509(67)80047-2; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P653, DOI 10.1016/0009-2509(67)80048-4; HATTORI R, 1989, J BIOL CHEM, V264, P7768; Hocde SA, 2009, BIOPHYS J, V97, P379, DOI 10.1016/j.bpj.2009.04.035; Huang MT, 2006, BLOOD, V107, P4721, DOI 10.1182/blood-2005-11-4683; Krasik EF, 2004, BIOPHYS J, V87, P2919, DOI 10.1529/biophysj.104.039693; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Pendl GG, 2002, BLOOD, V99, P946, DOI 10.1182/blood.V99.3.946; Pospieszalska MK, 2011, BIOPHYS J, V100, P1697, DOI 10.1016/j.bpj.2011.02.038; Pospieszalska MK, 2009, CURR TOP MEMBR, V64, P221, DOI 10.1016/S1063-5823(09)64008-4; Pospieszalska M, 2009, MICROCIRCULATION, V16, P115, DOI 10.1080/10739680802462792; Ramachandran V, 2004, P NATL ACAD SCI USA, V101, P13519, DOI 10.1073/pnas.0403608101; SCHMIDSCHONBEIN GW, 1990, CELL BIOPHYS, V17, P107, DOI 10.1007/BF02990492; Schmidtke DW, 2000, J CELL BIOL, V149, P719, DOI 10.1083/jcb.149.3.719; Shao JY, 2009, CURR TOP MEMBR, V64, P25, DOI 10.1016/S1063-5823(09)64002-3; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Sundd P, 2011, BIORHEOLOGY, V48, P1, DOI 10.3233/BIR-2011-0579; Sundd P, 2011, MICROCIRCULATION, V18, P361, DOI 10.1111/j.1549-8719.2011.00090.x; Sundd P, 2010, NAT METHODS, V7, P821, DOI [10.1038/NMETH.1508, 10.1038/nmeth.1508]; Tojo Akihiro, 2004, Medical Electron Microscopy, V37, P236, DOI 10.1007/s00795-004-0263-2; Waugh RE, 2009, CURR TOP MEMBR, V64, P3, DOI 10.1016/S1063-5823(09)64001-1; Wilcox R. R., 1987, NEW STAT PROCEDURES; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Xia LJ, 2002, J CLIN INVEST, V109, P939; Xu H, 1996, J IMMUNOL, V156, P4909; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011	39	127	127	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					399	+		10.1038/nature11248	http://dx.doi.org/10.1038/nature11248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22763437	Green Accepted			2022-12-01	WOS:000307501000046
J	Hammond, GRV; Fischer, MJ; Anderson, KE; Holdich, J; Koteci, A; Balla, T; Irvine, RF				Hammond, Gerald R. V.; Fischer, Michael J.; Anderson, Karen E.; Holdich, Jon; Koteci, Ardita; Balla, Tamas; Irvine, Robin F.			PI4P and PI(4,5)P-2 Are Essential But Independent Lipid Determinants of Membrane Identity	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; LIVING CELLS; K+ CHANNEL; PHOSPHOINOSITIDES; DOMAINS; POOLS; ACTIVATION; PROTEINS; MULTIPLE	The quantitatively minor phospholipid phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P-2] fulfills many cellular functions in the plasma membrane (PM), whereas its synthetic precursor, phosphatidylinositol 4-phosphate (PI4P), has no assigned PM roles apart from PI(4,5)P-2 synthesis. We used a combination of pharmacological and chemical genetic approaches to probe the function of PM PI4P, most of which was not required for the synthesis or functions of PI(4,5)P-2. However, depletion of both lipids was required to prevent PM targeting of proteins that interact with acidic lipids or activation of the transient receptor potential vanilloid 1 cation channel. Therefore, PI4P contributes to the pool of polyanionic lipids that define plasma membrane identity and to some functions previously attributed specifically to PI(4,5)P-2, which may be fulfilled by a more general polyanionic lipid requirement.	[Hammond, Gerald R. V.; Fischer, Michael J.; Holdich, Jon; Koteci, Ardita; Irvine, Robin F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Anderson, Karen E.] Babraham Inst, Inositide Lab, Cambridge CB22 3AT, England; [Hammond, Gerald R. V.; Balla, Tamas] NICHHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hammond, GRV (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	gerald.hammond@nih.gov; rfi20@cam.ac.uk	Hammond, Gerald R/A-5759-2016; Fischer, Michael J.M./P-8715-2014	Hammond, Gerald R/0000-0002-6660-3272; Anderson, Karen/0000-0002-7394-6660; Balla, Tamas/0000-0002-9077-3335; Fischer, Michael J.M./0000-0002-3811-7066; Koteci, Ardita/0000-0002-6074-7099	Wellcome Trust; Isaac Newton Trust; Alexander von Humboldt Foundation; UK Biotechnology and Biological Sciences Research Council; Dame Rosemary Murray Scholarship; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415] Funding Source: researchfish; BBSRC [BBS/E/B/000C0415] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dame Rosemary Murray Scholarship; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Lemmon, K. Moravcevic, D. Oliver, D. D. Saur, and L. Stephens for helpful discussions and constructs. G. R. V. H. and R. F. I. were supported by the Wellcome Trust and the Isaac Newton Trust, M.J.F. by the Alexander von Humboldt Foundation and the Isaac Newton Trust, K. E. A. by the UK Biotechnology and Biological Sciences Research Council, A. K. by a Dame Rosemary Murray Scholarship, and T. B. by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH. We thank V. Schram of the NICHD Microscopy and Imaging Core for technical assistance with fluorescence recovery after photobleaching experiments. Constructs used in this work are available from www.addgene.com.	Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	29	293	299	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					727	730		10.1126/science.1222483	http://dx.doi.org/10.1126/science.1222483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22722250	Green Accepted			2022-12-01	WOS:000307354500053
J	Liu, JG; Yang, W				Liu, Jianguo; Yang, Wu			Water Sustainability for China and Beyond	SCIENCE			English	Editorial Material							RESOURCES		[Liu, Jianguo; Yang, Wu] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA	Michigan State University	Liu, JG (corresponding author), Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	liuji@msu.edu	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087; Yang, Wu/0000-0002-1682-3349				Chen X., 2009, SANLIAN LIFE WKLY, V23, P40; Chinese Academy of Sciences, 2007, CHIN SUST DEV STRAT; Gleick P., 2008, WORLDS WATER 2008 20; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Guo F., 2011, CHINA EC WKLY, V33, P26; He DM, 2000, INT RIVERS CHINA; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; MEKONNEN M.M, 2011, NAT WAT FOOTPR ACC G; Ministry of Health of China, 2009, CHIN HLTH STAT YB 20; MWR, 2000, STAT B CHIN WAT ACT; Myint T., 2012, GOVERNING INT RIVERS; National Bureau of Statistics of China, 1985, CHIN STAT YB; National Development and Reform Commission, 2012, 12 5 YEAR PLAN DEV C; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Reynolds C. T., 2008, P WORLD ENV WAT RES, P1; Ward FA, 2008, P NATL ACAD SCI USA, V105, P18215, DOI 10.1073/pnas.0805554105; Xinhua News Agency, 2011, 400 MOR GOLF COURS H; Xinhua News Agency, 2011, INV WAT CONS CHIN RE; Yang C., 2005, WATER CONSERV EC, V23; Zhao SQ, 2006, FRONT ECOL ENVIRON, V4, P341, DOI 10.1890/1540-9295(2006)004[0341:ECORUE]2.0.CO;2	22	309	339	39	438	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					649	650		10.1126/science.1219471	http://dx.doi.org/10.1126/science.1219471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986PE	22879488				2022-12-01	WOS:000307354500025
J	Atasoy, D; Betley, JN; Su, HH; Sternson, SM				Atasoy, Deniz; Betley, J. Nicholas; Su, Helen H.; Sternson, Scott M.			Deconstruction of a neural circuit for hunger	NATURE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NEUROPEPTIDE-Y; PARABRACHIAL NUCLEUS; OXYTOCIN NEURONS; NPY/AGRP NEURONS; ARCUATE NUCLEUS; ENERGY-BALANCE; AGRP NEURONS; PROTEIN AGRP; RELEASE	Hunger is a complex behavioural state that elicits intense food seeking and consumption. These behaviours are rapidly recapitulated by activation of starvation-sensitive AGRP neurons, which present an entry point for reverse-engineering neural circuits for hunger. Here we mapped synaptic interactions of AGRP neurons with multiple cell populations in mice and probed the contribution of these distinct circuits to feeding behaviour using optogenetic and pharmacogenetic techniques. An inhibitory circuit with paraventricular hypothalamus (PVH) neurons substantially accounted for acute AGRP neuron-evoked eating, whereas two other prominent circuits were insufficient. Within the PVH, we found that AGRP neurons target and inhibit oxytocin neurons, a small population that is selectively lost in Prader-Willi syndrome, a condition involving insatiable hunger. By developing strategies for evaluating molecularly defined circuits, we show that AGRP neuron suppression of oxytocin neurons is critical for evoked feeding. These experiments reveal a new neural circuit that regulates hunger state and pathways associated with overeating disorders.	[Atasoy, Deniz; Betley, J. Nicholas; Su, Helen H.; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org	Atasoy, Deniz/AAR-7917-2020; Atasoy, Deniz/B-3414-2018	Atasoy, Deniz/0000-0002-3325-8820; Sternson, Scott/0000-0002-0835-444X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This research was funded by the Howard Hughes Medical Institute. We thank J. Cox, A. Wardlaw, K. Morris for mouse breeding, genotyping, and viral injection support; S. Michael and A. Hu for histology support; M. Ramirez and B. Zemelman for rAAV production; H. Gainer for discussions about the oxytocin promoter; and E. Boyden for technical assistance.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; ARLETTI R, 1990, PHYSIOL BEHAV, V48, P825, DOI 10.1016/0031-9384(90)90234-U; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baskin DG, 2010, ENDOCRINOLOGY, V151, P4207, DOI 10.1210/en.2010-0295; Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Blevins JE, 2003, BRAIN RES, V993, P30, DOI 10.1016/j.brainres.2003.08.036; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Cannon W.B., 1939, WISDOM BODY, DOI [10.1097/00000441-193907000-00031, DOI 10.1097/00000441-193907000-00031]; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dicken MS, 2012, J NEUROSCI, V32, P4042, DOI 10.1523/JNEUROSCI.6032-11.2012; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Fields RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032085; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Higgs S, 1996, EUR J PHARMACOL, V313, P1, DOI 10.1016/0014-2999(96)00446-3; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Holder JL, 2000, HUM MOL GENET, V9, P101; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; KELLY J, 1979, PHYSIOL BEHAV, V23, P1123, DOI 10.1016/0031-9384(79)90306-8; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; LEIBOWITZ SF, 1981, PHYSIOL BEHAV, V27, P1031, DOI 10.1016/0031-9384(81)90366-8; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Peng HC, 2010, BIOINFORMATICS, V26, pi38, DOI 10.1093/bioinformatics/btq212; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; SWAAB DF, 1995, J CLIN ENDOCR METAB, V80, P573, DOI 10.1210/jcem.80.2.7852523; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1980, BRAIN RES, V198, P190, DOI 10.1016/0006-8993(80)90354-6; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Traurig M, 2009, DIABETES, V58, P1682, DOI 10.2337/db09-0028; Wieland HA, 1998, BRIT J PHARMACOL, V125, P549, DOI 10.1038/sj.bjp.0702084; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036453; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Young WS, 1999, J NEUROENDOCRINOL, V11, P935; Zhang G, 2011, NEURON, V69, P523, DOI 10.1016/j.neuron.2010.12.036; Zhang M, 2003, BEHAV NEUROSCI, V117, P202, DOI 10.1037/0735-7044.117.2.202	53	581	594	4	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					172	+		10.1038/nature11270	http://dx.doi.org/10.1038/nature11270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22801496	Green Accepted			2022-12-01	WOS:000307267000025
J	Schuur, JD; Venkatesh, AK				Schuur, Jeremiah D.; Venkatesh, Arjun K.			The Growing Role of Emergency Departments in Hospital Admissions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schuur, Jeremiah D.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Venkatesh, Arjun K.] Massachusetts Gen Hosp, Brigham & Womens Hosp, Harvard Affiliated Emergency Med Residency Progra, Boston, MA 02114 USA; [Schuur, Jeremiah D.; Venkatesh, Arjun K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Schuur, JD (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.							Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; BEAL AC, 2007, CLOSING DIVIDE MED H; Newton MF, 2008, JAMA-J AM MED ASSOC, V300, P1914, DOI 10.1001/jama.300.16.1914; Pitts SR, 2010, HEALTH AFFAIR, V29, P1620, DOI 10.1377/hlthaff.2009.1026; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112	5	252	253	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					391	393		10.1056/NEJMp1204431	http://dx.doi.org/10.1056/NEJMp1204431			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981VZ	22784039				2022-12-01	WOS:000307001900002
J	Yu, M; Ting, DT; Stott, SL; Wittner, BS; Ozsolak, F; Paul, S; Ciciliano, JC; Smas, ME; Winokur, D; Gilman, AJ; Ulman, MJ; Xega, K; Contino, G; Alagesan, B; Brannigan, BW; Milos, PM; Ryan, DP; Sequist, LV; Bardeesy, N; Ramaswamy, S; Toner, M; Maheswaran, S; Haber, DA				Yu, Min; Ting, David T.; Stott, Shannon L.; Wittner, Ben S.; Ozsolak, Fatih; Paul, Suchismita; Ciciliano, Jordan C.; Smas, Malgorzata E.; Winokur, Daniel; Gilman, Anna J.; Ulman, Matthew J.; Xega, Kristina; Contino, Gianmarco; Alagesan, Brinda; Brannigan, Brian W.; Milos, Patrice M.; Ryan, David P.; Sequist, Lecia V.; Bardeesy, Nabeel; Ramaswamy, Sridhar; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel A.			RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis	NATURE			English	Article							STEM-CELL; TRANSCRIPTOME; PATHWAY	Circulating tumour cells (CTCs) shed into blood from primary cancers include putative precursors that initiate distal metastases(1). Although these cells are extraordinarily rare, they may identify cellular pathways contributing to the blood-borne dissemination of cancer. Here, we adapted a microfluidic device(2) for efficient capture of CTCs from an endogenous mouse pancreatic cancer model(3) and subjected CTCs to single-molecule RNA sequencing(4), identifying Wnt2 as a candidate gene enriched in CTCs. Expression of WNT2 in pancreatic cancer cells suppresses anoikis, enhances anchorage-independent sphere formation, and increases metastatic propensity in vivo. This effect is correlated with fibronectin upregulation and suppressed by inhibition of MAP3K7 (also known as TAK1) kinase. In humans, formation of non-adherent tumour spheres by pancreatic cancer cells is associated with upregulation of multiple WNT genes, and pancreatic CTCs revealed enrichment for WNT signalling in 5 out of 11 cases. Thus, molecular analysis of CTCs may identify candidate therapeutic targets to prevent the distal spread of cancer.	[Yu, Min; Ting, David T.; Stott, Shannon L.; Wittner, Ben S.; Paul, Suchismita; Ciciliano, Jordan C.; Smas, Malgorzata E.; Winokur, Daniel; Gilman, Anna J.; Ulman, Matthew J.; Xega, Kristina; Contino, Gianmarco; Alagesan, Brinda; Brannigan, Brian W.; Ryan, David P.; Sequist, Lecia V.; Bardeesy, Nabeel; Ramaswamy, Sridhar; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Ctr Engn Med, Boston, MA 02114 USA; [Yu, Min; Ting, David T.; Stott, Shannon L.; Wittner, Ben S.; Paul, Suchismita; Ciciliano, Jordan C.; Smas, Malgorzata E.; Winokur, Daniel; Gilman, Anna J.; Ulman, Matthew J.; Xega, Kristina; Contino, Gianmarco; Alagesan, Brinda; Brannigan, Brian W.; Ryan, David P.; Sequist, Lecia V.; Bardeesy, Nabeel; Ramaswamy, Sridhar; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Yu, Min; Ting, David T.; Stott, Shannon L.; Wittner, Ben S.; Paul, Suchismita; Ciciliano, Jordan C.; Smas, Malgorzata E.; Winokur, Daniel; Gilman, Anna J.; Ulman, Matthew J.; Xega, Kristina; Contino, Gianmarco; Alagesan, Brinda; Brannigan, Brian W.; Ryan, David P.; Sequist, Lecia V.; Bardeesy, Nabeel; Ramaswamy, Sridhar; Toner, Mehmet; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02114 USA; [Yu, Min; Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ozsolak, Fatih; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Maheswaran, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Ctr Engn Med, Boston, MA 02114 USA.	maheswaran@helix.mgh.harvard.edu; haber@helix.mgh.harvard.edu	Stott, Shannon L./AAC-5311-2019; Ting, David/F-4389-2017	Contino, Gianmarco/0000-0001-5874-0405; Yu, Min/0000-0002-3969-8720; Ting, David/0000-0002-3261-2322	Stand Up To Cancer; Howard Hughes Medical Institute; NIBIB [5R01EB008047]; NIH [CA129933]; Pancreatic Cancer Action Network - AACR Fellowship; Warshaw Institute for Pancreatic Cancer Research; K12 Paul Calabresi Award for Clinical Oncology Clinical Research Career Development Program NIH [5K12CA87723-09]; NATIONAL CANCER INSTITUTE [R01CA129933, K12CA087723, P01CA117969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008047, U01EB012493] Funding Source: NIH RePORTER	Stand Up To Cancer; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Action Network - AACR Fellowship; Warshaw Institute for Pancreatic Cancer Research; K12 Paul Calabresi Award for Clinical Oncology Clinical Research Career Development Program NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank C. Koris and the MGH clinical research coordinators for help with clinical studies, J. Gentry for computer informatics support, L. Libby for mouse studies, J. Walsh for microscopy expertise, Z. Nakamura for technical support, D. Jones for sequencing, and M. Rivera and S. Akhavanfard for RNA-ISH. This work was supported by Stand Up To Cancer (D. A. H., M. T., S. M.), Howard Hughes Medical Institute (D. A. H.), NIBIB Quantum Grant 5R01EB008047 (M. T.), NIH CA129933 (D. A. H.), Pancreatic Cancer Action Network - AACR Fellowship (D. T. T.), the Warshaw Institute for Pancreatic Cancer Research (D. T. T.), and the K12 Paul Calabresi Award for Clinical Oncology Clinical Research Career Development Program NIH 5K12CA87723-09 (D.T.T.).	Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bowers J, 2009, NAT METHODS, V6, P593, DOI 10.1038/nmeth.1354; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Ozsolak F, 2010, NAT METHODS, V7, P619, DOI [10.1038/NMETH.1480, 10.1038/nmeth.1480]; Ozsolak F, 2010, GENOME RES, V20, P519, DOI 10.1101/gr.102129.109; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	14	373	396	5	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					510	U130		10.1038/nature11217	http://dx.doi.org/10.1038/nature11217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22763454	Green Submitted, Green Accepted			2022-12-01	WOS:000306815300044
J	Chisty, A				Chisty, Alia			Forever Young	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chisty, A (corresponding author), Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA.	alia.chisty@ucsfmedctr.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2012	308	4					351	352		10.1001/jama.2012.8883	http://dx.doi.org/10.1001/jama.2012.8883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977SR	22820787				2022-12-01	WOS:000306685500022
J	Carey, R; Harber, M				Carey, Renata; Harber, Mark			Kidney dialysis-the need for humanity	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Harber, Mark] Royal Free Hosp, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Harber, M (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.	mark.harber@nhs.net							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 19	2012	345								e4492	10.1136/bmj.e4492	http://dx.doi.org/10.1136/bmj.e4492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MA	22815428	Bronze			2022-12-01	WOS:000306744300003
J	Lim, BK; Huang, KW; Grueter, BA; Rothwell, PE; Malenka, RC				Lim, Byung Kook; Huang, Kee Wui; Grueter, Brad A.; Rothwell, Patrick E.; Malenka, Robert C.			Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens	NATURE			English	Article							LONG-TERM DEPRESSION; CONDITIONED PLACE PREFERENCE; DISTINCT ROLES; RECEPTOR; EXPRESSION; NEURONS; PLASTICITY; PATHWAYS; CIRCUIT; REWARD	Chronic stress is a strong diathesis for depression in humans and is used to generate animal models of depression. It commonly leads to several major symptoms of depression, including dysregulated feeding behaviour, anhedonia and behavioural despair. Although hypotheses defining the neural pathophysiology of depression have been proposed, the critical synaptic adaptations in key brain circuits that mediate stress-induced depressive symptoms remain poorly understood. Here we show that chronic stress in mice decreases the strength of excitatory synapses on D1 dopamine receptor-expressing nucleus accumbens medium spiny neurons owing to activation of the melanocortin 4 receptor. Stress-elicited increases in behavioural measurements of anhedonia, but not increases in measurements of behavioural despair, are prevented by blocking these melanocortin 4 receptor-mediated synaptic changes in vivo. These results establish that stress-elicited anhedonia requires a neuropeptide-triggered, cell-type-specific synaptic adaptation in the nucleus accumbens and that distinct circuit adaptations mediate other major symptoms of stress-elicited depression.	[Lim, Byung Kook; Huang, Kee Wui; Grueter, Brad A.; Rothwell, Patrick E.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu		Rothwell, Patrick/0000-0003-0514-2510; Grueter, Brad/0000-0002-4224-3866; Lim, Byungkook/0000-0002-3766-5415	Davis Foundation Postdoctoral Fellowship in Eating Disorders Research; National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH096491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	Davis Foundation Postdoctoral Fellowship in Eating Disorders Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Kauer, D. Lyons and members of the Malenka laboratory for comments. The rabies virus complementary DNA plasmid and viral component-expressing plasmids were gifts from K. Conzelmann and I. Wickersham. BAC transgenic mice were provided by N. Calakos. BHK-B19G cells were a gift from E. Callaway. The AAVs used in this study were produced by the Stanford Neuroscience Gene Vector and Virus Core. The AAV-DJ helper plasmid was a gift from M. Kay. B. K. L. is supported by a Davis Foundation Postdoctoral Fellowship in Eating Disorders Research. We acknowledge funding from the National Institutes of Health (R.C.M.).	Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Chaki S, 2005, PEPTIDES, V26, P1952, DOI 10.1016/j.peptides.2004.11.029; Chaki S, 2003, EUR J PHARMACOL, V474, P95, DOI 10.1016/S0014-2999(03)02033-8; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Heusner CL, 2005, J NEUROSCI, V25, P6651, DOI 10.1523/JNEUROSCI.1474-05.2005; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hsu R, 2005, EUR J NEUROSCI, V21, P2233, DOI 10.1111/j.1460-9568.2005.04038.x; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Liu J, 2007, ENDOCRINOLOGY, V148, P5531, DOI 10.1210/en.2007-0745; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; Porsolt R. D., 2001, CURR PROTOC NEUROSCI, V14, p10A1; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Wolfart J, 2001, J NEUROSCI, V21, P3443, DOI 10.1523/JNEUROSCI.21-10-03443.2001; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Yang YK, 2011, EUR J PHARMACOL, V660, P125, DOI 10.1016/j.ejphar.2010.12.020	46	239	246	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					183	U64		10.1038/nature11160	http://dx.doi.org/10.1038/nature11160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22785313	Green Accepted			2022-12-01	WOS:000306278900029
J	Raymond, B; West, SA; Griffin, AS; Bonsall, MB				Raymond, Ben; West, Stuart A.; Griffin, Ashleigh S.; Bonsall, Michael B.			The Dynamics of Cooperative Bacterial Virulence in the Field	SCIENCE			English	Article							SOCIAL EVOLUTION; POPULATIONS; CONFLICT; COMPETITION; PARASITES; AMEBA; HOST	Laboratory experiments have shown that the fitness of microorganisms can depend on cooperation between cells. Although this insight has revolutionized our understanding of microbial life, results from artificial microcosms have not been validated in complex natural populations. We investigated the sociality of essential virulence factors (crystal toxins) in the pathogen Bacillus thuringiensis using diamondback moth larvae (Plutella xylostella) as hosts. We show that toxin production is cooperative, and in a manipulative field experiment, we observed persistent high relatedness and frequency-and density-dependent selection, which favor stable cooperation. Conditions favoring social virulence can therefore persist in the face of natural population processes, and social interactions (rapid cheat invasion) may account for the rarity of natural disease outbreaks caused by B. thuringiensis.	[Raymond, Ben] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [West, Stuart A.; Griffin, Ashleigh S.; Bonsall, Michael B.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Bonsall, Michael B.] St Peters Coll, Oxford OX1 2DL, England	University of London; Royal Holloway University London; University of Oxford; University of Oxford	Raymond, B (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	ben.raymond@rhul.ac.uk	West, Stuart A/M-3608-2014; Raymond, Ben/F-5872-2011; Griffin, Ashleigh/C-6244-2014	West, Stuart A/0000-0003-2152-3153; Griffin, Ashleigh/0000-0001-7674-9825; Bonsall, Michael/0000-0003-0250-0423	Natural Environment Research Fellowship award; Biotechnology and Biological Sciences Research Council [BBC 5127021]; European Research Council; Royal Society; NERC [NE/E012671/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C512702/1] Funding Source: researchfish; Natural Environment Research Council [NE/E012671/2] Funding Source: researchfish	Natural Environment Research Fellowship award; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Raw field data are available in the supplementary materials. This work was supported by a Natural Environment Research Fellowship award (to B.R.), the Biotechnology and Biological Sciences Research Council (grant no. BBC 5127021), the European Research Council, and the Royal Society. The authors declare no conflicts of interest.	AGAISSE H, 1995, J BACTERIOL, V177, P6027, DOI 10.1128/jb.177.21.6027-6032.1995; Brockhurst MA, 2006, CURR BIOL, V16, P2030, DOI 10.1016/j.cub.2006.08.068; Brown SP, 1999, P ROY SOC B-BIOL SCI, V266, P1899, DOI 10.1098/rspb.1999.0864; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Collier FA, 2005, FEMS MICROBIOL ECOL, V54, P417, DOI 10.1016/j.femsec.2005.05.005; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; MYERS JH, 1988, ADV ECOL RES, V18, P179; Porcar M, 2000, J APPL MICROBIOL, V89, P309, DOI 10.1046/j.1365-2672.2000.01115.x; Prescott L. M., 2002, MICROBIOLOGY, P5; Raymond B, 2008, J INVERTEBR PATHOL, V98, P307, DOI 10.1016/j.jip.2008.01.005; Raymond B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000905; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Ross-Gillespie A, 2007, AM NAT, V170, P331, DOI 10.1086/519860; Rumbaugh KP, 2009, CURR BIOL, V19, P341, DOI 10.1016/j.cub.2009.01.050; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	29	83	83	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2012	337	6090					85	88		10.1126/science.1218196	http://dx.doi.org/10.1126/science.1218196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22767928				2022-12-01	WOS:000306053100049
J	Devkota, S; Wang, YW; Musch, MW; Leone, V; Fehlner-Peach, H; Nadimpalli, A; Antonopoulos, DA; Jabri, B; Chang, EB				Devkota, Suzanne; Wang, Yunwei; Musch, Mark W.; Leone, Vanessa; Fehlner-Peach, Hannah; Nadimpalli, Anuradha; Antonopoulos, Dionysios A.; Jabri, Bana; Chang, Eugene B.			Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10(-/-) mice	NATURE			English	Article							SULFATE-REDUCING BACTERIA; CONJUGATED BILE-ACIDS; BILOPHILA-WADSWORTHIA; HYDROGEN-SULFIDE; HEALTHY; MICROBIOTA; SPECIMENS; DISEASES; CULTURE; LIVER	The composite human microbiome of Western populations has probably changed over the past century, brought on by new environmental triggers that often have a negative impact on human health(1). Here we show that consumption of a diet high in saturated (milk-derived) fat, but not polyunsaturated (safflower oil) fat, changes the conditions for microbial assemblage and promotes the expansion of a low-abundance, sulphite-reducing pathobiont, Bilophila wadsworthia(2). This was associated with a pro-inflammatory T helper type 1 (T(H)1) immune response and increased incidence of colitis in genetically susceptible Il10(-/-), but not wild-type mice. These effects are mediated by milk-derived-fat-promoted taurine conjugation of hepatic bile acids, which increases the availability of organic sulphur used by sulphite-reducing microorganisms like B. wadsworthia. When mice were fed a low-fat diet supplemented with taurocholic acid, but not with glycocholic acid, for example, a bloom of B. wadsworthia and development of colitis were observed in Il10(-/-) mice. Together these data show that dietary fats, by promoting changes in host bile acid composition, can markedly alter conditions for gut microbial assemblage, resulting in dysbiosis that can perturb immune homeostasis. The data provide a plausible mechanistic basis by which Western-type diets high in certain saturated fats might increase the prevalence of complex immune-mediated diseases like inflammatory bowel disease in genetically susceptible hosts.	[Devkota, Suzanne; Wang, Yunwei; Musch, Mark W.; Leone, Vanessa; Fehlner-Peach, Hannah; Nadimpalli, Anuradha; Jabri, Bana; Chang, Eugene B.] Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, Gastroenterol Sect, Chicago, IL 60637 USA; [Antonopoulos, Dionysios A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Chang, EB (corresponding author), Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, Gastroenterol Sect, 900 E 57th St, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu	Antonopoulos, Dionysios/ABE-6212-2020; Devkota, Suzanne/AAG-1958-2021	Antonopoulos, Dionysios/0000-0002-2238-5031; Devkota, Suzanne/0000-0001-5575-9362	National Center for Research Resources; NIDDK of the National Institutes of Health; NIGMS of the National Institutes of Health; NCCAM of the National Institutes of Health [DK-42086, DK47722, UH3DK083993, F31AT006073]; Gastrointestinal Research Foundation; Crohns and Colitis Foundation of America; Peter and Carol Goldman Family Research Fund; Harry and Leona Helmsley Trust Foundation (SHARE); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT006073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047722, UH3DK083993, P30DK042086, R01DK047722, T32DK007074, R01DK097268] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCCAM of the National Institutes of Health; Gastrointestinal Research Foundation; Crohns and Colitis Foundation of America; Peter and Carol Goldman Family Research Fund; Harry and Leona Helmsley Trust Foundation (SHARE); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Center for Research Resources and the NIDDK, NIGMS and NCCAM of the National Institutes of Health through grant number DK-42086 (E. B. C.), DK47722 (E. B. C.), UH3DK083993 (E. B. C.), F31AT006073 (S. D.). Also, the Gastrointestinal Research Foundation, Crohns and Colitis Foundation of America (Y.W.), the Peter and Carol Goldman Family Research Fund, and the Harry and Leona Helmsley Trust Foundation (SHARE). We are also indebted to S. Finegold for his suggestions on successful culture of B. wadsworthia and Alistipes, J. Tiedje and M. Vital for dsrA primer sequences, L. Hagey for mass spectrometry, E. Huang, B. Theriault and J. Stencel for assistance with experiments, and R. Bouziat for T-cell purification.	Ananieva O, 2002, CLIN DIAGN LAB IMMUN, V9, P1160, DOI 10.1128/CDLI.9.6.1160-1164.2002; Arzese A, 1997, ANAEROBE, V3, P219, DOI 10.1006/anae.1997.0076; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Baron EJ, 1997, ANAEROBE, V3, P83, DOI 10.1006/anae.1997.0075; BARON EJ, 1989, J GEN MICROBIOL, V135, P3405; BARON EJ, 1992, J CLIN MICROBIOL, V30, P1882, DOI 10.1128/JCM.30.7.1882-1884.1992; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x; GRAHAM TO, 1979, AM J PHYSIOL, V237, pE177, DOI 10.1152/ajpendo.1979.237.2.E177; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Laue H, 1997, APPL ENVIRON MICROB, V63, P2016, DOI 10.1128/AEM.63.5.2016-2021.1997; LINDSTEDT S, 1965, J CLIN INVEST, V44, P1754, DOI 10.1172/JCI105283; Loubinoux J, 2002, FEMS MICROBIOL ECOL, V40, P107, DOI 10.1111/j.1574-6941.2002.tb00942.x; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; NHANES, 2004, TRENDS INT EN MACR U; ROSSI SS, 1987, J LIPID RES, V28, P589; Rowan FE, 2009, BRIT J SURG, V96, P151, DOI 10.1002/bjs.6454; Rueda A, 1996, ARCH PHYSIOL BIOCHEM, V104, P246, DOI 10.1076/apab.104.2.246.12884; Scanlan PD, 2009, FEMS MICROBIOL ECOL, V69, P213, DOI 10.1111/j.1574-6941.2009.00709.x; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang YY, 2010, RES J BIOTECHNOL, V5, P5; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zinkevich V, 2000, FEMS MICROBIOL ECOL, V34, P147, DOI 10.1111/j.1574-6941.2000.tb00764.x	26	1130	1175	14	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					104	+		10.1038/nature11225	http://dx.doi.org/10.1038/nature11225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722865	Green Accepted, Green Submitted			2022-12-01	WOS:000305982900059
J	Behie, SW; Zelisko, PM; Bidochka, MJ				Behie, S. W.; Zelisko, P. M.; Bidochka, M. J.			Endophytic Insect-Parasitic Fungi Translocate Nitrogen Directly from Insects to Plants	SCIENCE			English	Article							COLONIZATION	Most plants obtain nitrogen through nitrogen-fixing bacteria and microbial decomposition of plant and animal material. Many vascular plants are able to form close symbiotic associations with endophytic fungi. Metarhizium is a common plant endophyte found in a large number of ecosystems. This abundant soil fungus is also a pathogen to a large number of insects, which are a source of nitrogen. It is possible that the endophytic capability and insect pathogenicity of Metarhizium are coupled to provide an active method of nitrogen transfer to plant hosts via fungal mycelia. We used soil microcosms to test the ability of M. robertsii to translocate insect-derived nitrogen to plants. Insects were injected with N-15-labeled nitrogen, and we tracked the incorporation of N-15 into amino acids in two plant species, haricot bean (Phaseolus vulgaris) and switchgrass (Panicum virgatum), in the presence of M. robertsii. These findings are evidence that active nitrogen acquisition by plants in this tripartite interaction may play a larger role in soil nitrogen cycling than previously thought.	[Behie, S. W.; Bidochka, M. J.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Zelisko, P. M.] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada	Brock University; Brock University	Bidochka, MJ (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	mbidochka@brocku.ca	Zelisko, Paul/K-2101-2016	Zelisko, Paul/0000-0002-3770-2562; Bidochka, Michael/0000-0002-2544-9977	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (M.J.B.). We thank M. K. Bidochka for Fig. 2.	BUSCHENA CA, 1992, CAN J FOREST RES, V22, P1883, DOI 10.1139/x92-246; Cocking EC, 2003, PLANT SOIL, V252, P169, DOI 10.1023/A:1024106605806; Fang WG, 2010, PLANT PHYSIOL, V154, P1549, DOI 10.1104/pp.110.163014; Galloway JN, 1998, ENVIRON POLLUT, V102, P15, DOI 10.1016/S0269-7491(98)80010-9; Klironomos JN, 2001, NATURE, V410, P651, DOI 10.1038/35070643; Milner R.J., 1991, BIOL CONTROL LOCUSTS, P200; RICHTER DL, 1993, SOIL BIOL BIOCHEM, V25, P355, DOI 10.1016/0038-0717(93)90135-X; Roberts D. W., 1992, Frontiers in industrial mycology, P144; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Schulze W, 2001, J EXP BOT, V52, P1041, DOI 10.1093/jexbot/52.358.1041; Scully LR, 2005, CAN J MICROBIOL, V51, P185, DOI 10.1139/W04-124; St Leger Raymond, 1993, P211; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0	14	235	247	24	538	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1576	1577		10.1126/science.1222289	http://dx.doi.org/10.1126/science.1222289			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723421				2022-12-01	WOS:000305507500056
J	Russell, CA; Fonville, JM; Brown, AEX; Burke, DF; Smith, DL; James, SL; Herfst, S; van Boheemen, S; Linster, M; Schrauwen, EJ; Katzelnick, L; Mosterin, A; Kuiken, T; Maher, E; Neumann, G; Osterhaus, ADME; Kawaoka, Y; Fouchier, RAM; Smith, DJ				Russell, Colin A.; Fonville, Judith M.; Brown, Andre E. X.; Burke, David F.; Smith, David L.; James, Sarah L.; Herfst, Sander; van Boheemen, Sander; Linster, Martin; Schrauwen, Eefje J.; Katzelnick, Leah; Mosterin, Ana; Kuiken, Thijs; Maher, Eileen; Neumann, Gabriele; Osterhaus, Albert D. M. E.; Kawaoka, Yoshihiro; Fouchier, Ron A. M.; Smith, Derek J.			The Potential for Respiratory Droplet-Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host	SCIENCE			English	Article							A VIRUSES; H5N1; MODEL; REPLICATION; DYNAMICS	Avian A/H5N1 influenza viruses pose a pandemic threat. As few as five amino acid substitutions, or four with reassortment, might be sufficient for mammal-to-mammal transmission through respiratory droplets. From surveillance data, we found that two of these substitutions are common in A/H5N1 viruses, and thus, some viruses might require only three additional substitutions to become transmissible via respiratory droplets between mammals. We used a mathematical model of within-host virus evolution to study factors that could increase and decrease the probability of the remaining substitutions evolving after the virus has infected a mammalian host. These factors, combined with the presence of some of these substitutions in circulating strains, make a virus evolving in nature a potentially serious threat. These results highlight critical areas in which more data are needed for assessing, and potentially averting, this threat.	[Russell, Colin A.; Fonville, Judith M.; Burke, David F.; James, Sarah L.; Katzelnick, Leah; Mosterin, Ana; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Russell, Colin A.; Fonville, Judith M.; Burke, David F.; James, Sarah L.; Katzelnick, Leah; Mosterin, Ana; Smith, Derek J.] World Hlth Org WHO Collaborating Ctr Modeling Evo, Cambridge CB2 3EJ, England; [Russell, Colin A.; Smith, David L.; Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Brown, Andre E. X.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Herfst, Sander; van Boheemen, Sander; Linster, Martin; Schrauwen, Eefje J.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Smith, Derek J.] Erasmus MC, Dept Virol, NL-3015 CE Rotterdam, Netherlands; [Mosterin, Ana] Univ Pompeu Fabra, Ctr Res Hlth & Econ, Barcelona 08005, Spain; [Maher, Eileen; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO Infect Induced, Saitama 1020076, Japan	University of Cambridge; World Health Organization; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); MRC Laboratory Molecular Biology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Erasmus University Rotterdam; Erasmus MC; Pompeu Fabra University; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk	Smith, David L/L-8850-2013; Burke, David F/C-2091-2013; Smith, Derek/Z-3075-2019; Linster, Martin/AAY-9088-2020; Fouchier, Ron A/A-1911-2014; Russell, Colin/ABE-7106-2020	Smith, David L/0000-0003-4367-3849; Burke, David F/0000-0001-8830-3951; Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Herfst, Sander/0000-0001-9866-8903; Linster, Martin/0000-0003-2636-2512; Russell, Colin/0000-0002-2113-162X; Brown, Andre/0000-0002-1324-8764; James, Sarah/0000-0002-6969-1167; Osterhaus, Albert/0000-0002-6074-1172; Kuiken, Thijs/0000-0001-5501-9049	University Research Fellowship from the Royal Society; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VICI grant; European Union (EU) FP7 program EMPERIE [223498]; European Union (EU) FP7 program ANTIGONE [278976]; Human Frontier Science Program (HFSP) program [P0050/2008]; Wellcome [087982AIA]; Bill and Melinda Gates Foundation [OPPGH5383]; NIH Director's Pioneer Award [DP1-OD000490-01]; National Institute of Allergy and Infectious Diseases (NIAID)-NIH [HHSN266200700010C.]; NIAID-NIH [R01 AI 069274]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; ERATO; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069274, R01AI069274] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	University Research Fellowship from the Royal Society(Royal Society of London); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VICI grant(Netherlands Organization for Scientific Research (NWO)); European Union (EU) FP7 program EMPERIE; European Union (EU) FP7 program ANTIGONE; Human Frontier Science Program (HFSP) program; Wellcome; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C.A.R. was supported by a University Research Fellowship from the Royal Society. The authors acknowledge an Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VICI grant, European Union (EU) FP7 programs EMPERIE (223498) and ANTIGONE (278976), Human Frontier Science Program (HFSP) program grant P0050/2008, Wellcome 087982AIA, the Bill and Melinda Gates Foundation (OPPGH5383), and NIH Director's Pioneer Award DP1-OD000490-01. R. A. M. F was supported by National Institute of Allergy and Infectious Diseases (NIAID)-NIH contract HHSN266200700010C. A. E. X. B. was supported by a long-term fellowship from the HFSP. E. M., G.N., and Y.K. are supported by the Bill and Melinda Gates Foundation (OPPGH5383) and NIAID-NIH grant R01 AI 069274; in addition, Y.K. was supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by ERATO. Y.K. and G.N. have a financial interest as founders of FluGen and hold a patent on influenza virus reverse genetics. Y.K and G.N. have a paid consulting relationship with Theraclone; Y.K. also has a paid consulting relationship with Crucell. Y.K. has received speaker's honoraria from Chugai Pharmaceuticals, Novartis, Daiichi-Sankyo Pharmaceutical, Toyama Chemical, Wyeth, GlaxoSmithKline, and Astellas and grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Otsuka Pharmaceutical Company A.D.M.E.O. (on behalf of Viroclinics Biosciences BV) has advisory affiliations with GlaxoSmithKline, Novartis, and Roche. A.D.M.E.O. is Chief Scientific Officer of Viroclinics Biosciences BV. We thank S. Cornell, E. Ghedin, R. Johnstone, L. Reperant, and D. M. Smith for helpful discussions and the reviewers for their detailed and thoughtful comments.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aditama TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029971; Anton A, 2010, DIAGN MICR INFEC DIS, V68, P214, DOI 10.1016/j.diagmicrobio.2010.08.003; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Bahl J., 2012, INFLUENZA OTHER RESP, V6, P1; Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lednicky JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-231; Luria SE, 1943, GENETICS, V28, P491; Mode CJ, 2011, J PROBAB STAT, V2011, DOI 10.1155/2011/867493; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Murcia PR, 2010, J VIROL, V84, P6943, DOI 10.1128/JVI.00112-10; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Ord T, 2010, J RISK RES, V13, P191, DOI 10.1080/13669870903126267; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qi X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004682; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Sidorenko Y, 2004, BIOTECHNOL BIOENG, V88, P1, DOI 10.1002/bit.20096; Spiegelhalter DJ, 2011, PHILOS T R SOC A, V369, P4730, DOI 10.1098/rsta.2011.0163; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; WAINHOBSON S, 1993, CURR OPIN GENET DEV, V3, P878, DOI 10.1016/0959-437X(93)90008-D; WEIBEL ER, 1979, B EUR PHYSIOPATH RES, V15, P999; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111; Zwickl DJ, 2006, THESIS U TEXAS	37	232	248	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1541	1547		10.1126/science.1222526	http://dx.doi.org/10.1126/science.1222526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723414	Green Accepted			2022-12-01	WOS:000305507500048
J	Zullo, JM; Demarco, IA; Pique-Regi, R; Gaffney, DJ; Epstein, CB; Spooner, CJ; Luperchio, TR; Bernstein, BE; Pritchard, JK; Reddy, KL; Singh, H				Zullo, Joseph M.; Demarco, Ignacio A.; Pique-Regi, Roger; Gaffney, Daniel J.; Epstein, Charles B.; Spooner, Chauncey J.; Luperchio, Teresa R.; Bernstein, Bradley E.; Pritchard, Jonathan K.; Reddy, Karen L.; Singh, Harinder			DNA Sequence-Dependent Compartmentalization and Silencing of Chromatin at the Nuclear Lamina	CELL			English	Article							TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; GENE-EXPRESSION; GAGA FACTOR; PERIPHERY; PROTEIN; ORGANIZATION; LOCUS; DEACETYLATION; MAINTENANCE	A large fraction of the mammalian genome is organized into inactive chromosomal domains along the nuclear lamina. The mechanism by which these lamina associated domains (LADs) are established remains to be elucidated. Using genomic repositioning assays, we show that LADs, spanning the developmentally regulated IgH and Cyp3a loci contain discrete DNA regions that associate chromatin with the nuclear lamina and repress gene activity in fibroblasts. Lamina interaction is established during mitosis and likely involves the localized recruitment of Lamin B during late anaphase. Fine-scale mapping of LADs reveals numerous lamina-associating sequences (LASs), which are enriched for a GAGA motif. This repeated motif directs lamina association and is bound by the transcriptional repressor cKrox, in a complex with HDAC3 and Lap2 beta. Knockdown of cKrox or HDAC3 results in dissociation of LASs/LADs from the nuclear lamina. These results reveal a mechanism that couples nuclear compartmentalization of chromatin domains with the control of gene activity.	[Zullo, Joseph M.; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Pique-Regi, Roger; Gaffney, Daniel J.; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Demarco, Ignacio A.; Spooner, Chauncey J.; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Pique-Regi, Roger; Gaffney, Daniel J.; Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Epstein, Charles B.; Bernstein, Bradley E.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Epstein, Charles B.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Epstein, Charles B.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Luperchio, Teresa R.; Reddy, Karen L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Epigenet, Baltimore, MD 21205 USA	University of Chicago; University of Chicago; Roche Holding; Genentech; Howard Hughes Medical Institute; University of Chicago; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University	Singh, H (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	harindsi@gene.com	Pique-Regi, Roger/A-4110-2009	Pique-Regi, Roger/0000-0002-1262-2275; Gaffney, Daniel/0000-0002-1529-1862; Epstein, Charles B./0000-0001-8358-8345; Reddy, Karen/0000-0003-4548-5999; Luperchio, Teresa/0000-0001-8586-3101	NIH [GM086213]; Cancer Research Institute; Howard Hughes Medical Institute; Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, R01GM086213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the University of Chicago Functional Genomics Facility for genome-wide expression and DamID analyses. We thank Lazlo Komuves and Allison Bruce at Genentech for assistance with confocal imaging and graphics art, respectively. We are grateful to members of the Singh laboratory for critical input. J.M.Z. was supported by an NIH training grant. I. A. D. acknowledges support by the Cancer Research Institute. H. S. acknowledges support by the Howard Hughes Medical Institute and the Chicago Biomedical Consortium and from NIH GM086213. H. S. and C.J.S. are employees of Genentech Inc.	Adkins NL, 2006, BIOCHEM CELL BIOL, V84, P559, DOI 10.1139/O06-062; Ahmed S, 2010, NAT CELL BIOL, V12, P111, DOI 10.1038/ncb2011; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Bhat KM, 1996, DEVELOPMENT, V122, P1113; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; de Nooijer S, 2009, NUCLEIC ACIDS RES, V37, P3558, DOI 10.1093/nar/gkp219; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; He X., 2008, ANNU REV IMMUNOL, V28, P295; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Li Y, 2009, MOL PHARMACOL, V75, P1171, DOI 10.1124/mol.108.052993; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Matharu NK, 2010, J MOL BIOL, V400, P434, DOI 10.1016/j.jmb.2010.05.010; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; RAFF JW, 1994, EMBO J, V13, P5977, DOI 10.1002/j.1460-2075.1994.tb06943.x; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	43	309	318	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1474	1487		10.1016/j.cell.2012.04.035	http://dx.doi.org/10.1016/j.cell.2012.04.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726435	Bronze			2022-12-01	WOS:000305753800014
J	Nakamura, T; Liu, YJ; Nakashima, H; Umehara, H; Inoue, K; Matoba, S; Tachibana, M; Ogura, A; Shinkai, Y; Nakano, T				Nakamura, Toshinobu; Liu, Yu-Jung; Nakashima, Hiroyuki; Umehara, Hiroki; Inoue, Kimiko; Matoba, Shogo; Tachibana, Makoto; Ogura, Atsuo; Shinkai, Yoichi; Nakano, Toru			PGC7 binds histone H3K9me2 to protect against conversion of 5mC to 5hmC in early embryos	NATURE			English	Article							DNA METHYLTRANSFERASES; 5-HYDROXYMETHYLCYTOSINE; METHYLATION; CHROMATIN; 5-METHYLCYTOSINE; TRANSCRIPTION; EXCISION; GENOME; CELLS; TET1	The modification of DNA by 5-methylcytosine (5mC) has essential roles in cell differentiation and development through epigenetic gene regulation(1). 5mC can be converted to another modified base, 5-hydroxymethylcytosine (5hmC), by the tet methylcytosine dioxygenase (Tet) family of enzymes(2,3). Notably, the balance between 5hmC and 5mC in the genome is linked with cell-differentiation processes such as pluripotency and lineage commitment(4-7). We have previously reported that the maternal factor PGC7 (also known as Dppa3, Stella) is required for the maintenance of DNA methylation in early embryogenesis, and protects 5mC from conversion to 5hmC in the maternal genome(8,9). Here we show that PGC7 protects 5mC from Tet3-mediated conversion to 5hmC by binding to maternal chromatin containing dimethylated histone H3 lysine 9 (H3K9me2) in mice. In addition, imprinted loci that are marked with H3K9me2 in mature sperm are protected by PGC7 binding in early embryogenesis. This type of regulatory mechanism could be involved in DNA modifications in somatic cells as well as in early embryos.	[Liu, Yu-Jung; Nakashima, Hiroyuki; Umehara, Hiroki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nakamura, Toshinobu; Nakano, Toru] Osaka Univ, Dept Pathol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Inoue, Kimiko; Matoba, Shogo; Ogura, Atsuo] RIKEN BioResouce Ctr, Tsukuba, Ibaraki 3050074, Japan; [Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Expt Res Ctr Infect Dis, Inst Virus Res, Kyoto 6068507, Japan	Osaka University; Osaka University; RIKEN; Kyoto University	Nakamura, T (corresponding author), Nagahama Inst Biosci & Technol, Shiga 5260829, Japan.	tnakamura@nagahama-i-bio.ac.jp; tnakano@patho.med.osaka-u.ac.jp	Shinkai, Yoichi/N-3909-2014; MATOBA, Shogo/D-9995-2016; Nakamura, Toshinobu/ABD-5906-2020; Ogura, Atsuo/J-3916-2014	Shinkai, Yoichi/0000-0002-6051-2484; MATOBA, Shogo/0000-0003-0474-232X; Ogura, Atsuo/0000-0003-0447-1988; Nakamura, Toshinobu/0000-0003-3881-3368	Ministry of Education, Science, Sports, Culture and Technology of Japan; Grants-in-Aid for Scientific Research [20062005, 19061001] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Okano, H. Niwa and H. Kimura for providing Dnmt1<SUP>-/-</SUP> Dnmt3a<SUP>-/-</SUP> Dnmt3b<SUP>-/-</SUP> ES cells, plasmids and antibody. We also thank N. Asada for assistance, and A. Mizokami and M. Imaizumi for secretarial assistance. This work was supported in part by grants from the Ministry of Education, Science, Sports, Culture and Technology of Japan.	Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Pogribny I, 1999, BIOCHEM BIOPH RES CO, V262, P624, DOI 10.1006/bbrc.1999.1187; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	25	332	345	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					415	+		10.1038/nature11093	http://dx.doi.org/10.1038/nature11093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722204				2022-12-01	WOS:000305466800046
J	Doupe, DP; Alcolea, MP; Roshan, A; Zhang, G; Klein, AM; Simons, BD; Jones, PH				Doupe, David P.; Alcolea, Maria P.; Roshan, Amit; Zhang, Gen; Klein, Allon M.; Simons, Benjamin D.; Jones, Philip H.			A Single Progenitor Population Switches Behavior to Maintain and Repair Esophageal Epithelium	SCIENCE			English	Article							STEM-CELLS; IDENTIFICATION; EPIDERMIS; MOUSE; DIFFERENTIATION; PROLIFERATION; ARCHITECTURE; FUSION; ADULT	Diseases of the esophageal epithelium (EE), such as reflux esophagitis and cancer, are rising in incidence. Despite this, the cellular behaviors underlying EE homeostasis and repair remain controversial. Here, we show that in mice, EE is maintained by a single population of cells that divide stochastically to generate proliferating and differentiating daughters with equal probability. In response to challenge with all-trans retinoic acid (atRA), the balance of daughter cell fate is unaltered, but the rate of cell division increases. However, after wounding, cells reversibly switch to producing an excess of proliferating daughters until the wound has closed. Such fate-switching enables a single progenitor population to both maintain and repair tissue without the need for a "reserve" slow-cycling stem cell pool.	[Doupe, David P.; Alcolea, Maria P.; Roshan, Amit; Jones, Philip H.] Hutchison MRC Res Ctr, Med Res Council MRC, Canc Cell Unit, Cambridge CB2 0XZ, England; [Zhang, Gen; Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Doupe, David P.; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; Harvard University; Harvard Medical School; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute	Jones, PH (corresponding author), Hutchison MRC Res Ctr, Med Res Council MRC, Canc Cell Unit, Cambridge CB2 0XZ, England.	phj20@cam.ac.uk	Simons, Benjamin/AAY-8920-2020; Roshan, Amit/AAV-5512-2020; Doupe, David/M-7914-2017; Jones, Philip/D-2464-2009	Simons, Benjamin/0000-0002-3875-7071; Roshan, Amit/0000-0002-2034-2759; Doupe, David/0000-0002-9748-9388; Jones, Philip/0000-0002-5904-795X; Alcolea, Maria P./0000-0002-8396-6454	MRC; EPSRC (Engineering and Physical Sciences Research Council); NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research); Wellcome Trust; Sidney Sussex College, Cambridge; European Union Marie Curie Fellowship [PIEF-LIF-2007-220016]; Royal College of Surgeons of England; Cambridge Cancer Centre; EPSRC [EP/F032773/1] Funding Source: UKRI; MRC [MC_U105370181, G0800784] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; Medical Research Council [MC_U105370181, G0601740, G0800784B, G0800784] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Wellcome Trust(Wellcome Trust); Sidney Sussex College, Cambridge; European Union Marie Curie Fellowship(European Commission); Royal College of Surgeons of England; Cambridge Cancer Centre; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank E. Choolun and the staff at ARES and CBS Cambridge for technical assistance; D. Winton and D. Adams (Cambridge) for mice; and M. Gonzalez (London) for the Geminin antibody. We acknowledge the support of the MRC, EPSRC (Engineering and Physical Sciences Research Council), the NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research), the Wellcome Trust, Sidney Sussex College, Cambridge (D. P. D.), European Union Marie Curie Fellowship PIEF-LIF-2007-220016 (M. P. A.), the Royal College of Surgeons of England (A. R.), and Cambridge Cancer Centre (A. R.). This work uses methods included in the patent WO2009010725 (A2), a method of detecting altered behavior in a population of cells; inventors were P.H.J., B. D. S., and A.M.K.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Collins CA, 2008, DEV BIOL, V324, P55, DOI 10.1016/j.ydbio.2008.08.034; Croagh D, 2008, STEM CELL REV, V4, P261, DOI 10.1007/s12015-008-9031-3; Croagh D, 2007, STEM CELLS, V25, P313, DOI 10.1634/stemcells.2006-0421; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Goetsch E, 1910, AM J ANAT, V10, P1, DOI 10.1002/aja.1000100102; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kalabis J, 2008, J CLIN INVEST, V118, P3860, DOI 10.1172/JCI35012; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Klein AM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021910; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; MARQUESPEREIRA JP, 1965, AM J ANAT, V117, P73, DOI 10.1002/aja.1001170106; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; POTTEN CS, 1975, J CELL SCI, V17, P413; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436	28	203	209	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1091	1093		10.1126/science.1218835	http://dx.doi.org/10.1126/science.1218835			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22821983	Green Accepted			2022-12-01	WOS:000308125800046
J	Naik, S; Bouladoux, N; Wilhelm, C; Molloy, MJ; Salcedo, R; Kastenmuller, W; Deming, C; Quinones, M; Koo, L; Conlan, S; Spencer, S; Hall, JA; Dzutsev, A; Kong, H; Campbell, DJ; Trinchieri, G; Segre, JA; Belkaid, Y				Naik, Shruti; Bouladoux, Nicolas; Wilhelm, Christoph; Molloy, Michael J.; Salcedo, Rosalba; Kastenmuller, Wolfgang; Deming, Clayton; Quinones, Mariam; Koo, Lily; Conlan, Sean; Spencer, Sean; Hall, Jason A.; Dzutsev, Amiran; Kong, Heidi; Campbell, Daniel J.; Trinchieri, Giorgio; Segre, Julia A.; Belkaid, Yasmine			Compartmentalized Control of Skin Immunity by Resident Commensals	SCIENCE			English	Article							REGULATORY T-CELLS; HUMAN MICROBIOME; DENDRITIC CELLS; INNATE IMMUNITY; SYSTEM; RECOGNITION; DIVERSITY; INTESTINE; INFECTION; RESPONSES	Intestinal commensal bacteria induce protective and regulatory responses that maintain host-microbial mutualism. However, the contribution of tissue-resident commensals to immunity and inflammation at other barrier sites has not been addressed. We found that in mice, the skin microbiota have an autonomous role in controlling the local inflammatory milieu and tuning resident T lymphocyte function. Protective immunity to a cutaneous pathogen was found to be critically dependent on the skin microbiota but not the gut microbiota. Furthermore, skin commensals tuned the function of local T cells in a manner dependent on signaling downstream of the interleukin-1 receptor. These findings underscore the importance of the microbiota as a distinctive feature of tissue compartmentalization, and provide insight into mechanisms of immune system regulation by resident commensal niches in health and disease.	[Naik, Shruti; Bouladoux, Nicolas; Wilhelm, Christoph; Molloy, Michael J.; Spencer, Sean; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Parasit Dis Lab, Bethesda, MD 20892 USA; [Naik, Shruti; Spencer, Sean] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Salcedo, Rosalba; Dzutsev, Amiran; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA; [Salcedo, Rosalba; Dzutsev, Amiran] NCI, SAIC Frederick Inc, Frederick, MD 21701 USA; [Kastenmuller, Wolfgang] NIAID, Lymphocyte Biol Sect, Immunol Lab, Bethesda, MD 20892 USA; [Deming, Clayton; Conlan, Sean; Segre, Julia A.] NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Quinones, Mariam] NIAID, Bioinformat & Computat Biosci Branch, Bethesda, MD 20892 USA; [Koo, Lily] NIAID, Res Technol Branch, Bethesda, MD 20892 USA; [Hall, Jason A.] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr Biol & Med,Mol Pathogenesis Program, New York, NY 10016 USA; [Kong, Heidi] NCI, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Campbell, Daniel J.] Benaroya Res Inst, Seattle, WA 98101 USA; [Campbell, Daniel J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Benaroya Research Institute; University of Washington; University of Washington Seattle	Belkaid, Y (corresponding author), NIAID, Mucosal Immun Sect, Parasit Dis Lab, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Trinchieri, Giorgio/F-9369-2015; Kong, Heidi H/L-4856-2018; Wilhelm, Christoph/ABE-7176-2020; Conlan, Sean/B-4401-2008	Trinchieri, Giorgio/0000-0001-5892-7464; Kong, Heidi H/0000-0003-4424-064X; Wilhelm, Christoph/0000-0002-9839-0291; Conlan, Sean/0000-0001-6848-3465; Quinones, Mariam/0000-0002-8520-5114; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X; Spencer, Sean/0000-0002-7328-5399	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute, the National Cancer Institute, NIH [F30 DK094708]; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [ZIABC010938, ZIABC011153] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051, ZIAAI001115, R01AI085130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094708] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute, the National Cancer Institute, NIH; Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID) and by the National Human Genome Research Institute, the National Cancer Institute, NIH grant F30 DK094708 (S. S.), and the Human Frontier Science Program (C. W.). We thank the NIAID gnotobiotic facility staff, in particular C. Acevedo and D. Trageser-Cesler; K. Holmes and the NIAID sorting facility; K. Beacht, B. Kelsall, T. Tamachi, C. Brown, J. Benchley, A. MacDonald, L. Mijares, K. Shenderov, and A. Sher; and Yakult Central Institute for Microbiological Research for sharing SFB via a material transfer agreement. DNA sequence data are available via GenBank (accession no. SRS345653). The data reported in this paper are tabulated in the main paper and in the supplementary materials.	Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; de Oliveira M R, 1999, Rev Inst Med Trop Sao Paulo, V41, P87, DOI 10.1590/S0036-46651999000200005; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	33	550	571	4	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1115	1119		10.1126/science.1225152	http://dx.doi.org/10.1126/science.1225152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22837383	Green Accepted			2022-12-01	WOS:000308125800053
J	Lee, E; Iskow, R; Yang, LX; Gokcumen, O; Haseley, P; Luquette, LJ; Lohr, JG; Harris, CC; Ding, L; Wilson, RK; Wheeler, DA; Gibbs, RA; Kucherlapati, R; Lee, C; Kharchenko, PV; Park, PJ				Lee, Eunjung; Iskow, Rebecca; Yang, Lixing; Gokcumen, Omer; Haseley, Psalm; Luquette, Lovelace J., III; Lohr, Jens G.; Harris, Christopher C.; Ding, Li; Wilson, Richard K.; Wheeler, David A.; Gibbs, Richard A.; Kucherlapati, Raju; Lee, Charles; Kharchenko, Peter V.; Park, Peter J.		Canc Genome Atlas Res Network	Landscape of Somatic Retrotransposition in Human Cancers	SCIENCE			English	Article							HUMAN GENOMES; ELEMENTS; CELLS; DISRUPTION; MECHANISMS; GENE	Transposable elements (TEs) are abundant in the human genome, and some are capable of generating new insertions through RNA intermediates. In cancer, the disruption of cellular mechanisms that normally suppress TE activity may facilitate mutagenic retrotranspositions. We performed single-nucleotide resolution analysis of TE insertions in 43 high-coverage whole-genome sequencing data sets from five cancer types. We identified 194 high-confidence somatic TE insertions, as well as thousands of polymorphic TE insertions in matched normal genomes. Somatic insertions were present in epithelial tumors but not in blood or brain cancers. Somatic L1 insertions tend to occur in genes that are commonly mutated in cancer, disrupt the expression of the target genes, and are biased toward regions of cancer-specific DNA hypomethylation, highlighting their potential impact in tumorigenesis.	[Lee, Eunjung; Yang, Lixing; Haseley, Psalm; Luquette, Lovelace J., III; Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Lee, Eunjung; Haseley, Psalm; Kucherlapati, Raju; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Iskow, Rebecca; Gokcumen, Omer; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lohr, Jens G.] Eli & Edythe Broad Inst, Cambridge, MA 02412 USA; [Lohr, Jens G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Harris, Christopher C.; Ding, Li; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kharchenko, Peter V.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kharchenko, PV (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	peter.kharchenko@post.harvard.edu; peter_park@harvard.edu	Wheeler, David A/M-9740-2018; Wilson, Richard K./AAF-4139-2019; Yang, Lixing/A-7073-2013; Kucherlapati, Raju/ABC-8807-2021; Gokcumen, Omer/J-6984-2013	Wheeler, David A/0000-0002-9056-6299; Wilson, Richard K./0000-0002-1992-1358; Gokcumen, Omer/0000-0003-4371-679X; Park, Peter/0000-0001-9378-960X	NIH [R01GM082798, RC1HG005482, K25AG037596, U01HG005209, U01HG005725, F32AG039979, U24CA144025]; NATIONAL CANCER INSTITUTE [T32CA009172, U24CA144025] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005482, U01HG005209, U01HG005725, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG037596, F32AG039979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Langdon and U. Samarakoon for technical assistance and T. Golub and the Broad Institute for a myeloma sample obtained under a materials transfer agreement (MTA) from the Multiple Myeloma Research Consortium. This work was supported by NIH grants R01GM082798 and RC1HG005482 (P.J.P.), K25AG037596 (P. V. K.), U01HG005209 and U01HG005725 (C. L.), F32AG039979 (R. I.), and U24CA144025 (R. K.). P.J.P. is a Sloan Research Fellow. R. K. is on the board of directors of AVEO, Metamark, Enlight, and KEW Group. The sequencing data are available at dbGaP (www.ncbi.nlm.nih.gov/gap) with the following accessions: TCGA ovarian cancer, glioblastoma multiforme, and colorectal cancer (phs000178.v5.p5); multiple myeloma (phs000348.v1.p1); and prostate cancer (phs000330.v1.p1). The Tea software is available at http://compbio.med.harvard.edu/Tea.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Dickinson RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027792; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Jin Z, 2007, ONCOGENE, V26, P6332, DOI 10.1038/sj.onc.1210461; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; MIKI Y, 1992, CANCER RES, V52, P643; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Prak ETL, 2000, NAT REV GENET, V1, P134; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Slovak ML, 2011, CLIN CANCER RES, V17, P3443, DOI 10.1158/1078-0432.CCR-10-1071; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	23	475	489	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					967	971		10.1126/science.1222077	http://dx.doi.org/10.1126/science.1222077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22745252	Green Accepted			2022-12-01	WOS:000307807600046
J	von Messling, V; Cattaneo, R				von Messling, Veronika; Cattaneo, Roberto			A Henipavirus Vaccine in Sight	SCIENCE			English	Editorial Material							NIPAH VIRUS; REACTIVITY; PROTECTS; MEASLES; HENDRA		[von Messling, Veronika] Duke NUS Grad Med Sch Singapore, Emerging Infect Dis Program, Singapore 169857, Singapore; [Cattaneo, Roberto] Mayo Clin, Dept Mol Med, Coll Med, Rochester, MN 55905 USA	National University of Singapore; Mayo Clinic	von Messling, V (corresponding author), Duke NUS Grad Med Sch Singapore, Emerging Infect Dis Program, Singapore 169857, Singapore.	veronika.vonmessling@duke-nus.edu.sg; cattaneo.roberto@mayo.edu						Balzer M, 2011, AUST VET J, V89, pN2; Bossart KN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004241; Callaway T. R., 2004, Animal Health Research Reviews, V5, P35, DOI 10.1079/AHR200462; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Marsh GA, 2012, CURR OPIN VIROL, V2, P242, DOI 10.1016/j.coviro.2012.03.006; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; West R, 1999, BIODRUGS, V12, P423, DOI 10.2165/00063030-199912060-00002	14	2	2	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					651	652		10.1126/science.1227810	http://dx.doi.org/10.1126/science.1227810			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879489				2022-12-01	WOS:000307354500026
J	Mayor, S				Mayor, Susan			Advertising watchdog orders website to remove claims linking MMR vaccine with autism	BRITISH MEDICAL JOURNAL			English	News Item																		BabyJabs, MMR VACC	1	1	1	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 9	2012	345								e5420	10.1136/bmj.e5420	http://dx.doi.org/10.1136/bmj.e5420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NF	22879643				2022-12-01	WOS:000307497000004
J	Rabar, S; Lau, R; O'Flynn, N; Li, LL; Barry, P				Rabar, Silvia; Lau, Rosa; O'Flynn, Norma; Li, Lilian; Barry, Peter		Guideline Dev Grp	Risk assessment of fragility fractures: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rabar, Silvia; Lau, Rosa; O'Flynn, Norma; Li, Lilian] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Barry, Peter] Leicester Royal Infirm, Dept Child Hlth, Leicester LE2 7LX, Leics, England	Royal College of Physicians; University of Leicester	Rabar, S (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	silvia.rabar@rcplondon.ac.uk	Collins, Gary Stephen/A-2258-2014	Collins, Gary Stephen/0000-0002-2772-2316; Selby, Peter/0000-0001-9465-9268				Kanis JA, 2007, 20041068 USGS; National Institute for Health and Care Excellence, 2012, NICE CLIN GUID 146 O	2	55	54	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e3698	10.1136/bmj.e3698	http://dx.doi.org/10.1136/bmj.e3698			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875946				2022-12-01	WOS:000307496800008
J	Sobotnik, J; Bourguignon, T; Hanus, R; Demianova, Z; Pytelkova, J; Mares, M; Foltynova, P; Preisler, J; Cvacka, J; Krasulova, J; Roisin, Y				Sobotnik, J.; Bourguignon, T.; Hanus, R.; Demianova, Z.; Pytelkova, J.; Mares, M.; Foltynova, P.; Preisler, J.; Cvacka, J.; Krasulova, J.; Roisin, Y.			Explosive Backpacks in Old Termite Workers	SCIENCE			English	Article									[Sobotnik, J.; Hanus, R.; Demianova, Z.; Pytelkova, J.; Mares, M.; Cvacka, J.; Krasulova, J.] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610, Czech Republic; [Bourguignon, T.; Hanus, R.; Roisin, Y.] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Bourguignon, T.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Foltynova, P.; Preisler, J.] Masaryk Univ, Fac Sci, CEITEC Cent European Inst Technol, Brno 62500, Czech Republic; [Foltynova, P.; Preisler, J.] Masaryk Univ, Fac Sci, Dept Chem, Brno 62500, Czech Republic; [Krasulova, J.] Charles Univ Prague, Fac Sci, Dept Analyt Chem, Prague 12843, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universite Libre de Bruxelles; Hokkaido University; Masaryk University Brno; Masaryk University Brno; Charles University Prague	Hanus, R (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610, Czech Republic.	robert@uochb.cas.cz	Foltynova, Pavla/B-6856-2012; Hanus, Robert/D-4765-2013; Pytelkova, Jana/G-6179-2014; Mares, Michael/B-2413-2009; Krasulova, Jana/G-8107-2014; Preisler, Jan/B-2005-2009; Cvačka, Josef/A-6126-2014	Foltynova, Pavla/0000-0002-4768-1910; Hanus, Robert/0000-0002-7054-1975; Mares, Michael/0000-0002-0847-5022; Preisler, Jan/0000-0002-9819-1284; Cvačka, Josef/0000-0002-3590-9009; Roisin, Yves/0000-0001-6635-3552; Bourguignon, Thomas/0000-0002-4035-8977; Sobotnik, Jan/0000-0002-8581-637X; demianova, zuzana/0000-0003-2822-2177	Fund for Scientific Research (F.R.S.-FNRS, Belgium); Japan Society for Promotion of Science [22-00393]; Grant Agency of the Czech Republic [P600/525/09, P206/12/0538]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic [Z40550506]; CEITEC from the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	Fund for Scientific Research (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic(Czech Academy of Sciences); CEITEC from the European Regional Development Fund	We are grateful to P. Cerdan and the staff of the Hydreco lab at Petit Saut for logistical help. Support was provided by the Fund for Scientific Research (F.R.S.-FNRS, Belgium); the Japan Society for Promotion of Science (no. 22-00393); the Grant Agency of the Czech Republic (P600/525/09, P206/12/0538); the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic (Z40550506); and the project CEITEC (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund. The data reported in this paper are presented in the supplementary materials.	Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Holldobler B., 1990, pi; Kaiser P., 1956, Mitteilungen der Hamburgischen Zoologischen Museum, V54, P129; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Shorter JR, 2012, INSECT SOC, V59, P1, DOI 10.1007/s00040-011-0210-x; Sobotnik J, 2010, J INSECT PHYSIOL, V56, P1012, DOI 10.1016/j.jinsphys.2010.02.012	7	46	49	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					436	436		10.1126/science.1219129	http://dx.doi.org/10.1126/science.1219129			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837520				2022-12-01	WOS:000306802300034
J	Lee, YJ; Morrison, BM; Li, Y; Lengacher, S; Farah, MH; Hoffman, PN; Liu, YT; Tsingalia, A; Jin, L; Zhang, PW; Pellerin, L; Magistretti, PJ; Rothstein, JD				Lee, Youngjin; Morrison, Brett M.; Li, Yun; Lengacher, Sylvain; Farah, Mohamed H.; Hoffman, Paul N.; Liu, Yiting; Tsingalia, Akivaga; Jin, Lin; Zhang, Ping-Wu; Pellerin, Luc; Magistretti, Pierre J.; Rothstein, Jeffrey D.			Oligodendroglia metabolically support axons and contribute to neurodegeneration	NATURE			English	Article							MONOCARBOXYLATE TRANSPORTER MCT1; AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; MOUSE-BRAIN; IN-VIVO; NEURONAL-ACTIVITY; GLUTAMATE UPTAKE; TRANSGENIC MICE; ADULT BRAIN; SPINAL-CORD	Oligodendroglia support axon survival and function through mechanisms independent of myelination, and their dysfunction leads to axon degeneration in several diseases. The cause of this degeneration has not been determined, but lack of energy metabolites such as glucose or lactate has been proposed. Lactate is transported exclusively by monocarboxylate transporters, and changes to these transporters alter lactate production and use. Here we show that the most abundant lactate transporter in the central nervous system, monocarboxylate transporter 1 (MCT1, also known as SLC16A1), is highly enriched within oligodendroglia and that disruption of this transporter produces axon damage and neuron loss in animal and cell culture models. In addition, this same transporter is reduced in patients with, and in mouse models of, amyotrophic lateral sclerosis, suggesting a role for oligodendroglial MCT1 in pathogenesis. The role of oligodendroglia in axon function and neuron survival has been elusive; this study defines a new fundamental mechanism by which oligodendroglia support neurons and axons.	[Lee, Youngjin; Morrison, Brett M.; Li, Yun; Farah, Mohamed H.; Hoffman, Paul N.; Liu, Yiting; Tsingalia, Akivaga; Jin, Lin; Zhang, Ping-Wu; Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Lengacher, Sylvain; Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Sch Life Sci, Stn 19, CH-1015 Lausanne, Switzerland; [Pellerin, Luc] Univ Lausanne, Dept Physiol, CH-1005 Lausanne, Switzerland; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Johns Hopkins University; Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol, 855 N Wolfe St,Rangos 248, Baltimore, MD 21205 USA.	jrothstein@jhmi.edu	Lee, Youngjin/K-8909-2012; rothstein, jeffrey d/C-9470-2013; Lengacher, Sylvain/C-2591-2009; Pellerin, Luc/A-8912-2017	Lengacher, Sylvain/0000-0003-2190-9654; Pellerin, Luc/0000-0002-1016-1970; Magistretti, Pierre Julius/0000-0002-6678-320X; Morrison, Brett/0000-0001-5404-3899; LEE, Youngjin/0000-0002-5942-6204	National Institutes of Health [P50AG05146, PO1NS16375]; Muscular Dystrophy Association; Packard Center for ALS; Human Frontier Science Program [RG118/1998-B]; Swiss Fonds National de Recherche Scientifique [31003A-125063]; Swiss National Science Foundation (FNRS) [3100AO-108336/1]; Biaggi Foundation; Puccini Foundation;  [NIH-NS33958];  [P2ALS]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958, P01NS016375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Packard Center for ALS; Human Frontier Science Program(Human Frontier Science Program); Swiss Fonds National de Recherche Scientifique; Swiss National Science Foundation (FNRS)(Swiss National Science Foundation (SNSF)); Biaggi Foundation; Puccini Foundation; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Coccia, S. Vidensky, I. Shats, L. Chakravarti, Y. Ayukawa and L. Mamedova for technical support, E. Potter for oligodendrocyte cultures, C. Cooke for electron microscopy, and S. Kang and D. Bergles for providing MOBP-eGFP BAC and CNP BacTrap mice, CASPR and Nav1.6 antibodies. Autopsy specimens were provided by the Johns Hopkins ALS Tissue Bank and the Johns Hopkins University Brain Resource Center supported by National Institutes of Health grants P50AG05146 and PO1NS16375. Support was provided by the Muscular Dystrophy Association (B. M. M. and Yo.L.), NIH-NS33958 (J.D.R.), P2ALS (J.D.R.), Packard Center for ALS (J. D. R.), Human Frontier Science Program-RG118/1998-B (L. P.), Swiss Fonds National de Recherche Scientifique-31003A-125063 (L. P.), Swiss National Science Foundation (FNRS)-3100AO-108336/1 (P. J. M.), Biaggi and Puccini Foundations (P. J. M). We dedicate this manuscript to J. W. Griffin, who passed away while this manuscript was under revision, and are grateful for his contributions to this manuscript and mentorship to many of the authors on this paper.	Benarroch EE, 2009, NEUROLOGY, V72, P1779, DOI 10.1212/WNL.0b013e3181a6b123; Bergersen L, 2002, NEUROCHEM RES, V27, P89, DOI 10.1023/A:1014806723147; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Buntinx M, 2003, J NEUROCYTOL, V32, P25, DOI 10.1023/A:1027324230923; Chiry O, 2006, BRAIN RES, V1070, P65, DOI 10.1016/j.brainres.2005.11.064; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Garbern JY, 2002, BRAIN, V125, P551, DOI 10.1093/brain/awf043; Gerhart DZ, 1997, AM J PHYSIOL-ENDOC M, V273, pE207, DOI 10.1152/ajpendo.1997.273.1.E207; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; HEYER EJ, 1982, BRAIN RES, V232, P41, DOI 10.1016/0006-8993(82)90609-6; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Koehler-Stec EM, 1998, AM J PHYSIOL-ENDOC M, V275, pE516, DOI 10.1152/ajpendo.1998.275.3.E516; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Maekawa F, 2008, J NEUROCHEM, V107, P789, DOI 10.1111/j.1471-4159.2008.05650.x; MAYER ML, 1984, J PHYSIOL-LONDON, V354, P29, DOI 10.1113/jphysiol.1984.sp015360; McIver SR, 2005, J NEUROSCI RES, V82, P397, DOI 10.1002/jnr.20626; Morrison BM, 2000, EXP NEUROL, V165, P207, DOI 10.1006/exnr.2000.7457; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pellerin L, 1998, P NATL ACAD SCI USA, V95, P3990, DOI 10.1073/pnas.95.7.3990; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Sanchez-Abarca LI, 2001, GLIA, V36, P321, DOI 10.1002/glia.1119; SASAKI S, 1992, J NEUROL SCI, V110, P114, DOI 10.1016/0022-510X(92)90017-F; Seilhean D, 2009, ACTA NEUROPATHOL, V118, P561, DOI 10.1007/s00401-009-0545-9; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; WALZ W, 1988, NEUROSCI LETT, V86, P296, DOI 10.1016/0304-3940(88)90499-5; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Yang YJ, 2010, GLIA, V58, P277, DOI 10.1002/glia.20922; You F, 2007, J CELL BIOCHEM, V100, P256, DOI 10.1002/jcb.21082; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	48	985	1016	4	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					443	U1502		10.1038/nature11314	http://dx.doi.org/10.1038/nature11314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22801498	Green Accepted			2022-12-01	WOS:000306815300030
J	Subramanian, S; Tawakol, A; Burdo, TH; Abbara, S; Wei, J; Vijayakumar, J; Corsini, E; Abdelbaky, A; Zanni, MV; Hoffmann, U; Williams, KC; Lo, J; Grinspoon, SK				Subramanian, Sharath; Tawakol, Ahmed; Burdo, Tricia H.; Abbara, Suhny; Wei, Jeffrey; Vijayakumar, Jayanthi; Corsini, Erin; Abdelbaky, Amr; Zanni, Markella V.; Hoffmann, Udo; Williams, Kenneth C.; Lo, Janet; Grinspoon, Steven K.			Arterial Inflammation in Patients With HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATHEROSCLEROTIC PLAQUE INFLAMMATION; ACTIVATED MACROPHAGES; SOLUBLE CD163; RISK; CALCIUM; POPULATION; EVENTS; MARKER	Context Cardiovascular disease is increased in patients with human immunodeficiency virus (HIV), but the specific mechanisms are unknown. Objective To assess arterial wall inflammation in HIV, using (18)fluorine-2-deoxy-D-glucose positron emission tomography (F-18-FDG-PET), in relationship to traditional and nontraditional risk markers, including soluble CD163 (sCD163), a marker of monocyte and macrophage activation. Design, Setting, and Participants A cross-sectional study of 81 participants investigated between November 2009 and July 2011 at the Massachusetts General Hospital. Twenty-seven participants with HIV without known cardiac disease underwent cardiac 18F-FDG-PET for assessment of arterial wall inflammation and coronary computed tomography scanning for coronary artery calcium. The HIV group was compared with 2 separate non-HIV control groups. One control group (n=27) was matched to the HIV group for age, sex, and Framingham risk score (FRS) and had no known atherosclerotic disease (non-HIV FRS-matched controls). The second control group (n=27) was matched on sex and selected based on the presence of known atherosclerotic disease (non-HIV atherosclerotic controls). Main Outcome Measure Arterial inflammation was prospectively determined as the ratio of FDG uptake in the arterial wall of the ascending aorta to venous background as the target-to-background ratio (TBR). Results Participants with HIV demonstrated well-controlled HIV disease (mean [SD] CD4 cell count, 641 [288] cells/mu L; median [interquartile range] HIV-RNA level, <48 [<48 to <48] copies/mL). All were receiving antiretroviral therapy (mean [SD] duration, 12.3 [4.3] years). The mean FRS was low in both HIV and non-HIV FRS-matched control participants (6.4; 95% CI, 4.8-8.0 vs 6.6; 95% CI, 4.9-8.2; P=.87). Arterial inflammation in the aorta (aortic TBR) was higher in the HIV group vs the non-HIV FRS-matched control group (2.23; 95% CI, 2.07-2.40 vs 1.89; 95% CI, 1.80-1.97; P < .001), but was similar compared with the non-HIV atherosclerotic control group (2.23; 95% CI, 2.07-2.40 vs 2.13; 95% CI, 2.03-2.23; P=.29). Aortic TBR remained significantly higher in the HIV group vs the non-HIV FRS-matched control group after adjusting for traditional cardiovascular risk factors (P=.002) and in stratified analyses among participants with undetectable viral load, zero calcium, FRS of less than 10, a low-density lipoprotein cholesterol level of less than 100 mg/dL (<2.59 mmol/L), no statin use, and no smoking (all P <= .01). Aortic TBR was associated with sCD163 level (P=.04) but not with C-reactive protein (P=.65) or D-dimer (P=.08) among patients with HIV. Conclusion Participants infected with HIV vs noninfected control participants with similar cardiac risk factors had signs of increased arterial inflammation, which was associated with a circulating marker of monocyte and macrophage activation. JAMA. 2012;308(4):379-386 www.jama.com	[Zanni, Markella V.; Lo, Janet; Grinspoon, Steven K.] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA; [Zanni, Markella V.; Lo, Janet; Grinspoon, Steven K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Subramanian, Sharath; Tawakol, Ahmed; Abbara, Suhny; Vijayakumar, Jayanthi; Corsini, Erin; Abdelbaky, Amr; Hoffmann, Udo] Massachusetts Gen Hosp, Dept Imaging, Boston, MA 02114 USA; [Subramanian, Sharath; Tawakol, Ahmed; Abbara, Suhny; Vijayakumar, Jayanthi; Corsini, Erin; Abdelbaky, Amr; Hoffmann, Udo] Massachusetts Gen Hosp, Cardiac MR PET CT Program, Boston, MA 02114 USA; [Tawakol, Ahmed] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Burdo, Tricia H.; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston College	Grinspoon, SK (corresponding author), Massachusetts Gen Hosp, Program Nutr Metab, 5 Longfellow Pl,Room 207, Boston, MA 02114 USA.	sgrinspoon@partners.org	Corsini, Erin/AAG-6248-2020; Abbara, Suhny/C-3692-2014; Zanni, Markella/U-9108-2017	Zanni, Markella/0000-0002-4711-3956; Abbara, Suhny/0000-0003-2552-7362; Bayley, Erin/0000-0003-4715-0244	National Institutes of Health [R01 HL 095123, K23 HL092792, NS37654, NS40237, K24 DK064545]; General Clinical Research Center [M01 RR01066-25S1]; Merck Co; GlaxoSmithKline; Genetech/Roche; Vascular Biogenics Ltd; Bristol-Myers Squibb; Bracco and Becton; Dickinson and Company; Elsevier and Amirsys; Siemens Healthcare; GE Healthcare; Bracco Diagnostics; American College of Radiology Imaging Network; National Institutes of Health; Amgen; Theratechnologies; Ferrer; sanofi-aventis; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095123, K23HL092792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK064545, P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037654, R01NS040237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Merck Co(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Genetech/Roche(Roche Holding); Vascular Biogenics Ltd; Bristol-Myers Squibb(Bristol-Myers Squibb); Bracco and Becton; Dickinson and Company; Elsevier and Amirsys; Siemens Healthcare(Siemens AG); GE Healthcare(General ElectricGE Healthcare); Bracco Diagnostics; American College of Radiology Imaging Network(General Electric); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen(Amgen); Theratechnologies; Ferrer; sanofi-aventis(Sanofi-Aventis); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Tawakol reported consulting for Roche, Bristol-Myers Squibb, and Novartis, and receiving grant support from Merck & Co, GlaxoSmithKline, Genetech/Roche, Vascular Biogenics Ltd, and Bristol-Myers Squibb, all unrelated to the manuscript. Dr Abbara reported consulting for Perceptive Informatics and Partners Imaging, receiving grant support from Bracco and Becton, Dickinson and Company, and receiving royalties from Elsevier and Amirsys, all unrelated to the manuscript. Dr Hoffmann reported receiving research support from Siemens Healthcare, GE Healthcare, Bracco Diagnostics, the American College of Radiology Imaging Network, and National Institutes of Health, all unrelated to the manuscript. Dr Grinspoon reported receiving research support from Amgen, Bristol-Myers Squibb, and Theratechnologies; consulting for Aileron, Theratechnologies, Alize Pharmaceuticals, Hoffmann-La Roche, and Serono; and receiving lecture fees from Ferrer and sanofi-aventis, all unrelated to the manuscript. No other authors reported any disclosures.; This work was supported by grant R01 HL 095123 from the National Institutes of Health (Dr Grinspoon). Relevant grants supporting investigators from the National Institutes of Health were K23 HL092792 (Dr Lo), NS37654 and NS40237 (Dr Williams), and K24 DK064545 (Dr Grinspoon). The General Clinical Research Center grant is M01 RR01066-25S1.	Alsheikh-Ali AA, 2010, ANN INTERN MED, V153, P387, DOI 10.7326/0003-4819-153-6-201009210-00272; Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Aziz K, 2008, CIRCULATION, V117, P2061, DOI 10.1161/CIRCULATIONAHA.106.652313; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Einstein AJ, 2010, J AM COLL CARDIOL, V56, P1914, DOI 10.1016/j.jacc.2010.05.057; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; Figueroa A, 2011, AM HEART ASS SCI SES; Fitch KV, 2010, JAIDS-J ACQ IMM DEF, V55, P495, DOI 10.1097/QAI.0b013e3181edab0b; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Graebe M, 2009, EUR J VASC ENDOVASC, V37, P714, DOI 10.1016/j.ejvs.2008.11.018; KUBOTA R, 1994, J NUCL MED, V35, P104; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Paulmier B, 2008, J NUCL CARDIOL, V15, P209, DOI 10.1016/j.nuclcard.2007.10.009; Pedersen SF, 2010, NUCL MED COMMUN, V31, P423, DOI 10.1097/MNM.0b013e32833767e0; Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0; Ratcliffe NR, 2001, IMMUNOL LETT, V77, P169, DOI 10.1016/S0165-2478(01)00217-6; Rogers IS, 2010, JACC-CARDIOVASC IMAG, V3, P388, DOI 10.1016/j.jcmg.2010.01.004; Rominger A, 2009, J NUCL MED, V50, P1611, DOI 10.2967/jnumed.109.065151; Rudd JHF, 2007, J AM COLL CARDIOL, V50, P892, DOI 10.1016/j.jacc.2007.05.024; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Yearley JH, 2007, AIDS RES HUM RETROV, V23, P515, DOI 10.1089/aid.2006.0211	28	341	344	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2012	308	4					379	386		10.1001/jama.2012.6698	http://dx.doi.org/10.1001/jama.2012.6698			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977SR	22820791	Green Accepted, Bronze			2022-12-01	WOS:000306685500026
J	Lynch, S; Ford, N; van Cutsem, G; Bygrave, H; Janssens, B; Decroo, T; Andrieux-Meyer, I; Roberts, T; Balkan, S; Casas, E; Ferreyra, C; Bemelmans, M; Cohn, J; Kahn, P; Goemaere, E				Lynch, Sharonann; Ford, Nathan; van Cutsem, Gilles; Bygrave, Helen; Janssens, Bart; Decroo, Tom; Andrieux-Meyer, Isabelle; Roberts, Teri; Balkan, Suna; Casas, Esther; Ferreyra, Cecilia; Bemelmans, Marielle; Cohn, Jen; Kahn, Patricia; Goemaere, Eric			Getting HIV Treatment to the Most People	SCIENCE			English	Editorial Material							ANTIRETROVIRAL THERAPY; AFRICA; RESISTANCE; HIV/AIDS; DRIVEN		[Kahn, Patricia] MSF Access Campaign, New York, NY 10001 USA; [Lynch, Sharonann] MSF Access Campaign, New York, NY 10001 USA; [Ford, Nathan] MSF, London EC1N 8QX, England; [van Cutsem, Gilles] MSF, ZA-1100 Cape Town, South Africa; [Bygrave, Helen; Goemaere, Eric] MSF, S Africa Med Unit, ZA-2017 Johannesburg, South Africa; [Janssens, Bart; Bemelmans, Marielle] MSF, B-1090 Brussels, Belgium; [Decroo, Tom] MSF, Tete, Mozambique; [Andrieux-Meyer, Isabelle; Roberts, Teri] MSF Access Campaign, CH-1211 Geneva 21, Switzerland; [Balkan, Suna] MSF, F-75011 Paris, France; [Casas, Esther] MSF, NL-1018 DD Amsterdam, Netherlands; [Ferreyra, Cecilia] MSF, Barcelona 08001, Spain; [Cohn, Jen] MSF Access Campaign, Nairobi 00200, Kenya	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Kahn, P (corresponding author), MSF Access Campaign, New York, NY 10001 USA.	patricia.kahn@newyork.msf.org	Van Cutsem, Gilles/ABB-1171-2021; Kahn, Patricia/AAC-3361-2020; Decroo, Tom/AAV-7208-2020	Van Cutsem, Gilles/0000-0002-8972-4480; Kahn, Patricia/0000-0002-3491-2839; Decroo, Tom/0000-0002-1205-1484	M�decins Sans Fronti�res [OCA_pilot_00_Bygrave] Funding Source: researchfish	M�decins Sans Fronti�res		[Anonymous], 2012, UN GEN ASS 66 SESS 2; Bermudez Jorge, 2010, Open AIDS J, V4, P37, DOI 10.2174/1874613601004020037; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Hamers R. L., 2012, AIDS, P1; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Kuwenyi K., 6 IAS C HIV PATH TRE; Matambo T., 2012, MSF UK SCI DAY 25 MA; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; MSF, 2010, NO TIM QUIT HIV AIDS; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; MURTAGH M, 2012, HIV AIDS DIAGNOSTIC; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; van Zyl GU, 2011, CLIN INFECT DIS, V52, P264, DOI 10.1093/cid/ciq084; Ventelou B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034101; WHO/UNICEF, 2011, JOINT POS PAP PROV M, P1; World Health Organization, 2003, SCAL ANT THER RES LI	25	19	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					298	300		10.1126/science.1225702	http://dx.doi.org/10.1126/science.1225702			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975WQ	22798404				2022-12-01	WOS:000306542600035
J	Brawley, OW				Brawley, Otis W.			Prostate Cancer Screening: What We Know, Don't Know, and Believe	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Brawley, Otis W.] Amer Canc Soc, Atlanta, GA 30329 USA	American Cancer Society	Brawley, OW (corresponding author), 250 Williams St, Atlanta, GA 30303 USA.	otis.brawley@cancer.org						Abrahamsson PA, 2009, EUR UROL, V56, P270, DOI 10.1016/j.eururo.2009.05.024; American Urological Association, 2012, AUA SPEAKS OUT USPST; [Anonymous], 2012, NCCN CLIN PRACT GUID; Carroll P, 2009, PROSTATE SPECIFIC AN; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Hoffman RM, 2009, ARCH INTERN MED, V169, P1611, DOI 10.1001/archinternmed.2009.262; Kaswick JA, 2004, UROLOGY, V64, P189, DOI 10.1016/j.urology.2004.02.034; Lin K., 2011, AHRQ PUBLICATION; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sinclair U, 1994, I CANDIDATE GOVERNOR, V109; Smith RA, 2011, CA-CANCER J CLIN, V61, P8, DOI 10.3322/caac.20096; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	13	19	20	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2012	157	2					135	+		10.7326/0003-4819-157-2-201207170-00460	http://dx.doi.org/10.7326/0003-4819-157-2-201207170-00460			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992ON	22801675				2022-12-01	WOS:000307787900018
J	Chatterton, H; Younger, T; Fischer, A; Khunti, K				Chatterton, Hilary; Younger, Tricia; Fischer, Alastair; Khunti, Kamlesh		Programme Dev Grp	Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Younger, Tricia; Fischer, Alastair] Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England; [Chatterton, Hilary] Natl Inst Hlth & Clin Excellence, Manchester, Lancs, England; [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	National Institute for Health & Care Excellence; National Institute for Health & Care Excellence; University of Leicester	Younger, T (corresponding author), Natl Inst Hlth & Clin Excellence, London WC1V 6NA, England.	tricia.younger@nice.org.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099	Department of Health [PDA/02/06/031] Funding Source: Medline; National Institute for Health Research [PDA/02/06/031] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		[Anonymous], 2009, METH DEV NICE PUBL H; Department of Health, 2009, PUTT PREV 1 NHS HLTH; Diabetes UK, 2012, DIAB UK 2012 KEY STA; John WG, 2012, USE HAEMOGLOBIN A1C; *NAT I HLTH CLIN E, 2008, CG66 NAT I HLTH CLIN; National Institute for Health and Clinical Excellence, 2003, TA60 NAT I HLTH CLIN; National Institute for Health and Clinical Excellence, 2009, CG87 NAT I HLTH CLIN; National Institute for Health and Clinical Excellence, 2011, PHG35 NAT I HLTH CLI; National Institute for Health and Clinical Excellence, 2006, CG43 NAT I HLTH CLIN; National Institute for Health and Clinical Excellence, 2009, NICE PUBL HLTH GUID; National Institute for Health and Clinical Excellence, 2012, PHG38 NAT I HLTH CLI, V38; Santaguida PL, 2005, EVIDENCE REPORTS TEC; Webb DR, 2011, DIABETES RES CLIN PR, V91, P280, DOI 10.1016/j.diabres.2010.11.021; WHO, 2011, USE GLYCATED HAEMOGL; World Health Organization, 2006, DEFINITION DIAGNOSIS	15	68	68	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 12	2012	345								e4624	10.1136/bmj.e4624	http://dx.doi.org/10.1136/bmj.e4624			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975NW	22791792				2022-12-01	WOS:000306519000004
J	Inuzuka, H; Gao, DM; Finley, LWS; Yang, W; Wan, LX; Fukushima, H; Chin, YR; Zhai, B; Shaik, S; Lau, AW; Wang, ZW; Gygi, SP; Nakayama, K; Teruya-Feldstein, J; Toker, A; Haigis, MC; Pandolfi, PP; Wei, WY				Inuzuka, Hiroyuki; Gao, Daming; Finley, Lydia W. S.; Yang, Wen; Wan, Lixin; Fukushima, Hidefumi; Chin, Y. Rebecca; Zhai, Bo; Shaik, Shavali; Lau, Alan W.; Wang, Zhiwei; Gygi, Steven P.; Nakayama, Keiko; Teruya-Feldstein, Julie; Toker, Alex; Haigis, Marcia C.; Pandolfi, Pier Paolo; Wei, Wenyi			Acetylation-Dependent Regulation of Skp2 Function	CELL			English	Article							CELL-CYCLE PROGRESSION; HUMAN BREAST-CANCER; BOX PROTEINS SKP2; UBIQUITIN LIGASE; E-CADHERIN; CYTOPLASMIC LOCALIZATION; FORKHEAD TRANSCRIPTION; HISTONE H3; INHIBITOR P27(KIP1); PROSTATE-CANCER	Aberrant Skp2 signaling has been implicated as a driving event in tumorigenesis. Although the underlying molecular mechanisms remain elusive, cytoplasmic Skp2 correlates with more aggressive forms of breast and prostate cancers. Here, we report that Skp2 is acetylated by p300 at K68 and K71, which is a process that can be antagonized by the SIRT3 deacetylase. Inactivation of SIRT3 leads to elevated Skp2 acetylation, which leads to increased Skp2 stability through impairment of the Cdh1-mediated proteolysis pathway. As a result, Skp2 oncogenic function is increased, whereby cells expressing an acetylation-mimetic mutant display enhanced cellular proliferation and tumorigenesis in vivo. Moreover, acetylation of Skp2 in the nuclear localization signal (NLS) promotes its cytoplasmic retention, and cytoplasmic Skp2 enhances cellular migration through ubiquitination and destruction of E-cadherin. Thus, our study identifies an acetylation-dependent regulatory mechanism governing Skp2 oncogenic function and provides insight into how cytoplasmic Skp2 controls cellular migration.	[Inuzuka, Hiroyuki; Gao, Daming; Wan, Lixin; Fukushima, Hidefumi; Chin, Y. Rebecca; Shaik, Shavali; Lau, Alan W.; Wang, Zhiwei; Toker, Alex; Pandolfi, Pier Paolo; Wei, Wenyi] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Finley, Lydia W. S.; Yang, Wen; Zhai, Bo; Gygi, Steven P.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; [Finley, Lydia W. S.; Yang, Wen; Haigis, Marcia C.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02215 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Div Dev Genet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tohoku University; Memorial Sloan Kettering Cancer Center	Wei, WY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Wan, Lixin/F-2124-2011	Wang, Zhiwei/0000-0002-6465-7779; Pandolfi, Pier Paolo/0000-0002-5352-5295; Gao, Daming/0000-0003-4374-1055; CHIN, Yuet Ming Rebecca/0000-0001-8976-3466	Susan G. Komen Breast Cancer Foundation [0706963]; Department of Defense [PC080377]; National Institutes of Health [GM089763, GM094777, CA122099, AG041218]; NATIONAL CANCER INSTITUTE [R01CA122099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089763, R01GM094777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041218] Funding Source: NIH RePORTER	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Lewis Cantley, Pengda Liu, and Qing Zhang for critical reading of the manuscript; Christoph Geisen, Yasuyujki Fujita, and Hui-Kuan Lin for providing reagents; and members of the Wei, Haigis, Pandolfi, and Toker labs for useful discussions. W.W. is an MLSC New Investigator and an American Cancer Society Research Scholar (W.W., RSG-12-096). This work was supported in part by the Susan G. Komen Breast Cancer Foundation (Y.R.C., 0706963), the Department of Defense Prostate Cancer Research Program (W.W., PC080377), and by grants from the National Institutes of Health (W.W., GM089763, GM094777; A.T., CA122099; H.I., AG041218).	Agarwal A, 2008, BLOOD, V112, P1960, DOI 10.1182/blood-2007-09-113860; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; di Bari MG, 2006, EMBO REP, V7, P727, DOI 10.1038/sj.embor.7400700; Dietschy T, 2009, J CELL SCI, V122, P1258, DOI 10.1242/jcs.037747; Dowen SE, 2003, INT J CANCER, V105, P326, DOI 10.1002/ijc.11066; Drobnjak M, 2003, CLIN CANCER RES, V9, P2613; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Fabbro M, 2003, EXP CELL RES, V282, P59, DOI 10.1016/S0014-4827(02)00019-8; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Karanam B, 2007, BIOCHEMISTRY-US, V46, P8207, DOI 10.1021/bi7000054; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Li JQ, 2004, INT J ONCOL, V25, P87; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lim MS, 2002, BLOOD, V100, P2950, DOI 10.1182/blood.V100.8.2950; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shim EH, 2003, CANCER RES, V63, P1583; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Sun LC, 2007, ACTA BIOCH BIOPH SIN, V39, P999, DOI 10.1111/j.1745-7270.2007.00361.x; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Traub F, 2006, BREAST CANCER RES TR, V99, P185, DOI 10.1007/s10549-006-9202-3; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Yang G, 2002, CLIN CANCER RES, V8, P3419; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yang YJ, 2011, GENE, V488, P46, DOI 10.1016/j.gene.2011.07.029; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang H, 2010, CELL CYCLE, V9, P868; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	69	150	159	4	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 6	2012	150	1					179	193		10.1016/j.cell.2012.05.038	http://dx.doi.org/10.1016/j.cell.2012.05.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770219	Bronze, Green Accepted			2022-12-01	WOS:000306115000016
J	Kono, K; Saeki, Y; Yoshida, S; Tanaka, K; Pellman, D				Kono, Keiko; Saeki, Yasushi; Yoshida, Satoshi; Tanaka, Keiji; Pellman, David			Proteasomal Degradation Resolves Competition between Cell Polarization and Cellular Wound Healing	CELL			English	Article							RSP5 UBIQUITIN LIGASE; PROTEIN-KINASE-C; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; ACTIN CABLES; SECRETORY VESICLES; SINGLE-CELL; YEAST; POLARITY	Cellular wound healing, enabling the repair of membrane damage, is ubiquitous in eukaryotes. One aspect of the wound healing response is the redirection of a polarized cytoskeleton and the secretory machinery to the damage site. Although there has been recent progress in identifying conserved proteins involved in wound healing, the mechanisms linking these components into a coherent response are not defined. Using laser damage in budding yeast, we demonstrate that local cell wall/membrane damage triggers the dispersal of proteins from the site of polarized growth, enabling their accumulation at the wound. We define a protein-kinase-C-dependent mechanism that mediates the destruction of the formin Bni1 and the exocyst component Sec3. This degradation is essential to prevent competition between the site of polarized growth and the wound. Mechanisms to overcome competition from a preexisting polarized cytoskeleton may be a general feature of effective wound healing in polarized cells.	[Kono, Keiko; Yoshida, Satoshi; Pellman, David] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kono, Keiko; Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Yoshida, Satoshi] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Yoshida, Satoshi] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Pellman, David] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tokyo Metropolitan Institute of Medical Science; Brandeis University; Brandeis University; Howard Hughes Medical Institute	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu	Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; Kono, Keiko/0000-0003-4057-8790	NIH [RO1 GM061345]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Finley and M. Springer for critical reading of the manuscript; C. Mann, W. Guo, M. Cyert, L. Hicke, and D. Lew for reagents; Z. Shi for pilot experiments; S. Gygi and R. Tomaino for mass spectrometry analysis; L. Cameron for advice on microscopy; members of the Pellman lab, especially S. Buttery and B. Atkins, for helpful discussions; and C. Kuroda for strain construction. This work was supported by NIH grant RO1 GM061345.	Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bement WM, 1999, CURR BIOL, V9, P579, DOI 10.1016/S0960-9822(99)80261-9; BEMENT WM, 1990, CELL REGUL, V1, P315, DOI 10.1091/mbc.1.3.315; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; de la Fuente N, 2000, BBA-BIOMEMBRANES, V1509, P189, DOI 10.1016/S0005-2736(00)00293-5; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Denis V, 2005, EUKARYOT CELL, V4, P36, DOI 10.1128/EC.4.1.36-45.2005; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoshikawa C, 2003, P NATL ACAD SCI USA, V100, P11505, DOI 10.1073/pnas.1933153100; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Kaminska J, 2011, EUR J CELL BIOL, V90, P1016, DOI 10.1016/j.ejcb.2011.08.002; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schmitz HP, 2002, MOL MICROBIOL, V44, P829, DOI 10.1046/j.1365-2958.2002.02925.x; Shcherbik N, 2004, J BIOL CHEM, V279, P53892, DOI 10.1074/jbc.M410325200; Shcherbik N, 2003, CURR BIOL, V13, P1227, DOI 10.1016/S0960-9822(03)00457-3; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Yoshiuchi S, 2006, GENETICS, V173, P527, DOI 10.1534/genetics.105.055210; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128	52	67	67	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					151	164		10.1016/j.cell.2012.05.030	http://dx.doi.org/10.1016/j.cell.2012.05.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22727045	Bronze			2022-12-01	WOS:000306115000014
J	Lorenz, A; Osman, F; Sun, WL; Nandi, S; Steinacher, R; Whitby, MC				Lorenz, Alexander; Osman, Fekret; Sun, Weili; Nandi, Saikat; Steinacher, Roland; Whitby, Matthew C.			The Fission Yeast FANCM Ortholog Directs Non-Crossover Recombination During Meiosis	SCIENCE			English	Article							HOLLIDAY JUNCTION RESOLVASE; MEIOTIC RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; CROSSING-OVER; D-LOOPS; COMPLEX; MUS81-EME1; MUTANT	The formation of healthy gametes depends on programmed DNA double-strand breaks (DSBs), which are each repaired as a crossover (CO) or non-crossover (NCO) from a homologous template. Although most of these DSBs are repaired without giving COs, little is known about the genetic requirements of NCO-specific recombination. We show that Fml1, the Fanconi anemia complementation group M (FANCM)-ortholog of Schizosaccharomyces pombe, directs the formation of NCOs during meiosis in competition with the Mus81-dependent pro-CO pathway. We also define the Rad51/Dmc1-mediator Swi5-Sfr1 as a major determinant in biasing the recombination process in favor of Mus81, to ensure the appropriate amount of COs to guide meiotic chromosome segregation. The conservation of these proteins from yeast to humans suggests that this interplay may be a general feature of meiotic recombination.	[Lorenz, Alexander; Osman, Fekret; Sun, Weili; Nandi, Saikat; Steinacher, Roland; Whitby, Matthew C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Whitby, MC (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	matthew.whitby@bioch.ox.ac.uk	Lorenz, Alexander/B-4735-2008; Nandi, Saikat/AAS-2466-2020	Lorenz, Alexander/0000-0003-1925-3713; Nandi, Saikat/0000-0002-5693-6129; Whitby, Matthew/0000-0003-0951-3374	Wellcome Trust [090767/Z/09/Z]; Austrian Science Fund (FWF) [J 2489-B03]	Wellcome Trust(Wellcome TrustEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank R. Mercier for discussions and sharing data before publication. We are grateful to A. Decottignies, J. Kohli, R. J. McFarlane, P. Russell, G. R. Smith, and W. W. Steiner for providing strains/reagents and to C. Bryer and J. Witzki for technical assistance. This work was supported by Wellcome Trust Programme grant 090767/Z/09/Z. A. L. was funded in part by an Erwin Schrodinger Fellowship (J 2489-B03) from the Austrian Science Fund (FWF).	Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bugreev DV, 2011, NAT STRUCT MOL BIOL, V18, P56, DOI 10.1038/nsmb.1946; Cromie GA, 2008, GENETICS, V179, P1157, DOI 10.1534/genetics.108.088955; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Lorenz A, 2010, NUCLEIC ACIDS RES, V38, P1866, DOI 10.1093/nar/gkp1179; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; SCHUCHERT P, 1988, GENETICS, V119, P507; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Sun W, 2011, NUCLEIC ACIDS RES, V39, P1718, DOI 10.1093/nar/gkq977; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	20	81	85	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1585	1588		10.1126/science.1220111	http://dx.doi.org/10.1126/science.1220111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723423	Green Submitted, Green Accepted			2022-12-01	WOS:000305507500059
J	Arthur, JC; Perez-Chanona, E; Muhlbauer, M; Tomkovich, S; Uronis, JM; Fan, TJ; Campbell, BJ; Abujamel, T; Dogan, B; Rogers, AB; Rhodes, JM; Stintzi, A; Simpson, KW; Hansen, JJ; Keku, TO; Fodor, AA; Jobin, C				Arthur, Janelle C.; Perez-Chanona, Ernesto; Muehlbauer, Marcus; Tomkovich, Sarah; Uronis, Joshua M.; Fan, Ting-Jia; Campbell, Barry J.; Abujamel, Turki; Dogan, Belgin; Rogers, Arlin B.; Rhodes, Jonathan M.; Stintzi, Alain; Simpson, Kenneth W.; Hansen, Jonathan J.; Keku, Temitope O.; Fodor, Anthony A.; Jobin, Christian			Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota	SCIENCE			English	Article							ESCHERICHIA-COLI STRAINS; DOUBLE-STRAND BREAKS; COLORECTAL-CANCER; CROHNS-DISEASE; COMMENSAL BACTERIA; BOWEL-DISEASE; IN-VIVO; CELLS; MICE; EXPRESSION	Inflammation alters host physiology to promote cancer, as seen in colitis-associated colorectal cancer (CRC). Here, we identify the intestinal microbiota as a target of inflammation that affects the progression of CRC. High-throughput sequencing revealed that inflammation modifies gut microbial composition in colitis-susceptible interleukin-10-deficient (Il10(-/-)) mice. Monocolonization with the commensal Escherichia coli NC101 promoted invasive carcinoma in azoxymethane (AOM)-treated Il10(-/-) mice. Deletion of the polyketide synthase (pks) genotoxic island from E. coli NC101 decreased tumor multiplicity and invasion in AOM/Il10(-/-) mice, without altering intestinal inflammation. Mucosa-associated pks(+) E. coli were found in a significantly high percentage of inflammatory bowel disease and CRC patients. This suggests that in mice, colitis can promote tumorigenesis by altering microbial composition and inducing the expansion of microorganisms with genotoxic capabilities.	[Arthur, Janelle C.; Perez-Chanona, Ernesto; Muehlbauer, Marcus; Tomkovich, Sarah; Uronis, Joshua M.; Fan, Ting-Jia; Hansen, Jonathan J.; Keku, Temitope O.; Jobin, Christian] Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27599 USA; [Campbell, Barry J.; Rhodes, Jonathan M.] Univ Liverpool, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Abujamel, Turki; Stintzi, Alain] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Abujamel, Turki] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Technol, Jeddah 21589, Saudi Arabia; [Dogan, Belgin; Simpson, Kenneth W.] Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA; [Rogers, Arlin B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Fodor, Anthony A.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Liverpool; University of Ottawa; King Abdulaziz University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Charlotte	Jobin, C (corresponding author), Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27599 USA.	job@med.unc.edu	Abujamel, Turki/GRS-5606-2022; Tomkovich, Sarah/ABF-7952-2020	Tomkovich, Sarah/0000-0003-1638-5307; Arthur, Janelle/0000-0002-4796-0207	NIH [T32 DK007737, R01 DK73338, R01 DK47700, R01 CA136887, R01 DK53347-11]; American Institute for Cancer Research; UNC University Cancer Research Fund; New York Presbyterian/Weill Cornell Medical College; Crohn's and Colitis foundation UK; NIH Research Specialist Biomedical Research Center in Microbial Disease; North West Cancer Research Fund UK; Canadian Institutes of Health Research MOP [114872]; King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA136887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007737, R01DK047700, P30DK034987, R01DK073338, R01DK053347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; UNC University Cancer Research Fund; New York Presbyterian/Weill Cornell Medical College; Crohn's and Colitis foundation UK; NIH Research Specialist Biomedical Research Center in Microbial Disease; North West Cancer Research Fund UK; Canadian Institutes of Health Research MOP(Canadian Institutes of Health Research (CIHR)); King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Bower and S. Tonkonogy of the National Gnotobiotic Rodent Resource Center at University of North Carolina (UNC) and North Carolina State University for assistance with gnotobiotic mice (NIH P40 R018603). Histology was performed at the Center for Gastrointestinal Biology and Diseases histology core (P30 DK034987). This work was supported by funding from NIH T32 DK007737 (J.C.A.), R01 DK73338 (C.J.), R01 DK47700 (C.J.), R01 CA136887 (T.O.K.), R01 DK53347-11 (K.W.S./A.B.S.), the American Institute for Cancer Research (C.J.), UNC University Cancer Research Fund (C.J.), New York Presbyterian/Weill Cornell Medical College (K.W.S.), Crohn's and Colitis foundation UK (B.J.C.), the NIH Research Specialist Biomedical Research Center in Microbial Disease (J.M.R.), the North West Cancer Research Fund UK (B.J.C.), and the Canadian Institutes of Health Research MOP#114872 (A.S.). T.A. is supported by a scholarship from King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada. J.M.R. is a member of advisory boards for Atlantic, Procter and Gamble, and Falk and has received speaking honoraria from Abbott, Falk, Ferring, GlaxoSmithKline, Procter and Gamble, Schering Plough, Shire, and Wyeth. All data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Illumina sequencing data are deposited in National Center for Biotechnology Information's (NCBI's) sequence read archive (SRA) and are accessible under SRA055272. Inflammation PCR array data are deposited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO series accession no. GSE39085. This work is in the memory of Mathieu Jobin, Lyne Gauthier, and Janine Drysdale.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Homburg S, 2007, FEMS MICROBIOL LETT, V275, P255, DOI 10.1111/j.1574-6968.2007.00889.x; Inaba Y, 2010, INFLAMM BOWEL DIS, V16, P1488, DOI 10.1002/ibd.21253; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luperchio SA, 2001, MICROBES INFECT, V3, P333, DOI 10.1016/S1286-4579(01)01387-9; MARSHALL BJ, 1995, JAMA-J AM MED ASSOC, V274, P1064, DOI 10.1001/jama.274.13.1064; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schwerbrock NMJ, 2004, INFLAMM BOWEL DIS, V10, P811, DOI 10.1097/00054725-200411000-00016; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026	24	1292	1362	16	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					120	123		10.1126/science.1224820	http://dx.doi.org/10.1126/science.1224820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22903521	Green Accepted, Green Submitted			2022-12-01	WOS:000309457400067
J	Deardorff, MA; Bando, M; Nakato, R; Watrin, E; Itoh, T; Minamino, M; Saitoh, K; Komata, M; Katou, Y; Clark, D; Cole, KE; De Baere, E; Decroos, C; Di Donato, N; Ernst, S; Francey, LJ; Gyftodimou, Y; Hirashima, K; Hullings, M; Ishikawa, Y; Jaulin, C; Kaur, M; Kiyono, T; Lombardi, PM; Magnaghi-Jaulin, L; Mortier, GR; Nozaki, N; Petersen, MB; Seimiya, H; Siu, VM; Suzuki, Y; Takagaki, K; Wilde, JJ; Willems, PJ; Prigent, C; Gillessen-Kaesbach, G; Christianson, DW; Kaiser, FJ; Jackson, LG; Hirota, T; Krantz, ID; Shirahige, K				Deardorff, Matthew A.; Bando, Masashige; Nakato, Ryuichiro; Watrin, Erwan; Itoh, Takehiko; Minamino, Masashi; Saitoh, Katsuya; Komata, Makiko; Katou, Yuki; Clark, Dinah; Cole, Kathryn E.; De Baere, Elfride; Decroos, Christophe; Di Donato, Nataliya; Ernst, Sarah; Francey, Lauren J.; Gyftodimou, Yolanda; Hirashima, Kyotaro; Hullings, Melanie; Ishikawa, Yuuichi; Jaulin, Christian; Kaur, Maninder; Kiyono, Tohru; Lombardi, Patrick M.; Magnaghi-Jaulin, Laura; Mortier, Geert R.; Nozaki, Naohito; Petersen, Michael B.; Seimiya, Hiroyuki; Siu, Victoria M.; Suzuki, Yutaka; Takagaki, Kentaro; Wilde, Jonathan J.; Willems, Patrick J.; Prigent, Claude; Gillessen-Kaesbach, Gabriele; Christianson, David W.; Kaiser, Frank J.; Jackson, Laird G.; Hirota, Toru; Krantz, Ian D.; Shirahige, Katsuhiko			HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle	NATURE			English	Article							SISTER-CHROMATID COHESION; X-CHROMOSOME-INACTIVATION; S-PHASE; HUMAN GENOME; NIPPED-B; RNA-SEQ; BINDING; COMPLEX; PROTEINS; NIPBL	Cornelia de Lange syndrome (CdLS) is a dominantly inherited congenital malformation disorder, caused by mutations in the cohesin-loading protein NIPBL1,2 for nearly 60% of individuals with classical CdLS3-5, and by mutations in the core cohesin components SMC1A (similar to 5%) and SMC3 (<1%) for a smaller fraction of probands(6,7). In humans, the multisubunit complex cohesin is made up of SMC1, SMC3, RAD21 and a STAG protein. These form a ring structure that is proposed to encircle sister chromatids to mediate sister chromatid cohesion(8) and also has key roles in gene regulation(9). SMC3 is acetylated during S-phase to establish cohesiveness of chromatin-loaded cohesin(10-13), and in yeast, the class I histone deacetylase Hos1 deacetylates SMC3 during anaphase(14-16). Here we identify HDAC8 as the vertebrate SMC3 deacetylase, as well as loss-of-function HDAC8 mutations in six CdLS probands. Loss of HDAC8 activity results in increased SMC3 acetylation and inefficient dissolution of the 'used' cohesin complex released from chromatin in both prophase and anaphase. SMC3 with retained acetylation is loaded onto chromatin, and chromatin immunoprecipitation sequencing analysis demonstrates decreased occupancy of cohesin localization sites that results in a consistent pattern of altered transcription seen in CdLS cell lines with either NIPBL or HDAC8 mutations.	[Deardorff, Matthew A.; Clark, Dinah; Ernst, Sarah; Francey, Lauren J.; Hullings, Melanie; Kaur, Maninder; Wilde, Jonathan J.; Jackson, Laird G.; Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; [Deardorff, Matthew A.; Krantz, Ian D.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bando, Masashige; Nakato, Ryuichiro; Minamino, Masashi; Saitoh, Katsuya; Komata, Makiko; Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Watrin, Erwan; Jaulin, Christian; Magnaghi-Jaulin, Laura; Prigent, Claude] Fac Med, Ctr Natl Rech Sci CNRS, Res Inst Genet & Dev IGDR, F-35043 Rennes, France; [Itoh, Takehiko] Tokyo Inst Technol, Sch & Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan; [Cole, Kathryn E.; Decroos, Christophe; Lombardi, Patrick M.; Christianson, David W.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [De Baere, Elfride] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Di Donato, Nataliya] Tech Univ Dresden, Inst Klin Genet, D-01307 Dresden, Germany; [Gyftodimou, Yolanda; Petersen, Michael B.] Inst Child Hlth, Dept Genet, Athens 11527, Greece; [Hirashima, Kyotaro; Seimiya, Hiroyuki] Japanese Fdn Canc Res, Div Mol Biotherapy, Tokyo 1358550, Japan; [Ishikawa, Yuuichi] Japanese Fdn Canc Res, Dept Pathol, Tokyo 1358550, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Virol, Tokyo 1040045, Japan; [Mortier, Geert R.] Univ Antwerp Hosp, Dept Med Genet, B-2650 Antwerp, Belgium; [Mortier, Geert R.] Univ Antwerp, B-2650 Antwerp, Belgium; [Nozaki, Naohito] Tokyo Inst Technol, Biofrontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Petersen, Michael B.] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Genet, DK-9100 Aalborg, Denmark; [Siu, Victoria M.] Univ Western Ontario, London, ON N6A 5W9, Canada; [Suzuki, Yutaka; Hirota, Toru] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 2778561, Japan; [Willems, Patrick J.] GENDIA, B-2020 Antwerp, Belgium; [Gillessen-Kaesbach, Gabriele; Kaiser, Frank J.] Med Univ Lubeck, Inst Humangenet Lubeck, D-23538 Lubeck, Germany; [Jackson, Laird G.] Drexel Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA; [Shirahige, Katsuhiko] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Tokyo Institute of Technology; University of Pennsylvania; Ghent University; Ghent University Hospital; Technische Universitat Dresden; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; National Cancer Center - Japan; University of Antwerp; University of Antwerp; Tokyo Institute of Technology; Aalborg University; Aalborg University Hospital; Aarhus University; Western University (University of Western Ontario); University of Tokyo; University of Lubeck; Drexel University; Japan Science & Technology Agency (JST)	Deardorff, MA (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA.	deardorff@email.chop.edu; ian2@mail.med.upenn.edu; kshirahi@iam.u-tokyo.ac.jp	Petersen, Michael Bjørn B/D-1483-2017; Nakato, Ryuichiro/AAV-6405-2020; Itoh, Takehiko/E-8873-2014; Di Donato, Nataliya/G-2357-2019; De Baere, Elfride/E-7405-2017; Mortier, Geert/D-2542-2012; Jaulin, Christian/L-9126-2018	Petersen, Michael Bjørn B/0000-0003-0316-8207; Nakato, Ryuichiro/0000-0003-3019-5817; Itoh, Takehiko/0000-0002-6113-557X; Di Donato, Nataliya/0000-0001-9439-4677; De Baere, Elfride/0000-0002-5609-6895; Mortier, Geert/0000-0001-9871-4578; Seimiya, Hiroyuki/0000-0003-3314-9736; Francey, Lauren J/0000-0002-9700-2277; Takagaki, Kentaro/0000-0001-8085-6201; watrin, erwan/0000-0002-4582-6493; Shirahige, Katsuhiko/0000-0002-7862-1144; Wilde, Jonathan/0000-0002-0800-8854	US and International Cornelia de Lange Syndrome Foundations; National Institutes of Health [K08HD055488, GM49758, P01 HD052860]; US CdLS Foundation; Children's Hospital of Philadelphia; University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung); Research Program of Innovative Cell Biology by Innovative Technology; MEXT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD055488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049758] Funding Source: NIH RePORTER	US and International Cornelia de Lange Syndrome Foundations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US CdLS Foundation; Children's Hospital of Philadelphia; University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung); Research Program of Innovative Cell Biology by Innovative Technology; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the individuals and families with Cornelia de Lange syndrome who participated in this study, as well as to the referring physicians and colleagues who have contributed samples and clinical information. We thank Riken Omics Science Center, K. Nakagawa, S. Watanabe, M. Albrecht and J. Eckhold for technical support. We thank J.-M. Peters for the sororin and RAD21 antibodies. We thank F. Beckouet and K. Nasmyth for sharing unpublished results. We are indebted to the continued support of the US and International Cornelia de Lange Syndrome Foundations. This work was supported by National Institutes of Health grants K08HD055488 (NICHD, M. A. D.), GM49758 (D. W. C.) and P01 HD052860 (NICHD; I. D. K.), research grants from the US CdLS Foundation, institutional funds from the Children's Hospital of Philadelphia, Intramural funding from the University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung; F. J. K., G.G.-K.), Research Program of Innovative Cell Biology by Innovative Technology, Grant-in-Aid for Scientific Research (S) and for innovative science from MEXT (K.Sh.).	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; [Anonymous], 2012, PYMOL MOL GRAPH SYST; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schmitz J, 2007, CURR BIOL, V17, P630, DOI 10.1016/j.cub.2007.02.029; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	44	379	393	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					313	+		10.1038/nature11316	http://dx.doi.org/10.1038/nature11316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22885700	Green Accepted			2022-12-01	WOS:000308635900046
J	Plechanovova, A; Jaffray, EG; Tatham, MH; Naismith, JH; Hay, RT				Plechanovova, Anna; Jaffray, Ellis G.; Tatham, Michael H.; Naismith, James H.; Hay, Ronald T.			Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis	NATURE			English	Article							DNA-DAMAGE; COMPLEX; RNF4; DEGRADATION; INSIGHTS; UBIQUITYLATION; DETERMINANTS; MECHANISM; PATHWAY; BINDING	Ubiquitin modification is mediated by a large family of specificity determining ubiquitin E3 ligases. To facilitate ubiquitin transfer, RING E3 ligases bind both substrate and a ubiquitin E2 conjugating enzyme linked to ubiquitin via a thioester bond, but the mechanism of transfer has remained elusive. Here we report the crystal structure of the dimeric RING domain of rat RNF4 in complex with E2 (UbcH5A) linked by an isopeptide bond to ubiquitin. While the E2 contacts a single protomer of the RING, ubiquitin is folded back onto the E2 by contacts from both RING protomers. The carboxy-terminal tail of ubiquitin is locked into an active site groove on the E2 by an intricate network of interactions, resulting in changes at the E2 active site. This arrangement is primed for catalysis as it can deprotonate the incoming substrate lysine residue and stabilize the consequent tetrahedral transition-state intermediate.	[Plechanovova, Anna; Jaffray, Ellis G.; Tatham, Michael H.; Hay, Ronald T.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland	University of Dundee; University of St Andrews	Hay, RT (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.	r.t.hay@dundee.ac.uk	Naismith, James Henderson/H-3408-2012; Hay, Ronald/S-3233-2019; Tatham, Michael H/E-9622-2010; Naismith, James Henderson/AAB-8614-2020	Naismith, James Henderson/0000-0001-6744-5061; Hay, Ronald/0000-0001-7113-9024; Tatham, Michael H/0000-0001-6986-1691; Naismith, James Henderson/0000-0001-6744-5061	Wellcome Trust; Cancer Research UK; Scottish Funding Council [SULSA]; Cancer Research UK [13067] Funding Source: researchfish; Wellcome Trust [098391/Z/12/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Scottish Funding Council; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M. Alphey and E. Branigan for assistance with data collection. His-UBE1 was a gift from the Division of Signal Transduction Therapy, University of Dundee. CHIP was a gift from A. Knebel and P. Cohen. A. P. was funded by the Wellcome Trust. This work was supported by a grant to R. T. H. from Cancer Research UK. Structural biology was supported by Scottish Funding Council (ref SULSA) and Wellcome Trust (program grant JHN).	Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Martin SF, 2007, ANAL BIOCHEM, V363, P83, DOI 10.1016/j.ab.2006.12.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang L, 2011, GENE DEV, V25, P1262, DOI 10.1101/gad.2056211; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	41	352	356	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					115	U135		10.1038/nature11376	http://dx.doi.org/10.1038/nature11376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22842904	Green Accepted			2022-12-01	WOS:000308347000045
J	Nijhawan, D; Zack, TI; Ren, Y; Strickland, MR; Lamothe, R; Schumacher, SE; Tsherniak, A; Besche, HC; Rosenbluh, J; Shehata, S; Cowley, GS; Weir, BA; Goldberg, AL; Mesirov, JP; Root, DE; Bhatia, SN; Beroukhim, R; Hahn, WC				Nijhawan, Deepak; Zack, Travis I.; Ren, Yin; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Tsherniak, Aviad; Besche, Henrike C.; Rosenbluh, Joseph; Shehata, Shyemaa; Cowley, Glenn S.; Weir, Barbara A.; Goldberg, Alfred L.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.			Cancer Vulnerabilities Unveiled by Genomic Loss	CELL			English	Article							COPY-NUMBER ALTERATION; OVARIAN-CANCER; PROTEASOMAL ATPASES; ONCOGENE ADDICTION; DRUG-SENSITIVITY; LUNG-CANCER; CELLS; GENE; IDENTIFICATION; THERAPY	Due to genome instability, most cancers exhibit loss of regions containing tumor suppressor genes and collateral loss of other genes. To identify cancer-specific vulnerabilities that are the result of copy number losses, we performed integrated analyses of genome-wide copy number and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy number loss of that gene. These CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components. One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome. Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression. Cells harboring partial PSMC2 copy number loss lack this complex and die after PSMC2 suppression. These observations define a distinct class of cancer-specific liabilities resulting from genome instability.	[Nijhawan, Deepak; Zack, Travis I.; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Rosenbluh, Joseph; Shehata, Shyemaa; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Nijhawan, Deepak; Zack, Travis I.; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Rosenbluh, Joseph; Shehata, Shyemaa; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Nijhawan, Deepak; Zack, Travis I.; Schumacher, Steven E.; Tsherniak, Aviad; Rosenbluh, Joseph; Cowley, Glenn S.; Weir, Barbara A.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Zack, Travis I.] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Besche, Henrike C.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ren, Yin; Bhatia, Sangeeta N.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Nijhawan, Deepak; Rosenbluh, Joseph; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bhatia, Sangeeta N.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	rameen_beroukhim@dfci.harvard.edu; william_hahn@dfci.harvard.edu	Mesirov, Jill/AGF-7626-2022; qiao, zhixin/I-3408-2012; Ren, Yin/ABD-7707-2021; Schumacher, Steven/E-9821-2013	Ren, Yin/0000-0002-7901-2439; Schumacher, Steven/0000-0002-6819-5647; Besche, Henrike/0000-0002-9841-9218; Rosenbluh, Joseph/0000-0001-9815-8049; Tsherniak, Aviad/0000-0002-3797-1877	NIH/NCI [RC2 CA148268, U54 CA143798, K08 CA122833, T32 GM008313, RO1 GM051923-17, U54 CA112962]; H.L. Snyder Medical Foundation; V Foundation; Conquer Cancer Foundation Young Investigator Award; Sass Foundation Fellowship; Marie D. & Pierre Casimir-Lambert Fund; NATIONAL CANCER INSTITUTE [R01CA109467, P01CA050661, RC2CA148268, U54CA151884, U54CA143798, K08CA122833, U54CA112962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM008313, R01GM051923] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); H.L. Snyder Medical Foundation; V Foundation; Conquer Cancer Foundation Young Investigator Award; Sass Foundation Fellowship; Marie D. & Pierre Casimir-Lambert Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Leslie Gaffney and Lauren Solomon for support in generating illustrations and graphics and Jesse Boehm, Scott Carter, George Demartino, and members of the Goldberg and Hahn lab for helpful discussion. This work was supported in part by NIH/NCI grants RC2 CA148268 (W. C. H.), U54 CA143798, K08 CA122833 (R. B.), T32 GM008313 (T.I.Z.), RO1 GM051923-17 (A. L. G and H. C. B.), and U54 CA112962 (A. T., J.P.M., W. C. H.), the H.L. Snyder Medical Foundation (W. C. H.), the V Foundation (R. B.), a Conquer Cancer Foundation Young Investigator Award (D.N.), Sass Foundation Fellowship (D.N.), and the Marie D. & Pierre Casimir-Lambert Fund. S.N.B. is a Howard Hughes Investigator. W. C. H. and R. B. are consultants for Novartis Pharmaceuticals.	Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brose MS, 2002, CANCER RES, V62, P6997; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; FREI E, 1993, LANCET, V342, P662, DOI 10.1016/0140-6736(93)91764-D; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	35	162	167	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					842	854		10.1016/j.cell.2012.07.023	http://dx.doi.org/10.1016/j.cell.2012.07.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901813	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000308002300017
J	Wang, TA; Yu, YV; Govindaiah, G; Ye, XY; Artinian, L; Coleman, TP; Sweedler, JV; Cox, CL; Gillette, MU				Wang, Tongfei A.; Yu, Yanxun V.; Govindaiah, Gubbi; Ye, Xiaoying; Artinian, Liana; Coleman, Todd P.; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.			Circadian Rhythm of Redox State Regulates Excitability in Suprachiasmatic Nucleus Neurons	SCIENCE			English	Article							CLOCK; TRANSCRIPTION; METABOLISM; COMPONENT; NPAS2	Daily rhythms of mammalian physiology, metabolism, and behavior parallel the day-night cycle. They are orchestrated by a central circadian clock in the brain, the suprachiasmatic nucleus (SCN). Transcription of clock genes is sensitive to metabolic changes in reduction and oxidation (redox); however, circadian cycles in protein oxidation have been reported in anucleate cells, where no transcription occurs. We investigated whether the SCN also expresses redox cycles and how such metabolic oscillations might affect neuronal physiology. We detected self-sustained circadian rhythms of SCN redox state that required the molecular clockwork. The redox oscillation could determine the excitability of SCN neurons through nontranscriptional modulation of multiple potassium (K+) channels. Thus, dynamic regulation of SCN excitability appears to be closely tied to metabolism that engages the clockwork machinery.	[Wang, Tongfei A.; Govindaiah, Gubbi; Artinian, Liana; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Yu, Yanxun V.; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Govindaiah, Gubbi; Ye, Xiaoying; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Ye, Xiaoying; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Coleman, Todd P.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Gillette, Martha U.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	mgillett@illinois.edu	Wang, Tongfei/C-1394-2015; Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Wang, Tongfei/0000-0002-6306-7371; Coleman, Todd/0000-0002-2144-2495; Cox, Charles/0000-0002-1179-7014	National Heart, Lung, and Blood Institute [RO1HL092571 Z ARRA, RO1HL086870]; National Eye Institute [EY014024]; National Institute on Drug Abuse [P30DA018310]; National Science Foundation [CHE 11-11705, CCF09-39370]; NATIONAL EYE INSTITUTE [R56EY014024, R01EY014024] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086870, R01HL092571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S.-H. Tyan for insightful discussions at the inception of this work; G. Robinson, R. Gillette, and J. M. Mitchell for critical feedback; J. M. Ding and G. F. Buchanan for data support; K. E. Weis and J. M. Arnold for technical support; S. C. Liu for data analysis consultation; and M. C. Holtz for manuscript preparation. Research was supported by the National Heart, Lung, and Blood Institute (RO1HL092571 Z ARRA, RO1HL086870) to M.U.G., the National Eye Institute (EY014024) to C.L.C., the National Institute on Drug Abuse (P30DA018310) to J.V.S., and the National Science Foundation (CHE 11-11705 to J.V.S. and CCF09-39370 to T.P.C.). Content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or NSF.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; de Jeu M, 2002, J NEUROPHYSIOL, V88, P869, DOI 10.1152/jn.2002.88.2.869; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Itri JN, 2010, J NEUROPHYSIOL, V103, P632, DOI 10.1152/jn.00670.2009; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Kim WS, 2002, ANAL CHEM, V74, P5614, DOI 10.1021/ac025917q; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; PROSSER RA, 1991, BRAIN RES, V568, P185, DOI 10.1016/0006-8993(91)91396-I; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sullivan DM, 2002, METHOD ENZYMOL, V353, P101; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750	27	138	144	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					839	842		10.1126/science.1222826	http://dx.doi.org/10.1126/science.1222826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22859819	Green Accepted			2022-12-01	WOS:000307535600042
J	Heijnsdijk, EAM; Wever, EM; Auvinen, A; Hugosson, J; Ciatto, S; Nelen, V; Kwiatkowski, M; Villers, A; Paez, A; Moss, SM; Zappa, M; Tammela, TLJ; Makinen, T; Carlsson, S; Korfage, IJ; Essink-Bot, ML; Otto, SJ; Draisma, G; Bangma, CH; Roobol, MJ; Schroder, FH; de Koning, HJ				Heijnsdijk, Eveline A. M.; Wever, Elisabeth M.; Auvinen, Anssi; Hugosson, Jonas; Ciatto, Stefano; Nelen, Vera; Kwiatkowski, Maciej; Villers, Arnauld; Paez, Alvaro; Moss, Sue M.; Zappa, Marco; Tammela, Teuvo L. J.; Makinen, Tuukka; Carlsson, Sigrid; Korfage, Ida J.; Essink-Bot, Marie-Louise; Otto, Suzie J.; Draisma, Gerrit; Bangma, Chris H.; Roobol, Monique J.; Schroder, Fritz H.; de Koning, Harry J.			Quality-of-Life Effects of Prostate-Specific Antigen Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMBINED ANDROGEN BLOCKADE; ACTIVE SURVEILLANCE; COST-EFFECTIVENESS; RADICAL PROSTATECTOMY; CANCER SURVIVORS; RANDOMIZED-TRIAL; LEAD TIME; FOLLOW-UP; OUTCOMES; HEALTH	Background After 11 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men who underwent screening for prostate-specific antigen (PSA) levels. However, the extent to which harms to quality of life resulting from overdiagnosis and treatment counterbalance this benefit is uncertain. Methods On the basis of ERSPC follow-up data, we used Microsimulation Screening Analysis (MISCAN) to predict the number of prostate cancers, treatments, deaths, and quality-adjusted life-years (QALYs) gained after the introduction of PSA screening. Various screening strategies, efficacies, and quality-of-life assumptions were modeled. Results Per 1000 men of all ages who were followed for their entire life span, we predicted that annual screening of men between the ages of 55 and 69 years would result in nine fewer deaths from prostate cancer (28% reduction), 14 fewer men receiving palliative therapy (35% reduction), and a total of 73 life-years gained (average, 8.4 years per prostate-cancer death avoided). The number of QALYs that were gained was 56 (range, -21 to 97), a reduction of 23% from unadjusted life-years gained. To prevent one prostate-cancer death, 98 men would need to be screened and 5 cancers would need to be detected. Screening of all men between the ages of 55 and 74 would result in more life-years gained (82) but the same number of QALYs (56). Conclusions The benefit of PSA screening was diminished by loss of QALYs owing to postdiagnosis long-term effects. Longer follow-up data from both the ERSPC and quality-of-life analyses are essential before universal recommendations regarding screening can be made. (Funded by the Netherlands Organization for Health Research and Development and others.)	[Heijnsdijk, Eveline A. M.; Wever, Elisabeth M.; Korfage, Ida J.; Otto, Suzie J.; Draisma, Gerrit; de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Bangma, Chris H.; Roobol, Monique J.; Schroder, Fritz H.] Erasmus MC, Dept Urol, NL-3000 CA Rotterdam, Netherlands; [Essink-Bot, Marie-Louise] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Auvinen, Anssi] Univ Tampere, Tampere Sch Hlth Sci, FIN-33101 Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Dept Urol, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Makinen, Tuukka] Seinajoki Cent Hosp, Dept Surg, Seinajoki, Finland; [Auvinen, Anssi] Int Agcy Res Canc, F-69372 Lyon, France; [Villers, Arnauld] Ctr Hosp Reg & Univ Lille, Dept Urol, F-59037 Lille, France; [Hugosson, Jonas] Sahlgrens Univ Hosp, Dept Urol, Gothenburg, Sweden; Inst Canc Prevent, Dept Diagnost Med Imaging, Florence, Italy; [Zappa, Marco] Inst Canc Prevent, Epidemiol Unit, Florence, Italy; [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium; [Kwiatkowski, Maciej] Kantonsspital Aarau, Dept Urol, Aarau, Switzerland; [Paez, Alvaro] Hosp Fuenlabrada, Dept Urol, Madrid, Spain; [Moss, Sue M.] Queen Mary Univ London, Ctr Canc Prevent, London, England; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Tampere University; Tampere University; Tampere University Hospital; Seinajoki Central Hospital; World Health Organization; International Agency for Research on Cancer (IARC); Universite de Lille - ISITE; CHU Lille; Sahlgrenska University Hospital; Kantonsspital Aarau AG (KSA); Hospital Universitario Fuenlabrada; University of London; Queen Mary University London; Memorial Sloan Kettering Cancer Center	Heijnsdijk, EAM (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.heijnsdijk@erasmusmc.nl	zappa, marco/AAB-3294-2019; Auvinen, Anssi/AAL-2111-2020; Arnauld, VILLERS A/K-6629-2016; Auvinen, Anssi/AAD-9311-2020; de+Koning, Harry/AAF-9062-2019; PAEZ, ALVARO/G-5458-2012	zappa, marco/0000-0002-6606-9786; Auvinen, Anssi/0000-0003-1125-4818; Arnauld, VILLERS A/0000-0002-6298-7758; de+Koning, Harry/0000-0003-4682-3646; Essink-Bot, Marie-Louise/0000-0002-4650-5886; Carlsson, Sigrid/0000-0003-3553-5710	Netherlands Organization for Health Research and Development, Europe against Cancer; fifth and sixth framework program of the European Union; agencies or health authorities in the participating countries; Beckman Coulter; Abbott Pharmaceuticals; GlaxoSmithKline; Astellas Pharma; Amgen; Pfizer; Orion Pharma; Abbott; 365/ArboNed; Ferring; Societe International d'Urologie; European Association of Urology; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Netherlands Organization for Health Research and Development, Europe against Cancer; fifth and sixth framework program of the European Union; agencies or health authorities in the participating countries; Beckman Coulter; Abbott Pharmaceuticals(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Astellas Pharma(Astellas Pharmaceuticals); Amgen(Amgen); Pfizer(Pfizer); Orion Pharma; Abbott(Abbott Laboratories); 365/ArboNed; Ferring(Ferring Pharmaceuticals); Societe International d'Urologie; European Association of Urology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Netherlands Organization for Health Research and Development, Europe against Cancer, and the fifth and sixth framework program of the European Union; by grants from agencies or health authorities in the participating countries; and by unconditional grants from Beckman Coulter.; Dr. Heijnsdijk reports receiving consulting fees from Beckman Coulter; Dr. Hugosson, receiving lecture fees from Abbott Pharmaceuticals and GlaxoSmithKline; Dr. Kwiatkowski, receiving consulting fees from GlaxoSmithKline; Dr. Villers, serving as a board member of GlaxoSmithKline and receiving travel support from Ferring; Dr. Tammela, receiving consulting fees from Astellas Pharma, GlaxoSmithKline, Amgen, Pfizer, and Orion Pharma, lecture fees from Abbott, GlaxoSmithKline, and Amgen, and travel support from Amgen; Dr. Essink-Bot, receiving lecture fees from 365/ArboNed; Dr. Draisma, receiving consulting fees from Beckman Coulter; Dr. Schorder, serving as a board member for European Urology, receiving consulting fees from GlaxoSmithKline and Ferring, and receiving lecture fees and travel support from GlaxoSmithKline, Ferring, Societe International d'Urologie, and the European Association of Urology; and Dr. de Koning, receiving consulting fees from Beckman Coulter. No other potential conflict of interest relevant to this article was reported.	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], FDSF; [Anonymous], EUR STAND POP; Auvinen A, 2009, CANCER EPIDEM BIOMAR, V18, P2000, DOI 10.1158/1055-9965.EPI-09-0146; Bennett CL, 1996, CANCER-AM CANCER SOC, V77, P1854; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Boorjian SA, 2011, CANCER-AM CANCER SOC, V117, P2883, DOI 10.1002/cncr.25900; Calvert NW, 2003, BRIT J CANCER, V88, P31, DOI 10.1038/sj.bjc.6600630; Carlsson S, 2011, EUR J CANCER, V47, P545, DOI 10.1016/j.ejca.2010.10.016; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P2825, DOI 10.1002/cncr.25914; Cooperberg MR, 2011, J CLIN ONCOL, V29, P3669, DOI 10.1200/JCO.2011.34.9738; Crawford ED, 2008, EUR UROL, V54, P262, DOI 10.1016/j.eururo.2008.05.032; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; Hayes JH, 2011, JAMA-J AM MED ASSOC, V305, P1862, DOI 10.1001/jama.2011.587; Hugosson J, 2000, BJU INT, V85, P1078, DOI 10.1046/j.1464-410x.2000.00679.x; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ilic D, 2007, CANCER CAUSE CONTROL, V18, P279, DOI 10.1007/s10552-006-0087-6; Institute for Clinical Research and Health Policy Studies, COST EFF AN REG; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Konski A, 2006, CANCER, V106, P51, DOI 10.1002/cncr.21575; Konski A, 2005, INT J RADIAT ONCOL, V63, P788, DOI 10.1016/j.ijrobp.2005.03.010; Korfage IJ, 2006, SOC SCI MED, V63, P911, DOI 10.1016/j.socscimed.2006.01.027; Korfage IJ, 2005, INT J CANCER, V116, P291, DOI 10.1002/ijc.21043; Korfage IJ, 2006, EUR J CANCER, V42, P165, DOI 10.1016/j.ejca.2005.10.011; Madalinska JB, 2001, J CLIN ONCOL, V19, P1619, DOI 10.1200/JCO.2001.19.6.1619; Moeremans K, 2004, VALUE HEALTH, V7, P472, DOI 10.1111/j.1524-4733.2004.74010.x; Mols F, 2009, INT J RADIAT ONCOL, V73, P30, DOI 10.1016/j.ijrobp.2008.04.004; Penson DF, 2005, J UROLOGY, V174, P547, DOI 10.1097/01.ju.0000165569.48372.4c; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Ramsey S, 2005, UROLOGY, V66, P835, DOI 10.1016/j.urology.2005.04.028; Roobol MJ, 2010, EUR UROL, V57, P79, DOI 10.1016/j.eururo.2009.08.025; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroder FH, 2003, BJU INT, V92, P1, DOI 10.1111/j.1464-410X.2003.04389.x; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Stattin P, 2008, J UROLOGY, V180, P2423, DOI 10.1016/j.juro.2008.08.044; Stewart ST, 2005, MED CARE, V43, P347, DOI 10.1097/01.mlr.0000156862.33341.45; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; Thong MSY, 2010, BJU INT, V105, P652, DOI 10.1111/j.1464-410X.2009.08815.x; van den Bergh RCN, 2007, EUR UROL, V52, P1560, DOI 10.1016/j.eururo.2007.05.011; van den Bergh RCN, 2009, EUR UROL, V55, P1, DOI 10.1016/j.eururo.2008.09.007; Wolters T, 2010, INT J CANCER, V126, P2387, DOI 10.1002/ijc.24870; Zappa M, 1998, ANN ONCOL, V9, P1297, DOI 10.1023/A:1008492013196; Zeliadt SB, 2005, AM J MED, V118, P850, DOI 10.1016/j.amjmed.2005.03.001	54	297	310	3	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					595	605		10.1056/NEJMoa1201637	http://dx.doi.org/10.1056/NEJMoa1201637			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894572	Green Accepted			2022-12-01	WOS:000307496600003
J	Lowenthal, J; Hull, SC; Pearson, SD				Lowenthal, Justin; Hull, Sara Chandros; Pearson, Steven D.			The Ethics of Early Evidence - Preparing for a Possible Breakthrough in Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lowenthal, Justin; Hull, Sara Chandros; Pearson, Steven D.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Hull, Sara Chandros] NHGRI, NIH, Off Clin Director, Bethesda, MD 20892 USA; [Pearson, Steven D.] Massachusetts Gen Hosp, Inst Clin & Econ Review, Inst Technol Assessment, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Massachusetts General Hospital	Lowenthal, J (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.		Lowenthal, Justin/H-3728-2013	Lowenthal, Justin/0000-0001-5909-0520	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIDHG200347] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HG999999] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dresser R, 2009, J LAW MED ETHICS, V37, P476, DOI 10.1111/j.1748-720X.2009.00408.x; Food and Drug Administration, 2011, TARGR BEX CAPS 75 MG; Frost J, 2011, J MED INTERNET RES, V13, P129, DOI 10.2196/jmir.1643; Wang SS, 2012, WALL STREET J, pA3	5	16	28	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					488	490		10.1056/NEJMp1203104	http://dx.doi.org/10.1056/NEJMp1203104			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986AE	22873528	Green Accepted			2022-12-01	WOS:000307310800002
J	Kit, BK; Carroll, MD; Lacher, DA; Sorlie, PD; DeJesus, JM; Ogden, CL				Kit, Brian K.; Carroll, Margaret D.; Lacher, David A.; Sorlie, Paul D.; DeJesus, Janet M.; Ogden, Cynthia L.			Trends in Serum Lipids Among US Youths Aged 6 to 19 Years, 1988-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; UNITED-STATES; CHILDREN; ADOLESCENTS; CHILDHOOD; PREVALENCE; ADULTHOOD; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS	Context For more than 20 years, primary prevention of coronary heart disease has included strategies intended to improve overall serum lipid concentrations among youths. Objective To examine trends in lipid concentrations among youths from 19881994 through 2007-2010. Design, Setting, and Participants Cross-sectional analysis of serum lipid concentrations among 16 116 youths aged 6 to 19 years who participated in the nationally representative National Health and Nutrition Examination Survey during 3 time periods: 1988-1994, 1999-2002, and 2007-2010. Main Outcome Measures Among all youths, mean serum total cholesterol (TC), non-high-density lipoprotein cholesterol (non-HDL-C), high-density lipoprotein cholesterol (HDL-C); and among adolescents only, low-density lipoprotein cholesterol (LDL-C) and geometric mean triglyceride levels. Trends in adverse lipid concentrations are reported for TC levels of 200 mg/dL and greater, non-HDL-C levels of 145 mg/dL and greater, HDL-C levels of less than 40 mg/dL, LDL-C levels of 130 mg/dL and greater, and triglyceride levels of 130 mg/dL and greater. Results Among youths aged 6 to 19 years between 1988-1994 and 2007-2010, there was a decrease in mean TC (from 165 mg/dL [95% CI, 164-167] to 160 mg/dL [95% CI, 158-161]; P<.001) and a decrease in the prevalence of elevated TC (from 11.3% [95% CI, 9.8%-12.7%] to 8.1% [95% CI, 6.7%-9.5%]; P=.002). Mean HDL-C significantly increased between 1988-1994 and 2007-2010, but the prevalence of low HDL-C did not change. Mean non-HDL-C and prevalence of elevated non-HDL-C both significantly decreased over the study period. In 2007-2010, 22% (95% CI, 20.3%-23.6%) of youths had either a low HDL-C level or high non-HDL-C, which was lower than the 27.2% (95% CI, 24.6%-29.7%) in 1988-1994 (P=.001). Among adolescents (aged 12-19 years) between 1988-1994 and 2007-2010, there was a decrease in mean LDL-C (from 95 mg/dL [95% CI, 92-98] to 90 mg/dL [95% CI, 88-91]; P=.003) and a decrease in geometric mean triglycerides (from 82 mg/dL [95% CI, 78-86] to 73 mg/dL [95% CI, 70-76]; P<.001). Prevalence of elevated LDL-C and triglycerides between 1988-1994 and 2007-2010 also significantly decreased. Conclusions Between 1988-1994 and 2007-2010, a favorable trend in serum lipid concentrations was observed among youths in the United States but almost 1 in 10 had elevated TC in 2007-2010. JAMA. 2012;308(6):591-600	[Kit, Brian K.; Carroll, Margaret D.; Lacher, David A.; Ogden, Cynthia L.] Ctr Dis Control & Prevent, Div Hlth & Nutr Examinat Surveys, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Kit, Brian K.] US PHS, Rockville, MD USA; [Sorlie, Paul D.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [DeJesus, Janet M.] NHLBI, Div Applicat Res Discoveries, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); United States Public Health Service; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kit, BK (corresponding author), Ctr Dis Control & Prevent, Div Hlth & Nutr Examinat Surveys, Natl Ctr Hlth Stat, 3311 Toledo Rd,MS PO8,Room 4419, Hyattsville, MD 20782 USA.	bkit@cdc.gov			National Heart, Lung, and Blood Institute, National Institutes of Health [Y1-HC-8039]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The laboratory analysis of the lipids described in this paper was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, Intra-agency Agreement number Y1-HC-8039.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 1995, JAMA, V273, P1429; [Anonymous], 1991, ARCH INTERN MED, V151, P1071, DOI 10.1001/archinte.151.6.1071; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1992, Pediatrics, V89, P525; [Anonymous], 2011, PEDIATRICS S5, V128, pS213, DOI [10.1542/peds.2009-2107C, DOI 10.1542/PEDS.2009-2107C]; BACHORIK PS, 1984, CLIN CHEM, V30, P839; BERENSON GS, 1981, AM J EPIDEMIOL, V113, P157, DOI 10.1093/oxfordjournals.aje.a113080; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Centers for Disease Control and Prevention Division of Adolescent and School Health, 1991, TRENDS PREV TOB US N; Centers for Disease Control and Prevention/National Center for Health Statistics, NHANES 2009 2010 PUB; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN HIGH DE; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN TRIGL; Centers for Disease Control and Prevention/National Center for Health Statistics, NHANES 1999 2010; Centers for Disease Control and Prevention/National Center for Health Statistics/Division of Health and Nutrition Surveys, 2010, LAB PROC MAN TOT CHO; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; DONAHUE RP, 1985, AM J EPIDEMIOL, V122, P458, DOI 10.1093/oxfordjournals.aje.a114127; FELDMAN J, 1991, PEDIATRICS, V88, P259; Ford ES, 2009, CIRCULATION, V119, P1108, DOI 10.1161/CIRCULATIONAHA.108.816769; Ford ES, 2004, PEDIATRICS, V114, P1534, DOI 10.1542/peds.2004-0674; Freedman DS, 2012, PEDIATRICS, V130, pE159, DOI 10.1542/peds.2011-3302; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedman LA, 2006, PEDIATRICS, V118, P165, DOI 10.1542/peds.2005-2968; Frontini MG, 2008, PEDIATRICS, V121, P924, DOI 10.1542/peds.2007-1472; Hickman TB, 1998, PREV MED, V27, P879, DOI 10.1006/pmed.1998.0376; Klish WJ, 1998, PEDIATRICS, V101, P141; Kuczmarski RJ., 2000, CDC GROWTH CHARTS US; LAUER RM, 1990, JAMA-J AM MED ASSOC, V264, P3034, DOI 10.1001/jama.264.23.3034; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; National Center for Health Statistics, NHANES RESP RAT CPS; National Center for Health Statistics, 2010, HLTH US 2010; Neufeld EJ, 1997, CIRCULATION, V96, P1403, DOI 10.1161/01.CIR.96.5.1403; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010; Research Triangle Institute, SUDAAN LANG MAN REL; Schober S. E., 2008, Morbidity and Mortality Weekly Report, V57, P744; Sofianou A, 2011, J AM DIET ASSOC, V111, P1563, DOI 10.1016/j.jada.2011.07.005; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; The Centers for Disease Control and Prevention /Lipid Standardization Program, 2012, LAB QUAL ASS STAND P; THORLAND WG, 1981, MED SCI SPORT EXER, V13, P316; US Department of Agriculture & US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Dept of Agriculture Agriculture Research Service, PERC EN PROT CARB FA; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Wahlefeld A.W., 1974, METHODS ENZYMATIC AN, P1604; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166; Wiegman A, 2004, JAMA-J AM MED ASSOC, V292, P331, DOI 10.1001/jama.292.3.331; Winer B.J., 1971, STAT PRINCIPLES EXPT; Wolters K.M., 1990, VARIANCE ESTIMATION	54	92	95	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					591	600		10.1001/jama.2012.9136	http://dx.doi.org/10.1001/jama.2012.9136			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871871	Bronze			2022-12-01	WOS:000307228400026
J	Kellosalo, J; Kajander, T; Kogan, K; Pokharel, K; Goldman, A				Kellosalo, Juho; Kajander, Tommi; Kogan, Konstantin; Pokharel, Kisun; Goldman, Adrian			The Structure and Catalytic Cycle of a Sodium-Pumping Pyrophosphatase	SCIENCE			English	Article							H+-PYROPHOSPHATASE; SUBSTRATE; K+	Membrane-integral pyrophosphatases (M-PPases) are crucial for the survival of plants, bacteria, and protozoan parasites. They couple pyrophosphate hydrolysis or synthesis to Na+ or H+ pumping. The 2.6-angstrom structure of Thermotoga maritima M-PPase in the resting state reveals a previously unknown solution for ion pumping. The hydrolytic center, 20 angstroms above the membrane, is coupled to the gate formed by the conserved Asp(243), Glu(246), and Lys(707) by an unusual "coupling funnel" of six a helices. Comparison with our 4.0-angstrom resolution structure of the product complex suggests that helix 12 slides down upon substrate binding to open the gate by a simple binding-change mechanism. Below the gate, four helices form the exit channel. Superimposing helices 3 to 6, 9 to 12, and 13 to 16 suggests that M-PPases arose through gene triplication.	[Kellosalo, Juho; Kajander, Tommi; Kogan, Konstantin; Pokharel, Kisun; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Struct Biol & Biophys Program, FIN-00014 Helsinki, Finland; [Kellosalo, Juho] Grad Sch Informat & Struct Biol, Helsinki, Finland; [Pokharel, Kisun] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland	University of Helsinki; University of Turku	Goldman, A (corresponding author), Univ Helsinki, Inst Biotechnol, Struct Biol & Biophys Program, POB 65, FIN-00014 Helsinki, Finland.	adrian.goldman@helsinki.fi	Pokharel, Kisun/D-4628-2011	Pokharel, Kisun/0000-0002-4924-946X; Kajander, Tommi/0000-0002-5094-227X; Goldman, Adrian/0000-0001-8032-9700; Kogan, Konstantin/0000-0003-3270-9391	European Union Seventh Framework Program EDICT; Sigrid Juselius Foundation; Academy of Finland; Biocenter Finland; National Graduate School of Informational and Structural Biology	European Union Seventh Framework Program EDICT; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Biocenter Finland; National Graduate School of Informational and Structural Biology	We thank D. Bansfield, K. Rosti, and R. Honkanen for technical assistance; S. Maki and the Biocenter Finland crystallization unit; A. Serrano (University of Seville) for the generous gift of plasmid pRS1024; I. Braakman (Utrecht University) for the generous gift of S. cerevisae BJ1991; and R. Kolodziejczyk, M. Wikstrom (University of Helsinki), E. Oksanen (European Spallation Source), and R. Lahti (University of Turku) for fruitful discussions. This work was supported by the European Union Seventh Framework Program EDICT (A.G.), the Sigrid Juselius Foundation (A.G.), the Academy of Finland (A.G. and T.K.), Biocenter Finland (K.K.), and the National Graduate School of Informational and Structural Biology (J.K.). We thank the beamline scientists at ID14-4, ID29, ID23-1 at the European Synchrotron Radiation Facility and at beamline 911-3, Max-Lab. Coordinates and structure factors for the resting state (TmPPase:Ca:Mg) and product complex (TmPPase:Pi<INF>2</INF>:Mg<INF>4</INF>) structures have been deposited in the Protein Data Bank with codes 4AV3 and 4AV6, respectively. The authors declare no competing financial interests.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; BAYKOV AA, 1994, FEBS LETT, V350, P323, DOI 10.1016/0014-5793(94)00800-0; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Hedlund J, 2006, FEBS J, V273, P5183, DOI 10.1111/j.1742-4658.2006.05514.x; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Kellosalo J, 2011, PROTEIN EXPRES PURIF, V79, P25, DOI 10.1016/j.pep.2011.05.020; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Luoto HH, 2011, J BIOL CHEM, V286, P21633, DOI 10.1074/jbc.M111.244483; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Malinen AM, 2008, BIOCHEMISTRY-US, V47, P13447, DOI 10.1021/bi801803b; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0	20	100	102	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					473	476		10.1126/science.1222505	http://dx.doi.org/10.1126/science.1222505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837527				2022-12-01	WOS:000306802300045
J	Deeks, SG; Barre-Sinoussi, F				Deeks, Steven G.; Barre-Sinoussi, Francoise			Towards a cure for HIV	NATURE			English	Editorial Material									[Deeks, Steven G.] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Barre-Sinoussi, Francoise] Inst Pasteur, Inst Natl Sante & Rech Med, F-75724 Paris, France	University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Deeks, SG (corresponding author), Univ Calif San Francisco, San Francisco, CA 94110 USA.	sdeeks@php.ucsf.edu	Barre-Sinoussi, Françoise/G-8355-2011					[Anonymous], NATURE REV IN PRESS; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2	3	17	17	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					293	294		10.1038/487293a	http://dx.doi.org/10.1038/487293a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JB	22810677	Bronze			2022-12-01	WOS:000306506500015
J	Gaston, KJ				Gaston, Kevin J.			ECOLOGY The importance of being rare	NATURE			English	Editorial Material									Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, England	University of Exeter	Gaston, KJ (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, England.	k.j.gaston@exeter.ac.uk		Gaston, Kevin J./0000-0002-7235-7928				Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Gaston KJ, 2011, BIOSCIENCE, V61, P354, DOI 10.1525/bio.2011.61.5.4; Hubbell Stephen P., 2001, V32, pi; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999	5	29	32	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					46	47		10.1038/487046a	http://dx.doi.org/10.1038/487046a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968LM	22763551				2022-12-01	WOS:000305982900044
J	Hendricks, M; Ha, H; Maffey, N; Zhang, Y				Hendricks, Michael; Ha, Heonick; Maffey, Nicolas; Zhang, Yun			Compartmentalized calcium dynamics in a C. elegans interneuron encode head movement	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GLUTAMATE-RECEPTOR; NERVOUS-SYSTEM; BEHAVIOR; CIRCUIT; DENDRITES; G(Q)ALPHA; RELEASE; NEURONS; PATHWAY	The confinement of neuronal activity to specific subcellular regions is a mechanism for expanding the computational properties of neurons. Although the circuit organization underlying compartmentalized activity has been studied in several systems(1-4), its cellular basis is still unknown. Here we characterize compartmentalized activity in Caenorhabditis elegans RIA interneurons, which have multiple reciprocal connections to head motor neurons and receive input from sensory pathways. We show that RIA spatially encodes head movement on a subcellular scale through axonal compartmentalization. This subcellular axonal activity is dependent on acetylcholine release from head motor neurons and is simultaneously present and additive with glutamate-dependent globally synchronized activity evoked by sensory inputs. Postsynaptically, the muscarinic acetylcholine receptor GAR-3 acts in RIA to compartmentalize axonal activity through the mobilization of intracellular calcium stores. The compartmentalized activity functions independently of the synchronized activity to modulate locomotory behaviour.	[Hendricks, Michael; Ha, Heonick; Maffey, Nicolas; Zhang, Yun] Harvard Univ, Ctr Brain Sci, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Zhang, Y (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	yzhang@oeb.harvard.edu		Hendricks, Michael/0000-0002-3408-3858	Esther A. and Joseph Klingenstein Fund; March of Dimes Foundation; Alfred P. Sloan Foundation; John Merck Fund; National Institutes of Health [DC009852]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009852] Funding Source: NIH RePORTER	Esther A. and Joseph Klingenstein Fund; March of Dimes Foundation(March of Dimes); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); John Merck Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the Caenorhabditis Genetics Center and C. elegans Gene Knockout Consortium for C. elegans strains; the Wellcome Trust Sanger Institute for cosmid; C. Bargmann for the TeTx cDNA, eat-4 cDNA and Pttx-3::GCaMP strain; Y. Kohara for the gar-3 cDNA; J. Nakai for the GCaMP DNA; N. Bhatla for help with integration; L. Tian and L. Looger for the GCaMP3.3 plasmid; Y. Shen for the lad-2 promoter; and C. Bargmann, K. Blum, F. Engert, C. Fang-Yen, S. Hendricks, S. Jesuthasan, A. Samuel, J. Sanes, E. Soucy and members of the Zhang laboratory for advice and discussion. M. H. thanks S. Moser for personal support. This work was supported by funding from The Esther A. and Joseph Klingenstein Fund, the March of Dimes Foundation, the Alfred P. Sloan Foundation, the John Merck Fund and the National Institutes of Health (DC009852) to Y.Z.	Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; Lockery SR, 2011, CURR OPIN NEUROBIOL, V21, P782, DOI 10.1016/j.conb.2011.06.009; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Park YS, 2003, BIOCHEM BIOPH RES CO, V308, P961, DOI 10.1016/S0006-291X(03)01508-0; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Steger KA, 2004, GENETICS, V167, P633, DOI 10.1534/genetics.103.020230; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang XL, 2008, J CELL BIOL, V180, P233, DOI 10.1083/jcb.200704178; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhu JJ, 2001, J NEUROSCI, V21, P1148	30	94	95	5	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2012	487	7405					99	+		10.1038/nature11081	http://dx.doi.org/10.1038/nature11081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722842	Green Accepted			2022-12-01	WOS:000305982900058
J	Landrum, ML; Neumann, C; Cook, C; Chukwuma, U; Ellis, MW; Hospenthal, DR; Murray, CK				Landrum, Michael L.; Neumann, Charlotte; Cook, Courtney; Chukwuma, Uzo; Ellis, Michael W.; Hospenthal, Duane R.; Murray, Clinton K.			Epidemiology of Staphylococcus aureus Blood and Skin and Soft Tissue Infections in the US Military Health System, 2005-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE UNITS; METHICILLIN-RESISTANT; STREAM INFECTIONS; STATES; HOSPITALIZATIONS; HOSPITALS; STRAINS; DISEASE; TRIAL; RISK	Context Rates of hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) infections are reported as decreasing, but recent rates of community-onset S aureus infections are less known. Objectives To characterize the overall and annual incidence rates of community-onset and hospital-onset S aureus bacteremia and skin and soft tissue infections (SSTIs) in a national health care system and to evaluate trends in the incidence rates of S aureus bacteremia and SSTIs and the proportion due to MRSA. Design, Setting, and Participants Observational study of all Department of Defense TRICARE beneficiaries from January 2005 through December 2010. Medical record databases were used to identify and classify all annual first-positive S aureus blood and wound or abscess cultures as methicillin-susceptible S aureus or MRSA, and as community-onset or hospital-onset infections (isolates collected >3 days after hospital admission). Main Outcome Measures Unadjusted incidence rates per 100 000 person-years of observation, the proportion of infections that was due to MRSA, and annual trends for 2005 through 2010 (examined using the Spearman rank correlation test or the Mantel-Haenszel chi(2) test for linear trend). Results During 56 million person-years (nonactive duty: 47 million person-years; active duty: 9 million person-years), there were 2643 blood and 80 281 wound or abscess annual first-positive Saureus cultures. Annual incidence rates varied from 3.6 to 6.0 per 100 000 person-years for S aureus bacteremia and 122.7 to 168.9 per 100 000 person-years for S aureus SSTIs. The annual incidence rates for community-onset MRSA bacteremia decreased from 1.7 per 100 000 person-years (95% CI, 1.5-2.0 per 100 000 person-years) in 2005 to 1.2 per 100 000 person-years (95% CI, 0.9-1.4 per 100 000 person-years) in 2010 (P=.005 for trend). The annual incidence rates for hospital-onset MRSA bacteremia also decreased from 0.7 per 100 000 person-years (95% CI, 0.6-0.9 per 100 000 person-years) in 2005 to 0.4 per 100 000 person-years (95% CI, 0.3-0.5 per 100 000 person-years) in 2010 (P=.005 for trend). Concurrently, the proportion of community-onset SSTI due to MRSA peaked at 62% in 2006 before decreasing annually to 52% in 2010 (P<.001 for trend). Conclusion In the Department of Defense population consisting of men and women of all ages from across the United States, the rates of both community-onset and hospital-onset MRSA bacteremia decreased in parallel, while the proportion of community-onset SSTIs due to MRSA has more recently declined. JAMA. 2012;308(1):50-59 www.jama.com	[Landrum, Michael L.; Hospenthal, Duane R.; Murray, Clinton K.] San Antonio Military Med Ctr, Infect Dis Serv, Ft Sam Houston, TX 78234 USA; [Landrum, Michael L.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Ellis, Michael W.] Uniformed Serv Univ Hlth Sci, Div Infect Dis, Bethesda, MD 20814 USA; [Neumann, Charlotte; Cook, Courtney; Chukwuma, Uzo] Navy & Marine Corps Public Hlth Ctr, EpiData Ctr Dept, Portsmouth, VA USA; [Landrum, Michael L.] Bellin Hlth, Green Bay, WI USA	San Antonio Military Medical Center; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Murray, CK (corresponding author), San Antonio Military Med Ctr, Infect Dis Serv, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	clinton.murray@amedd.army.mil			National Institute of Allergy and Infectious Diseases, National Institutes of Health [Y1-AI-5072]; Global Emerging Infections Surveillance and Response Program; Armed Forces Health Surveillance Center; Navy and Marine Corps Public Health Center (NMCPHC); Postgraduate Research Participation Program at the Navy and Marine Corps Public Health Center; IDCRP, a Department of Defense program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Global Emerging Infections Surveillance and Response Program; Armed Forces Health Surveillance Center; Navy and Marine Corps Public Health Center (NMCPHC); Postgraduate Research Participation Program at the Navy and Marine Corps Public Health Center; IDCRP, a Department of Defense program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under interagency agreement Y1-AI-5072. Support for this work was leveraged from grants provided by the Global Emerging Infections Surveillance and Response Program, Armed Forces Health Surveillance Center to the EpiData Center Department, Navy and Marine Corps Public Health Center (NMCPHC). Additional support was also provided in part by an appointment to the Postgraduate Research Participation Program at the Navy and Marine Corps Public Health Center administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the NMCPHC. At the time of the research for this study and writing of this article, Dr Landrum was an employee of the Infectious Disease Clinical Research Program (IDCRP). As such, he received support for this work provided by the IDCRP, a Department of Defense program executed through the Uniformed Services University of the Health Sciences.	Army Medical Surveillance Activity, 2006, MED SURVEILLANCE MON, V12, P208; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P992; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Crum NF, 2006, AM J MED, V119, P943, DOI 10.1016/j.amjmed.2006.01.004; El Atrouni WI, 2009, CLIN INFECT DIS, V49, pE130, DOI 10.1086/648442; Ellis MW, 2007, ANTIMICROB AGENTS CH, V51, P3591, DOI 10.1128/AAC.01086-06; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Hidron AI, 2011, AIDS, V25, P1001, DOI 10.1097/QAD.0b013e328343c595; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jenkins TC, 2009, INFECT CONT HOSP EP, V30, P233, DOI 10.1086/595963; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Kern WV, 2010, CURR OPIN INFECT DIS, V23, P346, DOI 10.1097/QCO.0b013e32833bcc8a; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kuehnert MJ, 2005, EMERG INFECT DIS, V11, P868; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Popovich KJ, 2011, 49 ANN M INF DIS SOC; Roalfe AK, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-275; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Stenehjem E, 2011, 49 ANN M INF DIS SOC; US Department of Defense, TRICARE POL ACC CAR; Velasco D, 2005, J ANTIMICROB CHEMOTH, V55, P379, DOI 10.1093/jac/dki017; Whitman TJ, 2010, INFECT CONT HOSP EP, V31, P1207, DOI 10.1086/657136	32	155	165	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2012	308	1					50	59		10.1001/jama.2012.7139	http://dx.doi.org/10.1001/jama.2012.7139			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971DD	22760291				2022-12-01	WOS:000306183000023
J	Clark, PJ; Muir, AJ				Clark, Paul J.; Muir, Andrew J.			Overcoming Barriers to Care for Hepatitis C	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Clark, Paul J.] Duke Univ, Med Ctr, Dept Gastroenterol, Durham, NC 27708 USA; Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University	Clark, PJ (corresponding author), Duke Univ, Med Ctr, Dept Gastroenterol, Durham, NC 27708 USA.		Clark, Paul J/A-1480-2012	Clark, Paul J/0000-0002-1821-4969				Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Chung RT, 2012, NEW ENGL J MED, V366, P273, DOI 10.1056/NEJMe1113272; *I MED COMM PREV C, 2010, HEP LIV CANC NAT STR; Stepanova M, 2011, HEPATOLOGY, V53, P737, DOI 10.1002/hep.24131; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220	5	24	24	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2436	2438		10.1056/NEJMp1202608	http://dx.doi.org/10.1056/NEJMp1202608			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965DP	22738095				2022-12-01	WOS:000305747000002
J	Conley, DJ				Conley, Daniel J.			Save the Baltic Sea	NATURE			English	Editorial Material									Lund Univ, GeoBiosphere Sci Ctr, Dept Geol, S-22100 Lund, Sweden	Lund University	Conley, DJ (corresponding author), Lund Univ, GeoBiosphere Sci Ctr, Dept Geol, S-22100 Lund, Sweden.	daniel.conley@geol.lu.se		Conley, Daniel Joseph/0000-0001-9668-9284				Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3407, DOI 10.1021/es8027633; Gustafsson B. G, 2012, AMBIO; Kumblad L., 2011, FOSFORFALLNING FORBA; Meier HEM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049929; Stigebrandt A, 2007, AMBIO, V36, P280, DOI 10.1579/0044-7447(2007)36[280:IOBPWQ]2.0.CO;2	5	82	83	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					463	464		10.1038/486463a	http://dx.doi.org/10.1038/486463a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739295				2022-12-01	WOS:000305760600016
J	Harris, TH; Banigan, EJ; Christian, DA; Konradt, C; Wojno, EDT; Norose, K; Wilson, EH; John, B; Weninger, W; Luster, AD; Liu, AJ; Hunter, CA				Harris, Tajie H.; Banigan, Edward J.; Christian, David A.; Konradt, Christoph; Wojno, Elia D. Tait; Norose, Kazumi; Wilson, Emma H.; John, Beena; Weninger, Wolfgang; Luster, Andrew D.; Liu, Andrea J.; Hunter, Christopher A.			Generalized Levy walks and the role of chemokines in migration of effector CD8(+) T cells	NATURE			English	Article							TOXOPLASMA-GONDII; RESISTANCE; MOVEMENT; MOTILITY; SUCCESS; LAWS	Chemokines have a central role in regulating processes essential to the immune function of T cells(1-3), such as their migration within lymphoid tissues and targeting of pathogens in sites of inflammation. Here we track T cells using multi-photon microscopy to demonstrate that the chemokine CXCL10 enhances the ability of CD8(+) T cells to control the pathogen Toxoplasma gondii in the brains of chronically infected mice. This chemokine boosts T-cell function in two different ways: it maintains the effector T-cell population in the brain and speeds up the average migration speed without changing the nature of the walk statistics. Notably, these statistics are not Brownian; rather, CD8(+) T-cell motility in the brain is well described by a generalized Levy walk. According to our model, this unexpected feature enables T cells to find rare targets with more than an order of magnitude more efficiency than Brownian random walkers. Thus, CD8(+) T-cell behaviour is similar to Levy strategies reported in organisms ranging from mussels to marine predators and monkeys(4-10), and CXCL10 aids T cells in shortening the average time taken to find rare targets.	[Banigan, Edward J.; Liu, Andrea J.] Univ Penn, Sch Arts & Sci, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Harris, Tajie H.; Christian, David A.; Konradt, Christoph; Wojno, Elia D. Tait; John, Beena; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Norose, Kazumi] Chiba Univ, Grad Sch Med, Dept Infect & Host Def, Chuo Ku, Chiba 2608670, Japan; [Wilson, Emma H.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Weninger, Wolfgang] Centenary Inst, Newtown, NSW 2042, Australia; [Weninger, Wolfgang] Sydney Med Sch, Discipline Dermatol, Sydney, NSW 2006, Australia; [Luster, Andrew D.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA	University of Pennsylvania; University of Pennsylvania; Chiba University; University of California System; University of California Riverside; University of Sydney; Centenary Institute; University of Sydney; Harvard University; Massachusetts General Hospital	Liu, AJ (corresponding author), Univ Penn, Sch Arts & Sci, Dept Phys & Astron, 209 S 33rd St, Philadelphia, PA 19104 USA.	ajliu@physics.upenn.edu; chunter@vet.upenn.edu	Liu, Andrea/GYD-4759-2022; Liu, Andrea J/K-3968-2017; Christian, David/AAE-6425-2019; Luster, Andrew/ABE-6504-2020	Liu, Andrea/0000-0002-2295-2729; Liu, Andrea J/0000-0002-2295-2729; Luster, Andrew/0000-0001-9679-7912; Banigan, Edward/0000-0001-5478-7425; Weninger, Wolfgang/0000-0003-3133-8699; Harris, Tajie/0000-0002-1355-2109; Tait Wojno, Elia/0000-0003-2822-296X	National Institutes of Health [AI-41158, AI-42334, EY-021314, T32-AI-055400, AI-081478, CA-069212, RNS-072298, AI-090234]; National Science Foundation [DMR-0520020, DMR-1104637]; state of Pennsylvania; Japan Society for the Promotion of Science [20592071]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Direct For Mathematical & Physical Scien [1104637] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY021314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090234, F32AI098374, T32AI007532, T32AI055400, F32AI081478, R01AI042334, R01AI041158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); state of Pennsylvania; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health AI-41158 (C. A. H.), AI-42334 (C. A. H.), EY-021314 (C. A. H.), T32-AI-055400 (T. H. H.), AI-081478 (T. H. H.), CA-069212 (A. D. L.), RNS-072298 (E. H. W.) and AI-090234 (B.J.); the National Science Foundation DMR-0520020 (E.J.B.) and DMR-1104637 (E.J.B. and A.J.L.); the state of Pennsylvania; Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research Grant 20592071 (K.N.); and the Ministry of Education, Culture, Sports, Science and Technology of Japan (K.N.). We acknowledge L. Zhang and the Penn Vet Imaging Facility for technical assistance.	Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Denkers EY, 1997, J IMMUNOL, V159, P1903; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Li YM, 2004, J EXP MED, V200, P613, DOI 10.1084/jem.20040725; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pepper M, 2004, INFECT IMMUN, V72, P7240, DOI 10.1128/IAI.72.12.7240-7246.2004; Potdar AA, 2009, ANN BIOMED ENG, V37, P230, DOI 10.1007/s10439-008-9592-y; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Strack A, 2002, GLIA, V40, P372, DOI 10.1002/glia.10104; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013; ZUMOFEN G, 1995, PHYS REV E, V51, P1818, DOI 10.1103/PhysRevE.51.1818	33	345	350	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					545	U145		10.1038/nature11098	http://dx.doi.org/10.1038/nature11098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722867	Green Accepted, Green Submitted			2022-12-01	WOS:000305760600046
J	Murooka, TT; Deruaz, M; Marangoni, F; Vrbanac, VD; Seung, E; von Andrian, UH; Tager, AM; Luster, AD; Mempel, TR				Murooka, Thomas T.; Deruaz, Maud; Marangoni, Francesco; Vrbanac, Vladimir D.; Seung, Edward; von Andrian, Ulrich H.; Tager, Andrew M.; Luster, Andrew D.; Mempel, Thorsten R.			HIV-infected T cells are migratory vehicles for viral dissemination	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL TRANSMISSION; IMMUNE-RESPONSES; DOWN-MODULATION; ENVELOPE; RECEPTOR; CD4(+); TYPE-1; ENV; MOTILITY	After host entry through mucosal surfaces, human immunodeficiency virus-1 (HIV-1) disseminates to lymphoid tissues to establish a generalized infection of the immune system. The mechanisms by which this virus spreads among permissive target cells locally during the early stages of transmission and systemically during subsequent dissemination are not known(1). In vitro studies suggest that the formation of virological synapses during stable contacts between infected and uninfected T cells greatly increases the efficiency of viral transfer(2). It is unclear, however, whether T-cell contacts are sufficiently stable in vivo to allow for functional synapse formation under the conditions of perpetual cell motility in epithelial(3) and lymphoid tissues(4). Here, using multiphoton intravital microscopy, we examine the dynamic behaviour of HIV-infected T cells in the lymph nodes of humanized mice. We find that most productively infected T cells migrate robustly, resulting in their even distribution throughout the lymph node cortex. A subset of infected cells formed multinucleated syncytia through HIV envelope-dependent cell fusion. Both uncoordinated motility of syncytia and adhesion to CD4(+) lymph node cells led to the formation of long membrane tethers, increasing cell lengths to up to ten times that of migrating uninfected T cells. Blocking the egress of migratory T cells from the lymph nodes into efferent lymph vessels, and thus interrupting T-cell recirculation, limited HIV dissemination and strongly reduced plasma viraemia. Thus, we have found that HIV-infected T cells are motile, form syncytia and establish tethering interactions that may facilitate cell-to-cell transmission through virological synapses. Migration of T cells in lymph nodes therefore spreads infection locally, whereas their recirculation through tissues is important for efficient systemic viral spread, suggesting new molecular targets to antagonize HIV infection.	[Murooka, Thomas T.; Deruaz, Maud; Marangoni, Francesco; Vrbanac, Vladimir D.; Seung, Edward; Tager, Andrew M.; Luster, Andrew D.; Mempel, Thorsten R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Mempel, TR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.	tmempel@mgh.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Marangoni, Francesco/I-9087-2012; Luster, Andrew/ABE-6504-2020	Marangoni, Francesco/0000-0002-2490-849X; Luster, Andrew/0000-0001-9679-7912; Murooka, Thomas/0000-0002-3030-2726	National Institutes of Health (NIH) [P01 AI0178897, R56 AI097052, R01 CA150975, P30 AI060354]; Ragon Institute of Massachusetts General Hospital (MGH); Massachusetts Institute of Technology (MIT); Harvard; MGH ECOR Tosteson Postdoctoral Fellowship Award; NIH [T32 AI007387]; NATIONAL CANCER INSTITUTE [R01CA150975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI097052, T32AI007387, R56AI097052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of Massachusetts General Hospital (MGH); Massachusetts Institute of Technology (MIT); Harvard; MGH ECOR Tosteson Postdoctoral Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Sodroski for the pSVIIIexE7 plasmid and A. Brown for HIV SF162R3; H. S. Shin, T. Tivey, K. Bankert and S. Tanno for technical assistance with the generation of humanized mice; A. Peixoto and D. Alvarez for management of the BL2<SUP>+</SUP> multiphoton microscopy facility; A. Brass, T. Allen and T. Dudek for assistance with virological techniques; and N. Elpek, M. Byrne and A. Finzi for technical assistance. Funding for this study was through National Institutes of Health (NIH) grants P01 AI0178897, R56 AI097052, R01 CA150975 and P30 AI060354, and a Platform Award from the Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard. T. T. M. was supported by the MGH ECOR Tosteson Postdoctoral Fellowship Award and NIH training grant T32 AI007387.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brown A, 2005, J LEUKOCYTE BIOL, V78, P675, DOI 10.1189/jlb.0505237; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kersh EN, 2009, J ANTIMICROB CHEMOTH, V63, P758, DOI 10.1093/jac/dkp008; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Murooka TT, 2011, METHODS MOL BIOL, V757, P247, DOI 10.1007/978-1-61779-166-6_16; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; Pirounaki M, 2000, J VIROL METHODS, V85, P151, DOI 10.1016/S0166-0934(99)00163-9; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	38	234	235	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					283	+		10.1038/nature11398	http://dx.doi.org/10.1038/nature11398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22854780	Green Accepted, Green Submitted			2022-12-01	WOS:000309733300054
J	Schmitz, R; Young, RM; Ceribelli, M; Jhavar, S; Xiao, WM; Zhang, MZ; Wright, G; Shaffer, AL; Hodson, DJ; Buras, E; Liu, XL; Powell, J; Yang, YD; Xu, WH; Zhao, H; Kohlhammer, H; Rosenwald, A; Kluin, P; Muller-Hermelink, HK; Ott, G; Gascoyne, RD; Connors, JM; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Ogwang, MD; Reynolds, SJ; Fisher, RI; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Pittaluga, S; Wilson, W; Waldmann, TA; Rowe, M; Mbulaiteye, SM; Rickinson, AB; Staudt, LM				Schmitz, Roland; Young, Ryan M.; Ceribelli, Michele; Jhavar, Sameer; Xiao, Wenming; Zhang, Meili; Wright, George; Shaffer, Arthur L.; Hodson, Daniel J.; Buras, Eric; Liu, Xuelu; Powell, John; Yang, Yandan; Xu, Weihong; Zhao, Hong; Kohlhammer, Holger; Rosenwald, Andreas; Kluin, Philip; Mueller-Hermelink, Hans Konrad; Ott, German; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Ogwang, Martin D.; Reynolds, Steven J.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, James R.; Weisenburger, Dennis D.; Chan, Wing C.; Pittaluga, Stefania; Wilson, Wyndham; Waldmann, Thomas A.; Rowe, Martin; Mbulaiteye, Sam M.; Rickinson, Alan B.; Staudt, Louis M.			Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics	NATURE			English	Article							CELL; IMMUNOGLOBULIN; REGION	Burkitt's lymphoma (BL) can often be cured by intensive chemotherapy, but the toxicity of such therapy precludes its use in the elderly and in patients with endemic BL in developing countries, necessitating new strategies(1). The normal germinal centre B cell is the presumed cell of origin for both BL and diffuse large B-cell lymphoma (DLBCL), yet gene expression analysis suggests that these malignancies may use different oncogenic pathways(2). BL is subdivided into a sporadic subtype that is diagnosed in developed countries, the Epstein-Barr-virus-associated endemic subtype, and an HIV-associated subtype, but it is unclear whether these subtypes use similar or divergent oncogenic mechanisms. Here we used high-throughput RNA sequencing and RNA interference screening to discover essential regulatory pathways in BL that cooperate with MYC, the defining oncogene of this cancer. In 70% of sporadic BL cases, mutations affecting the transcription factor TCF3 (E2A) or its negative regulator ID3 fostered TCF3 dependency. TCF3 activated the pro-survival phosphatidylinositol-3-OH kinase pathway in BL, in part by augmenting tonic B-cell receptor signalling. In 38% of sporadic BL cases, oncogenic CCND3 mutations produced highly stable cyclin D3 isoforms that drive cell cycle progression. These findings suggest opportunities to improve therapy for patients with BL.	[Schmitz, Roland; Young, Ryan M.; Ceribelli, Michele; Jhavar, Sameer; Zhang, Meili; Shaffer, Arthur L.; Hodson, Daniel J.; Buras, Eric; Yang, Yandan; Xu, Weihong; Zhao, Hong; Kohlhammer, Holger; Wilson, Wyndham; Waldmann, Thomas A.; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Xiao, Wenming; Liu, Xuelu; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, DCTD, NIH, Bethesda, MD 20892 USA; [Rosenwald, Andreas; Mueller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Kluin, Philip] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.] British Columbia Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.; Pittaluga, Stefania] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Delabie, Jan] Univ Hosp, Rikshosp, Pathol Clin, N-0372 Oslo, Norway; [Smeland, Erlend B.] Univ Hosp, Rikshosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, N-0310 Oslo, Norway; [Ogwang, Martin D.] St Marys Hosp Lacor, Gulu 256, Uganda; [Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, James R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA; [Rowe, Martin; Rickinson, Alan B.] Univ Birmingham, Birmingham Canc Res UK Ctr, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Mbulaiteye, Sam M.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wurzburg; University of Groningen; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Rochester; Oregon Health & Science University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Mbulaiteye, Sam/O-3056-2019; Wright, George W/M-1660-2017; Rowe, Martin/B-2880-2009; Connors, Joseph/AAF-5284-2019; Campo, Elias/AAC-5593-2019; Smeland, Erlend/AAO-3214-2020; Staudt, Louis/AAC-5324-2019; Gascoyne, Randy D/A-6009-2013; Hodson, Daniel J/K-6817-2016; Waldmann, Thomas/AAT-5972-2021; Jaffe, Elaine/G-8981-2014	Mbulaiteye, Sam/0000-0002-8273-9831; Rowe, Martin/0000-0003-4139-7326; Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Gascoyne, Randy D/0000-0002-2610-5690; Hodson, Daniel J/0000-0001-6225-2033; Waldmann, Thomas/0000-0003-4500-6660; Jaffe, Elaine/0000-0003-4632-0301; Delabie, Jan/0000-0001-5023-0689; Reynolds, Steven/0000-0002-5403-2759	NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant [UO1-CA 114778]; Foundation for NIH; Cancer Research UK; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe); NCI [N01-C0-12400]; Medical Research Council [G9818340B] Funding Source: researchfish; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIASC000550, ZIACP010176, U01CA114778, ZIASC004002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, ZIAAI001040] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant; Foundation for NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe)(Deutsche Krebshilfe); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant (UO1-CA 114778), by the Foundation for NIH, through a gift from the Richard A. Lauderbaugh Memorial Fund, and by Cancer Research UK. This study was conducted under the auspices of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP). R.S. was supported by the Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe). D.J.H. is a Kay Kendall Leukaemia Fund Intermediate research fellow. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health (http://biowulf.nih.gov). We thank K. Meyer for help with the GEO submission, T. Ellenberger for the TCF3 crystal structure coordinates, B. Tran (Center for Cancer Research Sequencing Facility) and K. Hartman for DNA sequencing and K. Rajewsky for discussions. The DLBCL data set is part of the Cancer Genomics Characterization Initiative (CGCI), supported by NCI contract N01-C0-12400 (http://cgap.nci.nih.gov/cgci.html/) and was obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap. We thank the participants in the EMBLEM Study (http://emblem.cancer.gov/) in Uganda, the EMBLEM Study staff for collecting and processing the samples and data, and the Government of Uganda for allowing the study to be done and samples to be exported for research.	Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Orem J, 2008, TROP DOCT, V38, P7, DOI 10.1258/td.2007.060093; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; PESCE S, 1993, MOL CELL BIOL, V13, P7874, DOI 10.1128/MCB.13.12.7874; Sander S., 2012, CANC CELL; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yustein JT, 2007, CURR OPIN HEMATOL, V14, P375, DOI 10.1097/MOH.0b013e3281bccdee	21	560	572	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					116	120		10.1038/nature11378	http://dx.doi.org/10.1038/nature11378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22885699	Green Accepted, Green Submitted			2022-12-01	WOS:000309446800044
J	Koppikar, P; Bhagwat, N; Kilpivaara, O; Manshouri, T; Adli, M; Hricik, T; Liu, F; Saunders, LM; Mullally, A; Abdel-Wahab, O; Leung, L; Weinstein, A; Marubayashi, S; Goel, A; Gonen, M; Estrov, Z; Ebert, BL; Chiosis, G; Nimer, SD; Bernstein, BE; Verstovsek, S; Levine, RL				Koppikar, Priya; Bhagwat, Neha; Kilpivaara, Outi; Manshouri, Taghi; Adli, Mazhar; Hricik, Todd; Liu, Fan; Saunders, Lindsay M.; Mullally, Ann; Abdel-Wahab, Omar; Leung, Laura; Weinstein, Abby; Marubayashi, Sachie; Goel, Aviva; Goenen, Mithat; Estrov, Zeev; Ebert, Benjamin L.; Chiosis, Gabriela; Nimer, Stephen D.; Bernstein, Bradley E.; Verstovsek, Srdan; Levine, Ross L.			Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy	NATURE			English	Article							TYROSINE KINASE; LUNG ADENOCARCINOMAS; RESISTANCE; MUTATION; GEFITINIB; CANCER; EFFICACY; IDENTIFICATION; SAFETY	The identification of somatic activating mutations in JAK2 (refs 1-4) and in the thrombopoietin receptor gene (MPL)(5) in most patients with myeloproliferative neoplasm (MPN) led to the clinical development of JAK2 kinase inhibitors(6,7). JAK2 inhibitor therapy improves MPN-associated splenomegaly and systemic symptoms but does not significantly decrease or eliminate the MPN clone in most patients with MPN. We therefore sought to characterize mechanisms by which MPN cells persist despite chronic inhibition of JAK2. Here we show that JAK2 inhibitor persistence is associated with reactivation of JAK-STAT signalling and with heterodimerization between activated JAK2 and JAK1 or TYK2, consistent with activation of JAK2 in trans by other JAK kinases. Further, this phenomenon is reversible: JAK2 inhibitor withdrawal is associated with resensitization to JAK2 kinase inhibitors and with reversible changes in JAK2 expression. We saw increased JAK2 heterodimerization and sustained JAK2 activation in cell lines, in murine models and in patients treated with JAK2 inhibitors. RNA interference and pharmacological studies show that JAK2-inhibitor-persistent cells remain dependent on JAK2 protein expression. Consequently, therapies that result in JAK2 degradation retain efficacy in persistent cells and may provide additional benefit to patients with JAK2-dependent malignancies treated with JAK2 inhibitors.	[Koppikar, Priya; Bhagwat, Neha; Kilpivaara, Outi; Hricik, Todd; Saunders, Lindsay M.; Abdel-Wahab, Omar; Leung, Laura; Weinstein, Abby; Marubayashi, Sachie; Goel, Aviva; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Bhagwat, Neha; Saunders, Lindsay M.] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Manshouri, Taghi; Estrov, Zeev; Verstovsek, Srdan] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Adli, Mazhar; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Adli, Mazhar; Bernstein, Bradley E.] MIT, Broad Inst Harvard, Boston, MA 02114 USA; [Mullally, Ann; Ebert, Benjamin L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol,Dept Med, Boston, MA 02115 USA; [Abdel-Wahab, Omar; Nimer, Stephen D.; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10065 USA; [Goenen, Mithat] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	leviner@mskcc.org	Gonen, Mithat/E-4826-2012; levine, ross/AAE-7658-2019	Gonen, Mithat/0000-0001-8683-8477; Abdel-Wahab, Omar/0000-0002-3907-6171; Beckmann, Aviva/0000-0002-5739-5512; Verstovsek, MD, PhD, Professor of Medicine, Srdan/0000-0002-6912-8569; Beckmann, Aviva/0000-0001-6099-6135	National Cancer Institute [1R01CA151949-01]; Leukemia and Lymphoma Society; Myeloproliferative Neoplasms Foundation; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [R01CA151949, P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Myeloproliferative Neoplasms Foundation; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Sawyers, J. Licht, P. Poulikakos and N. Rosen for advice and suggestions; P. Bhatt for his help in the saturation mutagenesis screen; T. Taldone for synthesis of PU-H71; L. Staudt and T. Look for shRNA constructs against JAK2 and TYK2, respectively; and T. Radimerski and P. Manley for providing BBT-594. We are grateful to the Genomics Core Laboratories at Memorial Sloan-Kettering Cancer Center and the Geoffrey Beene Core for their assistance with 454 sequencing. This work was supported in part by National Cancer Institute grant 1R01CA151949-01 to R. L. L., by a grant from the Leukemia and Lymphoma Society to R. L. L. and by a grant from the Myeloproliferative Neoplasms Foundation and the Starr Cancer Consortium to R. L. L., B. E. B. and B. L. E. B. E. B. is a Howard Hughes Medical Institute Early Career Scientist.	Andraos R, 2012, CANCER DISCOV, V2, P512, DOI 10.1158/2159-8290.CD-11-0324; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Guerini V, 2008, LEUKEMIA, V22, P740, DOI 10.1038/sj.leu.2405049; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pardanani A, 2011, J CLIN ONCOL, V29, P789, DOI 10.1200/JCO.2010.32.8021; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Rider L, 2007, J BIOL CHEM, V282, P30985, DOI 10.1074/jbc.M701794200; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Wang YC, 2009, BLOOD, V114, P5024, DOI 10.1182/blood-2009-05-222133; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	32	254	260	5	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					155	U222		10.1038/nature11303	http://dx.doi.org/10.1038/nature11303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22820254	Green Accepted, Green Submitted			2022-12-01	WOS:000308347000054
J	Mello, MM; Goodman, SN; Faden, RR				Mello, Michelle M.; Goodman, Steven N.; Faden, Ruth R.			Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RISK; ROSIGLITAZONE; DEATH; PIOGLITAZONE; NESIRITIDE		[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Goodman, Steven N.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Goodman, Steven N.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Faden, Ruth R.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Stanford University; Stanford University; Johns Hopkins University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 665 Huntington Ave, Boston, MA 02115 USA.			Goodman, Steven/0000-0002-3872-5723				Baucus M, 2010, PREFECT POLICE F PEC; Chen JY, 2010, AM J BIOETHICS, V10, P35, DOI 10.1080/15265161.2010.494220; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2010, ETH ISS STUD SAF APP; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Committee on the Assessment of the U.S. Drug Safety System Institute of Medicine, 2007, FUT DRUG SAF PROM PR; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Food and Drug Administration Center for Drug Evaluation and Research, 2010, JOINT M END MET DRUG; Graham D, 2008, PREFECT POLICE F PEC; Hamburg M, 2010, PREFECT POLICE F PEC; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Krumholz H., FORBES          0516; Levine C, 1988, Law Med Health Care, V16, P167, DOI 10.1111/j.1748-720X.1988.tb01942.x; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; London AJ, 2012, SCIENCE, V336, P544, DOI 10.1126/science.1216086; Mahoney K, 2010, ADV COMM CLIN BRIEF; Misbin RI, 2007, DIABETES CARE, V30, P3141, DOI 10.2337/dc07-1908; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Nissen SE, 2010, EUR HEART J, V31, P773, DOI 10.1093/eurheartj/ehq016; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Rising K, 2009, PLOS MED, V6, P117, DOI 10.1371/journal.pmed.1000017; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Sackner-Bernstein, 2005, CIRCULATION, V111, P2274; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Solomon DH, 2005, ARTHRITIS RHEUM, V52, P1968, DOI 10.1002/art.21132; Woodcock J, 2010, NEW ENGL J MED, V363, P1489, DOI 10.1056/NEJMp1010788	30	15	15	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					959	964		10.1056/NEJMhle1207160	http://dx.doi.org/10.1056/NEJMhle1207160			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22913661				2022-12-01	WOS:000308343300017
J	Anand, PK; Malireddi, RKS; Lukens, JR; Vogel, P; Bertin, J; Lamkanfi, M; Kanneganti, TD				Anand, Paras K.; Malireddi, R. K. Subbarao; Lukens, John R.; Vogel, Peter; Bertin, John; Lamkanfi, Mohamed; Kanneganti, Thirumala-Devi			NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens	NATURE			English	Article							LISTERIA-MONOCYTOGENES; INFLAMMASOME; SALMONELLA; CASPASE-1; INFECTION; ACTIVATION; RECEPTORS; KINASE; ROLES	Members of the intracellular nucleotide-binding and oligomerization domain (NOD)-like receptor (NLR) family contribute to immune responses through activation of nuclear factor-kappa B (NF-kappa B), type I interferon and inflammasome signalling(1). Mice lacking the NLR family member NLRP6 were recently shown to be susceptible to colitis and colorectal tumorigenesis(2-4), but the role of NLRP6 in microbial infections and the nature of the inflammatory signalling pathways regulated by NLRP6 remain unclear. Here we show that Nlrp6-deficient mice are highly resistant to infection with the bacterial pathogens Listeria monocytogenes, Salmonella typhimurium and Escherichia coli. Infected Nlrp6-deficient mice had increased numbers of monocytes and neutrophils in circulation, and NLRP6 signalling in both haematopoietic and radioresistant cells contributed to increased susceptibility. Nlrp6 deficiency enhanced activation of mitogen-activated protein kinase (MAPK) and the canonical NF-kappa B pathway after Toll-like receptor ligation, but not cytosolic NOD1/2 ligation, in vitro. Consequently, infected Nlrp6-deficient cells produced increased levels of NF-kappa B-and MAPK-dependent cytokines and chemokines. Thus, our results reveal NLRP6 as a negative regulator of inflammatory signalling, and demonstrate a role for this NLR in impeding clearance of both Gram-positive and -negative bacterial pathogens.	[Anand, Paras K.; Malireddi, R. K. Subbarao; Lukens, John R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA; [Bertin, John] GlaxoSmithKline, Immunoinflammat TA, Pattern Recognit Receptor DPU, Collegeville, PA 19426 USA; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; GlaxoSmithKline; Ghent University; Flanders Institute for Biotechnology (VIB)	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/M-9435-2018; Vogel, Peter/N-2490-2018; Malireddi, RKSubbarao/C-5804-2013; Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Vogel, Peter/0000-0002-7535-0545; Malireddi, RKSubbarao/0000-0001-8855-9447; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Anand, Paras/0000-0003-2503-3653; Lukens, John/0000-0002-6795-0866	European Union [256432]; European Research Council [281600]; Fund for Scientific Research Flanders [G030212N, 1.2.201.10.N.00, 1.5.122.11.N.00]; National Institute of Health [AR056296, AI101935]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI101935, R01AI101935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Fund for Scientific Research Flanders(FWO); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Coyle, E. Grant and R. Flavell for the supply of mutant mice. M. L. is supported by grants from the European Union Framework Program 7 (Marie-Curie Grant 256432), European Research Council (grant 281600) and the Fund for Scientific Research Flanders (G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00). This work was supported by National Institute of Health Grants (AR056296 and AI101935), and the American Lebanese Syrian Associated Charities (ALSAC) to T.-D.K.	Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; CDC (Centers for Disease Control & Prevention), CDC EST FOODB ILLN U; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hybiske K, 2008, NAT REV MICROBIOL, V6, P99, DOI 10.1038/nrmicro1821; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; STEVENSON MM, 1981, J IMMUNOL, V127, P402; van Ooij C, 2011, NAT REV MICROBIOL, V9, P481, DOI 10.1038/nrmicro2599; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	25	266	283	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					389	+		10.1038/nature11250	http://dx.doi.org/10.1038/nature11250			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22763455	Green Accepted			2022-12-01	WOS:000307501000044
J	Saalmann, YB; Pinsk, MA; Wang, L; Li, X; Kastner, S				Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine			The Pulvinar Regulates Information Transmission Between Cortical Areas Based on Attention Demands	SCIENCE			English	Article							TOP-DOWN; NEURONAL OSCILLATIONS; VISUAL-PERCEPTION; CORTEX; FREQUENCY; MODULATION; MECHANISMS; MONKEY; SYNCHRONIZATION; SELECTION	Selective attention mechanisms route behaviorally relevant information through large-scale cortical networks. Although evidence suggests that populations of cortical neurons synchronize their activity to preferentially transmit information about attentional priorities, it is unclear how cortical synchrony across a network is accomplished. Based on its anatomical connectivity with the cortex, we hypothesized that the pulvinar, a thalamic nucleus, regulates cortical synchrony. We mapped pulvino-cortical networks within the visual system, using diffusion tensor imaging, and simultaneously recorded spikes and field potentials from these interconnected network sites in monkeys performing a visuospatial attention task. The pulvinar synchronized activity between interconnected cortical areas according to attentional allocation, suggesting a critical role for the thalamus not only in attentional selection but more generally in regulating information transmission across the visual cortex.	[Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Saalmann, YB (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	saalmann@princeton.edu	Wang, Liang/AAC-7772-2019; Saalmann, Yuri B/AAW-5814-2021	Kastner, Sabine/0000-0002-9742-965X; Saalmann, Yuri/0000-0001-8880-6698	NIH [R21 EY021078]; NSF [BCS-1025149]; NATIONAL EYE INSTITUTE [R21EY021078, R01EY017699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank C. D. Brody and C. J. Honey for useful comments on the manuscript and M. Ding for Granger causality routines. Supported by NIH (grant R21 EY021078) and NSF (grant BCS-1025149).	Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BALEYDIER C, 1992, VISUAL NEUROSCI, V8, P391, DOI 10.1017/S0952523800004922; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; DESIMONE R, 1990, COLD SH Q B, V55, P963; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; LABERGE D, 1990, J NEUROSCI, V10, P613; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Molotchnikoff S, 1996, VISION RES, V36, P2037, DOI 10.1016/0042-6989(95)00311-8; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; Theyel BB, 2010, NAT NEUROSCI, V13, P84, DOI 10.1038/nn.2449; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wrobel A, 2007, J NEUROSCI, V27, P2230, DOI 10.1523/JNEUROSCI.4004-06.2007	28	552	559	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					753	756		10.1126/science.1223082	http://dx.doi.org/10.1126/science.1223082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879517	Green Accepted			2022-12-01	WOS:000307354500060
J	Northcott, PA; Shih, DJH; Peacock, J; Garzia, L; Morrissy, AS; Zichner, T; Stutz, AM; Korshunov, A; Reimand, J; Schumacher, SE; Beroukhim, R; Ellison, DW; Marshall, CR; Lionel, AC; Mack, S; Dubuc, A; Yao, Y; Ramaswamy, V; Luu, B; Rolider, A; Cavalli, FMG; Wang, X; Remke, M; Wu, XC; Chiu, RYB; Chu, A; Chuah, E; Corbett, RD; Hoad, GR; Jackman, SD; Li, YS; Lo, A; Mungall, KL; Nip, KM; Qian, JQ; Raymond, AGJ; Thiessen, N; Varhol, RJ; Birol, I; Moore, RA; Mungall, AJ; Holt, R; Kawauchi, D; Roussel, MF; Kool, M; Jones, DTW; Witt, H; Fernandez-L, A; Kenney, AM; Wechsler-Reya, RJ; Dirks, P; Aviv, T; Grajkowska, WA; Perek-Polnik, M; Haberler, CC; Delattre, O; Reynaud, SS; Doz, FF; Pernet-Fattet, SS; Cho, BK; Kim, SK; Wang, KC; Scheurlen, W; Eberhart, CG; Fevre-Montange, M; Jouvet, A; Pollack, IF; Fan, X; Muraszko, KM; Gillespie, GY; Di Rocco, C; Massimi, L; Michiels, EMC; Kloosterhof, NK; French, PJ; Kros, JM; Olson, JM; Ellenbogen, RG; Zitterbart, K; Kren, L; Thompson, RC; Cooper, MK; Lach, B; McLendon, RE; Bigner, DD; Fontebasso, A; Albrecht, S; Jabado, N; Lindsey, JC; Bailey, S; Gupta, N; Weiss, WA; Bognar, L; Klekner, A; Van Meter, TE; Kumabe, T; Tominaga, T; Elbabaa, SK; Leonard, JR; Rubin, JB; Liau, LM; Van Meir, EG; Fouladi, M; Nakamura, H; Cinalli, G; Garami, M; Hauser, P; Saad, AG; Iolascon, A; Jung, S; Carlotti, CG; Vibhakar, R; Ra, YS; Robinson, S; Zollo, M; Faria, CC; Chan, JA; Levy, ML; Sorensen, PHB; Meyerson, M; Pomeroy, SL; Cho, YJ; Bader, GD; Tabori, U; Hawkins, CE; Bouffet, E; Scherer, SW; Rutka, JT; Malkin, D; Clifford, SC; Jones, SJM; Korbel, JO; Pfister, SM; Marra, MA; Taylor, MD				Northcott, Paul A.; Shih, David J. H.; Peacock, John; Garzia, Livia; Morrissy, A. Sorana; Zichner, Thomas; Stuetz, Adrian M.; Korshunov, Andrey; Reimand, Jueri; Schumacher, Steven E.; Beroukhim, Rameen; Ellison, David W.; Marshall, Christian R.; Lionel, Anath C.; Mack, Stephen; Dubuc, Adrian; Yao, Yuan; Ramaswamy, Vijay; Luu, Betty; Rolider, Adi; Cavalli, Florence M. G.; Wang, Xin; Remke, Marc; Wu, Xiaochong; Chiu, Readman Y. B.; Chu, Andy; Chuah, Eric; Corbett, Richard D.; Hoad, Gemma R.; Jackman, Shaun D.; Li, Yisu; Lo, Allan; Mungall, Karen L.; Nip, Ka Ming; Qian, Jenny Q.; Raymond, Anthony G. J.; Thiessen, Nina; Varhol, Richard J.; Birol, Inanc; Moore, Richard A.; Mungall, Andrew J.; Holt, Robert; Kawauchi, Daisuke; Roussel, Martine F.; Kool, Marcel; Jones, David T. W.; Witt, Hendrick; Fernandez-L, Africa; Kenney, Anna M.; Wechsler-Reya, Robert J.; Dirks, Peter; Aviv, Tzvi; Grajkowska, Wieslawa A.; Perek-Polnik, Marta; Haberler, Christine C.; Delattre, Olivier; Reynaud, Stephanie S.; Doz, Francois F.; Pernet-Fattet, Sarah S.; Cho, Byung-Kyu; Kim, Seung-Ki; Wang, Kyu-Chang; Scheurlen, Wolfram; Eberhart, Charles G.; Fevre-Montange, Michelle; Jouvet, Anne; Pollack, Ian F.; Fan, Xing; Muraszko, Karin M.; Gillespie, G. Yancey; Di Rocco, Concezio; Massimi, Luca; Michiels, Erna M. C.; Kloosterhof, Nanne K.; French, Pim J.; Kros, Johan M.; Olson, James M.; Ellenbogen, Richard G.; Zitterbart, Karel; Kren, Leos; Thompson, Reid C.; Cooper, Michael K.; Lach, Boleslaw; McLendon, Roger E.; Bigner, Darell D.; Fontebasso, Adam; Albrecht, Steffen; Jabado, Nada; Lindsey, Janet C.; Bailey, Simon; Gupta, Nalin; Weiss, William A.; Bognar, Laszlo; Klekner, Almos; Van Meter, Timothy E.; Kumabe, Toshihiro; Tominaga, Teiji; Elbabaa, Samer K.; Leonard, Jeffrey R.; Rubin, Joshua B.; Liau, Linda M.; Van Meir, Erwin G.; Fouladi, Maryam; Nakamura, Hideo; Cinalli, Giuseppe; Garami, Miklos; Hauser, Peter; Saad, Ali G.; Iolascon, Achille; Jung, Shin; Carlotti, Carlos G.; Vibhakar, Rajeev; Ra, Young Shin; Robinson, Shenandoah; Zollo, Massimo; Faria, Claudia C.; Chan, Jennifer A.; Levy, Michael L.; Sorensen, Poul H. B.; Meyerson, Matthew; Pomeroy, Scott L.; Cho, Yoon-Jae; Bader, Gary D.; Tabori, Uri; Hawkins, Cynthia E.; Bouffet, Eric; Scherer, Stephen W.; Rutka, James T.; Malkin, David; Clifford, Steven C.; Jones, Steven J. M.; Korbel, Jan O.; Pfister, Stefan M.; Marra, Marco A.; Taylor, Michael D.			Subgroup-specific structural variation across 1,000 medulloblastoma genomes	NATURE			English	Article							HEDGEHOG PATHWAY INHIBITOR; COPY-NUMBER ALTERATION; ALPHA-SYNUCLEIN; BETA FAMILY; SYNPHILIN-1; PROTEIN; MYC; LANDSCAPE; MUTATION; TARGETS	Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive chemotherapy. As medulloblastoma exhibits marked intertumoural heterogeneity, with at least four distinct molecular variants, previous attempts to identify targets for therapy have been underpowered because of small samples sizes. Here we report somatic copy number aberrations (SCNAs) in 1,087 unique medulloblastomas. SCNAs are common in medulloblastoma, and are predominantly subgroup-enriched. The most common region of focal copy number gain is a tandem duplication of SNCAIP, a gene associated with Parkinson's disease, which is exquisitely restricted to Group 4 alpha. Recurrent translocations of PVT1, including PVT1-MYC and PVT1-NDRG1, that arise through chromothripsis are restricted to Group 3. Numerous targetable SCNAs, including recurrent events targeting TGF-beta signalling in Group 3, and NF-kappa B signalling in Group 4, suggest future avenues for rational, targeted therapy.	[Holt, Robert; Marra, Marco A.] Michael Smith Genome Sci Ctr, BC Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Northcott, Paul A.; Shih, David J. H.; Peacock, John; Garzia, Livia; Morrissy, A. Sorana; Mack, Stephen; Dubuc, Adrian; Yao, Yuan; Ramaswamy, Vijay; Luu, Betty; Rolider, Adi; Cavalli, Florence M. G.; Wang, Xin; Remke, Marc; Wu, Xiaochong; Taylor, Michael D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Toronto, ON M5G 1L7, Canada; [Northcott, Paul A.; Kool, Marcel; Jones, David T. W.; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Shih, David J. H.; Peacock, John; Mack, Stephen; Dubuc, Adrian; Yao, Yuan; Ramaswamy, Vijay; Wang, Xin; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Zichner, Thomas; Stuetz, Adrian M.; Korbel, Jan O.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, German Canc Res Ctr DKFZ, Dept Neuropathol, CCU Neuropathol, D-69120 Heidelberg, Germany; [Reimand, Jueri; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Schumacher, Steven E.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen] Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Beroukhim, Rameen] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Ellison, David W.; Kawauchi, Daisuke; Roussel, Martine F.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Marshall, Christian R.; Bader, Gary D.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 1L7, Canada; [Marshall, Christian R.; Bader, Gary D.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Lionel, Anath C.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom & Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Chiu, Readman Y. B.; Chu, Andy; Chuah, Eric; Corbett, Richard D.; Hoad, Gemma R.; Jackman, Shaun D.; Li, Yisu; Lo, Allan; Mungall, Karen L.; Nip, Ka Ming; Qian, Jenny Q.; Raymond, Anthony G. J.; Thiessen, Nina; Varhol, Richard J.; Birol, Inanc; Moore, Richard A.; Mungall, Andrew J.; Jones, Steven J. M.] Michael Smith Genome Sci Ctr, BC Canc Agcy, Vancouver, BC V5Z 4S6, Canada; [Witt, Hendrick; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol, D-69120 Heidelberg, Germany; [Witt, Hendrick] Univ Heidelberg Hosp, Dept Hematol, D-69120 Heidelberg, Germany; [Witt, Hendrick] Univ Heidelberg Hosp, Dept Immunol, D-69120 Heidelberg, Germany; [Fernandez-L, Africa] Mem Sloan Kettering Canc Ctr, Pediat Clin Trials Off, New York, NY 10174 USA; [Wechsler-Reya, Robert J.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Dirks, Peter; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Dept Surg, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Dirks, Peter; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Grajkowska, Wieslawa A.] Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland; [Perek-Polnik, Marta] Childrens Mem Hlth Inst, Dept Oncol, Warsaw, Poland; [Haberler, Christine C.] Med Univ Vienna, Inst Neurol, A-1097 Vienna, Austria; [Delattre, Olivier] Inst Curie, INSERM, U830, F-75238 Paris 5, France; [Reynaud, Stephanie S.] Inst Curie, Unit Somat Genet, F-75238 Paris 5, France; [Doz, Francois F.] Inst Curie, Dept Pediat Oncol, F-75248 Paris 5, France; [Pernet-Fattet, Sarah S.] CHUV Univ Hosp, CH-1011 Lausanne, Switzerland; [Cho, Byung-Kyu; Kim, Seung-Ki; Wang, Kyu-Chang] Seoul Natl Univ, Childrens Hosp, Dept Neurosurg, Div Pediat Neurosurg, Seoul 110744, South Korea; [Scheurlen, Wolfram] Cnopfsche Kinderklin, D-90419 Nurnberg, Germany; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol & Oncol, Baltimore, MD 21205 USA; [Fevre-Montange, Michelle] Univ Lyon, Ctr Rech Neurosci, CNRS UMR5292, INSERM U1028, F-69336 Lyon, France; [Jouvet, Anne] Univ Lyon, Grp Hosp EST, Ctr Pathol EST, F-69500 Bron, France; [Pollack, Ian F.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15224 USA; [Fan, Xing; Muraszko, Karin M.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Fan, Xing] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Di Rocco, Concezio; Massimi, Luca] Catholic Univ, Sch Med, I-00186 Rome, Italy; [Michiels, Erna M. C.; Kloosterhof, Nanne K.] Erasmus MC, Dept Pediat Oncol & Hematol, NL-3000 Rotterdam, Netherlands; [Kloosterhof, Nanne K.; French, Pim J.] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Kros, Johan M.] Erasmus MC, Dept Pathol, NL-3015 GE Rotterdam, Netherlands; [Olson, James M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Olson, James M.] Seattle Childrens Hosp, Seattle, WA 98104 USA; [Ellenbogen, Richard G.] Univ Washington, Sch Med, Harborview Med Ctr, Seattle, WA 98104 USA; [Zitterbart, Karel] Masaryk Univ, Sch Med, Dept Pediat Oncol, Brno 61300, Czech Republic; [Zitterbart, Karel] Univ Hosp Brno, Dept Pediat Oncol, Brno 62500, Czech Republic; [Kren, Leos] Univ Hosp Brno, Dept Pathol, Brno 62500, Czech Republic; [Cooper, Michael K.] Vanderbilt Univ Sch Med, Dept Neurol, Nashville, TN 37232 USA; [Lach, Boleslaw] McMaster Univ, Dept Pathol & Mol Med, Div Anat Pathol, Hamilton, ON L8S 4L8, Canada; [Lach, Boleslaw] Hamilton Gen Hosp, Dept Pathol, Hamilton, ON L8L 2X2, Canada; [Lach, Boleslaw] Hamilton Gen Hosp, Lab Med, Hamilton, ON L8L 2X2, Canada; [McLendon, Roger E.; Bigner, Darell D.] Duke Univ, Dept Pathol, DUMC 3712, Durham, NC 27710 USA; [Fontebasso, Adam; Jabado, Nada] McGill Univ, Div Expt Med, Montreal, PQ H3Z 2Z3, Canada; [Albrecht, Steffen] McGill Univ, Dept Pathol, Montreal, PQ H3A 2B4, Canada; [Albrecht, Steffen] Montreal Childrens Hosp, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Jabado, Nada] McGill Univ, Dept Pediat, Div Hemato Oncol, Montreal, PQ H3H 1P3, Canada; [Lindsey, Janet C.; Bailey, Simon; Clifford, Steven C.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Gupta, Nalin] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Gupta, Nalin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94158 USA; [Bognar, Laszlo; Klekner, Almos] Univ Debrecen, Med & Hlth Sci Ctr, Dept Neurosurg, H-4032 Debrecen, Hungary; [Van Meter, Timothy E.] Virginia Commonwealthy Univ, Sch Med, Richmond, VA 23298 USA; [Kumabe, Toshihiro; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Elbabaa, Samer K.] St Louis Univ, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, St Louis, MO 63104 USA; [Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, St Louis, MO 63110 USA; [Leonard, Jeffrey R.; Rubin, Joshua B.] St Louis Childrens Hosp, St Louis, MO 63110 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Liau, Linda M.] David Geffen Sch Med UCLA, Dept Neurosurg, Los Angeles, CA 90095 USA; [Van Meir, Erwin G.] Emory Univ, Dept Neurosurg, Mol Neurooncol Lab, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Fouladi, Maryam] Univ Cincinnati, Cincinnati Childrens Hosp, Med Ctr, Div Oncol, Cincinnati, OH 45229 USA; [Nakamura, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Honjo, Kumamoto 8608556, Japan; [Cinalli, Giuseppe] Osped Santobono Pausilipon, I-80145 Naples, Italy; [Garami, Miklos; Hauser, Peter] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Saad, Ali G.] Univ Arkansas Med Sci, Little Rock, AR 72202 USA; [Iolascon, Achille; Zollo, Massimo] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80145 Naples, Italy; [Iolascon, Achille; Zollo, Massimo] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [Jung, Shin] Chonnam Natl Univ, Hwasun Hosp, Res Inst Med Sci, Dept Neurosci, Chungnam 519763, South Korea; [Jung, Shin] Sch Med, Chungnam 519763, South Korea; [Carlotti, Carlos G.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Surg & Anat, BR-14049900 Sao Paulo, Brazil; [Vibhakar, Rajeev] Univ Colorado Denver, Aurora, CO 80045 USA; [Ra, Young Shin] Univ Ulsan, Asan Med Ctr, Dept Neurosurg, Seoul 138736, South Korea; [Robinson, Shenandoah] Div Pediat Neurosurg, Cleveland, OH 44106 USA; [Faria, Claudia C.] Hosp Santa Maria, Ctr Hosp Lisboa Norte EPE, Div Neurosurg, P-1169050 Lisbon, Portugal; [Faria, Claudia C.] Hosp Sick Children, Cell Biol Program, Toronto, ON MSG 1L7, Canada; [Chan, Jennifer A.] Univ Calgary, Dept Pathol, Calgary, AB T2N 4N1, Canada; [Chan, Jennifer A.] Univ Calgary, Lab Med, Calgary, AB T2N 4N1, Canada; [Levy, Michael L.] Rady Childrens Hosp San Diego, UCSD Div Neurosurg, San Diego, CA 92123 USA; [Sorensen, Poul H. B.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Pomeroy, Scott L.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurol, Boston, MA 02115 USA; [Cho, Yoon-Jae] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Bader, Gary D.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON MSG 1X5, Canada; [Tabori, Uri; Bouffet, Eric; Malkin, David] Hosp Sick Children, Dept Haematol & Oncol, Toronto, ON M5G 1X8, Canada; [Hawkins, Cynthia E.] Hosp Sick Children, Dept Pathol, Toronto, ON M5G 1X8, Canada; [Malkin, David] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; St Jude Children's Research Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); British Columbia Cancer Agency; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Memorial Sloan Kettering Cancer Center; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Memorial Health Institute; Children's Memorial Health Institute; Medical University of Vienna; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Seoul National University (SNU); Seoul National University Hospital; Johns Hopkins University; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Fred Hutchinson Cancer Center; Seattle Children's Hospital; Harborview Medical Center; University of Washington; University of Washington Seattle; Masaryk University Brno; University Hospital Brno; University Hospital Brno; Vanderbilt University; McMaster University; McMaster University; McMaster University; Duke University; McGill University; McGill University; McGill University; McGill University; Newcastle University - UK; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Debrecen; Tohoku University; Saint Louis University; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Emory University; Emory University; Emory University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Kumamoto University; Semmelweis University; University of Arkansas System; University of Arkansas Medical Sciences; University of Naples Federico II; CEINGE Biotecnologie Avanzate; Chonnam National University; Universidade de Sao Paulo; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Ulsan; Asan Medical Center; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Hospital Santa Maria; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Calgary; University of Calgary; Rady Childrens Hospital San Diego; British Columbia Cancer Agency; Harvard University; Boston Children's Hospital; Harvard Medical School; Stanford University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of British Columbia	Marra, MA (corresponding author), Michael Smith Genome Sci Ctr, BC Canc Agcy, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	mmarra@bcgsc.ca; mdtaylor@sickkids.ca	Northcott, Paul A/N-4022-2018; Wang, Xin/O-8779-2019; Bader, Gary/C-1176-2009; Pfister, Stefan M/F-6860-2013; Roussel, Martine F/F-1469-2016; Korbel, Jan O/G-6470-2012; cinalli, giuseppe/AAC-3889-2022; Wang, Kyu-Chang/J-5545-2012; Kool, Marcel/H-2541-2013; Jabado, Nada/AAN-4026-2020; Iolascon, Achille/A-4461-2014; Birol, Inanc/G-5440-2011; Marra, Marco A/B-5987-2008; Zollo, Massimo/K-5857-2016; Garami, Miklós/AAK-5680-2021; Malkin, David/AAW-8715-2021; Wang, Xin/U-7221-2017; Carlotti, Carlos G/C-1608-2012; Kawauchi, Daisuke/ABE-9133-2021; Jones, Steven J/C-3621-2009; Hawkins, Cynthia/M-2571-2019; Witt, Hendrik/L-7810-2015; Scherer, Stephen/B-3785-2013; Elbabaa, Samer/X-4709-2019; Shih, David J. H./AAE-8726-2019; Bouffet, Eric/AAB-8999-2020; Doz, Francois P/K-8616-2012; Meyerson, Matthew L/E-7123-2012; Kim, Seung-Ki/J-2742-2012; Mungall, Andrew J./U-7067-2018; Levy, Michael/AAL-4647-2020; Jones, David TW/G-9588-2013; Ellison, David/N-4806-2018; Reimand, Jüri/U-9264-2019; Jones, David T. W./Z-1963-2019; Shih, David J H/H-3186-2011; Holt, Robert A/C-3303-2009; Jackman, Shaun/G-9622-2013	Northcott, Paul A/0000-0002-1220-5252; Wang, Xin/0000-0001-6292-3087; Bader, Gary/0000-0003-0185-8861; Pfister, Stefan M/0000-0002-5447-5322; Roussel, Martine F/0000-0002-1740-8139; Korbel, Jan O/0000-0002-2798-3794; cinalli, giuseppe/0000-0002-7797-8483; Birol, Inanc/0000-0003-0950-7839; Marra, Marco A/0000-0001-7146-7175; Zollo, Massimo/0000-0002-0970-7243; Wang, Xin/0000-0001-6292-3087; Carlotti, Carlos G/0000-0002-7055-0564; Jones, Steven J/0000-0003-3394-2208; Scherer, Stephen/0000-0002-8326-1999; Elbabaa, Samer/0000-0003-1733-1941; Shih, David J. H./0000-0002-9802-4937; Mungall, Andrew J./0000-0002-0905-2742; Jones, David TW/0000-0002-2036-5141; Reimand, Jüri/0000-0002-2299-2309; Shih, David J H/0000-0002-9802-4937; Holt, Robert A/0000-0002-7259-1247; Weiss, William/0000-0003-2230-9132; Ramaswamy, Vijay/0000-0002-6557-895X; Jackman, Shaun/0000-0002-9275-5966; delattre, olivier/0000-0002-8730-2276; Van Meir, Erwin G./0000-0003-2444-7707; Remke, Marc/0000-0002-9404-9993; Wang, Xin/0000-0001-8783-4080; Clifford, Steve/0000-0003-4893-2184; Korshunov, Andrey/0000-0002-5257-3623; Faria, Claudia/0000-0003-1259-9922; Taylor, Michael/0000-0001-7009-3466; French, Pim/0000-0002-0668-9529; Tabori, Uri/0000-0002-5019-2683; Mack, Stephen C./0000-0001-9620-4742; iolascon, achille/0000-0002-9558-0356; Stuetz, Adrian/0000-0001-7650-3470; Zichner, Thomas/0000-0001-9848-7598; Liau, Linda/0000-0002-4053-0052; Cavalli, Florence M. G./0000-0002-4409-9642; Perek-Polnik, Marta/0000-0001-9043-6956; Gillespie, George/0000-0001-6436-9542; Meyerson, Matthew/0000-0002-9133-8108; Doz, Francois/0000-0001-9286-4831; Grajkowska, Wieslawa/0000-0001-8318-5781	CIHR Clinician-Scientist Phase II award; Sontag Foundation; Pediatric Brain Tumour Foundation; National Institutes of Health [CA159859]; The Family of Kathleen Lorette; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre; Chief of Research Fund; Cancer Genetics Program; Garron Family Cancer Centre; B.R.A.I.N. Child; CIHR [ATE-110814]; University of Toronto McLaughlin Centre; CIHR Institute of Cancer Research [AT1-112286]; BC Cancer Foundation; Children's Discovery Institute; Restracomp Fellowship (Hospital for Sick Children); Ontario Institute for Cancer Research; Government of Ontario; NIH [CA86335, CA116804, CA138292]; NCI [28XS100, 29XS193]; Southeastern Brain Tumour Foundation; Brain Tumour Foundation for Children; UK Children's Cancer and Leukaemia Group (CCLG) [BS-2007-04]; German Cancer Aid [109252]; Cancer Research UK [13457] Funding Source: researchfish; The Brain Tumour Charity [16/92] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA121941, P20CA151129, R01CA159859, R01CA155360, P30CA138292, R01CA086335, R01CA148621, R01CA163737, R01CA116804, R01CA114567, R01CA109467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061070, K08NS059790] Funding Source: NIH RePORTER	CIHR Clinician-Scientist Phase II award(Canadian Institutes of Health Research (CIHR)); Sontag Foundation; Pediatric Brain Tumour Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Family of Kathleen Lorette; Clark H. Smith Brain Tumour Centre; Montreal Children's Hospital Foundation; Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre; Chief of Research Fund; Cancer Genetics Program; Garron Family Cancer Centre; B.R.A.I.N. Child; CIHR(Canadian Institutes of Health Research (CIHR)); University of Toronto McLaughlin Centre; CIHR Institute of Cancer Research(Canadian Institutes of Health Research (CIHR)); BC Cancer Foundation; Children's Discovery Institute; Restracomp Fellowship (Hospital for Sick Children); Ontario Institute for Cancer Research; Government of Ontario; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Southeastern Brain Tumour Foundation; Brain Tumour Foundation for Children; UK Children's Cancer and Leukaemia Group (CCLG); German Cancer Aid(Deutsche Krebshilfe); Cancer Research UK(Cancer Research UK); The Brain Tumour Charity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M. D. T. is the recipient of a CIHR Clinician-Scientist Phase II award, and was formerly a Sontag Distinguished Scholar with funds from the Sontag Foundation. Funding is acknowledged from the Pediatric Brain Tumour Foundation (M. D. T. and J.T.R.), and the National Institutes of Health (CA159859 to M. D. T., R. W. R. and B. W.), The Canadian Cancer Society, Genome Canada, Genome BC, Terry Fox Research Institute, Ontario Institute for Cancer Research, Pediatric Oncology Group Ontario, Funds from 'The Family of Kathleen Lorette' and the Clark H. Smith Brain Tumour Centre, Montreal Children's Hospital Foundation, Hospital for Sick Children: Sonia and Arthur Labatt Brain Tumour Research Centre, Chief of Research Fund, Cancer Genetics Program, Garron Family Cancer Centre, B.R.A.I.N. Child, CIHR (grant no. ATE-110814); the University of Toronto McLaughlin Centre, CIHR Institute of Cancer Research (grant no. AT1-112286) and C17 through the Advancing Technology Innovation through Discovery competition (Project Title: The Canadian Pediatric Cancer Genome Consortium: Translating next-generation sequencing technologies into improved therapies for high-risk childhood cancer). Canada's Michael Smith Genome Sciences Centre is supported by the BC Cancer Foundation. J.R. is supported by The Children's Discovery Institute. P.A.N. was supported by a Restracomp Fellowship (Hospital for Sick Children) and is currently a Roman-Herzog Postdoctoral Fellow (Hertie Foundation). Salary support for L. G. was provided by the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. E. V. G. M. is supported by NIH grants CA86335, CA116804, CA138292, NCI contracts 28XS100 and 29XS193, the Southeastern Brain Tumour Foundation, and the Brain Tumour Foundation for Children. This study includes samples provided by the UK Children's Cancer and Leukaemia Group (CCLG) as part of CCLG-approved biological study BS-2007-04. J.K. and S. P. were supported by a grant from the German Cancer Aid (109252). We thank C. Lu, K. Otaka and The Centre for Applied Genomics for technical assistance. We thank N. S. Devi and Z. Zhang for technical assistance. We thank D. Stoll for project management, S. Archer for technical writing, and P. Paroutis for artwork. The MAGIC project is part of the International Cancer Genome Consortium.	Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Giaime E, 2006, J BIOL CHEM, V281, P11515, DOI 10.1074/jbc.M508619200; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Jia SJ, 2009, DEV BIOL, V333, P273, DOI 10.1016/j.ydbio.2009.06.037; Li X, 2010, NEUROSCIENCE, V165, P455, DOI 10.1016/j.neuroscience.2009.10.042; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; Marx FP, 2003, HUM MOL GENET, V12, P1223, DOI 10.1093/hmg/ddg134; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; MOLLER H, 1995, BRIT MED J, V310, P1500, DOI 10.1136/bmj.310.6993.1500; Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Northcott PA, 2011, ACTA NEUROPATHOL, V122, P231, DOI 10.1007/s00401-011-0846-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; SHTIVELMAN E, 1990, MOL CELL BIOL, V10, P1835, DOI 10.1128/MCB.10.4.1835; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	40	580	593	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					49	56		10.1038/nature11327	http://dx.doi.org/10.1038/nature11327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22832581	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-01	WOS:000307010700030
J	Sheridan, SL; Ware, RS; Grimwood, K; Lambert, SB				Sheridan, Sarah L.; Ware, Robert S.; Grimwood, Keith; Lambert, Stephen B.			Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VACCINATION		[Sheridan, Sarah L.; Ware, Robert S.; Grimwood, Keith; Lambert, Stephen B.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	University of Queensland	Sheridan, SL (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia.	s.sheridan@uq.edu.au	Grimwood, Keith/F-9334-2011; Ware, Robert S./B-2024-2014; Hall, Madeline/AGZ-8446-2022; Hall, Madeline/D-1345-2017; Lambert, Stephen/N-7819-2019	Ware, Robert S./0000-0002-6129-6736; Hall, Madeline/0000-0003-1533-5594; Hall, Madeline/0000-0003-1533-5594; Lambert, Stephen/0000-0002-2709-193X; Grimwood, Keith/0000-0003-3174-9834; Sheridan, Sarah/0000-0002-8451-3027				Cherry JD, 2010, CLIN VACCINE IMMUNOL, V17, P741, DOI 10.1128/CVI.00469-09; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Torvaldsen S, 2003, EUR J EPIDEMIOL, V18, P63, DOI 10.1023/A:1022588118030; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; Zhang LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub4	6	203	206	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					454	456		10.1001/jama.2012.6364	http://dx.doi.org/10.1001/jama.2012.6364			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851107	Bronze			2022-12-01	WOS:000306947400018
J	Mateen, FJ; Mills, EJ				Mateen, Farrah J.; Mills, Edward J.			Aging and HIV-Related Cognitive Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUB-SAHARAN AFRICA; NEUROCOGNITIVE IMPAIRMENT; PREVALENCE		[Mateen, Farrah J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21231 USA; [Mateen, Farrah J.] Johns Hopkins Univ, Johns Hopkins Hosp, Dept Neurol, Baltimore, MD 21231 USA; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Ottawa	Mateen, FJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Room E8527, Baltimore, MD 21231 USA.	fmateen@jhsph.edu		Mateen, Farrah/0000-0002-4293-8115				Centers for Disease Control and Prevention, HIV SURV REP, V21; Cysique LA, 2011, SEX HEALTH, V8, P541, DOI 10.1071/SH11003; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Valcour V, 2011, CLIN INFECT DIS, V53, P836, DOI 10.1093/cid/cir524; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d	10	18	18	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2012	308	4					349	350		10.1001/jama.2012.8538	http://dx.doi.org/10.1001/jama.2012.8538			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	977SR	22820786				2022-12-01	WOS:000306685500021
J	Flamand, M; Duchaine, TF				Flamand, Mathieu; Duchaine, Thomas F.			SnapShot: Endogenous RNA Pathways	CELL			English	Editorial Material							C-ELEGANS; INTERFERENCE; SIRNAS; PIRNAS		[Flamand, Mathieu; Duchaine, Thomas F.] McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ H3A 1A3, Canada	McGill University	Flamand, M (corresponding author), McGill Univ, Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ H3A 1A3, Canada.		Flamand, Mathieu/R-6102-2019; Duchaine, Thomas/U-2399-2019	Duchaine, Thomas/0000-0002-3454-1839				Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Li LD, 2011, METHODS MOL BIOL, V764, P169, DOI 10.1007/978-1-61779-188-8_11; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Tushir JS, 2009, CELL, V139, P830, DOI 10.1016/j.cell.2009.10.042; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	10	2	3	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 20	2012	150	2							442.e1	10.1016/j.cell.2012.07.006	http://dx.doi.org/10.1016/j.cell.2012.07.006			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	976PB	22817902	Bronze			2022-12-01	WOS:000306595700021
J	Tsai, HH; Li, HL; Fuentealba, LC; Molofsky, AV; Taveira-Marques, R; Zhuang, HL; Tenney, A; Murnen, AT; Fancy, SPJ; Merkle, F; Kessaris, N; Alvarez-Buylla, A; Richardson, WD; Rowitch, DH				Tsai, Hui-Hsin; Li, Huiliang; Fuentealba, Luis C.; Molofsky, Anna V.; Taveira-Marques, Raquel; Zhuang, Helin; Tenney, April; Murnen, Alice T.; Fancy, Stephen P. J.; Merkle, Florian; Kessaris, Nicoletta; Alvarez-Buylla, Arturo; Richardson, William D.; Rowitch, David H.			Regional Astrocyte Allocation Regulates CNS Synaptogenesis and Repair	SCIENCE			English	Article							SPINAL-CORD; CRUCIAL ROLE; NEURAL-TUBE; GLIAL-CELLS; OLIGODENDROCYTES; SPECIFICATION; NEURONS; TRANSFORMATION; PROGENITORS; GENERATION	Astrocytes, the most abundant cell population in the central nervous system (CNS), are essential for normal neurological function. We show that astrocytes are allocated to spatial domains in mouse spinal cord and brain in accordance with their embryonic sites of origin in the ventricular zone. These domains remain stable throughout life without evidence of secondary tangential migration, even after acute CNS injury. Domain-specific depletion of astrocytes in ventral spinal cord resulted in abnormal motor neuron synaptogenesis, which was not rescued by immigration of astrocytes from adjoining regions. Our findings demonstrate that region-restricted astrocyte allocation is a general CNS phenomenon and reveal intrinsic limitations of the astroglial response to injury.	[Fuentealba, Luis C.; Merkle, Florian; Alvarez-Buylla, Arturo; Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Tsai, Hui-Hsin; Molofsky, Anna V.; Tenney, April; Murnen, Alice T.; Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Tsai, Hui-Hsin; Tenney, April; Murnen, Alice T.; Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Molofsky, Anna V.] Univ Calif San Francisco, Langley Porter Inst, Dept Psychiat, San Francisco, CA 94143 USA; [Tsai, Hui-Hsin; Fuentealba, Luis C.; Molofsky, Anna V.; Murnen, Alice T.; Fancy, Stephen P. J.; Alvarez-Buylla, Arturo; Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Li, Huiliang; Taveira-Marques, Raquel; Zhuang, Helin; Kessaris, Nicoletta; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Li, Huiliang; Taveira-Marques, Raquel; Zhuang, Helin; Kessaris, Nicoletta; Richardson, William D.] UCL, Res Dept Cell & Dev Biol, London WC1E 6BT, England	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; University College London; University of London; University College London	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu; w.richardson@ucl.ac.uk; rowitchd@peds.ucsf.edu	Kessaris, Nicoletta/AAD-6774-2019; Ritter, Stefanie L/D-9312-2012; Molofsky, Anna Victoria/P-2506-2018; Richardson FMedSci FRS, William D/C-1762-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Molofsky, Anna Victoria/0000-0002-4709-2411; Merkle, Florian/0000-0002-8513-2998; Rowitch, David/0000-0002-0079-0060; Richardson FMedSci FRS, William D/0000-0001-7261-2485; Alvarez-Buylla, Arturo/0000-0003-4426-8925	Portuguese Fundacao para a Ciencia e a Tecnologia; NIH; UK Medical Research Council; Wellcome Trust; European Research Council; Medical Research Council [G0501173, G0800575] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478] Funding Source: NIH RePORTER; MRC [G0800575, G0501173] Funding Source: UKRI	Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Wong, S. Kaing, U. Dennehy, M. Grist, and S. Chang for technical help and E. Huillard, V. Heine, and C. Stiles for helpful comments. We thank A. Leiter (University of Massachusetts, Worcester) for Ngn3-cre mice. L. C. F. is a Howard Hughes Medical Institute (HHMI) Fellow of the Helen Hay Whitney Foundation. R.T.-M. was funded by the Portuguese Fundacao para a Ciencia e a Tecnologia. This work was supported by grants from the NIH, UK Medical Research Council, Wellcome Trust, and European Research Council. A.A.-B. holds the Heather and Melanie Muss Chair of Neurological Surgery. D. H. R. is a HHMI Investigator.	Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Houades V, 2008, J NEUROSCI, V28, P5207, DOI 10.1523/JNEUROSCI.5100-07.2008; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kettenmann H, 2005, NEUROGLIA, DOI Oxford University Press; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Shannon C, 2007, J ANAT, V210, P684, DOI 10.1111/j.1469-7580.2007.00731.x; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	30	335	340	5	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					358	362		10.1126/science.1222381	http://dx.doi.org/10.1126/science.1222381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22745251	Green Accepted			2022-12-01	WOS:000306542600056
J	Noakes, T; Spedding, M				Noakes, Timothy; Spedding, Michael			Run for your life	NATURE			English	Editorial Material							EVOLUTION		[Noakes, Timothy] Univ Cape Town, ZA-7701 Rondebosch, South Africa	University of Cape Town	Noakes, T (corresponding author), Univ Cape Town, ZA-7701 Rondebosch, South Africa.	timothy.noakes@uct.ac.za; spedves2@orange.fr	Spedding, Michael/AAE-7342-2019; Noakes, Timothy D./E-7253-2011; Noakes, Tim/AAD-3162-2020	Spedding, Michael/0000-0002-1248-8221; Noakes, Timothy D./0000-0001-7244-2375; Noakes, Tim/0000-0001-7244-2375				Agid Y, 2007, NAT REV DRUG DISCOV, V6, P189, DOI 10.1038/nrd2217; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Konopka G, 2010, NEURON, V68, P231, DOI 10.1016/j.neuron.2010.10.012; Markham A, 2012, EUR J NEUROSCI, V35, P366, DOI 10.1111/j.1460-9568.2011.07965.x; Mattson MP, 2012, AGEING RES REV, V11, P347, DOI 10.1016/j.arr.2012.01.007; Noakes T., 2012, WATERLOGGED SERIOUS; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Qi HS, 2009, NEUROPHARMACOLOGY, V56, P37, DOI 10.1016/j.neuropharm.2008.06.068	10	43	44	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2012	487	7407					295	296		10.1038/487295a	http://dx.doi.org/10.1038/487295a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975JB	22810678	Bronze			2022-12-01	WOS:000306506500016
J	Smetacek, V; Klaas, C; Strass, VH; Assmy, P; Montresor, M; Cisewski, B; Savoye, N; Webb, A; d'Ovidio, F; Arrieta, JM; Bathmann, U; Bellerby, R; Berg, GM; Croot, P; Gonzalez, S; Henjes, J; Herndl, GJ; Hoffmann, LJ; Leach, H; Losch, M; Mills, MM; Neill, C; Peeken, I; Rottgers, R; Sachs, O; Sauter, E; Schmidt, MM; Schwarz, J; Terbruggen, A; Wolf-Gladrow, D				Smetacek, Victor; Klaas, Christine; Strass, Volker H.; Assmy, Philipp; Montresor, Marina; Cisewski, Boris; Savoye, Nicolas; Webb, Adrian; d'Ovidio, Francesco; Arrieta, Jesus M.; Bathmann, Ulrich; Bellerby, Richard; Berg, Gry Mine; Croot, Peter; Gonzalez, Santiago; Henjes, Joachim; Herndl, Gerhard J.; Hoffmann, Linn J.; Leach, Harry; Losch, Martin; Mills, Matthew M.; Neill, Craig; Peeken, Ilka; Roettgers, Ruediger; Sachs, Oliver; Sauter, Eberhard; Schmidt, Maike M.; Schwarz, Jill; Terbrueggen, Anja; Wolf-Gladrow, Dieter			Deep carbon export from a Southern Ocean iron-fertilized diatom bloom	NATURE			English	Article							ATMOSPHERIC CO2; SEA-FLOOR; CYCLES; MODEL	Fertilization of the ocean by adding iron compounds has induced diatom-dominated phytoplankton blooms accompanied by considerable carbon dioxide drawdown in the ocean surface layer. However, because the fate of bloom biomass could not be adequately resolved in these experiments, the timescales of carbon sequestration from the atmosphere are uncertain. Here we report the results of a five-week experiment carried out in the closed core of a vertically coherent, mesoscale eddy of the Antarctic Circumpolar Current, during which we tracked sinking particles from the surface to the deep-sea floor. A large diatom bloom peaked in the fourth week after fertilization. This was followed by mass mortality of several diatom species that formed rapidly sinking, mucilaginous aggregates of entangled cells and chains. Taken together, multiple lines of evidence-although each with important uncertainties-lead us to conclude that at least half the bloom biomass sank far below a depth of 1,000 metres and that a substantial portion is likely to have reached the sea floor. Thus, iron-fertilized diatom blooms may sequester carbon for timescales of centuries in ocean bottom water and for longer in the sediments.	[Smetacek, Victor; Klaas, Christine; Strass, Volker H.; Assmy, Philipp; Cisewski, Boris; Bathmann, Ulrich; Henjes, Joachim; Losch, Martin; Peeken, Ilka; Sachs, Oliver; Sauter, Eberhard; Schwarz, Jill; Terbrueggen, Anja; Wolf-Gladrow, Dieter] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Smetacek, Victor] Natl Inst Oceanog, Panaji 403004, Goa, India; [Assmy, Philipp] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Montresor, Marina] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [Cisewski, Boris] Johann Heinrich von Thunen Inst, Inst Sea Fisheries, D-22767 Hamburg, Germany; [Savoye, Nicolas] Vrije Univ Brussel, Dept Analyt & Environm Chem, B-1050 Brussels, Belgium; [Savoye, Nicolas] Univ Bordeaux, CNRS, EPOC, UMR 5805,Stn Marine Arcachon, F-33120 Arcachon, France; [Webb, Adrian] Univ Cape Town, Dept Oceanog, ZA-7701 Cape Town, South Africa; [d'Ovidio, Francesco] CNRS UPMC IRD MNHN, LOCEAN IPSL, F-75252 Paris, France; [Arrieta, Jesus M.; Gonzalez, Santiago; Herndl, Gerhard J.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, NL-1790 AB Den Burg, Netherlands; [Arrieta, Jesus M.] CSIC UIB, Inst Mediterraneo Estudios Avanzados, Dept Global Change Res, Esporles 07190, Mallorca, Spain; [Bathmann, Ulrich] Leibniz Inst Balt Sea Res Warnemunde, D-18119 Rostock, Germany; [Bellerby, Richard; Neill, Craig] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Bellerby, Richard] Norwegian Inst Water Res, N-5006 Bergen, Norway; [Berg, Gry Mine; Mills, Matthew M.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Croot, Peter; Hoffmann, Linn J.] Helmholtz Ctr Ocean Res Kiel, D-24105 Kiel, Germany; [Croot, Peter] Natl Univ Ireland, Sch Nat Sci, Galway, Ireland; [Henjes, Joachim] Phytolut GmbH, D-28759 Bremen, Germany; [Herndl, Gerhard J.] Univ Vienna, Dept Marine Biol, A-1090 Vienna, Austria; [Leach, Harry] Univ Liverpool, Sch Environm Sci, Liverpool L69 3GP, Merseyside, England; [Neill, Craig] Commonwealth Sci & Ind Res Org, Wealth Oceans Flagship, Hobart, Tas 7000, Australia; [Peeken, Ilka] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Roettgers, Ruediger] Helmholtz Zentrum Geesthacht, Ctr Mat & Coastal Res, Inst Coastal Res, D-21502 Geesthacht, Germany; [Sachs, Oliver] Eberhard & Partner AG, CH-5000 Aarau, Switzerland; [Schmidt, Maike M.] Univ Bremen, Ctr Biomol Interact Bremen, FB 2, D-28359 Bremen, Germany; [Schwarz, Jill] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Norwegian Polar Institute; Stazione Zoologica Anton Dohrn di Napoli; Johann Heinrich von Thunen Institute; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; University of Barcelona; Leibniz Institut fur Ostseeforschung Warnemunde; Bjerknes Centre for Climate Research; University of Bergen; Norwegian Institute for Water Research (NIVA); Stanford University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Ollscoil na Gaillimhe-University of Galway; University of Vienna; University of Liverpool; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Bremen; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Bremen; University of Plymouth	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.	victor.smetacek@awi.de; christine.klaas@awi.de	Croot, Peter L/C-8460-2009; Cisewski, Boris/GWV-4320-2022; Herndl, Gerhard J./B-1513-2013; Losch, Martin/S-5896-2016; Croot, Peter/U-5296-2019; Herndl, Gerhard J./S-3011-2019; d'Ovidio, Francesco/ABA-8461-2021; Bellerby, Richard/ABD-6590-2021; Arrieta, Jesus M/B-1226-2008; Hoffmann, Linn/I-6042-2012; Hoffmann, Linn/J-3761-2019	Croot, Peter L/0000-0003-1396-0601; Cisewski, Boris/0000-0002-1130-6107; Herndl, Gerhard J./0000-0002-2223-2852; Losch, Martin/0000-0002-3824-5244; Herndl, Gerhard J./0000-0002-2223-2852; Bellerby, Richard/0000-0003-3598-4006; Arrieta, Jesus M/0000-0002-0190-6950; Hoffmann, Linn/0000-0001-9175-6097; Hoffmann, Linn/0000-0003-0242-4686; Wolf-Gladrow, Dieter/0000-0001-9531-8668; Sauter, Eberhard/0000-0001-7954-952X; Henjes, Joachim/0000-0002-6688-8802; Klaas, Christine/0000-0002-6679-8970; Strass, Volker/0000-0002-7539-1400; Montresor, Marina/0000-0002-2475-1787; d'Ovidio, Francesco/0000-0002-9664-7778; Peeken, Ilka/0000-0003-1531-1664	Cnes	Cnes(Centre National D'etudes Spatiales)	We thank C. Balt, K. Loquay, S. Mkatshwa, H. Prandke, H. Rohr, M. Thomas and I. Voge for help on board. We are also grateful to U. Struck for POC and PON analyses. The altimeter products were produced by Ssalto/Duacs and distributed by Aviso with support from Cnes. We thank the captain and crew of RV Polarstern (cruise ANT XXI/3) for support throughout the cruise.	Abelmann A, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001199; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Beaulieu SE, 2002, OCEANOGR MAR BIOL, V40, P171; Bishop JKB, 2004, SCIENCE, V304, P417, DOI 10.1126/science.1087717; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; Cisewski B, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004372; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; d'Ovidio F, 2009, DEEP-SEA RES PT I, V56, P15, DOI 10.1016/j.dsr.2008.07.014; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Hamme RC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044629; Hibbert A, 2009, J MAR RES, V67, P1, DOI 10.1357/002224009788597935; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; Jacquet SHM, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002902; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI [10.1126/science.1105375, 10.1126/science.11053 75]; Lampitt RS, 2001, PROG OCEANOGR, V50, P27, DOI 10.1016/S0079-6611(01)00047-7; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; RIEBESELL U, 1992, DEEP-SEA RES, V39, P1085, DOI 10.1016/0198-0149(92)90058-2; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; The Royal Society, 2009, 1009 RS	24	265	271	10	449	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					313	319		10.1038/nature11229	http://dx.doi.org/10.1038/nature11229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22810695				2022-12-01	WOS:000306506500032
J	Smith, A; Jones, G				Smith, Adam; Jones, Greg			Miracle pills and fireproof trainers: user endorsement in social media	BRITISH MEDICAL JOURNAL			English	Editorial Material												adam@adamesmith.co.uk	Smith, Adam/GPS-8322-2022					Advertising Standards Authority, 2011, ASA ADJ ION BAL; ASA, NONC ONL ADV ION BAL; ASA, ADV COD; Ionic Balance, WHY ION BAL; Merrell, PHOTOS MERRELL; PacificHealth Laboratories, END EXC NAT TRAIN SU; Sweney M, 2012, NIKE BECOMES 1 UK CO; YouTube, WAT WAT SUCKS GAT BE	8	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 19	2012	345								e4682	10.1136/bmj.e4682	http://dx.doi.org/10.1136/bmj.e4682			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MA	22810385				2022-12-01	WOS:000306744300007
J	Lauer, MS				Lauer, Michael S.			Lemons for Obesity	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNCERTAINTY		[Lauer, Michael S.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lauer, MS (corresponding author), 6701 Rockledge Dr,Room 8128, Bethesda, MD 20892 USA.	lauerm@nhlbi.nih.gov	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177				AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [DOI 10.1111/J.1539-6053.2008.00033.X, 10.1111/j.1539-6053.2008.00033.x]; Lauer Michael S, 2009, Cleve Clin J Med, V76 Suppl 2, pS18, DOI 10.3949/ccjm.76.s2.04; Moyer VA, 2012, ANN INTERN MED, V156, P392, DOI 10.7326/0003-4819-156-5-201203060-00015; Reyna VF, 2009, PSYCHOL BULL, V135, P943, DOI 10.1037/a0017327; Roan S, 2012, LOS ANGELES TIMES; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vivus, 2012, VI 0521 QNEX ADV COM; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005	9	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2012	157	2					139	+		10.7326/0003-4819-157-2-201207170-00438	http://dx.doi.org/10.7326/0003-4819-157-2-201207170-00438			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992ON	22801677				2022-12-01	WOS:000307787900020
J	Gregoire, LJ; Payne, AJ; Valdes, PJ				Gregoire, Lauren J.; Payne, Antony J.; Valdes, Paul J.			Deglacial rapid sea level rises caused by ice-sheet saddle collapses	NATURE			English	Article							MELTWATER PULSE 1A; CLIMATE-CHANGE; LAKE AGASSIZ; COLD EVENT; MODEL; RECONSTRUCTIONS; DRAINAGE; TRIGGER; AGES	The last deglaciation (21 to 7 thousand years ago) was punctuated by several abrupt meltwater pulses, which sometimes caused noticeable climate change(1,2). Around 14 thousand years ago, meltwater pulse 1A (MWP-1A), the largest of these events, produced a sea level rise of 14-18 metres over 350 years(3). Although this enormous surge of water certainly originated from retreating ice sheets, there is no consensus on the geographical source or underlying physical mechanisms governing the rapid sea level rise(4-6). Here we present an ice-sheet modelling simulation in which the separation of the Laurentide and Cordilleran ice sheets in North America produces a meltwater pulse corresponding to MWP-1A. Another meltwater pulse is produced when the Labrador and Baffin ice domes around Hudson Bay separate, which could be associated with the '8,200-year' event, the most pronounced abrupt climate event of the past nine thousand years(7). For both modelled pulses, the saddle between the two ice domes becomes subject to surface melting because of a general surface lowering caused by climate warming. The melting then rapidly accelerates as the saddle between the two domes gets lower, producing nine metres of sea level rise over 500 years. This mechanism of an ice 'saddle collapse' probably explains MWP-1A and the 8,200-year event and sheds light on the consequences of these events on climate.	[Gregoire, Lauren J.; Payne, Antony J.; Valdes, Paul J.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England	University of Bristol	Gregoire, LJ (corresponding author), Univ Bristol, Sch Geog Sci, Univ Rd, Bristol BS8 1SS, Avon, England.	lauren.gregoire@bristol.ac.uk	Valdes, Paul/T-2004-2019; Valdes, Paul/C-4129-2013; Gregoire, Lauren J/A-7005-2011; payne, antony/A-8916-2008	Valdes, Paul/0000-0002-1902-3283; Gregoire, Lauren J/0000-0003-0258-7282; payne, antony/0000-0001-8825-8425	Marie Curie Research Training Network NICE [MRTN-CT-2006-036127]; NERC QUEST [NE/D001846/1]; ORMEN [NE/C509558/1]; Directorate For Geosciences [1023724] Funding Source: National Science Foundation; Natural Environment Research Council [NE/D001846/1] Funding Source: researchfish; NERC [NE/D001846/1] Funding Source: UKRI	Marie Curie Research Training Network NICE(European Commission); NERC QUEST(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ORMEN; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Marie Curie Research Training Network NICE (MRTN-CT-2006-036127) and the NERC QUEST (NE/D001846/1) and ORMEN (NE/C509558/1) projects. Glimmer was developed within the NERC National Centre for Earth Observation. We thank R. Kahana for providing part of the input climate data and for comments on the manuscript. We also thank members of the BRIDGE group, the NICE network and PALSEA, a PAGES/INQUA/WUN network, for discussions and suggestions. The numerical simulations were carried out using the computational facilities of the BRIDGE group and those of the Advanced Computing Research Centre, University of Bristol (http://www.bris.ac.uk/acrc/).	Abe-Ouchi A, 2007, CLIM PAST, V3, P423, DOI 10.5194/cp-3-423-2007; Aharon P, 2006, EARTH PLANET SC LETT, V241, P260, DOI 10.1016/j.epsl.2005.10.034; Amante C., 2009, ETOPO1 1 ARC MINUTE; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; BERGER A, 1992, EARTH PLANET SC LETT, V111, P369, DOI 10.1016/0012-821X(92)90190-7; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Carlson AE, 2009, QUATERNARY SCI REV, V28, P1625, DOI 10.1016/j.quascirev.2009.02.011; Charbit S, 2007, CLIM PAST, V3, P15, DOI 10.5194/cp-3-15-2007; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; Clark PU, 2002, SCIENCE, V295, P2438; Davies MH, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002051; Deschamps P, 2012, NATURE, V483, P559, DOI 10.1038/nature10902; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Fulton RJ, 2004, DEV QUA SCI, V2, P39, DOI 10.1016/S1571-0866(04)80184-2; Ganopolski A, 2010, CLIM PAST, V6, P229, DOI 10.5194/cp-6-229-2010; Gregoire L, 2010, THESIS U BRISTOL; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; Laske G., 1997, EOS T AGU, V78, pF483; Le Meur E., 1996, ANN GLACIOL, V23, P309, DOI [10.3189/S0260305500013586, DOI 10.3189/S0260305500013586, DOI 10.013/EPIC.12717]; Li YX, 2012, EARTH PLANET SC LETT, V315, P41, DOI 10.1016/j.epsl.2011.05.034; Marshall SJ, 2002, QUATERNARY SCI REV, V21, P175, DOI 10.1016/S0277-3791(01)00089-0; Menviel L, 2011, QUATERNARY SCI REV, V30, P1155, DOI 10.1016/j.quascirev.2011.02.005; Munyikwa K, 2011, QUAT GEOCHRONOL, V6, P407, DOI 10.1016/j.quageo.2011.03.010; Murton JB, 2010, NATURE, V464, P740, DOI 10.1038/nature08954; PAYNE A, 1990, EARTH SURF PROCESSES, V15, P625, DOI 10.1002/esp.3290150705; Peltier WR, 2006, QUATERNARY SCI REV, V25, P3322, DOI 10.1016/j.quascirev.2006.04.010; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; REEH N, 1991, POLARFORSCHUNG, V0059; Rohling EJ, 2005, NATURE, V434, P975, DOI 10.1038/nature03421; Rutt IC, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001015; Smith RS, 2008, GEOSCI MODEL DEV, V1, P53, DOI 10.5194/gmd-1-53-2008; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Stanford JD, 2011, GLOBAL PLANET CHANGE, V79, P193, DOI 10.1016/j.gloplacha.2010.11.002; Stanford JD, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001340; Tarasov L, 2006, QUATERNARY SCI REV, V25, P659, DOI 10.1016/j.quascirev.2005.12.006; Tarasov L, 2012, EARTH PLANET SC LETT, V315, P30, DOI 10.1016/j.epsl.2011.09.010; Teller JT, 2002, QUATERNARY SCI REV, V21, P879, DOI 10.1016/S0277-3791(01)00145-7; Thornalley DJR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001772; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002; WEERTMAN J, 1961, J GEOPHYS RES, V66, P3783, DOI 10.1029/JZ066i011p03783; Zweck C, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005489	43	141	142	1	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					219	U1506		10.1038/nature11257	http://dx.doi.org/10.1038/nature11257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22785319	Green Submitted, Green Accepted			2022-12-01	WOS:000306278900036
J	Peters, BA; Kermani, BG; Sparks, AB; Alferov, O; Hong, P; Alexeev, A; Jiang, Y; Dahl, F; Tang, YT; Haas, J; Robasky, K; Zaranek, AW; Lee, JH; Ball, MP; Peterson, JE; Perazich, H; Yeung, G; Liu, J; Chen, LS; Kennemer, MI; Pothuraju, K; Konvicka, K; Tsoupko-Sitnikov, M; Pant, KP; Ebert, JC; Nilsen, GB; Baccash, J; Halpern, AL; Church, GM; Drmanac, R				Peters, Brock A.; Kermani, Bahram G.; Sparks, Andrew B.; Alferov, Oleg; Hong, Peter; Alexeev, Andrei; Jiang, Yuan; Dahl, Fredrik; Tang, Y. Tom; Haas, Juergen; Robasky, Kimberly; Zaranek, Alexander Wait; Lee, Je-Hyuk; Ball, Madeleine Price; Peterson, Joseph E.; Perazich, Helena; Yeung, George; Liu, Jia; Chen, Linsu; Kennemer, Michael I.; Pothuraju, Kaliprasad; Konvicka, Karel; Tsoupko-Sitnikov, Mike; Pant, Krishna P.; Ebert, Jessica C.; Nilsen, Geoffrey B.; Baccash, Jonathan; Halpern, Aaron L.; Church, George M.; Drmanac, Radoje			Accurate whole-genome sequencing and haplotyping from 10 to 20 human cells	NATURE			English	Article							OPEN-ACCESS DATABASE; JASPAR	Recent advances in whole-genome sequencing have brought the vision of personal genomics and genomic medicine closer to reality. However, current methods lack clinical accuracy and the ability to describe the context (haplotypes) in which genome variants co-occur in a cost-effective manner. Here we describe a low-cost DNA sequencing and haplotyping process, long fragment read (LFR) technology, which is similar to sequencing long single DNA molecules without cloning or separation of metaphase chromosomes. In this study, ten LFR libraries were made using only similar to 100 picograms of human DNA per sample. Up to 97% of the heterozygous single nucleotide variants were assembled into long haplotype contigs. Removal of false positive single nucleotide variants not phased by multiple LFR haplotypes resulted in a final genome error rate of 1 in 10 megabases. Cost-effective and accurate genome sequencing and haplotyping from 10-20 human cells, as demonstrated here, will enable comprehensive genetic studies and diverse clinical applications.	[Peters, Brock A.; Kermani, Bahram G.; Sparks, Andrew B.; Alferov, Oleg; Hong, Peter; Alexeev, Andrei; Jiang, Yuan; Dahl, Fredrik; Tang, Y. Tom; Haas, Juergen; Peterson, Joseph E.; Perazich, Helena; Yeung, George; Liu, Jia; Chen, Linsu; Kennemer, Michael I.; Pothuraju, Kaliprasad; Konvicka, Karel; Tsoupko-Sitnikov, Mike; Pant, Krishna P.; Ebert, Jessica C.; Nilsen, Geoffrey B.; Baccash, Jonathan; Halpern, Aaron L.; Drmanac, Radoje] Complete Genom Inc, Mountain View, CA 94043 USA; [Robasky, Kimberly; Zaranek, Alexander Wait; Lee, Je-Hyuk; Ball, Madeleine Price; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Robasky, Kimberly] Boston Univ, Program Bioinformat, Boston, MA 02215 USA; [Lee, Je-Hyuk] Harvard Univ, Sch Med, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02115 USA	Harvard University; Harvard Medical School; Boston University; Harvard University	Peters, BA (corresponding author), Complete Genom Inc, 2071 Stierlin Court, Mountain View, CA 94043 USA.	bpeters@completegenomics.com; rdrmanac@completegenomics.com	Nilsen, Geoffrey/AAY-8095-2021	Ball, Mad/0000-0003-0544-5925; Robasky, Kimberly/0000-0002-0090-8698; church, george/0000-0001-6232-9969; Peters, Brock/0000-0002-5137-3902; Zaranek, Alexander (Sasha) Wait/0000-0002-0415-9655	US Department of Commerce; National Institute of Standards and Technology [70NANB7H7027]; National Institutes of Health [P50HG005550]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER	US Department of Commerce; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to acknowledge the continuing contributions and support of all Complete Genomics employees, in particular M. McElwain, D. Bailey, D. Kruse and J. Turcotte for their help with preparing the manuscript. We also wish to thank W. Chao for his help with Figures 1 and 2. Some of this work was supported by the US Department of Commerce, National Institute of Standards and Technology, Advanced Technology Program, Cooperative Agreement Number 70NANB7H7027 and National Institutes of Health grant P50HG005550. We would like to thank J. Chen for managing the NIST grant.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 2010, Nature, V467, P1026, DOI 10.1038/4671026a; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Drmanac R., 2006, US patent, Patent No. [7,901 891, 7901891]; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kermani B. G., 2010, US patent, Patent No. [PCT/US2010/023083, 2010023083]; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/nmeth.1443, 10.1038/NMETH.1443]; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yang H, 2011, P NATL ACAD SCI USA, V108, P12, DOI 10.1073/pnas.1016725108; Zhang K, 2006, NAT GENET, V38, P382, DOI 10.1038/ng1741	37	163	253	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					190	195		10.1038/nature11236	http://dx.doi.org/10.1038/nature11236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22785314	Green Submitted, Green Accepted, hybrid			2022-12-01	WOS:000306278900030
J	Srivastava, R; Aslam, M; Kalluri, SR; Schirmer, L; Buck, D; Tackenberg, B; Rothhammer, V; Chan, A; Gold, R; Berthele, A; Bennett, JL; Korn, T; Hemmer, B				Srivastava, Rajneesh; Aslam, Muhammad; Kalluri, Sudhakar Reddy; Schirmer, Lucas; Buck, Dorothea; Tackenberg, Bjoern; Rothhammer, Veit; Chan, Andrew; Gold, Ralf; Berthele, Achim; Bennett, Jeffrey L.; Korn, Thomas; Hemmer, Bernhard			Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECTIFYING K+ CHANNEL; NEUROMYELITIS-OPTICA; SENSORINEURAL DEAFNESS; HETEROGENEITY; EXPRESSION; MUTATIONS; LESIONS; KCNJ10; IDENTIFICATION; DEMYELINATION	BACKGROUND Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system. Many findings suggest that the disease has an autoimmune pathogenesis; the target of the immune response is not yet known. METHODS We screened serum IgG from persons with multiple sclerosis to identify antibodies that are capable of binding to brain tissue and observed specific binding of IgG to glial cells in a subgroup of patients. Using a proteomic approach focusing on membrane proteins, we identified the ATP-sensitive inward rectifying potassium channel KIR4.1 as the target of the IgG antibodies. We used a multifaceted validation strategy to confirm KIR4.1 as a target of the autoantibody response in multiple sclerosis and to show its potential pathogenicity in vivo. RESULTS Serum levels of antibodies to KIR4.1 were higher in persons with multiple sclerosis than in persons with other neurologic diseases and healthy donors (P<0.001 for both comparisons). We replicated this finding in two independent groups of persons with multiple sclerosis or other neurologic diseases (P<0.001 for both comparisons). Analysis of the combined data sets indicated the presence of serum antibodies to KIR4.1 in 186 of 397 persons with multiple sclerosis (46.9%), in 3 of 329 persons with other neurologic diseases (0.9%), and in none of the 59 healthy donors. These antibodies bound to the first extracellular loop of KIR4.1. Injection of KIR4.1 serum IgG into the cisternae magnae of mice led to a profound loss of KIR4.1 expression, altered expression of glial fibrillary acidic protein in astrocytes, and activation of the complement cascade at sites of KIR4.1 expression in the cerebellum. CONCLUSIONS KIR4.1 is a target of the autoantibody response in a subgroup of persons with multiple sclerosis. (Funded by the German Ministry for Education and Research and Deutsche Forschungsgemeinschaft.)	[Srivastava, Rajneesh; Aslam, Muhammad; Kalluri, Sudhakar Reddy; Schirmer, Lucas; Buck, Dorothea; Rothhammer, Veit; Berthele, Achim; Korn, Thomas; Hemmer, Bernhard] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, D-81675 Munich, Germany; [Tackenberg, Bjoern] Univ Marburg, Dept Neurol, Marburg, Germany; [Chan, Andrew; Gold, Ralf] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany; [Bennett, Jeffrey L.] Univ Colorado, Dept Neurol, Denver, CO 80202 USA; [Bennett, Jeffrey L.] Univ Colorado, Dept Ophthalmol, Denver, CO 80202 USA	Technical University of Munich; Philipps University Marburg; Ruhr University Bochum; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Hemmer, B (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Ismaningerstr 22, D-81675 Munich, Germany.	hemmer@lrz.tu-muenchen.de	Hemmer, Bernhard/AAT-8388-2021; Korn, Thomas/AAE-6960-2019; Kalluri, Sudhakar Reddy/C-6928-2013; Hemmer, Bernhard/GPX-8451-2022	Korn, Thomas/0000-0002-3633-0955; Hemmer, Bernhard/0000-0001-5985-6784; Schirmer, Lucas/0000-0001-7142-4116; Chan, Andrew/0000-0003-3434-7283	German Competence Network Multiple Sclerosis through the German Ministry for Education and Research (Control-MS) [01GI0917]; Deutsche Forschungsgemeinschaft (DFG) [He2386/7-1]; Gemeinnutzige Hertie-Stiftung; German Academic Exchange Service; National Multiple Sclerosis Society [RG4320]; Guthy-Jackson Charitable Foundation; German Ministry for Education and Research; NATIONAL EYE INSTITUTE [R01EY022936] Funding Source: NIH RePORTER	German Competence Network Multiple Sclerosis through the German Ministry for Education and Research (Control-MS); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gemeinnutzige Hertie-Stiftung; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Guthy-Jackson Charitable Foundation; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from the German Competence Network Multiple Sclerosis through the German Ministry for Education and Research (Control-MS, 01GI0917) and from the Deutsche Forschungsgemeinschaft (DFG) (He2386/7-1). Dr. Korn is supported by grants from the DFG and the Gemeinnutzige Hertie-Stiftung; Dr. Aslam, by grants from the German Academic Exchange Service; and Dr. Bennett, by grants from the National Multiple Sclerosis Society (RG4320) and the Guthy-Jackson Charitable Foundation.; Funded by the German Ministry for Education and Research and Deutsche Forschungsgemeinschaft	Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Archelos JJ, 1998, ANN NEUROL, V43, P15, DOI 10.1002/ana.410430107; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Berger T, 2007, J NEUROL SCI, V259, P21, DOI 10.1016/j.jns.2006.05.070; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Breij ECW, 2008, ANN NEUROL, V63, P16, DOI 10.1002/ana.21311; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cortese I, 1996, P NATL ACAD SCI USA, V93, P11063, DOI 10.1073/pnas.93.20.11063; Derfuss T, 2010, J MOL MED, V88, P753, DOI 10.1007/s00109-010-0632-3; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Higashi K, 2001, AM J PHYSIOL-CELL PH, V281, pC922, DOI 10.1152/ajpcell.2001.281.3.C922; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; Klein M, 2003, ANN NEUROL, V54, P451, DOI 10.1002/ana.10684; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Poopalasundaram S, 2000, GLIA, V30, P362, DOI 10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; Somers V, 2008, J IMMUNOL, V180, P3957, DOI 10.4049/jimmunol.180.6.3957; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; Tang XF, 2009, GLIA, V57, P1706, DOI 10.1002/glia.20882; Uccelli A, 2005, TRENDS IMMUNOL, V26, P254, DOI 10.1016/j.it.2005.02.009	40	254	262	4	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2012	367	2					115	123		10.1056/NEJMoa1110740	http://dx.doi.org/10.1056/NEJMoa1110740			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972IO	22784115	Green Accepted			2022-12-01	WOS:000306270800008
J	Yu, EW; Finkelstein, JS				Yu, Elaine W.; Finkelstein, Joel S.			Bone Density Screening Intervals for Osteoporosis One Size Does Not Fit All	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FRACTURE RISK; FEMORAL-NECK; WOMEN		[Yu, Elaine W.; Finkelstein, Joel S.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Yu, EW (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, 50 Blossom St,Thier 1051, Boston, MA 02114 USA.		Finkelstein, Joel/M-6463-2019					[Anonymous], 2011, AM FAM PHYSICIAN, V83, P1197; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; King AB, 2011, HEALTH AFFAIR, V30, P2362, DOI 10.1377/hlthaff.2011.0233; National Osteoporosis Foundation, NOF CLIN GUID PREV T; Nguyen TV, 2005, J BONE MINER RES, V20, P1195, DOI 10.1359/JBMR.050215; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; Siris ES, 2008, OSTEOPOROSIS INT, V19, P681, DOI 10.1007/s00198-007-0493-y; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; World Health Organization Collaborating Centre for Metabolic Bone Diseases, WHO FRACT RISK ASS T	10	18	18	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2591	2592		10.1001/jama.2012.6977	http://dx.doi.org/10.1001/jama.2012.6977			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	964KF	22735425				2022-12-01	WOS:000305692600024
J	Oakeshott, P; Aghaizu, A; Reid, F; Howell-Jones, R; Hay, PE; Sadiq, ST; Lacey, CJ; Beddows, S; Soldan, K				Oakeshott, Pippa; Aghaizu, Adamma; Reid, Fiona; Howell-Jones, Rebecca; Hay, Phillip E.; Sadiq, S. Tariq; Lacey, Charles J.; Beddows, Simon; Soldan, Kate			Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							YOUNG-WOMEN; NATURAL-HISTORY; CERVICAL-CANCER; HPV INFECTION; VACCINES; CYTOLOGY; TRIAL; AGE; PREVENTION; CHLAMYDIA	Objective To investigate frequency and risk factors for prevalent, incident, and persistent carcinogenic human papillomavirus (HPV) in young women before the introduction of immunisation against HPV types 16 and 18 for schoolgirls. Design Cohort study Setting 20 London universities and further education colleges. Participants 2185 sexually active female students, mean age 21 years (range 16-27), 38% from ethnic minorities, who took part in the POPI (prevention of pelvic infection) chlamydia screening trial in 2004-08 and who provided duplicate, self taken vaginal swabs and completed questionnaires at baseline. At follow-up, a median of 16 months later, 821 women (38%) returned repeat vaginal swabs by post. In 2009-10, stored samples were tested for HPV. Results Samples from 404/2185 (18.5% (95% CI 16.9% to 20.2%)) of the cohort were positive for carcinogenic HPV at baseline, including 15.0% (327) positive for non-vaccine carcinogenic genotypes. Reporting two or more sexual partners in the previous year and concurrent Chlamydia trachomatis or bacterial vaginosis were independent risk factors for prevalent vaginal HPV infection. Infection with one or more new HPV types was found in 17.7% (145/821) of follow-up samples, giving an estimated annual incidence of carcinogenic HPV infection of 12.9% (95% CI 11.0% to 15.0%). Incident infection was more common in women reporting two or more partners in the previous year, aged<20, of black ethnicity, or with C trachomatis vaginosis at baseline. Multiple partners was the only independent risk factor for incident infection (adjusted relative risk 1.99 (95% CI 1.46 to 2.72)). Of 143 women with baseline carcinogenic HPV infection, 20 (14% (8.3% to 19.7%) had infection with the same carcinogenic HPV type(s) detected after 12-28 months. Of these women, 13 (65%) had redetected infection with HPV 16 or 18, and nine (45%) with non-vaccine carcinogenic HPV genotypes. Conclusion In the first UK cohort study of carcinogenic HPV in young women in the community, multiple sexual partners was an independent predictor of both prevalent and incident infection. Infection with non-vaccine carcinogenic genotypes was common. Although current HPV vaccines offer partial cross protection against some non-vaccine carcinogenic HPV types, immunised women will still need cervical screening.	[Oakeshott, Pippa; Aghaizu, Adamma; Reid, Fiona] Univ London, Div Populat Hlth Sci, London SW17 0RE, England; [Howell-Jones, Rebecca; Soldan, Kate] Hlth Protect Agcy, HIV & STI Dept, London NW9 5EQ, England; [Hay, Phillip E.; Sadiq, S. Tariq] Dept Genitourinary Med, London, England; [Lacey, Charles J.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Beddows, Simon] Hlth Protect Agcy, Virus Reference Dept, London, England	University of London; Health Protection Agency; University of Hull; University of York - UK; Health Protection Agency	Oakeshott, P (corresponding author), Univ London, Div Populat Hlth Sci, London SW17 0RE, England.	p.oakeshott@sgul.ac.uk		Reid, Fiona/0000-0002-0762-8111; Beddows, Simon/0000-0002-6879-6215; Soldan, Kate/0000-0002-0361-3174; Oakeshott, Pippa/0000-0003-2568-8211; Sadiq, S Tariq/0000-0002-0608-3818	BUPA foundation [TBF-08-025]; Medical Research Council [80280]; GlaxoSmithKline [EPI-HPV-109903]; Policy Research Programme in the Department of Health, UK [039/030]; UK Clinical Research Collaboration; Medical Research Council [G0901608, G0601669] Funding Source: researchfish; MRC [G0901608, G0601669] Funding Source: UKRI	BUPA foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); Policy Research Programme in the Department of Health, UK; UK Clinical Research Collaboration; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BUPA foundation grant TBF-08-025 and Medical Research Council grant 80280. Gen-Probe provided the Aptima test kits. The HPV testing was supported by a grant from GlaxoSmithKline (study No EPI-HPV-109903). RHJ was funded by the Policy Research Programme in the Department of Health, UK (grant reference No 039/030). PO, STS, and PEH are members of the eSTI2 consortium funded by the UK Clinical Research Collaboration. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health or other funders.	Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2569; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Howell-Jones R, 2010, BRIT J CANCER, V103, P209, DOI 10.1038/sj.bjc.6605747; Howell-Jones R, 2012, VACCINE IN PRESS; Kim S, 2011, SEX TRANSM DIS, V38, P587, DOI 10.1097/OLQ.0b013e31820a9324; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Maucort-Boulch D, 2010, INT J CANCER, V126, P684, DOI 10.1002/ijc.24752; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; Oakeshott P., 2010, BRIT MED J, V340, pc1642, DOI [10.1136/bmj.c1642, DOI 10.1136/BMJ.C1642]; Oakeshott P, 2010, CLIN INFECT DIS, V51, P1160, DOI 10.1086/656739; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Ronco G, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3005; Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Sinka K, 2011, SEX TRANSM INFECT, V87, P548, DOI 10.1136/sextrans-2011-050211; Steben M, 2007, GYNECOL ONCOL, V107, pS2, DOI 10.1016/j.ygyno.2007.07.067; Verheijen RHM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5720; Winer RL, 2007, SEX TRANSM DIS, V34, P371, DOI 10.1097/01.olq.0000240315.19652.59; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Winer RL, 2011, CANCER EPIDEM BIOMAR, V20, P699, DOI 10.1158/1055-9965.EPI-10-1108; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	28	35	39	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2012	344								e4168	10.1136/bmj.e4168	http://dx.doi.org/10.1136/bmj.e4168			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965CL	22730542	Green Accepted, Green Published, hybrid			2022-12-01	WOS:000305743600001
J	Di Angelantonio, E; Gao, P; Pennells, L; Kaptoge, S; Caslake, M; Thompson, A; Butterworth, AS; Sarwar, N; Wormser, D; Saleheen, D; Ballantyne, CM; Psaty, BM; Sundstrom, J; Ridker, PM; Nagel, D; Gillum, RF; Ford, I; Ducimetiere, P; Kiechl, S; Dullaart, RPF; Assmann, G; D'Agostino, RB; Dagenais, GR; Cooper, JA; Kromhout, D; Onat, A; Tipping, RW; Gomez-de-la-Camara, A; Rosengren, A; Sutherland, SE; Gallacher, J; Fowkes, FGR; Casiglia, E; Hofman, A; Salomaa, V; Barrett-Connor, E; Clarke, R; Brunner, E; Jukema, JW; Simons, LA; Sandhu, M; Wareham, NJ; Khaw, KT; Kauhanen, J; Salonen, JT; Howard, WJ; Nordestgaard, BG; Wood, AM; Thompson, SG; Boekholdt, SM; Sattar, N; Packard, C; Gudnason, V; Danesh, J				Di Angelantonio, Emanuele; Gao, Pei; Pennells, Lisa; Kaptoge, Stephen; Caslake, Muriel; Thompson, Alexander; Butterworth, Adam S.; Sarwar, Nadeem; Wormser, David; Saleheen, Danish; Ballantyne, Christie M.; Psaty, Bruce M.; Sundstrom, Johan; Ridker, Paul M.; Nagel, Dorothea; Gillum, Richard F.; Ford, Ian; Ducimetiere, Pierre; Kiechl, Stefan; Dullaart, Robin P. F.; Assmann, Gerd; D'Agostino, Ralph B.; Dagenais, Gilles R.; Cooper, Jackie A.; Kromhout, Daan; Onat, Altan; Tipping, Robert W.; Gomez-de-la-Camara, Agustin; Rosengren, Annika; Sutherland, Susan E.; Gallacher, John; Fowkes, F. Gerry R.; Casiglia, Edoardo; Hofman, Albert; Salomaa, Veikko; Barrett-Connor, Elizabeth; Clarke, Robert; Brunner, Eric; Jukema, J. Wouter; Simons, Leon A.; Sandhu, Manjinder; Wareham, Nicholas J.; Khaw, Kay-Tee; Kauhanen, Jussi; Salonen, Jukka T.; Howard, William J.; Nordestgaard, Borge G.; Wood, Angela M.; Thompson, Simon G.; Boekholdt, S. Matthijs; Sattar, Naveed; Packard, Chris; Gudnason, Vilmundur; Danesh, John		Emerging Risk Factors Collaboratio	Lipid-Related Markers and Cardiovascular Disease Prediction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NON-HDL CHOLESTEROL; APOLIPOPROTEIN-B; MYOCARDIAL-INFARCTION; LDL CHOLESTEROL; A-I; RISK; LIPOPROTEINS; GUIDELINES; METAANALYSIS; ASSOCIATION	Context The value of assessing various emerging lipid-related markers for prediction of first cardiovascular events is debated. Objective To determine whether adding information on apolipoprotein B and apolipoprotein A-I, lipoprotein(a), or lipoprotein-associated phospholipase A(2) to total cholesterol and high-density lipoprotein cholesterol (HDL-C) improves cardiovascular disease (CVD) risk prediction. Design, Setting, and Participants Individual records were available for 165 544 participants without baseline CVD in 37 prospective cohorts (calendar years of recruitment: 1968-2007) with up to 15 126 incident fatal or nonfatal CVD outcomes (10 132 CHD and 4994 stroke outcomes) during a median follow-up of 10.4 years (interquartile range, 7.6-14 years). Main Outcome Measures Discrimination of CVD outcomes and reclassification of participants across predicted 10-year risk categories of low (<10%), intermediate (10%-<20%), and high (>= 20%) risk. Results The addition of information on various lipid-related markers to total cholesterol, HDL-C, and other conventional risk factors yielded improvement in the model's discrimination: C-index change, 0.0006 (95% CI, 0.0002-0.0009) for the combination of apolipoprotein B and A-I; 0.0016 (95% CI, 0.0009-0.0023) for lipoprotein(a); and 0.0018 (95% CI, 0.0010-0.0026) for lipoprotein-associated phospholipase A(2) mass. Net reclassification improvements were less than 1% with the addition of each of these markers to risk scores containing conventional risk factors. We estimated that for 100 000 adults aged 40 years or older, 15 436 would be initially classified at intermediate risk using conventional risk factors alone. Additional testing with a combination of apolipoprotein B and A-I would reclassify 1.1%; lipoprotein(a), 4.1%; and lipoprotein-associated phospholipase A(2) mass, 2.7% of people to a 20% or higher predicted CVD risk category and, therefore, in need of statin treatment under Adult Treatment Panel III guidelines. Conclusion In a study of individuals without known CVD, the addition of information on the combination of apolipoprotein B and A-I, lipoprotein(a), or lipoprotein-associated phospholipase A(2) mass to risk scores containing total cholesterol and HDL-C led to slight improvement in CVD prediction. JAMA. 2012; 307(23):2499-2506 www.jama.com	[Di Angelantonio, Emanuele; Gao, Pei; Pennells, Lisa; Kaptoge, Stephen; Thompson, Alexander; Butterworth, Adam S.; Sarwar, Nadeem; Wormser, David; Saleheen, Danish; Wareham, Nicholas J.; Khaw, Kay-Tee; Thompson, Simon G.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Caslake, Muriel] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Univ Washington, Dept Med, Seattle, WA USA; [Ballantyne, Christie M.] Univ Washington, Dept Epidemiol, Seattle, WA USA; [Ballantyne, Christie M.] Univ Washington, Dept Hlth Serv, Seattle, WA USA; [Sundstrom, Johan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Nagel, Dorothea] LMU, Klinikum Univ Munchen, Munich, Germany; [Gillum, Richard F.] Ctr Dis Control & Prevent, Washington, DC USA; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; [Ducimetiere, Pierre] INSERM, F-75654 Paris 13, France; [Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Kiechl, Stefan] Univ Ulm, Dept Internal Med Cardiol 2, Med Ctr, Ulm, Germany; [Dullaart, Robin P. F.] Univ Groningen, Univ Groningen Hosp, Univ Med Ctr Groningen, Groningen, Netherlands; [D'Agostino, Ralph B.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Dagenais, Gilles R.] Inst Univ Cardiol & Pneumolo Quebec, Dept Med, Quebec City, PQ, Canada; [Cooper, Jackie A.] UCL, Ctr Cardiovasc Genet, London WC1E 6BT, England; [Kromhout, Daan] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Onat, Altan] Istanbul Univ, Inst Expt Med Res, Istanbul, Turkey; [Tipping, Robert W.] Merck Res Labs, Philadelphia, PA USA; [Gomez-de-la-Camara, Agustin] Hosp 12 Octubre, Unidad Invest, E-28041 Madrid, Spain; [Rosengren, Annika] Univ Gothenburg, Dept Med, Sahlgrenska Acad, Gothenburg, Sweden; [Sutherland, Susan E.] Med Univ S Carolina, Charleston, SC USA; [Gallacher, John] Cardiff Univ, Dept Epidemiol, Cardiff, S Glam, Wales; [Fowkes, F. Gerry R.] Univ Edinburgh, Wolfson Unit, Edinburgh, Midlothian, Scotland; [Casiglia, Edoardo] Univ Pavia, Dept Clin & Expt Med, Padua, Italy; [Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Epidemiol, Helsinki, Finland; [Barrett-Connor, Elizabeth] Univ Calif San Diego, San Diego, CA 92103 USA; [Brunner, Eric] Univ Oxford, Clin Trials Serv Unit, Oxford, England; [Brunner, Eric] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Simons, Leon A.] Univ New S Wales, Lipid Res Dept, Darlinghurst, NSW, Australia; [Kauhanen, Jussi] Univ Eastern Finland, Kuopio, Finland; [Salonen, Jukka T.] Metab Analyt Serv Inc, Helsinki, Finland; [Howard, William J.] Washington Hosp Ctr, Hlth Res Inst, Washington, DC 20010 USA; [Nordestgaard, Borge G.] Univ Copenhagen, Dept Clin Biochem, Copenhagen, Denmark; [Sattar, Naveed] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Packard, Chris] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Cambridge; University of Glasgow; Baylor College of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Uppsala University; Harvard University; Brigham & Women's Hospital; University of Munich; Centers for Disease Control & Prevention - USA; University of Glasgow; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Innsbruck; Ulm University; University of Groningen; Boston University; University of London; University College London; Wageningen University & Research; Istanbul University; Merck & Company; Hospital Universitario 12 de Octubre; University of Gothenburg; Medical University of South Carolina; Cardiff University; University of Edinburgh; University of Pavia; Erasmus University Rotterdam; Erasmus MC; Finland National Institute for Health & Welfare; University of California System; University of California San Diego; University of Oxford; University of London; University College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of New South Wales Sydney; University of Eastern Finland; MedStar Washington Hospital Center; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; University of Glasgow	Danesh, J (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	erfc@medschl.cam.ac.uk	Benn, Marianne/O-4164-2019; Marmot, M G/Y-3920-2019; Brunner, Eric/H-2114-2011; Gao, Pei/R-4794-2018; Gudnason, Vilmundur/K-6885-2015; Khaw, Kay-Tee/AAZ-3209-2021; Kauhanen, Jussi/ABC-4064-2021; Gudnason, Vilmundur/AAE-7126-2019; Boekholdt, Matthijs S.M./G-7562-2014; Cushman, Mary/K-1157-2019; Sundstrom, Johan/R-2139-2019; Ford, Ian/ABE-6145-2020; Ballantyne, Christie/A-6599-2008; Meisinger, Christine/B-5358-2014; Kromhout, Daan/A-8566-2014; Nordestgaard, Borge Gronne/ABF-1310-2020; Wood, Angela/GZA-5762-2022; Rubio, Miguel Angel/GRJ-0134-2022; de la Camara, Agustin Gomez/S-7123-2018; Sundström, Johan/A-6286-2009; DiAngelantonio, Emanuele/ABE-6852-2020; Gao, Pei/AAF-3065-2019; Jukema, J. Wouter/ABD-6503-2021; Bakker, Stephan J. L./J-4023-2015; Lamarche, Benoit/ABA-4785-2021	Benn, Marianne/0000-0002-1701-595X; Marmot, M G/0000-0002-2431-6419; Brunner, Eric/0000-0002-0595-4474; Gao, Pei/0000-0001-8649-1290; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Cushman, Mary/0000-0002-7871-6143; Sundstrom, Johan/0000-0003-2247-8454; Wood, Angela/0000-0002-7937-304X; Rubio, Miguel Angel/0000-0002-0495-6240; Sundström, Johan/0000-0003-2247-8454; Gao, Pei/0000-0001-8649-1290; Jukema, J. Wouter/0000-0002-3246-8359; Bakker, Stephan J. L./0000-0003-3356-6791; Lamarche, Benoit/0000-0002-4443-5378; Casiglia, Edoardo/0000-0002-0003-3289; Kivimaki, Mika/0000-0002-4699-5627; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Butterworth, Adam/0000-0002-6915-9015; Willeit, Peter/0000-0002-1866-7159; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Ballantyne, Christie/0000-0002-6432-1730; Sutherland, Susan/0000-0001-7184-8920; Koenig, Wolfgang/0000-0002-2064-9603; Gomez de la Camara, Agustin/0000-0001-6827-6319; Price, Jackie/0000-0003-3251-3970; Boekholdt, Matthijs/0000-0002-0861-0765; Di Angelantonio, Emanuele/0000-0001-8776-6719; Nordestgaard, Borge/0000-0002-1954-7220; Amouyel, Philippe/0000-0001-9088-234X; Pennells, Lisa Anne/0000-0002-8594-3061	British Heart Foundation; European Union; Lead-up Medical Network; Merck Sharp and Dohme; John Wiley Son; Elsevier (France); Medical Research Council; UK National Institute of Health Research; Cambridge Biomedical Research Centre; Roche; GlaxoSmithKline; National Institute of Health; Wellcome Trust; Abbott; Amarin; AstraZeneca; Bristol-Myers Squibb; Gentech; Kowa; Merck; Novartis; Sanofi-Synthelabo; Takeda; National Institutes of Health; American Diabetes Association; American Heart Association; Adnexus; Amylin; Esperion; Genetech; Idera Pharma, Kowa; Omthera; Pfizer; Resverlogix; Medtronic; Vascular Bio-genics; ISIS Inc; Genzyme; Else Kroner Fresenius Foundation; Vifor Company; Federal Ministry of Education and Research; Boehringer Ingelheim; Cerenis; BioInvet; National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes Health Research; Heart and Stroke of Canada; Netherlands Prevention Foundation; Swedish Research Council; Swedish Heart and Lung Foundation; BUPA Foundation; Denka; diaDexus; European Research Council; Evelyn Trust; Fogarty International Centre; UK Biobank; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085083, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674, RG/08/014/24067, RG/08/013/25942] Funding Source: researchfish; Medical Research Council [G1000143, G19/35, MC_U106179471, G0601284, G0701619, G0401527, G0100222, G0902037, MC_U137686857, G0701863, G0501792, MC_U105260792, G8802774] Funding Source: researchfish; MRC [G0601284, G0501792, MC_U137686857, MC_U105260792, G0902037, G0701863, G0701619] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); European Union(European Commission); Lead-up Medical Network; Merck Sharp and Dohme(Merck & Company); John Wiley Son; Elsevier (France); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health Research(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); Roche(Roche Holding); GlaxoSmithKline(GlaxoSmithKline); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Abbott(Abbott Laboratories); Amarin; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Gentech; Kowa; Merck(Merck & Company); Novartis(Novartis); Sanofi-Synthelabo; Takeda(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Adnexus; Amylin; Esperion; Genetech; Idera Pharma, Kowa; Omthera; Pfizer(Pfizer); Resverlogix; Medtronic(Medtronic); Vascular Bio-genics; ISIS Inc; Genzyme(Sanofi-AventisGenzyme Corporation); Else Kroner Fresenius Foundation; Vifor Company; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Boehringer Ingelheim(Boehringer Ingelheim); Cerenis; BioInvet; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Canadian Institutes Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke of Canada; Netherlands Prevention Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); BUPA Foundation; Denka; diaDexus; European Research Council(European Research Council (ERC)European Commission); Evelyn Trust; Fogarty International Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); UK Biobank; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Di Angelantonio reported that he has received research funding from the British Heart Foundation and European Union; compensation for consultancy and lecturers from Lead-up Medical Network, Merck Sharp and Dohme, and John Wiley & Sons; support for travel or accommodations from Pfizer; and royalties from Elsevier (France). Dr Gao reported that she has received research funding from the British Heart Foundation and the Medical Research Council. Dr Pennells reported that she has received research funding from the Medical Research Council. Dr Kaptoge reported that he has received research funding from British Heart Foundation, Medical Research Council, UK National Institute of Health Research, and Cambridge Biomedical Research Centre. Dr Caslake reported that she has received research funding from Roche and Merck Sharp and Dohme and support for travel and accommodations from Randox Laboratories and Denka Seiken. Dr A. Thompson reported that he has received research funding from the British Heart Foundation and Medical Research Council; has been an employee of Roche Products Ltd since September 2011; and has received compensation from GlaxoSmithKline for giving lectures. Dr Sarwar reported that he has been an employee of Pfizer Inc since April 2011. Dr Wormser reported that he has received research funding from the British Heart Foundation and Medical Research Council. Dr Saleheen reported that he has received research funding from the National Institute of Health and Wellcome Trust. Dr Ballantyne reported that she has received research funding from Abbott, Amarin, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Gentech, Kowa, Merck, Novartis, Roche, Sanofi-Synthelabo, Takeda, National Institutes of Health, American Diabetes Association, and American Heart Association and compensation for consultancy and for lectures from Abbott, Adnexus, Amarin, Amylin, AstraZeneca, Bristol-Myers Squibb, Esperion, Genetech, GlaxoSmithKline, Idera Pharma, Kowa, Merck, Novartis, Omthera, Pfizer, Resverlogix, Roche, Sanofi-Synthelabo, and Takeda. Dr Psaty reported that he serves on a data safety and monitoring board for a clinical trial of a device funded by the manufacturer Zoll LieCor and on the Steering Committee for the Yale Open-Data Project funded by Medtronic. Dr Ridker reported that he is listed as a coinventor on patents held by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease and diabetes that have been licensed to AstraZeneca and Seimens; received research funding from AstraZeneca and Novartis; and compensation for consultancy from Merck, Vascular Bio-genics, ISIS Inc, and Genzyme. Dr Kiechl reported that he has received research funding from the Fonds zur Forderung der wissenschaftlichen Forschung. Dr Koenig reported that he has received research funding from the Else Kroner Fresenius Foundation, Vifor Company, European Union, Federal Ministry of Education and Research and Boehringer Ingelheim; and compensation for consultancy and lecturers from Roche, Cerenis, Anthera, BioInvet, Novartis, AstraZeneca, Merck Sharp and Dohme, Roche, and Boehringer Ingelheim. Dr Assmann reported that he has received compensation for consultancy and lecturers from Merck Sharp and Dohme, and Residual Risk Reduction Initiative and has served on board for the Residual Risk Reduction Initiative.; Dr Dagenais reported that he has received research funding from the National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Canadian Institutes Health Research, and Heart and Stroke of Canada and compensation for expert testimony and lecturers from Abbott and Boehringer Ingelheim. Dr Kromhout reported that he has received research funding from the Netherlands Prevention Foundation. Mr Tipping reported that he is an employee of Merck. Dr Rosengren reported that she has received research funding from the Swedish Research Council and Swedish Heart and Lung Foundation. Dr Barrett-Connor reported that she has received research funding from the National Institutes of Health. Dr Clarke reported that he has received research funding from the British Heart Foundation. Dr Brunner reported that he has received research funding from the Medical Research Council and British Heart Foundation. Dr Jukema reported that he has received research funding from the European Union. Dr Sandhu reported that he has received research funding from the British Heart Foundation. Dr Wareham reported that he has received research funding from the Medical Research Council. Dr Khaw reported that she has received research funding from the UK Medical Research Council and Cancer Research. Dr Howard reported that he has received compensation for consultancy and lecturers from Merck, Abbott, and GlaxoSmithKline. Dr S. G. Thompson reported that he has received research funding from the British Heart Foundation. Dr Sattar reported that he has received research funding from Pfizer and has served on the advisory board for Niaspan for Merck Sharp and Dohme. Dr Packard reported that he has received compensation for consultancy and lecturers from AstraZeneca, Roche, and Merck Sharp and Dohme. Dr Danesh reported that he has received research funding from the British Heart Foundation, BUPA Foundation, Cambridge Biomedical Research Centre, Denka, diaDexus, European Union, European Research Council, Evelyn Trust, Fogarty International Centre, GlaxoSmithKline, Medical Research Council, Merck Sharp and Dohme, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke, National Institute for Health Research, Novartis, Pfizer, Roche, Wellcome Trust, and UK Biobank and has served on advisory boards for Merck, Pfizer, and Novartis. All other members of the writing committee declare that they have no conflicts of interest.	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Arsenault BJ, 2009, J AM COLL CARDIOL, V55, P35, DOI 10.1016/j.jacc.2009.07.057; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; ClinicalTrials. gov, TREATM HDL RED INC V; Contois JH, 2009, CLIN CHEM, V55, P407, DOI 10.1373/clinchem.2008.118356; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Maningat P, 2011, NEW ENGL J MED, V365, P2250, DOI 10.1056/NEJMp1112023; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Myers GL, 2009, CLIN CHEM, V55, P378, DOI 10.1373/clinchem.2008.115899; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Parish S, 2012, CIRCULATION, V125, P2469, DOI 10.1161/CIRCULATIONAHA.111.073684; Parish S, 2009, EUR HEART J, V30, P2137, DOI 10.1093/eurheartj/ehp221; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006	32	329	341	0	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2012	307	23					2499	2506		10.1001/jama.2012.6571	http://dx.doi.org/10.1001/jama.2012.6571			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960MB	22797450	Green Accepted			2022-12-01	WOS:000305391400026
J	Song, J; Zhong, C; Bonaguidi, MA; Sun, GJ; Hsu, D; Gu, Y; Meletis, K; Huang, ZJ; Ge, SY; Enikolopov, G; Deisseroth, K; Luscher, B; Christian, KM; Ming, GL; Song, HJ				Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Sun, Gerald J.; Hsu, Derek; Gu, Yan; Meletis, Konstantinos; Huang, Z. Josh; Ge, Shaoyu; Enikolopov, Grigori; Deisseroth, Karl; Luscher, Bernhard; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun			Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision	NATURE			English	Article							NEWLY GENERATED NEURONS; IMMUNOREACTIVE NEURONS; NEUROGENESIS; BRAIN; RECEPTORS; SYSTEM	Adult neurogenesis arises from neural stem cells within specialized niches(1-3). Neuronal activity and experience, presumably acting on this local niche, regulate multiple stages of adult neurogenesis, from neural progenitor proliferation to new neuron maturation, synaptic integration and survival(1,3). It is unknown whether local neuronal circuitry has a direct impact on adult neural stem cells. Here we show that, in the adult mouse hippocampus, nestin-expressing radial glia-like quiescent neural stem cells(4-9) (RGLs) respond tonically to the neurotransmitter gamma-aminobutyric acid (GABA) by means of gamma(2)-subunit-containing GABA(A) receptors. Clonal analysis(9) of individual RGLs revealed a rapid exit from quiescence and enhanced symmetrical self-renewal after conditional deletion of gamma(2). RGLs are in close proximity to terminals expressing 67-kDa glutamic acid decarboxylase (GAD67) of parvalbumin-expressing (PV+) interneurons and respond tonically to GABA released from these neurons. Functionally, optogenetic control of the activity of dentate PV+ interneurons, but not that of somatostatin-expressing or vasoactive intestinal polypeptide (VIP)-expressing interneurons, can dictate the RGL choice between quiescence and activation. Furthermore, PV+ interneuron activation restores RGL quiescence after social isolation, an experience that induces RGL activation and symmetrical division(8). Our study identifies a niche cell-signal-receptor trio and a local circuitry mechanism that control the activation and self-renewal mode of quiescent adult neural stem cells in response to neuronal activity and experience.	[Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Sun, Gerald J.; Hsu, Derek; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gu, Yan; Ge, Shaoyu] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Meletis, Konstantinos] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Huang, Z. Josh; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Luscher, Bernhard] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Karolinska Institutet; Cold Spring Harbor Laboratory; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu; shongju1@jhmi.edu	Luscher, Bernhard/C-3528-2009; Meletis, Konstantinos/ABE-6777-2020; Enikolopov, Grigori/P-5731-2019; Ming, Guo-li/J-7880-2013; Gu, Yan/K-4702-2017; Core, Vector/CAF-4832-2022	Luscher, Bernhard/0000-0003-1375-1906; Enikolopov, Grigori/0000-0001-8178-8917; Gu, Yan/0000-0001-5562-6279; Meletis, Konstantinos/0000-0001-5665-4781; Huang, Z. Josh/0000-0003-0592-028X	National Institutes of Health (NIH) [NS047344, NS048271, HD069184, MH089111, AG040209]; National Alliance for Research on Schizophrenia and Depression; Adelson Medical Research Foundation; New York State Stem Cell Science; Ellison Medical Foundation; Life Sciences Research Foundation; Maryland Stem Cell Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH089111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R56NS047344, R01NS048271, R01NS065915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); Adelson Medical Research Foundation; New York State Stem Cell Science; Ellison Medical Foundation(Lawrence Ellison Foundation); Life Sciences Research Foundation; Maryland Stem Cell Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. H. Tsai for initial help in the study; members of the Song and Ming laboratories for discussion; H. Davoudi for help; and Q. Hussaini, Y. Cai and L. Liu for technical support. This work was supported by grants from the National Institutes of Health (NIH) (NS047344) to H. S., the NIH (NS048271, HD069184), the National Alliance for Research on Schizophrenia and Depression and the Adelson Medical Research Foundation to G. L. M., the NIH (MH089111) to B. L., the NIH (AG040209) and New York State Stem Cell Science and the Ellison Medical Foundation to G. E., and by postdoctoral fellowships from the Life Sciences Research Foundation to J.S. and from the Maryland Stem Cell Research Fund to J.S., C.Z. and K.C.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Ibi D, 2008, J NEUROCHEM, V105, P921, DOI 10.1111/j.1471-4159.2007.05207.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; LOLOVA I, 1992, MECH AGEING DEV, V66, P195, DOI 10.1016/0047-6374(92)90136-2; Masiulis I, 2011, MOL NEUROBIOL, V44, P287, DOI 10.1007/s12035-011-8207-z; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; SATOH J, 1991, ACTA NEUROPATHOL, V81, P388, DOI 10.1007/BF00293459; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	30	346	359	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					150	U216		10.1038/nature11306	http://dx.doi.org/10.1038/nature11306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22842902	Green Accepted			2022-12-01	WOS:000308347000053
J	Conrad, T; Cavalli, FMG; Vaquerizas, JM; Luscombe, NM; Akhtar, A				Conrad, Thomas; Cavalli, Florence M. G.; Vaquerizas, Juan M.; Luscombe, Nicholas M.; Akhtar, Asifa			Drosophila Dosage Compensation Involves Enhanced Pol II Recruitment to Male X-Linked Promoters	SCIENCE			English	Article							MSL COMPLEX; H4K16 ACETYLATION; RNA-POLYMERASE; CHROMOSOME; MELANOGASTER; GENOME; GENES; TRANSCRIPTION; EXPRESSION; MOF	Through hyperacetylation of histone H4 lysine 16 (H4K16), the male-specific lethal (MSL) complex in Drosophila approximately doubles transcription from the single male X chromosome in order to match X-linked expression in females and expression from diploid autosomes. By obtaining accurate measurements of RNA polymerase II (Pol II) occupancies and short promoter-proximal RNA production, we detected a consistent, genome-scale increase in Pol II activity at the promoters of male X-linked genes. Moreover, we found that enhanced Pol II recruitment to male X-linked promoters is largely dependent on the MSL complex. These observations provide insights into how global modulation of chromatin structure by histone acetylation contributes to the precise control of Pol II function.	[Cavalli, Florence M. G.; Vaquerizas, Juan M.; Luscombe, Nicholas M.] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Conrad, Thomas; Akhtar, Asifa] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan; [Luscombe, Nicholas M.] Canc Res UK, London Res Inst, Lincolns Inn Fields 44, London WC2A 3LY, England; [Luscombe, Nicholas M.] UCL, UCL Genet Inst, Dept Genet Evolut & Environm, London WC1E 6BT, England	European Molecular Biology Laboratory (EMBL); Max Planck Society; Okinawa Institute of Science & Technology Graduate University; Cancer Research UK; University of London; University College London	Luscombe, NM (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	luscombe@ebi.ac.uk; akhtar@immunbio.mpg.de	Vaquerizas, Juan M/AAY-2339-2020; Vaquerizas, Juan M/F-2676-2011	Vaquerizas, Juan M/0000-0002-6583-6541; Vaquerizas, Juan M/0000-0002-6583-6541; Cavalli, Florence M. G./0000-0002-4409-9642; Conrad, Thomas/0000-0001-5618-6295	European Union; EMBL; Okinawa Institute of Science and Technology; Cancer Research UK; EMBL Ph.D. program; European Science Foundation Exchange Grant program; Cancer Research UK [16358] Funding Source: researchfish	European Union(European Commission); EMBL; Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University); Cancer Research UK(Cancer Research UK); EMBL Ph.D. program; European Science Foundation Exchange Grant program; Cancer Research UK(Cancer Research UK)	We thank K. Adelman and J. Lis for kindly providing Rpb3 antibodies, the European Molecular Biology Laboratory (EMBL) GeneCore facility and I. De la Rosa for Illumina sequencing services, and the members of our groups for critical reading of the manuscript and helpful discussions. Supported by the European Union-funded EpiGeneSys (N.M.L. and A. A.); EMBL, Okinawa Institute of Science and Technology, and Cancer Research UK (N.M.L.); the EMBL Ph.D. program (T. C. and F. M. G. C.); and the European Science Foundation Exchange Grant program (J.M.V.). The Pol II ChIP-seq data are available in ArrayExpress under accession no. E-MTAB-1112.	Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Conrad T, 2012, DEV CELL, V22, P610, DOI 10.1016/j.devcel.2011.12.016; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Johansson AM, 2012, MOL CELL BIOL, V32, P2121, DOI 10.1128/MCB.06622-11; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Laverty C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020455; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Malone JH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r28; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Park SW, 2010, BIOCHEM BIOPH RES CO, V399, P227, DOI 10.1016/j.bbrc.2010.07.059; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	16	53	53	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					742	746		10.1126/science.1221428	http://dx.doi.org/10.1126/science.1221428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22821985				2022-12-01	WOS:000307354500057
J	Barron, AB; Brown, MJF				Barron, Andrew B.; Brown, Mark J. F.			Let's talk about sex	NATURE			English	Editorial Material									[Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Brown, Mark J. F.] Royal Holloway Univ London, Sch Biol Sci, London, England	Macquarie University; University of London; Royal Holloway University London	Barron, AB (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	andrew.barron@mq.edu.au		Barron, Andrew/0000-0002-8135-6628	BBSRC [BB/J019453/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J019453/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bailey NW, 2009, TRENDS ECOL EVOL, V24, P439, DOI 10.1016/j.tree.2009.03.014; Brennan Zoe, 2010, DAILY MAIL; Casselman A, 2007, NATL GEOGR      1025; Cloud J., 2007, TIME MAGAZINE; Dolgin E., 2007, NATURE, DOI org/10.1038/news070917-7; Fox M, 2005, REUTERS         0624; Holmes B, 2008, NEW SCI; Hooper Rowan, 2007, NEW SCI; Levan KE, 2009, J EVOLUTION BIOL, V22, P60, DOI 10.1111/j.1420-9101.2008.01616.x; Milius S, 2001, SCIENCENEWS, V160, P311; Mooallem J., 2010, INDEPENDENT; Mooallem J, 2010, NY TIMES; Oakeshott I., 2006, SUNDAY TIMES; Perkins A, 2007, HORM BEHAV, V52, P70, DOI 10.1016/j.yhbeh.2007.03.016; Reinhardt K, 2007, AM NAT, V170, P931, DOI 10.1086/522844; Saletan William, 2007, WASHINGTON POST; Schwartz J, 2007, NY TIMES        0330; Shine R, 2001, NATURE, V414, P267, DOI 10.1038/35104687; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; Young LC, 2008, BIOL LETTERS, V4, P323, DOI 10.1098/rsbl.2008.0191	20	8	8	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					151	152		10.1038/488151a	http://dx.doi.org/10.1038/488151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985LE	22874947	Bronze			2022-12-01	WOS:000307267000011
J	Desai, CS; Bonow, RO				Desai, Chintan S.; Bonow, Robert O.			Transcatheter Valve Replacement for Aortic Stenosis Balancing Benefits, Risks, and Expectations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPLANTATION; REGISTRY; OUTCOMES		[Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Desai, Chintan S.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bonow, RO (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	r-bonow@northwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069771] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL 69771-8] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Mack MJ, 2011, JAMA-J AM MED ASSOC, V306, P2149, DOI 10.1001/jama.2011.1675; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Nietlispach F, 2010, JACC-CARDIOVASC INTE, V3, P1133, DOI 10.1016/j.jcin.2010.05.022; Piazza N, 2010, HEART, V96, P19, DOI 10.1136/hrt.2009.172809; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339	9	11	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					573	574		10.1001/jama.2012.9427	http://dx.doi.org/10.1001/jama.2012.9427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871866				2022-12-01	WOS:000307228400021
J	Mendillo, ML; Santagata, S; Koeva, M; Bell, GW; Hu, R; Tamimi, RM; Fraenkel, E; Ince, TA; Whitesell, L; Lindquist, S				Mendillo, Marc L.; Santagata, Sandro; Koeva, Martina; Bell, George W.; Hu, Rong; Tamimi, Rulla M.; Fraenkel, Ernest; Ince, Tan A.; Whitesell, Luke; Lindquist, Susan			HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers	CELL			English	Article							INVASIVE BREAST-CANCER; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; FACTOR-1; STRESS; TRANSFORMATION; ACTIVATION; RESPONSES; PROTEINS; GROWTH	Heat-Shock Factor 1 (HSF1), master regulator of the heat-shock response, facilitates malignant transformation, cancer cell survival, and proliferation in model systems. The common assumption is that these effects are mediated through regulation of heat-shock protein (HSP) expression. However, the transcriptional network that HSF1 coordinates directly in malignancy and its relationship to the heat-shock response have never been defined. By comparing cells with high and low malignant potential alongside their nontransformed counterparts, we identify an HSF1-regulated transcriptional program specific to highly malignant cells and distinct from heat shock. Cancer-specific genes in this program support oncogenic processes: cell-cycle regulation, signaling, metabolism, adhesion and translation. HSP genes are integral to this program, however, many are uniquely regulated in malignancy. This HSF1 cancer program is active in breast, colon and lung tumors isolated directly from human patients and is strongly associated with metastasis and death. Thus, HSF1 rewires the transcriptome in tumorigenesis, with prognostic and therapeutic implications.	[Mendillo, Marc L.; Santagata, Sandro; Koeva, Martina; Bell, George W.; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Koeva, Martina; Fraenkel, Ernest] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Hu, Rong; Tamimi, Rulla M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Rong; Tamimi, Rulla M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hu, Rong; Tamimi, Rulla M.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Dept Pathol, Braman Family Breast Canc Inst, Miami, FL 33136 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Miami; University of Miami	Whitesell, L (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	whitesell@wi.mit.edu; lindquist_admin@wi.mit.edu		Fraenkel, Ernest/0000-0001-9249-8181; Ince, Tan/0000-0003-0315-6425; Santagata, Sandro/0000-0002-7528-9668; Mendillo, Marc/0000-0001-8128-0128	J&J COSAT focused funding program; Marble Fund; American Cancer Society New England Division-SpinOdyssey [PF-09-253-01-DMC]; NIH [K08NS064168]; Brain Science Foundation; V Foundation; GSK [WE234 EPI40307]; Public Health Service Grants [CA087969]; SPORE in Breast Cancer NCI, NIH, Dept. of Health and Human Services [CA089393]; Breast Cancer Research Foundation, NCI [R01-CA146445-01]; DoD-CDMRP Breast Cancer Research Program [W81XWH-08-1-0282 BC-07456]; NATIONAL CANCER INSTITUTE [P50CA089393, R01CA146445, P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	J&J COSAT focused funding program; Marble Fund; American Cancer Society New England Division-SpinOdyssey; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Foundation; V Foundation; GSK(GlaxoSmithKline); Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); SPORE in Breast Cancer NCI, NIH, Dept. of Health and Human Services; Breast Cancer Research Foundation, NCI; DoD-CDMRP Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Frampton, I. Barrasa and S.Gupta for bioinformatic assistance. We thank T. Mazor, T. Volkert and the WIBR-GTC for sequencing support. We thank the Lindquist lab and T. Lee for discussion and K. Allendoerfer, B. Bevis, G. Karras, R. Shouval and K. Matlack for comments. The work was supported by the J&J COSAT focused funding program (L. W.) and the Marble Fund (S. L.). S. L. is an Investigator of the Howard Hughes Medical Institute. M. L. M. is supported by American Cancer Society New England Division-SpinOdyssey (PF-09-253-01-DMC). S. S. is supported by NIH (K08NS064168), the Brain Science Foundation and the V Foundation. Additional support was provided by GSK (WE234 EPI40307); Public Health Service Grants CA087969, and SPORE in Breast Cancer CA089393, from the NCI, NIH, Dept. of Health and Human Services. T. A. I is supported by the Breast Cancer Research Foundation, NCI (R01-CA146445-01) and DoD-CDMRP Breast Cancer Research Program (W81XWH-08-1-0282 BC-07456). T. A. Ince receivse royalty payments for WIT medium and was a consultant to Stemgent Inc. during 2008-2010. We thank the participants and staff of the NHS, and state cancer registries: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, WY.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Dowhan DH, 2005, MOL CELL, V17, P429, DOI 10.1016/j.molcel.2004.12.025; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee YJ, 2008, ONCOGENE, V27, P2999, DOI 10.1038/sj.onc.1210966; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Maruyama M, 2010, BIOCHEM BIOPH RES CO, V402, P75, DOI 10.1016/j.bbrc.2010.09.117; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamimi RM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2128; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Volovik Y, 2012, AGING CELL, V11, P491, DOI 10.1111/j.1474-9726.2012.00811.x; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127; Zhou JD, 2008, CHINESE MED J-PEKING, V121, P1269, DOI 10.1097/00029330-200807020-00004	49	456	467	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					549	562		10.1016/j.cell.2012.06.031	http://dx.doi.org/10.1016/j.cell.2012.06.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863008	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000307301400014
J	Straussman, R; Morikawa, T; Shee, K; Barzily-Rokni, M; Qian, ZR; Du, JY; Davis, A; Mongare, MM; Gould, J; Frederick, DT; Cooper, ZA; Chapman, PB; Solit, DB; Ribas, A; Lo, RS; Flaherty, KT; Ogino, S; Wargo, JA; Golub, TR				Straussman, Ravid; Morikawa, Teppei; Shee, Kevin; Barzily-Rokni, Michal; Qian, Zhi Rong; Du, Jinyan; Davis, Ashli; Mongare, Margaret M.; Gould, Joshua; Frederick, Dennie T.; Cooper, Zachary A.; Chapman, Paul B.; Solit, David B.; Ribas, Antoni; Lo, Roger S.; Flaherty, Keith T.; Ogino, Shuji; Wargo, Jennifer A.; Golub, Todd R.			Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion	NATURE			English	Article							C-MET; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; V600E MUTATION; GROWTH-FACTOR; COLON-CANCER; MELANOMA; BRAF; VEMURAFENIB; OVEREXPRESSION	Drug resistance presents a challenge to the treatment of cancer patients. Many studies have focused on cell-autonomous mechanisms of drug resistance. By contrast, we proposed that the tumour micro-environment confers innate resistance to therapy. Here we developed a co-culture system to systematically assay the ability of 23 stromal cell types to influence the innate resistance of 45 cancer cell lines to 35 anticancer drugs. We found that stroma-mediated resistance is common, particularly to targeted agents. We characterized further the stroma-mediated resistance of BRAF-mutant melanoma to RAF inhibitors because most patients with this type of cancer show some degree of innate resistance(1-4). Proteomic analysis showed that stromal cell secretion of hepatocyte growth factor (HGF) resulted in activation of the HGF receptor MET, reactivation of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K)-AKT signalling pathways, and immediate resistance to RAF inhibition. Immunohistochemistry experiments confirmed stromal cell expression of HGF in patients with BRAF-mutant melanoma and showed a significant correlation between HGF expression by stromal cells and innate resistance to RAF inhibitor treatment. Dual inhibition of RAF and either HGF or MET resulted in reversal of drug resistance, suggesting RAF plus HGF or MET inhibitory combination therapy as a potential therapeutic strategy for BRAF-mutant melanoma. A similar resistance mechanism was uncovered in a subset of BRAF-mutant colorectal and glioblastoma cell lines. More generally, this study indicates that the systematic dissection of interactions between tumours and their micro-environment can uncover important mechanisms underlying drug resistance.	[Straussman, Ravid; Shee, Kevin; Barzily-Rokni, Michal; Du, Jinyan; Davis, Ashli; Mongare, Margaret M.; Gould, Joshua; Golub, Todd R.] Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Morikawa, Teppei; Qian, Zhi Rong; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Frederick, Dennie T.; Cooper, Zachary A.; Flaherty, Keith T.; Wargo, Jennifer A.] Massachusetts Gen Hosp, Div Surg Oncol Med Oncol & Dermatol, Boston, MA 02114 USA; [Chapman, Paul B.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Solit, David B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Ribas, Antoni] Univ Calif Los Angeles, Div Hematol & Oncol, Dept Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Lo, Roger S.] Univ Calif Los Angeles, Div Dermatol, Dept Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Golub, TR (corresponding author), Eli & Edythe L Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	golub@broadinstitute.org	Hunt, David M/K-6024-2012; Solit, David B./AAC-5309-2019; Shee, Kevin/V-6803-2019	Hunt, David M/0000-0002-9264-3948; Shee, Kevin/0000-0001-5378-7650; Ogino, Shuji/0000-0002-3909-2323; Cooper, Zachary/0000-0003-1059-0940; Qian, Zhi rong/0000-0003-1633-4120	Howard Hughes Medical Institute; National Cancer Institute [P50CA093683, U54CA112962]; Melanoma Research Alliance Team Science Award; NATIONAL CANCER INSTITUTE [U54CA112962, UM1CA186709, R01CA166480, P50CA093683] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melanoma Research Alliance Team Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Golub laboratory for discussions. We thank C. M. Johannessen, I. Rabinowitch, N. Shoresh and A. Goren for critical reading of the manuscript, and L. Gaffney for expert assistance with the graphics. This work was supported by the Howard Hughes Medical Institute, National Cancer Institute grants P50CA093683 and U54CA112962 (T. R. G.) and a Melanoma Research Alliance Team Science Award.	Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Jiang CC, 2011, CLIN CANCER RES, V17, P721, DOI 10.1158/1078-0432.CCR-10-2225; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kammula US, 2007, CANCER LETT, V248, P219, DOI 10.1016/j.canlet.2006.07.007; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Lee YJ, 2011, ANN DERMATOL, V23, P33, DOI 10.5021/ad.2011.23.1.33; LIU C, 1992, ONCOGENE, V7, P181; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; TEICHER BA, 1990, SCIENCE, V247, P1457, DOI 10.1126/science.2108497; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang HS, 2011, CANCER RES, V71, P5535, DOI 10.1158/0008-5472.CAN-10-4351; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Wilson T. R., 2012, NATURE	30	1294	1346	9	312	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					500	U118		10.1038/nature11183	http://dx.doi.org/10.1038/nature11183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22763439	Green Accepted, Green Submitted			2022-12-01	WOS:000306815300042
J	Fan, HC; Gu, W; Wang, JB; Blumenfeld, YJ; El-Sayed, YY; Quake, SR				Fan, H. Christina; Gu, Wei; Wang, Jianbin; Blumenfeld, Yair J.; El-Sayed, Yasser Y.; Quake, Stephen R.			Non-invasive prenatal measurement of the fetal genome	NATURE			English	Article							MATERNAL PLASMA; DNA; ANEUPLOIDY	The vast majority of prenatal genetic testing requires invasive sampling. However, this poses a risk to the fetus, so one must make a decision that weighs the desire for genetic information against the risk of an adverse outcome due to hazards of the testing process. These issues are not required to be coupled, and it would be desirable to discover genetic information about the fetus without incurring a health risk. Here we demonstrate that it is possible to non-invasively sequence the entire prenatal genome. Our results show that molecular counting of parental haplotypes in maternal plasma by shotgun sequencing of maternal plasma DNA allows the inherited fetal genome to be deciphered non-invasively. We also applied the counting principle directly to each allele in the fetal exome by performing exome capture on maternal plasma DNA before shotgun sequencing. This approach enables non-invasive exome screening of clinically relevant and deleterious alleles that were paternally inherited or had arisen as de novo germline mutations, and complements the haplotype counting approach to provide a comprehensive view of the fetal genome. Non-invasive determination of the fetal genome may ultimately facilitate the diagnosis of all inherited and de novo genetic disease.	[Fan, H. Christina; Gu, Wei; Wang, Jianbin; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Blumenfeld, Yair J.; El-Sayed, Yasser Y.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Clark Ctr Rm E300,318 Campus Dr, Stanford, CA 94305 USA.	quake@stanford.edu	Blumenfeld, Yair/P-9396-2019; Wang, Jianbin/G-7533-2015	Blumenfeld, Yair/0000-0002-9440-8175; Wang, Jianbin/0000-0001-6725-7925; Gu, Wei/0000-0002-2480-6645	NATIONAL CANCER INSTITUTE [U54CA151459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bellis MA, 2005, J EPIDEMIOL COMMUN H, V59, P749, DOI 10.1136/jech.2005.036517; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Bodurtha J, 2012, NEW ENGL J MED, V366, P64, DOI 10.1056/NEJMra1105043; Chiu Rossa W K, 2011, BMJ, V342, pc7401, DOI 10.1136/bmj.c7401; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fan H. C., 2010, PREPRINT; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; MACINTYRE S, 1991, LANCET, V338, P869, DOI 10.1016/0140-6736(91)91513-T; MANDEL P, 1948, CR SOC BIOL, V142, P241; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116	20	267	359	1	97	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 19	2012	487	7407					320	+		10.1038/nature11251	http://dx.doi.org/10.1038/nature11251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22763444	Green Accepted			2022-12-01	WOS:000306506500033
J	Manske, M; Miotto, O; Campino, S; Auburn, S; Almagro-Garcia, J; Maslen, G; O'Brien, J; Djimde, A; Doumbo, O; Zongo, I; Ouedraogo, JB; Michon, P; Mueller, I; Siba, P; Nzila, A; Borrmann, S; Kiara, SM; Marsh, K; Jiang, H; Su, XZ; Amaratunga, C; Fairhurst, R; Socheat, D; Nosten, F; Imwong, M; White, NJ; Sanders, M; Anastasi, E; Alcock, D; Drury, E; Oyola, S; Quail, MA; Turner, DJ; Ruano-Rubio, V; Jyothi, D; Amenga-Etego, L; Hubbart, C; Jeffreys, A; Rowlands, K; Sutherland, C; Roper, C; Mangano, V; Modiano, D; Tan, JC; Ferdig, MT; Amambua-Ngwa, A; Conway, DJ; Takala-Harrison, S; Plowe, CV; Rayner, JC; Rockett, KA; Clark, TG; Newbold, CI; Berriman, M; MacInnis, B; Kwiatkowski, DP				Manske, Magnus; Miotto, Olivo; Campino, Susana; Auburn, Sarah; Almagro-Garcia, Jacob; Maslen, Gareth; O'Brien, Jack; Djimde, Abdoulaye; Doumbo, Ogobara; Zongo, Issaka; Ouedraogo, Jean-Bosco; Michon, Pascal; Mueller, Ivo; Siba, Peter; Nzila, Alexis; Borrmann, Steffen; Kiara, Steven M.; Marsh, Kevin; Jiang, Hongying; Su, Xin-Zhuan; Amaratunga, Chanaki; Fairhurst, Rick; Socheat, Duong; Nosten, Francois; Imwong, Mallika; White, Nicholas J.; Sanders, Mandy; Anastasi, Elisa; Alcock, Dan; Drury, Eleanor; Oyola, Samuel; Quail, Michael A.; Turner, Daniel J.; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Amenga-Etego, Lucas; Hubbart, Christina; Jeffreys, Anna; Rowlands, Kate; Sutherland, Colin; Roper, Cally; Mangano, Valentina; Modiano, David; Tan, John C.; Ferdig, Michael T.; Amambua-Ngwa, Alfred; Conway, David J.; Takala-Harrison, Shannon; Plowe, Christopher V.; Rayner, Julian C.; Rockett, Kirk A.; Clark, Taane G.; Newbold, Chris I.; Berriman, Matthew; MacInnis, Bronwyn; Kwiatkowski, Dominic P.			Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing	NATURE			English	Article							PAPUA-NEW-GUINEA; MALARIA PARASITE; LIBRARY PREPARATION; GENOME; RESISTANCE; TRANSMISSION; POLYMORPHISM; EVOLUTION; SELECTION; PATTERNS	Malaria elimination strategies require surveillance of the parasite population for genetic changes that demand a public health response, such as new forms of drug resistance(1,2). Here we describe methods for the large-scale analysis of genetic variation in Plasmodium falciparum by deep sequencing of parasite DNA obtained from the blood of patients with malaria, either directly or after short-term culture. Analysis of 86,158 exonic single nucleotide polymorphisms that passed genotyping quality control in 227 samples from Africa, Asia and Oceania provides genome-wide estimates of allele frequency distribution, population structure and linkage disequilibrium. By comparing the genetic diversity of individual infections with that of the local parasite population, we derive a metric of within-host diversity that is related to the level of inbreeding in the population. An open-access web application has been established for the exploration of regional differences in allele frequency and of highly differentiated loci in the P. falciparum genome.	[Manske, Magnus; Campino, Susana; Auburn, Sarah; Almagro-Garcia, Jacob; Maslen, Gareth; Sanders, Mandy; Anastasi, Elisa; Alcock, Dan; Drury, Eleanor; Oyola, Samuel; Quail, Michael A.; Turner, Daniel J.; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Rayner, Julian C.; Rockett, Kirk A.; Clark, Taane G.; Newbold, Chris I.; Berriman, Matthew; MacInnis, Bronwyn; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Manske, Magnus; Miotto, Olivo; Campino, Susana; Auburn, Sarah; Almagro-Garcia, Jacob; Maslen, Gareth; O'Brien, Jack; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Amenga-Etego, Lucas; Rockett, Kirk A.; Clark, Taane G.; Newbold, Chris I.; MacInnis, Bronwyn; Kwiatkowski, Dominic P.] Univ Oxford, MRC Ctr Genom & Global Hlth, Oxford OX3 7BN, England; [Miotto, Olivo; Nosten, Francois; White, Nicholas J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0811, Australia; [Almagro-Garcia, Jacob; O'Brien, Jack; Ruano-Rubio, Valentin; Amenga-Etego, Lucas; Hubbart, Christina; Jeffreys, Anna; Rowlands, Kate; Rockett, Kirk A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Djimde, Abdoulaye; Doumbo, Ogobara] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali; [Zongo, Issaka; Ouedraogo, Jean-Bosco] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso; [Michon, Pascal; Mueller, Ivo; Siba, Peter] Papua New Guinea Inst Med Res, Madang 511, Papua N Guinea; [Nzila, Alexis; Borrmann, Steffen; Kiara, Steven M.; Marsh, Kevin] KEMRI Wellcome Trust Res Program, Kilifi, Kenya; [Jiang, Hongying; Su, Xin-Zhuan; Amaratunga, Chanaki; Fairhurst, Rick] Nat Inst Allergy & Infect Dis, NIH, Rockville, MD 20892 USA; [Socheat, Duong] Cambodia Natl Malaria Ctr, Phnom Penh, Cambodia; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand; [Nosten, Francois; White, Nicholas J.] Univ Oxford, Ctr Trop Med, Oxford OX3 7LJ, England; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok 10400, Thailand; [Amenga-Etego, Lucas] Navrongo Hlth Ctr, Navrongo, Ghana; [Sutherland, Colin; Roper, Cally; Conway, David J.; Clark, Taane G.] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Mangano, Valentina; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth Sci, I-00185 Rome, Italy; [Tan, John C.; Ferdig, Michael T.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA; [Amambua-Ngwa, Alfred; Conway, David J.] MRC Labs, Fajara, Gambia; [Takala-Harrison, Shannon; Plowe, Christopher V.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Newbold, Chris I.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Wellcome Trust Sanger Institute; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Charles Darwin University; Menzies School of Health Research; University of Oxford; Wellcome Centre for Human Genetics; University of Bamako; PNG Institute Of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University; University of Oxford; Mahidol University; University of London; London School of Hygiene & Tropical Medicine; Sapienza University Rome; University of Notre Dame; MRC Laboratory Molecular Biology; University System of Maryland; University of Maryland Baltimore; University of Oxford	Kwiatkowski, DP (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	dominic@sanger.ac.uk	Roper, Cally/K-2989-2013; Clark, Taane G./AAM-2570-2020; Jyothi, Dushyanth/H-9517-2014; Berriman, Matthew/A-7618-2011; Campino, Susana/AAM-2577-2020; Miotto, Olivo/AAE-7124-2019; Mueller, Ivo/C-7251-2013; Imwong, Mallika/ABE-6493-2020; Quail, michael/ABE-6131-2020; Sutherland, Colin/AAN-3939-2020; Amambua-Ngwa, Alfred/AHD-7882-2022; Borrmann, Steffen/G-1838-2013; White, Nick/AAC-6527-2019; Amambua-Ngwa, Alfred/ABA-7305-2020; Ferdig, Michael/C-6627-2016; White, Nicholas J/I-4629-2012; mangano, valentina/I-2456-2012; Nosten, Francois/AAC-5509-2019; Auburn, Sarah/N-2266-2013	Roper, Cally/0000-0002-6545-309X; Clark, Taane G./0000-0001-8985-9265; Jyothi, Dushyanth/0000-0002-0448-5303; Berriman, Matthew/0000-0002-9581-0377; Campino, Susana/0000-0003-1403-6138; Miotto, Olivo/0000-0001-8060-6771; Mueller, Ivo/0000-0001-6554-6889; Sutherland, Colin/0000-0003-1592-6407; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Borrmann, Steffen/0000-0001-9189-4393; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Rayner, Julian/0000-0002-9835-1014; Conway, David/0000-0002-8711-3037; Newbold, Chris/0000-0002-9274-3789; Oyola, Samuel O./0000-0002-6425-7345; Mangano, Valentina D/0000-0002-2021-6162; Auburn, Sarah/0000-0002-4638-536X; Takala-Harrison, Shannon/0000-0003-4674-8500; Maslen, Gareth/0000-0001-7318-3678; Kwiatkowski, Dominic/0000-0002-5023-0176; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Su, Xinzhuan/0000-0003-3246-3248; Manske, Magnus/0000-0001-5916-0947	Wellcome Trust through Sanger Institute [077012/Z/05/Z, 098051, 090770/Z/09/Z]; Medical Research Council (MRC) through the MRC Centre for Genomics and Global Health [G0600718]; MRC [G19/9]; Wellcome Trust [075491/Z/04, 090532/Z/09/Z]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Howard Hughes Medical Institute [55005502]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001000, ZIAAI001066] Funding Source: NIH RePORTER; Medical Research Council [G19/9, G0600718] Funding Source: researchfish; MRC [G0600718] Funding Source: UKRI	Wellcome Trust through Sanger Institute; Medical Research Council (MRC) through the MRC Centre for Genomics and Global Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Dougan and N. Day for support, and T. Anderson and M. Mackinnon for comments. The sequencing and analysis components of this study were supported by the Wellcome Trust through Sanger Institute core funding (077012/Z/05/Z; 098051) and a Strategic Award (090770/Z/09/Z); the Medical Research Council (MRC) through the MRC Centre for Genomics and Global Health (G0600718) and an MRC Professorship to D.P.K. (G19/9). Other parts of this study were partly supported by the Wellcome Trust including core support to the Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z); the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; and a Howard Hughes Medical Institute International Scholarship (55005502) to A.D.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Auburn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032891; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Boisson B, 2011, MOL MICROBIOL, V81, P1343, DOI 10.1111/j.1365-2958.2011.07767.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hartl D. L., 2007, PRINCIPLES POPULATIO, V4th; HILL WG, 1995, GENET RES, V65, P53, DOI 10.1017/S0016672300033000; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/NMETH.1311, 10.1038/nmeth.1311]; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Mehlotra RK, 2001, P NATL ACAD SCI USA, V98, P12689, DOI 10.1073/pnas.221440898; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Paul REL, 1999, T ROY SOC TROP MED H, V93, P587, DOI 10.1016/S0035-9203(99)90057-3; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Smith DL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1107; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	30	328	330	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					375	379		10.1038/nature11174	http://dx.doi.org/10.1038/nature11174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722859	Green Accepted			2022-12-01	WOS:000306506500045
J	Strunk, BS; Novak, MN; Young, CL; Karbstein, K				Strunk, Bethany S.; Novak, Megan N.; Young, Crystal L.; Karbstein, Katrin			A Translation-Like Cycle Is a Quality Control Checkpoint for Maturing 40S Ribosome Subunits	CELL			English	Article							MESSENGER-RNA DECAY; SACCHAROMYCES-CEREVISIAE; INITIATION; BIOGENESIS; MATURATION; COMPLEX; PROTEINS; SITE	Assembly factors (AFs) prevent premature translation initiation on small (40S) ribosomal subunit assembly intermediates by blocking ligand binding. However, it is unclear how AFs are displaced from maturing 40S ribosomes, if or how maturing subunits are assessed for fidelity, and what prevents premature translation initiation once AFs dissociate. Here we show that maturation involves a translation-like cycle whereby the translation factor eIF5B, a GTPase, promotes joining of large (60S) subunits with pre-40S subunits to give 80S-like complexes, which are subsequently disassembled by the termination factor Rli1, an ATPase. The AFs Tsr1 and Rio2 block the mRNA channel and initiator tRNA binding site, and therefore 80S-like ribosomes lack mRNA or initiator tRNA. After Tsr1 and Rio2 dissociate from 80S-like complexes Rli1-directed displacement of 60S subunits allows for translation initiation. This cycle thus provides a functional test of 60S subunit binding and the GTPase site before ribosomes enter the translating pool.	[Strunk, Bethany S.; Novak, Megan N.; Young, Crystal L.; Karbstein, Katrin] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Novak, Megan N.] Furman Univ, Dept Chem, Greenville, SC 29613 USA; [Young, Crystal L.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Scripps Research Institute; University of Michigan System; University of Michigan	Karbstein, K (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	kkarbst@scripps.edu		Young-Erdos, Crystal/0000-0003-2323-8372; Strunk, Bethany/0000-0003-2337-4614; Karbstein, Katrin/0000-0002-4034-1331	National Science Foundation; Kellogg School of Science and Technology; National Institutes of Health [R01-GM086451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086451] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Kellogg School of Science and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hinnebusch and T. Dever for providing antibodies and plasmids and J. Hershey, C. Fraser, K. Nettles, and J. Cleveland for critical review of the manuscript. We also thank M. Chalmer and C. Steckler for carrying out mass spectrometry experiments. B.S.S. was partially supported by a National Science Foundation predoctoral fellowship. M.N.N. was supported by a Summer Undergraduate Research Fellows (SURF) fellowship from the Kellogg School of Science and Technology. This work is funded by grant R01-GM086451 from the National Institutes of Health.	Acker MG, 2009, J MOL BIOL, V385, P491, DOI 10.1016/j.jmb.2008.10.029; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Baudin-Baillieu A, 2009, NUCLEIC ACIDS RES, V37, P7665, DOI 10.1093/nar/gkp816; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Bhattacharya A, 2010, MOL CELL BIOL, V30, P5562, DOI 10.1128/MCB.00618-10; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pertschy B, 2009, J BIOL CHEM, V284, P35079, DOI 10.1074/jbc.M109.040774; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Valasek L, 2007, METHOD ENZYMOL, V429, P163, DOI 10.1016/S0076-6879(07)29008-1; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540	33	183	183	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 6	2012	150	1					111	121		10.1016/j.cell.2012.04.044	http://dx.doi.org/10.1016/j.cell.2012.04.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770215	Green Accepted, Bronze			2022-12-01	WOS:000306115000011
J	Macfarlan, TS; Gifford, WD; Driscoll, S; Lettieri, K; Rowe, HM; Bonanomi, D; Firth, A; Singer, O; Trono, D; Pfaff, SL				Macfarlan, Todd S.; Gifford, Wesley D.; Driscoll, Shawn; Lettieri, Karen; Rowe, Helen M.; Bonanomi, Dario; Firth, Amy; Singer, Oded; Trono, Didier; Pfaff, Samuel L.			Embryonic stem cell potency fluctuates with endogenous retrovirus activity	NATURE			English	Article							GENE-EXPRESSION; MUERV-L; TRANSPOSABLE ELEMENTS; MOUSE; EVOLUTION; DIFFERENTIATION; TROPHECTODERM; ESTABLISHMENT; REPRESSION; GENERATION	Embryonic stem (ES) cells are derived from blastocyst-stage embryos and are thought to be functionally equivalent to the inner cell mass, which lacks the ability to produce all extraembryonic tissues. Here we identify a rare transient cell population within mouse ES and induced pluripotent stem (iPS) cell cultures that expresses high levels of transcripts found in two-cell (2C) embryos in which the blastomeres are totipotent. We genetically tagged these 2C-like ES cells and show that they lack the inner cell mass pluripotency proteins Oct4 (also known as Pou5f1), Sox2 and Nanog, and have acquired the ability to contribute to both embryonic and extraembryonic tissues. We show that nearly all ES cells cycle in and out of this privileged state, which is partially controlled by histone-modifying enzymes. Transcriptome sequencing and bioinformatic analyses showed that many 2C transcripts are initiated from long terminal repeats derived from endogenous retroviruses, suggesting this foreign sequence has helped to drive cell-fate regulation in placental mammals.	[Macfarlan, Todd S.; Gifford, Wesley D.; Driscoll, Shawn; Lettieri, Karen; Bonanomi, Dario; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Rowe, Helen M.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Firth, Amy; Singer, Oded] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, 10010 N Torrey Pines, La Jolla, CA 92037 USA.	pfaff@salk.edu	Bonanomi, Dario/K-3450-2016; Firth, Amy/M-2302-2016; Macfarlan, Todd/S-3750-2017; Rowe, Helen/AAQ-7138-2021; Ryan, Amy L/AFO-2326-2022; Firth, Amy/H-9535-2012	Bonanomi, Dario/0000-0003-4517-1244; Firth, Amy/0000-0003-1363-905X; Macfarlan, Todd/0000-0003-2495-9809; Rowe, Helen/0000-0001-5881-0290; Ryan, Amy L/0000-0003-1363-905X; Firth, Amy/0000-0003-1363-905X	National Institute of Neurological Disorders and Stroke [R37NS037116]; Marshall Heritage Foundation; California Institute for Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037116] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Marshall Heritage Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Pfaff laboratory for discussion; S. Andrews, D. Chambers, Y. Dayn, T.-C. Sung, J. Fitzpatrick, M. Joens, Y. Sigal, D. Gibbs and L. Ouyang for technical assistance, Y. Shinkai and D. Gilbert for the G9a mutant ES cells, and T. Heidmann for MuERV-L-Gag antibodies. This research was supported by the National Institute of Neurological Disorders and Stroke (R37NS037116) and the Marshall Heritage Foundation. T.S.M. and W.D.G. were supported by the California Institute for Regenerative Medicine and S.L.P. is an investigator of the Howard Hughes Medical Institute and Benjamin H. Lewis Chair in Neurobiology.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Benit L, 1999, J VIROL, V73, P3301; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Choo KB, 2001, MOL REPROD DEV, V59, P249, DOI 10.1002/mrd.1029; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Huang CJ, 2004, GENE, V324, P117, DOI 10.1016/j.gene.2003.09.022; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanka J, 2003, THERIOGENOLOGY, V59, P3, DOI 10.1016/S0093-691X(02)01267-0; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; PAPAIOANNOU VE, 1989, DEVELOPMENT, V106, P817; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Ribet D, 2008, J VIROL, V82, P1622, DOI 10.1128/JVI.02097-07; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shao GB, 2009, THERIOGENOLOGY, V71, P1245, DOI 10.1016/j.theriogenology.2009.01.004; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Suzuki T, 2006, CLONING STEM CELLS, V8, P295, DOI 10.1089/clo.2006.8.295; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; Wiekowski M, 1997, J CELL SCI, V110, P1147; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631	42	636	653	9	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					57	+		10.1038/nature11244	http://dx.doi.org/10.1038/nature11244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722858	Green Accepted, Green Submitted			2022-12-01	WOS:000305982900049
J	Floudas, D; Binder, M; Riley, R; Barry, K; Blanchette, RA; Henrissat, B; Martinez, AT; Otillar, R; Spatafora, JW; Yadav, JS; Aerts, A; Benoit, I; Boyd, A; Carlson, A; Copeland, A; Coutinho, PM; de Vries, RP; Ferreira, P; Findley, K; Foster, B; Gaskell, J; Glotzer, D; Gorecki, P; Heitman, J; Hesse, C; Hori, C; Igarashi, K; Jurgens, JA; Kallen, N; Kersten, P; Kohler, A; Kues, U; Kumar, TKA; Kuo, A; LaButti, K; Larrondo, LF; Lindquist, E; Ling, A; Lombard, V; Lucas, S; Lundell, T; Martin, R; McLaughlin, DJ; Morgenstern, I; Morin, E; Murat, C; Nagy, LG; Nolan, M; Ohm, RA; Patyshakuliyeva, A; Rokas, A; Ruiz-Duenas, FJ; Sabat, G; Salamov, A; Samejima, M; Schmutz, J; Slot, JC; John, FS; Stenlid, J; Sun, H; Sun, S; Syed, K; Tsang, A; Wiebenga, A; Young, D; Pisabarro, A; Eastwood, DC; Martin, F; Cullen, D; Grigoriev, IV; Hibbett, DS				Floudas, Dimitrios; Binder, Manfred; Riley, Robert; Barry, Kerrie; Blanchette, Robert A.; Henrissat, Bernard; Martinez, Angel T.; Otillar, Robert; Spatafora, Joseph W.; Yadav, Jagjit S.; Aerts, Andrea; Benoit, Isabelle; Boyd, Alex; Carlson, Alexis; Copeland, Alex; Coutinho, Pedro M.; de Vries, Ronald P.; Ferreira, Patricia; Findley, Keisha; Foster, Brian; Gaskell, Jill; Glotzer, Dylan; Gorecki, Pawel; Heitman, Joseph; Hesse, Cedar; Hori, Chiaki; Igarashi, Kiyohiko; Jurgens, Joel A.; Kallen, Nathan; Kersten, Phil; Kohler, Annegret; Kuees, Ursula; Kumar, T. K. Arun; Kuo, Alan; LaButti, Kurt; Larrondo, Luis F.; Lindquist, Erika; Ling, Albee; Lombard, Vincent; Lucas, Susan; Lundell, Taina; Martin, Rachael; McLaughlin, David J.; Morgenstern, Ingo; Morin, Emanuelle; Murat, Claude; Nagy, Laszlo G.; Nolan, Matt; Ohm, Robin A.; Patyshakuliyeva, Aleksandrina; Rokas, Antonis; Ruiz-Duenas, Francisco J.; Sabat, Grzegorz; Salamov, Asaf; Samejima, Masahiro; Schmutz, Jeremy; Slot, Jason C.; John, Franz St.; Stenlid, Jan; Sun, Hui; Sun, Sheng; Syed, Khajamohiddin; Tsang, Adrian; Wiebenga, Ad; Young, Darcy; Pisabarro, Antonio; Eastwood, Daniel C.; Martin, Francis; Cullen, Dan; Grigoriev, Igor V.; Hibbett, David S.			The Paleozoic Origin of Enzymatic Lignin Decomposition Reconstructed from 31 Fungal Genomes	SCIENCE			English	Article							WOOD DECAY; GENE; EVOLUTION; DEGRADATION; PEROXIDASE; CELLULOSE; SEQUENCE; MODELS; FAMILY	Wood is a major pool of organic carbon that is highly resistant to decay, owing largely to the presence of lignin. The only organisms capable of substantial lignin decay are white rot fungi in the Agaricomycetes, which also contains non-lignin-degrading brown rot and ectomycorrhizal species. Comparative analyses of 31 fungal genomes (12 generated for this study) suggest that lignin-degrading peroxidases expanded in the lineage leading to the ancestor of the Agaricomycetes, which is reconstructed as a white rot species, and then contracted in parallel lineages leading to brown rot and mycorrhizal species. Molecular clock analyses suggest that the origin of lignin degradation might have coincided with the sharp decrease in the rate of organic carbon burial around the end of the Carboniferous period.	[Riley, Robert; Barry, Kerrie; Otillar, Robert; Aerts, Andrea; Copeland, Alex; Foster, Brian; Kuo, Alan; LaButti, Kurt; Lindquist, Erika; Lucas, Susan; Nolan, Matt; Ohm, Robin A.; Salamov, Asaf; Sun, Hui; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Floudas, Dimitrios; Binder, Manfred; Carlson, Alexis; Glotzer, Dylan; Kallen, Nathan; Ling, Albee; Martin, Rachael; Nagy, Laszlo G.; Young, Darcy; Hibbett, David S.] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Blanchette, Robert A.; Jurgens, Joel A.; Kumar, T. K. Arun; McLaughlin, David J.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Henrissat, Bernard; Coutinho, Pedro M.; Lombard, Vincent] Aix Marseille Univ, CNRS, UMR 6098, F-13288 Marseille 9, France; [Martinez, Angel T.; Ruiz-Duenas, Francisco J.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Spatafora, Joseph W.; Boyd, Alex; Hesse, Cedar] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Yadav, Jagjit S.; Syed, Khajamohiddin] Univ Cincinnati, Coll Med, Dept Environm Hlth, Environm Genet & Mol Toxicol Div, Cincinnati, OH 45267 USA; [Benoit, Isabelle; de Vries, Ronald P.] Univ Utrecht, Microbiol & Kluyver Ctr Genom Ind Fermentat, NL-3584 CH Utrecht, Netherlands; [Benoit, Isabelle; de Vries, Ronald P.; Patyshakuliyeva, Aleksandrina; Wiebenga, Ad] CBS KNAW Fungal Biodivers Ctr, NL-3584 CT Utrecht, Netherlands; [Ferreira, Patricia] Univ Zaragoza, Dept Biochem & Mol & Cellular Biol, E-50009 Zaragoza, Spain; [Ferreira, Patricia] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain; [Findley, Keisha; Heitman, Joseph; Sun, Sheng] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Gaskell, Jill; Kersten, Phil; John, Franz St.; Cullen, Dan] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Gorecki, Pawel] Warsaw Univ, Inst Informat, PL-02097 Warsaw, Poland; [Hori, Chiaki; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Kohler, Annegret; Morin, Emanuelle; Murat, Claude; Martin, Francis] Nancy Univ, INRA, UMR 1136, F-54280 Champenoux, France; [Kuees, Ursula] Univ Gottingen, Busgen Inst, D-37077 Gottingen, Germany; [Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Santiago 8331010, Chile; [Lundell, Taina] Univ Helsinki, Viikki Bioctr, Dept Appl Chem & Microbiol, FIN-00014 Helsinki, Finland; [Morgenstern, Ingo; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H4B 1R6, Canada; [Rokas, Antonis; Slot, Jason C.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Sabat, Grzegorz] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53726 USA; [Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Stenlid, Jan] Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, S-75007 Uppsala, Sweden; [Pisabarro, Antonio] Univ Publ Navarra, Genet & Microbiol Res Grp, Pamplona 31006, Spain; [Eastwood, Daniel C.] Univ Swansea, Coll Sci, Swansea SA2 8PP, W Glam, Wales	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Clark University; University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Oregon State University; University System of Ohio; University of Cincinnati; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Zaragoza; University of Zaragoza; Duke University; United States Department of Agriculture (USDA); United States Forest Service; University of Warsaw; University of Tokyo; INRAE; Universite de Lorraine; University of Gottingen; Pontificia Universidad Catolica de Chile; University of Helsinki; Concordia University - Canada; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; HudsonAlpha Institute for Biotechnology; Swedish University of Agricultural Sciences; Universidad Publica de Navarra; Swansea University	Grigoriev, IV (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	ivgrigoriev@lbl.gov; dhibbett@clarku.edu	St John, Franz/J-8970-2016; Slot, Jason/L-5500-2018; Neila, Patricia Ferreira/Y-4803-2019; Cullen, Daniel/AAN-5484-2020; Syed, Khajamohiddin/L-8774-2013; Lundell, Taina/P-6623-2016; Henrissat, Bernard/J-2475-2012; de Vries, Ronald P./F-8125-2011; Gorecki, Pawel/D-3160-2013; Kües, Ursula/B-8280-2008; Martínez, Angel T/G-7284-2017; Pisabarro, Antonio G./K-3622-2014; Lundell, Taina/ABA-8393-2021; Igarashi, Kiyohiko/E-6799-2016; Stenlid, Jan/K-5909-2019; Barry, Kerrie Whitelaw/AAA-5500-2020; Binder, Manfred/C-8571-2013; Ohm, Robin A/I-6689-2016; Heitman, Joseph/ABC-6006-2021; Rokas, Antonis/A-9775-2008; Slot, Jason/E-4802-2011; Yadav, Jagjit S./AAN-8805-2020; Schmutz, Jeremy/N-3173-2013; morin, emmanuelle/AAA-1246-2019; Hori, Chiaki/AAO-9734-2021; Ruiz-Dueñas, Francisco J/L-9837-2015; Riley, Robert/AAA-4531-2020; Kohler, Annegret/AAD-1876-2019; Murat, Claude/AAA-5226-2020; Kumar, TK Arun/S-2310-2019; Larrondo, Luis/J-1086-2016	St John, Franz/0000-0003-3458-5628; Syed, Khajamohiddin/0000-0002-1497-3570; Lundell, Taina/0000-0003-3899-1658; Henrissat, Bernard/0000-0002-3434-8588; de Vries, Ronald P./0000-0002-4363-1123; Gorecki, Pawel/0000-0002-2045-5892; Kües, Ursula/0000-0001-9180-4079; Martínez, Angel T/0000-0002-1584-2863; Pisabarro, Antonio G./0000-0001-6987-5794; Lundell, Taina/0000-0003-3899-1658; Igarashi, Kiyohiko/0000-0001-5152-7177; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Rokas, Antonis/0000-0002-7248-6551; Yadav, Jagjit S./0000-0001-5036-3609; Schmutz, Jeremy/0000-0001-8062-9172; morin, emmanuelle/0000-0002-7268-972X; Hori, Chiaki/0000-0002-5740-153X; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Riley, Robert/0000-0003-0224-0975; Murat, Claude/0000-0003-0685-7307; Hesse, Cedar/0000-0002-1006-0491; Grigoriev, Igor/0000-0002-3136-8903; Ferreira Neila, Patricia/0000-0003-4076-6118; Lombard, Vincent/0000-0002-9684-7067; Eastwood, Daniel/0000-0002-7015-0739; Ohm, Robin A./0000-0003-2548-0074; Stenlid, Jan/0000-0002-5344-2094; Sabat, Grzegorz/0000-0001-7668-7767; Larrondo, Luis/0000-0002-8832-7109; Blanchette, Robert A./0000-0003-2819-6511	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Assembling the Fungal Tree of Life (AFTOL) project under NSF [DEB-0732968, DEB-0732993, DEB-0732550]	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Assembling the Fungal Tree of Life (AFTOL) project under NSF	The work conducted by the U.S. Department of Energy Joint Genome Institute was supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231. Also supported by the Assembling the Fungal Tree of Life (AFTOL) project under NSF awards DEB-0732968 (D. S. H.), DEB-0732993 (J.W.S.), and DEB-0732550 (D.J.M.). We thank R. H. Petersen for the strain of A. delicata. The organisms A. delicata and Dacryopinax sp. were obtained in Costa Rica and can only be used for research purposes. Assemblies and annotations of the 12 genomes reported here are available from the JGI fungal portal MycoCosm (http://jgi.doe.gov/fungi) and from DDBJ/EMBL/GenBank under the following accessions: AFVO00000000, AEIT00000000, AEUS00000000, AEID00000000, AEJJ00000000, AEHC00000000, AFVP00000000, AEGM00000000, AEGX00000000, AEJI00000000, AFVY00000000, and AEHD00000000. Aligned sequence data for organismal and gene family phylogenies and molecular clock analyses, and secretome results are available at DRYAD (http://dx.doi.org/10.5061/dryad.5k3t47p0).	Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Barker D, 2007, BIOINFORMATICS, V23, P14, DOI 10.1093/bioinformatics/btl558; Berner R., 2004, PHANEROZOIC CARBON C; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Gorecki P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S15; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Krings M, 2011, MYCOSCIENCE, V52, P18, DOI 10.1007/s10267-010-0065-4; Larrondo LF, 2005, BIOPHYS CHEM, V116, P167, DOI 10.1016/j.bpc.2005.03.006; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; ROBINSON JM, 1990, GEOLOGY, V18, P607, DOI 10.1130/0091-7613(1990)015<0607:LLPAFB>2.3.CO;2; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; SCHMIDT O, 1980, HOLZFORSCHUNG, V34, P67, DOI 10.1515/hfsg.1980.34.2.67; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STUBBLEFIELD SP, 1986, BOT GAZ, V147, P116, DOI 10.1086/337577; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06	25	1045	1105	26	787	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1715	1719		10.1126/science.1221748	http://dx.doi.org/10.1126/science.1221748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745431	Green Submitted			2022-12-01	WOS:000305794500053
J	Marini, JC; Forlino, A				Marini, Joan C.; Forlino, Antonella			Replenishing Cartilage from Endogenous Stem Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marini, Joan C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD USA; [Forlino, Antonella] Univ Pavia, Dept Mol Med, Biochem Sect, I-27100 Pavia, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Pavia	Marini, JC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD USA.		Forlino, Antonella/H-5385-2015	Forlino, Antonella/0000-0002-6385-1182	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HD000408-25] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Johnson DJ, 2012, SCIENCE, V338, DOI 10.1126/science.1225996; Panaroni C, 2009, BLOOD, V114, P459, DOI 10.1182/blood-2008-12-195859; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005	5	21	23	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2522	2524		10.1056/NEJMcibr1204283	http://dx.doi.org/10.1056/NEJMcibr1204283			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738103	Green Accepted			2022-12-01	WOS:000305747000015
J	Pawar, S; Dell, AI; Savage, V				Pawar, Samraat; Dell, Anthony I.; Savage, Van M.			Dimensionality of consumer search space drives trophic interaction strengths	NATURE			English	Article							BODY-SIZE RELATIONSHIPS; TERRESTRIAL FOOD WEBS; POPULATION-DENSITY; REAL DIFFERENCES; DYNAMICS; STABILITY; ABUNDANCE; MARINE; PHYTOPLANKTON; CONSTRAINTS	Trophic interactions govern biomass fluxes in ecosystems, and stability in food webs. Knowledge of how trophic interaction strengths are affected by differences among habitats is crucial for understanding variation in ecological systems. Here we show how substantial variation in consumption-rate data, and hence trophic interaction strengths, arises because consumers tend to encounter resources more frequently in three dimensions (3D) (for example, arboreal and pelagic zones) than two dimensions (2D) (for example, terrestrial and benthic zones). By combining new theory with extensive data (376 species, with body masses ranging from 5.24 x 10(-14) kg to 800 kg), we find that consumption rates scale sublinearly with consumer body mass (exponent of approximately 0.85) for 2D interactions, but superlinearly (exponent of approximately 1.06) for 3D interactions. These results contradict the currently widespread assumption of a single exponent (of approximately 0.75) in consumer-resource and food-web research. Further analysis of 2,929 consumer-resource interactions shows that dimensionality of consumer search space is probably a major driver of species coexistence, and the stability and abundance of populations.	[Pawar, Samraat; Dell, Anthony I.; Savage, Van M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Dell, Anthony I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Savage, Van M.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Savage, Van M.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; James Cook University; University of California System; University of California Los Angeles; The Santa Fe Institute	Pawar, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.	samraat@ucla.edu	Pawar, Samraat/E-7388-2012	Pawar, Samraat/0000-0001-8375-5684	University of California, Los Angeles; US National Science Foundation Division of Environmental Biology [1021010]	University of California, Los Angeles(University of California System); US National Science Foundation Division of Environmental Biology(National Science Foundation (NSF))	We thank the authors who contributed data (Supplementary Tables 5-8), and P. Amarasekare, J. H. Brown, E. Economo, A. Mikheyev, C. Estrada, C. Johnson, M. Johnson and K. Lafferty for helpful discussions and comments. S. P., A. I. D. and V. M. S. were supported by University of California, Los Angeles Biomathematics start-up funds and by the US National Science Foundation Division of Environmental Biology award 1021010. The data reported in this paper are available in the Supplementary Information online.	Alexander RM., 2003, PRINCIPLES ANIMAL LO; Belgrano A, 2002, ECOL LETT, V5, P611, DOI 10.1046/j.1461-0248.2002.00364.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; BRIAND F, 1987, SCIENCE, V238, P956, DOI 10.1126/science.3672136; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brose U, 2010, FUNCT ECOL, V24, P28, DOI 10.1111/j.1365-2435.2009.01618.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cermeno P, 2006, ECOL LETT, V9, P1210, DOI 10.1111/j.1461-0248.2006.00973.x; Chase JM, 2000, TRENDS ECOL EVOL, V15, P408, DOI 10.1016/S0169-5347(00)01942-X; COHEN JE, 1994, PHILOS T R SOC B, V343, P57, DOI 10.1098/rstb.1994.0008; Cyr H, 1997, OIKOS, V80, P139, DOI 10.2307/3546525; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; FARLOW JO, 1976, ECOLOGY, V57, P841, DOI 10.2307/1941052; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.1890/0012-9658(1998)079[0461:TCAEAT]2.0.CO;2; Leaper R, 1999, ECOL LETT, V2, P191; Lewis HM, 2008, J ANIM ECOL, V77, P1056, DOI 10.1111/j.1365-2656.2008.01405.x; McGill BJ, 2006, EVOL ECOL RES, V8, P691; MILNE BT, 1992, THEOR POPUL BIOL, V41, P337, DOI 10.1016/0040-5809(92)90033-P; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Pawar S, 2009, J THEOR BIOL, V259, P601, DOI 10.1016/j.jtbi.2009.04.006; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reuman DC, 2009, ADV ECOL RES, V41, P1, DOI 10.1016/S0065-2504(09)00401-2; Rip JMK, 2011, ECOL LETT, V14, P733, DOI 10.1111/j.1461-0248.2011.01636.x; Ritchie M. E, 2009, HETEROGENEITY STRUCT, V112; Savage VM, 2007, J THEOR BIOL, V247, P213, DOI 10.1016/j.jtbi.2007.03.007; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Vucic-Pestic O, 2010, J ANIM ECOL, V79, P249, DOI 10.1111/j.1365-2656.2009.01622.x; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; Weitz JS, 2006, ECOL LETT, V9, P548, DOI 10.1111/j.1461-0248.2006.00900.x; WHITEHEAD H, 1992, THEOR POPUL BIOL, V42, P1, DOI 10.1016/0040-5809(92)90002-B; WITTING L, 1995, J THEOR BIOL, V177, P129, DOI 10.1006/jtbi.1995.0231; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	40	181	182	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					485	489		10.1038/nature11131	http://dx.doi.org/10.1038/nature11131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722834				2022-12-01	WOS:000305760600033
J	Prusiner, SB				Prusiner, Stanley B.			A Unifying Role for Prions in Neurodegenerative Diseases	SCIENCE			English	Editorial Material							CHRONIC TRAUMATIC ENCEPHALOPATHY; PARKINSONS-DISEASE; LONG-TERM; PROPAGATION; CELLS; TRANSMISSION; TAUOPATHY; DISORDER; NEURONS; BRAIN		[Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	stanley@ind.ucsf.edu			NIA NIH HHS [P01 AG010770, P01 AG021601, P01 AG002132] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG010770, P01AG021601, P01AG002132] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colby DW, 2011, NAT REV MICROBIOL, V9, P771, DOI 10.1038/nrmicro2650; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Stohr J., P NATL ACAD SCI USA, DOI [10.1073/pnas.1206555109, DOI 10.1073/PNAS.1206555109]	23	377	388	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1511	1513		10.1126/science.1222951	http://dx.doi.org/10.1126/science.1222951			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723400	Green Accepted			2022-12-01	WOS:000305507500034
J	Rosenstiel, TN; Shortlidge, EE; Melnychenko, AN; Pankow, JF; Eppley, SM				Rosenstiel, Todd N.; Shortlidge, Erin E.; Melnychenko, Andrea N.; Pankow, James F.; Eppley, Sarah M.			Sex-specific volatile compounds influence microarthropod-mediated fertilization of moss	NATURE			English	Article							FOLSOMIA-CANDIDA COLLEMBOLA; FLORAL SCENT; LAND PLANTS; EVOLUTION; SPERM; PREFERENCES; BRYOPHYTES; DIMORPHISM; DIVERSITY; PATTERNS	Sexual reproduction in non-vascular plants requires unicellular free-motile sperm to travel from male to female reproductive structures across the terrestrial landscape(1). Recent data suggest that microarthropods can disperse sperm in mosses(2). However, little is known about the chemical communication, if any, that is involved in this interaction or the relative importance of microarthropod dispersal compared to abiotic dispersal agents in mosses. Here we show that tissues of the cosmopolitan moss Ceratodon purpureus emit complex volatile scents, similar in chemical diversity to those described in pollination mutualisms between flowering plants and insects, that the chemical composition of C. purpureus volatiles are sex-specific, and that moss-dwelling microarthropods are differentially attracted to these sex-specific moss volatile cues. Furthermore, using experimental microcosms, we show that microarthropods significantly increase moss fertilization rates, even in the presence of water spray, highlighting the important role of microarthropod dispersal in contributing to moss mating success. Taken together, our results indicate the presence of a scent-based 'plant-pollinator-like' relationship that has evolved between two of Earth's most ancient terrestrial lineages, mosses and microarthropods.	[Rosenstiel, Todd N.; Shortlidge, Erin E.; Melnychenko, Andrea N.; Eppley, Sarah M.] Portland State Univ, Dept Biol, Portland, OR 97201 USA; [Rosenstiel, Todd N.; Shortlidge, Erin E.; Melnychenko, Andrea N.; Eppley, Sarah M.] Portland State Univ, Ctr Life Extreme Environm, Portland, OR 97201 USA; [Pankow, James F.] Portland State Univ, Dept Chem, Portland, OR 97201 USA; [Pankow, James F.] Portland State Univ, Dept Civil & Environm Engn, Portland, OR 97201 USA	Portland State University; Portland State University; Portland State University; Portland State University	Eppley, SM (corresponding author), Portland State Univ, Dept Biol, 1719 SW 10th Ave, Portland, OR 97201 USA.	eppley@pdx.edu	Shortlidge, Erin/ABA-9548-2021		3M Corporation; National Science Foundation [DEB-0743461, IOS-0719570]	3M Corporation(3M); National Science Foundation(National Science Foundation (NSF))	We are grateful to W. Luo and L. Isabelle for analytical assistance, to C. Rupert for assistance with the preference assays, and to L. Stark and N. McLetchie for plant material. Funding was provided by the 3M Corporation and the National Science Foundation (DEB-0743461 to S. M. E. and IOS-0719570 to T.N.R).	Andrew NR, 2003, J BIOGEOGR, V30, P731, DOI 10.1046/j.1365-2699.2003.00849.x; Ashman TL, 2009, FUNCT ECOL, V23, P852, DOI 10.1111/j.1365-2435.2009.01590.x; BENGTSSON G, 1988, SOIL BIOL BIOCHEM, V20, P25, DOI 10.1016/0038-0717(88)90122-8; Bisang I, 2005, J BRYOL, V27, P207, DOI 10.1179/174328205X69959; CREPET WL, 1984, ANN MO BOT GARD, V71, P607, DOI 10.2307/2399041; Cronberg N, 2006, SCIENCE, V313, P1255, DOI 10.1126/science.1128707; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Hemborg AM, 2005, BIOL J LINN SOC, V85, P97, DOI 10.1111/j.1095-8312.2005.00477.x; JOHNSON DL, 1980, RES POPUL ECOL, V22, P339, DOI 10.1007/BF02530855; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; Lawton E., 1971, MOSS FLORA PACIFIC N; LONGTON R E, 1976, Journal of the Hattori Botanical Laboratory, V41, P205; MISHLER BD, 1990, SYST BOT, V15, P86, DOI 10.2307/2419019; Muggoch H, 1942, PROC R SOC SER B-BIO, V130, P448, DOI 10.1098/rspb.1942.0012; Nickrent DL, 2000, MOL BIOL EVOL, V17, P1885, DOI 10.1093/oxfordjournals.molbev.a026290; Pankow J. F., 2011, ATMOS MEAS TECH, V4, P3647, DOI DOI 10.5194/AMTD-4-3647-2011; PAOLILLO DJ, 1981, BIOSCIENCE, V31, P367, DOI 10.2307/1308401; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Raspotnig G, 2005, J CHEM ECOL, V31, P419, DOI 10.1007/s10886-005-1350-0; Rosenstiel TN, 2009, BIOL LETTERS, V5, P857, DOI 10.1098/rsbl.2009.0380; Sadaka-Laulan N, 1998, EUR J SOIL BIOL, V34, P179, DOI 10.1016/S1164-5563(00)86660-1; SAS Institute, 2012, JMP WIND REL 10 0 0; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Shaw A.J., 2000, BRYOPHYTE BIOL, P369; SHAW AJ, 1993, AM J BOT, V80, P584, DOI 10.2307/2445376; Shortlidge EE, 2012, NEW PHYTOL, V194, P741, DOI 10.1111/j.1469-8137.2012.04106.x; Staaden S, 2011, SOIL BIOL BIOCHEM, V43, P1411, DOI 10.1016/j.soilbio.2010.10.002; Stark LR, 2010, BRYOLOGIST, V113, P788, DOI 10.1639/0007-2745-113.4.788; Steidle JLM, 1997, J INSECT BEHAV, V10, P331, DOI 10.1007/BF02765601; THIMM T, 1995, BIOL FERT SOILS, V19, P266, DOI 10.1007/BF00336171; van Dam NM, 2008, PLANT BIOLOGY, V10, P29, DOI 10.1055/s-2007-964961; Varga S, 2008, AM J BOT, V95, P1225, DOI 10.3732/ajb.0800068; VERHOEF HA, 1977, J INSECT PHYSIOL, V23, P1009, DOI 10.1016/0022-1910(77)90128-7; Voigt CC, 2005, J MAMMAL, V86, P745, DOI 10.1644/1545-1542(2005)086[0745:BBABSS]2.0.CO;2; Xu J, 2009, INSECT SCI, V16, P57, DOI 10.1111/j.1744-7917.2009.00254.x	36	42	44	1	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					431	U118		10.1038/nature11330	http://dx.doi.org/10.1038/nature11330			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22810584				2022-12-01	WOS:000308860900045
J	Venkatesh, S; Smolle, M; Li, H; Gogol, MM; Saint, M; Kumar, S; Natarajan, K; Workman, JL				Venkatesh, Swaminathan; Smolle, Michaela; Li, Hua; Gogol, Madelaine M.; Saint, Malika; Kumar, Shambhu; Natarajan, Krishnamurthy; Workman, Jerry L.			Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes	NATURE			English	Article							RNA-POLYMERASE-II; CHROMATIN; ACETYLATION; REGIONS; COMPLEX; DEACETYLATION; ELONGATION; HISTORIES; RECRUITS; DIRECTS	Set2-mediated methylation of histone H3 at Lys 36 (H3K36me) is a co-transcriptional event that is necessary for the activation of the Rpd3S histone deacetylase complex, thereby maintaining the coding region of genes in a hypoacetylated state(1,2). In the absence of Set2, H3K36 or Rpd3S acetylated histones accumulate on open reading frames (ORFs), leading to transcription initiation from cryptic promoters within ORFs(1,3). Although the co-transcriptional deacetylation pathway is well characterized, the factors responsible for acetylation are as yet unknown. Here we show that, in yeast, co-transcriptional acetylation is achieved in part by histone exchange over ORFs. In addition to its function of targeting and activating the Rpd3S complex, H3K36 methylation suppresses the interaction of H3 with histone chaperones, histone exchange over coding regions and the incorporation of new acetylated histones. Thus, Set2 functions both to suppress the incorporation of acetylated histones and to signal for the deacetylation of these histones in transcribed genes. By suppressing spurious cryptic transcripts from initiating within ORFs, this pathway is essential to maintain the accuracy of transcription by RNA polymerase II.	[Venkatesh, Swaminathan; Smolle, Michaela; Li, Hua; Gogol, Madelaine M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Saint, Malika; Kumar, Shambhu; Natarajan, Krishnamurthy] Jawarharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Stowers Institute for Medical Research; Jawaharlal Nehru University, New Delhi	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers.org	Kumar, Shambhu/K-1260-2019	Kumar, Shambhu/0000-0003-1225-1790; Gogol, Madelaine/0000-0002-8738-0995; Smolle, Michaela/0000-0001-8900-1541; Saint, Malika/0000-0001-7509-0619; Venkatesh, Swaminathan/0000-0001-9837-1501	National Institutes of Health [R01GM04867]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Winston and O. Rando for providing yeast strains used in this study, members of the Workman laboratory for discussion, and J. Chatfield and G. Dialynas for critical reading of our manuscript. This work was supported by National Institutes of Health grant R01GM04867 to J. L. W. and the Stowers Institute for Medical Research.	Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Arnold KM, 2011, BIOCHEMISTRY-US, V50, P727, DOI 10.1021/bi101355a; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Katan-Khaykovich Y, 2011, P NATL ACAD SCI USA, V108, P1296, DOI 10.1073/pnas.1018308108; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Pattenden SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012927; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	35	213	220	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					452	U145		10.1038/nature11326	http://dx.doi.org/10.1038/nature11326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22914091				2022-12-01	WOS:000308860900050
J	Raghu, G				Raghu, Ganesh			Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012	LANCET			English	Editorial Material							GASTROESOPHAGEAL-REFLUX THERAPY; PLACEBO-CONTROLLED TRIAL; ACETYLCYSTEINE; AZATHIOPRINE; GUIDELINES; PREDNISONE; STATEMENT; SURVIVAL; BOSENTAN		[Raghu, Ganesh] Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Raghu, G (corresponding author), Box 356175,1959 Pacific Ave, Seattle, WA 98195 USA.	graghu@uw.edu						Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Hunninghake GW, 2005, NEW ENGL J MED, V353, P2285, DOI 10.1056/NEJMe058210; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Lee JS, 2012, EUR RESPIR J, V39, P352, DOI 10.1183/09031936.00050911; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Noth I, 2012, EUR RESPIR J, V39, P344, DOI 10.1183/09031936.00099910; Noth I, 2012, AM J RESP CRIT CARE, V186, P88, DOI 10.1164/rccm.201202-0314OC; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; RAGHU G, 1991, AM REV RESPIR DIS, V144, P291, DOI 10.1164/ajrccm/144.2.291; Raghu G, 2012, EUR RESPIR J, V39, P242, DOI 10.1183/09031936.00211311; Raghu G, 2012, AM J RESP CRIT CARE, V185, pA3632; Raghu G, 2012, AM J RESP CRIT CARE, V185, pA3631; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2012, AM J RESP CRIT CARE, V185, P1044, DOI 10.1164/rccm.201201-0006PP; Raghu G, 2011, AM J RESP CRIT CARE, V184, P1330, DOI 10.1164/rccm.201110-1842ED; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Zisman DA, 2010, NEW ENGL J MED, V363, P620, DOI 10.1056/NEJMoa1002110	25	19	19	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					699	701		10.1016/S0140-6736(12)61256-2	http://dx.doi.org/10.1016/S0140-6736(12)61256-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901891				2022-12-01	WOS:000307721000035
J	Emlen, DJ; Warren, IA; Johns, A; Dworkin, I; Lavine, LC				Emlen, Douglas J.; Warren, Ian A.; Johns, Annika; Dworkin, Ian; Lavine, Laura Corley			A Mechanism of Extreme Growth and Reliable Signaling in Sexually Selected Ornaments and Weapons	SCIENCE			English	Article							STATIC ALLOMETRY; CONDITION DEPENDENCE; HANDICAP PRINCIPLE; EVOLUTION; SIZE; SHAPE; EXPRESSION; PATTERNS; CAPTURE; TRAITS	Many male animals wield ornaments or weapons of exaggerated proportions. We propose that increased cellular sensitivity to signaling through the insulin/insulin-like growth factor (IGF) pathway may be responsible for the extreme growth of these structures. We document how rhinoceros beetle horns, a sexually selected weapon, are more sensitive to nutrition and more responsive to perturbation of the insulin/IGF pathway than other body structures. We then illustrate how enhanced sensitivity to insulin/IGF signaling in a growing ornament or weapon would cause heightened condition sensitivity and increased variability in expression among individuals-critical properties of reliable signals of male quality. The possibility that reliable signaling arises as a by-product of the growth mechanism may explain why trait exaggeration has evolved so many different times in the context of sexual selection.	[Emlen, Douglas J.; Johns, Annika] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Warren, Ian A.; Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA	University of Montana System; University of Montana; Washington State University; Michigan State University	Emlen, DJ (corresponding author), Univ Montana, Div Biol Sci, 104 Hlth Sci Bldg, Missoula, MT 59812 USA.	doug.emlen@mso.umt.edu		Dworkin, Ian/0000-0002-2874-287X; Lavine, Laura/0000-0002-0262-359X	National Science Foundation [IOS-0919781, IOS-0919730, IOS-0920142]; Direct For Biological Sciences [0919781] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0920142] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. E. Allen, C. Breuner, K. L. Bright, S. T. Emlen, E. McCullough, A. Perkins, A. Shingleton, and three anonymous reviewers for helpful comments on the manuscript; Y. Hongo, H. Gotoh, and N. Kubota for help purchasing beetles; E. Paul (Echo Medical Media) for artwork on Figs. 1B, 2, and 3; and the National Science Foundation (IOS-0919781, IOS-0919730, and IOS-0920142) for funding. Images in Fig. 1A used under license from Shutterstock.com (rhinoceros beetle, NH; widowbird, Simon_g; elk, W. Aston; stag beetle, H. Larsson; fiddler crab, Manamana). Sequences are deposited in GenBank (accession nos. JX141307 to JX141311).	ALATALO RV, 1988, BIOL J LINN SOC, V34, P363, DOI 10.1111/j.1095-8312.1988.tb01969.x; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Bonduriansky R, 2005, EVOLUTION, V59, P138, DOI 10.1111/j.0014-3820.2005.tb00901.x; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bonduriansky R, 2007, AM NAT, V169, P9, DOI 10.1086/510214; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Cotton S, 2004, EVOLUTION, V58, P1038, DOI 10.1111/j.0014-3820.2004.tb00437.x; Cuervo JJ, 2009, J EVOLUTION BIOL, V22, P1503, DOI 10.1111/j.1420-9101.2009.01758.x; Darwin C., 1871, P423; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Fitzpatrick S, 1997, BIOL J LINN SOC, V62, P145; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Husak JF, 2011, BEHAVIOUR, V148, P1, DOI 10.1163/000579510X541265; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Knell RJ, 1999, ECOL ENTOMOL, V24, P323, DOI 10.1046/j.1365-2311.1999.00200.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; POMIANKOWSKI A, 1987, PROC R SOC SER B-BIO, V231, P123, DOI 10.1098/rspb.1987.0038; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Searcy W.A., 2005, EVOLUTION ANIMAL COM; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Smith JM, 2004, ANIMAL SIGNALS, V1; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	32	316	320	6	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					860	864		10.1126/science.1224286	http://dx.doi.org/10.1126/science.1224286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837386				2022-12-01	WOS:000307535600048
J	Gudjonsson, T; Altmeyer, M; Savic, V; Toledo, L; Dinant, C; Grofte, M; Bartkova, J; Poulsen, M; Oka, Y; Bekker-Jensen, S; Mailand, N; Neumann, B; Heriche, JK; Shearer, R; Saunders, D; Bartek, J; Lukas, J; Lukas, C				Gudjonsson, Thorkell; Altmeyer, Matthias; Savic, Velibor; Toledo, Luis; Dinant, Christoffel; Grofte, Merete; Bartkova, Jirina; Poulsen, Maria; Oka, Yasuyoshi; Bekker-Jensen, Simon; Mailand, Niels; Neumann, Beate; Heriche, Jean-Karim; Shearer, Robert; Saunders, Darren; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia			TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes	CELL			English	Article							E3 UBIQUITIN LIGASE; DOUBLE-STRAND BREAKS; END RULE PATHWAY; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; S-PHASE; 53BP1; REPAIR; EDD	Histone ubiquitylation is a prominent response to DNA double-strand breaks (DSBs), but how these modifications are confined to DNA lesions is not understood. Here, we show that TRIP12 and UBR5, two HECT domain ubiquitin E3 ligases, control accumulation of RNF168, a rate-limiting component of a pathway that ubiquitylates histones after DNA breakage. We find that RNF168 can be saturated by increasing amounts of DSBs. Depletion of TRIP12 and UBR5 allows accumulation of RNF168 to supra-physiological levels, followed by massive spreading of ubiquitin conjugates and hyperaccumulation of ubiquitin-regulated genome caretakers such as 53BP1 and BRCA1. Thus, regulatory and proteolytic ubiquitylations are wired in a self-limiting circuit that promotes histone ubiquitylation near the DNA lesions but at the same time counteracts its excessive spreading to undamaged chromosomes. We provide evidence that this mechanism is vital for the homeostasis of ubiquitin-controlled events after DNA breakage and can be subverted during tumorigenesis.	[Gudjonsson, Thorkell; Altmeyer, Matthias; Savic, Velibor; Toledo, Luis; Grofte, Merete; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc Res Ctr, Chromosome Biol Unit, DK-2100 Copenhagen, Denmark; [Dinant, Christoffel; Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc Res Ctr, Genome Integr Unit, DK-2100 Copenhagen, Denmark; [Dinant, Christoffel; Bartkova, Jirina; Bartek, Jiri] Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Poulsen, Maria; Oka, Yasuyoshi; Bekker-Jensen, Simon; Mailand, Niels; Lukas, Jiri] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Neumann, Beate; Heriche, Jean-Karim] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Shearer, Robert; Saunders, Darren] Univ New S Wales, Canc Res Program, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Shearer, Robert; Saunders, Darren] Univ New S Wales, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW 2010, Australia; [Bartek, Jiri] Palacky Univ, Fac Med, Inst Mol & Translat Med, CZ-77515 Olomouc, Czech Republic	Danish Cancer Society; Danish Cancer Society; Novo Nordisk Foundation; University of Copenhagen; European Molecular Biology Laboratory (EMBL); Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; Palacky University Olomouc	Lukas, J (corresponding author), Danish Canc Soc Res Ctr, Chromosome Biol Unit, Strandblvd 49, DK-2100 Copenhagen, Denmark.	jiri.lukas@cpr.ku.dk	Bartek, Jiri/G-5870-2014; Saunders, Darren/B-7677-2008; Toledo, Luis/R-2065-2016; Altmeyer, Matthias/AAE-8186-2019; Toledo, Luis/M-6685-2019	Toledo, Luis/0000-0001-9509-9944; Altmeyer, Matthias/0000-0003-3780-1170; Toledo, Luis/0000-0001-9509-9944; Heriche, Jean-Karim/0000-0001-6867-9425; Lukas, Claudia/0000-0001-7169-6883; Saunders, Darren/0000-0003-0924-0513; Gudjonsson, Thorkell/0000-0002-5230-4263; Dinant, Christoffel/0000-0001-7531-183X; Neumann, Beate/0000-0002-6899-502X; Savic, Velibor/0000-0002-4830-3591; Bekker-Jensen, Simon/0000-0002-7308-4597; Gudjonsson, Thorarinn/0000-0001-9645-9665; Lukas, Jiri/0000-0001-9087-506X	Danish Cancer Society; Danish National Research Foundation; Lundbeck Foundation [R44-A4400]; Novo Nordisk Foundation; Danish Council for Independent Research-Medical Sciences; John and Birthe Meyer Foundation; European Commission (DDR Response, Biomedreg, and Infla-Care); Cancer Institute NSW; NSW Office of Science and Medical Research; EMBO fellowships	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; European Commission (DDR Response, Biomedreg, and Infla-Care)(European Commission); Cancer Institute NSW; NSW Office of Science and Medical Research; EMBO fellowships	We thank D. Durocher, X. Yu, T. Halazonetis, E. Soutoglou, J. Lippincott Schwartz, S. Watanabe, T. Kohno, and R. Strauss for reagents and technical advice, and we thank members of the Center Genotoxic Stress Research for helpful discussions. This work was supported by the Danish Cancer Society, the Danish National Research Foundation, the Lundbeck Foundation (R44-A4400), the Novo Nordisk Foundation, the Danish Council for Independent Research-Medical Sciences, the John and Birthe Meyer Foundation, European Commission (DDR Response, Biomedreg, and Infla-Care), Cancer Institute NSW, and the NSW Office of Science and Medical Research. M. A., L. T., and C. D. are recipients of long-term EMBO fellowships. Special thanks go to Jan Ellenberg, Rainer Pepperkok, and the Advanced Light Microscopy Facility (ALMF) at EMBL, Heidelberg, for generously supporting this project and for providing the siRNA arrays.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsuda K, 2011, HISTOPATHOLOGY, V59, P441, DOI 10.1111/j.1365-2559.2011.03963.x; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Moudry P, 2012, CELL DEATH DIFFER, V19, P798, DOI 10.1038/cdd.2011.150; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Pegoraro G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031684; Peuscher MH, 2011, NAT CELL BIOL, V13, P1139, DOI 10.1038/ncb2326; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Yoo NJ, 2011, PATHOLOGY, V43, P753, DOI 10.1097/PAT.0b013e32834c7e78	47	221	231	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					697	709		10.1016/j.cell.2012.06.039	http://dx.doi.org/10.1016/j.cell.2012.06.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22884692	Bronze			2022-12-01	WOS:000308002300006
J	Matzuk, MM; McKeown, MR; Filippakopoulos, P; Li, QL; Ma, L; Agno, JE; Lemieux, ME; Picaud, S; Yu, RN; Qi, J; Knapp, S; Bradner, JE				Matzuk, Martin M.; McKeown, Michael R.; Filippakopoulos, Panagis; Li, Qinglei; Ma, Lang; Agno, Julio E.; Lemieux, Madeleine E.; Picaud, Sarah; Yu, Richard N.; Qi, Jun; Knapp, Stefan; Bradner, James E.			Small-Molecule Inhibition of BRDT for Male Contraception	CELL			English	Article							BET BROMODOMAINS; 1ST BROMODOMAIN; BINDING; TESTIS; MYC; DIFFERENTIATION; IDENTIFICATION; INFERTILITY; EXPRESSION; CHROMATIN	A pharmacologic approach to male contraception remains a longstanding challenge in medicine. Toward this objective, we explored the spermatogenic effects of a selective small-molecule inhibitor (JQ1) of the bromodomain and extraterminal (BET) subfamily of epigenetic reader proteins. Here, we report potent inhibition of the testis-specific member BRDT, which is essential for chromatin remodeling during spermatogenesis. Biochemical and crystallographic studies confirm that occupancy of the BRDT acetyl-lysine binding pocket by JQ1 prevents recognition of acetylated histone H4. Treatment of mice with JQ1 reduced seminiferous tubule area, testis size, and spermatozoa number and motility without affecting hormone levels. Although JQ1-treated males mate normally, inhibitory effects of JQ1 evident at the spermatocyte and round spermatid stages cause a complete and reversible contraceptive effect. These data establish a new contraceptive that can cross the blood: testis boundary and inhibit bromodomain activity during spermatogenesis, providing a lead compound targeting the male germ cell for contraception.	[Matzuk, Martin M.; Ma, Lang; Agno, Julio E.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [McKeown, Michael R.; Lemieux, Madeleine E.; Qi, Jun; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Filippakopoulos, Panagis; Picaud, Sarah; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Li, Qinglei] Texas A&M Univ, Dept Vet Integrat Biosci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Lemieux, Madeleine E.] Bioinfo, Ottawa, ON K1J 8G4, Canada; [Yu, Richard N.] Childrens Hosp, Dept Urol, Boston, MA 02115 USA; [Knapp, Stefan] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; University of Oxford; Texas A&M University System; Texas A&M University College Station; Harvard University; Boston Children's Hospital; George Washington University; Harvard University; Harvard Medical School	Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mmatzuk@bcm.edu; james_bradner@dfci.harvard.edu	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Lemieux, Madeleine/0000-0001-6355-8691; Filippakopoulos, Panagis/0000-0002-1515-1317	Eunice Kennedy Shriver NICHD/NIH [U01-HD060496]; Alkek Award for Pilot Projects in Experimental Therapeutics; Fidelity Foundation; Burroughs Wellcome Fund; NIH [K08CA128972]; Smith Family Foundation; Damon-Runyon Cancer Research Foundation; CIHR [1097737]; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Pfizer; Eli Lilly; Abbott; Takeda; Novartis Research Foundation; Ontario Ministry of Research and Innovation; Wellcome Trust; Wellcome Trust Career Development Fellowship [095751/Z/11/Z]; NICHD (SCCPRR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060496, U54HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA128972] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Alkek Award for Pilot Projects in Experimental Therapeutics; Fidelity Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation; Damon-Runyon Cancer Research Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Abbott(Abbott Laboratories); Takeda(Takeda Pharmaceutical Company Ltd); Novartis Research Foundation; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Career Development Fellowship(Wellcome Trust); NICHD (SCCPRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs. J. Brown and J. Plutzky for pharmacodynamic data; Dr. A. Roy for advice on the spermatozoa assays; Y. Vasquez and Dr. Z. Yu for technical help; J. Marineau, K. Shaw, and W. Smith for support of peptide synthesis; Dr. S. Kistler for the generous gift of the anti-TNP2 antibody; and Dr. S. Khochbin for helpful comments. These studies were supported, in part, by the Eunice Kennedy Shriver NICHD/NIH through cooperative agreement U01-HD060496 as part of the Cooperative Program in Male Contraception; an Alkek Award for Pilot Projects in Experimental Therapeutics; and a grant from the Fidelity Foundation (to M. M. M.), the Burroughs Wellcome Fund, the NIH (K08CA128972), the Smith Family Foundation, and Damon-Runyon Cancer Research Foundation (to J. E. B.). The SGC is a registered charity (number 1097737) that receives funds from the CIHR, Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, Abbott, Takeda, Novartis Research Foundation, Ontario Ministry of Research and Innovation, and Wellcome Trust. P. F. is supported by a Wellcome Trust Career Development Fellowship (095751/Z/11/Z). Serum FSH, LH, and testosterone analyses were performed at the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core supported by NICHD (SCCPRR) grant U54-HD28934. Baylor College of Medicine and Dana-Farber Cancer Institute have filed patent applications on technologies relating to this work, which have been licensed to Tensha Therapeutics.	Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Berkovits BD, 2011, DEV BIOL, V360, P358, DOI 10.1016/j.ydbio.2011.10.005; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dieterich K, 2007, NAT GENET, V39, P661, DOI 10.1038/ng2027; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Roy A, 2007, FASEB J, V21, P1013, DOI 10.1096/fj.06-7035com; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shang EY, 2004, GENE EXPR PATTERNS, V4, P513, DOI 10.1016/j.modgep.2004.03.002; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; WOLFES H, 1989, SCIENCE, V245, P740, DOI 10.1126/science.2475907; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhao M, 2004, BIOL REPROD, V71, P1016, DOI 10.1095/biolreprod.104.028191; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	29	273	352	2	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					673	684		10.1016/j.cell.2012.06.045	http://dx.doi.org/10.1016/j.cell.2012.06.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901802	Green Published, hybrid			2022-12-01	WOS:000308002300004
J	Rabinovich, L; Sigal, N; Borovok, I; Nir-Paz, R; Herskovits, AA				Rabinovich, Lev; Sigal, Nadejda; Borovok, Ilya; Nir-Paz, Ran; Herskovits, Anat A.			Prophage Excision Activates Listeria Competence Genes that Promote Phagosomal Escape and Virulence	CELL			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; SUBTILIS K-STATE; BACILLUS-SUBTILIS; DNA UPTAKE; REGULATORY PROTEIN; ESCHERICHIA-COLI; MONOCYTOGENES; HEMOLYSIN; BACTERIA; SYSTEM	The DNA uptake competence (Com) system of the intracellular bacterial pathogen Listeria monocytogenes is considered nonfunctional. There are no known conditions for DNA transformation, and the Com master activator gene, comK, is interrupted by a temperate prophage. Here, we show that the L. monocytogenes Com system is required during infection to promote bacterial escape from macrophage phagosomes in a manner that is independent of DNA uptake. Further, we find that regulation of the Com system relies on the formation of a functional comK gene via prophage excision. Prophage excision is specifically induced during intracellular growth, primarily within phagosomes, yet, in contrast to classic prophage induction, progeny virions are not produced. This study presents the characterization of an active prophage that serves as a genetic switch to modulate the virulence of its bacterial host in the course of infection.	[Rabinovich, Lev; Sigal, Nadejda; Borovok, Ilya; Herskovits, Anat A.] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Nir-Paz, Ran] Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem; Hadassah University Medical Center	Herskovits, AA (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	anathe@post.tau.ac.il	Nir-Paz, Ran/Q-6244-2019; Nir-Paz, Ran/I-5003-2012; BOROVOK, ILYA/ABB-7370-2022; Nir-Paz, Ran/GYA-4148-2022	Nir-Paz, Ran/0000-0002-1567-2550; BOROVOK, ILYA/0000-0003-1602-4499	ERA-NET PathoGenoMics; Israel Science Foundation; European Union FP7 (IRG) program; Legacy Heritage Fund, Israel Science Foundation	ERA-NET PathoGenoMics; Israel Science Foundation(Israel Science Foundation); European Union FP7 (IRG) program; Legacy Heritage Fund, Israel Science Foundation	We thank Avigdor Eldar, Martin Kupiec, and Gil Segal for critical reviews of the manuscript; Tamar Burg Golani and Millie Kaplan Zeevi for their kind help; and Daniel Portnoy, Howard Goldfine, and Helene Marquis for supplying us with antibodies. This study was partially funded by grants from the ERA-NET PathoGenoMics, the Israel Science Foundation and European Union FP7 (IRG) program (to A. A. H.), and the Legacy Heritage Fund, Israel Science Foundation (to R.N.-P.).	Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Borezee E, 2000, J BACTERIOL, V182, P5931, DOI 10.1128/JB.182.20.5931-5934.2000; Borezee E, 2001, MICROBIOL-SGM, V147, P2913, DOI 10.1099/00221287-147-11-2913; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; GOLDEN JW, 1985, NATURE, V314, P419, DOI 10.1038/314419a0; Grundling A, 2003, J BACTERIOL, V185, P6295, DOI 10.1128/JB.185.21.6295-6307.2003; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hodgson DA, 2000, MOL MICROBIOL, V35, P312, DOI 10.1046/j.1365-2958.2000.01643.x; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; KATHARIOU S, 1987, J BACTERIOL, V169, P1291, DOI 10.1128/jb.169.3.1291-1297.1987; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; LOESSNER MJ, 1995, MOL MICROBIOL, V16, P1231, DOI 10.1111/j.1365-2958.1995.tb02345.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Ripio MT, 1997, J BACTERIOL, V179, P7174, DOI 10.1128/jb.179.22.7174-7180.1997; Scott J, 2008, J BACTERIOL, V190, P6290, DOI 10.1128/JB.01569-07; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; STRAGIER P, 1989, SCIENCE, V243, P507, DOI 10.1126/science.2536191; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; ZINK R, 1992, APPL ENVIRON MICROB, V58, P296, DOI 10.1128/AEM.58.1.296-302.1992	41	143	147	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					792	802		10.1016/j.cell.2012.06.036	http://dx.doi.org/10.1016/j.cell.2012.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901809	Bronze			2022-12-01	WOS:000308002300013
J	Schiffrin, EL				Schiffrin, Ernesto L.			Hypertension: treatments, diabetes, and developing regions	LANCET			English	Editorial Material							BLOOD-PRESSURE; PREVALENCE; COMMITTEE; BURDEN; RISK		[Schiffrin, Ernesto L.] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Schiffrin, Ernesto L.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	McGill University; Lady Davis Institute; McGill University	Schiffrin, EL (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada.	ernesto.schiffrin@mcgill.ca	Schiffrin, Ernesto L/AAB-9061-2019	Schiffrin, Ernesto L/0000-0002-4502-2823				Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Cloutier L, 2012, CURR CARDIOVASC RISK, V6, P267, DOI 10.1007/s12170-012-0247-z; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Daskalopoulou SS, 2012, CAN J CARDIOL, V28, P270, DOI 10.1016/j.cjca.2012.02.018; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fagard RH, 2010, J HYPERTENS, V28, P635, DOI 10.1097/01.hjh.0000368700.79444.c1; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Laurent S, 2012, LANCET, V380, P591, DOI 10.1016/S0140-6736(12)60825-3; Leenen FHH, 2010, HYPERTENSION, V56, P571, DOI 10.1161/HYPERTENSIONAHA.110.157818; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Roush GC, 2012, HYPERTENSION, V59, P1110, DOI 10.1161/HYPERTENSIONAHA.112.191106; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; TARNOW L, 1994, DIABETES CARE, V17, P1247, DOI 10.2337/diacare.17.11.1247; Tran C. L., 2012, HYPERTENSION; World Health Organization, 2005, PREVENTING CHRONIC D; Zhang Wei-Zheng, HYPERTENSION, V48, P278, DOI [DOI 10.1161/01.HYP.0000107251.49515.C2, 10.1161/01.HYP.0000231509.27406.42, DOI 10.1161/01.HYP.9.2_PT_2.II36]	22	9	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2012	380	9841					539	541		10.1016/S0140-6736(12)61219-7	http://dx.doi.org/10.1016/S0140-6736(12)61219-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883490				2022-12-01	WOS:000307511400004
J	Hebert, C; Beaumont, J; Schwartz, G; Robicsek, A				Hebert, Courtney; Beaumont, Jennifer; Schwartz, Gene; Robicsek, Ari			The Influence of Context on Antimicrobial Prescribing for Febrile Respiratory Illness A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							TRACT INFECTIONS; DIAGNOSTIC-ACCURACY; ANTIBIOTICS; PREDICTORS; BRONCHITIS; A(H1N1); COLDS	Background: Little is known about the influence of contextual factors on a physician's likelihood to prescribe antimicrobials for febrile respiratory illness (FRI). Context includes epidemiologic context (for example, a pandemic period) and personal context (for example, recent exposure to other patients with FRI). Objective: To examine the association between contextual factors and antimicrobial prescribing for FRI. Design: 5.5-year retrospective cohort study. Setting: A network of Midwestern primary care providers. Patients: All patients presenting with FRI during influenza seasons between 2006 and 2011. Measurements: Antimicrobial prescribing for FRI during pandemic and seasonal influenza periods. Results: 28 301 unique patient encounters for FRI with 69 physicians in 26 practices were included. An antibiotic was prescribed in 12 795 (45.2%) cases. The range of prescribing among physicians was 17.9% to 83.7%. Antibiotics were prescribed in 47.5% of encounters during the seasonal period and 39.2% during the pandemic period (P < 0.001). After multivariable adjustment for patient and physician characteristics, antibiotic prescribing was lower in the pandemic period (odds ratio [OR], 0.72 [95% CI, 0.68 to 0.77]) than in the seasonal period. The likelihood of prescribing an antibiotic decreased as the number of FRI cases that a physician had seen in the previous week increased (OR, 0.93 [CI, 0.86 to 1.01] for 2 to 3 patients with FRI seen in the previous week; OR, 0.84 [CI, 0.77 to 0.91] for 4 to 6 patients; OR, 0.71 [CI, 0.64 to 0.78] for 7 to 11 patients; and OR, 0.57 [CI, 0.51 to 0.63] for >= 12 patients compared with the reference range of 0 to 1 patients). Pandemic season and recent personal context were also associated with antiviral prescribing. Limitation: Retrospective study in a single geographic area. Conclusion: Epidemiologic context and the number of cases of FRI that a physician had recently seen were associated with his or her likelihood to prescribe antimicrobials for FRI. Interventions that enhance a physician's contextual awareness may improve antimicrobial use.	[Hebert, Courtney] Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, Columbus, OH 43210 USA; Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; NorthShore Univ HealthSyst, Evanston, IL USA	Ohio State University; Northwestern University; Feinberg School of Medicine; University of Chicago; NorthShore University Health System	Hebert, C (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, 3190 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	courtney.hebert@osumc.edu	Beaumont, Jennifer/AAA-2825-2020; Hebert, Courtney/G-4900-2016	Beaumont, Jennifer/0000-0002-1484-260X; Schwartz, Gene/0000-0001-6918-1987	NorthShore University HealthSystem	NorthShore University HealthSystem	Dr. Robicsek was supported by a NorthShore University HealthSystem Research Career Development Award.	Aspinall SL, 2009, AM J EMERG MED, V27, P544, DOI 10.1016/j.ajem.2008.04.015; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; *CDCP, 2009, UPD INT REC US ANT M; Centers for Disease Control and Prevention, CDC GIS FLUVIEW; Centers for Disease Control and Prevention, 2009, INV INT REC SWIN FLU; Centers for Disease Control and Prevention, 2010, 2009 H1N1 PANDEMIC S; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; degli Atti MLC, 2006, EUR J CLIN PHARMACOL, V62, P1055, DOI 10.1007/s00228-006-0198-8; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Dosh SA, 2000, J FAM PRACTICE, V49, P407; Fine AM, 2011, ANN INTERN MED, V155, P345, DOI 10.7326/0003-4819-155-6-201109200-00002; Fischer Thomas, 2005, BMC Fam Pract, V6, P6, DOI 10.1186/1471-2296-6-6; Ganestam F, 2003, SCAND J INFECT DIS, V35, P836, DOI 10.1080/00365540310016880; Glass SK, 2010, J ANTIMICROB CHEMOTH, V65, P148, DOI 10.1093/jac/dkp391; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Hopstaken RM, 2006, FAM PRACT, V23, P180, DOI 10.1093/fampra/cmi100; Hopstaken RM, 2005, J CLIN EPIDEMIOL, V58, P175, DOI 10.1016/j.jclinepi.2004.08.004; Horst MA, 2010, J AM BOARD FAM MED, V23, P32, DOI 10.3122/jabfm.2010.01.090137; Illinois Department of Public Health, H1N1 FLU; Khiabanian H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012658; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Linder JA, 2005, PHARMACOEPIDEM DR S, V14, P531, DOI 10.1002/pds.1067; Linder JA, 2009, J GEN INTERN MED, V24, P504, DOI 10.1007/s11606-009-0933-9; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mamede S, 2010, JAMA-J AM MED ASSOC, V304, P1198, DOI 10.1001/jama.2010.1276; Misurski DA, 2011, AM J MANAG CARE, V17, P601; Moro ML, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-69; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; Polgreen PM, 2011, INFECT CONT HOSP EP, V32, P706, DOI 10.1086/660859; Strahilevitz J, 2005, CLIN MICROBIOL INFEC, V11, P955, DOI 10.1111/j.1469-0691.2005.01255.x; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Watson RL, 1999, PEDIATRICS, V104, P1251, DOI 10.1542/peds.104.6.1251	36	12	12	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					160	+		10.7326/0003-4819-157-3-201208070-00005	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868833				2022-12-01	WOS:000307789900003
J	Rounbehler, RJ; Fallahi, M; Yang, CY; Steeves, MA; Li, WM; Doherty, JR; Schaub, FX; Sanduja, S; Dixon, DA; Blackshear, PJ; Cleveland, JL				Rounbehler, Robert J.; Fallahi, Mohammad; Yang, Chunying; Steeves, Meredith A.; Li, Weimin; Doherty, Joanne R.; Schaub, Franz X.; Sanduja, Sandhya; Dixon, Dan A.; Blackshear, Perry J.; Cleveland, John L.			Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State	CELL			English	Article							MESSENGER-RNA STABILITY; ELEMENT-BINDING PROTEIN; AU-RICH ELEMENTS; C-MYC; BURKITT-LYMPHOMA; CANCER-CELLS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; GENE; EXPRESSION	Myc oncoproteins directly regulate transcription by binding to target genes, yet this only explains a fraction of the genes affected by Myc. mRNA turnover is controlled via AU-binding proteins (AUBPs) that recognize AU-rich elements (AREs) found within many transcripts. Analyses of precancerous and malignant Myc-expressing B cells revealed that Myc regulates hundreds of ARE-containing (ARED) genes and select AUBPs. Notably, Myc directly suppresses transcription of Tristetraprolin (TTP/ZFP36), an mRNA-destabilizing AUBP, and this circuit is also operational during B lymphopoiesis and IL7 signaling. Importantly, TTP suppression is a hallmark of cancers with MYC involvement, and restoring TTP impairs Myc-induced lymphomagenesis and abolishes maintenance of the malignant state. Further, there is a selection for TTP loss in malignancy; thus, TTP functions as a tumor suppressor. Finally, Myc/TTP-directed control of select cancer-associated ARED genes is disabled during lymphomagenesis. Thus, Myc targets AUBPs to regulate ARED genes that control tumorigenesis.	[Rounbehler, Robert J.; Fallahi, Mohammad; Yang, Chunying; Steeves, Meredith A.; Li, Weimin; Doherty, Joanne R.; Schaub, Franz X.; Cleveland, John L.] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Sanduja, Sandhya; Dixon, Dan A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Sanduja, Sandhya; Dixon, Dan A.] Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cleveland, JL (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	jcleve@scripps.edu	黎, 伟/GXM-4040-2022; Blackshear, Perry J./C-6206-2019; Doherty, Joanne/AAU-3288-2020	Blackshear, Perry J./0000-0002-9561-8529; 	NIH [DK44158, CA167093, F32-CA115075, CA134609]; ThinkPink Kids Foundation; State of Florida; NIH, NIEHS; National City Postdoctoral Fellowship; Glenn W. Bailey Postdoctoral Fellowship; PGA National Women's Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA134609, R01CA167093, F32CA115075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ThinkPink Kids Foundation; State of Florida; NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National City Postdoctoral Fellowship; Glenn W. Bailey Postdoctoral Fellowship; PGA National Women's Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Jerry Adams for providing the pE mu SR alpha plasmid; Mihaela Onciu and John Sandlund for providing Burkitt lymphoma samples; J. Alan Diehl for providing MSCV-cyclin D1a retrovirus; Thomas Saunders and the Transgenic Animal Model Core of the University of Michigan's Biomedical Research Core Facilities for generating the E mu-TTP and E mu-Tis11b transgenics; Wi Lai and Deborah Stumpo for technical assistance; Shannon Sunday of the Scripps Florida ARC for assistance; Brandon Young and Brad Long of the Scripps Florida Genomics Core; Bivian Torres and Kim Lowe of the Scripps Florida Flow Cytometry Core; Frank C. Dorsey for helpful discussions; and Marika Kernick for editing. This work was supported by NIH grants (DK44158 and CA167093 to J. L. C., F32-CA115075 to R. J. R. and CA134609 to D. A. D.), by monies from the ThinkPink Kids Foundation, and by monies from the State of Florida to TSRI. P. J. B. is supported by the Intramural Research Program of the NIH, NIEHS. R. J. R. also received support from the National City Postdoctoral Fellowship, the Glenn W. Bailey Postdoctoral Fellowship, and the PGA National Women's Cancer Foundation.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dean JLE, 2002, BIOCHEM J, V366, P709, DOI 10.1042/BJ20020402; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI12973; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gouble A, 2002, CANCER RES, V62, P1489; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; LAI WS, 1995, J BIOL CHEM, V270, P25266, DOI 10.1074/jbc.270.42.25266; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; MORROW MA, 1992, GENE DEV, V6, P61, DOI 10.1101/gad.6.1.61; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; PETERS G, 1994, J CELL SCI, P89; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sakai T, 2004, J BIOL CHEM, V279, P41131, DOI 10.1074/jbc.M402902200; Sanduja S, 2009, AGING-US, V1, P803, DOI 10.18632/aging.100086; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	49	84	85	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					563	574		10.1016/j.cell.2012.06.033	http://dx.doi.org/10.1016/j.cell.2012.06.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863009	Green Accepted, Bronze			2022-12-01	WOS:000307301400015
J	Nelson, LS; Perrone, J				Nelson, Lewis S.; Perrone, Jeanmarie			Curbing the Opioid Epidemic in the United States The Risk Evaluation and Mitigation Strategy (REMS)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRESCRIPTION; ABUSE		[Nelson, Lewis S.] NYU, Sch Med, Dept Emergency Med, New York, NY 10016 USA; [Perrone, Jeanmarie] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA	New York University; University of Pennsylvania; Pennsylvania Medicine	Nelson, LS (corresponding author), NYU, Sch Med, Dept Emergency Med, 455 1st Ave,Room 123, New York, NY 10016 USA.	lewis.nelson@nyumc.org		Nelson, Lewis/0000-0001-9551-3922				Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Purdue Pharma, PURD PHARM; Slevin Kieran A, 2011, J Opioid Manag, V7, P109; United States Food and Drug Administration, 2010, JOINT M AN LIF SUPP; US Food and Drug Administration, RISK EV MIT STRAT RE; Wolf MS, 2012, J GEN INTERN MED, V27, P1714, DOI 10.1007/s11606-012-2068-7; Zgierska A, 2012, JAMA-J AM MED ASSOC, V307, P1377, DOI 10.1001/jama.2012.419	10	71	72	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					457	458		10.1001/jama.2012.8165	http://dx.doi.org/10.1001/jama.2012.8165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851109				2022-12-01	WOS:000306947400020
J	Sessa, B				Sessa, Ben			Shaping the renaissance of psychedelic research	LANCET			English	Editorial Material							ASSISTED PSYCHOTHERAPY; PSILOCYBIN		CAMHS Team, Taunton TA2 7PQ, Somerset, England		Sessa, B (corresponding author), CAMHS Team, Fdn House,Wellsprings Rd, Taunton TA2 7PQ, Somerset, England.	bensessa@gmail.com						Carhart-Harris RL, 2012, BRIT J PSYCHIAT, V200, P238, DOI 10.1192/bjp.bp.111.103309; Griffiths RR, 2006, PSYCHOPHARMACOLOGY, V187, P268, DOI 10.1007/s00213-006-0457-5; Grob CS, 2011, ARCH GEN PSYCHIAT, V68, P71, DOI 10.1001/archgenpsychiatry.2010.116; Krupitsky EM, 2007, J PSYCHOACTIVE DRUGS, V39, P13, DOI 10.1080/02791072.2007.10399860; MALLESON N, 1971, BRIT J PSYCHIAT, V118, P229, DOI 10.1192/bjp.118.543.229; Mithoefer MC, 2011, J PSYCHOPHARMACOL, V25, P439, DOI 10.1177/0269881110378371; Moreno FA, 2006, J CLIN PSYCHIAT, V67, P1735, DOI 10.4088/JCP.v67n1110; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Sessa B, 2005, BRIT J PSYCHIAT, V186, P457, DOI 10.1192/bjp.186.6.457; Sessa B, 2011, PROG NEUROL PSYCHIAT, V15, P4, DOI 10.1002/pnp.216; Sewell RA, 2006, NEUROLOGY, V66, P1920, DOI 10.1212/01.wnl.0000219761.05466.43; Wade D, 2006, BRIT J PSYCHIAT, V189, P229, DOI 10.1192/bjp.bp.105.017236; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	13	36	36	1	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2012	380	9838					200	201		10.1016/S0140-6736(12)60600-X	http://dx.doi.org/10.1016/S0140-6736(12)60600-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	976TV	22817963				2022-12-01	WOS:000306609200011
J	Shirani, A; Zhao, YS; Karim, ME; Evans, C; Kingwell, E; van der Kop, ML; Oger, J; Gustafson, P; Petkau, J; Tremlett, H				Shirani, Afsaneh; Zhao, Yinshan; Karim, Mohammad Ehsanul; Evans, Charity; Kingwell, Elaine; van der Kop, Mia L.; Oger, Joel; Gustafson, Paul; Petkau, John; Tremlett, Helen			Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE-MODIFYING DRUGS; IMMORTAL TIME BIAS; NATURAL-HISTORY; BRITISH-COLUMBIA; HEALTH-CARE; DELAYING PROGRESSION; LIFE EXPECTANCY; ONSET MS; TRIALS; IMPAIRMENT	context Interferon beta is widely prescribed to treat multiple sclerosis (MS); however, its relationship with disability progression has yet to be established. Objective To investigate the association between interferon beta exposure and disability progression in patients with relapsing-remitting MS. Design, Setting, and Patients Retrospective cohort study based on prospectively collected data (1985-2008) from British Columbia, Canada. Patients with relapsing-remitting MS treated with interferon beta (n=868) were compared with untreated contemporary (n=829) and historical (n=959) cohorts. Main Outcome Measures The main outcome measure was time from interferon beta treatment eligibility (baseline) to a confirmed and sustained score of 6 (requiring a cane to walk 100 m; confirmed at >150 days with no measurable improvement) on the Expanded Disability Status Scale (EDSS) (range, 0-10, with higher scores indicating higher disability). A multivariable Cox regression model with interferon beta treatment included as a time-varying covariate was used to assess the hazard of disease progression associated with interferon beta treatment. Analyses also included propensity score adjustment to address confounding by indication. Results The median active follow-up times (first to last EDSS measurement) were as follows: for the interferon beta-treated cohort, 5.1 years (interquartile range [IQR], 3.0-7.0 years); for the contemporary control cohort, 4.0 years (IQR, 2.1-6.4 years); and for the historical control cohort, 10.8 years (IQR, 6.3-14.7 years). The observed outcome rates for reaching a sustained EDSS score of 6 were 10.8%, 5.3%, and 23.1% in the 3 cohorts, respectively. After adjustment for potential baseline confounders (sex, age, disease duration, and EDSS score), exposure to interferon beta was not associated with a statistically significant difference in the hazard of reaching an EDSS score of 6 when either the contemporary control cohort (hazard ratio, 1.30; 95% CI, 0.92-1.83; P=.14) or the historical control cohort (hazard ratio, 0.77; 95% CI, 0.58-1.02; P=.07) were considered. Further adjustment for comorbidities and socioeconomic status, where possible, did not change interpretations, and propensity score adjustment did not substantially change the results. Conclusion Among patients with relapsing-remitting MS, administration of interferon beta was not associated with a reduction in progression of disability. JAMA. 2012;308(3):247-256 www.jama.com	[Zhao, Yinshan] Univ British Columbia, Div Neurol, MS MRI Res Grp, Dept Med, Vancouver, BC V6T 2B5, Canada; [Shirani, Afsaneh; Evans, Charity; Kingwell, Elaine; van der Kop, Mia L.; Oger, Joel; Tremlett, Helen] Univ British Columbia, Dept Med, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Shirani, Afsaneh; Evans, Charity; Kingwell, Elaine; van der Kop, Mia L.; Oger, Joel; Tremlett, Helen] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Vancouver, BC V6T 2B5, Canada; [Karim, Mohammad Ehsanul; Gustafson, Paul; Petkau, John] Univ British Columbia, Dept Stat, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia	Tremlett, H (corresponding author), Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Room S178,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	helen.tremlett@ubc.ca	Karim, Ehsan/I-1803-2018; Zhao, Yinshan/K-4789-2014; Tremlett, Helen/AAE-7983-2020	Karim, Ehsan/0000-0002-0346-2871; Zhao, Yinshan/0000-0001-5433-4637; Tremlett, Helen/0000-0001-5804-2535; Kingwell, Elaine/0000-0002-1956-1700	endMS Research and Training Network; European Committee for Treatment and Research in Multiple Sclerosis; International Society for Pharmacoepidemiology; Bayer Schering Pharma; Aventis; Bayer; Biogen-Idec; BioMS; Corixa; Genentech; Novartis; Serono; Shering; Talecris; Teva-Neurosciences; Biogen Idec; Bayer Pharma; Bayer Canada; Bayhill Therapeutics; BTG International; Merck-Serono; Consortium of MS Centres; US National MS Society; Swiss Multiple Sclerosis Society; University of British Columbia Multiple Sclerosis Research Program; Bayer Pharmaceuticals; Teva Pharmaceuticals; Canadian Institutes of Health Research (CIHR) [MOP-93646]; National Multiple Sclerosis Society (NMSS) [RG 4202-A-2]; Multiple Sclerosis Society of Canada; CIHR [MOP-93646]; NMSS [RG 4202-A-2]; Michael Smith Foundation for Health Research; Christopher Foundation; University of British Columbia (UBC); Medical Services Commission of British Columbia; Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada (Don Paty Career Development Award); UK Multiple Sclerosis Trust; NMSS; Donald Paty	endMS Research and Training Network; European Committee for Treatment and Research in Multiple Sclerosis; International Society for Pharmacoepidemiology; Bayer Schering Pharma(Bayer AG); Aventis(Sanofi-Aventis); Bayer(Bayer AG); Biogen-Idec(Biogen); BioMS; Corixa; Genentech(Roche HoldingGenentech); Novartis(Novartis); Serono(Merck & Company); Shering; Talecris; Teva-Neurosciences(Teva Pharmaceutical Industries); Biogen Idec(Biogen); Bayer Pharma; Bayer Canada(Bayer AG); Bayhill Therapeutics; BTG International; Merck-Serono(Merck & Company); Consortium of MS Centres; US National MS Society(National Multiple Sclerosis Society); Swiss Multiple Sclerosis Society; University of British Columbia Multiple Sclerosis Research Program; Bayer Pharmaceuticals(Bayer AG); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Multiple Sclerosis Society of Canada; CIHR(Canadian Institutes of Health Research (CIHR)); NMSS(National Multiple Sclerosis Society); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Christopher Foundation; University of British Columbia (UBC); Medical Services Commission of British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Multiple Sclerosis Society of Canada (Don Paty Career Development Award); UK Multiple Sclerosis Trust; NMSS(National Multiple Sclerosis Society); Donald Paty	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shirani reports receiving travel grants to present at and attend conferences from the endMS Research and Training Network and the European Committee for Treatment and Research in Multiple Sclerosis. Mr Karim reports having had travel and accommodation costs covered to present at a conference from the endMS Research and Training Network. Dr Evans reports receiving travel grants to present at and attend conferences from the endMS Research and Training Network and the European Committee for Treatment and Research in Multiple Sclerosis. Dr Kingwell reports having had travel and accommodation costs covered to present at and attend conferences from the endMS Research and Training Network, the International Society for Pharmacoepidemiology, and Bayer Schering Pharma. Dr Oger reports receiving speaker honoraria, consulting fees, travel grants, research grants, and/or educational grants from Aventis, Bayer, Biogen-Idec, BioMS, Corixa, Genentech, Novartis, Serono, Shering, Talecris, and Teva-Neurosciences. He receives fees for services from Bayer, Novartis, and Biogen Idec to serve on advisory committees. Dr Petkau reports having received research funds from Bayer Pharma and consulting fees and/or fees for service on data safety monitoring boards from Bayer Canada, Bayer Pharma, Bayhill Therapeutics, BTG International, Merck-Serono, and Novartis. Dr Tremlett reports having received speaker honoraria and/or travel expenses to speak at conferences from the Consortium of MS Centres, US National MS Society, Swiss Multiple Sclerosis Society, University of British Columbia Multiple Sclerosis Research Program, Bayer Pharmaceuticals (invited speaker, honoraria declined), and Teva Pharmaceuticals (invited speaker). Unless otherwise stated, all speaker honoraria are either donated to an MS charity or to an unrestricted grant for use by her research group. No other disclosures were reported.; This study was supported by grant MOP-93646 from the Canadian Institutes of Health Research (CIHR; principal investigator: Dr Tremlett) and grant RG 4202-A-2 from the National Multiple Sclerosis Society (NMSS; principal investigator: Dr Tremlett). Dr Shirani is funded through a postdoctoral fellowship from the Multiple Sclerosis Society of Canada and grants from the CIHR (MOP-93646) and the NMSS (RG 4202-A-2). Dr Zhao receives research funding from the CIHR, the Multiple Sclerosis Society of Canada, and the NMSS. Dr Evans is funded through grants from the CIHR (MOP-93646), the NMSS (RG 4202-A-2), and the Michael Smith Foundation for Health Research. Dr Kingwell is supported by postdoctoral fellowships from the Multiple Sclerosis Society of Canada and the Michael Smith Foundation for Health Research. Dr Oger receives support from the Christopher Foundation and the University of British Columbia (UBC). He receives fees for service from the Medical Services Commission of British Columbia. Dr Gustafson is supported by the Natural Sciences and Engineering Research Council of Canada. Dr Petkau holds research grants from the CIHR, the Multiple Sclerosis Society of Canada, the NMSS, and the Natural Sciences and Engineering Research Council of Canada. Dr Tremlett is funded by the Multiple Sclerosis Society of Canada (Don Paty Career Development Award), is a Michael Smith Foundation for Health Research Scholar, and is the Canada Research Chair for Neuroepidemiology and Multiple Sclerosis. She has also received research support from the NMSS, CIHR, and UK Multiple Sclerosis Trust. The BCMS database has been funded from various sources (including the above) and also by an unrestricted grant from Donald Paty, MD, FRCPC, University of British Columbia, and the MS/MRI Research Group.	Arbizu T, 2000, ACTA NEUROL SCAND, V102, P209, DOI 10.1034/j.1600-0404.2000.102004209.x; Berkman L, 2008, NEW ENGL J MED, V358, P2509, DOI 10.1056/NEJMe0802773; Boggild M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4677; Brenner SR, 2008, NEUROLOGY, V71, P615, DOI 10.1212/01.wnl.0000324708.37575.5c; Brown MG, 2007, NEUROLOGY, V69, P1498, DOI 10.1212/01.wnl.0000271884.11129.f3; Coppola G, 2006, EUR J NEUROL, V13, P1014, DOI 10.1111/j.1468-1331.2006.01422.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dimick JB, 2010, ARCH SURG-CHICAGO, V145, P927, DOI 10.1001/archsurg.2010.223; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Ebers GC, 2010, J NEUROL NEUROSUR PS, V81, P907, DOI 10.1136/jnnp.2009.204123; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Filippini G, 2003, LANCET, V361, P545, DOI 10.1016/S0140-6736(03)12512-3; Giovannoni G, 2002, J NEUROL NEUROSUR PS, V73, P465, DOI 10.1136/jnnp.73.5.465; Gout O, 2008, ANN NEUROL, V63, P126, DOI 10.1002/ana.21186; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Haynes B, 1999, BRIT MED J, V319, P652, DOI 10.1136/bmj.319.7211.652; Kappos L, 2006, NEUROLOGY, V67, P944, DOI 10.1212/01.wnl.0000237994.95410.ce; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Koch M, 2008, ANN NEUROL, V63, P125, DOI 10.1002/ana.21185; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Liu C, 2000, J NEUROL NEUROSUR PS, V68, P450, DOI 10.1136/jnnp.68.4.450; Milanese C, 2003, J NEUROL NEUROSUR PS, V74, P1689, DOI 10.1136/jnnp.74.12.1689; Multiple Sclerosis Society of Canada, TREATM MOD DIS COURS; Noseworthy JH, 2006, NEUROLOGY, V67, P930, DOI 10.1212/01.wnl.0000241080.31577.df; Paolillo A, 2002, EUR J NEUROL, V9, P645, DOI 10.1046/j.1468-1331.2002.00476.x; Pozzilli C, 2005, NEUROL SCI, V26, pS174, DOI 10.1007/s10072-005-0510-x; Renoux C, 2008, ANN NEUROL, V64, P109, DOI 10.1002/ana.21352; Rosenbaum PR., 1987, STAT SCI, V2, P292, DOI [DOI 10.1214/SS/1177013232, 10.1214/ss/1177013232]; SADOVNICK AD, 1992, NEUROLOGY, V42, P991, DOI 10.1212/WNL.42.5.991; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Shirani A, 2012, MULT SCLER J, V18, P442, DOI 10.1177/1352458511422097; Skoog B, 2012, BRAIN, V135, P900, DOI 10.1093/brain/awr336; Sturmer T, 2011, EPIDEMIOLOGY, V22, P298, DOI 10.1097/EDE.0b013e318212640c; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; SWEENEY VP, 1986, CAN J NEUROL SCI, V13, P47, DOI 10.1017/S0317167100035782; Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805; Tremlett H, 2005, NEUROLOGY, V65, P1919, DOI 10.1212/01.wnl.0000188880.17038.1d; Tremlett H, 2006, NEUROLOGY, V66, P172, DOI 10.1212/01.wnl.0000194259.90286.fe; Tremlett H, 2009, NEUROLOGY, V73, P1616, DOI 10.1212/WNL.0b013e3181c1e44f; Tremlett H, 2008, MULT SCLER J, V14, P314, DOI 10.1177/1352458507084264; Tremlett H, 2006, NEUROLOGY, V67, P954, DOI 10.1212/01.wnl.0000237475.01655.9d; Trojano M, 2003, MULT SCLER J, V9, P451, DOI 10.1191/1352458503ms948oa; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; Uitdehaag Bernard, 2011, Ther Adv Neurol Disord, V4, P3, DOI 10.1177/1756285610391693; Wilkins R., 2002, HLTH REP S, V13, P1; WILLOUGHBY EW, 1988, NEUROLOGY, V38, P1793, DOI 10.1212/WNL.38.11.1793	46	201	202	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2012	308	3					247	256		10.1001/jama.2012.7625	http://dx.doi.org/10.1001/jama.2012.7625			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975AC	22797642	Bronze			2022-12-01	WOS:000306477900025
J	Lee, SW; Markham, PF; Coppo, MJC; Legione, AR; Markham, JF; Noormohammadi, AH; Browning, GF; Ficorilli, N; Hartley, CA; Devlin, JM				Lee, Sang-Won; Markham, Philip F.; Coppo, Mauricio J. C.; Legione, Alistair R.; Markham, John F.; Noormohammadi, Amir H.; Browning, Glenn F.; Ficorilli, Nino; Hartley, Carol A.; Devlin, Joanne M.			Attenuated Vaccines Can Recombine to Form Virulent Field Viruses	SCIENCE			English	Article							INFECTIOUS LARYNGOTRACHEITIS VIRUS		[Lee, Sang-Won; Markham, Philip F.; Coppo, Mauricio J. C.; Legione, Alistair R.; Browning, Glenn F.; Ficorilli, Nino; Hartley, Carol A.; Devlin, Joanne M.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3010, Australia; [Noormohammadi, Amir H.] Univ Melbourne, Asia Pacific Ctr Anim Hlth, Fac Vet Sci, Werribee, Vic 3030, Australia; [Markham, John F.] Univ Melbourne, Sch Engn, Dept Elect & Elect Engn, Natl ICT Australia NICTA Victoria Res Lab, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; NICTA; University of Melbourne	Devlin, JM (corresponding author), Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3010, Australia.	devlinj@unimelb.edu.au	Browning, Glenn Francis/P-4459-2014; Legione, Alistair/L-9102-2015; Legione, Alistair/AAX-6064-2020	Browning, Glenn Francis/0000-0002-0903-2469; Legione, Alistair/0000-0003-2407-4496; Legione, Alistair/0000-0003-2407-4496; Coppo, Mauricio/0000-0002-4344-9532; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; Devlin, Joanne/0000-0003-0400-9670; Hartley, Carol/0000-0001-6174-7341; Markham, John/0000-0002-5738-3861	Rural Industries Research and Development Corporation, Australia; NICTA; Australian government; Australian Research Council through the ICT Centre of Excellence program	Rural Industries Research and Development Corporation, Australia; NICTA(NICTA); Australian government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council)	The Rural Industries Research and Development Corporation, Australia, funded this study. This work is supported by NICTA, which is funded by the Australian government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. Sequence data for the class 8 and 9 viruses have been deposited in GenBank under accession nos. JN804826 and JN804827, respectively. The three reference sequences are Serva, GenBank accession no. HQ_630064; SA2, GenBank accession no. JN596962; A20, GenBank accession no. JN596963.	Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Devlin JM, 2011, VACCINE, V29, P5699, DOI 10.1016/j.vaccine.2011.06.002; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451	6	133	143	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					188	188		10.1126/science.1217134	http://dx.doi.org/10.1126/science.1217134			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22798607				2022-12-01	WOS:000306323500047
J	Grant, J; Mahadevaiah, SK; Khil, P; Sangrithi, MN; Royo, H; Duckworth, J; McCarrey, JR; VandeBerg, JL; Renfree, MB; Taylor, W; Elgar, G; Camerini-Otero, RD; Gilchrist, MJ; Turner, JMA				Grant, Jennifer; Mahadevaiah, Shantha K.; Khil, Pavel; Sangrithi, Mahesh N.; Royo, Helene; Duckworth, Janine; McCarrey, John R.; VandeBerg, John L.; Renfree, Marilyn B.; Taylor, Willie; Elgar, Greg; Camerini-Otero, R. Daniel; Gilchrist, Mike J.; Turner, James M. A.			Rsx is a metatherian RNA with Xist-like properties in X-chromosome inactivation	NATURE			English	Article							PRIMORDIAL GERM-CELLS; DOSAGE COMPENSATION; MOUSE; GENE; METHYLATION; EXPRESSION; MAMMALS	In female (XX) mammals, one of the two X chromosomes is inactivated to ensure an equal dose of X-linked genes with males (XY)(1). X-chromosome inactivation in eutherian mammals is mediated by the non-coding RNA Xist(2). Xist is not found in metatherians(3) (marsupials), and how X-chromosome inactivation is initiated in these mammals has been the subject of speculation for decades(4). Using the marsupial Monodelphis domestica, here we identify Rsx (RNA-on-the-silent X), an RNA that has properties consistent with a role in X-chromosome inactivation. Rsx is a large, repeat-rich RNA that is expressed only in females and is transcribed from, and coats, the inactive X chromosome. In female germ cells, in which both X chromosomes are active, Rsx is silenced, linking Rsx expression to X-chromosome inactivation and reactivation. Integration of an Rsx transgene on an autosome in mouse embryonic stem cells leads to gene silencing in cis. Our findings permit comparative studies of X-chromosome inactivation in mammals and pose questions about the mechanisms by which X-chromosome inactivation is achieved in eutherians.	[Grant, Jennifer; Mahadevaiah, Shantha K.; Sangrithi, Mahesh N.; Royo, Helene; Taylor, Willie; Elgar, Greg; Gilchrist, Mike J.; Turner, James M. A.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Khil, Pavel; Camerini-Otero, R. Daniel] NIDDKD, NIH, Bethesda, MD 20892 USA; [Duckworth, Janine] Landcare Res Manaaki Whenua, Pest Control Technol Grp, Lincoln 7640, New Zealand; [McCarrey, John R.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [VandeBerg, John L.] Texas Biomed Res Inst, San Antonio, TX 78227 USA; [Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Victoria 3010, Australia	MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Landcare Research - New Zealand; University of Texas System; University of Texas at San Antonio (UTSA); Texas Biomedical Research Institute; University of Melbourne	Turner, JMA (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jturner@nimr.mrc.ac.uk		Sangrithi, Mahesh/0000-0002-0008-4588; Elgar, Greg/0000-0001-7323-1596; Renfree, Marilyn/0000-0002-4589-0436; Khil, Pavel/0000-0002-4903-8777	Medical Research Council (MRC) [U117588498, U117597141, U117581331, U117597137]; NIH [HD60858]; Robert J. Kleberg Jr and Helen C. Kleberg Foundation; New Zealand Foundation for Research, Science and Technology, Possum Biocontrol [C10X0501]; Australian National Health and Medical Research Council [1010453]; NIDDK (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052035] Funding Source: NIH RePORTER; Medical Research Council [MC_U117597141, MC_U117597137] Funding Source: researchfish; MRC [MC_U117597141, MC_U117597137] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J. Kleberg Jr and Helen C. Kleberg Foundation; New Zealand Foundation for Research, Science and Technology, Possum Biocontrol(New Zealand Foundation for Research, Science and Technology); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIDDK (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Bell and R. Lovell-Badge for advice on the characterisation of Rsx, J. Cloutier and G. Polikiewicz for help with germ-cell preparations and quantitative PCR, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Genomics core (National Institutes of Health, NIH) for RNA sequencing, A. Toth for the HORMAD1 antibody, the Biological and Procedural Services units at the National Institute for Medical Research (NIMR) for animal husbandry and Rsx transgenesis, and J. Cocquet, L. Reynard, H. Byers and members of the Turner and P. Burgoyne laboratories for reading of the manuscript. This work was supported by the Medical Research Council (MRC) (U117588498, U117597141, U117581331, U117597137), the NIH (HD60858), the Robert J. Kleberg Jr and Helen C. Kleberg Foundation, the New Zealand Foundation for Research, Science and Technology, Possum Biocontrol (C10X0501), the Australian National Health and Medical Research Council (1010453) and the NIDDK (NIH) Intramural Research Program.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chaumeil J, 2004, METHOD ENZYMOL, V376, P405; Chaumeil J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019040; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; de Napoles M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000860; Deakin JE, 2009, CHROMOSOME RES, V17, P671, DOI 10.1007/s10577-009-9058-6; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lyon MF, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/59746; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mahadevaiah SK, 2009, CURR BIOL, V19, P1478, DOI 10.1016/j.cub.2009.07.041; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rens W, 2010, P NATL ACAD SCI USA, V107, P17657, DOI 10.1073/pnas.0910322107; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	38	103	110	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2012	487	7406					254	U1511		10.1038/nature11171	http://dx.doi.org/10.1038/nature11171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722828	Green Accepted			2022-12-01	WOS:000306278900044
J	Berg, MG; Singh, LN; Younis, I; Liu, Q; Pinto, AM; Kaida, D; Zhang, ZX; Cho, SC; Sherrill-Mix, S; Wan, LL; Dreyfuss, G				Berg, Michael G.; Singh, Larry N.; Younis, Ihab; Liu, Qiang; Pinto, Anna Maria; Kaida, Daisuke; Zhang, Zhenxi; Cho, Sungchan; Sherrill-Mix, Scott; Wan, Lili; Dreyfuss, Gideon			U1 snRNP Determines mRNA Length and Regulates Isoform Expression	CELL			English	Article							POLY(A) SITE-SELECTION; SPLICING-INDEPENDENT RECRUITMENT; POLYMERASE CHAIN-REACTION; 3' UNTRANSLATED REGIONS; ALTERNATIVE POLYADENYLATION; II TRANSCRIPTION; FACTOR CSTF-64; GENES; CELLS; CLEAVAGE	U1 snRNP (U1), in addition to its splicing role, protects pre-mRNAs from drastic premature termination by cleavage and polyadenylation (PCPA) at cryptic polyadenylation signals (PASs) in introns. Here, a high-throughput sequencing strategy of differentially expressed transcripts (HIDE-seq) mapped PCPA sites genome wide in divergent organisms. Surprisingly, whereas U1 depletion terminated most nascent gene transcripts within similar to 1 kb, moderate functional U1 level decreases, insufficient to inhibit splicing, dose-dependently shifted PCPA downstream and elicited mRNA 30 UTR shortening and proximal 3 ' exon switching characteristic of activated immune and neuronal cells, stem cells, and cancer. Activated neurons' signature mRNA shortening could be recapitulated by U1 decrease and antagonized by U1 overexpression. Importantly, we show that rapid and transient transcriptional upregulation inherent to neuronal activation physiology creates U1 shortage relative to pre-mRNAs. Additional experiments suggest cotranscriptional PCPA counteracted by U1 association with nascent transcripts, a process we term telescripting, ensuring transcriptome integrity and regulating mRNA length.	[Berg, Michael G.; Singh, Larry N.; Younis, Ihab; Liu, Qiang; Pinto, Anna Maria; Kaida, Daisuke; Zhang, Zhenxi; Cho, Sungchan; Sherrill-Mix, Scott; Wan, Lili; Dreyfuss, Gideon] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Berg, Michael G.; Singh, Larry N.; Younis, Ihab; Liu, Qiang; Pinto, Anna Maria; Kaida, Daisuke; Zhang, Zhenxi; Cho, Sungchan; Sherrill-Mix, Scott; Wan, Lili; Dreyfuss, Gideon] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Younis, Ihab/M-1849-2019; Singh, Larry N./AAG-6880-2021; Pinto, Anna Maria/AAB-6172-2020; wan, li/GRY-7634-2022; Pinto, Anna Maria/K-5846-2016	Younis, Ihab/0000-0003-3329-5979; Singh, Larry N./0000-0002-2478-5864; Pinto, Anna Maria/0000-0001-6259-6901; Pinto, Anna Maria/0000-0001-6259-6901; Sherrill-Mix, Scott/0000-0002-8955-8072; Kaida, Daisuke/0000-0003-4014-5231	Association Francaise Contre les Myopathies (AFM)	Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	We are grateful to the members of our laboratory for helpful discussions, especially Drs. Pilong Li, Jeongsik Yong, Kazuhiro Fukumura, and Lauren Brady. We thank the University of Pennsylvania Genomics core facility for 454 sequencing and Dr. Bin Tian for help with PAS analysis. This work was supported by the Association Francaise Contre les Myopathies (AFM). G.D. is an Investigator of the Howard Hughes Medical Institute.	Ashe MP, 2000, RNA, V6, P170, DOI 10.1017/S1355838200991957; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Brody Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000573; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Guo JG, 2011, MOL CELL BIOL, V31, P639, DOI 10.1128/MCB.00919-10; Gurskaya NG, 1996, ANAL BIOCHEM, V240, P90, DOI 10.1006/abio.1996.0334; Hartmann B, 2009, CURR OPIN CELL BIOL, V21, P377, DOI 10.1016/j.ceb.2009.02.006; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Lewis JD, 1996, GENE DEV, V10, P1683, DOI 10.1101/gad.10.13.1683; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Lou H, 1996, GENE DEV, V10, P208, DOI 10.1101/gad.10.2.208; LUKYANOV KA, 1995, ANAL BIOCHEM, V229, P198, DOI 10.1006/abio.1995.1402; Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Niibori Y, 2007, NEUROSCI RES, V57, P399, DOI 10.1016/j.neures.2006.11.014; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Pan ZH, 2006, GENE, V366, P325, DOI 10.1016/j.gene.2005.09.024; Patel SB, 2007, J CELL BIOL, V178, P937, DOI 10.1083/jcb.200706134; Sala C, 2003, J NEUROSCI, V23, P6327; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SAUTERER RA, 1988, EXP CELL RES, V176, P344, DOI 10.1016/0014-4827(88)90336-9; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Spiluttini B, 2010, J CELL SCI, V123, P2084, DOI 10.1242/jcs.061358; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Vagner S, 2000, RNA, V6, P178, DOI 10.1017/S1355838200991854; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	52	298	301	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 6	2012	150	1					53	64		10.1016/j.cell.2012.05.029	http://dx.doi.org/10.1016/j.cell.2012.05.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22770214	Green Accepted, Bronze			2022-12-01	WOS:000306115000006
J	Shirayama, M; Seth, M; Lee, HC; Gu, WF; Ishidate, T; Conte, D; Mello, CC				Shirayama, Masaki; Seth, Meetu; Lee, Heng-Chi; Gu, Weifeng; Ishidate, Takao; Conte, Darryl, Jr.; Mello, Craig C.			piRNAs Initiate an Epigenetic Memory of Nonself RNA in the C. elegans Germline	CELL			English	Article							DOUBLE-STRANDED-RNA; SILENCING PATHWAYS; INTERFERENCE; GENE; ARGONAUTE; PIWI; LINE; POLYMERASE; EXPRESSION; PROTEINS	Organisms employ a fascinating array of strategies to silence invasive nucleic acids such as transposons and viruses. Although evidence exists for several pathways that detect foreign sequences, including pathways that sense copy number, unpaired DNA, or aberrant RNA (e.g., dsRNA), in many cases, the mechanisms used to distinguish "self" from "nonself" nucleic acids remain mysterious. Here, we describe an RNA-induced epigenetic silencing pathway that permanently silences single-copy transgenes. We show that the Piwi Argonaute PRG-1 and its genomically encoded piRNA cofactors initiate permanent silencing, and maintenance depends on chromatin factors and the WAGO Argonaute pathway. Our findings support a model in which PRG-1 scans for foreign sequences and two other Argonaute pathways serve as epigenetic memories of "self" and "nonself" RNAs. These findings suggest how organisms can utilize RNAi-related mechanisms to detect foreign sequences not by any molecular signature, but by comparing the foreign sequence to a memory of previous gene expression.	[Shirayama, Masaki; Seth, Meetu; Lee, Heng-Chi; Gu, Weifeng; Ishidate, Takao; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Shirayama, Masaki; Ishidate, Takao; Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu		Lee, Heng-Chi/0000-0001-8154-906X	Ruth L. Kirschstein National Research Service Award [GM099372]; NIH [GM058800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099372, R01GM058800, R37GM058800] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kirsten Hagstrom and Anna Zinovyeva for primer information, technical advice on ChIP experiments, and helpful discussion. We are grateful to the members of the Mello lab for input and discussion, Sandra Vergara for help with genetic studies, William Stanney III for technical help, and Elaine Youngman and Colin Conine for advice on figure presentation. Some strains used in this study were obtained from the Caenorhabditis Genetic Center. H.-C.L. is supported by a Ruth L. Kirschstein National Research Service Award (GM099372). C.C.M. is a Howard Hughes Medical Institute Investigator and is supported by NIH grant GM058800.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Antonovics J, 2011, ANN NY ACAD SCI, V1230, P12, DOI 10.1111/j.1749-6632.2011.06127.x; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn M.P., 2012, SCIENCE; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bessler JB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000830; Birchler James A., 2003, P23; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; BRENNER S, 1974, GENETICS, V77, P71; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Couteau F, 2002, EMBO REP, V3, P235, DOI 10.1093/embo-reports/kvf051; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Dernburg AF, 2000, GENE DEV, V14, P1578; Erhard KF, 2011, CURR OPIN PLANT BIOL, V14, P210, DOI 10.1016/j.pbi.2011.02.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grentzinger T, 2012, GENOME RES; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Johnson CL, 2011, SCIENCE, V333, P1311, DOI 10.1126/science.1208178; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parrish S, 2001, RNA, V7, P1397; Praitis Vida, 2006, V351, P93; Rieckher Matthias, 2009, Methods Mol Biol, V561, P21, DOI 10.1007/978-1-60327-019-9_2; Robert VJP, 2004, COLD SPRING HARB SYM, V69, P397, DOI 10.1101/sqb.2004.69.397; Rulicke T, 2000, EXP PHYSIOL, V85, P589, DOI 10.1017/S0958067000020923; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	66	375	385	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					65	77		10.1016/j.cell.2012.06.015	http://dx.doi.org/10.1016/j.cell.2012.06.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22738726	Bronze, Green Accepted			2022-12-01	WOS:000306115000007
J	Herfst, S; Schrauwen, EJA; Linster, M; Chutinimitkul, S; de Wit, E; Munster, VJ; Sorrell, EM; Bestebroer, TM; Burke, DF; Smith, DJ; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM				Herfst, Sander; Schrauwen, Eefje J. A.; Linster, Martin; Chutinimitkul, Salin; de Wit, Emmie; Munster, Vincent J.; Sorrell, Erin M.; Bestebroer, Theo M.; Burke, David F.; Smith, Derek J.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.			Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets	SCIENCE			English	Article							PATHOGENIC AVIAN INFLUENZA; TO-PERSON TRANSMISSION; A VIRUS; H5N1 VIRUS; RECEPTOR SPECIFICITY; MEDIATED SELECTION; HEMAGGLUTININ; HOST; INFECTION; MODEL	Highly pathogenic avian influenza A/H5N1 virus can cause morbidity and mortality in humans but thus far has not acquired the ability to be transmitted by aerosol or respiratory droplet ("airborne transmission") between humans. To address the concern that the virus could acquire this ability under natural conditions, we genetically modified A/H5N1 virus by site-directed mutagenesis and subsequent serial passage in ferrets. The genetically modified A/H5N1 virus acquired mutations during passage in ferrets, ultimately becoming airborne transmissible in ferrets. None of the recipient ferrets died after airborne infection with the mutant A/H5N1 viruses. Four amino acid substitutions in the host receptor-binding protein hemagglutinin, and one in the polymerase complex protein basic polymerase 2, were consistently present in airborne-transmitted viruses. The transmissible viruses were sensitive to the antiviral drug oseltamivir and reacted well with antisera raised against H5 influenza vaccine strains. Thus, avian A/H5N1 influenza viruses can acquire the capacity for airborne transmission between mammals without recombination in an intermediate host and therefore constitute a risk for human pandemic influenza.	[Herfst, Sander; Schrauwen, Eefje J. A.; Linster, Martin; Chutinimitkul, Salin; de Wit, Emmie; Munster, Vincent J.; Sorrell, Erin M.; Bestebroer, Theo M.; Smith, Derek J.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Burke, David F.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England; [Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Fouchier, Ron A/A-1911-2014; Munster, Vincent/I-7607-2018; de Wit, Emmie/A-1549-2019; Smith, Derek/Z-3075-2019; Burke, David F/C-2091-2013; Linster, Martin/AAY-9088-2020	Fouchier, Ron A/0000-0001-8095-2869; Munster, Vincent/0000-0002-2288-3196; de Wit, Emmie/0000-0002-9763-7758; Smith, Derek/0000-0002-2393-1890; Burke, David F/0000-0001-8830-3951; Herfst, Sander/0000-0001-9866-8903; Osterhaus, Albert/0000-0002-6074-1172; Linster, Martin/0000-0003-2636-2512	NIAID-NIH [HHSN266200700010C]; NIH Director's Pioneer Award [DP1-OD000490-01]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant; European Union FP7 program EMPERIE [223498]; Human Frontier Science Program [P0050/2008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant; European Union FP7 program EMPERIE; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. de Meulder, G. van Amerongen, and D. Akkermans for technical assistance. M. Peiris, Univ. of Hong Kong, provided A/Indonesia/5/2005 with permission from I. Kandun of the Indonesian government. This work was financed through NIAID-NIH contract HHSN266200700010C. D.J.S. and D.F.B. were supported in part by NIH Director's Pioneer Award DP1-OD000490-01. We acknowledge a Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant, European Union FP7 program EMPERIE (223498), and Human Frontier Science Program grant P0050/2008. D.F.B. and D.J.S. acknowledge the use of the CamGrid distributed computing resource. Sequence data generated from this study were deposited in GenBank with accession numbers CY116643 to CY116698. Special arrangements are in place with the NIH and the contractor at Mount Sinai School of Medicine, New York, for sharing the viruses (and plasmids) in the present paper; please contact R.A.M.F. A.D.M. E.O. and G.F.R. are CSO and part-time employee of ViroClinics Biosciences BV. A.D.M.E.O. has advisory affiliations on behalf of Viroclinics Biosciences BV with GlaxoSmithKline, Novartis, and Roche. A.D.M.E.O. and R.A.M.F. are holders of certificates of shares in ViroClinics Biosciences B.V. To avoid any possible conflict of interests, Erasmus MC policy dictates that the shares as such are held by the Stichting Administratiekantoor Erasmus Personeelsparticipaties. The board of this foundation is appointed by the Board of Governors of the Erasmus MC and exercises all voting rights with regard to these shares.	Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bataille A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002094; Bodewes R, 2011, J VIROL, V85, P2695, DOI 10.1128/JVI.02371-10; Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Costa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-28; de Wit E, 2008, VACCINE, V26, pD54, DOI 10.1016/j.vaccine.2008.07.072; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; DEOM CM, 1986, P NATL ACAD SCI USA, V83, P3771, DOI 10.1073/pnas.83.11.3771; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fouchier RAM, 2012, SCIENCE, V335, P662, DOI 10.1126/science.1218376; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Palese P., 2007, FIELDS VIROLOGY, V3, P1647; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Rudneva IA, 2005, J GEN VIROL, V86, P2831, DOI 10.1099/vir.0.81185-0; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wright P. F., 2007, FIELDS VIROLOGY, V3, P1691; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	56	1121	1171	15	387	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1534	1541		10.1126/science.1213362	http://dx.doi.org/10.1126/science.1213362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723413	Green Accepted			2022-12-01	WOS:000305507500047
J	Baconguis, I; Gouaux, E				Baconguis, Isabelle; Gouaux, Eric			Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes	NATURE			English	Article							EPITHELIAL SODIUM-CHANNEL; GATED CATION CHANNEL; FUNCTIONAL EXPRESSION; EXTRACELLULAR DOMAIN; TARANTULA PEPTIDE; ASIC1A CHANNELS; NERVOUS-SYSTEM; P2X RECEPTORS; NA+ CHANNEL; PORE	Acid-sensing ion channels (ASICs) are voltage-independent, amiloride-sensitive channels involved in diverse physiological processes ranging from nociception to taste. Despite the importance of ASICs in physiology, we know little about the mechanism of channel activation. Here we show that psalmotoxin activates non-selective and Na+-selective currents in chicken ASIC1a at pH 7.25 and 5.5, respectively. Crystal structures of ASIC1a-psalmotoxin complexes map the toxin binding site to the extracellular domain and show how toxin binding triggers an expansion of the extracellular vestibule and stabilization of the open channel pore. At pH 7.25 the pore is approximately 10 angstrom in diameter, whereas at pH 5.5 the pore is largely hydrophobic and elliptical in cross-section with dimensions of approximately 5 by 7 angstrom, consistent with a barrier mechanism for ion selectivity. These studies define mechanisms for activation of ASICs, illuminate the basis for dynamic ion selectivity and provide the blueprints for new therapeutic agents.	[Baconguis, Isabelle; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Baconguis, Isabelle/AAH-3790-2021	Gouaux, Eric/0000-0002-8549-2360; Baconguis, Isabelle/0000-0002-5440-2289	National Institute of Neurological Disorders and Stroke; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS038631, F31NS070597, P30NS061800] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We appreciate assistance in the initial characterization of the action of PcTx1 on chicken ASIC1a by D. Samways and T. Egan, mass spectrometry analysis by D. King, together with comments from C. Jahr and R. MacKinnon. We are grateful to K. C. Garcia, C. Lee and A. Goehring for assistance with protein expression in mammalian cells. We thank L. Vaskalis for assistance with figures, H. Owen for help with manuscript preparation, H. Krishnamurthy for assistance in initial data collection, and Gouaux lab members for helpful discussion. This work was supported by an individual National Research Service Award from the National Institute of Neurological Disorders and Stroke (I. B.) and by the NIH (E. G.). E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hille B., 2001, ION CHANNELS EXCITAB, V3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Li WG, 2011, J BIOL CHEM, V286, P42635, DOI 10.1074/jbc.M111.289058; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER LG, 1982, J MEMBRANE BIOL, V67, P91, DOI 10.1007/BF01868651; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Samways DSK, 2009, CELL CALCIUM, V45, P319, DOI 10.1016/j.ceca.2008.12.002; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	58	201	205	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					400	U86		10.1038/nature11375	http://dx.doi.org/10.1038/nature11375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22842900	Green Accepted			2022-12-01	WOS:000308860900038
J	Claesson, MJ; Jeffery, IB; Conde, S; Power, SE; O'Connor, EM; Cusack, S; Harris, HMB; Coakley, M; Lakshminarayanan, B; O'Sullivan, O; Fitzgerald, GF; Deane, J; O'Connor, M; Harnedy, N; O'Connor, K; O'Mahony, D; van Sinderen, D; Wallace, M; Brennan, L; Stanton, C; Marchesi, JR; Fitzgerald, AP; Shanahan, F; Hill, C; Ross, RP; O'Toole, PW				Claesson, Marcus J.; Jeffery, Ian B.; Conde, Susana; Power, Susan E.; O'Connor, Eibhlis M.; Cusack, Siobhan; Harris, Hugh M. B.; Coakley, Mairead; Lakshminarayanan, Bhuvaneswari; O'Sullivan, Orla; Fitzgerald, Gerald F.; Deane, Jennifer; O'Connor, Michael; Harnedy, Norma; O'Connor, Kieran; O'Mahony, Denis; van Sinderen, Douwe; Wallace, Martina; Brennan, Lorraine; Stanton, Catherine; Marchesi, Julian R.; Fitzgerald, Anthony P.; Shanahan, Fergus; Hill, Colin; Ross, R. Paul; O'Toole, Paul W.			Gut microbiota composition correlates with diet and health in the elderly	NATURE			English	Article							PHYLOGENETIC MICROARRAY; FECAL MICROBIOTA; SEQUENCES; UNIFRAC; INDEX; AGE	Alterations in intestinal microbiota composition are associated with several chronic conditions, including obesity and inflammatory diseases. The microbiota of older people displays greater inter-individual variation than that of younger adults. Here we show that the faecal microbiota composition from 178 elderly subjects formed groups, correlating with residence location in the community, day-hospital, rehabilitation or in long-term residential care. However, clustering of subjects by diet separated them by the same residence location and microbiota groupings. The separation of microbiota composition significantly correlated with measures of frailty, co-morbidity, nutritional status, markers of inflammation and with metabolites in faecal water. The individual microbiota of people in long-stay care was significantly less diverse than that of community dwellers. Loss of community-associated microbiota correlated with increased frailty. Collectively, the data support a relationship between diet, microbiota and health status, and indicate a role for diet-driven microbiota alterations in varying rates of health decline upon ageing.	[Claesson, Marcus J.; Jeffery, Ian B.; Power, Susan E.; O'Connor, Eibhlis M.; Cusack, Siobhan; Harris, Hugh M. B.; Fitzgerald, Gerald F.; Deane, Jennifer; van Sinderen, Douwe; Hill, Colin; O'Toole, Paul W.] Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Claesson, Marcus J.; Jeffery, Ian B.; O'Connor, Eibhlis M.; Fitzgerald, Gerald F.; van Sinderen, Douwe; Stanton, Catherine; Shanahan, Fergus; Hill, Colin; Ross, R. Paul; O'Toole, Paul W.] Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Conde, Susana; Fitzgerald, Anthony P.] Univ Coll Cork, Dept Stat, Cork, Ireland; [Coakley, Mairead; Lakshminarayanan, Bhuvaneswari; O'Sullivan, Orla; Stanton, Catherine; Ross, R. Paul] TEAGASC, Moorepk Food Res Ctr, Fermoy, Cork, Ireland; [O'Connor, Michael; Harnedy, Norma; O'Mahony, Denis] Cork Univ Hosp, Cork, Ireland; [O'Connor, Michael; Harnedy, Norma; O'Connor, Kieran; O'Mahony, Denis] St Finbarrs Hosp, Cork, Ireland; [O'Connor, Kieran] Mercy Univ Hosp, Cork, Ireland; [O'Connor, Kieran; O'Mahony, Denis] Victoria Univ Hosp, South Infirm, Cork, Ireland; [Wallace, Martina; Brennan, Lorraine] Univ Coll Dublin, Inst Food & Hlth, Dublin, Ireland; [Marchesi, Julian R.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AT, S Glam, Wales; [Fitzgerald, Anthony P.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Shanahan, Fergus] Univ Coll Cork, Dept Med, Cork, Ireland	University College Cork; University College Cork; University College Cork; Teagasc; University College Cork; University College Cork; University College Dublin; Cardiff University; University College Cork; University College Cork	O'Toole, PW (corresponding author), Univ Coll Cork, Dept Microbiol, Cork, Ireland.	pwotoole@ucc.ie	Jeffery, Ian/I-4010-2013; Claesson, Marcus/K-7639-2015; Fitzgerald, Tony/AAB-5331-2020; Marchesi, Julian/AAC-9021-2020; Wallace, Martina/B-9441-2013; Stanton, Catherine/A-9549-2015; Van Sinderen, Douwe/A-6778-2015; Ross, Paul/A-7584-2015; O'Connor, Eibhlís/F-8851-2013; Hill, Colin/A-5611-2012; Marchesi, Julian/D-3731-2009; Shanahan, Fergus/ABF-2390-2020; O'Toole, Paul W/G-1593-2012; O'Sullivan, Orla/ABE-5980-2020; Claesson, Marcus/AAE-4145-2019	Claesson, Marcus/0000-0002-5712-0623; Stanton, Catherine/0000-0002-6724-7011; Van Sinderen, Douwe/0000-0003-1823-7957; Ross, Paul/0000-0003-4876-8839; O'Connor, Eibhlís/0000-0001-6727-6499; Hill, Colin/0000-0002-8527-1445; Marchesi, Julian/0000-0002-7994-5239; Shanahan, Fergus/0000-0003-0467-0936; O'Toole, Paul W/0000-0001-5377-0824; O'Sullivan, Orla/0000-0002-4332-1109; Claesson, Marcus/0000-0002-5712-0623; Brennan, Lorraine/0000-0002-7711-7499; Deane, Jennifer/0000-0002-4058-3568; Jeffery, Ian/0000-0001-9183-7292; Wallace, Martina/0000-0001-8272-5678	Government of Ireland National Development Plan; Health Research Board FHRI; Science Foundation Ireland; Health Research Board of Ireland	Government of Ireland National Development Plan; Health Research Board FHRI; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board of Ireland	This work was supported by the Government of Ireland National Development Plan by way of a Department of Agriculture Food and Marine, and Health Research Board FHRI award to the ELDERMET project, as well as by a Science Foundation Ireland award to the Alimentary Pharmabiotic Centre. M.J.C. is funded by a fellowship from the Health Research Board of Ireland. We thank K. O'Donovan and P. Egan for clinical assistance, staff in Cork City and County hospitals for facilitating subject recruitment, S. Wong and B. Clayton for supercomputer access.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bauer JM, 2008, NUTR CLIN PRACT, V23, P388, DOI 10.1177/0884533608321132; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dabney A, 2010, Q VALUE ESTIMATION F; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Drescher LS, 2007, J NUTR, V137, P647, DOI 10.1093/jn/137.3.647; European Commission, 2011, POP STRUCT AG; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Feng XD, 2011, BIOMETRIKA, V98, P995, DOI 10.1093/biomet/asr052; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Guigoz Y, 2008, CURR OPIN CLIN NUTR, V11, P13, DOI 10.1097/MCO.0b013e3282f2bfdf; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harrington J, 2011, PUBLIC HEALTH NUTR, V14, P2166, DOI 10.1017/S136898001100098X; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; KIDD D, 1995, DISABIL REHABIL, V17, P10, DOI 10.3109/09638289509166622; Kinsella K, 2009, AGING WORLD 2008; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lilburn TG, 2004, INT J SYST EVOL MICR, V54, P7, DOI 10.1099/ijs.0.02749-0; Lovat LB, 1996, GUT, V38, P306, DOI 10.1136/gut.38.3.306; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAHONEY F I, 1965, Md State Med J, V14, P61; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; MCCANCE RA, 2002, COMPOSITION FOODS; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Namiki T., 2011, ACM C BIOINF COMP BI; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Nyamundanda G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-571; O'Sullivan A, 2011, AM J CLIN NUTR, V93, P314, DOI 10.3945/ajcn.110.000950; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	55	1908	2010	23	681	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					178	+		10.1038/nature11319	http://dx.doi.org/10.1038/nature11319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22797518				2022-12-01	WOS:000307267000026
J	Kelliher, T; Walbot, V				Kelliher, Timothy; Walbot, Virginia			Hypoxia Triggers Meiotic Fate Acquisition in Maize	SCIENCE			English	Article							STEM-CELLS; ANTHER; GERMLINE; DIFFERENTIATION; PROLIFERATION; ROXY1	Evidence from confocal microscopic reconstruction of maize anther development in fertile, mac1 (excess germ cells), and msca1 (no germ cells) flowers indicates that the male germ line is multiclonal and uses the MAC1 protein to organize the somatic niche. Furthermore, we identified redox status as a determinant of germ cell fate, defining a mechanism distinct from the animal germ cell lineage. Decreasing oxygen or H2O2 increases germ cell numbers, stimulates superficial germ cell formation, and rescues germinal differentiation in msca1 flowers. Conversely, oxidizing environments inhibit germ cell specification and cause ectopic differentiation in deeper tissues. We propose that hypoxia, arising naturally within growing anther tissue, acts as a positional cue to set germ cell fate.	[Kelliher, Timothy; Walbot, Virginia] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Kelliher, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	tkellih1@stanford.edu; walbot@stanford.edu		Walbot, Virginia/0000-0002-1596-7279	NSF [PGRP07-01880]; NIH [5-T32-GM008412-17]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supplementary figures, tables, and experimental procedures are available on Science Online. We thank R. Wang for MAC1 immunohistolocalization, B. Marchant for tassel treatments, D. Tollenor for oxygen measurements, and R. Egger and W. James Nelson for discussions. Transcriptome data were deposited in the Gene Expression Omnibus (accession no. GSE39101). T. K. and V. W. are inventors on a patent application (61/598.544) filed by Stanford University entitled "Method for Modulating the Number of Archesporial Cells in a Developing Anther." Supported by NSF grant PGRP07-01880. T. K. was supported by an NIH Biotechnology Training Grant (5-T32-GM008412-17).	Albertsen MC, 2011, US Patent Application, Patent No. [US007915478B2, 007915478]; Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Bedinger Patricia A., 2009, P57, DOI 10.1007/978-0-387-79418-1_4; Bertoni G, 2011, PLANT CELL, V23, P3562, DOI 10.1105/tpc.111.231011; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Feng XQ, 2007, TRENDS GENET, V23, P503, DOI 10.1016/j.tig.2007.08.005; Feng XQ, 2010, DEVELOPMENT, V137, P2409, DOI 10.1242/dev.049320; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hong LL, 2012, PLANT CELL, V24, P577, DOI 10.1105/tpc.111.093740; Hord Carey L. H., 2008, V9, P361, DOI 10.1007/7089_2007_136; Juliano C, 2010, SCIENCE, V329, P640, DOI 10.1126/science.1194037; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kelliher T, 2011, DEV BIOL, V350, P32, DOI 10.1016/j.ydbio.2010.11.005; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Li S, 2009, PLANT CELL, V21, P429, DOI 10.1105/tpc.108.064477; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Murmu J, 2010, PLANT PHYSIOL, V154, P1492, DOI 10.1104/pp.110.159111; Nan GL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-120; Sheridan WF, 1999, GENETICS, V153, P933; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Wang CJR, 2012, DEVELOPMENT, V139, P2594, DOI 10.1242/dev.077891; Wang JW, 2005, PLANT CELL PHYSIOL, V46, P923, DOI 10.1093/pcp/pci098	27	139	144	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					345	348		10.1126/science.1220080	http://dx.doi.org/10.1126/science.1220080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822150	Green Accepted			2022-12-01	WOS:000306542600052
J	Berk, V; Fong, JCN; Dempsey, GT; Develioglu, ON; Zhuang, XW; Liphardt, J; Yildiz, FH; Chu, S				Berk, Veysel; Fong, Jiunn C. N.; Dempsey, Graham T.; Develioglu, Omer N.; Zhuang, Xiaowei; Liphardt, Jan; Yildiz, Fitnat H.; Chu, Steven			Molecular Architecture and Assembly Principles of Vibrio cholerae Biofilms	SCIENCE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; RUGOSE COLONY MORPHOLOGY; BACTERIAL BIOFILMS; ANTIBIOTIC-RESISTANCE; PATHOGENESIS; DISPERSAL; MATRIX	In their natural environment, microbes organize into communities held together by an extracellular matrix composed of polysaccharides and proteins. We developed an in vivo labeling strategy to allow the extracellular matrix of developing biofilms to be visualized with conventional and superresolution light microscopy. Vibrio cholerae biofilms displayed three distinct levels of spatial organization: cells, clusters of cells, and collections of clusters. Multiresolution imaging of living V. cholerae biofilms revealed the complementary architectural roles of the four essential matrix constituents: RbmA provided cell-cell adhesion; Bap1 allowed the developing biofilm to adhere to surfaces; and heterogeneous mixtures of Vibrio polysaccharide, RbmC, and Bap1 formed dynamic, flexible, and ordered envelopes that encased the cell clusters.	[Berk, Veysel; Liphardt, Jan] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Fong, Jiunn C. N.; Yildiz, Fitnat H.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Dempsey, Graham T.; Zhuang, Xiaowei] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Develioglu, Omer N.] Taksim Training & Res Hosp, Dept Otorhinolaryngol, Istanbul, Turkey; [Liphardt, Jan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Chu, Steven] US DOE, Washington, DC 20585 USA	University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; Istanbul Gaziosmanpasa Taksim Training & Research Hospital; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE)	Berk, V (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	vberk@berkeley.edu; fyildiz@ucsc.edu	develioglu, omer n/GQB-5341-2022; Develioglu, Omer N/AAA-6587-2020	Develioglu, Omer N/0000-0001-6725-1013; Liphardt, Jan/0000-0003-2835-5025; Dempsey, Graham/0000-0002-9273-7506	NSF [PHY-0647161]; NIH [AI055987, GM096450, GM068518]; U.S. Department of Energy Office of Basic Energy Sciences (FWP SISGRKN); Lawrence Berkeley National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055987, R56AI055987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518, R01GM096450] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy Office of Basic Energy Sciences (FWP SISGRKN); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Huang for providing image processing software and D. J. Wozniak, J. H. D. Cate, X. Nan, A. Arkin, and A. Yildiz for critical evaluation of the manuscript. This work is supported by the NSF [grant PHY-0647161 (J. L.)] and the NIH [grants AI055987 (F.H.Y.) and GM096450 and GM068518 (X.Z.)]. X.Z. is a HHMI Investigator. J. L. acknowledges support from the U.S. Department of Energy Office of Basic Energy Sciences (FWP SISGRKN) and Lawrence Berkeley National Laboratory.	Absalon C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002210; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fong JCN, 2007, J BACTERIOL, V189, P2319, DOI 10.1128/JB.01569-06; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Lieleg O, 2011, SOFT MATTER, V7, P3307, DOI 10.1039/c0sm01467b; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122; Masters B. R., 2008, J BIOMED OPT, V13, DOI DOI 10.1117/1.2911629; Moorthy S, 2004, MOL MICROBIOL, V52, P573, DOI 10.1111/j.1365-2958.2004.04000.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Reisner Andreas, 2005, V12, P114, DOI 10.1159/000081692; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x	28	248	255	4	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					236	239		10.1126/science.1222981	http://dx.doi.org/10.1126/science.1222981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22798614	Green Accepted			2022-12-01	WOS:000306323500059
J	Mackenzie, IS; MacDonald, TM; Thompson, A; Morant, S; Wei, L				Mackenzie, Isla S.; MacDonald, Thomas M.; Thompson, Alastair; Morant, Steve; Wei, Li			Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTIHYPERTENSIVE MEDICATION; FOLLOW-UP; HYPERTENSION; ASSOCIATION; DRUGS	Objective To investigate whether exposure to spironolactone treatment affects the risk of incident breast cancer in women over 55 years of age. Design Retrospective, matched cohort study. Setting General Practice Research Database, a primary care anonymised database representative of the general population in the United Kingdom. Participants 1 290 625 female patients, older than 55 years and with no history of breast cancer, from 557 general practices with a total follow-up time of 8.4 million patient years. We excluded patients with poor quality data and those with no contacts with their general practitioner after their current registration date. Intervention Exposed cohort included women who received at least two prescriptions of spironolactone after age 55 years, who were followed up from the first prescription (index date). We randomly selected two unexposed female controls for every exposed patient, matched by practice, year of birth, and socioeconomic scores (if information was available), and followed up from the same date. Main outcome measure New cases of breast cancer, using Read codes to confirm diagnoses. Results Index dates for study patients ranged from 1987 to 2010, and 29 491 new cases of breast cancer were recorded in the study population (incidence rate 0.35% per year). The exposed cohort of 28 032 patients and control cohort of 55 961 patients had unadjusted incidence rates of 0.39% and 0.38% per year, respectively, over a mean follow-up time of 4.1 years. Time-to-event analysis, adjusting for potential risk factors, provided no evidence of an increased incidence of breast cancer in patients exposed to spironolactone (hazard ratio 0.99, 95% confidence interval 0.87 to 1.12). Conclusions These data suggest that the long term management of cardiovascular conditions with spironolactone does not increase the risk of breast cancer in women older than 55 years with no history of the disease.	[Mackenzie, Isla S.; MacDonald, Thomas M.; Morant, Steve; Wei, Li] Univ Dundee, Med Monitoring Unit MEMO, Dundee DD1 9SY, Scotland; [Thompson, Alastair] Dundee Canc Ctr, Dundee, Scotland	University of Dundee; University of Dundee	Mackenzie, IS (corresponding author), Univ Dundee, Med Monitoring Unit MEMO, Dundee DD1 9SY, Scotland.	i.s.mackenzie@dundee.ac.uk		MacDonald, Thomas/0000-0001-5189-6669; Mackenzie, Isla/0000-0002-3680-7127; Morant, Steven/0000-0001-5674-3784	University of Dundee; MRC [G106/1249] Funding Source: UKRI; Medical Research Council [G106/1249] Funding Source: researchfish	University of Dundee; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	No specific funding was received for this study. The study was sponsored by the University of Dundee.	[Anonymous], 1974, LANCET, V2, P669; [Anonymous], 1988, Drug Ther Bull, V26, P88; ARMSTRONG B, 1974, LANCET, V2, P672; DANIELSON DA, 1982, AM J EPIDEMIOL, V116, P329, DOI 10.1093/oxfordjournals.aje.a113416; Fryzek JP, 2006, BREAST CANCER RES TR, V97, P231, DOI 10.1007/s10549-005-9091-x; GARDINER P, 1989, J CLIN PHARMACOL, V29, P342, DOI 10.1002/j.1552-4604.1989.tb03339.x; Gonzalez-Perez A, 2004, PHARMACOEPIDEM DR S, V13, P581, DOI 10.1002/pds.910; Goon PKY, 2006, J HUM HYPERTENS, V20, P722, DOI 10.1038/sj.jhh.1002053; IARC, 2012, IARC MON, V79, P319; JICK H, 1975, LANCET, V2, P368, DOI 10.1016/S0140-6736(75)92814-7; Largent JA, 2006, J HUM HYPERTENS, V20, P727, DOI 10.1038/sj.jhh.1002075; Li CI, 2003, CANCER, V98, P1504, DOI 10.1002/cncr.11663; LOUBE SD, 1975, LANCET, V1, P1428, DOI 10.1016/S0140-6736(75)92645-8; National Institute for Health and Care Excellence, 2019, HYP AD DIAGN MAN NIC; Parthasarathy HK, 2011, J HYPERTENS, V29, P980, DOI 10.1097/HJH.0b013e3283455ca5; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; SELBY JV, 1989, CANCER RES, V49, P5736; Shaw JC, 2002, J CUTAN MED SURG, V6, P541, DOI 10.1007/s10227-001-0152-4; STIERER M, 1990, ONKOLOGIE, V13, P128; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683	21	43	43	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2012	345								e4447	10.1136/bmj.e4447	http://dx.doi.org/10.1136/bmj.e4447			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975NX	22797844	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000306519100002
J	Shea, SA				Shea, Steven A.			Obesity and Pharmacologic Control of the Body Clock	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CIRCADIAN BEHAVIOR; SHIFT WORK; METABOLISM		Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Shea, SA (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.			Shea, Steven/0000-0003-1949-0954				Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298	6	12	12	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2012	367	2					175	178		10.1056/NEJMcibr1204644	http://dx.doi.org/10.1056/NEJMcibr1204644			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972IO	22784121				2022-12-01	WOS:000306270800016
J	Churchland, MM; Cunningham, JP; Kaufman, MT; Foster, JD; Nuyujukian, P; Ryu, SI; Shenoy, KV				Churchland, Mark M.; Cunningham, John P.; Kaufman, Matthew T.; Foster, Justin D.; Nuyujukian, Paul; Ryu, Stephen I.; Shenoy, Krishna V.			Neural population dynamics during reaching	NATURE			English	Article							OPTIMAL FEEDBACK-CONTROL; MOTOR CORTEX REFLECTS; PREPARATORY ACTIVITY; OUTPUT KINEMATICS; ISOMETRIC-FORCE; ARM MOVEMENTS; PREMOTOR; MUSCLE; DIRECTION; NEURONS	Most theories of motor cortex have assumed that neural activity represents movement parameters. This view derives from what is known about primary visual cortex, where neural activity represents patterns of light. Yet it is unclear how well the analogy between motor and visual cortex holds. Single-neuron responses in motor cortex are complex, and there is marked disagreement regarding which movement parameters are represented. A better analogy might be with other motor systems, where a common principle is rhythmic neural activity. Here we find that motor cortex responses during reaching contain a brief but strong oscillatory component, something quite unexpected for a non-periodic behaviour. Oscillation amplitude and phase followed naturally from the preparatory state, suggesting a mechanistic role for preparatory neural activity. These results demonstrate an unexpected yet surprisingly simple structure in the population response. This underlying structure explains many of the confusing features of individual neural responses.	[Churchland, Mark M.] Columbia Univ, Med Ctr, David Mahoney Ctr, Dept Neurosci,Kavli Inst Brain Sci, New York, NY 10032 USA; [Churchland, Mark M.; Kaufman, Matthew T.; Foster, Justin D.; Ryu, Stephen I.; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Churchland, Mark M.; Kaufman, Matthew T.; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Cunningham, John P.] Washington Univ St Louis, Dept Biomed Engn, St Louis, MO 63130 USA; [Cunningham, John P.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Nuyujukian, Paul; Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94705 USA; [Nuyujukian, Paul] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Ryu, Stephen I.] Palo Alto Med Fdn, Dept Neurosurg, Palo Alto, CA 94301 USA; [Shenoy, Krishna V.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Columbia University; Stanford University; Stanford University; Washington University (WUSTL); University of Cambridge; Stanford University; Stanford University; Palo Alto Medical Foundation Research Institute; Stanford University	Churchland, MM (corresponding author), Columbia Univ, Med Ctr, David Mahoney Ctr, Dept Neurosci,Kavli Inst Brain Sci, New York, NY 10032 USA.	mc3502@columbia.edu	Kaufman, Matthew/AAK-2860-2020; Kaufman, Matthew T/B-6273-2014	Kaufman, Matthew/0000-0002-8072-023X; Kaufman, Matthew T/0000-0002-8072-023X; Nuyujukian, Paul/0000-0001-7778-5473	Helen Hay Whitney postdoctoral fellowship; National Institutes of Health (NIH); Burroughs Wellcome Fund Career Awards in the Biomedical Sciences; Engineering and Physical Sciences Research Council [EP/H019472/1]; McDonnell Center; National Science Foundation; Texas Instruments Stanford Graduate Fellowship; Paul and Daisy Soros Fellowship; Stanford Medical Scientist Training Program; NIH [1DP1OD006409]; NIH NINDS EUREKA [R01-NS066311]; NIH NINDS BRP [R01-NS064318]; NIH NINDS CRCNS [R01-NS054283]; DARPA-DSO REPAIR [N66001-10-C-2010]; Stanford Center for Integrated Systems; NSF Center for Neuromorphic Systems Engineering at Caltech; Office of Naval Research; Whitaker Foundation; McKnight Foundation; Sloan Foundation; Weston Havens Foundation; EPSRC [EP/H019472/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064318, R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	Helen Hay Whitney postdoctoral fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Awards in the Biomedical Sciences(Burroughs Wellcome Fund); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); McDonnell Center; National Science Foundation(National Science Foundation (NSF)); Texas Instruments Stanford Graduate Fellowship; Paul and Daisy Soros Fellowship; Stanford Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NINDS EUREKA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NINDS BRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NINDS CRCNS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA-DSO REPAIR; Stanford Center for Integrated Systems; NSF Center for Neuromorphic Systems Engineering at Caltech(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Whitaker Foundation; McKnight Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Weston Havens Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are deeply grateful to K. Briggman and W. Kristan for providing data recorded from the leech. We thank M. Risch for animal care, S. Eisensee for administrative support, and D. Haven and B. Oskotsky for information technology support. We thank Z. Ghahramani and C. Rasmussen for discussion of jPCA and related methods. We thank D. Sussillo, S. Grossman and M. Sahani for analysis suggestions and commentary on the manuscript. This work was supported by a Helen Hay Whitney postdoctoral fellowship and National Institutes of Health (NIH) postdoctoral training fellowship (M.M.C.), the Burroughs Wellcome Fund Career Awards in the Biomedical Sciences (M.M.C., K.V.S.), Engineering and Physical Sciences Research Council grant EP/H019472/1 and the McDonnell Center (J.P.C.), a National Science Foundation graduate research fellowship (M.T.K.), a Texas Instruments Stanford Graduate Fellowship (J.D.F.), a Paul and Daisy Soros Fellowship (P.N.), the Stanford Medical Scientist Training Program (P.N.), and these awards to K.V.S.: NIH Director's Pioneer Award (1DP1OD006409), NIH NINDS EUREKA Award (R01-NS066311), NIH NINDS BRP (R01-NS064318), NIH NINDS CRCNS (R01-NS054283), DARPA-DSO REPAIR (N66001-10-C-2010), Stanford Center for Integrated Systems, NSF Center for Neuromorphic Systems Engineering at Caltech, Office of Naval Research, and the Whitaker Foundation, the McKnight Foundation, the Sloan Foundation and the Weston Havens Foundation.	Aflalo TN, 2007, J NEUROSCI, V27, P2760, DOI 10.1523/JNEUROSCI.3147-06.2007; Briggman KL, 2006, J NEUROSCI, V26, P10925, DOI 10.1523/JNEUROSCI.3265-06.2006; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2006, J NEUROPHYSIOL, V96, P2842, DOI 10.1152/jn.00857.2006; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FETZ EE, 1992, BEHAV BRAIN SCI, V15, P679; Foster J. D., 2011, P 5 INT IEEE EMBS C, P613; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gilja V, 2010, CURR OPIN NEUROBIOL, V20, P676, DOI 10.1016/j.conb.2010.06.007; Graziano MSA, 2011, NEURON, V71, P387, DOI 10.1016/j.neuron.2011.07.014; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hatsopoulos NG, 2005, J NEUROPHYSIOL, V94, P2261, DOI 10.1152/jn.00533.2005; Herter TM, 2009, J NEUROPHYSIOL, V101, P150, DOI 10.1152/jn.90230.2008; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kalaska JF, 2009, ADV EXP MED BIOL, V629, P139, DOI 10.1007/978-0-387-77064-2_8; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; KRISTAN WB, 1976, J EXP BIOL, V65, P643; Lemon RN, 2008, EXP PHYSIOL, V93, P798, DOI 10.1113/expphysiol.2007.039081; Llinas R, 2002, I VORTEX; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Miranda H, 2010, IEEE T BIOMED CIRC S, V4, P181, DOI 10.1109/TBCAS.2010.2044573; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Morrow MM, 2009, ADV EXP MED BIOL, V629, P179, DOI 10.1007/978-0-387-77064-2_9; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; Rokni U, 2012, NEURAL COMPUT, V24, P289, DOI 10.1162/NECO_a_00223; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Shenoy K. V., 2011, PROGR BRAIN RES ENHA; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Yakovenko S, 2011, J NEUROPHYSIOL, V105, P388, DOI 10.1152/jn.00469.2010; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	42	669	687	11	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					51	+		10.1038/nature11129	http://dx.doi.org/10.1038/nature11129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722855	Green Accepted			2022-12-01	WOS:000305982900048
J	James, JR; Vale, RD				James, John R.; Vale, Ronald D.			Biophysical mechanism of T-cell receptor triggering in a reconstituted system	NATURE			English	Article							PATTERN-FORMATION; ACTIVATION; CD45; SEGREGATION; ANTIGEN; MICROCLUSTERS; THRESHOLDS; CLUSTERS; ADHESION; KINASES	A T-cell-mediated immune response is initiated by the T-cell receptor (TCR) interacting with peptide-bound major histocompatibility complex (pMHC) on an infected cell. The mechanism by which this interaction triggers intracellular phosphorylation of the TCR, which lacks a kinase domain, remains poorly understood. Here, we have introduced the TCR and associated signalling molecules into a non-immune cell and reconstituted ligand-specific signalling when these cells are conjugated with antigen-presenting cells. We show that signalling requires the differential segregation of a phosphatase and kinase in the plasma membrane. An artificial, chemically controlled receptor system generates the same effect as TCR-pMHC, demonstrating that the binding energy of an extracellular protein-protein interaction can drive the spatial segregation of membrane proteins without a transmembrane conformational change. This general mechanism may extend to other receptors that rely on extrinsic kinases, including, as we demonstrate, chimaeric antigen receptors being developed for cancer immunotherapy.	[James, John R.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [James, John R.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	James, John/AAP-3607-2021; James, John R/B-5547-2008	James, John/0000-0003-1452-7578; James, John R/0000-0003-1452-7578	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alakoskela JM, 2011, BIOPHYS J, V100, P2865, DOI 10.1016/j.bpj.2011.05.013; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burroughs NJ, 2002, BIOPHYS J, V83, P1784, DOI 10.1016/S0006-3495(02)73944-1; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; He X, 2002, EUR J IMMUNOL, V32, P2578, DOI 10.1002/1521-4141(200209)32:9<2578::AID-IMMU2578>3.0.CO;2-3; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	38	220	235	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2012	487	7405					64	69		10.1038/nature11220	http://dx.doi.org/10.1038/nature11220			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22763440	Green Accepted, Green Submitted			2022-12-01	WOS:000305982900050
J	Campbell, RJ; Gill, SS; Bronskill, SE; Paterson, JM; Whitehead, M; Bell, CM				Campbell, Robert J.; Gill, Sudeep S.; Bronskill, Susan E.; Paterson, J. Michael; Whitehead, Marlo; Bell, Chaim M.			Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MACULAR DEGENERATION; COHORT ANALYSIS; RANIBIZUMAB; BEVACIZUMAB; THERAPY; SAFETY; PHARMACOKINETICS; MORTALITY; CANCER; RISKS	Objective To assess the risk of systemic adverse events associated with intravitreal injections of vascular endothelial growth factor inhibiting drugs. Design Population based nested case-control study. Setting Ontario, Canada. Participants 91 378 older adults with a history of physician diagnosed retinal disease identified between 1 April 2006 and 31 March 2011. Cases were 1477 patients admitted to hospital for ischaemic stroke, 2229 admitted for an acute myocardial infarction, 1059 admitted or assessed in an emergency department for venous thromboembolism, and 2623 admitted for congestive heart failure. Event-free controls (at a ratio of 5: 1) were matched to cases on the basis of year of birth, sex, history of the outcome in the previous 5 years, and diabetes. Main exposure measure Exposure to vascular endothelial growth factor inhibiting drugs identified within 180 days before the index date. Results After adjustment for potential confounders, participants who had ischaemic stroke, acute myocardial infarction, congestive heart failure, or venous thromboembolism were not more likely than control participants to have been exposed to either bevacizumab (adjusted odds ratios of 0.95 (95% confidence interval 0.68 to 1.34) for ischaemic stroke, 1.04 (0.77 to 1.39) for acute myocardial infarction, 0.81 (0.49 to 1.34) for venous thromboembolism, and 1.21 (0.91 to 1.62) for congestive heart failure) or ranibizumab (adjusted odds ratios 0.87 (0.68 to 1.10) for ischaemic stroke, 0.90 (0.72 to 1.11) for acute myocardial infarction, 0.88 (0.67 to 1.16) for venous thromboembolism, and 0.87 (0.70 to 1.07) for congestive heart failure). Similarly, a secondary analysis of exclusive users of bevacizumab or ranibizumab showed no differences in risk between the two drugs (adjusted odds ratios for bevacizumab relative to ranibizumab of 1.03 (0.67 to 1.60) for ischaemic stroke, 1.23 (0.85 to 1.77) for acute myocardial infarction, 0.92 (0.51 to 1.69) for venous thromboembolism, and 1.35 (0.93 to 1.95) for congestive heart failure). These findings were consistent for all but one outcome in subgroup analyses. Conclusions Intravitreal injections of bevacizumab and ranibizumab were not associated with significant risks of ischaemic stroke, acute myocardial infarction, congestive heart failure, or venous thromboembolism.	[Campbell, Robert J.] Queens Univ, Dept Ophthalmol, Kingston, ON, Canada; [Campbell, Robert J.] Hotel Dieu & Kingston Gen Hosp, Dept Ophthalmol, Kingston, ON, Canada; [Gill, Sudeep S.] Queens Univ, Div Geriatr Med, Kingston, ON, Canada; [Gill, Sudeep S.] St Marys Lake Hosp, Div Geriatr Med, Kingston, ON, Canada; [Bronskill, Susan E.; Paterson, J. Michael] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Paterson, J. Michael] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Bell, Chaim M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.] St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Bell, Chaim M.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	Queens University - Canada; Queens University - Canada; University of Toronto; McMaster University; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Campbell, RJ (corresponding author), Hop Hotel Dieu, Dept Ophthalmol, 166 Brock St, Kingston, ON K7L 5G2, Canada.	rob.campbell@queensu.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469	Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Ontario Ministry of Health and Long-Term Care's (MOHLTC); Southeastern Ontario Academic Medical Organization; CIHR from the Institute of Aging; Canadian Patient Safety Institute chair in patient safety and continuity of care; CIHR; Ontario MOHLTC; MOHLTC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Ministry of Health and Long-Term Care's (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Southeastern Ontario Academic Medical Organization; CIHR from the Institute of Aging(Canadian Institutes of Health Research (CIHR)); Canadian Patient Safety Institute chair in patient safety and continuity of care; CIHR(Canadian Institutes of Health Research (CIHR)); Ontario MOHLTC(Ministry of Health and Long-Term Care, Ontario); MOHLTC(Ministry of Health and Long-Term Care, Ontario)	We thank Erica Campbell for assistance with project management, creation of tables, and manuscript editing. She is funded through research grants from the Canadian Institutes of Health Research and the Ontario Ministry of Health and Long-Term Care. We also thank Brogan Inc, Ottawa, Canada, for use of their drug product and therapeutic class database.; This study was funded by the Canadian Institutes of Health Research (CIHR) and the Ontario Ministry of Health and Long-Term Care's (MOHLTC) drug innovation fund. RJC is supported by a clinician scientist award from the Southeastern Ontario Academic Medical Organization. SSG and SEB are supported by CIHR new investigator awards from the Institute of Aging. CMB is supported by a CIHR and Canadian Patient Safety Institute chair in patient safety and continuity of care. The sponsors of this study had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit for publication. The authors are affiliated with the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario MOHLTC. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: RJC is supported by a Clinician Scientist Award from the Southeastern Ontario Academic Medical Organization, which receives funding from the Ontario Ministry of Health and Long-Term Care (MOHLTC) and holds research grants from the Canadian Institutes of Health Research (CIHR) and the MOHLTC for related work; SSG and SEB are supported by CIHR new investigator awards from the Institute of Aging; CMB is supported by a CIHR and Canadian Patient Safety Institute chair in patient safety and continuity of care; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; SSG is a member of the Ontario MOHLTC Committee to Evaluate Drugs, which provides advice to the Ontario MOHLTC on drug related matters (such as drugs to list on provincial formulary), and RJC is an adviser to the Ontario MOHLTC Committee to Evaluate Drugs (in these roles, neither has reviewed bevacizumab or ranibizumab); no other relationships or activities that could appear to have influenced the submitted work.	Al-Qureshi S, 2012, CLIN EXP OPHTHALMOL, V40, P3, DOI 10.1111/j.1442-9071.2011.02739.x; [Anonymous], 2012, ANN REPORT 2011, P66; Bell CM, 2009, JAMA-J AM MED ASSOC, V301, P1991, DOI 10.1001/jama.2009.683; Berkrot B, 2011, REUTERS US EDITI SEP; Breslow N, 1987, FITTING MODELS CONTI, P178; BRESLOW NE, 1983, J AM STAT ASSOC, V78, P1, DOI 10.2307/2287093; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Campbell RJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2941; Campbell RJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P359, DOI 10.1001/archophthalmol.2010.19; Chakravarthy U, 2012, OPHTHALMOLOGY; Choueiri TK, 2011, J CLIN ONCOL, V29, P632, DOI 10.1200/JCO.2010.31.9129; Cruess A, 2007, CAN J OPHTHALMOL, V42, P836, DOI 10.3129/i07-153; Csaky K, 2009, AM J OPHTHALMOL, V148, P647, DOI 10.1016/j.ajo.2009.06.014; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Ferner RE, 2010, BMJ-BRIT MED J, V340, P245; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; French DD, 2011, RETINA-J RET VIT DIS, V31, P1036, DOI 10.1097/IAE.0b013e31821dc66f; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Gower EW, 2011, ADVERSE EVENT RATES; Gruneir A, 2010, J AM GERIATR SOC, V58, P510, DOI 10.1111/j.1532-5415.2010.02736.x; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Institute for Clinical Evaluative Sciences, ONT STROK EV REP 201; Ip MS, 2008, OPHTHALMOLOGY, V115, P1837, DOI 10.1016/j.ophtha.2008.08.012; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Javitt JC, 2003, OPHTHALMOLOGY, V110, P1534, DOI 10.1016/S0161-6420(03)00495-0; Juurlink D., 2006, CANADIAN I HLTH INFO; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; LIDDELL FDK, 1977, J R STAT SOC A STAT, V140, P469, DOI 10.2307/2345280; Liew G, 2007, NEW ENGL J MED, V356, P747; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Martin DF, 2012, OPHTHALMOLOGY; Medicare Payment Advisory Commission, 2010, DAT BOOK HEALTHC SPE; MITKA M, 2011, JAMA-J AM MED ASSOC, V306, P1073; Mordenti J, 1999, TOXICOL PATHOL, V27, P536, DOI 10.1177/019262339902700507; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; National Institute for Health and Clinical Excellence, 2010, BEV AV EYE COND REP; National Institute for Health and Clinical Excellence, 2010, NICES REP FEAS APPR; Pollack A, 2011, NY TIMES        1004; Public Health Agency of Canada, 2009, TRACK HEART DIS STRO; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2011, NEW ENGL J MED, V364, P1966, DOI 10.1056/NEJMe1103334; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Snider KL, 2009, TARGET ONCOL, V4, P67, DOI 10.1007/s11523-009-0106-0; Suissa S, 2005, NOVEL APPROACHES PHA, P811; Tu Karen, 2007, Open Med, V1, pe18; Tufail A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2459; Tunon J, 2009, SURV OPHTHALMOL, V54, P339, DOI 10.1016/j.survophthal.2009.02.003; Ueta T, 2009, OPHTHALMOLOGY, V116, P362, DOI 10.1016/j.ophtha.2008.09.046; Vandenbroucke JP, 2008, JAMA-J AM MED ASSOC, V300, P2417, DOI 10.1001/jama.2008.723; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Williams JI, 1996, PATTERNS HLTH CARE O, P339	57	54	55	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2012	344								e4203	10.1136/bmj.e4203	http://dx.doi.org/10.1136/bmj.e4203			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972KE	22763393	Green Published, hybrid			2022-12-01	WOS:000306275200002
J	Dunlay, SM; Weston, SA; Killian, JM; Bell, MR; Jaffe, AS; Roger, VL				Dunlay, Shannon M.; Weston, Susan A.; Killian, Jill M.; Bell, Malcolm R.; Jaffe, Allan S.; Roger, Veronique L.			Thirty-Day Rehospitalizations After Acute Myocardial Infarction A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; HEART-DISEASE; READMISSION; TRENDS; MORTALITY; FAILURE; CARE	Background: Rehospitalization is a quality-of-care indicator, yet little is known about its occurrence and predictors after myocardial infarction (MI) in the community. Objective: To examine 30-day rehospitalizations after incident MI. Design: Retrospective cohort study. Setting: Population-based registry in Olmsted County, Minnesota. Patients: 3010 patients who were hospitalized in Olmsted County with first-ever MI from 1987 to 2010 and survived to hospital discharge. Measurements: Diagnoses, therapies, and complications during incident and subsequent hospitalizations were identified. Manual chart review was performed to determine the cause of all rehospitalizations. The hazard ratios and cumulative incidence of 30-day rehospitalizations were determined by using Cox proportional hazards regression models. Results: Among 3010 patients (mean age, 67 years; 40.5% female) with incident MI (31.2% ST-segment elevation), 643 rehospitalizations occurred within 30 days in 561 (18.6%) patients. Overall, 30.2% of rehospitalizations were unrelated to the incident MI and 42.6% were related; the relationship was unclear in 27.2% of rehospitalizations. Angiography was performed in 153 (23.8%) rehospitalizations. Revascularization was performed in 103 (16.0%) rehospitalizations, of which 46 (44.7%) had no revascularization during the index hospitalization. After adjustment for potential confounders, diabetes, chronic obstructive pulmonary disease, anemia, higher Killip class, longer length of stay during the index hospitalization, and a complication of angiography or reperfusion or revascularization were associated with increased rehospitalization risk. The 30-day incidence of rehospitalization was 35.3% in patients who experienced a complication of angiography during the index MI hospitalization and 31.6% in those who experienced a complication of reperfusion or revascularization during the index MI hospitalization, compared with 16.8% in patients who had reperfusion or revascularization without complications. Limitation: This study represents the experiences of a single community. Conclusion: Comorbid conditions, longer length of stay, and complications of angiography and revascularization or reperfusion are associated with increased 30-day rehospitalization risk after MI. Many rehospitalizations seem to be unrelated to the incident MI.	[Roger, Veronique L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic	Roger, VL (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.	roger.veronique@mayo.edu	Roger, Veronique/AAV-5951-2020		National Institutes of Health [RO1-HL59205]; Rochester Epidemiology Project from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR30582]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rochester Epidemiology Project from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health.; By grants from the National Institutes of Health (RO1-HL59205) and the Rochester Epidemiology Project (R01-AR30582, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases).	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Curtis JP, 2009, J AM COLL CARDIOL, V54, P903, DOI 10.1016/j.jacc.2009.04.076; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fried TR, 2008, J AM GERIATR SOC, V56, P1839, DOI 10.1111/j.1532-5415.2008.01923.x; Gershon AS, 2010, ARCH INTERN MED, V170, P560, DOI 10.1001/archinternmed.2010.17; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kors JA, 2000, AM J EPIDEMIOL, V151, P790, DOI 10.1093/oxfordjournals.aje.a010279; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Leibson CL, 2001, JAMA-J AM MED ASSOC, V285, P60, DOI 10.1001/jama.285.1.60; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Miller WL, 2006, EUR HEART J, V27, P1061, DOI 10.1093/eurheartj/ehi760; NCDR, 2008, NCDR CATHPCI REG V4; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Smith SC, 2001, CIRCULATION, V103, P3019, DOI 10.1161/01.CIR.103.24.3019; Thygesen K, 2007, EUR HEART J, V28, P2525; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Zhang X, 2011, COMPUT METH PROG BIO, V101, P87, DOI 10.1016/j.cmpb.2010.07.005	26	81	84	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2012	157	1					11	U46		10.7326/0003-4819-157-1-201207030-00004	http://dx.doi.org/10.7326/0003-4819-157-1-201207030-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NS	22751756	Green Accepted			2022-12-01	WOS:000307784900002
J	Starck, SR; Jiang, VV; Pavon-Eternod, M; Prasad, S; McCarthy, B; Pan, T; Shastri, N				Starck, Shelley R.; Jiang, Vivian; Pavon-Eternod, Mariana; Prasad, Sharanya; McCarthy, Brian; Pan, Tao; Shastri, Nilabh			Leucine-tRNA Initiates at CUG Start Codons for Protein Synthesis and Presentation by MHC Class I	SCIENCE			English	Article							TRANSLATION INITIATION; MESSENGER-RNA; CRYPTIC EPITOPES; DENDRITIC CELLS; READING FRAME; VIRUS; LYMPHOCYTES; COMPLEXES; MOLECULES; PRESSURE	Effective immune surveillance by cytotoxic T cells requires newly synthesized polypeptides for presentation by major histocompatibility complex (MHC) class I molecules. These polypeptides are produced not only from conventional AUG-initiated, but also from cryptic non-AUG-initiated, reading frames by distinct translational mechanisms. Biochemical analysis of ribosomal initiation complexes at CUG versus AUG initiation codons revealed that cells use an elongator leucine-bound transfer RNA (Leu-tRNA) to initiate translation at cryptic CUG start codons. CUG/Leu-tRNA initiation was independent of the canonical initiator tRNA (AUG/Met-tRNA(i)(Met)) pathway but required expression of eukaryotic initiation factor 2A. Thus, a tRNA-based translation initiation mechanism allows non-AUG-initiated protein synthesis and supplies peptides for presentation by MHC class I molecules.	[Starck, Shelley R.; Jiang, Vivian; Prasad, Sharanya; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Pavon-Eternod, Mariana; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [McCarthy, Brian] Univ Calif Berkeley, DNA Sequencing Facil, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of Chicago; University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@berkeley.edu			NIH; Cancer Research Institute; Ruth Kirschstein NRSA predoctoral fellowship; International AIDS Vaccine Initiative	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Ruth Kirschstein NRSA predoctoral fellowship; International AIDS Vaccine Initiative	We thank K. Collins, A. H. Bakker, K. Chen, N. Nagarajan, and T. Greene for helpful discussions and advice; Y. Ow for initial experiments with NSC119893; and N. Nagarajan and K. Lind for assistance with intravenous injections. The data presented in this paper are tabulated in the main paper and in the supplementary materials. S. R. S. was supported in part by an NIH training grant, a postdoctoral fellowship from the Cancer Research Institute, and a National Research Service Award (NRSA) fellowship from the NIH. M.P.-E was supported by an NIH training grant and by the Ruth Kirschstein NRSA predoctoral fellowship. This research was supported by grants from the NIH to N.S. and T. P. and the International AIDS Vaccine Initiative to N.S. The authors declare no competing financial interests.	ADAMS SL, 1975, J BIOL CHEM, V250, P9083; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Berger CT, 2010, J EXP MED, V207, P61, DOI 10.1084/jem.20091808; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; Dolstra H, 1999, J EXP MED, V189, P301, DOI 10.1084/jem.189.2.301; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2001, RNA, V7, P765, DOI 10.1017/S1355838201002539; Kim JH, 2011, EMBO J, V30, P2454, DOI 10.1038/emboj.2011.146; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kozak M, 1998, NUCLEIC ACIDS RES, V26, P4853, DOI 10.1093/nar/26.21.4853; Lelouard H, 2007, J CELL BIOL, V179, P1427, DOI 10.1083/jcb.200707166; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Maness NJ, 2010, J VIROL, V84, P11569, DOI 10.1128/JVI.01419-10; Mayrand SM, 1998, J IMMUNOL, V160, P39; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MERRICK WC, 1975, J BIOL CHEM, V250, P1197; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; Pestova TV, 2000, CELL MOL LIFE SCI, V57, P651, DOI 10.1007/PL00000726; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Ronsin C, 1999, J IMMUNOL, V163, P483; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; Sisido M., 2007, CHEM BIOL SMALL MOL, V1, P271; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Weinzierl AO, 2008, CANCER RES, V68, P2447, DOI 10.1158/0008-5472.CAN-07-2540	36	145	147	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1719	1723		10.1126/science.1220270	http://dx.doi.org/10.1126/science.1220270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745432				2022-12-01	WOS:000305794500054
J	Hammar, P; Leroy, P; Mahmutovic, A; Marklund, EG; Berg, OG; Elf, J				Hammar, Petter; Leroy, Prune; Mahmutovic, Anel; Marklund, Erik G.; Berg, Otto G.; Elf, Johan			The lac Repressor Displays Facilitated Diffusion in Living Cells	SCIENCE			English	Article							ESCHERICHIA-COLI-LAC; PROTEIN TRANSLOCATION; OPERATOR INTERACTION; DRIVEN MECHANISMS; TARGET LOCATION; NUCLEIC-ACIDS; IN-VIVO; DNA; SEQUENCE; KINETICS	Transcription factors (TFs) are proteins that regulate the expression of genes by binding sequence-specific sites on the chromosome. It has been proposed that to find these sites fast and accurately, TFs combine one-dimensional (1D) sliding on DNA with 3D diffusion in the cytoplasm. This facilitated diffusion mechanism has been demonstrated in vitro, but it has not been shown experimentally to be exploited in living cells. We have developed a single-molecule assay that allows us to investigate the sliding process in living bacteria. Here we show that the lac repressor slides 45 T 10 base pairs on chromosomal DNA and that sliding can be obstructed by other DNA-bound proteins near the operator. Furthermore, the repressor frequently (>90%) slides over its natural lacO(1) operator several times before binding. This suggests a trade-off between rapid search on nonspecific sequences and fast binding at the specific sequence.	[Hammar, Petter; Leroy, Prune; Mahmutovic, Anel; Marklund, Erik G.; Berg, Otto G.; Elf, Johan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Uppsala University	Elf, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden.	johan.elf@icm.uu.se	Marklund, Erik G/G-7480-2012	Marklund, Erik G/0000-0002-9804-5009; elf, johan/0000-0001-5522-1810	European Research Council; Swedish Foundation for Strategic Research (SSF); Swedish Research Council (VR); Goran Gustafssons Stiftelse; EMBO young investigator programme; Knut and Alice Wallenberg Foundation; Centre for Interdisciplinary Mathematics, Uppsala University	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council); Goran Gustafssons Stiftelse; EMBO young investigator programme(European Molecular Biology Organization (EMBO)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Centre for Interdisciplinary Mathematics, Uppsala University	We are grateful to G.-W. Li, M. Ehrenberg, X. S. Xie, and N. Grantcharova for helpful suggestions and to members of the Elf lab for comments on the manuscript. This work was supported by the European Research Council, the Swedish Foundation for Strategic Research (SSF), the Swedish Research Council (VR), Goran Gustafssons Stiftelse, EMBO young investigator programme, and the Knut and Alice Wallenberg Foundation. A. M. was funded by the Centre for Interdisciplinary Mathematics, Uppsala University.	BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Czarniecki D, 1997, J BACTERIOL, V179, P423, DOI 10.1128/jb.179.2.423-429.1997; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; HSIEH WT, 1987, J BIOL CHEM, V262, P14583; Jeltsch A, 1996, EMBO J, V15, P5104, DOI 10.1002/j.1460-2075.1996.tb00891.x; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; Li GW, 2009, NAT PHYS, V5, P294, DOI 10.1038/NPHYS1222; RICHEY B, 1987, J BIOL CHEM, V262, P7157; RICHTER PH, 1974, BIOPHYS CHEM, V2, P255, DOI 10.1016/0301-4622(74)80050-5; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; RIMSKY S, 1990, BIOCHEMISTRY-US, V29, P3765, DOI 10.1021/bi00467a024; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030	20	281	285	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1595	1598		10.1126/science.1221648	http://dx.doi.org/10.1126/science.1221648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723426				2022-12-01	WOS:000305507500062
J	Rappuoli, R; Dormitzer, PR				Rappuoli, Rino; Dormitzer, Philip R.			Influenza: Options to Improve Pandemic Preparation	SCIENCE			English	Editorial Material							SEASONAL INFLUENZA; YOUNG-CHILDREN; VACCINE; VIRUS; HEMAGGLUTININS; INFECTIONS; CELLS	Science and society have been struggling to find a way to protect humankind from recurring epidemics and pandemics of influenza. Here, we review the options available in the short term and also briefly address the solutions that research may make available in the long term.	[Rappuoli, Rino] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Dormitzer, Philip R.] Novartis Vaccines & Diagnost, Cambridge, MA 02139 USA	Novartis; Novartis	Rappuoli, R (corresponding author), Novartis Vaccines & Diagnost, I-53100 Siena, Italy.	rino.rappuoli@novartis.com						CDC, 2009, UPD CDC EST 2009 H1N; CDC, 2012, SEAS INFL FLU VIEW 2; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Couch RB, 2012, CLIN INFECT DIS, V54, P311, DOI 10.1093/cid/cir809; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Kawaoka Y, 2012, NATURE, V482, P155, DOI 10.1038/nature10884; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Lorbetskie B, 2011, VACCINE, V29, P3377, DOI 10.1016/j.vaccine.2011.02.090; Mustaquim D., 2010, Morbidity and Mortality Weekly Report, V59, P901; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Osterholm MT, 2012, J INFECT DIS, V205, P1636, DOI 10.1093/infdis/jis259; Palese P, 2012, P NATL ACAD SCI USA, V109, P2211, DOI 10.1073/pnas.1121297109; Perez DR, 2012, SCIENCE, V335, P799, DOI 10.1126/science.1219066; Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P223; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331; WHO, 2009, INFL SEAS; Williams TL, 2008, VACCINE, V26, P2510, DOI 10.1016/j.vaccine.2008.03.014; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	23	58	60	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1531	1533		10.1126/science.1221466	http://dx.doi.org/10.1126/science.1221466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723412				2022-12-01	WOS:000305507500046
J	LeBlanc, PM; Hollinger, KA; Klontz, KC				LeBlanc, Pamela M.; Hollinger, Katherine A.; Klontz, Karl C.			Tattoo Ink-Related Infections - Awareness, Diagnosis, Reporting, and Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[LeBlanc, Pamela M.; Hollinger, Katherine A.; Klontz, Karl C.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	US Food & Drug Administration (FDA)	LeBlanc, PM (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA.							[Anonymous], 2012, ONE 5 US ADULTS NOW; Armstrong ML, 2005, J ENVIRON HEALTH, V67, P38; Drage LA, 2010, J AM ACAD DERMATOL, V62, P501, DOI 10.1016/j.jaad.2009.03.034; Food and Drug Administration, 2010, COSM TATT PERM MAK; Food and Drug Administration, 2012, REP SER PROBL FDA	5	35	35	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					985	987		10.1056/NEJMp1206063	http://dx.doi.org/10.1056/NEJMp1206063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003ZE	22913662				2022-12-01	WOS:000308649100003
J	Chen, ZH; Schaap, P				Chen, Zhi-hui; Schaap, Pauline			The prokaryote messenger c-di-GMP triggers stalk cell differentiation in Dictyostelium	NATURE			English	Article							GENE-EXPRESSION; PHYLOGENY; PHOSPHODIESTERASE; EVOLUTION; PATTERN	Cyclic di-(3':5')-guanosine monophosphate (c-di-GMP) is a major prokaryote signalling intermediate that is synthesized by diguanylate cyclases and triggers sessility and biofilm formation(1,2). We detected the first eukaryote diguanylate cyclases in all major groups of Dictyostelia. On food depletion, Dictyostelium discoideum amoebas collect into aggregates, which first transform into migrating slugs and then into sessile fruiting structures(3). These structures consist of a spherical spore mass that is supported by a column of stalk cells and a basal disk. Apolyketide, DIF-1, which induces stalklike cells in vitro, was isolated earlier(4). However, its role in vivo proved recently to be restricted to basal disk formation(5). Here we show that the Dictyostelium diguanylate cyclase, DgcA, produces c-di-GMP as the morphogen responsible for stalk cell differentiation. Dictyostelium discoideum DgcA synthesized c-di-GMP in a GTP-dependent manner and was expressed at the slug tip, which is the site of stalk cell differentiation. Disruption of the DgcA gene blocked the transition from slug migration to fructification and the expression of stalk genes. Fructification and stalk formation were restored by exposing DgcA-null slugs to wild-type secretion products or to c-di-GMP. Moreover, c-di-GMP, but not cyclic di-(3':5')-adenosine monophosphate, induced stalk gene expression in dilute cell monolayers. Apart from identifying the long-elusive stalk-inducing morphogen, our work also identifies a role for c-di-GMP in eukaryotes.	[Chen, Zhi-hui; Schaap, Pauline] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Schaap, P (corresponding author), Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland.	p.schaap@dundee.ac.uk	Schaap, Pauline/M-5355-2019	Schaap, Pauline/0000-0003-4500-2555	Wellcome Trust [090276]; BBSRC [BB/G020426]; BBSRC [BB/E016308/1, BB/G020426/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G020426/1, BB/E016308/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. R. Kay for alerting us to the presence of a putative diguanylate cyclase in the D. discoideum genome. U. Jenal is gratefully acknowledged for advice and an EAL-PDE construct in an early phase of the project. We are grateful to the late H. MacWilliams for plasmids PspA-ile-gal, EcmA-ile-gal and PstO-ile-gal, and to C.Thompson for dmta<SUP>-</SUP> cells. We thank W. Chen and D. Lamont for mass spectrometry and C. Sugden for guidance with qRT-PCR. We are grateful to H. Urushihara and the A. subglobosum genome project (http://acytodb.biol.tsukuba.ac.jp/cgi-bin/index.cgi?org=as) for the A. subglobosum DgcA sequence. This research was supported by Wellcome Trust Project grant 090276 and BBSRC grant BB/G020426.	Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; BROOKMAN JJ, 1982, DEV BIOL, V91, P191, DOI 10.1016/0012-1606(82)90022-7; CECCARELLI A, 1991, CELL, V65, P983, DOI 10.1016/0092-8674(91)90550-I; Ceccarelli A, 2000, DIFFERENTIATION, V66, P189, DOI 10.1111/j.1432-0436.2000.660405.x; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; EARLY AE, 1988, MOL CELL BIOL, V8, P3458, DOI 10.1128/MCB.8.8.3458; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; HARWOOD AJ, 1990, NUCLEIC ACIDS RES, V18, P4292, DOI 10.1093/nar/18.14.4292; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Meima ME, 2002, MOL BIOL CELL, V13, P3870, DOI 10.1091/mbc.E02-05-0285; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; RAPER KENNETH B., 1952, BULL TORREY BOT CLUB, V79, P25, DOI 10.2307/2482103; RICHARDSON DL, 1992, GENE DEV, V6, P1058, DOI 10.1101/gad.6.6.1058; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Saito T, 2008, DEV BIOL, V317, P444, DOI 10.1016/j.ydbio.2008.02.036; SCHAAP P, 1993, J BIOL CHEM, V268, P6323; Schaap P, 2007, BIOESSAYS, V29, P635, DOI 10.1002/bies.20599; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Shadwick LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006754; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; WANG M, 1988, DEVELOPMENT, V103, P611; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714; WILLIAMS JG, 1987, CELL, V49, P185, DOI 10.1016/0092-8674(87)90559-9	27	76	80	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					680	683		10.1038/nature11313	http://dx.doi.org/10.1038/nature11313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22864416	Green Accepted			2022-12-01	WOS:000308095100061
J	Black, ME				Black, Mary E.			An Olympic legacy for couch potatoes?	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 20	2012	345								e5578	10.1136/bmj.e5578	http://dx.doi.org/10.1136/bmj.e5578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GL	22906869				2022-12-01	WOS:000308072800004
J	Wedzicha, JA; Vestbo, J				Wedzicha, Jadwiga A.; Vestbo, Jorgen			Can patients with COPD self-manage?	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; EXACERBATIONS; IMPACT; CARE		[Wedzicha, Jadwiga A.] UCL, Ctr Resp Med, London NW3 2PF, England; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Vestbo, Jorgen] Univ So Denmark, Odense, Denmark	University of London; University College London; University of Manchester; University of Southern Denmark	Wedzicha, JA (corresponding author), UCL, Ctr Resp Med, Royal Free Campus, London NW3 2PF, England.	w.wedzicha@ucl.ac.uk	Vestbo, Jorgen/Y-2912-2019	Vestbo, Jorgen/0000-0001-6355-6362				Aaron SD, 2012, THORAX, V67, P238, DOI 10.1136/thoraxjnl-2011-200768; Bischoff EWMA, 2011, THORAX, V66, P26, DOI 10.1136/thx.2009.127621; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Bucknall CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1060; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Jeppesen E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003573.pub2; Patel ARC, 2012, CHEST, V141, P851, DOI 10.1378/chest.11-0853; Price LC, 2006, THORAX, V61, P837, DOI 10.1136/thx.2005.049940; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC	11	13	13	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					624	625		10.1016/S0140-6736(12)61339-7	http://dx.doi.org/10.1016/S0140-6736(12)61339-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901870				2022-12-01	WOS:000307721000005
J	Hulsmann, BB; Labokha, AA; Gorlich, D				Huelsmann, Bastian B.; Labokha, Aksana A.; Goerlich, Dirk			The Permeability of Reconstituted Nuclear Pores Provides Direct Evidence for the Selective Phase Model	CELL			English	Article							REPEAT REGIONS; IMPORTIN-BETA; NUCLEOPORIN NUP98; STRUCTURAL BASIS; DNA-REPLICATION; SINGLE-MOLECULE; XENOPUS EGGS; COMPLEX; TRANSPORT; PROTEIN	Nuclear pore complexes (NPCs) maintain a permeability barrier between the nucleus and the cytoplasm through FG-repeat-containing nucleoporins (Nups). We previously proposed a "selective phase model" in which the FG repeats interact with one another to form a sieve-like barrier that can be locally disrupted by the binding of nuclear transport receptors (NTRs), but not by inert macromolecules, allowing selective passage of NTRs and associated cargo. Here, we provide direct evidence for this model in a physiological context. By using NPCs reconstituted from Xenopus laevis egg extracts, we show that Nup98 is essential for maintaining the permeability barrier. Specifically, the multivalent cohesion between FG repeats is required, including cohesive FG repeats close to the anchorage point to the NPC scaffold. Our data exclude alternative models that are based solely on an interaction between the FG repeats and NTRs and indicate that the barrier is formed by a sieve-like FG hydrogel.	[Huelsmann, Bastian B.; Labokha, Aksana A.; Goerlich, Dirk] Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany	Max Planck Society	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Logist, Fassberg 11, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210				Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; CORDES VC, 1995, EUR J CELL BIOL, V68, P240; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; GROTE M, 1995, J CELL SCI, V108, P2963; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; Lu ZH, 1997, J CELL SCI, V110, P2745; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Milles S, 2011, BIOPHYS J, V101, P1710, DOI 10.1016/j.bpj.2011.08.025; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tu LC, 2011, BBA-MOL CELL RES, V1813, P1607, DOI 10.1016/j.bbamcr.2010.12.011; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; WATSON ML, 1954, BIOCHIM BIOPHYS ACTA, V15, P475, DOI 10.1016/0006-3002(54)90004-9; Weis K, 2007, CELL, V130, P405, DOI 10.1016/j.cell.2007.07.029; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Zhou HX, 2001, J PHYS CHEM B, V105, P6763, DOI 10.1021/jp011355n	64	190	191	1	74	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					738	751		10.1016/j.cell.2012.07.019	http://dx.doi.org/10.1016/j.cell.2012.07.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901806	Bronze			2022-12-01	WOS:000308002300009
J	O'Neill, D				O'Neill, Desmond			To Live (and Die) as an Original	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				[Anonymous], 1990, SUCCESSFUL AGEING PE; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Katsushika H, 1988, HOKUSAI 100 VIEWS MT; O'Neill D, 2009, BMJ-BRIT MED J, V339, pb4215; O'Neill D, 2011, LANCET, V377, P1828, DOI 10.1016/S0140-6736(11)60612-0	5	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					679	680		10.1001/jama.2012.9200	http://dx.doi.org/10.1001/jama.2012.9200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893164				2022-12-01	WOS:000307496700022
J	Dumont, S; Salmon, ED; Mitchison, TJ				Dumont, Sophie; Salmon, E. D.; Mitchison, Timothy J.			Deformations Within Moving Kinetochores Reveal Different Sites of Active and Passive Force Generation	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; DIRECTIONAL INSTABILITY; MITOTIC SPINDLE; CHROMOSOME; MICROTUBULES; ARCHITECTURE; DYNAMICS; MOTILITY; ANAPHASE; TENSION	Kinetochores mediate chromosome segregation at mitosis. They are thought to contain both active, force-producing and passive, frictional interfaces with microtubules whose relative locations have been unclear. We inferred mechanical deformation within single kinetochores during metaphase oscillations by measuring average separations between fluorescently labeled kinetochore subunits in living cells undergoing mitosis. Inter-subunit distances were shorter in kinetochores moving toward poles than in those moving away. Inter-subunit separation decreased abruptly when kinetochores switched to poleward movement and decreased further when pulling force increased, suggesting that active force generation during poleward movement compresses kinetochores. The data revealed an active force-generating interface within kinetochores and a separate passive frictional interface located at least 20 nanometers away poleward. Together, these interfaces allow persistent attachment with intermittent active force generation.	[Dumont, Sophie; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Salmon, E. D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Dumont, S (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	sophie.dumont@ucsf.edu			Charles A. King Trust; Bank of America; NIH [K99GM094335, R37GM024364, R01GM039565]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024364, K99GM094335, R37GM039565, R01GM039565] Funding Source: NIH RePORTER	Charles A. King Trust; Bank of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Shah for the stable Ptk2 EYFP-Cdc20 line, C. Carroll and A. Straight for the mCherry-CenpC construct, J. DeLuca for Hec1 constructs, X. Wan for sharing SpeckleTracker, and M. Kirschner for equipment loan. We thank I. Cheeseman, P. Choi, S. Churchman, J. DeLuca, M. Ginzberg, Q. Justman, J. Shah, X. Wan, and J. Waters (HMS Nikon Imaging Center) for discussions. S. D. was supported by the Charles A. King Trust, Bank of America and by NIH K99GM094335; E. D. S. was supported by NIH R37GM024364; and T. J. M. was supported by NIH R01GM039565. Data are presented in the supplementary materials.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Dumont S, 2009, CURR BIOL, V19, P1086, DOI 10.1016/j.cub.2009.05.056; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LaFountain JR, 2004, MOL BIOL CELL, V15, P5724, DOI 10.1091/mbc.E04-08-0750; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schittenhelm RB, 2007, CHROMOSOMA, V116, P385, DOI 10.1007/s00412-007-0103-y; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.E02-04-0236; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Venkei Z, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110032; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035	25	70	70	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					355	358		10.1126/science.1221886	http://dx.doi.org/10.1126/science.1221886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22722252	Green Submitted, Green Accepted			2022-12-01	WOS:000306542600055
J	Esbjornsson, J; Mansson, F; Kvist, A; Isberg, PE; Nowroozalizadeh, S; Biague, AJ; da Silva, ZJ; Jansson, M; Fenyo, EM; Norrgren, H; Medstrand, P				Esbjornsson, Joakim; Mansson, Fredrik; Kvist, Anders; Isberg, Per-Erik; Nowroozalizadeh, Salma; Biague, Antonio J.; da Silva, Zacarias J.; Jansson, Marianne; Fenyo, Eva Maria; Norrgren, Hans; Medstrand, Patrik			Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; WEST-AFRICA; GUINEA-BISSAU; VIRAL LOAD; PROTECTION; DIVERSITY; EVOLUTION; INDIVIDUALS; ACTIVATION; SENEGAL	BACKGROUND Progressive immune dysfunction and the acquired immunodeficiency syndrome (AIDS) develop in most persons with untreated infection with human immunodeficiency virus type 1 (HIV-1) but in only approximately 20 to 30% of persons infected with HIV type 2 (HIV-2); among persons infected with both types, the natural history of disease progression is poorly understood. METHODS We analyzed data from 223 participants who were infected with HIV-1 after enrollment (with either HIV-1 infection alone or HIV-1 and HIV-2 infection) in a cohort with a long follow-up duration (approximately 20 years), according to whether HIV-2 infection occurred first, the time to the development of AIDS (time to AIDS), CD4+ and CD8+ T-cell counts, and measures of viral evolution. RESULTS The median time to AIDS was 104 months (95% confidence interval [CI], 75 to 133) in participants with dual infection and 68 months (95% CI, 60 to 76) in participants infected with HIV-1 only (P = 0.003). CD4+ T-cell levels were higher and CD8+ T-cell levels increased at a lower rate among participants with dual infection, reflecting slower disease progression. Participants with dual infection with HIV-2 infection preceding HIV-1 infection had the longest time to AIDS and highest levels of CD4+ T-cell counts. HIV-1 genetic diversity was significantly lower in participants with dual infections than in those with HIV-1 infection alone at similar time points after infection. CONCLUSIONS Our results suggest that HIV-1 disease progression is inhibited by concomitant HIV-2 infection and that dual infection is associated with slower disease progression. The slower rate of disease progression was most evident in participants with dual infection in whom HIV-2 infection preceded HIV-1 infection. These findings could have implications for the development of HIV-1 vaccines and therapeutics. (Funded by the Swedish International Development Cooperation Agency-Swedish Agency for Research Cooperation with Developing Countries and others.)	[Esbjornsson, Joakim; Medstrand, Patrik] Lund Univ, Sect Mol Virol, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Kvist, Anders] Lund Univ, Dept Clin Sci, Sect Oncol, SE-22184 Lund, Sweden; [Kvist, Anders] Skane Univ Hosp, Lund, Sweden; [Isberg, Per-Erik] Lund Univ, Dept Stat, Sch Econ & Management, SE-22184 Lund, Sweden; [Jansson, Marianne; Fenyo, Eva Maria] Lund Univ, Dept Lab Med Lund, Div Med Microbiol, SE-22184 Lund, Sweden; [Norrgren, Hans] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Mansson, Fredrik] Lund Univ, Dept Clin Sci Malmo, Infect Dis Res Unit, Malmo, Sweden; [Medstrand, Patrik] Lund Univ, Dept Lab Med Malmo, Malmo, Sweden; [Nowroozalizadeh, Salma; Jansson, Marianne] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Biague, Antonio J.; da Silva, Zacarias J.] Natl Publ Hlth Lab, Bissau, Guinea Bissau	Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Lund University; Lund University; Karolinska Institutet	Esbjornsson, J (corresponding author), Lund Univ, Sect Mol Virol, Dept Expt Med Sci, BMC C13,Solvegatan 19, SE-22184 Lund, Sweden.	joakim.esbjornsson@med.lu.se	Esbjörnsson, Joakim/H-3219-2019	Norrgren, Hans/0000-0001-5780-530X; Esbjornsson, Joakim/0000-0002-6088-7796; Esbjornsson, Joakim/0000-0002-3822-4953; Jansson, Marianne/0000-0001-6536-8146; Kvist, Anders/0000-0002-1358-0695	Swedish International Development Cooperation Agency-Swedish Agency for Research Cooperation with Developing Countries; Swedish Research Council; Crafoord Foundation; Royal Physiographic Society; Lars Hierta Memorial Foundation; Konsul Thure Carlsson Fund for Medical Research; Tegger Foundation; Medical Faculty of Lund University; Region Skane	Swedish International Development Cooperation Agency-Swedish Agency for Research Cooperation with Developing Countries; Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Physiographic Society; Lars Hierta Memorial Foundation; Konsul Thure Carlsson Fund for Medical Research; Tegger Foundation; Medical Faculty of Lund University; Region Skane	Supported by grants from the Swedish International Development Cooperation Agency-Swedish Agency for Research Cooperation with Developing Countries, the Swedish Research Council, the Crafoord Foundation, the Royal Physiographic Society, the Lars Hierta Memorial Foundation, Konsul Thure Carlsson Fund for Medical Research, the Tegger Foundation, the Medical Faculty of Lund University, and the regional agreement on medical training and clinical research between Region Skane and the Medical Faculty of Lund University.	Akimoto H, 1998, IMMUNOLOGY, V95, P214, DOI 10.1046/j.1365-2567.1998.00537.x; Al-Harthi L, 1998, AIDS RES HUM RETROV, V14, P59, DOI 10.1089/aid.1998.14.59; Andersson S, 1997, AIDS, V11, P1815, DOI 10.1097/00002030-199715000-00005; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Arya SK, 1996, P NATL ACAD SCI USA, V93, P4486, DOI 10.1073/pnas.93.9.4486; Bello G, 2007, AIDS RES HUM RETROV, V23, P1242, DOI 10.1089/aid.2007.0074; Cavaleiro R, 2000, AIDS, V14, P2679, DOI 10.1097/00002030-200012010-00007; de Silva Thushan I., 2010, HIV Therapy, V4, P305, DOI 10.2217/HIV.10.26; DECOCK KM, 1994, JAMA-J AM MED ASSOC, V271, P196; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Greenberg AE, 2001, AIDS, V15, P2319, DOI 10.1097/00002030-200111230-00015; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Kokkotou EG, 2000, P NATL ACAD SCI USA, V97, P6797, DOI 10.1073/pnas.97.12.6797; Lee HY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000240; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Mansson F, 2009, AIDS, V23, P1575, DOI 10.1097/QAD.0b013e32832cedfb; Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Norrgren H, 1999, AIDS, V13, P701, DOI 10.1097/00002030-199904160-00011; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; O'Donovan D, 2000, AIDS, V14, P441, DOI 10.1097/00002030-200003100-00019; Otten RA, 2004, AIDS, V18, P1127, DOI 10.1097/00002030-200405210-00006; PUTKONEN P, 1990, AIDS, V4, P783, DOI 10.1097/00002030-199008000-00010; Sahin GO, 2012, J VIROL, V86, P961, DOI 10.1128/JVI.06315-11; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; TRAVERS K, 1995, SCIENCE, V268, P1833; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; WEISS RA, 1988, AIDS, V2, P95, DOI 10.1097/00002030-198804000-00004; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; World Health Organization, 2007, WHO CASE DEFINITIONS; Zheng NN, 2007, J VIROL, V81, P9061, DOI 10.1128/JVI.00117-07; Zheng NN, 2004, J VIROL, V78, P13934, DOI 10.1128/JVI.78.24.13934-13942.2004	40	68	68	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2012	367	3					224	232		10.1056/NEJMoa1113244	http://dx.doi.org/10.1056/NEJMoa1113244			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	975PI	22808957				2022-12-01	WOS:000306522900006
J	Tsai, A; Petrov, A; Marshall, RA; Korlach, J; Uemura, S; Puglisi, JD				Tsai, Albert; Petrov, Alexey; Marshall, R. Andrew; Korlach, Jonas; Uemura, Sotaro; Puglisi, Joseph D.			Heterogeneous pathways and timing of factor departure during translation initiation	NATURE			English	Article							TRANSFER-RNA; PROTEIN-SYNTHESIS; GUANOSINE TRIPHOSPHATE; COMPLEX-FORMATION; FACTOR IF2; REAL-TIME; RIBOSOME; BACTERIA; GUIDES	The initiation of translation establishes the reading frame for protein synthesis and is a key point of regulation(1). Initiation involves factor-driven assembly at a start codon of a messenger RNA of an elongation-competent 70S ribosomal particle (in bacteria) from separated 30S and 50S subunits and initiator transfer RNA. Here we establish in Escherichia coli, using direct single-molecule tracking, the timing of initiator tRNA, initiation factor 2 (IF2; encoded by infB) and 50S subunit joining during initiation. Our results show multiple pathways to initiation, with orders of arrival of tRNA and IF2 dependent on factor concentration and composition. IF2 accelerates 50S subunit joining and stabilizes the assembled 70S complex. Transition to elongation is gated by the departure of IF2 after GTP hydrolysis, allowing efficient arrival of elongator tRNAs to the second codon presented in the aminoacyl-tRNA binding site (A site). These experiments highlight the power of single-molecule approaches to delineate mechanisms in complex multicomponent systems.	[Tsai, Albert; Petrov, Alexey; Marshall, R. Andrew; Uemura, Sotaro; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Tsai, Albert] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Marshall, R. Andrew] McKinsey & Co Silicon Valley, Palo Alto, CA 94304 USA; [Korlach, Jonas] Pacific Biosci, Menlo Pk, CA 94025 USA; [Uemura, Sotaro] RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Puglisi, Joseph D.] Stanford Univ, Sch Med, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA	Stanford University; Stanford University; RIKEN; Stanford University	Uemura, S (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	s-uemura@gsc.riken.jp; puglisi@stanford.edu		Tsai, Albert/0000-0002-1643-0780	National Institutes of Health [GM51266]; Japan Science and Technology Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099687, R01GM051266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health grant GM51266 (J.D.P.) and the Japan Science and Technology Agency (S.U.).	Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Antoun A, 2003, EMBO J, V22, P5593, DOI 10.1093/emboj/cdg525; Antoun A, 2006, EMBO J, V25, P2539, DOI 10.1038/sj.emboj.7601140; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Caserta E, 2006, J MOL BIOL, V362, P787, DOI 10.1016/j.jmb.2006.07.043; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; LOCKWOOD AH, 1971, P NATL ACAD SCI USA, V68, P3122, DOI 10.1073/pnas.68.12.3122; LOCKWOOD AH, 1972, P NATL ACAD SCI USA, V69, P3602, DOI 10.1073/pnas.69.12.3602; Marshall R. A., 2008, THESIS STANFORD U; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; Milon P, 2010, EMBO REP, V11, P312, DOI 10.1038/embor.2010.12; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; PETERSEN HU, 1979, BIOCHEM BIOPH RES CO, V91, P1068, DOI 10.1016/0006-291X(79)91989-2; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925	18	68	68	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					390	394		10.1038/nature11172	http://dx.doi.org/10.1038/nature11172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722848	Green Accepted			2022-12-01	WOS:000306506500048
J	He, XM; Aizenberg, M; Kuksenok, O; Zarzar, LD; Shastri, A; Balazs, AC; Aizenberg, J				He, Ximin; Aizenberg, Michael; Kuksenok, Olga; Zarzar, Lauren D.; Shastri, Ankita; Balazs, Anna C.; Aizenberg, Joanna			Synthetic homeostatic materials with chemo-mechano-chemical self-regulation	NATURE			English	Article								Living organisms have unique homeostatic abilities, maintaining tight control of their local environment through interconversions of chemical and mechanical energy and self-regulating feedback loops organized hierarchically across many length scales(1-7). In contrast, most synthetic materials are incapable of continuous self-monitoring and self-regulating behaviour owing to their limited single-directional chemomechanical(7-12) or mechanochemical(13,14) modes. Applying the concept of homeostasis to the design of autonomous materials(15) would have substantial impacts in areas ranging from medical implants that help stabilize bodily functions to 'smart' materials that regulate energy usage(2,16,17). Here we present a versatile strategy for creating self-regulating, self-powered, homeostatic materials capable of precisely tailored chemo-mechanochemical feedback loops on the nano- or microscale. We design a bilayer system with hydrogel-supported, catalyst-bearing microstructures, which are separated from a reactant-containing 'nutrient' layer. Reconfiguration of the gel in response to a stimulus induces the reversible actuation of the microstructures into and out of the nutrient layer, and serves as a highly precise 'on/off' switch for chemical reactions. We apply this design to trigger organic, inorganic and biochemical reactions that undergo reversible, repeatable cycles synchronized with the motion of the microstructures and the driving external chemical stimulus. By exploiting a continuous feedback loop between various exothermic catalytic reactions in the nutrient layer and the mechanical action of the temperature-responsive gel, we then create exemplary autonomous, self-sustained homeostatic systems that maintain a user-defined parameter-temperature-in a narrow range. The experimental results are validated using computational modelling that qualitatively captures the essential features of the self-regulating behaviour and provides additional criteria for the optimization of the homeostatic function, subsequently confirmed experimentally. This design is highly customizable owing to the broad choice of chemistries, tunable mechanics and its physical simplicity, and may lead to a variety of applications in autonomous systems with chemo-mechano-chemical transduction at their core.	[He, Ximin; Aizenberg, Joanna] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [He, Ximin; Aizenberg, Michael; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA; [Kuksenok, Olga; Balazs, Anna C.] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15260 USA; [Zarzar, Lauren D.; Shastri, Ankita; Aizenberg, Joanna] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University	Aizenberg, J (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	jaiz@seas.harvard.edu	Zarzar, Lauren D./C-4239-2019; Kuksenok, Olga/L-9234-2018; He, Ximin/D-3533-2017	Kuksenok, Olga/0000-0002-1895-5206; He, Ximin/0000-0001-8845-4637; Zarzar, Lauren/0000-0002-3287-3602; Aizenberg, Michael/0000-0002-2901-7012; Balazs, Anna/0000-0002-5555-2692	US DOE [DE-SC0005247]; US NSF [CMMI-1124839]	US DOE(United States Department of Energy (DOE)); US NSF(National Science Foundation (NSF))	We thank P. Kim for assistance with the gel formulation, M. Khan for microstructure fabrication, R. S. Friedlander for assistance with confocal imaging, M. Kolle and A. Ehrlicher for technical assistance, and A. Grinthal for help with manuscript preparation. The work was supported by the US DOE under award DE-SC0005247 (experiment) and by the US NSF under award CMMI-1124839 (computational modelling).	Ariga K, 2011, CHEM SCI, V2, P195, DOI 10.1039/c0sc00300j; Bao G, 2010, CELL MOL BIOENG, V3, P91, DOI 10.1007/s12195-010-0109-z; Das M, 2006, ADV MATER, V18, P80, DOI 10.1002/adma.200501043; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Guyton A. C., 1997, HUMAN PHYSL MECH DIS, P3; Harris TJ, 1999, J PROCESS CONTR, V9, P1, DOI 10.1016/S0959-1524(98)00031-6; Hess H, 2011, ANNU REV BIOMED ENG, V13, P429, DOI 10.1146/annurev-bioeng-071910-124644; Horvath J, 2011, SOFT MATTER, V7, P8462, DOI 10.1039/c1sm05226h; Koga S, 2011, NAT CHEM, V3, P720, DOI [10.1038/NCHEM.1110, 10.1038/nchem.1110]; Kovacs K, 2009, J PHYS CHEM A, V113, P146, DOI 10.1021/jp807840g; Kuksenok O, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041406; Lahann J, 2005, MRS BULL, V30, P185, DOI 10.1557/mrs2005.50; Li DB, 2009, MRS BULL, V34, P671, DOI 10.1557/mrs2009.179; Maeda S, 2007, ADV MATER, V19, P3480, DOI 10.1002/adma.200700625; Murthy N, 2003, P NATL ACAD SCI USA, V100, P4995, DOI 10.1073/pnas.0930644100; Nayak S, 2004, J AM CHEM SOC, V126, P10258, DOI 10.1021/ja0474143; OKANO T, 1990, J CONTROL RELEASE, V11, P255, DOI 10.1016/0168-3659(90)90138-J; Paxton WF, 2006, ANGEW CHEM INT EDIT, V45, P5420, DOI 10.1002/anie.200600060; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Richter A, 2008, SENSORS-BASEL, V8, P561, DOI 10.3390/s8010561; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; Siegel RA, 2009, NATO SCI PEACE SEC A, P175, DOI 10.1007/978-90-481-2993-5_7; SPAET TH, 1966, BLOOD-J HEMATOL, V28, P112, DOI 10.1182/blood.V28.1.112.112; Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]; Todres Z.V., 2006, ORGANIC MECHANOCHEMI, DOI [DOI 10.1201/9781420005882, 10.1201/9781420005882]; Vanag VK, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016201; Yashin VV, 2006, SCIENCE, V314, P798, DOI 10.1126/science.1132412; Yashin VV, 2010, PROG POLYM SCI, V35, P155, DOI 10.1016/j.progpolymsci.2009.10.003; Yerushalmi R, 2005, J MATER CHEM, V15, P4480, DOI 10.1039/b505212b; Zarzar LD, 2011, ADV MATER, V23, P1442, DOI 10.1002/adma.201004231	33	337	341	23	573	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					214	218		10.1038/nature11223	http://dx.doi.org/10.1038/nature11223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22785318	Green Submitted			2022-12-01	WOS:000306278900035
J	Morrow, M; Harris, JR; Schnitt, SJ				Morrow, Monica; Harris, Jay R.; Schnitt, Stuart J.			Surgical Margins in Lumpectomy for Breast Cancer - Bigger Is Not Better	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							20-YEAR FOLLOW-UP; ESTROGEN-RECEPTOR; CONSERVING THERAPY; PROGESTERONE-RECEPTOR; RADICAL-MASTECTOMY; ADJUVANT BREAST; RECURRENCE; WOMEN; RADIATION; EXCISION		[Morrow, Monica] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Harris, Jay R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Harris, Jay R.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Schnitt, Stuart J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Harris, Jay R.; Schnitt, Stuart J.] Harvard Univ, Sch Med, Boston, MA USA	Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Morrow, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.							Abdulkarim BS, 2011, J CLIN ONCOL, V29, P2852, DOI 10.1200/JCO.2010.33.4714; Anderson SJ, 2009, J CLIN ONCOL, V27, P2466, DOI 10.1200/JCO.2008.19.8424; Arriagada R, 1996, J CLIN ONCOL, V14, P1558, DOI 10.1200/JCO.1996.14.5.1558; Azu M, 2010, ANN SURG ONCOL, V17, P558, DOI 10.1245/s10434-009-0765-1; Blichert-Toft M, 1992, J Natl Cancer Inst Monogr, P19; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Fisher B, 1996, J CLIN ONCOL, V14, P1982, DOI 10.1200/JCO.1996.14.7.1982; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Gage I, 1996, CANCER-AM CANCER SOC, V78, P1921, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO;2-#; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Ho AY, 2012, CANCER          0305; HOLLAND R, 1990, J CLIN ONCOL, V8, P113, DOI 10.1200/JCO.1990.8.1.113; HOLLAND R, 1985, CANCER, V56, P979, DOI 10.1002/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Houssami N, 2010, EUR J CANCER, V46, P3219, DOI 10.1016/j.ejca.2010.07.043; Hwang N, 2009, ANN SURG ONCOL, V16, P3000, DOI 10.1245/s10434-009-0607-1; Kyndi M, 2008, J CLIN ONCOL, V26, P1419, DOI 10.1200/JCO.2007.14.5565; Mamounas EP, 2010, J CLIN ONCOL, V28, P1677, DOI 10.1200/JCO.2009.23.7610; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Morrow M, 2012, JAMA-J AM MED ASSOC, V307, P509, DOI 10.1001/jama.2012.74; Morrow M, 2009, JAMA-J AM MED ASSOC, V302, P1551, DOI 10.1001/jama.2009.1450; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Nguyen PL, 2008, J CLIN ONCOL, V26, P3110; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Poggi MM, 2003, CANCER, V98, P697, DOI 10.1002/cncr.11580; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; SCHNITT SJ, 1987, CANCER, V59, P675, DOI 10.1002/1097-0142(19870215)59:4<675::AID-CNCR2820590402>3.0.CO;2-U; Solin LJ, 2008, J CLIN ONCOL, V26, P386, DOI 10.1200/JCO.2006.09.5448; Taghian A, 2005, ANN SURG, V241, P629, DOI 10.1097/01.sla.0000157272.04803.1b; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; VICINI F, 1991, ANN SURG, V214, P200, DOI 10.1097/00000658-199109000-00002; Vicini FA, 2004, INT J RADIAT ONCOL, V60, P86, DOI 10.1016/j.ijrobp.2004.02.002	35	132	134	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 5	2012	367	1					79	82		10.1056/NEJMsb1202521	http://dx.doi.org/10.1056/NEJMsb1202521			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968KJ	22762325				2022-12-01	WOS:000305979400013
J	Coombes, R				Coombes, Rebecca			NHS REFORMS How will secondary care need to shape up to survive? A roundtable discussion	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 27	2012	344								e4384	10.1136/bmj.e4384	http://dx.doi.org/10.1136/bmj.e4384			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MX	22740570				2022-12-01	WOS:000305987100026
J	Ellis, MJ; Ding, L; Shen, D; Luo, JQ; Suman, VJ; Wallis, JW; Van Tine, BA; Hoog, J; Goiffon, RJ; Goldstein, TC; Ng, S; Lin, L; Crowder, R; Snider, J; Ballman, K; Weber, J; Chen, K; Koboldt, DC; Kandoth, C; Schierding, WS; McMichael, JF; Miller, CA; Lu, C; Harris, CC; McLellan, MD; Wendl, MC; DeSchryver, K; Allred, DC; Esserman, L; Unzeitig, G; Margenthaler, J; Babiera, GV; Marcom, PK; Guenther, JM; Leitch, M; Hunt, K; Olson, J; Tao, Y; Maher, CA; Fulton, LL; Fulton, RS; Harrison, M; Oberkfell, B; Du, FY; Demeter, R; Vickery, TL; Elhammali, A; Piwnica-Worms, H; McDonald, S; Watson, M; Dooling, DJ; Ota, D; Chang, LW; Bose, R; Ley, TJ; Piwnica-Worms, D; Stuart, JM; Wilson, RK; Mardis, ER				Ellis, Matthew J.; Ding, Li; Shen, Dong; Luo, Jingqin; Suman, Vera J.; Wallis, John W.; Van Tine, Brian A.; Hoog, Jeremy; Goiffon, Reece J.; Goldstein, Theodore C.; Ng, Sam; Lin, Li; Crowder, Robert; Snider, Jacqueline; Ballman, Karla; Weber, Jason; Chen, Ken; Koboldt, Daniel C.; Kandoth, Cyriac; Schierding, William S.; McMichael, Joshua F.; Miller, Christopher A.; Lu, Charles; Harris, Christopher C.; McLellan, Michael D.; Wendl, Michael C.; DeSchryver, Katherine; Allred, D. Craig; Esserman, Laura; Unzeitig, Gary; Margenthaler, Julie; Babiera, G. V.; Marcom, P. Kelly; Guenther, J. M.; Leitch, Marilyn; Hunt, Kelly; Olson, John; Tao, Yu; Maher, Christopher A.; Fulton, Lucinda L.; Fulton, Robert S.; Harrison, Michelle; Oberkfell, Ben; Du, Feiyu; Demeter, Ryan; Vickery, Tammi L.; Elhammali, Adnan; Piwnica-Worms, Helen; McDonald, Sandra; Watson, Mark; Dooling, David J.; Ota, David; Chang, Li-Wei; Bose, Ron; Ley, Timothy J.; Piwnica-Worms, David; Stuart, Joshua M.; Wilson, Richard K.; Mardis, Elaine R.			Whole-genome analysis informs breast cancer response to aromatase inhibition	NATURE			English	Article							MYELOID-LEUKEMIA GENOME; CELL LUNG-CANCER; ENDOCRINE THERAPY; SUPPRESSOR GENE; MUTATION; PATHWAY; PHOSPHORYLATION; MECHANISMS; CARCINOMA; OUTCOMES	To correlate the variable clinical features of oestrogen-receptor-positive breast cancer with somatic alterations, we studied pretreatment tumour biopsies accrued from patients in two studies of neoadjuvant aromatase inhibitor therapy by massively parallel sequencing and analysis. Eighteen significantly mutated genes were identified, including five genes (RUNX1, CBFB, MYH9, MLL3 and SF3B1) previously linked to haematopoietic disorders. Mutant MAP3K1 was associated with luminal A status, low-grade histology and low proliferation rates, whereas mutant TP53 was associated with the opposite pattern. Moreover, mutant GATA3 correlated with suppression of proliferation upon aromatase inhibitor treatment. Pathway analysis demonstrated that mutations in MAP2K4, a MAP3K1 substrate, produced similar perturbations as MAP3K1 loss. Distinct phenotypes in oestrogen-receptor-positive breast cancer are associated with specific patterns of somatic mutations that map into cellular pathways linked to tumour biology, but most recurrent mutations are relatively infrequent. Prospective clinical trials based on these findings will require comprehensive genome sequencing.	[Ellis, Matthew J.; Van Tine, Brian A.; Hoog, Jeremy; Lin, Li; Crowder, Robert; Snider, Jacqueline; Weber, Jason; DeSchryver, Katherine; Maher, Christopher A.; Ley, Timothy J.] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ellis, Matthew J.; Margenthaler, Julie; McDonald, Sandra; Bose, Ron; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Ellis, Matthew J.; Luo, Jingqin; Allred, D. Craig; Chang, Li-Wei; Bose, Ron] Washington Univ, Breast Canc Program, St Louis, MO 63110 USA; [Ding, Li; Shen, Dong; Wallis, John W.; Koboldt, Daniel C.; Kandoth, Cyriac; Schierding, William S.; McMichael, Joshua F.; Miller, Christopher A.; Lu, Charles; Harris, Christopher C.; McLellan, Michael D.; Wendl, Michael C.; Maher, Christopher A.; Fulton, Lucinda L.; Fulton, Robert S.; Harrison, Michelle; Oberkfell, Ben; Du, Feiyu; Demeter, Ryan; Vickery, Tammi L.; Dooling, David J.; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Shen, Dong; Wallis, John W.; Koboldt, Daniel C.; Kandoth, Cyriac; Schierding, William S.; McMichael, Joshua F.; Miller, Christopher A.; Lu, Charles; Harris, Christopher C.; McLellan, Michael D.; Wendl, Michael C.; Fulton, Lucinda L.; Fulton, Robert S.; Harrison, Michelle; Oberkfell, Ben; Du, Feiyu; Demeter, Ryan; Vickery, Tammi L.; Dooling, David J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Dept Genet, St Louis, MO 63108 USA; [Luo, Jingqin; Tao, Yu; Watson, Mark] Washington Univ, Div Biostat, St Louis, MO 63110 USA; [Suman, Vera J.; Ballman, Karla] Mayo Clin, ACOSOG Stat Ctr, Rochester, MN 55905 USA; [Goiffon, Reece J.; Weber, Jason; Elhammali, Adnan; Piwnica-Worms, Helen; Piwnica-Worms, David] Washington Univ, BRIGHT Inst, Sch Med, St Louis, MO 63110 USA; [Goiffon, Reece J.; Elhammali, Adnan; Piwnica-Worms, David] Washington Univ, Mol Imaging Ctr, St Louis, MO 63110 USA; [Goiffon, Reece J.; Elhammali, Adnan; Piwnica-Worms, David] Washington Univ, Malinckrodt Inst Radiol, St Louis, MO 63110 USA; [Goldstein, Theodore C.; Ng, Sam; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Weber, Jason] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Chen, Ken; Babiera, G. V.; Hunt, Kelly] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Allred, D. Craig; Watson, Mark; Chang, Li-Wei] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Esserman, Laura] Univ Calif San Francisco, Helen Diller Canc Ctr, San Francisco, CA 94143 USA; [Unzeitig, Gary] Doctors Hosp Laredo, Laredo, TX 78045 USA; [Marcom, P. Kelly; Olson, John] Duke Univ, Ctr Canc, Durham, NC 27705 USA; [Guenther, J. M.] Good Samaritan Hosp, Cincinnati, OH 45406 USA; [Leitch, Marilyn] Univ Texas SW, Simmons Canc Ctr, Dallas, TX 75390 USA; [Piwnica-Worms, Helen] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [McDonald, Sandra; Watson, Mark] Washington Univ, ACOSOG Cent Specimen Bank, St Louis, MO 63110 USA; [Ota, David] Duke Univ, ACOSOG Operat Ctr, Durham, NC 27705 USA; [Piwnica-Worms, David] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Mayo Clinic; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Santa Cruz; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Duke University; Good Samaritan Hospital - Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Washington University (WUSTL); Duke University; Washington University (WUSTL)	Ellis, MJ (corresponding author), Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA.		Miller, Christopher A./A-1060-2009; Mardis, Elaine/W-2202-2019; van+Tine, Brain/AAI-1919-2019; Wilson, Richard K./AAF-4139-2019; Goiffon, Reece J/C-9686-2013; Marcom, Paul/M-4516-2019; Marcom, Paul/AAE-4761-2020; Piwnica-Worms, Helen/C-5214-2012; Chen, Ken/AAU-1432-2021; Wendl, Michael C/A-2741-2008	Miller, Christopher A./0000-0003-4266-6700; Wilson, Richard K./0000-0002-1992-1358; Goiffon, Reece J/0000-0003-1622-7253; Marcom, Paul/0000-0001-5302-6368; Chen, Ken/0000-0003-4013-5279; Weber, Jason/0000-0002-1069-6983; Schierding, William/0000-0001-5659-2701; Kandoth, Cyriac/0000-0002-1345-3573; Stuart, Joshua/0000-0002-2171-565X; MCLELLAN, MICHAEL/0000-0002-2703-8784	National Human Genome Research Institute (NHGRI) [U54 HG003079]; National Cancer Institute [NCI R01 CA095614, NCI U01 CA114722]; Susan G. Komen Breast Cancer Foundation [BCTR0707808]; Fashion Footwear Charitable Foundation, Inc. [NCI U10 CA076001]; Breast Cancer Research Foundation; Novartis; Pfizer; Center grant [NCI P50 CA94056]; NCI core grant [NCI 3P50 CA68438]; NATIONAL CANCER INSTITUTE [R01CA095614, U24CA143858, U10CA076001, U01CA114722, P30CA091842, P50CA094056, P50CA068438, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Fashion Footwear Charitable Foundation, Inc.; Breast Cancer Research Foundation; Novartis(Novartis); Pfizer(Pfizer); Center grant; NCI core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This article is dedicated to the memory of Evelyn Lauder in recognition of her efforts to eradicate breast cancer. We would like to thank the participating patients and their families, clinical investigators and their support staffs, and J. A. Zujewski and the Cancer Therapy Evaluation Program at the US National Cancer Institute. We would like to acknowledge the efforts of the following people and groups at The Genome Institute for their contributions to this manuscript: the Analysis Pipeline group for developing the automated analysis pipelines that generated alignments and somatic variants; the LIMS group for developing tools to manage validation array ordering, capture and sequencing, and J. Veizer and H. Schmidt for structural variant and recurrent screening analyses. We thank the many members of the Siteman Cancer Center at Washington University in St Louis for support, and the committed members of the American College of Surgeons Oncology Group and their patients for contributing samples to the Z1031 trial. This work was funded by grants to R. K. W. from the National Human Genome Research Institute (NHGRI U54 HG003079), grants to M. J. E. from the National Cancer Institute (NCI R01 CA095614, NCI U01 CA114722), the Susan G. Komen Breast Cancer Foundation (BCTR0707808), and the Fashion Footwear Charitable Foundation, Inc., grant awards to ACOSOG included NCI U10 CA076001, the Breast Cancer Research Foundation, and clinical trial support from Novartis and Pfizer, and a Center grant (NCI P50 CA94056) to D.P.-W. We also acknowledge institutional support in the form of the Washington University Cancer Genome Initiative (R. K. W.), and a productive partnership with Illumina, Inc. The tissue procurement core was supported by an NCI core grant to the Siteman Cancer Center (NCI 3P50 CA68438). The BRIGHT Institute is supported in part by an ATT/Emerson gift to the Siteman Cancer Center.	Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Chia YH, 2010, BRIT J CANCER, V103, P759, DOI 10.1038/sj.bjc.6605845; Dees N., GENOME RES IN PRESS; Delle H, 2012, J AM SOC NEPHROL, V23, P37, DOI 10.1681/ASN.2011010046; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Ellis MJ, 2011, J CLIN ONCOL, V29, P2342, DOI 10.1200/JCO.2010.31.6950; Ellis MJ, 2010, BREAST CANCER RES TR, V119, P379, DOI 10.1007/s10549-009-0575-y; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamant L, 2003, GENE CHROMOSOME CANC, V37, P427, DOI 10.1002/gcc.10232; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Olson JA, 2009, J AM COLL SURGEONS, V208, P906, DOI 10.1016/j.jamcollsurg.2009.01.035; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; PROSSER J, 1990, ONCOGENE, V5, P1573; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Spirin KS, 1996, CANCER RES, V56, P2400; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang XX, 2011, PATHOL ONCOL RES, V17, P429, DOI 10.1007/s12253-010-9316-0; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Widmann C, 1997, ONCOGENE, V15, P2439, DOI 10.1038/sj.onc.1201421; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007	45	753	779	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					353	360		10.1038/nature11143	http://dx.doi.org/10.1038/nature11143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722193	Green Submitted, hybrid, Green Accepted			2022-12-01	WOS:000305466800034
J	Lounkine, E; Keiser, MJ; Whitebread, S; Mikhailov, D; Hamon, J; Jenkins, JL; Lavan, P; Weber, E; Doak, AK; Cote, S; Shoichet, BK; Urban, L				Lounkine, Eugen; Keiser, Michael J.; Whitebread, Steven; Mikhailov, Dmitri; Hamon, Jacques; Jenkins, Jeremy L.; Lavan, Paul; Weber, Eckhard; Doak, Allison K.; Cote, Serge; Shoichet, Brian K.; Urban, Laszlo			Large-scale prediction and testing of drug activity on side-effect targets	NATURE			English	Article							PHARMACOLOGY; NETWORK; DATABASE; IDENTIFICATION; INHIBITION; GENERATION; TOXICITY; HERG	Discovering the unintended 'off-targets' that predict adverse drug reactions is daunting by empirical methods alone. Drugs can act on several protein targets, some of which can be unrelated by conventional molecular metrics, and hundreds of proteins have been implicated in side effects. Here we use a computational strategy to predict the activity of 656 marketed drugs on 73 unintended 'side-effect' targets. Approximately half of the predictions were confirmed, either from proprietary databases unknown to the method or by new experimental assays. Affinities for these new off-targets ranged from 1nM to 30 mu M. To explore relevance, we developed an association metric to prioritize those new off-targets that explained side effects better than any known target of a given drug, creating a drug-target-adverse drug reaction network. Among these new associations was the prediction that the abdominal pain side effect of the synthetic oestrogen chlorotrianisene was mediated through its newly discovered inhibition of the enzyme cyclooxygenase-1. The clinical relevance of this inhibition was borne out in whole human blood platelet aggregation assays. This approach may have wide application to de-risking toxicological liabilities in drug discovery.	[Lounkine, Eugen; Whitebread, Steven; Mikhailov, Dmitri; Jenkins, Jeremy L.; Urban, Laszlo] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Keiser, Michael J.] SeaChange Pharmaceut Inc, San Francisco, CA 94158 USA; [Keiser, Michael J.; Doak, Allison K.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Hamon, Jacques; Lavan, Paul; Weber, Eckhard; Cote, Serge] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland	Novartis; University of California System; University of California San Francisco; Novartis	Jenkins, JL (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	jeremy.jenkins@novartis.com; shoichet@cgl.ucsf.edu; laszlo.urban@novartis.com	Keiser, Michael J./F-2825-2016	Keiser, Michael J./0000-0002-1240-2192; Jenkins, Jeremy/0000-0001-9795-0771	US National Institutes of Health [GM71896, AG002132, GM93456]; QB3 Rogers Family Foundation 'Bridging-the-Gap' Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM093456, R44GM093456, R01GM071896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3 Rogers Family Foundation 'Bridging-the-Gap' Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	E. L. is a presidential postdoctoral fellow supported by the Education Office of the Novartis Institutes for Biomedical Research (co-mentors L. U. and B. K. S.). Supported by US National Institutes of Health grants GM71896 (to B. K. S. and J. Irwin), AG002132 (to S. Prusiner and B. K. S.), and GM93456 (to M. J. K.), and by QB3 Rogers Family Foundation 'Bridging-the-Gap' Award (to M. J. K.).	Akarasereenont P, 2006, PLATELETS, V17, P441, DOI 10.1080/09537100600745302; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antunes AMM, 2010, CHEM RES TOXICOL, V23, P1714, DOI 10.1021/tx100186t; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyer S, 2009, ATLA-ALTERN LAB ANIM, V37, P467, DOI 10.1177/026119290903700505; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cosgrove BD, 2010, MOL BIOSYST, V6, P1195, DOI 10.1039/b926287c; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Giacomini KM, 2007, NATURE, V446, P975, DOI 10.1038/446975a; Hert J, 2008, J CHEM INF MODEL, V48, P755, DOI 10.1021/ci8000259; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; James C.A., 2005, DAYLIGHT THEORY MANU; Ji ZL, 2003, DRUG SAFETY, V26, P685, DOI 10.2165/00002018-200326100-00002; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kong SX, 1998, AM J MANAG CARE, V4, P399; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Kuo CC, 2000, MOL PHARMACOL, V57, P135; Laggner C, 2012, NAT CHEM BIOL, V8, P144, DOI 10.1038/nchembio.732; Lee S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S2; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Marshall V, 2003, MOVEMENT DISORD, V18, pS22, DOI 10.1002/mds.10574; Matthews EJ, 2010, REGUL TOXICOL PHARM, V56, P247, DOI 10.1016/j.yrtph.2009.11.006; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Muchmore SW, 2008, J CHEM INF MODEL, V48, P941, DOI 10.1021/ci7004498; NORRIS LA, 1994, THROMB HAEMOSTASIS, V72, P926; Oprea TI, 2011, MOL INFORM, V30, P100, DOI 10.1002/minf.201100023; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Perrone MG, 2010, CURR MED CHEM, V17, P3769; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rothman RB, 2000, CIRCULATION, V102, P2836; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Scheiber J, 2009, J MED CHEM, V52, P3103, DOI 10.1021/jm801546k; SCHOEN RT, 1989, AM J MED, V86, P449, DOI 10.1016/0002-9343(89)90344-6; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Stein SE, 2003, PROCEEDINGS OF THE 2003 INTERNATIONAL CHEMICAL INFORMATION CONFERENCE, P131; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wong DR, 2005, CURR OPIN PHARMACOL, V5, P204, DOI 10.1016/j.coph.2005.02.001; Yang L, 2009, NUCLEIC ACIDS RES, V37, pW406, DOI 10.1093/nar/gkp312; Yang XA, 2010, J BIOMED INFORM, V43, P376, DOI 10.1016/j.jbi.2010.04.006; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang JX, 2007, BIOINFORMATICS, V23, P1710, DOI 10.1093/bioinformatics/btm139	53	587	598	13	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					361	+		10.1038/nature11159	http://dx.doi.org/10.1038/nature11159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722194	Green Accepted, Green Submitted			2022-12-01	WOS:000305466800035
J	Church, GM; Gao, Y; Kosuri, S				Church, George M.; Gao, Yuan; Kosuri, Sriram			Next-Generation Digital Information Storage in DNA	SCIENCE			English	Article							GENOME		[Church, George M.; Kosuri, Sriram] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Church, George M.; Kosuri, Sriram] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Gao, Yuan] Johns Hopkins Univ, Dept Biomed Engn, Neuroregenerat & Stem Cell Biol Program, Inst Cell Engn,Lieber Inst Brain Dev, Baltimore, MD 21205 USA	Harvard University; Harvard Medical School; Johns Hopkins University	Kosuri, S (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	sri.kosuri@wyss.harvard.edu		church, george/0000-0001-6232-9969; Kosuri, Sriram/0000-0002-4661-0600	U.S. Office of Naval Research [N000141010144]; Agilent Technologies; Wyss Institute	U.S. Office of Naval Research(Office of Naval Research); Agilent Technologies; Wyss Institute	This work was supported by U.S. Office of Naval Research (N000141010144), Agilent Technologies, and the Wyss Institute. Agilent Technologies is a commercial provider for DNA microchips. G. M. C. and S. K. designed and performed all experiments and analyses and wrote the manuscript; Y.G. performed the sequencing. We thank J. Aach, C. Fracchia, S. Raman, H. H. Wang, A. W. Briggs, J. Lee, T. Wu, and D. B. Goodman for helpful suggestions on the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Bancroft C, 2001, SCIENCE, V293, P1763; Benner SA, 2011, CR CHIM, V14, P372, DOI 10.1016/j.crci.2010.06.013; Bonnet J, 2010, NUCLEIC ACIDS RES, V38, P1531, DOI 10.1093/nar/gkp1060; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Davis J, 1996, ART J, V55, P70, DOI 10.2307/777811; Gantz J., 2011, IDC IVIEW, V6; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Kosuri S, 2012, ACS SYNTH BIOL, V1, P109, DOI 10.1021/sb300015f; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pennisi E, 2012, SCIENCE, V336, P534, DOI 10.1126/science.336.6081.534; St John J., 2011, SEQPREP	13	575	655	52	510	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1628	1628		10.1126/science.1226355	http://dx.doi.org/10.1126/science.1226355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22903519	Bronze			2022-12-01	WOS:000309215400037
J	Cherry, JD				Cherry, James D.			Epidemic Pertussis in 2012-The Resurgence of a Vaccine-Preventable Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cherry, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.							[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P517; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Cherry JD, 2010, CLIN INFECT DIS, V51, P663, DOI 10.1086/655826; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Winter K., 2012, J PEDIAT	5	339	363	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					785	787		10.1056/NEJMp1209051	http://dx.doi.org/10.1056/NEJMp1209051			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EN	22894554				2022-12-01	WOS:000308067400013
J	Morin, SA; Shepherd, RF; Kwok, SW; Stokes, AA; Nemiroski, A; Whitesides, GM				Morin, Stephen A.; Shepherd, Robert F.; Kwok, Sen Wai; Stokes, Adam A.; Nemiroski, Alex; Whitesides, George M.			Camouflage and Display for Soft Machines	SCIENCE			English	Article							CEPHALOPOD DYNAMIC CAMOUFLAGE; DISRUPTIVE COLORATION; EVOLUTION; VISION; CHROMATOPHORES; IRIDOPHORES; ORIGINS; LIGHT	Synthetic systems cannot easily mimic the color-changing abilities of animals such as cephalopods. Soft machines-machines fabricated from soft polymers and flexible reinforcing sheets-are rapidly increasing in functionality. This manuscript describes simple microfluidic networks that can change the color, contrast, pattern, apparent shape, luminescence, and surface temperature of soft machines for camouflage and display. The color of these microfluidic networks can be changed simultaneously in the visible and infrared-a capability that organisms do not have. These strategies begin to imitate the functions, although not the anatomies, of color-changing animals.	[Morin, Stephen A.; Shepherd, Robert F.; Kwok, Sen Wai; Stokes, Adam A.; Nemiroski, Alex; Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Whitesides, George M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Shepherd, Robert/A-7081-2018	Shepherd, Robert/0000-0002-0631-9587; Stokes, Adam/0000-0002-6140-619X	U.S. Department of Energy [DE-FG02-00ER45852]; Defense Advanced Research Projects Agency [W911NF-11-1-0094]	U.S. Department of Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The development of biomimetic camouflage strategies was supported by the U.S. Department of Energy under award DE-FG02-00ER45852. Soft machine development was supported by the Defense Advanced Research Projects Agency under award W911NF-11-1-0094. Patent applications "Flexible Robotic Actuators" and "Soft Robotic Actuators" have been filed but not yet published.	Cott HB., 1957, ADAPTIVE COLOURATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; HASTINGS JW, 1983, J MOL EVOL, V19, P309, DOI 10.1007/BF02101634; Hayes RA, 2003, NATURE, V425, P383, DOI 10.1038/nature01988; Heikenfeld J, 2009, NAT PHOTONICS, V3, P292, DOI 10.1038/NPHOTON.2009.68; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Langridge KV, 2009, ANIM BEHAV, V77, P847, DOI 10.1016/j.anbehav.2008.11.023; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Martinez RV, 2012, ADV FUNCT MATER, V22, P1376, DOI 10.1002/adfm.201102978; Mathger LM, 2007, CELL TISSUE RES, V329, P179, DOI 10.1007/s00441-007-0384-8; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; PETRIE M, 1991, ANIM BEHAV, V41, P323, DOI 10.1016/S0003-3472(05)80484-1; Rogalski A, 2003, PROG QUANT ELECTRON, V27, P59, DOI 10.1016/S0079-6727(02)00024-1; Scholes E, 2008, BIOL J LINN SOC, V94, P491, DOI 10.1111/j.1095-8312.2008.01012.x; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Sutherland RL, 2008, J OPT SOC AM A, V25, P588, DOI 10.1364/JOSAA.25.000588; Thayer G.H., 1909, CONCEALING COLORATIO; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197	28	524	549	36	658	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					828	832		10.1126/science.1222149	http://dx.doi.org/10.1126/science.1222149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904008	Green Submitted			2022-12-01	WOS:000307535600039
J	Walser, PJ; Ariotti, N; Howes, M; Ferguson, C; Webb, R; Schwudke, D; Leneva, N; Cho, KJ; Cooper, L; Rae, J; Floetenmeyer, M; Oorschot, VMJ; Skoglund, U; Simons, K; Hancock, JF; Parton, RG				Walser, Piers J.; Ariotti, Nicholas; Howes, Mark; Ferguson, Charles; Webb, Richard; Schwudke, Dominik; Leneva, Natalya; Cho, Kwang-Jin; Cooper, Leanne; Rae, James; Floetenmeyer, Matthias; Oorschot, Viola M. J.; Skoglund, Ulf; Simons, Kai; Hancock, John F.; Parton, Robert G.			Constitutive Formation of Caveolae in a Bacterium	CELL			English	Article							CLATHRIN-COATED PITS; C-TERMINAL DOMAIN; IN-VIVO; MOLECULAR DISSECTION; MEMBRANE-BINDING; COPII CAGE; NULL MICE; BIOGENESIS; PROTEINS; CELLS	Caveolin plays an essential role in the formation of characteristic surface pits, caveolae, which cover the surface of many animal cells. The fundamental principles of caveola formation are only slowly emerging. Here we show that caveolin expression in a prokaryotic host lacking any intracellular membrane system drives the formation of cytoplasmic vesicles containing polymeric caveolin. Vesicle formation is induced by expression of wild-type caveolins, but not caveolin mutants defective in caveola formation in mammalian systems. In addition, cryo-electron tomography shows that the induced membrane domains are equivalent in size and caveolin density to native caveolae and reveals a possible polyhedral arrangement of caveolin oligomers. The caveolin-induced vesicles or heterologous caveolae (h-caveolae) form by budding in from the cytoplasmic membrane, generating a membrane domain with distinct lipid composition. Periplasmic solutes are encapsulated in the budding h-caveola, and purified h-caveolae can be tailored to be targeted to specific cells of interest.	[Walser, Piers J.; Ariotti, Nicholas; Howes, Mark; Ferguson, Charles; Leneva, Natalya; Cho, Kwang-Jin; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Webb, Richard; Rae, James; Floetenmeyer, Matthias] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Schwudke, Dominik; Cooper, Leanne; Parton, Robert G.] GKVK, Natl Ctr Biol Sci, TIFR, Bangalore 560065, Karnataka, India; [Oorschot, Viola M. J.] Univ Med Ctr Utrecht, Dept Cell Biol, Cell Microscopy Ctr, NL-3584 CX Utrecht, Netherlands; [Skoglund, Ulf] Grad Univ, Okinawa Inst Sci & Technol, Struct Cellular Biol Unit, Okinawa 9040495, Japan; [Simons, Kai] Tech Univ Dresden, Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Queensland; University of Queensland; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Utrecht University; Utrecht University Medical Center; Okinawa Institute of Science & Technology Graduate University; Max Planck Society; Technische Universitat Dresden	Walser, PJ (corresponding author), NHSBT, Bristol Inst Transfus Sci, Bristol BS34 7QH, Avon, England.	piers.walser@nhsbt.nhs.uk; r.parton@imb.uq.edu.au	Parton, Robert G/C-5673-2009; Schwudke, Dominik/B-3478-2013; Ariotti, Nicholas/GXH-4833-2022; Cho, Kwang-jin/AAI-4923-2020; Skoglund, Ulf/B-5829-2015	Parton, Robert G/0000-0002-7494-5248; Schwudke, Dominik/0000-0002-1379-9451; Skoglund, Ulf/0000-0002-3407-0053; Ariotti, Nicholas/0000-0003-3901-0831; Howes, Mark/0000-0002-9666-3364; Hancock, John/0000-0003-0542-4710; Floetenmeyer, Matthias/0000-0002-0133-1632; Leneva, Natalya/0000-0001-8102-9769	National Health and Medical Research Council of Australia; Australian Research Council; Swiss National Science Foundation [PA00-109094]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the National Health and Medical Research Council of Australia (to R.G.P. and J.F.H.), the Australian Research Council (R.G.P.). P.J.W. was supported by a fellowship for advanced researchers by the Swiss National Science Foundation (PA00-109094). Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, which was established with the support of the ACRF. The Institute for Molecular Bioscience is a Special Research Centre of the Australian Research Council. The authors acknowledge the facilities as well as scientific and technical assistance from staff in the Australian Microscopy and Microanalysis Facility (AMMRF) at the Centre for Microscopy and Microanalysis at The University of Queensland. We would like to thank Alejandra Castillo-Alvarez and Angela Gardner for technical assistance. We are particularly grateful to Alasdair McDowall for help with preliminary cryo-TEM studies and Yoshinori Akiyama for providing ftsH depletion strain AD368. We thank Neil Marshall, Murray Stewart, Chris Fielding, Deborah Brown and for providing constructs.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; Das K, 1999, J BIOL CHEM, V274, P18721, DOI 10.1074/jbc.274.26.18721; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Fotin A, 2006, J STRUCT BIOL, V156, P453, DOI 10.1016/j.jsb.2006.07.001; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fujimoto T, 2000, J CELL SCI, V113, P3509; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hayashi K, 2001, CANCER RES, V61, P2361; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Razani B, 2001, J BIOL CHEM, V276, P38121; Ren XY, 2004, MOL BIOL CELL, V15, P4556, DOI 10.1091/mbc.E04-06-0480; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Vogel U, 1998, J CELL SCI, V111, P825; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n	46	89	89	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					752	763		10.1016/j.cell.2012.06.042	http://dx.doi.org/10.1016/j.cell.2012.06.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901807	Bronze			2022-12-01	WOS:000308002300010
J	Jing, SS; Newman, SDS; Baghla, DPS				Jing, S. S.; Newman, S. D. S.; Baghla, D. P. S.			Shoulder injury	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROXIMAL HUMERAL FRACTURES; CLASSIFICATION; AXILLARY		[Jing, S. S.; Newman, S. D. S.; Baghla, D. P. S.] Ealing Gen Hosp, Dept Trauma & Orthopaed Surg, Southall UB1 3HW, Middx, England		Jing, SS (corresponding author), Ealing Gen Hosp, Dept Trauma & Orthopaed Surg, Southall UB1 3HW, Middx, England.	shanshan.jing@gmail.com						Bahrs C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-33; BLOOM MH, 1967, J BONE JOINT SURG AM, VA 49, P943, DOI 10.2106/00004623-196749050-00011; Brorson S, 2009, INT ORTHOP, V33, P323, DOI 10.1007/s00264-008-0591-2; Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109; Court-Brown CM, 2001, ACTA ORTHOP SCAND, V72, P365, DOI 10.1080/000164701753542023; Hodgson S, 2006, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000194677.02506.45; Iyengar JJ, 2011, PHYSICIAN SPORTSMED, V39, P52, DOI 10.3810/psm.2011.02.1862; Kralinger F, 2004, J BONE JOINT SURG BR, V86B, P217, DOI 10.1302/0301-620X.86B2.14553; Mathei J, 2008, ACTA CHIR BELG, V108, P625, DOI 10.1080/00015458.2008.11680305; Monga Puneet, 2009, J Orthop Surg (Hong Kong), V17, P142; Muller ME, 1991, MANUAL INTERNAL FIXA, P118; Murray IR, 2011, J BONE JOINT SURG BR, V93B, P1, DOI 10.1302/0301-620X.93B1.25702; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Rohilla M, 2008, PAK J MED SCI, V24, P609; STROMQVIST B, 1987, INJURY, V18, P423, DOI 10.1016/0020-1383(87)90298-1; YOUNG TB, 1985, J BONE JOINT SURG BR, V67, P373, DOI 10.1302/0301-620X.67B3.3997943	16	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 3	2012	345								e3172	10.1136/bmj.e3172	http://dx.doi.org/10.1136/bmj.e3172			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XF	22864305				2022-12-01	WOS:000307303100001
J	Rathinam, VAK; Vanaja, SK; Waggoner, L; Sokolovska, A; Becker, C; Stuart, LM; Leong, JM; Fitzgerald, KA				Rathinam, Vijay A. K.; Vanaja, Sivapriya Kailasan; Waggoner, Lisa; Sokolovska, Anna; Becker, Christine; Stuart, Lynda M.; Leong, John M.; Fitzgerald, Katherine A.			TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria	CELL			English	Article							NF-KAPPA-B; CASPASE-1 ACTIVATION; GENE-EXPRESSION; CELL-DEATH; ASC; APOPTOSIS; RECEPTOR; TRAM; INTERLEUKIN-1-BETA; RECOGNITION	Systemic infections with Gram-negative bacteria are characterized by high mortality rates due to the "sepsis syndrome," a widespread and uncontrolled inflammatory response. Though it is well recognized that the immune response during Gram-negative bacterial infection is initiated after the recognition of endotoxin by Toll-like receptor 4, the molecular mechanisms underlying the detrimental inflammatory response during Gram-negative bacteremia remain poorly defined. Here, we identify a TRIF pathway that licenses NLRP3 inflammasome activation by all Gram-negative bacteria. By engaging TRIF, Gram-negative bacteria activate caspase-11. TRIF activates caspase-11 via type I IFN signaling, an event that is both necessary and sufficient for caspase-11 induction and autoactivation. Caspase-11 subsequently synergizes with the assembled NLRP3 inflammasome to regulate caspase-1 activation and leads to caspase-1-independent cell death. These events occur specifically during infection with Gram-negative, but not Gram-positive, bacteria. The identification of TRIF as a regulator of caspase-11 underscores the importance of TLRs as master regulators of inflammasomes during Gram-negative bacterial infection.	[Rathinam, Vijay A. K.; Vanaja, Sivapriya Kailasan; Waggoner, Lisa; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Vanaja, Sivapriya Kailasan; Leong, John M.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Sokolovska, Anna; Becker, Christine; Stuart, Lynda M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA	University of Massachusetts System; University of Massachusetts Worcester; Tufts University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Rathinam, Vijay/ABE-7544-2020; Fitzgerald, Katherine/ABE-6317-2020	Rathinam, Vijay/0000-0002-8009-3977; Fitzgerald, Kate/0000-0003-3175-609X	NIH [AI083713, AI046454, AI079198]; NERCE [NIH/NIAID U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, R01AI079198, U54AI057159, R01AI046454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NERCE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Anna Cerny for animal husbandry and genotyping; Sanjay Ram, Douglas Golenbock, Rahul Gupta, Victor Boyartchuk, Brian Akerley, Sandy Wong, Beth McCormick, and Stephen Lory for bacterial strains; Christine Biron and Delia Demers for Stat-1<SUP>-/-</SUP> femurs; Karen Mossman and Derek Cummings for Irf9<SUP>-/-</SUP> femurs; Vishva Dixit and Nobuhiko Kayagaki for caspase-11<SUP>-/-</SUP> mice and additional reagents; Bill Kaiser for caspase-8<SUP>-/-</SUP>Rip3<SUP>-/-</SUP> and caspase-8<SUP>+/-</SUP>Rip3<SUP>-/-</SUP> femurs; Jakob von Moltke and Russell Vance for immortalized BMDMs; Egil Lien, Douglas Golenbock, and Ann Rothstein for critical reading of the manuscript; and all members of the Fitzgerald lab for helpful discussions. This work is supported by NIH grants AI083713 (to K. A. F.), AI046454 (to J.M.L.), and AI079198 (to L. M. S.) and NERCE Post-Doctoral Fellowship Awards NIH/NIAID U54 AI057159 to V. A. K. R and S.K.V.	Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Rathinam VAK, 2011, CURR OPIN VIROL, V1, P455, DOI 10.1016/j.coviro.2011.11.004; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rathinam VAK, 2008, MICROBES INFECT, V10, P1316, DOI 10.1016/j.micinf.2008.07.030; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yen JH, 2009, BLOOD, V114, P1344, DOI 10.1182/blood-2008-12-196592; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	46	506	517	2	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					606	619		10.1016/j.cell.2012.07.007	http://dx.doi.org/10.1016/j.cell.2012.07.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22819539	Green Accepted, Bronze			2022-12-01	WOS:000307301400018
J	Chu, HT; Pazgier, M; Jung, G; Nuccio, SP; Castillo, PA; de Jong, MF; Winter, MG; Winter, SE; Wehkamp, J; Shen, B; Salzman, NH; Underwood, MA; Tsolis, RM; Young, GM; Lu, WY; Lehrer, RI; Baumler, AJ; Bevins, CL				Chu, Hiutung; Pazgier, Marzena; Jung, Grace; Nuccio, Sean-Paul; Castillo, Patricia A.; de Jong, Maarten F.; Winter, Maria G.; Winter, Sebastian E.; Wehkamp, Jan; Shen, Bo; Salzman, Nita H.; Underwood, Mark A.; Tsolis, Renee M.; Young, Glenn M.; Lu, Wuyuan; Lehrer, Robert I.; Baeumler, Andreas J.; Bevins, Charles L.			Human alpha-Defensin 6 Promotes Mucosal Innate Immunity Through Self-Assembled Peptide Nanonets	SCIENCE			English	Article							PANETH CELLS; MICE; HD5	Defensins are antimicrobial peptides that contribute broadly to innate immunity, including protection of mucosal tissues. Human alpha-defensin (HD) 6 is highly expressed by secretory Paneth cells of the small intestine. However, in contrast to the other defensins, it lacks appreciable bactericidal activity. Nevertheless, we report here that HD6 affords protection against invasion by enteric bacterial pathogens in vitro and in vivo. After stochastic binding to bacterial surface proteins, HD6 undergoes ordered self-assembly to form fibrils and nanonets that surround and entangle bacteria. This self-assembly mechanism occurs in vivo, requires histidine-27, and is consistent with x-ray crystallography data. These findings support a key role for HD6 in protecting the small intestine against invasion by diverse enteric pathogens and may explain the conservation of HD6 throughout Hominidae evolution.	[Chu, Hiutung; Nuccio, Sean-Paul; Castillo, Patricia A.; de Jong, Maarten F.; Winter, Maria G.; Winter, Sebastian E.; Wehkamp, Jan; Tsolis, Renee M.; Baeumler, Andreas J.; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem Mol Biol, Baltimore, MD 21201 USA; [Jung, Grace; Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Shen, Bo] Cleveland Clin Fdn, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA; [Salzman, Nita H.] Med Coll Wisconsin, Dept Pediat, Div Gastroenterol, Milwaukee, WI 53226 USA; [Underwood, Mark A.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Young, Glenn M.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation; Medical College of Wisconsin; University of California System; University of California Davis; University of California System; University of California Davis	Bevins, CL (corresponding author), Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA.	clbevins@ucdavis.edu	Bevins, Charles L/P-4438-2015; Winter, Sebastian E/A-4118-2009; Baumler, Andreas J/H-2301-2011; Lu, Wuyuan/J-8452-2017; Wehkamp, Jan/B-7319-2011; Lu, Wuyuan/B-2268-2010	Bevins, Charles L/0000-0003-2725-2622; Winter, Sebastian E/0000-0003-1532-9178; Baumler, Andreas J/0000-0001-9152-7809; Lu, Wuyuan/0000-0003-1318-9968; Salzman, Nita/0000-0003-0939-6139; Tsolis, Renee/0000-0001-9131-6657; de jong, maarten/0000-0003-2278-286X; Nuccio, Sean-Paul/0000-0002-9683-9278; Wehkamp, Jan/0000-0001-6788-841X; Chu, Hiutung/0000-0001-7489-0446	National Institutes of Health [AI032738, AI050843, HD059127, AI076246, AI040124, AI044170, AI073120, AI088122, AI072732, AI070726, AI082320, AI057757, T32AI060555]; Robert Bosch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073120, R01AI057757, R21AI057757, R01AI076246, R01AI072732, T32AI060555, R21AI082320, R01AI044170, R01AI032738, R21AI088122, R01AI040124, R37AI032738, R29AI040124, R01AI050843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Bosch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank W. Yuan for expert assistance in synthesizing the defensin peptides and R. W. Feathers and H. K. Rho for technical help related to transgenic mice. We thank G. Adamson, P. E. Kysar, and E. Lee from Electron Microscopy Laboratory, Department of Pathology and Laboratory Medicine, School of Medicine, University of California at Davis. We gratefully acknowledge A. J. Ouellette for help with HD6 antibody production. We are indebted to A. C. Gelli and S. C. Dawson for expert guidance in exploring possible biological activities of HD6 and to S. J. Howell for initial investigations of this peptide. Finally, we appreciate the many suggestions from colleagues and members of our laboratories that helped us unravel the properties of HD6 described here. This work was supported by grants from the National Institutes of Health: AI032738 (C.L.B.), AI050843 (C.L.B.), HD059127 (M.A.U. and C.L.B.), AI076246 (A.J.B. and C.L.B.), AI040124 (A.J.B.), AI044170 (A.J.B.), AI073120 (A.J.B.), AI088122 (A.J.B.), AI072732 (W.L.), AI070726 (R.I.L.), AI082320 (R.M.T.), AI057757 (N.H.S.), and T32AI060555 (H.C. and S.P.N.) and a fellowship from the Robert Bosch Foundation (J.W.). The authors declare no competing interests. The data described in this manuscript are tabulated in the main paper and in the supplementary materials. The structure factor files and coordinates for H27W-HD6 are deposited in the Protein Data Bank under accession code 3QTE.	Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Bevins C.L., 2004, MUCOSAL IMMUNOL, V1, P95; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2010, J CROHNS COLITIS, V4, P523, DOI 10.1016/j.crohns.2010.05.010; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085	20	243	257	12	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					477	481		10.1126/science.1218831	http://dx.doi.org/10.1126/science.1218831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22722251	Green Accepted			2022-12-01	WOS:000306802300046
J	Zhou, Q; Bachtrog, D				Zhou, Qi; Bachtrog, Doris			Sex-Specific Adaptation Drives Early Sex Chromosome Evolution in Drosophila	SCIENCE			English	Article							Y-CHROMOSOME; X-CHROMOSOMES; NEO-Y; MIRANDA; DEGENERATION; PATTERNS; GENES	Most species' sex chromosomes are derived from ancient autosomes and show few signatures of their origins. We studied the sex chromosomes of Drosophila miranda, where a neo-Y chromosome originated only approximately 1 million years ago. Whole-genome and transcriptome analysis reveals massive degeneration of the neo-Y, that male-beneficial genes on the neo-Y are more likely to undergo accelerated protein evolution, and that neo-Y genes evolve biased expression toward male-specific tissues-the shrinking gene content of the neo-Y becomes masculinized. In contrast, although older X chromosomes show a paucity of genes expressed in male tissues, neo-X genes highly expressed in male-specific tissues undergo increased rates of protein evolution if haploid in males. Thus, the response to sex-specific selection can shift at different stages of X differentiation, resulting in masculinization or demasculinization of the X-chromosomal gene content.	[Zhou, Qi; Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bachtrog, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	dbachtrog@berkeley.edu	Zhou, Qi/D-3469-2014	Zhou, Qi/0000-0002-7419-2047	NIH [R01GM076007, R01GM093182]; Packard Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093182, R01GM076007] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Nielsen, M. Eisen, X. Xun, and L. Tian for help and discussion. This work was funded by NIH grants (R01GM076007 and R01GM093182) and a Packard Fellowship to D. B. All DNA/RNA-seq reads are deposited at www.ncbi.nlm.nih.gov/sra under accession no. SRA048115. The genome assembly and annotation is available at the National Center for Biotechnology Information under BioProject ID PRJNA77213.	Bachtrog D, 2004, NAT GENET, V36, P518, DOI 10.1038/ng1347; Bachtrog D, 2003, GENETICS, V165, P1221; Bachtrog D, 2003, NAT GENET, V34, P215, DOI 10.1038/ng1164; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Bachtrog D, 2008, MOL BIOL EVOL, V25, P617, DOI 10.1093/molbev/msn020; Bachtrog D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r30; Bachtrog D, 2010, CURR BIOL, V20, P1476, DOI 10.1016/j.cub.2010.06.076; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Bull J.J., 1983, EVOLUTION SEX DETERM; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Koerich LB, 2008, NATURE, V456, P949, DOI 10.1038/nature07463; Kondrashov FA, 2004, TRENDS GENET, V20, P287, DOI 10.1016/j.tig.2004.05.001; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Marin I, 1996, NATURE, V383, P160, DOI 10.1038/383160a0; Muller HJ., 1940, NEW SYSTEMATICS, P185; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Steinemann M, 1998, GENETICA, V102-3, P409, DOI 10.1023/A:1017058119760; STEINEMANN M, 1993, P NATL ACAD SCI USA, V90, P5737, DOI 10.1073/pnas.90.12.5737; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Zhang YE, 2010, GENOME RES, V20, P1526, DOI 10.1101/gr.107334.110	24	120	122	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					341	345		10.1126/science.1225385	http://dx.doi.org/10.1126/science.1225385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822149	Green Accepted			2022-12-01	WOS:000306542600051
J	Cohen, D				Cohen, Deborah			The truth about sports drinks	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXERCISE; PERFORMANCE; HEALTH		BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						ACSM-(American College of Sport Medicine), 2007, MED SCI SPORTS EXERC, V39, P377; Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; American Academy of Pediatrics Policy Statement-Climatic heat stress and exercising children and adolescents, 2011, PEDIATRICS, V128, pe741; American College of Sports Medicine, 1993, ROUNDT EX FLUID REPL; Anderson SJ, 2000, PEDIATRICS, V106, P158; [Anonymous], SYMPT DEH; [Anonymous], 2000, ERROR HYPERLINK REFE; [Anonymous], 2005, URINE TESTS HELP AUS; [Anonymous], 2005, MARKETING WEEK  1006; [Anonymous], EX ASS HYP WHOS RISK; [Anonymous], NUTR TIPS FLUIDS; [Anonymous], HYP; [Anonymous], WAT IS NOT EN; British Soft Drinks Association, 2011, POP DEM; Cade Robert, 2007, TIMES; Coca-Cola, HYDR TIPS; Convertino VA, 1996, MED SCI SPORT EXER, V28, pR1, DOI 10.1097/00005768-199610000-00045; Diabetes UK, TRAINING EVENTS COMP; Eleftheriou-Smith L-M, 2011, MARKETING; Expert Group on Hydration, DRINK SCH; Jeukendrup Asker, ASK JEUK; Goulet EDB, 2011, BRIT J SPORT MED, V45, P1149, DOI 10.1136/bjsm.2010.077966; Harris J.L., 2011, SUGARY DRINK FACTS; Heneghan C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001702; Heneghan C, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4797; Heneghan C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4848; Institute of Medicine Food and Nutrition Board, DIET REF INT WAT POT; International Markets Bureau, 2010, OV GLOB SPORTS NUTR; Kays J, 2003, EXPLORE, V8; Kenny WL, 2004, NATA NEWS        JUN; Kleinman M, 2003, MARKETING; Marshall SW, 2010, BRIT J SPORT MED, V44, P8, DOI 10.1136/bjsm.2009.068171; Maughan R, 2001, SPORTS DRINKS BASIC; Maughan R J, 1993, Br J Sports Med, V27, P34; Mayo Clinic, DEH; McCartney M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4280; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Murray B, 2008, PREVENTING DEHYDRATI; Natural Hydration Council, 2012, NEW RES SHOWS NAT IN; Noakes TD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4171; Nutrition Working Group of the International Olympic Committee, 2010, NUTR ATHL; Pears E, 2012, PR WEEK         0131; Robert Wood Johnson Foundation, 2012, CONS SPORTS DRINKS C; Rogers D, 2003, MARKETING; Rosner MH, 2007, CLIN J AM SOC NEPHRO, V2, P151, DOI 10.2215/CJN.02730806; Thompson M, 2012, BMJ             0617, V345, pe4573; Virgin Active Health Clubs, OUR PARTN	47	41	41	1	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2012	345								e4737	10.1136/bmj.e4737	http://dx.doi.org/10.1136/bmj.e4737			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	978MA	22810386				2022-12-01	WOS:000306744300009
J	Baranova, E; Fronzes, R; Garcia-Pino, A; Van Gerven, N; Papapostolou, D; Pehau-Arnaudet, G; Pardon, E; Steyaert, J; Howorka, S; Remaut, H				Baranova, Ekaterina; Fronzes, Remi; Garcia-Pino, Abel; Van Gerven, Nani; Papapostolou, David; Pehau-Arnaudet, Gerard; Pardon, Els; Steyaert, Jan; Howorka, Stefan; Remaut, Han			SbsB structure and lattice reconstruction unveil Ca2+ triggered S-layer assembly	NATURE			English	Article							PROTEIN SBSB; DOMAINS; BINDING; SYSTEM; ORGANIZATION; SCATTERING; ANTHRACIS; RESIDUES; ADHESION; MODEL	S-layers are regular two-dimensional semipermeable protein layers that constitute a major cell-wall component in archaea and many bacteria(1-3). The nanoscale repeat structure of the S-layer lattices and their self-assembly from S-layer proteins (SLPs) have sparked interest in their use as patterning and display scaffolds for a range of nano-biotechnological applications(4-7). Despite their biological abundance and the technological interest in them, structural information about SLPs is limited to truncated and assembly-negative proteins(8-10). Here we report the X-ray structure of the SbsB SLP of Geobacillus stearothermophilus PV72/p2 by the use of nanobody-aided crystallization. SbsB consists of a seven-domain protein, formed by an amino-terminal cell-wall attachment domain and six consecutive immunoglobulin-like domains, that organize into a phi-shaped disk-like monomeric crystallization unit stabilized by interdomain Ca2+ ion coordination. A Ca2+-dependent switch to the condensed SbsB quaternary structure pre-positions intermolecular contact zones and renders the protein competent for S-layer assembly. On the basis of crystal packing, chemical crosslinking data and cryo-electron microscopy projections, we present a model for the molecular organization of this SLP into a porous protein sheet inside the S-layer. The SbsB lattice represents a previously undescribed structural model for protein assemblies and may advance our understanding of SLP physiology and self-assembly, as well as the rational design of engineered higher-order structures for biotechnology(4-7).	[Baranova, Ekaterina; Van Gerven, Nani; Remaut, Han] VIB, VIB Dept Struct Biol, B-1050 Brussels, Belgium; [Baranova, Ekaterina; Garcia-Pino, Abel; Van Gerven, Nani; Pardon, Els; Steyaert, Jan; Remaut, Han] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Fronzes, Remi] Inst Pasteur, Unite G5, F-75015 Paris, France; [Fronzes, Remi; Pehau-Arnaudet, Gerard] Inst Pasteur, CNRS, Unite Rech Mixte 3538, F-75015 Paris, France; [Papapostolou, David; Howorka, Stefan] UCL, Inst Struct & Mol Biol, Dept Chem, London WC1H 0AJ, England	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of London; Birkbeck University London; University College London	Remaut, H (corresponding author), VIB, VIB Dept Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium.	han.remaut@vib-vub.be	Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022; steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011	Steyaert, Jan/0000-0002-3825-874X; Van Gerven, Nani/0000-0002-4269-3904; Garcia-Pino, Abel/0000-0002-0634-0300; Pardon, Els/0000-0002-2466-0172; Fronzes, Remi/0000-0003-3031-9824; Baranova, Ekaterina/0000-0003-3211-7134; Remaut, Han/0000-0002-9775-4102; Howorka, Stefan/0000-0002-6527-2846	VIB (Vlaams Institute voor Biotechnologie) [PRJ9]; Fonds Wetenschappelijk Onderzoek-Vlaanderen through an Odysseus grant; Centre National de la Recherche Scientifique (CNRS); Institut Pasteur; Interuniversity Attraction Poles grant [P6/19]; Biotechnology and Biological Sciences Research Council [BB/E010466/1]; University College London;  [FWO551]; BBSRC [BB/E010466/1] Funding Source: UKRI	VIB (Vlaams Institute voor Biotechnologie); Fonds Wetenschappelijk Onderzoek-Vlaanderen through an Odysseus grant; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Interuniversity Attraction Poles grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University College London(General Electric); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank staff at beamlines Proxima-1 and SWING (Soleil), beamline BM30A (European Synchrotron Radiation Facility) and beamline X33 (Deutsches Elektronen-Synchrotron) for technical assistance during data collection. We thank G. Waksman for suggestions on the manuscript, and D. Levy for advice on cryo-EM grid preparation and data collection. This work was supported by VIB (Vlaams Institute voor Biotechnologie) grant PRJ9 to H. R., the Fonds Wetenschappelijk Onderzoek-Vlaanderen through an Odysseus grant to H. R., a postdoctoral fellowship to A. P. G. and research grant FWO551 to J.S. R. F. is supported by the Centre National de la Recherche Scientifique (CNRS) and the Institut Pasteur. G. P. A. is supported by the CNRS. E. P. received support from Interuniversity Attraction Poles grant P6/19. D. P. was funded by Biotechnology and Biological Sciences Research Council grant BB/E010466/1, and S. H. is grateful for support from University College London. We acknowledge Professor Emeritus U. Sleytr for his lifelong devotion to S-layer protein research and G. stearothermophilus SbsB in particular.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; De Genst E, 2004, J BIOL CHEM, V279, P53593, DOI 10.1074/jbc.M407843200; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; GLAUERT AM, 1962, BRIT MED BULL, V18, P245, DOI 10.1093/oxfordjournals.bmb.a069988; Howorka S, 2000, J BIOL CHEM, V275, P37876, DOI 10.1074/jbc.M003838200; Howorka S, 2011, CURR OPIN BIOTECH, V22, P485, DOI 10.1016/j.copbio.2011.05.003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kinns H, 2008, J MOL BIOL, V377, P589, DOI 10.1016/j.jmb.2008.01.019; Kinns H, 2010, J MOL BIOL, V395, P742, DOI 10.1016/j.jmb.2009.10.012; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Mader C, 1999, BBA-BIOMEMBRANES, V1418, P106, DOI 10.1016/S0005-2736(99)00030-9; Mark SS, 2006, LANGMUIR, V22, P3763, DOI 10.1021/la053115v; Messner P, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P53, DOI 10.1007/978-3-642-05062-6_2; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moll D, 2002, P NATL ACAD SCI USA, V99, P14646, DOI 10.1073/pnas.232299399; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nam YS, 2010, NAT NANOTECHNOL, V5, P340, DOI [10.1038/NNANO.2010.57, 10.1038/nnano.2010.57]; Pavkov T, 2008, STRUCTURE, V16, P1226, DOI 10.1016/j.str.2008.05.012; Pavkov-Keller T, 2011, PROG MOL BIOL TRANSL, V103, P73, DOI 10.1016/B978-0-12-415906-8.00004-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Runzler D, 2004, J BIOL CHEM, V279, P5207, DOI 10.1074/jbc.M308819200; Sara M, 1996, J BACTERIOL, V178, P2108, DOI 10.1128/jb.178.7.2108-2117.1996; Sara M, 1998, J BACTERIOL, V180, P6780; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Sleytr UB, 2011, PROG MOL BIOL TRANSL, V103, P277, DOI 10.1016/B978-0-12-415906-8.00003-0; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006	47	99	99	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					119	+		10.1038/nature11155	http://dx.doi.org/10.1038/nature11155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722836	Green Published			2022-12-01	WOS:000305982900062
J	Chalifoux, WA; Reznik, SK; Leighton, JL				Chalifoux, Wesley A.; Reznik, Samuel K.; Leighton, James L.			Direct and highly regioselective and enantioselective allylation of beta-diketones	NATURE			English	Article							ASYMMETRIC ALLYLBORATION; ALDEHYDE CROTYLATION; KETONES; REARRANGEMENTS; ACETOPHENONES; CONFORMATIONS; MACROLIDE; SILICON	The enantioselective allylation of ketones is a problem of fundamental importance in asymmetric reaction design, especially given that only a very small number of methods can generate tertiary carbinols. Despite the vast amount of attention that synthetic chemists have given to this problem(1-8), success has generally been limited to just a few simple ketone types. A method for the selective allylation of functionally complex ketones would greatly increase the utility of ketone allylation methods in the chemical synthesis of important targets. Here we describe the operationally simple, direct, regioselective and enantioselective allylation of beta-diketones. The strong tendency of beta-diketones to act as nucleophilic species was overcome by using their enol form to provide the necessary Bronsted-acid activation. This reaction significantly expands the pool of enantiomerically enriched and functionally complex tertiary carbinols that may be easily accessed. It also overturns more than a century of received wisdom regarding the reactivity of beta-diketones.	[Chalifoux, Wesley A.; Reznik, Samuel K.; Leighton, James L.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Leighton, JL (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	leighton@chem.columbia.edu		Chalifoux, Wesley/0000-0002-6849-6829	National Institute of General Medical Sciences [GM58133]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058133] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences (GM58133). W. A. C. was supported by a Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship. We thank the US National Science Foundation (CRIF-0840451) for acquisition of a 400 MHz NMR spectrometer. We thank our colleagues G. Parkin and W. Sattler for an X-ray structure analysis (see the Supplementary Information), and the US National Science Foundation (CHE-0619638) for acquisition of an X-ray diffractometer.	Barnett DS, 2009, ANGEW CHEM INT EDIT, V48, P8679, DOI 10.1002/anie.200904715; Burns NZ, 2006, ANGEW CHEM INT EDIT, V45, P3811, DOI 10.1002/anie.200600910; Canales E, 2005, J AM CHEM SOC, V127, P11572, DOI 10.1021/ja053865r; CHENG CL, 1973, J CHEM SOC PERK T 2, P1461, DOI 10.1039/p29730001461; Deng D., 1994, CHINESE CHEM LETT, V5, P173; FUSETANI N, 1993, J AM CHEM SOC, V115, P3977, DOI 10.1021/ja00063a017; Gaich T, 2010, J ORG CHEM, V75, P4657, DOI 10.1021/jo1006812; Hackman BM, 2004, ORG LETT, V6, P4375, DOI 10.1021/ol0480731; Kim H, 2011, J AM CHEM SOC, V133, P6517, DOI 10.1021/ja200712f; KIRA M, 1995, CHEM LETT, P281, DOI 10.1246/cl.1995.281; KOBAYASHI M, 1993, TETRAHEDRON LETT, V34, P2795, DOI 10.1016/S0040-4039(00)73564-7; Kulhanek J, 2004, J PHYS ORG CHEM, V17, P686, DOI 10.1002/poc.750; Leighton JL, 2010, ALDRICHIM ACTA, V43, P3; Marton D, 1997, J ORGANOMET CHEM, V540, P77, DOI 10.1016/S0022-328X(97)00083-1; MCCLARIN JA, 1980, J ORGANOMET CHEM, V188, P129, DOI 10.1016/S0022-328X(00)82808-9; Miller JJ, 2007, J AM CHEM SOC, V129, P2752, DOI 10.1021/ja068915m; MIRARCHI D, 1984, J MOL STRUCT, V118, P303, DOI 10.1016/0022-2860(84)87226-9; Nakamura M, 1998, J AM CHEM SOC, V120, P5846, DOI 10.1021/ja9804262; PETTIT GR, 1993, J ORG CHEM, V58, P1302, DOI 10.1021/jo00058a004; PINNAVAIA TJ, 1974, J AM CHEM SOC, V96, P3012, DOI 10.1021/ja00816a068; PINNAVAIA TJ, 1970, J AM CHEM SOC, V92, P4544, DOI 10.1021/ja00718a011; Ramachandran PV, 2004, TETRAHEDRON LETT, V45, P2603, DOI 10.1016/j.tetlet.2004.01.146; REICH HJ, 1973, J AM CHEM SOC, V95, P3418, DOI 10.1021/ja00791a077; Robak MT, 2010, CHEM REV, V110, P3600, DOI 10.1021/cr900382t; SEEMAN JI, 1983, CHEM REV, V83, P83, DOI 10.1021/cr00054a001; Shi SL, 2010, J AM CHEM SOC, V132, P6638, DOI 10.1021/ja101948s; Spletstoser JT, 2008, ORG LETT, V10, P5593, DOI 10.1021/ol802489w; Wadamoto M, 2005, J AM CHEM SOC, V127, P14556, DOI 10.1021/ja0553351; Waltz KM, 2002, ANGEW CHEM INT EDIT, V41, P3697, DOI 10.1002/1521-3773(20021004)41:19<3697::AID-ANIE3697>3.0.CO;2-U; Wu TR, 2004, ORG LETT, V6, P2701, DOI 10.1021/ol0490882	30	30	30	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2012	487	7405					86	89		10.1038/nature11189	http://dx.doi.org/10.1038/nature11189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22763452	Green Accepted			2022-12-01	WOS:000305982900055
J	Lipson, AB				Lipson, Alisa B.			How I Ended Up Watching Myself	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada	BC Childrens Hospital; University of British Columbia	Lipson, AB (corresponding author), BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada.	ablipson@cw.bc.ca							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2012	308	1					41	42		10.1001/jama.2012.7433	http://dx.doi.org/10.1001/jama.2012.7433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971DD	22760289				2022-12-01	WOS:000306183000021
J	von Caemmerer, S; Quick, WP; Furbank, RT				von Caemmerer, Susanne; Quick, W. Paul; Furbank, Robert T.			The Development of C-4 Rice: Current Progress and Future Challenges	SCIENCE			English	Editorial Material							PHOTOSYNTHETIC PATHWAY; CARBOXYLASE; RUBISCO	Another "green revolution" is needed for crop yields to meet demands for food. The international C-4 Rice Consortium is working toward introducing a higher-capacity photosynthetic mechanism-the C-4 pathway-into rice to increase yield. The goal is to identify the genes necessary to install C-4 photosynthesis in rice through different approaches, including genomic and transcriptional sequence comparisons and mutant screening.	[von Caemmerer, Susanne] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Quick, W. Paul] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Quick, W. Paul] Int Rice Res Inst, Los Banos, Philippines; [Furbank, Robert T.] CSIRO Plant Ind, High Resolut Plant Phen Ctr, Canberra, ACT 2601, Australia	Australian National University; University of Sheffield; CGIAR; International Rice Research Institute (IRRI); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	von Caemmerer, S (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	susanne.caemmerer@anu.edu.au	von Caemmerer, Susanne/C-9317-2009; Furbank, Robert T/A-1884-2010	Furbank, Robert T/0000-0001-8700-6613				Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Borlaug N, 2007, SCIENCE, V318, P359, DOI 10.1126/science.1151062; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cousins AB, 2010, PLANT CELL ENVIRON, V33, P444, DOI 10.1111/j.1365-3040.2009.02095.x; Furumoto T, 2007, PLANT PHYSIOL, V144, P1936, DOI 10.1104/pp.107.102541; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; Kajala K, 2011, J EXP BOT, V62, P3001, DOI 10.1093/jxb/err022; Langdale JA, 2011, PLANT CELL, V23, P3879, DOI 10.1105/tpc.111.092098; Miyao M, 2011, J EXP BOT, V62, P3021, DOI 10.1093/jxb/err023; Pengelly JJL, 2011, PLANT PHYSIOL, V156, P503, DOI 10.1104/pp.111.176495; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; von Caemmerer S., 2000, BIOCH MODELS LEAF PH, V2	12	230	233	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1671	1672		10.1126/science.1220177	http://dx.doi.org/10.1126/science.1220177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745421				2022-12-01	WOS:000305794500040
J	Luke, B; Brown, MB; Wantman, E; Lederman, A; Gibbons, W; Schattman, GL; Lobo, RA; Leach, RE; Stern, JE				Luke, Barbara; Brown, Morton B.; Wantman, Ethan; Lederman, Avi; Gibbons, William; Schattman, Glenn L.; Lobo, Rogerio A.; Leach, Richard E.; Stern, Judy E.			Cumulative Birth Rates with Linked Assisted Reproductive Technology Cycles	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; LIVE-BIRTH; COUPLES DISCONTINUE; PREGNANCY; SPERM; PROGRAM; DROPOUT	BACKGROUND Live-birth rates after treatment with assisted reproductive technology have traditionally been reported on a per-cycle basis. For women receiving continued treatment, cumulative success rates are a more important measure. METHODS We linked data from cycles of assisted reproductive technology in the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for the period from 2004 through 2009 to individual women in order to estimate cumulative live-birth rates. Conservative estimates assumed that women who did not return for treatment would not have a live birth; optimal estimates assumed that these women would have live-birth rates similar to those for women continuing treatment. RESULTS The data were from 246,740 women, with 471,208 cycles and 140,859 live births. Live-birth rates declined with increasing maternal age and increasing cycle number with autologous, but not donor, oocytes. By the third cycle, the conservative and optimal estimates of live-birth rates with autologous oocytes had declined from 63.3% and 74.6%, respectively, for women younger than 31 years of age to 18.6% and 27.8% for those 41 or 42 years of age and to 6.6% and 11.3% for those 43 years of age or older. When donor oocytes were used, the rates were higher than 60% and 80%, respectively, for all ages. Rates were higher with blastocyst embryos (day of transfer, 5 or 6) than with cleavage embryos (day of transfer, 2 or 3). At the third cycle, the conservative and optimal estimates of cumulative live-birth rates were, respectively, 42.7% and 65.3% for transfer of cleavage embryos and 52.4% and 80.7% for transfer of blastocyst embryos when fresh autologous oocytes were used. CONCLUSIONS Our results indicate that live-birth rates approaching natural fecundity can be achieved by means of assisted reproductive technology when there are favorable patient and embryo characteristics. Live-birth rates among older women are lower than those among younger women when autologous oocytes are used but are similar to the rates among young women when donor oocytes are used. (Funded by the National Institutes of Health and the Society for Assisted Reproductive Technology.)	[Luke, Barbara; Leach, Richard E.] Michigan State Univ, Dept Obstet, E Lansing, MI 48824 USA; [Luke, Barbara; Leach, Richard E.] Michigan State Univ, Dept Gynecol, E Lansing, MI 48824 USA; [Luke, Barbara; Leach, Richard E.] Michigan State Univ, Dept Reprod Biol, E Lansing, MI 48824 USA; [Brown, Morton B.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Leach, Richard E.] Spectrum Hlth Med Grp, Dept Obstet Gynecol & Womens Hlth, Grand Rapids, MI USA; [Wantman, Ethan; Lederman, Avi] Redshift Technol, New York, NY USA; [Schattman, Glenn L.] Cornell Med Ctr, Dept Obstet & Gynecol, New York, NY USA; [Lobo, Rogerio A.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY USA; [Gibbons, William] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Stern, Judy E.] Geisel Sch Med Dartmouth, Dartmouth Hitchcock Med Ctr, Dept Obstet & Gynecol, Lebanon, NH USA	Michigan State University; Michigan State University; Michigan State University; University of Michigan System; University of Michigan; Spectrum Health Medical Group; Cornell University; Columbia University; Baylor College of Medicine; Dartmouth College	Luke, B (corresponding author), Michigan State Univ, Dept Obstet, E Lansing, MI 48824 USA.			Stern, Judy/0000-0002-7672-3913	National Cancer Institute, National Institutes of Health [R01 CA151973]; Society for Assisted Reproductive Technology (SART); National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA151973] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Society for Assisted Reproductive Technology (SART); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Institutes of Health and the Society for Assisted Reproductive Technology.; Supported by the National Cancer Institute, National Institutes of Health (grant R01 CA151973), and the Society for Assisted Reproductive Technology (SART).	Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; Brandes M, 2009, HUM REPROD, V24, P3127, DOI 10.1093/humrep/dep340; [Centers for Disease Control and Prevention Assisted Reproductive Technology (ART)], 2008, 2008 ASS REPR TECHN; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; Domar AD, 2004, FERTIL STERIL, V81, P271, DOI 10.1016/j.fertnstert.2003.08.013; Donckers J, 2011, FERTIL STERIL, V96, P160, DOI 10.1016/j.fertnstert.2011.04.019; Gibbons WE, 2011, FERTIL STERIL, V95, P1645, DOI 10.1016/j.fertnstert.2010.11.029; Greenwood M., 1926, REPORTS PUBLIC HLTH, V33, P1; Land JA, 1997, FERTIL STERIL, V68, P278, DOI 10.1016/S0015-0282(97)81515-4; Lande Y, 2011, FERTIL STERIL, V95, P568, DOI 10.1016/j.fertnstert.2010.06.005; Luke B, 2011, FERTIL STERIL, V95, P1661, DOI 10.1016/j.fertnstert.2010.12.035; Luke B, 2011, HUM REPROD, V26, P245, DOI 10.1093/humrep/deq306; Luke B, 2010, FERTIL STERIL, V93, P490, DOI 10.1016/j.fertnstert.2009.02.077; Malizia BA, 2009, NEW ENGL J MED, V360, P236, DOI 10.1056/NEJMoa0803072; Nygren KG, 2011, FERTIL STERIL, V95, P2209, DOI 10.1016/j.fertnstert.2011.03.058; Olivius C, 2004, FERTIL STERIL, V81, P258, DOI 10.1016/j.fertnstert.2003.06.029; Olivius K, 2002, FERTIL STERIL, V77, P505, DOI 10.1016/S0015-0282(01)03217-4; Sharma V, 2002, FERTIL STERIL, V78, P40, DOI 10.1016/S0015-0282(02)03160-6; Stern JE, 2012, FERTIL STERIL, V97, P890, DOI 10.1016/j.fertnstert.2011.12.050; Stern JE, 2011, FERTIL STERIL, V95, P600, DOI 10.1016/j.fertnstert.2010.06.009; Stern JE, 2010, FERTIL STERIL, V94, P1334, DOI 10.1016/j.fertnstert.2009.05.052; Witsenburg C, 2005, FERTIL STERIL, V84, P99, DOI 10.1016/j.fertnstert.2005.02.013	22	147	155	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2483	2491		10.1056/NEJMoa1110238	http://dx.doi.org/10.1056/NEJMoa1110238			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738098	Green Accepted			2022-12-01	WOS:000305747000008
J	Yilmaz, OH; Katajisto, P; Lamming, DW; Gultekin, Y; Bauer-Rowe, KE; Sengupta, S; Birsoy, K; Dursun, A; Yilmaz, VO; Selig, M; Nielsen, GP; Mino-Kenudson, M; Zukerberg, LR; Bhan, AK; Deshpande, V; Sabatini, DM				Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Dursun, Abdulmetin; Yilmaz, V. Onur; Selig, Martin; Nielsen, G. Petur; Mino-Kenudson, Mari; Zukerberg, Lawrence R.; Bhan, Atul K.; Deshpande, Vikram; Sabatini, David M.			mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake	NATURE			English	Article							DIETARY RESTRICTION; MICE; HOMEOSTASIS; PTEN; LGR5; RENEWAL; C57BL/6; IMPACT; GROWTH; SIZE	How adult tissue stem and niche cells respond to the nutritional state of an organism is not well understood. Here we find that Paneth cells, a key constituent of the mammalian intestinal stem-cell (ISC) niche, augment stem-cell function in response to calorie restriction. Calorie restriction acts by reducing mechanistic target of rapamycin complex 1 (mTORC1) signalling in Paneth cells, and the ISC-enhancing effects of calorie restriction can be mimicked by rapamycin. Calorie intake regulates mTORC1 in Paneth cells, but not ISCs, and forced activation of mTORC1 in Paneth cells during calorie restriction abolishes the ISC-augmenting effects of the niche. Finally, increased expression of bone stromal antigen 1 (Bst1) in Paneth cells-an ectoenzyme that produces the paracrine factor cyclic ADP ribose-mediates the effects of calorie restriction and rapamycin on ISC function. Our findings establish that mTORC1 non-cell-autonomously regulates stem-cell self-renewal, and highlight a significant role of the mammalian intestinal niche in coupling stem-cell function to organismal physiology.	[Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] Whitehead Inst Biomed Res, Boston, MA 02142 USA; [Yilmaz, Oemer H.; Gueltekin, Yetis; Dursun, Abdulmetin; Selig, Martin; Nielsen, G. Petur; Mino-Kenudson, Mari; Zukerberg, Lawrence R.; Bhan, Atul K.; Deshpande, Vikram] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yilmaz, Oemer H.; Gueltekin, Yetis; Dursun, Abdulmetin; Selig, Martin; Nielsen, G. Petur; Mino-Kenudson, Mari; Zukerberg, Lawrence R.; Bhan, Atul K.; Deshpande, Vikram] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, Boston, MA 02142 USA.	sabatini@wi.mit.edu; sabatini@wi.mit.edu	Gultekin, Yetis/H-4194-2013; Parry, Lee/A-9623-2011; Lamming, Dudley/O-7191-2015	Parry, Lee/0000-0002-4467-9196; Lamming, Dudley/0000-0002-0079-4467; Katajisto, Pekka/0000-0002-3033-4189; /0000-0002-1446-7256; Gultekin, Yetis/0000-0003-0103-351X	National Institutes of Health [CA103866, CA129105, 1F32AG032833-01A1]; Koch Institute; Ellison Medical Foundation; Warshaw Institute from the Massachusetts General Hospital; Center for the study of Inflammatory Bowel Disease from the Massachusetts General Hospital; NCI [T32CA09216]; Academy of Finland; Foundations' Post Doc Pool; Jane Coffin Childs Medical Fund; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Warshaw Institute from the Massachusetts General Hospital; Center for the study of Inflammatory Bowel Disease from the Massachusetts General Hospital; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Academy of Finland(Academy of Finland); Foundations' Post Doc Pool; Jane Coffin Childs Medical Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (CA103866 and CA129105 to D. M. S.), the Koch Institute (Initiator award to D. M. S.), Ellison Medical Foundation (D. M. S.), the Warshaw Institute from the Massachusetts General Hospital (O.H.Y.), and the Center for the study of Inflammatory Bowel Disease from the Massachusetts General Hospital (O.H.Y. and D. M. S.), and fellowship support from the NCI (T32CA09216 to the Department of Pathology at the MGH to O.H.Y.), the Academy of Finland and the Foundations' Post Doc Pool (P. K.), the NIH (1F32AG032833-01A1 to D. W. L.) and Jane Coffin Childs Medical Fund (K. B.). We thank P. Wisniewski and C. Araneo of the Whitehead flow cytometry core facility, the Whitehead Genome Technology Core and Bioinformatics and Research Computing, S. Holder for histology and help with special stains, K. Ottina for laboratory management, and A. Hutchins for animal husbandry and genotyping. D. M. S. is an investigator of the Howard Hughes Medical Institute.	ALTMANN GG, 1972, AM J ANAT, V133, P391, DOI 10.1002/aja.1001330403; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Chen JC, 2003, EXP HEMATOL, V31, P1097, DOI 10.1016/S0301-472X(03)00238-8; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Dunel-Erb S, 2001, COMP BIOCHEM PHYS A, V129, P933, DOI 10.1016/S1095-6433(01)00360-9; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Gregorieff A., 2010, CURR PROTOC STEM CEL, V2; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hempenstall S, 2010, MECH AGEING DEV, V131, P111, DOI 10.1016/j.mad.2009.12.008; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; MCCAY CM, 1975, NUTR REV, V33, P241; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Podesta M, 2005, J BIOL CHEM, V280, P5343, DOI 10.1074/jbc.M408085200; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	31	467	486	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					490	U87		10.1038/nature11163	http://dx.doi.org/10.1038/nature11163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722868	Green Submitted, Green Accepted			2022-12-01	WOS:000305760600034
J	Cheung, ACM; Cramer, P				Cheung, Alan C. M.; Cramer, Patrick			A Movie of RNA Polymerase II Transcription	CELL			English	Review							3.3 ANGSTROM RESOLUTION; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; PREINITIATION COMPLEX; ELONGATION COMPLEX; ABORTIVE INITIATION; ALPHA-AMANITIN; TRIGGER LOOP; ACTIVE-SITE; DNA HYBRID		[Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de		Cheung, Alan/0000-0001-6430-5127				Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brueckner F, 2009, CURR OPIN STRUC BIOL, V19, P294, DOI 10.1016/j.sbi.2009.04.005; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BUROVA E, 1995, J BACTERIOL, V177, P1388, DOI 10.1128/jb.177.5.1388-1392.1995; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; Damsma GE, 2009, J BIOL CHEM, V284, P31658, DOI 10.1074/jbc.M109.022764; Dvir A, 2001, CURR OPIN GENET DEV, V11, P209, DOI 10.1016/S0959-437X(00)00181-7; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feig M, 2010, BIOPHYS J, V99, P2577, DOI 10.1016/j.bpj.2010.08.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hieb AR, 2006, EMBO J, V25, P3100, DOI 10.1038/sj.emboj.7601197; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Jasiak AJ, 2008, J BIOL CHEM, V283, P26423, DOI 10.1074/jbc.M803237200; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Knutson BA, 2011, SCIENCE, V333, P1637, DOI 10.1126/science.1207699; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; LUSE DS, 1987, J BIOL CHEM, V262, P14990; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; REINES D, 1989, J BIOL CHEM, V264, P10799; Reines D, 1996, TRENDS BIOCHEM SCI, V21, P351, DOI 10.1016/0968-0004(96)10045-1; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/S0968-0004(96)10050-5; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Sydow JF, 2009, CURR OPIN STRUC BIOL, V19, P732, DOI 10.1016/j.sbi.2009.10.009; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Treutlein B, 2012, MOL CELL, V46, P136, DOI 10.1016/j.molcel.2012.02.008; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	87	80	81	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1431	1437		10.1016/j.cell.2012.06.006	http://dx.doi.org/10.1016/j.cell.2012.06.006			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726432	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000305753800010
J	Crismani, W; Girard, C; Froger, N; Pradillo, M; Santos, JL; Chelysheva, L; Copenhaver, GP; Horlow, C; Mercier, R				Crismani, Wayne; Girard, Chloe; Froger, Nicole; Pradillo, Monica; Luis Santos, Juan; Chelysheva, Liudmila; Copenhaver, Gregory P.; Horlow, Christine; Mercier, Raphael			FANCM Limits Meiotic Crossovers	SCIENCE			English	Article							CROSSING-OVER; RECOMBINATION; INTERFERENCE; ORTHOLOG; MEIOSIS; REPAIR; SGS1	The number of meiotic crossovers (COs) is tightly regulated within a narrow range, despite a large excess of molecular precursors. The factors that limit COs remain largely unknown. Here, using a genetic screen in Arabidopsis thaliana, we identified the highly conserved FANCM helicase, which is required for genome stability in humans and yeasts, as a major factor limiting meiotic CO formation. The fancm mutant has a threefold-increased CO frequency as compared to the wild type. These extra COs arise not from the pathway that accounts for most of the COs in wild type, but from an alternate, normally minor pathway. Thus, FANCM is a key factor imposing an upper limit on the number of meiotic COs, and its manipulation holds much promise for plant breeding.	[Crismani, Wayne; Girard, Chloe; Froger, Nicole; Chelysheva, Liudmila; Horlow, Christine; Mercier, Raphael] INRA, Inst Jean Pierre Bourgin, UMR1318, F-78000 Versailles, France; [Crismani, Wayne; Girard, Chloe; Froger, Nicole; Chelysheva, Liudmila; Horlow, Christine; Mercier, Raphael] AgroParisTech, Inst Jean Pierre Bourgin, F-78000 Versailles, France; [Pradillo, Monica; Luis Santos, Juan] Univ Complutense Madrid, Fac Biol, Dept Genet, E-28040 Madrid, Spain; [Copenhaver, Gregory P.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Copenhaver, Gregory P.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Copenhaver, Gregory P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Complutense University of Madrid; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mercier, R (corresponding author), INRA, Inst Jean Pierre Bourgin, UMR1318, RD10, F-78000 Versailles, France.	raphael.mercier@versailles.inra.fr	Copenhaver, Gregory/AFL-9831-2022; Copenhaver, Gregory P/A-7549-2014; Girard, Chloé/AAA-3414-2022; Santos, Juan/R-1410-2017; mercier, Raphael/L-1497-2016; Copenhaver, Gregory/AAH-2031-2022; Pradillo, Mónica/G-2432-2017	Copenhaver, Gregory/0000-0002-7962-3862; Copenhaver, Gregory P/0000-0002-7962-3862; Santos, Juan/0000-0003-4475-9628; mercier, Raphael/0000-0001-6508-6608; Copenhaver, Gregory/0000-0002-7962-3862; Pradillo, Mónica/0000-0001-6625-6015; Girard, Chloe/0000-0002-1459-6226; Crismani, Associate Professor Wayne/0000-0003-0143-8293; Chelysheva, Liudmila/0000-0002-7538-2184	EU-FP7 program [Meiosys-KBBE-2009-222883]; NSF [MCB-1121563]; Direct For Biological Sciences [1121563] Funding Source: National Science Foundation	EU-FP7 program(European Commission); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	R.M. and J.L.S. thank the EU-FP7 program (Meiosys-KBBE-2009-222883), and G. P. C. thanks the NSF (MCB-1121563) for financial support. We thank V. Borde, M. Grelon, C. Mezard, F. Nogue, A. Demuyt, and O. Loudet for critical reading of the manuscript and helpful discussions. A provisional patent application based on the work has been filed by INRA.	Berchowitz LE, 2008, NAT PROTOC, V3, P41, DOI 10.1038/nprot.2007.491; Berchowitz LE, 2007, PLOS GENET, V3, P1355, DOI 10.1371/journal.pgen.0030132; Berchowitz LE, 2010, CURR GENOMICS, V11, P91, DOI 10.2174/138920210790886835; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chelysheva L, 2010, CYTOGENET GENOME RES, V129, P143, DOI 10.1159/000314096; Chelysheva L, 2007, PLOS GENET, V3, P802, DOI 10.1371/journal.pgen.0030083; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Hadany L, 2008, ANN NY ACAD SCI, V1133, P26, DOI 10.1196/annals.1438.011; Higgins JD, 2008, PLANT J, V54, P152, DOI 10.1111/j.1365-313X.2008.03403.x; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PERKINS DD, 1949, GENETICS, V34, P607; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Stahl FW, 2008, GENETICS, V179, P701, DOI 10.1534/genetics.108.086918; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012; Wijnker E, 2008, TRENDS PLANT SCI, V13, P640, DOI 10.1016/j.tplants.2008.09.004; Youds JL, 2011, J CELL SCI, V124, P501, DOI 10.1242/jcs.074427; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	20	180	185	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1588	1590		10.1126/science.1220381	http://dx.doi.org/10.1126/science.1220381			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723424				2022-12-01	WOS:000305507500060
J	Nudler, E				Nudler, Evgeny			RNA Polymerase Backtracking in Gene Regulation and Genome Instability	CELL			English	Review							INTRINSIC TRANSCRIPTION TERMINATION; II ELONGATION COMPLEX; CLEAVAGE FACTORS GREA; ESCHERICHIA-COLI; STRUCTURAL BASIS; TRIGGER LOOP; DNA HYBRID; NASCENT TRANSCRIPT; SIGMA(70) SUBUNIT; ALPHA-AMANITIN		NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	evgeny.nudler@nyumc.org		Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058750, R01 GM58750] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Alff-Steinberger C, 2000, J THEOR BIOL, V206, P307, DOI 10.1006/jtbi.2000.2126; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Chamberlin M.J., 1994, HARVEY LECT, V88, P1; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chiba K, 2010, EXP CELL RES, V316, P2723, DOI 10.1016/j.yexcr.2010.05.036; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Hatoum A, 2008, MOL MICROBIOL, V68, P17, DOI 10.1111/j.1365-2958.2008.06138.x; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Koyama H, 2003, GENES CELLS, V8, P779, DOI 10.1046/j.1365-2443.2003.00677.x; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; KRUMMEL B, 1992, J MOL BIOL, V225, P239, DOI 10.1016/0022-2836(92)90918-A; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lewis DEA, 2008, J MOL BIOL, V382, P843, DOI 10.1016/j.jmb.2008.07.060; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Nagaike T, 2011, MOL CELL, V41, P409, DOI 10.1016/j.molcel.2011.01.022; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Pomerantz RT, 2010, CELL CYCLE, V9, P2537, DOI 10.4161/cc.9.13.12122; Poteete AR, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-12; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; REINBERG D, 1987, J BIOL CHEM, V262, P3331; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roghanian M, 2011, NUCLEIC ACIDS RES, V39, P4352, DOI 10.1093/nar/gkq1359; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Santangelo TJ, 2006, J MOL BIOL, V355, P196, DOI 10.1016/j.jmb.2005.10.062; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Stepanova E, 2009, J BIOL CHEM, V284, P35702, DOI 10.1074/jbc.M109.053983; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Walter W, 2003, J BIOL CHEM, V278, P36148, DOI 10.1074/jbc.M305647200; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Washburn RS, 2011, P NATL ACAD SCI USA, V108, P792, DOI 10.1073/pnas.1009564108; Werner M, 2009, CURR OPIN STRUC BIOL, V19, P740, DOI 10.1016/j.sbi.2009.10.005; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	86	170	172	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1438	1445		10.1016/j.cell.2012.06.003	http://dx.doi.org/10.1016/j.cell.2012.06.003			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726433	Bronze, Green Accepted			2022-12-01	WOS:000305753800011
J	Trivedi, BP				Trivedi, Bijal P.			NEUROSCIENCE Hardwired for taste	NATURE			English	Editorial Material							RECEPTORS; SECRETION; GUSTDUCIN											Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Finger Thomas E, 2011, F1000 Biol Rep, V3, P20, DOI 10.3410/B3-20; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Li F, 2012, MOL HUM REPROD, V18, P289, DOI 10.1093/molehr/gas005; Meyer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032354; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107	9	36	37	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					S7	S9		10.1038/486S7a	http://dx.doi.org/10.1038/486S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RB	22717403	Bronze			2022-12-01	WOS:000311781000005
J	Kennedy, BS; Bedard, B; Younge, M; Tuttle, D; Ammerman, E; Ricci, J; Doniger, AS; Escuyer, VE; Mitchell, K; Noble-Wang, JA; O'Connell, HA; Lanier, WA; Katz, LM; Betts, RF; Mercurio, MG; Scott, GA; Lewis, MA; Goldgeier, MH				Kennedy, Byron S.; Bedard, Brenden; Younge, Mary; Tuttle, Deborah; Ammerman, Eric; Ricci, John; Doniger, Andrew S.; Escuyer, Vincent E.; Mitchell, Kara; Noble-Wang, Judith A.; O'Connell, Heather A.; Lanier, William A.; Katz, Linda M.; Betts, Robert F.; Mercurio, Mary Gail; Scott, Glynis A.; Lewis, Matthew A.; Goldgeier, Mark H.			Outbreak of Mycobacterium chelonae Infection Associated with Tattoo Ink	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAPIDLY GROWING MYCOBACTERIA; ATYPICAL MYCOBACTERIA; SKIN INFECTION; ABSCESSUS; IDENTIFICATION; PATTERNS; VECTOR	Background In January 2012, on the basis of an initial report from a dermatologist, we began to investigate an outbreak of tattoo-associated Mycobacterium chelonae skin and soft-tissue infections in Rochester, New York. The main goals were to identify the extent, cause, and form of transmission of the outbreak and to prevent further cases of infection. Methods We analyzed data from structured interviews with the patients, histopathological testing of skin-biopsy specimens, acid-fast bacilli smears, and microbial cultures and antimicrobial susceptibility testing. We also performed DNA sequencing, pulsed-field gel electrophoresis (PFGE), cultures of the ink and ingredients used in the preparation and packaging of the ink, assessment of source water and faucets at tattoo parlors, and investigation of the ink manufacturer. Results Between October and December 2011, a persistent, raised, erythematous rash in the tattoo area developed in 19 persons (13 men and 6 women) within 3 weeks after they received a tattoo from a single artist who used premixed gray ink; the highest occurrence of tattooing and rash onset was in November (accounting for 15 and 12 patients, respectively). The average age of the patients was 35 years (range, 18 to 48). Skin-biopsy specimens, obtained from 17 patients, showed abnormalities in all 17, with M. chelonae isolated from 14 and confirmed by means of DNA sequencing. PFGE analysis showed indistinguishable patterns in 11 clinical isolates and one of three unopened bottles of premixed ink. Eighteen of the 19 patients were treated with appropriate antibiotics, and their condition improved. Conclusions The premixed ink was the common source of infection in this outbreak. These findings led to a recall by the manufacturer.	[Kennedy, Byron S.; Bedard, Brenden; Younge, Mary; Tuttle, Deborah; Ammerman, Eric; Ricci, John; Doniger, Andrew S.] Monroe Cty Dept Publ Hlth, Rochester, NY 14620 USA; [Escuyer, Vincent E.; Mitchell, Kara] New York State Dept Hlth, Albany, NY USA; [Betts, Robert F.; Mercurio, Mary Gail; Scott, Glynis A.; Lewis, Matthew A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Goldgeier, Mark H.] Clinton Crossings Dermatol, Rochester, NY USA; [Noble-Wang, Judith A.; O'Connell, Heather A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Lanier, William A.; Katz, Linda M.] US FDA, College Pk, MD USA	State University of New York (SUNY) System; University of Rochester; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Kennedy, BS (corresponding author), Monroe Cty Dept Publ Hlth, 111 Westfall Rd,Rm 950, Rochester, NY 14620 USA.	bkennedy@monroecounty.gov		Moulton-Meissner, Heather/0000-0002-0728-2552				Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Bechara C, 2010, DERMATOLOGY, V221, P1, DOI 10.1159/000313974; Binic I, 2011, AM J CLIN DERMATOL, V12, P404, DOI 10.2165/11589500-000000000-00000; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Drage LA, 2010, J AM ACAD DERMATOL, V62, P501, DOI 10.1016/j.jaad.2009.03.034; Goldman J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5483; Hamsch C, 2011, ACTA DERM-VENEREOL, V91, P63, DOI 10.2340/00015555-1015; Hay RJ, 2009, CURR OPIN INFECT DIS, V22, P99, DOI 10.1097/QCO.0b013e328322b440; Hogsberg T, 2011, J EUR ACAD DERMATOL; Kappel S, 2011, J AM ACAD DERMATOL, V64, P998, DOI 10.1016/j.jaad.2009.08.029; Kay MK, 2011, EMERG INFECT DIS, V17, P1734, DOI 10.3201/eid1709.102011; Kluger N, 2008, ARCH DERMATOL, V144, P941, DOI 10.1001/archderm.144.7.941; Martin A, 2007, J MICROBIOL METH, V71, P39, DOI 10.1016/j.mimet.2007.07.008; Meyers H, 2002, CLIN INFECT DIS, V34, P1500, DOI 10.1086/340399; Mitchell Charles B, 2011, J Am Acad Dermatol, V64, pe70, DOI 10.1016/j.jaad.2009.12.037; Preda VA, 2009, MED J AUSTRALIA, V190, P278, DOI 10.5694/j.1326-5377.2009.tb02396.x; Ricciardo B, 2010, AUSTRALAS J DERMATOL, V51, P287, DOI 10.1111/j.1440-0960.2010.00659.x; Rodriguez-Blanco I, 2011, ACTA DERM-VENEREOL, V91, P61, DOI 10.2340/00015555-1034; SAFRANEK TJ, 1987, NEW ENGL J MED, V317, P197, DOI 10.1056/NEJM198707233170403; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vanitha JD, 2003, APPL ENVIRON MICROB, V69, P4337, DOI 10.1128/AEM.69.7.4337-4341.2003; WALLACE RJ, 1993, J CLIN MICROBIOL, V31, P2697, DOI 10.1128/JCM.31.10.2697-2701.1993; WENGER JD, 1990, JAMA-J AM MED ASSOC, V264, P373, DOI 10.1001/jama.264.3.373; Winthrop KL, 2002, NEW ENGL J MED, V346, P1366, DOI 10.1056/NEJMoa012643; Wolf R, 2003, J AM ACAD DERMATOL, V48, pS73, DOI 10.1067/mjd.2003.166	25	79	84	4	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1020	1024		10.1056/NEJMoa1205114	http://dx.doi.org/10.1056/NEJMoa1205114			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22913660				2022-12-01	WOS:000308649100008
J	Laurance, WF; Useche, DC; Rendeiro, J; Kalka, M; Bradshaw, CJA; Sloan, SP; Laurance, SG; Campbell, M; Abernethy, K; Alvarez, P; Arroyo-Rodriguez, V; Ashton, P; Benitez-Malvido, J; Blom, A; Bobo, KS; Cannon, CH; Cao, M; Carroll, R; Chapman, C; Coates, R; Cords, M; Danielsen, F; De Dijn, B; Dinerstein, E; Donnelly, MA; Edwards, D; Edwards, F; Farwig, N; Fashing, P; Forget, PM; Foster, M; Gale, G; Harris, D; Harrison, R; Hart, J; Karpanty, S; Kress, WJ; Krishnaswamy, J; Logsdon, W; Lovett, J; Magnusson, W; Maisels, F; Marshall, AR; McClearn, D; Mudappa, D; Nielsen, MR; Pearson, R; Pitman, N; van der Ploeg, J; Plumptre, A; Poulsen, J; Quesada, M; Rainey, H; Robinson, D; Roetgers, C; Rovero, F; Scatena, F; Schulze, C; Sheil, D; Struhsaker, T; Terborgh, J; Thomas, D; Timm, R; Urbina-Cardona, JN; Vasudevan, K; Wright, SJ; Arias-G, JC; Arroyo, L; Ashton, M; Auzel, P; Babaasa, D; Babweteera, F; Baker, P; Banki, O; Bass, M; Bila-Isia, I; Blake, S; Brockelman, W; Brokaw, N; Bruhl, CA; Bunyavejchewin, S; Chao, JT; Chave, J; Chellam, R; Clark, CJ; Clavijo, J; Congdon, R; Corlett, R; Dattaraja, HS; Dave, C; Davies, G; Beisiegel, BD; da Silva, RD; Di Fiore, A; Diesmos, A; Dirzo, R; Doran-Sheehy, D; Eaton, M; Emmons, L; Estrada, A; Ewango, C; Fedigan, L; Feer, F; Fruth, B; Willis, JG; Goodale, U; Goodman, S; Guix, JC; Guthiga, P; Haber, W; Hamer, K; Herbinger, I; Hill, J; Huang, ZL; Sun, IF; Ickes, K; Itoh, A; Ivanauskas, N; Jackes, B; Janovec, J; Janzen, D; Jiangming, M; Jin, C; Jones, T; Justiniano, H; Kalko, E; Kasangaki, A; Killeen, T; King, HB; Klop, E; Knott, C; Kone, I; Kudavidanage, E; Ribeiro, JLD; Lattke, J; Laval, R; Lawton, R; Leal, M; Leighton, M; Lentino, M; Leonel, C; Lindsell, J; Ling-Ling, L; Linsenmair, KE; Losos, E; Lugo, A; Lwanga, J; Mack, AL; Martins, M; McGraw, WS; McNab, R; Montag, L; Thompson, JM; Nabe-Nielsen, J; Nakagawa, M; Nepal, S; Norconk, M; Novotny, V; O'Donnell, S; Opiang, M; Ouboter, P; Parker, K; Parthasarathy, N; Pisciotta, K; Prawiradilaga, D; Pringle, C; Rajathurai, S; Reichard, U; Reinartz, G; Renton, K; Reynolds, G; Reynolds, V; Riley, E; Rodel, MO; Rothman, J; Round, P; Sakai, S; Sanaiotti, T; Savini, T; Schaab, G; Seidensticker, J; Siaka, A; Silman, MR; Smith, TB; de Almeida, SS; Sodhi, N; Stanford, C; Stewart, K; Stokes, E; Stoner, KE; Sukumar, R; Surbeck, M; Tobler, M; Tscharntke, T; Turkalo, A; Umapathy, G; van Weerd, M; Rivera, JV; Venkataraman, M; Venn, L; Verea, C; de Castilho, CV; Waltert, M; Wang, B; Watts, D; Weber, W; West, P; Whitacre, D; Whitney, K; Wilkie, D; Williams, S; Wright, DD; Wright, P; Xiankai, L; Yonzon, P; Zamzani, F				Laurance, William F.; Useche, D. Carolina; Rendeiro, Julio; Kalka, Margareta; Bradshaw, Corey J. A.; Sloan, Sean P.; Laurance, Susan G.; Campbell, Mason; Abernethy, Kate; Alvarez, Patricia; Arroyo-Rodriguez, Victor; Ashton, Peter; Benitez-Malvido, Julieta; Blom, Allard; Bobo, Kadiri S.; Cannon, Charles H.; Cao, Min; Carroll, Richard; Chapman, Colin; Coates, Rosamond; Cords, Marina; Danielsen, Finn; De Dijn, Bart; Dinerstein, Eric; Donnelly, Maureen A.; Edwards, David; Edwards, Felicity; Farwig, Nina; Fashing, Peter; Forget, Pierre-Michel; Foster, Mercedes; Gale, George; Harris, David; Harrison, Rhett; Hart, John; Karpanty, Sarah; Kress, W. John; Krishnaswamy, Jagdish; Logsdon, Willis; Lovett, Jon; Magnusson, William; Maisels, Fiona; Marshall, Andrew R.; McClearn, Deedra; Mudappa, Divya; Nielsen, Martin R.; Pearson, Richard; Pitman, Nigel; van der Ploeg, Jan; Plumptre, Andrew; Poulsen, John; Quesada, Mauricio; Rainey, Hugo; Robinson, Douglas; Roetgers, Christiane; Rovero, Francesco; Scatena, Frederick; Schulze, Christian; Sheil, Douglas; Struhsaker, Thomas; Terborgh, John; Thomas, Duncan; Timm, Robert; Urbina-Cardona, J. Nicolas; Vasudevan, Karthikeyan; Wright, S. Joseph; Arias-G, Juan Carlos; Arroyo, Luzmila; Ashton, Mark; Auzel, Philippe; Babaasa, Dennis; Babweteera, Fred; Baker, Patrick; Banki, Olaf; Bass, Margot; Bila-Isia, Inogwabini; Blake, Stephen; Brockelman, Warren; Brokaw, Nicholas; Bruehl, Carsten A.; Bunyavejchewin, Sarayudh; Chao, Jung-Tai; Chave, Jerome; Chellam, Ravi; Clark, Connie J.; Clavijo, Jose; Congdon, Robert; Corlett, Richard; Dattaraja, H. S.; Dave, Chittaranjan; Davies, Glyn; Beisiegel, Beatriz de Mello; da Silva, Rosa de Nazarepaes; Di Fiore, Anthony; Diesmos, Arvin; Dirzo, Rodolfo; Doran-Sheehy, Diane; Eaton, Mitchell; Emmons, Louise; Estrada, Alejandro; Ewango, Corneille; Fedigan, Linda; Feer, Francois; Fruth, Barbara; Willis, Jacalyn Giacalone; Goodale, Uromi; Goodman, Steven; Guix, Juan C.; Guthiga, Paul; Haber, William; Hamer, Keith; Herbinger, Ilka; Hill, Jane; Huang, Zhongliang; Sun, I. Fang; Ickes, Kalan; Itoh, Akira; Ivanauskas, Natalia; Jackes, Betsy; Janovec, John; Janzen, Daniel; Jiangming, Mo; Jin, Chen; Jones, Trevor; Justiniano, Hermes; Kalko, Elisabeth; Kasangaki, Aventino; Killeen, Timothy; King, Hen-biau; Klop, Erik; Knott, Cheryl; Kone, Inza; Kudavidanage, Enoka; Ribeiro, Jose Lahoz da Silva; Lattke, John; Laval, Richard; Lawton, Robert; Leal, Miguel; Leighton, Mark; Lentino, Miguel; Leonel, Cristiane; Lindsell, Jeremy; Ling-Ling, Lee; Linsenmair, K. Eduard; Losos, Elizabeth; Lugo, Ariel; Lwanga, Jeremiah; Mack, Andrew L.; Martins, Marlucia; McGraw, W. Scott; McNab, Roan; Montag, Luciano; Thompson, Jo Myers; Nabe-Nielsen, Jacob; Nakagawa, Michiko; Nepal, Sanjay; Norconk, Marilyn; Novotny, Vojtech; O'Donnell, Sean; Opiang, Muse; Ouboter, Paul; Parker, Kenneth; Parthasarathy, N.; Pisciotta, Katia; Prawiradilaga, Dewi; Pringle, Catherine; Rajathurai, Subaraj; Reichard, Ulrich; Reinartz, Gay; Renton, Katherine; Reynolds, Glen; Reynolds, Vernon; Riley, Erin; Roedel, Mark-Oliver; Rothman, Jessica; Round, Philip; Sakai, Shoko; Sanaiotti, Tania; Savini, Tommaso; Schaab, Gertrud; Seidensticker, John; Siaka, Alhaji; Silman, Miles R.; Smith, Thomas B.; de Almeida, Samuel Soares; Sodhi, Navjot; Stanford, Craig; Stewart, Kristine; Stokes, Emma; Stoner, Kathryn E.; Sukumar, Raman; Surbeck, Martin; Tobler, Mathias; Tscharntke, Teja; Turkalo, Andrea; Umapathy, Govindaswamy; van Weerd, Merlijn; Rivera, Jorge Vega; Venkataraman, Meena; Venn, Linda; Verea, Carlos; de Castilho, Carolina Volkmer; Waltert, Matthias; Wang, Benjamin; Watts, David; Weber, William; West, Paige; Whitacre, David; Whitney, Ken; Wilkie, David; Williams, Stephen; Wright, Debra D.; Wright, Patricia; Xiankai, Lu; Yonzon, Pralad; Zamzani, Franky			Averting biodiversity collapse in tropical forest protected areas	NATURE			English	Article							EXTINCTION; DEFORESTATION	The rapid disruption of tropical forests probably imperils global biodiversity more than any other contemporary phenomenon(1-3). With deforestation advancing quickly, protected areas are increasingly becoming final refuges for threatened species and natural ecosystem processes. However, many protected areas in the tropics are themselves vulnerable to human encroachment and other environmental stresses(4-9). As pressures mount, it is vital to know whether existing reserves can sustain their biodiversity. A critical constraint in addressing this question has been that data describing a broad array of biodiversity groups have been unavailable for a sufficiently large and representative sample of reserves. Here we present a uniquely comprehensive data set on changes over the past 20 to 30 years in 31 functional groups of species and 21 potential drivers of environmental change, for 60 protected areas stratified across the world's major tropical regions. Our analysis reveals great variation in reserve 'health': about half of all reserves have been effective or performed passably, but the rest are experiencing an erosion of biodiversity that is often alarmingly widespread taxonomically and functionally. Habitat disruption, hunting and forest-product exploitation were the strongest predictors of declining reserve health. Crucially, environmental changes immediately outside reserves seemed nearly as important as those inside in determining their ecological fate, with changes inside reserves strongly mirroring those occurring around them. These findings suggest that tropical protected areas are often intimately linked ecologically to their surrounding habitats, and that a failure to stem broad-scale loss and degradation of such habitats could sharply increase the likelihood of serious biodiversity declines.	[Laurance, William F.; Sloan, Sean P.; Laurance, Susan G.; Campbell, Mason; Edwards, David; Edwards, Felicity; Logsdon, Willis; Roetgers, Christiane] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia; [Laurance, William F.; Sloan, Sean P.; Laurance, Susan G.; Campbell, Mason; Edwards, David; Edwards, Felicity; Logsdon, Willis; Roetgers, Christiane] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia; [Laurance, William F.; Useche, D. Carolina; Rendeiro, Julio; Kalka, Margareta; Wright, S. Joseph] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Abernethy, Kate; Maisels, Fiona] Univ Stirling, Stirling FK9 4LA, Scotland; [Alvarez, Patricia; Pitman, Nigel; Struhsaker, Thomas; Terborgh, John; Clark, Connie J.] Duke Univ, Durham, NC 27705 USA; [Arroyo-Rodriguez, Victor; Benitez-Malvido, Julieta; Quesada, Mauricio] UNAM, Morelia, Michoacan, Mexico; [Ashton, Peter] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Blom, Allard; Carroll, Richard; Dinerstein, Eric; Itoh, Akira] World Wildlife Fund WWF, Washington, DC 20037 USA; [Bobo, Kadiri S.] Univ Dschang, Dschang, Cameroon; [Cannon, Charles H.; Cao, Min; Harrison, Rhett; Jin, Chen] Xishuangbanna Trop Bot Garden, Yunnan 666303, Peoples R China; [Chapman, Colin; Auzel, Philippe] McGill Univ, Montreal, PQ H3A 2T7, Canada; [Coates, Rosamond; Estrada, Alejandro] Univ Nacl Autonoma Mexico, Estn Biol Trop Los Tuxtlas, Veracruz 95701, Mexico; [Cords, Marina; West, Paige] Columbia Univ, New York, NY 10027 USA; [Danielsen, Finn] Nord Fdn Dev & Ecol, DK-1159 Copenhagen, Denmark; [De Dijn, Bart] Bart De Dijn Environm Consultancy, Paramaribo, Suriname; [Donnelly, Maureen A.] Florida Int Univ, Miami, FL 33199 USA; [Farwig, Nina] Univ Marburg, D-35043 Marburg, Germany; [Fashing, Peter] Calif State Univ Fullerton, Fullerton, CA 92834 USA; [Forget, Pierre-Michel; Feer, Francois] Museum Natl Hist Nat, F-91800 Brunoy, France; [Foster, Mercedes] US Geol Survey, Smithsonian Inst, Washington, DC 20013 USA; [Gale, George; Savini, Tommaso] King Mongkuts Univ Technol Thonburi, Bangkok 10150, Thailand; [Harris, David] Royal Bot Garden, Edinburgh EH3 5LR, Midlothian, Scotland; [Hart, John] Tshuapa Lomami Lualaba Project, Kinshasa, DEM REP CONGO; [Karpanty, Sarah] Virginia Tech Univ, Blacksburg, VA 24061 USA; [Kress, W. John; Emmons, Louise] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20013 USA; [Krishnaswamy, Jagdish] Ashoka Trust Res Ecol & Environm ATREE, Bangalore 560064, Karnataka, India; [Lovett, Jon] Univ Twente, NL-7500 AE Enschede, Netherlands; [Magnusson, William; Sanaiotti, Tania] INPA, BR-69011970 Manaus, Amazonas, Brazil; [Maisels, Fiona; Rainey, Hugo; Blake, Stephen; Stokes, Emma; Weber, William; Wilkie, David] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Marshall, Andrew R.; Hill, Jane] Univ York, York YO10 5DD, N Yorkshire, England; [McClearn, Deedra] La Selva Biol Stn, San Pedro, Costa Rica; [Mudappa, Divya] Nat Conservat Fdn, Mysore 570002, Karnataka, India; [Nielsen, Martin R.] Univ Copenhagen, Copenhagen, Denmark; [Pearson, Richard; Congdon, Robert; Jackes, Betsy; Williams, Stephen] James Cook Univ, Townsville, Qld 4811, Australia; [van der Ploeg, Jan; van Weerd, Merlijn] Leiden Univ, Leiden, Netherlands; [Plumptre, Andrew] Wildlife Conservat Soc, Kampala, Uganda; [Poulsen, John] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Robinson, Douglas; Thomas, Duncan] Oregon State Univ, Corvallis, OR 97331 USA; [Rovero, Francesco] Museo Sci, I-38122 Trento, Italy; [Scatena, Frederick; Janzen, Daniel] Univ Penn, Philadelphia, PA 19104 USA; [Schulze, Christian] Univ Vienna, A-1030 Vienna, Austria; [Sheil, Douglas] Bwindi Impenetrable Natl Pk, Kabale, Uganda; [Timm, Robert] Univ Kansas, Lawrence, KS 66045 USA; [Urbina-Cardona, J. Nicolas] Pontificia Univ Javeriana, Bogota, Colombia; [Vasudevan, Karthikeyan] Wildlife Inst India, Dehra Dun, India; [Arias-G, Juan Carlos] Unidad Parques Nacl Nat Colombia, Bogota, Colombia; [Arroyo, Luzmila] Museo Hist Nat Noel Kempff, Santa Cruz, Bolivia; [Ashton, Mark; Watts, David] Yale Univ, New Haven, CT 06511 USA; [Babaasa, Dennis] Inst Trop Forest Conservat, Kabale, Uganda; [Babweteera, Fred] Budongo Conservat Field Stn, Masindi, Uganda; [Baker, Patrick] Monash Univ, Melbourne, Vic 3800, Australia; [Banki, Olaf] Univ Utrecht, Utrecht, Netherlands; [Bass, Margot] Finding Species, Takoma Pk, MD 20912 USA; [Bila-Isia, Inogwabini] Univ Kent, Canterbury CT2 7NZ, Kent, England; [Brockelman, Warren] Mahidol Univ Salaya, Nakhon Pathom 73170, Thailand; [Brokaw, Nicholas] Univ Puerto Rico, San Juan, PR 00936 USA; [Bruehl, Carsten A.] Univ Koblenz Landau, D-76829 Landau, Germany; [Bunyavejchewin, Sarayudh] Dept Natl Pk, Bangkok 10900, Thailand; [Chao, Jung-Tai] Taiwan Forestry Res Inst, Taipei 10066, Taiwan; [Chave, Jerome] Univ Toulouse 3, F-31062 Toulouse, France; [Chellam, Ravi] Wildlife Conservat Soc, Bangalore 560070, Karnataka, India; [Clavijo, Jose] Cent Univ Venezuela, Aragua, Venezuela; [Corlett, Richard; Kudavidanage, Enoka; Sodhi, Navjot] Natl Univ Singapore, Singapore 117543, Singapore; [Dattaraja, H. S.] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Dave, Chittaranjan] World Wide Fund Nat WWF, New Delhi 110003, India; [Davies, Glyn] World Wide Fund Nat WWF, Surrey GU7 1XR, England; [Beisiegel, Beatriz de Mello] Inst Chico Mendes Conservacao Biodiversidade, BR-12952011 Sao Paulo, Brazil; [da Silva, Rosa de Nazarepaes] Conselho Reg Engn Arquitetura & Agron Para, Belem, Para, Brazil; [Di Fiore, Anthony] Univ Texas Austin, Austin, TX 78712 USA; [Diesmos, Arvin] Natl Museum Philippines, Manila, Philippines; [Dirzo, Rodolfo] Stanford Univ, Stanford, CA 94305 USA; [Eaton, Mitchell] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Eaton, Mitchell] Univ Colorado, Boulder, CO 80309 USA; [Ewango, Corneille] Wildlife Conservat Soc, Kinshasa, DEM REP CONGO; [Fedigan, Linda] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Fruth, Barbara; Surbeck, Martin] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Willis, Jacalyn Giacalone] Montclair State Univ, Montclair, NJ 07043 USA; [Goodale, Uromi] Univ Calif San Diego, San Diego, CA 92093 USA; [Goodman, Steven] Field Museum Nat Hist, Chicago, IL 60605 USA; [Guix, Juan C.] Univ Barcelona, E-08028 Barcelona, Spain; [Guthiga, Paul] Kenya Inst Publ Policy Res & Anal, Nairobi, Kenya; [Haber, William; Sun, I. Fang] Missouri Bot Garden, St Louis, MO 63166 USA; [Hamer, Keith] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Herbinger, Ilka] Wild Chimpanzee Fdn, Abidjan 23, Cote Ivoire; [Huang, Zhongliang] Dinghushan Biosphere Reserve, Zhaoqing, Peoples R China; Tunghai Univ, Taichung 407, Taiwan; [Ickes, Kalan] Clemson Univ, Clemson, SC 29634 USA; [Itoh, Akira] Osaka City Univ, Osaka 5588585, Japan; [Ivanauskas, Natalia] Inst Florestal, BR-02377000 Sao Paulo, Brazil; [Janovec, John; Tobler, Mathias] Bot Res Inst Texas, Ft Worth, TX 76107 USA; [Jiangming, Mo; Xiankai, Lu] S China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Jones, Trevor] Anglia Ruskin Univ, Cambridge CB1 1PT, England; [Justiniano, Hermes] Fdn Conservac Bosque, Chiquitano, Bolivia; [Kalko, Elisabeth] Univ Ulm, D-89069 Ulm, Germany; [Kasangaki, Aventino] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Killeen, Timothy] Conservat Int, Arlington, VA 22202 USA; [King, Hen-biau] Soc Subtrop Ecol, Taipei, Taiwan; [Klop, Erik] Royal Haskoning Water & Ecol Grp, Groningen, Netherlands; [Knott, Cheryl] Boston Univ, Boston, MA 02215 USA; [Kone, Inza] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Ribeiro, Jose Lahoz da Silva] Univ Estadual Londrina, Londrina, Parana, Brazil; [Lattke, John] Cent Univ Venezuela, Caracas, Venezuela; [Laval, Richard] Bat Jungle, Monteverde, Costa Rica; [Lawton, Robert] Univ Alabama, Huntsville, AL 35899 USA; [Lentino, Miguel] Colecc Ornitol Phelps, Caracas, Venezuela; [Leonel, Cristiane] Parque Estadual Horto Florestal, BR-02377000 Sao Paulo, Brazil; [Lindsell, Jeremy] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Ling-Ling, Lee] Natl Taiwan Univ, Taipei 10764, Taiwan; [Linsenmair, K. Eduard] Univ Wurzburg, D-97074 Wurzburg, Germany; [Losos, Elizabeth] Org Trop Studies, Durham, NC 27705 USA; [Lugo, Ariel] USDA Int Inst Trop Forestry, Rio Piedras, PR 00926 USA; [Lwanga, Jeremiah] Makerere Univ, Kampala, Uganda; [Mack, Andrew L.; Wright, Debra D.] Green Capac Inc, New Florence, PA 15944 USA; [Martins, Marlucia] Museu Paraense Emilio Goeldi, BR-66040170 Belem, Para, Brazil; [McGraw, W. Scott] Ohio State Univ, Columbus, OH 43210 USA; [McNab, Roan] Wildlife Conservat Soc, Flores, Guatemala; [Montag, Luciano] Fed Univ Para, BR-66040170 Belem, Para, Brazil; [Thompson, Jo Myers] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Nabe-Nielsen, Jacob] Aarhus Univ, DK-4000 Roskilde, Denmark; [Nepal, Sanjay] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Nakagawa, Michiko] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Novotny, Vojtech] Acad Sci Czech Republ, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; [O'Donnell, Sean] Univ Washington, Seattle, WA 98195 USA; [Opiang, Muse] PNG Inst Biol Res, Goroka, Papua N Guinea; [Ouboter, Paul] Univ Suriname, Paramaribo, Suriname; [Parthasarathy, N.] Pondicherry Univ, Pondicherry 605014, India; [Pisciotta, Katia] Fundacao Florestal, BR-02377000 Sao Paulo, Brazil; [Prawiradilaga, Dewi] Res Ctr Biol, Cibinong 16911, Indonesia; [Pringle, Catherine] Univ Georgia, Athens, GA 30602 USA; [Rajathurai, Subaraj] Strix Wildlife Consultancy, Singapore, Singapore; [Reichard, Ulrich] So Illinois Univ, Carbondale, IL 62901 USA; [Reinartz, Gay] Zool Soc Milwaukee, Milwaukee, WI 53226 USA; [Renton, Katherine; Rivera, Jorge Vega] Univ Nacl Autonoma Mexico, Estn Biol Chamela, Jalisco 48980, Mexico; [Reynolds, Glen] Danum Valley Field Ctr, Sabah, Malaysia; [Reynolds, Vernon] Univ Oxford, Oxford BN26 5UX, England; [Riley, Erin] San Diego State Univ, San Diego, CA 92182 USA; [Roedel, Mark-Oliver] Museum Naturkunde, Berlin, Germany; [Rothman, Jessica] CUNY, New York, NY 10065 USA; [Round, Philip] Mahidol Univ, Bangkok 10400, Thailand; [Sakai, Shoko] Res Inst Human & Nat, Kyoto, Japan; [Schaab, Gertrud] Karlsruhe Univ Appl Sci, Karlsruhe, Germany; [Seidensticker, John] Natl Zool Pk, Washington, DC 20013 USA; [Siaka, Alhaji] Gola Forest Programme, Kenema, Sierra Leone; [Silman, Miles R.] Wake Forest Univ, Winston Salem, NC 27106 USA; [Smith, Thomas B.; Wang, Benjamin] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Stanford, Craig] Univ So Calif, Los Angeles, CA 90089 USA; [Stewart, Kristine] Inst Appl Ethnobotany, Pompano Beach, FL 33069 USA; [Sukumar, Raman] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Stoner, Kathryn E.] Texas A&M Univ, Kingsville, TX 78363 USA; [Tscharntke, Teja; Waltert, Matthias] Univ Gottingen, Gottingen, Germany; [Turkalo, Andrea] Wildlife Conservat Soc, Bangui, Cent Afr Republ; [Umapathy, Govindaswamy] Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Venn, Linda] Paluma Environm Educ Ctr, Paluma, Qld 4816, Australia; [Verea, Carlos] Cent Univ Venezuela, Maracay, Venezuela; [de Castilho, Carolina Volkmer] Embrapa Roraima, Boa Vista, Roraima, Brazil; [Whitacre, David] Treasure Valley Math & Sci Ctr, Boise, ID 83714 USA; [Whitney, Ken] Rice Univ, Houston, TX 77005 USA; [Wright, Patricia] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Yonzon, Pralad] Resources Himalaya Fdn, Kathmandu, Nepal	James Cook University; James Cook University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Adelaide; University of Stirling; Duke University; Universidad Nacional Autonoma de Mexico; Royal Botanic Gardens, Kew; World Wildlife Fund; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; McGill University; Universidad Nacional Autonoma de Mexico; Columbia University; State University System of Florida; Florida International University; Philipps University Marburg; California State University System; California State University Fullerton; Museum National d'Histoire Naturelle (MNHN); Smithsonian Institution; United States Department of the Interior; United States Geological Survey; King Mongkuts University of Technology Thonburi; Virginia Polytechnic Institute & State University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Twente; Institute Nacional de Pesquisas da Amazonia; Wildlife Conservation Society; University of York - UK; University of Copenhagen; James Cook University; Leiden University; Leiden University - Excl LUMC; Woods Hole Research Center; Oregon State University; University of Pennsylvania; University of Vienna; University of Kansas; Pontificia Universidad Javeriana; Wildlife Institute of India; Yale University; Monash University; Utrecht University; University of Kent; Mahidol University; University of Puerto Rico; University of Koblenz & Landau; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Central Venezuela; National University of Singapore; Indian Institute of Science (IISC) - Bangalore; University of Texas System; University of Texas Austin; National Museum of the Philippines; Stanford University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Boulder; University of Calgary; Max Planck Society; Montclair State University; University of California System; University of California San Diego; Field Museum of Natural History (Chicago); University of Barcelona; Missouri Botanical Gardens; University of Leeds; Tunghai University; Clemson University; Osaka Metropolitan University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Anglia Ruskin University; Ulm University; Mbarara University of Science & Technology; Conservation International; Boston University; Universidade Estadual de Londrina; University of Central Venezuela; University of Alabama System; University of Alabama Huntsville; Royal Society for Protection of Birds; National Taiwan University; University of Wurzburg; United States Department of Agriculture (USDA); Makerere University; Museu Paraense Emilio Goeldi; University System of Ohio; Ohio State University; Universidade Federal do Para; Aarhus University; University of Waterloo; Nagoya University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Washington; University of Washington Seattle; Anton de Kom Universiteit van Suriname; Pondicherry University; University System of Georgia; University of Georgia; Southern Illinois University System; Southern Illinois University; Universidad Nacional Autonoma de Mexico; University of Oxford; California State University System; San Diego State University; Leibniz Institut fur Evolutions und Biodiversitatsforschung; City University of New York (CUNY) System; Mahidol University; Research Institute for Humanity & Nature (RIHN); Karlsruhe University of Applied Sciences; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Wake Forest University; University of California System; University of California Los Angeles; University of Southern California; Indian Institute of Science (IISC) - Bangalore; Texas A&M University System; Texas A&M University Kingsville; University of Gottingen; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Central Venezuela; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Rice University; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Laurance, WF (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld 4878, Australia.	bill.laurance@jcu.edu.au	Ivanauskas, Natalia/S-4951-2019; Sheil, Douglas/A-3867-2015; Rovero, Francesco/AAI-3157-2020; Bradshaw, Corey J.A./A-1311-2008; Nabe-Nielsen, Jacob/A-5891-2010; Bruhl, Carsten A/F-3385-2012; Novotny, Vojtech/G-9434-2014; Cannon, Charles H/D-7186-2012; B., John E. Lattke/K-2934-2015; Babweteera, Fred/AAC-3046-2022; Wright, Stuart Joseph/M-3311-2013; Nielsen, Martin Reinhardt/E-1173-2015; Linsenmair, Karl Eduard/Q-2268-2018; Cannon, Charles/AAE-7715-2019; Forget, Pierre-Michel/B-4355-2009; Sloan, Sean/A-8630-2012; Raman, Sukumar/C-9809-2013; Schulze, Christian/AGJ-7744-2022; Bunyavejchewin, Sarayudh/P-1529-2017; Arroyo-Rodríguez, Víctor/C-9255-2009; Ribeiro, Jose Eduardo L. S./A-8574-2013; Pringle, Catherine M/I-1841-2012; Laurance, William F/B-2709-2012; Tscharntke, Teja/N-5123-2014; Laurance, Susan/G-6021-2011; de Assis Montag, Luciano Fogaça/I-1485-2012; de Castilho, Carolina Volkmer/I-6618-2019; Whitney, Kenneth D/B-2971-2011; Tobler, Mathias/AFN-0051-2022; Plumptre, Andrew J./X-3145-2019; Campbell, Mason/G-4651-2017; Doran-Sheehy, Diane/GXV-9571-2022; Sakai, Shoko/AFN-1913-2022; Pearson, Richard/GQH-2760-2022; Pitman, Nigel C A/A-7681-2008; van der Ploeg, Jan/AAD-5179-2019; Kasangaki, Aventino/ABB-3243-2021; Montag, Luciano/AER-1730-2022; van Weerd, Merlijn/K-6790-2013; Kudavidanage, Enoka P./AAM-1316-2021; Lu, Xiankai/M-2127-2014; Poulsen, John/O-5332-2019; Hill, Jane K./AAJ-3374-2021; Chapman, Colin/S-1911-2019; Williams, Stephen E/A-7250-2008; Dave, Chittaranjan/GPX-0631-2022; Corlett, Richard T./S-2899-2019; Stoner, Kathryn E/E-1510-2015; Sheil, Douglas/N-3291-2019; Maisels, Fiona/E-7382-2015; Rainey, Hugo/I-6047-2012; Urbina-Cardona, J. Nicolas/B-5447-2008; Ivanauskas, Natalia/C-2224-2012; Waltert, Matthias/E-9134-2010; Diesmos, Arvin C./AGG-8542-2022; Edwards, David/AAC-5091-2019	Ivanauskas, Natalia/0000-0001-6643-8476; Sheil, Douglas/0000-0002-1166-6591; Rovero, Francesco/0000-0001-6688-1494; Bradshaw, Corey J.A./0000-0002-5328-7741; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Novotny, Vojtech/0000-0001-7918-8023; Cannon, Charles H/0000-0003-1901-0420; B., John E. Lattke/0000-0002-6793-3003; Wright, Stuart Joseph/0000-0003-4260-5676; Nielsen, Martin Reinhardt/0000-0002-8941-6031; Linsenmair, Karl Eduard/0000-0002-2132-8721; Cannon, Charles/0000-0003-1901-0420; Forget, Pierre-Michel/0000-0002-9252-974X; Sloan, Sean/0000-0002-7834-0203; Schulze, Christian/0000-0001-9442-7141; Bunyavejchewin, Sarayudh/0000-0002-1976-5041; Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Ribeiro, Jose Eduardo L. S./0000-0002-2389-5631; Laurance, William F/0000-0003-4430-9408; Laurance, Susan/0000-0002-2831-2933; de Assis Montag, Luciano Fogaça/0000-0001-9370-6747; de Castilho, Carolina Volkmer/0000-0002-1064-2758; Whitney, Kenneth D/0000-0002-2523-5469; Plumptre, Andrew J./0000-0002-9333-4047; Campbell, Mason/0000-0001-6803-271X; Sakai, Shoko/0000-0002-4267-8405; Pitman, Nigel C A/0000-0002-9211-2880; van der Ploeg, Jan/0000-0001-7099-4002; Kasangaki, Aventino/0000-0002-9762-4666; van Weerd, Merlijn/0000-0002-7173-3725; Poulsen, John/0000-0002-1532-9808; Hill, Jane K./0000-0003-1871-7715; Chapman, Colin/0000-0002-8827-8140; Williams, Stephen E/0000-0002-2510-7408; Corlett, Richard T./0000-0002-2508-9465; Stoner, Kathryn E/0000-0002-9964-1697; Maisels, Fiona/0000-0002-0778-0615; Urbina-Cardona, J. Nicolas/0000-0002-4174-8467; Ivanauskas, Natalia/0000-0001-6643-8476; Waltert, Matthias/0000-0001-7053-0291; Edwards, David/0000-0001-8562-3853; Harris, David/0000-0002-6801-2484; Bruhl, Carsten A./0000-0003-1332-535X; Krishnaswamy, Jagdish/0000-0001-7985-0005; Baker, Patrick/0000-0002-6560-7124; Dave, Chittaranjan/0000-0002-2006-383X; Eaton, Mitchell/0000-0001-7324-6333; Coates, Rosamond/0000-0003-0074-1565; Quesada, Mauricio/0000-0002-7776-9286; Abernethy, Katharine/0000-0002-0393-9342; Kone, Inza/0000-0002-2940-2439; Goodale, Uromi/0000-0003-3111-8899; Tobler, Mathias/0000-0002-8587-0560; Timm, Robert/0000-0001-6203-3316; Harrison, Rhett/0000-0001-9055-3546; Umapathy, Govindhaswamy/0000-0003-4086-7445; Edwards, Felicity/0000-0003-1742-2763; Inogwabini, Bila-Isia/0000-0002-6897-2477; Reichard, Ulrich H./0000-0002-5564-3922; Karpanty, Sarah/0000-0003-3831-8914; Verea, Carlos/0000-0002-1720-649X; Pearson, Richard/0000-0001-6047-031X; Danielsen, Finn/0000-0003-0229-2847; Vasudevan, Karthikeyan/0000-0003-2316-3382; Banki, Olaf/0000-0001-6197-9951; Mack, Andrew L./0000-0001-8823-9101; Lindsell, Jeremy/0000-0003-2088-8927	James Cook University; Smithsonian Tropical Research Institute; Australian Laureate Fellowship; NSF [RCN-0741956]; Direct For Social, Behav & Economic Scie [1028471] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1209072] Funding Source: National Science Foundation	James Cook University; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Australian Laureate Fellowship; NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was supported by James Cook University, the Smithsonian Tropical Research Institute, an Australian Laureate Fellowship (to W. F. L.) and NSF grant RCN-0741956. We thank A. Bruner, R. A. Butler, G. R. Clements, R. Condit, C. N. Cook, S. Goosem, J. Geldmann, L. Joppa, S. L. Pimm and O. Venter for comments.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Bradshaw CJA, 2009, FRONT ECOL ENVIRON, V7, P79, DOI 10.1890/070193; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Chan KMA, 2008, P NATL ACAD SCI USA, V105, P19342, DOI 10.1073/pnas.0810522105; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Porter-Bolland L, 2012, FOREST ECOL MANAG, V268, P6, DOI 10.1016/j.foreco.2011.05.034; Possingham HP, 2006, PRINCIPLES CONSERVAT, P516; Scherl L.M., 2004, OPPORTUNITIES LIMITA; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Shoo LP, 2011, GLOBAL CHANGE BIOL, V17, P186, DOI 10.1111/j.1365-2486.2010.02218.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Wells M, 2004, AMBIO, V33, P513, DOI 10.1639/0044-7447(2004)033[0513:IPAMWL]2.0.CO;2; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Wright SJ, 2007, ECOL APPL, V17, P1259, DOI 10.1890/06-1330.1	30	692	728	30	1211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					290	+		10.1038/nature11318	http://dx.doi.org/10.1038/nature11318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22832582	Green Accepted			2022-12-01	WOS:000308635900041
J	Ioannou, CC; Guttal, V; Couzin, ID				Ioannou, C. C.; Guttal, V.; Couzin, I. D.			Predatory Fish Select for Coordinated Collective Motion in Virtual Prey	SCIENCE			English	Article							INDIVIDUAL-BASED MODEL; ANIMAL GROUPS; SELFISH HERD; BEHAVIOR; DYNAMICS; SPARROWHAWKS; STRATEGIES; CONFUSION; ATTACK	Movement in animal groups is highly varied and ranges from seemingly disordered motion in swarms to coordinated aligned motion in flocks and schools. These social interactions are often thought to reduce risk from predators, despite a lack of direct evidence. We investigated risk-related selection for collective motion by allowing real predators ( bluegill sunfish) to hunt mobile virtual prey. By fusing simulated and real animal behavior, we isolated predator effects while controlling for confounding factors. Prey with a tendency to be attracted toward, and to align direction of travel with, near neighbors tended to form mobile coordinated groups and were rarely attacked. These results demonstrate that collective motion could evolve as a response to predation, without prey being able to detect and respond to predators.	[Ioannou, C. C.; Guttal, V.; Couzin, I. D.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Ioannou, C. C.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Guttal, V.] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Princeton University; University of Bristol; Indian Institute of Science (IISC) - Bangalore	Ioannou, CC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	C.C.Ioannou@bristol.ac.uk; icouzin@princeton.edu	Couzin, Iain D./Q-6862-2018; Guttal, Vishwesha/A-3007-2008	Couzin, Iain D./0000-0001-8556-4558; Guttal, Vishwesha/0000-0002-2677-857X; Ioannou, Christos/0000-0002-9739-889X	Office of Naval Research [N00014-09-1-1074]; NSF [PHY-0848755]; Searle Scholar award [08-SPP-201]; Army Research Office [W911NG-11-1-0385]; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; Leverhulme Trust; Department of Biotechnology, Government of India; Division Of Physics [0848755] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Searle Scholar award; Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Leverhulme Trust(Leverhulme Trust); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Hundal, M. Jiang, and M. Singh for assistance and A. S. I. Wade, the Couzin lab, and three anonymous reviewers for comments on the manuscript. Funded by Office of Naval Research award N00014-09-1-1074, NSF award PHY-0848755, Searle Scholar award 08-SPP-201, and Army Research Office grant W911NG-11-1-0385 (I. D. C.); Defense Advanced Research Projects Agency grant HR0011-05-1-0057 (Princeton University); Leverhulme Trust Early Career Fellowship (C. C. I.); and a Ramalingaswami Fellowship from the Department of Biotechnology, Government of India (V. G.). All experiments were conducted in accordance with federal and state regulations and were approved by the Princeton University Institutional Animal Care and Use Committee. Data and code are freely available at http://icouzin.princeton.edu.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Cresswell W, 2004, OIKOS, V104, P71, DOI 10.1111/j.0030-1299.2004.12814.x; Cresswell W, 1996, IBIS, V138, P684, DOI 10.1111/j.1474-919X.1996.tb04770.x; EHLINGER TJ, 1988, P NATL ACAD SCI USA, V85, P1878, DOI 10.1073/pnas.85.6.1878; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Ioannou CC, 2008, BEHAV ECOL, V19, P126, DOI 10.1093/beheco/arm109; Jones KA, 2011, BEHAV ECOL, V22, P831, DOI 10.1093/beheco/arr062; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Krause J., 2002, LIVING GROUPS; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Romey WL, 2008, BEHAV ECOL, V19, P74, DOI 10.1093/beheco/arm105; Ruxton GD, 2007, BEHAV ECOL, V18, P590, DOI 10.1093/beheco/arm009; Sayama H, 2009, IEEE SYMP ART LIFE, P85, DOI 10.1109/ALIFE.2009.4937698; Tosh CR, 2011, J THEOR BIOL, V281, P24, DOI 10.1016/j.jtbi.2011.04.014; TREHERNE JE, 1982, ANIM BEHAV, V30, P536, DOI 10.1016/S0003-3472(82)80066-3; Vabo R, 1997, FISH OCEANOGR, V6, P155, DOI 10.1046/j.1365-2419.1997.00037.x; Wood AJ, 2007, P R SOC B, V274, P1637, DOI 10.1098/rspb.2007.0306	26	202	208	5	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1212	1215		10.1126/science.1218919	http://dx.doi.org/10.1126/science.1218919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22903520	Green Submitted			2022-12-01	WOS:000308414000034
J	Liu, C; Placais, PY; Yamagata, N; Pfeiffer, BD; Aso, Y; Friedrich, AB; Siwanowicz, I; Rubin, GM; Preat, T; Tanimoto, H				Liu, Chang; Placais, Pierre-Yves; Yamagata, Nobuhiro; Pfeiffer, Barret D.; Aso, Yoshinori; Friedrich, Anja B.; Siwanowicz, Igor; Rubin, Gerald M.; Preat, Thomas; Tanimoto, Hiromu			A subset of dopamine neurons signals reward for odour memory in Drosophila	NATURE			English	Article							TARGETED GENE-EXPRESSION; MUSHROOM BODY; BRAIN; FLY; HYDROXYLASE; OCTOPAMINE; SEROTONIN; BEHAVIOR; REVEALS; AROUSAL	Animals approach stimuli that predict a pleasant outcome(1). After the paired presentation of an odour and a reward, Drosophila melanogaster can develop a conditioned approach towards that odour(2,3). Despite recent advances in understanding the neural circuits for associative memory and appetitive motivation(4), the cellular mechanisms for reward processing in the fly brain are unknown. Here we show that a group of dopamine neurons in the protocerebral anterior medial (PAM) cluster signals sugar reward by transient activation and inactivation of target neurons in intact behaving flies. These dopamine neurons are selectively required for the reinforcing property of, but not a reflexive response to, the sugar stimulus. In vivo calcium imaging revealed that these neurons are activated by sugar ingestion and the activation is increased on starvation. The output sites of the PAM neurons are mainly localized to the medial lobes of the mushroom bodies (MBs), where appetitive olfactory associative memory is formed(5,6). We therefore propose that the PAM cluster neurons endow a positive predictive value to the odour in the MBs. Dopamine in insects is known to mediate aversive reinforcement signals(5,7-11). Our results highlight the cellular specificity underlying the various roles of dopamine and the importance of spatially segregated local circuits within the MBs.	[Liu, Chang; Yamagata, Nobuhiro; Aso, Yoshinori; Friedrich, Anja B.; Siwanowicz, Igor; Tanimoto, Hiromu] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Liu, Chang] Chinese Acad Sci, Kunming Inst Zool, Lab Primate Cognit Neurosci, Kunming 650223, Yunnan, Peoples R China; [Liu, Chang] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Placais, Pierre-Yves; Preat, Thomas] Ecole Super Phys & Chim Ind Ville Paris, CNRS, Neurobiol Unit, F-75005 Paris, France; [Pfeiffer, Barret D.; Aso, Yoshinori; Rubin, Gerald M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Max Planck Society; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Universite Paris Cite; Howard Hughes Medical Institute	Tanimoto, H (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	hiromut@neuro.mpg.de	Aso, Yoshinori/ACJ-9439-2022; Tanimoto, Hiromu/J-6810-2016	Preat, Thomas/0000-0001-9976-1763; Rubin, Gerald/0000-0001-8762-8703	Max-Planck-Gesellschaft; Chinese Academy of Sciences; Deutscher Akademischer Austausch Dienst; Alexander von Humboldt Foundation; Region Ile-de-France; Agence Nationale pour la Recherche; Howard Hughes Medical Institute; Bundesministerium fur Bildung und Forschung; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081982] Funding Source: NIH RePORTER	Max-Planck-Gesellschaft(Max Planck Society); Chinese Academy of Sciences(Chinese Academy of Sciences); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Region Ile-de-France(Region Ile-de-France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Bracker, M. Feind, C. Murphy, C. Schnaitmann and T. Templier for technical assistance and experiments that inspired this study; P. Garrity, the Kyoto Drosophila Genetic Resource Center and the Bloomington Stock Center for fly stocks; and Y.Y. Ma, Z. Q. Meng, R. Menzel, A. Thum, S. Waddell and the members of the Tanimoto laboratory for discussion and/or critical reading of the manuscript. C.L., Y.A., N.Y. and P.-Y.P. were sponsored by a Chinese-European doctoral training program from Max-Planck-Gesellschaft and the Chinese Academy of Sciences, the Deutscher Akademischer Austausch Dienst, the Alexander von Humboldt Foundation, and the Region Ile-de-France, respectively. This work was supported by the Agence Nationale pour la Recherche (T.P.), the Howard Hughes Medical Institute (G.M.R.), Bernstein Focus Learning from the Bundesministerium fur Bildung und Forschung and the Max-Planck-Gesellschaft (H.T.).	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Mizunami M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00172; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Schnaitmann C, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00010; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trannoy S, 2011, CURR BIOL, V21, P1647, DOI 10.1016/j.cub.2011.08.032; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Yarali A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00189	37	336	342	5	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					512	+		10.1038/nature11304	http://dx.doi.org/10.1038/nature11304			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22810589				2022-12-01	WOS:000307761600037
J	Pronovost, PJ; Bo-Linn, GW				Pronovost, Peter J.; Bo-Linn, George W.			Preventing Patient Harms Through Systems of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTENSIVE-CARE		[Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Armstrong Inst Patient Safety & Qual, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Carey Business Sch, Baltimore, MD 21218 USA; [Bo-Linn, George W.] Gordon & Betty Moore Fdn, Patient Care Program, Palo Alto, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P39, DOI 10.1001/jama.2011.1927; Grossman C., 2011, ENG LEARNING HEALTHC; Gurses AP, 2008, QUAL SAF HEALTH CARE, V17, P351, DOI 10.1136/qshc.2006.021709; Pronovost P J, 2001, Eff Clin Pract, V4, P199; Pronovost PJ, 2010, AM J RESP CRIT CARE, V182, P1463, DOI 10.1164/rccm.201008-1255ED; US Department of Health and Human Services, PARTN PAT LEARN OUR	7	47	51	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					769	770		10.1001/jama.2012.9537	http://dx.doi.org/10.1001/jama.2012.9537			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910751				2022-12-01	WOS:000307705300017
J	Sarov, M; Murray, JI; Schanze, K; Pozniakovski, A; Niu, W; Angermann, K; Hasse, S; Rupprecht, M; Vinis, E; Tinney, M; Preston, E; Zinke, A; Enst, S; Teichgraber, T; Janette, J; Reis, K; Janosch, S; Schloissnig, S; Ejsmont, RK; Slightam, C; Xu, X; Kim, SK; Reinke, V; Stewart, AF; Snyder, M; Waterston, RH; Hyman, AA				Sarov, Mihail; Murray, John I.; Schanze, Kristin; Pozniakovski, Andrei; Niu, Wei; Angermann, Karolin; Hasse, Susanne; Rupprecht, Michaela; Vinis, Elisabeth; Tinney, Matthew; Preston, Elicia; Zinke, Andrea; Enst, Susanne; Teichgraber, Tina; Janette, Judith; Reis, Kadri; Janosch, Stephan; Schloissnig, Siegfried; Ejsmont, Radoslaw K.; Slightam, Cindie; Xu, Xiao; Kim, Stuart K.; Reinke, Valerie; Stewart, A. Francis; Snyder, Michael; Waterston, Robert H.; Hyman, Anthony A.			A Genome-Scale Resource for In Vivo Tag-Based Protein Function Exploration in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; SYSTEMATIC ANALYSIS; POSTGENOMIC ERA; GLOBAL ANALYSIS; HIGH-THROUGHPUT; COMPLEXES; YEAST; FATE; RECOMBINATION	Understanding the in vivo dynamics of protein localization and their physical interactions is important for many problems in biology. To enable systematic protein function interrogation in a multicellular context, we built a genome-scale transgenic platform for in vivo expression of fluorescent-and affinity-tagged proteins in Caenorhabditis elegans under endogenous cis regulatory control. The platform combines computer-assisted transgene design, massively parallel DNA engineering, and next-generation sequencing to generate a resource of 14,637 genomic DNA transgenes, which covers 73% of the proteome. The multipurpose tag used allows any protein of interest to be localized in vivo or affinity purified using standard tag-based assays. We illustrate the utility of the resource by systematic chromatin immunopurification and automated 4D imaging, which produced detailed DNA binding and cell/tissue distribution maps for key transcription factor proteins.	[Sarov, Mihail; Schanze, Kristin; Angermann, Karolin; Hasse, Susanne; Rupprecht, Michaela; Vinis, Elisabeth; Tinney, Matthew; Reis, Kadri; Janosch, Stephan; Schloissnig, Siegfried] Max Planck Inst Mol Cell Biol & Genet, Transgene Unit, D-01307 Dresden, Germany; [Murray, John I.; Preston, Elicia; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Niu, Wei; Janette, Judith; Reinke, Valerie] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Slightam, Cindie; Xu, Xiao; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Snyder, Michael] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Stewart, A. Francis] Tech Univ Dresden, Dept Genom, D-01307 Dresden, Germany	Max Planck Society; University of Washington; University of Washington Seattle; Yale University; Stanford University; Stanford University; Technische Universitat Dresden	Sarov, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Transgene Unit, D-01307 Dresden, Germany.	sarov@mpi-cbg.de	Stewart, A. Francis/E-7789-2010; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Schloissnig, Siegfried/0000-0003-4574-8330; Ejsmont, Radoslaw/0000-0001-7176-7848; Janosch, Stephan/0000-0002-2401-6862; Snyder, Michael/0000-0003-0784-7987; Reis, Kadri/0000-0002-2144-5856	Max Planck Society Initiative "BAC TransgeneOmics"; NIH initiative "modENCODE"; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004263, U01HG004267, U54HG007002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072675] Funding Source: NIH RePORTER	Max Planck Society Initiative "BAC TransgeneOmics"; NIH initiative "modENCODE"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The TransgeneOme project was partially funded by the Max Planck Society Initiative "BAC TransgeneOmics." The NIH initiative "modENCODE" funded grants to M.Sn. and R. H. W. J.I.M. was a fellow of the Jane Coffin Childs Memorial Fund for Medical Research and received funding from the NIH. A. F. S. is a shareholder of Gene Bridges GmbH, which holds the exclusive commercial rights to the Red/ET recombineering methodologies. M. Sa. holds the distribution rights for the transgenic constructs collection. M.Sn. is a member of the scientific advisory board of Personalis and Genapsys and is a consultant for Illumina.	Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEESEMAN IM, 2005, SCI STKE; CHEN LS, 1994, DEVELOPMENT, V120, P1631; Ciotta G, 2011, METHODS, V53, P113, DOI 10.1016/j.ymeth.2010.09.003; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cowing D, 1996, NATURE, V382, P353, DOI 10.1038/382353a0; de Souza N, 2012, NAT METHODS, V9, P27, DOI 10.1038/nmeth.1848; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Dunn RK, 2007, MOL CELL, V28, P708, DOI 10.1016/j.molcel.2007.11.022; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Ejsmont RK, 2011, METHODS MOL BIOL, V772, P445, DOI 10.1007/978-1-61779-228-1_26; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hallam S, 2000, DEVELOPMENT, V127, P4239; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hofemeister H, 2011, METHODS, V53, P437, DOI 10.1016/j.ymeth.2010.12.026; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janke DL, 1997, GENOME RES, V7, P974, DOI 10.1101/gr.7.10.974; Kelly WG, 1998, DEVELOPMENT, V125, P2451; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/nmeth.1366, 10.1038/NMETH.1366]; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nedelkova M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr668; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Polanowska J, 2004, BIOTECHNIQUES, V36, P778, DOI 10.2144/04365BM05; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Praitis V, 2001, GENETICS, V157, P1217; Priess James R, 2005, WormBook, P1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ristevski S, 2005, MOL BIOTECHNOL, V29, P153, DOI 10.1385/MB:29:2:153; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Saghatelian A, 2005, NAT CHEM BIOL, V1, P130, DOI 10.1038/nchembio0805-130; Sarov M, 2005, TRENDS BIOTECHNOL, V23, P446, DOI 10.1016/j.tibtech.2005.06.007; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Voutev R, 2009, FEBS LETT, V583, P456, DOI 10.1016/j.febslet.2008.12.046; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	62	164	167	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					855	866		10.1016/j.cell.2012.08.001	http://dx.doi.org/10.1016/j.cell.2012.08.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901814	Green Accepted, Bronze			2022-12-01	WOS:000308002300018
J	Spence, D				Spence, Des			Unhappy pills	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEROTONIN REUPTAKE INHIBITORS; DEPRESSION; SEVERITY					destwo@yahoo.co.uk						Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Borland S, 2012, DAILY MAIL; Deshauer D, 2008, CAN MED ASSOC J, V178, P1293, DOI 10.1503/cmaj.071068; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Haddad P.M., 2007, ADV PSYCHIAT TREATME, V13, P447, DOI DOI 10.1192/APT.BP.105.001966; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; NHS Health and Social Care Information Centre, 2012, PRESCR DISP COMM ENG; *NHS HLTH SOC CAR, 2006, PRESCR COST AN ENGL; Reid IC., 2011, BMJ; Reid S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1468	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2012	345								e5409	10.1136/bmj.e5409	http://dx.doi.org/10.1136/bmj.e5409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NG	22885400				2022-12-01	WOS:000307497100004
J	Layden, J; Michaels, J; Bermingham, S; Higgins, B				Layden, Jennifer; Michaels, Jonathan; Bermingham, Sarah; Higgins, Bernard		Guideline Dev Grp	Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Michaels, Jonathan] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Layden, Jennifer; Bermingham, Sarah; Higgins, Bernard] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of Sheffield; Royal College of Physicians	Michaels, J (corresponding author), Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England.	j.michaels@sheffield.ac.uk						[Anonymous], 2008, GUID PROM CREAT PHYS; [Anonymous], 2008, INT GUID WORKPL HLTH; Cayir A., 2018, INTERNAL MED REV, V4, DOI [10.18103/imr.v4i12.776, DOI 10.18103/IMR.V4I12.776]; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; *NAT I HLTH CLIN E, 2007, EZ TREATM PRIM HET F; National Institute for Health and Clinical Excellence, 2008, SMOK CESS SERV PRIM; National Institute for Health and Clinical Excellence, 2008, CARD RISK ASS MOD BL; National Institute for Health and Clinical Excellence, 2010, CLOP MOD REL DIP PRE; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; National Institute for Health and Clinical Excellence, 2006, BRIEF INT REF SMOK C; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2007, VAR SMOK CESS TECHN; National Institute for Health and Clinical Excellence, 2008, SOC VAL JUDG PRINC D, V2nd; National Institute for Health and Clinical Excellence, 2008, GUID PREV UPT SMOK C; National Institute for Health and Clinical Excellence, 2011, PREV TYP 2 DIAB POP; National Institute for Health and Clinical Excellence, 2012, LOW LIMB PER ART DIS; National Institute for Health and Clinical Excellence, 2003, CLIN EFF COST EFF PA; National Institute for Health and Clinical Excellence, 2006, STAT PREV CARD EV PA; National Institute for Health and Clinical Excellence, 2011, DIAB FOOT INP MAN PE; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; National Institute for Health & Clinical Excellence, 2006, 4 COMM US METH INCR; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; The Vascular Society of Great Britain and Ireland: the provision of services for patients with vascular disease, 2012, VAS SOC GREAT BRIT I	23	95	96	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e4947	10.1136/bmj.e4947	http://dx.doi.org/10.1136/bmj.e4947			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875949				2022-12-01	WOS:000307496800006
J	Cocucci, E; Aguet, F; Boulant, S; Kirchhausen, T				Cocucci, Emanuele; Aguet, Francois; Boulant, Steeve; Kirchhausen, Tom			The First Five Seconds in the Life of a Clathrin-Coated Pit	CELL			English	Article							MEDIATED ENDOCYTOSIS; LIVING CELLS; DYNAMICS; ADAPTER; RECRUITMENT; ACTIN; MEMBRANE; PROTEINS; RECEPTOR; CARGO	Coated pits assemble by growth of a clathrin lattice, which is linked by adaptors to the underlying membrane. How does this process start? We used live-cell TIRF imaging with single-molecule EGFP sensitivity and high temporal resolution to detect arrival of the clathrin triskelions and AP2 adaptors that initiate coat assembly. Unbiased object identification and trajectory tracking, together with a statistical model, yield the arrival times and numbers of individual proteins, as well as experimentally confirmed estimates of the extent of substitution of endogenous by expressed, fluorescently tagged proteins. Pits initiate by coordinated arrival of clathrin and AP2, which is usually detected as two sequential steps, each of one triskelion with two adaptors. PI-4,5-P-2 is essential for initiation. The accessory proteins FCHo1/2 are not; instead, they are required for sustained growth. This objective picture of coated pit initiation also shows that methods outlined here will be broadly useful for studies of dynamic assemblies in living cells.	[Cocucci, Emanuele; Aguet, Francois; Boulant, Steeve; Kirchhausen, Tom] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Cocucci, Emanuele; Boulant, Steeve; Kirchhausen, Tom] Boston Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Cocucci, Emanuele; Boulant, Steeve; Kirchhausen, Tom] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Kirchhausen, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	kirchhausen@crystal.harvard.edu	Boulant, Steeve/W-3754-2019	Boulant, Steeve/0000-0001-8614-4993; Cocucci, Emanuele/0000-0002-0088-9845	NIH [GM-075252, GM-073165, U54 AI057159]; GlaxoSmithKline; Swiss National Science Foundation; Harvard Digestive Disease Consortium Feasibility Award; New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252, R01GM073165] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Harvard Digestive Disease Consortium Feasibility Award; New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM-075252 (T. K.), a GlaxoSmithKline Fellowship (E. C.), a Swiss National Science Foundation fellowship (F. A.) and partial support from NIH grant GM-073165 (to G. Danuser, Harvard Medical School) (F. A.), and a Harvard Digestive Disease Consortium Feasibility Award (S. B.). We thank E. Marino (supported by NIH grant U54 AI057159, New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases) for maintaining the imaging resources, G. Findlay for qtPCR determinations, Janet Iwasa for the graphical abstract, and S. C. Harrison for editorial assistance. We gratefully acknowledge G. Danuser, K. Jaqaman, S. C. Harrison, and members of the Kirchhausen lab for thought-provoking discussions. E. C. and T. K. designed experiments; E. C. and S. B. performed experiments; E. C. and F. A. designed and implemented the computational methods; and E. C. and F. A. analyzed data. E. C., F. A., and T. K. discussed the results and contributed to the final manuscript.	Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Cureton DK, 2012, J VIROL, V86, P5330, DOI 10.1128/JVI.07194-11; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gottfried I, 2009, CELL MOL LIFE SCI, V66, P2897, DOI 10.1007/s00018-009-0077-4; Harrison SC, 2010, NATURE, V466, P1048, DOI 10.1038/4661048a; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jaqaman K, 2006, NAT REV MOL CELL BIO, V7, P813, DOI 10.1038/nrm2030; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Loerke D, 2011, TRAFFIC, V12, P815, DOI 10.1111/j.1600-0854.2011.01197.x; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Nunez D, 2011, TRAFFIC, V12, P1868, DOI 10.1111/j.1600-0854.2011.01273.x; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith DA, 1998, PHILOS T R SOC B, V353, P1969, DOI 10.1098/rstb.1998.0348; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	41	236	237	1	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					495	507		10.1016/j.cell.2012.05.047	http://dx.doi.org/10.1016/j.cell.2012.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863004	Bronze, Green Accepted			2022-12-01	WOS:000307301400010
J	Woloshin, S; Schwartz, LM				Woloshin, Steven; Schwartz, Lisa M.			NOT SO STORIES How a charity oversells mammography	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER		[Woloshin, Steven; Schwartz, Lisa M.] Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; [Woloshin, Steven; Schwartz, Lisa M.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med & Media, Lebanon, NH USA	VA Outcomes Group; Dartmouth College	Woloshin, S (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA.	Lisa.Schwartz@dartmouth.edu						Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Kolata G, 2011, NY TIMES        0330, pA21; Nelson HD, SCREENING BREAST CAN; NHS Cancer Screening Programmes, 2011, BREAST CANC SCREEN I; Singer N, 2011, NY TIMES        0330; Susan G Komen for the Cure, AB US; Susan G Komen For the Cure, 2011, SG KOM CUR WORLDS LA; US Department of Health and Human Services, HEALTHF GOV NAT HLTH; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	15	38	39	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2012	345								e5132	10.1136/bmj.e5132	http://dx.doi.org/10.1136/bmj.e5132			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XE	22859787				2022-12-01	WOS:000307303000001
J	Bartlett, S				Bartlett, Stephanie			Very heavy, very humble-the Higgs is (probably) here	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Bartlett, S (corresponding author), The Lancet, London NW1 7BY, England.	s.bartlett@lancet.com						CERN, LARG HADR COLL; Department of Energy and the Human Genome Project, HUM GEN PROJ INF; Science and Technology Facilities Council, LHC WHO BEN	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2012	380	9837					92	92		10.1016/S0140-6736(12)61138-6	http://dx.doi.org/10.1016/S0140-6736(12)61138-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	973KN	22794229				2022-12-01	WOS:000306359100014
J	Jagger, BW; Wise, HM; Kash, JC; Walters, KA; Wills, NM; Xiao, YL; Dunfee, RL; Schwartzman, LM; Ozinsky, A; Bell, GL; Dalton, RM; Lo, A; Efstathiou, S; Atkins, JF; Firth, AE; Taubenberger, JK; Digard, P				Jagger, B. W.; Wise, H. M.; Kash, J. C.; Walters, K-A; Wills, N. M.; Xiao, Y-L; Dunfee, R. L.; Schwartzman, L. M.; Ozinsky, A.; Bell, G. L.; Dalton, R. M.; Lo, A.; Efstathiou, S.; Atkins, J. F.; Firth, A. E.; Taubenberger, J. K.; Digard, P.			An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 Modulates the Host Response	SCIENCE			English	Article							ENDONUCLEASE; DEGRADATION; SUPPRESSION; SUBUNIT; BINDING; IMMUNE	Influenza A virus (IAV) infection leads to variable and imperfectly understood pathogenicity. We report that segment 3 of the virus contains a second open reading frame ("X-ORF"), accessed via ribosomal frameshifting. The frameshift product, termed PA-X, comprises the endonuclease domain of the viral PA protein with a C-terminal domain encoded by the X-ORF and functions to repress cellular gene expression. PA-X also modulates IAV virulence in a mouse infection model, acting to decrease pathogenicity. Loss of PA-X expression leads to changes in the kinetics of the global host response, which notably includes increases in inflammatory, apoptotic, and T lymphocyte-signaling pathways. Thus, we have identified a previously unknown IAV protein that modulates the host response to infection, a finding with important implications for understanding IAV pathogenesis.	[Jagger, B. W.; Wise, H. M.; Bell, G. L.; Dalton, R. M.; Lo, A.; Efstathiou, S.; Firth, A. E.; Digard, P.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Jagger, B. W.; Kash, J. C.; Xiao, Y-L; Dunfee, R. L.; Schwartzman, L. M.; Taubenberger, J. K.] NIAID, Viral Pathogenesis & Evolut Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Walters, K-A; Ozinsky, A.] Inst Syst Biol, Seattle, WA 98109 USA; [Wills, N. M.; Atkins, J. F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Atkins, J. F.] Univ Coll Cork, BioSci Inst, Cork, Ireland	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institute for Systems Biology (ISB); Utah System of Higher Education; University of Utah; University College Cork	Firth, AE (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	aef24@cam.ac.uk; taubenbergerj@niaid.nih.gov; paul.digard@roslin.ed.ac.uk	Taubenberger, Jeffery/AAQ-1407-2021; Digard, Paul/B-7717-2008; Kash, John/ABE-8280-2021	Digard, Paul/0000-0002-0872-9440; Atkins, John/0000-0001-7933-0165; Firth, Andrew/0000-0002-7986-9520	Wellcome Trust [088789, 073126]; U.K. Medical Research Council [G0700815]; NIH; National Institute of Allergy and Infectious Diseases (NIAID), NIH; Science Foundation Ireland [08/IN.1/B1889]; Defense Threat Reduction Agency [HDTRA-1-08-C-0023]; Luxembourg Centre for Systems Biomedicine; University of Luxembourg; U.K. Biotechnology and Biological Sciences Research Council; Cambridge Infectious Disease Consortium; NIH-Oxford-Cambridge Research Scholars program; BBSRC [BBS/E/D/20241864] Funding Source: UKRI; MRC [MR/J002232/1, G0700815, G9800943] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish; Medical Research Council [MR/J002232/1, G0700815, G9800943] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Luxembourg Centre for Systems Biomedicine; University of Luxembourg; U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Infectious Disease Consortium; NIH-Oxford-Cambridge Research Scholars program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.E.F. is supported by the Wellcome Trust (088789). P. D. was supported by the U.K. Medical Research Council (G0700815) and Wellcome Trust (073126). This work was supported in part by the intramural funds of the NIH and the National Institute of Allergy and Infectious Diseases (NIAID), NIH. J.F.A. is supported by Science Foundation Ireland (08/IN.1/B1889). K.-A. W. and A.O. were funded by Defense Threat Reduction Agency contract HDTRA-1-08-C-0023, the Luxembourg Centre for Systems Biomedicine, and the University of Luxembourg. G. L. B. and A. L. were supported by studentships from the U.K. Biotechnology and Biological Sciences Research Council and the Cambridge Infectious Disease Consortium, respectively. We thank the Comparative Medicine Branch (NIAID, NIH) for assistance with animal studies and M. Howard (Utah) for the pDluc variant of the dual luciferase vector. We also thank a number of colleagues for helpful discussion, including J. Gog and L. Tiley (University of Cambridge), W. Barclay (Imperial College London), Y. J. Tao (Rice University), J. I. Cohen, K. Subbarao, K. C. Zoon, D. C. Wilson, M. M. Gottesman, R. Wyatt, and H. Metzger (NIH). B. W. J., P. D., and J. K. T. are also thankful for the support of the NIH-Oxford-Cambridge Research Scholars program. The Gene Expression Omnibus accession no. for microarray data is GSE38112.	Atkins JF, 2010, NUCLEIC ACIDS MOL BI, V24, P1, DOI 10.1007/978-0-387-89382-2; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Easterbrook JD, 2011, INFLUENZA OTHER RESP, V5, P198, DOI 10.1111/j.1750-2659.2010.00191.x; EISINGER J, 1971, NATURE-NEW BIOL, V231, P126, DOI 10.1038/newbio231126a0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Grentzmann G, 1998, RNA, V4, P479; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Holmes EC, 2006, SCIENCE, V313, DOI 10.1126/science.1131729; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420, DOI 10.1128/JVI.69.4.2420-2426.1995; Smiley JR, 2004, J VIROL, V78, P1063, DOI 10.1128/JVI.78.3.1063-1068.2004; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; Vreede FT, 2010, VIROLOGY, V396, P125, DOI 10.1016/j.virol.2009.10.003; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Weber F, 2007, BIOCHIMIE, V89, P836, DOI 10.1016/j.biochi.2007.01.005; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	26	440	464	5	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2012	337	6091					199	204		10.1126/science.1222213	http://dx.doi.org/10.1126/science.1222213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22745253	Green Accepted			2022-12-01	WOS:000306323500050
J	Pasternak, B; Svanstrom, H; Molgaard-Nielsen, D; Krause, TG; Emborg, HD; Melbye, M; Hviid, A				Pasternak, Bjorn; Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Krause, Tyra G.; Emborg, Hanne-Dorthe; Melbye, Mads; Hviid, Anders			Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							H1N1 INFLUENZA; WOMEN; COHORT	Context Assessment of the fetal safety of vaccination against influenza A(H1N1) pdm09 in pregnancy has been limited. Objective To investigate whether exposure to an adjuvanted influenza A(H1N1) pdm09 vaccine during pregnancy was associated with increased risk of adverse fetal outcomes. Design, Setting, and Participants Registry-based cohort study based on all live-born singleton infants in Denmark, delivered between November 2, 2009, and September 30, 2010. In propensity score-matched analyses, we estimated prevalence odds ratios (PORs) of adverse fetal outcomes, comparing infants exposed and unexposed to an AS03-adjuvanted influenza A(H1N1) pdm09 vaccine during pregnancy. Main Outcome Measures Major birth defects, preterm birth, and small size for gestational age. Results From a cohort of 53 432 infants (6989 [13.1%] exposed to the influenza A[H1N1] pdm09 vaccine during pregnancy [345 in the first trimester and 6644 in the second or third trimester]), 660 (330 exposed) were included in propensity score-matched analyses of adverse fetal outcomes associated with first-trimester exposure. For analysis of small size for gestational age after second-or third-trimester exposure, 13 284 (6642 exposed) were included; for analyses of preterm birth, 12 909 (6543 exposed) were included. A major birth defect was diagnosed in 18 of 330 infants (5.5%) exposed to the vaccine in the first trimester, compared with 15 of 330 unexposed infants (4.5%) (POR, 1.21; 95% CI, 0.60-2.45). Preterm birth occurred in 31 of 330 infants (9.4%) exposed in the first trimester, compared with 24 of 330 unexposed infants (7.3%) (POR, 1.32; 95% CI, 0.76-2.31), and in 302 of 6543 infants (4.6%) with second- or third-trimester exposure, compared with 295 of 6366 unexposed infants (4.6%) (POR, 1.00; 95% CI, 0.84-1.17). Small size for gestational age was observed in 25 of 330 infants (7.6%) with first-trimester exposure compared with 31 of 330 unexposed infants (9.4%) (POR, 0.79; 95% CI, 0.46-1.37), and in 641 of 6642 infants (9.7%) with second-or third-trimester exposure, compared with 657 of 6642 unexposed infants (9.9%) (POR, 0.97; 95% CI, 0.87-1.09). Conclusions In this Danish cohort, exposure to an adjuvanted influenza A(H1N1) pdm09 vaccine during pregnancy was not associated with a significantly increased risk of major birth defects, preterm birth, or fetal growth restriction. JAMA. 2012;308(2):165-174	[Pasternak, Bjorn; Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Melbye, Mads; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Emborg, Hanne-Dorthe/GRS-8769-2022; Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466; melbye, mads/0000-0001-8264-6785	Danish Medical Research Council [11-115854]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Danish Medical Research Council (grant 11-115854 to Dr Pasternak).	Ahluwalia Indu B., 2012, Morbidity and Mortality Weekly Report, V61, P113; Andersen TF, 1999, DAN MED BULL, V46, P263; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; Buhimschi CS, 2009, OBSTET GYNECOL, V113, P166, DOI 10.1097/AOG.0b013e31818d6788; Danish National Board of Health, REC VACC PERS RISK S; EUROCAT Central Registry, EUR GUID 1 3 REF DOC; EUROCAT Central Registry, PREV TABL; European Medicines Agency, 11 PAND PHARM WEEKL; European Medicines Agency, 22 PAND PHARM UPD; Folkenberg M, 2011, VACCINE, V29, P1180, DOI 10.1016/j.vaccine.2010.12.008; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Huang WT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023049, 10.1371/journal.pone.0023829]; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lacroix I, 2011, VACCINE, V29, P1357, DOI 10.1016/j.vaccine.2010.12.011; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mackenzie IS, 2012, BRIT J CLIN PHARMACO, V73, P801, DOI 10.1111/j.1365-2125.2011.04142.x; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Moro PL, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.047; Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033; Omon E, 2011, VACCINE, V29, P9649, DOI 10.1016/j.vaccine.2011.10.034; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Pasternak B, 2010, JAMA-J AM MED ASSOC, V304, P859, DOI 10.1001/jama.2010.1206; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Skowronski DM, 2009, VACCINE, V27, P4754, DOI 10.1016/j.vaccine.2009.03.079; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tavares F, 2011, VACCINE, V29, P6358, DOI 10.1016/j.vaccine.2011.04.114; Tsatsaris V, 2011, ANN INTERN MED, V155, P733, DOI 10.7326/0003-4819-155-11-201112060-00005; Walter D, 2011, VACCINE, V29, P4008, DOI 10.1016/j.vaccine.2011.03.069; [No title captured]	35	105	105	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2012	308	2					165	174		10.1001/jama.2012.6131	http://dx.doi.org/10.1001/jama.2012.6131			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971QS	22782418	Bronze			2022-12-01	WOS:000306219500030
J	Fauci, AS; Collins, FS				Fauci, Anthony S.; Collins, Francis S.			Benefits and Risks of Influenza Research: Lessons Learned	SCIENCE			English	Editorial Material								Given the yearly challenge of seasonal influenza and the potential catastrophic consequences of future pandemics, the need for intensive basic and clinical influenza research is unquestionable. Although the fruits of decades of research have enabled dramatic improvements in our ability to prevent and treat influenza, many fundamental questions remain, including those related to the complex factors associated with host switching and transmission of influenza viruses. Recent public concern over two H5N1 influenza manuscripts that studied the transmissibility of influenza viruses has triggered intense discussion on dual-use research and the way forward.	[Fauci, Anthony S.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Fauci, AS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2011, NIH PRESS STAT NSABB; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; NSABB, 2012, FIND REC; WHO, 2012, CUM NUMB CONF HUM CA	7	32	33	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1522	1523		10.1126/science.1224305	http://dx.doi.org/10.1126/science.1224305			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723407	Green Published			2022-12-01	WOS:000305507500041
J	Jay, JS; Gostin, LO				Jay, Jonathan S.; Gostin, Lawrence O.			Ethical Challenges of Preexposure Prophylaxis for HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION; INFECTION		[Jay, Jonathan S.; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Jay, Jonathan/0000-0002-7543-4247; Gostin, Lawrence/0000-0001-5286-4044				Anderson P., 2012, 19 C RETR OPP INF MA; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; UNAIDS, 2011, GLOB HIV AIDS RESP E; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614	10	19	19	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					867	868		10.1001/2012.jama.10158	http://dx.doi.org/10.1001/2012.jama.10158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22847147	Bronze, Green Published			2022-12-01	WOS:000308292900013
J	Doege, CA; Inoue, K; Yamashita, T; Rhee, DB; Travis, S; Fujita, R; Guarnieri, P; Bhagat, G; Vanti, WB; Shih, A; Levine, RL; Nik, S; Chen, EI; Abeliovich, A				Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Guarnieri, Paolo; Bhagat, Govind; Vanti, William B.; Shih, Alan; Levine, Ross L.; Nik, Sara; Chen, Emily I.; Abeliovich, Asa			Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2	NATURE			English	Article							CHROMATIN-STRUCTURE; DNA DEMETHYLATION; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; MAPS; 5-METHYLCYTOSINE; PLURIPOTENT; CONVERSION; REVEALS; GENES	Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by using the pluripotency factors Oct4, Sox2, Klf4 and c-Myc (together referred to as OSKM)(1). iPSC reprogramming erases somatic epigenetic signatures-as typified by DNA methylation or histone modification at silent pluripotency loci-and establishes alternative epigenetic marks of embryonic stem cells (ESCs)(2). Here we describe an early and essential stage of somatic cell reprogramming, preceding the induction of transcription at endogenous pluripotency loci such as Nanog and Esrrb. By day 4 after transduction with OSKM, two epigenetic modification factors necessary for iPSC generation, namely poly(ADP-ribose) polymerase-1 (Parp1) and ten-eleven translocation-2 (Tet2), are recruited to the Nanog and Esrrb loci. These epigenetic modification factors seem to have complementary roles in the establishment of early epigenetic marks during somatic cell reprogramming: Parp1 functions in the regulation of 5-methylcytosine (5mC) modification, whereas Tet2 is essential for the early generation of 5-hydroxymethylcytosine (5hmC) by the oxidation of 5mC (refs 3,4). Although 5hmC has been proposed to serve primarily as an intermediate in 5mC demethylation to cytosine in certain contexts(5-7), our data, and also studies of Tet2-mutant human tumour cells(8), argue in favour of a role for 5hmC as an epigenetic mark distinct from 5mC. Consistent with this, Parp1 and Tet2 are each needed for the early establishment of histone modifications that typify an activated chromatin state at pluripotency loci, whereas Parp1 induction further promotes accessibility to the Oct4 reprogramming factor. These findings suggest that Parp1 and Tet2 contribute to an epigenetic program that directs subsequent transcriptional induction at pluripotency loci during somatic cell reprogramming.	[Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Bhagat, Govind; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Aging, New York, NY 10032 USA; [Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Bhagat, Govind; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Neurol, Taub Inst Aging, New York, NY 10032 USA; [Guarnieri, Paolo] Columbia Univ, Bioinformat Div, New York, NY 10032 USA; [Guarnieri, Paolo; Bhagat, Govind] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Shih, Alan; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10016 USA; [Nik, Sara; Chen, Emily I.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Chen, Emily I.] SUNY Stony Brook, Prote Ctr, Sch Med, Stony Brook, NY 11794 USA	Columbia University; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Abeliovich, A (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Aging, New York, NY 10032 USA.	aa900@columbia.edu	Bhagat, Govind/AAE-9493-2021; Vanti, William/E-6518-2016; levine, ross/AAE-7658-2019	Bhagat, Govind/0000-0001-6250-048X; Vanti, William/0000-0002-5591-5350; Inoue, Keiichi/0000-0002-7101-486X; Yamashita, Toru/0000-0003-3634-5679	New York State Stem Cell Science (NYSTEM) [C024402, C024403]; National Institutes of Health (NIH) [RO1 NS064433]; NYSTEM Institution Development [N08G-071]; NIH [RO1 138424]; NIH/National Center for Research Resources [1 S10 RR023680-1]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA173636] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064433] Funding Source: NIH RePORTER	New York State Stem Cell Science (NYSTEM); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM Institution Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Q. Daley, A. P. Feinberg, A. Doi, R. M. Santella and M. A. Kappil for reagents and for technical assistance with pyrosequencing; A. Califano and A. Lachmann for assistance with the bioinformatics analyses; E. O. Mazzoni for assistance with the ChIP analyses; and O. Hobert for critical reading of the manuscript. This work was supported by New York State Stem Cell Science (NYSTEM) grants C024402 and C024403 and National Institutes of Health (NIH) grant RO1 NS064433 to A. A., NYSTEM Institution Development Grant N08G-071 to E. I. C., NIH grant RO1 138424 to R. L. L, and a shared NIH/National Center for Research Resources instrument grant for mass spectrometry, 1 S10 RR023680-1.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054	30	287	300	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					652	655		10.1038/nature11333	http://dx.doi.org/10.1038/nature11333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22902501	Green Accepted			2022-12-01	WOS:000308095100055
J	Chen, J; Li, YJ; Yu, TS; McKay, RM; Burns, DK; Kernie, SG; Parada, LF				Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Burns, Dennis K.; Kernie, Steven G.; Parada, Luis F.			A restricted cell population propagates glioblastoma growth after chemotherapy	NATURE			English	Article							EXPRESSING PROGENITORS; INITIATING CELLS; MOUSE MODELS; STEM-CELLS; NEUROGENESIS; GLIOMA; ASTROCYTOMAS; BRAIN; RARE	Glioblastoma multiforme is the most common primary malignant brain tumour, with a median survival of about one year(1). This poor prognosis is due to therapeutic resistance and tumour recurrence after surgical removal. Precisely how recurrence occurs is unknown. Using a genetically engineered mouse model of glioma, here we identify a subset of endogenous tumour cells that are the source of new tumour cells after the drug temozolomide (TMZ) is administered to transiently arrest tumour growth. A nestin-Delta TK-IRES-GFP (Nes-Delta TK-GFP) transgene that labels quiescent subventricular zone adult neural stem cells also labels a subset of endogenous glioma tumour cells. On arrest of tumour cell proliferation with TMZ, pulse-chase experiments demonstrate a tumour re-growth cell hierarchy originating with the Nes-Delta TK-GFP transgene subpopulation. Ablation of the GFP(+) cells with chronic ganciclovir administration significantly arrested tumour growth, and combined TMZ and ganciclovir treatment impeded tumour development. Thus, a relatively quiescent subset of endogenous glioma cells, with properties similar to those proposed for cancer stem cells, is responsible for sustaining long-term tumour growth through the production of transient populations of highly proliferative cells.	[Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; [Yu, Tzong-Shiue; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Burns, Dennis K.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Parada, luis F/B-9400-2014; Kernie, Steven/AAT-9912-2020	Yu, Tzong-Shiue/0000-0003-4277-6213; Kernie, Steven/0000-0003-1371-0549	James S. McDonnell Foundation [JSMF-220020206]; Goldhirsh Foundation; Cancer Prevention Research Institute of Texas [RP 100782]; National Institutes of Health [R01 CA131313];  [RO1 NS048192-01]; NATIONAL CANCER INSTITUTE [R01CA131313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048192] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Goldhirsh Foundation; Cancer Prevention Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank S. McKinnon, A. Deshaw, L. McClellan, S. Kennedy and P. Leake for technical assistance, and Parada laboratory members for helpful suggestions and discussion. CldU and IdU preparation and staining protocol was provided by D.A. Peterson at Rosalind Franklin University. This work was supported by grants awarded to S.G.K. (RO1 NS048192-01) and to L.F.P. by the Goldhirsh Foundation, the James S. McDonnell Foundation (JSMF-220020206), Cancer Prevention Research Institute of Texas (RP 100782) and the National Institutes of Health (R01 CA131313). L.F.P. is an American Cancer Society Research Professor.	Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; IshiiMorita H, 1997, GENE THER, V4, P244, DOI 10.1038/sj.gt.3300379; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	19	1477	1536	9	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					522	+		10.1038/nature11287	http://dx.doi.org/10.1038/nature11287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22854781	Green Accepted			2022-12-01	WOS:000307761600039
J	Rosenbaum, JT				Rosenbaum, James T.			Eyeing Macular Degeneration - A Few Inflammatory Remarks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA.							Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036	5	9	12	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					768	770		10.1056/NEJMcibr1204973	http://dx.doi.org/10.1056/NEJMcibr1204973			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CX	22913688				2022-12-01	WOS:000307754200015
J	Brosi, BJ; Biber, EGN				Brosi, Berry J.; Biber, Eric G. N.			Citizen Involvement in the US Endangered Species Act	SCIENCE			English	Editorial Material							EXTINCTION		[Brosi, Berry J.] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Biber, Eric G. N.] Univ Calif Berkeley, Sch Law, Berkeley, CA 94720 USA	Emory University; University of California System; University of California Berkeley	Brosi, BJ (corresponding author), Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA.	bbrosi@emory.edu		Brosi, Berry/0000-0002-9233-1151				Biber E, 2010, UCLA LAW REV, V58, P321; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cronin M. A., 2006, RANGE MAGAZINE, V2006, P14; Holthouse David, 2005, DENVER WESTWORD 0120; Patlis JM., 2003, TULANE ENV LAW J, V16, P257; Restani M, 2002, BIOSCIENCE, V52, P169, DOI 10.1641/0006-3568(2002)052[0169:FEBNAP]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sugg IC, 1993, CUMB L REV, V24, P1; 1983, FED REG, V48, P43098	9	18	19	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					802	803		10.1126/science.1220660	http://dx.doi.org/10.1126/science.1220660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	989BQ	22903999				2022-12-01	WOS:000307535600027
J	Castanon, A; Brocklehurst, P; Evans, H; Peebles, D; Singh, N; Walker, P; Patnick, J; Sasieni, P				Castanon, Alejandra; Brocklehurst, Peter; Evans, Heather; Peebles, Donald; Singh, Naveena; Walker, Patrick; Patnick, Julietta; Sasieni, Peter		PaCT Study Grp	Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LARGE LOOP EXCISION; PRECANCEROUS CHANGES; TRANSFORMATION ZONE; PREGNANCY; METAANALYSIS; CONIZATION; DELIVERY; OUTCOMES	Objective To explore the association between preterm delivery and treatment at colposcopy. Design Retrospective-prospective cohort study using record linkage. Setting 12 National Health Service hospitals in England. Participants Women who had a cervical histology sample taken between 1987 and 2009. These women were linked by hospital episode statistics to hospital obstetric records between 1998 and 2009 for the whole of England to identify singleton live births between 20-43 gestational weeks before or after cervical histology. Main outcome measures Proportion of preterm births (<37 weeks); the relative risk for the strength of association between preterm births and treatment for cervical intraepithelial neoplasia. Results 18 441 singleton births occurred: 4176 before histology and 14 265 after histology. Of the singleton births after histology, 9.0% (n=1284) were preterm compared with 6.7% of all births in England over the same period (excess risk 2.3 per 100 births, 95% confidence interval 1.8% to 2.8%). Among first births after histology, the adjusted relative risk associated with previous treatment was 1.19 (95% confidence interval 1.01 to 1.41); among first births before histology the relative risk associated with subsequent treatment was 1.47 (1.05 to 2.05). Combining these, the relative risk associated with treatment adjusted for timing relative to histology was 0.91 (0.66 to 1.26) corresponding to an absolute difference of -0.25 (-2.61 to 2.11) per 100 singleton births. Among 372 women who gave birth both before and after treatment, there were 30 preterm births after treatment and 32 before treatment (relative risk 0.94, 0.62 to 1.43). Conclusion The risk of preterm delivery in women treated by colposcopy in England was substantially less than that in many other studies, predominantly from Nordic countries. The increased risk may be a consequence of confounding and not caused by treatment. Although this study is reassuring for large loop excision of the transformation zone overall, it is possible that deep conisation or repeated treatment leads to an increased risk of preterm delivery.	[Castanon, Alejandra; Sasieni, Peter] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England; [Brocklehurst, Peter; Peebles, Donald] Inst Womens Hlth UCL, London, England; [Evans, Heather; Walker, Patrick] Royal Free Hampstead NHS Trust, Dept Gynaecol, London, England; [Singh, Naveena] Barts Hlth NHS Trust, Div Cellular Pathol, London, England; [Patnick, Julietta] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Barts Health NHS Trust	Sasieni, P (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England.	p.sasieni@qmul.ac.uk	Singh, Naveena/AAH-2651-2020; Wood, Nicholas/E-7124-2018; Castanon, Alejandra/G-1506-2013	Wood, Nicholas/0000-0002-5909-7885; Castanon, Alejandra/0000-0002-1101-6548; Sasieni, Peter/0000-0003-1509-8744	National Institute for Health Research (NIHR) [PB-PG-1208-16187]; National Institute for Health Research [PB-PG-1208-16187] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its research for patient benefit programme (No PB-PG-1208-16187). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: This study was approved by the Brompton, Harefield, and NHLI research ethics committee, Charing Cross Hospital, London (No 09/H0708/65).	Acharya Ganesh, 2005, Archives of Gynecology and Obstetrics, V272, P109, DOI 10.1007/s00404-005-0727-1; Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; British Society for Colposcopy and Cervical Pathology, 1975, CONST BSCCP; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; CRUICKSHANK ME, 1995, BRIT J OBSTET GYNAEC, V102, P467, DOI 10.1111/j.1471-0528.1995.tb11319.x; HAFFENDEN DK, 1993, BRIT J OBSTET GYNAEC, V100, P1059, DOI 10.1111/j.1471-0528.1993.tb15153.x; HES Online, 2011, WHAT IS HES 2005 200; Jakobsson M, 2009, OBSTET GYNECOL, V114, P504, DOI 10.1097/AOG.0b013e3181b052de; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lancucki L, 2006, CERVICAL SCREENING P; Luesley D, 2004, GUIDELINES NHS CERVI; NHS Information Centre, 2010, NHS MAT STAT 2000 20; Noehr B, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.004; Office for National Statistics, 2009, GEST SPEC INF MORT E; Ortoft G, 2010, BJOG-INT J OBSTET GY, V117, P258, DOI 10.1111/j.1471-0528.2009.02438.x; Reilly R, 2012, BJOG-INT J OBSTET GY, V119, P236, DOI 10.1111/j.1471-0528.2011.03052.x; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Shanbhag S, 2009, OBSTET GYNECOL, V114, P727, DOI 10.1097/AOG.0b013e3181b5cba3; Tan Linda, 2004, J Obstet Gynaecol, V24, P25	19	83	91	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2012	345								e5174	10.1136/bmj.e5174	http://dx.doi.org/10.1136/bmj.e5174			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CV	22899563	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000307754000002
J	Wei, P; Wong, WW; Park, JS; Corcoran, EE; Peisajovich, SG; Onuffer, JJ; Weiss, A; Lim, WA				Wei, Ping; Wong, Wilson W.; Park, Jason S.; Corcoran, Ethan E.; Peisajovich, Sergio G.; Onuffer, James J.; Weiss, Arthur; Lim, Wendell A.			Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells	NATURE			English	Article							NF-KAPPA-B; T-CELLS; PHOSPHOTHREONINE LYASE; TYROSINE-PHOSPHATASE; SYNTHETIC BIOLOGY; GENE-EXPRESSION; ADVERSE EVENT; ACTIVATION; YERSINIA; ADAPTATION	Bacterial pathogens have evolved specific effector proteins that, by interfacing with host kinase signalling pathways, provide a mechanism to evade immune responses during infection(1,2). Although these effectors contribute to pathogen virulence, we realized that they might also serve as valuable synthetic biology reagents for engineering cellular behaviour. Here we exploit two effector proteins, the Shigella flexneri OspF protein(3) and Yersinia pestis YopH protein(4), to rewire kinase-mediated responses systematically both in yeast and mammalian immune cells. Bacterial effector proteins can be directed to inhibit specific mitogen-activated protein kinase pathways selectively in yeast by artificially targeting them to pathway-specific complexes. Moreover, we show that unique properties of the effectors generate new pathway behaviours: OspF, which irreversibly inactivates mitogen-activated protein kinases(4), was used to construct a synthetic feedback circuit that shows novel frequency-dependent input filtering. Finally, we show that effectors can be used in T cells, either as feedback modulators to tune the T-cell response amplitude precisely, or as an inducible pause switch that can temporarily disable T-cell activation. These studies demonstrate how pathogens could provide a rich toolkit of parts to engineer cells for therapeutic or biotechnological applications.	[Wei, Ping; Wong, Wilson W.; Park, Jason S.; Peisajovich, Sergio G.; Onuffer, James J.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Wei, Ping; Wong, Wilson W.; Park, Jason S.; Corcoran, Ethan E.; Peisajovich, Sergio G.; Weiss, Arthur; Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Wong, Wilson W.; Park, Jason S.; Corcoran, Ethan E.; Onuffer, James J.; Weiss, Arthur; Lim, Wendell A.] Univ Calif San Francisco, Cell Prop Lab, San Francisco, CA 94158 USA; [Corcoran, Ethan E.; Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu		Wei, Ping/0000-0002-1275-7145	American Cancer Society fellowship [PF-09-137-01-TBE]; Li Foundation Fellowship; California Institute for Regenerative Medicine fellowship [TG2-01153]; National Institutes of Health [PN2EY016546, RO1GM055040, RO1GM062583, P50GM081879]; NSF Synthetic Biology and Engineering Research Center; Packard Foundation; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, T32GM007618, R01GM055040, R01GM062583] Funding Source: NIH RePORTER	American Cancer Society fellowship(American Cancer Society); Li Foundation Fellowship; California Institute for Regenerative Medicine fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Synthetic Biology and Engineering Research Center; Packard Foundation(The David & Lucile Packard Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Orth for the YopH plasmid; K. McNally and S. Neou for tissue culture support; H. El-Samad, C. Voigt, C. Tang and the Lim laboratory for discussions. We acknowledge the 2007 UCSF iGEM team (M. Chen, E. Chou, J. Huang, L. Jann, E. Meltzer, A. Ng and R. Ovadia) for their initial work on bacterial effectors in yeast. This work was supported by American Cancer Society fellowship PF-09-137-01-TBE (W.W.W), a Li Foundation Fellowship (P. W.), a California Institute for Regenerative Medicine fellowship (grant number TG2-01153) (J. S. P.), National Institutes of Health grants PN2EY016546, RO1GM055040, RO1GM062583 and P50GM081879 (W. A. L.), the NSF Synthetic Biology and Engineering Research Center (W. A. L.), the Packard Foundation (W. A. L.) and the Howard Hughes Medical Institute (A. W. and W.A.L.).	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bonini C, 2007, MOL THER, V15, P1248, DOI 10.1038/sj.mt.6300190; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brentjens R, 2010, MOL THER, V18, P666, DOI 10.1038/mt.2010.31; Broberg CA, 2010, CURR OPIN MICROBIOL, V13, P34, DOI 10.1016/j.mib.2009.12.004; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; de Witte MA, 2008, J IMMUNOL, V180, P6365, DOI 10.4049/jimmunol.180.9.6365; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gerke C, 2005, J EXP MED, V201, P361, DOI 10.1084/jem.20041120; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kieback E, 2008, P NATL ACAD SCI USA, V105, P623, DOI 10.1073/pnas.0710198105; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Lee PJ, 2008, BIOTECHNIQUES, V44, P91, DOI 10.2144/000112673; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Morgan RA, 2010, CANCER J, V16, P336, DOI 10.1097/PPO.0b013e3181eb3879; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ribet D, 2010, CELL, V143, P694, DOI 10.1016/j.cell.2010.11.019; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759; Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011	32	94	105	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					384	+		10.1038/nature11259	http://dx.doi.org/10.1038/nature11259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22820255	Green Submitted, Green Accepted			2022-12-01	WOS:000307501000043
J	Franco, SJ; Gil-Sanz, C; Martinez-Garay, I; Espinosa, A; Harkins-Perry, SR; Ramos, C; Muller, U				Franco, Santos J.; Gil-Sanz, Cristina; Martinez-Garay, Isabel; Espinosa, Ana; Harkins-Perry, Sarah R.; Ramos, Cynthia; Mueller, Ulrich			Fate-Restricted Neural Progenitors in the Mammalian Cerebral Cortex	SCIENCE			English	Article							INTERMEDIATE PROGENITORS; LAMINAR FATE; STEM-CELLS; NEOCORTEX; NEURONS; MOUSE; CRE; RECOMBINATION; SPECIFICATION; EXPRESSION	During development of the mammalian cerebral cortex, radial glial cells (RGCs) generate layer-specific subtypes of excitatory neurons in a defined temporal sequence, in which lower-layer neurons are formed before upper-layer neurons. It has been proposed that neuronal subtype fate is determined by birthdate through progressive restriction of the neurogenic potential of a common RGC progenitor. Here, we demonstrate that the murine cerebral cortex contains RGC sublineages with distinct fate potentials. Using in vivo genetic fate mapping and in vitro clonal analysis, we identified an RGC lineage that is intrinsically specified to generate only upper-layer neurons, independently of niche and birthdate. Because upper cortical layers were expanded during primate evolution, amplification of this RGC pool may have facilitated human brain evolution.	[Mueller, Ulrich] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Muller, U (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umueller@scripps.edu	Espinosa Martínez, Ana Belén/AAD-4487-2021; Gil-Sanz, Cristina/K-9859-2017; Gil-Sanz, Cristina/AAX-3558-2021; Franco, Santos/V-3413-2019; Garay, Isabel Martinez/AAI-8951-2021	Espinosa Martínez, Ana Belén/0000-0002-3738-3514; Gil-Sanz, Cristina/0000-0002-7827-5480; Gil-Sanz, Cristina/0000-0002-7827-5480; Franco, Santos/0000-0002-4478-5634; Garay, Isabel Martinez/0000-0001-6849-7496	NIH [NS060355, NS046456, MH078833]; Generalitat Valenciana [APOSTD/2010/064]; Ministerio de Educacion [EX2009-0416, FU-2006-1238]; CIRM; Skaggs Institute for Chemical Biology; Dorris Neuroscience Center; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046456, F32NS060355] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Educacion; CIRM(California Institute for Regenerative Medicine); Skaggs Institute for Chemical Biology; Dorris Neuroscience Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Fishell for Nestin-CreERT2 mice; H. Zeng for Ai9 reporter mice; P. Chambon for pCreERT2; A. Maximov for the FLEx backbone; T. Wagner, S. Courtes, and P. Kazmierczak for experiments that did not appear in the final manuscript; and F. Polleux, E. Grove, N. Grillet, and S. Courtes for critical comments. This work was supported by the NIH (S.J.F., NS060355; U. M., NS046456 and MH078833), Generalitat Valenciana (C.G.-S., APOSTD/2010/064), Ministerio de Educacion (C.G.-S., EX2009-0416; I. M.-G., FU-2006-1238), CIRM training grant (I. M.-G. and A. E.), the Skaggs Institute for Chemical Biology (U. M.), and the Dorris Neuroscience Center (U. M.). S.J.F., I. M.-G., C.G.-S., and U. M. conceived the project; S.J.F., C.G.-S., I. M.-G., and A. E. designed, performed, and analyzed experiments with assistance from S. R. H.-P. and C. R.; and S.J.F. and U. M. prepared the manuscript, with revisions from C.G.-S., I. M.-G., and A.E.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Takahashi T, 1999, J NEUROSCI, V19, P10357; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	20	213	214	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					746	749		10.1126/science.1223616	http://dx.doi.org/10.1126/science.1223616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879516	Green Accepted			2022-12-01	WOS:000307354500058
J	Koren, O; Goodrich, JK; Cullender, TC; Spor, A; Laitinen, K; Backhed, HK; Gonzalez, A; Werner, JJ; Angenent, LT; Knight, R; Backhed, F; Isolauri, E; Salminen, S; Ley, RE				Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Laitinen, Kirsi; Backhed, Helene Kling; Gonzalez, Antonio; Werner, Jeffrey J.; Angenent, Largus T.; Knight, Rob; Backhed, Fredrik; Isolauri, Erika; Salminen, Seppo; Ley, Ruth E.			Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy	CELL			English	Article							MATERNAL METABOLISM; INSULIN-RESISTANCE; OBESITY; ASSOCIATIONS; INFLAMMATION; MECHANISMS; CYTOKINES; WEIGHT; DIET	Many of the immune and metabolic changes occurring during normal pregnancy also describe metabolic syndrome. Gut microbiota can cause symptoms of metabolic syndrome in nonpregnant hosts. Here, to explore their role in pregnancy, we characterized fecal bacteria of 91 pregnant women of varying prepregnancy BMIs and gestational diabetes status and their infants. Similarities between infant-mother microbiotas increased with children's age, and the infant microbiota was unaffected by mother's health status. Gut microbiota changed dramatically from first (T1) to third (T3) trimesters, with vast expansion of diversity between mothers, an overall increase in Proteobacteria and Actinobacteria, and reduced richness. T3 stool showed strongest signs of inflammation and energy loss; however, microbiome gene repertoires were constant between trimesters. When transferred to germ-free mice, T3 microbiota induced greater adiposity and insulin insensitivity compared to T1. Our findings indicate that host-microbial interactions that impact host metabolism can occur and may be beneficial in pregnancy.	[Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Werner, Jeffrey J.; Angenent, Largus T.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA; [Laitinen, Kirsi] Univ Turku, Inst Biomed, Turku 20610, Finland; [Laitinen, Kirsi; Salminen, Seppo] Univ Turku, Funct Foods Forum, Turku 20610, Finland; [Isolauri, Erika] Turku Univ Hosp, Dept Pediat, Turku 20521, Finland; [Backhed, Helene Kling; Backhed, Fredrik] Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, SE-41345 Gothenburg, Sweden; [Backhed, Helene Kling; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, SE-40530 Gothenburg, Sweden; [Gonzalez, Antonio] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Cornell University; Cornell University; Cornell University; University of Turku; University of Turku; University of Turku; University of Gothenburg; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ley, RE (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	rel222@cornell.edu	Ley, Ruth E/M-8542-2014; Spor, Aymé/A-6271-2012; Backhed, Fredrik/ABE-6613-2020; Angenent, Largus T/A-6219-2018; Goodrich, Julia/ABD-8368-2021; Koren, Omry/A-5222-2016; Knight, Rob/D-1299-2010; Gonzalez, Antonio/A-6421-2018	Ley, Ruth E/0000-0002-9087-1672; Spor, Aymé/0000-0002-4707-9559; Backhed, Fredrik/0000-0002-4871-8818; Angenent, Largus T/0000-0003-0180-1865; Koren, Omry/0000-0002-7738-1337; Laitinen, Kirsi/0000-0001-5245-8118; Knight, Rob/0000-0002-0975-9019	Hartwell Foundation; NIH Human Microbiome Project DACC; David and Lucile Packard Foundation; Arnold and Mabel Beckman Foundation; Cornell Center for Comparative Population Genomics; Ragnar Soderberg Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093595] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007444] Funding Source: NIH RePORTER	Hartwell Foundation; NIH Human Microbiome Project DACC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Arnold and Mabel Beckman Foundation; Cornell Center for Comparative Population Genomics; Ragnar Soderberg Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Mary-Claire King, Andrew Clark, and Andrew Gewirtz for their contributions to the manuscript, and we thank Daniel McDonlad and Nick Scalfone for technical assistance. This research was supported by The Hartwell Foundation, the NIH Human Microbiome Project DACC, the David and Lucile Packard Foundation, the Arnold and Mabel Beckman Foundation, the Cornell Center for Comparative Population Genomics, the Ragnar Soderberg Foundation, the Paivikki and Sakari Sohlberg Foundation, and the Academy of Finland.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Beigi RH, 2007, J INFECT DIS, V196, P1355, DOI 10.1086/521628; Caesar R, 2012, GUT; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Carvalho FA, 2012, CELL HOST MICROBE; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Di Cianni G, 2003, DIABETES-METAB RES, V19, P259, DOI 10.1002/dmrr.390; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Laitinen K, 2009, BRIT J NUTR, V101, P1679, DOI 10.1017/S0007114508111461; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Saiki T, 1998, SCAND J GASTROENTERO, V33, P616; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Straka M, 2011, NEUROENDOCRINOL LETT, V32, P34; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	46	1073	1170	15	349	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					470	480		10.1016/j.cell.2012.07.008	http://dx.doi.org/10.1016/j.cell.2012.07.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863002	Bronze, Green Accepted			2022-12-01	WOS:000307301400008
J	Lee, IM; Shiroma, EJ; Lobelo, F; Puska, P; Blair, SN; Katzmarzyk, PT				Lee, I-Min; Shiroma, Eric J.; Lobelo, Felipe; Puska, Pekka; Blair, Steven N.; Katzmarzyk, Peter T.		Lancet Phys Activity Series Workin	Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy	LANCET			English	Article							ALL-CAUSE MORTALITY; CORONARY-HEART-DISEASE; BREAST-CANCER; METAANALYSIS; RISK; SMOKING; POPULATION; INTENSITY; CHINA	Background Strong evidence shows that physical inactivity increases the risk of many adverse health conditions, including major non-communicable diseases such as coronary heart disease, type 2 diabetes, and breast and colon cancers, and shortens life expectancy. Because much of the world's population is inactive, this link presents a major public health issue. We aimed to quantify the effect of physical inactivity on these major non-communicable diseases by estimating how much disease could be averted if inactive people were to become active and to estimate gain in life expectancy at the population level. Methods For our analysis of burden of disease, we calculated population attributable fractions (PAFs) associated with physical inactivity using conservative assumptions for each of the major non-communicable diseases, by country, to estimate how much disease could be averted if physical inactivity were eliminated. We used life-table analysis to estimate gains in life expectancy of the population. Findings Worldwide, we estimate that physical inactivity causes 6% (ranging from 3.2% in southeast Asia to 7.8% in the eastern Mediterranean region) of the burden of disease from coronary heart disease, 7% (3.9-9.6) of type 2 diabetes, 10% (5.6-14.1) of breast cancer, and 10% (5.7-13.8) of colon cancer. Inactivity causes 9% (range 5.1-12.5) of premature mortality, or more than 5.3 million of the 57 million deaths that occurred worldwide in 2008. If inactivity were not eliminated, but decreased instead by 10% or 25%, more than 533 000 and more than 1.3 million deaths, respectively, could be averted every year. We estimated that elimination of physical inactivity would increase the life expectancy of the world's population by 0.68 (range 0.41-0.95) years. Interpretation Physical inactivity has a major health effect worldwide. Decrease in or removal of this unhealthy behaviour could improve health substantially.	[Lee, I-Min] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Shiroma, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lobelo, Felipe] Ctr Dis Control & Prevent, Global Hlth Promot Off, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Puska, Pekka] Natl Inst Hlth & Welf, Helsinki, Finland; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol Biostat, Columbia, SC 29208 USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Katzmarzyk, Peter T.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA; Finland National Institute for Health & Welfare; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Lee, IM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA.	ilee@rics.bwh.harvard.edu	Reis, Rodrigo/F-7447-2012; Owen, Neville/K-5986-2012; Parra, Diana C/D-7633-2013; Martin, Brian W/H-3241-2012; Shiroma, Eric/AAV-5487-2021; Lobelo, R.L Felipe/AAB-2264-2021; lobelo, felipe/B-9148-2013; Lambert, Estelle/ABF-1268-2020; Katzmarzyk, Peter T/N-1974-2017; Lee, I-Min/ABD-5409-2021; Kahlmeier, Sonja/B-8141-2014; Sarmiento, Olga L/AAS-4165-2020; Sallis, James F/D-3001-2014; Loos, Ruth/Q-2862-2016; Wells, Jonathan/A-4604-2009	Reis, Rodrigo/0000-0002-9872-9865; Owen, Neville/0000-0003-2784-4820; Parra, Diana C/0000-0002-9797-6231; Shiroma, Eric/0000-0003-4920-2642; Lobelo, R.L Felipe/0000-0003-4185-7193; Lambert, Estelle/0000-0003-4315-9153; Katzmarzyk, Peter T/0000-0002-9280-6022; Kahlmeier, Sonja/0000-0001-6905-9244; Sarmiento, Olga L/0000-0002-9190-3568; Sallis, James F/0000-0003-2555-9452; Guthold, Regina/0000-0003-3073-6468; Loos, Ruth/0000-0002-8532-5087; Wells, Jonathan/0000-0003-0411-8025; Goenka, Shifalika/0000-0001-6993-2883	US National Institutes of Health [CA154647, HL007575]; Louisiana Public Facilities Authority Endowed Chair in Nutrition; NATIONAL CANCER INSTITUTE [R01CA154647] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007575] Funding Source: NIH RePORTER; MRC [MC_U106188470] Funding Source: UKRI; Medical Research Council [MC_U106188470] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Public Facilities Authority Endowed Chair in Nutrition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention. I-ML was supported in part by grant CA154647 from the US National Institutes of Health. EJS was supported in part by grant HL007575 from the US National Institutes of Health. PTK was supported in part by the Louisiana Public Facilities Authority Endowed Chair in Nutrition. We thank Kenneth E Powell, Shane A Norris, and Beverly J Levine for reviewing a previous draft of the report and providing critical input. We thank several people for providing data to calculate the adjustment factor: David Batty, Kennet Harald, Duck-chul Lee, Charles E Matthews, Martin Shipley, Emmanuel Stamatakis, Xuemei Sui, and Nicholas J Wareham. We thank Jacob R Sattelmair and Kathleen Y Wolin for assisting with meta-analyses.	[Anonymous], 2011, LIF TABL WHO MEMB ST; [Anonymous], 2010, GLOB REC PHYS ACT HL; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Blair SN, 2010, ANN EPIDEMIOL, V20, P651, DOI 10.1016/j.annepidem.2010.06.001; Courneya KS, 2011, RECENT RESULTS CANC, V186, P1, DOI 10.1007/978-3-642-04231-7; Crimmins EM, 2011, EXPLAINING DIVERGENT LEVELS OF LONGEVITY IN HIGH-INCOME COUNTRIES, P1; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ezzati M., 2004, COMP QUANTIFICATION; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee I-M, 2009, EPIDEMIOLOGIC METHOD, P100; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; POWELL KE, 1994, MED SCI SPORT EXER, V26, P851; Rastogi T, 2004, INT J EPIDEMIOL, V33, P759, DOI 10.1093/ije/dyh042; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; ROOK A, 1954, Br Med J, V1, P773; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Tian XB, 2011, J EPIDEMIOL, V21, P376, DOI 10.2188/jea.JE20110001; US Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; WHO, 2011, GLOB STAT REP NONC D; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; World Health Organization, 2011, GLOB HLTH OBS DAT RE; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	30	4519	4698	38	683	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2012	380	9838					219	229		10.1016/S0140-6736(12)61031-9	http://dx.doi.org/10.1016/S0140-6736(12)61031-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976TV	22818936	Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000306609200031
J	Liu, B; Du, HW; Rutkowski, R; Gartner, A; Wang, XC				Liu, Bin; Du, Hongwei; Rutkowski, Rachael; Gartner, Anton; Wang, Xiaochen			LAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; CYSTINE; PROTEIN; DEGRADATION; AUTOPHAGY; KINASE; FIBROBLASTS; ENDOCYTOSIS; REMOVAL	Defective catabolite export from lysosomes results in lysosomal storage diseases in humans. Mutations in the cystine transporter gene CTNS cause cystinosis, but other lysosomal amino acid transporters are poorly characterized at the molecular level. Here, we identified the Caenorhabditis elegans lysosomal lysine/arginine transporter LAAT-1. Loss of laat-1 caused accumulation of lysine and arginine in enlarged, degradation-defective lysosomes. In mutants of ctns-1 (C. elegans homolog of CTNS), LAAT-1 was required to reduce lysosomal cystine levels and suppress lysosome enlargement by cysteamine, a drug that alleviates cystinosis by converting cystine to a lysine analog. LAAT-1 also maintained availability of cytosolic lysine/arginine during embryogenesis. Thus, LAAT-1 is the lysosomal lysine/arginine transporter, which suggests a molecular explanation for how cysteamine alleviates a lysosomal storage disease.	[Liu, Bin; Du, Hongwei; Wang, Xiaochen] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Bin] Chinese Acad Med Sci, Grad Program, Beijing, Peoples R China; [Liu, Bin] Peking Union Med Coll, Beijing, Peoples R China; [Du, Hongwei] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Du, Hongwei] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Rutkowski, Rachael; Gartner, Anton] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Dundee	Wang, XC (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	wangxiaochen@nibs.ac.cn	Du, Hongwei/K-9074-2019; liu, Bin/V-3391-2019	liu, Bin/0000-0001-7489-9125; Gartner, Anton/0000-0003-4639-9902; , Hongwei/0000-0002-7997-4507	Ministry of Science and Technology [2010CB835201]; CR-UK Career Development Award [C11852/A4500]; CR-UK Project Grant [C11852/A5991]; Wellcome Trust [0909444/Z/09/Z]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); CR-UK Career Development Award; CR-UK Project Grant; Wellcome Trust(Wellcome Trust)	We thank B. Zhu and X. Wang for discussion and critical reading of the manuscript; M. Dong for antibodies; B. Grant, H. Fares, D. Xue, H. Zhang, and the C. elegans Genetic Center (CGC) for strains; the Moerman laboratory (University of British Columbia) for performing the comparative genomic hybridization array; and I. Hanson for editing services. Data described in the paper are presented in the main text and the supplementary materials. This work was supported by a Ministry of Science and Technology grant (2010CB835201) to X. W. and a CR-UK Career Development Award (C11852/A4500), a CR-UK Project Grant (C11852/A5991), and a Wellcome Trust Senior Research Fellowship (0909444/Z/09/Z) to A.G.	Audhya A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000956; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; GAHL WA, 1985, BIOCHEM J, V228, P545, DOI 10.1042/bj2280545; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Guo PF, 2010, P NATL ACAD SCI USA, V107, P18016, DOI 10.1073/pnas.1008946107; JONAS AJ, 1982, P NATL ACAD SCI-BIOL, V79, P4442, DOI 10.1073/pnas.79.14.4442; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; PISONI RL, 1985, J BIOL CHEM, V260, P4791; Sagne C, 2008, J INHERIT METAB DIS, V31, P258, DOI 10.1007/s10545-008-0879-9; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; THOENE JG, 1976, J CLIN INVEST, V58, P180, DOI 10.1172/JCI108448; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wu YC, 2000, GENE DEV, V14, P536; Zhai YF, 2001, BBA-BIOMEMBRANES, V1511, P206, DOI 10.1016/S0005-2736(00)00389-8; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	24	99	104	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					351	354		10.1126/science.1220281	http://dx.doi.org/10.1126/science.1220281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22822152	Green Accepted			2022-12-01	WOS:000306542600054
J	Chown, SL; Lee, JE; Hughes, KA; Barnes, J; Barrett, PJ; Bergstrom, DM; Convey, P; Cowan, DA; Crosbie, K; Dyer, G; Frenot, Y; Grant, SM; Herr, D; Kennicutt, MC; Lamers, M; Murray, A; Possingham, HP; Reid, K; Riddle, MJ; Ryan, PG; Sanson, L; Shaw, JD; Sparrow, MD; Summerhayes, C; Terauds, A; Wall, DH				Chown, S. L.; Lee, J. E.; Hughes, K. A.; Barnes, J.; Barrett, P. J.; Bergstrom, D. M.; Convey, P.; Cowan, D. A.; Crosbie, K.; Dyer, G.; Frenot, Y.; Grant, S. M.; Herr, D.; Kennicutt, M. C., II; Lamers, M.; Murray, A.; Possingham, H. P.; Reid, K.; Riddle, M. J.; Ryan, P. G.; Sanson, L.; Shaw, J. D.; Sparrow, M. D.; Summerhayes, C.; Terauds, A.; Wall, D. H.			Challenges to the Future Conservation of the Antarctic	SCIENCE			English	Editorial Material									[Chown, S. L.; Lee, J. E.] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [Chown, S. L.] Monash Univ, Clayton, Vic 3800, Australia; [Barrett, P. J.] Victoria Univ Wellington, Wellington, New Zealand; [Cowan, D. A.] Univ Western Cape, ZA-7535 Bellville, South Africa; [Frenot, Y.] Univ Rennes, CNRS, Unite Mixte Rech Ecobio, Rennes, France; [Kennicutt, M. C., II] Texas A&M Univ, College Stn, TX 77843 USA; [Lamers, M.] Wageningen Univ, Wageningen, Netherlands; [Possingham, H. P.; Shaw, J. D.] Univ Queensland, Brisbane, Qld 4072, Australia; [Ryan, P. G.] Univ Cape Town, ZA-7700 Rondebosch, South Africa; [Wall, D. H.] Colorado State Univ, Ft Collins, CO 80523 USA	Stellenbosch University; Monash University; Victoria University Wellington; University of the Western Cape; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes 1; Texas A&M University System; Texas A&M University College Station; Wageningen University & Research; University of Queensland; University of Cape Town; Colorado State University	Chown, SL (corresponding author), Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa.	steven.chown@monash.edu	Bergstrom, Dana/AAC-2837-2022; Possingham, Hugh/B-1337-2008; Chown, Steven/ABD-7646-2021; Convey, Peter/AAV-5728-2020; Cowan, Donald A/E-3991-2012; Chown, Steven L/H-3347-2011; POSSINGHAM, HUGH/R-8310-2019; Wall, Diana H/F-5491-2011	Bergstrom, Dana/0000-0001-8484-8954; Possingham, Hugh/0000-0001-7755-996X; Convey, Peter/0000-0001-8497-9903; Cowan, Donald A/0000-0001-8059-861X; Chown, Steven L/0000-0001-6069-5105; POSSINGHAM, HUGH/0000-0001-7755-996X; Ryan, Peter/0000-0002-3356-2056; Frenot, Yves/0000-0003-2666-1272; Lamers, Machiel/0000-0002-4189-3066; Shaw, Justine/0000-0002-9603-2271	NERC [bas010013] Funding Source: UKRI; Natural Environment Research Council [bas010013] Funding Source: researchfish; Office of Polar Programs (OPP) [1115245] Funding Source: National Science Foundation	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		[Anonymous], 2011, SCI DIPLOMACY ANTARC; Blight LK, 2010, SCIENCE, V330, P1316, DOI 10.1126/science.330.6009.1316; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; Committee for Environmental Protection, 2011, NONN SPEC MAN; Dyer Gwynne, 2010, CLIMATE WARS FIGHT S; Joyner CC, 2011, SCIENCE DIPLOMACY: ANTARCTICA, SCIENCE, AND THE GOVERNANCE OF INTERNATIONAL SPACES, P97; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Ruoppolo V, 2013, POLAR REC, V49, P97, DOI 10.1017/S0032247411000763; Segan DB, 2011, ENVIRON MODELL SOFTW, V26, P1434, DOI 10.1016/j.envsoft.2011.08.002; Sutherland WJ, 2012, TRENDS ECOL EVOL, V27, P12, DOI 10.1016/j.tree.2011.10.011; Terauds A, 2012, DIVERS DISTRIB, V18, P726, DOI 10.1111/j.1472-4642.2012.00925.x; Tin T, 2009, ANTARCT SCI, V21, P3, DOI 10.1017/S0954102009001722; Vaughan NE, 2011, CLIMATIC CHANGE, V109, P745, DOI 10.1007/s10584-011-0027-7	14	116	119	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					158	159		10.1126/science.1222821	http://dx.doi.org/10.1126/science.1222821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22798586	Green Submitted			2022-12-01	WOS:000306323500028
J	Bhullar, BAS; Marugan-Lobon, J; Racimo, F; Bever, GS; Rowe, TB; Norell, MA; Abzhanov, A				Bhullar, Bhart-Anjan S.; Marugan-Lobon, Jesus; Racimo, Fernando; Bever, Gabe S.; Rowe, Timothy B.; Norell, Mark A.; Abzhanov, Arhat			Birds have paedomorphic dinosaur skulls	NATURE			English	Article							EVOLUTION; SIZE; ONTOGENY; GROWTH; BRAIN; EAR	The interplay of evolution and development has been at the heart of evolutionary theory for more than a century(1). Heterochrony-change in the timing or rate of developmental events-has been implicated in the evolution of major vertebrate lineages such as mammals(2), including humans(1). Birds are the most speciose land vertebrates, with more than 10,000 living species(3) representing a bewildering array of ecologies. Their anatomy is radically different from that of other vertebrates. The unique bird skull houses two highly specialized systems: the sophisticated visual and neuromuscular coordination system(4,5) allows flight coordination and exploitation of diverse visual landscapes, and the astonishing variations of the beak enable a wide range of avian lifestyles. Here we use a geometric morphometric approach integrating developmental, neontological and palaeontological data to show that the heterochronic process of paedomorphosis, by which descendants resemble the juveniles of their ancestors, is responsible for several major evolutionary transitions in the origin of birds. We analysed the variability of a series of landmarks on all known theropod dinosaur skull ontogenies as well as outgroups and birds. The first dimension of variability captured ontogeny, indicating a conserved ontogenetic trajectory. The second dimension accounted for phylogenetic change towards more bird-like dinosaurs. Basally branching eumaniraptorans and avialans clustered with embryos of other archosaurs, indicating paedomorphosis. Our results reveal at least four paedomorphic episodes in the history of birds combined with localized peramorphosis (development beyond the adult state of ancestors) in the beak. Paedomorphic enlargement of the eyes and associated brain regions parallels the enlargement of the nasal cavity and olfactory brain in mammals(6). This study can be a model for investigations of heterochrony in evolutionary transitions, illuminating the origin of adaptive features and inspiring studies of developmental mechanisms.	[Bhullar, Bhart-Anjan S.; Racimo, Fernando; Abzhanov, Arhat] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Marugan-Lobon, Jesus] Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain; [Bever, Gabe S.] New York Inst Technol, New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Harvard University; Autonomous University of Madrid; New York Institute Technology; University of Texas System; University of Texas Austin; American Museum of Natural History (AMNH)	Bhullar, BAS (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	bhartanjan.bhullar@gmail.com; abzhanov@fas.harvard.edu	Marugán-Lobón, Jesús/AAA-7614-2019	Racimo, Fernando/0000-0002-5025-2607	National Science Foundation [1110564];  [BFU2008-00642]; Direct For Biological Sciences [1110564] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. M. Elsey and colleagues at the Rockefeller Wildlife Refuge, Louisiana Department of Wildlife and Fisheries for assistance in obtaining alligator embryos, S. Majadla for imaging assistance, C. Sanchez for constructing the Supplementary Movie, I. Sarris for assistance with the R script packages, and J. B. Losos, H. E. Hoekstra, F. A. Jenkins Jr and B. Zweig for comments that improved the manuscript. B.-A. S. B. was partly funded by National Science Foundation dissertation improvement grant 1110564. J. M.-L. was supported by project BFU2008-00642.	ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Brusatte SL, 2012, J EVOLUTION BIOL, V25, P365, DOI 10.1111/j.1420-9101.2011.02427.x; Butler A., 1996, COMP VERTEBRATE NEUR; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; FINK WL, 1982, PALEOBIOLOGY, V8, P254, DOI 10.1017/S0094837300006977; GILL F.B., 2006, ORNITHOLOGY; Gould S.J., 1977, ONTOGENY PHYLOGENY; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; JOLLIE MALCOLM T., 1957, J MORPH, V100, P389, DOI 10.1002/jmor.1051000302; Kielan-Jaworowska Z., 2004, MAMMALS AGE DINOSAUR; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Norell MA, 2009, AM MUS NOVIT, P1; Northcutt RG, 2011, SCIENCE, V332, P926, DOI 10.1126/science.1206915; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PEARSON R, 1972, AVIAN BRAIN; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Smith KK, 2003, INT J DEV BIOL, V47, P613; Thulborn RA, 2006, NEUES JAHRB GEOL P-A, V242, P205, DOI 10.1127/njgpa/242/2006/205; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wellnhofer P., 2009, ARCHAEOPTERYX ICON E	29	145	147	3	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					223	226		10.1038/nature11146	http://dx.doi.org/10.1038/nature11146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722850				2022-12-01	WOS:000306278900037
J	James, A; Pitchford, JW; Plank, MJ				James, Alex; Pitchford, Jonathan W.; Plank, Michael J.			Disentangling nestedness from models of ecological complexity	NATURE			English	Article							MUTUALISTIC NETWORKS; ARCHITECTURE; BIODIVERSITY; ECOSYSTEMS; STABILITY	Complex networks of interactions are ubiquitous(1) and are particularly important in ecological communities, in which large numbers of species exhibit negative (for example, competition or predation) and positive (for example, mutualism) interactions with one another. Nestedness in mutualistic ecological networks is the tendency for ecological specialists to interact with a subset of species that also interact with more generalist species(2). Recent mathematical and computational analysis has suggested that such nestedness increases species richness(3,4). By examining previous results and applying computational approaches to 59 empirical data sets representing mutualistic plant-pollinator networks, we show that this statement is incorrect. A simpler metric-the number of mutualistic partners a species has-is a much better predictor of individual species survival and hence, community persistence. Nestedness is, at best, a secondary covariate rather than a causative factor for biodiversity in mutualistic communities. Analysis of complex networks should be accompanied by analysis of simpler, underpinning mechanisms that drive multiple higher-order network properties.	[James, Alex; Plank, Michael J.] Univ Canterbury, Biomath Res Ctr, Christchurch 8040, New Zealand; [Pitchford, Jonathan W.] Univ York, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England; [Pitchford, Jonathan W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Pitchford, Jonathan W.] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England	University of Canterbury; University of York - UK; University of York - UK; University of York - UK	James, A (corresponding author), Univ Canterbury, Biomath Res Ctr, Private Bag 4800, Christchurch 8040, New Zealand.	alex.james@canterbury.ac.nz	Plank, Michael John/H-8030-2019	Plank, Michael John/0000-0002-7539-3465; James, Alex/0000-0002-1543-7139	Royal Society of New Zealand [08-UOC-034]; University of Canterbury	Royal Society of New Zealand(Royal Society of New Zealand); University of Canterbury	We thank D. Franks, D. Kelly, R. Law, D. Stouffer, C. Thomas and J. Tylianakis for discussions and constructive criticisms, and J. Williams for independent verification of numerical results. M. J. P., A. J. and J. W. P. were supported by the Royal Society of New Zealand Marsden Fund, grant number 08-UOC-034. J. W. P. acknowledges the support of the University of Canterbury Erskine Programme.	Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2005, J THEOR BIOL, V235, P521, DOI 10.1016/j.jtbi.2005.02.005; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Long J. S., 1997, REGRESSION MODELS CA, V7, P34; May R.M., 1973, STABILITY COMPLEXITY; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1; Wiggins S., 2003, INTRO APPL NONLINEAR; Williams RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017645; Williams RJ, 2010, THEOR ECOL-NETH, V3, P45, DOI 10.1007/s12080-009-0052-6; Zar JH., 1999, BIOSTAT ANAL; Zhang F, 2011, ECOL LETT, V14, P797, DOI 10.1111/j.1461-0248.2011.01647.x	21	129	136	6	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2012	487	7406					227	230		10.1038/nature11214	http://dx.doi.org/10.1038/nature11214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722863				2022-12-01	WOS:000306278900038
J	Ashe, A; Sapetschnig, A; Weick, EM; Mitchell, J; Bagijn, MP; Cording, AC; Doebley, AL; Goldstein, LD; Lehrbach, NJ; Le Pen, J; Pintacuda, G; Sakaguchi, A; Sarkies, P; Ahmed, S; Miska, EA				Ashe, Alyson; Sapetschnig, Alexandra; Weick, Eva-Maria; Mitchell, Jacinth; Bagijn, Marloes P.; Cording, Amy C.; Doebley, Anna-Lisa; Goldstein, Leonard D.; Lehrbach, Nicolas J.; Le Pen, Jeremie; Pintacuda, Greta; Sakaguchi, Aisa; Sarkies, Peter; Ahmed, Shawn; Miska, Eric A.			piRNAs Can Trigger a Multigenerational Epigenetic Memory in the Germline of C. elegans	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; ARGONAUTE FAMILY; INHERITANCE; SIRNA; EXPRESSION; 21U-RNAS; REQUIREMENTS; REVEALS	Transgenerational effects have wide-ranging implications for human health, biological adaptation, and evolution; however, their mechanisms and biology remain poorly understood. Here, we demonstrate that a germline nuclear small RNA/chromatin pathway can maintain stable inheritance for many generations when triggered by a piRNA-dependent foreign RNA response in C. elegans. Using forward genetic screens and candidate approaches, we find that a core set of nuclear RNAi and chromatin factors is required for multigenerational inheritance of environmental RNAi and piRNA silencing. These include a germline-specific nuclear Argonaute HRDE1/WAGO-9, a HP1 ortholog HPL-2, and two putative histone methyltransferases, SET-25 and SET-32. piRNAs can trigger highly stable long-term silencing lasting at least 20 generations. Once established, this long-term memory becomes independent of the piRNA trigger but remains dependent on the nuclear RNAi/chromatin pathway. Our data present a multigenerational epigenetic inheritance mechanism induced by piRNAs.	[Mitchell, Jacinth; Sakaguchi, Aisa; Ahmed, Shawn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Ashe, Alyson; Sapetschnig, Alexandra; Weick, Eva-Maria; Bagijn, Marloes P.; Cording, Amy C.; Goldstein, Leonard D.; Lehrbach, Nicolas J.; Le Pen, Jeremie; Pintacuda, Greta; Sarkies, Peter; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Ashe, Alyson; Sapetschnig, Alexandra; Weick, Eva-Maria; Bagijn, Marloes P.; Cording, Amy C.; Goldstein, Leonard D.; Lehrbach, Nicolas J.; Le Pen, Jeremie; Sarkies, Peter; Miska, Eric A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Mitchell, Jacinth; Doebley, Anna-Lisa; Ahmed, Shawn] Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA; [Mitchell, Jacinth; Ahmed, Shawn] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA; [Pintacuda, Greta] Scuola Normale Super Pisa, I-56126 Pisa, Italy	University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Scuola Normale Superiore di Pisa	Ahmed, S (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA.	shawn@med.unc.edu; eric.miska@gurdon.cam.ac.uk		Weick, Eva-Maria/0000-0002-3504-2572; Sarkies, Peter/0000-0003-0279-6199; Miska, Eric/0000-0002-4450-576X; Lehrbach, Nicolas/0000-0001-7342-4136; Pintacuda, Greta/0000-0001-5126-2279; Le Pen, Jeremie/0000-0001-7025-9526; Doebley, Anna-Lisa/0000-0002-3371-3352	Cancer Research UK; Wellcome Trust; ERC; NIH [GM083048]; Cancer Research UK [11832] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083048, T32GM007092] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sylviane Moss for excellent laboratory management and help with genetic crosses and high-throughput sequencing. We thank Craig Mello and Scott Kennedy for sharing unpublished information. We thank Andrew Bannister and Anne Ferguson-Smith for helpful comments on the manuscript. This work was supported by Cancer Research UK, the Wellcome Trust, and an ERC Starting Grant to E.A.M. and by NIH grant GM083048 to S.A.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Bagijn M.P., 2012, SCIENCE; Bateson W, 1919, NATURE, V103, P344, DOI 10.1038/103344b0; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRENNER S, 1974, GENETICS, V77, P71; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chandler VL, 2010, SCIENCE, V330, P628, DOI 10.1126/science.1191044; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haig D, 2007, BIOL PHILOS, V22, P415, DOI 10.1007/s10539-006-9033-y; Han W, 2008, GENETICS, V178, P1875, DOI 10.1534/genetics.107.085472; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hynes MJ, 2003, BIOESSAYS, V25, P99, DOI 10.1002/bies.10241; Johnson CL, 2011, SCIENCE, V333, P1311, DOI 10.1126/science.1208178; Jose AM, 2011, NAT STRUCT MOL BIOL, V18, P1183, DOI 10.1038/nsmb.2134; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee JT, 2005, CURR BIOL, V15, pR249, DOI 10.1016/j.cub.2005.03.024; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mello C, 1995, METHOD CELL BIOL, V48, P451; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stam M, 2005, TRENDS PLANT SCI, V10, P283, DOI 10.1016/j.tplants.2005.04.009; Suter CM, 2010, TRENDS GENET, V26, P9, DOI 10.1016/j.tig.2009.11.003; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Varmuza S, 2003, GENOME, V46, P963, DOI 10.1139/G03-115; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; WEISMANN A, 1891, ESSAYS HEREDITY; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang C, 2012, CURR BIOL, V22, P881, DOI 10.1016/j.cub.2012.04.011	61	469	482	3	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					88	99		10.1016/j.cell.2012.06.018	http://dx.doi.org/10.1016/j.cell.2012.06.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22738725	hybrid, Green Submitted, Green Published			2022-12-01	WOS:000306115000009
J	Morens, DM; Subbarao, K; Taubenberger, JK				Morens, David M.; Subbarao, Kanta; Taubenberger, Jeffery K.			Engineering H5N1 avian influenza viruses to study human adaptation	NATURE			English	Article							A VIRUSES; RECEPTOR SPECIFICITY; MOUSE MODEL; VIRULENCE DETERMINANTS; SWINE INFLUENZA; CLEAVAGE SITE; TRANSMISSION; HEMAGGLUTININ; FERRETS; REPLICATION	Two studies of H5N1 avian influenza viruses that had been genetically engineered to render them transmissible between ferrets have proved highly controversial. Divergent opinions exist about the importance of these studies of influenza transmission and about potential 'dual use' research implications. No consensus has developed yet about how to balance these concerns. After not recommending immediate full publication of earlier, less complete versions of the studies, the United States National Science Advisory Board for Biosecurity subsequently recommended full publication of more complete manuscripts; however, controversy about this and similar research remains.	[Morens, David M.; Subbarao, Kanta; Taubenberger, Jeffery K.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	dm270q@nih.gov	Taubenberger, Jeffery/AAQ-1407-2021	Subbarao, Kanta/0000-0003-1713-3056	National Institutes of Health; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000933, ZIAAI000986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health and the National Institute of Allergy and Infectious Diseases. The authors declare no competing financial interests. We thank L. Qi for translation and discussion of a Chinese language publication.	Aditama TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029971; Aditama TY, 2011, CLIN INFECT DIS, V53, P1237, DOI 10.1093/cid/cir740; BEARE AS, 1991, ARCH VIROL, V119, P37, DOI 10.1007/BF01314321; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bogs J, 2011, J VIROL, V85, P10691, DOI 10.1128/JVI.00786-11; Bogs J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011826; Brady RC, 2009, VACCINE, V27, P5091, DOI 10.1016/j.vaccine.2009.06.057; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Brown T., 2012, H5N1 RES DISCUSSED S; Chen GL, 2010, J VIROL, V84, P7695, DOI 10.1128/JVI.00511-10; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chen YX, 2009, ARCH VIROL, V154, P227, DOI 10.1007/s00705-008-0277-5; Chosewood L. C., 2009, BIOSAFETY MICROBIOLO; Doherty PC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-10; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fouchier R, 2012, NATURE, V481, P257, DOI 10.1038/481257a; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Gohrbandt S, 2011, J GEN VIROL, V92, P51, DOI 10.1099/vir.0.023887-0; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S., 2012, SCIENCE         0622; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Horby P, 2010, EPIDEMIOL INFECT, V138, P1550, DOI 10.1017/S0950268810000518; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kawaoka Y., 2012, ROYAL SOC M H5N1 RES; Kawaoka Y, 2012, NATURE, V482, P155, DOI 10.1038/nature10884; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; MacKenzie D, 2011, NEW SCI; Mackenzie D, 2012, NEW SCI; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0; MASUREL N, 1973, AM J EPIDEMIOL, V97, P44, DOI 10.1093/oxfordjournals.aje.a121483; Memoli MJ, 2011, J INFECT DIS, V203, P348, DOI 10.1093/infdis/jiq067; Mernoli MJ, 2009, VIROLOGY, V393, P338, DOI 10.1016/j.virol.2009.08.021; Morens DM, 2011, REV MED VIROL, V21, P262, DOI 10.1002/rmv.689; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Morens DM, 2010, INFLUENZA OTHER RESP, V4, P327, DOI 10.1111/j.1750-2659.2010.00148.x; Morens DM, 2010, CRIT CARE MED, V38, pE10, DOI 10.1097/CCM.0b013e3181ceb25b; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; National Research Council, 2007, SCI SEC POST 9 11 WO, P57; NSABB, 2012, NAT SCI ADV BOARD BI; Osterholm M. T., 2012, DISCUSSION NSABBS PU; Osterholm MT, 2012, MBIO, V3, DOI 10.1128/mBio.00045-12; Palese P, 2012, P NATL ACAD SCI USA, V109, P2211, DOI 10.1073/pnas.1121297109; Palese P, 2012, NATURE, V481, P115, DOI 10.1038/481115a; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Roos R., 2012, NO SIGN MISSED H5N1; Rudneva IA, 2010, VIRAL IMMUNOL, V23, P181, DOI 10.1089/vim.2009.0086; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Song HC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-126; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Spesock A, 2011, J VIROL, V85, P7048, DOI 10.1128/JVI.00417-11; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suguitan AL, 2012, J VIROL, V86, P2706, DOI 10.1128/JVI.05546-11; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Taubenberger JK, 2011, VIRUS RES, V162, P2, DOI 10.1016/j.virusres.2011.09.003; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Trammell RA, 2008, EXPERT REV MOL DIAGN, V8, P515, DOI 10.1586/14737159.8.4.515; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Webster RG, 2012, MBIO, V3, DOI 10.1128/mBio.00005-12; WHO, 2012, REP TECHN CONS H5N1; *WHO, 2006, WHO CAS DEF HUM INF; WHO, 2012, CUM NUMB CONF HUM CA; WHO, 2012, PUBL HLTH INFL EXP A; WILSON HE, 1947, J EXP MED, V85, P199, DOI 10.1084/jem.85.2.199; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yamanaka T, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-25; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106; Zhang L, 2009, INFECT GENET EVOL, V9, P1148, DOI 10.1016/j.meegid.2009.07.006; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	101	43	45	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					335	340		10.1038/nature11170	http://dx.doi.org/10.1038/nature11170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722191	Green Published, Green Accepted			2022-12-01	WOS:000305466800031
J	Kahan, D				Kahan, Dan			Why we are poles apart on climate change	NATURE			English	Editorial Material									Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Kahan, D (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.	dmkahan@gmail.com						Goebbert K, 2012, WEATHER CLIM SOC, V4, P132, DOI 10.1175/WCAS-D-11-00044.1; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246	3	110	110	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					255	255		10.1038/488255a	http://dx.doi.org/10.1038/488255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OS	22895298	Bronze			2022-12-01	WOS:000307501000003
J	Killen, J; Harrington, M; Fauci, AS				Killen, Jack; Harrington, Mark; Fauci, Anthony S.			MSM, AIDS research activism, and HAART	LANCET			English	Editorial Material									[Killen, Jack] NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA; [Harrington, Mark] Treatment Act Grp, New York, NY USA; [Fauci, Anthony S.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Killen, J (corresponding author), NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA.	jack.killen@nih.gov						Ad-hoc coalition of AIDS and health organisations, 1990, HIV AIDS BIOM RES PR; [Anonymous], 1981, MMWR-MORBID MORTAL W, V30, P1; *CDCP, 1981, MMWR-MORBID MORTAL W, V30, P305; DELANEY M, 1989, J INFECT DIS, V159, P416, DOI 10.1093/infdis/159.3.416; Epstein S., 1996, IMPURE SCI; Food and Drug Administration, EXP ACC EXP APPR NEW; Geffen Nathan., 2010, DEBUNKING DELUSIONS; Goldberg R, C CALL PWAS SAT HIGH; Jennings V, 1990, WASH POST, pB1; Killen John Y., 2008, OXFORD TXB CLIN RES, P97; Nunn A., 2009, POLITICS HIST AIDS T; WACHTER RM, 1992, NEW ENGL J MED, V326, P128, DOI 10.1056/NEJM199201093260209	12	11	11	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2012	380	9839					314	316		10.1016/S0140-6736(12)60635-7	http://dx.doi.org/10.1016/S0140-6736(12)60635-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	979TN	22819655				2022-12-01	WOS:000306842800007
J	Leslie, T; Mikhail, A; Mayan, I; Anwar, M; Bakhtash, S; Nader, M; Chandler, C; Whitty, CJM; Rowland, M				Leslie, Toby; Mikhail, Amy; Mayan, Ismail; Anwar, Mohammed; Bakhtash, Sayed; Nader, Mohammed; Chandler, Clare; Whitty, Christopher J. M.; Rowland, Mark			Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study	BRITISH MEDICAL JOURNAL			English	Article							RAPID DIAGNOSTIC-TESTS; PLASMODIUM-VIVAX; CHILDREN; TANZANIA; AREA; TRANSMISSION; MISDIAGNOSIS; CHALLENGES; MICROSCOPY; MANAGEMENT	Objective To assess the accuracy of malaria diagnosis and treatment at primary level clinics in Afghanistan. Design Prospective observational study. Setting 22 clinics in two Afghan provinces, one in the north (adjoining Tajikistan) and one in the east (adjoining Pakistan); areas with seasonal transmission of Plasmodium vivax and Plasmodium falciparum. Participants 2357 patients of all ages enrolled if clinicians suspected malaria. Interventions Established (>5 years) microscopy (12 clinics in east Afghanistan), newly established microscopy (five clinics in north Afghanistan), and no laboratory (five clinics in north Afghanistan). All clinics used the national malaria treatment guidelines. Main outcome measures Proportion of patients positive and negative for malaria who received a malaria drug; sensitivity and specificity of clinic based diagnosis; prescriber's response to the result of the clinic slide; and proportion of patients positive and negative for malaria who were prescribed antibiotics. Outcomes were measured against a double read reference blood slide. Results In health centres using clinical diagnosis, although 413 of 414 patients were negative by the reference slide, 412 (99%) received a malaria drug and 47 (11%) received an antibiotic. In clinics using new microscopy, 37% (75/202) of patients who were negative by the reference slide received a malaria drug and 60% (103/202) received an antibiotic. In clinics using established microscopy, 50.8% (645/1269) of patients who were negative by the reference slide received a malaria drug and 27.0% (342/1269) received an antibiotic. Among the patients who tested positive for malaria, 94% (443/472) correctly received a malaria drug but only 1 of 6 cases of falciparum malaria was detected and appropriately treated. The specificity of established and new microscopy was 72.9% and 79.9%, respectively. In response to negative clinic slide results, malaria drugs were prescribed to 270/905 (28.8%) and 32/154 (21%) and antibiotics to 347/930 (37.3%) and 99/154 (64%) patients in established and new microscopy arms, respectively. Nurses were less likely to misprescribe than doctors. Conclusions Despite a much lower incidence of malaria in Afghanistan than in Africa, fever was substantially misdiagnosed as malaria in this south Asian setting. Inaccuracy was attributable to false positive laboratory diagnoses of malaria and the clinicians' disregard of negative slide results. Rare but potentially fatal cases of falciparum malaria were not detected, emphasising the potential role of rapid diagnostic tests. Microscopy increased the proportion of patients treated with antibiotics producing a trade-off between overtreatment with malaria drugs and probable overtreatment with antibiotics.	[Leslie, Toby; Mikhail, Amy; Chandler, Clare; Whitty, Christopher J. M.; Rowland, Mark] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Leslie, Toby; Mikhail, Amy; Mayan, Ismail] Hlth Protect & Res Org, Kabul, Afghanistan; [Anwar, Mohammed; Nader, Mohammed] HealthNet TPO, Karte Se, Kabul, Afghanistan; [Bakhtash, Sayed] Med Emergency Relief Int, Kabul, Afghanistan	University of London; London School of Hygiene & Tropical Medicine	Leslie, T (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	toby.leslie@lshtm.ac.uk	nader, mohammed/AAH-3475-2021	nader, mohammed/0000-0002-9994-9077; Whitty, Christopher/0000-0002-6076-5027; Mikhail, Amy Frances Wahid/0000-0003-3414-2173; Chandler, Clare/0000-0001-6499-7522	Bill and Melinda Gates Foundation as part of the ACT Consortium; London School of Hygiene and Tropical Medicine	Bill and Melinda Gates Foundation as part of the ACT Consortium; London School of Hygiene and Tropical Medicine	The study was funded by a grant from the Bill and Melinda Gates Foundation as part of the ACT Consortium (www.actconsortium.org) and sponsored by the London School of Hygiene and Tropical Medicine. Neither the funder nor sponsor had any role in the design or conduct of the study, analysis or interpretation of the data, or in the decision to publish.	A-Elgayoum SME, 2009, DIAGN MICR INFEC DIS, V64, P20, DOI 10.1016/j.diagmicrobio.2009.01.029; Acerra JR, 2009, INT J EMERG MED, V2, P77, DOI 10.1007/s12245-009-0106-y; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Ashton RA, MALAR J, V9, P297; Bailey MS, 2011, J ROY ARMY MED CORPS, V157, P150, DOI 10.1136/jramc-157-02-05; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Bisoffi Z, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000063; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Chandler CI, MALAR J, V9, P95; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hay SI, PLOS MED, V7; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Kolaczinski J, 2005, LANCET, V365, P1506, DOI 10.1016/S0140-6736(05)66423-9; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Nadjm B, BMJ             0617, V340, pc1350; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Peters DH, 2007, B WORLD HEALTH ORGAN, V85, P146, DOI 10.2471/BLT.06.033746; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Wallace MR, 2002, CLIN INFECT DIS, V34, pS171, DOI 10.1086/340704; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; WHO, 2010, GUID TREATM MAL; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization (WHO), 2010, GUID TREATM MAL; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	37	47	49	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 24	2012	345								e4389	10.1136/bmj.e4389	http://dx.doi.org/10.1136/bmj.e4389			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UQ	22833603	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-01	WOS:000306996900001
J	Sare, J				Sare, Jeremy			Tensions between drug use policies and infection control	BRITISH MEDICAL JOURNAL			English	Editorial Material												jeremysare@btinternet.com						Cseste J, 2012, INT J DRUG POLICY, V23, P82; Glaister Dan, 2009, GUARDIAN; Global Commission on Drug Policy, 2012, WAR DRUGS HIV AIDS C; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Inter-Ministerial Group on Drugs, 2012, PUTT FULL REC 1; Mozynski P, 2012, BMJ             0617, V344; United Nations Office on Drugs and Crime, WORLD DRUG REP 2012	7	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 23	2012	345								e4930	10.1136/bmj.e4930	http://dx.doi.org/10.1136/bmj.e4930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UP	22826579				2022-12-01	WOS:000306996800010
J	O'Halloran, T; Bell, RJ; Robinson, PJ; Davis, SR				O'Halloran, Tessa; Bell, Robin J.; Robinson, Penelope J.; Davis, Susan R.			Urinary Incontinence in Young Nulligravid Women A Cross-sectional Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; SEEKING BEHAVIOR; PREVALENCE; QUESTIONNAIRE; COHORT; RISK; AGE	Background: Although pregnancy is a risk factor for urinary incontinence (UI), the extent of UI in nulligravid women has not been reported. Objective: To investigate the rate of UI in a sample of young nulligravid women and its potential risk factors and effect on quality of life. Design: Cross-sectional, self-administered questionnaire-based study. Setting: University campuses and medical and allied health clinics. Participants: Nulligravid Australian women aged 16 to 30 years. Measurements: The Questionnaire for Urinary Incontinence Diagnosis, the Psychological General Well-Being Index (PGWBI), the King's Health Questionnaire, and the International Physical Activity Questionnaire-Short Form. Demographic variables and potential risk factors were also documented. Results: 1018 of 1620 questionnaires (63%) were returned, and 1002 provided analyzable data. The mean age of participants was 22.5 years (SD, 3.2). The rate of any UI was 12.6% (95% CI, 10.5% to 14.7%). Incontinence was slightly more common in students than in nonstudents (13.2% [CI, 11.0% to 15.8%] vs. 10.6% [CI, 6.7% to 14.6%]). Rates of UI varied according to sexual activity and use of combined oral contraceptives (COCs), with highest rates reported by students who were ever sexually active and not using COCs (21.5% [CI, 16.7% to 27.3%]). Women with UI reported significantly lower overall well-being than women without UI and had worse PGWBI scores related to anxiety, depression, positive well-being, and self-control. Limitation: A convenience sample of healthy, well-educated women was recruited, and response rates and participant characteristics varied by setting. Conclusion: In a sample of young nulligravid women, UI was associated with ever being sexually active and no COC use, as well as lower psychological well-being. Further research is needed to assess the prevalence and risk factors for UI in nulligravid women.	[O'Halloran, Tessa; Bell, Robin J.; Robinson, Penelope J.; Davis, Susan R.] Monash Univ, Sch Publ Hlth, Womens Hlth Res Program, Melbourne, Vic 3004, Australia	Monash University	Davis, SR (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	susan.davis@monash.edu	Davis, Susan R/A-3111-2009; Davis, Susan D/GZL-2361-2022; Bell, Robin J/H-6750-2014	Davis, Susan R/0000-0002-2955-0415; Bell, Robin J/0000-0003-1935-7627	Australian National Health and Medical Research Council [490939]; Victorian Cancer Agency Public Health Research Fellowship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency Public Health Research Fellowship	By grant 490939 from the Australian National Health and Medical Research Council (Dr. Davis) and a Victorian Cancer Agency Public Health Research Fellowship (Dr. Bell).	Bell RJ, 2010, SUPPORT CARE CANCER, V18, P921, DOI 10.1007/s00520-009-0726-z; Booth M, 2000, RES Q EXERCISE SPORT, V71, pS114; Botlero R, 2008, INT J UROL, V15, P230, DOI 10.1111/j.1442-2042.2007.01976.x; Botlero R, 2010, MENOPAUSE, V17, P332, DOI 10.1097/gme.0b013e3181ba571a; Botlero R, 2009, MATURITAS, V62, P134, DOI 10.1016/j.maturitas.2008.12.017; Bradley CS, 2005, AM J OBSTET GYNECOL, V192, P66, DOI 10.1016/j.ajog.2004.07.037; Brown SJ, 2010, INT UROGYNECOL J, V21, P193, DOI 10.1007/s00192-009-1011-x; Brown WJ, 2001, J SCI MED SPORT, V4, P373, DOI 10.1016/S1440-2440(01)80046-3; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dupuy H.J., 1984, ASSESSMENT QUALITY L, P170; Hagglund D, 1999, FAM PRACT, V16, P506, DOI 10.1093/fampra/16.5.506; Hagglund D, 2007, J CLIN NURS, V16, P1946, DOI 10.1111/j.1365-2702.2007.01787.x; Hagglund D, 2007, SCAND J CARING SCI, V21, P305, DOI 10.1111/j.1471-6712.2007.00481.x; Iliadou A, 2009, FERTIL STERIL, V92, P428, DOI 10.1016/j.fertnstert.2008.07.002; Kelleher CJ, 1997, BRIT J OBSTET GYNAEC, V104, P1374, DOI 10.1111/j.1471-0528.1997.tb11006.x; MacLennan AH, 2000, BRIT J OBSTET GYNAEC, V107, P1460, DOI 10.1111/j.1471-0528.2000.tb11669.x; NEMIR A, 1954, AM J OBSTET GYNECOL, V68, P1166; NYGAARD IE, 1994, OBSTET GYNECOL, V84, P183; Shaw C, 2001, J CLIN NURS, V10, P15, DOI 10.1046/j.1365-2702.2001.00443.x; Siracusano S, 2003, EUR J OBSTET GYN R B, V107, P201, DOI 10.1016/S0301-2115(02)00407-4; Townsend MK, 2009, J UROLOGY, V181, P2170, DOI 10.1016/j.juro.2009.01.040; WOLIN LH, 1969, J UROLOGY, V101, P545, DOI 10.1016/S0022-5347(17)62378-4	22	35	35	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 17	2012	157	2					87	+		10.7326/0003-4819-157-2-201207170-00005	http://dx.doi.org/10.7326/0003-4819-157-2-201207170-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992ON	22801671				2022-12-01	WOS:000307787900014
J	Lee, HC; Gu, WF; Shirayama, M; Youngman, E; Conte, D; Mello, CC				Lee, Heng-Chi; Gu, Weifeng; Shirayama, Masaki; Youngman, Elaine; Conte, Darryl, Jr.; Mello, Craig C.			C. elegans piRNAs Mediate the Genome-wide Surveillance of Germline Transcripts	CELL			English	Article							SMALL RNAS; EPIGENETIC MEMORY; ARGONAUTE FAMILY; PIWI; SIRNA; RECOGNITION; BIOGENESIS; MICRORNAS; 21U-RNAS; REVEALS	Piwi Argonautes and Piwi-interacting RNAs (piRNAs) mediate genome defense by targeting transposons. However, many piRNA species lack obvious sequence complementarity to transposons or other loci; only one C. elegans transposon is a known piRNA target. Here, we show that, in mutants lacking the Piwi Argonaute PRG-1 (and consequently its associated piRNAs/21U-RNAs), many silent loci in the germline exhibit increased levels of mRNA expression with a concomitant depletion of RNA-dependent RNA polymerase (RdRP)-derived secondary small RNAs termed 22G-RNAs. Sequences depleted of 22G-RNAs are proximal to potential target sites that base pair imperfectly but extensively to 21U-RNAs. We show that PRG-1 is required to initiate, but not to maintain, silencing of transgenes engineered to contain complementarity to endogenous 21U-RNAs. Our findings support a model in which C. elegans piRNAs utilize their enormous repertoire of targeting capacity to scan the germline transcriptome for foreign sequences, while endogenous germline-expressed genes are actively protected from piRNA-induced silencing.	[Lee, Heng-Chi; Gu, Weifeng; Shirayama, Masaki; Youngman, Elaine; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Shirayama, Masaki; Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Youngman, Elaine/O-7449-2019	Lee, Heng-Chi/0000-0001-8154-906X	Ruth L. Kirschstein National Research Service Award [GM099372]; NIH [GM058800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800, R37GM058800, F32GM099372] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Miska for sharing unpublished results and G. Seydoux for providing the multisite gateway system. H.-C.L. is supported by a Ruth L. Kirschstein National Research Service Award (GM099372). C.C.M. is a Howard Hughes Medical Institute Investigator. This work is supported by NIH grant GM058800 to C.C.M.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BRENNER S, 1974, GENETICS, V77, P71; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Conine CC, 2010, P NATL ACAD SCI USA, V107, P3588, DOI 10.1073/pnas.0911685107; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Klobutcher LA, 1991, CURR OPIN GENET DEV, V1, P397, DOI 10.1016/S0959-437X(05)80306-5; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	36	254	264	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					78	87		10.1016/j.cell.2012.06.016	http://dx.doi.org/10.1016/j.cell.2012.06.016			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22738724	Green Accepted, Bronze			2022-12-01	WOS:000306115000008
J	Zhang, J; Xie, FL; Delzell, E; Chen, L; Winthrop, KL; Lewis, JD; Saag, KG; Baddley, JW; Curtis, JR				Zhang, Jie; Xie, Fenglong; Delzell, Elizabeth; Chen, Lang; Winthrop, Kevin L.; Lewis, James D.; Saag, Kenneth G.; Baddley, John W.; Curtis, Jeffrey R.			Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RHEUMATOID-ARTHRITIS; UNITED-STATES; VARICELLA; RECOMMENDATIONS; CHILDREN; SAFETY; RATES	Context Based on limited data, the live attenuated herpes zoster (HZ) vaccine is contraindicated in patients taking anti-tumor necrosis factor (anti-TNF) therapies or other biologics commonly used to treat immune-mediated diseases. The safety and effectiveness of the vaccine are unclear for these patients. Objective To examine the association between HZ vaccination and HZ incidence within and beyond 42 days after vaccination in patients with selected immune-mediated diseases and in relation to biologics and other therapies used to treat these conditions. Design, Setting, and Patients Retrospective cohort study of 463 541 Medicare beneficiaries 60 years and older with rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis, or inflammatory bowel disease using Medicare claims data from January 1, 2006, through December 31, 2009. Main Outcome Measures Herpes zoster incidence rate within 42 days after vaccination (a safety concern) and beyond 42 days; hazard ratios estimated using Cox proportional hazards models for HZ comparing vaccinated vs unvaccinated patients. Results Median duration of follow-up was 2.0 years (interquartile range, 0.8-3.0); 4.0% of patients received HZ vaccine. The overall crude HZ incidence rate was 7.8 cases per 1000 person-years (95% CI, 3.7-16.5) within 42 days after vaccination. The rate among the unvaccinated was 11.6 cases per 1000 person-years (95% CI, 11.4-11.9). Among 633 patients exposed to biologics at the time of vaccination or within the subsequent 42 days, no case of HZ or varicella occurred. After multivariable adjustment, HZ vaccination was associated with a hazard ratio of 0.61 (95% CI, 0.52-0.71) for HZ risk after 42 days. Conclusions Receipt of HZ vaccine was not associated with a short-term increase in HZ incidence among Medicare beneficiaries with selected immune-mediated diseases, including those exposed to biologics. The vaccine was associated with a lower HZ incidence over a median of 2 years of follow-up. JAMA. 2012; 308(1):43-49 www.jama.com	[Zhang, Jie; Delzell, Elizabeth; Curtis, Jeffrey R.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Xie, Fenglong; Chen, Lang; Saag, Kenneth G.; Curtis, Jeffrey R.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Baddley, John W.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Dept Med, Div Infect Dis, Portland, OR 97201 USA; [Lewis, James D.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Baddley, John W.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Curtis, JR (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, FOT 805D,510 20th St S, Birmingham, AL 35294 USA.	jcurtis@uab.edu			Amgen; Pfizer; UCB; Abbott; Centocor; Takeda; Shire; Merck; Genentech/Roche; BMS; Agency for Healthcare Research and Quality (AHRQ) [R01 HS018517, T32HS013852]; National Institutes of Health [AR 053351]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018517, T32HS013852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR053351] Funding Source: NIH RePORTER	Amgen(Amgen); Pfizer(Pfizer); UCB(UCB Pharma SA); Abbott(Abbott Laboratories); Centocor; Takeda(Takeda Pharmaceutical Company Ltd); Shire; Merck(Merck & Company); Genentech/Roche(Roche HoldingGenentech); BMS(Bristol-Myers Squibb); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr Zhang reported having received research support from Amgen. Dr Delzell reported having received research support from Amgen. Dr Winthrop reported having received consulting fees from Pfizer, Amgen, UCB, and Abbott and grants from Pfizer. Dr Lewis reported having received research grants from Centocor, Takeda, and Shire and having served as a consultant for Amgen, Abbott, Pfizer, and Millennium Pharmaceuticals. Dr Saag is the chair of the American College of Rheumatology Quality of Care Committee and reported having received consulting fees from Merck. Dr Baddley reported having received consulting fees from Abbott and Merck. Dr Curtis reported having received research grants and consulting fees from Amgen, UCB, Abbott, Genentech/Roche, Centocor, BMS, and Merck. No other disclosures were reported.; This project was supported by the Agency for Healthcare Research and Quality (AHRQ) (R01 HS018517). Dr Zhang received support from the AHRQ (T32HS013852), and Dr Curtis received support from the National Institutes of Health (AR 053351).	Baker CJ, 2011, ANN INTERN MED, V154, P168, DOI 10.7326/0003-4819-154-3-201102010-00006; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Gershon AA, 2009, PEDIATR INFECT DIS J, V28, P653, DOI 10.1097/INF.0b013e3181998f06; Gupta G, 2006, CLIN GASTROENTEROL H, V4, P1483, DOI 10.1016/j.cgh.2006.09.019; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Insinga RP, 2005, J GEN INTERN MED, V20, P748, DOI 10.1111/j.1525-1497.2005.0150.x; Kilgore Paul E., 2003, Journal of Medical Virology, V70, pS111, DOI 10.1002/jmv.10364; Marehbian J, 2009, AM J GASTROENTEROL, V104, P2524, DOI 10.1038/ajg.2009.322; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; Mueller NH, 2008, NEUROL CLIN, V26, P675, DOI 10.1016/j.ncl.2008.03.011; Nelson KE, 2004, INFECT DIS EPIDEMIOL; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Scheinberg M, 2010, ARTHRIT CARE RES, V62, P896, DOI 10.1002/acr.20045; Schmader KE, 2012, CLIN INFECT DIS, V54, P922, DOI 10.1093/cid/cir970; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Son M, 2010, J INFECT DIS, V201, P1806, DOI 10.1086/652798; Strangfeld A, 2009, JAMA-J AM MED ASSOC, V301, P737, DOI 10.1001/jama.2009.146; Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983; Wolfe F, 2006, RHEUMATOLOGY, V45, P1370, DOI 10.1093/rheumatology/kel328; Yawn BP, 2011, AM J EPIDEMIOL, V174, P1054, DOI 10.1093/aje/kwr206; Zhang J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3497	23	201	208	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2012	308	1					43	49		10.1001/jama.2012.7304	http://dx.doi.org/10.1001/jama.2012.7304			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971DD	22760290	Green Accepted, Bronze			2022-12-01	WOS:000306183000022
J	Saito, D; Takase, Y; Murai, H; Takahashi, Y				Saito, Daisuke; Takase, Yuta; Murai, Hidetaka; Takahashi, Yoshiko			The Dorsal Aorta Initiates a Molecular Cascade That Instructs Sympatho-Adrenal Specification	SCIENCE			English	Article							NEURAL CREST; SYMPATHETIC NEURONS; CHROMAFFIN CELLS; IN-VIVO; DIFFERENTIATION; GLUCOCORTICOIDS; RECEPTORS; PERSPECTIVES; GENERATION; MIGRATION	The autonomic nervous system, which includes the sympathetic neurons and adrenal medulla, originates from the neural crest. Combining avian blood vessel-specific gene manipulation and mouse genetics, we addressed a long-standing question of how neural crest cells (NCCs) generate sympathetic and medullary lineages during embryogenesis. We found that the dorsal aorta acts as a morphogenetic signaling center that coordinates NCC migration and cell lineage segregation. Bone morphogenetic proteins (BMPs) produced by the dorsal aorta are critical for the production of the chemokine stromal cell-derived factor-1 (SDF 1) and Neuregulin 1 in the para-aortic region, which act as chemoattractants for early migration. Later, BMP signaling is directly involved in the sympatho-medullary segregation. This study provides insights into the complex developmental signaling cascade that instructs one of the earliest events of neurovascular interactions guiding embryonic development.	[Saito, Daisuke; Takase, Yuta; Murai, Hidetaka; Takahashi, Yoshiko] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan; [Saito, Daisuke; Takahashi, Yoshiko] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Takase, Yuta; Murai, Hidetaka; Takahashi, Yoshiko] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Kyoto University	Takahashi, Y (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	yotayota@develop.zool.kyoto-u.ac.jp	Saito, Daisuke/AAL-8492-2021	Saito, Daisuke/0000-0002-5999-2505	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Global Centers of Excellence (GCOE) program (Frontier Biosciences, Nara Institute of Science and Technology) from MEXT, Japan; CREST (JST); Mitsubishi Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centers of Excellence (GCOE) program (Frontier Biosciences, Nara Institute of Science and Technology) from MEXT, Japan; CREST (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank S. F. Gilbert, L. Niswander, G. Corfas, S. O. Yoon, and Y. Wakamatsu for experimental materials and discussions and K. Morohashi for providing us with Sf1 KO mice. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, and Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Global Centers of Excellence (GCOE) program (Frontier Biosciences, Nara Institute of Science and Technology) from MEXT, Japan; CREST (JST); The Mitsubishi Foundation; and Takeda Science Foundation. Y. Takase is a fellow of the Japan Society for the Promotion of Science.	ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; ANDERSON DJ, 1993, ANNU REV NEUROSCI, V16, P129, DOI 10.1146/annurev.ne.16.030193.001021; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; DOUPE AJ, 1985, J NEUROSCI, V5, P2119; Gut P, 2005, DEVELOPMENT, V132, P4611, DOI 10.1242/dev.02052; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Huber K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-28; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Kim JY, 2003, J NEUROSCI, V23, P5561; Langley K, 1999, CELL TISSUE RES, V298, P185, DOI 10.1007/PL00008810; Le Douarin N.M., 1999, NEURAL CREST; LEDOUARIN N, 1971, CR ACAD SCI D NAT, V272, P481; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Ohata E, 2009, DEV BIOL, V335, P33, DOI 10.1016/j.ydbio.2009.08.010; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; TEILLET MA, 1974, ARCH ANAT MICROSC MO, V63, P51; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Yokota Y, 2011, DEV BIOL, V353, P382, DOI 10.1016/j.ydbio.2011.02.001; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	30	97	98	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1578	1581		10.1126/science.1222369	http://dx.doi.org/10.1126/science.1222369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723422				2022-12-01	WOS:000305507500057
J	Gewin, V				Gewin, Virginia			THE SEQUENCING MACHINE	NATURE			English	News Item							HUMAN MICROBIOME; GUT MICROBIOME; BODY HABITATS; COMMUNITIES											Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; KNIGHT RD, 2001, GENOME BIOL, V2; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yatsunenko T, 2012, NATURE	13	10	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					156	158		10.1038/487156a	http://dx.doi.org/10.1038/487156a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22816112	Bronze			2022-12-01	WOS:000306278900011
